{"meta":{"query_hash":"432dfe733d98","filters":{"venue":"British Journal of Cancer"},"cohort_total":856,"direct_labels_cover":2,"predictions_cover":856,"exported":856,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/432dfe733d98","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Cancer"},"results":[{"id":"W107843614","doi":"10.1054/bjoc.2001.1944","title":"A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"CDKN2A; Haplotype; Mutation; Founder effect; Genetics; Biology; Cancer; Genotype; Gene","score_opus":0.009766246735765715,"score_gpt":0.27076031012066176,"score_spread":0.26099406338489606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W107843614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866293,0.010785691,0.001530294,0.0005121013,0.00021439996,0.00015802056,0.00005719263,0.0000013330753,0.00011167913],"genre_scores_gemma":[0.97597575,0.022381298,0.0002924182,0.0006502336,0.00054230256,0.00003445657,0.000018086264,0.00001546908,0.000089984846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936825,0.000021643427,0.00025084318,0.00010279616,0.00009972446,0.00015674063],"domain_scores_gemma":[0.99947214,0.000052413518,0.00020731443,0.00008649216,0.00013903626,0.0000425848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013474992,0.00007279153,0.00015062315,0.000029888737,0.0000634635,0.00004810816,0.00014538245,0.00002961428,0.000008314405],"category_scores_gemma":[0.000064083615,0.00006980702,0.00008217004,0.000099471516,0.00007698917,0.000005642896,0.000025547904,0.00009041304,3.6430092e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005637441,0.000098073455,0.120370105,0.000018217916,0.00017089398,0.000120904915,0.00017689896,0.0071776942,0.0023938473,0.000014426193,0.0060648015,0.8628304],"study_design_scores_gemma":[0.0022267697,0.0006521981,0.7371772,0.0000774233,0.000086263746,0.00091940496,0.0006039451,0.00030115512,0.0017316326,0.00020059812,0.255777,0.0002464377],"about_ca_topic_score_codex":0.002436227,"about_ca_topic_score_gemma":0.123665,"teacher_disagreement_score":0.86258394,"about_ca_system_score_codex":0.000053343338,"about_ca_system_score_gemma":0.00014844089,"threshold_uncertainty_score":0.8923258},"labels":[],"label_agreement":null},{"id":"W112815597","doi":"10.1038/bjc.2012.120","title":"Occupational cancer in Britain","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Pathology; Internal medicine","score_opus":0.014418180716164467,"score_gpt":0.31901465409880925,"score_spread":0.3045964733826448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W112815597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520795,0.046555944,0.000011115659,0.00040899817,0.00028695667,0.0000585574,0.00007201794,0.0000029353769,0.0005239936],"genre_scores_gemma":[0.9943778,0.0034353812,0.00016942303,0.00067597884,0.0008961194,0.000010744875,0.0000057914785,0.00000901252,0.00041973274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923515,0.000017661065,0.00023753298,0.000051256553,0.0003036197,0.00015479297],"domain_scores_gemma":[0.99964285,0.000018561397,0.00009892795,0.000030317184,0.000049087837,0.00016027258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011938243,0.000053124706,0.00014561534,0.000054085194,0.00002337387,0.000009570992,0.000037770318,0.000030189725,0.002508599],"category_scores_gemma":[0.000031935906,0.000055538952,0.000075356984,0.000079334124,0.000036248868,0.00021997461,0.000010634041,0.00012784335,0.000008179691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023980651,0.00021595992,0.9095517,0.000022571006,0.00003565448,0.0000687631,0.000026196198,0.00009526325,0.0002960986,0.000015814257,0.0033020321,0.08613018],"study_design_scores_gemma":[0.0009662142,0.00003367657,0.9808141,0.00043012443,0.000050990067,0.00043592305,0.000027208167,0.000010569357,0.00016486988,0.000035967667,0.016970592,0.000059745806],"about_ca_topic_score_codex":0.00070454966,"about_ca_topic_score_gemma":0.00034673105,"teacher_disagreement_score":0.08607043,"about_ca_system_score_codex":0.00021261953,"about_ca_system_score_gemma":0.00016103231,"threshold_uncertainty_score":0.99840325},"labels":[],"label_agreement":null},{"id":"W1195715571","doi":"10.1038/bjc.2015.271","title":"TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Saint John Regional Hospital; McMaster University; Queen's University; University of British Columbia; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society Research Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Biomarker; Internal medicine; Taxane; Clinical trial; Oncology; Predictive value; Bioinformatics; Breast cancer; Cancer; Biology","score_opus":0.07907511513273946,"score_gpt":0.374545435195704,"score_spread":0.29547032006296453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1195715571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909389,0.0048359637,0.0013538698,0.0009168569,0.001322485,0.00034940458,0.000087464374,0.0000026183582,0.00019240593],"genre_scores_gemma":[0.99382895,0.0014235007,0.0005386584,0.0016521635,0.0020127476,0.00004925413,0.000016735992,0.00001776434,0.00046022882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985159,0.00020242453,0.00054429984,0.00020668871,0.0003129085,0.00021776425],"domain_scores_gemma":[0.9989706,0.00006880935,0.00033450004,0.0001128579,0.00041614808,0.000097079486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025916563,0.00011240271,0.00026000864,0.00003303747,0.00004740487,0.000049223298,0.00018517821,0.00016974029,0.000024772009],"category_scores_gemma":[0.00040325167,0.000096822136,0.00021432756,0.00009235794,0.00010684201,0.000010963565,0.00004163601,0.00020675935,0.0000015500425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.115878195,0.0006806091,0.026370239,0.000051229494,0.00097416004,0.00045988985,0.0007250965,0.00016268952,0.019402653,0.000011678129,0.5992503,0.23603322],"study_design_scores_gemma":[0.09460173,0.003370731,0.10531034,0.0005331557,0.00031319048,0.001466806,0.0007041119,0.00023067782,0.037047323,0.0003780761,0.75529563,0.00074824604],"about_ca_topic_score_codex":0.00008873762,"about_ca_topic_score_gemma":0.0004034232,"teacher_disagreement_score":0.23528497,"about_ca_system_score_codex":0.00004824755,"about_ca_system_score_gemma":0.00058883324,"threshold_uncertainty_score":0.3948292},"labels":[],"label_agreement":null},{"id":"W1275758655","doi":"10.1038/bjc.2015.284","title":"Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreatic cancer; Hypoxia (environmental); Stromal cell; Tumour heterogeneity; Pathology; Nitroimidazole; Medicine; Immunohistochemistry; Oncology; Internal medicine; Cancer; Biology; Chemistry; Oxygen","score_opus":0.012143342267712314,"score_gpt":0.26138549190006943,"score_spread":0.2492421496323571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1275758655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557639,0.04335502,0.000014778423,0.00009089312,0.00054829766,0.000104380386,0.00007077116,7.618943e-7,0.000051235857],"genre_scores_gemma":[0.9893187,0.010187031,0.000028751454,0.00012950895,0.00027672938,0.000011348347,0.0000030343024,0.0000117463,0.000033131277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998813,0.00013724426,0.0004902757,0.00013783766,0.00025645876,0.00016519427],"domain_scores_gemma":[0.9989045,0.000016753544,0.0004947238,0.00015861812,0.00034829858,0.00007709366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037137783,0.000105980536,0.00038159394,0.00007443618,0.00003361143,0.000021704622,0.0002501913,0.000065435466,0.000013439926],"category_scores_gemma":[0.00012985531,0.00007883651,0.00019730926,0.00029744103,0.00015606586,0.000014397768,0.00008339122,0.00016015285,4.1123116e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003159576,0.0001785107,0.87114465,0.000036870857,0.0009484573,0.0000019911683,0.000495246,0.0016973366,0.048447985,0.0000018570079,0.0011173231,0.0756138],"study_design_scores_gemma":[0.0014313115,0.000080068385,0.95849824,0.00020015014,0.0006354857,0.000024116576,0.00016928391,0.000090868634,0.034518793,0.000017701483,0.004226778,0.00010722586],"about_ca_topic_score_codex":0.0021474839,"about_ca_topic_score_gemma":0.018233154,"teacher_disagreement_score":0.08735355,"about_ca_system_score_codex":0.00004184227,"about_ca_system_score_gemma":0.0002065559,"threshold_uncertainty_score":0.99968153},"labels":[],"label_agreement":null},{"id":"W1480740744","doi":"10.1054/bjoc.2000.1359","title":"Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Biology; Allele; Point mutation; Genotype; Molecular biology; Restriction fragment length polymorphism; Enzyme; Genetics; Mutation; Biochemistry; Gene","score_opus":0.014985762193178783,"score_gpt":0.30051467733111215,"score_spread":0.2855289151379334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480740744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678755,0.0023415666,0.0004889885,0.00004043155,0.000046006553,0.000094700976,0.000045079425,9.889612e-7,0.00015468185],"genre_scores_gemma":[0.9982538,0.0006512587,0.0009245872,0.000020082634,0.00005841705,0.0000032504217,0.0000027364213,0.000007644451,0.00007818638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993054,0.00010651789,0.00025148515,0.00007414264,0.00016707955,0.000095341195],"domain_scores_gemma":[0.99941075,0.000035746863,0.00030506038,0.0000933474,0.0001045793,0.00005051083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023067385,0.000051299325,0.00013601696,0.000020844907,0.000034055964,0.000010467834,0.00007153276,0.000054803342,0.00005080321],"category_scores_gemma":[0.000105179555,0.00004816322,0.000071285715,0.000060448958,0.0000505832,0.000009559228,0.000019118283,0.00010118984,9.1895934e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121056604,0.00013686316,0.41079515,0.00018204884,0.00024282506,0.00001882335,0.00016960004,0.00062696915,0.32846722,0.000075765936,0.00021645501,0.25894722],"study_design_scores_gemma":[0.00049276394,0.00013658771,0.90015155,0.00014633892,0.00006195778,0.00008758824,0.000025257248,0.000024626705,0.098153636,0.00044880496,0.00022226937,0.000048630962],"about_ca_topic_score_codex":0.00019508998,"about_ca_topic_score_gemma":0.0001675056,"teacher_disagreement_score":0.48935637,"about_ca_system_score_codex":0.000030393545,"about_ca_system_score_gemma":0.00020747332,"threshold_uncertainty_score":0.1964039},"labels":[],"label_agreement":null},{"id":"W1484628085","doi":"10.1054/bjoc.1999.0964","title":"Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Colorectal cancer; Immunohistochemistry; Medicine; Thymidylate synthase; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Cancer; Immunostaining; Retrospective cohort study; Confidence interval; Gastroenterology; Pathology; Fluorouracil","score_opus":0.007577149139346323,"score_gpt":0.27618548461265835,"score_spread":0.26860833547331203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1484628085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96665186,0.03093198,0.00000464337,0.00015498961,0.00037077462,0.00059029786,0.00037398405,0.000014995636,0.0009064589],"genre_scores_gemma":[0.97058743,0.028043807,0.00011614447,0.00019551151,0.0002551772,0.00013756502,0.000014361416,0.000029695133,0.00062031305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99877894,0.000024568732,0.0003695788,0.00022205486,0.00034365934,0.00026118418],"domain_scores_gemma":[0.99905217,0.00008618898,0.00023899933,0.000045350396,0.0003729907,0.00020431304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066764456,0.00018370399,0.00051719707,0.00005367131,0.00018779968,0.000034393182,0.00006014336,0.00006796694,0.00050458807],"category_scores_gemma":[0.000074857024,0.00015502179,0.00015326201,0.000082525985,0.000089477704,0.00024557573,0.000023431025,0.0001856495,6.286824e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018712476,0.0007394577,0.17254764,0.0002193986,0.0007972091,0.00024946438,0.0012767015,0.00008737039,0.008955728,9.884842e-7,0.004028103,0.79238546],"study_design_scores_gemma":[0.00969561,0.004078597,0.9507122,0.0023433669,0.0004945602,0.00019694926,0.0002483901,0.000014492801,0.02033684,0.000057329697,0.011582074,0.0002395921],"about_ca_topic_score_codex":0.00035772167,"about_ca_topic_score_gemma":0.00024563394,"teacher_disagreement_score":0.7921459,"about_ca_system_score_codex":0.00037013824,"about_ca_system_score_gemma":0.00024820174,"threshold_uncertainty_score":0.6321605},"labels":[],"label_agreement":null},{"id":"W1485401317","doi":"10.1038/bjc.2015.181","title":"Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celgene","keywords":"Medicine; Internal medicine; Carboplatin; Lung cancer; Quality of life (healthcare); Toxicity; Surgery; Paclitaxel; Gastroenterology; Oncology; Cancer; Chemotherapy; Cisplatin","score_opus":0.04050747418019523,"score_gpt":0.3860574733065346,"score_spread":0.3455499991263394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485401317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98295313,0.013335463,0.00003615154,0.00038434027,0.0006476943,0.00069438183,0.00017707804,0.0000139369295,0.0017578043],"genre_scores_gemma":[0.9936019,0.0035493893,0.0004071848,0.00053873553,0.00031892597,0.00007070346,0.000022068909,0.00007280274,0.001418289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741393,0.00023472494,0.0010112034,0.00035905067,0.0005957792,0.0003852923],"domain_scores_gemma":[0.9976487,0.00015743951,0.0006370405,0.00017617195,0.0008808458,0.00049977115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067735696,0.00025955684,0.00086788833,0.0001383075,0.000071346425,0.00007830087,0.00011035259,0.00014521893,0.00019178558],"category_scores_gemma":[0.00011872027,0.0002232158,0.00012470718,0.0003024017,0.00015061964,0.00025242058,0.00002980939,0.00041854402,0.0000018375014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011090051,0.0010463747,0.9707671,0.00013297665,0.00053537544,0.00026322322,0.0006208295,0.00003558191,0.000036239653,0.000003827302,0.0013585672,0.024090916],"study_design_scores_gemma":[0.035587534,0.0008121222,0.95540404,0.0019565646,0.0007713551,0.00008216356,0.0008451673,0.00002831343,0.00013320855,0.000011756115,0.004079929,0.0002878527],"about_ca_topic_score_codex":0.011920453,"about_ca_topic_score_gemma":0.022300519,"teacher_disagreement_score":0.03447853,"about_ca_system_score_codex":0.0004940365,"about_ca_system_score_gemma":0.0010453567,"threshold_uncertainty_score":0.99553996},"labels":[],"label_agreement":null},{"id":"W1490479332","doi":"10.1054/bjoc.2000.1489","title":"Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Comet assay; Hypoxia (environmental); Pathology; Medicine; Chemistry; Cancer research; Biochemistry; Oxygen; DNA damage; DNA","score_opus":0.024850880079954955,"score_gpt":0.2943039160931508,"score_spread":0.26945303601319587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490479332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93627334,0.062137343,0.00038644814,0.00022231028,0.0004989242,0.00012972894,0.00007520248,0.0000031786435,0.0002734978],"genre_scores_gemma":[0.983218,0.012213217,0.00032475064,0.00014644278,0.0035367531,0.000013679766,0.000008648345,0.00002238327,0.00051613024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906266,0.000062655956,0.00032932774,0.00014326099,0.0001784622,0.00022361924],"domain_scores_gemma":[0.9994562,0.00003307911,0.00019194758,0.00008652389,0.00013110708,0.000101130485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059015624,0.00010360416,0.00027178114,0.000030469773,0.00017544207,0.00009608205,0.0001875091,0.0000749442,0.000055204095],"category_scores_gemma":[0.000056165787,0.000095432995,0.00012880405,0.0000619854,0.00006868324,0.000010911806,0.000026173775,0.00016777824,9.0955626e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001590564,0.000037688525,0.017809227,0.000035253688,0.0002550321,0.0000037434115,0.00007040276,0.00021221593,0.11266581,0.0000041299463,0.022774655,0.8459728],"study_design_scores_gemma":[0.0015479535,0.0001211723,0.118606195,0.00014971485,0.0001701239,0.00027578083,0.000080070036,0.000022656717,0.048615623,0.000045198838,0.8301667,0.00019881164],"about_ca_topic_score_codex":0.000109621455,"about_ca_topic_score_gemma":0.00025160468,"teacher_disagreement_score":0.845774,"about_ca_system_score_codex":0.000019159601,"about_ca_system_score_gemma":0.000095166535,"threshold_uncertainty_score":0.38916445},"labels":[],"label_agreement":null},{"id":"W1501445218","doi":"10.1038/bjc.2015.194","title":"SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Wallonie-Bruxelles International; Fondation Medic; Amis de l'Institut Bordet; Institut National Du Cancer; Université Libanaise","keywords":"Messenger RNA; Biology; Untranslated region; Molecular biology; Single-nucleotide polymorphism; microRNA; Cancer research; Genotype; Gene; Genetics","score_opus":0.020855771270648644,"score_gpt":0.27859477050181236,"score_spread":0.2577389992311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501445218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833513,0.016137697,0.00003448112,0.0000905339,0.00004726012,0.00014638205,0.00003719913,0.0000013969524,0.00015377077],"genre_scores_gemma":[0.9973249,0.0012453886,0.00096829474,0.00001627075,0.00018332456,0.00001083272,0.000026105428,0.00001060606,0.00021426703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991863,0.00007158897,0.00031755486,0.00013376022,0.00016599447,0.00012485182],"domain_scores_gemma":[0.99950755,0.000015319647,0.00022642671,0.000052850708,0.00009739852,0.00010043314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034816083,0.00008123392,0.00019368916,0.00005008457,0.000029965833,0.00002461038,0.00006285842,0.00007924625,0.0000096095555],"category_scores_gemma":[0.00015878791,0.000083629304,0.000028803672,0.000057892736,0.000053194715,0.000013707497,0.00005316002,0.00008448358,2.65368e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019167918,0.000041974396,0.68409467,0.000101490434,0.00007460167,0.00009604129,0.0002143979,0.000011104362,0.29847822,0.000022242833,0.00076832535,0.015905267],"study_design_scores_gemma":[0.006132285,0.0016115239,0.49519527,0.0020066772,0.00013580143,0.0015008321,0.00044683338,0.00004217728,0.4835232,0.0005103846,0.008429773,0.00046524534],"about_ca_topic_score_codex":0.00017456965,"about_ca_topic_score_gemma":0.00044729712,"teacher_disagreement_score":0.18889937,"about_ca_system_score_codex":0.000031026324,"about_ca_system_score_gemma":0.00006827982,"threshold_uncertainty_score":0.3410304},"labels":[],"label_agreement":null},{"id":"W1501785654","doi":"10.1054/bjoc.1999.0941","title":"Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Immunosuppression; Incidence (geometry); Cancer; Breast cancer; House mice; Biology; House mouse; Immunology; Virology; Genetics; Zoology","score_opus":0.011268264321995231,"score_gpt":0.25975462176437686,"score_spread":0.24848635744238162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501785654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96027184,0.038999394,0.000040337665,0.00022123563,0.00007281049,0.00007198766,0.00008978645,0.0000010501699,0.00023153816],"genre_scores_gemma":[0.938489,0.060805053,0.00014026529,0.00005145351,0.00027510792,0.0000055445844,0.000001562918,0.000012464824,0.00021951528],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99907374,0.00007541909,0.00039072847,0.000093717405,0.00024681992,0.000119546006],"domain_scores_gemma":[0.99933416,0.00002242393,0.00026885033,0.0001143621,0.00022461885,0.000035603993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029474014,0.000071753915,0.00020177473,0.00003659208,0.000022394883,0.000016020827,0.00021167537,0.00006869006,0.00021528243],"category_scores_gemma":[0.000029189807,0.00006518841,0.00008019886,0.00011610379,0.00010272891,0.000008226865,0.000015671505,0.00010920568,3.7988633e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005313022,0.00037833053,0.124978654,0.000108095235,0.000141789,0.00007001747,0.0003850471,0.00457822,0.6220464,0.000015642981,0.0010323353,0.24573417],"study_design_scores_gemma":[0.001166158,0.00019721537,0.81352,0.00035561874,0.000055087523,0.00015800657,0.00006743658,0.000007071945,0.17802949,0.000084185056,0.006227104,0.00013258729],"about_ca_topic_score_codex":0.0017826667,"about_ca_topic_score_gemma":0.003432033,"teacher_disagreement_score":0.68854135,"about_ca_system_score_codex":0.000019740679,"about_ca_system_score_gemma":0.00012635424,"threshold_uncertainty_score":0.26948705},"labels":[],"label_agreement":null},{"id":"W1508317033","doi":"10.1054/bjoc.2000.1332","title":"BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"Cancer Care Ontario","keywords":"Breast cancer; Family history; Ovarian cancer; Turkish population; BRCA2 Protein; Population; Oncology; Medicine; Cancer; Genetic counseling; Germline mutation; BRCA mutation; Mutation; Male breast cancer; Internal medicine; Genetics; Biology; Gene; Genotype","score_opus":0.0040988347143655285,"score_gpt":0.2414855450724439,"score_spread":0.23738671035807837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508317033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318535,0.015159882,0.000014456847,0.0004565832,0.00027409618,0.00010725448,0.00045105306,0.0000031567727,0.0003481497],"genre_scores_gemma":[0.9781002,0.020680863,0.00021965332,0.0002865504,0.0003495874,0.000025357082,0.000018940289,0.00002345801,0.00029543327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990017,0.000049686372,0.0003444233,0.00022683044,0.00017534246,0.0002020394],"domain_scores_gemma":[0.99941367,0.000008158182,0.0001391373,0.00008387177,0.0002523801,0.00010277907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011990176,0.00012420655,0.00018231702,0.00007148217,0.00009155755,0.00009218011,0.00011196884,0.00010312783,0.00027157224],"category_scores_gemma":[0.000016362366,0.00014601463,0.00004673797,0.00013644416,0.0001442185,0.00003110624,0.0000322751,0.00016232928,7.0705937e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016133432,0.00009660788,0.29475772,0.000027575681,0.00013634429,0.000035011715,0.00033997427,0.00048323913,0.0025092794,0.0000034930843,0.0026575178,0.6987919],"study_design_scores_gemma":[0.0019566645,0.000059281017,0.9847128,0.00020471986,0.000049082573,0.0022062971,0.00014112293,0.000030110405,0.0005349299,0.000074588475,0.0098358635,0.0001945809],"about_ca_topic_score_codex":0.0020909384,"about_ca_topic_score_gemma":0.009196946,"teacher_disagreement_score":0.6985973,"about_ca_system_score_codex":0.00010365455,"about_ca_system_score_gemma":0.000269227,"threshold_uncertainty_score":0.5954304},"labels":[],"label_agreement":null},{"id":"W1509428552","doi":"10.1038/bjc.2015.189","title":"The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Institut National Du Cancer; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale","keywords":"Gene isoform; Tumor suppressor gene; Cancer research; Gene; Suppressor; Biology; Von Hippel–Lindau disease; Gene expression; Pathology; Medicine; Genetics; Carcinogenesis; Disease","score_opus":0.010429803657703665,"score_gpt":0.2533353408332486,"score_spread":0.24290553717554494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509428552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89678895,0.0985964,0.00011774137,0.0005262824,0.0034355533,0.00013205849,0.00004533973,0.0000020410343,0.0003556504],"genre_scores_gemma":[0.98008996,0.015297653,0.000060142065,0.00027776163,0.0033770034,0.0000114341965,0.0000019726683,0.000021557127,0.00086253416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881226,0.00009415839,0.00035998278,0.00012137366,0.00038357143,0.00022866884],"domain_scores_gemma":[0.9988534,0.00002153142,0.00042595033,0.00025334238,0.0003541582,0.00009163531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056660234,0.00010837257,0.00017357337,0.000012602358,0.00019120675,0.00006978728,0.0005704853,0.00008551404,0.000014316649],"category_scores_gemma":[0.00019248379,0.0000619131,0.00021083836,0.00007532873,0.00014657556,0.000013120946,0.00016057534,0.00023743135,5.597277e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034589518,0.000038865084,0.00081002625,0.00001682213,0.000094904346,0.000005021636,0.0002348486,0.0009386103,0.8739797,0.000014953981,0.059191164,0.06432921],"study_design_scores_gemma":[0.0007518109,0.00005495187,0.005844138,0.000107672364,0.000043668155,0.0002895487,0.00020063588,0.0000068692716,0.5164102,0.00012048728,0.4760896,0.000080434496],"about_ca_topic_score_codex":0.00028749273,"about_ca_topic_score_gemma":0.00078172854,"teacher_disagreement_score":0.41689843,"about_ca_system_score_codex":0.0000328483,"about_ca_system_score_gemma":0.0003890572,"threshold_uncertainty_score":0.25247428},"labels":[],"label_agreement":null},{"id":"W1512421662","doi":"10.1054/bjoc.2000.1283","title":"Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Wilms' tumor; Wilms tumour; Genetics; Genetic linkage; Biology; Chromosome; Gene; Linkage (software); Cancer research","score_opus":0.0166380690193381,"score_gpt":0.2980254269478705,"score_spread":0.28138735792853237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512421662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801647,0.018698027,0.00013368129,0.00050645584,0.00018725537,0.00018715886,0.000059915772,0.0000016881665,0.00006113064],"genre_scores_gemma":[0.97562206,0.022217145,0.00043320935,0.0006151839,0.00061379716,0.000027042128,0.0000047249964,0.000010532219,0.0004563278],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924487,0.000030669773,0.00025556723,0.00018582169,0.00011596081,0.00016708215],"domain_scores_gemma":[0.99959993,0.000012644571,0.000060094586,0.00006006833,0.00013048167,0.00013679375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019884533,0.00007734265,0.00014493693,0.000032424698,0.000041721592,0.000031880518,0.000105278494,0.00008086433,0.000106090396],"category_scores_gemma":[0.00006777654,0.000079348225,0.00007086283,0.000082992214,0.000031770294,0.000012391936,0.000017779199,0.00008721831,0.0000015698492],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009886889,0.000026422229,0.0023582275,0.000029588651,0.000029965286,0.000026692504,0.000046831323,0.0020155755,0.33880538,5.486629e-7,0.010835161,0.6448369],"study_design_scores_gemma":[0.004268932,0.0031048902,0.27541828,0.0040881764,0.00011033159,0.0011949369,0.00019357125,0.00007817593,0.3848415,0.0002344908,0.32566637,0.0008003385],"about_ca_topic_score_codex":0.0004394185,"about_ca_topic_score_gemma":0.0025967057,"teacher_disagreement_score":0.6440366,"about_ca_system_score_codex":0.00004831783,"about_ca_system_score_gemma":0.00012392076,"threshold_uncertainty_score":0.3235727},"labels":[],"label_agreement":null},{"id":"W1513533768","doi":"10.1054/bjoc.2000.1464","title":"Expression of the novel tumour suppressor p33ING1 is independent of p53","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Vancouver Infectious Diseases Centre; University of British Columbia","funders":"Medical Research Council; Medical Research Council Canada; Canadian Dermatology Foundation","keywords":"HaCaT; Carcinogenesis; Biology; Cancer research; Apoptosis; Keratinocyte; Cell culture; Tumor suppressor gene; Suppressor; Cell growth; Cell biology; Knockout mouse; Molecular biology; Cancer; Gene; Genetics","score_opus":0.011297333942718785,"score_gpt":0.2600544144026229,"score_spread":0.2487570804599041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1513533768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833156,0.01370383,0.00010490373,0.0005217135,0.0003900017,0.00018991237,0.00008737465,0.000004797546,0.0016818804],"genre_scores_gemma":[0.9958508,0.0024790305,0.00029553022,0.00032587,0.00023251871,0.0000042358183,8.5337945e-7,0.00002750842,0.00078368123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982243,0.0000386825,0.0006382617,0.00012775257,0.00079102535,0.0001799553],"domain_scores_gemma":[0.99875504,0.000021621076,0.00053840014,0.00020008396,0.00037363652,0.00011124931],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021073267,0.00010614748,0.00040266835,0.000064094995,0.00004035489,0.000012419875,0.00023104782,0.00011118411,0.0024465625],"category_scores_gemma":[0.00007025764,0.000089844216,0.00030396803,0.00017484036,0.00009779447,0.00008968188,0.0000401707,0.00046445554,0.0000017012133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004827684,0.00026075434,0.0013034993,0.0001224041,0.00013511808,0.00013557599,0.00037266855,0.00047189317,0.94355965,0.0000038144094,0.00962568,0.043526206],"study_design_scores_gemma":[0.0040346077,0.00018051147,0.059509605,0.005252626,0.00022638157,0.002754111,0.00006279003,0.000029457713,0.91093874,0.000032612003,0.016876696,0.00010186688],"about_ca_topic_score_codex":0.00062005094,"about_ca_topic_score_gemma":0.00010646827,"teacher_disagreement_score":0.058206104,"about_ca_system_score_codex":0.00011038295,"about_ca_system_score_gemma":0.00041295,"threshold_uncertainty_score":0.99846536},"labels":[],"label_agreement":null},{"id":"W1516737592","doi":"10.1054/bjoc.2000.1203","title":"True","year":2000,"lang":"fr","type":"review","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine","score_opus":0.02665370392028779,"score_gpt":0.34200776626536206,"score_spread":0.31535406234507424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516737592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010206512,0.98640454,0.000001341386,0.00044104934,0.003926387,0.00038287352,0.00024507951,0.0000060386556,0.0075720414],"genre_scores_gemma":[0.00043948815,0.9840116,0.00012736117,0.00045202128,0.0073495377,0.000051196646,0.000017739141,0.00006783981,0.007483231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969207,0.00018558909,0.001478084,0.0002567748,0.0006510202,0.0005078485],"domain_scores_gemma":[0.9977825,0.00017068278,0.0010269339,0.00019393023,0.00029433484,0.0005315848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032384042,0.00039197496,0.0025009434,0.0001383936,0.00009711878,0.0001270234,0.000247903,0.00033997424,0.025929937],"category_scores_gemma":[0.000077305944,0.00036552627,0.0014546629,0.00024471624,0.0001240162,0.00014349645,0.000023959756,0.00062251254,0.00043814743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043848882,0.0005889746,0.00067593105,0.0043756664,0.0018483162,0.017483158,0.000024596635,0.0000057321517,1.837159e-7,0.000019535382,0.035529632,0.9394044],"study_design_scores_gemma":[0.0025031816,0.00033372443,0.004069352,0.17433181,0.005938037,0.02898926,0.000009079075,7.389994e-7,0.000006892313,0.000020862986,0.7835675,0.00022954798],"about_ca_topic_score_codex":0.0011768697,"about_ca_topic_score_gemma":0.00028968762,"teacher_disagreement_score":0.9391749,"about_ca_system_score_codex":0.001566367,"about_ca_system_score_gemma":0.0025697006,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W1520347472","doi":"10.1038/bjc.2015.6","title":"MicroRNA in radiotherapy: miRage or miRador?","year":2015,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Prostate Cancer Canada; Movember Foundation","keywords":"Radioresistance; Radiation therapy; microRNA; Prostate cancer; Medicine; Cancer; Radiobiology; Bioinformatics; Cancer research; DNA damage; Oncology; Biology; Internal medicine; DNA; Genetics; Gene","score_opus":0.03150720619588156,"score_gpt":0.3534881633461657,"score_spread":0.32198095715028413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520347472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012160426,0.99785626,0.00003871485,0.000014123279,0.0004263356,0.0002764799,0.000114182614,0.000002450295,0.000055395743],"genre_scores_gemma":[0.000035246823,0.99748766,0.00042617836,0.00006811142,0.0011651145,0.000020504094,0.000051735966,0.00007056999,0.0006748981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983412,0.0001907536,0.00078322156,0.00023907275,0.00022023656,0.00022549041],"domain_scores_gemma":[0.9986668,0.000010363942,0.00078334106,0.00018766281,0.0002045798,0.00014724121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003937493,0.00023806449,0.0009556806,0.00012250952,0.00002073959,0.000060828308,0.00036663187,0.00034643544,0.00015974155],"category_scores_gemma":[0.0000635589,0.00022563712,0.00042206753,0.00017142072,0.00005405865,0.0000071372865,0.00004410901,0.00029563907,0.0000026929695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007571143,0.0000402672,0.000009125244,0.0015364247,0.00023018493,0.0003748324,0.0000075517137,0.000010994514,0.0005131336,2.6131826e-7,0.018805841,0.9783957],"study_design_scores_gemma":[0.00074803,0.00008501343,0.000044342614,0.010121647,0.00019376518,0.002908262,0.000003680487,7.730202e-7,0.00006922961,0.0000044214244,0.9855659,0.00025494874],"about_ca_topic_score_codex":0.0000712462,"about_ca_topic_score_gemma":0.0004488159,"teacher_disagreement_score":0.9781407,"about_ca_system_score_codex":0.00033854006,"about_ca_system_score_gemma":0.0019488244,"threshold_uncertainty_score":0.9201215},"labels":[],"label_agreement":null},{"id":"W1524781181","doi":"10.1038/bjc.2015.171","title":"Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lung cancer; Medicine; Value (mathematics); Parametric statistics; Lung; Pathology; Internal medicine; Oncology; Statistics; Mathematics","score_opus":0.04659178315381654,"score_gpt":0.36188258368458565,"score_spread":0.3152908005307691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524781181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84710646,0.150255,0.00008329895,0.0010458843,0.00046876675,0.0006509917,0.000036132224,0.0000065961067,0.00034686935],"genre_scores_gemma":[0.9721926,0.025698107,0.0005282967,0.00021500932,0.00046556012,0.00012003035,6.358122e-7,0.00003053829,0.000749258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997673,0.0001373834,0.00066552236,0.00020007278,0.000872071,0.0004520032],"domain_scores_gemma":[0.9979193,0.00023285547,0.00046380275,0.00016182596,0.000987138,0.00023504347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010126177,0.00016523495,0.00062835694,0.00025177037,0.000056385437,0.000044884007,0.00032951366,0.00007663666,0.000065536144],"category_scores_gemma":[0.00078787433,0.00012679334,0.00015671185,0.00085029606,0.0001944113,0.00015034327,0.000097811666,0.0006760524,0.0000018694295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058410363,0.00059866335,0.92274517,0.001319417,0.00058373914,0.001049505,0.0026918894,0.0022838807,0.0023542738,0.00000362059,0.009655303,0.056130454],"study_design_scores_gemma":[0.007884442,0.0005491443,0.97024286,0.005417834,0.00044037047,0.00041743982,0.0012922236,0.0020233104,0.0089812465,0.00003345937,0.0024898578,0.00022781164],"about_ca_topic_score_codex":0.00800566,"about_ca_topic_score_gemma":0.006629873,"teacher_disagreement_score":0.1250861,"about_ca_system_score_codex":0.0005515741,"about_ca_system_score_gemma":0.0016350375,"threshold_uncertainty_score":0.9986001},"labels":[],"label_agreement":null},{"id":"W1544307618","doi":"10.1054/bjoc.1999.0984","title":"Evidence of a founder BRCA1 mutation in Scotland","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; University of Toronto; Occupational Cancer Research Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"University of St Andrews; Medical Research Council; National Cancer Institute; National Institutes of Health; University of Glasgow; University of Toronto","keywords":"Founder effect; Haplotype; Genealogy; Mutation; Ethnic group; Genetics; Population; Demography; Genotype; Breast cancer; Medicine; Geography; Biology; Cancer; History; Anthropology; Gene; Sociology","score_opus":0.01838225682872707,"score_gpt":0.3114991038513147,"score_spread":0.2931168470225876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1544307618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94801885,0.050979737,0.00024402341,0.00016040997,0.00014129243,0.00005813302,0.000006580317,9.3161134e-7,0.00039005248],"genre_scores_gemma":[0.9842914,0.014338166,0.0006376481,0.00014824596,0.00023268245,0.0000068132426,0.0000019109814,0.000010136844,0.00033304526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999262,0.000045304343,0.00032504817,0.00010296414,0.00016314382,0.00010157384],"domain_scores_gemma":[0.99952227,0.000014024608,0.00016043111,0.000078651436,0.00019172546,0.000032900884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021732392,0.00005431127,0.00012212982,0.00004258407,0.000018758985,0.000019471261,0.00012406205,0.00006078512,0.0004251107],"category_scores_gemma":[0.00006773425,0.000064722626,0.00006146043,0.000114483235,0.000057919635,0.000014699509,0.000010379853,0.000088167806,0.0000013950333],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046748016,0.00009042176,0.015377102,0.00007189694,0.00011376982,0.00012069019,0.00021791364,0.0126323905,0.08082079,0.0000050538356,0.0042890827,0.8857934],"study_design_scores_gemma":[0.007468712,0.0014100712,0.56726724,0.0064618713,0.00018059206,0.005825094,0.00037490088,0.0002786669,0.33304065,0.0014511945,0.07546794,0.00077305443],"about_ca_topic_score_codex":0.00031781875,"about_ca_topic_score_gemma":0.0023603896,"teacher_disagreement_score":0.8850204,"about_ca_system_score_codex":0.00006867229,"about_ca_system_score_gemma":0.00035345426,"threshold_uncertainty_score":0.4654664},"labels":[],"label_agreement":null},{"id":"W1546193247","doi":"10.1054/bjoc.2000.1495","title":"Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"Hydro-Québec; Université de Sherbrooke; Université Laval","keywords":"Medicine; Odds ratio; Risk factor; Pediatrics; Population; Etiology; Breast cancer; Breast feeding; Pregnancy; Case-control study; Cancer; Internal medicine","score_opus":0.005391761235841223,"score_gpt":0.26282444549451867,"score_spread":0.25743268425867744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546193247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936221,0.003576742,0.00008672171,0.00036028321,0.00016124782,0.00013767536,0.00003905374,0.000012158582,0.002004],"genre_scores_gemma":[0.981958,0.01607719,0.0003692242,0.0002071375,0.0005134157,0.0000049554883,0.000001966786,0.0000319919,0.000836168],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99837357,0.000042174768,0.0005423557,0.00015913481,0.00059139257,0.00029136997],"domain_scores_gemma":[0.9988619,0.00009312373,0.00023076253,0.00009794254,0.00042494055,0.00029132454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003059827,0.00013027423,0.000448614,0.00016445042,0.000075127566,0.000044106295,0.000090992595,0.00010406499,0.0018056682],"category_scores_gemma":[0.00011610186,0.00013193654,0.00014102526,0.0002887658,0.00018818688,0.00023778543,0.00003102353,0.00031918703,0.0000053644926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002259434,0.00024437727,0.081168815,0.00024853338,0.0014622549,0.0015655116,0.00023285518,0.00015846745,0.0032791689,0.000009700415,0.015205102,0.89416575],"study_design_scores_gemma":[0.0069608334,0.0005108882,0.9032228,0.0022985411,0.00050766184,0.081997395,0.00003174571,0.00024190708,0.00069126283,0.00006317937,0.0033310878,0.00014271472],"about_ca_topic_score_codex":0.0010347422,"about_ca_topic_score_gemma":0.00007188316,"teacher_disagreement_score":0.89402306,"about_ca_system_score_codex":0.000547532,"about_ca_system_score_gemma":0.0010893568,"threshold_uncertainty_score":0.9991068},"labels":[],"label_agreement":null},{"id":"W1547816603","doi":"10.1054/bjoc.1999.0993","title":"No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôtel-Dieu de Montréal; Montreal Heart Institute; Jewish General Hospital; Montreal General Hospital","funders":"Cancer Research Society","keywords":"Head and neck squamous-cell carcinoma; Head and neck; Basal cell; Epidermoid carcinoma; Medicine; Oncology; Head and neck cancer; Pathology; Internal medicine; Cancer; Surgery","score_opus":0.006620101483053699,"score_gpt":0.2256495858015179,"score_spread":0.2190294843184642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547816603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569489,0.041074093,0.0000059841022,0.0001865189,0.00014599798,0.00014661656,0.0001420914,0.0000027928784,0.0013470433],"genre_scores_gemma":[0.9896512,0.009060157,0.00007942484,0.00008017088,0.00026752616,0.0000014490004,0.000001564166,0.000018608791,0.00083990383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988077,0.00008458174,0.00044435888,0.00010451638,0.00039854617,0.00016027494],"domain_scores_gemma":[0.9988361,0.000061762716,0.0006316907,0.0001014472,0.00026675218,0.00010223935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027571447,0.000087852546,0.0003785989,0.000045544213,0.000053406242,0.000012950329,0.0000681369,0.00011959041,0.0001940196],"category_scores_gemma":[0.00010372259,0.00008246587,0.0001196317,0.000109603214,0.0000725708,0.00006171226,0.000020329267,0.00036129978,8.5282977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027520492,0.00008370377,0.85265124,0.0001336937,0.00019402943,0.00007136359,0.00024774802,0.0000363951,0.009588001,0.0000010845619,0.002738179,0.13397938],"study_design_scores_gemma":[0.0043341685,0.00042018652,0.9716301,0.00065916486,0.0006817258,0.0003127274,0.000015349124,0.000017410408,0.017234309,0.000021161339,0.0045957956,0.00007788124],"about_ca_topic_score_codex":0.0046976693,"about_ca_topic_score_gemma":0.00048637835,"teacher_disagreement_score":0.13390149,"about_ca_system_score_codex":0.00016257212,"about_ca_system_score_gemma":0.00020433769,"threshold_uncertainty_score":0.71015024},"labels":[],"label_agreement":null},{"id":"W1547880281","doi":"10.1038/bjc.2015.220","title":"BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Gemcitabine; Pancreatic cancer; Cisplatin; Medicine; Oncology; Cancer research; Internal medicine; Chemotherapy; BRCA mutation; Germline mutation; Cancer; Germline; Mutation; Ovarian cancer; Biology; Genetics; Gene","score_opus":0.03079712940837903,"score_gpt":0.35476318512389077,"score_spread":0.32396605571551174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547880281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212516,0.0120472545,0.00006727773,0.004655336,0.00018006176,0.0003394432,0.000017844046,0.00000769347,0.00055993337],"genre_scores_gemma":[0.98940367,0.0061663734,0.0018342925,0.0019249921,0.0003322251,0.000043648557,0.000002203559,0.000022339376,0.00027028457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986599,0.000090164336,0.00043173932,0.00014630503,0.00039238905,0.00027946924],"domain_scores_gemma":[0.99868995,0.000085800486,0.00014772407,0.000085098196,0.0005276986,0.00046375254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003491823,0.0001040097,0.0005506944,0.00017258475,0.000045363464,0.000035790836,0.000059548267,0.0000784486,0.00019025427],"category_scores_gemma":[0.0002776755,0.00010379689,0.00005444784,0.00026026322,0.0001081506,0.00010314432,0.00002217346,0.00028185724,0.0000042019647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017152932,0.00034172597,0.59021586,0.00011318982,0.0005189525,0.0037168728,0.006144868,0.00011483038,0.010762196,0.000009452326,0.0132298125,0.37311694],"study_design_scores_gemma":[0.010572689,0.0011538989,0.96149385,0.0020626374,0.0002717697,0.0051770294,0.0018229149,0.00023108635,0.001882297,0.00022164946,0.01488442,0.00022576527],"about_ca_topic_score_codex":0.0039868252,"about_ca_topic_score_gemma":0.0036382459,"teacher_disagreement_score":0.37289116,"about_ca_system_score_codex":0.00032339204,"about_ca_system_score_gemma":0.0008847885,"threshold_uncertainty_score":0.60269135},"labels":[],"label_agreement":null},{"id":"W1550139395","doi":"10.1038/bjc.2015.151","title":"18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; St. Joseph’s Healthcare Hamilton; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University Health Network; Hamilton Health Sciences; University of Toronto; Thunder Bay Regional Health Sciences Centre; Ontario Clinical Oncology Group; London Health Sciences Centre; McMaster University","funders":"American Society of Clinical Oncology","keywords":"Medicine; Positron emission tomography; Breast cancer; Prospective cohort study; Fluorodeoxyglucose; Cancer; Radiology; Lymphoma; Lung cancer; Malignancy; Confidence interval; Nuclear medicine; Internal medicine","score_opus":0.02320160797071249,"score_gpt":0.34285535143968415,"score_spread":0.3196537434689717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550139395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89929485,0.06718065,0.0058198622,0.024862945,0.0011769987,0.00080164283,0.00008918924,0.00015588448,0.00061798206],"genre_scores_gemma":[0.95402336,0.009222017,0.029573906,0.0047283308,0.0018260167,0.00021572421,0.000015925652,0.00006027887,0.0003344514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981513,0.00004953006,0.0005630834,0.00023798569,0.0006803872,0.00031774005],"domain_scores_gemma":[0.99750787,0.000039743285,0.0002598845,0.00020714077,0.0008341152,0.0011512215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040885728,0.0001620694,0.00042767273,0.00024404714,0.00007685902,0.0000692266,0.0002507226,0.00007356364,0.00023014525],"category_scores_gemma":[0.00014816412,0.00015524808,0.00025133448,0.00069091603,0.00007879424,0.00012363614,0.00006547539,0.0005049874,0.0000033095557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020333767,0.000440371,0.018141046,0.00005369644,0.00012034953,0.00032762688,0.00011529213,0.000018576568,0.004394742,0.000020570822,0.5281296,0.4480348],"study_design_scores_gemma":[0.0038620895,0.0010355163,0.06985284,0.008621922,0.00050723506,0.0024162387,0.00007583207,0.00039275154,0.026691971,0.0007121938,0.8853143,0.00051710784],"about_ca_topic_score_codex":0.00094689825,"about_ca_topic_score_gemma":0.00010936107,"teacher_disagreement_score":0.44751766,"about_ca_system_score_codex":0.00017165893,"about_ca_system_score_gemma":0.000392329,"threshold_uncertainty_score":0.6330833},"labels":[],"label_agreement":null},{"id":"W1561709169","doi":"10.1054/bjoc.2000.1221","title":"True","year":2000,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hôtel-Dieu de Montréal; Montreal General Hospital; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine","score_opus":0.005702731378127752,"score_gpt":0.24619075542878752,"score_spread":0.24048802405065978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1561709169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5685595,0.4259633,0.00008060823,0.0019570205,0.0010919578,0.00003778772,0.00011967914,0.000001281001,0.0021887892],"genre_scores_gemma":[0.6791673,0.28640512,0.00023513309,0.0010276064,0.0024664293,0.0000024134897,0.000007194025,0.000026659825,0.030662185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989368,0.0000777253,0.00039773938,0.0001389182,0.00017323042,0.000275623],"domain_scores_gemma":[0.9994624,0.000007260952,0.000102792124,0.00009798149,0.00014498741,0.00018453601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015647092,0.00012583622,0.00022165717,0.000020490912,0.00007196381,0.00006742837,0.0001794083,0.00018561353,0.010321455],"category_scores_gemma":[0.000011249165,0.00015717563,0.0002808314,0.0000697648,0.000121008285,0.000011680459,0.000008668975,0.00025252483,0.00002903242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020245273,0.00011557913,0.00035763823,0.000035791843,0.00019326765,0.000559817,0.00004408181,0.0004741817,0.012207659,0.000029150568,0.032237347,0.953543],"study_design_scores_gemma":[0.0012832505,0.00038809894,0.0031986495,0.00048331928,0.00012937041,0.004735568,0.00001794531,0.000009788644,0.013106444,0.00008845602,0.976365,0.00019413444],"about_ca_topic_score_codex":0.00078479794,"about_ca_topic_score_gemma":0.0008348616,"teacher_disagreement_score":0.9533489,"about_ca_system_score_codex":0.00002656744,"about_ca_system_score_gemma":0.00026591812,"threshold_uncertainty_score":0.99058324},"labels":[],"label_agreement":null},{"id":"W1564728191","doi":"10.1038/bjc.2015.196","title":"Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"Astellas Pharma; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Royal Marsden NHS Foundation Trust; Pfizer; Bristol-Myers Squibb","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Expanded access; Internal medicine; Adverse effect; Clear cell renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Confidence interval; Surgery; Cancer; Chemotherapy","score_opus":0.1058398097867058,"score_gpt":0.3561710599735537,"score_spread":0.2503312501868479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564728191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767106,0.018035572,0.000033363416,0.00093994447,0.0006858675,0.00045124145,0.00055279373,0.000007127797,0.0025834574],"genre_scores_gemma":[0.9971575,0.0004641761,0.00030853268,0.00046547566,0.001235347,0.00002265373,0.000043580316,0.000019639478,0.00028308164],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99732,0.00029201203,0.00092383754,0.00023089598,0.0008605194,0.00037272947],"domain_scores_gemma":[0.9983149,0.00017899972,0.00053198927,0.00022140732,0.00041226295,0.00034043143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009360113,0.00018482859,0.00057177444,0.00005934451,0.000059160993,0.00013907709,0.000322898,0.0000668848,0.00017073308],"category_scores_gemma":[0.00035424306,0.0001430708,0.00022470017,0.00028807178,0.00006964013,0.00024173564,0.00007646362,0.0004488051,0.0000068613153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42211875,0.003729633,0.23599043,0.00011572573,0.0008685568,0.078101,0.0026050603,0.0005265893,0.0004999231,0.000032397675,0.14836244,0.10704947],"study_design_scores_gemma":[0.35032764,0.0023530705,0.6188308,0.0009538095,0.0008309233,0.0046533397,0.00095503224,0.000056649184,0.0027868773,0.0005374584,0.01740368,0.000310701],"about_ca_topic_score_codex":0.011651068,"about_ca_topic_score_gemma":0.008353048,"teacher_disagreement_score":0.3828404,"about_ca_system_score_codex":0.00059381954,"about_ca_system_score_gemma":0.0013501431,"threshold_uncertainty_score":0.99493045},"labels":[],"label_agreement":null},{"id":"W1565078991","doi":"10.1038/bjc.2015.190","title":"A clinically applicable molecular-based classification for endometrial cancers","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Oncology; Internal medicine; Endometrial cancer; Survival analysis; Immunohistochemistry; Biology; Bioinformatics; Medicine; Cancer","score_opus":0.07945659241102301,"score_gpt":0.38652456061108775,"score_spread":0.30706796820006477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565078991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8732976,0.05574803,0.048655797,0.006516155,0.004544005,0.002982265,0.0003483086,0.00008369949,0.007824165],"genre_scores_gemma":[0.9889298,0.000830519,0.0066323555,0.0016319854,0.0014924369,0.00017638505,0.000016283528,0.000032270338,0.0002579709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982634,0.000046777277,0.00070555124,0.0001832187,0.0005634016,0.0002376515],"domain_scores_gemma":[0.99781466,0.00020225828,0.00047154957,0.00011828961,0.0009483819,0.0004448802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067242124,0.00011322513,0.0005129852,0.00015253882,0.000039798473,0.000046686677,0.00012937332,0.00010373655,0.00013263561],"category_scores_gemma":[0.0008751333,0.00010813351,0.000335,0.00047373108,0.000059545433,0.00008331758,0.0000104691435,0.00021055357,0.000003854224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023988038,0.0007949147,0.018645521,0.00018729884,0.0008567767,0.00043883646,0.000037019297,0.0010042088,0.0043768147,0.00015041072,0.015521738,0.9339984],"study_design_scores_gemma":[0.24513167,0.01559734,0.035096478,0.0023334688,0.0035435588,0.0013064353,0.00044164463,0.0017323365,0.021619715,0.0031468614,0.6690961,0.000954353],"about_ca_topic_score_codex":0.00054701034,"about_ca_topic_score_gemma":0.00010080802,"teacher_disagreement_score":0.9330441,"about_ca_system_score_codex":0.0006978427,"about_ca_system_score_gemma":0.001736164,"threshold_uncertainty_score":0.44095564},"labels":[],"label_agreement":null},{"id":"W1590931923","doi":"10.1038/bjc.2015.147","title":"Effect of specialized diagnostic assessment units on the time to diagnosis in screen-detected breast cancer patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Kingston General Hospital; Cancer Care Ontario; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Breast cancer; Cancer; Cancer registry; Retrospective cohort study; Percentile; Population; Cohort; Biopsy; Psychosocial; Medical diagnosis; Internal medicine; Radiology","score_opus":0.03334209656528978,"score_gpt":0.3421570833477593,"score_spread":0.3088149867824695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590931923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941137,0.0022404382,0.0000054691504,0.0017928912,0.00029713043,0.00058387534,0.00018688271,0.0000068646536,0.0007727871],"genre_scores_gemma":[0.997397,0.0009580632,0.00004100294,0.00093342405,0.0004693226,0.00009711393,0.0000042275533,0.00002237157,0.000077489785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772036,0.00028467874,0.0005594223,0.0001587777,0.0009994352,0.00027731646],"domain_scores_gemma":[0.997522,0.000627316,0.0003488928,0.0001318416,0.0010685149,0.00030142377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009192429,0.00015774464,0.00055967976,0.00014568701,0.000042276108,0.000039591596,0.00022005352,0.00006813663,0.0010017648],"category_scores_gemma":[0.0018074673,0.000121009085,0.00010504323,0.00068383216,0.000056121797,0.00013068033,0.000046699162,0.00037739443,0.000012908742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002578693,0.00019658965,0.69708204,0.00004663752,0.0001562214,0.0003950257,0.00012226844,0.0005857568,0.00012977247,0.000003889164,0.04423696,0.25446618],"study_design_scores_gemma":[0.005591007,0.0026669165,0.9788098,0.007021307,0.0002036971,0.00015493977,0.000041224142,0.000028776843,0.0018997185,0.000012118382,0.0034259171,0.00014459647],"about_ca_topic_score_codex":0.0046767704,"about_ca_topic_score_gemma":0.0016692033,"teacher_disagreement_score":0.28172776,"about_ca_system_score_codex":0.0006552741,"about_ca_system_score_gemma":0.00059095345,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W1597735813","doi":"10.1038/bjc.2015.206","title":"miR-30e* is an independent subtype-specific prognostic marker in breast cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; BC Cancer Agency; Ministero della Salute; Cancer Research UK","keywords":"Breast cancer; Oncology; Medicine; Cancer; Internal medicine; Carcinogenesis; Lymph node; Metastasis; Proportional hazards model; Pathology","score_opus":0.01636811051352493,"score_gpt":0.2714049934706052,"score_spread":0.25503688295708027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597735813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648549,0.034067277,0.000050622406,0.000329254,0.00036117647,0.000119996395,0.000106586755,0.0000028576883,0.000107331565],"genre_scores_gemma":[0.99545753,0.0032555857,0.0001208779,0.00023998265,0.00071319914,0.00001659521,0.000016813918,0.000026151985,0.00015323467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890053,0.00007846402,0.0003293848,0.0001991811,0.00028838753,0.00020403706],"domain_scores_gemma":[0.9990084,0.0000035233452,0.00022358604,0.00013046195,0.00041997535,0.00021401545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027586817,0.000107540574,0.00015907724,0.000057322985,0.000024642315,0.00006297737,0.0001845312,0.00011731541,0.000329427],"category_scores_gemma":[0.000022292208,0.00012275066,0.00007396517,0.00010066849,0.000046662488,0.000022521244,0.00003926107,0.00014564859,0.000003060942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014396233,0.0005035657,0.58231837,0.00006351442,0.0002261058,0.0004811457,0.00022337331,0.0009609131,0.20467152,0.000006650063,0.077946596,0.13115866],"study_design_scores_gemma":[0.0017377695,0.00008438398,0.9385013,0.00029419744,0.000033368437,0.0012114556,0.0000751668,0.000037204045,0.0084941005,0.00006659833,0.049244676,0.00021976777],"about_ca_topic_score_codex":0.00041996248,"about_ca_topic_score_gemma":0.0014656363,"teacher_disagreement_score":0.35618296,"about_ca_system_score_codex":0.0001353415,"about_ca_system_score_gemma":0.00045841804,"threshold_uncertainty_score":0.50056267},"labels":[],"label_agreement":null},{"id":"W1662191918","doi":"10.1054/bjoc.2001.1895","title":"Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"DMBA; Mammary gland; Endocrinology; Genetically modified mouse; Internal medicine; Breast cancer; Hormone; Transgene; Carcinogen; Carcinogenesis; Biology; Antagonist; Cancer; Receptor; Medicine; Genetics","score_opus":0.016819899564213554,"score_gpt":0.2667064441661971,"score_spread":0.24988654460198353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1662191918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92929417,0.06797253,0.00014910378,0.00094970263,0.00034765375,0.00016475083,0.0000150175865,0.000017401764,0.0010896703],"genre_scores_gemma":[0.9571892,0.0409421,0.00043208315,0.00046458887,0.00072230503,0.000009895722,0.0000059936897,0.000040512714,0.00019332375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797124,0.00007586582,0.00080774835,0.00023739082,0.00047783394,0.00042989576],"domain_scores_gemma":[0.9989375,0.000036452613,0.00027978374,0.0001365723,0.00030793808,0.0003017412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030189886,0.00019895539,0.0006085473,0.0002795319,0.00009672169,0.00008928929,0.00020885804,0.00014985602,0.00007724355],"category_scores_gemma":[0.000067240704,0.00021280696,0.00024894904,0.00049166015,0.000073535186,0.00045713282,0.000022745588,0.00050728925,0.0000023149416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002749336,0.0005517608,0.21780741,0.0002034575,0.00036156294,0.008899602,0.000946111,0.000010817122,0.62589055,0.0000120969125,0.009421723,0.13314557],"study_design_scores_gemma":[0.007574459,0.0004198162,0.9357863,0.0011002535,0.00025430272,0.011846353,0.00018382864,0.000026598915,0.034626883,0.00010439145,0.0077418736,0.0003349258],"about_ca_topic_score_codex":0.0017365525,"about_ca_topic_score_gemma":0.00036301854,"teacher_disagreement_score":0.7179789,"about_ca_system_score_codex":0.0002049758,"about_ca_system_score_gemma":0.00042887463,"threshold_uncertainty_score":0.8678016},"labels":[],"label_agreement":null},{"id":"W1753041476","doi":"10.1054/bjoc.2001.2123","title":"Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Radiosensitivity; Cancer research; Yield (engineering); Perfusion; Medicine; Radiation tolerance; Biology; Pathology; Radiation therapy; Internal medicine","score_opus":0.010259938105367775,"score_gpt":0.2264933631284711,"score_spread":0.21623342502310333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1753041476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458736,0.0033013604,0.000114807975,0.00017153341,0.00011073309,0.00009165851,0.000014009511,0.000019910985,0.0015886417],"genre_scores_gemma":[0.99520975,0.0041731494,0.00012811198,0.00008259805,0.00029187943,0.00001360395,0.0000021636038,0.000020678091,0.000078079705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992067,0.000035995443,0.00033633813,0.00009113553,0.0001422823,0.00018750915],"domain_scores_gemma":[0.9996396,0.00009135867,0.00006268839,0.00006074415,0.000063890424,0.00008175316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017529096,0.000093040464,0.00020523873,0.00013484199,0.00005272573,0.0000614947,0.00009731863,0.000046563375,0.0001287234],"category_scores_gemma":[0.000037432925,0.000113702416,0.000060652288,0.00026900318,0.00001293249,0.00022218353,0.000008664299,0.00034633835,0.0000048728853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037080008,0.00039465463,0.030576343,0.000040807616,0.000018130824,0.0010421464,0.0005644898,0.019948397,0.8836748,0.000021525075,0.0022747808,0.061406817],"study_design_scores_gemma":[0.0026093817,0.00005422337,0.9129729,0.0016640036,0.000053486358,0.0040971283,0.0006688314,0.005615147,0.06354624,0.000253099,0.007826256,0.00063925236],"about_ca_topic_score_codex":0.0036373404,"about_ca_topic_score_gemma":0.02688275,"teacher_disagreement_score":0.8823966,"about_ca_system_score_codex":0.00013918524,"about_ca_system_score_gemma":0.00007136633,"threshold_uncertainty_score":0.9908741},"labels":[],"label_agreement":null},{"id":"W1873761649","doi":"10.1038/bjc.2015.318","title":"Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Imperial Experimental Cancer Medicine Centre; University of Birmingham; National Institute for Health and Care Research; Children's Cancer and Leukaemia Group; Cancer Research UK; Wellcome Trust","keywords":"Retinoblastoma; Choline; Pathology; Metabolite; Phosphocholine; Medicine; Taurine; Histopathology; Magnetic resonance imaging; In vivo magnetic resonance spectroscopy; In vivo; Biology; Internal medicine; Radiology; Biochemistry; Phospholipid; Genetics","score_opus":0.049683860724277405,"score_gpt":0.3612110967685064,"score_spread":0.311527236044229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1873761649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732279,0.024856219,0.00007368914,0.0004288218,0.0006457487,0.00012400419,0.000009802058,0.00000859119,0.00062522443],"genre_scores_gemma":[0.9947354,0.0014797105,0.0026402383,0.0003309556,0.00037579166,0.000008885708,0.000003215574,0.000011482943,0.00041429157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988448,0.00007586687,0.00049691665,0.00012740164,0.00027114054,0.00018387593],"domain_scores_gemma":[0.99919087,0.000037329723,0.0002390625,0.00007079697,0.00029950458,0.00016244933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008136733,0.00008224136,0.00042073333,0.00008892684,0.000025547086,0.000023051107,0.00007420239,0.00011892827,0.000047249756],"category_scores_gemma":[0.00041978335,0.000075557095,0.00012369914,0.0001366244,0.000087002314,0.00014700362,0.000025934532,0.00039042835,0.00000816364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011829191,0.00083756517,0.94057304,0.00003658818,0.0001415996,0.012684913,0.00017781273,0.00003070084,0.0025801158,0.000058636,0.0005696481,0.04112647],"study_design_scores_gemma":[0.009977261,0.0006474734,0.9645603,0.0006144597,0.00028051928,0.012882391,0.0002358417,0.000022779665,0.004336994,0.00041186475,0.0059166155,0.00011352118],"about_ca_topic_score_codex":0.00006482349,"about_ca_topic_score_gemma":0.0002048297,"teacher_disagreement_score":0.04101295,"about_ca_system_score_codex":0.00011675645,"about_ca_system_score_gemma":0.00029703323,"threshold_uncertainty_score":0.3081129},"labels":[],"label_agreement":null},{"id":"W1875720097","doi":"10.1038/bjc.2015.223","title":"Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research UK; Myriad Genetics; National Institutes of Health; Queen Mary University of London","keywords":"Medicine; Hazard ratio; Prostate cancer; Cohort; Internal medicine; Cancer; Prostate; Univariate analysis; Oncology; Framingham Risk Score; Proportional hazards model; Biopsy; Multivariate analysis; Confidence interval; Disease","score_opus":0.033035862704172345,"score_gpt":0.3263623784245855,"score_spread":0.29332651572041313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875720097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821119,0.015386213,0.000052346328,0.00033073648,0.00026819482,0.0012895967,0.00043788133,0.0000103412785,0.000112841444],"genre_scores_gemma":[0.99353635,0.003431486,0.0022227273,0.00009204809,0.00022893699,0.0003590531,0.000049476042,0.000029962624,0.000049930073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985746,0.00005953127,0.00057356205,0.0002012145,0.00037920207,0.00021189517],"domain_scores_gemma":[0.9983388,0.00004784968,0.00065001467,0.000094128845,0.0006624021,0.00020678515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004163181,0.00012940183,0.00044511142,0.00009614219,0.00004245212,0.000039956893,0.00008090175,0.00006319725,0.000036109148],"category_scores_gemma":[0.00006766169,0.00012156817,0.000083489285,0.00016528048,0.000047056114,0.00033329433,0.000020311105,0.00016448591,2.19534e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013781757,0.00044789334,0.905952,0.00015728285,0.00016868717,0.0002642913,0.00096549216,0.00075234624,0.0027015356,0.000001495986,0.0003357617,0.08687507],"study_design_scores_gemma":[0.013625553,0.0014046819,0.8571266,0.006890259,0.00045627996,0.00011364412,0.0006797131,0.0010311574,0.11771081,0.0003490845,0.00043130253,0.00018094596],"about_ca_topic_score_codex":0.0061401348,"about_ca_topic_score_gemma":0.0006599094,"teacher_disagreement_score":0.11500927,"about_ca_system_score_codex":0.00041805048,"about_ca_system_score_gemma":0.0006331134,"threshold_uncertainty_score":0.9282088},"labels":[],"label_agreement":null},{"id":"W1882337125","doi":"10.1054/bjoc.1999.0975","title":"Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Glioma; Hypoxia (environmental); Vascular endothelial growth factor; Pathology; Vascular endothelial growth factor A; Cancer research; Angiogenesis; Biology; Medicine; VEGF receptors; Chemistry; Oxygen","score_opus":0.007008418123244916,"score_gpt":0.2431157245418058,"score_spread":0.2361073064185609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882337125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95074487,0.048573658,0.000021069953,0.000025637482,0.0003079643,0.00009095366,0.000095542506,0.0000017380249,0.00013855062],"genre_scores_gemma":[0.9690629,0.029487656,0.000113908936,0.000092842434,0.0009548099,0.000006075869,0.000003407416,0.000021867598,0.00025651182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880797,0.00006271257,0.00042347834,0.00020405675,0.00029032028,0.00021148697],"domain_scores_gemma":[0.99943024,0.000005326865,0.00020623747,0.000113275564,0.00012887633,0.00011606004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016356235,0.00012944394,0.00030602812,0.000059467035,0.000043963562,0.000030935727,0.00017113719,0.00012549857,0.00048299247],"category_scores_gemma":[0.000021704607,0.00013572788,0.00015357902,0.00007165655,0.000076274206,0.000016063419,0.00003722016,0.00015436114,3.9776666e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014465062,0.00007532906,0.0045630517,0.000029660338,0.000050286955,0.00004236005,0.000114143695,0.000017336622,0.95162827,0.000002542602,0.0011267635,0.04220559],"study_design_scores_gemma":[0.00311526,0.00019683353,0.13259089,0.00037305354,0.00004564709,0.00052969705,0.00006438476,0.000001354338,0.8288675,0.000091879134,0.03391468,0.00020882387],"about_ca_topic_score_codex":0.00087167183,"about_ca_topic_score_gemma":0.0005373143,"teacher_disagreement_score":0.12802784,"about_ca_system_score_codex":0.000021813303,"about_ca_system_score_gemma":0.00011931149,"threshold_uncertainty_score":0.55348223},"labels":[],"label_agreement":null},{"id":"W1900170853","doi":"10.1038/sj.bjc.6603295","title":"Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Strong; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Oestrogen receptor; Phenotype; Estrogen receptor; Basal (medicine); Receptor; Progesterone receptor; Internal medicine; Breast cancer; Tissue microarray; Biology; Mammary gland; Gene isoform; Estrogen receptor alpha; Endocrinology; Estrogen; Cancer research; Immunohistochemistry; Medicine; Gene; Cancer; Genetics","score_opus":0.018497775031478175,"score_gpt":0.3388497727771877,"score_spread":0.32035199774570955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1900170853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98801327,0.008871546,0.000013234773,0.0007082072,0.00027074353,0.00032576337,0.00015483501,0.000012944247,0.0016294561],"genre_scores_gemma":[0.99514765,0.0015407609,0.0012256005,0.000067351466,0.0012521609,0.000028258146,0.000016510625,0.000057748424,0.00066398917],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969961,0.00019931502,0.0009936183,0.0002554235,0.0010823137,0.00047320043],"domain_scores_gemma":[0.998149,0.00007120737,0.00057778176,0.00019426136,0.0007502776,0.00025747364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006934535,0.00018449675,0.00066343514,0.0002770986,0.000074859985,0.000043899116,0.00029875652,0.0001496611,0.002189304],"category_scores_gemma":[0.00012315271,0.00019407744,0.0002287428,0.000431593,0.00023504507,0.00023274569,0.00006379096,0.0008056241,0.00001019014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096407946,0.0006064177,0.46671823,0.00024373535,0.00009671466,0.00070717186,0.00026336545,0.0001521754,0.40578574,0.00004163915,0.07018015,0.054240603],"study_design_scores_gemma":[0.007963993,0.0008285242,0.47213688,0.0111242775,0.00010165192,0.0032578872,0.0005632738,0.000007728682,0.48441577,0.0005140746,0.018691456,0.00039447565],"about_ca_topic_score_codex":0.00707795,"about_ca_topic_score_gemma":0.001335904,"teacher_disagreement_score":0.07863004,"about_ca_system_score_codex":0.00066514855,"about_ca_system_score_gemma":0.0007977664,"threshold_uncertainty_score":0.999534},"labels":[],"label_agreement":null},{"id":"W1921977259","doi":"10.1038/sj.bjc.6605571","title":"Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Sanofi","keywords":"PTEN; Prostate cancer; ErbB; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Tissue microarray; Epidermal growth factor receptor; Biochemical recurrence; ERBB3; Medicine; Prostate; Oncology; Cancer; Biology; Internal medicine; Signal transduction; Prostatectomy; Cell biology","score_opus":0.006430402495050277,"score_gpt":0.24938403526240227,"score_spread":0.242953632767352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921977259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322605,0.0059496155,0.0002152573,0.00007962021,0.00019148829,0.00019898677,0.00010865693,0.0000025219633,0.000027810867],"genre_scores_gemma":[0.99828273,0.00090669794,0.00056033704,0.000043569216,0.0001225934,0.000018792043,0.0000068941313,0.000023146105,0.00003525466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842596,0.00009989502,0.00068472774,0.0002438864,0.0003039656,0.00024154197],"domain_scores_gemma":[0.99872977,0.00006142146,0.0006294546,0.00017337927,0.00032197832,0.000083984276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043197974,0.00014855708,0.000443874,0.00011828983,0.000050969506,0.000025424357,0.00031590727,0.0001406475,0.000035683606],"category_scores_gemma":[0.0002566522,0.00013710765,0.00020470352,0.00043256985,0.00029164238,0.000011407168,0.00010964273,0.0005470824,3.9955424e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025391625,0.00007215867,0.028668595,0.00006729525,0.00037543665,0.000019257957,0.00016083953,0.0033060824,0.9567384,0.0000030825497,0.000016871905,0.010318056],"study_design_scores_gemma":[0.0007967829,0.00010927109,0.031299513,0.00053897215,0.00023978957,0.00007490945,0.00003940869,0.00050378486,0.9658526,0.00003334908,0.00034393737,0.00016768988],"about_ca_topic_score_codex":0.0006741043,"about_ca_topic_score_gemma":0.0023450186,"teacher_disagreement_score":0.0101503655,"about_ca_system_score_codex":0.0000384021,"about_ca_system_score_gemma":0.00041079032,"threshold_uncertainty_score":0.55910873},"labels":[],"label_agreement":null},{"id":"W192747251","doi":"10.1054/bjoc.2001.2170","title":"Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Conjugate; Cytotoxicity; Monoclonal antibody; Molecular biology; Carcinoembryonic antigen; Chemistry; Cell culture; Antigen; Incubation; Antibody; Monoclonal; Biology; Biochemistry; In vitro; Medicine; Immunology; Cancer; Internal medicine","score_opus":0.02649090783885711,"score_gpt":0.36613529755553115,"score_spread":0.33964438971667404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W192747251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892711,0.008998356,0.00014781072,0.000345582,0.00023279508,0.0002119423,0.0000318492,0.000010040569,0.00075052545],"genre_scores_gemma":[0.97713995,0.021857772,0.00016005353,0.00015274585,0.00040011705,0.000008950642,0.0000042227803,0.000017796037,0.00025840293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983276,0.00006852208,0.0006016038,0.00013622755,0.0006238688,0.0002421928],"domain_scores_gemma":[0.9984528,0.00008402367,0.00048037025,0.00009618707,0.0007476618,0.00013894857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045376434,0.00012448938,0.0005405508,0.00013568293,0.000057193472,0.00002852692,0.00016951824,0.000059346356,0.00086652423],"category_scores_gemma":[0.0002273657,0.00011932094,0.00018469822,0.00020284907,0.00014957975,0.00021549764,0.000036688376,0.00035084027,0.000001702711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012155666,0.00018195633,0.02089597,0.00006142394,0.00047323393,0.0007269838,0.00017297994,0.000007064136,0.95777535,0.000004697918,0.00028100007,0.01820378],"study_design_scores_gemma":[0.0034137662,0.001008445,0.25765595,0.0021562604,0.000101331374,0.0054009687,0.00021228085,0.00016349636,0.728384,0.00020076899,0.0011553648,0.00014738037],"about_ca_topic_score_codex":0.0021117595,"about_ca_topic_score_gemma":0.00058337185,"teacher_disagreement_score":0.23675996,"about_ca_system_score_codex":0.000161912,"about_ca_system_score_gemma":0.00024267791,"threshold_uncertainty_score":0.9487833},"labels":[],"label_agreement":null},{"id":"W1955289205","doi":"10.1054/bjoc.2000.1426","title":"Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Case Western Reserve University","keywords":"Photodynamic therapy; Photosensitizer; Apoptosis; Pathology; Terminal deoxynucleotidyl transferase; TUNEL assay; Karyorrhexis; Necrosis; In vivo; Biology; Coagulative necrosis; Programmed cell death; Protoporphyrin IX; Cancer research; Chemistry; Medicine; Biochemistry","score_opus":0.008638387065204253,"score_gpt":0.3033632616231661,"score_spread":0.29472487455796187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955289205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611224,0.011367864,0.0000014002826,0.001697673,0.000081754915,0.0003227545,0.000040840754,0.0000071759346,0.00036827187],"genre_scores_gemma":[0.9516847,0.046935804,0.000040613602,0.00068203406,0.00016411301,0.00002589716,0.0000013708835,0.0000256501,0.00043978821],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984298,0.00011165383,0.00050031184,0.00017699861,0.00040473085,0.00037651273],"domain_scores_gemma":[0.99950105,0.00007911251,0.00011020011,0.00007074918,0.00008803776,0.00015082445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050374214,0.0001459837,0.00050212664,0.00019275969,0.00004533077,0.00004515906,0.00013037283,0.0000917543,0.001499617],"category_scores_gemma":[0.00006715047,0.00015096065,0.000056428646,0.0002975174,0.00009496385,0.00021373588,0.000017405215,0.00065688597,0.0000012966233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011225509,0.00016754115,0.0028546355,0.000020007128,0.00006435893,0.00045283948,0.00032718698,0.000006698067,0.5837167,2.7690257e-7,0.0011338432,0.41013336],"study_design_scores_gemma":[0.037902877,0.003531836,0.5733784,0.0033763135,0.000049083388,0.006380927,0.0005322905,0.00037937867,0.35263982,0.00018989255,0.020893676,0.00074553443],"about_ca_topic_score_codex":0.0056544966,"about_ca_topic_score_gemma":0.0065493705,"teacher_disagreement_score":0.57052374,"about_ca_system_score_codex":0.00025047196,"about_ca_system_score_gemma":0.00019332037,"threshold_uncertainty_score":0.99941313},"labels":[],"label_agreement":null},{"id":"W1956692029","doi":"10.1038/bjc.2015.265","title":"Is England closing the international gap in cancer survival?","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Monash University; Macquarie University; Barts Health NHS Trust; Uppsala Universitet; Syddansk Universitet; London School of Hygiene and Tropical Medicine; Cancer Research UK; King's College London; University of Alberta; Karolinska Institutet; McMaster University","keywords":"Medicine; Context (archaeology); Cancer registry; Relative survival; Population; Cancer; Lung cancer; Colorectal cancer; Breast cancer; Demography; Oncology; Internal medicine; Geography; Environmental health","score_opus":0.20828662729198472,"score_gpt":0.4165390833955539,"score_spread":0.20825245610356918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1956692029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400608,0.040162586,0.000049214403,0.011734163,0.0019056587,0.0000855926,0.000019009516,0.0000052787154,0.0059776837],"genre_scores_gemma":[0.9879263,0.006101027,0.00013669743,0.0034552733,0.0018182887,0.0000067787873,9.71178e-7,0.000010959058,0.0005437217],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986462,0.000038560487,0.00034583098,0.00009852457,0.000696957,0.00017394139],"domain_scores_gemma":[0.99902827,0.0000340073,0.00019674454,0.00007024422,0.00053677376,0.00013398271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074237084,0.00007307038,0.00022043743,0.000060385413,0.000035106856,0.00007749923,0.00020088724,0.000046000278,0.0004497374],"category_scores_gemma":[0.0001738081,0.00005967406,0.000085016436,0.00016006576,0.000048050046,0.00020344941,0.000032144588,0.00036271205,0.0000029546686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006279383,0.00005004747,0.6896352,0.000017556085,0.00016436186,0.0010686115,0.0012423856,0.0004210433,0.0002701284,0.000031542633,0.05290486,0.25356627],"study_design_scores_gemma":[0.0073665283,0.00019994474,0.41161627,0.0033231196,0.00014065208,0.0032276427,0.0014478412,0.000333646,0.0009652125,0.0006299485,0.57054716,0.00020200461],"about_ca_topic_score_codex":0.008914881,"about_ca_topic_score_gemma":0.010062556,"teacher_disagreement_score":0.5176423,"about_ca_system_score_codex":0.0003937112,"about_ca_system_score_gemma":0.0005996691,"threshold_uncertainty_score":0.99768484},"labels":[],"label_agreement":null},{"id":"W1962449772","doi":"10.1054/bjoc.2000.1119","title":"Nested case–control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; McGill University; Jewish General Hospital","funders":"","keywords":"Nested case-control study; Breast cancer; Medicine; Stage (stratigraphy); Oncology; Case-control study; Inflammatory breast cancer; Cancer; Internal medicine; Biology","score_opus":0.002517698831784702,"score_gpt":0.23536576988531172,"score_spread":0.232848071053527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962449772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934287,0.00485884,0.0000017367362,0.00005032345,0.0006059448,0.0008507835,0.00014373705,0.0000060389284,0.00005386475],"genre_scores_gemma":[0.996895,0.002227927,0.000004014769,0.00013447399,0.0005111596,0.00002282991,1.7419342e-7,0.000032436074,0.00017196006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808687,0.00028712262,0.00064526557,0.000168452,0.0005724262,0.00023987824],"domain_scores_gemma":[0.9984078,0.00022180156,0.0007061927,0.00020878292,0.00027461533,0.00018085184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053720345,0.00018650235,0.0007183609,0.00009699196,0.000107772656,0.000019239213,0.000121923484,0.00009347052,0.00024584364],"category_scores_gemma":[0.00006770519,0.00014310442,0.0001708084,0.00015686528,0.00013103166,0.00011871463,0.000018427934,0.00048358415,7.654842e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016495964,0.0005408167,0.6433121,0.0010073907,0.00072225975,0.0064776205,0.002039634,0.00037472724,0.0051837126,5.8964787e-7,0.0003890941,0.33830243],"study_design_scores_gemma":[0.012915325,0.0009793863,0.9734702,0.0029053374,0.00078018627,0.0041673807,0.00030746756,0.00009625051,0.004030501,0.0000011897986,0.00021252848,0.00013421064],"about_ca_topic_score_codex":0.0021314737,"about_ca_topic_score_gemma":0.0010698738,"teacher_disagreement_score":0.33816823,"about_ca_system_score_codex":0.00008561361,"about_ca_system_score_gemma":0.00025928396,"threshold_uncertainty_score":0.5835629},"labels":[],"label_agreement":null},{"id":"W1963500271","doi":"10.1054/bjoc.2001.2165","title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Sensitization; Poloxamer; Copolymer; Mechanism (biology); Cancer; Chemistry; Block (permutation group theory); Cancer research; Medicine; Immunology; Internal medicine","score_opus":0.005091498015092187,"score_gpt":0.23247845445354914,"score_spread":0.22738695643845697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963500271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940883,0.0454447,0.0108419275,0.00060033135,0.0009240337,0.00021406775,0.00014924584,0.00001478556,0.00092789956],"genre_scores_gemma":[0.9591582,0.0391201,0.00019536361,0.0001796899,0.00024365689,0.000005445772,0.000009931979,0.00002980051,0.0010578171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855965,0.000039358136,0.0005736471,0.00013915797,0.00047894864,0.0002092416],"domain_scores_gemma":[0.9985144,0.000020788717,0.0006070984,0.000077382305,0.0006645966,0.000115739356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014469765,0.00012318754,0.00048222023,0.00011198027,0.000042001848,0.000008153043,0.000074096,0.00011561084,0.00035702594],"category_scores_gemma":[0.00000936646,0.00013024817,0.00016783173,0.00028199525,0.000062680796,0.00010247433,0.000006157235,0.00017026425,3.2821202e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082961103,0.0002764989,0.0010053985,0.00019835788,0.0004531889,0.00027312912,0.00020594004,0.00042406408,0.9664526,0.0003502374,0.0032727683,0.026258219],"study_design_scores_gemma":[0.0026811408,0.00034149873,0.0014097056,0.0018299485,0.00046688493,0.00063005736,0.00013686823,0.00014472696,0.9873668,0.00036821404,0.004469858,0.00015430622],"about_ca_topic_score_codex":0.0022999502,"about_ca_topic_score_gemma":0.0023420542,"teacher_disagreement_score":0.026103914,"about_ca_system_score_codex":0.00016425789,"about_ca_system_score_gemma":0.0003866127,"threshold_uncertainty_score":0.53113663},"labels":[],"label_agreement":null},{"id":"W1963523058","doi":"10.1038/sj.bjc.6604558","title":"Fusion in the ETS gene family and prostate cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Chromoplexy; Biology; Prostate; Carcinogenesis; Cancer research; Cancer; Genetics; PCA3; Gene; Pathology; Medicine; Disease","score_opus":0.06031547168416199,"score_gpt":0.39752636842868,"score_spread":0.337210896744518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963523058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052007777,0.9927963,4.1876538e-7,0.000405976,0.0002959544,0.00089774135,0.00012097765,0.000004274092,0.0002775547],"genre_scores_gemma":[0.00012475713,0.9976436,0.000039959872,0.00025582578,0.00071994064,0.00016090798,0.000018162167,0.000042967327,0.0009939076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795127,0.00017519238,0.0006706093,0.00022166863,0.00064358494,0.00033765187],"domain_scores_gemma":[0.9989797,0.00008041229,0.00042073987,0.00013244548,0.00023559638,0.0001511423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034709452,0.00024058645,0.0012667188,0.00021184197,0.00010318839,0.00006910666,0.0001903026,0.00016946798,0.000069471665],"category_scores_gemma":[0.00003119286,0.00015183403,0.0002956451,0.0003675219,0.00014770869,0.00010020948,0.000046851783,0.0010153517,0.0000021714593],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009493533,0.00007126439,0.00034887134,0.002669987,0.00020638996,0.006245753,0.00019737444,5.6339206e-7,0.000006535979,3.89521e-7,0.0073450864,0.9828128],"study_design_scores_gemma":[0.001801345,0.00017402995,0.0036530644,0.04316381,0.000452657,0.012698221,0.00004300699,6.429391e-7,0.000005174447,0.00000793849,0.9378533,0.0001468023],"about_ca_topic_score_codex":0.0011496007,"about_ca_topic_score_gemma":0.00042406915,"teacher_disagreement_score":0.9826661,"about_ca_system_score_codex":0.00039436037,"about_ca_system_score_gemma":0.0018856004,"threshold_uncertainty_score":0.6191612},"labels":[],"label_agreement":null},{"id":"W1963863438","doi":"10.1038/bjc.2016.441","title":"Erratum: Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis","year":2017,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; York University; St. Michael's Hospital","funders":"","keywords":"Cancer research; PI3K/AKT/mTOR pathway; Clear cell renal cell carcinoma; Protein kinase B; Biology; Renal cell carcinoma; Galectin-1; Metastasis; Immunohistochemistry; Targeted therapy; Galectin-3; P70-S6 Kinase 1; Signal transduction; Cancer; Medicine; Pathology; Internal medicine; Immunology; Cell biology","score_opus":0.016317400778053937,"score_gpt":0.264368342216069,"score_spread":0.24805094143801504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963863438","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2733178,0.69373477,0.00006458127,0.0021847934,0.02398742,0.0012113587,0.0003972931,0.00003473555,0.005067236],"genre_scores_gemma":[0.9420037,0.021479243,0.000095033705,0.00033329873,0.0017847689,0.000098439494,0.00008310078,0.00009731409,0.034025066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968709,0.00047568942,0.0009905925,0.0006819504,0.00017492697,0.00080598355],"domain_scores_gemma":[0.99696845,0.00009321019,0.0019668639,0.00042285683,0.00047704656,0.00007160414],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004906978,0.00047963837,0.0009991246,0.00013312772,0.0009221071,0.0002995022,0.0010619947,0.0011665965,0.0006561813],"category_scores_gemma":[0.00010697287,0.00040386757,0.00030497252,0.00018321567,0.0008491344,0.00018817876,0.0002485578,0.0035149285,0.000012493881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008006005,0.00020026244,0.0017419513,0.00024827945,0.00021447895,0.0005233966,0.0006679329,0.0000068472655,0.10727754,6.694497e-7,0.8650055,0.023312522],"study_design_scores_gemma":[0.0049520917,0.0021039925,0.039910205,0.0029924938,0.0007513088,0.005260952,0.00035040878,0.0000066233565,0.047264952,0.00040237408,0.8949639,0.0010406836],"about_ca_topic_score_codex":0.003897913,"about_ca_topic_score_gemma":0.0016248279,"teacher_disagreement_score":0.6722555,"about_ca_system_score_codex":0.00019684169,"about_ca_system_score_gemma":0.0014137259,"threshold_uncertainty_score":0.99984133},"labels":[],"label_agreement":null},{"id":"W1964113171","doi":"10.1038/sj.bjc.6600659","title":"Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital; Alberta Ministry of Agriculture and Forestry; University of Alberta","funders":"Killam Trusts","keywords":"Fish oil; Fish <Actinopterygii>; Medicine; Cancer; Composition (language); Internal medicine; Biology; Fishery","score_opus":0.016031808941839008,"score_gpt":0.3145401840697231,"score_spread":0.2985083751278841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964113171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855589,0.0037235962,0.0000065752706,0.010075956,0.0003304125,0.0001282913,0.00014573973,0.000004799037,0.000025708146],"genre_scores_gemma":[0.9863309,0.011430837,0.0007268098,0.0013336639,0.00011406573,0.000022073136,0.000005557085,0.000014581307,0.000021492384],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987325,0.00018506788,0.00034239428,0.0001462924,0.0003180412,0.00027567873],"domain_scores_gemma":[0.99934655,0.00006388814,0.00014262175,0.000039151702,0.00018275314,0.00022505698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026008885,0.00008361266,0.00019019017,0.00015767833,0.00013175697,0.00009074249,0.00006404018,0.000043226617,0.00016995278],"category_scores_gemma":[0.00006883537,0.000098704266,0.000023688475,0.0001532316,0.000043011198,0.00036636638,0.000022222493,0.00025808753,0.0000010460831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006891093,0.00015635505,0.07403752,0.00010803369,0.000015702568,0.000085378524,0.0010307655,0.00017611751,0.03780137,6.445332e-7,0.007674214,0.8720228],"study_design_scores_gemma":[0.0078023495,0.0010343181,0.96261126,0.0010970222,0.000015639027,0.00012328675,0.00011388147,0.00022694496,0.022796018,0.000016446795,0.0040040347,0.00015881642],"about_ca_topic_score_codex":0.0007796197,"about_ca_topic_score_gemma":0.006997987,"teacher_disagreement_score":0.8885737,"about_ca_system_score_codex":0.00031274316,"about_ca_system_score_gemma":0.000034745,"threshold_uncertainty_score":0.40250432},"labels":[],"label_agreement":null},{"id":"W1964160901","doi":"10.1038/sj.bjc.6605245","title":"Increased expression of class III β-tubulin in castration-resistant human prostate cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Association pour la Recherche sur les Tumeurs de la Prostate; Institut National de la Santé et de la Recherche Médicale; Université Laval; Association pour la Recherche sur le Cancer","keywords":"Prostate cancer; Prostate; Castration; Oncology; Cancer; Tubulin; Medicine; Cancer research; Biology; Internal medicine; Microtubule; Genetics; Hormone","score_opus":0.006683826579094448,"score_gpt":0.27090882952416895,"score_spread":0.2642250029450745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964160901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858954,0.013573763,0.000021128288,0.000091932096,0.00007902663,0.000109660104,0.00005595872,0.0000014954253,0.0001716583],"genre_scores_gemma":[0.99302804,0.0062160967,0.00017145068,0.00017327155,0.00021188575,0.0000073401716,0.000017714816,0.000010330831,0.00016384291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990376,0.000046782756,0.00047068033,0.00013353406,0.00015381668,0.00015753393],"domain_scores_gemma":[0.9992892,0.000003822538,0.0003405881,0.00009273783,0.00020715287,0.000066502806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016628005,0.00009233506,0.00020767479,0.000050814342,0.000040759747,0.000022814238,0.0001363622,0.00009791219,0.000049469367],"category_scores_gemma":[0.000018641516,0.0001002347,0.00008721604,0.00007150365,0.000037225396,0.000010844715,0.00001719588,0.00014150259,1.205816e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027026862,0.000094976174,0.0028298628,0.000017680013,0.000018011744,0.000044175078,0.000045773926,0.0003093798,0.98109686,0.0000073165047,0.0014520109,0.013813673],"study_design_scores_gemma":[0.0026779263,0.0004010992,0.067298666,0.0008827124,0.000031575444,0.000100714744,0.00007708741,0.000011722269,0.9182816,0.00007991601,0.009970148,0.00018679615],"about_ca_topic_score_codex":0.0013599953,"about_ca_topic_score_gemma":0.006470304,"teacher_disagreement_score":0.0644688,"about_ca_system_score_codex":0.000041625863,"about_ca_system_score_gemma":0.00023221453,"threshold_uncertainty_score":0.40874526},"labels":[],"label_agreement":null},{"id":"W1964176895","doi":"10.1038/bjc.2013.769","title":"FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Royal Victoria Regional Health Centre; Université de Montréal; Université Laval; Royal Victoria Hospital; Centre hospitalier universitaire de Québec; Amgen (Canada); Public Health Ontario; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; National Cancer Institute; Institute of Biomedical Sciences, Academia Sinica; Universitätsklinikum Hamburg-Eppendorf; Canadian Institutes of Health Research; U.S. Army; National Institutes of Health; National University Health System; Biomedical Research Council; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Ministero dello Sviluppo Economico; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Institut National Du Cancer; Medizinischen Hochschule Hannover; Associazione Italiana per la Ricerca sul Cancro; KWF Kankerbestrijding; National Health and Medical Research Council; Universiti Malaya; Academia Sinica; Kuopion Yliopistollinen Sairaala; Yale University; Karolinska Institutet; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Robert Bosch Stiftung; Kementerian Sains, Teknologi dan Inovasi; King's College London; Academy of Finland; Agence Nationale de la Recherche; Medical Research Council; University of Galway; Cancerfonden; National University of Ireland; National Science Council; Stockholms Läns Landsting; Singapore Eye Research Institute; Seoul National University; National Breast Cancer Foundation; European Commission; Deutsche Krebshilfe; University of Oxford; Wellcome Trust; Fondation du cancer du sein du Québec; Rheinische Friedrich-Wilhelms-Universität Bonn; Breast Cancer Research Trust; CHIST-ERA; Cancer Council Tasmania; World Health Organization; National University of Singapore; Cancer Research UK; Norges Forskningsråd; QIMR Berghofer Medical Research Institute; National Institute for Health and Care Research; Itä-Suomen Yliopisto; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Deutsche Gesetzliche Unfallversicherung; Cancer Research UK Cambridge Institute, University of Cambridge; David F. and Margaret T. Grohne Family Foundation; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; College of Medicine, Seoul National University; Virginia Department of Health; University of Toronto; Ohio State University; Peter MacCallum Cancer Centre; Helsingin ja Uudenmaan Sairaanhoitopiiri; Fondation de France; California Breast Cancer Research Program; Breast Cancer Research Foundation; Cancer Council Victoria; California Department of Public Health; National Medical Research Council; Ministério da Ciência, Tecnologia e Inovação; European Social Fund; Menzies Centre for Australian Studies, King's College London, University of London; Cancer Research Institute","keywords":"Breast cancer; Odds ratio; Single-nucleotide polymorphism; Cancer; Oncology; Case-control study; Risk factor; Internal medicine; Breast disease; Medicine; Biology; Genotype; Genetics; Gene","score_opus":0.008639210369057255,"score_gpt":0.26798794142068116,"score_spread":0.2593487310516239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964176895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747134,0.014209917,0.000025451589,0.0062725,0.0005597597,0.00013538939,0.004006773,0.0000054172447,0.00007141798],"genre_scores_gemma":[0.9746953,0.021414122,0.00005914609,0.0004677702,0.0027232275,0.00002028527,0.000035237066,0.000030960717,0.000553916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981583,0.0002785706,0.00045289515,0.00031790845,0.00045774362,0.00033458477],"domain_scores_gemma":[0.99825704,0.00011722399,0.00048105462,0.00019545722,0.0007873228,0.00016192852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007617328,0.00015056157,0.00025319407,0.000025797068,0.00015101113,0.00015163531,0.00027863614,0.00017952522,0.0003810402],"category_scores_gemma":[0.000281136,0.00013110209,0.0001132835,0.00009824885,0.00014273557,0.00002326377,0.00010616219,0.00032458553,0.000002716606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009877464,0.000050729188,0.42119226,0.00002514795,0.00039964748,0.0000055685587,0.00007570277,0.00009217453,0.3323147,0.0000022052552,0.057658456,0.18719566],"study_design_scores_gemma":[0.0023088823,0.000099050885,0.8899506,0.0004343152,0.00008498782,0.00023651402,0.00006682871,0.00004056028,0.025056796,0.000037159567,0.08142204,0.00026229347],"about_ca_topic_score_codex":0.011095677,"about_ca_topic_score_gemma":0.019595794,"teacher_disagreement_score":0.4687583,"about_ca_system_score_codex":0.00019190321,"about_ca_system_score_gemma":0.0003650528,"threshold_uncertainty_score":0.99829406},"labels":[],"label_agreement":null},{"id":"W1964256573","doi":"10.1038/sj.bjc.6601837","title":"A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; RAD51; Breast cancer; Proportional hazards model; Genetics; Hazard ratio; Penetrance; Logistic regression; Medicine; Odds ratio; Oncology; Internal medicine; Biology; Genotype; Cancer; Confidence interval; Gene; Homologous recombination","score_opus":0.012139143511998907,"score_gpt":0.26181067978431927,"score_spread":0.24967153627232036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964256573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719654,0.024339173,0.00006444417,0.0018219809,0.000773447,0.00027785613,0.000668816,0.000004444818,0.00008447866],"genre_scores_gemma":[0.9825583,0.014876341,0.00033302145,0.0011797164,0.00081167486,0.00008995524,0.000010004871,0.000053124615,0.00008783579],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975887,0.00022276625,0.0007871435,0.0004051299,0.00045493073,0.0005413492],"domain_scores_gemma":[0.99888694,0.000034214157,0.00044398077,0.00028708865,0.00020189543,0.0001458966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006586357,0.00026158075,0.00041633507,0.00023216338,0.00011171496,0.00010658934,0.0005766467,0.00023186672,0.00006787298],"category_scores_gemma":[0.00016072107,0.00025030322,0.00017633634,0.00055187,0.00028866777,0.00004143982,0.00007045329,0.00064088986,7.5961367e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005194905,0.0006499532,0.19241759,0.00014906251,0.00089278526,0.00567312,0.009771306,0.1813726,0.32970363,0.000024235878,0.005614662,0.26853615],"study_design_scores_gemma":[0.026860498,0.0008081195,0.69352627,0.0024287072,0.00035352953,0.011404362,0.01040232,0.00015884878,0.22046234,0.00065977883,0.03088373,0.0020514955],"about_ca_topic_score_codex":0.032203827,"about_ca_topic_score_gemma":0.14815469,"teacher_disagreement_score":0.5011087,"about_ca_system_score_codex":0.0011438655,"about_ca_system_score_gemma":0.0020727583,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W1964777676","doi":"10.1038/bjc.2013.417","title":"Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clinical trial; Cancer; Pharmacodynamics; Reporting bias; MEDLINE; Oncology; Internal medicine","score_opus":0.8412142510138525,"score_gpt":0.7353133138146231,"score_spread":0.10590093719922944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964777676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83825564,0.15319929,9.123569e-7,0.0071856054,0.00033587683,0.0006386536,0.000005578448,0.0000046919768,0.00037377],"genre_scores_gemma":[0.710914,0.28704163,0.00042472203,0.00023708827,0.0006504005,0.000120050914,2.992654e-7,0.000021132459,0.00059064105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916901,0.0010260433,0.0042498675,0.00027617285,0.0022982461,0.0004595973],"domain_scores_gemma":[0.88283753,0.06251924,0.027803479,0.0004442689,0.025820863,0.0005746348],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.048176635,0.00011527482,0.0012855184,0.00041563532,0.00010399335,0.00008850568,0.0003112415,0.00019623795,0.00061140023],"category_scores_gemma":[0.63168496,0.000101687074,0.00021174454,0.0006608704,0.0005070575,0.00052978133,0.00018209788,0.0036821526,0.000002618707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015804752,0.0008807482,0.6091755,0.011078759,0.0023677114,0.0037042354,0.0040385546,0.00031018004,0.1955925,0.00012766819,0.0193318,0.15181187],"study_design_scores_gemma":[0.0140066035,0.0020857987,0.65773386,0.15624781,0.00082062563,0.0029376373,0.03140009,0.00032372357,0.09217789,0.039989106,0.0016392844,0.00063758827],"about_ca_topic_score_codex":0.012135972,"about_ca_topic_score_gemma":0.044929963,"teacher_disagreement_score":0.5835083,"about_ca_system_score_codex":0.0005381532,"about_ca_system_score_gemma":0.006689649,"threshold_uncertainty_score":0.9989415},"labels":[],"label_agreement":null},{"id":"W1965495456","doi":"10.1038/sj.bjc.6600059","title":"Local hypoxia is produced at sites of intratumour injection","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Tirapazamine; Hypoxia (environmental); Oxygenation; Pathology; Biopsy; Biodistribution; Medicine; Chemistry; Cytotoxicity; Oxygen; Internal medicine; In vitro","score_opus":0.01069703295424153,"score_gpt":0.2403006668577579,"score_spread":0.22960363390351635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965495456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952513,0.10270856,0.00014114821,0.0001554152,0.0010881615,0.000067720204,0.00003545002,0.0000027180731,0.00054956373],"genre_scores_gemma":[0.96941876,0.025329225,0.000119324475,0.00030348875,0.002424775,0.000004695845,0.0000042674756,0.00001598399,0.0023794537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907553,0.000035050096,0.0003370943,0.00016120767,0.00022232866,0.00016879012],"domain_scores_gemma":[0.99915975,0.000003970826,0.00028980293,0.00011368831,0.00034579076,0.00008701877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014072219,0.00009609062,0.00021747085,0.000042464515,0.00005118614,0.000019754265,0.00012569643,0.00010973345,0.00038591123],"category_scores_gemma":[0.000053998414,0.00010730362,0.00014937262,0.000096877,0.00008628546,0.000010622232,0.000038019916,0.000142421,0.0000028620002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012267118,0.00007435147,0.00084326044,0.000031341577,0.000101558595,0.000008898522,0.00008491242,0.00011055305,0.7166457,0.000002882414,0.115064025,0.16690986],"study_design_scores_gemma":[0.0010474753,0.00028022894,0.008790043,0.000102051075,0.00007360561,0.0015130574,0.000044818138,0.00003067291,0.6037115,0.000024341953,0.38422042,0.00016181252],"about_ca_topic_score_codex":0.000158873,"about_ca_topic_score_gemma":0.000588538,"teacher_disagreement_score":0.2691564,"about_ca_system_score_codex":0.000037802776,"about_ca_system_score_gemma":0.00007776931,"threshold_uncertainty_score":0.43757144},"labels":[],"label_agreement":null},{"id":"W1965568377","doi":"10.1038/bjc.2012.272","title":"PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Gertrude von Meissner-Stiftung; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"PIM1; Cancer research; Diffuse large B-cell lymphoma; Biology; Kinase; Lymphoma; Tissue microarray; Signal transduction; Cell growth; Cell biology; Phosphorylation; Immunohistochemistry; Immunology; Serine","score_opus":0.010186483452341643,"score_gpt":0.2936566803929901,"score_spread":0.28347019694064846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965568377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7606149,0.23833728,0.000062876024,0.00030332967,0.0003945383,0.00012607168,0.000009016408,0.000006711666,0.00014532113],"genre_scores_gemma":[0.97431266,0.024142068,0.00019703925,0.0007042408,0.0004672562,0.000012053163,0.0000012226367,0.000026784315,0.00013669099],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989849,0.000043335785,0.00028031392,0.00010030521,0.0002695643,0.00032158307],"domain_scores_gemma":[0.999399,0.000019199828,0.00024737132,0.0000653844,0.00008383758,0.00018521941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031860062,0.00010697325,0.00029805192,0.000097620534,0.000059381753,0.000031047857,0.000051728683,0.000059202208,0.00024064194],"category_scores_gemma":[0.000013678392,0.00009992809,0.0000795931,0.000110435714,0.000026302181,0.00019290585,0.00001891309,0.000155223,7.0181835e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010354161,0.0027218226,0.110525265,0.0001793974,0.000109013876,0.00069781014,0.0006569692,6.7327755e-7,0.005235015,0.000034994748,0.0010025358,0.87780106],"study_design_scores_gemma":[0.05050878,0.00060894556,0.7916821,0.0055490145,0.00022454256,0.0031598625,0.0017442171,0.00008557871,0.011738756,0.00036200212,0.13390432,0.00043184473],"about_ca_topic_score_codex":0.00011014497,"about_ca_topic_score_gemma":0.0002621542,"teacher_disagreement_score":0.8773692,"about_ca_system_score_codex":0.00012474504,"about_ca_system_score_gemma":0.00008235592,"threshold_uncertainty_score":0.4074949},"labels":[],"label_agreement":null},{"id":"W1965713922","doi":"10.1038/bjc.2015.83","title":"Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"Universitat de Barcelona; Bundesamt für Strahlenschutz; Associazione Italiana per la Ricerca sul Cancro; Ministerio de Economía y Competitividad; Fondation de France; Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; World Health Organization","keywords":"Endocrine system; Lymphoma; Medicine; Occupational exposure; Incidence (geometry); Internal medicine; Physiology; Oncology; Environmental health; Hormone","score_opus":0.02028289842986274,"score_gpt":0.3108551157700091,"score_spread":0.2905722173401464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965713922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930523,0.0062117227,0.00031724278,0.00003430806,0.00015991443,0.00014138974,0.000045338445,0.000001247638,0.000036522204],"genre_scores_gemma":[0.99827987,0.0008963367,0.00038525026,0.000100893405,0.00024332645,0.0000057366515,0.0000036612685,0.000011054657,0.00007388413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991947,0.00012505105,0.00024212108,0.00013667249,0.00017450536,0.00012696716],"domain_scores_gemma":[0.9994909,0.0000054845636,0.00011448396,0.00006737224,0.00016364428,0.00015811724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032322563,0.00007232756,0.0001233314,0.000056070865,0.000030134628,0.00004099064,0.00008793121,0.0000184621,0.0000080543205],"category_scores_gemma":[0.00011303715,0.00007779989,0.000039498802,0.00008514711,0.000015149342,0.000005343288,0.00007616773,0.000059724316,7.25256e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026072742,0.0005112156,0.8930892,0.0000045453867,0.000060212264,0.0004332537,0.00025657951,0.0007144856,0.0051238285,4.1088396e-7,0.0011845009,0.098361045],"study_design_scores_gemma":[0.0040840115,0.0006774007,0.9837733,0.000029380953,0.000022448325,0.00038438564,0.00042483746,0.000011581037,0.0009852883,0.000001694835,0.009504385,0.0001012659],"about_ca_topic_score_codex":0.00061265234,"about_ca_topic_score_gemma":0.004066925,"teacher_disagreement_score":0.098259784,"about_ca_system_score_codex":0.000047429545,"about_ca_system_score_gemma":0.00013849487,"threshold_uncertainty_score":0.31725875},"labels":[],"label_agreement":null},{"id":"W1965930974","doi":"10.1038/sj.bjc.6605876","title":"Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Medical Research Council; National Cancer Institute; National Institutes of Health; University of Melbourne; Huntsman Cancer Institute; Medical Research Council; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Cancer; Ovarian cancer; Internal medicine; Oncology; Gynecology; Prostate cancer; Incidence (geometry); Population; Lung cancer; Male breast cancer; Family history","score_opus":0.013921684513501335,"score_gpt":0.3100951462656065,"score_spread":0.2961734617521052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965930974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987175,0.017438289,0.00018117765,0.0002764646,0.00023585922,0.00021612391,0.0017505368,0.000003498609,0.000026285636],"genre_scores_gemma":[0.99101764,0.006584596,0.0016218992,0.00010868617,0.00041067236,0.000105009596,0.00001528812,0.000035292273,0.00010092924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905545,0.000042485575,0.0003200989,0.00023287015,0.00016668344,0.00018238852],"domain_scores_gemma":[0.9986522,0.000054269465,0.000409856,0.00011791063,0.000638518,0.00012721236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017777273,0.00014554519,0.0002653622,0.00006676733,0.00013144234,0.000054477594,0.00010865492,0.0001242512,0.00006659506],"category_scores_gemma":[0.00008618731,0.000144839,0.000063459105,0.000096103126,0.00040416908,0.000032500044,0.000033214284,0.0002166189,6.5298856e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013887956,0.00009222219,0.8071639,0.00012717335,0.0009101113,0.000026144966,0.00041807792,0.00041173337,0.111498445,0.000012773788,0.0022058066,0.07574484],"study_design_scores_gemma":[0.0029629217,0.00029830472,0.9560468,0.0004225037,0.00034488545,0.002952776,0.00017647218,0.000032975575,0.03304797,0.00009399248,0.0033515624,0.00026882088],"about_ca_topic_score_codex":0.005941489,"about_ca_topic_score_gemma":0.021339323,"teacher_disagreement_score":0.14888294,"about_ca_system_score_codex":0.000043847034,"about_ca_system_score_gemma":0.0007681962,"threshold_uncertainty_score":0.9965187},"labels":[],"label_agreement":null},{"id":"W1966268953","doi":"10.1038/sj.bjc.6603184","title":"Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Protein kinase B; Prostate cancer; Medicine; Cancer; PI3K/AKT/mTOR pathway; Internal medicine; Perineural invasion; Biochemical recurrence; Oncology; Pathology; Cancer research; Prostatectomy; Biology; Phosphorylation; Signal transduction","score_opus":0.009590674987163629,"score_gpt":0.2921222671562387,"score_spread":0.28253159216907503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966268953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831373,0.015949452,0.00021882466,0.000047685407,0.00032173927,0.00015181731,0.00011705077,0.000002268275,0.00005386702],"genre_scores_gemma":[0.99520427,0.003863464,0.00038789937,0.00008829902,0.00026675587,0.000009507594,0.000013991662,0.000024134553,0.00014164919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984701,0.00007936795,0.0007796282,0.00021586323,0.00029095108,0.00016406413],"domain_scores_gemma":[0.99838185,0.000026111466,0.0008968704,0.0001037114,0.0005050419,0.00008640896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030221473,0.00013113323,0.00035362164,0.000040382893,0.000041829688,0.000022017368,0.00010213836,0.0001468074,0.000024416731],"category_scores_gemma":[0.000058323232,0.00012083036,0.000075677875,0.00006538447,0.00024851225,0.000021547805,0.00005043562,0.00018027301,8.782296e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083109015,0.00015630455,0.9263945,0.00012197705,0.000099433164,0.000014277596,0.000044115703,0.0006758656,0.041649543,0.0000021307253,0.0018407407,0.028169986],"study_design_scores_gemma":[0.008322038,0.0020905968,0.77976525,0.002182395,0.0002461368,0.00015654152,0.000054874537,0.000070358576,0.1971522,0.00010698446,0.0094283605,0.0004242741],"about_ca_topic_score_codex":0.0007934134,"about_ca_topic_score_gemma":0.00059519615,"teacher_disagreement_score":0.15550266,"about_ca_system_score_codex":0.000029948324,"about_ca_system_score_gemma":0.00014861142,"threshold_uncertainty_score":0.49273193},"labels":[],"label_agreement":null},{"id":"W1966385112","doi":"10.1038/bjc.2013.517","title":"Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Aging; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Capecitabine; Colorectal cancer; Medicine; Internal medicine; Oncology; Fluorouracil; Cancer","score_opus":0.006457078922198525,"score_gpt":0.255815041071987,"score_spread":0.24935796214978848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737078,0.022675922,0.000001781376,0.0010302915,0.00057102926,0.0005112341,0.00003334751,0.000011521719,0.0014570524],"genre_scores_gemma":[0.9934697,0.0044410774,0.00024708934,0.00033385507,0.00029061746,0.00020759771,0.0000042348915,0.00003297872,0.0009728055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853903,0.000025229932,0.0004360184,0.00019823285,0.0004618356,0.0003396332],"domain_scores_gemma":[0.998725,0.000030212152,0.00026705986,0.000071207374,0.00073503656,0.00017150944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005522501,0.00018625888,0.0005649559,0.00010432551,0.00006859285,0.000044695604,0.000086488784,0.00006192292,0.002263439],"category_scores_gemma":[0.000023368642,0.00014940684,0.00009964801,0.00026991326,0.00008713591,0.00031291728,0.00002395227,0.00030078652,0.0000053597673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011330761,0.00039028632,0.54061455,0.000039598257,0.0003358665,0.00026173057,0.00015717914,0.00003930574,0.00022139169,0.000002505824,0.0040038167,0.45280072],"study_design_scores_gemma":[0.009817014,0.0018998281,0.9741564,0.0010182604,0.00013790304,0.00008726283,0.00007579906,0.0000039249617,0.00021781375,0.000025578933,0.0123856375,0.00017458576],"about_ca_topic_score_codex":0.0045803697,"about_ca_topic_score_gemma":0.009593834,"teacher_disagreement_score":0.45262614,"about_ca_system_score_codex":0.00054629956,"about_ca_system_score_gemma":0.00026200752,"threshold_uncertainty_score":0.99864864},"labels":[],"label_agreement":null},{"id":"W1966796326","doi":"10.1038/bjc.2013.691","title":"HDAC inhibitor confers radiosensitivity to prostate stem-like cells","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radioresistance; Radiosensitivity; Stem cell; Cancer research; Trichostatin A; Comet assay; Biology; Prostate cancer; Cancer stem cell; Population; Prostate; Molecular biology; Pathology; DNA damage; Histone deacetylase; Cell culture; Radiation therapy; Cancer; Histone; Medicine; Cell biology; Internal medicine; Genetics; DNA","score_opus":0.0072465360454552165,"score_gpt":0.259111076767119,"score_spread":0.25186454072166375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966796326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473244,0.0032000972,0.0001441114,0.0004689284,0.00069418974,0.00032792357,0.000056581404,0.000004874838,0.00037086266],"genre_scores_gemma":[0.99169326,0.0012027243,0.00035246945,0.00062178273,0.0009080441,0.000027713575,0.0000047962217,0.000036822523,0.0051523903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985566,0.000119151664,0.00036940153,0.00022703719,0.00038155614,0.00034626795],"domain_scores_gemma":[0.99860454,0.0000132032665,0.00017018462,0.00016390614,0.00070950453,0.0003386814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003312885,0.00012491323,0.00023610891,0.000071750976,0.00008113362,0.00011882575,0.00017972077,0.000105984844,0.00012875651],"category_scores_gemma":[0.000055959827,0.0001440015,0.0001364182,0.00011132406,0.0000984057,0.000017769215,0.00007962471,0.00025322355,0.000052307096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007958523,0.000046651225,0.00016542464,0.000025317315,0.00005311691,0.00013467639,0.00005112138,0.0000952953,0.80411,5.3594414e-7,0.15155976,0.043678556],"study_design_scores_gemma":[0.00082464307,0.0003406118,0.001371326,0.00020573096,0.0000126242785,0.00055721053,0.0000817935,0.000011054491,0.8168351,0.0000042113843,0.17954959,0.0002060897],"about_ca_topic_score_codex":0.0006195235,"about_ca_topic_score_gemma":0.00045787232,"teacher_disagreement_score":0.043472465,"about_ca_system_score_codex":0.00009445081,"about_ca_system_score_gemma":0.0003376971,"threshold_uncertainty_score":0.5872211},"labels":[],"label_agreement":null},{"id":"W1966868760","doi":"10.1054/bjoc.2000.1538","title":"Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Apoptosis; Programmed cell death; Biology; Cancer cell; Chinese hamster ovary cell; Cancer research; Transfection; Cell culture; Cancer; Ovarian cancer; Immunology; Genetics","score_opus":0.02986125080838409,"score_gpt":0.30980188662445707,"score_spread":0.279940635816073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966868760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94771063,0.048545368,0.00019011088,0.0017566531,0.00048135954,0.00085172703,0.000063706706,0.000012719544,0.00038774655],"genre_scores_gemma":[0.8772284,0.115951255,0.0038916953,0.00031282377,0.0008948213,0.0002826862,0.000003922947,0.000053144788,0.0013812887],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981081,0.0000378578,0.0005907315,0.00042240025,0.00050289533,0.0003380321],"domain_scores_gemma":[0.9980263,0.000110684436,0.00062770455,0.00024781298,0.0007820237,0.00020543784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019013303,0.0002603721,0.00084491115,0.000121990895,0.00010967809,0.000048681206,0.00011243783,0.000079979676,0.00011635832],"category_scores_gemma":[0.000046013996,0.00021518939,0.00047561363,0.00022852486,0.00004036599,0.00025545424,0.000014319298,0.00011297992,0.0000015504512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010303142,0.010873312,0.2554563,0.0016253268,0.008914987,0.0039680977,0.004295375,0.0008643209,0.16706662,0.0001495199,0.0036360733,0.5328469],"study_design_scores_gemma":[0.015460417,0.004618551,0.009417269,0.007213266,0.0033565082,0.0003848403,0.0005637167,0.000024519095,0.954463,0.00016060287,0.003988171,0.00034915135],"about_ca_topic_score_codex":0.002078745,"about_ca_topic_score_gemma":0.00022122041,"teacher_disagreement_score":0.7873964,"about_ca_system_score_codex":0.0005549013,"about_ca_system_score_gemma":0.000732594,"threshold_uncertainty_score":0.87751687},"labels":[],"label_agreement":null},{"id":"W1966945481","doi":"10.1054/bjoc.2001.2196","title":"The surgical management of women with ovarian cancer in the south west of England","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Gynecology; Epithelial ovarian cancer; Multivariate analysis; Surgery; Internal medicine","score_opus":0.010527599922157781,"score_gpt":0.26899921502353485,"score_spread":0.25847161510137706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966945481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744158,0.020831011,0.000006075905,0.0027817327,0.0001290873,0.00023784577,0.000025305719,0.0000016509345,0.001571514],"genre_scores_gemma":[0.9587213,0.040645998,0.000053693824,0.000099076795,0.00022651438,0.00006589531,4.7618457e-7,0.000010805304,0.00017626927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987428,0.00006182891,0.00040786708,0.00009669833,0.00045667784,0.00023413113],"domain_scores_gemma":[0.9992401,0.0000747069,0.0003152397,0.00013806079,0.00015331573,0.00007857707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057656487,0.00008844589,0.00032928135,0.000042050153,0.000047849066,0.000025031977,0.00014561648,0.000030224099,0.00037150414],"category_scores_gemma":[0.000006253119,0.00004913488,0.00007017996,0.00023902293,0.00010073074,0.00004584854,0.000015166672,0.0001744404,3.6312298e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027807585,0.00053526834,0.4966723,0.00014471839,0.0012426798,0.005646397,0.0026272123,0.0002526318,0.000005993927,0.00025385627,0.00042591864,0.48941225],"study_design_scores_gemma":[0.008793916,0.00049703394,0.9300837,0.0018644339,0.0002467782,0.0013230371,0.0015353706,0.000003670777,0.00005526839,0.000045200464,0.055488203,0.00006342065],"about_ca_topic_score_codex":0.0014980168,"about_ca_topic_score_gemma":0.0025505372,"teacher_disagreement_score":0.48934883,"about_ca_system_score_codex":0.00024310088,"about_ca_system_score_gemma":0.00019359279,"threshold_uncertainty_score":0.40677097},"labels":[],"label_agreement":null},{"id":"W1967036025","doi":"10.1038/sj.bjc.6604901","title":"Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Faculty of Medicine, McGill University; McGill University","keywords":"Focal adhesion; Proto-oncogene tyrosine-protein kinase Src; Cell biology; Cell migration; Extracellular matrix; Biology; ErbB; Receptor tyrosine kinase; Tyrosine kinase; Motility; Kinase; Signal transduction; Cell; Cancer research; Biochemistry","score_opus":0.012257391740921946,"score_gpt":0.29410036280405977,"score_spread":0.2818429710631378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967036025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447514,0.013496907,0.00011753973,0.0013262884,0.00011686158,0.0001998988,0.000040882598,0.0000043670966,0.00022214328],"genre_scores_gemma":[0.9908445,0.007889979,0.00021079749,0.00033276566,0.00026852777,0.0000024183114,0.0000041046665,0.00001871256,0.00042817846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806565,0.00007595497,0.00063099724,0.00016156155,0.00081465306,0.0002511962],"domain_scores_gemma":[0.99872166,0.00006996183,0.00035413544,0.00008667438,0.00058582856,0.0001817496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032746725,0.000109827015,0.00040183213,0.00018888549,0.000028858343,0.000026369175,0.00012614903,0.00011288988,0.0011235923],"category_scores_gemma":[0.00006679264,0.000114464354,0.00013996984,0.00031817995,0.000056493875,0.00017426786,0.00001965454,0.00045549008,0.0000024249248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065884343,0.00017760326,0.004073948,0.00007178345,0.000031251086,0.00029506214,0.00007302657,0.0006653237,0.84880084,0.0000017509619,0.009991595,0.135159],"study_design_scores_gemma":[0.003579927,0.0004283842,0.40107659,0.0044410164,0.000070960894,0.0009326434,0.0000679735,0.00029128374,0.5873064,0.00012532067,0.0015219569,0.00015754631],"about_ca_topic_score_codex":0.0010110822,"about_ca_topic_score_gemma":0.0006761814,"teacher_disagreement_score":0.39700264,"about_ca_system_score_codex":0.0003470029,"about_ca_system_score_gemma":0.0005244336,"threshold_uncertainty_score":0.99978954},"labels":[],"label_agreement":null},{"id":"W1967649543","doi":"10.1038/sj.bjc.6602063","title":"Interstitial lung disease associated with drug therapy","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"AstraZeneca","keywords":"Medicine; Interstitial lung disease; Gefitinib; Lung cancer; Diffuse alveolar damage; Disease; Radiation therapy; Internal medicine; Chemotherapy; Intensive care medicine; Oncology; Pathology; Cancer; Lung; Epidermal growth factor receptor; Acute respiratory distress","score_opus":0.01802343363430449,"score_gpt":0.32297866921994367,"score_spread":0.3049552355856392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967649543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017011994,0.9975644,0.000030100857,0.00011150845,0.0008306822,0.0005313107,0.0004932797,0.000022669321,0.00024597926],"genre_scores_gemma":[0.0020596697,0.99490833,0.000021211603,0.00021950285,0.0016169603,0.00004100778,0.0001011998,0.00010620856,0.0009258863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776405,0.00012946838,0.00083939853,0.0002689334,0.0006601183,0.00033804885],"domain_scores_gemma":[0.9977641,0.00005250787,0.00097544154,0.0001642115,0.00048182395,0.000561889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021327233,0.0003761454,0.0018233153,0.0001766008,0.00009328793,0.00011243935,0.00025164176,0.00015722,0.00048357414],"category_scores_gemma":[0.00008962993,0.00030373622,0.0012731367,0.00023717452,0.00014606972,0.00017991306,0.000031086016,0.00089543086,0.000004241046],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027617316,0.0004455124,0.000055151617,0.010731184,0.0019221358,0.014303885,0.000031671767,0.000005975038,1.777811e-7,0.000012307783,0.0066095297,0.96312076],"study_design_scores_gemma":[0.0017687605,0.00072142115,0.00018245765,0.37508875,0.004334562,0.0024688148,0.000010017817,0.0000032117296,2.1607707e-7,0.00001558367,0.6150968,0.00030936717],"about_ca_topic_score_codex":0.00016361682,"about_ca_topic_score_gemma":0.000045767312,"teacher_disagreement_score":0.96281135,"about_ca_system_score_codex":0.0010539674,"about_ca_system_score_gemma":0.0038193588,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W1967961552","doi":"10.1038/bjc.2014.173","title":"Common infection-related conditions and risk of lymphoid malignancies in older individuals","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Cancer Institute; National Institutes of Health; Department for Employment and Learning, Northern Ireland; Queen's University; Queen's University Belfast","keywords":"Medicine; Immunology; Oncology; Internal medicine","score_opus":0.006098518011183291,"score_gpt":0.2657300370907459,"score_spread":0.2596315190795626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967961552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866818,0.011785068,0.000015246873,0.00021233001,0.00016862502,0.00009857445,0.000055529363,0.0000060513457,0.0009767796],"genre_scores_gemma":[0.9768386,0.022785302,0.000027413656,0.00018797068,0.00005282849,0.000006159336,0.0000049249456,0.000011187418,0.00008561553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999056,0.00008142595,0.0004440085,0.00007803236,0.00020589828,0.0001346516],"domain_scores_gemma":[0.99919194,0.000056161094,0.0004565737,0.000050704268,0.00016558281,0.00007901612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036555695,0.000072485775,0.00035907433,0.00013486209,0.000054753127,0.000019156176,0.00003552672,0.00009276499,0.00021649123],"category_scores_gemma":[0.00015302545,0.00007736491,0.000086927284,0.00019595466,0.000085043874,0.00012354675,0.000011220916,0.00022184454,7.068138e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003120314,0.000100055375,0.96600616,0.000042253927,0.00017843362,0.00001897976,0.0002216619,0.0002419599,0.0002530907,0.000039637238,0.002298959,0.03056761],"study_design_scores_gemma":[0.0061956802,0.00018859586,0.98775923,0.0011913776,0.00023959366,0.00042560554,0.00011583239,0.000043468575,0.00033086346,0.0010084426,0.0024214543,0.000079879035],"about_ca_topic_score_codex":0.005712898,"about_ca_topic_score_gemma":0.0046642553,"teacher_disagreement_score":0.030487731,"about_ca_system_score_codex":0.00009510986,"about_ca_system_score_gemma":0.0001465717,"threshold_uncertainty_score":0.86362314},"labels":[],"label_agreement":null},{"id":"W1968818485","doi":"10.1038/bjc.2013.380","title":"A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Progressive disease; Pharmacology; Nausea; Angiogenesis; Internal medicine; Adverse effect; Vascular endothelial growth factor; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy; VEGF receptors","score_opus":0.004725087741611764,"score_gpt":0.2583241261718354,"score_spread":0.25359903843022363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968818485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962206,0.0033243364,0.00001699298,0.0000290136,0.00009492057,0.00026088385,0.000017283553,5.2709777e-7,0.000035475157],"genre_scores_gemma":[0.99924535,0.00057894905,0.000039085753,0.000043980235,0.000040733168,0.000013445493,0.0000021221128,0.000010638419,0.000025725187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992541,0.00004373305,0.0003052015,0.00009862186,0.000200773,0.000097537224],"domain_scores_gemma":[0.9990949,0.0000053182175,0.0003790359,0.00008636189,0.00039885455,0.000035500638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009588746,0.00007162508,0.00018697967,0.000029323855,0.000026630085,0.000010631289,0.00011663176,0.000038601458,0.000020426276],"category_scores_gemma":[0.000023051818,0.000056358593,0.000047361482,0.00008364519,0.00006000894,0.000014253593,0.00003170889,0.000064461135,5.407861e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000757233,0.002927064,0.8147536,0.000052698935,0.00018971346,0.00000549118,0.0003022665,0.0003672443,0.04804626,0.000004021925,0.0006740618,0.13192035],"study_design_scores_gemma":[0.011337064,0.002706582,0.95909065,0.00025506582,0.000048520662,0.000014321636,0.00032608354,0.00001053935,0.02586665,0.00001724129,0.0002296606,0.00009760663],"about_ca_topic_score_codex":0.00028601722,"about_ca_topic_score_gemma":0.00051993644,"teacher_disagreement_score":0.14433707,"about_ca_system_score_codex":0.000017599708,"about_ca_system_score_gemma":0.00007302476,"threshold_uncertainty_score":0.22982368},"labels":[],"label_agreement":null},{"id":"W1968864885","doi":"10.1038/sj.bjc.6604803","title":"Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Paclitaxel; Bioluminescence imaging; Ovarian cancer; Bioluminescence; Medicine; Luciferase; Cancer research; Apoptosis; Ovarian carcinoma; Chemotherapy; Cytotoxicity; In vivo; Oncology; Internal medicine; Cancer; Pathology; In vitro; Biology; Cell culture","score_opus":0.02210422114630125,"score_gpt":0.293406102279716,"score_spread":0.27130188113341475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968864885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867307,0.008569309,0.004220815,0.00008748669,0.000099434415,0.00014016044,0.000046753277,0.0000108224995,0.00009451012],"genre_scores_gemma":[0.98189354,0.014549754,0.0033352089,0.00002697714,0.00014269815,0.000013529914,0.0000015227162,0.000028008491,0.000008752649],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989466,0.000018947761,0.00055317715,0.00008801383,0.00020401538,0.00018926448],"domain_scores_gemma":[0.99942654,0.00002685381,0.00017981062,0.00008998988,0.0002150803,0.000061709274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012020802,0.00010696699,0.00033262296,0.00012076753,0.000039376257,0.000012975045,0.00013937528,0.000038733688,0.000058050384],"category_scores_gemma":[0.000008033641,0.000118933036,0.00010020923,0.00022151087,0.00007581326,0.00013537522,0.00001018673,0.00019733912,3.7312972e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079885416,0.0004063392,0.058934048,0.00013446268,0.0002113925,0.00006782705,0.00082442164,0.39695522,0.4600876,0.00006885683,0.000121797806,0.08210814],"study_design_scores_gemma":[0.010017064,0.00010797051,0.42466512,0.0018883953,0.00011731372,0.0009514251,0.0005110733,0.5331943,0.026307005,0.00017280925,0.0014091814,0.00065833057],"about_ca_topic_score_codex":0.0015002204,"about_ca_topic_score_gemma":0.0002992806,"teacher_disagreement_score":0.4337806,"about_ca_system_score_codex":0.00019123284,"about_ca_system_score_gemma":0.00029001795,"threshold_uncertainty_score":0.48499486},"labels":[],"label_agreement":null},{"id":"W1969069350","doi":"10.1038/bjc.2011.256","title":"Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Leukopenia; Medicine; Carboplatin; Internal medicine; Gastroenterology; Chemotherapy; Oncology; Surgery; Cisplatin","score_opus":0.03812314010986336,"score_gpt":0.3147218956654109,"score_spread":0.2765987555555476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969069350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791492,0.014424737,0.000009418743,0.0006047754,0.0019018634,0.00035642946,0.000048011636,0.000018658264,0.0034868661],"genre_scores_gemma":[0.990697,0.007879142,0.00020489722,0.00022778392,0.00074842334,0.00007032222,0.0000012643544,0.000037315953,0.00013382181],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99829566,0.000118548356,0.00058365765,0.00024148944,0.00045553135,0.0003051072],"domain_scores_gemma":[0.9988742,0.000031840482,0.00032684597,0.00018854353,0.000289103,0.0002895002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037972457,0.00016547223,0.00048114982,0.00014870416,0.00008610363,0.0000511514,0.00017056502,0.00009039273,0.0005525155],"category_scores_gemma":[0.00012438768,0.00016074034,0.00010906696,0.0002725499,0.0000797797,0.0002517152,0.00007542978,0.0006693487,0.0000013263531],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013607923,0.00037279766,0.47045144,0.00014143932,0.00017482729,0.0024090707,0.000705708,0.0000045444745,0.0045437105,0.00005683646,0.0024542105,0.5173246],"study_design_scores_gemma":[0.005539788,0.00084529014,0.9797518,0.0025203973,0.00021950658,0.002392207,0.00010484736,0.000015770316,0.0018220464,0.00014858753,0.006438244,0.0002015077],"about_ca_topic_score_codex":0.0046483544,"about_ca_topic_score_gemma":0.0095827365,"teacher_disagreement_score":0.5171231,"about_ca_system_score_codex":0.00019127966,"about_ca_system_score_gemma":0.0006089464,"threshold_uncertainty_score":0.70269525},"labels":[],"label_agreement":null},{"id":"W1969252475","doi":"10.1038/sj.bjc.6600895","title":"Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Health Utilities Index; Psychosocial; Construct validity; Psychometrics; Quality of life (healthcare); Medicine; Physical therapy; EQ-5D; Visual analogue scale; Psychology; Health related quality of life; Clinical psychology; Psychiatry; Internal medicine; Nursing","score_opus":0.012257078044795467,"score_gpt":0.3115146192791826,"score_spread":0.29925754123438714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969252475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8404507,0.12328295,0.000083651685,0.03522051,0.0003460489,0.0004921868,0.000022935357,0.0000065893355,0.00009440678],"genre_scores_gemma":[0.9499533,0.042432338,0.00006353059,0.007259042,0.00023683364,0.000010041993,8.5972437e-7,0.00001981776,0.000024191368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759793,0.0006013809,0.0008840746,0.000153148,0.0005252497,0.00023821356],"domain_scores_gemma":[0.99846077,0.00008527547,0.0010094931,0.00016031362,0.00016561127,0.00011856337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017475899,0.0001302585,0.00060682686,0.00007873422,0.00019091474,0.000037774276,0.00012831375,0.000055456156,0.00005792676],"category_scores_gemma":[0.00026535362,0.000098482386,0.0001322301,0.00025932267,0.00040465576,0.00013089257,0.000017539596,0.00050226634,7.3467e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003502412,0.00008523998,0.9286114,0.00035586438,0.00023831567,0.0000018627259,0.00427187,0.00013752878,0.0000029301268,0.0007803598,0.0007079853,0.064456396],"study_design_scores_gemma":[0.008718375,0.00011991591,0.97762495,0.009155518,0.000031686603,0.0014127078,0.0008957878,0.0000099143635,0.00020745868,0.00096186943,0.00076415186,0.000097679],"about_ca_topic_score_codex":0.024004014,"about_ca_topic_score_gemma":0.018960796,"teacher_disagreement_score":0.10950262,"about_ca_system_score_codex":0.00034142967,"about_ca_system_score_gemma":0.0023935244,"threshold_uncertainty_score":0.9989406},"labels":[],"label_agreement":null},{"id":"W1969696346","doi":"10.1038/sj.bjc.6601099","title":"Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Svenska Läkaresällskapet; Turner Foundation; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Breast cancer; Gene transfer; Cancer research; Cancer; Medicine; Gene; Biology; Pathology; Internal medicine; Genetics","score_opus":0.02421727473901761,"score_gpt":0.29863187512381856,"score_spread":0.2744146003848009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969696346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890626,0.009250773,0.00036610817,0.0005183213,0.000294819,0.00013621825,0.0002982793,0.0000065399113,0.00022265916],"genre_scores_gemma":[0.99256945,0.0065015396,0.00024425666,0.00016398897,0.00025771678,0.000017136703,0.0000036922129,0.00002813028,0.00021406708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984547,0.000054723918,0.000697478,0.00016860405,0.0003877652,0.00023674022],"domain_scores_gemma":[0.9992029,0.00002192703,0.00022129927,0.00008436098,0.00031583547,0.00015365721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020799489,0.00015042015,0.0005065995,0.00014983471,0.00004246868,0.000019534844,0.00009943877,0.00009194822,0.0006353513],"category_scores_gemma":[0.000036629226,0.00014008446,0.00018410958,0.00020561277,0.00004713008,0.00023130175,0.0000061217634,0.00052788464,5.6148906e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003009901,0.00030124263,0.0022471796,0.000066203436,0.000086264874,0.0001263185,0.0001668788,0.00060993823,0.9812537,0.000010958184,0.0013228181,0.013507499],"study_design_scores_gemma":[0.0037064955,0.00030581944,0.021441637,0.004624048,0.00015699866,0.0036002884,0.00010719177,0.00051716476,0.96448314,0.0000478697,0.0008036337,0.00020570862],"about_ca_topic_score_codex":0.001984349,"about_ca_topic_score_gemma":0.000806864,"teacher_disagreement_score":0.019194458,"about_ca_system_score_codex":0.00019234777,"about_ca_system_score_gemma":0.00053822773,"threshold_uncertainty_score":0.6956651},"labels":[],"label_agreement":null},{"id":"W1970053010","doi":"10.1038/sj.bjc.6604896","title":"Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; University of South Carolina","keywords":"Photodynamic therapy; Ceramide; In vivo; Cancer research; Cancer; In vitro; Sphingolipid; Biology; Pathology; Medicine; Internal medicine; Apoptosis; Chemistry; Biochemistry","score_opus":0.005406259888965835,"score_gpt":0.2166880040697486,"score_spread":0.21128174418078277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970053010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959628,0.038549054,0.00022660087,0.0011411224,0.00014235039,0.00026681233,0.000034536977,0.000006077796,0.00000544318],"genre_scores_gemma":[0.99619323,0.0017680897,0.000118230164,0.00091096445,0.0007804369,0.000040450606,0.00000774439,0.000025075777,0.00015576574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852204,0.00030592486,0.0003363126,0.00030193463,0.00029042066,0.00024339293],"domain_scores_gemma":[0.99896085,0.000065163724,0.00032846438,0.00020795068,0.00033143442,0.00010610758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007546386,0.00018825638,0.0002350401,0.000047075748,0.00016434063,0.00017619146,0.00022659959,0.00008321695,0.000016054815],"category_scores_gemma":[0.00019520851,0.00013214182,0.00009514915,0.00011849585,0.000119558434,0.000048940903,0.000040720854,0.00030604855,4.4907915e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008135758,0.00007028251,0.0034278096,0.000011889595,0.00003558738,0.00009055049,0.00028653472,0.00016714643,0.98599154,2.0247538e-7,0.00031846855,0.0014642136],"study_design_scores_gemma":[0.0016758714,0.00042381004,0.44576794,0.00016007485,0.00018544172,0.00052643934,0.00015980781,0.000113475864,0.54992574,0.000024269075,0.0008151925,0.00022191445],"about_ca_topic_score_codex":0.0017551099,"about_ca_topic_score_gemma":0.001722272,"teacher_disagreement_score":0.44234014,"about_ca_system_score_codex":0.000040797353,"about_ca_system_score_gemma":0.00018526847,"threshold_uncertainty_score":0.5388587},"labels":[],"label_agreement":null},{"id":"W1970080542","doi":"10.1038/bjc.2013.670","title":"ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Cancer Research Society; National Natural Science Foundation of China; Canadian Dermatology Foundation","keywords":"Angiogenesis; Melanoma; Cancer research; Metastasis; Biology; Cancer; Medicine; Internal medicine","score_opus":0.004236368533769617,"score_gpt":0.2107123923744515,"score_spread":0.20647602384068187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970080542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744989,0.025180789,0.000015887128,0.00006129412,0.00008499072,0.00009779292,0.00000730118,0.000001324686,0.000051662642],"genre_scores_gemma":[0.9963749,0.0031869914,0.00016712045,0.0000942967,0.00011055706,0.000013554476,0.0000041588874,0.000012005703,0.000036401085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993701,0.000039642906,0.00026103875,0.000114823495,0.00007684159,0.00013754696],"domain_scores_gemma":[0.9996644,0.00001000076,0.000110283625,0.00005415123,0.000113515525,0.000047605998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011207762,0.000074732685,0.00014190932,0.000045813005,0.000018211802,0.00003424655,0.00007963275,0.00006965619,0.000021229853],"category_scores_gemma":[0.000058078214,0.000072430725,0.000046000296,0.00006651443,0.000029512958,0.000009545787,0.000029643175,0.00006995169,4.0361797e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005015898,0.00011313318,0.6316281,0.000046816327,0.000055730372,0.000017503562,0.00015469072,0.0013328716,0.0436296,0.0000014617175,0.0010752532,0.32189468],"study_design_scores_gemma":[0.0015538262,0.00017791906,0.973704,0.0006496161,0.000011109311,0.00013511964,0.00008464426,0.00053475023,0.021607203,0.00027941438,0.0010898248,0.00017258884],"about_ca_topic_score_codex":0.0009760972,"about_ca_topic_score_gemma":0.0007297772,"teacher_disagreement_score":0.34207588,"about_ca_system_score_codex":0.000028427767,"about_ca_system_score_gemma":0.00006434025,"threshold_uncertainty_score":0.2953639},"labels":[],"label_agreement":null},{"id":"W1971081363","doi":"10.1038/sj.bjc.6603924","title":"FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Prostate Cancer Research Initiative; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"PTEN; Prostate cancer; Biology; Prostate; Fluorescence in situ hybridization; Cancer research; Tissue microarray; Oncology; Pathology; Internal medicine; Medicine; Cancer; Gene; Genetics; Chromosome; PI3K/AKT/mTOR pathway","score_opus":0.057729583069028256,"score_gpt":0.39167460119885167,"score_spread":0.3339450181298234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971081363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208343,0.0056350026,0.000101290316,0.0010202118,0.00020178569,0.00030705731,0.00027548464,0.000010701348,0.00036504163],"genre_scores_gemma":[0.98826855,0.008156177,0.00015587178,0.0010747443,0.00020678274,0.000008025587,0.0000406202,0.000029653644,0.0020595714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749374,0.000076845085,0.00097438274,0.00022564482,0.0008168223,0.000412539],"domain_scores_gemma":[0.99771005,0.00013300162,0.0008497431,0.00013332957,0.00087050465,0.00030338162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015120046,0.00015142803,0.0009518309,0.0003596366,0.000071599265,0.000038775608,0.0001402531,0.0001320984,0.00058086234],"category_scores_gemma":[0.00011653051,0.00012515965,0.00046215646,0.00073119695,0.00020699223,0.00014941407,0.000025113704,0.00048838335,0.0000010449143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024481954,0.00017494686,0.9143792,0.000041937652,0.0064660497,0.0012459172,0.0001973832,0.00009809943,0.0004390947,4.976055e-7,0.002790783,0.07171792],"study_design_scores_gemma":[0.006076936,0.00068822765,0.9830193,0.00060001935,0.003659898,0.00018399995,0.00019458187,0.00015306061,0.0016541724,0.0000057463494,0.0036154024,0.00014866609],"about_ca_topic_score_codex":0.001817428,"about_ca_topic_score_gemma":0.012681916,"teacher_disagreement_score":0.07156925,"about_ca_system_score_codex":0.0009795842,"about_ca_system_score_gemma":0.0007094051,"threshold_uncertainty_score":0.7076807},"labels":[],"label_agreement":null},{"id":"W1971239528","doi":"10.1038/sj.bjc.6603614","title":"Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"National Cancer Institute; Swedish Foundation for International Cooperation in Research and Higher Education","keywords":"DDR1; Discoidin domain; Lung cancer; Biology; Receptor; Carcinoma; Receptor tyrosine kinase; Hazard ratio; Survival analysis; Cancer research; Adenocarcinoma; Pathology; Internal medicine; Oncology; Medicine; Cancer; Confidence interval","score_opus":0.008987139302141976,"score_gpt":0.28817825274685654,"score_spread":0.2791911134447146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971239528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911901,0.008045951,0.00024462675,0.00011933298,0.000051645955,0.00013694691,0.0000039760425,8.0033624e-7,0.00020663642],"genre_scores_gemma":[0.99791515,0.0012941255,0.0005096548,0.00003946434,0.000045245357,0.0000017044406,0.0000012215685,0.000008252473,0.00018517647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990051,0.000065699496,0.00036227307,0.00010134679,0.00033202363,0.00013358731],"domain_scores_gemma":[0.9994115,0.00008306872,0.00020114593,0.00007076103,0.00012877873,0.00010470938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062789605,0.000057101337,0.00024952122,0.00028136212,0.00003509967,0.000018143797,0.00006178887,0.0000501341,0.00007751356],"category_scores_gemma":[0.00006183908,0.00004567567,0.000080565704,0.0004831219,0.0000709391,0.000052231593,0.000042945692,0.0002430655,6.176019e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002913473,0.00006145699,0.7292204,0.00010924731,0.00006972641,0.0003844364,0.0006798729,0.00006525945,0.23178335,4.8723683e-7,0.00027498126,0.037059437],"study_design_scores_gemma":[0.0011392704,0.000065397544,0.92242265,0.0004523937,0.00018952372,0.00016303116,0.0005880241,0.00018389322,0.07458877,0.000010715785,0.00015152457,0.00004482923],"about_ca_topic_score_codex":0.00058932096,"about_ca_topic_score_gemma":0.0019957304,"teacher_disagreement_score":0.19320223,"about_ca_system_score_codex":0.00008765638,"about_ca_system_score_gemma":0.00007979278,"threshold_uncertainty_score":0.18625998},"labels":[],"label_agreement":null},{"id":"W1971399507","doi":"10.1038/sj.bjc.6602064","title":"Diagnosis and management of drug-associated interstitial lung disease","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Interstitial lung disease; Chest radiograph; Radiology; Differential diagnosis; Medical diagnosis; Lung; High-resolution computed tomography; Disease; Intensive care medicine; Internal medicine; Pathology; Radiography","score_opus":0.01661454196836549,"score_gpt":0.32714509747887927,"score_spread":0.3105305555105138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971399507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035904706,0.9975726,0.000010971223,0.000084472485,0.000658697,0.0005265659,0.00060880976,0.000008498984,0.00017033757],"genre_scores_gemma":[0.0035302718,0.9954864,0.00004668815,0.00005379919,0.00042544908,0.00006769061,0.000042350624,0.000051178937,0.00029621922],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998044,0.000079508165,0.0009611491,0.00022223286,0.00046068666,0.00023241185],"domain_scores_gemma":[0.99828917,0.000039173243,0.0009044547,0.00012387718,0.00025040912,0.00039291417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019375912,0.00026216786,0.0015599256,0.00016567086,0.000051805328,0.000044876375,0.00016764866,0.0001147659,0.00022803312],"category_scores_gemma":[0.000043538228,0.00025680172,0.0009469213,0.00017320951,0.00012959349,0.00011226796,0.00008820357,0.00039759313,0.0000012541858],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005097918,0.0003404622,0.00012418037,0.093361266,0.0017911699,0.0064426474,0.00001945314,0.00000170491,6.123424e-8,0.000039194714,0.0031972285,0.89417285],"study_design_scores_gemma":[0.0012262558,0.00029675345,0.00097147323,0.59455264,0.0133518055,0.0007204575,0.000024882202,0.0000028851114,3.3943863e-7,0.000032568703,0.3885814,0.00023853572],"about_ca_topic_score_codex":0.00022817527,"about_ca_topic_score_gemma":0.000025354657,"teacher_disagreement_score":0.8939343,"about_ca_system_score_codex":0.0005574722,"about_ca_system_score_gemma":0.0006268597,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W1971546178","doi":"10.1038/sj.bjc.6601478","title":"Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital","funders":"","keywords":"Gefitinib; Medicine; Oncology; Radiation therapy; Chemotherapy; Quality of life (healthcare); Lung cancer; Internal medicine; Brain metastasis; Clinical trial; Epidermal growth factor receptor; Cancer; Metastasis","score_opus":0.08069286411793578,"score_gpt":0.42054096828390813,"score_spread":0.33984810416597233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971546178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060739424,0.9370314,0.000049257313,0.0000382583,0.00005102466,0.001001645,0.0010581039,0.0000032638854,0.000027654149],"genre_scores_gemma":[0.016353622,0.98232883,0.0009821353,0.00004647654,0.00006225898,0.000067581255,0.00003150369,0.00004186723,0.000085712214],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982863,0.00014084781,0.0007527218,0.00021091434,0.00043889228,0.00017028776],"domain_scores_gemma":[0.9963444,0.0004298896,0.001967601,0.00012750072,0.00096073805,0.00016987053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029542125,0.00024039169,0.0020608567,0.00013667237,0.000053236006,0.000023524088,0.00007237001,0.00008305043,0.000031306747],"category_scores_gemma":[0.00027769452,0.000167733,0.00025626688,0.00023564979,0.00011092274,0.00021247416,0.000009617792,0.00017852729,7.877211e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080371246,0.0004203179,0.011090438,0.017565124,0.0026109668,0.000030923853,0.000022070186,0.0000046315154,0.0000012223676,0.000015160129,0.00028217392,0.96715325],"study_design_scores_gemma":[0.024456108,0.009342033,0.085267015,0.5632754,0.030664109,0.001434369,0.000064049054,7.0669824e-7,0.00007614894,0.000009711559,0.28454837,0.0008620024],"about_ca_topic_score_codex":0.00065691967,"about_ca_topic_score_gemma":0.0004538362,"teacher_disagreement_score":0.96629125,"about_ca_system_score_codex":0.00013044871,"about_ca_system_score_gemma":0.0015956415,"threshold_uncertainty_score":0.68399537},"labels":[],"label_agreement":null},{"id":"W1971549450","doi":"10.1038/bjc.2014.25","title":"First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Clinical trial; Population; Proportional hazards model; Progression-free survival; Hazard ratio; Renal cell carcinoma; Oncology; Overall survival; Surgery; Confidence interval","score_opus":0.04437082598213789,"score_gpt":0.30390294821716096,"score_spread":0.2595321222350231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971549450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90207005,0.053755518,0.02935068,0.0075972117,0.002358748,0.004071269,0.00027179503,0.00001753999,0.00050721667],"genre_scores_gemma":[0.97127336,0.0050551007,0.010634276,0.003033039,0.00857516,0.00043897174,0.00004364048,0.0000655072,0.00088092155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859375,0.00009143267,0.00055050594,0.00018478998,0.00031938276,0.00026015786],"domain_scores_gemma":[0.9977028,0.0011453967,0.00040768954,0.00018054809,0.00041788095,0.00014568651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085918995,0.00015944536,0.0005112095,0.00003505558,0.00015868315,0.00007829497,0.00019338491,0.000102329606,0.00077067164],"category_scores_gemma":[0.00026026342,0.000112298774,0.00045951852,0.000057514215,0.00005450798,0.000092258255,0.000011249737,0.00022002078,0.0000012618102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18063566,0.0006356485,0.0010990001,0.00010557863,0.0017543806,0.00013238228,0.00044537146,0.00038620282,0.0019996571,0.000053688098,0.3435559,0.46919653],"study_design_scores_gemma":[0.24115272,0.015359322,0.026068062,0.0011618874,0.0009947378,0.0007797233,0.000104282764,0.0010793578,0.021816092,0.004460059,0.6866505,0.00037322548],"about_ca_topic_score_codex":0.00026933305,"about_ca_topic_score_gemma":0.0005785093,"teacher_disagreement_score":0.4688233,"about_ca_system_score_codex":0.00015006358,"about_ca_system_score_gemma":0.0002889016,"threshold_uncertainty_score":0.8438314},"labels":[],"label_agreement":null},{"id":"W1971781813","doi":"10.1038/sj.bjc.6604453","title":"Rapid progression of prostate cancer in men with a BRCA2 mutation","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; University of Toronto; University Health Network; Women's College Hospital","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; Canadian Breast Cancer Research Alliance","keywords":"Prostate cancer; Medicine; BRCA2 Protein; Oncology; Prostate; Cancer; Mutation; Internal medicine; Germline mutation; Biology; Genetics; Gene","score_opus":0.008813128673983065,"score_gpt":0.28261027456261856,"score_spread":0.2737971458886355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971781813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95521826,0.04379751,0.00008411359,0.00019864553,0.00011097464,0.00017626488,0.000037503956,0.0000020711443,0.00037464083],"genre_scores_gemma":[0.976739,0.021650875,0.0010270724,0.000061890096,0.00019862424,0.00005482607,0.000006986366,0.0000204586,0.00024030564],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906737,0.00004836204,0.0003474004,0.000142425,0.00024845128,0.00014597308],"domain_scores_gemma":[0.9990832,0.0000057872276,0.00037993788,0.00008401272,0.00039858243,0.00004844403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015583436,0.000085235355,0.00017427535,0.00006686319,0.000041730997,0.000010893403,0.000115435294,0.000066305445,0.00007339145],"category_scores_gemma":[0.000025753297,0.00008324388,0.000050603507,0.00016945564,0.0001197984,0.000015223239,0.000020242069,0.00012135313,2.2311924e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014002956,0.00020612414,0.092111275,0.00010641487,0.0002679459,0.00048734024,0.0010427018,0.0089615155,0.09782665,0.0000026989483,0.007886552,0.7897005],"study_design_scores_gemma":[0.008243911,0.0017172659,0.35372305,0.0021248586,0.00010065022,0.004807953,0.000479085,0.00017077818,0.5866599,0.00006851687,0.041410476,0.00049357227],"about_ca_topic_score_codex":0.00029684955,"about_ca_topic_score_gemma":0.0012542639,"teacher_disagreement_score":0.7892069,"about_ca_system_score_codex":0.00010045996,"about_ca_system_score_gemma":0.0008126722,"threshold_uncertainty_score":0.3394587},"labels":[],"label_agreement":null},{"id":"W1972415660","doi":"10.1038/bjc.2014.494","title":"Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Rash; Pancreatic cancer; Erlotinib Hydrochloride; Internal medicine; Hazard ratio; Adverse effect; Clinical endpoint; Gastroenterology; Oncology; Confidence interval; Cancer; Epidermal growth factor receptor; Clinical trial","score_opus":0.05602157314813496,"score_gpt":0.43344776619419956,"score_spread":0.3774261930460646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972415660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729752,0.0043405085,0.012970407,0.0054801763,0.00035273118,0.0036562227,0.00009949482,0.000011904639,0.000113352406],"genre_scores_gemma":[0.98883486,0.00066657097,0.00383658,0.0010476963,0.0012660302,0.0012719135,0.000009991235,0.000042077492,0.0030242724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99799705,0.00017220253,0.0007310386,0.00021103214,0.0004919927,0.00039666158],"domain_scores_gemma":[0.9975734,0.0006879884,0.0003694867,0.0001845151,0.0009046915,0.0002799421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022111281,0.00015483005,0.0008937462,0.0001190614,0.00034812433,0.000053967968,0.00020915522,0.000053172786,0.00023660087],"category_scores_gemma":[0.0015202031,0.00011776646,0.00020831081,0.00020921849,0.00008274203,0.000114759896,0.00003829465,0.00026254437,0.0000022217082],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117861265,0.0033326966,0.04638927,0.0006252865,0.0028857319,0.000107715394,0.0035940027,0.0005763443,0.0027346956,0.00009796063,0.051811624,0.8760585],"study_design_scores_gemma":[0.20898764,0.046130236,0.50406843,0.0036016032,0.015627233,0.0017914581,0.0037993095,0.03523524,0.0007780184,0.0017826239,0.1772989,0.00089927245],"about_ca_topic_score_codex":0.0007027588,"about_ca_topic_score_gemma":0.001557499,"teacher_disagreement_score":0.87515926,"about_ca_system_score_codex":0.00029294143,"about_ca_system_score_gemma":0.0007546275,"threshold_uncertainty_score":0.4802377},"labels":[],"label_agreement":null},{"id":"W1972466496","doi":"10.1038/sj.bjc.6603829","title":"Comparative analysis of xanafide cytotoxicity in breast cancer cell lines","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Docetaxel; Vinorelbine; Topoisomerase; Paclitaxel; Doxorubicin; Cytotoxicity; Cell culture; In vivo; Pharmacology; Gemcitabine; Cancer research; MCF-7; Chemistry; Biology; Internal medicine; Medicine; In vitro; Breast cancer; Cancer; Chemotherapy; Cisplatin; Biochemistry","score_opus":0.01310169827237698,"score_gpt":0.31017053105226666,"score_spread":0.29706883277988966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972466496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97527534,0.022880297,0.0010433032,0.00005545144,0.00017553732,0.00005860162,0.00018902514,0.0000010547733,0.00032141773],"genre_scores_gemma":[0.98544836,0.013741881,0.0001791285,0.0002435333,0.00026259196,0.0000035932353,0.000006443969,0.00000827898,0.00010617112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903655,0.000028619801,0.00044024977,0.00013336653,0.00017887652,0.00018230897],"domain_scores_gemma":[0.99912244,0.000010590181,0.0003658076,0.00008897415,0.00033391046,0.000078250305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032634407,0.0000932245,0.00037188068,0.00010511731,0.000022995591,0.000014026559,0.00015227676,0.00008237769,0.00015952549],"category_scores_gemma":[0.0000035103071,0.00010224232,0.00020526913,0.00030583108,0.00004612676,0.0000074476484,0.000026710215,0.00011027314,1.1060244e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045879316,0.00016547996,0.016209703,0.000019402063,0.0009341858,0.000036898,0.00014320175,0.0027761054,0.9602807,0.00001208431,0.00030384638,0.018659571],"study_design_scores_gemma":[0.0011164437,0.00012116703,0.20726228,0.00012376242,0.0004611092,0.00007539443,0.00027028332,0.000105296465,0.7847266,0.000026937327,0.005529952,0.00018073866],"about_ca_topic_score_codex":0.0036513542,"about_ca_topic_score_gemma":0.06737693,"teacher_disagreement_score":0.19105257,"about_ca_system_score_codex":0.00007594503,"about_ca_system_score_gemma":0.0001679248,"threshold_uncertainty_score":0.949641},"labels":[],"label_agreement":null},{"id":"W1972668078","doi":"10.1038/bjc.2013.533","title":"The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Immunohistochemistry; Hypoxia (environmental); Stromal cell; Cancer research; Proliferation Marker; Pathology; Univariate analysis; Internal medicine; Biology; Medicine; Oncology; Multivariate analysis","score_opus":0.004195678493158846,"score_gpt":0.23103135046292828,"score_spread":0.22683567196976942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972668078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780455,0.021479042,0.000007039111,0.00008555889,0.00009813535,0.000120228826,0.000010378034,9.981483e-7,0.0001531179],"genre_scores_gemma":[0.9986725,0.0009852307,0.000012808262,0.00007442557,0.000095404896,0.000008252031,0.000005423223,0.0000085834345,0.00013736513],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994431,0.000052817843,0.0002149981,0.00006983024,0.00009289695,0.00012633666],"domain_scores_gemma":[0.99952745,0.000016826538,0.00015795122,0.000058791677,0.00017690434,0.000062067025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011599806,0.00006688234,0.00011417505,0.00002583489,0.00003474589,0.00003582575,0.000063785395,0.00007763457,0.000046638277],"category_scores_gemma":[0.0000661308,0.000053409734,0.000078112156,0.000059788792,0.000058119123,0.00000951731,0.000019036826,0.00015304255,2.899614e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004506249,0.00022551754,0.18982986,0.00005656747,0.00005133807,0.00006123843,0.00008853838,0.00034663826,0.76219755,0.0000056668705,0.028994858,0.017691622],"study_design_scores_gemma":[0.0049382015,0.0026306363,0.8884691,0.00016929652,0.000054332297,0.000526674,0.00019083248,0.0001976253,0.10088171,0.00013383522,0.0015763323,0.00023140911],"about_ca_topic_score_codex":0.0010395068,"about_ca_topic_score_gemma":0.000897079,"teacher_disagreement_score":0.6986393,"about_ca_system_score_codex":0.00002550252,"about_ca_system_score_gemma":0.00013647115,"threshold_uncertainty_score":0.21779858},"labels":[],"label_agreement":null},{"id":"W1972670768","doi":"10.1038/sj.bjc.6604119","title":"How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK; Sanofi; Pfizer","keywords":"Tact; Medicine; Breast cancer; Clinical trial; Family medicine; Next of kin; Telephone survey; Cancer; Internal medicine; Psychology","score_opus":0.3680018666523295,"score_gpt":0.5429190339267637,"score_spread":0.17491716727443418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972670768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837439,0.0049197925,0.00003568457,0.0012448257,0.0030528046,0.0012000254,0.005609592,0.0000073240567,0.00018603074],"genre_scores_gemma":[0.995127,0.003556692,0.00042799962,0.00031015888,0.00032730668,0.000031469706,0.00004273827,0.000039711784,0.00013690324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9855551,0.0053416444,0.007054061,0.00027665216,0.0012596794,0.00051282527],"domain_scores_gemma":[0.97451395,0.0042143534,0.009716843,0.00052602246,0.010556478,0.00047235948],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010771346,0.00018935175,0.0017120169,0.00027406463,0.00017815699,0.00001265054,0.000731098,0.00033545357,0.0001424105],"category_scores_gemma":[0.018726617,0.00018432009,0.0003356534,0.0006125292,0.00017228881,0.00026658556,0.00024153793,0.0011815436,0.0000020882853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005011704,0.0005276345,0.76947975,0.00033561685,0.00012296278,0.000002369782,0.001467619,0.000016984939,0.000020413634,0.0000035337887,0.007822446,0.21518895],"study_design_scores_gemma":[0.008974471,0.0006563368,0.97971135,0.0052351416,0.00006536761,0.0000025544964,0.00087855203,0.0000052384867,0.00010547681,0.000023658018,0.0041950946,0.00014673523],"about_ca_topic_score_codex":0.037656434,"about_ca_topic_score_gemma":0.029669244,"teacher_disagreement_score":0.2150422,"about_ca_system_score_codex":0.0003347113,"about_ca_system_score_gemma":0.0019578654,"threshold_uncertainty_score":0.9895391},"labels":[],"label_agreement":null},{"id":"W1972719755","doi":"10.1038/sj.bjc.6601766","title":"Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Extracellular; Fibrosarcoma; Hypoxia (environmental); Cell culture; Melanoma; In vivo; Cancer research; Metastasis; Hyperthermia; Cell; Chemistry; Pathology; Biology; Medicine; Internal medicine; Oxygen; Cancer; Biochemistry","score_opus":0.004500252891964359,"score_gpt":0.229531440434076,"score_spread":0.22503118754211165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972719755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96360797,0.034815118,0.0008344402,0.0001044397,0.00040915213,0.00015213303,0.000023841798,0.0000014656426,0.00005147111],"genre_scores_gemma":[0.9871321,0.011220737,0.0005873156,0.00010800762,0.0008267676,0.000008368395,0.0000045729635,0.000017194714,0.00009498615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915737,0.000056667155,0.00030074318,0.000115632574,0.00024149044,0.00012808408],"domain_scores_gemma":[0.99909204,0.000018128056,0.00043656747,0.000110216155,0.00028956815,0.00005350454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016294776,0.00010071474,0.0002362559,0.000035234585,0.00003477909,0.000013944665,0.0001665317,0.00003309255,0.000016231217],"category_scores_gemma":[0.000046378078,0.00007828438,0.00012567228,0.00007579975,0.00008041579,0.000005893615,0.000017295217,0.00011300286,4.4317764e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045798393,0.0001631411,0.0000137380375,0.00009286136,0.00011156101,0.00011911657,0.000028280558,0.0030322475,0.984886,0.000015207927,0.00024274105,0.010837147],"study_design_scores_gemma":[0.0026172267,0.0005046639,0.0031356947,0.00026614158,0.0002130757,0.0016208999,0.00003091516,0.000003002492,0.9884765,0.00007138842,0.0029677604,0.00009274163],"about_ca_topic_score_codex":0.00032209852,"about_ca_topic_score_gemma":0.0004092099,"teacher_disagreement_score":0.02359438,"about_ca_system_score_codex":0.000017350481,"about_ca_system_score_gemma":0.00022555896,"threshold_uncertainty_score":0.31923443},"labels":[],"label_agreement":null},{"id":"W1973293106","doi":"10.1038/bjc.2013.766","title":"Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Biopsy; Surgical pathology; Histology; Hysterectomy; Adenocarcinoma; Lymphovascular invasion; Concordance; Cancer; Clear cell; Anatomical pathology; Carcinoma; Pathology; Radiology; Internal medicine; Metastasis","score_opus":0.0462073817853215,"score_gpt":0.37294596797226964,"score_spread":0.3267385861869481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973293106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974546,0.022132874,0.000059451246,0.00025113486,0.001341367,0.0005544925,0.00013619348,0.0000060831594,0.00097236247],"genre_scores_gemma":[0.98413193,0.012942217,0.0010932402,0.000071432536,0.0015275485,0.00009064216,0.0000063577604,0.00002386202,0.000112739785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967266,0.00017925279,0.0015228543,0.00023619518,0.0009658183,0.0003693155],"domain_scores_gemma":[0.99720305,0.0007366657,0.00094157155,0.00013529287,0.0007194826,0.000263924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000713935,0.00018580955,0.0013829698,0.00079221145,0.000028183309,0.000023012315,0.00019625456,0.0001763945,0.0052438267],"category_scores_gemma":[0.0010114652,0.00016717077,0.00043884388,0.0012706236,0.00013393618,0.00018236152,0.000058431055,0.0005207444,0.0000020073417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074034873,0.0020043133,0.54540986,0.00041672372,0.0011514431,0.0024052854,0.00011512244,0.00028350388,0.010546952,0.00014156873,0.00033964,0.4297821],"study_design_scores_gemma":[0.084675044,0.0040792935,0.89550203,0.0023757212,0.00059495255,0.002452146,0.00008725112,0.00003472764,0.004956789,0.0005113667,0.004487348,0.00024333132],"about_ca_topic_score_codex":0.0069907783,"about_ca_topic_score_gemma":0.00043213397,"teacher_disagreement_score":0.42953876,"about_ca_system_score_codex":0.00041059908,"about_ca_system_score_gemma":0.0010227995,"threshold_uncertainty_score":0.99962175},"labels":[],"label_agreement":null},{"id":"W1973416725","doi":"10.1054/bjoc.2001.1793","title":"Lactation and breast cancer risk: a case–control study in Connecticut","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Lactation; Medicine; Case-control study; Risk assessment; Cancer; Oncology; Gynecology; Obstetrics; Environmental health; Pregnancy; Internal medicine; Biology; Computer science; Genetics","score_opus":0.011160383580517949,"score_gpt":0.31092907381066975,"score_spread":0.2997686902301518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973416725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839958,0.014754464,0.000032102816,0.00046663877,0.0002600086,0.00029273532,0.00012228746,0.0000066713096,0.000069311034],"genre_scores_gemma":[0.9836792,0.015492836,0.000014226506,0.00021284945,0.0004897128,0.00001878576,2.5500628e-7,0.000015956279,0.00007617812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903077,0.000071015114,0.00037365124,0.00013004814,0.00022275775,0.00017176688],"domain_scores_gemma":[0.9992483,0.00005836905,0.0002679716,0.00005552558,0.00022558673,0.00014423057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032160297,0.00009235435,0.00035193775,0.00011539765,0.000057988567,0.000048358892,0.000033160228,0.000045173358,0.0005571832],"category_scores_gemma":[0.00005408385,0.000090827736,0.000061005096,0.00017171746,0.00003523646,0.0001735978,0.0000075626904,0.00034403638,5.029278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005441065,0.00012656671,0.68544877,0.000010445104,0.00012232405,0.00848441,0.00037474572,0.000063779466,0.000033028748,3.272619e-7,0.00017023193,0.3046213],"study_design_scores_gemma":[0.008003795,0.00025811588,0.92286974,0.00034123068,0.00033458337,0.06595922,0.0010483473,0.00010585231,0.0000042421916,0.0000125362585,0.0009724825,0.00008984506],"about_ca_topic_score_codex":0.046634573,"about_ca_topic_score_gemma":0.14036629,"teacher_disagreement_score":0.30453146,"about_ca_system_score_codex":0.00023196056,"about_ca_system_score_gemma":0.00020289113,"threshold_uncertainty_score":0.959714},"labels":[],"label_agreement":null},{"id":"W1973461633","doi":"10.1038/sj.bjc.6605665","title":"Adipose tissue pathways involved in weight loss of cancer cachexia","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"European Commission; Vetenskapsrådet; Karolinska Institutet; Swedish Cancer Foundation","keywords":"Adipose tissue; Cachexia; Endocrinology; Adipocyte; Biology; Internal medicine; Extracellular matrix; White adipose tissue; Adipose tissue macrophages; Cancer research; Cancer; Cell biology; Medicine","score_opus":0.027457205559181186,"score_gpt":0.34126982576105713,"score_spread":0.31381262020187595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973461633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95585555,0.039311003,0.000014391574,0.0027824435,0.0011995261,0.0001643533,0.000044396544,0.000008224548,0.00062011264],"genre_scores_gemma":[0.977296,0.019239943,0.0009342661,0.0011582678,0.0011154019,0.000015315882,0.000002254774,0.000022577404,0.00021595265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858147,0.00003445066,0.0006727232,0.00011750124,0.00034586992,0.00024801077],"domain_scores_gemma":[0.99882275,0.000032662872,0.00036553649,0.00010231252,0.00042493155,0.0002517802],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003779387,0.000094329254,0.00044772166,0.00016648119,0.00003862612,0.000014585994,0.00011302984,0.00011886726,0.0015955686],"category_scores_gemma":[0.00007032617,0.00010096275,0.00008333874,0.00020547722,0.00009525919,0.00012242468,0.00001646704,0.0008228904,0.0000027574927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054024457,0.00040559343,0.555568,0.0009125986,0.00011048935,0.002322076,0.0005223015,0.000010050728,0.0676271,0.00021706412,0.013444279,0.35832024],"study_design_scores_gemma":[0.0092212865,0.00025046122,0.6702047,0.0066920626,0.00014607597,0.0018071609,0.00009911186,0.000048380538,0.05178232,0.0008028015,0.25871077,0.00023484838],"about_ca_topic_score_codex":0.0031978514,"about_ca_topic_score_gemma":0.02073866,"teacher_disagreement_score":0.3580854,"about_ca_system_score_codex":0.00013157279,"about_ca_system_score_gemma":0.00063742825,"threshold_uncertainty_score":0.9993171},"labels":[],"label_agreement":null},{"id":"W1973823907","doi":"10.1038/sj.bjc.6605039","title":"Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Toronto; Hillman Foundation; U.S. Public Health Service; Texas Tech University","keywords":"Curcumin; CHEK1; Cyclin B1; Cell cycle; Apoptosis; Cyclin-dependent kinase 1; Molecular biology; Cancer research; Biology; Cell cycle checkpoint; DNA damage; Phosphorylation; Pancreatic cancer; Chemistry; Cell biology; Cancer; DNA; Biochemistry","score_opus":0.005620806136872605,"score_gpt":0.26648107389500786,"score_spread":0.26086026775813526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973823907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915678,0.007534245,0.00021544177,0.00033988914,0.000053894517,0.00010337639,0.00006990857,0.000001871295,0.00011358556],"genre_scores_gemma":[0.99361676,0.0057053617,0.00013217167,0.0001950431,0.00018585053,0.000014885152,0.000016311309,0.000010378211,0.00012322264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917716,0.000028613975,0.00034464864,0.00014933974,0.00015678303,0.00014347691],"domain_scores_gemma":[0.9994274,0.000012438665,0.00027634125,0.00008921315,0.00010538194,0.000089235706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001001249,0.00008832855,0.0001920256,0.000040686275,0.000040495364,0.000020236408,0.00011989324,0.00009557668,0.000048429047],"category_scores_gemma":[0.000018646444,0.00009960017,0.000048740552,0.0001201534,0.000086758075,0.00001137423,0.00001938097,0.00011592387,2.1819253e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022943526,0.00012927818,0.0020038972,0.000026276011,0.000020514934,0.0000017117503,0.00003102289,0.00003678461,0.9739355,0.0000028163556,0.005094587,0.01869467],"study_design_scores_gemma":[0.0007401068,0.00012500005,0.021534817,0.00020936104,0.000034794026,0.000010834727,0.000039350904,0.0000067268675,0.968254,0.00008861229,0.008843117,0.000113225986],"about_ca_topic_score_codex":0.0012655234,"about_ca_topic_score_gemma":0.00035119726,"teacher_disagreement_score":0.01953092,"about_ca_system_score_codex":0.000039155228,"about_ca_system_score_gemma":0.00008388794,"threshold_uncertainty_score":0.4061577},"labels":[],"label_agreement":null},{"id":"W1974447083","doi":"10.1038/sj.bjc.6600099","title":"A cyclin-dependent kinase inhibitor (p21WAF1/CIP1) affects thymidine incorporation in human liver cancer cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Thymidine; Cancer research; Thymidine kinase; Cancer; Kinase; Cyclin-dependent kinase; Cancer cell; Biology; Cyclin-dependent kinase 4; Medicine; Cell biology; Internal medicine; Biochemistry; Cyclin-dependent kinase 2; Cell cycle; Genetics; Protein kinase A; DNA","score_opus":0.017655658945861002,"score_gpt":0.2664471450855874,"score_spread":0.24879148613972643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974447083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319407,0.06473489,0.000094629795,0.0006734625,0.0012313273,0.0005008034,0.000048074045,0.000027154905,0.0007489883],"genre_scores_gemma":[0.9772327,0.019532973,0.00018324191,0.00060960645,0.0014917551,0.00004992571,0.0000060155353,0.00006726388,0.0008265396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976593,0.00011697702,0.00075337436,0.00030380092,0.0007756054,0.0003909054],"domain_scores_gemma":[0.9984958,0.00003041665,0.0006289185,0.0001955749,0.0003486367,0.00030060794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036299325,0.00023410546,0.0005821338,0.00032223357,0.000093707255,0.000076495904,0.0001560286,0.0002187815,0.0015582398],"category_scores_gemma":[0.00006702404,0.00026811857,0.00022788202,0.00040468824,0.000085186795,0.00029455387,0.00004885873,0.0009103334,0.00001824582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048020668,0.0009798919,0.005263427,0.000339365,0.00028465793,0.017545998,0.0006271351,0.002594592,0.7625689,0.000020827945,0.0342478,0.1750472],"study_design_scores_gemma":[0.029467262,0.0024007948,0.051210396,0.016738513,0.0010436815,0.007090837,0.00020385896,0.0016733606,0.84563357,0.00018396284,0.04299602,0.0013577574],"about_ca_topic_score_codex":0.002348157,"about_ca_topic_score_gemma":0.009506758,"teacher_disagreement_score":0.17368944,"about_ca_system_score_codex":0.0010357401,"about_ca_system_score_gemma":0.00027185745,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W1974784556","doi":"10.1038/bjc.2011.207","title":"Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lung cancer; Medicine; Epidermal growth factor receptor; Oncology; Chemotherapy; Internal medicine; Disease; Targeted therapy; Cancer; Tyrosine kinase; Receptor","score_opus":0.057280688703651786,"score_gpt":0.4023850470155091,"score_spread":0.3451043583118573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974784556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04952398,0.94519436,0.000026806596,0.00002369837,0.0012660245,0.002063619,0.001717406,0.0000052834957,0.00017880103],"genre_scores_gemma":[0.002765624,0.9949106,0.0009879288,0.00008229332,0.00048593397,0.00021395276,0.00012362254,0.000105166546,0.00032485952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967639,0.00007677102,0.0020399445,0.00036544938,0.00037827884,0.0003756785],"domain_scores_gemma":[0.99598855,0.00013778127,0.002408938,0.0001750881,0.0009940492,0.0002955917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026847306,0.000372971,0.002763537,0.00027261113,0.00005061234,0.000025746096,0.00023523712,0.000311813,0.00045036804],"category_scores_gemma":[0.00007622207,0.00029858042,0.0008729434,0.00028416366,0.00008488124,0.00015832938,0.000032379485,0.00047669027,0.0000012077297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035391742,0.00075287564,0.23351012,0.010911698,0.0032440675,0.000055717974,0.00006458675,0.0000014222323,1.3383166e-7,9.141838e-7,0.0036262323,0.7474783],"study_design_scores_gemma":[0.019219015,0.0012693715,0.40844202,0.120818004,0.0123066185,0.00007378404,0.000019801828,0.000003583309,0.000010256869,0.0000032679684,0.4372662,0.0005680941],"about_ca_topic_score_codex":0.0017423315,"about_ca_topic_score_gemma":0.000599835,"teacher_disagreement_score":0.7469102,"about_ca_system_score_codex":0.00050037535,"about_ca_system_score_gemma":0.002241566,"threshold_uncertainty_score":0.99994665},"labels":[],"label_agreement":null},{"id":"W1975186639","doi":"10.1038/bjc.2014.565","title":"A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Tolerability; Neutropenia; Internal medicine; Pharmacodynamics; Pharmacokinetics; Rash; Febrile neutropenia; Dosing; Cancer; Gastroenterology; Toxicity; Refractory (planetary science); Pharmacology; Response Evaluation Criteria in Solid Tumors; Adverse effect; Phases of clinical research","score_opus":0.03146655708732439,"score_gpt":0.3865964881331453,"score_spread":0.3551299310458209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975186639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887665,0.008058901,0.00016835776,0.00009174167,0.0013402844,0.0014158484,0.000081772014,0.000012937786,0.00006368486],"genre_scores_gemma":[0.9959936,0.0026509664,0.00020947379,0.00023847871,0.00073470746,0.000070375354,0.000008805963,0.000067693334,0.000025890646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942695,0.0008925813,0.0028013021,0.00041610101,0.0012386669,0.00038185468],"domain_scores_gemma":[0.99613243,0.00026102277,0.0021313315,0.00031581355,0.00077116076,0.00038824228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033809124,0.00026866235,0.001850264,0.00028553698,0.000053266078,0.000033397962,0.00021768226,0.0002003599,0.00015145238],"category_scores_gemma":[0.0013728848,0.00025136248,0.00031768228,0.00041343755,0.00011829923,0.00021102963,0.000057143112,0.0010866157,0.0000014900703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016713357,0.011805853,0.20640999,0.00012281117,0.0006855109,0.0008342882,0.00036084745,0.0004883045,0.0017008499,0.0000022508223,0.00054491597,0.76033103],"study_design_scores_gemma":[0.3487741,0.04064022,0.5882253,0.009661524,0.0019258073,0.00028187488,0.00055588497,0.00008433409,0.003483944,0.000041056264,0.0056409547,0.0006850093],"about_ca_topic_score_codex":0.001403539,"about_ca_topic_score_gemma":0.0066486727,"teacher_disagreement_score":0.759646,"about_ca_system_score_codex":0.000447944,"about_ca_system_score_gemma":0.0006370753,"threshold_uncertainty_score":0.99999386},"labels":[],"label_agreement":null},{"id":"W1975220436","doi":"10.1038/bjc.2011.307","title":"Genetic architecture of prostate cancer in the Ashkenazi Jewish population","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Prostate cancer; Single-nucleotide polymorphism; Population; Cancer; Prostate; Medicine; Oncology; Genetics; Biology; Internal medicine; Genotype; Gene","score_opus":0.017237836515079315,"score_gpt":0.27832016292425454,"score_spread":0.2610823264091752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975220436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296175,0.06889713,0.000009432721,0.00061349274,0.00020342477,0.00031517018,0.000058304657,0.0000029236703,0.00028261158],"genre_scores_gemma":[0.9771947,0.021752696,0.00036999237,0.00036533852,0.0001971783,0.000060532777,0.0000023052935,0.000014561225,0.000042667063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894196,0.000053833908,0.0004310375,0.00010327198,0.00030329102,0.00016659242],"domain_scores_gemma":[0.99931437,0.000021853502,0.00032395733,0.000098433215,0.00017734466,0.00006401773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017369397,0.000090195615,0.00028663463,0.000076628654,0.00002622,0.000014463308,0.00009809398,0.000040797568,0.0002582028],"category_scores_gemma":[0.000023057508,0.000066670436,0.000108805754,0.00016894488,0.00004610134,0.00006623137,0.000010685206,0.00022088771,4.35495e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017150644,0.00015948382,0.55751795,0.00006781568,0.00008646094,0.0003838201,0.001040181,0.00014256808,0.00008392385,0.000006201515,0.00042476723,0.4399153],"study_design_scores_gemma":[0.00176936,0.0003294277,0.99195576,0.0014409495,0.00016541037,0.0006743838,0.00007772587,0.0000053512513,0.0010249631,0.00065632566,0.0018341206,0.00006624623],"about_ca_topic_score_codex":0.0049518156,"about_ca_topic_score_gemma":0.0050248494,"teacher_disagreement_score":0.43984905,"about_ca_system_score_codex":0.00013627837,"about_ca_system_score_gemma":0.00017117987,"threshold_uncertainty_score":0.7485697},"labels":[],"label_agreement":null},{"id":"W1975442922","doi":"10.1038/sj.bjc.6603514","title":"Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temsirolimus; Clinical trial; Internal medicine; Oncology; Medicine; Biology; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.035967408200075275,"score_gpt":0.3969696250004598,"score_spread":0.3610022168003845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975442922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97883415,0.014844902,0.0000039026745,0.0050950814,0.00026115956,0.00029674062,0.000017823828,0.00000770897,0.0006385174],"genre_scores_gemma":[0.9928032,0.0049080863,0.00011381056,0.00042650796,0.0005914891,0.000032683958,4.2727225e-7,0.000027922759,0.0010958737],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977739,0.00019238763,0.0006029747,0.00017363013,0.00088730204,0.0003698333],"domain_scores_gemma":[0.9985992,0.00019456963,0.00051356235,0.00018159572,0.0004197734,0.00009132048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036634345,0.000116279865,0.00044814398,0.00014289097,0.000053401513,0.000028522692,0.00020293787,0.0000049493274,0.00021977465],"category_scores_gemma":[0.0005549831,0.00009577693,0.00014329056,0.00039553235,0.00014910642,0.00021271815,0.000056507317,0.0006799346,6.7940306e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030523513,0.0007176849,0.24484824,0.00043368607,0.00013598218,0.027632687,0.000037883765,0.0049659307,0.1518205,0.00003082382,0.00960329,0.556721],"study_design_scores_gemma":[0.005498683,0.0011089356,0.8737469,0.0016876276,0.00012622858,0.027180534,0.00004781806,0.000524716,0.06693414,0.00038870765,0.022593787,0.00016194434],"about_ca_topic_score_codex":0.015879272,"about_ca_topic_score_gemma":0.005035669,"teacher_disagreement_score":0.6288986,"about_ca_system_score_codex":0.00016129721,"about_ca_system_score_gemma":0.00047522195,"threshold_uncertainty_score":0.9906741},"labels":[],"label_agreement":null},{"id":"W1975585168","doi":"10.1038/sj.bjc.6604826","title":"Identification of paediatric cancer patients with poor quality of life","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hospital for Sick Children; University of British Columbia; Children's Hospital of Eastern Ontario; University of Manitoba; SickKids Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Quality of life (healthcare); Sibling; Cross-sectional study; Cancer; Pediatric cancer; Pediatrics; Public health; Gerontology; Internal medicine; Psychology; Pathology","score_opus":0.02416408503876524,"score_gpt":0.3129698030310393,"score_spread":0.28880571799227406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975585168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784941,0.019706653,0.00011454986,0.00070952775,0.0004502988,0.00024420887,0.00020583325,0.000008455773,0.00006635263],"genre_scores_gemma":[0.9919384,0.006658427,0.00018477484,0.0004903748,0.000563838,0.000010250908,0.000006786564,0.000027755068,0.000119353725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964651,0.00015063948,0.0016973595,0.00017683282,0.001317648,0.00019241445],"domain_scores_gemma":[0.99525285,0.00010547298,0.0024022737,0.00018331567,0.0018263574,0.00022971061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072594057,0.00013328138,0.0008065666,0.00015627785,0.000057688067,0.000009862971,0.00017721987,0.00008185993,0.00024364657],"category_scores_gemma":[0.00052212074,0.00013278572,0.00021898234,0.0004113088,0.00019712157,0.00023441152,0.000023508399,0.00027615935,0.0000011118349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012549801,0.00071299943,0.97613025,0.0006668701,0.00042902323,0.000020625694,0.000799176,0.00008732254,0.0009268302,0.0000074484847,0.0050419024,0.013922574],"study_design_scores_gemma":[0.0049417024,0.00031193023,0.9899061,0.00086544704,0.00020230944,0.000067150286,0.00012738825,0.000003644105,0.002712087,0.000017293158,0.0007069835,0.00013801799],"about_ca_topic_score_codex":0.0055431,"about_ca_topic_score_gemma":0.0016614232,"teacher_disagreement_score":0.013784556,"about_ca_system_score_codex":0.00014381735,"about_ca_system_score_gemma":0.0011937423,"threshold_uncertainty_score":0.83795464},"labels":[],"label_agreement":null},{"id":"W1975927169","doi":"10.1038/bjc.2014.466","title":"Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; BC Cancer Agency; Alberta Health Services; University of British Columbia; University of Victoria; University of Alberta","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Aerobic exercise; Breast cancer; Overweight; Physical therapy; Body mass index; Internal medicine; Psychological intervention; Cancer; Randomized controlled trial; Chemotherapy","score_opus":0.004702921879807613,"score_gpt":0.25046256354289553,"score_spread":0.24575964166308792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975927169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97981936,0.019091567,0.000011282462,0.00016868283,0.00047948156,0.00035495317,0.00001598472,0.0000032378884,0.000055429242],"genre_scores_gemma":[0.9785775,0.020871824,0.000011525311,0.000043673313,0.00038790447,0.000029443603,5.144243e-7,0.000017833148,0.00005977968],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989415,0.00006550683,0.00045848356,0.00010633717,0.0002884707,0.00013973523],"domain_scores_gemma":[0.99923486,0.000089663634,0.0003362993,0.00007824331,0.00016488195,0.00009602779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022857722,0.00010590119,0.0007617408,0.00010502404,0.000015748661,0.000011862103,0.0000647052,0.000063044026,0.0001280046],"category_scores_gemma":[0.000041261195,0.0000943779,0.00015277474,0.000108201675,0.000068421905,0.00006123897,0.0000124274,0.00016295792,5.198105e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32946587,0.00044338152,0.11214798,0.0025696938,0.000300348,0.00008591546,0.001139385,0.000017384391,0.024089906,0.0000076552915,0.00011904934,0.52961344],"study_design_scores_gemma":[0.3173162,0.0004108898,0.64753044,0.009145833,0.00026369584,0.0002438764,0.00007108945,0.000016778997,0.024684008,0.000060951923,0.00012811257,0.00012812275],"about_ca_topic_score_codex":0.0030048043,"about_ca_topic_score_gemma":0.0043057487,"teacher_disagreement_score":0.53538245,"about_ca_system_score_codex":0.0000693496,"about_ca_system_score_gemma":0.000091317816,"threshold_uncertainty_score":0.4542385},"labels":[],"label_agreement":null},{"id":"W1976201942","doi":"10.1038/bjc.2012.554","title":"Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Survivorship curve; Cancer survivorship; Medicine; Cancer; Health care; MEDLINE; Family medicine; Gerontology; Nursing; Economic growth; Political science","score_opus":0.053863825643566204,"score_gpt":0.36948779165784734,"score_spread":0.3156239660142811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976201942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018306589,0.97718036,0.0000047500425,0.00011397731,0.0011123512,0.0011156226,0.0021276185,0.0000031614684,0.000035564386],"genre_scores_gemma":[0.00862715,0.9883372,0.000053156968,0.000104596016,0.0015916862,0.00056209665,0.0001077759,0.000055182376,0.0005611351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981262,0.00012759624,0.0007106243,0.0002477965,0.00029960027,0.00048814763],"domain_scores_gemma":[0.9982433,0.00023222693,0.00067593146,0.00015952814,0.00049017306,0.00019887544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002877588,0.00031529905,0.0015421798,0.00008970703,0.00016033469,0.00007479865,0.00012516027,0.00013270731,0.00024130718],"category_scores_gemma":[0.00002457587,0.0002094416,0.00030976877,0.00019450342,0.00006878793,0.00008433664,0.00002796349,0.00047380105,1.2765496e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030328453,0.000017879634,0.005732903,0.0021209696,0.0007774022,0.00007903938,0.0010757403,9.059962e-7,8.9404256e-7,0.0000012918183,0.000008323883,0.98988134],"study_design_scores_gemma":[0.003384537,0.00016601832,0.0021750678,0.0089940885,0.0036255051,0.00052963773,0.0007917652,2.9107954e-7,0.0000045467664,0.0000016729604,0.9801022,0.00022466683],"about_ca_topic_score_codex":0.9974112,"about_ca_topic_score_gemma":0.9999955,"teacher_disagreement_score":0.9896567,"about_ca_system_score_codex":0.0016965921,"about_ca_system_score_gemma":0.00334571,"threshold_uncertainty_score":0.85407805},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"split"},{"id":"W1976301747","doi":"10.1038/bjc.2012.307","title":"Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Carboplatin; Medicine; Hazard ratio; Paclitaxel; Internal medicine; Confidence interval; Ovarian cancer; Chemotherapy; Clinical endpoint; Oncology; Urology; Surgery; Gastroenterology; Randomized controlled trial; Cancer; Cisplatin","score_opus":0.022326826636536557,"score_gpt":0.30727154723815603,"score_spread":0.28494472060161946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976301747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064755,0.0064025074,0.00000433237,0.0003180338,0.000687349,0.0006502421,0.0008728078,0.000004923445,0.00041226397],"genre_scores_gemma":[0.99662215,0.0023111207,0.00019697857,0.000059649028,0.0006460215,0.000024084375,0.00003541697,0.000031764634,0.000072846575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971253,0.00017261117,0.0014222161,0.00026957202,0.0006135187,0.00039674403],"domain_scores_gemma":[0.9977332,0.00025357786,0.0011323863,0.00013309717,0.00047137274,0.00027641095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005752022,0.0002582094,0.0011595293,0.0001972575,0.00005022873,0.000024952726,0.000059668262,0.00017678269,0.000054897173],"category_scores_gemma":[0.00019185501,0.00025272506,0.00014492388,0.0002147844,0.0001593128,0.00024085703,0.000044543995,0.00038374742,1.3242985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24856254,0.007013604,0.5525373,0.00047047302,0.0018609542,0.0009308916,0.0047029704,0.00018572803,0.005729949,0.00009040163,0.0017591424,0.17615604],"study_design_scores_gemma":[0.26666164,0.0027916748,0.7220309,0.002225284,0.0005772695,0.00014800706,0.00012346622,0.00012211976,0.004792516,0.000020585894,0.00028822833,0.00021831246],"about_ca_topic_score_codex":0.03216758,"about_ca_topic_score_gemma":0.0060045817,"teacher_disagreement_score":0.17593773,"about_ca_system_score_codex":0.0002777331,"about_ca_system_score_gemma":0.00039087833,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W1976577798","doi":"10.1038/bjc.2012.147","title":"Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Fluconazole; Meta-analysis; Medicine; Transplantation; Chemotherapy; Haematopoiesis; Hematopoietic stem cell transplantation; Stem cell; Randomized controlled trial; Oncology; Cancer; Internal medicine; Surgery; Antifungal; Biology; Dermatology","score_opus":0.07631400875532027,"score_gpt":0.36905139411310184,"score_spread":0.2927373853577816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976577798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054247794,0.980061,0.000021602718,0.00004640723,0.000046233163,0.013372752,0.0010112487,0.0000041111257,0.000011875891],"genre_scores_gemma":[0.031758808,0.9654212,0.00003941301,0.00018575968,0.00004271635,0.002217665,0.0000306331,0.00004237871,0.0002614152],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9921051,0.0021986684,0.0041611325,0.0003750977,0.0008773941,0.00028258088],"domain_scores_gemma":[0.9917376,0.0018182945,0.004876718,0.00025712384,0.0009950012,0.0003152558],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0023663607,0.00049750175,0.025477283,0.00038374777,0.000046752044,0.000044543023,0.00018932264,0.00014430056,0.00070106704],"category_scores_gemma":[0.0006279754,0.00028070842,0.0032951003,0.0008442634,0.00007772418,0.00017099404,0.000013051975,0.00036919478,4.6751072e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013537349,0.0008499823,0.0003090763,0.8207814,0.1476188,0.00017436717,0.0003903944,0.0000074394225,0.0000014639485,1.4744047e-7,0.00003500324,0.01629454],"study_design_scores_gemma":[0.019948842,0.00036123238,0.0009761736,0.21757148,0.760581,0.00010004573,0.00007496945,5.838853e-7,0.000013739138,3.938809e-7,0.00012237244,0.00024916203],"about_ca_topic_score_codex":0.0001672812,"about_ca_topic_score_gemma":0.0021080747,"teacher_disagreement_score":0.6129622,"about_ca_system_score_codex":0.00035443166,"about_ca_system_score_gemma":0.0012981393,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W1977081777","doi":"10.1038/bjc.2011.101","title":"Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Institute for Clinical Evaluative Sciences; Canada Research Chairs; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Antibiotics; Ambulatory care; Willingness to pay; Emergency medicine; Internal medicine; Intensive care medicine; Health care","score_opus":0.04261533414015744,"score_gpt":0.3299494410942128,"score_spread":0.28733410695405537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977081777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951437,0.002295545,0.00005604286,0.000028189836,0.0008835582,0.00095734175,0.00017776035,0.0000050965104,0.00045272766],"genre_scores_gemma":[0.995835,0.0032590537,0.00011438048,0.000082868595,0.0001726195,0.00041583163,0.000006086004,0.000025692769,0.00008846451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889237,0.00006727322,0.0004844127,0.00014388897,0.00020400394,0.00020805457],"domain_scores_gemma":[0.99854,0.000053015327,0.0003387209,0.000084979496,0.00086073286,0.00012255213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012635901,0.00012213411,0.0004943896,0.00011557081,0.000039893104,0.000009383932,0.00006842244,0.00005997225,0.00019642814],"category_scores_gemma":[0.00003809339,0.000115006915,0.00021292195,0.00015368812,0.00005078392,0.000119321936,0.00001099212,0.00013401054,8.6510784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004473223,0.0019609125,0.8351098,0.00031866046,0.00030207608,0.00006859113,0.00047073394,0.00010295435,0.0013716881,0.000033464963,0.0005709303,0.15521699],"study_design_scores_gemma":[0.013376045,0.0032969892,0.94384265,0.0025046968,0.0003179366,0.000115746094,0.00005431239,0.000006432002,0.032959457,0.000037039455,0.003360709,0.00012801388],"about_ca_topic_score_codex":0.009269216,"about_ca_topic_score_gemma":0.0062573766,"teacher_disagreement_score":0.15508898,"about_ca_system_score_codex":0.0006705343,"about_ca_system_score_gemma":0.0003443387,"threshold_uncertainty_score":0.99732816},"labels":[],"label_agreement":null},{"id":"W1977313875","doi":"10.1038/bjc.2013.502","title":"Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Cancer research; Metastasis; Mammary gland; Cancer cell; Lung cancer; Pathology; Medicine; Biology; Breast cancer; Internal medicine","score_opus":0.006324325791044212,"score_gpt":0.24689436630654527,"score_spread":0.24057004051550104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977313875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9240667,0.07535092,0.00028148058,0.000059746224,0.000060562597,0.000100775644,0.00006203169,0.0000012054611,0.000016556804],"genre_scores_gemma":[0.97815156,0.019481821,0.0021369914,0.00002758027,0.00007134744,0.000025513305,0.000017203167,0.000008798976,0.00007921218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993574,0.000025904148,0.00030956243,0.00009561672,0.00012328003,0.00008825172],"domain_scores_gemma":[0.9992723,0.000010804994,0.00034065256,0.000053532232,0.00028222858,0.000040507923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006588824,0.00008113943,0.00018326202,0.000023581784,0.000034410274,0.000015645508,0.00005971318,0.00004094936,0.000042524138],"category_scores_gemma":[0.000011728469,0.00008005906,0.000039901865,0.000029625777,0.000035905272,0.000024756488,0.00003091522,0.000033109725,8.707563e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028503247,0.0002731859,0.31763896,0.0004010014,0.0012758671,0.0000064444052,0.0008783461,0.0012353277,0.41620415,0.0000025657125,0.0043049506,0.25749415],"study_design_scores_gemma":[0.0013520438,0.00008729123,0.5599526,0.0001668191,0.000106213556,0.000033105513,0.00008201289,0.000045830508,0.43621194,0.00000784973,0.0018405358,0.000113721006],"about_ca_topic_score_codex":0.0032082486,"about_ca_topic_score_gemma":0.0041355193,"teacher_disagreement_score":0.25738043,"about_ca_system_score_codex":0.00004003746,"about_ca_system_score_gemma":0.00016352923,"threshold_uncertainty_score":0.48499337},"labels":[],"label_agreement":null},{"id":"W1977356115","doi":"10.1038/sj.bjc.6604311","title":"A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Irinotecan; Medicine; Colorectal cancer; Pharmacodynamics; Pharmacokinetics; Oncology; Internal medicine; Pharmacology; Camptothecin; Cancer; Biology","score_opus":0.014253542016320852,"score_gpt":0.3037113305033121,"score_spread":0.2894577884869913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977356115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098456,0.008189243,0.000027090266,0.00003432471,0.00041217724,0.00025993548,0.000054440537,0.00000199819,0.00003621165],"genre_scores_gemma":[0.9887042,0.010751004,0.000034835506,0.00021916251,0.00016694424,0.000045257202,0.0000033652543,0.000024667073,0.00005058093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990428,0.000071930175,0.00031349016,0.00019396911,0.00018000674,0.00019777325],"domain_scores_gemma":[0.9995506,0.000008705019,0.00019203847,0.000051113853,0.00010362422,0.000093952076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013612077,0.0001288071,0.00023428933,0.00009035588,0.00005464976,0.00001752434,0.00012622036,0.000030706822,0.000051549217],"category_scores_gemma":[0.000008812801,0.00014179242,0.00006735636,0.00008776994,0.0000469232,0.000007876507,0.000036577265,0.00017352002,4.4602945e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019558757,0.0024714277,0.10532864,0.000035667203,0.0009807389,0.00039132172,0.0005727249,0.0018312241,0.48809698,0.0000030567817,0.00046645498,0.3978659],"study_design_scores_gemma":[0.02470056,0.005339338,0.76962185,0.00025974584,0.00043182785,0.0005821028,0.00029978922,0.00037688154,0.18520935,0.00003886116,0.012396956,0.0007427383],"about_ca_topic_score_codex":0.0005393144,"about_ca_topic_score_gemma":0.0014917961,"teacher_disagreement_score":0.6642932,"about_ca_system_score_codex":0.000096742435,"about_ca_system_score_gemma":0.0001606577,"threshold_uncertainty_score":0.57821274},"labels":[],"label_agreement":null},{"id":"W1977392502","doi":"10.1054/bjoc.2000.1316","title":"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Temozolomide; Medicine; Procarbazine; Internal medicine; Chemotherapy; Adverse effect; Quality of life (healthcare); Phases of clinical research; Cancer; Dacarbazine; Progression-free survival; Oncology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.00595770731350117,"score_gpt":0.25678295623552244,"score_spread":0.2508252489220213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977392502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724174,0.0017575872,1.1496105e-7,0.00017562861,0.000051375886,0.00064706896,0.000029488541,0.0000052788455,0.000091715025],"genre_scores_gemma":[0.9990013,0.0005923529,0.00006461917,0.00006871925,0.00005689139,0.000044245186,0.0000031502934,0.000021892069,0.0001467792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860734,0.000023076644,0.0005559064,0.00014941418,0.00046889248,0.00019540136],"domain_scores_gemma":[0.99919003,0.000022440569,0.00028997465,0.00011459492,0.00024272932,0.00014024708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009632456,0.00012938124,0.0004910762,0.00013007513,0.000073017196,0.000010900116,0.00006940465,0.000042634383,0.00052910217],"category_scores_gemma":[0.000029548339,0.00010613748,0.00007599219,0.00024235001,0.000039438277,0.00012705327,0.00001991626,0.00015743269,0.0000030658962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012954648,0.026525838,0.8121233,0.00005234106,0.0003371708,0.0022795242,0.0007843315,0.00016298535,0.00004012655,1.3806142e-7,0.0015655713,0.14317401],"study_design_scores_gemma":[0.09150997,0.033931434,0.8676962,0.0018886976,0.00028493168,0.0005385004,0.00008580096,0.000018029585,0.0007577658,0.0000013020912,0.003172647,0.00011469638],"about_ca_topic_score_codex":0.00076903857,"about_ca_topic_score_gemma":0.010781332,"teacher_disagreement_score":0.14305931,"about_ca_system_score_codex":0.00027633834,"about_ca_system_score_gemma":0.00008157838,"threshold_uncertainty_score":0.6016236},"labels":[],"label_agreement":null},{"id":"W1977532013","doi":"10.1038/sj.bjc.6603826","title":"Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Lustgarten Foundation","keywords":"Pancreatic cancer; Internal medicine; Prospective cohort study; Medicine; Quartile; Insulin-like growth factor; Risk factor; Endocrinology; Oncology; Cancer; Case-control study; Proportional hazards model; Relative risk; Confidence interval; Gastroenterology; Growth factor; Receptor","score_opus":0.010367883521818206,"score_gpt":0.2608032210156316,"score_spread":0.25043533749381336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977532013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95855945,0.03970921,0.00013812394,0.00018924367,0.00034976527,0.0004959906,0.000050501316,0.000008624323,0.0004990913],"genre_scores_gemma":[0.97241706,0.0267353,0.00017283708,0.00020557921,0.00036855583,0.000016188522,7.437655e-7,0.000031677824,0.00005203528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770176,0.00012172652,0.0010324249,0.00021105006,0.00057745195,0.0003555863],"domain_scores_gemma":[0.99785095,0.0003391619,0.0008607975,0.0001247083,0.0006332304,0.00019116975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011507041,0.00019236267,0.000854215,0.0002023962,0.00009945238,0.00003416267,0.00012378565,0.00012583274,0.000095709904],"category_scores_gemma":[0.0007105339,0.0001497723,0.0002038392,0.00044006016,0.00027367083,0.0002300038,0.000037945967,0.0007567527,4.4558615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010990602,0.0000699407,0.9474181,0.00012172828,0.0004163785,0.0005008023,0.0012141094,0.000014956534,0.0007392601,0.00002959545,0.00009158314,0.048284497],"study_design_scores_gemma":[0.0072724186,0.00019295268,0.98710054,0.001258294,0.00038883358,0.0011465728,0.00031744357,0.00006609421,0.0014655264,0.0004893531,0.00015012789,0.00015184276],"about_ca_topic_score_codex":0.009192614,"about_ca_topic_score_gemma":0.0026325542,"teacher_disagreement_score":0.048132654,"about_ca_system_score_codex":0.00026288806,"about_ca_system_score_gemma":0.00029828193,"threshold_uncertainty_score":0.99740523},"labels":[],"label_agreement":null},{"id":"W1978311359","doi":"10.1054/bjoc.2001.2061","title":"Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Medicine; Thyroid cancer; Incidence (geometry); Cohort; Cohort effect; Cohort study; Demography; Thyroid; Internal medicine","score_opus":0.014282228670194349,"score_gpt":0.2907149439135352,"score_spread":0.27643271524334084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978311359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9261972,0.071284905,0.0000064705205,0.00087516615,0.00027880404,0.00012195731,0.0000137806255,0.000008304735,0.0012134673],"genre_scores_gemma":[0.98654455,0.010610484,0.00024252027,0.00151779,0.0005382713,0.000018586941,0.0000025886252,0.00002483872,0.00050038064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978558,0.000099629586,0.0005746267,0.00025385508,0.00075969595,0.00045638057],"domain_scores_gemma":[0.9989165,0.00008597077,0.00029455134,0.00012073654,0.00022319057,0.0003590532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054151315,0.00018984884,0.0006770519,0.00018261369,0.00009536781,0.000079732716,0.00016415604,0.00008197255,0.00040492765],"category_scores_gemma":[0.00020759711,0.00020306483,0.000089471185,0.00050689874,0.00008429453,0.00035786084,0.000044868724,0.00053262105,0.0000013169288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003614173,0.00001556877,0.700959,0.000039290837,0.00007647906,0.014041029,0.00008123233,0.00010281138,0.001817772,8.2254707e-7,0.002600575,0.27990395],"study_design_scores_gemma":[0.001804153,0.00015380963,0.9679803,0.0038333915,0.00015828825,0.020662604,0.0000736956,0.00013656713,0.00027847118,0.000015084705,0.004693107,0.00021049341],"about_ca_topic_score_codex":0.9552156,"about_ca_topic_score_gemma":0.9610367,"teacher_disagreement_score":0.27969345,"about_ca_system_score_codex":0.0015377033,"about_ca_system_score_gemma":0.0021015287,"threshold_uncertainty_score":0.82807434},"labels":[],"label_agreement":null},{"id":"W1978713285","doi":"10.1038/bjc.2012.144","title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Fondation pour la Recherche Médicale; Alberta Health Services","keywords":"Selumetinib; Wasting; Cachexia; Skeletal muscle; Anabolism; Medicine; Internal medicine; Endocrinology; Cancer; Sarcopenia; Oncology; Colorectal cancer","score_opus":0.003100686230026315,"score_gpt":0.2228247894269122,"score_spread":0.21972410319688587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978713285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877044,0.011895516,0.0000058574033,0.00006272111,0.00007103481,0.00013364239,0.0000140134,0.0000010057701,0.000111817135],"genre_scores_gemma":[0.9987924,0.0006417212,0.00002281312,0.00030583673,0.00019522978,0.000010130012,0.000005901727,0.0000137290035,0.000012247848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993239,0.00011111103,0.0001527863,0.00008939168,0.00014348234,0.00017934009],"domain_scores_gemma":[0.99955755,0.000015348822,0.0001840266,0.00009329225,0.000099808065,0.00004997344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020110405,0.000092945695,0.00017498236,0.000025639778,0.000034929773,0.000008466282,0.00011459864,0.000060143204,0.00002325899],"category_scores_gemma":[0.000013365493,0.00006004133,0.00006973813,0.00007675256,0.00010067934,0.000013919626,0.000016966846,0.00013225096,2.9130925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002307464,0.0002754414,0.8320871,0.000030230794,0.00024814784,0.000007022627,0.00035067488,0.000057455298,0.016798433,0.0000016259554,0.0024124286,0.14542401],"study_design_scores_gemma":[0.003773212,0.0014916386,0.97338134,0.00006441484,0.000023920882,0.000016274626,0.000042696203,3.9761645e-7,0.015520414,0.0000023675352,0.0055927914,0.000090559195],"about_ca_topic_score_codex":0.00013725187,"about_ca_topic_score_gemma":0.0001552533,"teacher_disagreement_score":0.14533344,"about_ca_system_score_codex":0.0000074712602,"about_ca_system_score_gemma":0.00005081052,"threshold_uncertainty_score":0.24484143},"labels":[],"label_agreement":null},{"id":"W1978729129","doi":"10.1038/sj.bjc.6603523","title":"Wait times for breast cancer care","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Cancer Care Nova Scotia; Nova Scotia Health Authority","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Referral; Breast cancer; Adjuvant; Cancer; Psychological intervention; Retrospective cohort study; Stage (stratigraphy); Adjuvant therapy; Adjuvant chemotherapy; Oncology; Internal medicine; Surgery; Family medicine; Nursing","score_opus":0.023190268124800344,"score_gpt":0.3306351704090039,"score_spread":0.30744490228420357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978729129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7514081,0.23561706,0.00042114404,0.003797309,0.001192213,0.00043501877,0.0008361128,0.000032759017,0.0062602623],"genre_scores_gemma":[0.9912282,0.0025066037,0.00078617915,0.00093917496,0.0030203573,0.000027476308,0.000006477751,0.000024541621,0.0014609515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988503,0.000011686606,0.0003687973,0.00012711305,0.00038099554,0.00026109544],"domain_scores_gemma":[0.99859774,0.000019792868,0.00022991118,0.00006972973,0.00096089824,0.000121909514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011646076,0.00010171124,0.00032744487,0.000054488784,0.00008875753,0.00005531086,0.00010831099,0.000068272646,0.00089892716],"category_scores_gemma":[0.00001947333,0.00010297811,0.00022203458,0.00011683568,0.000047162353,0.00018123358,0.000012666029,0.0001852707,0.000002037153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095970865,0.000058247537,0.090564996,0.0002533085,0.00019168848,0.00066754024,0.000114102855,0.0005053367,0.0012480862,0.00014381034,0.18602268,0.71927047],"study_design_scores_gemma":[0.0051574414,0.00032817983,0.70640886,0.00447303,0.0005967867,0.009704654,0.00061991677,0.00007325016,0.0023370602,0.0003918124,0.26959518,0.0003138066],"about_ca_topic_score_codex":0.0065446906,"about_ca_topic_score_gemma":0.004067889,"teacher_disagreement_score":0.71895665,"about_ca_system_score_codex":0.00030423902,"about_ca_system_score_gemma":0.00049394905,"threshold_uncertainty_score":0.9893658},"labels":[],"label_agreement":null},{"id":"W1978916413","doi":"10.1038/bjc.2013.579","title":"γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Methotrexate; Antifolate; Cancer cell; In vivo; In vitro; Cytotoxicity; Cancer research; Chemosensitivity assay; Cancer; Intracellular; Chemistry; Folate receptor; Biology; Pharmacology; Antimetabolite; Biochemistry; Immunology; Genetics","score_opus":0.0128582839721783,"score_gpt":0.3100236801526774,"score_spread":0.2971653961804991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978916413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922266,0.0064771445,0.000052491327,0.00075247494,0.000053401738,0.00032679064,0.000023216306,0.0000046676396,0.000083195424],"genre_scores_gemma":[0.991248,0.007126568,0.0008773175,0.0002892833,0.00011532413,0.000014564734,5.767884e-7,0.000016066353,0.00031231166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882585,0.000059914008,0.0003615901,0.00015916188,0.00037449726,0.00021899016],"domain_scores_gemma":[0.99868155,0.00006333677,0.0001950384,0.00008839514,0.0006738387,0.00029782622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036698233,0.000105169805,0.00037867372,0.00011551528,0.000050812498,0.000057794434,0.00005215311,0.000071499686,0.00014783973],"category_scores_gemma":[0.000104485225,0.00010184475,0.000055809727,0.00018030273,0.00008587164,0.0003805338,0.000048662525,0.00026455944,0.0000028534619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014544967,0.000037040867,0.015542714,0.0001148595,0.00009629689,0.00012704532,0.00015772296,0.00021717338,0.51924664,7.3287254e-7,0.00036934286,0.46394497],"study_design_scores_gemma":[0.0017447816,0.00039061505,0.8376673,0.0012401507,0.000108665256,0.00074655365,0.00004121269,0.002263274,0.1544632,0.00009047934,0.0010999358,0.00014383525],"about_ca_topic_score_codex":0.007951627,"about_ca_topic_score_gemma":0.00066324364,"teacher_disagreement_score":0.8221246,"about_ca_system_score_codex":0.00006984634,"about_ca_system_score_gemma":0.00013942401,"threshold_uncertainty_score":0.9986545},"labels":[],"label_agreement":null},{"id":"W1979276629","doi":"10.1038/sj.bjc.6600796","title":"Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Medical Research and Materiel Command; Medical Research Council; Medical Research Council Canada; Wellcome Trust","keywords":"Breast cancer; Immunohistochemistry; Hypoxia (environmental); Biology; Univariate analysis; Internal medicine; Carcinoma; Pathology; Cancer research; Carbonic anhydrase; Mammary gland; Cancer; Oncology; Medicine; Enzyme; Multivariate analysis; Chemistry","score_opus":0.006357992248124134,"score_gpt":0.22729281655223796,"score_spread":0.22093482430411382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979276629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885146,0.009294805,0.000014372113,0.00012788754,0.0001531301,0.000072580246,0.000043017135,0.0000010011025,0.0017785921],"genre_scores_gemma":[0.99700975,0.0021706657,0.000076742275,0.0003267564,0.00012074533,0.00000849178,0.000005095024,0.0000112542275,0.00027051178],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925864,0.0000666509,0.0002973303,0.0001149963,0.00013368647,0.00012870533],"domain_scores_gemma":[0.9994332,0.000005653551,0.00020332783,0.00006307015,0.00021891692,0.0000757832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016876931,0.00007184003,0.00014582502,0.00005177425,0.0000190514,0.0000137948455,0.000060050625,0.00008508534,0.00031266478],"category_scores_gemma":[0.00007653747,0.00008212398,0.00010495089,0.000105077386,0.000040210998,0.000009412332,0.000012746741,0.00011221344,5.5024583e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037717918,0.00042167373,0.52812076,0.00011848754,0.00016542379,0.00023266581,0.00012104181,0.00006228226,0.42630342,0.00003749633,0.027053045,0.016986515],"study_design_scores_gemma":[0.002774448,0.00044606946,0.21799111,0.0005300884,0.000053665113,0.0033802418,0.00017174474,0.0000059298422,0.7561639,0.0000516,0.018215416,0.00021578454],"about_ca_topic_score_codex":0.00024528787,"about_ca_topic_score_gemma":0.0011995677,"teacher_disagreement_score":0.32986048,"about_ca_system_score_codex":0.000036795773,"about_ca_system_score_gemma":0.00033863194,"threshold_uncertainty_score":0.342346},"labels":[],"label_agreement":null},{"id":"W1979687843","doi":"10.1038/sj.bjc.6604960","title":"Cancer neurology in clinical practice, neurological complications of cancer and its treatment (2nd Edn)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Neurology; Medicine; Cancer; Clinical Practice; Clinical neurology; Internal medicine; Physical therapy; Psychology; Psychiatry; Neuroscience","score_opus":0.0573256548277383,"score_gpt":0.45236094634042867,"score_spread":0.39503529151269035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979687843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8745722,0.094253674,0.0000023489,0.029722575,0.00048754437,0.00031311752,0.000058754526,0.000007002911,0.0005827646],"genre_scores_gemma":[0.8249159,0.16692454,0.00011380917,0.0071950285,0.00060930615,0.00004817242,0.0000026170899,0.000011161565,0.00017947277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99832267,0.00015756203,0.00082960655,0.00024586928,0.00019535163,0.00024895527],"domain_scores_gemma":[0.9985392,0.00027141467,0.00055085233,0.00008895212,0.00034495266,0.00020460176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022709997,0.0001459846,0.00067205564,0.000109426815,0.00004418928,0.000012533452,0.00008954832,0.00014391383,0.00045065308],"category_scores_gemma":[0.00010702774,0.00013284339,0.00014994925,0.00018371806,0.00011611416,0.00013114527,0.000017101305,0.00045548225,9.814304e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039029627,0.0022502015,0.32279682,0.000027069229,0.0004107147,0.001509456,0.00011158188,0.00018217444,0.0011253799,0.000067973364,0.003959444,0.66365623],"study_design_scores_gemma":[0.00694149,0.0037148937,0.8741591,0.00013761515,0.0006052061,0.0017340796,0.000007766523,0.00011093641,0.00019423365,0.00006274228,0.112241104,0.00009084331],"about_ca_topic_score_codex":0.0019359336,"about_ca_topic_score_gemma":0.0039298045,"teacher_disagreement_score":0.6635654,"about_ca_system_score_codex":0.00010934229,"about_ca_system_score_gemma":0.00048203405,"threshold_uncertainty_score":0.5417196},"labels":[],"label_agreement":null},{"id":"W1979782687","doi":"10.1038/sj.bjc.6604995","title":"Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Pancreatic cancer; Ribosomal protein s6; Cancer research; Pharmacology; Internal medicine; Cancer; P70-S6 Kinase 1; Phosphorylation; Biology; Signal transduction","score_opus":0.02621350793459556,"score_gpt":0.34372713953262185,"score_spread":0.3175136315980263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979782687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579377,0.0061792196,0.00003969733,0.0007254056,0.00029748044,0.00045183246,0.00004387117,0.000018020542,0.006450716],"genre_scores_gemma":[0.9910657,0.0044329837,0.0007108092,0.000915415,0.0014096132,0.000022333836,0.000008689213,0.000027913335,0.0014065468],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974239,0.00011627325,0.00079419505,0.00025557974,0.00091703335,0.00049303786],"domain_scores_gemma":[0.9980394,0.00011802973,0.00062901,0.00022121186,0.0005858701,0.00040643167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060377974,0.00021779876,0.0012031444,0.00022699207,0.00016003959,0.000036925936,0.00017994817,0.00019719686,0.00039948043],"category_scores_gemma":[0.00024017942,0.00021720678,0.00028739628,0.0003248419,0.00028821582,0.0002471393,0.000038931204,0.0007417001,0.0000031611432],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036071718,0.0030642555,0.24915574,0.0010218122,0.0016742679,0.006610229,0.00081413495,0.000043009135,0.41669494,0.00011180167,0.014895214,0.30230743],"study_design_scores_gemma":[0.0112182945,0.003568684,0.9596993,0.004362892,0.00082481344,0.0029972482,0.00014760756,0.00004726285,0.010266152,0.00009438537,0.0064253686,0.00034799302],"about_ca_topic_score_codex":0.002049571,"about_ca_topic_score_gemma":0.00070527015,"teacher_disagreement_score":0.7105436,"about_ca_system_score_codex":0.000804977,"about_ca_system_score_gemma":0.0023286878,"threshold_uncertainty_score":0.8857435},"labels":[],"label_agreement":null},{"id":"W1979791033","doi":"10.1038/bjc.2011.355","title":"Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University; Université du Québec","funders":"National Institute of General Medical Sciences; Winship Cancer Institute; National Cancer Institute; National Institutes of Health; Georgia Research Alliance; Emory University","keywords":"Breast cancer; Bead; Pathology; Medicine; Cancer; Biology; Materials science; Internal medicine","score_opus":0.05657751986548907,"score_gpt":0.3345027286124366,"score_spread":0.2779252087469475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979791033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199826,0.0035701913,0.0016605101,0.0006001033,0.0006773338,0.00052286393,0.000643467,0.000026079088,0.00030117156],"genre_scores_gemma":[0.99423593,0.0011397352,0.0029678752,0.00044458103,0.0010000425,0.0000379849,0.000020561985,0.000101624966,0.00005166984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962928,0.0000945981,0.0012173887,0.00032857896,0.0013636824,0.0007029203],"domain_scores_gemma":[0.99653363,0.000033445707,0.0010738051,0.00030021742,0.0015516866,0.0005072313],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000745228,0.0003138689,0.00090762204,0.00036136102,0.00011491271,0.00006643326,0.0003456905,0.00020036912,0.0024820461],"category_scores_gemma":[0.000046581637,0.00033592948,0.00039103226,0.00048598283,0.00021597235,0.00047221017,0.00004698867,0.0007560957,0.000008752613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003943636,0.0006556733,0.020829039,0.00059517415,0.0006888456,0.0020154854,0.0008907034,0.0007610391,0.8879905,0.000022610247,0.0005622905,0.08104504],"study_design_scores_gemma":[0.0075464435,0.00050071866,0.2670901,0.0058633727,0.0006346591,0.012453574,0.00026574556,0.0012328158,0.70282865,0.000062868785,0.00095624186,0.00056478736],"about_ca_topic_score_codex":0.004819203,"about_ca_topic_score_gemma":0.00053663226,"teacher_disagreement_score":0.24626106,"about_ca_system_score_codex":0.000940222,"about_ca_system_score_gemma":0.002461046,"threshold_uncertainty_score":0.9999093},"labels":[],"label_agreement":null},{"id":"W1980208656","doi":"10.1038/bjc.2014.66","title":"Breast cancer: trends in international incidence in men and women","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Provincial Laboratory of Public Health","funders":"University of Canterbury","keywords":"Incidence (geometry); Breast cancer; Medicine; Cancer; Gynecology; Oncology; Demography; Internal medicine","score_opus":0.009184822938600998,"score_gpt":0.3195259888368601,"score_spread":0.3103411658982591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980208656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98282003,0.0069493144,0.0000046430964,0.007150841,0.0002445677,0.000051282044,0.000020348423,0.0000036788404,0.002755309],"genre_scores_gemma":[0.98778003,0.010551648,0.00008188982,0.00059159717,0.00049532927,0.000023741874,5.442469e-7,0.000008882658,0.00046635314],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99894047,0.000039919138,0.00040673235,0.000113044705,0.00028675693,0.00021308838],"domain_scores_gemma":[0.9994529,0.000034208522,0.00018269713,0.000042786927,0.00015426305,0.00013313799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051487697,0.00007136411,0.0003190408,0.00025334462,0.000020843543,0.00001864302,0.00008226066,0.00003842688,0.00053198374],"category_scores_gemma":[0.000053006588,0.000075241805,0.000024796755,0.00018234077,0.000054462947,0.00014190568,0.00003762765,0.000274148,5.0469407e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022483371,0.000033491702,0.4424535,0.000036821264,0.00002283337,0.00015387576,0.00050162844,0.00001545835,0.000024655075,0.0000056834515,0.0009739649,0.55555326],"study_design_scores_gemma":[0.0027339386,0.000055867666,0.9855999,0.0014026595,0.000009546674,0.0043293554,0.00023723993,0.00017592024,0.0000058139135,0.000062890525,0.0053231264,0.00006376297],"about_ca_topic_score_codex":0.0061807223,"about_ca_topic_score_gemma":0.008899147,"teacher_disagreement_score":0.5554895,"about_ca_system_score_codex":0.0005089209,"about_ca_system_score_gemma":0.00014343423,"threshold_uncertainty_score":0.9343445},"labels":[],"label_agreement":null},{"id":"W1980208663","doi":"10.1054/bjoc.2000.1315","title":"Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Testosterone (patch); Prostate cancer; Cancer; Internal medicine; Antibody; Hormone; Prostate; Endocrinology; Prostate-specific antigen; Urology; Immunology","score_opus":0.01890449417211312,"score_gpt":0.31046679837093255,"score_spread":0.29156230419881946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980208663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824261,0.015818257,4.2045153e-7,0.00050173735,0.0001003076,0.00046233626,0.00035670798,0.0000060045645,0.00032815125],"genre_scores_gemma":[0.9833004,0.014991789,0.00017903208,0.000097524775,0.00008159966,0.000021572512,0.000009037368,0.000032072465,0.0012869696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982549,0.00004546933,0.00052827207,0.00019450144,0.00058652874,0.00039033906],"domain_scores_gemma":[0.99878985,0.000020461774,0.00029236218,0.000112547496,0.0006154402,0.00016934285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014359545,0.0001676827,0.000599194,0.0001557839,0.00005161343,0.000029171104,0.00010874221,0.000060056136,0.00059963035],"category_scores_gemma":[0.000016835857,0.00013826399,0.00006549945,0.00035083244,0.00017638243,0.0002688985,0.000015309299,0.00037756475,0.0000010340711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016889366,0.0002862689,0.62475646,0.0001380516,0.0001688297,0.0005646934,0.00037344632,0.00023717844,0.0018435288,3.0694417e-7,0.0001313796,0.36981094],"study_design_scores_gemma":[0.011463867,0.0011100376,0.9725518,0.0040630605,0.00008657162,0.00015716952,0.00009259095,0.000002978885,0.009447327,0.000008368844,0.0008669425,0.00014926879],"about_ca_topic_score_codex":0.0018479533,"about_ca_topic_score_gemma":0.0024618169,"teacher_disagreement_score":0.36966166,"about_ca_system_score_codex":0.00026498327,"about_ca_system_score_gemma":0.0008181048,"threshold_uncertainty_score":0.65655315},"labels":[],"label_agreement":null},{"id":"W1981010480","doi":"10.1038/bjc.2015.54","title":"Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Toronto Public Health; St. Michael's Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; Surgery; Incidence (geometry); Comorbidity; Cumulative incidence; Prostate; Retrospective cohort study; Prostatectomy; Cancer; Hazard ratio; Cohort; Internal medicine","score_opus":0.05088168441984392,"score_gpt":0.3550951065472629,"score_spread":0.304213422127419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981010480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7564817,0.22542298,0.0032126992,0.011118068,0.0011791174,0.0021703604,0.00027959858,0.000052218915,0.00008328096],"genre_scores_gemma":[0.78468573,0.18026003,0.021258544,0.0058814436,0.0019958396,0.0021036284,0.000038272312,0.00022828163,0.0035482456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842364,0.00003903134,0.0005303265,0.00023530136,0.00042643634,0.00034527716],"domain_scores_gemma":[0.9982336,0.00015495277,0.00043993612,0.00016269406,0.00062409916,0.0003846801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034277554,0.00020140554,0.0008951238,0.00010903659,0.000110786255,0.000094935116,0.000096919524,0.00005718563,0.00012421136],"category_scores_gemma":[0.00004864846,0.00013861485,0.00023857286,0.00025703548,0.00007680399,0.00023874472,0.0000058190217,0.00015779103,4.5584682e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014907397,0.00067868206,0.33687678,0.00020481992,0.0030864335,0.0011790432,0.0009866143,0.00032502532,0.00045606785,0.0000041780913,0.06812674,0.5731682],"study_design_scores_gemma":[0.050696876,0.005406978,0.10371598,0.0100952145,0.0015015521,0.0077758073,0.00050948357,0.00040488542,0.0032600244,0.000058654652,0.81578815,0.0007863956],"about_ca_topic_score_codex":0.0012157784,"about_ca_topic_score_gemma":0.0026285974,"teacher_disagreement_score":0.7476614,"about_ca_system_score_codex":0.00083329674,"about_ca_system_score_gemma":0.0025283112,"threshold_uncertainty_score":0.565255},"labels":[],"label_agreement":null},{"id":"W1981255635","doi":"10.1054/bjoc.2001.1776","title":"MDR1 causes resistance to the antitumour drug miltefosine","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Cancer Institute; Austrian Science Fund","keywords":"Miltefosine; Vinblastine; P-glycoprotein; Pharmacology; Biology; IC50; Drug resistance; Cancer research; Multiple drug resistance; Molecular biology; In vitro; Chemistry; Immunology; Chemotherapy; Biochemistry; Microbiology; Visceral leishmaniasis; Leishmaniasis","score_opus":0.01082683677644481,"score_gpt":0.27235188527555226,"score_spread":0.26152504849910746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981255635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.900348,0.070548125,0.000685873,0.023391083,0.0013272613,0.00027792307,0.000030787323,0.000024181343,0.0033667362],"genre_scores_gemma":[0.9486823,0.017581146,0.0008528611,0.0025348598,0.0013552076,0.0000088401775,0.0000017148343,0.000030423489,0.028952658],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986282,0.00002662885,0.00041813424,0.00013674356,0.0005216527,0.0002686497],"domain_scores_gemma":[0.99907017,0.000020071766,0.00017494163,0.00015381032,0.00037197082,0.0002090491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035312324,0.00011412377,0.00033424248,0.000073507974,0.00013985613,0.00005307244,0.00020338653,0.000038195787,0.00039619967],"category_scores_gemma":[0.000042723754,0.000085945285,0.0001645986,0.00031584158,0.000052384315,0.000108016386,0.000010978864,0.0002965233,0.000012420229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005238056,0.00085107976,0.0647034,0.0005268379,0.00093484746,0.033389527,0.0020789865,0.00049860403,0.032704487,0.0007211325,0.7134811,0.1448719],"study_design_scores_gemma":[0.0013472199,0.00006159912,0.11859466,0.002130503,0.00018534405,0.0023549274,0.00022592732,0.0000014588326,0.005982647,0.00013566292,0.868839,0.00014102575],"about_ca_topic_score_codex":0.00019144361,"about_ca_topic_score_gemma":0.015025577,"teacher_disagreement_score":0.1553579,"about_ca_system_score_codex":0.000082005856,"about_ca_system_score_gemma":0.00021302515,"threshold_uncertainty_score":0.8384625},"labels":[],"label_agreement":null},{"id":"W1982014175","doi":"10.1054/bjoc.2001.1857","title":"Tcf-3 expression and β -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Medical Research Council; Vlaamse regering; Medical Research Council Canada","keywords":"Cancer research; Immunoprecipitation; Beta-catenin; Fibromatosis; Catenin; Aggressive fibromatosis; Biology; Cell culture; Pathology; Medicine; Wnt signaling pathway; Signal transduction; Cell biology; Genetics","score_opus":0.015646336883165406,"score_gpt":0.2827128031109853,"score_spread":0.2670664662278199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982014175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735864,0.024515765,0.000051529427,0.0013538455,0.00014149622,0.00013252684,0.000010597238,0.000013127601,0.00019474902],"genre_scores_gemma":[0.9876495,0.011346834,0.00037029138,0.0001938721,0.0002851896,0.000016309717,0.000006494616,0.000018758234,0.00011272363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884224,0.00004958324,0.00041383886,0.00013394553,0.00038209543,0.00017832119],"domain_scores_gemma":[0.9991711,0.000089593035,0.00034412404,0.000040797793,0.00023216924,0.00012223158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016647833,0.000108583394,0.00034838752,0.00017633323,0.00006307469,0.000023695877,0.00004773851,0.00006076828,0.00029128644],"category_scores_gemma":[0.00031598954,0.0001097389,0.00006692118,0.00022296498,0.00008215004,0.0002522279,0.000013995892,0.00028279604,0.0000017613547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001321485,0.0002495131,0.18457022,0.00015393313,0.00016712735,0.0065990197,0.0014602626,0.000022439463,0.74436074,0.000008105397,0.005638088,0.055449076],"study_design_scores_gemma":[0.0046684593,0.00016881459,0.9516188,0.0055180485,0.00006371771,0.010663708,0.00051490753,0.000021067295,0.02311041,0.00011691623,0.003391886,0.00014325941],"about_ca_topic_score_codex":0.0002519853,"about_ca_topic_score_gemma":0.00014174278,"teacher_disagreement_score":0.7670486,"about_ca_system_score_codex":0.00012174141,"about_ca_system_score_gemma":0.00011006015,"threshold_uncertainty_score":0.44750226},"labels":[],"label_agreement":null},{"id":"W1982388744","doi":"10.1038/sj.bjc.6601259","title":"Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Chemotherapy; Vincristine; Neuroblastoma; Cyclophosphamide; Surgery","score_opus":0.009485818501001077,"score_gpt":0.2838486978984315,"score_spread":0.2743628793974304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982388744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933986,0.004795521,0.000022087375,0.00037062523,0.000074025855,0.00026551128,0.000006396929,0.0000070443048,0.0010602102],"genre_scores_gemma":[0.9926035,0.0054969094,0.000282042,0.0009844404,0.00005880702,0.000012461297,6.917656e-7,0.00003326401,0.000527897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861705,0.00007753221,0.00035724128,0.00017029494,0.0004595334,0.00031833348],"domain_scores_gemma":[0.99928206,0.00004884532,0.0001372253,0.000102879545,0.00014829531,0.00028072056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018736771,0.00013009683,0.0003897503,0.00015039789,0.000040264742,0.000049874387,0.000063931104,0.000041954492,0.00023013697],"category_scores_gemma":[0.00006554934,0.00011171725,0.000057061286,0.00022798622,0.00009013375,0.00017413197,0.000013748751,0.0003683664,0.0000019735014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011972671,0.0022917928,0.686218,0.00067665894,0.00055022934,0.04283617,0.00020128509,0.00018005422,0.014555022,0.000014512714,0.0027803148,0.23772325],"study_design_scores_gemma":[0.029016688,0.0019568936,0.93940586,0.0016386741,0.000055675708,0.011419606,0.000042946485,0.000020908314,0.007969786,0.0000374018,0.008253029,0.00018255072],"about_ca_topic_score_codex":0.00020763274,"about_ca_topic_score_gemma":0.00041991938,"teacher_disagreement_score":0.2531878,"about_ca_system_score_codex":0.000146557,"about_ca_system_score_gemma":0.00034100385,"threshold_uncertainty_score":0.45556974},"labels":[],"label_agreement":null},{"id":"W1983294325","doi":"10.1038/bjc.2014.28","title":"Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Alberta Cancer Foundation; University of Calgary","funders":"BC Cancer Agency; Yonsei University; Alberta Health Services","keywords":"Medicine; Internal medicine; Cohort; Retrospective cohort study; Renal cell carcinoma; Toxicity; Cohort study; Asian americans; Targeted therapy; Ethnic group; Oncology; Cancer","score_opus":0.015125402951028693,"score_gpt":0.2651320945689757,"score_spread":0.250006691617947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983294325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938802,0.003599283,0.0000141474275,0.0006297024,0.00014183288,0.00016434089,0.0000070982173,0.0000037594664,0.0015596233],"genre_scores_gemma":[0.9953225,0.0039096815,0.00013897807,0.0001503232,0.00037370078,0.0000053170797,0.0000031690765,0.000016893853,0.000079405734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998899,0.000059244372,0.00036937327,0.00013888387,0.00033705993,0.00019645283],"domain_scores_gemma":[0.9993713,0.000027413686,0.00020538762,0.00007873037,0.00013354392,0.0001836553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015953004,0.000117669406,0.00047910053,0.00010909227,0.000038239094,0.00004647705,0.000079195066,0.00006441243,0.00006121866],"category_scores_gemma":[0.000027455913,0.00010126743,0.00007924134,0.000096070136,0.00005856584,0.000104897306,0.000014773173,0.00023087708,0.0000014290416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042004107,0.00006770009,0.6229457,0.00001655166,0.000047131423,0.000094683506,0.00012508291,2.2048852e-7,0.000079890415,5.2279205e-7,0.000111852,0.37646866],"study_design_scores_gemma":[0.004434995,0.0009673734,0.9913249,0.00078191294,0.000054625794,0.0001630138,0.00004867443,0.0000035213368,0.0006612458,0.00006235036,0.0014036783,0.00009370647],"about_ca_topic_score_codex":0.00045579302,"about_ca_topic_score_gemma":0.0003359085,"teacher_disagreement_score":0.37637493,"about_ca_system_score_codex":0.00009183787,"about_ca_system_score_gemma":0.00007463907,"threshold_uncertainty_score":0.4129566},"labels":[],"label_agreement":null},{"id":"W1984609427","doi":"10.1038/bjc.2011.204","title":"A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Economic and Social Research Council; Queen's University; Queen's University Belfast","keywords":"Ductal carcinoma; Breast cancer; Medicine; Carcinoma in situ; Oncology; Cancer; Internal medicine; Pathology; Immunohistochemistry; Carcinoma; Breast disease; Carcinogenesis","score_opus":0.01170429034964729,"score_gpt":0.2615554241101634,"score_spread":0.24985113376051613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984609427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20357533,0.7921889,3.2189223e-7,0.00013679921,0.0003896751,0.0028516715,0.00081904064,0.0000026203768,0.000035650883],"genre_scores_gemma":[0.10753103,0.89144856,0.000018292105,0.00019278601,0.00040198292,0.00030660664,0.0000059343565,0.00007275582,0.000022042881],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99468935,0.0009975487,0.0027128018,0.0003912261,0.00071113714,0.0004979534],"domain_scores_gemma":[0.99501854,0.0003172159,0.0029878595,0.0005533968,0.00082184095,0.00030114036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014775873,0.0005497864,0.0042258403,0.00038387533,0.00007084094,0.000030944328,0.0006969866,0.00028631097,0.00010573786],"category_scores_gemma":[0.00037155312,0.0003384084,0.0007808125,0.0008241917,0.00025162188,0.0002496701,0.00020578802,0.0011285979,0.000001617679],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017532217,0.00021052397,0.02652413,0.91534966,0.00039914213,0.0019461729,0.0010407412,0.0000014193934,0.00070125016,0.000005171272,0.00078781974,0.05285864],"study_design_scores_gemma":[0.0011256656,0.00008385795,0.10702812,0.8205874,0.002298337,0.06794429,0.00013617014,2.840622e-7,0.0002249652,0.0000039478455,0.00027062537,0.00029634743],"about_ca_topic_score_codex":0.006580389,"about_ca_topic_score_gemma":0.009064585,"teacher_disagreement_score":0.099259675,"about_ca_system_score_codex":0.00050192955,"about_ca_system_score_gemma":0.0028597957,"threshold_uncertainty_score":0.9999068},"labels":[],"label_agreement":null},{"id":"W1985388571","doi":"10.1038/bjc.2012.350","title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":812,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Health Services; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Sarcopenia; Medicine; Odds ratio; Confidence interval; Rehabilitation; Colorectal cancer; Multivariate analysis; Internal medicine; Inpatient care; Cancer; Physical therapy; Surgery; Health care","score_opus":0.02848923601270954,"score_gpt":0.32341952104034755,"score_spread":0.294930285027638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985388571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782818,0.019124927,0.000029902507,0.001390196,0.0007900455,0.00014158386,0.00008459136,0.0000121726,0.00014480241],"genre_scores_gemma":[0.97422945,0.022804448,0.00010997285,0.0019018997,0.00075464277,0.000016837452,0.000013069698,0.000018824521,0.00015087475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990147,0.000097781834,0.00032308153,0.000096900716,0.000258221,0.00020931584],"domain_scores_gemma":[0.9988531,0.00014104511,0.0003056564,0.000030178157,0.0004639611,0.00020605102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039445492,0.00008409302,0.00033367565,0.00010598901,0.00013903064,0.000042324085,0.00001634522,0.00008894684,0.0006860943],"category_scores_gemma":[0.00013982666,0.00008191366,0.000059760707,0.00017466127,0.000044249748,0.0004266467,0.00000789165,0.00036651886,0.0000013405157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003168026,0.00018866964,0.88184524,0.00005321841,0.00053327554,0.00013213491,0.00062476675,0.0000057228813,0.0043722666,0.0000012189284,0.029985681,0.07908978],"study_design_scores_gemma":[0.0020682956,0.0003443528,0.9809319,0.0029201314,0.00017428881,0.0012413872,0.00007217698,0.00001637068,0.0049347784,0.000022390916,0.0071594683,0.00011446801],"about_ca_topic_score_codex":0.008956461,"about_ca_topic_score_gemma":0.009636132,"teacher_disagreement_score":0.09908665,"about_ca_system_score_codex":0.0004174234,"about_ca_system_score_gemma":0.00031930226,"threshold_uncertainty_score":0.997643},"labels":[],"label_agreement":null},{"id":"W1986352449","doi":"10.1038/bjc.2013.492","title":"‘Being there’ for women with metastatic breast cancer: a pan-European patient survey","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Society for Medical Oncology; Eisai Canada; Medical Research Council; Eisai; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Family medicine; Quality of life (healthcare); Cancer; Breast cancer awareness; Oncology; Nursing; Internal medicine","score_opus":0.013551594533720786,"score_gpt":0.25990416932231547,"score_spread":0.24635257478859468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986352449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789895,0.009229939,0.00018213115,0.0006361738,0.00045942317,0.00042457986,0.0002793112,0.0000136468725,0.00087583537],"genre_scores_gemma":[0.99536794,0.00236727,0.00012322425,0.0009093297,0.00040489496,0.00015280647,0.0000050048493,0.000058975504,0.0006105297],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985105,0.0001465963,0.0004236865,0.00016657673,0.00039660902,0.00035603027],"domain_scores_gemma":[0.99820185,0.00007333992,0.00034947813,0.00012314136,0.0009943802,0.00025779798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047466127,0.0001455258,0.00044027984,0.00006360384,0.000076165714,0.00010641396,0.000118389355,0.000023654491,0.0010437642],"category_scores_gemma":[0.00004012597,0.00012164339,0.000103739105,0.00017195982,0.00005653946,0.00019754365,0.000019550653,0.00022808103,0.000004152211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010009567,0.00011206161,0.060044765,0.00020791903,0.0005748209,0.00026793353,0.0014140102,0.000032524706,0.00022857328,0.0000024024184,0.0052265027,0.9308875],"study_design_scores_gemma":[0.0032780494,0.0008437863,0.9664713,0.0018849015,0.00018887085,0.0022738245,0.0014584316,0.000015224727,0.00015803118,0.000068768364,0.023123352,0.00023546453],"about_ca_topic_score_codex":0.020650022,"about_ca_topic_score_gemma":0.029902542,"teacher_disagreement_score":0.9306521,"about_ca_system_score_codex":0.0003314855,"about_ca_system_score_gemma":0.0003700859,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W1986462840","doi":"10.1038/bjc.2013.695","title":"Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Oncolytic virus; Immune system; Gemcitabine; Cancer research; Medicine; Tumor microenvironment; Cancer; Immunology; Context (archaeology); Biology; Internal medicine","score_opus":0.013177078510222807,"score_gpt":0.30753223080611247,"score_spread":0.29435515229588965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986462840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687327,0.029070769,0.00100546,0.0006443782,0.00013189747,0.00020309993,0.000028464567,0.0000027792235,0.0001804422],"genre_scores_gemma":[0.98195267,0.016718995,0.00063164264,0.0003097943,0.0002227699,0.000029613046,0.0000057641005,0.000014017432,0.00011470705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989995,0.000086916676,0.00029503356,0.00013605552,0.00026425542,0.00021824044],"domain_scores_gemma":[0.99925065,0.000030091358,0.0002530842,0.00013772714,0.00027359556,0.000054856806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015194675,0.00010140168,0.00021120001,0.000020083853,0.00007818817,0.000049290433,0.00029752316,0.000070030284,0.0004573511],"category_scores_gemma":[0.00006283427,0.000072881616,0.00017872964,0.000084825435,0.00015008589,0.000013628511,0.000033268196,0.00014533303,0.0000041440635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003109666,0.00021114068,0.00035082715,0.000010443858,0.0002629882,0.000032098986,0.000018254676,0.00007206568,0.9406303,0.000028258626,0.0019796814,0.056092944],"study_design_scores_gemma":[0.0029642282,0.0010746114,0.030620594,0.00016987606,0.000027574917,0.00013464705,0.000042939424,0.000005856433,0.9480963,0.0005101368,0.016236506,0.000116760195],"about_ca_topic_score_codex":0.0017855306,"about_ca_topic_score_gemma":0.0004042793,"teacher_disagreement_score":0.055976182,"about_ca_system_score_codex":0.000029381094,"about_ca_system_score_gemma":0.00021485836,"threshold_uncertainty_score":0.50076735},"labels":[],"label_agreement":null},{"id":"W1986709694","doi":"10.1038/sj.bjc.6600114","title":"FDG–PET. A possible prognostic factor in head and neck cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Standardized uptake value; Medicine; Positron emission tomography; Head and neck cancer; Stage (stratigraphy); Head and neck squamous-cell carcinoma; Nuclear medicine; Univariate analysis; Cancer; Multivariate analysis; Head and neck; Carcinoma; Oncology; Internal medicine; Surgery; Biology","score_opus":0.03192314064905917,"score_gpt":0.34140979116885034,"score_spread":0.3094866505197912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986709694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96829176,0.023266174,0.000089273366,0.007605895,0.00006775684,0.00019295236,0.000017959794,0.000016987486,0.00045126298],"genre_scores_gemma":[0.97317976,0.021323534,0.0034273195,0.0009938681,0.00026567018,0.00004761351,6.597279e-7,0.000014380561,0.00074717693],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992187,0.000013181065,0.00029149753,0.00010254002,0.00021017456,0.00016390908],"domain_scores_gemma":[0.9994946,0.000025784517,0.00011328495,0.000062666855,0.00011689466,0.0001867519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007620362,0.0000668218,0.00022895302,0.00006468537,0.000032097658,0.00003412954,0.00006385312,0.000033080818,0.0011764517],"category_scores_gemma":[0.00009227838,0.00006428772,0.000044610875,0.00015263706,0.0000617047,0.000084167594,0.000015627127,0.00032240766,0.0000018988843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003364856,0.00030919106,0.38467795,0.00014919786,0.000049813385,0.0011755276,0.00015339731,0.0000027799988,0.0016707246,0.000030934,0.047955345,0.56379145],"study_design_scores_gemma":[0.0030183883,0.0002481474,0.8574033,0.006207495,0.00010427809,0.0062246867,0.000029169938,0.0012084111,0.00069870654,0.00028356153,0.12438366,0.00019019473],"about_ca_topic_score_codex":0.000944909,"about_ca_topic_score_gemma":0.0005036963,"teacher_disagreement_score":0.5636013,"about_ca_system_score_codex":0.000073525196,"about_ca_system_score_gemma":0.000080254766,"threshold_uncertainty_score":0.9997366},"labels":[],"label_agreement":null},{"id":"W1988330920","doi":"10.1038/bjc.2012.599","title":"Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Genetic predisposition; Breast cancer; Anxiety; Cancer; Medicine; Depression (economics); Genetic testing; Distress; Internal medicine; Clinical psychology; Psychology; Oncology; Psychiatry; Disease","score_opus":0.01153879146308891,"score_gpt":0.3014702609902837,"score_spread":0.2899314695271948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988330920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671197,0.0013782845,0.000057395726,0.00053171266,0.00015716605,0.00060977176,0.00051333825,0.0000023952796,0.000037974543],"genre_scores_gemma":[0.9978449,0.0009301981,0.0003654933,0.00018619969,0.00027436507,0.00034607467,0.0000018805652,0.000024127245,0.000026762038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984918,0.00008977908,0.000563509,0.00029371362,0.00025774594,0.0003034296],"domain_scores_gemma":[0.99851066,0.00002091658,0.00028352693,0.00026969,0.0007641059,0.00015111247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020392853,0.00016530497,0.00031918098,0.00006523656,0.00004641579,0.000036521047,0.00040641995,0.0001106332,0.0001784405],"category_scores_gemma":[0.00006786563,0.0001189231,0.000121424775,0.00033647873,0.00013152552,0.000021545226,0.00008720902,0.0001891793,3.1058758e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063092407,0.00016480572,0.47971892,0.000032099055,0.00012274322,0.0000030892134,0.00043090334,0.013755683,0.39924902,1.0242243e-7,0.00075771555,0.10513399],"study_design_scores_gemma":[0.0006786151,0.0005645129,0.98649985,0.00067431753,0.000025834914,0.00020330648,0.00017433646,0.000014004941,0.0109404465,0.000030222192,0.000043351356,0.0001511979],"about_ca_topic_score_codex":0.00230082,"about_ca_topic_score_gemma":0.0033084902,"teacher_disagreement_score":0.5067809,"about_ca_system_score_codex":0.00062154885,"about_ca_system_score_gemma":0.00051163405,"threshold_uncertainty_score":0.48495433},"labels":[],"label_agreement":null},{"id":"W1988471743","doi":"10.1038/sj.bjc.6601221","title":"Glucocorticoid use and skin cancers","year":2003,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Glucocorticoid; Asthma; Medicine; Hay fever; Confounding; Allergy; Cancer; Immunology; Lung cancer; Relative risk; Skin cancer; Basal cell carcinoma; Internal medicine; Basal cell; Confidence interval","score_opus":0.01848235734466415,"score_gpt":0.26175948252172604,"score_spread":0.2432771251770619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988471743","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4268554,0.13400456,0.00036843063,0.4279067,0.0060734437,0.0010124312,0.00022771682,0.000031263586,0.0035200526],"genre_scores_gemma":[0.011624081,0.09920855,0.00056629925,0.873053,0.005949944,0.0000064323813,0.00005261435,0.000103611084,0.009435429],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985334,0.000062537525,0.00051403255,0.00017543354,0.00048724154,0.00022730998],"domain_scores_gemma":[0.99870545,0.000052160623,0.00051213073,0.00010126566,0.0005279206,0.00010108919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010562837,0.00016426152,0.0005993528,0.00010559619,0.00004421452,0.00013475693,0.000050189716,0.00035447621,0.00047793594],"category_scores_gemma":[0.00010532754,0.00017545949,0.00015464923,0.0000875921,0.00007150906,0.00017318963,0.000010481261,0.0012652528,0.000002666527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004291847,0.000008180631,0.0010601778,0.0001459255,0.000245512,0.01026121,0.00003995925,0.000023118642,0.000026851632,0.0000013163175,0.94853336,0.039611444],"study_design_scores_gemma":[0.0014206958,0.00012322688,0.011546252,0.0019458765,0.00030356046,0.021123845,0.000023518549,0.000023028784,0.000045270783,0.000016236532,0.96324587,0.00018260792],"about_ca_topic_score_codex":0.0014508843,"about_ca_topic_score_gemma":0.00039265517,"teacher_disagreement_score":0.44514635,"about_ca_system_score_codex":0.00030311404,"about_ca_system_score_gemma":0.00069482584,"threshold_uncertainty_score":0.71550304},"labels":[],"label_agreement":null},{"id":"W1989143916","doi":"10.1038/sj.bjc.6601159","title":"Quality of life and understanding of disease status among cancer patients of different ethnic origin","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ethnic group; Medicine; Disease; Quality of life (healthcare); Cancer; Portuguese; Family medicine; Gerontology; Internal medicine; Linguistics; Nursing","score_opus":0.14436851668895487,"score_gpt":0.39455765336344784,"score_spread":0.25018913667449294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989143916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96739227,0.031717937,0.00016495405,0.00004108523,0.00021213932,0.00013244778,0.0001213327,0.0000020980133,0.00021574434],"genre_scores_gemma":[0.98711103,0.012643438,0.000066988985,0.00008176085,0.000054413977,0.0000033872725,0.0000017479659,0.000010994289,0.000026209967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807274,0.00010350982,0.0008206793,0.00011720912,0.00067875185,0.00020708924],"domain_scores_gemma":[0.99807864,0.00007046009,0.0009190991,0.00008874101,0.00048325935,0.00035979706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003184424,0.00010366923,0.0006043518,0.000078968136,0.000028857965,0.000008197138,0.0000653923,0.000049684262,0.00020908851],"category_scores_gemma":[0.00040666532,0.00009876343,0.00014448204,0.00016462323,0.00019245046,0.00014880355,0.000017816452,0.00019252325,3.46736e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080922246,0.00012686927,0.98986,0.0004403757,0.00016664705,0.00001391727,0.00018054084,0.00005501328,0.0004364417,0.00016214872,0.0002920077,0.007456806],"study_design_scores_gemma":[0.002990465,0.00025366797,0.99216133,0.0025349068,0.00016409975,0.0000054598563,0.0005052899,0.000008208351,0.00082536665,0.00035903626,0.00010227344,0.00008989802],"about_ca_topic_score_codex":0.00369373,"about_ca_topic_score_gemma":0.0025095572,"teacher_disagreement_score":0.019718798,"about_ca_system_score_codex":0.000288132,"about_ca_system_score_gemma":0.00055145123,"threshold_uncertainty_score":0.55838394},"labels":[],"label_agreement":null},{"id":"W1989313702","doi":"10.1038/sj.bjc.6604830","title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Family history; Medicine; Cancer; Ovarian cancer; Oncology; Gynecology; Proband; Internal medicine; Incidence (geometry); Obstetrics; First-degree relatives; Mutation; Genetics; Biology","score_opus":0.023951235829560647,"score_gpt":0.28945842533159866,"score_spread":0.265507189502038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989313702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815942,0.01472685,0.000660903,0.00044686295,0.00043368846,0.00052105956,0.0014639238,0.0000062895974,0.0001462028],"genre_scores_gemma":[0.98457587,0.009438404,0.0013225614,0.0006404585,0.00070960703,0.00063545164,0.000012988304,0.00007606335,0.002588589],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981475,0.00009062129,0.0006638337,0.00035565937,0.00034990552,0.00039249094],"domain_scores_gemma":[0.99758905,0.000051066043,0.0007975679,0.00017493838,0.0012380884,0.00014928843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023742017,0.00023382079,0.00049513526,0.00015516159,0.0000794824,0.000021939202,0.00026464037,0.0001788662,0.00032386294],"category_scores_gemma":[0.00006724523,0.00021326999,0.00010105139,0.0002640015,0.00030308828,0.000045010966,0.000035700752,0.00024021846,2.456826e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052705456,0.0008638713,0.048499085,0.00059750694,0.0027799048,0.0011645076,0.010055032,0.022939594,0.06484934,0.0000052594546,0.0784904,0.7170501],"study_design_scores_gemma":[0.015522821,0.0013176879,0.9289159,0.0022961795,0.0002346646,0.012471547,0.0018673977,0.000363129,0.007976154,0.000043708133,0.02819041,0.0008003787],"about_ca_topic_score_codex":0.011326199,"about_ca_topic_score_gemma":0.03568048,"teacher_disagreement_score":0.8804168,"about_ca_system_score_codex":0.002116481,"about_ca_system_score_gemma":0.0067125997,"threshold_uncertainty_score":0.9989184},"labels":[],"label_agreement":null},{"id":"W1989399572","doi":"10.1038/bjc.2012.464","title":"Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Université de Montréal","funders":"","keywords":"Nomogram; Lymphovascular invasion; Cystectomy; Medicine; Cohort; Bladder cancer; Concordance; Internal medicine; Oncology; Cancer; Surgery","score_opus":0.01130117259524235,"score_gpt":0.28863928669110867,"score_spread":0.27733811409586634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989399572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966455,0.030188784,0.0021229254,0.00008690528,0.0004666722,0.00041449728,0.00016108339,0.0000056959884,0.00009845346],"genre_scores_gemma":[0.9893418,0.00852583,0.0010475733,0.00019950068,0.0007211714,0.00004547668,0.000008021422,0.000025663061,0.000084940126],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99890614,0.000031403146,0.00044119539,0.00008963204,0.0003351812,0.00019647265],"domain_scores_gemma":[0.9989392,0.000035938774,0.00038960436,0.00008101669,0.00040388564,0.0001503399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021979651,0.00009548508,0.00032590603,0.00004772933,0.00003912848,0.000014319009,0.00005529858,0.00006823765,0.00026388397],"category_scores_gemma":[0.000025741037,0.00008860682,0.00016799761,0.000070493836,0.00005017354,0.00015594198,0.0000020548591,0.00014713136,0.0000012826862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003194232,0.000986821,0.4784063,0.00020849223,0.00059636816,0.000014617958,0.0008126738,0.000009911214,0.000983855,0.0000066007783,0.0024041755,0.51237595],"study_design_scores_gemma":[0.014042765,0.0009785783,0.93653905,0.001100513,0.00073538907,0.00018126323,0.000055815657,0.000030052754,0.015081304,0.00016504277,0.030919487,0.00017075642],"about_ca_topic_score_codex":0.00016528864,"about_ca_topic_score_gemma":0.000045795685,"teacher_disagreement_score":0.5122052,"about_ca_system_score_codex":0.00010048953,"about_ca_system_score_gemma":0.00014113402,"threshold_uncertainty_score":0.36132815},"labels":[],"label_agreement":null},{"id":"W1989604070","doi":"10.1038/sj.bjc.6605380","title":"Family history and the risk of gastric cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; Women's College Hospital; University of Toronto","funders":"","keywords":"Odds ratio; Cancer; Family history; Etiology; Population; Genome-wide association study; Risk factor; Genetic association; Genetic predisposition; Case-control study; Genetics; Medicine; Biology; Oncology; Internal medicine; Genotype; Environmental health; Gene; Single-nucleotide polymorphism","score_opus":0.012126981570175917,"score_gpt":0.2527010709617574,"score_spread":0.2405740893915815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989604070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7805951,0.21603405,0.000033210417,0.0024881414,0.0003738364,0.00008937581,0.00001354491,0.000004457552,0.00036827815],"genre_scores_gemma":[0.85607255,0.1409439,0.00014593483,0.002213857,0.00033988486,0.000004707745,2.4799814e-7,0.000008636807,0.000270262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897945,0.00009535416,0.0004252337,0.000091984155,0.00023248454,0.00017551881],"domain_scores_gemma":[0.9989379,0.000050988336,0.00046720827,0.00008013856,0.00037658916,0.000087195556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036318254,0.00009049278,0.00045140384,0.00007653466,0.0000450761,0.000005827987,0.00008403296,0.000053205964,0.00006415072],"category_scores_gemma":[0.00014843843,0.00006812255,0.0001185582,0.00008886558,0.00031866008,0.00007017403,0.000016261609,0.00047920563,4.6821566e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00239016,0.00013190674,0.47692016,0.00004102199,0.0016016907,0.00036963125,0.00076627714,0.000049753402,0.0014879084,0.000012508687,0.05827934,0.45794964],"study_design_scores_gemma":[0.0057530166,0.0003758886,0.96974933,0.0005163208,0.00076366763,0.0013518208,0.00007072019,0.000011292802,0.000037014746,0.00004428185,0.021281436,0.000045183537],"about_ca_topic_score_codex":0.0011646826,"about_ca_topic_score_gemma":0.00030242404,"teacher_disagreement_score":0.4928292,"about_ca_system_score_codex":0.00020094156,"about_ca_system_score_gemma":0.00017636312,"threshold_uncertainty_score":0.27779567},"labels":[],"label_agreement":null},{"id":"W1989911288","doi":"10.1038/sj.bjc.6604910","title":"Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council; National Cancer Institute; Norris Cotton Cancer Center; National Institutes of Health; University of Melbourne; Michael Smith Health Research BC; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Absolute risk reduction; Population; Breast cancer; Risk assessment; Risk perception; Medicine; Relative risk; Demography; Risk factor; Family history; Gynecology; Cancer; Environmental health; Psychology; Internal medicine; Perception; Confidence interval","score_opus":0.017975801757354096,"score_gpt":0.28185212196530146,"score_spread":0.2638763202079474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989911288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343254,0.024439253,0.0007703752,0.00001559795,0.00018190948,0.00011238059,0.001015305,0.000002302081,0.000030350911],"genre_scores_gemma":[0.94901884,0.0500486,0.00065929745,0.000006911879,0.00022584642,0.000007636668,0.0000059096665,0.000010243873,0.000016688928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998784,0.0001338397,0.0005127821,0.00017543706,0.00023596013,0.00015794995],"domain_scores_gemma":[0.9979878,0.000022545566,0.001312077,0.000115596304,0.00047663294,0.00008533848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004493985,0.00011544742,0.0003342083,0.000085745014,0.00011858479,0.000020853808,0.00010739113,0.00009522902,0.000053348387],"category_scores_gemma":[0.00008611939,0.00012574215,0.000090560075,0.000115285824,0.00016829591,0.000028123566,0.00003301193,0.00021884963,9.127697e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021900605,0.000057830744,0.9061793,0.000044136894,0.0004610263,0.0000011985587,0.0008512957,0.0056242947,0.011109771,0.0000028644915,0.00025136993,0.07519788],"study_design_scores_gemma":[0.0008557864,0.00018652731,0.9936672,0.000252243,0.00030996543,0.000071830545,0.00033658583,0.00013466761,0.0036358885,0.00026763632,0.00016754716,0.00011414936],"about_ca_topic_score_codex":0.005074422,"about_ca_topic_score_gemma":0.0068823644,"teacher_disagreement_score":0.087487854,"about_ca_system_score_codex":0.000117882744,"about_ca_system_score_gemma":0.00015712639,"threshold_uncertainty_score":0.76710415},"labels":[],"label_agreement":null},{"id":"W1990378122","doi":"10.1038/bjc.2014.214","title":"Sunitinib re-challenge in advanced renal-cell carcinoma","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Carcinoma; Kidney cancer; Pathology; Oncology; Internal medicine; Cancer research","score_opus":0.05057340882865962,"score_gpt":0.34380958598262956,"score_spread":0.29323617715396993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990378122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004516562,0.98523575,0.0000041704907,0.00008653452,0.0005129328,0.00075614685,0.000049397277,0.000011692778,0.008826818],"genre_scores_gemma":[0.0067336806,0.9897132,0.00030396073,0.00009292313,0.0011410939,0.000089606074,0.00004422489,0.00014233388,0.0017390017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961956,0.00031983855,0.0018270817,0.00041702995,0.0007246775,0.00051576406],"domain_scores_gemma":[0.9970666,0.00019912324,0.0015643121,0.00038140023,0.00038584796,0.00040271104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058496563,0.0005097528,0.0036192986,0.00047201721,0.000046337074,0.000049787355,0.00031826715,0.00038708164,0.00054005627],"category_scores_gemma":[0.00010453796,0.00047894282,0.001147522,0.0003369312,0.00007598896,0.00011662207,0.00006321236,0.0015016784,0.000027823455],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009708418,0.00021328442,0.0000644097,0.012398199,0.0001480562,0.011422478,0.000038021983,0.000004382699,0.0000023937755,0.000002460157,0.0017733969,0.9738358],"study_design_scores_gemma":[0.003207479,0.00083816267,0.0006264962,0.07032347,0.0016675203,0.007650082,0.000025899028,7.240488e-7,0.000024968007,0.000015138708,0.9152628,0.000357261],"about_ca_topic_score_codex":0.0003722156,"about_ca_topic_score_gemma":0.00086008303,"teacher_disagreement_score":0.97347856,"about_ca_system_score_codex":0.0010392887,"about_ca_system_score_gemma":0.001276738,"threshold_uncertainty_score":0.99976623},"labels":[],"label_agreement":null},{"id":"W1991282910","doi":"10.1038/bjc.2015.95","title":"Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Papanicolaou stain; Cost effectiveness; Aneuploidy; Medicine; Cost-effectiveness analysis; Ploidy; Cytology; Oncology; Biology; Cervical cancer; Internal medicine; Pathology; Cancer; Genetics; Chromosome","score_opus":0.10456966712261172,"score_gpt":0.42402618358091804,"score_spread":0.3194565164583063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991282910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831115,0.007912762,0.005291579,0.0019499316,0.00021215604,0.00033505665,0.00007968541,0.000006394368,0.0011009313],"genre_scores_gemma":[0.9978972,0.00021968129,0.00084798905,0.0003163483,0.00061634526,0.0000292566,0.000017447006,0.000015244999,0.000040467527],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982704,0.000119211254,0.00055310654,0.00014387345,0.0007005547,0.00021287856],"domain_scores_gemma":[0.9971475,0.000116208714,0.00027884668,0.00011132235,0.0020592795,0.0002868675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019278403,0.00007745856,0.0005828847,0.00027228435,0.00003319621,0.000021901235,0.00012756762,0.000091343594,0.0028529528],"category_scores_gemma":[0.00031883278,0.00008111506,0.0003488108,0.00023625816,0.00007897648,0.000088045024,0.000019666917,0.00020531616,0.0000016995174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028552003,0.00044538133,0.080353,0.0004110385,0.004239132,0.000108441,0.00023039032,0.04950312,0.00092342694,0.00006779271,0.008967924,0.82619834],"study_design_scores_gemma":[0.037922774,0.005743689,0.7993989,0.00040983205,0.011538618,0.00044961125,0.00034379453,0.10967456,0.013313138,0.00064680114,0.02017636,0.00038190823],"about_ca_topic_score_codex":0.0009023935,"about_ca_topic_score_gemma":0.0038913414,"teacher_disagreement_score":0.82581645,"about_ca_system_score_codex":0.00043418276,"about_ca_system_score_gemma":0.001719069,"threshold_uncertainty_score":0.99805856},"labels":[],"label_agreement":null},{"id":"W1991488995","doi":"10.1038/bjc.2011.451","title":"TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fondation Medic; Amis de l'Institut Bordet","keywords":"Melanoma; Breslow Thickness; Tissue microarray; Medicine; Immunohistochemistry; Population; Oncology; Pathology; Metastasis; Lymph node; Survival analysis; Internal medicine; Cancer; Cancer research; Sentinel lymph node","score_opus":0.04884439496947994,"score_gpt":0.3292777412253414,"score_spread":0.28043334625586147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991488995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075633,0.004522072,0.0002753184,0.0001334836,0.0006818314,0.00016532025,0.0000051324632,0.000015064127,0.0034454642],"genre_scores_gemma":[0.99439824,0.0020129113,0.0018241939,0.00041539807,0.00020660218,0.0000062349836,8.143545e-7,0.000017513443,0.0011181122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987612,0.0000643268,0.00064069964,0.00012358661,0.00025950393,0.00015071372],"domain_scores_gemma":[0.9992842,0.000038675134,0.00030802508,0.00009243926,0.0001274345,0.00014920345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003865039,0.00008869634,0.00038885485,0.000117784926,0.000028944429,0.000018868632,0.00007808293,0.000056071414,0.0012423303],"category_scores_gemma":[0.0000864754,0.00007262621,0.00012187149,0.00011094122,0.00005508027,0.00009757359,0.000023663808,0.00036411072,0.000008396067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002201284,0.0005058903,0.7484934,0.00005967194,0.00023297455,0.0143288225,0.00016130957,0.000014035915,0.0003133309,0.000015776312,0.004388123,0.22928542],"study_design_scores_gemma":[0.0064453627,0.0017256521,0.9093548,0.0019021606,0.00040522704,0.020241523,0.00045724266,0.000025300467,0.002464058,0.00006964731,0.05669058,0.00021844897],"about_ca_topic_score_codex":0.00027401897,"about_ca_topic_score_gemma":0.00087892433,"teacher_disagreement_score":0.22906697,"about_ca_system_score_codex":0.00005994384,"about_ca_system_score_gemma":0.000074730764,"threshold_uncertainty_score":0.9996707},"labels":[],"label_agreement":null},{"id":"W1991652053","doi":"10.1038/sj.bjc.6604540","title":"Dietary intake of selected B vitamins in relation to risk of major cancers in women","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Niacin; Riboflavin; Medicine; Physiology; Internal medicine; Breast cancer; B vitamins; Cancer; Vitamin; Endocrinology; Methionine; Methylenetetrahydrofolate reductase; Micronutrient; Biology; Pathology; Food science; Biochemistry","score_opus":0.01593278232751421,"score_gpt":0.29431748176186645,"score_spread":0.27838469943435223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991652053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950029,0.0043346873,0.0000063976195,0.00016521107,0.0000666185,0.00016744567,0.000028596714,0.0000020376349,0.00022606978],"genre_scores_gemma":[0.9878303,0.011562794,0.00022940016,0.00006424343,0.00007569072,0.000009479867,0.0000018730583,0.000012399234,0.00021381017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859214,0.000073455485,0.00059294933,0.000097094235,0.00042037424,0.00022399396],"domain_scores_gemma":[0.9991251,0.000048080456,0.00022915259,0.00007380202,0.00040168682,0.00012216733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038885794,0.000067138084,0.00040242693,0.00041039716,0.000018101402,0.0000031878976,0.000086038446,0.000070172,0.0001672702],"category_scores_gemma":[0.000293318,0.00007134752,0.000055423956,0.00097100384,0.00006090884,0.00012263755,0.000017688282,0.00042949204,0.0000010110724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022693044,0.0002702446,0.79605347,0.00015779577,0.000198799,0.0011185262,0.003156551,0.00097244495,0.038051017,6.1372424e-7,0.0018673777,0.15588383],"study_design_scores_gemma":[0.0027833462,0.0006727797,0.9899078,0.0011517042,0.000021779577,0.00034360855,0.00024158713,0.00007253249,0.0042269165,0.000012436912,0.0005043392,0.000061165825],"about_ca_topic_score_codex":0.014144462,"about_ca_topic_score_gemma":0.013266767,"teacher_disagreement_score":0.19385432,"about_ca_system_score_codex":0.0006705198,"about_ca_system_score_gemma":0.00074447575,"threshold_uncertainty_score":0.99242043},"labels":[],"label_agreement":null},{"id":"W1991836995","doi":"10.1038/sj.bjc.6602098","title":"Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Epidermal growth factor receptor; A431 cells; Biology; Epidermal growth factor; Tyrosine kinase; Epidermoid carcinoma; Cancer research; Autophosphorylation; DNA synthesis; Molecular biology; Biochemistry; DNA; Kinase; Receptor; Cell cycle; Cancer; Cell; Protein kinase A; Oncogene","score_opus":0.018930168018259818,"score_gpt":0.2920890244876561,"score_spread":0.2731588564693963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991836995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712885,0.009281238,0.0001878282,0.0019030242,0.00020016609,0.0009209275,0.00031740917,0.0000036562305,0.000056906734],"genre_scores_gemma":[0.99759054,0.001000272,0.0008994892,0.00018973065,0.00021207085,0.00002661389,0.0000056394783,0.00003481333,0.000040841063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967258,0.00042523403,0.0012351602,0.00022044059,0.0009919697,0.00040137558],"domain_scores_gemma":[0.9974657,0.0003299354,0.0009787123,0.00018188858,0.0008877584,0.0001559501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010925219,0.00019689275,0.0007522508,0.00015317579,0.00007635802,0.00002146037,0.0002954762,0.00013023453,0.000096811724],"category_scores_gemma":[0.001177305,0.0001440418,0.00021355576,0.00046554988,0.0002896017,0.00016696933,0.00011348764,0.0007044138,2.0053461e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018224801,0.0010590384,0.13368413,0.0019050987,0.00029905228,0.0003394507,0.012684994,0.00029126278,0.82656103,0.000045339348,0.0025269762,0.018781135],"study_design_scores_gemma":[0.0072477795,0.001169034,0.08518853,0.0022942638,0.000084604915,0.00029179797,0.0024110456,0.00015241519,0.90065926,0.00019225368,0.00015485709,0.00015415838],"about_ca_topic_score_codex":0.0030585206,"about_ca_topic_score_gemma":0.0005473188,"teacher_disagreement_score":0.074098215,"about_ca_system_score_codex":0.00025657384,"about_ca_system_score_gemma":0.00097625516,"threshold_uncertainty_score":0.5873854},"labels":[],"label_agreement":null},{"id":"W1992316647","doi":"10.1054/bjoc.2001.1844","title":"p53 missense but not truncation mutations are associated with low levels of p21CIP1/WAF1mRNA expression in primary human sarcomas","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Biology; Missense mutation; Cancer research; Exon; Nonsense mutation; Cyclin-dependent kinase; Gene; Mutation; Tumor suppressor gene; Genetics; Cell cycle; Carcinogenesis","score_opus":0.019720371527357217,"score_gpt":0.2786494499669078,"score_spread":0.2589290784395506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992316647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940277,0.004066094,0.00035757193,0.0005686872,0.000108079745,0.00026059922,0.000087591805,0.000015437037,0.00050824217],"genre_scores_gemma":[0.99811435,0.00063021877,0.00043101213,0.0003700824,0.0001487419,0.000010384609,0.000025953794,0.00003999042,0.00022924013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982199,0.000098951314,0.00067887467,0.00017049296,0.00061719905,0.00021458116],"domain_scores_gemma":[0.99815756,0.000051473042,0.0008876617,0.00012492723,0.00061388244,0.00016447582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023705802,0.00013659436,0.000491392,0.00018439782,0.00006559971,0.000021836435,0.00009862141,0.00013018369,0.00014906893],"category_scores_gemma":[0.000247754,0.00014553516,0.00012084107,0.00037772124,0.00010188025,0.00017516853,0.000016407337,0.0004923228,0.000001131057],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010577202,0.00061431545,0.019773422,0.00016494805,0.00024265544,0.0062244595,0.000714743,0.0013625759,0.9365822,0.0000037420377,0.0012183618,0.032040823],"study_design_scores_gemma":[0.007948889,0.00040436556,0.8754421,0.009774304,0.00020441916,0.0027343314,0.00025320423,0.00006528525,0.10243422,0.000037667094,0.0005055121,0.00019573237],"about_ca_topic_score_codex":0.00026583867,"about_ca_topic_score_gemma":0.0012307529,"teacher_disagreement_score":0.85566866,"about_ca_system_score_codex":0.00054824294,"about_ca_system_score_gemma":0.00053508277,"threshold_uncertainty_score":0.59347516},"labels":[],"label_agreement":null},{"id":"W1992374037","doi":"10.1038/sj.bjc.6603451","title":"A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council; National Cancer Institute; Medical Research Council; Michael Smith Health Research BC","keywords":"Genetic counseling; Genetic testing; Medicine; Test (biology); Cancer; Family medicine; Cancer genetics; Judaism; Psychology; Genetics; Biology","score_opus":0.009572423306660553,"score_gpt":0.2820222334585997,"score_spread":0.2724498101519392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992374037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8718992,0.124120586,0.0031383212,0.000026754667,0.00042339732,0.00020122332,0.00013324727,0.0000035393718,0.00005372652],"genre_scores_gemma":[0.9771666,0.01788111,0.0030974685,0.00008683131,0.0013348762,0.00019101061,0.000014094636,0.000038626833,0.00018939482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985229,0.00004079006,0.00059141923,0.00024359624,0.00029382575,0.00030749082],"domain_scores_gemma":[0.9985528,0.000023589828,0.000640276,0.00014452117,0.00056094595,0.00007787392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018447601,0.00015550233,0.00027512794,0.000051856165,0.00009135418,0.000077517165,0.000315579,0.00011648352,0.000060710612],"category_scores_gemma":[0.00000930217,0.00017668148,0.00012934103,0.000100150086,0.000113643255,0.00001552157,0.000030169673,0.000098933306,1.2790524e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032526904,0.00019350278,0.23185086,0.0006921904,0.0009380414,0.00001771698,0.0012660902,0.09234036,0.52702814,0.0000058766186,0.002974485,0.14236747],"study_design_scores_gemma":[0.0038447871,0.0007956998,0.23293835,0.0016352121,0.0003468019,0.00014727014,0.00094244134,0.0016978241,0.61932456,0.0011457552,0.13627951,0.00090176234],"about_ca_topic_score_codex":0.001247477,"about_ca_topic_score_gemma":0.0060097463,"teacher_disagreement_score":0.14146571,"about_ca_system_score_codex":0.00014583618,"about_ca_system_score_gemma":0.00033730487,"threshold_uncertainty_score":0.72048616},"labels":[],"label_agreement":null},{"id":"W1992461749","doi":"10.1038/sj.bjc.6600792","title":"Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Medicine; Xanthine oxidase; Ischemia; Pharmacology; Necrosis; Proinflammatory cytokine; Pathology; Inflammation; Cancer research; Internal medicine; Enzyme; Biology; Chemistry; Biochemistry","score_opus":0.011819677532497188,"score_gpt":0.3149650246525794,"score_spread":0.30314534712008223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992461749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743341,0.024119776,0.0000044578505,0.00027098722,0.0001690077,0.00033071605,0.00002320274,0.000016744296,0.0007310007],"genre_scores_gemma":[0.92477393,0.073378794,0.00007781886,0.00035500122,0.000094319854,0.000022946419,0.00000206407,0.000037850517,0.0012572898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818504,0.00015564205,0.00052017655,0.00018695692,0.00055795873,0.00039423187],"domain_scores_gemma":[0.99906576,0.000044863187,0.00022078062,0.00014433573,0.00033890366,0.00018534201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006273594,0.00016594124,0.000528415,0.00026427445,0.00007601997,0.000033906585,0.00014396658,0.000090182744,0.0005937551],"category_scores_gemma":[0.00021608346,0.000155649,0.00016854257,0.0003672627,0.00012242257,0.00016606222,0.000022246528,0.00067462673,0.0000035043524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018570087,0.0005039895,0.041723486,0.000044902532,0.00025881923,0.002254148,0.00031257814,0.00004305842,0.84656596,0.000007800687,0.00198039,0.104447834],"study_design_scores_gemma":[0.017736016,0.0019612522,0.177795,0.0030905826,0.000099559606,0.0064043645,0.0005941722,0.000105825224,0.76862735,0.00027081484,0.02271083,0.00060421834],"about_ca_topic_score_codex":0.0013133503,"about_ca_topic_score_gemma":0.001082945,"teacher_disagreement_score":0.13607152,"about_ca_system_score_codex":0.000432045,"about_ca_system_score_gemma":0.00039633404,"threshold_uncertainty_score":0.65012026},"labels":[],"label_agreement":null},{"id":"W1992584926","doi":"10.1038/bjc.2013.6","title":"Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; BC Cancer Agency","funders":"Public Health Agency; National Institute for Health and Care Research; Cancer Research UK; London School of Hygiene and Tropical Medicine","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Population; Demography; Danish; Cancer registry; Cancer; Environmental health; Biology; Internal medicine; Sociology","score_opus":0.04409165956299617,"score_gpt":0.327210861293424,"score_spread":0.28311920173042787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992584926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537093,0.011467988,0.0000015045052,0.0021268474,0.0002980916,0.0005144171,0.00011563851,0.0000017999934,0.00010279611],"genre_scores_gemma":[0.9957485,0.0013010594,0.000025948844,0.0006742261,0.00033903043,0.00010017789,0.0000016099464,0.000014159234,0.001795277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826974,0.00012090064,0.0004956304,0.00018622779,0.0006360999,0.00029139398],"domain_scores_gemma":[0.9989253,0.00015735124,0.00027546304,0.00010136975,0.0003053353,0.00023516401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045882142,0.00014619804,0.00046857592,0.00006130878,0.000119597426,0.000103980725,0.000110719484,0.00005324312,0.004243577],"category_scores_gemma":[0.00006577681,0.00011954691,0.000055778797,0.00016820751,0.000074506286,0.00017331299,0.000039592043,0.00031424314,0.0000017171114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004739512,0.000035226243,0.9783884,0.000029168566,0.000089915346,0.00037398803,0.00012589173,0.00026783737,0.000005420864,0.0000013572097,0.006672412,0.013536391],"study_design_scores_gemma":[0.005763094,0.00007862091,0.99130654,0.000706895,0.00014200863,0.0004801556,0.00064646674,0.000069982736,0.000007210224,0.0000108552695,0.000656616,0.00013155787],"about_ca_topic_score_codex":0.9821245,"about_ca_topic_score_gemma":0.99075526,"teacher_disagreement_score":0.013404833,"about_ca_system_score_codex":0.0008484269,"about_ca_system_score_gemma":0.00076888216,"threshold_uncertainty_score":0.99666667},"labels":[],"label_agreement":null},{"id":"W1992935310","doi":"10.1038/bjc.2013.506","title":"Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Toronto Public Health; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Regione Lombardia; Fondazione Cariplo","keywords":"Medicine; Lung cancer; Odds ratio; Internal medicine; Confidence interval; Hormone replacement therapy (female-to-male); Oncology; Cancer; Adenocarcinoma; Gynecology; Epidemiology; Testosterone (patch)","score_opus":0.010477942706757021,"score_gpt":0.31886773180015293,"score_spread":0.3083897890933959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992935310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8537318,0.13829757,0.00087484287,0.004328821,0.00054547447,0.00057727605,0.0015715186,0.000010379803,0.000062278305],"genre_scores_gemma":[0.9073806,0.088015154,0.000824395,0.0012889627,0.0010288509,0.000440153,0.000043977205,0.000027508877,0.000950427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987035,0.00003865184,0.00046755298,0.00021141945,0.00036133223,0.00021755247],"domain_scores_gemma":[0.9980582,0.00022668892,0.00051712536,0.00012590899,0.00089399895,0.00017810262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013741717,0.0001447448,0.0004278111,0.00010375123,0.00018316139,0.0002808001,0.00014185783,0.00006393639,0.0012001625],"category_scores_gemma":[0.00012388351,0.00011147747,0.00026527222,0.00022460773,0.000080964026,0.00041287762,0.000029488398,0.00023579928,4.6378443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002533696,0.000082783015,0.84521383,0.000019245084,0.022473676,0.000042044132,0.00045151275,0.0006226704,0.0005031454,0.000008771964,0.062035754,0.068293184],"study_design_scores_gemma":[0.004694525,0.000058794336,0.95226765,0.00042007052,0.023580333,0.00006684786,0.00017687446,0.007848809,0.00012581504,0.00004587356,0.010568094,0.00014631503],"about_ca_topic_score_codex":0.111993045,"about_ca_topic_score_gemma":0.021492096,"teacher_disagreement_score":0.1070538,"about_ca_system_score_codex":0.00044032064,"about_ca_system_score_gemma":0.00046915817,"threshold_uncertainty_score":0.9997129},"labels":[],"label_agreement":null},{"id":"W1993163519","doi":"10.1038/sj.bjc.6600549","title":"Potential role of p53 on metallothionein induction in human epithelial breast cancer cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Trace Elements in Health","field":"Nursing","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Metallothionein; Apoptosis; Cytoplasm; Biology; Receptor; Immunohistochemistry; Molecular biology; Cancer research; Cell culture; TUNEL assay; Cancer cell; Pathology; Cancer; Cell biology; Medicine; Immunology; Biochemistry; Gene","score_opus":0.013527483921507513,"score_gpt":0.2901945862564314,"score_spread":0.2766671023349239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993163519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898758,0.006018032,0.0000063074935,0.0009631139,0.0026340808,0.00016080901,0.00013717516,0.000009521542,0.0001951628],"genre_scores_gemma":[0.9965816,0.0016184397,0.0001458733,0.00020572117,0.0012978741,0.000008836383,8.54112e-7,0.00003421633,0.000106588974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980379,0.00015443274,0.00076041825,0.0001704751,0.00057106686,0.00030570885],"domain_scores_gemma":[0.9989442,0.000019323532,0.00063461706,0.00010249498,0.00019646103,0.0001028753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003520137,0.0001255128,0.00034845143,0.00021986272,0.00009631891,0.00003907104,0.00019300728,0.00010661734,0.0019333482],"category_scores_gemma":[0.000013444201,0.00014818199,0.0001235079,0.00020440774,0.00006468401,0.00030050924,0.000015603506,0.00057012815,0.000004143199],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044090673,0.0006587987,0.0044672117,0.00007704709,0.00009435099,0.000100612626,0.0005952242,0.004008261,0.30128837,0.000028455228,0.0027474398,0.68549335],"study_design_scores_gemma":[0.008710374,0.0011181496,0.6250426,0.0043982477,0.00032352083,0.0016683175,0.00060399726,0.00039248433,0.3425175,0.0008884414,0.013659982,0.0006763568],"about_ca_topic_score_codex":0.0068049915,"about_ca_topic_score_gemma":0.003953379,"teacher_disagreement_score":0.68481696,"about_ca_system_score_codex":0.00045062436,"about_ca_system_score_gemma":0.000049894104,"threshold_uncertainty_score":0.9998088},"labels":[],"label_agreement":null},{"id":"W1993263958","doi":"10.1038/bjc.2015.5","title":"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"Government of Ontario; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"SLCO1B1; Irinotecan; Pharmacology; Toxicity; Multidrug resistance-associated protein 2; Internal medicine; Medicine; Pharmacogenetics; Doxorubicin; Chemotherapy; Drug; Oncology; Metabolite; Colorectal cancer; Biology; Cancer; ATP-binding cassette transporter; Transporter; Genotype","score_opus":0.014581520121555622,"score_gpt":0.2608983730471585,"score_spread":0.2463168529256029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993263958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734598,0.023518603,0.00067490473,0.0015112686,0.00039879026,0.00012711427,0.000018826846,0.000015057555,0.0002756458],"genre_scores_gemma":[0.9942926,0.0030632876,0.0009203183,0.0008451553,0.0004291042,0.0000060253788,0.0000014836301,0.000034207045,0.0004078192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988024,0.000029491286,0.00034555106,0.00016319359,0.0004379123,0.00022140874],"domain_scores_gemma":[0.9991015,0.000014232627,0.0001510142,0.000080355225,0.0002758279,0.000377022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037568316,0.0001409127,0.0004250035,0.00007811233,0.000038539583,0.00005686182,0.00006267144,0.000089245856,0.00008877828],"category_scores_gemma":[0.00001664167,0.00013265363,0.00008738357,0.00008805301,0.000097909084,0.000116385345,0.000009099719,0.00024854156,7.2962047e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012111077,0.0015186282,0.36879382,0.0010453429,0.00090441137,0.014699257,0.001295422,0.0002535514,0.053490333,0.00008788186,0.003633961,0.5421663],"study_design_scores_gemma":[0.022237532,0.0013220293,0.9171659,0.0024289875,0.00035962905,0.0026616538,0.00024199692,0.00016331194,0.030063739,0.0008752785,0.021964166,0.00051582855],"about_ca_topic_score_codex":0.00015818012,"about_ca_topic_score_gemma":0.0007305183,"teacher_disagreement_score":0.54837203,"about_ca_system_score_codex":0.00005922795,"about_ca_system_score_gemma":0.00026645893,"threshold_uncertainty_score":0.54094577},"labels":[],"label_agreement":null},{"id":"W1993463141","doi":"10.1038/bjc.2014.116","title":"A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Eisai; Public Health Agency; National Institute for Health and Care Research; Cancer Research UK; American Society of Clinical Oncology","keywords":"Carboplatin; Decitabine; Medicine; Hypomethylating agent; Azacitidine; Oncology; Ovarian cancer; Internal medicine; Neutropenia; Chemotherapy; Cisplatin; Cancer; DNA methylation; Biology","score_opus":0.008043018515239787,"score_gpt":0.2546705349677168,"score_spread":0.24662751645247702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993463141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969594,0.0011481363,0.0005152568,0.00010940664,0.0003228863,0.00079417694,0.00005002202,0.0000020729722,0.000098656645],"genre_scores_gemma":[0.99882483,0.00037337255,0.0003744869,0.00003920139,0.00025713252,0.000048415124,0.000029188643,0.000030478506,0.000022873746],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977692,0.0003628525,0.0008629463,0.00025803217,0.0004910926,0.0002559259],"domain_scores_gemma":[0.9981058,0.00007546296,0.0010577799,0.00016980038,0.00050898857,0.00008214818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087790214,0.00019682215,0.0004935099,0.00009375054,0.00007456191,0.000031122658,0.00015670201,0.00012564551,0.000012126692],"category_scores_gemma":[0.00039300692,0.00016074475,0.000103255,0.00032403518,0.000086346336,0.000021819986,0.00005440001,0.00028285378,5.9162943e-8],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29771084,0.0034223732,0.13593236,0.00012756152,0.00056512456,0.000043631113,0.0015551713,0.03222829,0.13895594,0.000022670632,0.00009164757,0.3893444],"study_design_scores_gemma":[0.5602483,0.008998151,0.29833502,0.0016974007,0.00018640868,0.000012661474,0.00007211514,0.0014504704,0.12790464,0.00007750378,0.0005128466,0.00050445803],"about_ca_topic_score_codex":0.0011108032,"about_ca_topic_score_gemma":0.012248563,"teacher_disagreement_score":0.38883993,"about_ca_system_score_codex":0.000105003615,"about_ca_system_score_gemma":0.000281417,"threshold_uncertainty_score":0.68349856},"labels":[],"label_agreement":null},{"id":"W1993505171","doi":"10.1038/bjc.2014.75","title":"Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Ligue Contre le Cancer","keywords":"Chemotherapy; Ovarian cancer; Oncology; Medicine; Kinetics; Pharmacodynamics; Biomarker; Internal medicine; Cancer; Biology; Pharmacokinetics","score_opus":0.055971171319145946,"score_gpt":0.30789753157368654,"score_spread":0.2519263602545406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993505171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022675,0.0007075013,0.0083719,0.00007487748,0.00025011576,0.00018351912,0.00012869883,0.0000049143714,0.00005172596],"genre_scores_gemma":[0.9936431,0.000424309,0.0057549085,0.00003285149,0.000094855866,0.000006603236,0.0000017389569,0.000028716722,0.00001293955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978493,0.00027455695,0.0011383345,0.00013772362,0.00039153732,0.0002085787],"domain_scores_gemma":[0.9979794,0.0002728756,0.0010971997,0.00011330756,0.0004561487,0.000081091435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009956621,0.00013619193,0.00056026294,0.00013628705,0.000023681243,0.00001185312,0.00019169637,0.00012608232,0.00010588592],"category_scores_gemma":[0.00052005675,0.00014183849,0.000102069804,0.00020849177,0.00006663385,0.00009620799,0.000024881705,0.00030158105,1.6043482e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009262126,0.0073335893,0.04387733,0.0032074861,0.0008701093,0.00004883399,0.005081541,0.007090106,0.8297472,0.0014130066,0.0045549506,0.08751374],"study_design_scores_gemma":[0.038216647,0.0063581206,0.17586897,0.038858764,0.0010746347,0.00046185657,0.00045431158,0.20092659,0.42820534,0.10606861,0.0015555589,0.0019505919],"about_ca_topic_score_codex":0.00038778485,"about_ca_topic_score_gemma":0.00010666833,"teacher_disagreement_score":0.40154183,"about_ca_system_score_codex":0.00020417172,"about_ca_system_score_gemma":0.00012864791,"threshold_uncertainty_score":0.57840055},"labels":[],"label_agreement":null},{"id":"W1993796592","doi":"10.1038/sj.bjc.6603205","title":"Nuclear ING2 expression is reduced in human cutaneous melanomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health; SKiN Health","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Melanoma; Tissue microarray; Cancer research; Cancer; Immunohistochemistry; Medicine; Skin cancer; Pathology; Oncology; Biology; Internal medicine","score_opus":0.0037335692949647305,"score_gpt":0.2361811451015519,"score_spread":0.23244757580658715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993796592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984245,0.013376771,0.000004939355,0.00014429772,0.0001873156,0.000037452017,0.0000064963524,0.00000246518,0.0019952364],"genre_scores_gemma":[0.994472,0.003697162,0.0000747887,0.00019357655,0.00053304934,0.0000016371567,0.000004173011,0.00001754034,0.0010060288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992832,0.000027148399,0.00028141975,0.00012223978,0.00013743558,0.00014855692],"domain_scores_gemma":[0.99963826,0.0000020012171,0.00017282678,0.00006523732,0.00007342917,0.00004825719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000612803,0.00007412666,0.00013322625,0.00003890995,0.0000546308,0.000029690274,0.00012852738,0.00012708304,0.00010585869],"category_scores_gemma":[0.0000070520655,0.00007489601,0.00009153459,0.00005807642,0.000040932788,0.0000055626133,0.000025124904,0.00018242218,0.0000011840907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008620462,0.000037831604,0.0007566774,0.000010274779,0.000025221614,0.0004133815,0.000022750288,0.00062176574,0.96520746,0.000004330255,0.0221986,0.0106155295],"study_design_scores_gemma":[0.0015790793,0.00028615558,0.004454333,0.0008592932,0.000028680714,0.004011035,0.000050189527,0.000011687252,0.7882786,0.00023489266,0.19993955,0.0002665451],"about_ca_topic_score_codex":0.00053762813,"about_ca_topic_score_gemma":0.00027016157,"teacher_disagreement_score":0.17774095,"about_ca_system_score_codex":0.000047967478,"about_ca_system_score_gemma":0.00006110742,"threshold_uncertainty_score":0.30541706},"labels":[],"label_agreement":null},{"id":"W1993873445","doi":"10.1038/bjc.2013.553","title":"A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Cancer Institute, University of Pittsburgh; Hospital for Sick Children; V Foundation for Cancer Research","keywords":"Medicine; Bevacizumab; Cyclophosphamide; Imatinib; Nausea; Internal medicine; Oncology; Gastroenterology; Chemotherapy; Pharmacology","score_opus":0.010802426090970953,"score_gpt":0.3192174602099995,"score_spread":0.3084150341190286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993873445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455537,0.05261083,0.000002788756,0.00037237414,0.00039897687,0.0006214018,0.000045851866,0.0000046147607,0.0003894367],"genre_scores_gemma":[0.97699463,0.02204602,0.00036413872,0.00007359287,0.00019719201,0.00019157556,0.0000013875591,0.000016744883,0.00011474177],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987364,0.000030714644,0.00063520944,0.00015149184,0.00023176191,0.00021444139],"domain_scores_gemma":[0.9991036,0.000066927205,0.0004008914,0.000055242523,0.00025213812,0.000121207035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013904364,0.0001341408,0.0007078424,0.000113339695,0.0000399937,0.000023037284,0.00006138002,0.000049939455,0.0004749959],"category_scores_gemma":[0.00009005049,0.00012446014,0.00012954738,0.00015875815,0.000106567306,0.00020017954,0.000029560197,0.00019709537,7.7715424e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039586946,0.0009514299,0.022258177,0.00009213931,0.0004868622,0.00016367517,0.00042292848,0.000029490586,0.003760022,0.000003965903,0.0007239109,0.93152046],"study_design_scores_gemma":[0.40926743,0.009370918,0.5642203,0.0021567217,0.00053476886,0.000590031,0.0007642047,0.00011887026,0.008574219,0.00019299098,0.0038765203,0.0003330314],"about_ca_topic_score_codex":0.0049587595,"about_ca_topic_score_gemma":0.0034075335,"teacher_disagreement_score":0.9311874,"about_ca_system_score_codex":0.00033523762,"about_ca_system_score_gemma":0.00030830078,"threshold_uncertainty_score":0.74961936},"labels":[],"label_agreement":null},{"id":"W1994831520","doi":"10.1054/bjoc.2000.1157","title":"Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Photodynamic therapy; Nitric oxide; Superoxide; Superoxide dismutase; Nitric oxide synthase; Blood flow; Medicine; Endogeny; Pathology; Cancer research; Internal medicine; Chemistry; Biochemistry; Enzyme; Oxidative stress","score_opus":0.012273894465228911,"score_gpt":0.34004494478239256,"score_spread":0.32777105031716364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994831520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97803634,0.013405272,0.0000027602828,0.0075313016,0.00010115816,0.0006396198,0.000051850853,0.00001774732,0.00021394793],"genre_scores_gemma":[0.9675985,0.025062913,0.000021092954,0.0012725955,0.00031980293,0.000049416412,0.0000014622495,0.000036702786,0.0056375335],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980884,0.00027847872,0.0003540185,0.00019187696,0.00073136075,0.00035585414],"domain_scores_gemma":[0.99899805,0.00016653864,0.00013776825,0.00019219704,0.00029485958,0.0002105762],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011616935,0.00015987975,0.00036365318,0.00015044204,0.00016495229,0.000063149906,0.00021587344,0.000045749875,0.0017873449],"category_scores_gemma":[0.0003611728,0.00011179523,0.0001616211,0.00047371277,0.00008971989,0.00010817473,0.000012139192,0.00053667877,0.000028625955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014192154,0.00016274188,0.000107331456,0.000005722874,0.0002402965,0.00023322353,0.00012687941,0.00012249537,0.6947516,1.7462749e-7,0.04985961,0.24019773],"study_design_scores_gemma":[0.003998129,0.002936403,0.66740644,0.0013370342,0.00007275688,0.0053824484,0.00019300553,0.000027207692,0.18759887,0.00008816352,0.13062854,0.00033102717],"about_ca_topic_score_codex":0.0007246401,"about_ca_topic_score_gemma":0.00008966865,"teacher_disagreement_score":0.6672991,"about_ca_system_score_codex":0.000539463,"about_ca_system_score_gemma":0.0003175531,"threshold_uncertainty_score":0.9991252},"labels":[],"label_agreement":null},{"id":"W1995048156","doi":"10.1038/sj.bjc.6601052","title":"Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Vetenskapsrådet","keywords":"Medicine; Radiological weapon; Retrospective cohort study; Disease; Surgery; Radiology; Pediatrics; Internal medicine","score_opus":0.009867171702763702,"score_gpt":0.26549342799210357,"score_spread":0.2556262562893399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995048156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983625,0.014795744,0.000008714819,0.00034812413,0.00021765912,0.0003134936,0.00015459044,0.0000026722876,0.0005340312],"genre_scores_gemma":[0.99775547,0.0015846671,0.00013022682,0.00016439961,0.000054042663,0.000021656422,0.000006906405,0.000018490544,0.00026417107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987576,0.000075024196,0.00040287338,0.00012474583,0.00047396764,0.00016579704],"domain_scores_gemma":[0.9988664,0.00007171712,0.00044434014,0.00014772876,0.00030330036,0.00016653903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106744636,0.00013906241,0.00046565337,0.0000469386,0.00006649241,0.000017489725,0.00006722651,0.000018676195,0.00016790633],"category_scores_gemma":[0.000080295,0.00008649471,0.00034321818,0.0001610542,0.00007135717,0.00011403867,0.0000083812865,0.000060963866,6.4523283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006787065,0.0011635701,0.9509798,0.00003305506,0.0014616455,0.00042774327,0.00048096207,0.00002608638,0.000012623695,0.000066926856,0.00081953884,0.043849308],"study_design_scores_gemma":[0.01932396,0.0013461284,0.9639941,0.0016911302,0.0017421584,0.00009547356,0.00017627924,0.0000047205253,0.0058212755,0.0000728677,0.0056243255,0.00010761438],"about_ca_topic_score_codex":0.0008982287,"about_ca_topic_score_gemma":0.0001451485,"teacher_disagreement_score":0.04374169,"about_ca_system_score_codex":0.00027015322,"about_ca_system_score_gemma":0.00049480534,"threshold_uncertainty_score":0.3527152},"labels":[],"label_agreement":null},{"id":"W1995318670","doi":"10.1038/sj.bjc.6605283","title":"An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Cohort; Adjuvant; Internal medicine; Oncology; Cancer; Cohort study; Cancer registry; Adjuvant therapy","score_opus":0.01210410022630315,"score_gpt":0.27328071782547947,"score_spread":0.2611766175991763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995318670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661416,0.0017319118,0.0000034082975,0.00095785636,0.00007777274,0.00050180074,0.00011073425,9.672856e-7,0.0000014028351],"genre_scores_gemma":[0.99839294,0.0010025096,0.00006850173,0.00029828347,0.00012599923,0.00007302033,0.00002806004,0.000008278275,0.0000024299363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904644,0.00010796998,0.000365925,0.00010965259,0.00021599511,0.00015400173],"domain_scores_gemma":[0.9990544,0.000024019262,0.00037556872,0.00012506268,0.0003963961,0.00002457634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030167212,0.000092844864,0.0001732705,0.000042109306,0.000056780773,0.000014954169,0.00028439195,0.00004902328,0.000001365626],"category_scores_gemma":[0.0000562681,0.00005675733,0.00006622718,0.00027703587,0.00014704268,0.000016120317,0.000019785455,0.0001235501,1.2845945e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020726712,0.00023092519,0.9392596,0.000022619464,0.000051474384,8.9043954e-7,0.0007604353,0.00038252075,0.00079750165,0.0000030707588,0.000042734107,0.058240943],"study_design_scores_gemma":[0.0013580633,0.00037343468,0.9955261,0.00048298272,0.00006789712,0.000018662926,0.00013375611,0.00007712777,0.0017021401,0.000032555887,0.00016499203,0.00006233799],"about_ca_topic_score_codex":0.0066811433,"about_ca_topic_score_gemma":0.015404735,"teacher_disagreement_score":0.058178607,"about_ca_system_score_codex":0.000055325854,"about_ca_system_score_gemma":0.00017864304,"threshold_uncertainty_score":0.9999335},"labels":[],"label_agreement":null},{"id":"W1995752721","doi":"10.1038/sj.bjc.6604635","title":"Mammographic density, lobular involution, and risk of breast cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Involution (esoterism); Breast cancer; Breast tissue; Mammography; Medicine; Oncology; Internal medicine; Biology; Cancer","score_opus":0.014109221055429017,"score_gpt":0.28945237575471455,"score_spread":0.27534315469928555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995752721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005873669,0.99277776,0.000019053807,0.000048107875,0.00032604468,0.00022843733,0.00056996703,0.000009755929,0.00014722651],"genre_scores_gemma":[0.0021927292,0.9968507,0.000101202255,0.00004705176,0.0006746659,0.000010232323,0.000008458311,0.00004748045,0.000067474066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979228,0.000094625924,0.0009599329,0.00022749309,0.00052650465,0.0002686514],"domain_scores_gemma":[0.99747276,0.000050513932,0.0013659898,0.0001481384,0.00067693484,0.00028567406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022300318,0.0002857273,0.0019627875,0.00053744676,0.000081863436,0.000052180636,0.00016006464,0.00018349644,0.00006235479],"category_scores_gemma":[0.00004122575,0.0002657981,0.0010601259,0.00070988707,0.00038541784,0.00024393214,0.000047503974,0.000757875,6.0322174e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004244028,0.00008962196,0.029596446,0.0050443793,0.0016667589,0.00085021544,0.000011562034,8.1209174e-7,4.1839345e-7,0.0000036044141,0.002589683,0.96010405],"study_design_scores_gemma":[0.0010146738,0.0000969075,0.082294546,0.10580133,0.005467165,0.18996699,0.0000107604565,0.0000011141798,0.000001345879,0.00006266725,0.6149775,0.00030502732],"about_ca_topic_score_codex":0.001881883,"about_ca_topic_score_gemma":0.0003713339,"teacher_disagreement_score":0.95979905,"about_ca_system_score_codex":0.00010390378,"about_ca_system_score_gemma":0.0007955972,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W1996270518","doi":"10.1054/bjoc.2001.2125","title":"First do no harm: extending the debate on the provision of preventive tamoxifen","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Ottawa; Statistics Canada","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Gynecology; Endometrial cancer; Population; Internal medicine; Cancer; Demography; Oncology; Obstetrics; Environmental health","score_opus":0.019349140794071087,"score_gpt":0.30899005761449994,"score_spread":0.28964091682042886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996270518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810154,0.013424867,0.000058608017,0.002340058,0.00054777827,0.00030460433,0.000019685276,0.000005365181,0.002283629],"genre_scores_gemma":[0.9719267,0.025639953,0.000027200134,0.00041594054,0.0006610528,0.000009905051,4.810242e-7,0.000016169242,0.0013026157],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99894065,0.000045374676,0.00034270377,0.00009542951,0.00041723714,0.00015861187],"domain_scores_gemma":[0.9990477,0.00010734536,0.00037637886,0.00012529263,0.00027374167,0.00006952461],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040568004,0.000085324034,0.00023467877,0.000040614854,0.00012630082,0.000043907727,0.00015809532,0.00003736431,0.0010350909],"category_scores_gemma":[0.00013477448,0.00004949627,0.00018162835,0.00013942302,0.00008697625,0.00009162681,0.000025095656,0.0003388083,0.000005086634],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019032331,0.00033338807,0.06343754,0.00012104897,0.0004809182,0.0007262645,0.0013575199,0.0002332391,0.0018192041,0.00009819172,0.05535917,0.8741303],"study_design_scores_gemma":[0.002319485,0.00074607745,0.55351794,0.0057101417,0.00027203222,0.0023139399,0.00037400794,0.00009113895,0.0017430686,0.00029574888,0.43246713,0.00014925734],"about_ca_topic_score_codex":0.00091742555,"about_ca_topic_score_gemma":0.0004744267,"teacher_disagreement_score":0.87398106,"about_ca_system_score_codex":0.00012418319,"about_ca_system_score_gemma":0.00013572331,"threshold_uncertainty_score":0.9998781},"labels":[],"label_agreement":null},{"id":"W1996273831","doi":"10.1038/sj.bjc.6605722","title":"Insulin-like growth factors and risk of kidney cancer in men","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Renal function; Kidney cancer; Odds ratio; Internal medicine; Cancer; Risk factor; Prospective cohort study; Kidney; Endocrinology; Cohort study; Kidney disease","score_opus":0.00815073961386248,"score_gpt":0.257471031834554,"score_spread":0.24932029222069152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996273831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861864,0.011337924,0.0000075419784,0.0004624564,0.0008554523,0.0001757095,0.00016757041,0.0000091233505,0.00079784886],"genre_scores_gemma":[0.9448306,0.05415775,0.00018089882,0.0003099416,0.00035947972,0.000007076003,0.0000033727524,0.000033103577,0.00011776568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816763,0.00006030331,0.0008032155,0.00019951296,0.00046347457,0.00030583603],"domain_scores_gemma":[0.99811745,0.00008016083,0.00059545814,0.0001281752,0.00048801943,0.0005907506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004227716,0.00019486863,0.0006895307,0.00027419554,0.000055716864,0.000030967905,0.00015659117,0.00019473358,0.00038132916],"category_scores_gemma":[0.0008061063,0.0001773335,0.00016468887,0.00032054374,0.00017558312,0.00030371832,0.000042166645,0.0011222548,8.819086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025923405,0.00013577742,0.95627475,0.0001082389,0.00023201956,0.00014188801,0.0005017951,0.0000019225681,0.010713799,0.00001547516,0.005676651,0.025938427],"study_design_scores_gemma":[0.003798728,0.00023320668,0.9745039,0.0006709493,0.000277822,0.00033014562,0.00016217456,0.000021751115,0.010813042,0.00015906396,0.008847676,0.00018155927],"about_ca_topic_score_codex":0.01248313,"about_ca_topic_score_gemma":0.0029935318,"teacher_disagreement_score":0.042819824,"about_ca_system_score_codex":0.00008270108,"about_ca_system_score_gemma":0.00072258804,"threshold_uncertainty_score":0.9940928},"labels":[],"label_agreement":null},{"id":"W1996330154","doi":"10.1038/bjc.2012.319","title":"A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Aflibercept; Pemetrexed; Neutropenia; Internal medicine; Febrile neutropenia; Adverse effect; Cisplatin; Gastroenterology; Pharmacology; Bevacizumab; Chemotherapy","score_opus":0.015153943021905881,"score_gpt":0.3460659373982292,"score_spread":0.33091199437632335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996330154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981366,0.0010836141,0.0000044104454,0.00005488591,0.00009151422,0.0005499629,0.0000084235335,0.00000238359,0.000068252404],"genre_scores_gemma":[0.99957377,0.0001485578,0.00012860878,0.000034809324,0.000041746644,0.000022901844,0.000008220331,0.000013035716,0.000028378972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911225,0.000057599394,0.00034827003,0.00008773468,0.00024918639,0.00014493804],"domain_scores_gemma":[0.9993479,0.000029935225,0.0003296112,0.00004079517,0.00016290156,0.000088838555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014014289,0.00008710149,0.00034144014,0.00017515503,0.000017244425,0.000007607576,0.00002686175,0.00002890013,0.000070445734],"category_scores_gemma":[0.000012644635,0.00007672098,0.000017250195,0.00022478924,0.00003399395,0.00026126375,0.0000072515404,0.00015137352,9.9210226e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008212403,0.007879673,0.8751259,0.000029424138,0.0000701362,0.000061733925,0.0016274407,0.000027972923,0.00019298401,4.3593732e-7,0.00002693891,0.106745],"study_design_scores_gemma":[0.08402444,0.011109439,0.9033482,0.0005078389,0.00017292179,0.000056901077,0.00043403273,0.00001793827,0.00021899765,0.0000022642782,0.000037613427,0.0000694164],"about_ca_topic_score_codex":0.00021601153,"about_ca_topic_score_gemma":0.0024275593,"teacher_disagreement_score":0.10667558,"about_ca_system_score_codex":0.00014316045,"about_ca_system_score_gemma":0.000082996485,"threshold_uncertainty_score":0.31285906},"labels":[],"label_agreement":null},{"id":"W1996412513","doi":"10.1038/sj.bjc.6604377","title":"SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Association of Gastroenterology","keywords":"Demethylating agent; DNA methylation; Cancer research; CpG site; Methylation; Colorectal cancer; Deoxycytidine; Cell growth; DNMT1; Cell culture; Biology; Promoter; Apoptosis; Molecular biology; Cancer; Gene expression; DNA; Gene; Genetics","score_opus":0.017669555800618048,"score_gpt":0.28004060186077956,"score_spread":0.2623710460601615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996412513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985943,0.011215209,0.0000075548087,0.0019939023,0.00014720515,0.0005257622,0.000062000305,0.000008280892,0.0000970859],"genre_scores_gemma":[0.9907998,0.0071672453,0.00043968277,0.0008472507,0.00019812683,0.000046395056,0.0000035696673,0.000022800905,0.00047513944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986621,0.00012834808,0.00039939783,0.00019912633,0.00038120247,0.00022978506],"domain_scores_gemma":[0.999198,0.00006113219,0.00018911032,0.00007385544,0.00024504642,0.00023281586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043085395,0.0001389429,0.0004149801,0.0001256689,0.000109404085,0.000019930296,0.00005661566,0.00007981751,0.00009508555],"category_scores_gemma":[0.00027258595,0.00013247663,0.000060165603,0.00021571845,0.00010779469,0.0001547513,0.000037964743,0.00030173035,6.24024e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01588872,0.00011438418,0.022681965,0.000030186995,0.00006555677,0.001971131,0.0010638975,0.000007424515,0.9133464,1.4838749e-7,0.015631715,0.029198457],"study_design_scores_gemma":[0.012869534,0.002392745,0.50554097,0.0017123017,0.00005535157,0.0056164428,0.0004915908,0.000023643446,0.45864347,0.000028649252,0.01226912,0.00035616566],"about_ca_topic_score_codex":0.0080569275,"about_ca_topic_score_gemma":0.0015014833,"teacher_disagreement_score":0.48285902,"about_ca_system_score_codex":0.00038196193,"about_ca_system_score_gemma":0.00040768785,"threshold_uncertainty_score":0.9985485},"labels":[],"label_agreement":null},{"id":"W1997464162","doi":"10.1038/sj.bjc.6603010","title":"Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bafilomycin; Cytotoxicity; Endosome; Pharmacology; Chloroquine; Doxorubicin; Clonogenic assay; Chemistry; Mitoxantrone; Cancer research; Biology; Apoptosis; Chemotherapy; Cell; Immunology; Biochemistry; In vitro; Autophagy","score_opus":0.006219305817989429,"score_gpt":0.25551595677361855,"score_spread":0.2492966509556291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997464162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996563,0.002001748,0.0003915886,0.00012524344,0.00007826832,0.00015954133,0.000030363719,0.0000048006073,0.00064545847],"genre_scores_gemma":[0.9980158,0.0012459414,0.00038877648,0.000058982037,0.00019943004,0.0000035762791,0.000006973316,0.000009469213,0.00007102408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887085,0.000023323553,0.0005037914,0.00009712087,0.00040512354,0.000099772944],"domain_scores_gemma":[0.9991364,0.000018925975,0.0004019242,0.000054035783,0.00033927918,0.00004942091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019130894,0.000077659126,0.000279022,0.00008404687,0.000030201118,0.0000121005005,0.0000292673,0.000065633045,0.00005593668],"category_scores_gemma":[0.000015863097,0.00007878339,0.000055156343,0.000114023685,0.00009568791,0.0001934342,0.0000027720732,0.00013851914,2.1544123e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047193872,0.0001837979,0.017568529,0.0003222762,0.000033508477,0.00014148555,0.00012036765,0.00043215105,0.9615354,0.00059383287,0.00006346551,0.018533252],"study_design_scores_gemma":[0.0012464725,0.00035225868,0.38230723,0.0017377085,0.00007845651,0.00013418579,0.00003969969,0.000016153035,0.61348075,0.00045627734,0.00009182204,0.000058970007],"about_ca_topic_score_codex":0.0005424439,"about_ca_topic_score_gemma":0.00067102147,"teacher_disagreement_score":0.3647387,"about_ca_system_score_codex":0.000052615553,"about_ca_system_score_gemma":0.00016783942,"threshold_uncertainty_score":0.32126936},"labels":[],"label_agreement":null},{"id":"W1998087959","doi":"10.1038/sj.bjc.6605616","title":"Risks of second primary cancer among patients with major histological types of lung cancers in both men and women","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Manitoba; Manitoba Health; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; European Commission; Centre International de Recherche sur le Cancer","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Cancer; Incidence (geometry); Lung; Carcinoma; Etiology; Gynecology","score_opus":0.010131867342530949,"score_gpt":0.2672691298764386,"score_spread":0.2571372625339076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998087959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865615,0.010280265,0.000002147174,0.000051671992,0.00023139533,0.00023931116,0.00013314316,0.0000033581957,0.0024972546],"genre_scores_gemma":[0.99663824,0.0024380516,0.0002478137,0.0002480051,0.00010797409,0.000023833301,0.0000046807477,0.000019920279,0.0002714801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986349,0.000035339104,0.00056377146,0.00017058705,0.00034954297,0.00024590731],"domain_scores_gemma":[0.9988117,0.00004715983,0.00058631727,0.000101900434,0.00027119223,0.00018172058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024203034,0.0001320481,0.000686103,0.0001342053,0.000028510489,0.0000102616905,0.000112675305,0.00011160238,0.0021473274],"category_scores_gemma":[0.000035117177,0.000116022056,0.00006266348,0.00013639875,0.00031254208,0.00021437721,0.00002796588,0.0005383858,7.187428e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015051478,0.00009306884,0.92151326,0.0003699842,0.0002932671,0.00008862743,0.0006831239,0.000032250544,0.0022130476,0.0000013366148,0.0012332594,0.07197364],"study_design_scores_gemma":[0.0060993456,0.00036522187,0.9892181,0.00062756124,0.00012881844,0.00006781936,0.00009764346,0.00002303474,0.0005907702,0.00000908774,0.0026464604,0.00012609921],"about_ca_topic_score_codex":0.005635158,"about_ca_topic_score_gemma":0.0132178245,"teacher_disagreement_score":0.071847536,"about_ca_system_score_codex":0.00057315506,"about_ca_system_score_gemma":0.0009986466,"threshold_uncertainty_score":0.9987649},"labels":[],"label_agreement":null},{"id":"W1998742701","doi":"10.1038/bjc.2013.146","title":"Independent contributors to overall quality of life in people with advanced cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Université du Québec; McGill University","funders":"Terry Fox Research Institute","keywords":"Quality of life (healthcare); Cancer; Medicine; Construct (python library); Gerontology; Ranking (information retrieval); Social support; Medical diagnosis; Multivariate statistics; Perception; Multivariate analysis; Stepwise regression; Clinical psychology; Psychology; Pathology; Internal medicine; Social psychology; Statistics","score_opus":0.011668088114702147,"score_gpt":0.30067899496873585,"score_spread":0.2890109068540337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998742701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822166,0.014936679,0.000086573236,0.0015520866,0.000465583,0.00037586185,0.00006307104,0.000006405603,0.00029715782],"genre_scores_gemma":[0.9950359,0.002688309,0.0000860851,0.0015279051,0.00025493233,0.00007895767,0.0000018972148,0.000021549928,0.0003045009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998157,0.00006530265,0.00069880584,0.00015943222,0.0006501092,0.00026932047],"domain_scores_gemma":[0.9981525,0.000052422365,0.0004243442,0.0001261381,0.00090492563,0.00033967776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031079704,0.00012331746,0.0007199472,0.000114776885,0.000021885173,0.000030155043,0.00012578987,0.00007142186,0.0012388157],"category_scores_gemma":[0.00014321874,0.00011573982,0.00011927988,0.0002775917,0.000034868975,0.0002159013,0.000026285363,0.0003318323,0.000002244854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017029302,0.00015950487,0.8955026,0.00021376689,0.00018058077,0.000075918084,0.0009904138,0.0007468047,0.002289378,0.000020321238,0.0022493973,0.09586836],"study_design_scores_gemma":[0.0047415495,0.00033959508,0.9862219,0.0016203993,0.000045406305,0.00008688215,0.00058682583,0.0000051864927,0.000806069,0.000029502758,0.005366596,0.00015006335],"about_ca_topic_score_codex":0.11816129,"about_ca_topic_score_gemma":0.33086175,"teacher_disagreement_score":0.21270047,"about_ca_system_score_codex":0.00038043477,"about_ca_system_score_gemma":0.000808381,"threshold_uncertainty_score":0.9996742},"labels":[],"label_agreement":null},{"id":"W1998796510","doi":"10.1038/bjc.2013.50","title":"ING1b-inducible microRNA203 inhibits cell proliferation","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Heritage Foundation for Medical Research; Alberta Cancer Foundation","keywords":"microRNA; Ectopic expression; Biology; Epigenetics; Cyclin-dependent kinase 6; Cell growth; Cancer research; Cell cycle; Histone deacetylase; Transfection; Molecular biology; Histone; Cancer; Cell culture; Cyclin D1; Genetics; Gene","score_opus":0.006144464768496926,"score_gpt":0.23553048947610494,"score_spread":0.22938602470760802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998796510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860726,0.012653251,0.00035964668,0.00014297085,0.00020764102,0.00014942218,0.00000842935,0.000003063396,0.00040297006],"genre_scores_gemma":[0.9968614,0.0010074172,0.0005216378,0.0002424292,0.00069794315,0.000014914686,0.000013096831,0.00001812942,0.0006230591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992724,0.000039666174,0.0002810371,0.00012410212,0.00014318054,0.00013958747],"domain_scores_gemma":[0.9991533,0.000002789615,0.000249188,0.00009068315,0.0004124004,0.00009161173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121916135,0.000076316464,0.00010387577,0.0000383973,0.000051500636,0.000094029616,0.000107316686,0.000090240144,0.00022015913],"category_scores_gemma":[0.000037148795,0.000087661705,0.00008064605,0.00006289777,0.00002688915,0.000020754405,0.000028866958,0.00009722392,0.000011284077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018672079,0.00004555715,0.0030916939,0.000021898042,0.00002593739,0.000006335415,0.000015610774,0.00011947015,0.95046616,0.0000010049166,0.02184012,0.02434752],"study_design_scores_gemma":[0.0006725332,0.00007987523,0.025115985,0.00012003822,0.0000225824,0.00029613686,0.000018771416,0.000019744124,0.9477345,0.00005852605,0.025733322,0.00012801985],"about_ca_topic_score_codex":0.00011645036,"about_ca_topic_score_gemma":0.00009803067,"teacher_disagreement_score":0.0242195,"about_ca_system_score_codex":0.00003359009,"about_ca_system_score_gemma":0.0002007311,"threshold_uncertainty_score":0.35747406},"labels":[],"label_agreement":null},{"id":"W1998858050","doi":"10.1038/sj.bjc.6605358","title":"Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"LNCaP; Androgen; Endocrinology; Prostate cancer; Internal medicine; Cancer research; Biology; Protein kinase B; Autocrine signalling; Medicine; Cancer; Signal transduction; Cell biology; Hormone","score_opus":0.010719101627815602,"score_gpt":0.30383232770995106,"score_spread":0.29311322608213547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998858050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971609,0.00097409094,0.00018622632,0.0005832537,0.00028830805,0.00037913828,0.000108896056,0.000009096638,0.0003100843],"genre_scores_gemma":[0.9979774,0.00029372625,0.00024917204,0.0008619537,0.0003100665,0.000013790848,0.000002722189,0.000020943276,0.0002702628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998351,0.00006323347,0.00066544604,0.00022316667,0.00042664786,0.0002705364],"domain_scores_gemma":[0.9987776,0.000026046888,0.00032498775,0.00012967522,0.00046552476,0.00027613138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002873669,0.00015360344,0.0005594654,0.00022792775,0.000056131434,0.000040118193,0.00008562288,0.000065550725,0.00033159638],"category_scores_gemma":[0.00005312964,0.0001560799,0.00014571927,0.00023014998,0.000023604327,0.00017130697,0.000033940683,0.00036510307,0.0000028039915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008286975,0.0002598974,0.0010527484,0.000036669935,0.00005361488,0.0007258382,0.00082731183,0.001136,0.94153863,0.000002815975,0.0019811545,0.051556624],"study_design_scores_gemma":[0.002056067,0.0009924127,0.030453343,0.006559491,0.000051570893,0.0011804225,0.00014829719,0.000019965628,0.9559573,0.000025094118,0.0023889767,0.00016704],"about_ca_topic_score_codex":0.002303051,"about_ca_topic_score_gemma":0.0043375255,"teacher_disagreement_score":0.051389586,"about_ca_system_score_codex":0.0003318549,"about_ca_system_score_gemma":0.00026044433,"threshold_uncertainty_score":0.6364753},"labels":[],"label_agreement":null},{"id":"W1998892163","doi":"10.1038/sj.bjc.6601388","title":"Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Yale University; State of Connecticut Department of Public Health","keywords":"Medicine; Follicular lymphoma; Lymphoma; Internal medicine; Population; Hodgkin lymphoma; Non-Hodgkin's lymphoma; Epidemiology; Risk factor; Etiology; Oncology; Environmental health","score_opus":0.005941546187466647,"score_gpt":0.24532152094221069,"score_spread":0.23937997475474404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998892163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739513,0.024757937,0.0000099949975,0.000047794434,0.00018189331,0.0000873463,0.00001701054,0.0000035511891,0.00094318396],"genre_scores_gemma":[0.9775654,0.021915816,0.00015629405,0.000104956256,0.000114015194,0.00001176001,5.1259514e-7,0.000015082644,0.00011615886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901813,0.000046277994,0.00035196796,0.000109624794,0.000284547,0.00018945581],"domain_scores_gemma":[0.99914294,0.000055246655,0.0003744688,0.000079634156,0.00017902975,0.00016865911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032663305,0.00009467692,0.00038573763,0.000069318114,0.00005234825,0.000029605342,0.000042510896,0.000060357594,0.00020276196],"category_scores_gemma":[0.00010111374,0.00008817737,0.00009837449,0.00009797946,0.00008036503,0.00010270999,0.000010970715,0.00008469995,3.2888659e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067187546,0.00013749888,0.77251774,0.000031968928,0.00064538734,0.000545148,0.00022030053,0.0000064208243,0.00005219448,0.0000068814015,0.0006755917,0.22509366],"study_design_scores_gemma":[0.0050604874,0.00029434825,0.9815379,0.0009267964,0.00045490434,0.0013733786,0.0001668216,0.000006209127,0.005131906,0.00006947841,0.0048962072,0.00008156227],"about_ca_topic_score_codex":0.00097454566,"about_ca_topic_score_gemma":0.00020925495,"teacher_disagreement_score":0.22501211,"about_ca_system_score_codex":0.00024009089,"about_ca_system_score_gemma":0.00019544712,"threshold_uncertainty_score":0.35957685},"labels":[],"label_agreement":null},{"id":"W1999458378","doi":"10.1038/sj.bjc.6604518","title":"Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Breast cancer; Cancer research; Estrogen receptor alpha; Breast carcinoma; Carcinogenesis; Estrogen receptor; Immunohistochemistry; Biology; Alpha (finance); Cancer; Pathology; Internal medicine; Medicine","score_opus":0.008742125638781696,"score_gpt":0.2522497094700075,"score_spread":0.24350758383122584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999458378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851264,0.010842651,0.000059232156,0.0002251418,0.000099360936,0.00018485749,0.000051281775,0.0000030157712,0.00002180339],"genre_scores_gemma":[0.9963555,0.0030530253,0.00019860608,0.000050954506,0.00019239286,0.000026396214,0.000018525378,0.000023755016,0.000080847356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907076,0.00006403947,0.00028921053,0.00014964918,0.00024025083,0.00018610375],"domain_scores_gemma":[0.99898255,0.000008422661,0.0005308662,0.00006622185,0.00034308288,0.00006885063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019253975,0.000112555,0.0002190993,0.00005792582,0.000052154224,0.000013634117,0.00010667976,0.00016065853,0.000044935874],"category_scores_gemma":[0.00004942125,0.000103742896,0.00007206722,0.00015274469,0.00007966264,0.000015989246,0.000025339796,0.00023965798,2.499366e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054294366,0.00021947101,0.044436987,0.00003633453,0.00023995385,0.0001225595,0.00018936727,0.00015892542,0.93429995,4.5708975e-7,0.0004798283,0.01927321],"study_design_scores_gemma":[0.0022810902,0.0005705078,0.01763716,0.0034564503,0.000050123355,0.00155884,0.00008053854,0.00006492405,0.97328657,0.0000017449837,0.0008201239,0.00019191182],"about_ca_topic_score_codex":0.00041184202,"about_ca_topic_score_gemma":0.0005618122,"teacher_disagreement_score":0.038986623,"about_ca_system_score_codex":0.00007152412,"about_ca_system_score_gemma":0.00023404499,"threshold_uncertainty_score":0.42305124},"labels":[],"label_agreement":null},{"id":"W2000159893","doi":"10.1038/sj.bjc.6603579","title":"The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"DKK1; Breast cancer; Cancer; Wnt signaling pathway; Cancer research; Lung cancer; CA 15-3; Medicine; Biology; Internal medicine; Oncology; CA15-3; Pathology; Gene","score_opus":0.006650725839693632,"score_gpt":0.24461588944960352,"score_spread":0.23796516360990988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000159893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92231303,0.07684246,0.000008105032,0.0003756144,0.00023895763,0.00009242725,0.00003926677,0.0000021652215,0.00008797107],"genre_scores_gemma":[0.97691524,0.022084419,0.00003564981,0.000203399,0.00035833343,0.000015847458,0.0000038882567,0.000020128758,0.00036311333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987746,0.000047306912,0.00046418997,0.00018163583,0.00023842539,0.00029388143],"domain_scores_gemma":[0.9994428,0.000019202687,0.00023475564,0.000091865506,0.00012680651,0.00008453264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609743,0.00012636046,0.00020614844,0.00005440884,0.000077665085,0.00007751482,0.00022041339,0.00010971972,0.000028407283],"category_scores_gemma":[0.000016629301,0.000112216425,0.00005962717,0.00009509229,0.000095636875,0.00001748047,0.000049967774,0.00020246753,2.7424315e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002480384,0.00009254812,0.04999159,0.00003680493,0.00014630517,0.000113943475,0.0002536816,0.00013524361,0.8136591,0.000024692723,0.006734834,0.1263309],"study_design_scores_gemma":[0.0018519924,0.00009121542,0.60234207,0.0005226744,0.000023275112,0.00009751786,0.00011924828,0.0000039148426,0.3725469,0.000303932,0.021835763,0.000261503],"about_ca_topic_score_codex":0.00077562296,"about_ca_topic_score_gemma":0.013309025,"teacher_disagreement_score":0.55235046,"about_ca_system_score_codex":0.000081571925,"about_ca_system_score_gemma":0.00028248443,"threshold_uncertainty_score":0.7426748},"labels":[],"label_agreement":null},{"id":"W2000442055","doi":"10.1038/sj.bjc.6603837","title":"A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Colorectal cancer; Dietary iron; Medicine; Cohort; Heme; Hemochromatosis; Internal medicine; Cohort study; Cancer; Oncology; Physiology; Environmental health; Iron deficiency; Chemistry; Anemia; Biochemistry","score_opus":0.006531333075278448,"score_gpt":0.2719238950775675,"score_spread":0.26539256200228906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000442055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581348,0.04123508,0.0000024079138,0.000030758263,0.00013602231,0.00027768704,0.000028833,0.0000018780925,0.00015256379],"genre_scores_gemma":[0.9590455,0.040700518,0.000064816835,0.000049119222,0.00008550101,0.000008461537,4.5777315e-7,0.000011667319,0.000033926928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998823,0.00004657231,0.0005167374,0.00012004181,0.0003067535,0.00018689818],"domain_scores_gemma":[0.99931705,0.000038754886,0.00034811132,0.000052819127,0.00011921183,0.00012407215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069657515,0.0000895942,0.0005076774,0.00013093968,0.000023333334,0.000006686902,0.000046396737,0.00005343978,0.000115912626],"category_scores_gemma":[0.00006329583,0.000089337234,0.000034136217,0.00013316845,0.000118508775,0.000091371265,0.000025579475,0.00024045142,5.2542696e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014877142,0.00033428604,0.85891885,0.00013842306,0.00007274825,0.00012143726,0.002021213,0.000027100148,0.0014163639,4.6790345e-7,0.000090197864,0.13537118],"study_design_scores_gemma":[0.0057512885,0.0007683676,0.98834014,0.00030367874,0.00024382658,0.00015109153,0.0039281906,0.0000054271263,0.0002558565,0.000014305395,0.0001609149,0.00007693845],"about_ca_topic_score_codex":0.010392129,"about_ca_topic_score_gemma":0.017855953,"teacher_disagreement_score":0.13529424,"about_ca_system_score_codex":0.000069507194,"about_ca_system_score_gemma":0.000103975675,"threshold_uncertainty_score":0.99640405},"labels":[],"label_agreement":null},{"id":"W2000457925","doi":"10.1038/bjc.2015.55","title":"Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Fondation pour la Recherche Nuovo-Soldati","keywords":"Erlotinib; Medicine; Gemcitabine; Placebo; Internal medicine; Randomized controlled trial; Pairwise comparison; Erlotinib Hydrochloride; Pancreatic cancer; Oncology; Cancer; Statistics; Alternative medicine","score_opus":0.15114447591656663,"score_gpt":0.4478693342757278,"score_spread":0.2967248583591612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000457925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95237464,0.046114955,0.00014386719,0.0006095908,0.00015466518,0.00036695413,0.000032086347,0.0000025500447,0.00020070963],"genre_scores_gemma":[0.9893311,0.0078959,0.0020518685,0.00011480179,0.00032483684,0.000015081939,0.0000012117754,0.000018552473,0.00024662548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980671,0.00032655115,0.00080913695,0.000116160976,0.00042361717,0.00025748208],"domain_scores_gemma":[0.99796706,0.00032155451,0.0008022817,0.00018905623,0.0005194651,0.00020057171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012309746,0.00012301376,0.0008081663,0.0000987794,0.00009222548,0.000034470653,0.00016622558,0.00007972664,0.00013380098],"category_scores_gemma":[0.00036793912,0.00007761808,0.00015168411,0.0003117994,0.00023430705,0.00015348074,0.000034080356,0.00040152864,3.219715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037153988,0.00023234915,0.9355615,0.00006289852,0.000722505,0.0015697421,0.0012660816,0.0017333236,0.00041996563,0.0000075814373,0.0021690903,0.05588347],"study_design_scores_gemma":[0.012436288,0.00056941813,0.9497984,0.0038090458,0.0035075878,0.011120451,0.005541262,0.011233357,0.00080436486,0.00032117782,0.0006997358,0.00015890432],"about_ca_topic_score_codex":0.09804807,"about_ca_topic_score_gemma":0.012043381,"teacher_disagreement_score":0.08600469,"about_ca_system_score_codex":0.00034945316,"about_ca_system_score_gemma":0.0021558031,"threshold_uncertainty_score":0.9079581},"labels":[],"label_agreement":null},{"id":"W2000968839","doi":"10.1038/bjc.2013.805","title":"Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Fonds NutsOhra","keywords":"Medicine; Breast cancer; Mastectomy; Odds ratio; Confidence interval; Genetic testing; Prophylactic Mastectomy; Randomized controlled trial; Genetic counseling; Cancer; Internal medicine; Prophylactic Surgery; Surgery; Gynecology","score_opus":0.010340221807835451,"score_gpt":0.27343468642933894,"score_spread":0.2630944646215035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000968839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409723,0.0031231286,0.0010645913,0.00009905209,0.0003620277,0.0011502377,0.00009271585,0.000001982609,0.0000090099065],"genre_scores_gemma":[0.99599767,0.0025331194,0.00056508457,0.00022009671,0.00045430518,0.00018915569,0.0000032343082,0.000029641189,0.000007714993],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99831396,0.00021179434,0.00070330803,0.0002378656,0.00031401642,0.0002190517],"domain_scores_gemma":[0.9979281,0.00082551653,0.00052260485,0.00013280845,0.0004957416,0.00009525171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004962765,0.0001682268,0.0004566191,0.00009169061,0.00008318638,0.00009879673,0.00019580747,0.000099009056,0.000084415355],"category_scores_gemma":[0.0010452463,0.00011951002,0.00015208861,0.00020445051,0.00006917834,0.0000129261325,0.000019549809,0.00018232342,4.0303618e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64433056,0.00032722627,0.018016702,0.000021681943,0.0005874857,0.000029252591,0.00028942607,0.020064054,0.03377969,4.1289016e-7,0.00070232875,0.28185117],"study_design_scores_gemma":[0.7753254,0.004186286,0.21425746,0.00094754837,0.00023669092,0.00007766336,0.000042780037,0.0011777327,0.0030248086,0.00015164488,0.00020946219,0.00036250017],"about_ca_topic_score_codex":0.0012088864,"about_ca_topic_score_gemma":0.0017620077,"teacher_disagreement_score":0.28148866,"about_ca_system_score_codex":0.00016052344,"about_ca_system_score_gemma":0.0005557804,"threshold_uncertainty_score":0.48734772},"labels":[],"label_agreement":null},{"id":"W2001071815","doi":"10.1038/sj.bjc.6603086","title":"Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Anxiety; Medicine; Psychosocial; Psychological intervention; Cervical cancer; Hospital Anxiety and Depression Scale; Depression (economics); Psychiatry; Clinical psychology; Obstetrics; Cancer; Internal medicine","score_opus":0.009112005470159414,"score_gpt":0.2750419750220685,"score_spread":0.2659299695519091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001071815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656535,0.011914949,0.00001267796,0.00026121343,0.0004531152,0.00012638165,0.000057815058,0.000014715508,0.00059377955],"genre_scores_gemma":[0.99632156,0.0027601176,0.000034774792,0.00023444195,0.00044568506,0.0000038958374,0.000007727125,0.000017992861,0.00017381313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.00006834343,0.00048216863,0.00016057026,0.00046388627,0.00024528874],"domain_scores_gemma":[0.99895203,0.00018621632,0.00031409328,0.00008511234,0.00028716656,0.00017537155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021962522,0.00012965113,0.00048574433,0.000064022504,0.000048554535,0.00003233456,0.00008962444,0.00017637477,0.00010525692],"category_scores_gemma":[0.00027213967,0.00011865552,0.00019376061,0.00021640824,0.00012148898,0.00009160552,0.000022037271,0.00045662274,4.82244e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034796173,0.00079044484,0.9566198,0.00032590216,0.00013182896,0.0007911689,0.00026138572,0.0000065053896,0.0059532253,0.000010359994,0.005477852,0.029283537],"study_design_scores_gemma":[0.0031823753,0.0005232845,0.98734725,0.0012567382,0.0001458435,0.000953366,0.00006397871,0.0000064186493,0.003695252,0.00005769532,0.0026455263,0.00012225815],"about_ca_topic_score_codex":0.0028555766,"about_ca_topic_score_gemma":0.0041533518,"teacher_disagreement_score":0.030727435,"about_ca_system_score_codex":0.00010556409,"about_ca_system_score_gemma":0.00008100238,"threshold_uncertainty_score":0.48386317},"labels":[],"label_agreement":null},{"id":"W2001111741","doi":"10.1038/sj.bjc.6601254","title":"Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells","year":2003,"lang":"es","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Kamillo Eisner Stiftung; Oesterreichische Nationalbank; Austrian Science Fund","keywords":"Bcl-xL; Clonogenic assay; Apoptosis; Colorectal cancer; Cancer research; Cisplatin; Oligonucleotide; Programmed cell death; Cancer; Cancer cell; Biology; Chemotherapy; Gene; Biochemistry","score_opus":0.005848662692833701,"score_gpt":0.25097583574026416,"score_spread":0.24512717304743045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001111741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82390326,0.1722608,0.00024230202,0.00019211366,0.0026162681,0.00017746979,0.00012938518,0.000004658731,0.00047373166],"genre_scores_gemma":[0.7418517,0.25494796,0.0004999442,0.00026696504,0.0010481742,0.000004258534,0.0000069163843,0.000049055885,0.0013250088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980723,0.00019963371,0.0006394043,0.00032692938,0.000339222,0.00042249644],"domain_scores_gemma":[0.9983561,0.000017092087,0.0006529812,0.00018529133,0.00053826533,0.00025024204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037062878,0.00026099026,0.0004648445,0.00007838513,0.00018182978,0.00020182176,0.00016155546,0.0003278885,0.00040087447],"category_scores_gemma":[0.000053524967,0.00030170707,0.00034360692,0.00014346781,0.00013375458,0.000020493479,0.000036972204,0.0002834938,0.00000534032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013530103,0.0001222433,0.0004782554,0.00010565355,0.00031609435,0.00069512957,0.000044319346,0.001258702,0.82897633,0.000081770435,0.009720513,0.15806566],"study_design_scores_gemma":[0.0016180623,0.00026986844,0.004260199,0.0008698982,0.00026283192,0.0020679876,0.000048528305,0.000054447763,0.5927905,0.00005685221,0.39733067,0.00037015902],"about_ca_topic_score_codex":0.00044392736,"about_ca_topic_score_gemma":0.00040404173,"teacher_disagreement_score":0.38761017,"about_ca_system_score_codex":0.000101464015,"about_ca_system_score_gemma":0.00049916573,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W2001272106","doi":"10.1038/bjc.2013.618","title":"Validation of the Children’s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Canada Research Chairs; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; National Institutes of Health; World Health Organization","keywords":"Mucositis; Medicine; Construct validity; Respondent; Prospective cohort study; Pediatrics; Surgery; Chemotherapy","score_opus":0.014355359556321032,"score_gpt":0.3329554070576263,"score_spread":0.3186000475013052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001272106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97185564,0.022685397,0.000004330841,0.0038820738,0.0007442847,0.0006525486,0.000036560796,0.0000024765407,0.00013669564],"genre_scores_gemma":[0.98809946,0.010626884,0.0002407751,0.00030543996,0.00053081743,0.000110316214,0.00000408365,0.000010849359,0.0000713884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986526,0.00007322239,0.00045322836,0.00010718798,0.0005826394,0.00013115609],"domain_scores_gemma":[0.9989129,0.000026011687,0.0003923929,0.000072027215,0.00051388284,0.000082801984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039381746,0.00007102604,0.00020419002,0.00010656281,0.000035166748,0.000023968401,0.0000837843,0.000049491482,0.00076631986],"category_scores_gemma":[0.000055511406,0.00005970387,0.00006386645,0.0001784548,0.000048242357,0.00020890389,0.00002531265,0.0001915811,0.0000012528217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034769222,0.000058066402,0.59901315,0.000024983714,0.000043103384,0.0000025509082,0.00007530201,0.00020482083,0.00015404225,9.0231515e-7,0.001015522,0.3993728],"study_design_scores_gemma":[0.0028323198,0.00008202379,0.9920864,0.00089966,0.00014208928,0.00033447167,0.000028072689,0.00041084786,0.002747775,0.000119277865,0.0002664755,0.000050546365],"about_ca_topic_score_codex":0.008173007,"about_ca_topic_score_gemma":0.0016447919,"teacher_disagreement_score":0.39932224,"about_ca_system_score_codex":0.00068016356,"about_ca_system_score_gemma":0.0005268226,"threshold_uncertainty_score":0.9984317},"labels":[],"label_agreement":null},{"id":"W2001293876","doi":"10.1038/sj.bjc.6600087","title":"Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hypoxia (environmental); Mitochondrion; Oxygen tension; Cell biology; Biology; Oxygen; Cell culture; Membrane potential; Cell; Inner mitochondrial membrane; Biochemistry; Chemistry; Genetics","score_opus":0.011131458195491481,"score_gpt":0.2350591613640777,"score_spread":0.22392770316858623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001293876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413913,0.0030141731,0.00080264715,0.00009596999,0.00147106,0.000119260985,0.000012779633,0.0000024423703,0.00034253093],"genre_scores_gemma":[0.9966719,0.0013238082,0.00025595096,0.00023781786,0.0011457419,0.000007882832,0.0000054361867,0.0000139205495,0.00033749835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898577,0.00014239745,0.00038528763,0.00019870355,0.00012388028,0.00016394047],"domain_scores_gemma":[0.99955213,0.000013356668,0.00018718156,0.00007022348,0.00011343826,0.00006365591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015833534,0.00009739389,0.00019810423,0.00012841627,0.000045856606,0.000035479243,0.00005656827,0.00016792356,0.00015382751],"category_scores_gemma":[0.00004956029,0.00011596337,0.000060787756,0.000119741024,0.000041891843,0.000015250758,0.000020606873,0.0001994449,0.0000026568123],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000266516,0.00007713164,0.00037803245,0.0000073538554,0.0000215176,0.00021650395,0.00011201597,0.00026065888,0.988179,0.000010746194,0.0016640628,0.00880645],"study_design_scores_gemma":[0.026749121,0.0035353154,0.63759154,0.0008492112,0.00019614845,0.00724263,0.0004322971,0.0008195998,0.23259558,0.0007768563,0.08789147,0.0013202592],"about_ca_topic_score_codex":0.00029174707,"about_ca_topic_score_gemma":0.002592987,"teacher_disagreement_score":0.75558347,"about_ca_system_score_codex":0.000034204135,"about_ca_system_score_gemma":0.000029033732,"threshold_uncertainty_score":0.4728849},"labels":[],"label_agreement":null},{"id":"W2002199128","doi":"10.1038/sj.bjc.6604895","title":"Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Pediatric Oncology Group of Ontario; American Lebanese Syrian Associated Charities","keywords":"Medicine; Socioeconomic status; Incidence (geometry); Demographics; Cumulative incidence; Pediatrics; Demography; Internal medicine; Environmental health; Population; Cohort","score_opus":0.010764385697023472,"score_gpt":0.3154169474961295,"score_spread":0.304652561799106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002199128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880687,0.011135156,0.000008623272,0.00024076781,0.00010123987,0.00021363058,0.00002419696,0.0000053531326,0.00020233224],"genre_scores_gemma":[0.9797606,0.019786302,0.00010446838,0.00009256662,0.00014072543,0.0000049715736,0.0000024739732,0.000011172762,0.000096750315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832916,0.00007425286,0.0007314199,0.00015922872,0.0004382778,0.00026768318],"domain_scores_gemma":[0.9991795,0.000091652946,0.00027626974,0.00010180207,0.00016890222,0.00018190614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040030258,0.00011593182,0.0005292492,0.00029882585,0.0000165313,0.000014563372,0.00010601548,0.00012879386,0.00007026536],"category_scores_gemma":[0.00020700674,0.00011018832,0.00008546908,0.00052608416,0.00011177848,0.00019918816,0.000022204315,0.00036225285,6.7502316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042621174,0.00019698498,0.9263739,0.000040603452,0.00018455127,0.004059502,0.000311341,0.00012862822,0.002024921,0.000005741398,0.0003497196,0.06589787],"study_design_scores_gemma":[0.008098468,0.00085946795,0.98639566,0.00079498364,0.00019476473,0.0022498395,0.00004483291,0.00034850373,0.0006656242,0.0002040162,0.00006303869,0.00008083087],"about_ca_topic_score_codex":0.002995008,"about_ca_topic_score_gemma":0.001443647,"teacher_disagreement_score":0.06581704,"about_ca_system_score_codex":0.0016470576,"about_ca_system_score_gemma":0.0016221269,"threshold_uncertainty_score":0.4527576},"labels":[],"label_agreement":null},{"id":"W2002555910","doi":"10.1054/bjoc.2001.2068","title":"No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CDKN2A; Loss of heterozygosity; Cancer research; Head and neck cancer; Germline; Cancer; Germline mutation; Biology; Medicine; Oncology; Allele; Mutation; Pathology; Genetics; Gene","score_opus":0.004690030542003254,"score_gpt":0.226430711792654,"score_spread":0.22174068125065075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002555910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987837,0.018678349,0.000004651802,0.00023007864,0.00014912945,0.0003004562,0.00006089545,0.0000025226734,0.00069555466],"genre_scores_gemma":[0.99695486,0.0021484047,0.00013337689,0.00038609124,0.00007727398,0.000011666028,0.0000038819744,0.00002335539,0.0002610837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989154,0.000040328163,0.00042142058,0.00013938326,0.0002998788,0.00018358786],"domain_scores_gemma":[0.99923134,0.00002623632,0.0002931032,0.000088315464,0.00026123336,0.00009979736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011802729,0.000105691026,0.00033177796,0.000120497854,0.00003060489,0.000016176658,0.00006289262,0.0000641217,0.00013903258],"category_scores_gemma":[0.000035240573,0.000092105765,0.000043221862,0.00026682334,0.00011283282,0.0001141075,0.000025531503,0.00041063252,2.090857e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007920357,0.00029429165,0.97367465,0.00016939348,0.000029764959,0.00036646862,0.00027957725,0.00046173699,0.0016134891,7.395817e-7,0.00046401282,0.021853838],"study_design_scores_gemma":[0.01040894,0.00034270706,0.9845645,0.0017070476,0.00007909264,0.0004926384,0.000030219664,0.000027783219,0.0005756712,0.000011345994,0.0016611463,0.00009895237],"about_ca_topic_score_codex":0.0019815299,"about_ca_topic_score_gemma":0.021091375,"teacher_disagreement_score":0.021754885,"about_ca_system_score_codex":0.00023534812,"about_ca_system_score_gemma":0.00045126467,"threshold_uncertainty_score":0.99677116},"labels":[],"label_agreement":null},{"id":"W2002561481","doi":"10.1038/bjc.2011.120","title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Women's College Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oophorectomy; Cancer; Internal medicine; Oncology; Family history; BRCA mutation; Mastectomy; Gynecology; Prophylactic Surgery; First-degree relatives; Obstetrics; Surgery; Hysterectomy","score_opus":0.007360750393747948,"score_gpt":0.24859131119566943,"score_spread":0.24123056080192148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002561481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983337,0.01563519,0.000060698167,0.000077594,0.00046169935,0.00008083449,0.00020577107,0.0000016250984,0.00013958657],"genre_scores_gemma":[0.9941244,0.0052524554,0.00019875573,0.00008583708,0.00024993267,0.000013256502,0.000003891961,0.00001560158,0.000055873552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991923,0.00004187511,0.00035592073,0.00013344554,0.00013276935,0.00014371672],"domain_scores_gemma":[0.99934536,0.0000048266365,0.0002582833,0.00006833504,0.0002510884,0.00007208618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015255885,0.00008227246,0.00017274538,0.00006166199,0.000023537152,0.000013790258,0.000105902276,0.000090294736,0.00015335066],"category_scores_gemma":[0.000021528032,0.00009420269,0.000057033278,0.000083896266,0.00012574084,0.0000173061,0.000021960583,0.000109286775,9.624882e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069065404,0.0000975749,0.724772,0.000084430474,0.00059857126,0.00014345456,0.0017998985,0.0010876366,0.08172437,0.000013575994,0.0021450277,0.18684281],"study_design_scores_gemma":[0.0017545415,0.00012794821,0.9518339,0.00024110742,0.00006400191,0.0010289727,0.00020819128,0.000024504017,0.04321264,0.0000723842,0.00129266,0.0001391489],"about_ca_topic_score_codex":0.0016368792,"about_ca_topic_score_gemma":0.0034474274,"teacher_disagreement_score":0.2270619,"about_ca_system_score_codex":0.00008393843,"about_ca_system_score_gemma":0.00034468027,"threshold_uncertainty_score":0.38414744},"labels":[],"label_agreement":null},{"id":"W2002783201","doi":"10.1038/bjc.2012.366","title":"Projections of cancer prevalence in the United Kingdom, 2010–2040","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; King's College London; Macmillan Cancer Support","keywords":"Medicine; Demography; Cancer registry; Cancer; Incidence (geometry); Population; Cancer incidence; Prostate cancer; Projections of population growth; Colorectal cancer; Quarter (Canadian coin); Lung cancer; Gerontology; Relative survival; Environmental health; Geography; Population growth; Pathology; Internal medicine","score_opus":0.049573930463883004,"score_gpt":0.3510223883193181,"score_spread":0.30144845785543506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002783201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95272255,0.043745123,0.000027005046,0.0009952034,0.0015372965,0.00020435583,0.00003503755,0.0000053276594,0.00072811614],"genre_scores_gemma":[0.98792094,0.009715784,0.000035696707,0.0006238315,0.0009738043,0.000040634462,0.0000015721715,0.000014097158,0.0006736114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998747,0.000099516066,0.00039613395,0.00007798748,0.00044094175,0.00023844469],"domain_scores_gemma":[0.999075,0.000060370603,0.00028353752,0.00012266779,0.00036519533,0.00009325819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054357847,0.00008508758,0.00025101914,0.0001665206,0.00004704389,0.000019345593,0.00015662325,0.00006341892,0.0006673546],"category_scores_gemma":[0.00007980689,0.000069663714,0.00012698692,0.0005910899,0.0000861636,0.00018485228,0.000015882044,0.00043421704,0.0000012236906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035747277,0.00032903353,0.9300992,0.00049079,0.00015707307,0.00009225319,0.0032390377,0.00007175676,0.00085883937,0.000090463014,0.010671353,0.05354271],"study_design_scores_gemma":[0.0012089958,0.00012046608,0.87470037,0.0026213254,0.0002613906,0.0009203315,0.0007382343,0.000009943958,0.0008477592,0.000020102236,0.11844612,0.00010497192],"about_ca_topic_score_codex":0.052113064,"about_ca_topic_score_gemma":0.032254525,"teacher_disagreement_score":0.107774764,"about_ca_system_score_codex":0.00015256388,"about_ca_system_score_gemma":0.00032452328,"threshold_uncertainty_score":0.9854043},"labels":[],"label_agreement":null},{"id":"W2002876811","doi":"10.1038/sj.bjc.6601147","title":"Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"University Health Network","keywords":"Epirubicin; Irinotecan; Cisplatin; Medicine; Solid tumor; Camptothecin; Chemotherapy; Oncology; Internal medicine; Cancer; Cyclophosphamide; Chemistry; Colorectal cancer","score_opus":0.008783136715454705,"score_gpt":0.28836142954853355,"score_spread":0.27957829283307883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002876811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589753,0.0035755052,0.00009422956,0.000010779521,0.00013359288,0.0002014535,0.000025807614,8.986726e-7,0.000060222697],"genre_scores_gemma":[0.9988095,0.000807603,0.00017734106,0.00009473225,0.000038708986,0.000008465761,0.000002911552,0.000018285502,0.000042414373],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991167,0.00005260136,0.00034281026,0.00015377665,0.00018049985,0.00015358756],"domain_scores_gemma":[0.999312,0.0000058212763,0.0003027801,0.00009822508,0.00020527985,0.00007589423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014363811,0.00010290284,0.00024810887,0.000049711794,0.000027820442,0.000015947735,0.00008162886,0.000049073355,0.0000168369],"category_scores_gemma":[0.000020301786,0.00010547637,0.000035685527,0.000072449635,0.000033655244,0.000009132082,0.000018171871,0.0001107376,4.83842e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009675745,0.010266909,0.17333965,0.00012095085,0.0007224297,0.00028808875,0.00080183754,0.00081764243,0.21903025,0.000028756851,0.00024385496,0.58466387],"study_design_scores_gemma":[0.117053136,0.061674926,0.38334692,0.0012659791,0.00038106495,0.00047596352,0.0018680693,0.000017413791,0.4178197,0.00016493128,0.014908359,0.0010235423],"about_ca_topic_score_codex":0.000065492575,"about_ca_topic_score_gemma":0.0009928889,"teacher_disagreement_score":0.58364034,"about_ca_system_score_codex":0.0000232729,"about_ca_system_score_gemma":0.00013825641,"threshold_uncertainty_score":0.43012017},"labels":[],"label_agreement":null},{"id":"W2002931314","doi":"10.1038/sj.bjc.6600874","title":"Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Endoglin; Angiogenesis; Medicine; Colorectal cancer; Metastasis; CD34; Pathology; Internal medicine; Carcinoma; Gastroenterology; Cancer; Biology; Stem cell","score_opus":0.008583511918195627,"score_gpt":0.2547344994738327,"score_spread":0.24615098755563708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002931314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391806,0.0054881917,0.00008130875,0.000010456579,0.0002021006,0.00016708374,0.00012273688,0.0000018332876,0.0000082552815],"genre_scores_gemma":[0.9966862,0.0022398373,0.0008509915,0.0000708611,0.0000873767,0.000008029804,0.000008066599,0.000028247383,0.000020393192],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988476,0.00007371573,0.0004224673,0.00022228197,0.00017985539,0.0002540668],"domain_scores_gemma":[0.9990262,0.000010109297,0.0004516003,0.000048976595,0.0003713815,0.000091769354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014608186,0.00016240973,0.00034641993,0.000059183996,0.000056198896,0.000033940905,0.00009771887,0.00012970573,0.000027239015],"category_scores_gemma":[0.000028649009,0.0001601545,0.00007262093,0.00014854147,0.00012967216,0.000021108228,0.00002875139,0.00013311928,6.531415e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044250634,0.0001133128,0.42891723,0.00003407088,0.00012343291,0.00005022857,0.000024162458,0.00015912653,0.5626754,0.0000013605624,0.000055535766,0.0074036173],"study_design_scores_gemma":[0.0023738893,0.00041018648,0.55576044,0.00042250042,0.000084621315,0.0002562437,0.000022710521,0.000065442844,0.4401501,0.000004149537,0.00025313153,0.00019655236],"about_ca_topic_score_codex":0.0006619331,"about_ca_topic_score_gemma":0.0016014935,"teacher_disagreement_score":0.12684321,"about_ca_system_score_codex":0.000067540605,"about_ca_system_score_gemma":0.00037608246,"threshold_uncertainty_score":0.6530911},"labels":[],"label_agreement":null},{"id":"W2003048954","doi":"10.1038/bjc.2012.400","title":"International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostatectomy; Nomogram; Medicine; Logistic regression; Prostate cancer; Receiver operating characteristic; Disease; Watchful waiting; Gynecology; Internal medicine; Oncology; Cancer; Demography","score_opus":0.030629199984379022,"score_gpt":0.35476231148256393,"score_spread":0.3241331114981849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003048954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945976,0.0032689155,0.000119782104,0.00032157573,0.0006218337,0.00073370093,0.000032480333,0.000008095711,0.00029597495],"genre_scores_gemma":[0.9959611,0.0023517963,0.0006994292,0.00007475634,0.0006949125,0.00013710075,0.0000070974525,0.000018951858,0.000054806744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896866,0.00006378595,0.0003531608,0.00012435883,0.00024681896,0.00024322131],"domain_scores_gemma":[0.99923605,0.00013576355,0.00022242355,0.000036636102,0.00024783763,0.00012130796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000387832,0.000093004135,0.00027545734,0.000092296985,0.000045849276,0.00004261977,0.000051588417,0.000035656987,0.00014475954],"category_scores_gemma":[0.00016962114,0.00009404099,0.000056067,0.00010303704,0.00002016465,0.00031021208,0.000015292348,0.00016695674,5.3961634e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012583876,0.001070075,0.85710245,0.00004791101,0.00035608181,0.00010373096,0.0011489608,0.000030287836,0.0005160832,0.0000024184683,0.00070732407,0.13765627],"study_design_scores_gemma":[0.012159513,0.000662491,0.978077,0.0007414578,0.000083029336,0.00039676914,0.0014220567,0.00013814065,0.0016247889,0.000009985887,0.0045854864,0.00009928106],"about_ca_topic_score_codex":0.00023598927,"about_ca_topic_score_gemma":0.0007842178,"teacher_disagreement_score":0.13755699,"about_ca_system_score_codex":0.0007479842,"about_ca_system_score_gemma":0.00018280184,"threshold_uncertainty_score":0.38348803},"labels":[],"label_agreement":null},{"id":"W2003394553","doi":"10.1038/bjc.2012.452","title":"Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute; McGill University","keywords":"MSH6; MSH2; MLH1; Ovarian cancer; Germline mutation; Lynch syndrome; Biology; Genetics; Population; Cancer; Germline; DNA mismatch repair; Colorectal cancer; Mutation frequency; Mutation; Oncology; Cancer research; Medicine; Gene","score_opus":0.01700810875316382,"score_gpt":0.3006949185728887,"score_spread":0.2836868098197249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003394553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129516,0.007908994,0.000010537753,0.00008374689,0.00022564258,0.0004007201,0.000020425045,0.000005076571,0.00004972015],"genre_scores_gemma":[0.9982186,0.00017265203,0.0012859382,0.000057021974,0.00012073891,0.00010382046,0.0000015215361,0.000021868798,0.000017842844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983207,0.00009167869,0.0007432906,0.00011268911,0.0004609112,0.00027074976],"domain_scores_gemma":[0.9988792,0.000063340376,0.00046414946,0.000118888776,0.00034571014,0.00012873787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044095312,0.00010315284,0.0004965587,0.00025185946,0.00001744511,0.0000053409303,0.000084191444,0.0000606594,0.00043939383],"category_scores_gemma":[0.000096148375,0.0001016816,0.000053669315,0.00049340696,0.00003856857,0.00011390951,0.000009362969,0.00021485495,1.2706593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036429614,0.00072369335,0.98219377,0.0001317896,0.00011404761,0.00006611222,0.0026581527,0.0032732994,0.0014265877,0.0000014849984,0.000017922319,0.009028862],"study_design_scores_gemma":[0.0041835285,0.00059632235,0.9915859,0.0010835752,0.00008896734,0.00007482437,0.0013097475,0.00003597919,0.00088518165,0.000029179282,0.00003229209,0.000094468276],"about_ca_topic_score_codex":0.037056845,"about_ca_topic_score_gemma":0.0561941,"teacher_disagreement_score":0.019137256,"about_ca_system_score_codex":0.0008296342,"about_ca_system_score_gemma":0.00071998267,"threshold_uncertainty_score":0.96935546},"labels":[],"label_agreement":null},{"id":"W2003411025","doi":"10.1038/sj.bjc.6603127","title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Nottingham","keywords":"Medicine; Gallbladder cancer; Gallbladder; Biliary tract; Gastroenterology; Intrahepatic bile ducts; Liver cancer; Bile duct; Internal medicine; Cancer registry; Incidence (geometry); Cancer; Bile duct cancer; Intrahepatic Cholangiocarcinoma; Population","score_opus":0.019393586575322783,"score_gpt":0.2717813328617017,"score_spread":0.2523877462863789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003411025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8270968,0.17153053,8.54095e-7,0.0005590726,0.000054547705,0.00006176347,0.0000118413745,0.0000014087576,0.00068314176],"genre_scores_gemma":[0.9657435,0.03360684,0.000063325606,0.00025860665,0.00023034231,0.0000061996543,0.0000014301929,0.0000069288203,0.00008281774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990994,0.000049421305,0.00034633276,0.00011165695,0.00023728504,0.00015590985],"domain_scores_gemma":[0.9995892,0.000095644726,0.0001495817,0.000056960835,0.00006833348,0.0000402947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003597479,0.000086240674,0.00034912967,0.00016981535,0.00002714211,0.000018481363,0.00006291843,0.000042056687,0.000028175062],"category_scores_gemma":[0.000025734746,0.0000693224,0.00005112603,0.00021868397,0.00014515503,0.00013601172,0.000019240493,0.00025150002,4.1259643e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000155032,0.000057851357,0.7449203,0.00008182293,0.00002235329,0.0010306992,0.0012454166,0.000011711556,0.00021775285,0.0000016083173,0.0015003488,0.2507551],"study_design_scores_gemma":[0.0025452033,0.00014557448,0.9899701,0.00078808906,0.00006883436,0.0024420654,0.00024769644,0.000011748925,0.00006313021,0.00003678165,0.003611263,0.00006951207],"about_ca_topic_score_codex":0.023015043,"about_ca_topic_score_gemma":0.07619144,"teacher_disagreement_score":0.2506856,"about_ca_system_score_codex":0.00014213,"about_ca_system_score_gemma":0.00015485144,"threshold_uncertainty_score":0.98349077},"labels":[],"label_agreement":null},{"id":"W2003704622","doi":"10.1038/bjc.2013.688","title":"Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Dermatology Foundation","keywords":"Melanoma; Cancer research; Protein kinase B; Medicine; PI3K/AKT/mTOR pathway; Eukaryotic initiation factor; Eukaryotic translation; Tissue microarray; Cell; Pathology; Biology; Immunohistochemistry; Signal transduction; Translation (biology); Cell biology","score_opus":0.004266176620538545,"score_gpt":0.2217760721020288,"score_spread":0.21750989548149025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003704622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738519,0.025004871,0.00003854944,0.000040516912,0.00013364835,0.00013504214,0.000031029147,0.0000016587126,0.000762767],"genre_scores_gemma":[0.99704856,0.0013862568,0.001151587,0.00004706419,0.00024381171,0.0000134841475,0.0000060307166,0.000020587646,0.000082626284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875265,0.00006447319,0.0005864985,0.00015698628,0.00023615568,0.00020323868],"domain_scores_gemma":[0.998817,0.000015019722,0.0005983598,0.00012886025,0.00036306537,0.00007764926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002727797,0.000107386404,0.00029103967,0.000067375026,0.000019274701,0.000017843138,0.00024769883,0.00012850137,0.00023981993],"category_scores_gemma":[0.000080992264,0.000117103846,0.00012600134,0.000110261986,0.00006887127,0.000016694403,0.00006155936,0.0001712607,0.0000011533731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053384883,0.000116986135,0.034460764,0.000078835066,0.00004254468,0.000013231549,0.000090177535,0.00028892158,0.933203,9.1660604e-7,0.0009035523,0.030747732],"study_design_scores_gemma":[0.0010487286,0.00039373242,0.0193426,0.0006151278,0.000019198354,0.00013275442,0.000098829456,0.000050793038,0.9749537,0.00015673623,0.0030589127,0.00012885973],"about_ca_topic_score_codex":0.0012253254,"about_ca_topic_score_gemma":0.00036772108,"teacher_disagreement_score":0.041750778,"about_ca_system_score_codex":0.00004084817,"about_ca_system_score_gemma":0.0002688525,"threshold_uncertainty_score":0.4775356},"labels":[],"label_agreement":null},{"id":"W2004303134","doi":"10.1038/bjc.2012.467","title":"Functional genomic screening to enhance oncolytic virotherapy","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Alberta Children's Hospital","funders":"","keywords":"RNA interference; Oncolytic virus; Virotherapy; Biology; Computational biology; Genome; Cancer; Bioinformatics; Gene; Genetics; RNA","score_opus":0.049016797144411296,"score_gpt":0.3897149546037802,"score_spread":0.3406981574593689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004303134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016397794,0.996259,0.0010057156,0.00003817466,0.00050060614,0.00036453275,0.00008161636,0.0000035285836,0.000107052016],"genre_scores_gemma":[0.00017501593,0.99267,0.00039222627,0.00034090097,0.0044846777,0.00008067918,0.000029485213,0.00010493214,0.0017220575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980081,0.00020926338,0.0006449633,0.00029314272,0.00041819265,0.0004263799],"domain_scores_gemma":[0.9987166,0.00002410076,0.00047720483,0.00023626428,0.00024781065,0.00029799755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006645877,0.00026881578,0.00080677617,0.00013934073,0.0000934438,0.00008027236,0.00047648637,0.0002612581,0.00075034285],"category_scores_gemma":[0.0000324004,0.00028600337,0.00056272815,0.00016968914,0.000055407247,0.0000082666775,0.000085501895,0.0005025318,0.00004092002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037438178,0.00003958477,0.0000049837527,0.00037040928,0.00046929735,0.00002675125,0.0000043596588,0.000044278306,0.004266102,2.835322e-7,0.0038207737,0.9905788],"study_design_scores_gemma":[0.0002803417,0.0007868133,0.000044097356,0.0033278142,0.00018636842,0.00085238897,0.000002200928,2.6151588e-7,0.0016484826,0.0000026939374,0.992569,0.00029950208],"about_ca_topic_score_codex":0.000038190534,"about_ca_topic_score_gemma":0.00040888632,"teacher_disagreement_score":0.9902793,"about_ca_system_score_codex":0.00017341913,"about_ca_system_score_gemma":0.001002551,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W2004516600","doi":"10.1038/bjc.2014.164","title":"Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital","funders":"Ministry of Science and Technology of the People's Republic of China; Leukemia and Lymphoma Society","keywords":"Downregulation and upregulation; Apoptosis; Puma; Cancer research; Multiple myeloma; In vivo; Gene knockdown; Unfolded protein response; XBP1; Bortezomib; Endoplasmic reticulum; Dexamethasone; Doxorubicin; Biology; Medicine; Immunology; Chemotherapy; Internal medicine; Cell biology; RNA splicing; Biochemistry","score_opus":0.013532566386534968,"score_gpt":0.25949235392176534,"score_spread":0.24595978753523037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004516600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856244,0.013958824,0.000066006476,0.000057654026,0.00012775313,0.00009371185,0.00003054069,0.0000027290778,0.00003841953],"genre_scores_gemma":[0.99655735,0.0030139866,0.00014625864,0.000088655645,0.00015098171,0.0000089097675,0.0000025086701,0.000020651049,0.000010665487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.000118212636,0.00024086123,0.00025475022,0.00016437775,0.00022394628],"domain_scores_gemma":[0.9994657,0.000017543858,0.00019908005,0.00010029534,0.000085447864,0.00013192075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024572678,0.0001439103,0.00027023628,0.00007403614,0.000038525926,0.00006507829,0.0001329126,0.00008737771,0.000008048191],"category_scores_gemma":[0.00008873258,0.00015029691,0.000041870222,0.00009580421,0.000112327885,0.000016074666,0.00007092125,0.00020156163,1.15242166e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033836524,0.00012257714,0.043483302,0.00006397151,0.000040245675,0.00017144239,0.000033038308,0.000089614165,0.88964,6.489385e-7,0.00010929433,0.06590755],"study_design_scores_gemma":[0.0016726371,0.00011891222,0.3037347,0.0004777024,0.000024807534,0.00025934464,0.000017133343,0.000052537027,0.6925075,0.000011651453,0.0009354446,0.00018763477],"about_ca_topic_score_codex":0.00017661812,"about_ca_topic_score_gemma":0.0006506488,"teacher_disagreement_score":0.26025137,"about_ca_system_score_codex":0.000023996574,"about_ca_system_score_gemma":0.000116593124,"threshold_uncertainty_score":0.612893},"labels":[],"label_agreement":null},{"id":"W2004861918","doi":"10.1038/bjc.2012.41","title":"HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast-conserving surgery; Breast cancer; Ductal carcinoma; Oncology; Radiation therapy; Internal medicine; Progesterone receptor; Immunohistochemistry; Mammary gland; Mastectomy; Cancer; Estrogen receptor","score_opus":0.009591687012722406,"score_gpt":0.2673764975972009,"score_spread":0.2577848105844785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004861918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343701,0.064648785,0.00005015738,0.00016826717,0.00047848804,0.0001665035,0.00006739926,0.0000021464518,0.000048160062],"genre_scores_gemma":[0.9911996,0.007438344,0.00035400927,0.00013851564,0.0007701257,0.000055934644,0.000008037715,0.000019551382,0.000015885553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913925,0.00004022616,0.0002443282,0.0001713907,0.00012885747,0.00027594177],"domain_scores_gemma":[0.9995044,0.00003288501,0.00017154693,0.000081865684,0.00010988144,0.00009942801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001825199,0.00013250677,0.00022058854,0.000036572757,0.00008874255,0.000027243099,0.0001084618,0.000077029246,0.0000043248465],"category_scores_gemma":[0.000048017588,0.0001335637,0.00012055061,0.00004917278,0.000046606077,0.000033434797,0.000057985668,0.000099382036,1.331263e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004441299,0.00010718953,0.7179103,0.000037922353,0.0001463753,0.00005222091,0.00036459393,0.0000050745775,0.22880776,4.6296088e-7,0.0010328837,0.051091094],"study_design_scores_gemma":[0.003001989,0.00015002427,0.90065515,0.0006754611,0.000041799573,0.0012110044,0.0002514181,0.0000016602041,0.09295966,0.000018627474,0.0008674522,0.00016574384],"about_ca_topic_score_codex":0.0002842585,"about_ca_topic_score_gemma":0.0007567105,"teacher_disagreement_score":0.18274486,"about_ca_system_score_codex":0.00004867638,"about_ca_system_score_gemma":0.00013585656,"threshold_uncertainty_score":0.544657},"labels":[],"label_agreement":null},{"id":"W2005410969","doi":"10.1038/sj.bjc.6600609","title":"Choroid plexus tumours","year":2002,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Choroid plexus papilloma; Choroid plexus; Medicine; Papilloma; Choroid; Radiation therapy; Pathology; Carcinoma; Radiology; Internal medicine; Central nervous system; Biology","score_opus":0.047842467371327406,"score_gpt":0.35708976964753825,"score_spread":0.30924730227621083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005410969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001299482,0.9974191,6.114314e-7,0.0000992379,0.00066698843,0.0003214039,0.00007764228,0.000008925746,0.0012761484],"genre_scores_gemma":[0.0001043298,0.9973192,0.000103970524,0.00010994967,0.0015381451,0.00004768825,0.000011324219,0.000062699175,0.0007026643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998231,0.0000565339,0.00081381697,0.00017907908,0.0004627805,0.00025677524],"domain_scores_gemma":[0.9984849,0.000054566885,0.0008043155,0.00014465374,0.00022840568,0.00028313967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013774843,0.0002548739,0.0020362507,0.00018463656,0.000047775087,0.00007116569,0.0001466075,0.0001749839,0.0018480787],"category_scores_gemma":[0.000059642243,0.00021801199,0.0010618333,0.00020515374,0.000040998253,0.00006485169,0.000021181191,0.0005707716,0.00004789871],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005221521,0.0002245653,0.0001104994,0.0024166855,0.00058234105,0.009591657,0.000005418931,3.9155597e-7,1.12341205e-7,0.00000254565,0.038112316,0.94894826],"study_design_scores_gemma":[0.0010306623,0.00015614432,0.0005428779,0.07339193,0.0037989516,0.038571235,0.0000031124373,2.0890621e-7,0.0000019874758,0.0000050413714,0.8823468,0.00015106285],"about_ca_topic_score_codex":0.00014968457,"about_ca_topic_score_gemma":0.00007762112,"teacher_disagreement_score":0.94879717,"about_ca_system_score_codex":0.00040625743,"about_ca_system_score_gemma":0.00040006958,"threshold_uncertainty_score":0.9990644},"labels":[],"label_agreement":null},{"id":"W2005464272","doi":"10.1038/sj.bjc.6603389","title":"Familial breast cancer: management of ‘lower risk’ referrals","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Family history; Family medicine; Population; Quarter (Canadian coin); Cancer; Relative risk; Gynecology; Surgery; Environmental health; Internal medicine","score_opus":0.007194686131789714,"score_gpt":0.2718769470057392,"score_spread":0.2646822608739495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005464272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642155,0.031795435,0.00034399546,0.00027059895,0.0010085014,0.00010392376,0.0004583745,0.0000035539053,0.0018000837],"genre_scores_gemma":[0.9663218,0.029906562,0.0011134117,0.00009903263,0.0011346564,0.000020528782,0.000009434748,0.000024858462,0.0013696977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99893034,0.000045243993,0.00040481365,0.00016955254,0.00026683396,0.00018322282],"domain_scores_gemma":[0.9989695,0.0000043892105,0.0004630809,0.00014908134,0.00036427143,0.000049703947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019156867,0.00010628791,0.00019375097,0.000042225638,0.000056511813,0.000024174498,0.00022672286,0.000088548164,0.00023264831],"category_scores_gemma":[0.000005742483,0.000121020596,0.00015747402,0.00011225035,0.000087763576,0.000009087686,0.000052425574,0.00013026298,0.0000011172439],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009694314,0.00034263282,0.03013613,0.00017386368,0.0012531189,0.00027803786,0.00003075185,0.013867155,0.09816326,0.00008395163,0.2126596,0.64204204],"study_design_scores_gemma":[0.0038878336,0.0003220267,0.55170685,0.00093334564,0.00048963184,0.0014578872,0.00015300665,0.000024827104,0.08212264,0.00043636575,0.35793525,0.0005303536],"about_ca_topic_score_codex":0.0016119775,"about_ca_topic_score_gemma":0.0015858448,"teacher_disagreement_score":0.64151174,"about_ca_system_score_codex":0.00011594874,"about_ca_system_score_gemma":0.00020818636,"threshold_uncertainty_score":0.49350768},"labels":[],"label_agreement":null},{"id":"W2005592863","doi":"10.1038/sj.bjc.6600424","title":"Cytostatic potential of novel agents that inhibit the regulation of intracellular pH","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Amiloride; Antiporter; Sodium–hydrogen antiporter; Intracellular pH; Extracellular; Clonogenic assay; Intracellular; Cytotoxicity; Chemistry; Pharmacology; Cell culture; Biochemistry; In vitro; Biology; Sodium; Membrane","score_opus":0.016065953527741143,"score_gpt":0.2316348415009436,"score_spread":0.21556888797320245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005592863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991793,0.006100307,0.0034446323,0.0001758521,0.00019636289,0.00006549115,0.000022113947,8.084806e-7,0.00007649309],"genre_scores_gemma":[0.9972712,0.0020098903,0.00008339758,0.000034355227,0.00022320313,8.8408916e-7,0.000013139536,0.00000890931,0.00035503268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930555,0.000019366265,0.0003036705,0.00006615796,0.00022473943,0.000080535305],"domain_scores_gemma":[0.99931395,0.0000031660825,0.00038273138,0.0000705182,0.0002029866,0.00002666793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013114327,0.000055355456,0.000117998934,0.000025924224,0.00003130474,0.00000882176,0.00009484883,0.00006269207,0.0001684769],"category_scores_gemma":[0.000010400388,0.000050307863,0.000109924506,0.0000545913,0.00006795679,0.0000090621315,0.000007250519,0.00006188845,2.0234819e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077067816,0.000104699815,0.0012751289,0.00004086383,0.000089107736,0.0000066724565,0.00009688282,0.004460554,0.97229844,0.000010316873,0.0015611717,0.019979099],"study_design_scores_gemma":[0.0015612402,0.00015752998,0.092027776,0.0002603886,0.00010587952,0.00024921919,0.00009642714,0.0011561273,0.89930606,0.0000658989,0.004909755,0.000103717364],"about_ca_topic_score_codex":0.00004288111,"about_ca_topic_score_gemma":0.0000412222,"teacher_disagreement_score":0.09075265,"about_ca_system_score_codex":0.000008273854,"about_ca_system_score_gemma":0.00002388928,"threshold_uncertainty_score":0.20514952},"labels":[],"label_agreement":null},{"id":"W2006122379","doi":"10.1038/sj.bjc.6605280","title":"KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; St. Michael's Hospital; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Kallikrein; Ovarian cancer; Proportional hazards model; Ovarian carcinoma; Ovary; Oncology; Gene expression; Survival analysis; Internal medicine; Cancer; Biology; Medicine; Cancer research; Pathology; Gene; Enzyme; Genetics","score_opus":0.011050602803560914,"score_gpt":0.2696305466118003,"score_spread":0.2585799438082394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006122379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95870596,0.038668312,0.00003613669,0.0013982744,0.00037329033,0.00012945771,0.000023667857,0.000009313945,0.0006556006],"genre_scores_gemma":[0.9949,0.0028716796,0.0003200009,0.0007208869,0.00089120347,0.0000024395106,0.0000022777206,0.000010708152,0.00028080432],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998859,0.00003404922,0.00045924398,0.00014540718,0.00028412737,0.00021818928],"domain_scores_gemma":[0.9993408,0.000031021093,0.00020794751,0.00007572492,0.00015731461,0.0001872333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723341,0.000103348604,0.0003394756,0.00011163199,0.000050927658,0.000046882644,0.00007769462,0.000052558233,0.00019545293],"category_scores_gemma":[0.00011675115,0.00010953697,0.000084563435,0.00016262082,0.000058906946,0.00019648338,0.0000111073205,0.00025385144,0.000001209301],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040988548,0.00013403247,0.41702262,0.000045634813,0.000031851447,0.0018400631,0.00037252175,0.000014577471,0.00086304743,0.00009006356,0.003358887,0.5758168],"study_design_scores_gemma":[0.0028763593,0.00035027284,0.9811652,0.0012496867,0.000060722552,0.0044539864,0.00004406675,0.00012663343,0.00075974164,0.00053336954,0.008269812,0.0001101968],"about_ca_topic_score_codex":0.0008048985,"about_ca_topic_score_gemma":0.00046228062,"teacher_disagreement_score":0.57570666,"about_ca_system_score_codex":0.00007641779,"about_ca_system_score_gemma":0.00028507804,"threshold_uncertainty_score":0.44667882},"labels":[],"label_agreement":null},{"id":"W2006367336","doi":"10.1038/sj.bjc.6604819","title":"A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Nova Scotia Cancer Centre; Cancer Care Nova Scotia; University of Ottawa; Hamilton Health Sciences; Dalhousie University","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Colorectal cancer; Prospective cohort study; Prostate cancer; Lung cancer; Referral; Cancer; Prostate; Confidence interval; Rectum; Internal medicine","score_opus":0.010746182329297254,"score_gpt":0.2801294330620345,"score_spread":0.2693832507327373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006367336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915612,0.0063777883,0.000007468548,0.000036063608,0.00014589408,0.0016886645,0.00010578876,0.000012316055,0.00006484421],"genre_scores_gemma":[0.99648637,0.0024741292,0.000107253865,0.000016665932,0.0002014288,0.00034299845,0.0000019888257,0.000025727953,0.00034345177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879515,0.00004110888,0.00036424046,0.00020634077,0.00040693526,0.00018622517],"domain_scores_gemma":[0.9982212,0.00020449293,0.00036208663,0.00005440479,0.0010249139,0.00013290824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010857888,0.00013372177,0.0004873249,0.00008296883,0.00012679692,0.000019958954,0.0000481031,0.000050943672,0.000097467564],"category_scores_gemma":[0.00020016624,0.0001039667,0.000066911576,0.00018725962,0.00013475995,0.00015206788,0.000020269801,0.0002116758,9.449856e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0547173,0.0008243897,0.9235263,0.00011016402,0.000496654,0.00039216442,0.002276073,0.00006487099,0.000010525046,5.482897e-7,0.00089122815,0.016689822],"study_design_scores_gemma":[0.016064934,0.025580889,0.9541956,0.0010130898,0.0003567406,0.0013215853,0.0003857075,0.00007213539,0.00035542107,0.0000056558792,0.0005108495,0.00013738824],"about_ca_topic_score_codex":0.0013788496,"about_ca_topic_score_gemma":0.002168651,"teacher_disagreement_score":0.038652364,"about_ca_system_score_codex":0.0001812094,"about_ca_system_score_gemma":0.0004032247,"threshold_uncertainty_score":0.42396387},"labels":[],"label_agreement":null},{"id":"W2006709656","doi":"10.1038/sj.bjc.6603055","title":"Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Internal medicine; Colorectal cancer; Cancer; Epidermal growth factor receptor; Adverse effect; Oncology; Gastroenterology; Progressive disease; Phases of clinical research; Chemotherapy","score_opus":0.011757581329705306,"score_gpt":0.30578929820612233,"score_spread":0.29403171687641705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006709656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973244,0.008930116,0.0000017146162,0.000085169326,0.0001966018,0.000646988,0.000085765525,0.00000523568,0.00031595526],"genre_scores_gemma":[0.9990126,0.00047045568,0.00008552416,0.00004554303,0.00012504318,0.00007561305,0.0000040961736,0.000021434415,0.0001596973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984251,0.000040758532,0.00059346925,0.00015850023,0.0005417043,0.00024046219],"domain_scores_gemma":[0.99891645,0.000026602736,0.00042666792,0.0000618443,0.00049461925,0.000073801595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012743619,0.00014986884,0.0006775985,0.00012991439,0.00008507067,0.000014784225,0.00007001608,0.000024100591,0.00021126779],"category_scores_gemma":[0.000020853393,0.00012209674,0.00008411643,0.0002947879,0.0000694947,0.00011790843,0.000029898269,0.0001907404,2.2286487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007511218,0.016058348,0.83603275,0.00006363731,0.00092021376,0.0006452709,0.00090351386,0.00017825927,0.00010989485,0.0000019186527,0.0012646201,0.13631034],"study_design_scores_gemma":[0.047897354,0.01959071,0.9294296,0.0006899351,0.0006365983,0.00007099998,0.00047751912,0.000006137495,0.0003366919,0.0000100033985,0.0007307071,0.00012372533],"about_ca_topic_score_codex":0.010482241,"about_ca_topic_score_gemma":0.041264907,"teacher_disagreement_score":0.13618661,"about_ca_system_score_codex":0.00029406263,"about_ca_system_score_gemma":0.00025572596,"threshold_uncertainty_score":0.99610704},"labels":[],"label_agreement":null},{"id":"W2006827588","doi":"10.1038/bjc.2014.497","title":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Medicine; Rash; Internal medicine; PI3K/AKT/mTOR pathway; Cancer; Oncology; Pharmacology; Biology; Signal transduction; Genetics","score_opus":0.006350034164310448,"score_gpt":0.2746686210074111,"score_spread":0.2683185868431006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006827588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951281,0.001187988,0.00014222032,0.0010403085,0.0009811718,0.0013805877,0.00008296551,0.0000066315074,0.00005004416],"genre_scores_gemma":[0.99748105,0.00035355307,0.00007704076,0.00054427603,0.001258018,0.00011658691,0.000023386472,0.00006919828,0.000076901575],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673796,0.00050922413,0.0009191503,0.0003937842,0.000945422,0.00049444544],"domain_scores_gemma":[0.9973784,0.00014126042,0.0012700015,0.00051431323,0.0006148374,0.00008119379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010757179,0.0003472342,0.00055360387,0.00008421365,0.00029136677,0.00013768296,0.0008875258,0.00017442323,0.00002870066],"category_scores_gemma":[0.000268322,0.0001663513,0.00019560574,0.00042794086,0.00049101864,0.0000599053,0.00013307974,0.0006959314,7.072151e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34035623,0.013107099,0.08490962,0.00048098518,0.0017660244,0.00022521276,0.004577234,0.022829156,0.4041455,0.00017095801,0.021049716,0.106382266],"study_design_scores_gemma":[0.46034855,0.027866157,0.15005219,0.0054097767,0.00063712744,0.0003579177,0.0011764686,0.00046015496,0.31415558,0.00022555585,0.037426252,0.0018842684],"about_ca_topic_score_codex":0.00022343306,"about_ca_topic_score_gemma":0.0026496158,"teacher_disagreement_score":0.11999234,"about_ca_system_score_codex":0.00018993944,"about_ca_system_score_gemma":0.0007715856,"threshold_uncertainty_score":0.6783609},"labels":[],"label_agreement":null},{"id":"W2007476566","doi":"10.1038/sj.bjc.6600329","title":"CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Associazione Italiana per la Ricerca sul Cancro; Regione Calabria; Consiglio Nazionale delle Ricerche","keywords":"Apoptosis; Cancer research; Internal medicine; Medicine; Biology; Genetics","score_opus":0.01599779813696848,"score_gpt":0.24349139082618032,"score_spread":0.22749359268921185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007476566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96541595,0.032664098,0.00009521422,0.0008552453,0.0004220664,0.00033131355,0.000034037308,0.000006905558,0.00017514556],"genre_scores_gemma":[0.9875803,0.006004653,0.0004253516,0.0023512621,0.000059153033,0.00003141112,0.0000016015132,0.000026553018,0.0035197034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990104,0.00010703732,0.00037809854,0.00014555326,0.000047743346,0.0003111712],"domain_scores_gemma":[0.99945223,0.00007516008,0.00019726007,0.000098610646,0.0001473902,0.000029372844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029829115,0.000119847406,0.0003497193,0.00011329438,0.00009482403,0.000038024024,0.00019065975,0.00011059592,0.0015366045],"category_scores_gemma":[0.000051578085,0.00011075892,0.00011610094,0.00012195756,0.00005352796,0.00014436131,0.000020756976,0.00030182317,0.000023392568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005280339,0.000751419,0.003952381,0.00004751114,0.0011231233,0.00006481855,0.0031721522,0.00010369284,0.5066644,0.0000039698443,0.040715124,0.4381211],"study_design_scores_gemma":[0.008140428,0.0011713107,0.07504457,0.0014285583,0.0001119946,0.0016551766,0.00019076523,0.0000037847444,0.5069032,0.000022111313,0.40490416,0.00042398387],"about_ca_topic_score_codex":0.00030846917,"about_ca_topic_score_gemma":0.0002287775,"teacher_disagreement_score":0.4376971,"about_ca_system_score_codex":0.00006556405,"about_ca_system_score_gemma":0.00007510979,"threshold_uncertainty_score":0.9993761},"labels":[],"label_agreement":null},{"id":"W2007533011","doi":"10.1038/sj.bjc.6605603","title":"Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; McGill University","keywords":"Lung cancer; C-reactive protein; Medicine; Oncology; Cancer; Value (mathematics); Internal medicine; Pathology; Cancer research; Bioinformatics; Biology; Inflammation; Statistics; Mathematics","score_opus":0.0075983236790452624,"score_gpt":0.30493553638063153,"score_spread":0.29733721270158625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007533011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179626,0.0052839704,0.00058417034,0.00008656041,0.00040083996,0.0012065386,0.00004317943,0.000009206913,0.0005892781],"genre_scores_gemma":[0.9858434,0.00044380655,0.013146345,0.000039085917,0.00019367904,0.0002330365,0.0000021425333,0.000042569125,0.000055896937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99786943,0.000055482415,0.0009912719,0.00022446315,0.00054566766,0.0003137007],"domain_scores_gemma":[0.9977053,0.000053289197,0.00090993644,0.00017586352,0.0009763319,0.000179307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055647886,0.00018279593,0.0006374369,0.00023068443,0.000035594476,0.000019723178,0.00021095903,0.00013778516,0.000097294615],"category_scores_gemma":[0.0001588272,0.00019503258,0.00021575885,0.00026075804,0.00010099415,0.00024515335,0.000054332082,0.00069142936,1.420886e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006587249,0.0005525395,0.31354588,0.0017660131,0.0002661162,0.0002052579,0.00019214259,0.002416642,0.6462512,0.0000155095,0.00003597397,0.03409399],"study_design_scores_gemma":[0.00732191,0.00042765867,0.50122595,0.01253759,0.0006996324,0.00014904667,0.00034297947,0.04131434,0.43539062,0.00015014382,0.00007818849,0.0003619438],"about_ca_topic_score_codex":0.0008741376,"about_ca_topic_score_gemma":0.0004884834,"teacher_disagreement_score":0.21086058,"about_ca_system_score_codex":0.00024004372,"about_ca_system_score_gemma":0.0019567912,"threshold_uncertainty_score":0.7953198},"labels":[],"label_agreement":null},{"id":"W2007806401","doi":"10.1038/sj.bjc.6604376","title":"Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temsirolimus; Ketoconazole; Medicine; Pharmacology; Discovery and development of mTOR inhibitors; Chemistry; Antifungal; Dermatology","score_opus":0.010775008666487833,"score_gpt":0.27536502817667446,"score_spread":0.2645900195101866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007806401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689806,0.0016628193,0.00013264066,0.00006139892,0.0005879396,0.00034817244,0.000022233377,0.000005596932,0.00028116247],"genre_scores_gemma":[0.99666816,0.0025129467,0.00020678791,0.00015997887,0.00021807652,0.000010278888,0.0000038677904,0.000019655115,0.00020022411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986003,0.000036675847,0.0005630585,0.00010774033,0.000527313,0.00016492415],"domain_scores_gemma":[0.9991776,0.00009104654,0.00030577843,0.00009260079,0.0001644705,0.00016854465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049151487,0.00012345532,0.00058388093,0.00015282164,0.000053940974,0.000006570061,0.00007999675,0.00006846916,0.00006591661],"category_scores_gemma":[0.000041437554,0.000109706765,0.0003016192,0.00013141759,0.000030610223,0.000059893922,0.000009778701,0.00016700388,0.000001657939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006613676,0.0033273152,0.3671671,0.0034129862,0.0030716273,0.018732874,0.0029447689,0.0008774086,0.27917662,0.000048042624,0.00053896714,0.3140886],"study_design_scores_gemma":[0.009840503,0.0033165927,0.87764007,0.006459254,0.00055626215,0.0019509532,0.000025234129,0.0000046966966,0.099807955,0.000015967062,0.00026812407,0.0001143908],"about_ca_topic_score_codex":0.00026247915,"about_ca_topic_score_gemma":0.000033412816,"teacher_disagreement_score":0.510473,"about_ca_system_score_codex":0.00006218151,"about_ca_system_score_gemma":0.0001219658,"threshold_uncertainty_score":0.44737118},"labels":[],"label_agreement":null},{"id":"W2007940855","doi":"10.1038/sj.bjc.6600939","title":"Characterisation of integrin-linked kinase signalling in sporadic human colon cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; Bell (Canada)","funders":"National Cancer Institute; Cancer Research Society","keywords":"Integrin-linked kinase; Cancer research; Colorectal cancer; Kinase; Cancer; Biology; Oncogene; Medicine; Cell cycle; Internal medicine; Cell biology; Cyclin-dependent kinase 2","score_opus":0.032281339854553136,"score_gpt":0.3487986929386659,"score_spread":0.3165173530841128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007940855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897804,0.009185487,0.000044941902,0.00021238021,0.00016294436,0.00020152502,0.000007619148,0.000003819799,0.0004008767],"genre_scores_gemma":[0.9933578,0.005690114,0.00017772715,0.00013370225,0.0001679347,0.0000129239015,0.0000035916564,0.000022703269,0.00043354442],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99836403,0.00011012772,0.00065275736,0.00012966791,0.0005292949,0.00021409553],"domain_scores_gemma":[0.99886614,0.000038167705,0.00039015184,0.0000801737,0.0004779938,0.00014736434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006070862,0.00009136715,0.0004022972,0.00025303834,0.00003432926,0.000022327065,0.000100711266,0.00008597923,0.0016370482],"category_scores_gemma":[0.00018520157,0.00009991202,0.00011327951,0.0002909348,0.00007126246,0.00010497574,0.000012987452,0.00056012714,0.0000018912978],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004061416,0.00030261374,0.07662013,0.00023425667,0.000079454774,0.001784649,0.0002765059,0.00014694677,0.8355313,0.000034781973,0.0005222205,0.08406101],"study_design_scores_gemma":[0.007094638,0.0007051014,0.7308599,0.0064873416,0.0001291799,0.0010675491,0.0002954004,0.00012738962,0.23679504,0.00018275702,0.016000763,0.0002549423],"about_ca_topic_score_codex":0.0016171734,"about_ca_topic_score_gemma":0.0013909852,"teacher_disagreement_score":0.6542398,"about_ca_system_score_codex":0.00037391623,"about_ca_system_score_gemma":0.000527496,"threshold_uncertainty_score":0.99927557},"labels":[],"label_agreement":null},{"id":"W2008309936","doi":"10.1038/bjc.2013.347","title":"NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Bone marrow; Cancer research; Cytokine; Homing (biology); Tumor necrosis factor alpha; Vascular endothelial growth factor; Lewis lung carcinoma; Medicine; Angiogenesis; Chemokine; Progenitor cell; Immunology; Biology; Immune system; Internal medicine; Stem cell; Cell biology; Cancer; Metastasis","score_opus":0.03179472477592168,"score_gpt":0.28317936001224736,"score_spread":0.2513846352363257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008309936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930236,0.0044004815,0.00042805044,0.0012571432,0.00014581163,0.0004519284,0.000073042764,0.000013931891,0.00020600647],"genre_scores_gemma":[0.99247515,0.0021514574,0.0027225954,0.000985305,0.00054468977,0.000055257577,0.000011971974,0.00003207645,0.0010214827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979079,0.000059374972,0.0009061896,0.00019886515,0.00063881977,0.00028886716],"domain_scores_gemma":[0.99808335,0.000028944241,0.0007293768,0.00014931361,0.0007460684,0.00026294673],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004109081,0.00016398642,0.0006298644,0.00019360794,0.00006703585,0.000052978263,0.00011333806,0.00009399673,0.002274909],"category_scores_gemma":[0.00010315285,0.00014036761,0.0006120328,0.000262928,0.00007655697,0.00020617813,0.00004099287,0.00030347993,0.000013986573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063918495,0.00031704776,0.0005274505,0.00012727547,0.00063484546,0.00019172742,0.000120949364,0.00003314756,0.959603,0.0000024961623,0.0028791006,0.035499055],"study_design_scores_gemma":[0.0054092766,0.00022816265,0.021900335,0.0044839177,0.0008780882,0.0007978537,0.0003922194,0.00013933095,0.95301116,0.00003127952,0.0124250045,0.00030338834],"about_ca_topic_score_codex":0.0008521175,"about_ca_topic_score_gemma":0.0001342206,"teacher_disagreement_score":0.035195667,"about_ca_system_score_codex":0.00014695515,"about_ca_system_score_gemma":0.00020625435,"threshold_uncertainty_score":0.99863714},"labels":[],"label_agreement":null},{"id":"W2008511767","doi":"10.1038/bjc.2011.402","title":"Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Ki-67; Internal medicine; Oncology; Breast cancer; Adjuvant chemotherapy; Chemotherapy; Gynecology; Lymph node; Cancer; Immunohistochemistry","score_opus":0.026595215300208325,"score_gpt":0.27327682555671606,"score_spread":0.24668161025650773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008511767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725374,0.026075238,0.000060579263,0.00022198749,0.00040293514,0.000077542274,0.000081245176,0.0000017604596,0.00054131827],"genre_scores_gemma":[0.9899388,0.008875842,0.00032679757,0.00037137402,0.0002630039,0.000012029585,0.0000015758915,0.0000134680795,0.00019713423],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991912,0.00003308207,0.00028782946,0.00014003669,0.00017671759,0.00017110615],"domain_scores_gemma":[0.9991601,0.000009311788,0.00033341997,0.00015386628,0.00029072125,0.000052568972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012464046,0.000105338215,0.00019778353,0.00001927261,0.00007432698,0.000015550055,0.0002570191,0.000061580366,0.0000925012],"category_scores_gemma":[0.000035993107,0.0000847294,0.00014138735,0.000054899454,0.00016596164,0.000009220761,0.00007682718,0.00011460492,0.0000013971857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018873009,0.00048446696,0.14060244,0.0001381677,0.0013508394,0.00033250864,0.0022969898,0.000006191668,0.105927415,0.000016819233,0.023955092,0.7230018],"study_design_scores_gemma":[0.001597386,0.00052961556,0.45225278,0.0007318402,0.00025198012,0.0015293607,0.00035224282,0.0000023161674,0.5250746,0.00007874138,0.01736057,0.00023854966],"about_ca_topic_score_codex":0.0016762752,"about_ca_topic_score_gemma":0.0018448726,"teacher_disagreement_score":0.72276324,"about_ca_system_score_codex":0.000026551053,"about_ca_system_score_gemma":0.00018572835,"threshold_uncertainty_score":0.34551647},"labels":[],"label_agreement":null},{"id":"W2008546211","doi":"10.1038/sj.bjc.6604746","title":"Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Gene signature; Proportional hazards model; Microarray; Microarray analysis techniques; Oncology; Breast cancer; Cancer; Multivariate statistics; Bioinformatics; Survival analysis; Biology; Medicine; Internal medicine; Computational biology; Gene expression; Computer science; Gene; Machine learning; Genetics","score_opus":0.026078401594578873,"score_gpt":0.3049250044833589,"score_spread":0.27884660288878005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008546211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8762272,0.12191874,0.001051235,0.000110054745,0.0004587126,0.0001567169,0.000054325545,0.000003527891,0.000019505513],"genre_scores_gemma":[0.9904748,0.008518739,0.00018957494,0.00015157372,0.0004004948,0.000060043396,0.000014443037,0.000018515098,0.0001717943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989304,0.00008503358,0.0003837875,0.0001840431,0.00020718445,0.00020954115],"domain_scores_gemma":[0.99861926,0.000012488728,0.0004288242,0.00009980844,0.00077145855,0.00006817176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012676838,0.00012533157,0.00024316108,0.000037591824,0.0001514288,0.000018126133,0.00012115891,0.00010855506,0.000022068481],"category_scores_gemma":[0.0001000537,0.00011385345,0.00011907702,0.00009866762,0.00007967171,0.000009435069,0.00003267917,0.00015804886,2.9027908e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044032527,0.0005159128,0.068877265,0.000206318,0.00037635912,0.000027780095,0.0016494512,0.010150778,0.8679825,0.000005345522,0.0154125355,0.034355413],"study_design_scores_gemma":[0.001871213,0.0004311323,0.08399159,0.0013511799,0.000084351224,0.00010164978,0.00043627652,0.00018024663,0.8922589,0.000010684404,0.0190306,0.0002522152],"about_ca_topic_score_codex":0.000022402546,"about_ca_topic_score_gemma":0.00032053096,"teacher_disagreement_score":0.114247635,"about_ca_system_score_codex":0.00006270528,"about_ca_system_score_gemma":0.00032202783,"threshold_uncertainty_score":0.4642809},"labels":[],"label_agreement":null},{"id":"W2008601705","doi":"10.1054/bjoc.2001.1795","title":"Differential cell death response to photodynamic therapy is dependent on dose and cell type","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Programmed cell death; Photodynamic therapy; Necrosis; Apoptosis; Cell; Cell type; Medicine; Cancer research; Pathology; Biology; Chemistry; Biochemistry","score_opus":0.018619768672443977,"score_gpt":0.3261069551576371,"score_spread":0.30748718648519313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008601705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873571,0.010563641,0.000013957266,0.0009304961,0.00026270334,0.00033191254,0.000031798314,0.000010549733,0.00049788126],"genre_scores_gemma":[0.93143266,0.06347247,0.000058039917,0.0012681014,0.00021441893,0.00001105713,8.9599627e-7,0.000031792842,0.0035105282],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984675,0.00011121088,0.00030055278,0.00020388678,0.0005929717,0.00032384595],"domain_scores_gemma":[0.999048,0.00009839527,0.0001279443,0.00014332357,0.00027922718,0.0003031068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028926972,0.00015590247,0.0003751881,0.00017212432,0.00009906234,0.000062199055,0.0001385744,0.000063759544,0.0008963377],"category_scores_gemma":[0.000052607596,0.00014084202,0.000101384896,0.00015829601,0.000047639624,0.000063132036,0.00004219133,0.00039926847,0.000009099661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039987493,0.0005178005,0.0038916299,0.000035775058,0.00021731501,0.0024205027,0.00066503417,0.000015737094,0.8741035,4.90581e-7,0.0029347737,0.07520997],"study_design_scores_gemma":[0.020571057,0.008107141,0.7586741,0.0011659104,0.0001394966,0.0033584803,0.00031395,0.00010135651,0.16416426,0.00009154398,0.04282682,0.00048589683],"about_ca_topic_score_codex":0.0003742031,"about_ca_topic_score_gemma":0.00020931865,"teacher_disagreement_score":0.75478244,"about_ca_system_score_codex":0.0002358885,"about_ca_system_score_gemma":0.00022838273,"threshold_uncertainty_score":0.9814269},"labels":[],"label_agreement":null},{"id":"W2009497825","doi":"10.1038/bjc.2011.13","title":"Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Histone deacetylase inhibitor; Histone deacetylase; Medicine; Pharmacology; Internal medicine; Histone; Chemistry; Biochemistry","score_opus":0.023074027725210004,"score_gpt":0.392730181775085,"score_spread":0.369656154049875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009497825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604553,0.0031293996,0.00001592195,0.000007468375,0.00025309535,0.00044233544,0.000046805402,0.0000039086603,0.000055528846],"genre_scores_gemma":[0.9979669,0.0014075105,0.00028196973,0.00005057222,0.0001599803,0.00002026678,0.0000131785955,0.00004456046,0.00005505053],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977571,0.00030112977,0.00086301623,0.00034242962,0.00042443306,0.0003118901],"domain_scores_gemma":[0.99849117,0.0000130134595,0.0005042286,0.00017689304,0.00052961236,0.0002850898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054902403,0.00018717589,0.00045968455,0.00014960126,0.00005743461,0.000016700897,0.00024572824,0.000087217166,0.00005792193],"category_scores_gemma":[0.000070474154,0.0001958877,0.00007609992,0.00017185506,0.00025160983,0.000043794174,0.00007828562,0.00041426503,4.968853e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018321559,0.03211117,0.1638023,0.00013632301,0.0005140057,0.00095316424,0.001115149,0.0002650687,0.2328015,5.303107e-7,0.0012026454,0.54877657],"study_design_scores_gemma":[0.16948994,0.06238671,0.37613085,0.0010024512,0.0005376128,0.00045625138,0.0011445452,0.00024569567,0.3840432,0.000007347019,0.0032769253,0.0012784756],"about_ca_topic_score_codex":0.00048589625,"about_ca_topic_score_gemma":0.0018244277,"teacher_disagreement_score":0.5474981,"about_ca_system_score_codex":0.00007070097,"about_ca_system_score_gemma":0.00027696084,"threshold_uncertainty_score":0.79880685},"labels":[],"label_agreement":null},{"id":"W2009692616","doi":"10.1038/sj.bjc.6600708","title":"Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Genotype; Medicine; Internal medicine; Oncology; Glutathione S-transferase; Case-control study; Cancer; Alcohol consumption; Physiology; Gynecology; Alcohol; Glutathione; Biology; Genetics; Gene","score_opus":0.0076932823097798295,"score_gpt":0.24831744716643142,"score_spread":0.24062416485665158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009692616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83443886,0.1638617,0.0007187991,0.00022341157,0.00024293046,0.000107580694,0.00037893528,0.0000038586268,0.000023944214],"genre_scores_gemma":[0.78836536,0.21064925,0.00033337963,0.00029881988,0.00022129592,0.000010878715,0.0000044525495,0.000024630159,0.000091950285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881744,0.00012552035,0.0003671097,0.0002499187,0.00018354815,0.00025643647],"domain_scores_gemma":[0.9993615,0.0000143986745,0.00014476042,0.000098537945,0.00014372375,0.00023707845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020535116,0.00017588322,0.00024699906,0.000051972438,0.00015603958,0.00007509333,0.00008007726,0.00013710691,0.00024954017],"category_scores_gemma":[0.000019195691,0.00019047667,0.00009797252,0.000057588863,0.00016650867,0.000016695178,0.000013279505,0.00022290055,0.0000013089198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071823935,0.00018925114,0.29662085,0.000109653854,0.0006190283,0.00042377927,0.0001880464,0.00031275625,0.29816645,0.00008396856,0.0014065957,0.4011614],"study_design_scores_gemma":[0.0071242666,0.00046030246,0.89961207,0.00051815197,0.00062092923,0.023844447,0.00006616834,0.000035379722,0.040623184,0.00021871222,0.026155975,0.00072041596],"about_ca_topic_score_codex":0.0009107154,"about_ca_topic_score_gemma":0.0010953912,"teacher_disagreement_score":0.6029912,"about_ca_system_score_codex":0.000019474783,"about_ca_system_score_gemma":0.00014978524,"threshold_uncertainty_score":0.7767413},"labels":[],"label_agreement":null},{"id":"W2010194189","doi":"10.1038/sj.bjc.6602092","title":"Reduced Apaf-1 expression in human cutaneous melanomas","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"National Cancer Institute; Canadian Dermatology Foundation","keywords":"Melanoma; Cancer research; Loss of heterozygosity; Cancer; Apoptosis; Immunohistochemistry; Tumor suppressor gene; Medicine; Pathology; Biology; Internal medicine; Gene; Carcinogenesis","score_opus":0.006537865322123385,"score_gpt":0.2581312182511441,"score_spread":0.25159335292902074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010194189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902633,0.008651636,0.00044447923,0.0000711822,0.00021640399,0.000051084553,0.0000031159043,0.0000017449307,0.00029706937],"genre_scores_gemma":[0.99587655,0.0027804708,0.00054422586,0.000053174754,0.0003783652,0.0000025358142,0.0000067953297,0.000011385554,0.00034651934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994408,0.000018246476,0.00021945177,0.000098608856,0.00011471978,0.00010815902],"domain_scores_gemma":[0.9996892,0.0000013354944,0.000131046,0.000061303566,0.00006831792,0.000048753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080150385,0.00005723121,0.00010304943,0.000033895365,0.000042448963,0.000020691263,0.00008302705,0.00008773943,0.000043001462],"category_scores_gemma":[0.000011667106,0.000060437702,0.00006396232,0.000038480208,0.000018217752,0.000004675661,0.000019938541,0.0000905627,4.3232333e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000364446,0.000037190068,0.00012556578,0.0000058392357,0.000009433095,0.00020648321,0.000019197734,0.0016344389,0.97420204,0.000019236311,0.00019728803,0.02350682],"study_design_scores_gemma":[0.0014625256,0.00023510212,0.005016574,0.00039483505,0.000012339116,0.0027078497,0.000031158677,0.0000033559993,0.9719445,0.000949093,0.01710762,0.00013504691],"about_ca_topic_score_codex":0.00012185502,"about_ca_topic_score_gemma":0.00052450085,"teacher_disagreement_score":0.023371775,"about_ca_system_score_codex":0.000041960408,"about_ca_system_score_gemma":0.000069978174,"threshold_uncertainty_score":0.2464578},"labels":[],"label_agreement":null},{"id":"W2010201867","doi":"10.1038/bjc.2011.593","title":"CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Tumor progression; Carboplatin; Hazard ratio; Progression-free survival; Confidence interval; Internal medicine; Radiological weapon; Response Evaluation Criteria in Solid Tumors; Ovarian cancer; Chemotherapy; Cancer; Oncology; Surgery; Phases of clinical research; Cisplatin","score_opus":0.10808988722431266,"score_gpt":0.4141243571881464,"score_spread":0.3060344699638337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010201867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677667,0.022242265,0.000003877726,0.004376588,0.0040708906,0.0010341232,0.00020744464,0.0000017926088,0.00029632336],"genre_scores_gemma":[0.995427,0.0020319067,0.00004339391,0.00035262544,0.0017585562,0.00023975462,0.0000023056323,0.000018279792,0.0001261711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671835,0.0006369539,0.0012593473,0.00014560093,0.0009648958,0.0002748462],"domain_scores_gemma":[0.99774975,0.00015307532,0.001253606,0.0002426817,0.00048736823,0.00011352753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023783075,0.0001457302,0.00077425153,0.00006695229,0.00006988969,0.000025196847,0.00022063623,0.00008866347,0.0014107861],"category_scores_gemma":[0.00072965526,0.00009453225,0.00037862547,0.00035369545,0.00014189207,0.00015340287,0.00004177638,0.00025208667,1.9098862e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018738579,0.0040792674,0.6294596,0.00039188386,0.0016327811,0.000095035066,0.0107852155,0.00073208305,0.021290114,0.00020963539,0.06580913,0.24677667],"study_design_scores_gemma":[0.053287238,0.00028155095,0.88242304,0.0037514206,0.0014340956,0.00019802955,0.0005345824,0.000045179055,0.042016517,0.000087513596,0.015772937,0.00016788873],"about_ca_topic_score_codex":0.021758994,"about_ca_topic_score_gemma":0.013645267,"teacher_disagreement_score":0.25296345,"about_ca_system_score_codex":0.0006113769,"about_ca_system_score_gemma":0.001475427,"threshold_uncertainty_score":0.99950206},"labels":[],"label_agreement":null},{"id":"W2010336330","doi":"10.1038/sj.bjc.6600278","title":"A prospective cohort study of cigarette smoking and the risk of endometrial cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Endometrial cancer; Medicine; Prospective cohort study; Hazard ratio; Cohort study; Cohort; Breast cancer; Cancer; Gynecology; Proportional hazards model; Relative risk; Hormone replacement therapy (female-to-male); Cancer prevention; Internal medicine; Obstetrics; Oncology; Confidence interval","score_opus":0.015164301804682668,"score_gpt":0.28611859249425226,"score_spread":0.2709542906895696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010336330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94651127,0.051957306,0.0000074906093,0.000095677424,0.00042744924,0.0006338394,0.000057906476,0.0000032690843,0.0003058185],"genre_scores_gemma":[0.9574346,0.04184896,0.000008718995,0.000044549648,0.0005212631,0.000030444085,1.3891972e-7,0.00001450361,0.000096815755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845207,0.000089770125,0.0005806319,0.00012702323,0.000616846,0.00013363792],"domain_scores_gemma":[0.9984063,0.00014571566,0.00084022357,0.00010681402,0.0004253084,0.0000756393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064696814,0.00009589428,0.0006873312,0.00011415817,0.000060894992,0.000019954869,0.00008874702,0.00004641706,0.0004943009],"category_scores_gemma":[0.00027399164,0.00007023132,0.00016130003,0.00029239015,0.00020294295,0.00008074973,0.000026661479,0.0004189091,5.4182934e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010330118,0.00018607343,0.91619503,0.000025218966,0.0014882677,0.000047772824,0.0013435668,0.000035439443,0.00003348174,0.0000027997103,0.0006026144,0.079006724],"study_design_scores_gemma":[0.017691696,0.0005785118,0.9776836,0.0005133117,0.0016651916,0.0002510302,0.00052136474,0.000031684925,0.00024026351,0.00002871828,0.0007250053,0.00006962399],"about_ca_topic_score_codex":0.019365616,"about_ca_topic_score_gemma":0.004068175,"teacher_disagreement_score":0.0789371,"about_ca_system_score_codex":0.00013136258,"about_ca_system_score_gemma":0.0000849031,"threshold_uncertainty_score":0.9871645},"labels":[],"label_agreement":null},{"id":"W2010490561","doi":"10.1038/sj.bjc.6606053","title":"Attenuated reovirus displays oncolysis with reduced host toxicity","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; University of Calgary","funders":"National Cancer Institute; Fondation pour la Recherche Médicale; Canadian Institutes of Health Research; Terry Fox Foundation; University of Calgary","keywords":"Oncolytic virus; Biology; Virology; Cell culture; In vitro; Cancer cell; Pancreatic cancer; Cancer research; Virus; Cancer; Molecular biology","score_opus":0.009718381219689641,"score_gpt":0.30013185053712804,"score_spread":0.2904134693174384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010490561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963266,0.0025344521,0.00004785495,0.00036358216,0.00020695227,0.00010038125,0.000047208043,0.0000041336284,0.0003688345],"genre_scores_gemma":[0.9960022,0.0019852102,0.00026391176,0.0003021413,0.00077735685,0.0000116171,0.000008762058,0.000032183627,0.00061664893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886465,0.000070309114,0.00026123793,0.00019365738,0.00034500813,0.00026514626],"domain_scores_gemma":[0.99893945,0.0000104950705,0.00021104625,0.00020676515,0.0004516151,0.00018060379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036436607,0.0001149271,0.00020310521,0.00005124632,0.000100595484,0.00007106561,0.00030456076,0.00012244738,0.0002834732],"category_scores_gemma":[0.00008027005,0.00011067218,0.000111225534,0.00015772795,0.00013162736,0.000010018337,0.000040660772,0.00043050072,0.000003869553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002116048,0.00007672398,0.0018112861,0.0000063050647,0.00017306424,0.0001327855,0.000013232099,0.00004155049,0.9559113,6.8548525e-7,0.0026652727,0.037051752],"study_design_scores_gemma":[0.0015354016,0.0018010172,0.013893626,0.000078090525,0.000043649557,0.0009051674,0.000020171217,0.000009070012,0.96144843,0.000007286344,0.02006714,0.00019094782],"about_ca_topic_score_codex":0.00022640763,"about_ca_topic_score_gemma":0.012986517,"teacher_disagreement_score":0.036860805,"about_ca_system_score_codex":0.000031164494,"about_ca_system_score_gemma":0.000446386,"threshold_uncertainty_score":0.7246781},"labels":[],"label_agreement":null},{"id":"W2010666032","doi":"10.1038/sj.bjc.6603043","title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer; Tissue inhibitor of metalloproteinase; Drug; Pharmacology; Metalloproteinase; Medicine; Clinical trial; Cancer research; Internal medicine","score_opus":0.03517154971347457,"score_gpt":0.3501934623059883,"score_spread":0.3150219125925137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010666032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041017437,0.9955686,0.0010127326,0.00003924529,0.00149279,0.0009715996,0.0004390946,0.000005877322,0.000059896534],"genre_scores_gemma":[0.000063442225,0.98677504,0.0010165167,0.000119019,0.009985461,0.0005889937,0.0001943364,0.000088242225,0.0011689584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980877,0.00011859058,0.00086745404,0.0003319315,0.00030324428,0.0002911047],"domain_scores_gemma":[0.9982359,0.000006104177,0.0010242418,0.00017444788,0.00044735256,0.00011196828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042097183,0.00033810432,0.0009766028,0.000089984336,0.00011167605,0.00012256826,0.00029863865,0.00047021784,0.000055163422],"category_scores_gemma":[0.000043455082,0.0003158695,0.0010356484,0.00010670826,0.00003729318,0.000015702939,0.0000429715,0.0002861796,0.0000010422128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003334612,0.000049067876,2.5165383e-7,0.000892168,0.00036883878,0.00003921489,0.0000022015722,0.000012240972,0.010841939,0.000009174093,0.03642166,0.9513299],"study_design_scores_gemma":[0.00064460555,0.00027443128,2.6653407e-7,0.0034831713,0.0003920329,0.00036138736,0.00000147922,0.000002645173,0.059895914,0.000049218175,0.9345505,0.00034430544],"about_ca_topic_score_codex":0.0004902685,"about_ca_topic_score_gemma":0.0004712788,"teacher_disagreement_score":0.9509856,"about_ca_system_score_codex":0.00011213589,"about_ca_system_score_gemma":0.0012615522,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W2010741280","doi":"10.1038/sj.bjc.6601850","title":"Is there a role for chemotherapy in prostate cancer?","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mitoxantrone; Docetaxel; Medicine; Estramustine; Oncology; Chemotherapy; Internal medicine; Context (archaeology); Prostate cancer; Cancer; Clinical trial; Prednisone; Prostate; Cardiotoxicity; Paclitaxel; Prostate disease","score_opus":0.04388279243030324,"score_gpt":0.414976426730879,"score_spread":0.37109363430057574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010741280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003909048,0.99597466,0.000002456207,0.0008814435,0.00027351957,0.0018498994,0.000446992,0.000007958952,0.00017214622],"genre_scores_gemma":[0.000064680076,0.9949806,0.00014955392,0.00020670141,0.00075560843,0.00061988947,0.00002162448,0.000089769856,0.0031115739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798226,0.000044543718,0.0008033654,0.0002742408,0.00043776282,0.0004578323],"domain_scores_gemma":[0.99865043,0.000047660884,0.0005922382,0.00013794632,0.00037413504,0.00019759727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029527798,0.0002947176,0.0018310618,0.00023785165,0.000053489573,0.00007335863,0.00020830805,0.00019964002,0.0004958391],"category_scores_gemma":[0.000021641004,0.00023845825,0.00075317465,0.0003459079,0.00007611801,0.000106412685,0.000019375162,0.00072184054,0.0000029224245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003716798,0.00014580383,0.00023743881,0.016821092,0.000704997,0.0008280007,0.00015931178,0.0000017944242,0.000001674471,0.0000017776775,0.002015054,0.97871137],"study_design_scores_gemma":[0.005586293,0.00029803062,0.00018784139,0.14400189,0.0005641635,0.0011189384,0.000031284297,9.73856e-7,0.00003721826,0.00013460916,0.84784883,0.00018993873],"about_ca_topic_score_codex":0.0011441959,"about_ca_topic_score_gemma":0.00052252074,"teacher_disagreement_score":0.9785214,"about_ca_system_score_codex":0.0015529747,"about_ca_system_score_gemma":0.004997205,"threshold_uncertainty_score":0.9724045},"labels":[],"label_agreement":null},{"id":"W2010780607","doi":"10.1038/bjc.2012.542","title":"Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Novo Nordisk Fonden; National Institute for Health and Care Research; Cancer Institute NSW; Tenovus; Medical Research Council; Public Health Agency; Cancer Research UK","keywords":"Benchmarking; General partnership; Cancer; Cancer survival; Medicine; Cancer genetics; Demography; Environmental health; Oncology; Internal medicine; Political science; Business; Sociology","score_opus":0.10633033644429923,"score_gpt":0.3607831343611841,"score_spread":0.25445279791688485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010780607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542851,0.030066693,0.000008033313,0.013945656,0.0008280919,0.00054244534,0.00015801175,0.000002778087,0.00016320187],"genre_scores_gemma":[0.97526693,0.021086851,0.00001746097,0.0013324772,0.0012756641,0.00034339278,0.0000026608782,0.000017173139,0.00065737125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969532,0.00020141338,0.0008280558,0.00037154582,0.0010619679,0.00058380293],"domain_scores_gemma":[0.9980666,0.00048181368,0.00045183385,0.00014391346,0.00054076326,0.00031506442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008919517,0.0002867404,0.00089528784,0.00013138355,0.0002032451,0.00034909026,0.00053105375,0.00011791083,0.0013745043],"category_scores_gemma":[0.00017064049,0.00019461935,0.00008650005,0.0003107494,0.00025431658,0.00029071834,0.00015090764,0.0007198651,0.0000010949262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025458517,0.000014111297,0.9537534,0.000041786316,0.00024110617,0.000086378655,0.0008775541,0.000095138756,0.000042180003,0.000025608811,0.0028666074,0.041701544],"study_design_scores_gemma":[0.0029807729,0.000066306435,0.989802,0.0037160187,0.00014516154,0.00007392655,0.00097114604,0.00007733496,0.000063937645,0.00023520156,0.0016160207,0.00025219502],"about_ca_topic_score_codex":0.9642889,"about_ca_topic_score_gemma":0.9895182,"teacher_disagreement_score":0.04144935,"about_ca_system_score_codex":0.000811665,"about_ca_system_score_gemma":0.0013796228,"threshold_uncertainty_score":0.99953836},"labels":[],"label_agreement":null},{"id":"W2011619648","doi":"10.1038/sj.bjc.6600654","title":"Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Tamoxifen; Oestrogen receptor; Breast cancer; Antiestrogen; Gene isoform; Mammary gland; Human breast; Internal medicine; Cancer research; Oncology; Medicine; Cancer; Biology; Endocrinology; Gynecology; Genetics; Gene","score_opus":0.0076214476503989464,"score_gpt":0.2557485524608742,"score_spread":0.24812710481047523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011619648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663406,0.033035297,0.000023423867,0.00022221064,0.00007636982,0.00009760912,0.00005408705,0.0000020359118,0.0001483504],"genre_scores_gemma":[0.9956174,0.002994158,0.00058707723,0.00007178747,0.00020197395,0.000011925215,0.0000030520155,0.000017185128,0.00049544906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99919266,0.000050585815,0.0003087336,0.00013430505,0.00013671185,0.00017698483],"domain_scores_gemma":[0.9994558,0.000010990684,0.00019921285,0.00008553254,0.000117249205,0.0001311976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016569834,0.000087731016,0.00017172893,0.000056855402,0.00005914916,0.00001760905,0.000111678935,0.00014179881,0.00007688971],"category_scores_gemma":[0.00003844269,0.000092072434,0.00006038386,0.00010664866,0.00005743588,0.000012590647,0.000032059113,0.00017012244,4.9740015e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002839353,0.00008510903,0.17006172,0.000054893633,0.00004974625,0.000044150536,0.00019886435,0.00015521093,0.81134504,0.000021903505,0.008264391,0.00943504],"study_design_scores_gemma":[0.0027177858,0.00028715978,0.6870828,0.0019317681,0.00005956946,0.0008057038,0.000065514396,0.000011329977,0.29621,0.00014218662,0.010358521,0.0003276249],"about_ca_topic_score_codex":0.00010440141,"about_ca_topic_score_gemma":0.00047123004,"teacher_disagreement_score":0.5170211,"about_ca_system_score_codex":0.000057947454,"about_ca_system_score_gemma":0.00006026518,"threshold_uncertainty_score":0.37546048},"labels":[],"label_agreement":null},{"id":"W2011640324","doi":"10.1038/sj.bjc.6601301","title":"The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Ubiquitin ligase; Biology; Ubiquitin; Molecular biology; Immunoprecipitation; Complementary DNA; Nuclear protein; Cancer research; Psychological repression; Gene; Transcription factor; Gene expression; Biochemistry","score_opus":0.006848971644092133,"score_gpt":0.24331561688664946,"score_spread":0.23646664524255734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011640324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95601016,0.0424725,0.000015423078,0.0005194036,0.00007727465,0.00016678168,0.00021591022,0.0000012174617,0.0005213389],"genre_scores_gemma":[0.9868,0.011921917,0.00019852858,0.00044426773,0.0001659516,0.000035507626,0.0000010419644,0.000016887367,0.0004159099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999081,0.00006879175,0.00032305476,0.00014803148,0.00017303492,0.00020607334],"domain_scores_gemma":[0.99934256,0.000009133025,0.0002618598,0.00011236469,0.00018733862,0.00008674519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031081628,0.000102944716,0.0001840447,0.000025670564,0.00006625122,0.000044709792,0.00014358606,0.00009207345,0.0001892186],"category_scores_gemma":[0.000052381896,0.000093094975,0.000080999496,0.00007332656,0.00009109498,0.000009808476,0.00003522514,0.00017329425,3.213405e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004031607,0.00011728337,0.02614703,0.00013381445,0.00017110494,0.00005594712,0.00024700232,0.000031686253,0.9257017,0.00006146921,0.006701875,0.040227924],"study_design_scores_gemma":[0.0013410443,0.00009694255,0.00981257,0.00057846087,0.0000143874495,0.00045560385,0.0000608177,0.000008555975,0.917072,0.00029416586,0.07012508,0.00014037408],"about_ca_topic_score_codex":0.00057355803,"about_ca_topic_score_gemma":0.00026836808,"teacher_disagreement_score":0.0634232,"about_ca_system_score_codex":0.000021612927,"about_ca_system_score_gemma":0.0002563844,"threshold_uncertainty_score":0.3796303},"labels":[],"label_agreement":null},{"id":"W2012062654","doi":"10.1038/sj.bjc.6603067","title":"COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Breast Cancer Research Alliance","keywords":"Lymphangiogenesis; Cancer research; Breast cancer; Downregulation and upregulation; Angiogenesis; Cancer; Vascular endothelial growth factor C; Vascular endothelial growth factor; Biology; Medicine; Internal medicine; Vascular endothelial growth factor A; Endocrinology; Metastasis; VEGF receptors; Biochemistry","score_opus":0.006965603652572542,"score_gpt":0.2673795443986101,"score_spread":0.2604139407460376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012062654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913382,0.007518454,0.0000050348026,0.0001918272,0.00053934293,0.0002000314,0.0000901951,0.0000057639168,0.00011117566],"genre_scores_gemma":[0.99842465,0.00039977024,0.000008924322,0.00011707799,0.0008523443,0.000008949721,0.0000041792505,0.000020175932,0.00016392482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986996,0.00006645461,0.00052671914,0.000091243855,0.0004232367,0.00019271714],"domain_scores_gemma":[0.99908364,0.000041374577,0.00042397963,0.000090383954,0.0002872412,0.00007339417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019744191,0.00009952266,0.00033638053,0.000109671004,0.00004773807,0.000013192332,0.00010170471,0.000088333734,0.00051399786],"category_scores_gemma":[0.00003601838,0.00008250838,0.00017712118,0.00024558703,0.00007187254,0.0001030216,0.00001544626,0.00017063638,0.0000014686935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020400356,0.00014143203,0.92358655,0.0001346315,0.00008420046,0.00021251952,0.00010133148,0.00066579477,0.055897467,0.0000074719505,0.002210148,0.01675446],"study_design_scores_gemma":[0.0031779732,0.000049985993,0.9861591,0.0013531389,0.00008438455,0.00042491537,0.000011844343,0.00009879764,0.0075818794,0.000025485835,0.0009496354,0.00008287092],"about_ca_topic_score_codex":0.0038623225,"about_ca_topic_score_gemma":0.0038328397,"teacher_disagreement_score":0.06257255,"about_ca_system_score_codex":0.0002776946,"about_ca_system_score_gemma":0.0003514644,"threshold_uncertainty_score":0.58387023},"labels":[],"label_agreement":null},{"id":"W2012308231","doi":"10.1054/bjoc.2001.1822","title":"A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Follicular lymphoma; Medicine; Randomized controlled trial; Maintenance therapy; Chlorambucil; Follicular phase; Internal medicine; Lymphoma; Interferon alfa; Gastroenterology; Alpha interferon; Chemotherapy; Interferon; Surgery; Immunology; Cyclophosphamide","score_opus":0.008052774753800444,"score_gpt":0.28113286387969433,"score_spread":0.2730800891258939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012308231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851199,0.011470791,0.0000044678163,0.0005209024,0.00012975918,0.0023793275,0.00000388355,0.000001991888,0.00036901495],"genre_scores_gemma":[0.9932191,0.005814128,0.000025981743,0.0004958154,0.00012946864,0.0002689869,8.5674355e-7,0.000011873471,0.00003379809],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854726,0.00020693436,0.0005738412,0.00010662459,0.00041498814,0.00015035132],"domain_scores_gemma":[0.9990336,0.000165389,0.00027700033,0.00007923725,0.000354183,0.00009063872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006560361,0.00011386928,0.0010616166,0.000073813084,0.000028092581,0.000030266818,0.00006502504,0.00003569338,0.000083173705],"category_scores_gemma":[0.00019382044,0.000061183586,0.00020569927,0.00010153446,0.00007446182,0.00006334644,0.000012384411,0.000059361595,5.940698e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8195851,0.0006082727,0.013076316,0.0000025860213,0.0005933145,0.0001705559,0.00016660789,0.000008382261,0.000016167018,0.000010282431,0.000041977986,0.16572048],"study_design_scores_gemma":[0.92066026,0.0033921255,0.0734407,0.0008727382,0.0003003274,0.0002680761,0.000060262522,0.000018648929,0.00027938938,0.00010561135,0.000540026,0.000061810686],"about_ca_topic_score_codex":0.0009750024,"about_ca_topic_score_gemma":0.00022375131,"teacher_disagreement_score":0.16565867,"about_ca_system_score_codex":0.00013042559,"about_ca_system_score_gemma":0.00022302165,"threshold_uncertainty_score":0.24949943},"labels":[],"label_agreement":null},{"id":"W2013102726","doi":"10.1038/bjc.2011.157","title":"Statistical issues in the use of dynamic allocation methods for balancing baseline covariates","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Clinical trial; Credibility; Statistical inference; Baseline (sea); Covariate; Inference; Computer science; Medicine; Statistics; Artificial intelligence; Machine learning; Mathematics","score_opus":0.5326053452684013,"score_gpt":0.5987837027161158,"score_spread":0.0661783574477145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013102726","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036181558,0.0011782185,0.9939712,0.0002660448,0.00043194604,0.00031343172,0.00018798768,0.0000050745107,0.000027915448],"genre_scores_gemma":[0.010782507,0.0010043938,0.9877765,0.00019249534,0.00015909024,0.000027501495,0.000001201081,0.00002067846,0.000035633922],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9962061,0.0018376725,0.0013867373,0.00012768486,0.0002631206,0.0001786684],"domain_scores_gemma":[0.94770986,0.050938983,0.00067619514,0.0001402096,0.00048071606,0.000054033982],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010522194,0.00009568878,0.00059249287,0.000058992366,0.000031364365,0.000038393184,0.00024985636,0.00008768996,0.00031314275],"category_scores_gemma":[0.12135776,0.00007750255,0.000113103924,0.00014071501,0.00011760154,0.000121255114,0.000021704693,0.00026746542,3.3554824e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045470477,0.00034107108,0.0004022442,0.00025676526,0.00013868058,0.000044312346,0.0005502615,0.000017913622,0.00045070407,0.04370369,0.0031129976,0.95052665],"study_design_scores_gemma":[0.0013445303,0.00025684392,0.01019105,0.0007964098,0.00027567535,0.00010598159,0.00010476633,0.0069870106,0.00074888597,0.9768525,0.0022042713,0.00013207771],"about_ca_topic_score_codex":0.00038711744,"about_ca_topic_score_gemma":0.00027706622,"teacher_disagreement_score":0.9503946,"about_ca_system_score_codex":0.000050615065,"about_ca_system_score_gemma":0.00010567732,"threshold_uncertainty_score":0.8860434},"labels":[],"label_agreement":null},{"id":"W2013426357","doi":"10.1038/bjc.2012.486","title":"An inherited NBN mutation is associated with poor prognosis prostate cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"Ministerstwo Edukacji i Nauki","keywords":"Prostate cancer; Medicine; CHEK2; Cancer; Prostate; Mutation; Nijmegen breakage syndrome; Allele; Internal medicine; Oncology; Genetics; Germline mutation; Biology; DNA damage; Gene; DNA","score_opus":0.02492486793701148,"score_gpt":0.34331637563185075,"score_spread":0.31839150769483926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013426357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624579,0.034730382,0.000009652889,0.0018213458,0.00021132323,0.00045997632,0.00011906325,0.000023639544,0.00016669281],"genre_scores_gemma":[0.9893321,0.00791653,0.00020823305,0.0006330367,0.00053446944,0.00011756966,0.000032578988,0.000044557524,0.0011809227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983427,0.0000782046,0.00033640032,0.00014150237,0.00065120705,0.00045000418],"domain_scores_gemma":[0.998247,0.000024553125,0.00032665062,0.000068656445,0.0009456527,0.0003874719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387138,0.00013896849,0.0003510352,0.00011708058,0.000111263405,0.00008292379,0.00008217543,0.00008399388,0.0006321066],"category_scores_gemma":[0.000046425626,0.000113018046,0.000085235384,0.00038318968,0.00009978536,0.0006264247,0.000010502162,0.00034085935,0.0000027703759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019716516,0.0010136494,0.6962123,0.000117944284,0.0012047073,0.0012059757,0.0020344104,0.000023007808,0.0053368397,0.0000015787625,0.008213514,0.28266442],"study_design_scores_gemma":[0.010552772,0.0016494424,0.9449674,0.003337108,0.0007075748,0.0017858542,0.00050056895,0.000090856236,0.026953459,0.000018850627,0.0091462545,0.00028987098],"about_ca_topic_score_codex":0.0010044463,"about_ca_topic_score_gemma":0.0006072064,"teacher_disagreement_score":0.28237453,"about_ca_system_score_codex":0.00047340122,"about_ca_system_score_gemma":0.0005947102,"threshold_uncertainty_score":0.69211245},"labels":[],"label_agreement":null},{"id":"W2014664970","doi":"10.1038/bjc.2013.675","title":"Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Fondation du cancer du sein du Québec","keywords":"Breast cancer; Focal adhesion; Cancer; Metastasis; Cancer cell; Cancer research; In vivo; Chemistry; Motility; Cell migration; Integrin; Cell biology; Cell; Pathology; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.010636584766940753,"score_gpt":0.27809688696001783,"score_spread":0.2674603021930771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014664970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97466063,0.016982842,0.00003686163,0.007369227,0.00021624904,0.00046846372,0.00004669947,0.000005728613,0.00021328613],"genre_scores_gemma":[0.97902507,0.016871091,0.00021062435,0.0015282361,0.00054202386,0.00004340978,0.000005233094,0.00003934011,0.0017349552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798876,0.00013780306,0.00053780293,0.0001933063,0.0007563131,0.00038604205],"domain_scores_gemma":[0.9984113,0.00016125044,0.00029426906,0.00011659407,0.0007879124,0.00022870013],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035581528,0.00014483054,0.00037153534,0.000111258014,0.00008496279,0.00007683293,0.00022792979,0.000088772766,0.0047941105],"category_scores_gemma":[0.00016584442,0.00011379024,0.00012251902,0.0003691023,0.0001380377,0.0002695829,0.00007770558,0.00083406596,0.00002352543],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037144756,0.00018584207,0.016537352,0.00011048626,0.00010815406,0.0007479878,0.0002809976,0.00013884467,0.61283183,7.5924254e-7,0.29724598,0.07144034],"study_design_scores_gemma":[0.011148175,0.0006364399,0.579788,0.0071695866,0.0001831039,0.005815996,0.0015024247,0.0004711859,0.33426136,0.00010967125,0.058294162,0.00061986415],"about_ca_topic_score_codex":0.0073184846,"about_ca_topic_score_gemma":0.0010123209,"teacher_disagreement_score":0.56325066,"about_ca_system_score_codex":0.0004655189,"about_ca_system_score_gemma":0.00044778956,"threshold_uncertainty_score":0.9992919},"labels":[],"label_agreement":null},{"id":"W2015481921","doi":"10.1038/bjc.2011.260","title":"Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Cancer research; Cancer cell; Cancer; Zymography; Biology; Cell; Pathology; Matrix metalloproteinase; Medicine; Chemistry; Internal medicine","score_opus":0.008656387187380035,"score_gpt":0.24197327331071763,"score_spread":0.2333168861233376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015481921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96053845,0.03719354,0.000073959534,0.000112743284,0.0010706657,0.00033495759,0.00012811292,0.0000094676525,0.0005380823],"genre_scores_gemma":[0.97774917,0.020285917,0.00015412136,0.0002771269,0.0008979812,0.000037697355,0.000008643802,0.000034772525,0.0005545835],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982373,0.00007787288,0.00071246544,0.00016325199,0.0005429281,0.00026617077],"domain_scores_gemma":[0.9984288,0.000026775288,0.0007291301,0.00012754026,0.00041147976,0.0002762297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003657293,0.00015925926,0.00047769904,0.000075765645,0.0000562362,0.000012458255,0.00011939727,0.00010934946,0.0027851353],"category_scores_gemma":[0.00003378143,0.00015646771,0.00018789359,0.00014374408,0.00006255991,0.00024356013,0.000024042341,0.00026220374,0.000005340483],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024436857,0.0016403458,0.06932316,0.0012589624,0.00060537615,0.0007203234,0.0015371459,0.000011138967,0.36376944,0.0000051551383,0.16322604,0.39545923],"study_design_scores_gemma":[0.007282935,0.0007332127,0.13780849,0.0042250785,0.00043968222,0.0008703173,0.00014941827,0.00003914062,0.83245486,0.000018127981,0.015673116,0.0003056104],"about_ca_topic_score_codex":0.0026600028,"about_ca_topic_score_gemma":0.0005034276,"teacher_disagreement_score":0.46868545,"about_ca_system_score_codex":0.00028918247,"about_ca_system_score_gemma":0.000502629,"threshold_uncertainty_score":0.99812645},"labels":[],"label_agreement":null},{"id":"W2015690088","doi":"10.1038/sj.bjc.6601682","title":"Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Autocrine signalling; Cancer research; Receptor tyrosine kinase; Receptor; Cell growth; Insulin-like growth factor; Growth factor; Apoptosis; Stem cell factor; Tyrosine kinase; Biology; Signal transduction; Cell biology; Stem cell; Biochemistry; Progenitor cell","score_opus":0.008516542123459677,"score_gpt":0.27185778807605315,"score_spread":0.26334124595259345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015690088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903371,0.008753505,0.000495901,0.00007896165,0.00006305936,0.00015826951,0.000024646937,8.710971e-7,0.00008773424],"genre_scores_gemma":[0.98844635,0.011004259,0.00033690315,0.000021587783,0.00012627484,0.000011449867,0.0000093259205,0.000008728847,0.000035095978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992427,0.00004692573,0.00033838098,0.000114713956,0.0001497594,0.000107474094],"domain_scores_gemma":[0.99938506,0.000006397185,0.00025787044,0.000038820617,0.00026019316,0.000051650964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023417379,0.00006437908,0.00014605641,0.000081858285,0.000034400153,0.000020358191,0.000034267272,0.000089367706,0.000018934828],"category_scores_gemma":[0.00005008301,0.00007282269,0.0000309319,0.00008394035,0.000059519334,0.000015774514,0.000015142974,0.00012707064,5.3537402e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011737357,0.00005196158,0.0058866353,0.00019932084,0.000017609043,0.000004292266,0.000088870715,0.0018734151,0.9821268,0.000004110138,0.0001147715,0.009514895],"study_design_scores_gemma":[0.0013913192,0.00014847389,0.00813106,0.0003939774,0.00001753404,0.000022866669,0.00007416344,0.000065112996,0.9894262,0.00003164096,0.00022426096,0.00007337343],"about_ca_topic_score_codex":0.00093872374,"about_ca_topic_score_gemma":0.0009164382,"teacher_disagreement_score":0.009441522,"about_ca_system_score_codex":0.000041527077,"about_ca_system_score_gemma":0.00018249018,"threshold_uncertainty_score":0.2969623},"labels":[],"label_agreement":null},{"id":"W2015753784","doi":"10.1038/bjc.2013.732","title":"Breast cancer survival and prognosis by screening history","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Survival analysis; Breast cancer screening; Survival rate; Disease; Gynecology; Mammography","score_opus":0.052734457417432504,"score_gpt":0.31101139877082945,"score_spread":0.25827694135339696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015753784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8036108,0.19014633,0.0001638609,0.0039263596,0.0006008518,0.00021370867,0.000054130025,0.000019089215,0.0012648624],"genre_scores_gemma":[0.981523,0.014242405,0.00075617427,0.0013226145,0.000855325,0.000039348935,0.0000021591272,0.000027882032,0.0012311361],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862707,0.00003576949,0.00038227654,0.0001628878,0.000513367,0.00027861955],"domain_scores_gemma":[0.9987395,0.00002448837,0.00027191645,0.000064869775,0.0005852116,0.00031400716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023251328,0.00012286096,0.0003759019,0.000058030477,0.000065261454,0.00006332505,0.000104043305,0.000074844276,0.0023828226],"category_scores_gemma":[0.000029534878,0.0001257691,0.00010567973,0.00009459622,0.00011431882,0.00045821985,0.00002983777,0.00034913037,0.0000029915382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012867959,0.000033457505,0.21415485,0.00005066004,0.00014878788,0.00015561753,0.00006215795,0.00000669489,0.0015908394,0.0000042360857,0.21257919,0.5710848],"study_design_scores_gemma":[0.0024003875,0.00018291545,0.8564718,0.002939426,0.0002730321,0.008166124,0.00037290566,0.00008580928,0.00031790131,0.000024426898,0.12850186,0.0002634057],"about_ca_topic_score_codex":0.019131657,"about_ca_topic_score_gemma":0.000817459,"teacher_disagreement_score":0.64231694,"about_ca_system_score_codex":0.00035985786,"about_ca_system_score_gemma":0.0002981948,"threshold_uncertainty_score":0.99852914},"labels":[],"label_agreement":null},{"id":"W2015943054","doi":"10.1038/bjc.2014.418","title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Malignancy; BRCA mutation; Internal medicine; Oncology; Adenocarcinoma; Stage (stratigraphy); Cancer; Pancreatic ductal adenocarcinoma; Gastroenterology; Breast cancer; Biology","score_opus":0.029042815528843104,"score_gpt":0.38768398371729446,"score_spread":0.3586411681884514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015943054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946891,0.0036941564,0.000112356654,0.00043142898,0.00029853842,0.00012459679,0.000025301535,0.0000023330979,0.00062216545],"genre_scores_gemma":[0.97921574,0.019677112,0.00028177927,0.00013672374,0.000437235,0.000005863642,0.000002165839,0.000011358047,0.00023203835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984833,0.00019338557,0.00073488324,0.00010664309,0.00030968222,0.00017208983],"domain_scores_gemma":[0.9987516,0.0003138386,0.00036395676,0.00006781009,0.00033115325,0.00017167017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011213868,0.000071622664,0.00075583387,0.00008318948,0.000024614726,0.000012660586,0.000059293772,0.00010385068,0.00024405585],"category_scores_gemma":[0.00081258145,0.000070673326,0.000079268575,0.00008159333,0.0001880963,0.00007075046,0.000016570813,0.00035982658,5.3052815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039844983,0.00007007181,0.8386984,0.00011152934,0.00015607993,0.00018221443,0.00008778176,0.0000027312583,0.00014063972,0.000026377636,0.00016148256,0.15996428],"study_design_scores_gemma":[0.0037902312,0.0004447687,0.9921237,0.0011163116,0.00029043318,0.00035873574,0.00007241303,0.00060925836,0.000027673394,0.000114233095,0.0009908916,0.000061356775],"about_ca_topic_score_codex":0.0022989265,"about_ca_topic_score_gemma":0.0016691919,"teacher_disagreement_score":0.15990293,"about_ca_system_score_codex":0.00010625513,"about_ca_system_score_gemma":0.0005324259,"threshold_uncertainty_score":0.34753042},"labels":[],"label_agreement":null},{"id":"W2016203746","doi":"10.1038/sj.bjc.6605051","title":"Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunology; Medicine; Immune system; Chemotherapy; Immunity; Mesenteric lymph nodes; Cellular immunity; Internal medicine","score_opus":0.027220027059184287,"score_gpt":0.3052629971746325,"score_spread":0.2780429701154482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016203746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882924,0.010066982,0.000084589876,0.00072630844,0.00027339387,0.00045190458,0.0000027090387,0.00001609962,0.00008559621],"genre_scores_gemma":[0.99494654,0.0042585693,0.000057918034,0.00021789134,0.0002911615,0.000025299114,0.0000016353573,0.000018283628,0.00018273057],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988528,0.00006573219,0.0004930617,0.0001994097,0.00019225638,0.00019674047],"domain_scores_gemma":[0.9991346,0.000026610684,0.00030399015,0.00008427131,0.00033235957,0.00011813907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019892205,0.00015198138,0.00047487882,0.00013968478,0.00008108027,0.00007283863,0.00003700376,0.000057322097,0.000029609722],"category_scores_gemma":[0.000048159804,0.00014481945,0.000072533854,0.00017903691,0.00004544811,0.00021397618,0.000010972781,0.0002804056,3.380858e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002762361,0.00048118635,0.22591968,0.00040703168,0.0003642035,0.0015038826,0.00069183944,0.00027553222,0.47528395,0.000048165286,0.00007982921,0.29218236],"study_design_scores_gemma":[0.0055019436,0.0014968128,0.97095156,0.0032164713,0.00030786832,0.00834017,0.00021682927,0.00007806104,0.009549105,0.0001482039,0.000048602516,0.00014435827],"about_ca_topic_score_codex":0.003174751,"about_ca_topic_score_gemma":0.0010132693,"teacher_disagreement_score":0.7450319,"about_ca_system_score_codex":0.0004212426,"about_ca_system_score_gemma":0.00019291646,"threshold_uncertainty_score":0.5905566},"labels":[],"label_agreement":null},{"id":"W2016345267","doi":"10.1038/sj.bjc.6603863","title":"MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Matrix metalloproteinase; Gelatinase; Motility; Ovarian cancer; Biology; Cancer research; Ectopic expression; Metastasis; Cell culture; Matrix metalloproteinase inhibitor; Cell; Cancer cell; Cell biology; Gelatinase A; Cancer; Biochemistry; Genetics","score_opus":0.0077445142826772,"score_gpt":0.28416903815834355,"score_spread":0.27642452387566635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016345267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576829,0.038227797,0.0031354348,0.00041686048,0.0003263927,0.00009015519,0.000068836234,0.0000011722501,0.0000504569],"genre_scores_gemma":[0.98955697,0.009054349,0.00043413235,0.00043423683,0.00035322367,0.000003883226,0.000002462957,0.0000106483385,0.00015009816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928194,0.000033304044,0.00027357158,0.000106448744,0.00016282336,0.00014193647],"domain_scores_gemma":[0.9995035,0.000017031072,0.00016033156,0.000073365765,0.00017319286,0.000072585826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034812035,0.000068424604,0.000117651645,0.000019415878,0.000065083856,0.00002690284,0.00010035254,0.000089496985,0.00005580744],"category_scores_gemma":[0.000047852413,0.000058049827,0.00006304217,0.00004160488,0.00006734743,0.000011019676,0.000033280507,0.000107550266,2.3990592e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076502496,0.000023104207,0.00020243009,0.000021150952,0.000021977829,0.00001862502,0.000021180507,9.0477755e-7,0.9394329,0.000013117493,0.0075941635,0.052573934],"study_design_scores_gemma":[0.00038732105,0.00015816721,0.0007043352,0.0001841456,0.00003978292,0.00023510783,0.000035640158,0.000009045766,0.9803878,0.00011607853,0.017667638,0.000074916585],"about_ca_topic_score_codex":0.00045285752,"about_ca_topic_score_gemma":0.00031007602,"teacher_disagreement_score":0.05249902,"about_ca_system_score_codex":0.000016446184,"about_ca_system_score_gemma":0.00009300993,"threshold_uncertainty_score":0.23672032},"labels":[],"label_agreement":null},{"id":"W2016636564","doi":"10.1038/sj.bjc.6605519","title":"Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; Emory University","keywords":"TMPRSS2; Erg; Prostate cancer; Biochemical recurrence; Fusion gene; Prostatectomy; Oncology; Proportional hazards model; Nomogram; Internal medicine; Medicine; Prostate; PCA3; Cohort; Biology; Cancer; Gene; Genetics","score_opus":0.0157146526414504,"score_gpt":0.2990337131224295,"score_spread":0.2833190604809791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016636564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95570076,0.04321859,0.0000021416922,0.0003610202,0.00017368946,0.00042886508,0.000086890774,0.000005629825,0.00002239945],"genre_scores_gemma":[0.96795714,0.031436715,0.00025289188,0.000025675308,0.000105581945,0.000051523843,0.000013802581,0.000018627898,0.00013801249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987263,0.000035176494,0.00037076353,0.00017829187,0.0004255275,0.0002639322],"domain_scores_gemma":[0.9988094,0.00007952839,0.0002757693,0.00007371746,0.00058408064,0.00017751308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027655557,0.000117186595,0.0003979412,0.000112046015,0.000045667693,0.000024232668,0.00007202065,0.00009524732,0.00007602095],"category_scores_gemma":[0.0002397857,0.000094335825,0.000046588873,0.00026396906,0.00023373718,0.00010706908,0.000031707023,0.00047339793,1.7073468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084011385,0.00021765384,0.77162683,0.00010267405,0.000117893935,0.00059523707,0.00013752488,0.000008670891,0.14961675,3.2971516e-7,0.00022908034,0.07650722],"study_design_scores_gemma":[0.006056184,0.0004543251,0.8932446,0.0035262608,0.00013441528,0.00066553825,0.000040533436,0.000119844306,0.09517644,0.000015928457,0.0004349864,0.00013091601],"about_ca_topic_score_codex":0.0010955965,"about_ca_topic_score_gemma":0.0039543784,"teacher_disagreement_score":0.121617764,"about_ca_system_score_codex":0.000110979265,"about_ca_system_score_gemma":0.0006121192,"threshold_uncertainty_score":0.38469034},"labels":[],"label_agreement":null},{"id":"W2017082986","doi":"10.1038/sj.bjc.6603419","title":"A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Temsirolimus; Medicine; Pharmacodynamics; Rash; Internal medicine; Sirolimus; Everolimus; Adverse effect; Oncology; Pharmacology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology; Pharmacokinetics","score_opus":0.025426725496395658,"score_gpt":0.41002983679405325,"score_spread":0.38460311129765756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017082986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879664,0.010663168,0.0000017760207,0.0003395648,0.00023561693,0.00057618367,0.000016167476,0.0000091660395,0.00019196759],"genre_scores_gemma":[0.9944215,0.004653357,0.00011052693,0.00009505322,0.0002999403,0.00001813572,0.0000010704924,0.000029796918,0.0003706284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753296,0.00017048382,0.0011637914,0.00024507946,0.0005457942,0.00034188837],"domain_scores_gemma":[0.9988829,0.00010741207,0.0004080173,0.00012923624,0.00026840816,0.00020402375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022093636,0.00014124229,0.0007195438,0.0002534055,0.00004668181,0.000015467405,0.00014056782,0.0000061749006,0.00005469594],"category_scores_gemma":[0.00020083228,0.00014611012,0.00010897162,0.0002975714,0.00016490562,0.00022545773,0.00008772993,0.0006752887,2.790644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00478139,0.012201629,0.59851736,0.00018110558,0.00010880993,0.107210785,0.00004397093,0.00025946437,0.015297963,0.0000050504786,0.00066103734,0.2607314],"study_design_scores_gemma":[0.10768025,0.019936385,0.81793237,0.00068093714,0.00022764302,0.041920472,0.00031616,0.00037314952,0.0029382643,0.000098634526,0.0076726535,0.00022308373],"about_ca_topic_score_codex":0.001391107,"about_ca_topic_score_gemma":0.0027268827,"teacher_disagreement_score":0.26050833,"about_ca_system_score_codex":0.000049806004,"about_ca_system_score_gemma":0.00017842796,"threshold_uncertainty_score":0.5958198},"labels":[],"label_agreement":null},{"id":"W2017157952","doi":"10.1038/bjc.2012.345","title":"Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canada Research Chairs; Ontario Ministry of Health and Long-Term Care; Cancer Research Institute","keywords":"Osteopontin; Medicine; Prostate cancer; Oncology; Biomarker; Prostatectomy; Internal medicine; Metastasis; Prostate-specific antigen; Chemotherapy; Urology; Androgen deprivation therapy; Cancer; Biology","score_opus":0.027080322783702353,"score_gpt":0.3286458796795494,"score_spread":0.301565556895847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017157952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8705841,0.12765343,0.0000024396647,0.0009580229,0.0002276605,0.00028514976,0.000045423665,0.0000050303265,0.00023878587],"genre_scores_gemma":[0.9759367,0.021334685,0.00024651224,0.00011026499,0.00019421686,0.000050011204,7.5219174e-7,0.000016009139,0.0021108203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989348,0.00012597413,0.00038512066,0.00009855713,0.00026094748,0.00019461062],"domain_scores_gemma":[0.99896467,0.00012558584,0.00035744335,0.00007660231,0.0002401968,0.00023547868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047082372,0.00010575854,0.00034039744,0.00010504667,0.00010198887,0.000015641634,0.000030751096,0.00005534922,0.00014438266],"category_scores_gemma":[0.00034338268,0.0000879994,0.000078094134,0.00017133281,0.00007872929,0.00014269119,0.000030614352,0.0001422218,0.000005002435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009145901,0.00015549413,0.6312528,0.00004472657,0.00026661236,0.0002449602,0.0017385422,0.0000038297126,0.0020959347,0.0000022044396,0.0069028814,0.34814605],"study_design_scores_gemma":[0.0032838085,0.00070001814,0.9610864,0.002231815,0.00029841764,0.0017251256,0.00053172885,0.0000026896716,0.005240618,0.000029206145,0.024768343,0.000101837664],"about_ca_topic_score_codex":0.0030415414,"about_ca_topic_score_gemma":0.00073625374,"teacher_disagreement_score":0.34804422,"about_ca_system_score_codex":0.00015401377,"about_ca_system_score_gemma":0.0002113977,"threshold_uncertainty_score":0.4597921},"labels":[],"label_agreement":null},{"id":"W2018009395","doi":"10.1038/sj.bjc.6601716","title":"Methylation analysis of the glypican 3 gene in embryonal tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; HEC Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Methylation; DNA methylation; Biology; Molecular biology; Epigenetics; Gene expression; Gene; Regulation of gene expression; Promoter; Gene silencing; Cancer research; Genetics","score_opus":0.005382517639364735,"score_gpt":0.2567698863523647,"score_spread":0.25138736871299994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018009395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890631,0.009524392,0.00084718,0.0002470583,0.0001910425,0.00005231677,0.000022359423,7.6316735e-7,0.00005180933],"genre_scores_gemma":[0.9982803,0.0012132635,0.00018975364,0.000051748313,0.00019147061,0.0000023099233,0.0000094297875,0.0000075438493,0.000054172197],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99922603,0.000046138393,0.00033216993,0.00009621627,0.00020504715,0.000094386516],"domain_scores_gemma":[0.99935275,0.0000044012872,0.0003374261,0.00009570689,0.00017795725,0.000031762374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019498188,0.000055914836,0.00016544286,0.00010256584,0.000024936782,0.000010904326,0.00012995905,0.000072760515,0.000029066985],"category_scores_gemma":[0.00004216649,0.000054664342,0.0002028956,0.00047464896,0.000049681028,0.0000060777566,0.000022547785,0.000101306774,1.00090176e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012220787,0.00005318632,0.028926592,0.0000063858893,0.0005683359,0.000006713079,0.00005356267,0.43183258,0.50402534,0.000015493404,0.00013136097,0.034258254],"study_design_scores_gemma":[0.00086915575,0.00005243474,0.77343637,0.00007804064,0.00031468592,0.00007363549,0.000018908628,0.00012944486,0.22401239,0.00011972388,0.0008219564,0.00007325676],"about_ca_topic_score_codex":0.00065038295,"about_ca_topic_score_gemma":0.008319905,"teacher_disagreement_score":0.74450976,"about_ca_system_score_codex":0.00009669881,"about_ca_system_score_gemma":0.00026039217,"threshold_uncertainty_score":0.46427023},"labels":[],"label_agreement":null},{"id":"W2018476933","doi":"10.1038/bjc.2013.64","title":"In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"American Society of Clinical Oncology","keywords":"Sorafenib; Medicine; Pharmacodynamics; Biomarker; Oncology; Cyclophosphamide; Internal medicine; Pharmacokinetics; Pharmacology; Clinical trial; In vivo; Chemotherapy; Hepatocellular carcinoma; Biology","score_opus":0.009560983902794555,"score_gpt":0.2940602698108349,"score_spread":0.28449928590804036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018476933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950507,0.0009163861,0.00003977686,0.0025683302,0.00024622513,0.0011065943,0.00001908167,0.000008602667,0.00004425135],"genre_scores_gemma":[0.9983241,0.0004181004,0.00026446028,0.0002906274,0.000215829,0.00008258237,0.000003253721,0.000043604316,0.00035742924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980495,0.000080641425,0.0005349652,0.00022964609,0.0006233628,0.0004819016],"domain_scores_gemma":[0.99899155,0.000056127246,0.00020344775,0.000085168096,0.0004393342,0.00022435917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000094580835,0.00015264405,0.0004097171,0.00035090168,0.00003758536,0.000060790073,0.00013195956,0.000008433601,0.0013488553],"category_scores_gemma":[0.00012935245,0.00014426075,0.000119625896,0.00032869173,0.00009099946,0.0006348786,0.000015223845,0.00041546274,0.0000035714918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045268282,0.008064123,0.43901026,0.000804221,0.0004047217,0.06853741,0.00015432219,0.0029416415,0.0638423,0.00001256541,0.027193693,0.34376645],"study_design_scores_gemma":[0.035090204,0.0026674797,0.9302768,0.0009526775,0.00007738456,0.012026509,0.000063620064,0.00010351665,0.013647427,0.000120126366,0.004748756,0.00022549115],"about_ca_topic_score_codex":0.0010058695,"about_ca_topic_score_gemma":0.00055502617,"teacher_disagreement_score":0.49126655,"about_ca_system_score_codex":0.00013623736,"about_ca_system_score_gemma":0.0002254855,"threshold_uncertainty_score":0.99956405},"labels":[],"label_agreement":null},{"id":"W2018971639","doi":"10.1038/sj.bjc.6604554","title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":651,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Warburg effect; Glycolysis; Pyruvate dehydrogenase kinase; Mitochondrion; Pyruvate dehydrogenase complex; Cancer; Anaerobic glycolysis; Cancer cell; Cancer research; Citric acid cycle; Apoptosis; In vivo; Biology; Biochemistry; Medicine; Metabolism; Internal medicine; Enzyme; Genetics","score_opus":0.020254691862175978,"score_gpt":0.3297046630877982,"score_spread":0.30944997122562223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018971639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005763617,0.9915934,0.00019993524,0.000045237037,0.006266915,0.00068866427,0.00053058774,0.000008040144,0.000090865564],"genre_scores_gemma":[0.00003223665,0.9749008,0.00038572666,0.0003390626,0.022137506,0.00032359557,0.0001022312,0.00015845239,0.0016203858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728197,0.00015443834,0.0010882494,0.00049150304,0.00041820182,0.00056562584],"domain_scores_gemma":[0.9974221,0.000021076565,0.0014370187,0.00023043991,0.00063692924,0.00025243478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033826946,0.00049136183,0.0019297702,0.00012795335,0.00020560074,0.00011425263,0.00056616147,0.0004511476,0.00015316518],"category_scores_gemma":[0.000108660926,0.0004791552,0.0018609102,0.00017115516,0.0001214774,0.00001784857,0.00007488814,0.0004831029,0.0000025056358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014239289,0.00005409505,0.0000016900905,0.00059811625,0.0012972212,0.000034176308,0.000018922474,0.000033275373,0.00057449227,0.0000030328758,0.03737283,0.95986974],"study_design_scores_gemma":[0.0016709301,0.00013323218,0.0000151566555,0.0025900041,0.0009158302,0.0026038438,0.000010523448,0.0000010569182,0.0005225394,0.00001681493,0.9909902,0.0005298717],"about_ca_topic_score_codex":0.0005513029,"about_ca_topic_score_gemma":0.00027247492,"teacher_disagreement_score":0.95933986,"about_ca_system_score_codex":0.000057804493,"about_ca_system_score_gemma":0.0022267317,"threshold_uncertainty_score":0.999766},"labels":[],"label_agreement":null},{"id":"W2019832083","doi":"10.1038/sj.bjc.6605017","title":"Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis","year":2009,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Mayo Clinic","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Hazard ratio; Vascular endothelial growth factor; Meta-analysis; Oncology; Survival analysis; Gastroenterology; Pathology; VEGF receptors; Confidence interval","score_opus":0.0715324370404567,"score_gpt":0.3007726055922088,"score_spread":0.2292401685517521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019832083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011580002,0.9949978,0.0000053295207,0.000039174087,0.000027482964,0.003450824,0.00028353842,0.00000721093,0.000030645206],"genre_scores_gemma":[0.03177796,0.9674817,0.000104582345,0.0000787026,0.00007934573,0.00030114644,0.000037821326,0.000057561378,0.000081199556],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949983,0.0007252556,0.002740099,0.00039658303,0.00079981633,0.0003399953],"domain_scores_gemma":[0.9964457,0.0002416992,0.0021546672,0.0003438171,0.00053783506,0.00027627937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009083305,0.00056130573,0.0142274,0.0006956508,0.00003507464,0.000050545576,0.00026582376,0.0002776026,0.00036564653],"category_scores_gemma":[0.00040514537,0.0004237184,0.006159108,0.0010418842,0.00006285508,0.000120715034,0.000037712667,0.0006066276,0.0000025601857],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008415714,0.00023766998,0.023993444,0.82287437,0.13423258,0.0022860824,0.00003792388,6.373197e-8,7.358144e-7,0.0000037873378,0.000019300613,0.016305635],"study_design_scores_gemma":[0.00052107126,0.00019200995,0.0005702944,0.11286824,0.878301,0.0015914277,0.0000063236457,0.0000073845003,0.0000071130207,0.000010389062,0.005639668,0.0002850295],"about_ca_topic_score_codex":0.00056369486,"about_ca_topic_score_gemma":0.00009029755,"teacher_disagreement_score":0.74406844,"about_ca_system_score_codex":0.00020558388,"about_ca_system_score_gemma":0.00057198526,"threshold_uncertainty_score":0.9998215},"labels":[],"label_agreement":null},{"id":"W2020301278","doi":"10.1054/bjoc.2000.1621","title":"Comparison of99mTc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; BC Cancer Agency; University of Toronto; McGill University","keywords":"Doxorubicin; P-glycoprotein; Flow cytometry; Medicine; Chemotherapy; Pathology; Cell culture; Efflux; Cancer research; Multiple drug resistance; Internal medicine; Biology; Immunology; Drug resistance; Biochemistry","score_opus":0.013684665925206684,"score_gpt":0.2939991486008324,"score_spread":0.28031448267562575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020301278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867841,0.008403493,0.0034210319,0.000497073,0.00035789973,0.00020911789,0.00001005283,0.000008908328,0.00030829513],"genre_scores_gemma":[0.9955341,0.0024585517,0.00087758346,0.00018568643,0.00040992573,0.0000063689163,0.0000028745815,0.000015756323,0.00050911785],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989051,0.000018829365,0.00047582,0.00010676339,0.00034955656,0.00014388147],"domain_scores_gemma":[0.99922824,0.000009914166,0.00024216638,0.00006234895,0.0002976997,0.00015966046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020512524,0.00008519661,0.00037614716,0.0001151045,0.00004307809,0.000017561166,0.000032215044,0.00006752788,0.00013340368],"category_scores_gemma":[0.000016878757,0.00008502222,0.00008050877,0.00017980924,0.000039266222,0.00011191153,0.0000062781282,0.0001932203,0.000001300441],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034559811,0.0003817107,0.066292845,0.00030956572,0.0001516025,0.0009039501,0.0002964162,0.00013276825,0.3507875,0.00006346396,0.002719508,0.57450473],"study_design_scores_gemma":[0.0056017097,0.001823693,0.7717997,0.0066669276,0.00044958715,0.0017902704,0.0011434073,0.0000354149,0.18348621,0.00034620473,0.026601728,0.00025513972],"about_ca_topic_score_codex":0.00036247418,"about_ca_topic_score_gemma":0.0007642105,"teacher_disagreement_score":0.70550686,"about_ca_system_score_codex":0.000059146154,"about_ca_system_score_gemma":0.00006243671,"threshold_uncertainty_score":0.34671053},"labels":[],"label_agreement":null},{"id":"W2020339402","doi":"10.1054/bjoc.2000.1681","title":"Codon 89 polymorphism in the human 5 α -reductase gene in primary breast cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Genotype; Biology; Allele; Exon; Androgen receptor; Prostate cancer; Molecular biology; Genetics; Gene; Cancer","score_opus":0.010743845701263617,"score_gpt":0.2798356079173419,"score_spread":0.2690917622160783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020339402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796714,0.018726826,0.000016680942,0.0008344384,0.00017541386,0.0000693921,0.000044731067,0.0000012583967,0.0004598419],"genre_scores_gemma":[0.9915568,0.0059320685,0.000012641248,0.0018900078,0.0003529651,0.000012430983,0.00003861831,0.000010624956,0.00019379314],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992325,0.00007062734,0.00026375026,0.00011285109,0.000161077,0.00015923395],"domain_scores_gemma":[0.9996806,0.000004278406,0.00012756551,0.00008014972,0.000063633925,0.00004382065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015583435,0.000076292636,0.00012399537,0.000054923552,0.000039155875,0.00003679592,0.00018021089,0.00006370932,0.00023370341],"category_scores_gemma":[0.000010478398,0.00007161859,0.00005684765,0.000114079994,0.000042133943,0.000008780705,0.000019502428,0.00014145531,6.407845e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003869318,0.0006427574,0.33369818,0.000029035637,0.00010070546,0.00046707026,0.00034188622,0.00035371858,0.49712753,0.000029021148,0.016519492,0.15030369],"study_design_scores_gemma":[0.0019802887,0.00005073928,0.98253524,0.0000891567,0.000015793177,0.0010798516,0.00019295556,0.000003141298,0.0031898043,0.000057357567,0.010673838,0.00013185779],"about_ca_topic_score_codex":0.0016656158,"about_ca_topic_score_gemma":0.0059443456,"teacher_disagreement_score":0.64883703,"about_ca_system_score_codex":0.00004587194,"about_ca_system_score_gemma":0.00012552884,"threshold_uncertainty_score":0.33170843},"labels":[],"label_agreement":null},{"id":"W2020684281","doi":"10.1038/bjc.2011.100","title":"Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":473,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Pfizer Australia; Pfizer","keywords":"Medicine; Internal medicine; Colorectal cancer; Oncology; Chemotherapy; Neutrophil to lymphocyte ratio; Cohort; Biomarker; Progression-free survival; Cancer; Lymphocyte","score_opus":0.007573937637656779,"score_gpt":0.24328955711300027,"score_spread":0.23571561947534347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020684281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416023,0.0043746205,0.000008997989,0.00012790768,0.0004348522,0.00049339933,0.000046890254,0.00001830038,0.0003347822],"genre_scores_gemma":[0.99586606,0.0023718933,0.00081847946,0.000607681,0.00014556534,0.00008417016,0.0000035248486,0.000046018093,0.00005663573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845207,0.00004318457,0.00051876245,0.0001844858,0.00051131286,0.00029018952],"domain_scores_gemma":[0.9987638,0.00001729911,0.000408581,0.00010473753,0.00049749407,0.00020809635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001276977,0.0001753251,0.00048479077,0.00013583573,0.000047398997,0.000022892185,0.00014518671,0.00008335747,0.0005971843],"category_scores_gemma":[0.000040271392,0.00015784168,0.00012456489,0.00019249972,0.00011851533,0.00030120404,0.000018505196,0.00022411677,0.0000014879728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066144033,0.00038147983,0.89151555,0.000052521238,0.00036025693,0.00041959123,0.00022225648,0.000015147598,0.00015871615,0.0000015417464,0.00027635746,0.0999822],"study_design_scores_gemma":[0.015780022,0.0005676052,0.97776854,0.0011183227,0.00014378021,0.000083856954,0.000029177903,0.000011936383,0.003751138,0.000012475977,0.0005632274,0.00016992642],"about_ca_topic_score_codex":0.00023089717,"about_ca_topic_score_gemma":0.00043383767,"teacher_disagreement_score":0.09981228,"about_ca_system_score_codex":0.0004785198,"about_ca_system_score_gemma":0.00060299627,"threshold_uncertainty_score":0.6538749},"labels":[],"label_agreement":null},{"id":"W2020769895","doi":"10.1038/sj.bjc.6604234","title":"Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Sanofi","keywords":"Helicobacter pylori; Adenocarcinoma; Gene; Metalloproteinase; Inflammation; Medicine; Helicobacter pylori infection; Biology; Gastroenterology; Immunology; Internal medicine; Microbiology; Cancer; Matrix metalloproteinase; Genetics","score_opus":0.010288710079028419,"score_gpt":0.2301443297107634,"score_spread":0.21985561963173497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020769895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9057268,0.09338942,0.000033397435,0.0004163762,0.0001786215,0.00020835243,0.000020862006,0.00000532679,0.00002083429],"genre_scores_gemma":[0.93318516,0.06621096,0.00014900512,0.00013374804,0.00024165843,0.000010777317,8.046993e-7,0.000016108517,0.000051766754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859685,0.0001731423,0.00065642537,0.0001289825,0.00027067756,0.00017392692],"domain_scores_gemma":[0.9985812,0.00006648028,0.00070816075,0.00011365211,0.00042037363,0.000110145294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047140266,0.00013478563,0.00061492855,0.00012633385,0.00010327873,0.000007709116,0.000060039136,0.00009459581,0.000029924397],"category_scores_gemma":[0.00015337246,0.00010480067,0.00013977353,0.000112453825,0.0008541483,0.00015119459,0.000059099442,0.00040860116,3.466202e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011464295,0.000051403666,0.9768457,0.00007362031,0.0012717622,0.00036788863,0.0005156623,0.0000057310076,0.0024295652,0.00000566692,0.00011697455,0.017169612],"study_design_scores_gemma":[0.0062583745,0.00044758266,0.97896844,0.00029642164,0.00078479847,0.008785965,0.000038543803,0.000008527218,0.0039557973,0.000024720726,0.0003723406,0.00005846462],"about_ca_topic_score_codex":0.0014008195,"about_ca_topic_score_gemma":0.00032005928,"teacher_disagreement_score":0.027458362,"about_ca_system_score_codex":0.00003840817,"about_ca_system_score_gemma":0.0001035347,"threshold_uncertainty_score":0.42736474},"labels":[],"label_agreement":null},{"id":"W2021052544","doi":"10.1038/sj.bjc.6605634","title":"Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Government of Ontario","keywords":"microRNA; Kallikrein; Cell growth; Ovarian cancer; Cancer research; Cancer; Biology; Medicine; Bioinformatics; Gene; Genetics; Enzyme; Biochemistry","score_opus":0.008271594817374363,"score_gpt":0.25875401312362784,"score_spread":0.25048241830625345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021052544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786553,0.018525012,0.0003022502,0.0013342256,0.0005354849,0.00031120356,0.000015486405,0.000012029642,0.00030900384],"genre_scores_gemma":[0.99624586,0.00131754,0.00042419648,0.00034828926,0.00089575205,0.000020969193,0.0000048694965,0.000025113388,0.00071739627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875605,0.000029357718,0.00050671695,0.00017308234,0.00031877047,0.00021601895],"domain_scores_gemma":[0.999049,0.000037885686,0.0003117303,0.00009766903,0.00032026056,0.0001834646],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030440275,0.00012775652,0.00036022274,0.00011963563,0.00007733525,0.00007530625,0.00007280165,0.00015248386,0.0011225896],"category_scores_gemma":[0.00006615647,0.00012633721,0.00007892271,0.0001344885,0.00006206608,0.00026064742,0.000013158505,0.00038654165,0.0000015901799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013541152,0.0002548605,0.42683652,0.00013056172,0.000093742805,0.00041349165,0.00040876362,0.00016973469,0.35521302,0.000043175623,0.006355447,0.20872657],"study_design_scores_gemma":[0.009850689,0.00014991213,0.94309974,0.0012783955,0.00012617184,0.0007063976,0.000023989105,0.0012843864,0.034859106,0.0003497874,0.008083071,0.00018837785],"about_ca_topic_score_codex":0.0015418351,"about_ca_topic_score_gemma":0.015235139,"teacher_disagreement_score":0.5162632,"about_ca_system_score_codex":0.00005891687,"about_ca_system_score_gemma":0.00030766492,"threshold_uncertainty_score":0.99979055},"labels":[],"label_agreement":null},{"id":"W2021429060","doi":"10.1038/bjc.2014.201","title":"Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"DU145; Prostate cancer; Carcinogenesis; Stem cell; Aldehyde dehydrogenase; Cancer research; Pathology; Cancer stem cell; Prostate; Biology; Immunohistochemistry; Metastasis; Cancer; Medicine; Internal medicine; Enzyme","score_opus":0.023573555516500415,"score_gpt":0.33459036111354323,"score_spread":0.3110168055970428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021429060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814064,0.00915999,0.00010456102,0.0015137363,0.00021954495,0.00019455398,0.000008722041,0.000020351334,0.0006379173],"genre_scores_gemma":[0.9912298,0.0041246344,0.00055724377,0.002564389,0.00054849806,0.000014960079,0.0000023865923,0.000028509237,0.0009296334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988401,0.00007693182,0.0003328667,0.00011166757,0.00038555675,0.00025285417],"domain_scores_gemma":[0.9987978,0.000066549714,0.0003453671,0.00007662322,0.0004083308,0.00030536993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000501339,0.00009615704,0.00035628732,0.0000703845,0.0001000065,0.000038561313,0.00006060943,0.000051007544,0.00026560054],"category_scores_gemma":[0.0001460723,0.00008502339,0.00008964611,0.00011811955,0.00005379392,0.0001021514,0.000008646649,0.00026413632,0.00001537754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024471309,0.00041015726,0.49818602,0.0009318425,0.0006723766,0.0029877052,0.00040879217,0.00010539948,0.0051850867,0.00006627615,0.024585579,0.46401364],"study_design_scores_gemma":[0.007938502,0.0012536244,0.8191,0.0029635096,0.0004775559,0.007931103,0.000054754586,0.00014145614,0.0062468066,0.000095213596,0.15351893,0.00027851475],"about_ca_topic_score_codex":0.00023779426,"about_ca_topic_score_gemma":0.0006372151,"teacher_disagreement_score":0.4637351,"about_ca_system_score_codex":0.00014548875,"about_ca_system_score_gemma":0.00038120738,"threshold_uncertainty_score":0.34671533},"labels":[],"label_agreement":null},{"id":"W2021926444","doi":"10.1038/sj.bjc.6601104","title":"A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Hypercalcaemia; Chemotherapy; Internal medicine; Progressive disease; Gastroenterology; Toxicity; Cancer; Oncology; Vitamin D and neurology; Surgery; Calcium","score_opus":0.013446570007913201,"score_gpt":0.2953229735743543,"score_spread":0.28187640356644106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021926444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976073,0.0014348367,0.000003431472,0.00006864857,0.00009549592,0.00065506593,0.00001305682,0.000002392807,0.00011979499],"genre_scores_gemma":[0.9995396,0.000092153365,0.000048971386,0.00007784736,0.000033861827,0.000017980296,6.896764e-7,0.00001897441,0.00016991318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822205,0.00018741883,0.00044128607,0.00014134242,0.0007476247,0.0002602765],"domain_scores_gemma":[0.9990103,0.00002645681,0.00023979094,0.00016976996,0.00042778137,0.00012588016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017797634,0.0001036529,0.00038467435,0.00012451579,0.000070912596,0.000015423437,0.00016096295,0.00000785782,0.00008251214],"category_scores_gemma":[0.00019911113,0.00007527321,0.00006291558,0.0004478234,0.00007908295,0.00015990941,0.000036824647,0.00043866804,2.8506733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006790707,0.0047003655,0.9844826,0.00004380668,0.00005928267,0.004346225,0.00013179077,0.000060406644,0.00043499525,0.000002093259,0.00020764954,0.004851732],"study_design_scores_gemma":[0.0510089,0.016987273,0.914723,0.0009231806,0.00012386123,0.0023492244,0.00072345394,0.000035642788,0.0106300665,0.000017506449,0.0023248591,0.00015306564],"about_ca_topic_score_codex":0.0008452375,"about_ca_topic_score_gemma":0.0013661233,"teacher_disagreement_score":0.069759615,"about_ca_system_score_codex":0.00011094379,"about_ca_system_score_gemma":0.00031913698,"threshold_uncertainty_score":0.30695522},"labels":[],"label_agreement":null},{"id":"W2022540212","doi":"10.1038/sj.bjc.6601314","title":"Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"University of Toronto","keywords":"Relative risk; Medicine; Breast cancer; Confidence interval; Cohort study; Cohort; Meta-analysis; Cancer; Internal medicine","score_opus":0.04609238137663645,"score_gpt":0.34487777377553536,"score_spread":0.2987853923988989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022540212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032212796,0.99189067,8.3513635e-7,0.000839621,0.00023330165,0.0003434227,0.0064422707,0.0000028741774,0.0002147831],"genre_scores_gemma":[0.000059845846,0.9979863,0.000086470165,0.00053921755,0.0006072706,0.000047765003,0.000038705602,0.000030976444,0.0006034231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973053,0.0002912528,0.0011841285,0.00029545443,0.0007050652,0.00021881127],"domain_scores_gemma":[0.9964217,0.00012550635,0.0018854692,0.0002586916,0.001136435,0.00017223207],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050913956,0.0003233233,0.0050912793,0.00026889224,0.0001308683,0.00013951957,0.00021724276,0.00021987941,0.0014160761],"category_scores_gemma":[0.00013294001,0.00019151949,0.0049958825,0.0016274925,0.00012820576,0.00015634648,0.00007470301,0.0010271576,2.4711287e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057776837,0.00012683209,0.00083071383,0.008663773,0.3299282,0.00021824312,0.000022265984,0.000003225083,1.9426365e-7,0.000008513683,0.06902188,0.5911184],"study_design_scores_gemma":[0.0002949579,0.000023189863,0.00323065,0.010210792,0.40874153,0.0015722981,0.000006507738,2.893076e-7,7.500291e-8,0.00002535541,0.5757842,0.00011013463],"about_ca_topic_score_codex":0.0007412771,"about_ca_topic_score_gemma":0.0005325493,"teacher_disagreement_score":0.59100825,"about_ca_system_score_codex":0.00014277926,"about_ca_system_score_gemma":0.00026509215,"threshold_uncertainty_score":0.99949676},"labels":[],"label_agreement":null},{"id":"W2023408161","doi":"10.1038/bjc.2013.807","title":"Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; Cancer Care Ontario; National Health and Medical Research Council; National Institutes of Health; National Cancer Institute; National Center for Research Resources; Medical Research Council","keywords":"Breast cancer; Medicine; Breastfeeding; Gynecology; Odds ratio; Obstetrics; Population; Cancer; Parity (physics); Cancer registry; Confidence interval; Breast feeding; Oncology; Internal medicine; Pediatrics","score_opus":0.01200590687469941,"score_gpt":0.27865279961555445,"score_spread":0.266646892740855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023408161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976821,0.017296685,0.000015354983,0.0029370328,0.0007574087,0.0003648173,0.0016570406,0.000015683963,0.00013496228],"genre_scores_gemma":[0.9542216,0.043125045,0.000058063204,0.0004700258,0.0018809062,0.000058229813,0.0000042265956,0.000047554266,0.0001343717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975939,0.00022615794,0.0006541421,0.00046325976,0.0006369349,0.0004255994],"domain_scores_gemma":[0.9979753,0.00012505529,0.0008302897,0.00030737405,0.00051646394,0.00024551133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006925082,0.00029736845,0.0007171949,0.0001210876,0.00016280537,0.00011949593,0.00024596346,0.000146076,0.00031601544],"category_scores_gemma":[0.00012629991,0.00022296647,0.00019074418,0.0003600139,0.00033052097,0.0003352354,0.00004499541,0.0010628442,0.0000011837209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064049754,0.00010662673,0.80327994,0.000052965937,0.00027085032,0.000055747845,0.0011768719,0.000067590794,0.00059359486,0.000004443669,0.0047036987,0.18904719],"study_design_scores_gemma":[0.002421304,0.00015346313,0.9847366,0.0014103063,0.00031202013,0.0029313911,0.0015894808,0.000011905404,0.00029656655,0.00007790748,0.0058095898,0.00024944718],"about_ca_topic_score_codex":0.087669596,"about_ca_topic_score_gemma":0.015903266,"teacher_disagreement_score":0.18879774,"about_ca_system_score_codex":0.0005220171,"about_ca_system_score_gemma":0.0004962241,"threshold_uncertainty_score":0.9184057},"labels":[],"label_agreement":null},{"id":"W2023959957","doi":"10.1038/sj.bjc.6604395","title":"Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Stage (stratigraphy); Internal medicine; Anxiety; Performance status; Cancer; Intensive care medicine; Psychiatry","score_opus":0.13633444190166571,"score_gpt":0.4358898854765684,"score_spread":0.29955544357490266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023959957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95310545,0.042916507,0.00024865806,0.00009503048,0.0011012492,0.0021812555,0.00009603967,0.000016086424,0.00023975433],"genre_scores_gemma":[0.96434116,0.031046104,0.003117498,0.00015998328,0.0002499211,0.000660519,0.0000024229453,0.0000596049,0.00036279098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99515027,0.000769305,0.0024570075,0.00036891294,0.0006492429,0.0006052828],"domain_scores_gemma":[0.99466074,0.0016944627,0.0018644102,0.00061344285,0.00089758355,0.0002693859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040848876,0.00030155,0.0009611786,0.00039645674,0.0006911436,0.000016793556,0.0005108367,0.00013136136,0.0005301641],"category_scores_gemma":[0.00022862769,0.00028663216,0.00014830759,0.00048172093,0.000051423347,0.0002571116,0.00015226148,0.0006737112,0.0000062740924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020361515,0.003291721,0.8618039,0.00023952796,0.00015833414,0.0004758742,0.03468198,0.0036741078,0.0003158545,0.0000014137705,0.00053623476,0.09278493],"study_design_scores_gemma":[0.041814398,0.017097931,0.86467403,0.026011236,0.00033878232,0.00015395532,0.037777297,0.0010585099,0.00075186096,0.000099341494,0.009428229,0.0007944284],"about_ca_topic_score_codex":0.051956978,"about_ca_topic_score_gemma":0.2278674,"teacher_disagreement_score":0.17591043,"about_ca_system_score_codex":0.0051696883,"about_ca_system_score_gemma":0.0036141267,"threshold_uncertainty_score":0.9999586},"labels":[],"label_agreement":null},{"id":"W2024159061","doi":"10.1038/sj.bjc.6602505","title":"Second primary malignancies in patients with male breast cancer","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Male breast cancer; Prostate; Rectum; Incidence (geometry); Pancreatic cancer; Prostate cancer; Gynecology","score_opus":0.005861139639701475,"score_gpt":0.25164474699158373,"score_spread":0.24578360735188226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024159061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735346,0.021353314,0.0000028320287,0.0026024247,0.00018022156,0.00022608304,0.00013717012,0.0000068980394,0.0019564496],"genre_scores_gemma":[0.98992234,0.0036331252,0.0005301201,0.0028226078,0.00084943534,0.000026764903,0.000002863139,0.000028845674,0.0021839049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853504,0.000026658889,0.00049287244,0.00014228039,0.00047851697,0.00032463338],"domain_scores_gemma":[0.99886465,0.00001873828,0.00031152368,0.00008208472,0.00055133033,0.0001716968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001738908,0.0001261245,0.0004666111,0.00011227391,0.000053969092,0.00002002436,0.000083598185,0.000052875876,0.0029239666],"category_scores_gemma":[0.000012910516,0.00011492299,0.0000605708,0.00017041339,0.00007991388,0.00024436618,0.000025851645,0.0003311671,0.000004069843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007970028,0.0001983166,0.815136,0.000268334,0.000069734735,0.00022195268,0.000107953274,0.000029732948,0.00002303029,0.0000014673711,0.008721836,0.17442465],"study_design_scores_gemma":[0.005047703,0.0001398018,0.95962757,0.0025970493,0.000060455244,0.002703427,0.00003230694,0.0000020066498,0.00002567042,0.00000213066,0.029644405,0.00011745781],"about_ca_topic_score_codex":0.0005377597,"about_ca_topic_score_gemma":0.007430363,"teacher_disagreement_score":0.1743072,"about_ca_system_score_codex":0.00051116775,"about_ca_system_score_gemma":0.0006015575,"threshold_uncertainty_score":0.9979875},"labels":[],"label_agreement":null},{"id":"W2024862214","doi":"10.1038/bjc.2014.653","title":"A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pharmacokinetics; Adverse effect; Pharmacodynamics; Toxicity; Internal medicine; Gastroenterology; Pharmacology","score_opus":0.01714316983249088,"score_gpt":0.3379790717243566,"score_spread":0.3208359018918657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024862214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984438,0.00081794226,0.000031231677,0.000045757653,0.000047566835,0.0005485527,0.00002697941,0.000001543542,0.000036636477],"genre_scores_gemma":[0.99936503,0.00016744726,0.00025644116,0.000028724391,0.00005794326,0.000035906196,0.000010831534,0.000019500838,0.000058172354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984779,0.000107069376,0.00054743333,0.00018389575,0.00044181183,0.0002419403],"domain_scores_gemma":[0.9983541,0.00000786183,0.00024996206,0.00014094404,0.0011021518,0.00014498293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022858166,0.00010902631,0.00027098155,0.0000953305,0.000032282922,0.000026235271,0.00019874793,0.00006825873,0.000019161553],"category_scores_gemma":[0.00024021493,0.00010941907,0.00003740888,0.00016161983,0.000048347007,0.000023483515,0.00005611023,0.00015975021,3.2344425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073677576,0.008271157,0.8756909,0.00016811416,0.00019527078,0.0006907556,0.0024450703,0.004309036,0.048002545,0.0000013722831,0.00038647567,0.05247159],"study_design_scores_gemma":[0.09344235,0.017028164,0.85072005,0.0020984232,0.000048704846,0.000091917864,0.0030276552,0.00019427825,0.031164316,0.000017432145,0.0016441558,0.00052256853],"about_ca_topic_score_codex":0.0007239141,"about_ca_topic_score_gemma":0.028061567,"teacher_disagreement_score":0.08607459,"about_ca_system_score_codex":0.00008796399,"about_ca_system_score_gemma":0.00032288526,"threshold_uncertainty_score":0.9896738},"labels":[],"label_agreement":null},{"id":"W2025238642","doi":"10.1038/sj.bjc.6605179","title":"Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University; McGill University Health Centre; McGill University and Génome Québec Innovation Centre; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research; Hungarian Scientific Research Fund","keywords":"Gene duplication; Medicine; Pilocytic astrocytoma; Biology; Cancer research; Gene; Pathology; Genetics; Astrocytoma; Glioma","score_opus":0.011652785172964388,"score_gpt":0.26292750329688397,"score_spread":0.2512747181239196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025238642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669023,0.031387508,0.000023870278,0.0012770965,0.000039631264,0.00017218784,0.000024243716,0.0000024226536,0.00017071824],"genre_scores_gemma":[0.99243325,0.005689245,0.0015979145,0.000146717,0.0000879565,0.0000043484047,0.0000011113012,0.000008745378,0.000030720512],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99911994,0.0000149640755,0.00038873276,0.000119372206,0.00023994535,0.00011702376],"domain_scores_gemma":[0.9992178,0.000026569753,0.00026770486,0.00008923432,0.00023408618,0.0001645782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012121248,0.00008337354,0.00038052842,0.00010014264,0.000025375748,0.000017802984,0.000042228145,0.000034565357,0.000065373955],"category_scores_gemma":[0.000024531737,0.000082185055,0.00006642861,0.00011773245,0.000041110794,0.000058365094,0.0000108633885,0.000077830526,6.302717e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010197121,0.001294373,0.109302714,0.0002993772,0.0003448468,0.001348131,0.00087418477,0.00006942476,0.09687253,0.00020679209,0.009034844,0.77933306],"study_design_scores_gemma":[0.0037173629,0.0017793801,0.90887624,0.0017207919,0.00021056976,0.0030349893,0.00010845982,0.000018992747,0.07686357,0.000121440025,0.0034545315,0.00009367413],"about_ca_topic_score_codex":0.0001039997,"about_ca_topic_score_gemma":0.00003654911,"teacher_disagreement_score":0.79957354,"about_ca_system_score_codex":0.00007373601,"about_ca_system_score_gemma":0.00009147649,"threshold_uncertainty_score":0.3351409},"labels":[],"label_agreement":null},{"id":"W2025764144","doi":"10.1038/sj.bjc.6604104","title":"Reply: Breast cancer, human papilloma virus and sexual activities","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Human papilloma virus; Incidence (geometry); Gynecology; Medicine; Intraductal papilloma; Cervical cancer; Oncology; Internal medicine","score_opus":0.033847181325989045,"score_gpt":0.34809853328247353,"score_spread":0.31425135195648446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025764144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554349,0.04055867,0.0000047992876,0.0013978173,0.00018642163,0.00010593702,0.00010506134,0.000013987666,0.0021924058],"genre_scores_gemma":[0.9652918,0.029440816,0.000030551197,0.0012953373,0.0016793018,0.000014529788,0.0000018055412,0.00002724825,0.002218598],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99855006,0.000040415238,0.0003369069,0.00017290944,0.0006013628,0.00029832945],"domain_scores_gemma":[0.9990156,0.000035062974,0.0001476941,0.00010312566,0.00036453726,0.00033392376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019076324,0.00011289726,0.00041253807,0.00009534402,0.00022743529,0.00004831809,0.0000959471,0.000062692336,0.0050944053],"category_scores_gemma":[0.000029188368,0.00011227011,0.000087442706,0.00013929706,0.00026895525,0.00021440283,0.00004562026,0.0005175648,0.0000014744546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010751007,0.00018775776,0.082115196,0.00023358158,0.00029342072,0.0029730233,0.00035622294,0.000004533555,0.010518003,0.000015249937,0.030832188,0.8713957],"study_design_scores_gemma":[0.002953622,0.00036620197,0.9251468,0.00024479153,0.00008787013,0.022083223,0.00018079834,0.0000068702475,0.0020230443,0.000039515966,0.046720505,0.00014673448],"about_ca_topic_score_codex":0.0113304425,"about_ca_topic_score_gemma":0.0032958062,"teacher_disagreement_score":0.87124896,"about_ca_system_score_codex":0.00020964378,"about_ca_system_score_gemma":0.00049188785,"threshold_uncertainty_score":0.9958151},"labels":[],"label_agreement":null},{"id":"W2025843504","doi":"10.1038/sj.bjc.6602363","title":"Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Inhibitor of apoptosis; Molecular biology; Cancer research; Biology; Fusion protein; Apoptosis; Chemistry; Recombinant DNA; Programmed cell death; Biochemistry; Caspase","score_opus":0.0203745548329204,"score_gpt":0.3432954736120303,"score_spread":0.3229209187791099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025843504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623245,0.0012213301,0.0011549222,0.00057514786,0.0002709611,0.00047929832,0.000047243648,0.00000161059,0.00001705319],"genre_scores_gemma":[0.99705493,0.0005998385,0.0014952229,0.00011257477,0.0006364907,0.000007410331,0.000014569974,0.000014876685,0.00006409501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838734,0.00026932335,0.0007479407,0.00014264652,0.00033224613,0.00012049671],"domain_scores_gemma":[0.99868786,0.000027626458,0.0004738716,0.000171757,0.00055771775,0.00008116201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012096368,0.00009006379,0.00024628857,0.000040481424,0.000053971944,0.000016936241,0.00021915363,0.00008658515,0.000043337015],"category_scores_gemma":[0.00012371311,0.00006661318,0.00017481126,0.0001248775,0.000065096276,0.000010873859,0.000049415856,0.00012084887,6.631973e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038364838,0.00014996663,0.00006184816,0.000015215086,0.00009287623,8.88619e-7,0.000054322638,0.008030508,0.8890529,0.0000047249996,0.00046268897,0.10169041],"study_design_scores_gemma":[0.0014558883,0.0005979715,0.008261312,0.0001900681,0.000111066685,0.000035245248,0.000032634995,0.0007839618,0.984391,0.000019001274,0.0040337574,0.00008810279],"about_ca_topic_score_codex":0.00009097914,"about_ca_topic_score_gemma":0.0000916244,"teacher_disagreement_score":0.10160231,"about_ca_system_score_codex":0.000019562865,"about_ca_system_score_gemma":0.00013790147,"threshold_uncertainty_score":0.27164066},"labels":[],"label_agreement":null},{"id":"W2025983332","doi":"10.1038/bjc.2014.584","title":"Reply to Comment on: ‘Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers’","year":2014,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Indoor Air Quality and Microbial Exposure","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Occupational Safety and Health","keywords":"Lung cancer; Carcinogen; Medicine; Association (psychology); Environmental health; Textile; Occupational exposure; Cancer; Oncology; Internal medicine; Biology; Psychology; Geography; Genetics","score_opus":0.011011125487132735,"score_gpt":0.2522688003738904,"score_spread":0.24125767488675764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025983332","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38153976,0.0012535909,0.00005830383,0.60510606,0.0028504657,0.0017222279,0.000690201,0.000034193105,0.0067451885],"genre_scores_gemma":[0.07734238,0.0004419797,0.00011063726,0.9006924,0.0031843258,0.000214478,0.00002182173,0.00009014203,0.017901843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631333,0.00036497958,0.00094660925,0.00041676068,0.0012742064,0.00068411033],"domain_scores_gemma":[0.9976709,0.00014737823,0.0016001943,0.0002855893,0.00011585731,0.00018008928],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012635557,0.00031207962,0.00075723993,0.000121617384,0.00016212638,0.00012182197,0.0006137131,0.00045452465,0.0055371667],"category_scores_gemma":[0.00010626468,0.00033973157,0.00031748044,0.00022680042,0.00009484402,0.00018333568,0.00011783719,0.0016886555,0.000043050295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013426378,0.00008138931,0.020024365,0.00011089602,0.00018689818,0.00014940229,0.0012732623,0.0012025961,0.00041001508,6.13637e-7,0.9653573,0.011069007],"study_design_scores_gemma":[0.001038795,0.00042124157,0.016686311,0.0025969304,0.00010516243,0.00004292515,0.000050294504,0.000010138687,0.0029142136,0.000028116558,0.9757108,0.00039507155],"about_ca_topic_score_codex":0.009521213,"about_ca_topic_score_gemma":0.001992525,"teacher_disagreement_score":0.30419737,"about_ca_system_score_codex":0.0055912426,"about_ca_system_score_gemma":0.00017015415,"threshold_uncertainty_score":0.99990547},"labels":[],"label_agreement":null},{"id":"W2026697154","doi":"10.1038/bjc.2011.334","title":"Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Cancer Research UK","keywords":"Medicine; Carboplatin; Internal medicine; Placebo; Chemotherapy; Ovarian cancer; Adverse effect; Oncology; Toxicity; Surgery; Cancer; Gastroenterology; Cisplatin; Pathology","score_opus":0.035242061252903516,"score_gpt":0.3413820964353197,"score_spread":0.30614003518241617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026697154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154073,0.0021916064,0.0001625601,0.00044199373,0.000906475,0.0011219099,0.00013131219,0.0000060957736,0.003497325],"genre_scores_gemma":[0.991957,0.0056171617,0.0013302708,0.00031423222,0.0006062826,0.00008972565,0.000003569003,0.00003174677,0.0000500157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975546,0.00015120363,0.001256325,0.00021496412,0.0005736513,0.0002492848],"domain_scores_gemma":[0.99791956,0.00014382943,0.0011183935,0.00015512912,0.0005091711,0.00015394432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006507101,0.00019024283,0.0012455021,0.00017810984,0.00002992116,0.000012853824,0.000110525674,0.00014810628,0.001326306],"category_scores_gemma":[0.0000884008,0.00018417489,0.0003682028,0.00023671085,0.00013030396,0.00013705788,0.000017385324,0.00037509316,2.4223883e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64317566,0.0062769107,0.036166932,0.00046971065,0.004852588,0.0036010419,0.0056264265,0.00020898279,0.007819843,0.00026756164,0.0017390405,0.2897953],"study_design_scores_gemma":[0.6650608,0.0025272043,0.28207794,0.0034745825,0.00063823676,0.00028638676,0.00022441712,0.00008842227,0.0449724,0.00011407748,0.00032703643,0.00020848995],"about_ca_topic_score_codex":0.006044148,"about_ca_topic_score_gemma":0.00194544,"teacher_disagreement_score":0.2895868,"about_ca_system_score_codex":0.0005749147,"about_ca_system_score_gemma":0.0016894875,"threshold_uncertainty_score":0.99958664},"labels":[],"label_agreement":null},{"id":"W2027176779","doi":"10.1038/bjc.2011.201","title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"","keywords":"Folinic acid; Oxaliplatin; Medicine; Bevacizumab; Capecitabine; Internal medicine; FOLFOX; Colorectal cancer; Population; Placebo; Hazard ratio; Fluorouracil; Oncology; Neutropenia; Gastroenterology; Surgery; Chemotherapy; Cancer; Confidence interval; Pathology","score_opus":0.04379543442494756,"score_gpt":0.3317247483501661,"score_spread":0.28792931392521853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027176779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327781,0.06006806,0.000051037605,0.0022811848,0.0010642167,0.0008811821,0.00052809925,0.000029244437,0.0023188528],"genre_scores_gemma":[0.9333563,0.06278714,0.00089474325,0.0008363639,0.00059485144,0.00023620912,0.000022431013,0.000046345907,0.0012256525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982457,0.000034569464,0.0007171286,0.00025452446,0.00038239,0.0003656815],"domain_scores_gemma":[0.998249,0.0000839099,0.00051562523,0.0001045586,0.00084114284,0.0002057755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002753498,0.00022358453,0.00075401214,0.0001021571,0.00019802652,0.000038403818,0.0001407076,0.00006483773,0.0008632574],"category_scores_gemma":[0.00013338773,0.00019117343,0.00032471205,0.00021921968,0.00010761601,0.00015986135,0.000026464055,0.0002270516,0.000003776111],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077318974,0.0016680466,0.01674323,0.00016642071,0.006369534,0.0021002707,0.0030061204,0.000035467416,0.0007106083,0.000039938637,0.068657845,0.82318354],"study_design_scores_gemma":[0.060360417,0.019495277,0.3954279,0.002206307,0.002356562,0.0034920499,0.00050177664,0.00009566661,0.02576689,0.0010624115,0.48846322,0.00077150797],"about_ca_topic_score_codex":0.0050948383,"about_ca_topic_score_gemma":0.009926096,"teacher_disagreement_score":0.822412,"about_ca_system_score_codex":0.00032009045,"about_ca_system_score_gemma":0.0005421924,"threshold_uncertainty_score":0.94520634},"labels":[],"label_agreement":null},{"id":"W2027177342","doi":"10.1038/sj.bjc.6602171","title":"Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"National Cancer Institute; Canadian Institutes of Health Research; American Institute for Cancer Research","keywords":"Dicoumarol; In vivo; Mitomycin C; Pharmacology; Toxicity; Ratón; NAD+ kinase; In vitro; Chemistry; Biology; Enzyme; Biochemistry; Medicine; Immunology; Internal medicine","score_opus":0.08621952986380309,"score_gpt":0.42144747229488816,"score_spread":0.33522794243108506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027177342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994458,0.0042119003,0.000003793997,0.00037475108,0.00051520823,0.00014655634,0.000058205966,0.0000028619852,0.00022873019],"genre_scores_gemma":[0.9968555,0.0027739862,0.00002496702,0.00011749332,0.00018624225,0.000005461978,8.29824e-7,0.000009565208,0.000025984818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998689,0.0003350528,0.00047952041,0.00011364947,0.00018711238,0.00019565405],"domain_scores_gemma":[0.9991027,0.000079993595,0.0005475625,0.000061072984,0.00014689937,0.000061744395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006941249,0.00010608213,0.00036172144,0.00015412063,0.00007841206,0.000010353492,0.00022011415,0.000119509146,0.00019797328],"category_scores_gemma":[0.000050483006,0.00010033533,0.000114480754,0.00027842927,0.00026738344,0.00021156635,0.000040279076,0.00071803376,3.0222412e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069654285,0.0015788777,0.40064466,0.00009324487,0.00012331216,0.0004432106,0.00027822435,0.0019204821,0.5790187,0.00005121148,0.0007385956,0.014412955],"study_design_scores_gemma":[0.002626519,0.00018232051,0.7284435,0.00043873463,0.00006487798,0.00024670773,0.00014661539,0.0000133296635,0.26670137,0.0003163176,0.0007264788,0.00009322445],"about_ca_topic_score_codex":0.007802533,"about_ca_topic_score_gemma":0.010445626,"teacher_disagreement_score":0.32779884,"about_ca_system_score_codex":0.00014353986,"about_ca_system_score_gemma":0.00019969647,"threshold_uncertainty_score":0.99880457},"labels":[],"label_agreement":null},{"id":"W2028021497","doi":"10.1038/bjc.2011.172","title":"Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; National Institutes of Health","keywords":"PMS2; MLH1; MSH2; MSH6; Medicine; Germline mutation; Hazard ratio; Lynch syndrome; Internal medicine; Colorectal cancer; Body mass index; Oncology; Cancer; DNA mismatch repair; Genetics; Confidence interval; Mutation; Biology; Gene","score_opus":0.011324568619395283,"score_gpt":0.270149731711336,"score_spread":0.2588251630919407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028021497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819146,0.016671782,0.00008427619,0.00007084225,0.0003953084,0.0005739469,0.00022209779,0.000007008194,0.00006015091],"genre_scores_gemma":[0.9878605,0.009001083,0.0027517837,0.00005358953,0.00015019144,0.000118981385,0.000002084403,0.0000347672,0.00002700402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984166,0.00006089911,0.0007093732,0.00024257477,0.00028023685,0.00029030105],"domain_scores_gemma":[0.99876314,0.00009374572,0.0004380814,0.00008432425,0.00040066167,0.00022005562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039921797,0.00016175305,0.0005733749,0.00024004554,0.000046707733,0.000015548345,0.00008619387,0.00015986267,0.00008850353],"category_scores_gemma":[0.0002300106,0.0001773839,0.00011681429,0.00025363787,0.00022504518,0.00012791787,0.000024239167,0.00035627058,6.493668e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014685167,0.000059854054,0.9644664,0.0001905823,0.00019061576,0.00013230734,0.0031310907,0.000075920296,0.0068591936,8.6358557e-7,0.00015052332,0.02327417],"study_design_scores_gemma":[0.005279366,0.00071709714,0.97874165,0.0009417506,0.00021011214,0.00023714002,0.0012517951,0.00048580274,0.011615344,0.00018502465,0.00016265514,0.00017224853],"about_ca_topic_score_codex":0.01026436,"about_ca_topic_score_gemma":0.015617811,"teacher_disagreement_score":0.02310192,"about_ca_system_score_codex":0.00020398854,"about_ca_system_score_gemma":0.00061355386,"threshold_uncertainty_score":0.9963264},"labels":[],"label_agreement":null},{"id":"W2028149292","doi":"10.1038/bjc.2013.637","title":"DICER1 hotspot mutations in non-epithelial gonadal tumours","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"Medical Research Council; Sparks; Children's Cancer and Leukaemia Group; Susan G. Komen; McGill University; TD Bank","keywords":"Biology; Somatic cell; Germline mutation; Sanger sequencing; Cancer research; Mutation; Germline; Gene; Disorders of sex development; Genetics","score_opus":0.008994248972996262,"score_gpt":0.2765955895335263,"score_spread":0.26760134056053003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028149292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890588,0.0052012955,0.00002865747,0.0022365586,0.00034493217,0.00023674603,0.000028510043,0.000006899951,0.0028575875],"genre_scores_gemma":[0.99681133,0.0010158593,0.00041114073,0.00042690997,0.00041373106,0.000034746372,0.0000016339549,0.000018133793,0.0008665089],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988506,0.000025981391,0.00046763246,0.00009182917,0.00034825815,0.00021569709],"domain_scores_gemma":[0.99918324,0.00006826313,0.00016676754,0.00006275524,0.0003666999,0.00015226782],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016010174,0.00009162618,0.00034625523,0.00012545707,0.000046376594,0.000046312452,0.00008533104,0.000042988755,0.0013438344],"category_scores_gemma":[0.0002188243,0.00009393457,0.00011243449,0.00017833516,0.000080452555,0.00019537147,0.000023077671,0.0003016178,0.000047721114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118384894,0.0003097871,0.16558605,0.00013410006,0.00030344716,0.0023211841,0.0014026149,0.00007705178,0.0068700993,0.000009500627,0.014853788,0.808014],"study_design_scores_gemma":[0.0021227917,0.00009800085,0.9913234,0.0007350747,0.00009430498,0.0013914084,0.00051624374,0.00007749625,0.00017797414,0.00019577195,0.0031662264,0.00010127657],"about_ca_topic_score_codex":0.004062632,"about_ca_topic_score_gemma":0.0052568996,"teacher_disagreement_score":0.82573736,"about_ca_system_score_codex":0.00015459069,"about_ca_system_score_gemma":0.0002539128,"threshold_uncertainty_score":0.99956906},"labels":[],"label_agreement":null},{"id":"W2028944115","doi":"10.1038/bjc.2014.305","title":"Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Neutrophil to lymphocyte ratio; Proportional hazards model; Internal medicine; Urology; Bladder cancer; Receiver operating characteristic; Cohort; Gastroenterology; Log-rank test; Oncology; Lymphocyte; Cancer","score_opus":0.0068621890917840616,"score_gpt":0.2576992877885423,"score_spread":0.25083709869675824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028944115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997357,0.0006059798,0.00005869748,0.00021778025,0.00049969356,0.0010700087,0.00010559538,0.00000473915,0.00008047071],"genre_scores_gemma":[0.99891466,0.00008984468,0.00038440357,0.0002172201,0.00020899651,0.00007137637,0.0000022800868,0.000027203228,0.00008401148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998262,0.000112756155,0.00075836864,0.0001493395,0.0005093147,0.00020825144],"domain_scores_gemma":[0.9986599,0.00013791583,0.00050520845,0.00017978251,0.00035821585,0.00015899721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021234104,0.0001421208,0.0005125987,0.00012085816,0.000044375094,0.0000074993604,0.00017297608,0.00007905812,0.00005741293],"category_scores_gemma":[0.00041539877,0.00011158847,0.00033795927,0.00012229518,0.0001166094,0.00008507899,0.000039765862,0.00009093164,5.811305e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029420117,0.00039852902,0.9849276,0.00020768262,0.00038850945,0.000025985795,0.0002014799,0.00014224948,0.000599746,0.000013216163,0.0002032379,0.009949756],"study_design_scores_gemma":[0.018531905,0.0012689341,0.96925855,0.0011394378,0.00036999732,0.000050808907,0.00003367307,0.00010009797,0.008269766,0.000034398956,0.00084922055,0.00009319537],"about_ca_topic_score_codex":0.00022200854,"about_ca_topic_score_gemma":0.00021869096,"teacher_disagreement_score":0.015669033,"about_ca_system_score_codex":0.0004307506,"about_ca_system_score_gemma":0.0008727668,"threshold_uncertainty_score":0.4550446},"labels":[],"label_agreement":null},{"id":"W2029374754","doi":"10.1038/sj.bjc.6603508","title":"Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Inulin; Photodynamic therapy; Complement system; Adjuvant; Cancer research; Medicine; Immunology; Immune system; Chemistry; Biochemistry","score_opus":0.0071004572068327065,"score_gpt":0.3192214247781015,"score_spread":0.3121209675712688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029374754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9111822,0.087400064,0.000042188767,0.00039570933,0.00012712915,0.00042982446,0.0002551235,0.0000032026076,0.00016454319],"genre_scores_gemma":[0.96847445,0.031109951,0.000022135371,0.00005315245,0.00012542668,0.000025199119,0.000008979569,0.000018598119,0.00016210262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980774,0.00015293468,0.00070587086,0.00009880941,0.00076104957,0.00020397016],"domain_scores_gemma":[0.99835235,0.00015348523,0.00083416345,0.00012555569,0.00049127755,0.00004315837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070504326,0.00011690313,0.0006091124,0.00008941067,0.000048965965,0.000009038637,0.00020360813,0.000042621024,0.00042876755],"category_scores_gemma":[0.000044219152,0.00008495648,0.00023579171,0.0002155107,0.00022785326,0.00006796543,0.000020589772,0.00022495104,1.5772027e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019571702,0.00018933543,0.030703412,0.00026021164,0.0010402353,0.000022378383,0.00012745635,0.0002523483,0.8265405,0.0000044788476,0.006229044,0.13267343],"study_design_scores_gemma":[0.009853853,0.001929618,0.35904512,0.0018243312,0.00022709549,0.00011974362,0.00009586176,0.0002518652,0.62125224,0.00008204115,0.0051955846,0.00012269328],"about_ca_topic_score_codex":0.013097162,"about_ca_topic_score_gemma":0.002582668,"teacher_disagreement_score":0.3283417,"about_ca_system_score_codex":0.0001394763,"about_ca_system_score_gemma":0.0001577937,"threshold_uncertainty_score":0.9934747},"labels":[],"label_agreement":null},{"id":"W2029712223","doi":"10.1038/bjc.2012.21","title":"A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Carboplatin; Medicine; Etoposide; Adverse effect; Clinical endpoint; Internal medicine; Chemotherapy; Anesthesia; Clinical trial; Cisplatin","score_opus":0.02277835739252881,"score_gpt":0.3474266205460649,"score_spread":0.32464826315353607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029712223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808295,0.0097984625,0.000006825564,0.00023575871,0.00017054685,0.00147335,0.00006903321,0.000004671061,0.00015840615],"genre_scores_gemma":[0.99517673,0.0039269044,0.0001823694,0.00012927376,0.00014784207,0.00011288551,0.00000671373,0.00003099684,0.00028627692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980013,0.00011869527,0.0006289557,0.0001876244,0.00069022324,0.00037321032],"domain_scores_gemma":[0.9984204,0.00009778581,0.0005710302,0.000112265276,0.00059725525,0.00020124545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038945035,0.00017924553,0.00067752367,0.00025205986,0.00005401245,0.000035855493,0.00008102573,0.00007344389,0.00005958423],"category_scores_gemma":[0.00017160478,0.00013788517,0.00004567183,0.00035998403,0.00014843691,0.00027451784,0.000049690574,0.0004312037,1.3375993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19942747,0.0029216763,0.7541454,0.00085952424,0.00021888268,0.0008216755,0.002436029,0.000014110283,0.00094725424,0.0000031666857,0.00031041153,0.0378944],"study_design_scores_gemma":[0.37683472,0.012757273,0.5977963,0.0077351015,0.0002943644,0.00017915705,0.0007822277,0.00007367639,0.002498544,0.000003696428,0.00077026634,0.00027465352],"about_ca_topic_score_codex":0.007174488,"about_ca_topic_score_gemma":0.019239435,"teacher_disagreement_score":0.17740725,"about_ca_system_score_codex":0.0005911192,"about_ca_system_score_gemma":0.0011663099,"threshold_uncertainty_score":0.9994368},"labels":[],"label_agreement":null},{"id":"W2029739752","doi":"10.1038/sj.bjc.6602933","title":"Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University Health Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Burroughs Wellcome Fund","keywords":"Gene expression profiling; Ovarian cancer; Epithelial ovarian cancer; Biology; Gene expression; Cancer research; Gene; Profiling (computer programming); Pathology; Computational biology; Oncology; Cancer; Medicine; Genetics; Computer science","score_opus":0.007671174781372509,"score_gpt":0.2647239156067567,"score_spread":0.25705274082538415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029739752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94742066,0.011167392,0.040124323,0.00008546479,0.00016181721,0.00022586335,0.0004640508,0.000004156103,0.00034627147],"genre_scores_gemma":[0.97473925,0.0030262526,0.021712204,0.00008266352,0.00021994434,0.000029238014,0.000053968255,0.000022858545,0.000113616705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987082,0.00005104415,0.0006640279,0.00019825815,0.00021735618,0.00016112739],"domain_scores_gemma":[0.9984378,0.000006685546,0.0008508075,0.00019148039,0.00046472624,0.00004847228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020808302,0.00012809009,0.00033774506,0.000057294066,0.00004194636,0.000011457618,0.00027635673,0.00020908428,0.000027644444],"category_scores_gemma":[0.000018714678,0.00012947613,0.00022778439,0.00010244253,0.0001920606,0.000008490549,0.00007483378,0.00013735618,6.7308115e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001094631,0.00013031681,0.00056583807,0.00008234108,0.0001003821,0.000008701213,0.000010918774,0.00051832653,0.9945797,0.00011445108,0.001110592,0.0026689738],"study_design_scores_gemma":[0.00068450056,0.00009252807,0.0035467984,0.00023771219,0.000078161465,0.00006176651,0.000019398507,0.000005907984,0.99215955,0.00020511856,0.0027831013,0.00012548728],"about_ca_topic_score_codex":0.00078834133,"about_ca_topic_score_gemma":0.00010001476,"teacher_disagreement_score":0.027318593,"about_ca_system_score_codex":0.000023340486,"about_ca_system_score_gemma":0.00023063613,"threshold_uncertainty_score":0.5279883},"labels":[],"label_agreement":null},{"id":"W2029743705","doi":"10.1038/sj.bjc.6602796","title":"Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Vancouver General Hospital; Université de Montréal; Concordia University; Hôpital du Sacré-Cœur de Montréal; University of British Columbia; MAB-Mackay Rehabilitation Centre","funders":"Canadian Prostate Cancer Research Initiative; Cancer Research Society","keywords":"RELB; Prostate cancer; Transcription factor; Cancer research; Immunohistochemistry; Cell nucleus; Biology; P50; Cancer; Protein subunit; Pathology; Medicine; Internal medicine; Nucleus; Cell biology; Gene; Genetics","score_opus":0.012822568527421509,"score_gpt":0.27426325665098655,"score_spread":0.261440688123565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029743705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569553,0.0037846947,0.000014773617,0.00005444029,0.00016447938,0.00019323887,0.000065312386,0.000005700552,0.000021843323],"genre_scores_gemma":[0.9984248,0.0010862128,0.0001147825,0.000060348168,0.00023813124,0.000005177127,0.000011573235,0.000036756537,0.000022215241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987356,0.000088501605,0.00053019717,0.00019341423,0.0002703076,0.00018198804],"domain_scores_gemma":[0.9992688,0.000004300826,0.0003109218,0.00012374853,0.0002074893,0.000084778236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019527336,0.0001267288,0.00025178288,0.00006564862,0.000044339897,0.000032990694,0.00020808687,0.00010110943,0.00016292914],"category_scores_gemma":[0.000026029053,0.000145021,0.00010633069,0.00008799253,0.00007082005,0.000035308134,0.000019284573,0.00022549446,4.870705e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034198537,0.00036207307,0.016345775,0.00001711311,0.00006564031,0.000011850248,0.0014971932,0.001154069,0.9583333,0.0000016590287,0.00021289504,0.021656439],"study_design_scores_gemma":[0.0074896123,0.0026986895,0.23696265,0.0007077846,0.00015768546,0.00018034052,0.0034311037,0.00029774802,0.7161238,0.000027443366,0.031140918,0.0007822335],"about_ca_topic_score_codex":0.0012048425,"about_ca_topic_score_gemma":0.0015714102,"teacher_disagreement_score":0.24220951,"about_ca_system_score_codex":0.00014192302,"about_ca_system_score_gemma":0.00012758606,"threshold_uncertainty_score":0.59137845},"labels":[],"label_agreement":null},{"id":"W2029833118","doi":"10.1054/bjoc.1999.1127","title":"Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Activin type 2 receptors; Antibody; SMAD; Ovarian carcinoma; Receptor; Biology; Endocrinology; Internal medicine; Activin receptor; Cancer research; Western blot; Polyclonal antibodies; Cell culture; Signal transduction; Messenger RNA; Ovarian cancer; Molecular biology; Transforming growth factor; Cancer; Cell biology; Medicine; Immunology; TGF beta signaling pathway; Gene; Biochemistry","score_opus":0.005415904962909668,"score_gpt":0.2275070726240145,"score_spread":0.22209116766110484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029833118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994955,0.0044549233,0.00019143346,0.00003715184,0.000112448244,0.00006492193,0.00007330519,0.0000014370898,0.00010940397],"genre_scores_gemma":[0.99810994,0.000984332,0.00032393716,0.000029780549,0.0004001642,0.0000036699387,0.0000033018625,0.000011849029,0.00013303955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918884,0.00007408075,0.00030065572,0.00013554437,0.00015490787,0.00014599228],"domain_scores_gemma":[0.99963266,0.0000108329905,0.00012893917,0.00006783749,0.0000801406,0.00007961434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015809789,0.00007974458,0.0001545474,0.000040602696,0.000031917534,0.000023123102,0.00012196352,0.00008104287,0.0006012535],"category_scores_gemma":[0.000013828173,0.00009525884,0.00006735384,0.000059964477,0.00008462539,0.000017693634,0.0000116927395,0.00012138002,3.585908e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006811422,0.00011376256,0.007266848,0.000037320995,0.00004550514,0.000079335856,0.00012290363,0.0016603867,0.8579806,0.0000010480803,0.00019453754,0.1318166],"study_design_scores_gemma":[0.0014878163,0.00021494381,0.15353452,0.00019145169,0.000036424637,0.00039616262,0.000035919104,0.000048186033,0.83780205,0.000024477198,0.0060908715,0.00013715592],"about_ca_topic_score_codex":0.00059700856,"about_ca_topic_score_gemma":0.0004691956,"teacher_disagreement_score":0.14626767,"about_ca_system_score_codex":0.000014629449,"about_ca_system_score_gemma":0.00019468933,"threshold_uncertainty_score":0.6583304},"labels":[],"label_agreement":null},{"id":"W2030074595","doi":"10.1038/sj.bjc.6600012","title":"Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Medicine; Relative risk; Miscarriage; Confidence interval; Pediatrics; Cohort study; Cohort; Gestation; Risk factor; Pregnancy; Obstetrics; Internal medicine","score_opus":0.016442534108378773,"score_gpt":0.2749635731068426,"score_spread":0.25852103899846385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030074595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888259,0.009308786,0.000009407712,0.000859692,0.0004868913,0.00032119185,0.000019886997,0.000010617614,0.00015761593],"genre_scores_gemma":[0.9957635,0.003007874,0.00004454307,0.00026985406,0.00040223362,0.000007128388,0.0000010202806,0.000025642463,0.00047823653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740577,0.00015819156,0.0009997418,0.0001991501,0.000999038,0.00023811588],"domain_scores_gemma":[0.99832433,0.00019197672,0.0008148577,0.00011517872,0.00028683513,0.00026681685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071949547,0.000151682,0.00088122755,0.00018321547,0.000043819637,0.00003286399,0.00011269396,0.00011904463,0.00023404765],"category_scores_gemma":[0.00078708667,0.00016291234,0.00014464742,0.00026737363,0.00003152047,0.00020504069,0.000029800278,0.00043917348,0.0000014253377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009317007,0.000657253,0.9866711,0.00003817317,0.0006531925,0.00015415817,0.0027503613,0.000007351107,0.00003627643,6.0705366e-7,0.005625479,0.00331286],"study_design_scores_gemma":[0.0044291886,0.0007262423,0.99235445,0.00058533734,0.0005453187,0.00019602926,0.00029096525,0.000008984896,0.000027840639,0.000010322853,0.0006880127,0.00013731886],"about_ca_topic_score_codex":0.00840112,"about_ca_topic_score_gemma":0.0036356882,"teacher_disagreement_score":0.006937557,"about_ca_system_score_codex":0.0016811918,"about_ca_system_score_gemma":0.00024320738,"threshold_uncertainty_score":0.998202},"labels":[],"label_agreement":null},{"id":"W2030522586","doi":"10.1038/sj.bjc.6600013","title":"The effects of tricyclic antidepressants on breast cancer risk","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research Institute","keywords":"Tricyclic; Breast cancer; Medicine; Tricyclic antidepressant; Population; Internal medicine; Cancer; Cancer registry; Confidence interval; Medical prescription; Antidepressant; Oncology; Pharmacology; Environmental health","score_opus":0.005066163343384773,"score_gpt":0.25140190104961263,"score_spread":0.24633573770622785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030522586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93343705,0.06554188,0.000031408406,0.00016479599,0.0004437088,0.00009166987,0.00010758776,0.0000011797817,0.0001807037],"genre_scores_gemma":[0.8696148,0.1294796,0.000014449337,0.00012274252,0.00043904092,0.000008669639,5.8835656e-7,0.000011349593,0.00030878047],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991582,0.0000754696,0.00025749864,0.00011373895,0.00022825695,0.00016682663],"domain_scores_gemma":[0.9992559,0.00003975744,0.00034311737,0.00012966551,0.00016536887,0.00006616681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001438767,0.0000840502,0.0001651914,0.000023806102,0.00010929235,0.000032539043,0.00017902935,0.000060087,0.00006190873],"category_scores_gemma":[0.00006166704,0.000068916204,0.00016275421,0.000070007285,0.00006467947,0.000003872217,0.00003163064,0.00014884371,7.0649605e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021089352,0.00019383496,0.035505433,0.000054857017,0.000417136,0.00008054272,0.000030489906,0.00029126997,0.18935986,0.0000041571525,0.024410287,0.74944127],"study_design_scores_gemma":[0.0023426851,0.00054909283,0.69189614,0.000515676,0.00016556118,0.0006545036,0.000028200084,0.00004733866,0.25944635,0.000030208852,0.044110816,0.00021344428],"about_ca_topic_score_codex":0.0004935673,"about_ca_topic_score_gemma":0.00065015676,"teacher_disagreement_score":0.7492278,"about_ca_system_score_codex":0.000024235878,"about_ca_system_score_gemma":0.000043200274,"threshold_uncertainty_score":0.28103215},"labels":[],"label_agreement":null},{"id":"W2030646983","doi":"10.1038/sj.bjc.6605727","title":"Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"Gemcitabine; Pancreatic cancer; Medicine; Hypoxia (environmental); Oncology; Internal medicine; Pancreatic ductal adenocarcinoma; Cancer; Apoptosis; Cancer research; Biology; Chemistry","score_opus":0.004677069748060372,"score_gpt":0.23605263962634418,"score_spread":0.2313755698782838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030646983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92180794,0.0766696,0.0000043517616,0.00012962369,0.0011597422,0.00009778677,0.000027554275,0.0000031434322,0.00010024281],"genre_scores_gemma":[0.9803448,0.015722476,0.00027870352,0.00007427452,0.003288719,0.000013462753,0.000008605315,0.000027890497,0.00024110866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988964,0.000045758952,0.00040288945,0.0002494063,0.00014561383,0.00025990044],"domain_scores_gemma":[0.9993201,0.000012002846,0.00023393995,0.00010480309,0.00018665509,0.0001425381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002469859,0.0001530944,0.000322486,0.00009832387,0.00008992272,0.00008591523,0.00021131322,0.00011981363,0.000083302875],"category_scores_gemma":[0.00012947737,0.00016567738,0.000104424376,0.000073432406,0.00014871058,0.000027556858,0.000078349345,0.0003164369,4.1619302e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076026394,0.000046331028,0.009922252,0.000022668797,0.00004665818,0.000022646733,0.00004754725,0.0000024338426,0.9779841,0.000012264879,0.0018191796,0.009997933],"study_design_scores_gemma":[0.0018093211,0.00018448544,0.5938388,0.00009785206,0.00010561018,0.0017258079,0.00013573421,0.0000032734529,0.39142793,0.00014455093,0.010269856,0.0002567439],"about_ca_topic_score_codex":0.0009980178,"about_ca_topic_score_gemma":0.0024215209,"teacher_disagreement_score":0.58655614,"about_ca_system_score_codex":0.000017791219,"about_ca_system_score_gemma":0.00018696825,"threshold_uncertainty_score":0.67561275},"labels":[],"label_agreement":null},{"id":"W2030988924","doi":"10.1038/sj.bjc.6600332","title":"Prognostic impact of chromosomal aberrations in Ewing tumours","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"Hospital for Sick Children; Sick Kids Foundation","keywords":"Cytogenetics; Pathognomonic; Survival analysis; Internal medicine; Chromosome; Adverse effect; Oncology; Biology; Medicine; Pathology; Disease; Genetics; Gene","score_opus":0.027262936804394025,"score_gpt":0.31805423932157695,"score_spread":0.29079130251718294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030988924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95529145,0.043503992,0.0000026888322,0.00034971008,0.00008138782,0.00011422901,0.000012740713,0.000002834786,0.00064095453],"genre_scores_gemma":[0.9963131,0.003255032,0.00015517403,0.00004395447,0.00016184498,0.000010912661,9.682432e-7,0.000010011558,0.00004898361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924445,0.000020968075,0.00033784803,0.000062346575,0.00020085342,0.00013350826],"domain_scores_gemma":[0.9995029,0.000046758083,0.00017306452,0.000049300328,0.00013830184,0.000089699795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071843264,0.00006274487,0.00026798018,0.00009344733,0.000020995429,0.00001593328,0.00003995168,0.000029433137,0.00088719133],"category_scores_gemma":[0.00009615337,0.000057671987,0.00017341453,0.0001531385,0.00002793562,0.00009859321,0.000005995085,0.00013732878,0.0000022948925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020957072,0.0006350388,0.9211096,0.000016924958,0.00012310543,0.0015873513,0.00014427403,0.00016136299,0.0003368455,0.0000029956373,0.0022337611,0.073627785],"study_design_scores_gemma":[0.0019381036,0.00032948676,0.99231815,0.0014719983,0.00013521561,0.003071459,0.000032975753,0.00011775475,0.0003778011,0.000016759317,0.0001427644,0.000047534624],"about_ca_topic_score_codex":0.0007304263,"about_ca_topic_score_gemma":0.00044996117,"teacher_disagreement_score":0.07358025,"about_ca_system_score_codex":0.00018828418,"about_ca_system_score_gemma":0.00010921631,"threshold_uncertainty_score":0.9714123},"labels":[],"label_agreement":null},{"id":"W2031505107","doi":"10.1038/bjc.2014.215","title":"Oncogenic KRAS signalling in pancreatic cancer","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutschen Konsortium für Translationale Krebsforschung; Partenariat Canadien Contre Le Cancer; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"KRAS; Pancreatic cancer; Context (archaeology); Druggability; Cancer research; Cancer; Biology; Pancreatic Intraepithelial Neoplasia; Effector; Medicine; Bioinformatics; Oncology; Internal medicine; Colorectal cancer; Immunology; Gene; Genetics","score_opus":0.06952848065448751,"score_gpt":0.4345967426747374,"score_spread":0.3650682620202499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031505107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002530191,0.9950119,0.00004695035,0.00010461297,0.00040036283,0.00061103696,0.00003177661,0.000008234165,0.0012548921],"genre_scores_gemma":[0.0002616008,0.9944078,0.00030883466,0.00017786489,0.0018881236,0.00016034795,0.000008688512,0.000076586424,0.0027101715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964322,0.00038723944,0.0016710594,0.0002857296,0.0006947883,0.00052899966],"domain_scores_gemma":[0.99753207,0.0004914556,0.0010621184,0.00017667389,0.00039338705,0.00034428344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013431561,0.00031572345,0.0046739145,0.0004115405,0.000060081104,0.000048052774,0.00031928657,0.00044665032,0.0021598658],"category_scores_gemma":[0.00040104252,0.0002818411,0.00078376406,0.00043365735,0.00013934704,0.000080230755,0.00004823111,0.0017347534,0.000041008876],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068766385,0.0001030795,0.0038420027,0.012488104,0.0009866642,0.0022786271,0.000026089521,0.000004222886,0.000002653978,0.000004047092,0.0027445825,0.97745115],"study_design_scores_gemma":[0.0015073575,0.00022691971,0.0010936595,0.15069367,0.0042846366,0.0050325366,0.0000121145,0.00001973964,0.0000011273595,0.000032609896,0.8368705,0.00022513006],"about_ca_topic_score_codex":0.0018458368,"about_ca_topic_score_gemma":0.0011079793,"teacher_disagreement_score":0.977226,"about_ca_system_score_codex":0.0011119978,"about_ca_system_score_gemma":0.005030204,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W2032045378","doi":"10.1038/bjc.2013.34","title":"Innovative estimation of survival using log-normal survival modelling on ACCENT database","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Queen's University","keywords":"Proportional hazards model; Survival analysis; Medicine; Internal medicine; Relative survival; Hazard ratio; Colorectal cancer; Cancer; Surgery; Oncology; Cancer registry; Confidence interval","score_opus":0.17798926306323487,"score_gpt":0.416067982778762,"score_spread":0.23807871971552713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032045378","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3721435,0.00014765598,0.626722,0.000023524526,0.00034933488,0.000082660365,0.00006887,0.0000037277862,0.00045872424],"genre_scores_gemma":[0.57890874,0.00017633384,0.4206653,0.00003576663,0.00017065085,0.0000033294675,0.0000020811237,0.000016898246,0.00002089308],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983709,0.00015968551,0.00070204365,0.00010725091,0.0004736115,0.00018653416],"domain_scores_gemma":[0.99755645,0.00062932336,0.00061683025,0.000101488185,0.0010147423,0.00008119305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076856324,0.00010620042,0.00038418538,0.0000784989,0.000054947137,0.000061187915,0.00015350625,0.000049504142,0.0005656524],"category_scores_gemma":[0.0009547871,0.000105599975,0.000053787873,0.00021990691,0.00006912258,0.00031276885,0.000039224396,0.00029145897,0.0000018045794],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025022536,0.0005319679,0.0017194869,0.0004669513,0.00028128928,0.00011114164,0.00035697265,0.10862978,0.0028985576,0.09248843,0.001101398,0.7911638],"study_design_scores_gemma":[0.002130944,0.00037859986,0.0068068486,0.004103278,0.00016587513,0.00021009306,0.00034841232,0.81307805,0.009636492,0.16247147,0.0001514215,0.0005185155],"about_ca_topic_score_codex":0.0010468432,"about_ca_topic_score_gemma":0.000033664102,"teacher_disagreement_score":0.7906453,"about_ca_system_score_codex":0.00007984596,"about_ca_system_score_gemma":0.00015685156,"threshold_uncertainty_score":0.61934966},"labels":[],"label_agreement":null},{"id":"W2032063018","doi":"10.1038/sj.bjc.6600933","title":"Smoking and breast cancer","year":2003,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.014309255255431735,"score_gpt":0.2900620670236459,"score_spread":0.27575281176821415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032063018","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08930037,0.3651707,0.000022833136,0.53718525,0.0054121525,0.0003710073,0.0011152549,0.000028946619,0.0013934876],"genre_scores_gemma":[0.016266836,0.19327977,0.00008230596,0.76537657,0.019706681,0.00002484072,0.000016416092,0.00015406901,0.0050924937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982417,0.000040464318,0.0005241745,0.00023127283,0.00061480433,0.00034757977],"domain_scores_gemma":[0.9987119,0.00002975116,0.00057147094,0.00011847888,0.000399736,0.00016868133],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016165483,0.00023464517,0.00078615005,0.00015032575,0.000070406844,0.00011355475,0.00010582716,0.0004571053,0.0022947206],"category_scores_gemma":[0.000018398208,0.00023679376,0.0002551598,0.00012362612,0.000112243244,0.00012174927,0.000021569884,0.002492256,9.52007e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048839825,0.000011602394,0.02890466,0.00021188731,0.0003808263,0.003508055,0.000025710424,0.0000016663513,0.0000149446705,2.2822049e-7,0.75213796,0.21475363],"study_design_scores_gemma":[0.0013900673,0.000055058543,0.08285451,0.003589229,0.00071563263,0.030952035,0.000015867075,8.388611e-7,0.000014502437,0.000018697965,0.88016725,0.00022628838],"about_ca_topic_score_codex":0.006214112,"about_ca_topic_score_gemma":0.0010174877,"teacher_disagreement_score":0.22819133,"about_ca_system_score_codex":0.00044459902,"about_ca_system_score_gemma":0.00072283857,"threshold_uncertainty_score":0.999809},"labels":[],"label_agreement":null},{"id":"W2032397328","doi":"10.1038/sj.bjc.6605187","title":"Societal preference values for advanced melanoma health states in the United Kingdom and Australia","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Preference; Medicine; Unintended consequences; Environmental health; Population; Health economics; Melanoma; Demography; Family medicine; Public economics; Public health; Political science; Economics; Pathology; Sociology; Cancer research","score_opus":0.423800755621011,"score_gpt":0.47890601611921435,"score_spread":0.05510526049820336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032397328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94967836,0.013964524,0.00095009396,0.034404963,0.00026734386,0.00044694293,0.00023832647,0.000005664955,0.000043786273],"genre_scores_gemma":[0.9814599,0.003921431,0.00231826,0.011856066,0.00027701544,0.000028277602,0.000013789625,0.000010668771,0.000114584705],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970684,0.00019720382,0.0021666153,0.00018738057,0.000087711924,0.000292702],"domain_scores_gemma":[0.99741936,0.00040885937,0.0018695146,0.00010106,0.00009954874,0.00010164261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008109663,0.000099346995,0.00058674556,0.00015217438,0.00014637862,0.00013036861,0.00021713444,0.000058667567,0.000054691678],"category_scores_gemma":[0.00059300434,0.000111522415,0.000083949366,0.000153435,0.000050357037,0.00038432935,0.000008149688,0.00021314838,0.0000041009216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065913144,0.0011045516,0.30351186,0.002295996,0.0006036047,0.000060295508,0.03753603,0.01208127,0.00003590322,0.1324313,0.38040993,0.12927014],"study_design_scores_gemma":[0.004239477,0.0008945524,0.7992368,0.0011058087,0.000014569611,0.00022012182,0.0026399805,0.0015620895,0.000008359816,0.0766704,0.11301537,0.00039251926],"about_ca_topic_score_codex":0.0033630184,"about_ca_topic_score_gemma":0.0013492506,"teacher_disagreement_score":0.49572492,"about_ca_system_score_codex":0.00028261382,"about_ca_system_score_gemma":0.0001592399,"threshold_uncertainty_score":0.50839},"labels":[],"label_agreement":null},{"id":"W2032402100","doi":"10.1038/sj.bjc.6603978","title":"Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Mutation; Breast cancer; Cancer; Cancer research; Medicine; DNA repair; Oncology; Genetics; DNA; Biology; Internal medicine; Gene","score_opus":0.006853715373333404,"score_gpt":0.2793265579012389,"score_spread":0.2724728425279055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032402100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835284,0.009926632,0.00018067054,0.00034679178,0.0005869431,0.00013111078,0.00028997258,0.000006525818,0.00017850086],"genre_scores_gemma":[0.99663585,0.001517878,0.0007342972,0.00034888208,0.000469048,0.000014664863,0.000014703884,0.000030667423,0.00023400348],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998508,0.000055369943,0.0006600006,0.00022810005,0.00027786932,0.00027070567],"domain_scores_gemma":[0.9986939,0.000013950312,0.0005006971,0.00018181348,0.00050730415,0.00010232738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066210894,0.00011981485,0.00024490268,0.00012937332,0.000052839583,0.000015507045,0.0001850274,0.00013432425,0.00010988962],"category_scores_gemma":[0.0001076372,0.00014669594,0.00015950705,0.0002997228,0.0001149096,0.000018975814,0.000033813594,0.00020108183,3.1578682e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019423709,0.00022964425,0.06862126,0.00023114432,0.0008764976,0.00077004684,0.0009950949,0.008536481,0.3928331,0.000011595016,0.03046047,0.49449226],"study_design_scores_gemma":[0.0030108711,0.00040189663,0.5195737,0.0008444412,0.00012674062,0.0049661337,0.0010085872,0.000058963826,0.4488141,0.00020634427,0.020613963,0.00037427232],"about_ca_topic_score_codex":0.0027978378,"about_ca_topic_score_gemma":0.016629228,"teacher_disagreement_score":0.494118,"about_ca_system_score_codex":0.00041873302,"about_ca_system_score_gemma":0.0010455643,"threshold_uncertainty_score":0.92794997},"labels":[],"label_agreement":null},{"id":"W2032698893","doi":"10.1038/sj.bjc.6603528","title":"DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Coalition for Research in Women's Health; London Health Sciences Centre; Women's College Hospital","funders":"Cancer Research UK; London Health Sciences Centre","keywords":"DNA damage; DNA repair; Comet assay; Breast cancer; Biology; Cancer; Cancer research; Biomarker; Mutation; Synthetic lethality; DNA; Genetics; Molecular biology; Gene","score_opus":0.010906726076006179,"score_gpt":0.2888021234281337,"score_spread":0.27789539735212754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032698893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98231083,0.015628248,0.0006044111,0.000081944185,0.0005751044,0.00013131084,0.00024477387,0.000005494687,0.00041790403],"genre_scores_gemma":[0.99348015,0.0040603406,0.0017602514,0.0001446182,0.0003368452,0.000014955632,0.000007672582,0.00002800182,0.00016718936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984858,0.00008434343,0.0006459257,0.00023452089,0.0002752562,0.00027414144],"domain_scores_gemma":[0.9985015,0.00002340821,0.0006103376,0.00016634153,0.0005777826,0.00012064464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009300628,0.00013139128,0.00024804752,0.00014441684,0.00006593257,0.000021820411,0.00018190642,0.00016900421,0.00019254272],"category_scores_gemma":[0.00014945002,0.00015589858,0.00019900301,0.00032046658,0.00016887425,0.000021638216,0.000035734683,0.00021639514,8.243519e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00123212,0.0002279346,0.28946707,0.00013597496,0.0008277977,0.0002901442,0.00089632283,0.0032521696,0.29317793,0.000013629463,0.0052242903,0.4052546],"study_design_scores_gemma":[0.002072622,0.00014899971,0.7717025,0.00038778677,0.00011029288,0.0018435875,0.00056275714,0.000058858823,0.21719506,0.00016537718,0.0054857684,0.0002663459],"about_ca_topic_score_codex":0.0072273957,"about_ca_topic_score_gemma":0.017713554,"teacher_disagreement_score":0.48223546,"about_ca_system_score_codex":0.00031898246,"about_ca_system_score_gemma":0.0007931651,"threshold_uncertainty_score":0.99938357},"labels":[],"label_agreement":null},{"id":"W2032778349","doi":"10.1038/sj.bjc.6604072","title":"In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Breast Cancer Alliance","keywords":"Matrigel; Basement membrane; Breast cancer; Cancer research; Cancer cell; Matrix metalloproteinase; Pathology; Cancer; Biology; Downregulation and upregulation; Cell culture; Medicine; Internal medicine; Angiogenesis","score_opus":0.005180198040301306,"score_gpt":0.24855747926222857,"score_spread":0.24337728122192726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032778349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877207,0.0111938175,0.00032076272,0.00015344906,0.00036600573,0.00010131987,0.000086558524,4.5322108e-7,0.00005689985],"genre_scores_gemma":[0.992479,0.0067839557,0.00009044358,0.0002000325,0.00039357404,0.0000069802477,0.0000026224768,0.00000736383,0.00003597605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918014,0.000042754742,0.00037854738,0.000082486615,0.00019305015,0.00012301753],"domain_scores_gemma":[0.99927795,0.000011485944,0.0003890255,0.000072683,0.00021178246,0.000037052978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047731894,0.00006212695,0.00015666096,0.0000378904,0.000020213265,0.000006891294,0.00014116245,0.000057217992,0.000078272016],"category_scores_gemma":[0.000013910017,0.000055154553,0.00008070592,0.0000823456,0.000043462103,0.000011842661,0.000021445883,0.00008166208,1.3140308e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030185614,0.000055118613,0.00013962064,0.000040598825,0.00004191601,0.00001337958,0.000030062816,0.0001079125,0.9829742,0.000004513982,0.00027901118,0.016011847],"study_design_scores_gemma":[0.0005825423,0.00007008285,0.004272521,0.00022497092,0.000021378992,0.00006428053,0.000060645045,0.000004212148,0.99308723,0.00003453774,0.0015177114,0.000059881797],"about_ca_topic_score_codex":0.001268803,"about_ca_topic_score_gemma":0.0013145753,"teacher_disagreement_score":0.015951965,"about_ca_system_score_codex":0.000029979336,"about_ca_system_score_gemma":0.00018148257,"threshold_uncertainty_score":0.22491373},"labels":[],"label_agreement":null},{"id":"W2032931702","doi":"10.1038/sj.bjc.6600906","title":"Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca; University of Alberta","keywords":"Angiogenesis; Nitric oxide; Chemistry; Pharmacology; In vivo; Biochemistry; Cell growth; Endothelial stem cell; Cancer research; In vitro; Biology","score_opus":0.04903399066040607,"score_gpt":0.2568546937617395,"score_spread":0.20782070310133346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032931702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8663161,0.1326375,0.000032386637,0.00010813498,0.0001251934,0.0001598554,0.000012534413,0.000012073567,0.000596216],"genre_scores_gemma":[0.99314755,0.005348133,0.0005454992,0.00016567671,0.00012587816,0.0000065191616,9.442853e-7,0.000034072295,0.00062569615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825114,0.00018150936,0.00061328325,0.00014495403,0.0005359148,0.00027320578],"domain_scores_gemma":[0.99832875,0.000037158665,0.0005970218,0.00014109947,0.0007527511,0.00014322718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039898738,0.00016139333,0.0007410381,0.00018212349,0.000093083414,0.00004711022,0.00015408052,0.00007121392,0.0005371934],"category_scores_gemma":[0.000287729,0.00013377443,0.00030880285,0.00036165465,0.00015341019,0.00015447036,0.000017113389,0.0002483552,0.0000036619551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081197853,0.00025680894,0.041245103,0.00053699437,0.00093367515,0.0002155741,0.00021537271,0.000033317505,0.9388501,0.000031810014,0.003892726,0.0129765505],"study_design_scores_gemma":[0.0021453064,0.00019461544,0.18488652,0.0040743453,0.0005582509,0.005066842,0.0006297612,0.000017307011,0.7874001,0.00006245166,0.014688442,0.00027603065],"about_ca_topic_score_codex":0.00045537745,"about_ca_topic_score_gemma":0.00012510832,"teacher_disagreement_score":0.15144996,"about_ca_system_score_codex":0.000067166206,"about_ca_system_score_gemma":0.00030193108,"threshold_uncertainty_score":0.58818907},"labels":[],"label_agreement":null},{"id":"W2033008724","doi":"10.1038/sj.bjc.6606074","title":"Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech","keywords":"Bevacizumab; Medicine; Colorectal cancer; Adverse effect; Placebo; Internal medicine; Surgery; Clinical trial; Lung cancer; Cancer; Oncology; Chemotherapy; Pathology","score_opus":0.028596045017725023,"score_gpt":0.2997507750314482,"score_spread":0.2711547300137232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033008724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973062,0.0011568135,0.0000021487149,0.00012120687,0.00026848773,0.0006428239,0.000007726611,0.000008043054,0.00048650772],"genre_scores_gemma":[0.9941484,0.005325364,0.00004226707,0.0001916573,0.00013788106,0.000031023046,0.0000024866997,0.000023174001,0.00009779725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986548,0.00006619657,0.00049733743,0.00018843541,0.00038377647,0.00020946408],"domain_scores_gemma":[0.9991716,0.000018375957,0.00032216831,0.0000806693,0.00028580063,0.00012136248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028618242,0.00012775042,0.0005008046,0.00019912617,0.000066080844,0.000018782699,0.000070111775,0.000051336483,0.00019075246],"category_scores_gemma":[0.000071445465,0.00012771938,0.00005491137,0.00018816703,0.000021591344,0.0001777342,0.000030509877,0.00019539388,0.0000012483453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007565241,0.0020068525,0.9236136,0.00005523059,0.00026700078,0.00020960798,0.0012453869,0.000035673635,0.00017327032,0.000004369093,0.000550852,0.07108161],"study_design_scores_gemma":[0.007398413,0.001471756,0.98747885,0.0024770817,0.0002848366,0.00002698217,0.00034586393,0.00004386391,0.00018042134,0.000028042812,0.00014645475,0.000117424854],"about_ca_topic_score_codex":0.0035953172,"about_ca_topic_score_gemma":0.0032727069,"teacher_disagreement_score":0.07096419,"about_ca_system_score_codex":0.00023533852,"about_ca_system_score_gemma":0.00005370634,"threshold_uncertainty_score":0.5435068},"labels":[],"label_agreement":null},{"id":"W2033102749","doi":"10.1038/sj.bjc.6602331","title":"Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University Health Network; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Princess Margaret Hospital Foundation","keywords":"Photodynamic therapy; Singlet oxygen; In vivo; Luminescence; Photochemistry; Biophysics; Oxygen; Reactive oxygen species; Chemistry; Materials science; Optoelectronics; Biochemistry; Biology; Organic chemistry","score_opus":0.01651773018169987,"score_gpt":0.32523683970004047,"score_spread":0.3087191095183406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033102749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272597,0.0058640023,0.000033710057,0.0006869716,0.00007318895,0.00039557373,0.000015274563,0.000012779989,0.0001925401],"genre_scores_gemma":[0.98487025,0.013229065,0.00064154115,0.0005067043,0.0003464399,0.000028740336,0.000004398443,0.000030545212,0.00034228983],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978456,0.0001612488,0.0006237335,0.00024833906,0.00070728746,0.0004138031],"domain_scores_gemma":[0.99907655,0.00007296439,0.00024145974,0.00016537259,0.0002531977,0.00019046446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066544744,0.00017715045,0.00052464224,0.00043577093,0.00005176659,0.000064292675,0.00023754379,0.000096594566,0.00044633687],"category_scores_gemma":[0.00014284701,0.00016128301,0.00009183516,0.00057113654,0.00012506671,0.00052751694,0.00002946312,0.0006264415,0.0000026176035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007535521,0.002039643,0.054822724,0.00008170766,0.00033378036,0.0026435251,0.0016373813,0.0007809761,0.46421343,0.000006409601,0.0002455923,0.4656593],"study_design_scores_gemma":[0.022483073,0.0035594457,0.70599777,0.0013010228,0.0000610246,0.0036134082,0.0005518258,0.0011472092,0.2560141,0.000042743075,0.0047151493,0.00051320955],"about_ca_topic_score_codex":0.0020681287,"about_ca_topic_score_gemma":0.017490901,"teacher_disagreement_score":0.6511751,"about_ca_system_score_codex":0.00061493315,"about_ca_system_score_gemma":0.0004996149,"threshold_uncertainty_score":0.97603333},"labels":[],"label_agreement":null},{"id":"W2033119689","doi":"10.1038/bjc.2013.735","title":"A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Aflibercept; Pemetrexed; Internal medicine; Nausea; Lung cancer; Adverse effect; Phases of clinical research; Oncology; Cisplatin; Progressive disease; Gastroenterology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.008271514152304687,"score_gpt":0.2689566194956499,"score_spread":0.2606851053433452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033119689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963964,0.0015224195,0.000035126257,0.000079043646,0.000023431177,0.0018866489,0.000013046817,0.0000043943865,0.000039485163],"genre_scores_gemma":[0.9986967,0.00037022264,0.0006187357,0.00006880599,0.000007970403,0.00012368783,0.0000056803747,0.000020837644,0.000087345994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863017,0.000071121314,0.0005667718,0.0002113004,0.00030732297,0.0002133107],"domain_scores_gemma":[0.99875945,0.00006769277,0.0004550228,0.000111536676,0.00048534592,0.00012092519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010504931,0.00015120536,0.0005426183,0.00020330594,0.0000454682,0.000022086566,0.000083580635,0.00003298468,0.00013170573],"category_scores_gemma":[0.000030669602,0.000118688185,0.000027907568,0.00041942924,0.000047346013,0.00019242779,0.00002531491,0.00027900466,2.8171414e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012990184,0.009083333,0.91034377,0.00019854055,0.000068522946,0.00020970323,0.0014991771,0.0006094568,0.00030139435,1.937995e-7,0.00005835155,0.07632855],"study_design_scores_gemma":[0.054675963,0.01045549,0.9317203,0.00095646706,0.00020599728,0.00006050599,0.00041310207,0.0013070932,0.00006986257,0.0000038792646,0.000008196622,0.0001231051],"about_ca_topic_score_codex":0.0020785502,"about_ca_topic_score_gemma":0.0039422214,"teacher_disagreement_score":0.07620545,"about_ca_system_score_codex":0.00009984126,"about_ca_system_score_gemma":0.00009977369,"threshold_uncertainty_score":0.48399636},"labels":[],"label_agreement":null},{"id":"W2033168622","doi":"10.1038/bjc.2013.2","title":"The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Alberta Health Services","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Uterine sarcoma; Odds ratio; Epidemiology; Sarcoma; Uterine cancer; Endometrial cancer; Gynecology; Incidence (geometry); Risk factor; Body mass index; Internal medicine; Cancer; Oncology; Pathology","score_opus":0.026187519758832906,"score_gpt":0.3474204163849416,"score_spread":0.32123289662610865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033168622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703586,0.026527522,0.00003730028,0.0021269973,0.00048061274,0.00022034722,0.00012380307,0.0000017316834,0.00012304749],"genre_scores_gemma":[0.9870439,0.01196607,0.00019718528,0.00020599258,0.00018486867,0.00002438499,0.0000019750978,0.0000090971325,0.0003665033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980747,0.00026650773,0.0011375605,0.00010620187,0.00021376775,0.00020122547],"domain_scores_gemma":[0.99701875,0.0005922318,0.0014727412,0.00020929017,0.00063136674,0.000075610704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053116045,0.000099947676,0.0010988505,0.00017477857,0.0000400309,0.000003440106,0.00020657748,0.00007249761,0.001037748],"category_scores_gemma":[0.0007000476,0.000058628404,0.0005426576,0.000536177,0.00036656926,0.00004423186,0.00006185647,0.00017817809,3.8242356e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006397522,0.00019317947,0.8906358,0.00007130091,0.011121108,0.000033537588,0.000058538146,0.00015018616,0.006273103,0.00009130049,0.0012259105,0.08950631],"study_design_scores_gemma":[0.0033602337,0.00039123045,0.98480606,0.00023827318,0.0029328472,0.00026731013,0.000034389548,0.00008153096,0.0024449725,0.00014067376,0.00525403,0.00004846468],"about_ca_topic_score_codex":0.009509705,"about_ca_topic_score_gemma":0.0019069408,"teacher_disagreement_score":0.09417027,"about_ca_system_score_codex":0.00006172205,"about_ca_system_score_gemma":0.00021335778,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W2034052150","doi":"10.1038/sj.bjc.6603288","title":"A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Amgen","keywords":"Cardiotoxicity; Medicine; Toxicity; Daunorubicin; Neutropenia; Pharmacokinetics; Adverse effect; Cardiac toxicity; Cumulative dose; Internal medicine; Pharmacology; Anthracycline; Chemotherapy; Cancer; Breast cancer","score_opus":0.00777165921795052,"score_gpt":0.2701121673968785,"score_spread":0.26234050817892796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034052150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973161,0.0017471844,0.000020743832,0.00007161282,0.00012896754,0.00055212306,0.000028687247,0.0000076179585,0.00012691732],"genre_scores_gemma":[0.99890214,0.00037230787,0.00010833363,0.00007669269,0.0004096707,0.000011512871,0.0000074338104,0.000029827495,0.00008209306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814975,0.00008444134,0.00074624305,0.00016214373,0.0006297155,0.00022768644],"domain_scores_gemma":[0.99879676,0.000042230236,0.0005338961,0.00011405807,0.0004144384,0.000098596356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028045688,0.00013437228,0.0005793835,0.00024436874,0.00004408037,0.000023561679,0.00008968285,0.00007664832,0.000054543005],"category_scores_gemma":[0.00005639873,0.00011851862,0.0000941953,0.00048081478,0.000048686674,0.00014261341,0.00001062316,0.00037017427,3.1319604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056042977,0.04461112,0.45239887,0.00055009587,0.0010650748,0.0102761835,0.004754471,0.0012332856,0.11791059,0.000009477328,0.0020122763,0.3091356],"study_design_scores_gemma":[0.07889647,0.0151817305,0.87197024,0.0017406925,0.00048131673,0.0007695522,0.0011012917,0.000013492751,0.029321138,0.000033723416,0.00023803249,0.0002523348],"about_ca_topic_score_codex":0.0015872862,"about_ca_topic_score_gemma":0.0043519214,"teacher_disagreement_score":0.41957137,"about_ca_system_score_codex":0.00024896185,"about_ca_system_score_gemma":0.00039870592,"threshold_uncertainty_score":0.4833049},"labels":[],"label_agreement":null},{"id":"W2034728055","doi":"10.1038/sj.bjc.6605046","title":"Optimisation and molecular signalling of apoptosis in sequential cryotherapy and chemotherapy combination in human A549 lung cancer xenografts in SCID mice","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cryotherapy; Apoptosis; Chemotherapy; Vinorelbine; Oncogene; Cancer research; Puma; Biology; Etoposide; Lung cancer; Cancer; Cisplatin; Medicine; Pathology; Surgery; Internal medicine; Cell cycle","score_opus":0.005980208851277828,"score_gpt":0.2747257075849991,"score_spread":0.2687454987337213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034728055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810448,0.017836528,0.00073811616,0.00019691422,0.000044932603,0.000123735,0.0000023300317,7.729548e-7,0.000011850488],"genre_scores_gemma":[0.9796849,0.019694053,0.00040974602,0.00012767277,0.000055399618,0.000004322676,0.0000060482616,0.000008166945,0.000009713869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993394,0.00004203538,0.00029429002,0.00011992729,0.00010663452,0.00009770727],"domain_scores_gemma":[0.99969465,0.0000029803962,0.00017306345,0.00003037664,0.00007245048,0.000026464893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022900135,0.00006914424,0.00015082055,0.00011577574,0.000019537496,0.00002319052,0.00004355089,0.000090618676,0.000015275069],"category_scores_gemma":[0.0000045117317,0.00008273769,0.000029237848,0.00009597668,0.000026271244,0.000015244876,0.0000062667614,0.000081946026,4.9252677e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008841456,0.000061001796,0.006063154,0.000021135946,0.0000144975365,0.0000062526765,0.00012750839,0.0030395815,0.93871146,0.000023747258,0.000009918523,0.051833324],"study_design_scores_gemma":[0.0052174423,0.00030807822,0.13756144,0.00079798175,0.000019357512,0.00003883375,0.000056045457,0.0017566826,0.8533122,0.0005680961,0.00017162744,0.00019223409],"about_ca_topic_score_codex":0.00064899446,"about_ca_topic_score_gemma":0.0008759538,"teacher_disagreement_score":0.13149828,"about_ca_system_score_codex":0.000042664677,"about_ca_system_score_gemma":0.000038603357,"threshold_uncertainty_score":0.33739454},"labels":[],"label_agreement":null},{"id":"W2035608162","doi":"10.1038/sj.bjc.6603822","title":"Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Human papillomavirus; Gynecology; Multivariate analysis; Obstetrics; HPV infection; Pregnancy; Childbirth; Young adult; Demography; Cervical cancer; Gerontology; Internal medicine; Cancer","score_opus":0.0143832739657256,"score_gpt":0.29909157417968923,"score_spread":0.28470830021396365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035608162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950763,0.0040089604,0.00003031514,0.00011395383,0.00010056655,0.000111752146,0.00001142304,0.000009023251,0.0005376863],"genre_scores_gemma":[0.99005264,0.009427957,0.00001299249,0.00012828445,0.00025045496,0.0000047342824,0.0000026196901,0.00001696477,0.000103323706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987105,0.000054717315,0.00031268416,0.00011723475,0.00046941213,0.000335457],"domain_scores_gemma":[0.99910736,0.0001236429,0.00018888166,0.00004706793,0.00026055015,0.00027246712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009489596,0.000088193025,0.00032284635,0.0002329854,0.00007570694,0.000042074167,0.000041948133,0.00010454871,0.001039079],"category_scores_gemma":[0.00023140704,0.00007891515,0.000057372992,0.00043869088,0.00010742931,0.00010971864,0.000015273223,0.0007012063,3.659478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032313672,0.00007852812,0.86832196,0.000022484992,0.00012886684,0.00019262472,0.00022678712,0.00000540161,0.00002685271,0.0000018072309,0.00018191407,0.13048963],"study_design_scores_gemma":[0.0037859112,0.0005980874,0.9940998,0.00019048167,0.00005778899,0.00012395729,0.00016844443,0.000003066298,0.000105495994,0.00014980571,0.0006284955,0.00008866868],"about_ca_topic_score_codex":0.0064811073,"about_ca_topic_score_gemma":0.028952915,"teacher_disagreement_score":0.13040096,"about_ca_system_score_codex":0.0004521844,"about_ca_system_score_gemma":0.00020682519,"threshold_uncertainty_score":0.9998741},"labels":[],"label_agreement":null},{"id":"W2035754366","doi":"10.1038/sj.bjc.6601327","title":"Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Matrix metalloproteinase; Extracellular matrix; Cell biology; Cancer research; Biology; Metastasis; Carcinogenesis; Cell migration; Cell adhesion; Cell growth; Matrix metalloproteinase inhibitor; Cancer cell; Cancer; Cell; Biochemistry; Genetics","score_opus":0.012954151224905303,"score_gpt":0.28810227680804096,"score_spread":0.27514812558313567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035754366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006438604,0.99227536,0.0000261287,0.000005299611,0.00057458854,0.0004158574,0.000101325975,0.000005176546,0.00015764742],"genre_scores_gemma":[0.0009231903,0.9956129,0.0003566249,0.000030080708,0.00092888763,0.0001464183,0.000017384593,0.0000773383,0.0019071588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822265,0.00014190104,0.0007508507,0.00035551822,0.00020711837,0.00032198968],"domain_scores_gemma":[0.99872786,0.000007666353,0.0007782562,0.00014221581,0.00016304561,0.00018094455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027096595,0.00038769707,0.0010351241,0.00009279563,0.00013773827,0.00009644724,0.00021781561,0.00030618144,0.000088148365],"category_scores_gemma":[0.000024087094,0.00034549128,0.00030719244,0.000104311264,0.00004470808,0.000013326634,0.00010974408,0.00032538848,0.0000019221602],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017538925,0.000044422904,0.0000024798132,0.004040456,0.00041565992,0.00015199152,0.00001679702,0.0000026227067,0.023626428,5.014971e-7,0.0009261277,0.970755],"study_design_scores_gemma":[0.0002500293,0.000055825953,0.0000013175835,0.007146656,0.0001764853,0.0006119263,0.0000066805615,2.9567738e-8,0.3180057,0.0000031760699,0.67345273,0.00028942403],"about_ca_topic_score_codex":0.00009181869,"about_ca_topic_score_gemma":0.00014146349,"teacher_disagreement_score":0.97046554,"about_ca_system_score_codex":0.00010281503,"about_ca_system_score_gemma":0.0008028253,"threshold_uncertainty_score":0.9998997},"labels":[],"label_agreement":null},{"id":"W2035801850","doi":"10.1038/bjc.2012.483","title":"The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; McGill University; Université de Montréal; University of Toronto; Cancer Care Ontario; Women's College Hospital","funders":"Canadian Cancer Society Research Institute","keywords":"Pancreatic cancer; Medicine; BRCA mutation; Germline mutation; Cancer; Internal medicine; Incidence (geometry); Oncology; BRCA2 Protein; Breast cancer; Mutation; Genetics; Biology","score_opus":0.019886564809976505,"score_gpt":0.3595286960281431,"score_spread":0.33964213121816655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035801850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89367306,0.10499466,0.000023535946,0.00062890956,0.00014383737,0.00013372565,0.000006853026,0.0000014615163,0.00039394962],"genre_scores_gemma":[0.9588473,0.04038578,0.00015356792,0.00010418488,0.00021980915,0.000018320312,3.0166396e-7,0.0000075323346,0.0002632452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891627,0.000092552225,0.0003850518,0.000059199487,0.00031861613,0.00022830274],"domain_scores_gemma":[0.9990637,0.00024357114,0.00023106685,0.0000628708,0.00024925545,0.0001495427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008941112,0.00005687469,0.00033911562,0.000063450716,0.000062155515,0.000013483502,0.00006947275,0.000055601526,0.00014358635],"category_scores_gemma":[0.0004464974,0.000044663513,0.00004224587,0.00014328035,0.000221548,0.00014869255,0.000017699967,0.00026021604,5.124456e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019982582,0.000032671884,0.86912,0.00006942369,0.00012241292,0.00010131471,0.00072828174,0.000007885306,0.00064899755,0.000025207475,0.0004089847,0.128535],"study_design_scores_gemma":[0.0014185614,0.0001263467,0.99329215,0.0009812271,0.00017652258,0.0013916349,0.0006248253,0.000101504345,0.00039489064,0.00010842722,0.0013387105,0.000045219855],"about_ca_topic_score_codex":0.0037640077,"about_ca_topic_score_gemma":0.0030261867,"teacher_disagreement_score":0.12848978,"about_ca_system_score_codex":0.000180969,"about_ca_system_score_gemma":0.00052239926,"threshold_uncertainty_score":0.5690079},"labels":[],"label_agreement":null},{"id":"W2035888142","doi":"10.1038/bjc.2014.474","title":"Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute","keywords":"Biology; Gene silencing; Cancer research; PTEN; Cancer; Gene; Transcriptome; Clusterin; CDKN2A; Gene expression; Genetics; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.08497990341358552,"score_gpt":0.4082376150283377,"score_spread":0.3232577116147522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035888142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057999928,0.94133264,0.000091231865,0.000007285248,0.0001609843,0.00019840887,0.00018420175,6.9699337e-7,0.000024596584],"genre_scores_gemma":[0.12366635,0.8758092,0.000121279205,0.00002585053,0.00026342843,0.00001852398,0.000028358343,0.000029290824,0.000037710044],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99708146,0.0005985881,0.0014667108,0.00027600347,0.00038843558,0.00018878082],"domain_scores_gemma":[0.9972463,0.000036863912,0.0019050753,0.00040487823,0.00032783308,0.00007900708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094500027,0.00023173672,0.0022679958,0.00021422122,0.00004308868,0.000026417436,0.0006800552,0.00028469926,0.00009374414],"category_scores_gemma":[0.000072920615,0.00019225288,0.0026312785,0.00043812237,0.000115585506,0.000011196896,0.00006209358,0.00029872064,8.368243e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008473179,0.00015553579,0.00016807625,0.0024573717,0.075912595,0.000021703758,0.00009871977,0.0036431784,0.112733714,0.000006861192,0.000035278685,0.80468225],"study_design_scores_gemma":[0.0011190287,0.001044937,0.0013001405,0.006306237,0.45846137,0.00014336738,0.000031617277,0.00004843973,0.12624197,0.00014575728,0.4041758,0.0009813443],"about_ca_topic_score_codex":0.0028874143,"about_ca_topic_score_gemma":0.011250712,"teacher_disagreement_score":0.80370086,"about_ca_system_score_codex":0.000095157586,"about_ca_system_score_gemma":0.00084192253,"threshold_uncertainty_score":0.7839845},"labels":[],"label_agreement":null},{"id":"W2036147404","doi":"10.1038/sj.bjc.6605033","title":"The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"General Secretariat for Research and Technology","keywords":"Colorectal cancer; Kallikrein; Medicine; Cancer; Internal medicine; Oncology; Stage (stratigraphy); Univariate analysis; Survival analysis; Cancer biomarkers; Gastroenterology; Pathology; Multivariate analysis; Biology","score_opus":0.018931964548935632,"score_gpt":0.287669215680338,"score_spread":0.26873725113140234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036147404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94083637,0.056623865,0.0000033552337,0.0017257927,0.00032125102,0.00027296002,0.00001758973,0.000010121521,0.00018868837],"genre_scores_gemma":[0.98179674,0.01680617,0.00007890951,0.00039668966,0.00019083156,0.000009803757,0.0000033139656,0.00001741655,0.00070014264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838966,0.00006412274,0.00072360504,0.00012909234,0.00042276958,0.00027072022],"domain_scores_gemma":[0.9987565,0.00020286065,0.00045665028,0.0000759468,0.00036927027,0.00013874046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025758863,0.00012606339,0.00040609733,0.00009489159,0.00008113087,0.000054974545,0.00011136969,0.00008288426,0.00026373848],"category_scores_gemma":[0.0004379198,0.00010619149,0.00018610054,0.00028234525,0.00011561173,0.0002106512,0.000012438603,0.00027640013,0.0000015906699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015480269,0.0002538135,0.3017158,0.00004469327,0.00026539515,0.0008961704,0.00035104025,0.0008543812,0.0021471987,0.00006492237,0.009602701,0.68225586],"study_design_scores_gemma":[0.002466704,0.0004829956,0.9817528,0.0029272106,0.00018008713,0.0010754348,0.000102049155,0.00034456578,0.0015746941,0.00018651357,0.00878246,0.00012445817],"about_ca_topic_score_codex":0.0030886705,"about_ca_topic_score_gemma":0.002760791,"teacher_disagreement_score":0.6821314,"about_ca_system_score_codex":0.00014372315,"about_ca_system_score_gemma":0.00056349265,"threshold_uncertainty_score":0.46691665},"labels":[],"label_agreement":null},{"id":"W2036319230","doi":"10.1038/sj.bjc.6603020","title":"Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Ovarian cancer; Relative risk; Cohort study; Prospective cohort study; Body mass index; Cohort; Internal medicine; Proportional hazards model; Oncology; Cancer; Physiology; Confidence interval","score_opus":0.01753804341093503,"score_gpt":0.3200312903753389,"score_spread":0.3024932469644039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036319230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8318597,0.16616619,0.00001838276,0.0009606119,0.00019432373,0.00017766,0.00018757927,0.0000059979975,0.00042952885],"genre_scores_gemma":[0.91434795,0.08412221,0.00034128787,0.00016524168,0.00040677018,0.000043310556,0.0000062809627,0.000016940143,0.0005500214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984772,0.000053691405,0.0006654023,0.00020356946,0.00040708054,0.0001930326],"domain_scores_gemma":[0.99834394,0.000076853095,0.0006714587,0.00012708233,0.00066131016,0.000119370074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032547227,0.0001458048,0.0009810479,0.00025984485,0.00007100224,0.000033356322,0.000062918356,0.00006335409,0.0009292446],"category_scores_gemma":[0.00006463671,0.00013278428,0.00030202864,0.0005266734,0.00012318903,0.00009648099,0.000024463397,0.00018023237,6.43679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023162618,0.00024472934,0.85707766,0.00006126301,0.025696423,0.00041850095,0.00010377732,0.00040117957,0.00012608044,0.000021625734,0.0074920035,0.10812515],"study_design_scores_gemma":[0.0034821827,0.00019093086,0.9578837,0.0007943806,0.029328285,0.0001906199,0.00009409204,0.000054380303,0.0007347137,0.0000746609,0.007057188,0.00011486981],"about_ca_topic_score_codex":0.016477138,"about_ca_topic_score_gemma":0.015684672,"teacher_disagreement_score":0.10801028,"about_ca_system_score_codex":0.0002815798,"about_ca_system_score_gemma":0.00023774442,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W2036551301","doi":"10.1038/bjc.2014.662","title":"Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Aerobic exercise; Erythropoietin; Medicine; Internal medicine; Cytokine; Immune system; Aerobic capacity; VO2 max; Immunology; Oncology; Blood pressure","score_opus":0.022593246680641325,"score_gpt":0.2905265655931172,"score_spread":0.26793331891247585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036551301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958666,0.0028838317,0.0000042376573,0.000043421325,0.00049839524,0.00055105065,0.000013040731,0.000005266609,0.00013415946],"genre_scores_gemma":[0.9995653,0.000059571754,0.0000023316647,0.00012214752,0.00017012363,0.00003335433,0.0000018514011,0.000024153407,0.000021159987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982629,0.00044770597,0.00037916715,0.00012671486,0.000620573,0.00016296204],"domain_scores_gemma":[0.9988113,0.00011759459,0.00034856112,0.00012797189,0.00044449585,0.00015008466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010857389,0.00012357692,0.00050918444,0.000095810305,0.000031099837,0.000019303396,0.00012045522,0.000052380867,0.00002090796],"category_scores_gemma":[0.00011809246,0.00008537594,0.00006275235,0.00020929142,0.00006336774,0.0001616613,0.000012275762,0.00050705735,8.9226825e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006655167,0.0005547979,0.9242142,0.000099277684,0.00022934223,0.00044836313,0.04080453,0.0003265545,0.00007615122,0.0000021363524,0.0003553305,0.026234161],"study_design_scores_gemma":[0.018296491,0.025038924,0.88447654,0.010617938,0.0003979571,0.0003265948,0.059862986,0.000018642106,0.00062407623,0.000003163914,0.00010976252,0.0002269143],"about_ca_topic_score_codex":0.0006214883,"about_ca_topic_score_gemma":0.0065756254,"teacher_disagreement_score":0.039737638,"about_ca_system_score_codex":0.0002433388,"about_ca_system_score_gemma":0.0003553853,"threshold_uncertainty_score":0.36693534},"labels":[],"label_agreement":null},{"id":"W2036753674","doi":"10.1038/bjc.2013.444","title":"Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the ‘Jade Goody effect’ in the UK","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colposcopy; Incidence (geometry); Odds ratio; Rate ratio; Cervical cancer; Quarter (Canadian coin); Medical diagnosis; Obstetrics; Gynecology; Internal medicine; Pediatrics; Confidence interval; Cancer; Pathology","score_opus":0.02189963832578633,"score_gpt":0.3182348104078243,"score_spread":0.29633517208203797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036753674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539841,0.033762697,0.0000062532276,0.010876672,0.000107593965,0.00045309786,0.000048311183,0.000006117434,0.0007551788],"genre_scores_gemma":[0.98741627,0.009038724,0.00003449072,0.002365009,0.00095312676,0.00012384265,0.000004013882,0.000021553617,0.00004295866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978561,0.00031165342,0.00035865637,0.00017335925,0.00091765705,0.00038262163],"domain_scores_gemma":[0.99814177,0.0011502507,0.00011083183,0.00016890495,0.00019801305,0.00023021553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068352855,0.0001594012,0.00045785247,0.00006612939,0.00013966013,0.0003081598,0.00028383866,0.000094724484,0.0043255533],"category_scores_gemma":[0.00028560724,0.000090023845,0.00018649643,0.00024272474,0.00015125166,0.00014643176,0.00004273058,0.0010624226,0.0000075614357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007737904,0.00014636679,0.6083428,0.00006140235,0.00021441243,0.0003945142,0.0003947807,0.000040369363,0.00008841704,0.000016334609,0.046096887,0.3434299],"study_design_scores_gemma":[0.0031830985,0.0008171041,0.9910672,0.00059381296,0.000103858816,0.0004531445,0.00027808978,0.000052748186,0.00039425853,0.00038418503,0.0025718743,0.000100672136],"about_ca_topic_score_codex":0.070964284,"about_ca_topic_score_gemma":0.0075787376,"teacher_disagreement_score":0.38272431,"about_ca_system_score_codex":0.00014345751,"about_ca_system_score_gemma":0.0001547408,"threshold_uncertainty_score":0.99658465},"labels":[],"label_agreement":null},{"id":"W2037269181","doi":"10.1038/sj.bjc.6603294","title":"The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Lægeforeningen; Kræftens Bekæmpelse","keywords":"Medicine; Breast cancer; Socioeconomic status; Odds ratio; Confidence interval; Demography; Gynecology; Cancer; Internal medicine; Obstetrics; Population; Environmental health","score_opus":0.013443231115502576,"score_gpt":0.27032888826357515,"score_spread":0.2568856571480726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037269181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754196,0.02362922,0.00000442319,0.00063623325,0.000044933804,0.00014046028,0.000048481787,0.0000030277624,0.00007365125],"genre_scores_gemma":[0.98885024,0.010738718,0.00002109312,0.000112959766,0.00019459543,0.00001638319,0.0000010768124,0.000013512387,0.000051404862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895096,0.000051009567,0.00039028368,0.00013843308,0.0002031003,0.00026624315],"domain_scores_gemma":[0.999398,0.00012012844,0.00025013517,0.00004645192,0.00007957459,0.00010570715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043066838,0.0001088005,0.00031531524,0.00011555325,0.00008724783,0.000078530284,0.00006196736,0.00006928864,0.00005707088],"category_scores_gemma":[0.00001775653,0.00008558726,0.0000331687,0.00014864109,0.0001253851,0.0002934391,0.000015548296,0.00039440856,1.908512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026427972,0.000010192329,0.9680875,0.000019686264,0.000037534282,0.00018962352,0.00022329569,0.00011752736,0.00004873871,0.000005576351,0.0001052441,0.030890796],"study_design_scores_gemma":[0.0026964024,0.00008933321,0.9942894,0.00092092645,0.0000386426,0.00028120042,0.00093108776,0.000017947568,0.000017846553,0.000097272896,0.0005197537,0.000100192425],"about_ca_topic_score_codex":0.021061571,"about_ca_topic_score_gemma":0.08243085,"teacher_disagreement_score":0.061369278,"about_ca_system_score_codex":0.00038692955,"about_ca_system_score_gemma":0.00022173686,"threshold_uncertainty_score":0.98545724},"labels":[],"label_agreement":null},{"id":"W2037737757","doi":"10.1038/bjc.2012.204","title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Mammography; Breast cancer; Magnetic resonance imaging; BRCA mutation; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Breast MRI; Prospective cohort study; Mastectomy; Radiology; Gynecology","score_opus":0.007518906663478972,"score_gpt":0.26141951993968654,"score_spread":0.25390061327620755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037737757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361393,0.062381595,0.00088960165,0.00012113944,0.000079008016,0.00008603846,0.000047148504,0.0000019839597,0.00025420784],"genre_scores_gemma":[0.99441236,0.0013492552,0.0036777838,0.00011434254,0.00024750095,0.00002438497,0.0000064285073,0.00002334372,0.00014458863],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999003,0.000043966487,0.0003436543,0.00013109233,0.00021367062,0.0002646312],"domain_scores_gemma":[0.99922204,0.000013947052,0.00028494938,0.0001225462,0.00027265368,0.00008386971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002767366,0.00009160207,0.00015568428,0.0000727508,0.000038943195,0.000024118573,0.00013996121,0.00003848179,0.000033971122],"category_scores_gemma":[0.000040949737,0.000091873706,0.000027170987,0.00018350629,0.0001319268,0.000027603763,0.000025049865,0.00013128306,2.4772237e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017954624,0.000110309855,0.39321396,0.000031489926,0.000051144023,0.00010567356,0.00065650255,0.0018306809,0.012997363,0.0000019659283,0.000629831,0.5885756],"study_design_scores_gemma":[0.0032560755,0.00032186802,0.9756249,0.0007214067,0.000029904528,0.0011533835,0.0002787919,0.00000842596,0.012578523,0.0000059164454,0.005857456,0.00016334215],"about_ca_topic_score_codex":0.00012908627,"about_ca_topic_score_gemma":0.0009857268,"teacher_disagreement_score":0.5884123,"about_ca_system_score_codex":0.00009919586,"about_ca_system_score_gemma":0.00029611815,"threshold_uncertainty_score":0.3746501},"labels":[],"label_agreement":null},{"id":"W2037911234","doi":"10.1038/sj.bjc.6605038","title":"Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CHEK2; Cancer; Breast cancer; Proband; Medicine; Prostate cancer; Family history; Colorectal cancer; Internal medicine; Oncology; First-degree relatives; Prostate; Mutation; Gynecology; Germline mutation; Genetics; Biology; Gene","score_opus":0.015211476474332887,"score_gpt":0.3080242400064988,"score_spread":0.2928127635321659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037911234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91336143,0.0858779,0.00007873674,0.0001690537,0.00020920753,0.00021010268,0.000035934558,0.0000013159233,0.00005632487],"genre_scores_gemma":[0.976691,0.022683095,0.00035388404,0.000058186273,0.00013052774,0.000026733846,0.0000072778294,0.000013345149,0.00003594566],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989598,0.00007130494,0.0004700006,0.00017374237,0.00017974207,0.00014543333],"domain_scores_gemma":[0.99895006,0.00003052773,0.00047947932,0.00007786148,0.00041624185,0.000045838755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019781687,0.000108160195,0.00026708964,0.000126833,0.000025159567,0.0000135204255,0.000086205095,0.00013140345,0.000020945095],"category_scores_gemma":[0.00016483373,0.00012408695,0.00004678867,0.00031033278,0.000092254006,0.000030506275,0.000015723512,0.00016500651,7.3721615e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008706883,0.00016244341,0.18711352,0.00043448337,0.00023453914,0.00013400232,0.0033278188,0.026384324,0.20964755,0.000008634949,0.0005805551,0.5711014],"study_design_scores_gemma":[0.0028401478,0.0004600308,0.80581045,0.0015637127,0.00007528583,0.00008604826,0.00013693063,0.00015797642,0.18791096,0.00021348291,0.00057350576,0.00017147251],"about_ca_topic_score_codex":0.003243975,"about_ca_topic_score_gemma":0.015406687,"teacher_disagreement_score":0.6186969,"about_ca_system_score_codex":0.00016596311,"about_ca_system_score_gemma":0.0004639745,"threshold_uncertainty_score":0.8597293},"labels":[],"label_agreement":null},{"id":"W2038781838","doi":"10.1038/sj.bjc.6605298","title":"Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Centre Hospitalier Universitaire de Rennes; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Clear cell renal cell carcinoma; Cancer research; Vascular endothelial growth factor; Angiogenesis; Multiplex ligation-dependent probe amplification; Biology; Renal cell carcinoma; DNA methylation; Pathology; Medicine; Gene expression; Gene; VEGF receptors; Genetics","score_opus":0.012262583784001049,"score_gpt":0.24258670978154637,"score_spread":0.23032412599754531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038781838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977164,0.022334736,0.00006248332,0.00014778058,0.00006341834,0.00014324278,0.00003689409,0.0000030933966,0.00004440787],"genre_scores_gemma":[0.99745524,0.0020228927,0.00028568011,0.000035794463,0.00011045501,0.0000025540407,0.000007494972,0.000012965993,0.00006692601],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987768,0.00008098924,0.00041720358,0.00014890006,0.00043848262,0.00013760854],"domain_scores_gemma":[0.9982751,0.000047722362,0.000923774,0.00007477373,0.0005473137,0.00013134404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018105922,0.0001227325,0.0005047156,0.00007859042,0.000042006715,0.000019539282,0.00004984845,0.0000621478,0.000017996797],"category_scores_gemma":[0.00004685972,0.00010366817,0.00005367714,0.000100529076,0.00007223646,0.00012634395,0.000014092657,0.00014669925,5.3721905e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013916419,0.00033488072,0.17476343,0.00018890171,0.000103348364,0.002833793,0.00018961678,0.00015930705,0.80545145,0.0000020802709,0.00016747943,0.014414042],"study_design_scores_gemma":[0.0027854065,0.00078388286,0.6188662,0.002576846,0.0001254363,0.00081091357,0.00004251924,0.000021119551,0.37390253,0.000016666125,0.000005644746,0.00006284235],"about_ca_topic_score_codex":0.00026782736,"about_ca_topic_score_gemma":0.000112699476,"teacher_disagreement_score":0.44410276,"about_ca_system_score_codex":0.00008649284,"about_ca_system_score_gemma":0.00015389669,"threshold_uncertainty_score":0.42274654},"labels":[],"label_agreement":null},{"id":"W2039063575","doi":"10.1054/bjoc.2001.1743","title":"Relationship of hypoxia to metastatic ability in rodent tumours","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; University of Toronto","keywords":"Pathology; Metastasis; Oxygenation; Hypoxia (environmental); Fibrosarcoma; Lung; In vivo; Biology; Lung cancer; Cancer; Cancer research; Medicine; Internal medicine; Oxygen; Chemistry","score_opus":0.01759644752512282,"score_gpt":0.29318588735420187,"score_spread":0.275589439829079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039063575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96926004,0.029152814,0.00038341735,0.00022094842,0.0006332946,0.000106790154,0.00002517907,0.0000012896543,0.00021620817],"genre_scores_gemma":[0.99356836,0.00461035,0.00075069437,0.00017555086,0.0005961655,0.000009740878,0.000003102071,0.000011844157,0.00027421102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989726,0.000077896126,0.00044948983,0.00013671536,0.00019773176,0.00016555282],"domain_scores_gemma":[0.99932396,0.000017373242,0.0002071785,0.00012170484,0.00021922568,0.000110532084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044904096,0.000077684934,0.00023611003,0.0000725505,0.000023618213,0.000015889405,0.00014916959,0.000046289242,0.0000662751],"category_scores_gemma":[0.00028092097,0.00008947498,0.000119802855,0.00017056659,0.00004265927,0.0000093612,0.000028759952,0.00013229191,0.0000010180595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010619491,0.00053129415,0.40082297,0.00011409054,0.00017014088,0.000113741204,0.00036660425,0.0088515,0.31253606,0.00008383479,0.014677986,0.26066986],"study_design_scores_gemma":[0.0011224712,0.00013007596,0.89961165,0.0001285086,0.000054946024,0.00047900912,0.000086428205,0.0000055700707,0.0094841095,0.00022613222,0.08854075,0.00013037477],"about_ca_topic_score_codex":0.00067223585,"about_ca_topic_score_gemma":0.0048998534,"teacher_disagreement_score":0.49878865,"about_ca_system_score_codex":0.000039861687,"about_ca_system_score_gemma":0.00021972465,"threshold_uncertainty_score":0.36486837},"labels":[],"label_agreement":null},{"id":"W2039310969","doi":"10.1038/sj.bjc.6600261","title":"Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Paclitaxel; Oncology; Internal medicine; Breast cancer; Chemotherapy; Phases of clinical research; Cancer; Colorectal cancer","score_opus":0.022443216307930947,"score_gpt":0.3270490110939391,"score_spread":0.30460579478600813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039310969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905558,0.0066971453,0.000035646484,0.00057777454,0.00026664688,0.0014413915,0.00018091561,0.000019340561,0.00022531534],"genre_scores_gemma":[0.99583834,0.0022327506,0.00064970006,0.00020396894,0.00034535653,0.00018117896,0.000025537918,0.00005759532,0.0004655629],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978592,0.00009955515,0.00071271096,0.00029977495,0.0005847258,0.00044403537],"domain_scores_gemma":[0.9982397,0.00006811925,0.0006462768,0.00012755548,0.0006387285,0.0002796098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015683423,0.0003204644,0.0012217469,0.00019682282,0.00012907565,0.00004439516,0.00010908258,0.000051083112,0.0015469525],"category_scores_gemma":[0.000018735846,0.00022534422,0.00010950568,0.00047509966,0.00018649451,0.00042962382,0.00001678829,0.0004235939,9.245576e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62377,0.0058221007,0.26802486,0.000078340985,0.0015448969,0.001419472,0.0003162973,0.0010006982,0.0000673542,6.4946767e-7,0.0010867293,0.09686862],"study_design_scores_gemma":[0.8659806,0.011711359,0.11580698,0.001857022,0.0017543287,0.0011463107,0.00007670983,0.00022491117,0.00017496955,0.0000029483056,0.0009381804,0.00032562704],"about_ca_topic_score_codex":0.0012976864,"about_ca_topic_score_gemma":0.008644492,"teacher_disagreement_score":0.24221069,"about_ca_system_score_codex":0.0003704055,"about_ca_system_score_gemma":0.00025212517,"threshold_uncertainty_score":0.99936575},"labels":[],"label_agreement":null},{"id":"W2040122586","doi":"10.1038/sj.bjc.6601416","title":"Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Nonsteroidal; Medicine; Prostate cancer; Meta-analysis; Cancer; Oncology; Anti-inflammatory; Prostate; MEDLINE; Internal medicine; Pharmacology","score_opus":0.034264359352461325,"score_gpt":0.332148677920477,"score_spread":0.29788431856801567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040122586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071211066,0.9963974,0.0000028074433,0.00007056288,0.00014039509,0.0023603588,0.00030235888,0.000008036457,0.0000059718927],"genre_scores_gemma":[0.000117071024,0.9987641,0.00008316119,0.00024388546,0.00013341634,0.00023617716,0.000008895537,0.00006627013,0.00034700244],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957554,0.00039749703,0.0025163712,0.00033275085,0.0006984706,0.00029954073],"domain_scores_gemma":[0.99506265,0.00022261815,0.003432741,0.00030885957,0.0006232568,0.0003498684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001355654,0.00049560383,0.012324228,0.0004359592,0.000060628947,0.00008902667,0.00014548938,0.00022938075,0.00016767831],"category_scores_gemma":[0.0002409701,0.00036158503,0.0023816603,0.0004970158,0.00018533858,0.00026774593,0.00005777808,0.0006492603,0.000001229325],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009943622,0.000026063544,0.000067513545,0.87259805,0.106142,0.0006517469,0.000060452236,0.0000027961062,4.2650657e-7,0.0000016035026,0.00018925917,0.020250173],"study_design_scores_gemma":[0.0003910291,0.000047542202,0.000049903127,0.3557031,0.6190851,0.0020505227,0.0000063573516,6.2606205e-7,0.0000021841417,9.614835e-7,0.022451295,0.00021145993],"about_ca_topic_score_codex":0.00024650968,"about_ca_topic_score_gemma":0.00014227668,"teacher_disagreement_score":0.51689494,"about_ca_system_score_codex":0.00016992928,"about_ca_system_score_gemma":0.00110903,"threshold_uncertainty_score":0.9998836},"labels":[],"label_agreement":null},{"id":"W2040291607","doi":"10.1038/sj.bjc.6605243","title":"CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"Pfizer","keywords":"Gemcitabine; Medicine; Axitinib; Internal medicine; Pancreatic cancer; Biomarker; Oncology; Gastroenterology; Population; Confidence interval; Cancer","score_opus":0.02325453379314503,"score_gpt":0.3661477160749084,"score_spread":0.3428931822817634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040291607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97952104,0.011834485,0.00006665874,0.00384432,0.0003237322,0.0015014882,0.00006368108,0.000018502249,0.002826092],"genre_scores_gemma":[0.97715926,0.011788856,0.0014605117,0.0037042745,0.00034653986,0.00021264706,0.000016926137,0.000042864172,0.005268127],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965869,0.00018523716,0.0012321328,0.00035145474,0.000906168,0.00073810376],"domain_scores_gemma":[0.9974894,0.00028719936,0.0004159139,0.00021141858,0.0008342289,0.00076185836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008101649,0.00027856618,0.0016073865,0.00041646542,0.000108443215,0.000049988084,0.00024910853,0.00017046276,0.004139744],"category_scores_gemma":[0.0018777035,0.00024179045,0.00021492528,0.00074559567,0.00010998852,0.00023497717,0.000042222124,0.0005525948,0.000029539502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16468622,0.0021569063,0.26296058,0.0004030912,0.0011048509,0.009188702,0.0011771698,0.00020158838,0.007143041,0.000011682772,0.04662304,0.50434315],"study_design_scores_gemma":[0.117495835,0.0026108143,0.8605283,0.003552472,0.00047953503,0.0011856258,0.0001441682,0.00025275213,0.0002473724,0.00010783223,0.013058911,0.00033636193],"about_ca_topic_score_codex":0.0034262203,"about_ca_topic_score_gemma":0.0031421003,"teacher_disagreement_score":0.59756774,"about_ca_system_score_codex":0.0010421701,"about_ca_system_score_gemma":0.0020124596,"threshold_uncertainty_score":0.9967706},"labels":[],"label_agreement":null},{"id":"W2041053765","doi":"10.1054/bjoc.1999.1254","title":"Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials","year":2000,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Meta-analysis; Randomized controlled trial; Internal medicine; Chemotherapy; Relative risk; Oncology; Confidence interval; Cancer; Clinical trial; Surgery","score_opus":0.10356721154314862,"score_gpt":0.419892512357432,"score_spread":0.3163253008142834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041053765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020683636,0.9926272,0.0000036571907,0.00011919539,0.0002714705,0.003373545,0.0011265987,0.0000039391475,0.0004060283],"genre_scores_gemma":[0.0019807713,0.9959404,0.00010038173,0.000042254655,0.00016892387,0.0011894053,0.00002283742,0.00004935732,0.0005057088],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98961383,0.0017413355,0.006982821,0.0003194739,0.0010434833,0.0002990297],"domain_scores_gemma":[0.98719245,0.00386299,0.007841436,0.00016905769,0.00080410147,0.00012997683],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.006626981,0.00056559354,0.07242468,0.0011573035,0.000032662043,0.000029731516,0.00022108763,0.00017282972,0.0055902475],"category_scores_gemma":[0.00105425,0.00034761493,0.02668717,0.0013306105,0.00022253829,0.0000659161,0.000021095775,0.0004288501,2.7295795e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064266294,0.0002607882,0.000018265566,0.0014049311,0.51840323,0.00012695641,0.00007976936,0.00005220228,5.8222895e-7,0.0000037914967,0.000053613287,0.41532958],"study_design_scores_gemma":[0.18749665,0.00027314248,0.000091181406,0.004896352,0.7731299,0.000096130985,0.000025145802,0.000008763696,0.0000066774883,0.000022791135,0.03375843,0.00019485578],"about_ca_topic_score_codex":0.0058900886,"about_ca_topic_score_gemma":0.009402074,"teacher_disagreement_score":0.41513473,"about_ca_system_score_codex":0.00040895608,"about_ca_system_score_gemma":0.0014559951,"threshold_uncertainty_score":0.9998976},"labels":[],"label_agreement":null},{"id":"W2041158359","doi":"10.1038/sj.bjc.6600057","title":"A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Medical prescription; Conformity; Colorectal cancer; Family medicine; Cancer; Medical record; Clinical Practice; Internal medicine; Nursing; Psychology","score_opus":0.23981626029705966,"score_gpt":0.5537257032086796,"score_spread":0.31390944291162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041158359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585333,0.011607716,0.00025678443,0.027940148,0.00060422666,0.0009811769,0.000015260675,0.000015459469,0.00004594146],"genre_scores_gemma":[0.967853,0.019369239,0.0018741648,0.006372981,0.0043270225,0.000043082317,0.000005432465,0.000042392367,0.000112704336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99392694,0.00051250396,0.0036351425,0.00025377845,0.0013906206,0.00028103008],"domain_scores_gemma":[0.99097353,0.0017341984,0.002501081,0.0001511556,0.0041862554,0.00045379894],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050295205,0.00017366782,0.0011022864,0.00008305519,0.000063654385,0.000058469785,0.000122507,0.00016964495,0.0021530641],"category_scores_gemma":[0.047230836,0.00014203924,0.00030783124,0.00040779976,0.0001351616,0.00036372253,0.00004551045,0.00071508787,0.0000024663357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006680924,0.001609356,0.38335013,0.000026654769,0.0012783906,0.00069643673,0.00014845164,0.00015520224,0.0000031438578,0.0000045037223,0.03429317,0.5717536],"study_design_scores_gemma":[0.06752292,0.009838341,0.8759288,0.0029060715,0.0031025663,0.0059930915,0.0007012908,0.003578209,0.0000019266129,0.00007182768,0.03007509,0.00027983455],"about_ca_topic_score_codex":0.0027546939,"about_ca_topic_score_gemma":0.0028294222,"teacher_disagreement_score":0.57147384,"about_ca_system_score_codex":0.0001553922,"about_ca_system_score_gemma":0.0010290126,"threshold_uncertainty_score":0.9987591},"labels":[],"label_agreement":null},{"id":"W2041257997","doi":"10.1038/sj.bjc.6601293","title":"Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Cancer Institute; National Institutes of Health; University of Melbourne; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario; University of Otago","keywords":"Oestrogen receptor; Breast cancer; Progesterone receptor; Medicine; Internal medicine; Oncology; Gynecology; Population; Cancer; Endocrinology; Physiology; Estrogen receptor; Environmental health","score_opus":0.008221190300679502,"score_gpt":0.2728402483328303,"score_spread":0.2646190580321508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041257997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97125274,0.024004117,0.000026169659,0.00016248898,0.0006516211,0.00044768897,0.003405994,0.000010853302,0.00003830396],"genre_scores_gemma":[0.94456095,0.054203138,0.0002535974,0.00008167463,0.0002841602,0.00010797729,0.00001101342,0.00005230477,0.0004452025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983172,0.00006287194,0.0005347196,0.00023723367,0.00030908108,0.00053888216],"domain_scores_gemma":[0.9987707,0.00005097043,0.00041753773,0.000087395674,0.00024347247,0.00042992254],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032295744,0.00018872751,0.0005500372,0.000102395774,0.00007684233,0.00007294567,0.00006902504,0.00011426157,0.0011737078],"category_scores_gemma":[0.00010651338,0.00018313894,0.0001074349,0.0001700581,0.00008537702,0.00023370651,0.000011780758,0.000389522,6.7632556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000562956,0.000113281385,0.8596608,0.00006895208,0.000194697,0.0000097585025,0.00075852755,0.000008697202,0.0021039713,0.0000017426838,0.0058448887,0.13067175],"study_design_scores_gemma":[0.007635379,0.0005692235,0.85454077,0.000918474,0.00016531526,0.0006165985,0.0015545479,0.000005417585,0.0021038528,0.00003042729,0.1315102,0.00034981602],"about_ca_topic_score_codex":0.007525406,"about_ca_topic_score_gemma":0.004261951,"teacher_disagreement_score":0.13032193,"about_ca_system_score_codex":0.0009489844,"about_ca_system_score_gemma":0.0005026563,"threshold_uncertainty_score":0.99973935},"labels":[],"label_agreement":null},{"id":"W2041772218","doi":"10.1038/bjc.2014.428","title":"The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Medicine; Prostate; BRCA2 Protein; Cancer; Mutation; Rectal examination; Oncology; Internal medicine; Germline mutation; Biology; Gene; Genetics","score_opus":0.016026473434308474,"score_gpt":0.3323389348483007,"score_spread":0.3163124614139922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041772218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790192,0.01932765,0.000020703432,0.0005416316,0.00023735197,0.00029159518,0.0003769171,0.000008039205,0.00017688592],"genre_scores_gemma":[0.98207676,0.017232422,0.000047084897,0.0001180752,0.00038888425,0.000047680405,0.000012604048,0.000020916741,0.000055561464],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986778,0.0000804815,0.00048097727,0.00014092521,0.00041747358,0.00020235998],"domain_scores_gemma":[0.9984648,0.00013246835,0.000577992,0.00015387498,0.0005204486,0.00015042297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026320707,0.00012657764,0.00037244748,0.000042213058,0.00008712379,0.000050563587,0.00009054306,0.00004721471,0.00018831775],"category_scores_gemma":[0.000121885256,0.000086632914,0.0002491021,0.00013098163,0.000088170236,0.000098049095,0.000011946238,0.00021840085,0.0000014841878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012652193,0.00027005613,0.30516526,0.000030725612,0.0014608686,0.00019614377,0.00020832746,0.00093891413,0.0014951024,0.000009361535,0.0032665126,0.6856935],"study_design_scores_gemma":[0.0034597267,0.0011879277,0.98284626,0.0015034335,0.00029428463,0.00008443545,0.000030093059,0.00016021461,0.008951642,0.00033763493,0.0010578257,0.00008654592],"about_ca_topic_score_codex":0.029664902,"about_ca_topic_score_gemma":0.0043094857,"teacher_disagreement_score":0.68560696,"about_ca_system_score_codex":0.0004082338,"about_ca_system_score_gemma":0.0004292081,"threshold_uncertainty_score":0.9767966},"labels":[],"label_agreement":null},{"id":"W2041991343","doi":"10.1038/sj.bjc.6604223","title":"Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Ministry of Health and Medical Education","keywords":"Cisplatin; Protein kinase B; Apoptosis; Apoptosis-inducing factor; Cancer research; UVB-induced apoptosis; Caspase; Ovarian cancer; Biology; Programmed cell death; Cell biology; Chemistry; Cancer; Chemotherapy; Biochemistry","score_opus":0.012753619048402201,"score_gpt":0.2440335178067487,"score_spread":0.2312798987583465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041991343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945778,0.003385444,0.0013269751,0.000056187528,0.00038583268,0.00008712054,0.000039291204,0.0000036333256,0.00013771196],"genre_scores_gemma":[0.9942395,0.0045532207,0.00038185302,0.000053412325,0.00036804323,0.0000035259538,0.00004246925,0.000021961803,0.00033598213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988899,0.00004398077,0.00045687688,0.00015802165,0.00028984135,0.00016132688],"domain_scores_gemma":[0.99898446,0.0000118539365,0.00050049816,0.0001113427,0.0003035439,0.00008833332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001311504,0.0001107062,0.00022389402,0.000052098905,0.00009321828,0.00001607046,0.000116960975,0.00017880929,0.000110695706],"category_scores_gemma":[0.000055212287,0.00012027513,0.0001464993,0.00009966245,0.00003804124,0.000016709524,0.000025560728,0.00012100215,8.3443194e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005089874,0.000040064784,0.0007632771,0.000012973871,0.00006647133,0.0000019994025,0.000043957756,0.00011586594,0.95807064,0.0000038497574,0.0024072775,0.038422734],"study_design_scores_gemma":[0.0008540284,0.00020238076,0.016220715,0.0001399074,0.000030362135,0.00018941078,0.000028389692,0.00004901432,0.9767984,0.000021401323,0.005316838,0.00014911995],"about_ca_topic_score_codex":0.00019361587,"about_ca_topic_score_gemma":0.000039586022,"teacher_disagreement_score":0.038273614,"about_ca_system_score_codex":0.000032792846,"about_ca_system_score_gemma":0.00012249696,"threshold_uncertainty_score":0.49046773},"labels":[],"label_agreement":null},{"id":"W2042306244","doi":"10.1038/bjc.2015.56","title":"Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health","funders":"","keywords":"Medicine; Formulary; Cancer drugs; Per capita; Cancer; Drug; Internal medicine; Environmental health; Pharmacology; Population","score_opus":0.036956095699909854,"score_gpt":0.26781527467637173,"score_spread":0.23085917897646188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042306244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87505955,0.11460128,0.000066805645,0.0013293219,0.0017628727,0.00007874943,0.0001238178,0.00000890252,0.0069686784],"genre_scores_gemma":[0.9749864,0.02157755,0.00060687156,0.0007782359,0.00055642985,0.0000256631,0.0000028657637,0.000040036637,0.001425995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983151,0.000014731633,0.0010011734,0.00026472786,0.000050917497,0.00035333657],"domain_scores_gemma":[0.9988356,0.000014184262,0.00073547516,0.00011335143,0.00006037681,0.00024101428],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081240473,0.00016669279,0.0006110758,0.0003612909,0.00005138872,0.00015503437,0.00023548833,0.00011209581,0.0009504643],"category_scores_gemma":[0.000016535261,0.00021436026,0.00009305746,0.00011140744,0.00007780978,0.00063563406,0.000036561414,0.00027364603,0.00008360941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024974023,0.00010299943,0.18898793,0.000027914455,0.00025945494,0.000049334114,0.002091538,0.0007980267,0.0000051341317,0.00860261,0.033598125,0.7652272],"study_design_scores_gemma":[0.0035820187,0.00007111972,0.24652544,0.00017461153,0.000017023593,0.00007560267,0.00024551223,0.00014185844,0.000084536376,0.006772343,0.7418517,0.00045823384],"about_ca_topic_score_codex":0.0043652793,"about_ca_topic_score_gemma":0.007876628,"teacher_disagreement_score":0.76476896,"about_ca_system_score_codex":0.000787618,"about_ca_system_score_gemma":0.0003468637,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W2042593536","doi":"10.1038/bjc.2013.764","title":"Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Occupational Cancer Research Centre","funders":"World Health Organization","keywords":"Medulloblastoma; microRNA; Gene silencing; Biology; Cancer research; Epigenetics; DNA methylation; HES1; Downregulation and upregulation; Genetics; Gene expression; Gene","score_opus":0.0058357235548174465,"score_gpt":0.231199060969836,"score_spread":0.22536333741501854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042593536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997754,0.009652336,0.00006698568,0.00006624086,0.00003325215,0.00014336646,0.000039134084,0.0000013194282,0.000019844842],"genre_scores_gemma":[0.99861073,0.0009835287,0.00025016628,0.00003334735,0.000057362264,0.000008762095,0.0000023812827,0.000014396754,0.00003932246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992443,0.000053050935,0.00026892562,0.000116039715,0.00019391386,0.00012378338],"domain_scores_gemma":[0.9988132,0.000013888315,0.0005567003,0.00006417706,0.00047168302,0.00008036476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011798498,0.00008146222,0.00021594549,0.000034434477,0.000024486963,0.000014907756,0.00008624303,0.000081490616,0.000081270104],"category_scores_gemma":[0.000073114905,0.000082526145,0.00008267477,0.00007565403,0.00009768419,0.000012475892,0.00002798518,0.000064647116,1.854011e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007582017,0.000080591955,0.016782643,0.000047613,0.00027363838,0.0000053590556,0.00003315207,0.00003516323,0.949529,1.3724626e-7,0.00043091975,0.03270596],"study_design_scores_gemma":[0.0005487657,0.0002468471,0.32085556,0.00037085006,0.00008028296,0.000091534646,0.000020753454,0.000024149303,0.67762035,0.000010893972,0.000061357605,0.00006864969],"about_ca_topic_score_codex":0.00043200038,"about_ca_topic_score_gemma":0.000399728,"teacher_disagreement_score":0.30407292,"about_ca_system_score_codex":0.0000317178,"about_ca_system_score_gemma":0.0001896047,"threshold_uncertainty_score":0.33653185},"labels":[],"label_agreement":null},{"id":"W2043218413","doi":"10.1038/bjc.2013.309","title":"A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Breast Cancer Research Alliance; DNA Genotek","keywords":"Genetic testing; Genetic counseling; Medicine; Population; Referral; BRCA mutation; Medical genetics; Genetics; Cancer; Mutation; Family medicine; Internal medicine; Biology; Breast cancer; Environmental health; Gene","score_opus":0.026392977516959376,"score_gpt":0.30983565488000114,"score_spread":0.28344267736304174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043218413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98564947,0.004996263,0.008577858,0.00007513718,0.00019342294,0.00044207342,0.00002687575,0.000003535974,0.000035354493],"genre_scores_gemma":[0.9845768,0.000020826661,0.015131669,0.00007360346,0.00012399339,0.000034498495,0.000006409088,0.00002570823,0.0000064760534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981862,0.00017862837,0.0009002531,0.00017655536,0.00040601235,0.00015236781],"domain_scores_gemma":[0.9963461,0.00016610335,0.0017688482,0.00023991399,0.001441798,0.000037223355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020668372,0.00012727345,0.00029505728,0.000043149506,0.00013286986,0.000029076631,0.00027025686,0.00009104596,0.000018964389],"category_scores_gemma":[0.000520633,0.00009966708,0.00011686258,0.00037939713,0.00020759896,0.000014942808,0.000027110791,0.0001730216,1.5331013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010502472,0.000082874736,0.37502858,0.00013194577,0.000091178736,0.0000014139989,0.00014096682,0.32799402,0.19163044,1.7555503e-7,0.0000997859,0.1046936],"study_design_scores_gemma":[0.0014135377,0.0006197881,0.72734857,0.0007223647,0.00017860494,0.00007165756,0.0002780012,0.016889827,0.25217706,0.00006695521,0.00009411759,0.00013950847],"about_ca_topic_score_codex":0.0025213375,"about_ca_topic_score_gemma":0.0014956782,"teacher_disagreement_score":0.35232,"about_ca_system_score_codex":0.00008858455,"about_ca_system_score_gemma":0.00075810833,"threshold_uncertainty_score":0.40643054},"labels":[],"label_agreement":null},{"id":"W2043385216","doi":"10.1038/bjc.2012.479","title":"EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; St Mary's Hospital Centre; McGill University","funders":"","keywords":"Cetuximab; Epidermal growth factor receptor; Cancer research; Chemistry; Exon; Head and neck squamous-cell carcinoma; EGFR inhibitors; Immunohistochemistry; Pathology; Molecular biology; Cancer; Gene; Internal medicine; Receptor; Head and neck cancer; Colorectal cancer; Medicine; Biology","score_opus":0.00944423111436195,"score_gpt":0.26335878365063004,"score_spread":0.2539145525362681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043385216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88827974,0.11097933,0.000041824063,0.00014769754,0.00026531724,0.00018458275,0.000031398664,0.0000028831923,0.00006722881],"genre_scores_gemma":[0.9972174,0.0016816077,0.000111843096,0.00009974065,0.0008090654,0.000013213658,0.000010620736,0.000011499016,0.000045020985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991869,0.000028318895,0.00029792392,0.00009401003,0.00016626537,0.00022663282],"domain_scores_gemma":[0.99939674,0.00004800026,0.00017459865,0.000024717552,0.00013307124,0.0002228736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020222923,0.000081222424,0.00022864777,0.000103640494,0.000043191194,0.00003253068,0.000018377663,0.000050404295,0.000025257767],"category_scores_gemma":[0.00005367789,0.00007765421,0.000055576602,0.00008603178,0.00003698512,0.000224241,0.00001216816,0.00015088693,2.581072e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037806548,0.00015499546,0.5913316,0.00016757663,0.000018465773,0.000121006145,0.0010097254,0.000013946203,0.0076367003,0.000008022319,0.00063102285,0.39852887],"study_design_scores_gemma":[0.0055184476,0.0005569674,0.9793421,0.00012743266,0.00013435965,0.0013097465,0.0004133166,0.00041777416,0.007051731,0.000042947868,0.004971976,0.0001132004],"about_ca_topic_score_codex":0.00084434095,"about_ca_topic_score_gemma":0.0007069329,"teacher_disagreement_score":0.39841568,"about_ca_system_score_codex":0.00017122329,"about_ca_system_score_gemma":0.0001290408,"threshold_uncertainty_score":0.31666467},"labels":[],"label_agreement":null},{"id":"W2043605505","doi":"10.1038/bjc.2013.609","title":"Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Cancer Research UK; Government of Ontario; Ontario Institute for Cancer Research; Pfizer","keywords":"Tamoxifen; Exemestane; Hazard ratio; Internal medicine; Oncology; Medicine; Breast cancer; Subgroup analysis; Tissue microarray; Confidence interval; Estrogen receptor; Prospective cohort study; Cancer","score_opus":0.0407244504869702,"score_gpt":0.3703711812747373,"score_spread":0.3296467307877671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043605505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878712,0.007767573,0.0000019802205,0.001027548,0.0005603536,0.0009609413,0.00008998434,0.000007825535,0.0017125411],"genre_scores_gemma":[0.9912781,0.0045842887,0.00012524202,0.00015279683,0.00097372074,0.000093482195,0.0000057571156,0.000023091305,0.002763485],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980873,0.00006404945,0.0006136188,0.00014550854,0.00082732615,0.00026220607],"domain_scores_gemma":[0.9979252,0.00010489764,0.00047254728,0.0002186472,0.0010994197,0.00017925618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002836488,0.00012777971,0.00064852764,0.00022709362,0.000072463015,0.00007822374,0.00021057062,0.000081438535,0.003361654],"category_scores_gemma":[0.0005488621,0.00008835023,0.00037997396,0.001071668,0.00013057108,0.00015842295,0.000036106878,0.00029163682,0.000009645842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029630817,0.0017055676,0.34909308,0.000177258,0.009503363,0.00008868959,0.000977098,0.00021958932,0.0066268677,0.00002161534,0.10809858,0.49385747],"study_design_scores_gemma":[0.039534323,0.006502652,0.8213824,0.0014706352,0.0024208804,0.00022025118,0.00026703332,0.000077741424,0.010379299,0.000038825732,0.117491744,0.00021420777],"about_ca_topic_score_codex":0.0071356096,"about_ca_topic_score_gemma":0.0025160955,"teacher_disagreement_score":0.49364325,"about_ca_system_score_codex":0.0007900934,"about_ca_system_score_gemma":0.0010063271,"threshold_uncertainty_score":0.99947596},"labels":[],"label_agreement":null},{"id":"W2043758546","doi":"10.1054/bjoc.2000.1755","title":"‘Background to clinical guidelines in cancer’: SOR, a programmatic approach to guideline development and aftercare","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Guideline; Medicine; Cancer; Family medicine; Internal medicine; Pathology","score_opus":0.3369478932033216,"score_gpt":0.5519357513726665,"score_spread":0.2149878581693449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043758546","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96570766,0.0068578133,0.0063097025,0.019428536,0.0005377668,0.0009606073,0.000011026457,0.000017206865,0.0001697085],"genre_scores_gemma":[0.43302846,0.011280952,0.51393473,0.03619185,0.0041455817,0.00034918543,0.000026586393,0.000101127844,0.0009415108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99434686,0.00012738415,0.0041308464,0.00035208726,0.00066902756,0.0003738031],"domain_scores_gemma":[0.9967269,0.00020375934,0.0006073349,0.00015960289,0.0017072547,0.0005952002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003420048,0.00018926329,0.0007373012,0.00021631116,0.00005586715,0.000109883076,0.00016901302,0.00011085237,0.00016704464],"category_scores_gemma":[0.0033756571,0.00019007016,0.00012014446,0.00050561473,0.000042902033,0.00024722097,0.00010708555,0.0004555686,0.0000072977973],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007259391,0.00029707362,0.09343012,0.000074154035,0.00010520742,0.00033164726,0.00021478478,0.00023158012,0.000036935533,0.0000024551716,0.023375219,0.88117486],"study_design_scores_gemma":[0.00596254,0.00061808294,0.23939203,0.00243491,0.00023904431,0.0029437218,0.0016352053,0.00046604418,0.000038355367,0.00004785979,0.7458827,0.00033951722],"about_ca_topic_score_codex":0.0030346229,"about_ca_topic_score_gemma":0.014192922,"teacher_disagreement_score":0.88083535,"about_ca_system_score_codex":0.0003692114,"about_ca_system_score_gemma":0.00101988,"threshold_uncertainty_score":0.7919983},"labels":[],"label_agreement":null},{"id":"W2043857622","doi":"10.1038/bjc.2012.574","title":"Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Biology; AMPK; Clear cell renal cell carcinoma; Cancer research; Cell growth; Gene knockdown; In vivo; Clear cell; Cell culture; Protein kinase A; Kinase; Immunohistochemistry; Renal cell carcinoma; Pathology; Cell biology; Medicine; Immunology","score_opus":0.004800920872776112,"score_gpt":0.22341556116002473,"score_spread":0.2186146402872486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043857622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8422159,0.15732025,0.0000031609504,0.000028061655,0.00005520725,0.00009805714,0.000044762943,5.270834e-7,0.0002340736],"genre_scores_gemma":[0.9392793,0.060297847,0.0000824191,0.00019824308,0.00007027028,0.0000080065265,0.0000027122771,0.000014297602,0.000046864814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990258,0.00008869209,0.0003836381,0.00017059405,0.00012887944,0.00020237423],"domain_scores_gemma":[0.99955046,0.000013431607,0.00019979125,0.000069796384,0.0000791401,0.000087398716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016159893,0.00010608864,0.000302721,0.000085663014,0.000015360725,0.000028166654,0.00010819308,0.00010678596,0.00009284319],"category_scores_gemma":[0.000012233274,0.00011452143,0.000042259613,0.0000591005,0.0000740356,0.000024384977,0.000056841338,0.00019400306,1.5335407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027767415,0.0000685424,0.027957903,0.000109841174,0.0000055387586,0.000031950392,0.00012303924,0.000010553788,0.96060556,6.34989e-7,0.001267704,0.009541057],"study_design_scores_gemma":[0.0027698125,0.00010978042,0.07806808,0.00020801827,0.000010981778,0.000030134177,0.00025954342,0.00003376889,0.91543084,0.00007236783,0.002878056,0.0001285893],"about_ca_topic_score_codex":0.0018368112,"about_ca_topic_score_gemma":0.00097151153,"teacher_disagreement_score":0.09706344,"about_ca_system_score_codex":0.000021537802,"about_ca_system_score_gemma":0.00008013072,"threshold_uncertainty_score":0.46700484},"labels":[],"label_agreement":null},{"id":"W2044367685","doi":"10.1038/bjc.2011.123","title":"Early toxicity predicts long-term survival in high-grade glioma","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"Glioma; Toxicity; Medicine; Term (time); Oncology; Internal medicine; Cancer research","score_opus":0.027540024557539258,"score_gpt":0.27858821122785116,"score_spread":0.2510481866703119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044367685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989174,0.009390692,0.000009428542,0.00021449184,0.0006064727,0.00016360835,0.000023044142,0.000010178787,0.0004080907],"genre_scores_gemma":[0.99704796,0.0022225734,0.0001754482,0.00009736728,0.0003745724,0.00001469246,0.0000019600157,0.000020287485,0.000045113185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987372,0.000047631485,0.00042905117,0.00013882517,0.00039646987,0.0002508267],"domain_scores_gemma":[0.9992714,0.000026588188,0.00021014787,0.00010492229,0.00016340041,0.00022352641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018484115,0.00011503241,0.00040238714,0.0001511182,0.000031507283,0.000031694883,0.00010547704,0.00007951323,0.0005125358],"category_scores_gemma":[0.000041764397,0.00011162917,0.0001385061,0.00019265783,0.000050819566,0.00016399592,0.000022514694,0.00023634969,0.0000060455054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022224746,0.0010064597,0.9421415,0.0000337668,0.00020059658,0.021045117,0.00017729786,0.00000191581,0.0012008339,0.000025004356,0.0003593025,0.033585962],"study_design_scores_gemma":[0.005402161,0.00047982723,0.97694564,0.0011471887,0.00015608656,0.0028175623,0.000015063637,9.002277e-7,0.012769355,0.00007783737,0.0000947908,0.00009360581],"about_ca_topic_score_codex":0.0032043727,"about_ca_topic_score_gemma":0.0033731125,"teacher_disagreement_score":0.034804124,"about_ca_system_score_codex":0.0001619673,"about_ca_system_score_gemma":0.00013307101,"threshold_uncertainty_score":0.5611908},"labels":[],"label_agreement":null},{"id":"W2044745832","doi":"10.1038/bjc.2011.533","title":"Cytology of the vulva: feasibility and preliminary results of a new brush","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Biopsy; Vulvar intraepithelial neoplasia; Malignancy; Vulva; Cytology; Lichen sclerosus; Vulvar cancer; Brush; Lesion; Intraepithelial neoplasia; Squamous intraepithelial lesion; Pathology; Dermatology; Cancer; Cervical intraepithelial neoplasia; Internal medicine; Prostate; Cervical cancer","score_opus":0.08948381832282823,"score_gpt":0.3576722011553569,"score_spread":0.26818838283252866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044745832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95967805,0.03181492,0.000011904953,0.00075638306,0.00015218685,0.00017829619,0.000036932895,0.0000019813272,0.007369361],"genre_scores_gemma":[0.9943869,0.0046833428,0.00018580853,0.0001241495,0.0001652176,0.0000012566306,2.966626e-7,0.00000673809,0.00044628757],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989244,0.000061273015,0.00045997306,0.00009887166,0.00032233415,0.00013319113],"domain_scores_gemma":[0.9989329,0.000055687196,0.0002604841,0.00014314608,0.00046263635,0.00014512094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038138992,0.00005371037,0.0003323168,0.00003923985,0.00002393579,0.0000039599367,0.00013469651,0.0000634189,0.000898862],"category_scores_gemma":[0.00035966345,0.000040996136,0.00011195703,0.00012887976,0.0002409968,0.00005183587,0.000066726505,0.00029838286,2.5408383e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020501107,0.00036140843,0.15972692,0.0004522416,0.00019782365,0.00020026084,0.0014801684,0.0000014300828,0.00097313046,0.000038465358,0.013119095,0.80294794],"study_design_scores_gemma":[0.0040643928,0.0011896357,0.98497206,0.0003108865,0.00009837602,0.0011445648,0.00007764495,0.000003805135,0.00510213,0.00054733915,0.0024528047,0.00003633734],"about_ca_topic_score_codex":0.005689281,"about_ca_topic_score_gemma":0.0020449471,"teacher_disagreement_score":0.82524514,"about_ca_system_score_codex":0.000051107283,"about_ca_system_score_gemma":0.00058072276,"threshold_uncertainty_score":0.98419094},"labels":[],"label_agreement":null},{"id":"W2044752132","doi":"10.1038/bjc.2013.115","title":"Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Wallonie-Bruxelles International; Fondation Medic; Amis de l'Institut Bordet; Université Libanaise","keywords":"Melanoma; Lymph node; Medicine; Breslow Thickness; Lymph; Proportional hazards model; Pathology; Survival analysis; Internal medicine; Oncology; Gastroenterology; Cancer; Cancer research; Sentinel lymph node","score_opus":0.007043574127679635,"score_gpt":0.22654930398742232,"score_spread":0.21950572985974268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044752132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588776,0.0021338689,0.000022989363,0.00019459212,0.0006021782,0.0006564616,0.00003604898,0.000017140106,0.00044895353],"genre_scores_gemma":[0.9973824,0.0012174638,0.00034539154,0.00013061966,0.00012609869,0.000058769623,0.000010914596,0.000027967482,0.00070037256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809384,0.00017703565,0.00073257135,0.00019389833,0.00052500307,0.00027762842],"domain_scores_gemma":[0.9990382,0.000029956167,0.0004250145,0.00012164655,0.00021472156,0.00017043749],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029070285,0.00014848617,0.00043513632,0.00026505502,0.00004332071,0.000060254166,0.000105882726,0.000094726565,0.0010387655],"category_scores_gemma":[0.00017444114,0.0001458492,0.00010167515,0.00020772831,0.00003439742,0.0002556122,0.000047699574,0.00035937337,0.000014875926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015073032,0.0018264357,0.7063657,0.00024575356,0.00029387712,0.0039022684,0.00026387002,0.001046394,0.014264077,0.000019091181,0.0067086145,0.2635566],"study_design_scores_gemma":[0.01094339,0.00035222757,0.9793404,0.0024999985,0.00007992405,0.00034980205,0.000077170684,0.00014866398,0.0037621101,0.00016224652,0.00210789,0.00017621029],"about_ca_topic_score_codex":0.008443317,"about_ca_topic_score_gemma":0.0013503159,"teacher_disagreement_score":0.27297464,"about_ca_system_score_codex":0.00034858444,"about_ca_system_score_gemma":0.0001021136,"threshold_uncertainty_score":0.9998744},"labels":[],"label_agreement":null},{"id":"W2044866803","doi":"10.1038/bjc.2013.592","title":"A reanalysis of cancer mortality in Canadian nuclear workers (1956–1994) based on revised exposure and cohort data","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Nuclear Safety Commission","funders":"National Cancer Institute; Canadian Nuclear Safety Commission; National Institutes of Health; National Strength and Conditioning Association","keywords":"Poisson regression; Confidence interval; Medicine; Relative risk; Cohort; Risk assessment; Environmental health; Cohort study; Population; Internal radiation; Nuclear medicine; Demography; Internal medicine","score_opus":0.020245472631789937,"score_gpt":0.30948762209441383,"score_spread":0.2892421494626239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044866803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992455,0.0073710815,0.000004568378,0.0017749722,0.00008592649,0.00018534022,0.000072742216,0.0000030324888,0.00057778857],"genre_scores_gemma":[0.99373484,0.004460272,0.00017256153,0.0013631154,0.00015607418,0.000005370185,0.000011095547,0.000016742442,0.00007993841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987422,0.000060257677,0.00048038794,0.00017172574,0.00034363646,0.00020177971],"domain_scores_gemma":[0.9989656,0.00003203456,0.00027542358,0.00026418548,0.00014872369,0.00031400166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052128755,0.00008479952,0.00040796428,0.00022640382,0.000037850677,0.000051205556,0.00015151256,0.00005051807,0.0011322094],"category_scores_gemma":[0.00018109844,0.00008854779,0.000062635896,0.0002809637,0.000057393692,0.00027811746,0.0000135147775,0.00024761038,7.367671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003548358,0.000024950532,0.9015189,0.000042615793,0.0001921017,0.00014834784,0.000033055712,0.00013901561,0.0001129429,6.3622315e-7,0.010510252,0.087241694],"study_design_scores_gemma":[0.0012065116,0.000042844473,0.9879489,0.001569254,0.0002983641,0.000044886277,0.00007440086,0.002867513,0.00004501975,0.0000060214666,0.0058121085,0.00008418824],"about_ca_topic_score_codex":0.65648913,"about_ca_topic_score_gemma":0.4185454,"teacher_disagreement_score":0.23794374,"about_ca_system_score_codex":0.00024298948,"about_ca_system_score_gemma":0.00078425556,"threshold_uncertainty_score":0.9997809},"labels":[],"label_agreement":null},{"id":"W2045406141","doi":"10.1038/bjc.2013.287","title":"Reply: Comment on ‘Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage’ – Psychological distress in patients with cancer: is screening the effective solution?","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Triage; Medicine; Distress; Psychological distress; Physical therapy; Clinical trial; Randomized controlled trial; Cancer; Internal medicine; Emergency medicine; Psychiatry; Anxiety; Clinical psychology","score_opus":0.019340450941538825,"score_gpt":0.3144049672509227,"score_spread":0.2950645163093839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045406141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65832496,0.0038842496,0.0020072835,0.3033818,0.0031269407,0.023432884,0.005789085,0.00001891692,0.000033909204],"genre_scores_gemma":[0.7422642,0.0011470958,0.00016226344,0.24602662,0.004426707,0.0049692225,0.00081930275,0.000110670386,0.00007391684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946199,0.0013128238,0.0017592341,0.00054200244,0.0011854746,0.0005805735],"domain_scores_gemma":[0.9933176,0.0027950574,0.0025039753,0.00035270528,0.00090166286,0.00012899135],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010532266,0.0005106805,0.0026549124,0.00019656673,0.00016894036,0.00008225248,0.00052087597,0.0004539755,0.0001305064],"category_scores_gemma":[0.00047270601,0.0003118802,0.0008516916,0.00029872896,0.00035505783,0.00012497163,0.00006389766,0.0023548112,1.6353513e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66100585,0.0013846713,0.0050200582,0.00014597042,0.0009473606,0.00027441833,0.00079051446,0.00021847515,0.0000014750269,1.6845043e-7,0.1911244,0.13908666],"study_design_scores_gemma":[0.88578945,0.0092816455,0.05341892,0.0060803522,0.00086512475,0.000022856557,0.0003512708,0.00027782188,0.000006006189,0.0000064023325,0.043527845,0.00037232967],"about_ca_topic_score_codex":0.009155566,"about_ca_topic_score_gemma":0.0054333108,"teacher_disagreement_score":0.2247836,"about_ca_system_score_codex":0.0007359924,"about_ca_system_score_gemma":0.00024123424,"threshold_uncertainty_score":0.9999468},"labels":[],"label_agreement":null},{"id":"W2045650818","doi":"10.1038/sj.bjc.6605097","title":"Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; Canadian Institutes of Health Research; American Institute for Cancer Research","keywords":"Apolipoprotein E; Colorectal cancer; Red meat; Single-nucleotide polymorphism; Genotype; Internal medicine; Allele; Logistic regression; Medicine; Cancer; Gastroenterology; Biology; Oncology; Disease; Genetics; Pathology; Gene","score_opus":0.012065249491466675,"score_gpt":0.27837172383737135,"score_spread":0.26630647434590465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045650818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97619283,0.021725452,0.000003099483,0.001189341,0.0004219143,0.00020479172,0.000039321563,0.000005700231,0.00021753594],"genre_scores_gemma":[0.9925596,0.006533804,0.00019409112,0.00023471622,0.00026603683,0.0000075892376,0.0000016130239,0.000014277161,0.0001882865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854773,0.000049779952,0.00052938977,0.0001359234,0.00049916265,0.00023801168],"domain_scores_gemma":[0.999007,0.00005554571,0.00049230934,0.000050207058,0.00026240933,0.00013251822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025741084,0.00012234885,0.0004971541,0.00014625012,0.000026951026,0.000017202927,0.000080951584,0.0001393474,0.00031500548],"category_scores_gemma":[0.00019231647,0.00012640652,0.000108928994,0.00021961669,0.000052472147,0.000110358895,0.000015041814,0.00036309302,2.2983971e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053198065,0.00013162415,0.7387665,0.000047250498,0.00015081117,0.000100804835,0.00040112028,0.00006795968,0.1082423,0.000001913534,0.0013469283,0.15021083],"study_design_scores_gemma":[0.0017146665,0.00060938584,0.92570126,0.00075554027,0.00011165866,0.00016252219,0.000060526087,0.000015496975,0.07013538,0.00012050222,0.00050353666,0.00010953967],"about_ca_topic_score_codex":0.004018538,"about_ca_topic_score_gemma":0.0049908846,"teacher_disagreement_score":0.18693477,"about_ca_system_score_codex":0.0005737344,"about_ca_system_score_gemma":0.0003297108,"threshold_uncertainty_score":0.6074854},"labels":[],"label_agreement":null},{"id":"W2045707438","doi":"10.1038/sj.bjc.6604676","title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Dasatinib; EPH receptor A2; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Pancreatic cancer; Receptor tyrosine kinase; Cortactin; Biology; Erythropoietin-producing hepatocellular (Eph) receptor; Kinase; Chemistry; Internal medicine; Signal transduction; Cell biology; Medicine; Cancer; Biochemistry; Cell","score_opus":0.02414531854458201,"score_gpt":0.27888338343537067,"score_spread":0.25473806489078865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045707438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154294,0.00777083,0.000037308215,0.00011364649,0.00026491893,0.00016646464,0.000023221697,0.0000073421334,0.00007333801],"genre_scores_gemma":[0.97067434,0.028596856,0.000060666836,0.00034866628,0.00022207378,0.00001662093,1.369627e-7,0.000020158057,0.00006046957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847835,0.00017621747,0.00041410368,0.00024075822,0.0004392091,0.00025138096],"domain_scores_gemma":[0.9986969,0.0005793812,0.00046125217,0.000062695275,0.000081169914,0.000118598145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018396063,0.00014473364,0.00042251102,0.000116162475,0.00010776694,0.000023999046,0.00015395711,0.00005886668,0.000090353235],"category_scores_gemma":[0.0004121956,0.00014957426,0.000084615225,0.0002756059,0.0001576117,0.00027917762,0.0000267455,0.00038043078,0.0000011598992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043236327,0.0001848911,0.00908763,0.00011666532,0.00001170503,0.00077157945,0.00012456281,0.00059966056,0.93033624,0.000007418186,0.00016184387,0.058165472],"study_design_scores_gemma":[0.0015824877,0.00030282562,0.07941781,0.0023399314,0.000025884787,0.00028288818,0.000007332087,0.00008322916,0.9154826,0.000029196119,0.00029797232,0.00014783541],"about_ca_topic_score_codex":0.0009521539,"about_ca_topic_score_gemma":0.00017545494,"teacher_disagreement_score":0.07033018,"about_ca_system_score_codex":0.000093607596,"about_ca_system_score_gemma":0.00016831952,"threshold_uncertainty_score":0.60994613},"labels":[],"label_agreement":null},{"id":"W2046216743","doi":"10.1038/sj.bjc.6603841","title":"The context influences doctors' support of shared decision-making in cancer care","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Multivariate analysis; Context (archaeology); Breast cancer; Family medicine; Cancer; Univariate; Patient participation; Multivariate statistics; Gynecology; MEDLINE; Internal medicine","score_opus":0.10442398818538914,"score_gpt":0.47898740714787463,"score_spread":0.37456341896248546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046216743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8184647,0.17668214,0.00003315605,0.0010047301,0.0022687959,0.0005265252,0.000117219126,0.000010385708,0.0008923261],"genre_scores_gemma":[0.98702466,0.01093247,0.00043752478,0.0011777964,0.00028263847,0.00006694866,0.0000018082175,0.000020579331,0.000055555392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646693,0.00037747077,0.0019305985,0.00013735885,0.00061641383,0.00047119556],"domain_scores_gemma":[0.99355286,0.0024202366,0.0016141055,0.00029614122,0.0019777808,0.00013887843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010319373,0.00011296815,0.00037580758,0.00015452167,0.0005850523,0.000025398158,0.00073160644,0.00015405378,0.00061141956],"category_scores_gemma":[0.0011875903,0.00009875541,0.000105574974,0.00037194582,0.00013815575,0.00030415243,0.00013997716,0.0010510831,0.0000040908094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002661954,0.000019255469,0.5460659,0.00015577352,0.00002689466,0.000038321712,0.016381407,0.000054516997,0.000023010625,0.00005009022,0.0038560354,0.43306255],"study_design_scores_gemma":[0.0014337681,0.00010118912,0.8154618,0.010213572,0.00002242014,0.000032037493,0.0523525,0.0000074867944,0.000047826084,0.0004248235,0.11975444,0.00014811255],"about_ca_topic_score_codex":0.011932133,"about_ca_topic_score_gemma":0.21957564,"teacher_disagreement_score":0.43291444,"about_ca_system_score_codex":0.0007702708,"about_ca_system_score_gemma":0.0019290531,"threshold_uncertainty_score":0.9946475},"labels":[],"label_agreement":null},{"id":"W2046299412","doi":"10.1038/sj.bjc.6605791","title":"Differential effects of smoking on lung cancer mortality before and after household stove improvement in Xuanwei, China","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institutes of Health; U.S. Environmental Protection Agency","keywords":"Stove; Lung cancer; Medicine; Environmental health; Hazard ratio; Proportional hazards model; Smoke; Cohort; Confidence interval; Cohort study; Demography; Cancer; Surgery; Internal medicine; Waste management; Engineering","score_opus":0.0036487589901406004,"score_gpt":0.22768689508477857,"score_spread":0.22403813609463796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046299412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857783,0.0005455098,0.000016311804,0.000058157748,0.00055351236,0.00011213288,0.000021313268,0.000003217738,0.00011203091],"genre_scores_gemma":[0.99839723,0.0011765147,0.000028227143,0.00015285565,0.00014699402,0.000019216326,5.493192e-7,0.000016260517,0.00006217761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988721,0.000027128763,0.00030327015,0.00016240595,0.00039704904,0.00023804723],"domain_scores_gemma":[0.99950856,0.000018273224,0.00023355451,0.000105261985,0.0000041320836,0.00013024209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013364453,0.00012712879,0.00022961068,0.00003640938,0.000042582902,0.000028802839,0.00012780551,0.00008371933,0.0009240813],"category_scores_gemma":[0.000019180163,0.00012132848,0.00006585136,0.00006518328,0.00013532124,0.00023553852,0.00008104999,0.0004152851,2.6586122e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080894715,0.00016112208,0.8712081,0.000061093684,0.000058054866,0.0001386078,0.0002263632,0.0031604948,0.0277318,0.000003993781,0.0001032993,0.097066216],"study_design_scores_gemma":[0.0009517688,0.00014162497,0.98358774,0.00038103695,0.00005609039,0.00002294072,0.000004872581,0.000057198737,0.014461381,0.000079298785,0.0001389825,0.00011703749],"about_ca_topic_score_codex":0.005219604,"about_ca_topic_score_gemma":0.02366102,"teacher_disagreement_score":0.11237971,"about_ca_system_score_codex":0.00016068878,"about_ca_system_score_gemma":0.000015054481,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2046530370","doi":"10.1038/sj.bjc.6602452","title":"Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Genome Canada","keywords":"Biology; Comparative genomic hybridization; Isochromosome; Gene; Molecular biology; Chromosome; Lung cancer; genomic DNA; Genetics; Cancer research; Karyotype; Pathology; Medicine","score_opus":0.007135902796587672,"score_gpt":0.21823842214936695,"score_spread":0.21110251935277927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046530370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97966534,0.019772412,0.00020444227,0.000026338774,0.000077642806,0.000086314794,0.00007951019,6.4211395e-7,0.00008733841],"genre_scores_gemma":[0.9908269,0.0030308473,0.0057027736,0.000024562822,0.00025581208,0.0000057009515,0.000009917784,0.000010136986,0.00013332204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992551,0.000033288736,0.00042964425,0.000103690494,0.00006563159,0.00011259687],"domain_scores_gemma":[0.9994496,0.000006563763,0.00029427983,0.00007594443,0.00012943054,0.000044194752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011697271,0.00007227629,0.00017796356,0.00004993593,0.000030707924,0.000013923747,0.0000953466,0.00006276427,0.000029831732],"category_scores_gemma":[0.0000060424527,0.00008180461,0.000060279857,0.000037292193,0.000042101892,0.0000101435535,0.000043357322,0.000074145304,1.4156177e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030024437,0.00014947791,0.012540599,0.00006946071,0.000019464569,0.000007939944,0.00018047188,0.001208541,0.9844751,0.0000044457656,0.00007977419,0.001234704],"study_design_scores_gemma":[0.0013861491,0.00010424765,0.01086862,0.00011413835,0.000025888914,0.00015143564,0.00012392443,0.0001032436,0.986588,0.000011074304,0.00044085234,0.00008242809],"about_ca_topic_score_codex":0.00013451469,"about_ca_topic_score_gemma":0.00028623373,"teacher_disagreement_score":0.016741564,"about_ca_system_score_codex":0.000027674867,"about_ca_system_score_gemma":0.00015891939,"threshold_uncertainty_score":0.33358952},"labels":[],"label_agreement":null},{"id":"W2046739711","doi":"10.1038/bjc.2012.221","title":"An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"European Commission","keywords":"Bladder cancer; microRNA; Urinary system; Medicine; Cancer; Urinary Bladder Cancer; Urinary bladder; Oncology; Pathology; Urology; Internal medicine; Biology; Genetics; Gene","score_opus":0.020924764698696998,"score_gpt":0.32953205970025085,"score_spread":0.30860729500155387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046739711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650545,0.033320203,0.0007810386,0.00006807868,0.00034237784,0.00022162788,0.00019465646,0.0000016620254,0.000015864693],"genre_scores_gemma":[0.99668586,0.00096759066,0.00083949126,0.0000925272,0.0013005354,0.00002694697,0.000034382105,0.000019470113,0.000033164415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998986,0.00017914687,0.00029714208,0.0001117786,0.00025379832,0.0001721293],"domain_scores_gemma":[0.9983633,0.000011337019,0.0004128216,0.000116582196,0.0009897213,0.00010622903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011067966,0.00008101054,0.00016567293,0.000032484815,0.000040544906,0.000014228943,0.00007133892,0.0000919727,0.0000977547],"category_scores_gemma":[0.00009154989,0.00009425236,0.00011476332,0.000045516485,0.00004313425,0.000025831201,0.000016909813,0.000054967884,2.423008e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018079636,0.0001669535,0.0064266436,0.00004159172,0.00016169097,0.0000023519824,0.000028692097,0.00088183954,0.9371702,0.0000038208473,0.0031525725,0.051782843],"study_design_scores_gemma":[0.0018279344,0.00022150854,0.46010634,0.00024999792,0.00047058857,0.00043875942,0.000031852698,0.00020486598,0.5308981,0.00010445493,0.0052498477,0.00019573432],"about_ca_topic_score_codex":0.00017071964,"about_ca_topic_score_gemma":0.00016742978,"teacher_disagreement_score":0.45367968,"about_ca_system_score_codex":0.00007206001,"about_ca_system_score_gemma":0.00026598357,"threshold_uncertainty_score":0.38434997},"labels":[],"label_agreement":null},{"id":"W2046952440","doi":"10.1038/sj.bjc.6603619","title":"A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Jewish General Hospital; McGill University; Novartis Foundation","keywords":"Medicine; Receiver operating characteristic; Epidermal growth factor receptor; Colorectal cancer; Brachytherapy; Oncology; Internal medicine; Radiation therapy; Rectum; Multivariate analysis; Immunohistochemistry; Cancer; Pathology","score_opus":0.015900640538464246,"score_gpt":0.3248877173513774,"score_spread":0.30898707681291315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046952440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512954,0.012348249,0.0004347926,0.0005546302,0.00009505209,0.0013240419,0.00008200817,0.0000067847614,0.000024912228],"genre_scores_gemma":[0.99712104,0.0016074869,0.0005740461,0.00006453584,0.00018466829,0.00041162432,0.0000010451581,0.000011803077,0.00002377836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991177,0.000024633226,0.0003621776,0.00020721757,0.00014921036,0.00013911053],"domain_scores_gemma":[0.99928355,0.000074198644,0.00014250561,0.00004570216,0.00035051777,0.00010353752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007001842,0.0000772301,0.00031818863,0.00012941936,0.0000629795,0.000017169094,0.000025014198,0.000032096377,0.0000024702226],"category_scores_gemma":[0.0001101378,0.00007503517,0.000032042164,0.00022049618,0.000026229753,0.00007967483,0.000016319344,0.000066604225,3.596052e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021742353,0.00011154476,0.5940345,0.0002623854,0.00019037601,0.000032121523,0.0026253676,0.00011395394,0.066121474,0.0000057861757,0.00020650023,0.31455365],"study_design_scores_gemma":[0.0025213656,0.0023050827,0.94536966,0.0012200433,0.0000804117,0.00021266015,0.0008525418,0.000045403463,0.045907404,0.0000063697935,0.0014188194,0.00006021037],"about_ca_topic_score_codex":0.0015930476,"about_ca_topic_score_gemma":0.006168331,"teacher_disagreement_score":0.3513352,"about_ca_system_score_codex":0.00038843698,"about_ca_system_score_gemma":0.00012448996,"threshold_uncertainty_score":0.34420735},"labels":[],"label_agreement":null},{"id":"W2047924643","doi":"10.1038/sj.bjc.6601662","title":"Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Health Canada","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Lobular carcinoma; Histology; Cancer; Radiation therapy; Survival rate; Confounding; Internal medicine; Gynecology; Ductal carcinoma; Biology","score_opus":0.0060959448408825995,"score_gpt":0.23072439656453228,"score_spread":0.22462845172364967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047924643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908681,0.007887658,0.000039454277,0.00068318786,0.00009897531,0.00009948279,0.00027630036,0.000001405978,0.000045415545],"genre_scores_gemma":[0.99490345,0.004602909,0.00016874234,0.00006635996,0.00011677953,0.00004293722,0.000004992334,0.000016393258,0.00007743591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915737,0.000033632754,0.0002347409,0.00016857956,0.0001753742,0.00023032662],"domain_scores_gemma":[0.99940443,0.000008051964,0.00026684868,0.000074744385,0.00015812236,0.00008782657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000745498,0.00013541312,0.00032056647,0.000037359154,0.000041147276,0.000010425934,0.00006472268,0.00004647929,0.000019851917],"category_scores_gemma":[0.0000051997613,0.00011283853,0.000021129114,0.000088125125,0.00012359787,0.000010143701,0.000014668503,0.00006884733,1.8341458e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038117375,0.0006689737,0.9024379,0.00010146416,0.0025632933,0.0016786375,0.0013100796,0.010435071,0.005875662,0.00006182268,0.00025650792,0.07079883],"study_design_scores_gemma":[0.0053544664,0.0004895685,0.9890173,0.00019666461,0.000077523124,0.0007650241,0.00024020394,4.5574012e-7,0.0011206372,0.000011156212,0.0025885103,0.00013848013],"about_ca_topic_score_codex":0.6301291,"about_ca_topic_score_gemma":0.9719534,"teacher_disagreement_score":0.3418243,"about_ca_system_score_codex":0.0011746876,"about_ca_system_score_gemma":0.0014667268,"threshold_uncertainty_score":0.46014214},"labels":[],"label_agreement":null},{"id":"W2048733214","doi":"10.1038/sj.bjc.6602072","title":"Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Anxiety; Medicine; Psychosocial; Distress; Health care; Cancer; Family medicine; Gerontology; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.00823651011783391,"score_gpt":0.27988361367736775,"score_spread":0.27164710355953386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048733214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805757,0.016281541,0.000026281014,0.0022355511,0.00031714543,0.00041725262,0.0001128717,0.0000074735135,0.00002621816],"genre_scores_gemma":[0.97490686,0.0236157,0.000018347308,0.00092240627,0.00027442948,0.0001323584,0.0000010174213,0.000019665818,0.000109201355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989086,0.000025665586,0.00035135297,0.00019979019,0.00027707472,0.0002375623],"domain_scores_gemma":[0.9992997,0.0000111495165,0.00015002888,0.00007552156,0.00023263249,0.00023093764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002193393,0.00012981726,0.00041708464,0.00008331365,0.000060996266,0.000052552063,0.000054853655,0.00005854963,0.00018414878],"category_scores_gemma":[0.0000139581025,0.00012584066,0.00006853801,0.00009664636,0.00005514603,0.000118574106,0.000027512035,0.0002260009,1.4823229e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007087443,0.00031401534,0.73353916,0.00015025506,0.00013789134,0.00017049305,0.0064146165,0.000005962003,0.00014029238,0.0000037790899,0.00034802844,0.25806674],"study_design_scores_gemma":[0.008162904,0.00051339454,0.9827049,0.0014315333,0.00014380047,0.0022469135,0.0016802953,0.0000042429606,0.00013676054,0.000141576,0.002688745,0.00014497328],"about_ca_topic_score_codex":0.006454846,"about_ca_topic_score_gemma":0.03820989,"teacher_disagreement_score":0.25792176,"about_ca_system_score_codex":0.0005706303,"about_ca_system_score_gemma":0.0003234517,"threshold_uncertainty_score":0.97934026},"labels":[],"label_agreement":null},{"id":"W2049441387","doi":"10.1038/bjc.2012.309","title":"Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Baker Hughes (Canada); Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Triage; Medicine; Anxiety; Distress; Randomized controlled trial; Depression (economics); Clinical trial; Physical therapy; Emergency medicine; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.026132662005150298,"score_gpt":0.3263087388110574,"score_spread":0.3001760768059071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049441387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989947,0.010505306,0.0024833437,0.0010843027,0.002436143,0.0031542708,0.00032466164,0.000007752454,0.000104740284],"genre_scores_gemma":[0.99504226,0.00104572,0.00032668814,0.000654304,0.0025202886,0.00024960373,0.000045973804,0.000029299483,0.00008584852],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975596,0.00032892433,0.0011417627,0.00013789833,0.00047916488,0.00035263487],"domain_scores_gemma":[0.9971662,0.0010773283,0.0009789882,0.000120748984,0.00045891776,0.00019780936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011920246,0.00017104176,0.0013744573,0.00010440168,0.000065388034,0.000030427234,0.00018797614,0.0001252287,0.0001418387],"category_scores_gemma":[0.000757141,0.00013348574,0.0006680126,0.00016771475,0.000114781054,0.00017253502,0.000024916519,0.00036343862,1.6657637e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8235916,0.0014878812,0.0032587622,0.000087309745,0.0004537865,0.00011109106,0.0017037052,0.00007205904,0.00022610328,0.0000030317963,0.0017706684,0.16723402],"study_design_scores_gemma":[0.9705964,0.0022538677,0.011991864,0.00090169895,0.00055093167,0.00010647023,0.0012950734,0.00020424595,0.00010678795,0.000008704809,0.011833745,0.00015021699],"about_ca_topic_score_codex":0.0012163054,"about_ca_topic_score_gemma":0.0049002427,"teacher_disagreement_score":0.1670838,"about_ca_system_score_codex":0.00020168362,"about_ca_system_score_gemma":0.00038192509,"threshold_uncertainty_score":0.54433906},"labels":[],"label_agreement":null},{"id":"W2050229870","doi":"10.1038/sj.bjc.6602770","title":"A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital","funders":"Cancer Research Society; Dartmouth College; GlaxoSmithKline; Cancer Research Institute","keywords":"Medicine; Insulin resistance; Colorectal cancer; Internal medicine; Gastroenterology; Vitamin B12; Randomized controlled trial; Cancer; Homocysteine; Eicosapentaenoic acid; Vitamin; Insulin; Endocrinology; Polyunsaturated fatty acid; Fatty acid; Biology; Biochemistry","score_opus":0.010816714537933614,"score_gpt":0.2892551283907073,"score_spread":0.2784384138527737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050229870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98300403,0.012480433,0.00001756268,0.0014108311,0.00017715829,0.0022722518,0.000038279988,0.000013739698,0.00058568345],"genre_scores_gemma":[0.9891647,0.008403469,0.0002105971,0.00011399336,0.00055767776,0.0002732731,0.0000030606552,0.000026794298,0.001246432],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977003,0.00028244042,0.00070058496,0.00021419492,0.0007467186,0.00035578702],"domain_scores_gemma":[0.9978991,0.00038119077,0.0005697085,0.00007712115,0.00079127256,0.00028159606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015393476,0.00015562808,0.00074123946,0.00018836414,0.00016309481,0.00010056153,0.00011283617,0.00007953538,0.00017616629],"category_scores_gemma":[0.0019513975,0.00013389453,0.000120604695,0.00040573158,0.00011953476,0.00020917007,0.000020663798,0.0005065103,0.0000020714508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92974657,0.00028492406,0.0024244399,0.000033254943,0.0005542407,0.00022203404,0.00021572245,0.00017213804,0.0076835924,0.0000016534061,0.0038640185,0.054797422],"study_design_scores_gemma":[0.8459027,0.0039161886,0.1440297,0.0015481319,0.00052918907,0.00018935425,0.00006885056,0.00023973819,0.0017362739,0.0000053106137,0.0016339214,0.00020063695],"about_ca_topic_score_codex":0.0007110243,"about_ca_topic_score_gemma":0.022490006,"teacher_disagreement_score":0.14160526,"about_ca_system_score_codex":0.0005921738,"about_ca_system_score_gemma":0.001122007,"threshold_uncertainty_score":0.995347},"labels":[],"label_agreement":null},{"id":"W2050689883","doi":"10.1038/bjc.2011.165","title":"Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Memorial University of Newfoundland; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; University of Toronto","keywords":"Microsatellite instability; Colorectal cancer; DNA methylation; Epigenetics; Methylation; Biology; Oncology; V600E; Wnt signaling pathway; Internal medicine; Context (archaeology); Cancer; Cancer research; Medicine; Mutation; Genetics; Microsatellite; Gene; Allele; Gene expression","score_opus":0.015254169623061632,"score_gpt":0.27514090008034253,"score_spread":0.2598867304572809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050689883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967259,0.002773441,0.00008545545,0.000011698287,0.00009284285,0.00014182462,0.000116893265,0.0000012544822,0.00005065598],"genre_scores_gemma":[0.9987793,0.0005240419,0.0005609339,0.000029934474,0.000022466715,0.000010969029,0.000036901278,0.000010960371,0.000024491952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911356,0.00006128328,0.00041823593,0.00012524088,0.00016379908,0.00011785197],"domain_scores_gemma":[0.99887836,0.0000072274506,0.0004974845,0.000039481514,0.0005440121,0.000033415883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026841433,0.00007939602,0.00019314396,0.000052100157,0.000027500215,0.00000847657,0.00006440601,0.00006699689,0.000073794115],"category_scores_gemma":[0.00004954344,0.000080364625,0.000042381544,0.00012842978,0.0000676712,0.000022406943,0.000020504956,0.000082452374,4.6032422e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003193786,0.00019674619,0.923136,0.00003125713,0.00011806225,0.0000037830662,0.0009941455,0.00004045757,0.06351022,0.0000023526932,0.000047052377,0.011600564],"study_design_scores_gemma":[0.0016183989,0.00016644454,0.7309773,0.00023341792,0.00003700857,0.000007127032,0.000030396874,0.000014413177,0.26668638,0.00008490614,0.00006135487,0.00008284788],"about_ca_topic_score_codex":0.0008612006,"about_ca_topic_score_gemma":0.0063123005,"teacher_disagreement_score":0.20317617,"about_ca_system_score_codex":0.000049239698,"about_ca_system_score_gemma":0.00015391191,"threshold_uncertainty_score":0.3522412},"labels":[],"label_agreement":null},{"id":"W2051165279","doi":"10.1038/bjc.2013.301","title":"Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality’ – IARC and Chrysotile Risks","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chrysotile; Mesothelioma; Asbestos; Lung cancer; Medicine; Environmental health; Cancer; Pathology; Oncology; Internal medicine; Metallurgy","score_opus":0.022519089946690555,"score_gpt":0.3153437612809574,"score_spread":0.2928246713342669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051165279","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47023872,0.06041216,0.000008632209,0.46624857,0.0010781018,0.00052716496,0.0010719607,0.00001701861,0.00039767104],"genre_scores_gemma":[0.18193007,0.015657695,0.00043261293,0.78276956,0.016390894,0.00021121048,0.00041598675,0.00017207318,0.0020199209],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978458,0.00010590234,0.0006185856,0.00025979287,0.0009005892,0.0002693045],"domain_scores_gemma":[0.99874246,0.00016697252,0.00064250425,0.00018710765,0.00010248856,0.0001584829],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014858018,0.00026918712,0.000555205,0.00007250749,0.00016772444,0.000115951116,0.0001916147,0.00025859062,0.003790652],"category_scores_gemma":[0.000044609045,0.000208948,0.00021816237,0.00007091064,0.00018289134,0.00011587554,0.0000612383,0.0014230068,0.0000121299245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006424987,0.00005719417,0.04145231,0.00016573799,0.0012238416,0.0011294087,0.00008349045,0.00046881425,0.000027476293,0.0000011825124,0.92294425,0.03238204],"study_design_scores_gemma":[0.0020152326,0.00018066981,0.53750557,0.008486603,0.0024975156,0.00061808445,0.000040325634,0.0019749613,0.0000390347,0.0002480314,0.44602084,0.00037314897],"about_ca_topic_score_codex":0.017309135,"about_ca_topic_score_gemma":0.00012684778,"teacher_disagreement_score":0.49605325,"about_ca_system_score_codex":0.0003333003,"about_ca_system_score_gemma":0.00016245057,"threshold_uncertainty_score":0.99712},"labels":[],"label_agreement":null},{"id":"W2052123873","doi":"10.1038/sj.bjc.6604110","title":"Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Endometrial cancer; Medicine; Prospective cohort study; Red meat; Dietary iron; Cohort; Cohort study; Proportional hazards model; Cancer; Physiology; Internal medicine; Iron deficiency; Environmental health; Anemia; Pathology","score_opus":0.014794592424804997,"score_gpt":0.2986917503940733,"score_spread":0.2838971579692683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052123873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8373868,0.16102514,0.000012949032,0.000061184,0.00030282605,0.0005467791,0.000041223917,0.000005395408,0.0006177224],"genre_scores_gemma":[0.8896078,0.109640546,0.00014501283,0.000030961277,0.00047298998,0.000017286999,4.5973488e-7,0.000012116849,0.00007282173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987102,0.00006355182,0.00048778628,0.00017552717,0.00037445143,0.00018847249],"domain_scores_gemma":[0.99900526,0.00015426094,0.00042069558,0.0000771874,0.00021947517,0.00012311377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088145735,0.000121841396,0.0006167443,0.00012264196,0.00009930476,0.000016715281,0.00005359694,0.000057556426,0.000041920488],"category_scores_gemma":[0.00023859096,0.00011403307,0.00007629361,0.00016893707,0.00017634568,0.00012507974,0.00005048926,0.00038575538,1.11239586e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014136519,0.00014918525,0.77233416,0.00008268541,0.00061800383,0.00029723506,0.0008671337,0.0000023795421,0.00010669748,0.0000010861842,0.00015240052,0.22397539],"study_design_scores_gemma":[0.0067165857,0.0012687688,0.98735654,0.0010942247,0.0011209224,0.0006465575,0.0006991808,0.0000018898037,0.00046373668,0.000062116516,0.00046555366,0.00010394325],"about_ca_topic_score_codex":0.0044643437,"about_ca_topic_score_gemma":0.010039304,"teacher_disagreement_score":0.22387145,"about_ca_system_score_codex":0.00010193744,"about_ca_system_score_gemma":0.00009347175,"threshold_uncertainty_score":0.67487824},"labels":[],"label_agreement":null},{"id":"W2052141774","doi":"10.1038/bjc.2011.503","title":"Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Anxiety; Medicine; Depression (economics); Internal medicine; Cancer; Breast cancer; Stage (stratigraphy); Lung cancer; Disease; Prostate cancer; Distress; Oncology; Psychiatry; Clinical psychology","score_opus":0.015125218643715,"score_gpt":0.2763474800655354,"score_spread":0.26122226142182037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052141774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85495746,0.1437369,0.0000032859064,0.00015506857,0.0004565864,0.00012495105,0.00022642493,0.0000054703537,0.0003338752],"genre_scores_gemma":[0.9352059,0.06357379,0.000033592027,0.00060918636,0.00032562387,0.000022722028,0.0000025846023,0.000018594468,0.00020805573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897766,0.000038216516,0.000352596,0.0001419916,0.0003193557,0.00017016979],"domain_scores_gemma":[0.99905276,0.000022812874,0.00023086228,0.00009681383,0.00033325198,0.0002635081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014850071,0.00009795233,0.00032343698,0.00009975067,0.000024651035,0.0000131590805,0.00008296168,0.000064340114,0.0007018189],"category_scores_gemma":[0.00007548873,0.00009583751,0.000096488104,0.000118672324,0.00007093618,0.0002298553,0.000033865465,0.00023418006,3.28016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008510404,0.00011883737,0.80751044,0.00025063017,0.000064688174,0.00034712057,0.0006078026,0.000008346524,0.00021171109,0.0000062472513,0.00061692187,0.18940619],"study_design_scores_gemma":[0.0016992387,0.00011894724,0.9863906,0.0031900483,0.00018707669,0.000093698596,0.00027518644,0.000008865375,0.002212921,0.000050955998,0.0056705545,0.00010193055],"about_ca_topic_score_codex":0.017631704,"about_ca_topic_score_gemma":0.027060162,"teacher_disagreement_score":0.18930426,"about_ca_system_score_codex":0.00009096938,"about_ca_system_score_gemma":0.0005371438,"threshold_uncertainty_score":0.99069345},"labels":[],"label_agreement":null},{"id":"W2052207496","doi":"10.1038/sj.bjc.6604172","title":"Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Radiation therapy; Receiver operating characteristic; Univariate analysis; Epidermal growth factor receptor; Internal medicine; Predictive marker; Oncology; Vascular endothelial growth factor; Colorectal cancer; Odds ratio; Cancer; Pathology; Multivariate analysis; VEGF receptors","score_opus":0.020629972510804836,"score_gpt":0.2937921139123036,"score_spread":0.27316214140149875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052207496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822357,0.016798135,0.000012213639,0.00032123312,0.00004915589,0.00032141688,0.00014116618,0.000009081693,0.000111873735],"genre_scores_gemma":[0.9868607,0.012430988,0.00022206998,0.0001265663,0.00006005352,0.000040142968,0.0000062362355,0.000023408289,0.00022983104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983652,0.00022032218,0.0005312324,0.00021483157,0.00045197256,0.00021641147],"domain_scores_gemma":[0.99880797,0.00016024018,0.00034107853,0.00009382771,0.0004029762,0.00019390867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023017489,0.00016890695,0.0010197645,0.00037424627,0.00005544845,0.000015112153,0.000074902724,0.00006628713,0.0003275066],"category_scores_gemma":[0.000060159757,0.00014442955,0.00015324823,0.0010714062,0.00023134427,0.00013764304,0.000013461377,0.00025590466,1.3185713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053545132,0.0003707095,0.9241181,0.000032158267,0.0038071242,0.004205882,0.001053197,0.0007707915,0.005882154,7.7572315e-7,0.00014900847,0.0060649654],"study_design_scores_gemma":[0.01181633,0.0033913087,0.9783498,0.00095227035,0.0010321393,0.0013644585,0.000060432132,0.0005659665,0.0020920488,0.0000015071989,0.00024388597,0.00012986397],"about_ca_topic_score_codex":0.003768175,"about_ca_topic_score_gemma":0.0029225373,"teacher_disagreement_score":0.05423169,"about_ca_system_score_codex":0.0005488326,"about_ca_system_score_gemma":0.0004953568,"threshold_uncertainty_score":0.5889666},"labels":[],"label_agreement":null},{"id":"W2052283407","doi":"10.1038/bjc.2011.115","title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Arthritis Network; McGill University Health Centre; McGill University","keywords":"Medicine; Endometrial cancer; Ovarian cancer; Oncology; Breast cancer; Internal medicine; Population; Incidence (geometry); Standardized mortality ratio; Relative risk; Gynecology; Cancer; Confidence interval","score_opus":0.10221180755632271,"score_gpt":0.3645129247595522,"score_spread":0.2623011172032295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052283407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004576172,0.99691325,0.00004837582,0.00002909875,0.00059606537,0.001347396,0.0003092946,0.00001548638,0.00028339843],"genre_scores_gemma":[0.0006360845,0.99585783,0.00023109956,0.000019182495,0.0007234168,0.00025485738,0.000011059973,0.00011309411,0.0021533961],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99344945,0.0008856055,0.0031968034,0.00057609717,0.0012498806,0.0006421342],"domain_scores_gemma":[0.99520975,0.00062100054,0.0023770703,0.00050644827,0.0008279674,0.00045777325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034124015,0.0005941386,0.011945203,0.0029819822,0.000060376875,0.00017939086,0.0005091611,0.0005268267,0.0012343732],"category_scores_gemma":[0.00044957377,0.00046305513,0.004804048,0.0027659768,0.00016732106,0.00021320455,0.00015133225,0.0012361745,0.0000139490785],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003770237,0.00024469796,0.0030030732,0.08257519,0.3690019,0.011045558,0.00040324216,0.0000016013196,0.0000016334399,0.000066775145,0.0019225479,0.53135675],"study_design_scores_gemma":[0.001858011,0.00006298502,0.000014078636,0.031411704,0.25117078,0.5949617,0.00009066993,9.1804515e-7,3.3685873e-7,0.000015176726,0.12017096,0.00024270923],"about_ca_topic_score_codex":0.0012019376,"about_ca_topic_score_gemma":0.00059566647,"teacher_disagreement_score":0.5839161,"about_ca_system_score_codex":0.0006333898,"about_ca_system_score_gemma":0.0017049658,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W2052299248","doi":"10.1038/sj.bjc.6605846","title":"Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gary Bennett Family Fund; National Institutes of Health; Uehara Memorial Foundation; National Cancer Institute; Entertainment Industry Foundation","keywords":"Colorectal cancer; Protein kinase A; Cancer research; Protein expression; Kinase; Oncology; Immunohistochemistry; Medicine; Internal medicine; Biology; Cancer; Cell biology; Biochemistry; Gene","score_opus":0.006107953102943957,"score_gpt":0.2599063714650868,"score_spread":0.2537984183621429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052299248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8615723,0.13779277,0.00002307406,0.000006342519,0.00022260183,0.00031036054,0.000049892144,0.0000016658595,0.000020992686],"genre_scores_gemma":[0.98338175,0.015970584,0.00026105676,0.000015130198,0.00022693153,0.00010164638,0.000004088085,0.000020031974,0.000018753488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988978,0.00011236878,0.00040627574,0.00018416552,0.00020407558,0.00019530227],"domain_scores_gemma":[0.999118,0.000027915412,0.00046121416,0.00008763274,0.00021825664,0.00008703942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003438079,0.00012889753,0.00038058998,0.00006065997,0.0000273711,0.000016521692,0.00014271445,0.00013894413,0.00006365075],"category_scores_gemma":[0.00022339284,0.00012493391,0.00008169244,0.0001117071,0.00013937007,0.000016500642,0.000039891736,0.00026648448,8.3997115e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047607868,0.00004653139,0.020007512,0.00020701851,0.000036042078,0.0000096045715,0.000037644688,0.00005833558,0.8564381,8.9642356e-7,0.000082000166,0.12260023],"study_design_scores_gemma":[0.0016193358,0.00026300337,0.024706058,0.0008673178,0.000034890105,0.000024217781,0.000010387764,0.000008053348,0.967831,0.000015827176,0.004492259,0.00012761579],"about_ca_topic_score_codex":0.000562181,"about_ca_topic_score_gemma":0.0012336947,"teacher_disagreement_score":0.122472614,"about_ca_system_score_codex":0.000016563043,"about_ca_system_score_gemma":0.00019789572,"threshold_uncertainty_score":0.5094657},"labels":[],"label_agreement":null},{"id":"W2052562958","doi":"10.1038/bjc.2013.372","title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Concordance; Medicine; Proportional hazards model; Oncology; Disease; Internal medicine; Bladder cancer; Hazard ratio; Cohort; Retrospective cohort study; Cancer; Confidence interval","score_opus":0.013127931856085167,"score_gpt":0.2676740225934418,"score_spread":0.2545460907373566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052562958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940425,0.003388402,0.000024620796,0.00082560687,0.00033476023,0.0008329737,0.00026136715,0.0000015989274,0.0002881776],"genre_scores_gemma":[0.9972831,0.0018240375,0.000106769665,0.00032632664,0.00012504755,0.0000353085,1.8126374e-7,0.00002272651,0.00027649815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841595,0.00008432152,0.0006326827,0.00013873448,0.00052701606,0.0002013134],"domain_scores_gemma":[0.9984918,0.000119351134,0.00065755495,0.00029546252,0.00035244907,0.00008333639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019186115,0.00014373854,0.00049811084,0.000059289796,0.00007220762,0.000017851058,0.0003384055,0.0000627765,0.00006490749],"category_scores_gemma":[0.00031951175,0.000079255646,0.00025018604,0.00021760284,0.00017948201,0.00015628837,0.00013891209,0.00030073352,2.617664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013128183,0.00014474991,0.9607615,0.00011915337,0.00025867118,0.000007141177,0.0011455765,0.0013408327,0.008766248,0.000004249308,0.00089257304,0.026428018],"study_design_scores_gemma":[0.002717781,0.00014216865,0.96406966,0.0019543506,0.00031797265,0.000080746024,0.00027885,0.00018247339,0.029896013,0.00022631578,0.00006236999,0.000071269955],"about_ca_topic_score_codex":0.017000234,"about_ca_topic_score_gemma":0.0043280064,"teacher_disagreement_score":0.026356747,"about_ca_system_score_codex":0.000089604975,"about_ca_system_score_gemma":0.00075085287,"threshold_uncertainty_score":0.98954564},"labels":[],"label_agreement":null},{"id":"W2052847579","doi":"10.1038/sj.bjc.6606078","title":"Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Statistical Methods and Bayesian Inference","field":"Mathematics","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"NIHR Cambridge Biomedical Research Centre; BC Cancer Agency; Cancer Council Victoria; National Institute for Health and Care Research; National Health and Medical Research Council; Cancer Research UK","keywords":"Missing data; Imputation (statistics); Proportional hazards model; Breast cancer; Hazard ratio; Statistics; Oncology; Medicine; Data mining; Computer science; Internal medicine; Cancer; Mathematics; Confidence interval","score_opus":0.3276888214765711,"score_gpt":0.579606906818396,"score_spread":0.2519180853418249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052847579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000125357155,0.7060081,0.29151803,0.0000060477537,0.0002839619,0.00019520523,0.0018918971,0.0000020473906,0.00008221033],"genre_scores_gemma":[0.00002072964,0.5962554,0.40357152,0.000003103596,0.000083393585,0.000013953896,0.000017396582,0.000028777018,0.000005687209],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958896,0.00075081113,0.0025015355,0.0003116867,0.00028469582,0.00026169285],"domain_scores_gemma":[0.99127686,0.0046214443,0.0031237921,0.000412935,0.00046082147,0.00010412233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003168378,0.0002715953,0.004681317,0.0004282769,0.000035717243,0.000033553886,0.0008480119,0.000248657,0.00037019004],"category_scores_gemma":[0.002255421,0.00025480473,0.00071456924,0.0006656895,0.00015169689,0.00008231889,0.00010728502,0.00062557886,6.059249e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014656459,0.00017111376,0.00009963889,0.008020066,0.0023099678,0.000005773544,0.000039293293,0.0000014392335,0.000014505588,0.0006309478,0.00029332776,0.98826736],"study_design_scores_gemma":[0.0041182446,0.0005834216,0.0038427291,0.54634255,0.11783304,0.000486139,0.00030823573,0.0058139013,0.00022424245,0.036280528,0.28150156,0.0026653905],"about_ca_topic_score_codex":0.0009942023,"about_ca_topic_score_gemma":0.00028471317,"teacher_disagreement_score":0.98560196,"about_ca_system_score_codex":0.00022919723,"about_ca_system_score_gemma":0.000654555,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W2054071295","doi":"10.1038/sj.bjc.6604375","title":"Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Chinese University of Hong Kong","keywords":"Cisplatin; Downregulation and upregulation; Apoptosis; Cancer research; Ovarian cancer; Nitric oxide synthase; Nitric oxide; Gene knockdown; Chemistry; Biology; Cell biology; Endocrinology; Cancer; Biochemistry; Chemotherapy; Gene","score_opus":0.02880168302085476,"score_gpt":0.2915930241685952,"score_spread":0.26279134114774044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054071295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933564,0.0051184637,0.00011346011,0.0008127893,0.00009029786,0.00033233644,0.000024250246,0.000009712579,0.00014225637],"genre_scores_gemma":[0.9949076,0.002599862,0.0013490554,0.00048288656,0.00023640213,0.000018904557,0.0000047465624,0.00003772684,0.00036280171],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980393,0.000091337395,0.00085519586,0.00024950205,0.00049508177,0.00026960482],"domain_scores_gemma":[0.99898386,0.00006243917,0.00049621303,0.00012599028,0.00017929332,0.00015222502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004172407,0.00016398041,0.00044997557,0.00037287816,0.00009399843,0.000033513403,0.00008856359,0.00012479222,0.00026521052],"category_scores_gemma":[0.00008171749,0.0002015321,0.00006544103,0.000491451,0.00009646127,0.000301747,0.000017417944,0.0004614111,6.5296496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034102425,0.0001945109,0.07760254,0.00018998056,0.00006660216,0.0011131868,0.0010945665,0.00044763798,0.8972899,0.000015645146,0.0015589218,0.020085517],"study_design_scores_gemma":[0.0051479754,0.000048206326,0.7815434,0.0028357476,0.000036191657,0.00032764347,0.00012161854,0.00010368131,0.20916334,0.00020820266,0.00028662672,0.00017739771],"about_ca_topic_score_codex":0.0030339223,"about_ca_topic_score_gemma":0.015105019,"teacher_disagreement_score":0.7039408,"about_ca_system_score_codex":0.0009292509,"about_ca_system_score_gemma":0.0003511389,"threshold_uncertainty_score":0.84289557},"labels":[],"label_agreement":null},{"id":"W2054420426","doi":"10.1038/bjc.2012.548","title":"Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Vlaamse regering; Hellenic Society of Medical Oncology; Vlaamse Liga Tegen Kanker","keywords":"Sunitinib; Medicine; Single-nucleotide polymorphism; Internal medicine; Oncology; Renal cell carcinoma; Clear cell renal cell carcinoma; Proportional hazards model; Progression-free survival; Kidney cancer; Genotype; Biology; Chemotherapy; Gene","score_opus":0.029628351071134377,"score_gpt":0.2537770313473713,"score_spread":0.2241486802762369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054420426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929138,0.0041669696,0.000011623387,0.00038100424,0.0000559822,0.00049246417,0.000024820152,0.00001794136,0.001935394],"genre_scores_gemma":[0.99706334,0.00009051199,0.0006481014,0.00030966013,0.00010821606,0.000037963375,0.00001783517,0.000071999624,0.0016523518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770516,0.00014257281,0.00076142896,0.00023333888,0.0006910582,0.00046643818],"domain_scores_gemma":[0.9981507,0.00010635483,0.00063360814,0.00016345686,0.0005987822,0.00034708087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021952942,0.0002716516,0.0008263568,0.00026600313,0.00005606639,0.00009373603,0.00012684526,0.00006520427,0.0006230744],"category_scores_gemma":[0.000050246443,0.0002089002,0.00014598857,0.0004476849,0.00012727638,0.00028428633,0.000016856713,0.0004696837,0.000010036736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008381755,0.000916578,0.95351017,0.000059395086,0.00041051762,0.020097312,0.000153146,0.0000787826,0.010389755,9.890309e-7,0.00061925786,0.01292594],"study_design_scores_gemma":[0.011272837,0.0029371916,0.9592383,0.0013212186,0.0007501843,0.005272863,0.00018855032,0.000023623883,0.018541269,0.00000922791,0.00018586741,0.00025890427],"about_ca_topic_score_codex":0.007992973,"about_ca_topic_score_gemma":0.0036022856,"teacher_disagreement_score":0.014824449,"about_ca_system_score_codex":0.0007090886,"about_ca_system_score_gemma":0.00034682505,"threshold_uncertainty_score":0.9986129},"labels":[],"label_agreement":null},{"id":"W2055011486","doi":"10.1038/bjc.2011.325","title":"Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Terry Fox Research Institute; Fondation pour la Recherche Médicale; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Oncolytic virus; Apoptosis; Annexin; Biology; Cell culture; Cancer research; Gene knockdown; Virology; Viral replication; Cancer cell; Virus; Molecular biology; Cancer","score_opus":0.038731203454883144,"score_gpt":0.31587490404076213,"score_spread":0.277143700585879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055011486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431515,0.004605213,0.00032014633,0.00006092997,0.00014647686,0.00014126004,0.000027295931,0.0000029346347,0.00038059897],"genre_scores_gemma":[0.98782206,0.011390164,0.00033490086,0.00010049265,0.00024680104,0.000013358728,0.000005389857,0.000020352454,0.000066513225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988072,0.0001225654,0.00037446676,0.00018771418,0.0003287439,0.00017932545],"domain_scores_gemma":[0.9990277,0.000015771826,0.00036608498,0.00014144489,0.00038003523,0.000068929105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038861288,0.000106893734,0.00020019646,0.000048952304,0.00006258089,0.000028009783,0.00017417815,0.000114757495,0.00019636816],"category_scores_gemma":[0.00008860114,0.00011599621,0.000079360776,0.00008527432,0.000088373265,0.000039143793,0.000043566346,0.0001568661,8.4323875e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014388413,0.00008013368,0.0005761741,0.000024378829,0.00011544074,0.0000028658908,0.00026378082,0.000009822239,0.9215415,0.000003554615,0.0001649538,0.075778544],"study_design_scores_gemma":[0.00080344843,0.0014177362,0.0030189024,0.00011891771,0.000025755522,0.00003479593,0.00015586166,0.0000021824967,0.9934229,0.00017660613,0.0007022608,0.000120608245],"about_ca_topic_score_codex":0.0012798544,"about_ca_topic_score_gemma":0.00188138,"teacher_disagreement_score":0.07565794,"about_ca_system_score_codex":0.000043619355,"about_ca_system_score_gemma":0.00020414405,"threshold_uncertainty_score":0.47301883},"labels":[],"label_agreement":null},{"id":"W2055264437","doi":"10.1054/bjoc.2000.1514","title":"Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Topoisomerase; DNA; Chemistry; Molecular biology; Biology; Cell biology; Biochemistry","score_opus":0.005840493849363004,"score_gpt":0.2325158587353968,"score_spread":0.2266753648860338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055264437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661714,0.0027778444,0.00004565533,0.00003873486,0.00015433914,0.000083313025,0.00020831513,8.3385686e-7,0.00007382446],"genre_scores_gemma":[0.9913814,0.008069985,0.000021260048,0.00010971566,0.00015105293,0.0000039804017,0.000028383301,0.000013556567,0.00022063899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992165,0.000025247136,0.0003992671,0.00010346153,0.00013911026,0.00011642444],"domain_scores_gemma":[0.99951285,0.0000040823243,0.00025073474,0.0000771667,0.00010665275,0.000048535054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010495731,0.00007775896,0.00021550714,0.000039418228,0.000013416727,0.000012353678,0.000103931445,0.000084618536,0.00014215997],"category_scores_gemma":[0.000004595475,0.000089742636,0.000080738864,0.00008329293,0.000031557123,0.00001024309,0.000009978056,0.00007939301,2.5508834e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016378137,0.00008999431,0.00011274061,0.000029176621,0.000038367747,0.000008289781,0.000055243203,0.000009883531,0.913321,0.0000010499124,0.00008359048,0.08608689],"study_design_scores_gemma":[0.001229032,0.00025543384,0.0021364149,0.00022096248,0.000025582623,0.00006121274,0.000021199974,0.000003290032,0.98772514,0.000013133441,0.008219206,0.00008940762],"about_ca_topic_score_codex":0.00039069427,"about_ca_topic_score_gemma":0.00038968973,"teacher_disagreement_score":0.085997485,"about_ca_system_score_codex":0.000020102209,"about_ca_system_score_gemma":0.00012801775,"threshold_uncertainty_score":0.36595985},"labels":[],"label_agreement":null},{"id":"W2055340778","doi":"10.1038/bjc.2014.538","title":"TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; Institut National Du Cancer; Collegio Ghislieri di Pavia; Advanced Remanufacturing and Technology Centre; Ligue Contre le Cancer","keywords":"Telomerase reverse transcriptase; Molecular biology; Biology; Telomerase; Mutation; Cancer research; Genetics; Gene","score_opus":0.019402354782506924,"score_gpt":0.3127777742327413,"score_spread":0.2933754194502344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055340778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940696,0.0033985951,0.0006152258,0.0012066071,0.00022748372,0.00013001141,0.000020045602,0.0000101648875,0.00032229396],"genre_scores_gemma":[0.9955038,0.0012767721,0.0023079978,0.0003722518,0.00029810198,0.000008545945,0.000005470039,0.00001038127,0.00021668308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893475,0.000090797716,0.0004898959,0.00011955067,0.00021074904,0.00015427693],"domain_scores_gemma":[0.9992657,0.00012882496,0.00021576237,0.00006103044,0.00020304677,0.00012568763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030482595,0.00007071455,0.0002668834,0.00012885149,0.000077775585,0.0000405371,0.00005448516,0.000089036,0.00011399718],"category_scores_gemma":[0.00055357814,0.00007140637,0.00006859095,0.00019184162,0.000084833366,0.00010262518,0.000012544232,0.00030647256,0.000003633291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003026446,0.00018789373,0.7128996,0.000019131914,0.000033026794,0.0004997701,0.0003217066,0.000051572013,0.00083159836,0.00003171837,0.0005908327,0.28450286],"study_design_scores_gemma":[0.0013387491,0.00019154197,0.99225897,0.00029244696,0.00007944573,0.0024238655,0.000046462246,0.00030894048,0.000054732074,0.00039018624,0.0025361232,0.000078542296],"about_ca_topic_score_codex":0.00013495081,"about_ca_topic_score_gemma":0.00053368224,"teacher_disagreement_score":0.28442433,"about_ca_system_score_codex":0.00006515548,"about_ca_system_score_gemma":0.0001276063,"threshold_uncertainty_score":0.29118672},"labels":[],"label_agreement":null},{"id":"W2055376801","doi":"10.1038/sj.bjc.6600862","title":"Antitumour effect of cyclin-dependent kinase inhibitors (p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1) on malignant glioma cells","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Cancer research; Glioma; Biology; Cyclin D1; Apoptosis; Cell cycle; Kinase; Autophagy; Cyclin-dependent kinase; Cyclin-dependent kinase 4; Cyclin; Cell cycle checkpoint; Cell biology; Cyclin-dependent kinase 2; Genetics","score_opus":0.005614852411264531,"score_gpt":0.251530167905328,"score_spread":0.24591531549406348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055376801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96144116,0.035097696,0.000063550084,0.00016568182,0.0016097063,0.00048179546,0.00006229084,0.000019099672,0.0010590048],"genre_scores_gemma":[0.991771,0.0070351358,0.00024315421,0.00022027409,0.00041939548,0.000013157294,0.000002660861,0.000075167554,0.00022007042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969789,0.00026702395,0.0009778923,0.00035939072,0.00096696505,0.0004498356],"domain_scores_gemma":[0.9980973,0.00011578484,0.00074059295,0.00026259685,0.0003509292,0.00043280865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009637176,0.00031616364,0.00093982846,0.0003425065,0.000094178686,0.00006043603,0.00015105434,0.00024235541,0.00024222788],"category_scores_gemma":[0.00029022168,0.00031008513,0.00036409457,0.00033751386,0.00016411312,0.00014193413,0.00004156499,0.00078947865,0.000010712673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019176324,0.0005095989,0.0074042194,0.0007308193,0.0006433562,0.01880263,0.00017200391,0.0005060392,0.88372314,0.000073254385,0.0069610863,0.0785562],"study_design_scores_gemma":[0.009647185,0.0028818483,0.005210827,0.005372214,0.0006249383,0.0110071255,0.000056949186,0.000017211454,0.95645344,0.00004613103,0.008343027,0.00033909242],"about_ca_topic_score_codex":0.00039359232,"about_ca_topic_score_gemma":0.00015628406,"teacher_disagreement_score":0.07821711,"about_ca_system_score_codex":0.0002813174,"about_ca_system_score_gemma":0.00039770425,"threshold_uncertainty_score":0.99993515},"labels":[],"label_agreement":null},{"id":"W2055443426","doi":"10.1038/bjc.2013.753","title":"Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; St. Boniface Hospital; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"Bristol-Myers Squibb","keywords":"Epiregulin; Cetuximab; Colorectal cancer; Biomarker; Medicine; Oncology; Internal medicine; Hazard ratio; Cancer; Epidermal growth factor receptor; Biology; Amphiregulin","score_opus":0.014471277158109046,"score_gpt":0.2991732421950126,"score_spread":0.2847019650369036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055443426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8931969,0.1050045,0.0000020656062,0.0005850131,0.00021679334,0.00045577742,0.00012933758,0.0000030344286,0.00040660056],"genre_scores_gemma":[0.95414996,0.044858575,0.0003818273,0.00008968679,0.00016227613,0.0002002832,0.0000056594818,0.00001566635,0.00013604174],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986118,0.0000461211,0.00058825494,0.00015987354,0.0003990148,0.00019491081],"domain_scores_gemma":[0.998904,0.00010715393,0.0004564459,0.00011126538,0.00034649184,0.00007465549],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000077898905,0.00015657429,0.00067169743,0.00008082741,0.000045365916,0.000014559173,0.000111564084,0.00006303768,0.0010184919],"category_scores_gemma":[0.000026804319,0.000105461746,0.00022350934,0.000186705,0.000107211265,0.00011680586,0.000017552751,0.00009389434,0.0000012428706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027238973,0.0014532541,0.0663178,0.000041069667,0.00067476014,0.00026462128,0.002420003,0.000057402412,0.104135595,0.0000018128904,0.0009416033,0.8209682],"study_design_scores_gemma":[0.008322811,0.0021728633,0.8618536,0.0013266804,0.00028957144,0.0001691799,0.0008185202,0.000022147507,0.1219761,0.00017890276,0.0027560126,0.00011362137],"about_ca_topic_score_codex":0.024495931,"about_ca_topic_score_gemma":0.007098699,"teacher_disagreement_score":0.82085454,"about_ca_system_score_codex":0.00031828106,"about_ca_system_score_gemma":0.00019488865,"threshold_uncertainty_score":0.99989474},"labels":[],"label_agreement":null},{"id":"W2055557358","doi":"10.1038/bjc.2013.725","title":"Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":470,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Cancer Care Ontario","keywords":"Observational study; Population; Medicine; Randomized controlled trial; MEDLINE; Family medicine; Internal medicine; Biology; Environmental health","score_opus":0.8739839157445691,"score_gpt":0.6345413603989247,"score_spread":0.2394425553456444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055557358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9304902,0.040986013,0.01178146,0.014956195,0.00027732863,0.0012149486,0.00000660273,6.496384e-7,0.00028661365],"genre_scores_gemma":[0.9983904,0.0006430674,0.0003270128,0.00025460467,0.00022704618,0.000045915098,5.81521e-7,0.0000027735364,0.00010863379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9075231,0.06512936,0.012346378,0.0002659403,0.014565878,0.00016934867],"domain_scores_gemma":[0.8673835,0.11942069,0.008897809,0.0005521881,0.0035972516,0.00014855537],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.62309796,0.00008318509,0.0035644562,0.00032336064,0.00009117792,0.00041777352,0.0009832326,0.00007190626,0.0027714083],"category_scores_gemma":[0.589415,0.000037463047,0.001036845,0.00081719825,0.00009983864,0.00024256905,0.00002063165,0.0002641835,0.000004062933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045123026,0.00018904777,0.6683715,0.0001605279,0.0006249713,0.00003907395,0.0005516363,0.004877645,0.00015330693,0.007975263,0.077639565,0.23490517],"study_design_scores_gemma":[0.031852134,0.00009868832,0.8877156,0.0022779761,0.00036203387,0.00007261625,0.00057338906,0.049391728,0.000005269613,0.02077916,0.0067651668,0.0001062377],"about_ca_topic_score_codex":0.00088127726,"about_ca_topic_score_gemma":0.0016208673,"teacher_disagreement_score":0.23479892,"about_ca_system_score_codex":0.00006951963,"about_ca_system_score_gemma":0.000614916,"threshold_uncertainty_score":0.9981402},"labels":[],"label_agreement":null},{"id":"W2055645461","doi":"10.1038/sj.bjc.6603167","title":"Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health; Genome British Columbia; National Cancer Institute; Genome Canada","keywords":"Downregulation and upregulation; Biology; Cell cycle; Wnt signaling pathway; Lung cancer; Cancer research; CDKN2A; Cell; Transcriptome; Cell growth; Cancer; Cell biology; Gene expression; Gene; Signal transduction; Genetics; Pathology; Medicine","score_opus":0.005985744317921311,"score_gpt":0.22437835360233088,"score_spread":0.21839260928440957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055645461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96739644,0.030177724,0.0012103359,0.000026743757,0.00021225505,0.00012216515,0.000093464754,0.0000016601768,0.00075919554],"genre_scores_gemma":[0.9821905,0.01646236,0.00026658297,0.00003355382,0.00042763675,0.000023730772,0.00001531625,0.000021722215,0.00055859843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990424,0.000035933685,0.0004170666,0.00019405622,0.000111461304,0.00019909443],"domain_scores_gemma":[0.9993069,0.0000061486016,0.0003489988,0.00011173833,0.00015979333,0.00006638293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009112581,0.000120628785,0.00021204787,0.000054722877,0.000045631128,0.000039637696,0.00014267203,0.000118214826,0.00009833812],"category_scores_gemma":[0.000002933072,0.00013385351,0.00010177811,0.000074081945,0.000050230457,0.000009795581,0.00003924693,0.00014848354,3.453261e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007523105,0.00021082532,0.03371073,0.00014640138,0.000015097862,0.000017621034,0.000052514242,0.0011808327,0.9535684,0.0000024321976,0.00084313,0.010176765],"study_design_scores_gemma":[0.0027763841,0.00014709895,0.24243012,0.00026892955,0.0000940934,0.000037573354,0.00009152868,0.00038121513,0.7508661,0.000054381155,0.0025725605,0.00027997541],"about_ca_topic_score_codex":0.0020277742,"about_ca_topic_score_gemma":0.004551785,"teacher_disagreement_score":0.20871939,"about_ca_system_score_codex":0.000047151247,"about_ca_system_score_gemma":0.00017540535,"threshold_uncertainty_score":0.5458388},"labels":[],"label_agreement":null},{"id":"W2055781154","doi":"10.1038/bjc.2013.3","title":"Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Cytarabine; MSH2; DNA mismatch repair; Cancer research; DNA repair; DNA damage; Biology; Oxidative stress; Nucleoside analogue; Cytosine; Nucleoside; Cytotoxicity; DNA; Biochemistry; In vitro","score_opus":0.011987442337051965,"score_gpt":0.25710423677813854,"score_spread":0.24511679444108658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055781154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902212,0.0055522854,0.002059522,0.0006411364,0.0004753094,0.00061340164,0.00026523063,0.000025962123,0.00014594957],"genre_scores_gemma":[0.9945258,0.00014168976,0.0041844924,0.0005887162,0.00025139726,0.00003730741,0.0000034826228,0.000060152637,0.00020699372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971371,0.00014094102,0.0009622276,0.0003620152,0.00091933756,0.00047833307],"domain_scores_gemma":[0.9966988,0.00014437993,0.00084275595,0.00019247347,0.0017177578,0.00040384446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040848975,0.00026571937,0.00080557005,0.0001976882,0.000082048464,0.000071146176,0.00024622932,0.00014812678,0.0012653464],"category_scores_gemma":[0.000303875,0.00028338577,0.00028635553,0.0004624318,0.00012564565,0.00017366721,0.000050159248,0.0005467681,0.000011224015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023014078,0.0002803039,0.004382727,0.00020809294,0.00019960232,0.00022313547,0.00037244955,0.0014925519,0.9701411,6.260263e-7,0.015149458,0.0073198285],"study_design_scores_gemma":[0.0014652222,0.0008276279,0.082275935,0.0023956764,0.00017070773,0.00026467885,0.0006354246,0.0001539469,0.910761,0.000014405393,0.0007816061,0.00025377076],"about_ca_topic_score_codex":0.002084134,"about_ca_topic_score_gemma":0.0008402423,"teacher_disagreement_score":0.07789321,"about_ca_system_score_codex":0.000610619,"about_ca_system_score_gemma":0.0006733934,"threshold_uncertainty_score":0.99996185},"labels":[],"label_agreement":null},{"id":"W2056464795","doi":"10.1054/bjoc.1999.1243","title":"Mortality from cutaneous melanoma: evidence for contrasting trends between populations","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Demography; Mortality rate; Cohort; Medicine; Cohort study; Pathology","score_opus":0.09397237790815856,"score_gpt":0.37478923204837905,"score_spread":0.2808168541402205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056464795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908905,0.005393269,0.0009908889,0.00072366954,0.00040840555,0.00017049513,0.000116488234,0.000025182539,0.0012811163],"genre_scores_gemma":[0.99319917,0.0008226408,0.0010869195,0.00024097826,0.0014858618,0.000011142897,0.000011964977,0.000017373335,0.0031239365],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99888366,0.000028858989,0.0004920588,0.00014037332,0.00028222622,0.00017282693],"domain_scores_gemma":[0.9992616,0.00011768702,0.00021411506,0.00009470054,0.00016145558,0.00015043614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015193406,0.000089369794,0.00033398985,0.00007085295,0.00010782552,0.000057475874,0.0000777175,0.00005333487,0.0029087206],"category_scores_gemma":[0.00012550596,0.00009795037,0.00018937363,0.00011779243,0.00002941552,0.000111243884,0.0000074962372,0.00016916811,0.0000041038434],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025893102,0.000043127326,0.046107244,0.000023758103,0.00028070324,0.000783424,0.000046543013,0.000107551634,0.00024867704,0.000005264419,0.0031083643,0.9489864],"study_design_scores_gemma":[0.0025822478,0.0005011854,0.89142495,0.001545226,0.0015764667,0.0057008443,0.000060975955,0.00036926876,0.00032622585,0.0003696527,0.09532747,0.00021550985],"about_ca_topic_score_codex":0.0018202261,"about_ca_topic_score_gemma":0.001577318,"teacher_disagreement_score":0.9487709,"about_ca_system_score_codex":0.00013641763,"about_ca_system_score_gemma":0.000069423884,"threshold_uncertainty_score":0.99800277},"labels":[],"label_agreement":null},{"id":"W2056661251","doi":"10.1038/sj.bjc.6605905","title":"Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Ontario Ministry of Health and Long-Term Care; Nathaniel Wharton Fund; Princess Margaret Hospital Foundation","keywords":"Epithelial dysplasia; Dysplasia; Carcinoma; Pathology; Cancer; Medicine; Cytometry; Carcinoma in situ; Biology; Internal medicine; Flow cytometry; Immunology","score_opus":0.018164626215802983,"score_gpt":0.3106900109999077,"score_spread":0.29252538478410467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056661251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978313,0.00077751,0.000005803328,0.000112949245,0.00058399094,0.00023645074,0.0003513859,0.000006399921,0.000094218405],"genre_scores_gemma":[0.9990271,0.00008525885,0.00046060068,0.00017001158,0.000118122356,0.000018685967,0.000004454156,0.000015662721,0.0001001304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985206,0.0001875351,0.0005352959,0.00014235315,0.0003409703,0.0002732617],"domain_scores_gemma":[0.99868065,0.00006314214,0.00062201393,0.000095532574,0.00034800795,0.00019066231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005641525,0.000116217685,0.0004043725,0.00009335732,0.00007693982,0.000020043797,0.00013271757,0.00015687387,0.00033339867],"category_scores_gemma":[0.00014677017,0.000100992955,0.00008167865,0.00014559712,0.00008120471,0.00011095319,0.000025460957,0.0005944672,0.000007836892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011001826,0.00034970255,0.9549434,0.00001991533,0.00009064968,0.0044469982,0.0001440952,0.00000441667,0.0014823277,0.0000039696756,0.00045828766,0.036956023],"study_design_scores_gemma":[0.0049586566,0.0007040005,0.9812591,0.0006150945,0.00010823675,0.0017123965,0.000040704617,0.000008200932,0.010180444,0.000022450993,0.0002910999,0.0000996202],"about_ca_topic_score_codex":0.006811602,"about_ca_topic_score_gemma":0.052071787,"teacher_disagreement_score":0.045260184,"about_ca_system_score_codex":0.00011890236,"about_ca_system_score_gemma":0.00027982306,"threshold_uncertainty_score":0.9998021},"labels":[],"label_agreement":null},{"id":"W2057149497","doi":"10.1038/sj.bjc.6603248","title":"Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Health Technology Assessment Programme","keywords":"Genetic counseling; Medicine; Family medicine; Breast cancer; Randomized controlled trial; Intervention (counseling); Anxiety; Clinical trial; Nursing; Cancer; Psychiatry; Surgery; Internal medicine","score_opus":0.03675228449937733,"score_gpt":0.3913376078677502,"score_spread":0.35458532336837284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057149497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8463127,0.08605315,0.058955844,0.00034666248,0.0012350477,0.004264583,0.0028178662,0.00000770618,0.000006416266],"genre_scores_gemma":[0.8677221,0.11309848,0.010368781,0.00081639923,0.0054087047,0.002292184,0.000029083272,0.00008699353,0.00017726229],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995343,0.0011352784,0.001742717,0.00077209243,0.00049912045,0.0005077813],"domain_scores_gemma":[0.99510384,0.0010726233,0.001606897,0.0003251024,0.0015165395,0.00037502436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022647092,0.00037196808,0.0012973975,0.000090537476,0.00022083544,0.00029502623,0.00051318604,0.00021063769,0.00015779339],"category_scores_gemma":[0.00074365665,0.00037717578,0.0004723482,0.00014170216,0.00030167826,0.000044466924,0.000031165106,0.00025945637,5.88837e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05577242,0.00030271837,0.037341367,0.00005084117,0.002183752,0.00009498394,0.00044046144,0.2893261,0.03568618,0.0000028720249,0.0094516445,0.56934667],"study_design_scores_gemma":[0.3981962,0.0040668114,0.4882851,0.0024830305,0.007191791,0.0012217071,0.00044125228,0.015196531,0.037824348,0.0025320174,0.039564416,0.0029968368],"about_ca_topic_score_codex":0.008821761,"about_ca_topic_score_gemma":0.024467953,"teacher_disagreement_score":0.5663498,"about_ca_system_score_codex":0.00023235197,"about_ca_system_score_gemma":0.0009001513,"threshold_uncertainty_score":0.99986804},"labels":[],"label_agreement":null},{"id":"W2057213394","doi":"10.1038/sj.bjc.6604730","title":"Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Phytase and its Applications","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Urological Oncology Group; Institute of Cancer Research; AstraZeneca","keywords":"MG132; Cycloheximide; DU145; Proteasome inhibitor; Proteasome; Biology; Transcription factor; Cancer research; Cancer cell; Protein biosynthesis; LNCaP; Chemistry; Cell biology; Molecular biology; Biochemistry; Cancer; Gene; Genetics","score_opus":0.013456864244208206,"score_gpt":0.23656348893129908,"score_spread":0.2231066246870909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057213394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516594,0.0042355037,0.000014826342,0.00012390215,0.00008907245,0.00030533093,0.000042174008,0.0000045590396,0.000018658788],"genre_scores_gemma":[0.99447316,0.0051943064,0.00011449719,0.000040004696,0.00011323173,0.000029871546,0.0000028776046,0.000001721178,0.000030350453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902457,0.000030873784,0.00037128315,0.00012494861,0.00028214743,0.00016620249],"domain_scores_gemma":[0.9992028,0.000018523508,0.0004284314,0.000022767923,0.00026123543,0.00006625182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113565395,0.00008323181,0.00020987558,0.000021106373,0.00010860085,0.000024046016,0.000112754926,0.00004491409,0.000055327742],"category_scores_gemma":[0.0000039807005,0.00004386717,0.000050732342,0.00033627308,0.000055868357,0.0002647783,0.000015938007,0.00014911559,3.4409592e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013330948,0.00026834707,0.027586054,0.000024050012,0.000034260545,0.00006427424,0.0002836799,0.00095291925,0.8233447,0.0000066530242,0.00009201082,0.14720975],"study_design_scores_gemma":[0.00087503804,0.00022152123,0.0922827,0.00089940487,0.00002128757,0.00014840334,0.00014194964,0.000116078125,0.9037372,0.000071658746,0.0013190967,0.00016567005],"about_ca_topic_score_codex":0.0034967281,"about_ca_topic_score_gemma":0.0025742264,"teacher_disagreement_score":0.14704408,"about_ca_system_score_codex":0.00008116227,"about_ca_system_score_gemma":0.000091069356,"threshold_uncertainty_score":0.528603},"labels":[],"label_agreement":null},{"id":"W2057510061","doi":"10.1038/sj.bjc.6602841","title":"A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Medical Research Council","keywords":"Medicine; Hazard ratio; Asymptomatic; Colorectal cancer; Internal medicine; Confidence interval; Chemotherapy; Randomized controlled trial; Surgery; Cancer; Quality of life (healthcare); Fluorouracil","score_opus":0.15649570192656467,"score_gpt":0.4504292015240024,"score_spread":0.29393349959743775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057510061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009867012,0.9873334,0.000007894817,0.00008317784,0.00016248718,0.001688476,0.00072269706,0.0000043566133,0.0001304547],"genre_scores_gemma":[0.004550789,0.99398196,0.0003650278,0.000055888762,0.00019707398,0.000554978,0.000012973981,0.000052125368,0.00022920304],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931806,0.000786074,0.004602233,0.00028935884,0.00085058174,0.000291164],"domain_scores_gemma":[0.99228245,0.0011054178,0.0057075196,0.0001759432,0.0005937841,0.00013489647],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025051152,0.00046747597,0.020425282,0.0010041035,0.000029504468,0.00002789526,0.00022286945,0.00012369918,0.0030208356],"category_scores_gemma":[0.00032102552,0.000329398,0.009334403,0.0014787606,0.00013994974,0.0000971638,0.0000265401,0.0004044208,4.809007e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016289696,0.00026831563,0.00009086579,0.0021320907,0.40223637,0.00012288507,0.00019911514,0.000038171704,0.000003105234,0.0000010326875,0.000101481084,0.5931776],"study_design_scores_gemma":[0.02655457,0.00054549234,0.0011309874,0.008415979,0.91919863,0.00021404818,0.000028874154,0.0000101300275,0.000029609715,0.000011879468,0.043593347,0.00026645118],"about_ca_topic_score_codex":0.0039125374,"about_ca_topic_score_gemma":0.007666811,"teacher_disagreement_score":0.5929111,"about_ca_system_score_codex":0.000553161,"about_ca_system_score_gemma":0.0014662851,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2057750876","doi":"10.1038/bjc.2013.730","title":"BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genome Canada; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Cancer Research UK; Medical Research Council","keywords":"Breast cancer; Cancer; Pathology; Medicine; Interface (matter); Oncology; Computer science; Internal medicine","score_opus":0.00573871593396774,"score_gpt":0.26534285518559714,"score_spread":0.2596041392516294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057750876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94392496,0.050434563,0.0016947687,0.0017213895,0.0009316233,0.00022638756,0.0009932288,0.0000099194185,0.00006317789],"genre_scores_gemma":[0.9378514,0.058641627,0.0011623265,0.0006617757,0.0010379037,0.00019382821,0.000006784127,0.00003904542,0.00040528257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854976,0.000090291076,0.00047414846,0.0003442223,0.00023592517,0.00030565268],"domain_scores_gemma":[0.99855214,0.000011997562,0.00038454172,0.0001446346,0.000689266,0.00021744356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002593297,0.00017943043,0.00026263137,0.000088610366,0.00012881844,0.00011402864,0.00026345855,0.00015874283,0.0004127423],"category_scores_gemma":[0.00005868951,0.00019350728,0.00008029541,0.00014010591,0.00013109048,0.000048612834,0.00012609684,0.0002938927,0.000004379448],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026530144,0.00008122067,0.09596664,0.00006568746,0.00046088026,0.000039743067,0.0003522497,0.073462695,0.36753863,0.0000044163785,0.14755331,0.31420925],"study_design_scores_gemma":[0.005959524,0.0010465124,0.7174367,0.0025895578,0.00095754536,0.012982221,0.0010032845,0.020972231,0.12471115,0.0010276505,0.10943618,0.001877449],"about_ca_topic_score_codex":0.003665161,"about_ca_topic_score_gemma":0.0070972927,"teacher_disagreement_score":0.6214701,"about_ca_system_score_codex":0.0002148507,"about_ca_system_score_gemma":0.00075131643,"threshold_uncertainty_score":0.78909975},"labels":[],"label_agreement":null},{"id":"W2057805403","doi":"10.1038/bjc.2013.261","title":"A personalised approach to prostate cancer screening based on genotyping of risk founder alleles","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"Ministerstwo Edukacji i Nauki","keywords":"Prostate cancer; CHEK2; Single-nucleotide polymorphism; Genotyping; Rectal examination; Allele; Prostate; Medicine; Cancer; Prostate cancer screening; Genotype; Internal medicine; Oncology; Prostate-specific antigen; Germline mutation; Biology; Genetics; Mutation; Gene","score_opus":0.021123688022015783,"score_gpt":0.28190107136303694,"score_spread":0.26077738334102113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057805403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680951,0.024884619,0.0023286599,0.0023277253,0.00021780841,0.0009976024,0.0002010605,0.00001578349,0.0009316082],"genre_scores_gemma":[0.9801161,0.0070291376,0.010066626,0.001973102,0.00035277478,0.00027871225,0.000008249838,0.000044622564,0.00013064861],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983884,0.000057345093,0.0004839919,0.00022304367,0.0005450469,0.00030215736],"domain_scores_gemma":[0.99840677,0.00007324606,0.00044525802,0.0001288646,0.000657636,0.00028821177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022887239,0.00016934446,0.0005092244,0.00014285787,0.000086542015,0.00006671608,0.00010445653,0.000055961395,0.00056460506],"category_scores_gemma":[0.00007684257,0.000153661,0.00022006985,0.00020302685,0.000056089324,0.00014494463,0.000018321896,0.0002713352,0.000002879664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015022634,0.00095280807,0.19379994,0.00036203337,0.0010530236,0.00016049082,0.0015290747,0.023969088,0.0008312538,0.000018379515,0.0112320995,0.76458955],"study_design_scores_gemma":[0.012600849,0.0013407852,0.9499135,0.00860706,0.0008429482,0.0002578106,0.00083487394,0.0061845984,0.0032034237,0.000091329595,0.01565074,0.0004720639],"about_ca_topic_score_codex":0.005841408,"about_ca_topic_score_gemma":0.00030531312,"teacher_disagreement_score":0.7641175,"about_ca_system_score_codex":0.0003106017,"about_ca_system_score_gemma":0.00037826938,"threshold_uncertainty_score":0.88305},"labels":[],"label_agreement":null},{"id":"W2057851318","doi":"10.1038/sj.bjc.6604612","title":"Estimation of renal function and its potential impact on carboplatin dosing in children with cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; University College London; Cancer Research UK; Hospital for Sick Children; Children's Cancer and Leukaemia Group","keywords":"Carboplatin; Dosing; Medicine; Renal function; Urology; Cancer; Internal medicine; Oncology; Chemotherapy; Cisplatin","score_opus":0.008832073011949012,"score_gpt":0.26880527464174797,"score_spread":0.259973201629799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057851318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962262,0.0031560776,0.00018812038,0.00017907674,0.00005349829,0.00015770037,0.0000139980175,0.000004883167,0.000020460438],"genre_scores_gemma":[0.99812514,0.0013485362,0.00015047682,0.00008309676,0.00025156816,0.0000024244018,0.0000043606765,0.000018008699,0.000016421998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999165,0.00002489847,0.00028685862,0.00009650107,0.00031890871,0.00010781637],"domain_scores_gemma":[0.9994358,0.00001064411,0.00030577785,0.00003990877,0.00013610267,0.00007175884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104525636,0.00008611311,0.0002437751,0.0001336079,0.00003793644,0.000011334989,0.0000252544,0.00006023156,0.000097270924],"category_scores_gemma":[0.000024896348,0.00007937203,0.000046597095,0.00016463514,0.000036995552,0.00018042706,0.0000037806562,0.00023932816,1.7862975e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031894497,0.00024280394,0.30159226,0.00006847481,0.0005175396,0.00016926046,0.000501534,0.048616968,0.36526245,0.0000026888126,0.00024517023,0.2795914],"study_design_scores_gemma":[0.0037636724,0.00046219895,0.8962381,0.0012968482,0.00009246223,0.0033417384,0.000009177118,0.0015901078,0.093119636,0.000014296361,0.0000016701977,0.0000700933],"about_ca_topic_score_codex":0.00113479,"about_ca_topic_score_gemma":0.00027063125,"teacher_disagreement_score":0.59464586,"about_ca_system_score_codex":0.00022289054,"about_ca_system_score_gemma":0.00026751007,"threshold_uncertainty_score":0.32366976},"labels":[],"label_agreement":null},{"id":"W2058736678","doi":"10.1038/bjc.2012.543","title":"Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Genentech; Bayer HealthCare; Exelixis; Sanofi; Pfizer","keywords":"Sorafenib; Tolerability; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Cumulative incidence; Incidence (geometry); Dosing; Population; Oncology; Confidence interval; Cohort; Hepatocellular carcinoma","score_opus":0.0068845273697906014,"score_gpt":0.23108474868871218,"score_spread":0.2242002213189216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058736678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935412,0.0048000575,0.000050863146,0.0002535341,0.00008762002,0.00050304946,0.00026695768,0.000008841705,0.00048791044],"genre_scores_gemma":[0.9980107,0.0001394875,0.0012253751,0.00013797439,0.00012322621,0.00003447035,0.00010798607,0.000026005513,0.00019477542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974565,0.00012288094,0.0009537776,0.00036804983,0.00070643664,0.0003923868],"domain_scores_gemma":[0.9978805,0.000088091765,0.00060194335,0.000295074,0.0008257071,0.00030868113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023523197,0.000213841,0.00085094984,0.0002436292,0.000052149713,0.00006340477,0.00014289437,0.000094821655,0.0005784591],"category_scores_gemma":[0.00007787148,0.00018381866,0.00029146488,0.0005967914,0.00004950186,0.00031352282,0.000029038387,0.00043560003,0.000007916407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032146112,0.0012867013,0.9441307,0.00003338086,0.00075356866,0.0011320768,0.0003344604,0.00047220895,0.0008068913,2.3762146e-7,0.0006232851,0.047211863],"study_design_scores_gemma":[0.020705072,0.0011097566,0.97332186,0.00029569355,0.0014992415,0.000035579207,0.000102242855,0.00007122975,0.0023376574,0.000025277774,0.00031587863,0.00018054564],"about_ca_topic_score_codex":0.009340326,"about_ca_topic_score_gemma":0.006255962,"teacher_disagreement_score":0.047031317,"about_ca_system_score_codex":0.00050045206,"about_ca_system_score_gemma":0.00028742626,"threshold_uncertainty_score":0.9972566},"labels":[],"label_agreement":null},{"id":"W2059066343","doi":"10.1038/bjc.2012.279","title":"Microbubble and ultrasound radioenhancement of bladder cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Terry Fox Foundation","keywords":"Microbubbles; Ultrasound; Medicine; Pathology; Bladder cancer; Radiation therapy; Mechanical index; Fibrosis; Nuclear medicine; Cancer; Radiology; Internal medicine","score_opus":0.0071292405800608034,"score_gpt":0.23506329302477347,"score_spread":0.22793405244471265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059066343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85668194,0.14137532,0.0006783946,0.000042339027,0.0003134783,0.000055735392,0.00004305668,0.000009848125,0.0007999126],"genre_scores_gemma":[0.9574691,0.041280918,0.0005996672,0.000053412547,0.00040155213,0.000014058876,8.786115e-7,0.000017765347,0.00016264924],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994341,0.000007613514,0.00023965098,0.000043170578,0.00010954794,0.00016587989],"domain_scores_gemma":[0.99966675,0.00003181597,0.00008233642,0.000050069786,0.000077925,0.000091106645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092292554,0.000067793255,0.00016586894,0.000031597207,0.000033279615,0.00002234118,0.00007241174,0.000035095527,0.0006802956],"category_scores_gemma":[0.000006444841,0.0000742361,0.000044837056,0.000071375485,0.00004392763,0.00016856147,0.0000051860743,0.000114831375,0.0000017625509],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018242607,0.00014707932,0.035124928,0.00019061369,0.0007066808,0.000005645979,0.0011035815,0.002620139,0.7318051,0.00010919575,0.025770295,0.20239851],"study_design_scores_gemma":[0.0018145922,0.00005837342,0.19000125,0.0007993617,0.00039707962,0.0018433731,0.00035643543,0.000079816804,0.16161217,0.00018703431,0.64232516,0.00052535866],"about_ca_topic_score_codex":0.0001731436,"about_ca_topic_score_gemma":0.0001863451,"teacher_disagreement_score":0.61655486,"about_ca_system_score_codex":0.00004893769,"about_ca_system_score_gemma":0.000029475385,"threshold_uncertainty_score":0.74487597},"labels":[],"label_agreement":null},{"id":"W2059370935","doi":"10.1038/bjc.2013.523","title":"Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"FOLFIRI; Aflibercept; Medicine; Internal medicine; Oxaliplatin; Population; Irinotecan; Placebo; Colorectal cancer; Survival analysis; Oncology; Regimen; Surgery; Bevacizumab; Cancer; Chemotherapy","score_opus":0.011769297903893437,"score_gpt":0.26168183645577364,"score_spread":0.2499125385518802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059370935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673236,0.0098258685,0.000019342164,0.00042750733,0.00024619236,0.0016715121,0.00008302604,0.000025804135,0.0009683567],"genre_scores_gemma":[0.9948017,0.002872329,0.00032430602,0.00030764643,0.00017554662,0.00039796843,0.000019479648,0.00007872242,0.0010222823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722373,0.00013258152,0.0006951715,0.00038163448,0.0009396927,0.00062717363],"domain_scores_gemma":[0.9980875,0.00010356973,0.00051652576,0.00014250129,0.0008143385,0.00033554577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020010555,0.00039914396,0.0012801093,0.00017673873,0.00012948111,0.0001130558,0.00015663225,0.00007700836,0.0009794207],"category_scores_gemma":[0.00004327921,0.00029584614,0.00016845712,0.00036882368,0.00017627316,0.00040604136,0.00004478268,0.00043464804,0.000005421248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033757173,0.0009776785,0.8593768,0.00023379736,0.003826536,0.0018105988,0.0038150114,0.001879228,0.000037583726,0.000006002625,0.006311391,0.087968186],"study_design_scores_gemma":[0.044152014,0.0050777826,0.94450074,0.0024779742,0.0010322396,0.0003252902,0.00038809967,0.00013461446,0.00010956227,0.000018701294,0.0013502948,0.00043270068],"about_ca_topic_score_codex":0.021595497,"about_ca_topic_score_gemma":0.08052226,"teacher_disagreement_score":0.087535486,"about_ca_system_score_codex":0.001915871,"about_ca_system_score_gemma":0.0009727862,"threshold_uncertainty_score":0.9999494},"labels":[],"label_agreement":null},{"id":"W2060435066","doi":"10.1038/bjc.2013.152","title":"An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China; McGill University","keywords":"Bcl-2 family; Immunoprecipitation; Blot; Bcl-xL; Apoptosis; Phosphorylation; Chemistry; Cancer research; Cell culture; Molecular biology; Biology; Programmed cell death; Biochemistry; Genetics; Gene","score_opus":0.005631975957412326,"score_gpt":0.23373877293893694,"score_spread":0.2281067969815246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060435066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922514,0.005194004,0.0011889887,0.0005062703,0.00034198802,0.0004678842,0.000022920423,0.0000027264957,0.00002381053],"genre_scores_gemma":[0.99707896,0.0012359491,0.00017234846,0.00030203973,0.00062345434,0.000029282404,0.0000041159037,0.000019447976,0.00053440814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884915,0.00019282155,0.00036368638,0.00014340562,0.00027571604,0.00017519043],"domain_scores_gemma":[0.99908185,0.000014587582,0.00027483917,0.00022339133,0.00031738056,0.000087979475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004983955,0.00010074539,0.00014995034,0.00003500329,0.000096449425,0.0000715711,0.0003029547,0.00010968096,0.000048376045],"category_scores_gemma":[0.000047834477,0.00006771263,0.00010218792,0.00009712161,0.000066047265,0.000015325519,0.00004887655,0.00014896001,0.0000046048685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027215484,0.000040310173,0.00011547791,0.000012113711,0.000037388618,0.0000058343817,0.000064851614,0.00081006315,0.94853735,0.0000026336188,0.005202478,0.044899367],"study_design_scores_gemma":[0.0009472558,0.00091080595,0.06627347,0.0003884287,0.000046258578,0.00018589404,0.0002980004,0.0002793369,0.8944957,0.00008465526,0.035907526,0.00018261254],"about_ca_topic_score_codex":0.00043458163,"about_ca_topic_score_gemma":0.00020464118,"teacher_disagreement_score":0.066158,"about_ca_system_score_codex":0.000022938812,"about_ca_system_score_gemma":0.00020027174,"threshold_uncertainty_score":0.2761241},"labels":[],"label_agreement":null},{"id":"W2061460324","doi":"10.1038/sj.bjc.6604729","title":"Two-marker protein profile predicts poor prognosis in patients with early rectal cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Universitätsspital Basel; Novartis Foundation","keywords":"Medicine; Colorectal cancer; Internal medicine; Gastroenterology; Immunohistochemistry; Stage (stratigraphy); Oncology; Cancer; Tissue microarray; Biology","score_opus":0.010925899522709517,"score_gpt":0.2552812456886944,"score_spread":0.24435534616598492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061460324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280125,0.003808729,0.0000011440455,0.0002536965,0.00021895333,0.0012895694,0.00007737463,0.000023181825,0.0015260759],"genre_scores_gemma":[0.9973411,0.00058185786,0.0005531495,0.00011851041,0.00029738105,0.0003752623,0.000005945609,0.000053077194,0.00067370204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978219,0.00007583218,0.0005333912,0.00027089447,0.00089948584,0.00039845626],"domain_scores_gemma":[0.99864036,0.00002380419,0.00035485768,0.00008652486,0.00060723146,0.00028725067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013560771,0.00020384254,0.0005561796,0.00014102977,0.0000805694,0.00003033228,0.0001204292,0.000088181645,0.0008969651],"category_scores_gemma":[0.00007107843,0.00017646867,0.00014004932,0.00044902478,0.00012866444,0.00032522253,0.00003353785,0.0004765435,0.0000047466074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005036096,0.00071908516,0.9234823,0.000057803434,0.0002628822,0.0023979833,0.00012307236,0.000009169288,0.00008232703,6.233412e-7,0.00068708864,0.06714155],"study_design_scores_gemma":[0.013225677,0.0022076783,0.978178,0.0029013418,0.00012921244,0.0007268116,0.000010702435,0.000009244511,0.000935349,0.0000043303567,0.0014829506,0.00018865133],"about_ca_topic_score_codex":0.0027055163,"about_ca_topic_score_gemma":0.0013430779,"teacher_disagreement_score":0.06695289,"about_ca_system_score_codex":0.00066779775,"about_ca_system_score_gemma":0.00064545544,"threshold_uncertainty_score":0.98211384},"labels":[],"label_agreement":null},{"id":"W2061547059","doi":"10.1038/bjc.2015.17","title":"RETRACTED ARTICLE: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":54,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Docetaxel; Pantoprazole; Pharmacology; Apoptosis; Chemistry; Chemotherapy; Cancer research; Medicine; Internal medicine; Biochemistry","score_opus":0.010968436238068697,"score_gpt":0.3358028560096915,"score_spread":0.3248344197716228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061547059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895574,0.00986086,0.000062551844,0.00014085922,0.00019746242,0.00022717332,0.000046128098,0.000015485097,0.00049373205],"genre_scores_gemma":[0.9986728,0.0004765267,0.000088543406,0.00020681652,0.00039349688,0.000008235508,0.000003171268,0.000026630025,0.00012381496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982355,0.00012610045,0.000602601,0.00015232437,0.000627717,0.00025574106],"domain_scores_gemma":[0.9982412,0.000063862244,0.00067434716,0.00012299247,0.00051958027,0.00037801036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000732068,0.00014343199,0.0006553595,0.00009852381,0.000045613768,0.000020612559,0.00013226597,0.00010399857,0.00008382082],"category_scores_gemma":[0.00028787332,0.00014285262,0.00018444342,0.00028191882,0.00008405226,0.00022156771,0.000028982411,0.00041592805,0.0000021074602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008317253,0.00029166276,0.0036759581,0.00013095562,0.00020130724,0.0003218921,0.00018149633,0.000027345928,0.87551546,0.0000015284339,0.0036975006,0.11512317],"study_design_scores_gemma":[0.002862173,0.0010349195,0.058944423,0.0015961366,0.00013384785,0.00020247737,0.000029552059,0.000023368257,0.93439305,0.000020190853,0.00064427673,0.00011558573],"about_ca_topic_score_codex":0.00029811103,"about_ca_topic_score_gemma":0.00004530676,"teacher_disagreement_score":0.11500758,"about_ca_system_score_codex":0.00011251464,"about_ca_system_score_gemma":0.00023747314,"threshold_uncertainty_score":0.58253604},"labels":[],"label_agreement":null},{"id":"W2061613070","doi":"10.1038/bjc.2014.309","title":"Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Lynch syndrome; Medicine; Internal medicine; Cancer; Oncology; Epidemiology; Logistic regression; Gastroenterology; DNA mismatch repair","score_opus":0.009733273010589297,"score_gpt":0.27109778722111894,"score_spread":0.26136451421052964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061613070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648316,0.008222853,0.000034463825,0.00032487977,0.0039167437,0.0004694785,0.00016062782,0.000018266752,0.00036954743],"genre_scores_gemma":[0.9854103,0.012220006,0.00029214082,0.00031414858,0.0014031329,0.000071734525,0.000009771531,0.000066408495,0.00021238979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997356,0.00010552307,0.00091617607,0.00035999215,0.00082012726,0.00044217776],"domain_scores_gemma":[0.9975782,0.000114350514,0.0007766629,0.0001287684,0.0010805499,0.0003214787],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004458628,0.00029587446,0.0009846156,0.00019046213,0.00010719475,0.000049526763,0.00021065197,0.00027299652,0.000944993],"category_scores_gemma":[0.00025029745,0.0003100988,0.00019820228,0.00037411816,0.0003280413,0.00021095721,0.00007552817,0.0005790134,0.0000033310798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004318116,0.00025172552,0.39194635,0.0005179919,0.0007088116,0.00023676397,0.00071358134,0.00021416298,0.36264697,0.0000051616985,0.0043433476,0.23409703],"study_design_scores_gemma":[0.003643555,0.0019743606,0.9418347,0.0014772958,0.00042313721,0.00175315,0.00007114257,0.0004146119,0.0446214,0.000030287429,0.0034375587,0.00031878438],"about_ca_topic_score_codex":0.004909646,"about_ca_topic_score_gemma":0.0041865474,"teacher_disagreement_score":0.5498884,"about_ca_system_score_codex":0.0004999344,"about_ca_system_score_gemma":0.0011052405,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W2062905872","doi":"10.1038/bjc.2012.596","title":"Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; University of New Brunswick; Toronto Metropolitan University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University of Cambridge","keywords":"Medicine; Breast cancer; Cancer; Demography; Obstetrics; Gynecology; Mammography; Breast disease; Internal medicine; Oncology","score_opus":0.06252360899457941,"score_gpt":0.37747870782693477,"score_spread":0.31495509883235534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062905872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837254,0.005896237,0.000047267036,0.0084225135,0.00020997469,0.0012589887,0.00017578393,0.000006796055,0.00025703068],"genre_scores_gemma":[0.9955025,0.00013210652,0.0012003714,0.002188524,0.00059376407,0.00032921773,0.000005919464,0.000017200548,0.0000304533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821085,0.000054377615,0.000435091,0.0001639963,0.0007793987,0.00035627803],"domain_scores_gemma":[0.9979593,0.00019184203,0.0002499167,0.00007531842,0.001300504,0.00022308597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063452485,0.00012812189,0.00029787482,0.00015193125,0.00020866095,0.00022836027,0.00022228737,0.000067936475,0.00041103354],"category_scores_gemma":[0.00028278347,0.00009956772,0.00011145953,0.00024746393,0.000066524815,0.00043119,0.000017095681,0.0003584009,0.0000019786394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021679462,0.00011366207,0.76940304,0.000034603847,0.00012352552,0.000300034,0.00043444725,0.00027952908,0.00005685291,0.0000069921716,0.011861659,0.21716885],"study_design_scores_gemma":[0.0020480915,0.00022654288,0.98710203,0.0019219737,0.00010995746,0.0061823498,0.0011853216,0.000313745,0.000028870192,0.00020192152,0.00055876834,0.000120454344],"about_ca_topic_score_codex":0.3608942,"about_ca_topic_score_gemma":0.6591054,"teacher_disagreement_score":0.29821122,"about_ca_system_score_codex":0.0004780113,"about_ca_system_score_gemma":0.0015583461,"threshold_uncertainty_score":0.6433616},"labels":[],"label_agreement":null},{"id":"W2063290052","doi":"10.1054/bjoc.2001.2167","title":"Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Medical Research Council; Medical Research Council","keywords":"Progesterone receptor; Transfection; Mifepristone; Receptor; Internal medicine; Endocrinology; Chemistry; Medicine; Biology; Cell culture; Cancer; Estrogen receptor; Pregnancy; Genetics","score_opus":0.020824708777164743,"score_gpt":0.24799194697882246,"score_spread":0.2271672382016577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063290052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788006,0.018686626,0.0017691657,0.00007173745,0.00010811164,0.00050539273,0.000042395153,0.0000021917194,0.000013812771],"genre_scores_gemma":[0.9958775,0.0034585479,0.0004309589,0.0000088386905,0.00006751877,0.000051379713,0.000012905933,0.000015742191,0.000076616976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989042,0.00009409366,0.00057420623,0.00011820586,0.00016212444,0.00014714488],"domain_scores_gemma":[0.9991043,0.000013746141,0.0003749189,0.000092657516,0.00037807497,0.00003629779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003176905,0.00009998932,0.00027058105,0.000059077905,0.000036777175,0.000011406568,0.00012747914,0.0001236129,0.0000022771821],"category_scores_gemma":[0.000028775617,0.00008069065,0.00013188068,0.00013484426,0.00012631566,0.000017229953,0.00001595132,0.00013803931,7.001732e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006668728,0.0002795443,0.005220718,0.00014448128,0.00022146781,0.0000022358192,0.00019308248,0.0034700253,0.9763019,0.000002347519,0.00017949141,0.013317802],"study_design_scores_gemma":[0.001993963,0.0011270155,0.0032981776,0.0008961898,0.00015953701,0.00010955719,0.00029945056,0.0012479576,0.9906155,0.000010133871,0.00012452809,0.00011800897],"about_ca_topic_score_codex":0.00008994928,"about_ca_topic_score_gemma":0.0004829861,"teacher_disagreement_score":0.017076924,"about_ca_system_score_codex":0.000018747507,"about_ca_system_score_gemma":0.00019322384,"threshold_uncertainty_score":0.3290469},"labels":[],"label_agreement":null},{"id":"W2063513563","doi":"10.1038/bjc.2012.87","title":"Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; University of Ottawa; McGill University Health Centre; Children's Hospital of Eastern Ontario; McGill University","funders":"Vlaamse regering; Universiteit Gent; Susan G. Komen; Fonds Wetenschappelijk Onderzoek; McGill University","keywords":"Ovarian cancer; Breast cancer; Missense mutation; Proband; Oncology; Biology; Ovarian carcinoma; Allele; Genetics; Cancer; Mutation; Internal medicine; Cancer research; Medicine; Gene","score_opus":0.006294149648827082,"score_gpt":0.27679331241116634,"score_spread":0.27049916276233926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063513563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723514,0.02643467,0.0004508547,0.00015570229,0.00026897722,0.00005820865,0.0001514371,0.0000010224087,0.00012776142],"genre_scores_gemma":[0.98896277,0.010002024,0.0004842779,0.00011941356,0.0003378639,0.000014356785,0.000012130641,0.00001246639,0.00005472576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991605,0.000043453347,0.00035885136,0.00011501446,0.00015785877,0.0001642833],"domain_scores_gemma":[0.9993145,0.000011530223,0.00028364395,0.00008634815,0.00023460804,0.00006938671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026715404,0.00008191264,0.00024040989,0.00019330114,0.000029244025,0.000019343479,0.00009509831,0.00008376907,0.00010925809],"category_scores_gemma":[0.000027327638,0.00009392806,0.00009666075,0.00038673126,0.00007870992,0.00002223272,0.00002815978,0.00009639003,1.5885841e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020442679,0.00012452301,0.57480896,0.00005800157,0.0018340087,0.000020178572,0.000785054,0.007857194,0.06419492,0.000012077022,0.0013248824,0.3487758],"study_design_scores_gemma":[0.0007929068,0.000032760865,0.9845838,0.00009876631,0.00042111787,0.0002483894,0.00028058395,0.0001482728,0.011060685,0.000012994195,0.0022004114,0.00011933466],"about_ca_topic_score_codex":0.001736593,"about_ca_topic_score_gemma":0.0052471217,"teacher_disagreement_score":0.40977484,"about_ca_system_score_codex":0.000089160516,"about_ca_system_score_gemma":0.00019334067,"threshold_uncertainty_score":0.3830275},"labels":[],"label_agreement":null},{"id":"W2063648710","doi":"10.1038/bjc.2012.367","title":"Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Novartis Pharmaceuticals Corporation","keywords":"Renal cell carcinoma; Hazard ratio; Medicine; Internal medicine; Confidence interval; Oncology; Progression-free survival; Proportional hazards model; Chemotherapy","score_opus":0.035887020276444595,"score_gpt":0.34489422547890264,"score_spread":0.30900720520245806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063648710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819298,0.017226275,0.0000012010266,0.00013208324,0.00016536866,0.00046033756,0.000045018136,0.0000024127023,0.000037522128],"genre_scores_gemma":[0.99783707,0.0014765322,0.00027223985,0.000032945638,0.0002677708,0.000018798957,0.000013305109,0.000017515345,0.0000637977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981228,0.000310788,0.0005748731,0.000138543,0.00062556035,0.00022740195],"domain_scores_gemma":[0.99826777,0.00046316293,0.00065574574,0.00007931867,0.00024261657,0.0002913767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052273035,0.00014914697,0.0006899343,0.00008817709,0.000029308809,0.000010719579,0.000031662064,0.000040030594,0.000011809695],"category_scores_gemma":[0.00017742481,0.00010672466,0.00012167914,0.00006791299,0.00004511924,0.00012930795,0.000017528451,0.00016777648,5.67645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018841184,0.001024206,0.9337707,0.0002093354,0.00055038655,0.0002847175,0.00014490752,0.0000018218332,0.000014831862,5.941543e-7,0.00007414011,0.062040232],"study_design_scores_gemma":[0.012511127,0.0039334116,0.97868717,0.0013460757,0.0014392224,0.000009748429,0.000022249673,8.884926e-7,0.0018655183,0.00001355021,0.000085703934,0.00008534724],"about_ca_topic_score_codex":0.00009414426,"about_ca_topic_score_gemma":0.00006221689,"teacher_disagreement_score":0.061954886,"about_ca_system_score_codex":0.0006837166,"about_ca_system_score_gemma":0.00013964128,"threshold_uncertainty_score":0.43521056},"labels":[],"label_agreement":null},{"id":"W2063726066","doi":"10.1054/bjoc.2001.1854","title":"Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Medical Research Council Canada","keywords":"Glioma; Biology; Matrix metalloproteinase; Pathology; In situ hybridization; Malignancy; Matrigel; Phenotype; U87; Gene expression; Cancer research; Angiogenesis; Medicine; Gene","score_opus":0.005942036515029781,"score_gpt":0.25398271958678786,"score_spread":0.24804068307175808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063726066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900212,0.008206637,0.0015941394,0.000011963262,0.000056420013,0.00004253933,0.000004884244,6.984523e-7,0.00006148402],"genre_scores_gemma":[0.9957015,0.0039805546,0.00005684457,0.000031074836,0.00017386858,0.00000185851,0.00000405599,0.000005976259,0.000044253306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995822,0.000024185922,0.00017448615,0.000073516785,0.00007742466,0.000068218695],"domain_scores_gemma":[0.99975806,0.0000015046982,0.00011036445,0.0000342556,0.00005505898,0.00004075793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056356144,0.000044371904,0.00009707211,0.00003279403,0.00002601186,0.000014215567,0.00003566739,0.000061443236,0.000039015456],"category_scores_gemma":[0.0000123440295,0.000046611258,0.000021383654,0.000030042953,0.000028681308,0.000007797656,0.000029632085,0.000048492453,3.239609e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060809274,0.0000273831,0.0051752967,0.000014382362,0.000008062467,0.000021246735,0.000014727872,0.000011488846,0.9819435,0.0000052485757,0.00035328572,0.012364569],"study_design_scores_gemma":[0.0011070636,0.0002059663,0.005213242,0.00032048245,0.00001116935,0.00031545453,0.000016659178,0.000048532995,0.9902638,0.0002298123,0.002199973,0.000067809895],"about_ca_topic_score_codex":0.00007683826,"about_ca_topic_score_gemma":0.0001203646,"teacher_disagreement_score":0.0122967595,"about_ca_system_score_codex":0.000005477899,"about_ca_system_score_gemma":0.0000190637,"threshold_uncertainty_score":0.19007519},"labels":[],"label_agreement":null},{"id":"W2064747770","doi":"10.1038/bjc.2012.10","title":"Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Retrospective cohort study; Clinical trial; Internal medicine; Lesion; Progressive disease; Target lesion; Oncology; Disease; Radiology; Nuclear medicine; Surgery","score_opus":0.01646098267440435,"score_gpt":0.3153818528380368,"score_spread":0.29892087016363245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064747770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904159,0.0061186845,0.00012427793,0.0010434411,0.000579222,0.00057029235,0.00013174367,0.000015532592,0.0010009393],"genre_scores_gemma":[0.9900268,0.004818422,0.0023963004,0.0017766606,0.0005600058,0.00013684796,0.00001806508,0.00007846113,0.00018848092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974499,0.00011976069,0.0006836042,0.00023314176,0.00095180015,0.0005618226],"domain_scores_gemma":[0.99791867,0.000044741108,0.000425171,0.00013462728,0.00090358255,0.0005732043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023578074,0.00023304798,0.0005928042,0.00026924064,0.00004553559,0.00006273451,0.00019705991,0.000104051884,0.00070974237],"category_scores_gemma":[0.00010210924,0.00023142647,0.000118485754,0.0006941206,0.000048129,0.00030900093,0.000038513295,0.00047753303,0.000004406075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047313966,0.0010827208,0.9527993,0.00008974196,0.0002700085,0.00038884487,0.00018137418,0.00015650778,0.0031343459,0.000005229229,0.023257794,0.01816096],"study_design_scores_gemma":[0.005692565,0.00093537127,0.9679584,0.0030339858,0.00033693705,0.00020582555,0.000034179935,0.000017729673,0.01309786,0.0000072195526,0.008408634,0.00027127532],"about_ca_topic_score_codex":0.0056780297,"about_ca_topic_score_gemma":0.0017400711,"teacher_disagreement_score":0.017889684,"about_ca_system_score_codex":0.0012759576,"about_ca_system_score_gemma":0.00036673236,"threshold_uncertainty_score":0.94372976},"labels":[],"label_agreement":null},{"id":"W2065233640","doi":"10.1038/sj.bjc.6604744","title":"Portable stove use is associated with lower lung cancer mortality risk in lifetime smoky coal users","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Cancer Institute; Yale University; National Institutes of Health; U.S. Environmental Protection Agency","keywords":"Stove; Lung cancer; Medicine; Environmental health; Hazard ratio; Confidence interval; Proportional hazards model; Cancer; Toxicology; Surgery; Internal medicine; Waste management; Biology; Engineering","score_opus":0.013064790047113571,"score_gpt":0.2428297880473803,"score_spread":0.22976499800026673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065233640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724644,0.0016307202,0.000024292016,0.00009383599,0.00019006315,0.00008690441,0.0000982924,0.00000869145,0.000620745],"genre_scores_gemma":[0.98577154,0.011396465,0.00007102146,0.00070943934,0.000074548705,0.000008364615,0.0000029913913,0.000026557313,0.0019390915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981622,0.000091812144,0.00040454196,0.00021968043,0.0006985247,0.00042322945],"domain_scores_gemma":[0.9990862,0.00004223539,0.0004802133,0.00013393752,0.000019395971,0.00023798765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034405148,0.00016531094,0.00032116103,0.000036038447,0.00015444186,0.00004837018,0.00019504817,0.000109166744,0.0064315745],"category_scores_gemma":[0.00007263591,0.00016475245,0.00009190456,0.00022270778,0.00023459726,0.0009568328,0.000049578048,0.0004505248,0.0000070454585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007801207,0.00014189057,0.8674444,0.0000020323873,0.00012998168,0.0011910427,0.00015264454,0.11846988,0.000058981288,1.7557748e-7,0.011625967,0.0007049883],"study_design_scores_gemma":[0.0012428681,0.000075974116,0.9933474,0.00025827982,0.000095104326,0.00021538863,0.000016942135,0.00026801412,0.00022349978,0.000009251227,0.0040176986,0.00022955019],"about_ca_topic_score_codex":0.04252045,"about_ca_topic_score_gemma":0.038434356,"teacher_disagreement_score":0.12590303,"about_ca_system_score_codex":0.00076149515,"about_ca_system_score_gemma":0.00009217355,"threshold_uncertainty_score":0.9944767},"labels":[],"label_agreement":null},{"id":"W2065284533","doi":"10.1038/sj.bjc.6605316","title":"Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Hong Kong; McGill University; University of Ottawa; Thomas Jefferson University","keywords":"Gene knockdown; Ovarian cancer; Biology; Cell growth; Cancer research; Transforming growth factor; Downregulation and upregulation; Small hairpin RNA; Western blot; Cancer; Molecular biology; Cell culture; Endocrinology; Gene; Genetics","score_opus":0.009454196064547688,"score_gpt":0.2791322032378598,"score_spread":0.26967800717331214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065284533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98020416,0.01463558,0.0039554695,0.0005383568,0.0001691225,0.0001663518,0.00011845243,0.0000021384906,0.00021037023],"genre_scores_gemma":[0.99608284,0.0023834035,0.0010735899,0.0001976089,0.00012611975,0.000006654475,0.0000136988765,0.000010367909,0.00010572966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878913,0.000071010254,0.00058461336,0.00015614876,0.00025299654,0.00014608032],"domain_scores_gemma":[0.99898297,0.000008921457,0.00042970115,0.00011434244,0.00041403598,0.00005003375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017440872,0.00009828753,0.00026002454,0.00007091678,0.000028348139,0.000014183446,0.00010908623,0.0001321621,0.000055554607],"category_scores_gemma":[0.00007602588,0.000107847285,0.00010134883,0.00015081184,0.000043059437,0.000034477507,0.000015679847,0.00010962179,1.7313467e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007494391,0.00008497572,0.0020732873,0.00003660119,0.000018183697,0.0000052573564,0.0000775377,0.0009421167,0.98842996,0.000053780477,0.0032262097,0.004302645],"study_design_scores_gemma":[0.0015485465,0.00013780409,0.15213065,0.0025908235,0.000013586316,0.000008015043,0.000028858982,0.0000025207012,0.8357622,0.0005678148,0.0071161934,0.00009300039],"about_ca_topic_score_codex":0.00024423745,"about_ca_topic_score_gemma":0.000801066,"teacher_disagreement_score":0.15266778,"about_ca_system_score_codex":0.00006328359,"about_ca_system_score_gemma":0.00013249261,"threshold_uncertainty_score":0.4397885},"labels":[],"label_agreement":null},{"id":"W2065948425","doi":"10.1038/bjc.2014.572","title":"The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bowel Disease Research Foundation; Medical Research Council; National Institute for Health and Care Research; Pfizer","keywords":"Colorectal cancer; Chemokine; Chemokine receptor; Infiltration (HVAC); Cancer research; Chemokine receptor CCR5; Immunology; Biology; Chemotaxis; Flow cytometry; Receptor; Cancer; Inflammation","score_opus":0.010550592706517972,"score_gpt":0.28035184701896204,"score_spread":0.26980125431244406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065948425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885514,0.009025426,0.00003851098,0.00067805604,0.0007900867,0.00031927432,0.0000039654433,0.0000048736333,0.0005884559],"genre_scores_gemma":[0.9945385,0.0035341007,0.0000711551,0.0004776529,0.00094343367,0.000039229253,7.3491265e-7,0.000018056586,0.00037715485],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894065,0.000056051023,0.00033744576,0.000096555275,0.000413682,0.00015564363],"domain_scores_gemma":[0.9991089,0.00016441137,0.00026395445,0.00007266746,0.00025115538,0.00013892158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003806273,0.00008369179,0.00027823748,0.00004879074,0.00007189888,0.00002063861,0.000057037192,0.00005165289,0.000085934225],"category_scores_gemma":[0.00015040982,0.00006645946,0.00013557983,0.00010167031,0.000040230996,0.000033846783,0.00001458315,0.00020813869,0.0000015172373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006732366,0.0001686752,0.002378453,0.00025943803,0.00010768538,0.000059515914,0.00018973686,0.00014118667,0.38385367,0.000026883583,0.024945835,0.5871957],"study_design_scores_gemma":[0.0024886853,0.0011908923,0.025393886,0.0044621564,0.00012369677,0.00016148631,0.000031760108,0.000021791386,0.90403837,0.00005123586,0.061937362,0.00009866305],"about_ca_topic_score_codex":0.0001620705,"about_ca_topic_score_gemma":0.00017365448,"teacher_disagreement_score":0.58709705,"about_ca_system_score_codex":0.00022679847,"about_ca_system_score_gemma":0.00014758478,"threshold_uncertainty_score":0.27101383},"labels":[],"label_agreement":null},{"id":"W2065957423","doi":"10.1038/sj.bjc.6600552","title":"Treatment of paediatric pontine glioma with oral trophosphamide and etoposide","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Glioma; Etoposide; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer research","score_opus":0.011964350240452807,"score_gpt":0.25110478655416557,"score_spread":0.23914043631371276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065957423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8585496,0.14028546,0.0000026432654,0.0007780481,0.000069660186,0.00012763271,0.000015705,0.00000419139,0.00016707736],"genre_scores_gemma":[0.96114457,0.03765246,0.0007695823,0.000051684983,0.00018057415,0.000011440912,0.0000010106559,0.000015603726,0.00017310516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99916226,0.000017815479,0.00031197263,0.000104443054,0.00025189918,0.0001516107],"domain_scores_gemma":[0.99930847,0.000031569856,0.00024308161,0.00007218058,0.00018534184,0.00015937652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003767133,0.00010992908,0.00043523125,0.00010457051,0.000032392047,0.000020625712,0.000029207253,0.000036280515,0.0002900966],"category_scores_gemma":[0.000014223601,0.00008226901,0.00010807859,0.00017788977,0.000054379827,0.00007106522,0.0000057846096,0.00005696079,0.0000012141965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053391675,0.0015547134,0.4045562,0.000051274637,0.00068770297,0.014736897,0.0001706038,0.000022015412,0.0016262606,0.000011121906,0.0016095055,0.57443976],"study_design_scores_gemma":[0.02558472,0.0078273555,0.8873441,0.0007480892,0.0017331133,0.036692936,0.00008839724,0.000059016984,0.025475921,0.000023733226,0.014230994,0.00019157314],"about_ca_topic_score_codex":0.00104995,"about_ca_topic_score_gemma":0.00043217585,"teacher_disagreement_score":0.5742482,"about_ca_system_score_codex":0.00010488117,"about_ca_system_score_gemma":0.000044450164,"threshold_uncertainty_score":0.33548328},"labels":[],"label_agreement":null},{"id":"W2066652089","doi":"10.1038/sj.bjc.6606042","title":"Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Colposcopy; Anxiety; Hospital Anxiety and Depression Scale; Psychosocial; Obstetrics; Depression (economics); Randomized controlled trial; Distress; Odds ratio; Cervical cancer; Gynecology; Surgery; Internal medicine; Psychiatry; Cancer; Clinical psychology","score_opus":0.018235415304761696,"score_gpt":0.38593005349204257,"score_spread":0.3676946381872809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066652089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941378,0.00066827267,0.00007987099,0.0005468689,0.00041754116,0.0029403039,0.000049775677,0.000005162506,0.001154353],"genre_scores_gemma":[0.9965327,0.0012138195,0.00012064417,0.00018763213,0.0012126449,0.0005846252,0.0000036928147,0.000026250407,0.00011803143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781305,0.00010582319,0.00081288186,0.00017898476,0.00058841804,0.00050082215],"domain_scores_gemma":[0.99837,0.0002149411,0.00044225028,0.000112724,0.0005682662,0.00029181837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071352057,0.00016295318,0.0012335762,0.0002581529,0.00004999177,0.000044285764,0.00021735251,0.00012695874,0.0015616204],"category_scores_gemma":[0.00013109014,0.00012797632,0.00035511176,0.0002194399,0.00021090906,0.00010787941,0.000028771008,0.0006251644,4.4851078e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94898957,0.00076451636,0.009384096,0.0002099274,0.001287095,0.00038002746,0.0004397049,0.000020987203,0.00056262943,0.000020918755,0.00035553292,0.037584968],"study_design_scores_gemma":[0.58880633,0.0030880966,0.40707242,0.0001932622,0.00014013205,0.00020533317,0.000056045017,0.00002407055,0.00015083785,0.00009493802,0.00007890736,0.000089645655],"about_ca_topic_score_codex":0.0008975131,"about_ca_topic_score_gemma":0.003718949,"teacher_disagreement_score":0.39768833,"about_ca_system_score_codex":0.00038536201,"about_ca_system_score_gemma":0.00064002123,"threshold_uncertainty_score":0.9993511},"labels":[],"label_agreement":null},{"id":"W2067006079","doi":"10.1038/sj.bjc.6603876","title":"The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Cancer Institute; European Organisation for Research and Treatment of Cancer","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Glioblastoma; Oncology; Proportional hazards model; Cancer; Radiation therapy; Brain cancer; Survival analysis","score_opus":0.10010030332051865,"score_gpt":0.47856269791547484,"score_spread":0.3784623945949562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067006079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844339,0.011888793,0.0000170624,0.0010081225,0.00082007,0.0013616101,0.0004622026,0.0000034146005,0.000004816919],"genre_scores_gemma":[0.99302477,0.0064431885,0.000040843162,0.0001003348,0.00026506785,0.000026008087,0.00008660098,0.000012317127,8.4995816e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99179876,0.0027060164,0.0044892468,0.00028924082,0.0005247487,0.0001919763],"domain_scores_gemma":[0.98952997,0.006766891,0.00312711,0.00014557323,0.00024613997,0.00018433896],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025993176,0.000118943215,0.0012662663,0.000173138,0.00005643894,0.000026446061,0.00015745225,0.00009483119,0.000009088091],"category_scores_gemma":[0.01584057,0.00009687499,0.000073587405,0.00018840967,0.00010702127,0.0002450057,0.000060278635,0.00033692212,2.5493526e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03884691,0.0034306992,0.71867734,0.00001684672,0.00041054472,0.00011091139,0.0009473373,0.000016362033,0.000040887087,0.0000047616895,0.000055286677,0.2374421],"study_design_scores_gemma":[0.21297185,0.00240815,0.7822173,0.00075184734,0.00014068876,0.0000184263,0.00088838406,0.0004700861,0.000011977491,0.00002214311,0.00004438472,0.0000547216],"about_ca_topic_score_codex":0.030524792,"about_ca_topic_score_gemma":0.08785118,"teacher_disagreement_score":0.23738739,"about_ca_system_score_codex":0.00022086833,"about_ca_system_score_gemma":0.00046590352,"threshold_uncertainty_score":0.9924494},"labels":[],"label_agreement":null},{"id":"W2068138131","doi":"10.1038/bjc.2011.34","title":"Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Downregulation and upregulation; Epithelial–mesenchymal transition; Cancer research; Mesenchymal stem cell; Ovarian carcinoma; Carcinoma; Cell; Cell growth; Signalling; Medicine; Chemistry; Pathology; Cell biology; Biology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.01688090347514298,"score_gpt":0.2520357346927184,"score_spread":0.2351548312175754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068138131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961348,0.0024314327,0.0007565216,0.000072705094,0.00007553563,0.00016135571,0.00003595046,0.0000014766375,0.00033021442],"genre_scores_gemma":[0.99708265,0.0009788582,0.0016220019,0.000039705996,0.00012668631,0.0000033644571,0.000005750062,0.00001310731,0.00012784834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897623,0.00010838676,0.00035361742,0.00015970407,0.00023158657,0.00017045334],"domain_scores_gemma":[0.99937135,0.000009833674,0.000165079,0.0000748642,0.0002694408,0.00010942618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037664286,0.00008775543,0.00017198431,0.00009575886,0.000041005245,0.000023967097,0.00011154085,0.00011637919,0.00006244831],"category_scores_gemma":[0.000023685274,0.000098349046,0.00005863527,0.00012615304,0.000054051565,0.000019100009,0.000023885561,0.00014522279,6.7559716e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030819583,0.000105688945,0.0017153963,0.000038498787,0.000015449314,0.000041374882,0.0004717523,0.0008314411,0.9898058,0.0000047856506,0.00008009903,0.006581472],"study_design_scores_gemma":[0.0016503341,0.0003018087,0.10007825,0.00014295435,0.000012378823,0.00006413378,0.00014364213,0.00008790689,0.89669406,0.000040495474,0.0006675413,0.00011647967],"about_ca_topic_score_codex":0.0025647501,"about_ca_topic_score_gemma":0.0013681797,"teacher_disagreement_score":0.09836285,"about_ca_system_score_codex":0.00002771145,"about_ca_system_score_gemma":0.00015881564,"threshold_uncertainty_score":0.40105578},"labels":[],"label_agreement":null},{"id":"W2068164466","doi":"10.1038/sj.bjc.6602618","title":"Guidelines for confidentiality and cancer registration","year":2005,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Patient Dignity and Privacy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health","keywords":"Confidentiality; Bioethics; Informed consent; Legislation; Political science; Medicine; Library science; Family medicine; Alternative medicine; Law; Pathology","score_opus":0.13681704520690713,"score_gpt":0.41515254888409214,"score_spread":0.278335503677185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068164466","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079521015,0.12545685,0.0005916453,0.86273587,0.0016375406,0.0004964289,0.00054531754,0.00001203372,0.0005722251],"genre_scores_gemma":[0.0018116481,0.072030395,0.0018960154,0.8690221,0.044914063,0.000057696358,0.00013612917,0.00005755942,0.010074438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984691,0.000038553942,0.00073277694,0.00015968051,0.00041526594,0.0001846314],"domain_scores_gemma":[0.9972374,0.000061027167,0.00078307017,0.00009850811,0.0017378266,0.000082194114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032242344,0.0001411516,0.0005075837,0.00007443706,0.000058916958,0.00008961239,0.00010067168,0.00033996842,0.00034243622],"category_scores_gemma":[0.00035771987,0.00015105908,0.00019619984,0.000045101333,0.00007208739,0.00016602926,0.000013841868,0.0008008719,5.6202504e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099974466,0.000012137736,0.0002033507,0.0003566992,0.00017413493,0.00019466842,0.000032163764,0.0000036981544,0.00004862717,0.0000012830466,0.8515516,0.14732167],"study_design_scores_gemma":[0.0016911759,0.00011861881,0.0014655368,0.0029786055,0.0005873874,0.0013787177,0.000012414145,0.000014983628,0.00014524064,0.00020830476,0.9912501,0.00014890298],"about_ca_topic_score_codex":0.0018256562,"about_ca_topic_score_gemma":0.0009755778,"teacher_disagreement_score":0.14717276,"about_ca_system_score_codex":0.00011770342,"about_ca_system_score_gemma":0.00058754283,"threshold_uncertainty_score":0.61600107},"labels":[],"label_agreement":null},{"id":"W2068786165","doi":"10.1038/bjc.2014.208","title":"Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; European Organisation for Research and Treatment of Cancer; Pfizer","keywords":"Medicine; Internal medicine; Lung cancer; Proportional hazards model; Quality of life (healthcare); Hazard ratio; Survival analysis; Cancer; Oncology; Confidence interval","score_opus":0.04807912975397806,"score_gpt":0.36512531584002983,"score_spread":0.3170461860860518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068786165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96080786,0.034655653,0.000045307006,0.0012968383,0.0022824754,0.0004301746,0.00031334077,0.000009520843,0.00015884139],"genre_scores_gemma":[0.9852044,0.013210736,0.000017028064,0.00042408862,0.00093002757,0.000042123684,0.000014183502,0.000024981662,0.00013240623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579865,0.00052014785,0.0021943925,0.00023495637,0.00093816983,0.00031367154],"domain_scores_gemma":[0.9965778,0.0002073742,0.0019878398,0.00023442255,0.0006848671,0.0003077135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002698285,0.00016614773,0.0019408672,0.00047272816,0.000036111815,0.000016115495,0.00019112365,0.0001562256,0.0010425108],"category_scores_gemma":[0.0005132139,0.00013754412,0.0005887083,0.0012456898,0.00012262067,0.00015407016,0.00003261361,0.00045094232,1.3039666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013625405,0.00025922866,0.9055734,0.0011796601,0.0023922687,0.00002702729,0.0016426238,0.0002819956,0.000084003485,0.00003093887,0.0003848817,0.07451856],"study_design_scores_gemma":[0.024368132,0.00043514007,0.96860874,0.003199668,0.0011788605,0.000009313145,0.0002896845,0.00040831426,0.00010968564,0.00003078356,0.0011905421,0.00017115095],"about_ca_topic_score_codex":0.25140458,"about_ca_topic_score_gemma":0.4307633,"teacher_disagreement_score":0.17935869,"about_ca_system_score_codex":0.00030461902,"about_ca_system_score_gemma":0.00087522384,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W2068888322","doi":"10.1038/sj.bjc.6604762","title":"Estimation of lead time and overdiagnosis in breast cancer screening","year":2009,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overdiagnosis; Breast cancer; Medicine; Mammography; Estimation; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.028787931316795533,"score_gpt":0.3239645096213897,"score_spread":0.29517657830459415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068888322","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28550425,0.15464194,0.00024792258,0.5568312,0.00055067363,0.0005659656,0.00072372874,0.000023715731,0.00091062],"genre_scores_gemma":[0.32089454,0.08649939,0.005159582,0.5744909,0.011291304,0.000047506477,0.00009934485,0.00016061628,0.0013568214],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978253,0.000064560394,0.00079262955,0.00022124856,0.00078539463,0.000310836],"domain_scores_gemma":[0.9985477,0.00007282479,0.0008001196,0.000108390115,0.00038441463,0.00008655299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034537146,0.00021145107,0.0009236068,0.00026668783,0.00003687618,0.000055165947,0.00014235116,0.00038034207,0.00034779974],"category_scores_gemma":[0.00006891535,0.00023493268,0.00019370508,0.00025247244,0.000093908595,0.00031365658,0.000021776506,0.0014240406,0.0000012846288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019526902,0.000020653986,0.012219532,0.00019748505,0.00013649443,0.0021354014,0.00003981303,0.00055411377,0.0001368041,2.0597896e-7,0.46178943,0.5225748],"study_design_scores_gemma":[0.0052634613,0.0005212224,0.79270345,0.0754552,0.0013152427,0.022067374,0.00004897147,0.0013588693,0.0006273329,0.00011242771,0.09979216,0.0007343013],"about_ca_topic_score_codex":0.007509856,"about_ca_topic_score_gemma":0.0005474666,"teacher_disagreement_score":0.7804839,"about_ca_system_score_codex":0.00030151746,"about_ca_system_score_gemma":0.00042459555,"threshold_uncertainty_score":0.9990992},"labels":[],"label_agreement":null},{"id":"W2069036425","doi":"10.1038/sj.bjc.6602380","title":"Specific fatty acid intake and the risk of pancreatic cancer in Canada","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"National Cancer Institute; Health Canada; BC Cancer Agency; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Cancer Care Ontario","keywords":"Quartile; Medicine; Body mass index; Confidence interval; Odds ratio; Internal medicine; Saturated fatty acid; Gastroenterology; Pancreatic cancer; Population; Logistic regression; Case-control study; Cancer; Endocrinology; Fatty acid; Animal science; Chemistry; Biology; Environmental health; Biochemistry","score_opus":0.01647423348957774,"score_gpt":0.3005340926269793,"score_spread":0.28405985913740156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069036425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8965253,0.10020102,0.000023304885,0.0019769652,0.00009914701,0.00017590272,0.00004340896,0.0000010506462,0.00095386757],"genre_scores_gemma":[0.86166555,0.13728781,0.0003241633,0.00024009116,0.0003114201,0.000014274644,4.1896706e-7,0.000008149026,0.00014811277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986688,0.00014231054,0.0005101799,0.00008976153,0.0003845963,0.00020436653],"domain_scores_gemma":[0.99907994,0.00021743382,0.00029639044,0.000091730995,0.00019223333,0.00012228855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006563431,0.00007672955,0.0006130571,0.000056505964,0.00004501176,0.000010795668,0.00010324346,0.000042133895,0.00089293136],"category_scores_gemma":[0.00016129397,0.000055620654,0.000055669392,0.00013242096,0.00023058035,0.000059095204,0.000021627555,0.0004690853,5.7662373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000747454,0.00003315166,0.77568644,0.000045449127,0.00022545912,0.00020412628,0.00020079405,0.000049391856,0.00026398292,0.000013913913,0.0027835427,0.21974628],"study_design_scores_gemma":[0.0062310523,0.000070390786,0.98284656,0.0007894376,0.0002686712,0.0008611057,0.00032726492,0.00028373275,0.00064930675,0.00006817977,0.0075434917,0.000060783277],"about_ca_topic_score_codex":0.7950168,"about_ca_topic_score_gemma":0.9396024,"teacher_disagreement_score":0.2196855,"about_ca_system_score_codex":0.00055944343,"about_ca_system_score_gemma":0.002378824,"threshold_uncertainty_score":0.97769725},"labels":[],"label_agreement":null},{"id":"W2069136947","doi":"10.1038/bjc.2011.401","title":"miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; York University; University of Toronto; Western University; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Government of Ontario; Cancer Research Society","keywords":"microRNA; Renal cell carcinoma; Metastasis; Gene expression profiling; Kidney cancer; Cancer research; Medicine; Microarray; Cancer; Carcinoma; Microarray analysis techniques; Oncology; Biology; Pathology; Internal medicine; Gene expression; Gene","score_opus":0.01611616043464681,"score_gpt":0.2681088941853504,"score_spread":0.2519927337507036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069136947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084825,0.017895536,0.00052705256,0.000015923075,0.00014854196,0.00036618492,0.00007251328,0.0000019521178,0.00012402059],"genre_scores_gemma":[0.995439,0.00015373944,0.0039087045,0.000049113914,0.00023516724,0.000059077298,0.000018087445,0.000026367781,0.00011074992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896425,0.00011403287,0.00039991655,0.00017106127,0.0001334149,0.00021729815],"domain_scores_gemma":[0.9992865,0.00001894251,0.00031883482,0.000096888645,0.00018481779,0.00009404863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042261893,0.000111666384,0.00023217007,0.000056201137,0.00003367387,0.000023524366,0.0001610695,0.000063807645,0.00004597823],"category_scores_gemma":[0.0001056079,0.00012071939,0.00016992413,0.000058699407,0.000033303106,0.00001162398,0.000027479367,0.00010259736,6.556768e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005448115,0.000070047594,0.0069235875,0.00018331672,0.000049451235,0.00009604323,0.000036850906,0.000047959413,0.98713297,0.0000018427464,0.0018741285,0.0030390134],"study_design_scores_gemma":[0.0022592836,0.00036760975,0.05603327,0.00023101486,0.000105437764,0.00028658623,0.000014764596,0.00003300022,0.93937147,0.00010119595,0.0010488696,0.0001475111],"about_ca_topic_score_codex":0.00009904062,"about_ca_topic_score_gemma":0.00013906696,"teacher_disagreement_score":0.049109682,"about_ca_system_score_codex":0.000040313163,"about_ca_system_score_gemma":0.00015842893,"threshold_uncertainty_score":0.4922794},"labels":[],"label_agreement":null},{"id":"W2069162303","doi":"10.1038/bjc.2013.381","title":"Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chronic lymphocytic leukemia; Medicine; Follicular lymphoma; Lymphoma; Incidence (geometry); Internal medicine; Immunosuppression; Cohort; Population; Cancer; Oncology; Gastroenterology; Leukemia","score_opus":0.007210907487999676,"score_gpt":0.2524244376014164,"score_spread":0.24521353011341673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069162303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633414,0.0018524101,0.0000022572897,0.000016668002,0.00010020586,0.001447537,0.00009992419,0.000007831216,0.00013902022],"genre_scores_gemma":[0.99929684,0.00009477575,0.00007983184,0.00018011348,0.00008803326,0.000095679585,0.000048956346,0.000051140963,0.00006461865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967257,0.0002256168,0.0009975078,0.00028345318,0.0011921003,0.0005756335],"domain_scores_gemma":[0.99683094,0.00013234114,0.0006713482,0.0002942333,0.0014959647,0.00057515496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003632464,0.00023731099,0.0007947696,0.00049789663,0.00010101509,0.00007402624,0.0002644882,0.00011392526,0.0011356181],"category_scores_gemma":[0.00036251105,0.00022388536,0.00014651963,0.0005707719,0.00009471315,0.00029275738,0.000029958032,0.00023482105,0.0000119142705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005740192,0.0004694687,0.9850924,0.00019912739,0.000322637,0.0005745117,0.00019828258,0.002200634,0.00002269737,6.9337534e-7,0.00046917165,0.009876327],"study_design_scores_gemma":[0.07621151,0.0014673346,0.9170497,0.0018217352,0.00019938062,0.00012891834,0.00018977438,0.0023039116,0.00020133206,0.000013036767,0.0002039725,0.0002093718],"about_ca_topic_score_codex":0.90660155,"about_ca_topic_score_gemma":0.7736597,"teacher_disagreement_score":0.13294184,"about_ca_system_score_codex":0.080182776,"about_ca_system_score_gemma":0.05086973,"threshold_uncertainty_score":0.9997775},"labels":[],"label_agreement":null},{"id":"W2069225985","doi":"10.1038/sj.bjc.6603993","title":"Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Cure Brain Cancer Foundation","keywords":"Autocrine signalling; Cancer research; Cell migration; Receptor; Biology; Metastasis; Neuropilin 1; Receptor tyrosine kinase; Vascular endothelial growth factor; Cancer cell; Cell biology; Internal medicine; Cell; Cancer; Medicine; Biochemistry; VEGF receptors","score_opus":0.007922465934891548,"score_gpt":0.2827490453369675,"score_spread":0.27482657940207594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069225985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767727,0.022391757,0.0000056471486,0.00011161116,0.00027359964,0.000115002724,0.000025640973,0.0000048018637,0.00029919166],"genre_scores_gemma":[0.9976841,0.0015691468,0.000079300764,0.000060899434,0.00049272773,0.000003682401,0.0000016803596,0.000016101229,0.00009235961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987443,0.000031330776,0.0006057736,0.00011002214,0.00031618713,0.00019238514],"domain_scores_gemma":[0.9991075,0.000043816806,0.00040128242,0.000055374057,0.00021758674,0.00017448509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044853624,0.00008753265,0.00033914685,0.00016638853,0.00004980612,0.000027608521,0.000058621157,0.000056962363,0.0002675814],"category_scores_gemma":[0.00003604273,0.00008965272,0.00007665769,0.00018261586,0.000051649542,0.0001478105,0.000013678623,0.000055166918,5.764717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013247719,0.00014093885,0.74945587,0.00029523092,0.00008181639,0.00020971918,0.0010228596,0.000010809212,0.1351454,0.000005248198,0.0005056071,0.112994],"study_design_scores_gemma":[0.004034528,0.00014764557,0.8867395,0.010180781,0.00020377983,0.0018275633,0.0024167402,0.000032547567,0.0930445,0.000049811875,0.0011344941,0.00018811168],"about_ca_topic_score_codex":0.004228339,"about_ca_topic_score_gemma":0.003194169,"teacher_disagreement_score":0.1372836,"about_ca_system_score_codex":0.00017904602,"about_ca_system_score_gemma":0.00022021298,"threshold_uncertainty_score":0.6392012},"labels":[],"label_agreement":null},{"id":"W2069320638","doi":"10.1038/sj.bjc.6605879","title":"Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Government of Canada; Canadian Cancer Society Research Institute; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia; Corporación de Fomento de la Producción","keywords":"Lung cancer; Biology; Arsenic; Lung; Population; Somatic cell; Cancer research; Genetics; Oncology; Pathology; Medicine; Internal medicine; Gene; Chemistry","score_opus":0.003917785795877276,"score_gpt":0.22939774123779108,"score_spread":0.2254799554419138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069320638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938203,0.0023981868,0.000037677237,0.000113167625,0.00056542497,0.000061419385,0.00003959739,0.0000022644638,0.0029619397],"genre_scores_gemma":[0.99712294,0.00036075118,0.0002805127,0.00010916114,0.00035572425,0.0000074575364,0.000017313629,0.000014140419,0.0017319773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999248,0.00003326513,0.0003525672,0.0001099772,0.00009680641,0.0001593283],"domain_scores_gemma":[0.9995085,0.00000824582,0.00016566092,0.00009560519,0.00015455854,0.000067449226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013525115,0.00007867376,0.00012572599,0.000030688934,0.000065521985,0.000054818738,0.00012799875,0.00011216917,0.0004950678],"category_scores_gemma":[0.000026453585,0.00009194054,0.00008746393,0.00006156665,0.000036681966,0.000011382974,0.00002817865,0.00024670054,0.0000041675685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001076232,0.00031226178,0.2854775,0.00005838152,0.0000993825,0.00029474375,0.00058312615,0.0014590693,0.69402575,0.00029508985,0.013470124,0.0038169418],"study_design_scores_gemma":[0.007594834,0.00033652957,0.3354125,0.0001779099,0.00020187697,0.0075341766,0.0006755451,0.00029377246,0.5069635,0.00060949905,0.1392211,0.0009787623],"about_ca_topic_score_codex":0.00051497394,"about_ca_topic_score_gemma":0.0046331924,"teacher_disagreement_score":0.18706228,"about_ca_system_score_codex":0.00002272731,"about_ca_system_score_gemma":0.00021782333,"threshold_uncertainty_score":0.54206455},"labels":[],"label_agreement":null},{"id":"W2069485773","doi":"10.1038/sj.bjc.6602654","title":"Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; Manitoba Health; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute; Centre International de Recherche sur le Cancer","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Oncology; Pathology","score_opus":0.008630476264784581,"score_gpt":0.26716797460924036,"score_spread":0.2585374983444558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069485773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605593,0.033363346,0.0000045882844,0.00026056566,0.0003013185,0.00016137538,0.00009708546,0.0000070941196,0.00524532],"genre_scores_gemma":[0.9876622,0.009173639,0.0005360244,0.0008422897,0.0008174697,0.000019761581,0.000004957423,0.000025602427,0.0009180846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985802,0.000024145998,0.00057752826,0.00014974234,0.00042403472,0.00024433908],"domain_scores_gemma":[0.99883145,0.00006959228,0.0004665131,0.0001296644,0.00027122424,0.0002315746],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014170793,0.00014400037,0.00056910666,0.00010221141,0.000052772473,0.000030405967,0.00010275244,0.00007872917,0.0017940652],"category_scores_gemma":[0.0000287068,0.00013972301,0.0002552693,0.0001287339,0.000115850555,0.00023541445,0.000022322212,0.000094888564,0.0000035539701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031468313,0.00045090765,0.17035231,0.00013380086,0.00055376167,0.0037848859,0.00014744716,0.00010062444,0.0005770788,0.0000027668693,0.029566888,0.7940149],"study_design_scores_gemma":[0.0067006443,0.00046969278,0.9060334,0.0016904864,0.0003486298,0.006838266,0.00006259372,0.000017525483,0.012418984,0.0000053796402,0.06527751,0.00013688425],"about_ca_topic_score_codex":0.0037611383,"about_ca_topic_score_gemma":0.0050983513,"teacher_disagreement_score":0.79387796,"about_ca_system_score_codex":0.001184573,"about_ca_system_score_gemma":0.0009128822,"threshold_uncertainty_score":0.99911845},"labels":[],"label_agreement":null},{"id":"W2069922776","doi":"10.1038/bjc.2011.140","title":"Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Discontinuation; Medicine; Breast cancer; Cohort; Internal medicine; Population; Gynecology; Cohort study; Cancer; Aromatase inhibitor; Oncology; Obstetrics","score_opus":0.023316978828095407,"score_gpt":0.2744574982820403,"score_spread":0.2511405194539449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069922776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979495,0.0015195087,0.000034149736,0.00012672406,0.00004734558,0.00015298901,0.00011713304,0.0000024411916,0.00005025661],"genre_scores_gemma":[0.99850786,0.0007385035,0.00036546914,0.00024212396,0.000051247676,0.000025502219,0.0000039554166,0.000008879732,0.000056461948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902946,0.000026609263,0.00042349147,0.00008821361,0.00028956778,0.00014268808],"domain_scores_gemma":[0.9990501,0.000019722676,0.00044378804,0.000084057145,0.00025691325,0.00014544289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022726662,0.00006457525,0.0003290416,0.00009220608,0.000013365298,0.0000058197656,0.00005064775,0.000037182348,0.0010056224],"category_scores_gemma":[0.00004044761,0.000058426893,0.000025379772,0.00017388756,0.00006132155,0.00015008175,0.000007359316,0.00012704304,4.4954317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057303265,0.0001583336,0.9847636,0.0001196359,0.000058200458,0.00007560659,0.00019120183,0.000011348277,0.00033919455,0.0000039975835,0.00052388664,0.0131819155],"study_design_scores_gemma":[0.0018625619,0.00013756022,0.9934394,0.0029150723,0.000049793656,0.00028298207,0.00007617638,0.000041053067,0.00083665183,0.000018351524,0.00028187968,0.000058564277],"about_ca_topic_score_codex":0.0071636927,"about_ca_topic_score_gemma":0.0008875916,"teacher_disagreement_score":0.013123351,"about_ca_system_score_codex":0.00010628236,"about_ca_system_score_gemma":0.00036994903,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W2070267699","doi":"10.1038/bjc.2015.13","title":"A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Penetrance; Wilms' tumor; Germline mutation; Biology; Loss of heterozygosity; Germline; Genetics; Uniparental disomy; Mutation; Incidence (geometry); Cancer research; Allele; Gene; Phenotype; Chromosome; Karyotype","score_opus":0.003999266435862699,"score_gpt":0.23631967361743636,"score_spread":0.23232040718157365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070267699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803544,0.019253014,0.000010823714,0.00019044806,0.000050923914,0.000114605245,0.000007895461,6.013697e-7,0.000017235601],"genre_scores_gemma":[0.9927311,0.00699548,0.00007265497,0.000092853625,0.00006931746,0.0000075237554,0.000004566004,0.000006416878,0.000020117732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991838,0.00008760508,0.00034677054,0.00011139246,0.00014580318,0.00012463416],"domain_scores_gemma":[0.9995585,0.000008123287,0.00022666893,0.000051587944,0.00011067695,0.000044425964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045318928,0.00007461664,0.00020183098,0.000051301788,0.000011789874,0.000017490645,0.00010726718,0.00006703121,0.00000298559],"category_scores_gemma":[0.000032737353,0.000054461387,0.00002849789,0.00015089507,0.00016562975,0.00002052973,0.000018288296,0.00019973954,5.6974127e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013398749,0.00004262019,0.9680497,0.000016878319,0.000044974826,0.000092505885,0.00025025025,0.018090958,0.0031780223,0.00000674119,0.000042404667,0.008845052],"study_design_scores_gemma":[0.0053311074,0.00017811877,0.98274684,0.000455002,0.000013700318,0.0012306717,0.000068864334,0.000070922164,0.009653932,0.00014515613,0.000018149254,0.00008754958],"about_ca_topic_score_codex":0.0071398076,"about_ca_topic_score_gemma":0.010243952,"teacher_disagreement_score":0.018020036,"about_ca_system_score_codex":0.000035123296,"about_ca_system_score_gemma":0.00018851776,"threshold_uncertainty_score":0.9994717},"labels":[],"label_agreement":null},{"id":"W2070811342","doi":"10.1038/bjc.2012.74","title":"Mitochondrial D310 mutations in the early development of breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Breast Cancer Research Alliance; University Health Network","keywords":"Pathology; Biology; Ductal carcinoma; Breast cancer; Mitochondrial DNA; Carcinoma; Cancer; Mammary gland; Medicine; Gene; Genetics","score_opus":0.012938547930129454,"score_gpt":0.276282682448277,"score_spread":0.26334413451814753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070811342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120855,0.00610923,0.00058207155,0.00018955945,0.0015323219,0.00008396502,0.00004029032,9.118137e-7,0.0002530867],"genre_scores_gemma":[0.9959814,0.0006901041,0.001150522,0.00025451396,0.0016877347,0.000023600385,0.0000069375847,0.00000892874,0.00019623773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992174,0.00008553203,0.00032689533,0.00006940644,0.00014854356,0.00015224537],"domain_scores_gemma":[0.99952286,0.000011471762,0.00019409943,0.000065720495,0.00015437596,0.00005144008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020099521,0.000061159735,0.00012148213,0.000037819544,0.000045445013,0.000013865958,0.00013676184,0.0000752607,0.00020509823],"category_scores_gemma":[0.000033571123,0.00005342013,0.00006829621,0.00008423206,0.000045428795,0.000010083775,0.000016703832,0.00012689251,0.000001615087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065335614,0.00037505256,0.10721078,0.000035994108,0.00020551273,0.000034334014,0.0028755483,0.00016503154,0.72189426,0.00006088677,0.014612655,0.15187661],"study_design_scores_gemma":[0.0020664153,0.00011794689,0.76471347,0.00017652482,0.000061203755,0.0016931039,0.00034880041,0.0000012818804,0.04205579,0.000030168041,0.1885345,0.00020078053],"about_ca_topic_score_codex":0.00020726766,"about_ca_topic_score_gemma":0.0015828431,"teacher_disagreement_score":0.6798384,"about_ca_system_score_codex":0.000019389458,"about_ca_system_score_gemma":0.00022465667,"threshold_uncertainty_score":0.22456817},"labels":[],"label_agreement":null},{"id":"W2070855246","doi":"10.1038/sj.bjc.6602304","title":"Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Term (time); Cancer; Surgery; Oncology; Internal medicine","score_opus":0.009585676431239868,"score_gpt":0.28726506979981525,"score_spread":0.2776793933685754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070855246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96319616,0.03318417,0.000031764263,0.0024531009,0.00051395374,0.00023763085,0.0001749049,0.000012805945,0.00019552957],"genre_scores_gemma":[0.9894319,0.006837374,0.000105012696,0.0008529351,0.000718835,0.000027850714,0.000007675754,0.000040153383,0.0019782302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985206,0.00009017755,0.0004860529,0.00016929362,0.00042457998,0.00030930972],"domain_scores_gemma":[0.99848044,0.000063333464,0.00043259506,0.000104643026,0.0006803859,0.00023862679],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031446293,0.00017665245,0.0006229111,0.00014004478,0.000047536265,0.000019298493,0.0001303263,0.00008376248,0.004366047],"category_scores_gemma":[0.00001413535,0.00015497491,0.00020788179,0.00024900583,0.00011775786,0.0002225006,0.000018023897,0.0003112911,0.0000030909375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031681228,0.00044735,0.5330929,0.00024560356,0.001338629,0.0029165621,0.00023237,0.000091716516,0.0028798708,0.0000015195657,0.0021409641,0.45344436],"study_design_scores_gemma":[0.010495258,0.0012027818,0.95552754,0.0022316123,0.0008678388,0.024389943,0.000054511835,0.0000080280115,0.001243909,0.0000021774185,0.0037867487,0.00018964802],"about_ca_topic_score_codex":0.0047365846,"about_ca_topic_score_gemma":0.048241295,"teacher_disagreement_score":0.4532547,"about_ca_system_score_codex":0.0003295492,"about_ca_system_score_gemma":0.0006296522,"threshold_uncertainty_score":0.9965441},"labels":[],"label_agreement":null},{"id":"W2071876402","doi":"10.1038/sj.bjc.6603629","title":"A cohort study of reproductive and hormonal factors and renal cell cancer risk in women","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Cohort study; Obstetrics; Gynecology; Cohort; Confidence interval; Pregnancy; Parity (physics); Relative risk; Cancer; Internal medicine; Biology","score_opus":0.011923008972024597,"score_gpt":0.2728643878861293,"score_spread":0.26094137891410474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071876402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674553,0.031834118,0.0000029023254,0.000029900533,0.000084512816,0.00038155052,0.000018982191,0.0000024051271,0.0001902767],"genre_scores_gemma":[0.99039704,0.009191076,0.00006482809,0.000019603762,0.00018008397,0.000014328911,4.5967747e-7,0.000015039811,0.000117531774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998587,0.000056203568,0.00050135504,0.00022904268,0.00041054742,0.0002158322],"domain_scores_gemma":[0.9990202,0.000057839716,0.0004090377,0.00009675949,0.00022956013,0.0001865602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007706646,0.00012101173,0.00050355226,0.00015396978,0.000034076606,0.000014155579,0.000042508575,0.00004657226,0.000059297992],"category_scores_gemma":[0.000058028112,0.00010651861,0.000043169475,0.00015218278,0.00008320758,0.0000947723,0.000027373177,0.00031851386,7.109833e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010922864,0.0004101706,0.95937186,0.000035708297,0.0002755141,0.00093509763,0.002653174,0.000015201799,0.0023379477,1.3170632e-7,0.00010208583,0.032770813],"study_design_scores_gemma":[0.003884879,0.0014683042,0.9844105,0.00026556573,0.00024878222,0.000491929,0.0023314883,0.0000013549744,0.0066300156,0.00001733272,0.00016297308,0.000086867054],"about_ca_topic_score_codex":0.010169218,"about_ca_topic_score_gemma":0.0038255006,"teacher_disagreement_score":0.032683946,"about_ca_system_score_codex":0.00039015213,"about_ca_system_score_gemma":0.00015066718,"threshold_uncertainty_score":0.9964222},"labels":[],"label_agreement":null},{"id":"W2072532597","doi":"10.1038/sj.bjc.6603048","title":"Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nausea and vomiting management","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Dexamethasone; Medicine; Nausea; Vomiting; Chemotherapy; Internal medicine; Corticosteroid; Anesthesia; Antiemetic; Gastroenterology","score_opus":0.019470147078291877,"score_gpt":0.26396643186383717,"score_spread":0.2444962847855453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072532597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991312,0.00454854,0.0030937628,0.00034554908,0.00005581444,0.0005740947,0.000031376607,0.0000058843502,0.000032960346],"genre_scores_gemma":[0.9959901,0.00042883828,0.0025207626,0.00034241762,0.00014541567,0.000043146618,0.000002593213,0.00003150703,0.00049524393],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99884164,0.00005981377,0.00042601992,0.00010608929,0.00038380956,0.00018263872],"domain_scores_gemma":[0.9983198,0.0002808252,0.00058304396,0.000108047345,0.0006636181,0.000044663524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037837698,0.000107944405,0.00044825216,0.00007654183,0.000036910318,0.000026174877,0.00008009835,0.00005846204,0.00002589763],"category_scores_gemma":[0.00017082288,0.000078429126,0.00019618202,0.00020405134,0.00007693976,0.00008981761,0.000010429462,0.00014120757,9.781712e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03465996,0.002951478,0.09231895,0.0023457871,0.011871758,0.0011711012,0.0006676292,0.0046263454,0.0885863,0.000066548855,0.03311968,0.72761446],"study_design_scores_gemma":[0.016725149,0.0043101916,0.8658424,0.003581576,0.0019293486,0.00023158955,0.000048333837,0.0004808768,0.1026189,0.00026783062,0.0036674584,0.00029631337],"about_ca_topic_score_codex":0.0006771036,"about_ca_topic_score_gemma":0.00088160223,"teacher_disagreement_score":0.77352345,"about_ca_system_score_codex":0.00008239361,"about_ca_system_score_gemma":0.00012947466,"threshold_uncertainty_score":0.3198247},"labels":[],"label_agreement":null},{"id":"W2072884377","doi":"10.1038/bjc.2011.391","title":"Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia","year":2011,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Eicosapentaenoic acid; Cachexia; Cancer cachexia; Clinical trial; Lean body mass; Cancer; Appetite; Medicine; Polyunsaturated fatty acid; Internal medicine; Oncology; Bioinformatics; Endocrinology; Fatty acid; Biology; Body weight; Biochemistry","score_opus":0.08672535062207809,"score_gpt":0.4434882364426714,"score_spread":0.3567628858205933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072884377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006391658,0.9920166,0.0000039944243,0.0001485031,0.00037831007,0.0005866177,0.00015815049,0.000005900152,0.0003102271],"genre_scores_gemma":[0.0040480997,0.9944037,0.00020142978,0.00052545295,0.0004974773,0.000081181446,0.000027263857,0.00004559586,0.0001698041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974457,0.000103826205,0.0015212812,0.0002015274,0.00043643866,0.00029122195],"domain_scores_gemma":[0.9979209,0.000042850443,0.0014018626,0.00012935241,0.0003101627,0.00019487663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046195457,0.00021913381,0.0015421052,0.00043238743,0.000039500064,0.00001694278,0.00018305554,0.0001690778,0.001285133],"category_scores_gemma":[0.00004770024,0.00022511245,0.0002946048,0.00030858384,0.000059329992,0.00013421164,0.000017578144,0.000940014,0.0000064599653],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013740493,0.00019362706,0.0021753078,0.020956814,0.00015886118,0.00043361858,0.00006506381,0.000010677648,0.000035172572,0.00003438797,0.002888592,0.97291046],"study_design_scores_gemma":[0.0022379467,0.00030144793,0.005769539,0.1695455,0.0005995541,0.000886046,0.00002764007,7.5672784e-7,0.00012212807,0.00006104925,0.8202587,0.00018972029],"about_ca_topic_score_codex":0.0017316577,"about_ca_topic_score_gemma":0.0012903827,"teacher_disagreement_score":0.97272074,"about_ca_system_score_codex":0.000768297,"about_ca_system_score_gemma":0.0012083555,"threshold_uncertainty_score":0.9996278},"labels":[],"label_agreement":null},{"id":"W2073492934","doi":"10.1038/sj.bjc.6605842","title":"Insulin-like growth factors and liver cancer risk in male smokers","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Odds ratio; Medicine; Internal medicine; Liver cancer; Cohort; Cancer; Confidence interval; Endocrinology; Risk factor; Oncology; Gastroenterology","score_opus":0.010632519940437278,"score_gpt":0.2546554373241684,"score_spread":0.2440229173837311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073492934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712062,0.02637576,0.000009160869,0.00029323623,0.001310102,0.0001912404,0.00007139439,0.00001408157,0.0005288596],"genre_scores_gemma":[0.93530977,0.06314727,0.00023857641,0.00046988815,0.0005324195,0.0000104389,0.0000032283044,0.000040717052,0.00024771586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815387,0.000060602168,0.00066297746,0.0002559033,0.00046706956,0.00039958485],"domain_scores_gemma":[0.9985447,0.00009049378,0.00042600255,0.00013165046,0.00039619283,0.00041098733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037531415,0.00023150435,0.0005929319,0.0002813174,0.00009890051,0.00006905788,0.0001600148,0.00023016495,0.0008025398],"category_scores_gemma":[0.00028863284,0.00021736656,0.00017522101,0.0003202674,0.0001866983,0.00041505878,0.000046171022,0.0015334954,0.0000036602464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023318196,0.00012390094,0.9486787,0.000068737274,0.00013675152,0.0007560808,0.00045090218,0.0000024978976,0.0027048823,0.000011632391,0.003609039,0.04322373],"study_design_scores_gemma":[0.0032580278,0.0002063845,0.97761637,0.0004256177,0.00020601098,0.0013833373,0.00017177626,0.000027695032,0.002619402,0.00007372604,0.013772895,0.00023876029],"about_ca_topic_score_codex":0.016726708,"about_ca_topic_score_gemma":0.009479711,"teacher_disagreement_score":0.04298497,"about_ca_system_score_codex":0.00012920678,"about_ca_system_score_gemma":0.0003724364,"threshold_uncertainty_score":0.989821},"labels":[],"label_agreement":null},{"id":"W2074503147","doi":"10.1038/bjc.2012.545","title":"Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Bevacizumab; Medicine; Colorectal cancer; Internal medicine; Adverse effect; Gastroenterology; Pharmacology; Oncology; Chemotherapy; Cancer","score_opus":0.011498500264287243,"score_gpt":0.2740689947198434,"score_spread":0.2625704944555562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074503147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96306735,0.033613447,0.0000110477495,0.001016494,0.00014217928,0.0009811915,0.00004183484,0.000022712231,0.0011037557],"genre_scores_gemma":[0.9868905,0.010626822,0.00049636303,0.00034066028,0.00021640262,0.00044630084,0.000005537706,0.00005648861,0.00092091365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793047,0.00006454138,0.0005856818,0.00029712325,0.0006148976,0.0005073166],"domain_scores_gemma":[0.99849313,0.0000609308,0.00040105186,0.00011164557,0.0006770151,0.00025620754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013992554,0.0003036817,0.0010062425,0.0001717424,0.00010802556,0.00009225563,0.0001240868,0.00006000549,0.0011690059],"category_scores_gemma":[0.000033281274,0.00021625277,0.00013651882,0.00049159845,0.00016964704,0.0003426806,0.000024940535,0.00040202652,0.0000056608637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012382459,0.0010519071,0.64363575,0.0003613666,0.0038074085,0.007476378,0.0019022756,0.00031168544,0.00074133807,0.000007443691,0.0062457365,0.32207626],"study_design_scores_gemma":[0.018795121,0.0066150506,0.95546734,0.004187733,0.0014399874,0.005944544,0.0005953887,0.00005539318,0.0014443845,0.000030317236,0.0050002304,0.00042447873],"about_ca_topic_score_codex":0.018687641,"about_ca_topic_score_gemma":0.058831383,"teacher_disagreement_score":0.3216518,"about_ca_system_score_codex":0.0007557239,"about_ca_system_score_gemma":0.0007164339,"threshold_uncertainty_score":0.99974406},"labels":[],"label_agreement":null},{"id":"W2074952360","doi":"10.1038/bjc.2012.451","title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; U.S. Public Health Service; National Cancer Institute; U.S. Department of Health and Human Services; Science Foundation Ireland; Conquer Cancer Foundation; National Institutes of Health; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Loss of heterozygosity; Homologous recombination; Ovarian cancer; Biology; Homologous chromosome; Cancer research; Breast cancer; DNA repair; BRCA2 Protein; Genome instability; Cancer; Genetics; Oncology; Allele; DNA; Gene; Medicine; DNA damage; Mutation; Germline mutation","score_opus":0.017011516756691564,"score_gpt":0.2972541560484307,"score_spread":0.28024263929173915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074952360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98399603,0.013878999,0.00017439676,0.00019104804,0.0011594542,0.000246565,0.00021949729,0.000012168288,0.00012185402],"genre_scores_gemma":[0.98943776,0.0092923455,0.00024791874,0.00020509436,0.0006849452,0.000026398222,0.0000046532627,0.000027030565,0.000073831034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981972,0.00014602777,0.0008485314,0.00013377568,0.0003959156,0.00027856516],"domain_scores_gemma":[0.99845153,0.00005548038,0.00082322344,0.00014576041,0.00037840242,0.00014557844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006840534,0.00012298407,0.0005590813,0.00019952098,0.00002771938,0.000006652245,0.00011669422,0.00012637634,0.00062457524],"category_scores_gemma":[0.000057317156,0.00013809485,0.00024317266,0.00014974449,0.00007986455,0.00023713936,0.000024129311,0.0003479181,0.0000010772586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081549963,0.00045700735,0.9438352,0.00030378916,0.00023029823,0.00015601124,0.0004941977,0.00014243263,0.025617557,0.000017067012,0.0005279734,0.027402984],"study_design_scores_gemma":[0.005503068,0.00034879174,0.9546437,0.0022750357,0.00013187242,0.0013431372,0.000037484475,0.000014657128,0.034447752,0.00010781424,0.0010308825,0.00011580558],"about_ca_topic_score_codex":0.0031372008,"about_ca_topic_score_gemma":0.0011090692,"teacher_disagreement_score":0.027287178,"about_ca_system_score_codex":0.00056578673,"about_ca_system_score_gemma":0.00033910104,"threshold_uncertainty_score":0.6838661},"labels":[],"label_agreement":null},{"id":"W2075330581","doi":"10.1038/sj.bjc.6601195","title":"Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; BioPhage Pharma (Canada); McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Norges Forskningsråd; Susan G. Komen; Kreftforeningen","keywords":"Germline; Breast cancer; Germline mutation; Oncology; Internal medicine; Chemotherapy; Medicine; Cancer; Adverse effect; Cancer research; Mutation; Biology; Genetics; Gene","score_opus":0.007865768143918764,"score_gpt":0.2772444342573136,"score_spread":0.26937866611339484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075330581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845209,0.014566806,0.00015566098,0.00025784597,0.00017125689,0.00013303927,0.00015713528,0.000005221172,0.000032130993],"genre_scores_gemma":[0.9965726,0.002000383,0.0006118928,0.00038045424,0.00022341427,0.00004173695,0.000026614744,0.000029429348,0.00011343348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989426,0.00007384253,0.0003176278,0.00023305451,0.0002310136,0.00020182102],"domain_scores_gemma":[0.9991242,0.000008383725,0.00027487942,0.000104490224,0.00037285214,0.00011514707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016899628,0.00015745654,0.00026595703,0.000039322327,0.00019225146,0.000046490506,0.00007208829,0.00008542819,0.000057736805],"category_scores_gemma":[0.000049134003,0.00014831903,0.00012173854,0.000102804006,0.000067238834,0.000032478954,0.00001783612,0.00011218376,2.7377033e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024890143,0.0004477742,0.861454,0.00004011756,0.0022386243,0.00024250531,0.00058530655,0.00057954254,0.11779181,0.0000041295016,0.0011035168,0.015263753],"study_design_scores_gemma":[0.008508976,0.00024656556,0.90561944,0.0008585426,0.00085876236,0.0022527936,0.0005663743,0.000012635003,0.07477239,0.000032152304,0.0057015955,0.0005698005],"about_ca_topic_score_codex":0.00029079462,"about_ca_topic_score_gemma":0.0019927449,"teacher_disagreement_score":0.044165395,"about_ca_system_score_codex":0.000088754015,"about_ca_system_score_gemma":0.00020719437,"threshold_uncertainty_score":0.6048274},"labels":[],"label_agreement":null},{"id":"W2075723261","doi":"10.1054/bjoc.2001.2008","title":"Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Medical Research Council; Alder Hey Children's NHS Foundation Trust","keywords":"Alveolar rhabdomyosarcoma; PAX3; Rhabdomyosarcoma; Ganglioneuroblastoma; Fusion gene; Chromosomal translocation; Pathology; Biology; Medicine; Oncology; Sarcoma; Gene; Neuroblastoma; Transcription factor; Genetics; Ganglioneuroma","score_opus":0.01888359842424582,"score_gpt":0.28167081553189355,"score_spread":0.26278721710764774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075723261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94923896,0.049397893,0.000016536755,0.0005857182,0.0004110721,0.00023383654,0.000013213479,0.000003629342,0.00009912406],"genre_scores_gemma":[0.9859631,0.013368403,0.0001492851,0.000075915865,0.00034351536,0.000010758556,6.2545837e-7,0.000013183119,0.00007519888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984862,0.000067342175,0.0007326058,0.00014464263,0.00042444203,0.00014476973],"domain_scores_gemma":[0.99885845,0.000055160934,0.0005464256,0.0002120188,0.00026227796,0.00006566825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000431204,0.0000853273,0.00040177436,0.00014623457,0.000031230473,0.00000695841,0.000098939425,0.00006175443,0.00009437564],"category_scores_gemma":[0.0002446808,0.00006524339,0.00022981034,0.00046134333,0.000045653276,0.0000712589,0.000034701457,0.00020386101,5.109748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020348345,0.00050712714,0.8343136,0.000048544436,0.000064701075,0.0002571449,0.0000606134,0.0000437748,0.0065756035,0.000001048638,0.00016986024,0.15775451],"study_design_scores_gemma":[0.0032941105,0.00022815667,0.9549861,0.00053313957,0.00020489638,0.0018322166,0.000040901952,0.00001684477,0.03699053,0.000045264544,0.0017780225,0.000049837578],"about_ca_topic_score_codex":0.0014377333,"about_ca_topic_score_gemma":0.0012104112,"teacher_disagreement_score":0.15770467,"about_ca_system_score_codex":0.00015799185,"about_ca_system_score_gemma":0.0001270368,"threshold_uncertainty_score":0.2660548},"labels":[],"label_agreement":null},{"id":"W2076172881","doi":"10.1038/sj.bjc.6604020","title":"Expression of thymidylate synthase in human cells is an early G1 event regulated by CDK4 and p16INK4A but not E2F","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Thymidylate synthase; E2F; Cancer research; Biology; Gene expression; Molecular biology; Genetics; Cell biology; Gene; Cancer; Fluorouracil","score_opus":0.010560168883799886,"score_gpt":0.2813980103055241,"score_spread":0.2708378414217242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076172881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98425585,0.014734285,0.00018652501,0.00012579036,0.00022466894,0.00023130371,0.00007922405,0.000009156309,0.00015316924],"genre_scores_gemma":[0.9966155,0.0023155755,0.00023286467,0.00025992657,0.00015384448,0.0000030042988,0.0000050279923,0.000043428347,0.00037078743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797225,0.00006401882,0.0008450737,0.0002366658,0.00056596857,0.0003160502],"domain_scores_gemma":[0.998681,0.00002660994,0.0005305529,0.00018853032,0.00026012678,0.00031314822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059456,0.00016054345,0.0004965419,0.00020499271,0.000055558525,0.000030228091,0.000121883844,0.0001959433,0.000239641],"category_scores_gemma":[0.000034253193,0.00017790422,0.00012473579,0.00018203666,0.00011142596,0.000158196,0.00003507821,0.000536189,8.4192965e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006740739,0.00021444014,0.0013173971,0.00007357659,0.000056155535,0.0012672615,0.00036088715,0.00004241594,0.96021783,0.0000014986491,0.0018730074,0.03390145],"study_design_scores_gemma":[0.004541698,0.0006399619,0.049971808,0.0038725177,0.00011082239,0.00078477856,0.00009967236,0.000029157787,0.937776,0.000028380577,0.0019670234,0.00017814462],"about_ca_topic_score_codex":0.0022760055,"about_ca_topic_score_gemma":0.0005387698,"teacher_disagreement_score":0.048654407,"about_ca_system_score_codex":0.00020959628,"about_ca_system_score_gemma":0.00015098714,"threshold_uncertainty_score":0.72547233},"labels":[],"label_agreement":null},{"id":"W2076203534","doi":"10.1038/sj.bjc.6602080","title":"Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Gemcitabine; Pancreatic cancer; Cancer research; Molecular biology; Oligonucleotide; Endonuclease; Biology; Chemistry; Cancer; Enzyme; Biochemistry; DNA; Genetics","score_opus":0.0037793965493451965,"score_gpt":0.22458517359847016,"score_spread":0.22080577704912496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076203534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084027,0.01849655,0.00011514424,0.00010518462,0.00019199993,0.00020096435,0.000023613875,0.0000018044238,0.000024453495],"genre_scores_gemma":[0.97993004,0.01964796,0.000117283285,0.00013985977,0.00011652736,0.000009285422,4.7181646e-7,0.000019496107,0.000019064535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991015,0.00012826153,0.0002800392,0.00014013845,0.00019333824,0.00015668067],"domain_scores_gemma":[0.99936056,0.00003588423,0.00033489906,0.00011022001,0.00010477493,0.0000536739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023210279,0.00011275829,0.00032682225,0.000045811805,0.000029462648,0.000014516556,0.00012873097,0.000072166185,0.0000107216465],"category_scores_gemma":[0.00004866774,0.00009543472,0.00013316095,0.000072994975,0.00016853445,0.0000095355335,0.000039669423,0.00014407748,1.5835671e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011148077,0.00015498912,0.00025186062,0.00013459951,0.00016137553,0.00009924081,0.00004231585,0.00086223695,0.9682416,0.00003424765,0.000016696633,0.028886043],"study_design_scores_gemma":[0.005458638,0.00034285395,0.031492256,0.000568459,0.00014234376,0.00015126445,0.000023303985,0.000028235609,0.96137077,0.0002426001,0.000083240666,0.000096021235],"about_ca_topic_score_codex":0.0012632756,"about_ca_topic_score_gemma":0.000432258,"teacher_disagreement_score":0.031240394,"about_ca_system_score_codex":0.000031444175,"about_ca_system_score_gemma":0.00012692474,"threshold_uncertainty_score":0.38917148},"labels":[],"label_agreement":null},{"id":"W2076423158","doi":"10.1038/sj.bjc.6600168","title":"Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Oxaliplatin; Irinotecan; Tolerability; Medicine; Circadian rhythm; Chemotherapy; Camptothecin; Internal medicine; Anesthesia; Adverse effect; Colorectal cancer; Cancer; Biology","score_opus":0.011768452023314998,"score_gpt":0.2397905785101323,"score_spread":0.2280221264868173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076423158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854304,0.013882397,0.00016219729,0.00016366936,0.000066091365,0.00006894216,0.000012712847,9.1707483e-7,0.00021266281],"genre_scores_gemma":[0.99303985,0.0059324848,0.00066971564,0.00012387951,0.00011936263,0.000002682642,0.0000020484295,0.00001195486,0.000098053024],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945843,0.000022427368,0.00020692374,0.00009736103,0.00010637676,0.00010844927],"domain_scores_gemma":[0.99962234,0.0000064052033,0.00017184041,0.00005450964,0.00008813803,0.000056778874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009490146,0.00006330859,0.0001331031,0.00004141876,0.00001956836,0.000018337969,0.00007186387,0.00005739468,0.000044724075],"category_scores_gemma":[0.000009633181,0.000068600275,0.00003399815,0.00006134521,0.000042597487,0.000005878871,0.000013163765,0.00008788326,1.337415e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020429934,0.0001430856,0.0019100452,0.00003302891,0.00008786314,0.00005053187,0.00022870675,0.00046223562,0.48308438,0.000031576634,0.00015185011,0.5136124],"study_design_scores_gemma":[0.011369081,0.0029359371,0.075777255,0.0011545548,0.00013939544,0.0027157976,0.00031235686,0.00032385087,0.84269595,0.00011946626,0.061890185,0.0005661831],"about_ca_topic_score_codex":0.0002636325,"about_ca_topic_score_gemma":0.0019060895,"teacher_disagreement_score":0.5130462,"about_ca_system_score_codex":0.000018975801,"about_ca_system_score_gemma":0.00004359483,"threshold_uncertainty_score":0.27974382},"labels":[],"label_agreement":null},{"id":"W2076480857","doi":"10.1038/sj.bjc.6605154","title":"Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Science Foundation of Heilongjiang Province; Fondation pour la Recherche Médicale; National Natural Science Foundation of China","keywords":"RHOA; PI3K/AKT/mTOR pathway; Protein kinase B; Focal adhesion; Fibronectin; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Cell migration; Biology; Cell biology; Signal transduction; Chemistry; Extracellular matrix; Cell; Biochemistry","score_opus":0.018061569810196083,"score_gpt":0.28980031742530415,"score_spread":0.2717387476151081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076480857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97742915,0.021654923,0.00007783334,0.00046492965,0.00006458423,0.00019170808,0.000010489218,0.00000425669,0.00010215227],"genre_scores_gemma":[0.96318525,0.036246784,0.00019009375,0.00014868453,0.00014006771,0.0000044880753,0.000008817964,0.00001095104,0.0000648911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987511,0.0000618491,0.00048455258,0.000120554716,0.00042724473,0.00015471467],"domain_scores_gemma":[0.99913865,0.000057685782,0.00031876046,0.000050686518,0.00032176304,0.00011245617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031904498,0.00007808887,0.00027683482,0.00013797748,0.000028565484,0.00002646453,0.000052444848,0.00007849051,0.00024947769],"category_scores_gemma":[0.00010864804,0.000083166364,0.000055240245,0.00018085417,0.000023337725,0.00020022325,0.000011855098,0.00027571068,4.0685177e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029710453,0.00010416204,0.033632945,0.000157692,0.000013796758,0.00016191149,0.00034988174,0.00008330468,0.85995215,6.5881795e-7,0.00024681402,0.104999565],"study_design_scores_gemma":[0.002663736,0.00044446075,0.78625023,0.002656803,0.000050580154,0.00020351169,0.00015823655,0.0023049868,0.20468208,0.000022463088,0.000451919,0.000110964625],"about_ca_topic_score_codex":0.0019890338,"about_ca_topic_score_gemma":0.0020627505,"teacher_disagreement_score":0.7526173,"about_ca_system_score_codex":0.00021912892,"about_ca_system_score_gemma":0.00027104423,"threshold_uncertainty_score":0.3391426},"labels":[],"label_agreement":null},{"id":"W2076838198","doi":"10.1038/bjc.2012.209","title":"Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Sorafenib; Clusterin; Apoptosis; In vivo; Downregulation and upregulation; Renal cell carcinoma; Cancer research; Medicine; Internal medicine; Pharmacology; Endocrinology; Biology; Hepatocellular carcinoma; Biochemistry","score_opus":0.03720430961535985,"score_gpt":0.33376301152986076,"score_spread":0.2965587019145009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076838198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207765,0.0027270897,0.0042461404,0.000057426645,0.00021514934,0.00014388753,0.00004123504,0.00000565796,0.00048577294],"genre_scores_gemma":[0.99719197,0.00018687057,0.0020179683,0.00007729678,0.00042937382,0.0000059050813,0.000002303008,0.000025145075,0.00006319045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984739,0.0001077354,0.0005994135,0.0001436921,0.00034746033,0.00032781655],"domain_scores_gemma":[0.99892753,0.000031316584,0.00048115206,0.00011472881,0.00023921744,0.00020606272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041139306,0.00013037036,0.00050535286,0.0001843752,0.000047530128,0.000016131653,0.00008283828,0.000107770444,0.00015236303],"category_scores_gemma":[0.00008015812,0.0001504545,0.000142236,0.00013791054,0.00015146864,0.00029791964,0.00007147261,0.00035720057,7.17605e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006368305,0.0005960097,0.016958479,0.00036015883,0.000022034823,0.0008347329,0.00019576527,0.0020523288,0.9752396,0.000012662963,0.00012737136,0.0029640335],"study_design_scores_gemma":[0.0062265266,0.00046364593,0.5011991,0.003155625,0.00043138152,0.005953363,0.00010883522,0.008623963,0.4731885,0.00021221304,0.00006124766,0.00037562218],"about_ca_topic_score_codex":0.0005841148,"about_ca_topic_score_gemma":0.00039764756,"teacher_disagreement_score":0.5020511,"about_ca_system_score_codex":0.00024191862,"about_ca_system_score_gemma":0.00030731282,"threshold_uncertainty_score":0.61353564},"labels":[],"label_agreement":null},{"id":"W2076908467","doi":"10.1038/bjc.2013.187","title":"Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":268,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Institut National de la Santé et de la Recherche Médicale; McMaster University","keywords":"Metformin; AMPK; Lung cancer; Medicine; Oncology; Internal medicine; Cell growth; Cancer research; non-small cell lung cancer (NSCLC); Biology; Kinase; Protein kinase A; A549 cell; Cell biology","score_opus":0.005009198573266756,"score_gpt":0.2446573350131916,"score_spread":0.23964813643992483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076908467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5621943,0.43729737,0.00012265639,0.000028202672,0.00015824643,0.00009995467,0.00002492555,0.0000010474453,0.00007329416],"genre_scores_gemma":[0.6075633,0.39137858,0.00039357803,0.00021326232,0.0003088149,0.000025230016,0.000002200006,0.000013440837,0.000101555095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897003,0.00008618044,0.00038182925,0.00019051085,0.00016538733,0.00020604514],"domain_scores_gemma":[0.9990984,0.000027704362,0.0004012829,0.00008344648,0.00028492475,0.00010419693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002803905,0.00013203965,0.0002937419,0.000039927938,0.000057170175,0.000057047753,0.00010895685,0.00011614731,0.000083563595],"category_scores_gemma":[0.00006557698,0.00013419006,0.000075088465,0.00008076447,0.00010080466,0.000046293488,0.00004326172,0.00011877814,2.8681535e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003225728,0.000041786618,0.00672019,0.00020479602,0.00014254068,0.000006308233,0.00035541662,0.00001588935,0.6470851,0.000004211603,0.0043891366,0.34071207],"study_design_scores_gemma":[0.0016465976,0.00018351941,0.0319136,0.00033586397,0.00011205761,0.00006175563,0.00011409345,0.000020344693,0.9423185,0.000068237554,0.023021454,0.00020398191],"about_ca_topic_score_codex":0.0010947583,"about_ca_topic_score_gemma":0.00029891275,"teacher_disagreement_score":0.3405081,"about_ca_system_score_codex":0.000019317986,"about_ca_system_score_gemma":0.00024592888,"threshold_uncertainty_score":0.54721117},"labels":[],"label_agreement":null},{"id":"W2076952890","doi":"10.1038/bjc.2012.524","title":"Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Office of Defense Programs; BC Cancer Foundation; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Defense","keywords":"FOXP3; Breast cancer; Tumor-infiltrating lymphocytes; Immune system; Cytotoxic T cell; CD8; Medicine; Cancer research; Oncology; Cancer; Internal medicine; IL-2 receptor; Immunology; Biology; T cell; In vitro","score_opus":0.023032510732416127,"score_gpt":0.29431198321791685,"score_spread":0.2712794724855007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076952890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93659914,0.061621293,0.0000031524853,0.00037784883,0.00090379105,0.00016261976,0.00023959349,0.000019847917,0.00007270669],"genre_scores_gemma":[0.9931272,0.0056876694,0.00007805521,0.00019491797,0.0002121592,0.000026943224,0.000008659706,0.00003440025,0.0006299779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970605,0.000859875,0.0011175757,0.00023657951,0.00009166449,0.000633819],"domain_scores_gemma":[0.9976455,0.0006669022,0.0012147785,0.00011286779,0.00028092813,0.00007905297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011470518,0.00024798466,0.0008762137,0.00013321458,0.0002008134,0.000043676846,0.00023962364,0.00036731843,0.0005055524],"category_scores_gemma":[0.00044901058,0.00022389194,0.00015940492,0.00021318396,0.00050453295,0.0003598164,0.00007604655,0.0009417579,0.000012997909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001199149,0.00030202753,0.747224,0.000012198521,0.0005754761,0.00007688717,0.00020859654,0.000004011401,0.2377078,0.000006799684,0.00026624068,0.01241683],"study_design_scores_gemma":[0.006539115,0.0002971515,0.9290809,0.0011129119,0.0001474599,0.0036002717,0.00072299683,6.6836895e-7,0.057248756,0.000015615888,0.00093114463,0.0003030186],"about_ca_topic_score_codex":0.0020795772,"about_ca_topic_score_gemma":0.0024192084,"teacher_disagreement_score":0.1818569,"about_ca_system_score_codex":0.00029670325,"about_ca_system_score_gemma":0.00037312618,"threshold_uncertainty_score":0.9130049},"labels":[],"label_agreement":null},{"id":"W2077080354","doi":"10.1038/sj.bjc.6603745","title":"The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; York University; Ontario Institute for Cancer Research; University of Toronto","funders":"National Cancer Institute; Turun Yliopisto","keywords":"Apoptosis; Biology; Cancer research; Terminal deoxynucleotidyl transferase; Programmed cell death; Immunohistochemistry; Mutation; Cell growth; Gene; TUNEL assay; Genetics; Immunology","score_opus":0.010769437075153643,"score_gpt":0.2510579462707686,"score_spread":0.24028850919561495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077080354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847525,0.0136705795,0.00026002305,0.0001623263,0.00009730745,0.00039856543,0.000006337453,0.000004703557,0.000647662],"genre_scores_gemma":[0.99817866,0.00031052297,0.0012236141,0.00006165376,0.00011923172,0.000012511893,7.1644683e-7,0.000029073084,0.00006399981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998567,0.00006400705,0.0004915994,0.00014360806,0.0004560339,0.00027779568],"domain_scores_gemma":[0.99906534,0.00004789077,0.00037353396,0.0001316482,0.0002237516,0.00015781057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062966463,0.00011989091,0.00033207217,0.00010961696,0.000067889785,0.00002472628,0.00009964518,0.00010185543,0.000025918624],"category_scores_gemma":[0.00005509647,0.00009263259,0.000073006304,0.00019949501,0.00007680383,0.000077788936,0.000027358197,0.00046923297,2.1457964e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026723018,0.00018889172,0.022135377,0.00015169202,0.000030694715,0.0013291507,0.00042591066,0.00002501423,0.91120076,0.0000143655,0.00030825278,0.061517574],"study_design_scores_gemma":[0.007905155,0.0010874509,0.09600559,0.0018323235,0.00008528512,0.0016752298,0.0004969376,0.0000053665403,0.88927126,0.000062228304,0.0014247097,0.0001484378],"about_ca_topic_score_codex":0.0012288812,"about_ca_topic_score_gemma":0.0020024814,"teacher_disagreement_score":0.07387021,"about_ca_system_score_codex":0.00018826031,"about_ca_system_score_gemma":0.00032920463,"threshold_uncertainty_score":0.3777447},"labels":[],"label_agreement":null},{"id":"W2077413329","doi":"10.1038/sj.bjc.6603110","title":"Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Telomerase reverse transcriptase; Telomerase; Adenocarcinoma; Cancer research; Carcinogenesis; Biology; Lung cancer; Gene duplication; Cancer; Pathology; Gene; Medicine","score_opus":0.009228636025640275,"score_gpt":0.2663810444292169,"score_spread":0.2571524084035766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573276,0.04059651,0.00022359575,0.00069914403,0.0003006192,0.0004355706,0.00007646764,0.0000093305825,0.00033114466],"genre_scores_gemma":[0.98683274,0.0095494315,0.0013308411,0.0006572345,0.0005640532,0.00004945915,0.000010251638,0.00004068308,0.00096532825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979025,0.000051750514,0.0009532628,0.0002508736,0.00048455803,0.00035705732],"domain_scores_gemma":[0.9984569,0.00006277154,0.0005918566,0.0001646901,0.0005597641,0.00016404431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030490028,0.00018472185,0.00056250626,0.00026322578,0.000047788075,0.00003948167,0.00017399609,0.00011770651,0.00054410653],"category_scores_gemma":[0.000058879712,0.00019566396,0.00017254792,0.0004527928,0.000085186235,0.00016148822,0.000022391094,0.00035810945,0.000002469988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053160137,0.00070477265,0.81342936,0.000787118,0.00012308672,0.0012503667,0.00034059706,0.00012626054,0.08727211,0.0000023987182,0.012732454,0.08269988],"study_design_scores_gemma":[0.0036904467,0.00011945813,0.944705,0.0028915298,0.00027842086,0.0009844283,0.0000798943,0.00053104275,0.043219328,0.000023154298,0.0032334868,0.00024379343],"about_ca_topic_score_codex":0.008521087,"about_ca_topic_score_gemma":0.002523888,"teacher_disagreement_score":0.13127565,"about_ca_system_score_codex":0.0002477555,"about_ca_system_score_gemma":0.0005845943,"threshold_uncertainty_score":0.99808127},"labels":[],"label_agreement":null},{"id":"W2077666724","doi":"10.1038/sj.bjc.6603501","title":"Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Cervical cancer; Vaccination; Medicine; Context (archaeology); Cervical screening; Incidence (geometry); Transmission (telecommunications); Cohort; Public health; Demography; Cancer; Environmental health; HPV infection; Human papillomavirus; Population; Cohort study; Immunology; Internal medicine; Pathology; Geography","score_opus":0.03456881327959199,"score_gpt":0.389495270925728,"score_spread":0.354926457646136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077666724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817382,0.012600449,0.000013540642,0.0025566893,0.00009357807,0.00047063708,0.00003431037,0.0000031429245,0.0024894334],"genre_scores_gemma":[0.9975193,0.00048163533,0.000013978402,0.00022329915,0.0015688823,0.00003897455,0.000001867741,0.000022661105,0.00012939234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975853,0.00020492022,0.0007384616,0.0001436532,0.0009998332,0.0003278251],"domain_scores_gemma":[0.9984239,0.00026651897,0.0004646571,0.00026555403,0.0005009562,0.000078467834],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009447552,0.00014933244,0.0004946814,0.00009338296,0.00013164422,0.000060398324,0.00046148984,0.00006970675,0.0070497734],"category_scores_gemma":[0.00015067094,0.00007409522,0.00031548872,0.00042983796,0.00016182565,0.000067863526,0.00005037289,0.0008944453,0.0000011644745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038997137,0.000909366,0.48316285,0.0010902917,0.0006449678,0.00093963556,0.0014769956,0.008486659,0.007875893,0.00015451587,0.0091846725,0.48217446],"study_design_scores_gemma":[0.0023778747,0.000783174,0.9935321,0.0009322914,0.00015215145,0.00045475853,0.00010077644,0.0002348911,0.00094302325,0.00033865217,0.000064997446,0.00008527334],"about_ca_topic_score_codex":0.050790053,"about_ca_topic_score_gemma":0.010704138,"teacher_disagreement_score":0.5103693,"about_ca_system_score_codex":0.00037614375,"about_ca_system_score_gemma":0.00047540807,"threshold_uncertainty_score":0.9938579},"labels":[],"label_agreement":null},{"id":"W2078122892","doi":"10.1038/bjc.2014.430","title":"Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Breast Cancer Research Foundation; U.S. Department of Health and Human Services","keywords":"Bevacizumab; Medicine; Genome-wide association study; Internal medicine; Oncology; Blood pressure; SNP; Single-nucleotide polymorphism; Genotype; Biology; Chemotherapy; Genetics","score_opus":0.01655960237681365,"score_gpt":0.28424061643413523,"score_spread":0.2676810140573216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078122892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798637,0.017330362,0.000019587065,0.0013063608,0.0007833092,0.00015497112,0.0000063913253,0.000006809576,0.00052848813],"genre_scores_gemma":[0.9878447,0.008692238,0.00031837018,0.0016896642,0.001231437,0.000008125741,0.000001445602,0.000020772506,0.00019326081],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989333,0.00007213507,0.00041703388,0.00014738843,0.00021695723,0.0002131559],"domain_scores_gemma":[0.9992687,0.00006758173,0.00020529276,0.00007097808,0.00018236134,0.0002050855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022774964,0.000114891955,0.0004350239,0.00012986922,0.00003449319,0.00002772415,0.00006474665,0.000093543815,0.00036762367],"category_scores_gemma":[0.00006475002,0.00011091101,0.00007687458,0.00010311067,0.000033145843,0.00010244095,0.0000209506,0.0002764688,0.0000039910133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011975168,0.00045786626,0.03638009,0.000098675395,0.00028576286,0.009090512,0.00020367486,0.0000599846,0.01163823,0.000006085752,0.01302879,0.9275528],"study_design_scores_gemma":[0.019141207,0.0026600221,0.89228624,0.0011726936,0.0006997639,0.025875479,0.00003061658,0.0005576372,0.0015026183,0.00019563717,0.055671364,0.0002067448],"about_ca_topic_score_codex":0.00089984393,"about_ca_topic_score_gemma":0.0021363643,"teacher_disagreement_score":0.92734605,"about_ca_system_score_codex":0.00016455275,"about_ca_system_score_gemma":0.0002411423,"threshold_uncertainty_score":0.45228195},"labels":[],"label_agreement":null},{"id":"W2078648764","doi":"10.1038/bjc.2011.107","title":"Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; Discovery Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Aggressive fibromatosis; Testosterone (patch); Fibromatosis; Androgen; Androgen receptor; Orchiectomy; Internal medicine; Biology; Endocrinology; Cancer research; Dihydrotestosterone; Medicine; Pathology; Hormone; Cancer; Prostate cancer","score_opus":0.02174352005441693,"score_gpt":0.26607817497710334,"score_spread":0.2443346549226864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078648764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95877105,0.0390909,0.0000067919154,0.00024077273,0.00021461437,0.00019953997,0.000007129868,0.0000147767005,0.0014544369],"genre_scores_gemma":[0.99524623,0.0026905572,0.0011098329,0.00015881672,0.0003057792,0.000019509484,0.0000014217378,0.000025921789,0.00044193442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988254,0.000043462114,0.0004932343,0.00013125218,0.00029807107,0.00020859417],"domain_scores_gemma":[0.9989318,0.000035036825,0.0005178014,0.000082752376,0.00032262196,0.00010996089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018090692,0.00011616237,0.00039865766,0.00014474118,0.000049155195,0.000021862073,0.00007555785,0.00005267585,0.00034372282],"category_scores_gemma":[0.00020358745,0.000120136254,0.000083655614,0.00018280237,0.00007844451,0.00019492072,0.000027438153,0.00025793156,0.000007698407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016830647,0.00096469687,0.79787505,0.000683018,0.0003394477,0.040923793,0.0070626317,0.000023069033,0.043719947,0.000013622795,0.019229418,0.087482214],"study_design_scores_gemma":[0.0033630366,0.00066500326,0.8454447,0.0041434313,0.00017609171,0.017807147,0.00043668275,0.000012233904,0.12703209,0.000186039,0.0005507198,0.0001828685],"about_ca_topic_score_codex":0.00043118763,"about_ca_topic_score_gemma":0.0004350848,"teacher_disagreement_score":0.08729935,"about_ca_system_score_codex":0.00012449137,"about_ca_system_score_gemma":0.00015211123,"threshold_uncertainty_score":0.48990142},"labels":[],"label_agreement":null},{"id":"W2078770747","doi":"10.1054/bjoc.2000.1524","title":"No evidence of linkage to chromosome 1q42.2–43 in 131 prostate cancer families from the ACTANE Consortium","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; National Cancer Institute; Medical Research Council","keywords":"Genetic linkage; Locus (genetics); Genetics; Biology; Prostate cancer; Linkage (software); Recombination Fraction; Genetic heterogeneity; Gene mapping; Cancer; Gene; Chromosome; Phenotype","score_opus":0.012050635579032442,"score_gpt":0.2872604915103971,"score_spread":0.27520985593136466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078770747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668597,0.031290285,0.0000030441138,0.0009037947,0.00020819552,0.00012316371,0.000113948416,0.0000020657812,0.0004957778],"genre_scores_gemma":[0.9296207,0.0656571,0.000096849406,0.0013184871,0.0004975226,0.000018215298,0.0000039458573,0.000010925071,0.0027762812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987714,0.00007039434,0.0005622236,0.00016972804,0.00024037137,0.00018584827],"domain_scores_gemma":[0.9992171,0.0000593771,0.00020894935,0.00013149242,0.00029115193,0.00009192884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001951666,0.000109088454,0.0002502551,0.000019763807,0.000044521385,0.000040210918,0.00030757426,0.000084362575,0.0012854292],"category_scores_gemma":[0.00012505484,0.00009148682,0.000110728295,0.00009213542,0.00014331423,0.000016109072,0.000043163138,0.00016617155,0.0000074091095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001985305,0.00032443187,0.05325432,0.00015152157,0.00028250422,0.00024845544,0.000986764,0.0012511119,0.2684761,0.000007765539,0.0092754355,0.66375625],"study_design_scores_gemma":[0.003414297,0.0022476397,0.47049078,0.005615275,0.00014607857,0.00026977836,0.0012298044,0.00003558376,0.2059861,0.00023548181,0.30961734,0.00071183],"about_ca_topic_score_codex":0.0015768838,"about_ca_topic_score_gemma":0.002663203,"teacher_disagreement_score":0.66304445,"about_ca_system_score_codex":0.000019816973,"about_ca_system_score_gemma":0.0001995009,"threshold_uncertainty_score":0.99962753},"labels":[],"label_agreement":null},{"id":"W2078978161","doi":"10.1038/sj.bjc.6600537","title":"The association of breast mitogens with mammographic densities","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Health Sciences Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Prolactin; Internal medicine; Endocrinology; Sex hormone-binding globulin; Hormone; Risk factors for breast cancer; Anthropometry; Risk factor; Globulin; Mammography; MAMMOGRAPHIC DENSITY; Cancer","score_opus":0.005265437800796183,"score_gpt":0.2095724450219589,"score_spread":0.2043070072211627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078978161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745568,0.01982029,0.00001989557,0.0018648976,0.00015674123,0.000058557634,0.000029468662,0.000006771865,0.0034865963],"genre_scores_gemma":[0.9946004,0.0043221554,0.00007350315,0.00011816437,0.00023203873,0.0000015078514,4.0872925e-7,0.000009211919,0.00064257986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991488,0.000020677944,0.00023536116,0.000048992188,0.00040219646,0.00014398928],"domain_scores_gemma":[0.9990236,0.000056729503,0.00032063195,0.00005239373,0.00047944026,0.000067201654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017763597,0.000055710818,0.00018058537,0.000080407364,0.00006804484,0.00006395946,0.000059656624,0.000025551086,0.00004071067],"category_scores_gemma":[0.000026832831,0.00004091504,0.00015858255,0.00025496527,0.00009269053,0.00016029605,0.000005146713,0.00015547326,5.3404057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017869477,0.00012792108,0.56571853,0.00003961922,0.0006738198,0.0003047547,0.00010273006,0.000008397512,0.0002672624,0.000028514713,0.0065662973,0.42598346],"study_design_scores_gemma":[0.0018176042,0.00020884488,0.958246,0.0013312001,0.00034396097,0.024157481,0.00029149427,0.000018860323,0.0003336832,0.000082119856,0.013077383,0.00009136137],"about_ca_topic_score_codex":0.000084992585,"about_ca_topic_score_gemma":0.00026239318,"teacher_disagreement_score":0.4258921,"about_ca_system_score_codex":0.000044190274,"about_ca_system_score_gemma":0.00003833845,"threshold_uncertainty_score":0.1668467},"labels":[],"label_agreement":null},{"id":"W2079023951","doi":"10.1038/sj.bjc.6601405","title":"Variation in RNA expression and genomic DNA content acquired during cell culture","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Biology; Gene; Chromosome; Comparative genomic hybridization; Genetics; RNA; DNA; Copy-number variation; Gene expression; genomic DNA; Complementary DNA; Molecular biology; Genome","score_opus":0.007039667260675517,"score_gpt":0.2080975013199045,"score_spread":0.201057834059229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079023951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899513,0.0105232475,0.00013683026,0.00005528581,0.00011758649,0.00005052025,0.0000148107365,0.000001256995,0.000105336716],"genre_scores_gemma":[0.99423397,0.0047700624,0.00044770853,0.00005462035,0.000242904,0.00000427327,0.0000039735237,0.00000758973,0.00023487883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999505,0.000019527768,0.00021690739,0.000091171874,0.00006731704,0.00010010474],"domain_scores_gemma":[0.9996935,0.0000012680007,0.00014645133,0.000043708318,0.000072641895,0.00004244072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007098472,0.000058998678,0.000096100826,0.000023602084,0.000051137704,0.000037081063,0.000063160674,0.00006601478,0.000018075403],"category_scores_gemma":[0.000009250634,0.00006207213,0.000038419068,0.00002372738,0.000016548143,0.000011996751,0.000030483809,0.000053245167,3.2639187e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049303606,0.000029163784,0.0013161112,0.000017461069,0.0000122543015,0.000023823737,0.0002923178,0.00070387113,0.99701923,0.0000063663256,0.000027220563,0.0005028686],"study_design_scores_gemma":[0.0029255447,0.00010179637,0.31229052,0.00020524928,0.000016838647,0.00044361036,0.00032896185,0.0000018394779,0.68219876,0.00012641105,0.0012322417,0.00012819943],"about_ca_topic_score_codex":0.00018831273,"about_ca_topic_score_gemma":0.00021223933,"teacher_disagreement_score":0.31482047,"about_ca_system_score_codex":0.00005129932,"about_ca_system_score_gemma":0.00007398465,"threshold_uncertainty_score":0.2531228},"labels":[],"label_agreement":null},{"id":"W2079711247","doi":"10.1038/bjc.2014.308","title":"Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Indoor Air Quality and Microbial Exposure","field":"Environmental Science","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Lung cancer; Carcinogen; Medicine; Environmental health; Association (psychology); Oncology; Internal medicine; Biology; Psychology; Genetics","score_opus":0.0057153320566776,"score_gpt":0.23864870813885541,"score_spread":0.23293337608217782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079711247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995007,0.0006187644,0.000043853637,0.00021916261,0.00041335108,0.00017290382,0.000041437048,0.000007840686,0.0034757068],"genre_scores_gemma":[0.9947472,0.00036023723,0.00007013847,0.00037257822,0.00026376356,0.000026252757,0.0000012109556,0.00001779445,0.004140775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833983,0.00016040207,0.00046217875,0.00016127754,0.0005233407,0.00035298808],"domain_scores_gemma":[0.9989628,0.000059263984,0.00069582276,0.000095154166,0.000064151805,0.00012279634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009902801,0.00011122226,0.00028973792,0.000043803855,0.00010839234,0.00005108339,0.0002449336,0.000112542286,0.0035166733],"category_scores_gemma":[0.00010175739,0.00012035065,0.00013537955,0.00019963544,0.00008420703,0.00029215883,0.00004746516,0.00030519423,0.000011626941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017400755,0.00015826538,0.83088994,0.00006562454,0.00013940044,0.00001940465,0.0021878611,0.0055404715,0.024703896,0.00001039407,0.03272579,0.10338495],"study_design_scores_gemma":[0.002240703,0.00029985045,0.9368436,0.0009987921,0.0000913872,0.000043404023,0.00025633193,0.00027102724,0.032584917,0.00012680117,0.02590562,0.0003375891],"about_ca_topic_score_codex":0.0040262905,"about_ca_topic_score_gemma":0.005817876,"teacher_disagreement_score":0.105953634,"about_ca_system_score_codex":0.0015378057,"about_ca_system_score_gemma":0.00008318713,"threshold_uncertainty_score":0.99739426},"labels":[],"label_agreement":null},{"id":"W2080171736","doi":"10.1038/sj.bjc.6604503","title":"High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Tissue microarray; Carcinogenesis; Metastasis; Cancer; Cancer research; Oncology; Immunohistochemistry; Biology; Polymerase chain reaction; Medicine; Internal medicine; Pathology; Gene; Genetics","score_opus":0.011767282349523475,"score_gpt":0.3057789251668985,"score_spread":0.294011642817375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080171736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415076,0.0044290265,0.0000041454764,0.00052218215,0.00009450638,0.0004273317,0.000097247204,0.0000066198313,0.00026819538],"genre_scores_gemma":[0.990165,0.008835626,0.000016018768,0.00013439503,0.00038568384,0.00013781418,0.0000015045027,0.000022328886,0.000301654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850047,0.00016771002,0.00041813802,0.00020034963,0.00039351586,0.00031981946],"domain_scores_gemma":[0.9990799,0.000057902354,0.00025317818,0.00009512507,0.0003060982,0.00020783774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056763185,0.00012374227,0.0005097524,0.00019846454,0.00017438032,0.000072527844,0.00011792486,0.00008244625,0.0018818692],"category_scores_gemma":[0.000038941915,0.00010403197,0.000029110552,0.0003960371,0.00006171232,0.0002442748,0.00005578773,0.0007277845,7.229661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063546404,0.0006596476,0.9126965,0.00003286545,0.00010634812,0.00056278316,0.0027078923,0.000052521526,0.0025723495,4.924138e-7,0.00066074164,0.07931244],"study_design_scores_gemma":[0.00942058,0.0007191601,0.985145,0.00040009228,0.000025491776,0.0010045066,0.0009110108,0.000001464565,0.0006313523,0.000048968483,0.0015707421,0.00012166918],"about_ca_topic_score_codex":0.044109087,"about_ca_topic_score_gemma":0.0940586,"teacher_disagreement_score":0.07919077,"about_ca_system_score_codex":0.001238374,"about_ca_system_score_gemma":0.0004255608,"threshold_uncertainty_score":0.99903053},"labels":[],"label_agreement":null},{"id":"W2080370558","doi":"10.1038/bjc.2014.567","title":"Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of British Columbia; University of Toronto; Calgary Laboratory Services; Princess Margaret Cancer Centre; BC Cancer Agency; Foothills Medical Centre; University of Calgary","funders":"Cancer Council South Australia; Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; Fred C. and Katherine B. Andersen Foundation; National Cancer Institute; University College London; Cancer Council Victoria; Calgary Laboratory Services; Mayo Foundation for Medical Education and Research; Cancer Council Tasmania; National Institutes of Health; Cancer Council NSW; National Health and Medical Research Council; Cancer Research UK; University of Sydney; NIHR Cambridge Biomedical Research Centre; U.S. Department of Defense","keywords":"Ovarian carcinoma; Ovarian cancer; Survival analysis; Oncology; Medicine; Ovarian carcinomas; Carcinoma; Ovarian tissue; Ovary; Pathology; Gynecology; Internal medicine; Biology; Cancer","score_opus":0.14634467256947445,"score_gpt":0.44882921154727534,"score_spread":0.3024845389778009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080370558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888501,0.0015218194,0.0073232246,0.0010099967,0.00012520462,0.00084618875,0.00028164985,0.000013232321,0.000028550341],"genre_scores_gemma":[0.99456817,0.00021236281,0.003162367,0.000062524654,0.0015900818,0.00007418749,0.000038698312,0.00002473956,0.00026684187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771774,0.00036726551,0.000846297,0.0003417181,0.00045454534,0.0002724186],"domain_scores_gemma":[0.9949007,0.0026255173,0.00060741534,0.00019774801,0.0013415175,0.00032712778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033582957,0.00011978918,0.00072369043,0.00015226669,0.00021880277,0.0001503776,0.0001779502,0.00013744064,0.000052538864],"category_scores_gemma":[0.004263461,0.0001192585,0.00017633368,0.0002643415,0.0000354983,0.0002621871,0.000046388337,0.00029973956,0.000001149131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002994058,0.00026152097,0.9275223,0.00002164202,0.0008165308,0.0000115893,0.000072627176,0.0000063816165,0.0066386564,0.0000010587763,0.0007618824,0.063586384],"study_design_scores_gemma":[0.004298946,0.001688266,0.9886879,0.00024093223,0.0032769546,0.000023316588,0.00007595322,0.0005115503,0.00045181485,0.00012085517,0.00049971277,0.00012385254],"about_ca_topic_score_codex":0.0024692349,"about_ca_topic_score_gemma":0.0016466674,"teacher_disagreement_score":0.063462526,"about_ca_system_score_codex":0.00016488219,"about_ca_system_score_gemma":0.00031554513,"threshold_uncertainty_score":0.5104069},"labels":[],"label_agreement":null},{"id":"W2080529956","doi":"10.1038/sj.bjc.6601802","title":"Chemotherapy in metastatic gastric cancer: population-based perceptions and practice patterns of medical oncologists","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Oncology; Quality of life (healthcare); Internal medicine; Population; Clinical trial; Intensive care medicine","score_opus":0.024568666769851654,"score_gpt":0.3680627352064086,"score_spread":0.34349406843655694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080529956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743861,0.0059518972,0.0013224347,0.017894402,0.00018339498,0.00018274169,0.000016247972,0.000005559782,0.000057253983],"genre_scores_gemma":[0.97571445,0.020315956,0.0017204375,0.0020061769,0.00017107872,0.000012866229,0.0000036659403,0.000011813497,0.000043554897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985632,0.00005404483,0.00048577122,0.00010470615,0.0006450375,0.00014729402],"domain_scores_gemma":[0.9991621,0.00012590217,0.00036196286,0.000060090602,0.00016617372,0.0001237923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051417114,0.00008270002,0.0003665882,0.00018866493,0.000025664725,0.00002134394,0.00008654041,0.000046685425,0.00077773636],"category_scores_gemma":[0.00032422753,0.000082123726,0.00008215088,0.00024124587,0.000042440926,0.0001449195,0.0000129795035,0.0002509906,2.7865661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030662416,0.0002730673,0.7845229,0.00016332086,0.00013282194,0.0005515799,0.00014171713,0.0009495773,0.00003429752,0.00002018402,0.00029983907,0.21260406],"study_design_scores_gemma":[0.007358696,0.00022719563,0.98795795,0.0012704387,0.00022219094,0.0008663271,0.00033789847,0.000043500226,0.0000150128435,0.000040251103,0.0015949971,0.00006552792],"about_ca_topic_score_codex":0.019721584,"about_ca_topic_score_gemma":0.011008689,"teacher_disagreement_score":0.21253854,"about_ca_system_score_codex":0.00035957096,"about_ca_system_score_gemma":0.00057047716,"threshold_uncertainty_score":0.98680615},"labels":[],"label_agreement":null},{"id":"W2082067798","doi":"10.1038/sj.bjc.6602902","title":"mTOR signaling: implications for cancer and anticancer therapy","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University; Howard Hughes Medical Institute","keywords":"PI3K/AKT/mTOR pathway; EIF4E; Carcinogenesis; Translation (biology); Cancer research; Biology; RPTOR; Sirolimus; Signal transduction; Cancer; Cell biology; Genetics; Gene; Messenger RNA; Biochemistry","score_opus":0.021032777966903952,"score_gpt":0.32679862031722945,"score_spread":0.3057658423503255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082067798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8226721,0.17106126,0.0017998507,0.003560061,0.0003890619,0.00022004383,0.00021118317,0.000006758001,0.00007966544],"genre_scores_gemma":[0.93542004,0.05551787,0.0031660835,0.001763629,0.0035354586,0.00013669411,0.0000079882175,0.00004653723,0.00040569055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989891,0.000022856993,0.00036021258,0.00023476912,0.0001373114,0.00025575422],"domain_scores_gemma":[0.99892235,0.000025956764,0.0002896744,0.00015044943,0.00048053745,0.00013105513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023112503,0.00013493409,0.0002241313,0.000039145147,0.000119942364,0.00007128492,0.00026090478,0.0001129581,0.00010973401],"category_scores_gemma":[0.000069137786,0.00014589705,0.00013912882,0.00007319523,0.00010071691,0.000017119362,0.000036395024,0.00012737983,4.2476708e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020111256,0.000052664833,0.006312959,0.000017683948,0.00022074975,0.000001847158,0.000032472813,0.00045485463,0.4866892,0.000024674067,0.018873105,0.48711866],"study_design_scores_gemma":[0.0020349016,0.00026755693,0.0138780195,0.00016844881,0.00006725489,0.00019758701,0.000016028045,0.000029993867,0.19992135,0.0002300645,0.782921,0.00026780026],"about_ca_topic_score_codex":0.00010053271,"about_ca_topic_score_gemma":0.00045731672,"teacher_disagreement_score":0.76404786,"about_ca_system_score_codex":0.00006924337,"about_ca_system_score_gemma":0.0003549983,"threshold_uncertainty_score":0.5949509},"labels":[],"label_agreement":null},{"id":"W2082357643","doi":"10.1038/sj.bjc.6601809","title":"Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Autocrine signalling; NOS1; Immunohistochemistry; Pathology; Nitric oxide synthase; Biology; Kidney; Nitric oxide; Cancer research; Endocrinology; Medicine; Biochemistry; Receptor","score_opus":0.008747623237597335,"score_gpt":0.23959643989487428,"score_spread":0.23084881665727694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082357643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408734,0.005253097,0.00018394923,0.00008331921,0.00009095495,0.00011727563,0.000019263329,0.0000036644003,0.0001611531],"genre_scores_gemma":[0.9982658,0.0005622064,0.0008438192,0.000060878858,0.00018837751,0.0000030124677,0.0000025110164,0.000020260572,0.000053102118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998682,0.00005339118,0.0005123302,0.000101934966,0.00045959698,0.00019069668],"domain_scores_gemma":[0.9989161,0.00009128483,0.0005454756,0.000067395675,0.0002776349,0.00010210804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002963006,0.000097568605,0.0004992445,0.00013487563,0.000017733832,0.0000070495503,0.000090728776,0.00008481591,0.00006804952],"category_scores_gemma":[0.000102595244,0.0000871287,0.00010187925,0.00022614747,0.000059171125,0.00009450727,0.000013051218,0.00033333624,6.6456255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028925014,0.0014997364,0.29113173,0.00070168683,0.00020418216,0.006947169,0.0008307984,0.0073880004,0.68368363,0.000007118832,0.00043542503,0.004277983],"study_design_scores_gemma":[0.015202778,0.0012269457,0.43565854,0.011031368,0.00017220207,0.00036152627,0.00005127562,0.000013339731,0.5359553,0.00013941918,0.00005482935,0.00013245035],"about_ca_topic_score_codex":0.0016103716,"about_ca_topic_score_gemma":0.0004566507,"teacher_disagreement_score":0.14772834,"about_ca_system_score_codex":0.00014676998,"about_ca_system_score_gemma":0.00036592083,"threshold_uncertainty_score":0.35530052},"labels":[],"label_agreement":null},{"id":"W2083008315","doi":"10.1038/sj.bjc.6602994","title":"Tumours and tremors: how PTEN regulation underlies both","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"PTEN; Tensin; Disease; Suppressor; Cancer research; Phosphatase; Biology; Tumor suppressor gene; Cancer; Genetics; Medicine; Pathology; PI3K/AKT/mTOR pathway; Carcinogenesis; Signal transduction; Phosphorylation","score_opus":0.02369870367206538,"score_gpt":0.3125894481061461,"score_spread":0.2888907444340807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083008315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048182288,0.99815965,0.00023115639,0.00009730402,0.0005079961,0.00015635908,0.00010189488,0.0000052133014,0.0002586173],"genre_scores_gemma":[0.00094175135,0.99415874,0.0002566288,0.00006590805,0.002473158,0.000015402975,0.000065920925,0.000069087684,0.0019534102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985687,0.00012143852,0.0005036719,0.00029112687,0.00027842377,0.0002366001],"domain_scores_gemma":[0.9986123,0.00002224583,0.0009142802,0.00016011328,0.0001906525,0.00010041735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026337337,0.0002690698,0.00083648757,0.00008963263,0.00007200933,0.00017433128,0.00024469773,0.00033656944,0.00003451682],"category_scores_gemma":[0.000053448348,0.00027867968,0.00036497525,0.00009958998,0.0001241783,0.000012746079,0.000053052518,0.00030816038,6.005053e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013085341,0.000015322341,0.000044198594,0.0011691792,0.00019234566,0.000056539622,0.0000036901106,0.000018479608,0.000113306014,0.0000031932566,0.03767662,0.960694],"study_design_scores_gemma":[0.00036045472,0.000101491416,0.00025901475,0.008752433,0.0005019185,0.0020929328,0.000006797574,0.0000016774014,0.00012093627,0.00004882395,0.9874468,0.0003067136],"about_ca_topic_score_codex":0.00011981022,"about_ca_topic_score_gemma":0.00041454937,"teacher_disagreement_score":0.96038735,"about_ca_system_score_codex":0.00011851824,"about_ca_system_score_gemma":0.0005488824,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W2083053655","doi":"10.1038/sj.bjc.6601881","title":"HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society","keywords":"Medicine; Lymph node; Trastuzumab; Breast cancer; Immunohistochemistry; Oncology; Cancer; CISH; Pathology; Cancer research; Internal medicine; Gene expression; Biology; Gene; In situ hybridization","score_opus":0.05765193668666164,"score_gpt":0.4376919582824539,"score_spread":0.38004002159579225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083053655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006865993,0.9947594,0.000004871195,0.00070248405,0.00045227827,0.00092643104,0.0030140253,0.000008261552,0.00006363219],"genre_scores_gemma":[0.0000072730422,0.9973495,0.0006309283,0.00045974445,0.0009946034,0.000056514175,0.00020455384,0.00008403481,0.00021285629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961281,0.00042676355,0.0012820726,0.00063731254,0.00102528,0.0005004913],"domain_scores_gemma":[0.9976243,0.00014908024,0.00088465295,0.0004667217,0.00036890135,0.0005063927],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018383417,0.0004468663,0.0029639464,0.0004608569,0.000077036304,0.00023418252,0.0005530704,0.00026680736,0.00066754746],"category_scores_gemma":[0.00019046756,0.00038293633,0.00022303175,0.0008286336,0.0001761624,0.00053251645,0.00029112233,0.0025045297,0.0000015165776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010486217,0.000044472476,0.00059361325,0.14678521,0.0001299104,0.008942643,0.00001807596,3.5125174e-7,0.0000017876476,6.0661097e-7,0.015883947,0.8274945],"study_design_scores_gemma":[0.0007067158,0.000037394017,0.0009627454,0.4696558,0.00081198354,0.045996863,0.000004509101,5.2202057e-7,5.6214685e-7,0.0000031729992,0.4816472,0.00017252934],"about_ca_topic_score_codex":0.0006916266,"about_ca_topic_score_gemma":0.0003425904,"teacher_disagreement_score":0.827322,"about_ca_system_score_codex":0.0009787322,"about_ca_system_score_gemma":0.004913216,"threshold_uncertainty_score":0.99986225},"labels":[],"label_agreement":null},{"id":"W2083797461","doi":"10.1038/sj.bjc.6605168","title":"EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"H. Lundbeck A/S; Lundbeckfonden; Sundhed og Sygdom, Det Frie Forskningsråd; Kræftens Bekæmpelse; National Center for Chronic Disease Prevention and Health Promotion; Aarhus Universitetshospital; Medical Research Council; Aarhus Universitet","keywords":"Nasopharyngeal carcinoma; Gastric carcinoma; Incidence (geometry); Epstein–Barr virus; Carcinoma; Medicine; Population; Pathology; Internal medicine; Oncology; Virus; Gastroenterology; Cancer; Immunology; Radiation therapy","score_opus":0.009236911274914944,"score_gpt":0.2590383335599919,"score_spread":0.24980142228507696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083797461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96368307,0.03414052,0.000019646377,0.0013425604,0.00025281872,0.0002840898,0.00005141009,0.000011313649,0.00021454546],"genre_scores_gemma":[0.995252,0.0027902578,0.00010450707,0.0013390972,0.00030328805,0.000013464894,0.000009341609,0.000021700445,0.0001663499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842566,0.000043482003,0.00053359824,0.00020935769,0.0003713307,0.0004165504],"domain_scores_gemma":[0.99887663,0.000054215303,0.00038720027,0.00007809466,0.00037227222,0.00023158808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003303265,0.00015830947,0.00058243686,0.00017703812,0.00008263531,0.00005574168,0.00010983496,0.0001388311,0.000059939262],"category_scores_gemma":[0.00025725772,0.0001769815,0.00015488875,0.00032764848,0.00005118701,0.00021662722,0.000012669606,0.00036031316,5.231312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014370981,0.00035871085,0.80560756,0.00010217698,0.00011545006,0.0020084914,0.00024818286,0.0000956765,0.001218675,0.000029289504,0.012129654,0.176649],"study_design_scores_gemma":[0.012325994,0.0010054774,0.98342633,0.0008674433,0.00016404368,0.00072634907,0.00013309029,0.00017695382,0.00023754421,0.00053149235,0.00023318423,0.00017212253],"about_ca_topic_score_codex":0.0023982816,"about_ca_topic_score_gemma":0.0022204865,"teacher_disagreement_score":0.17781872,"about_ca_system_score_codex":0.0005633275,"about_ca_system_score_gemma":0.00056777,"threshold_uncertainty_score":0.7217096},"labels":[],"label_agreement":null},{"id":"W2084065248","doi":"10.1038/sj.bjc.6602161","title":"Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Immunostaining; Biology; Immunohistochemistry; Epitope; Tumor suppressor gene; Gene; Exon; Glioma; Pathology; Single-strand conformation polymorphism; Cancer research; Antibody; Gene expression; Monoclonal antibody; Immunology; Genetics; Medicine; Carcinogenesis","score_opus":0.02536595954045023,"score_gpt":0.3470325229637638,"score_spread":0.32166656342331357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084065248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97645146,0.021213347,0.00040607154,0.00026831852,0.0011573976,0.00026885566,0.00004918767,0.000014294574,0.00017108255],"genre_scores_gemma":[0.9826488,0.006546938,0.009240212,0.00024887003,0.0011839549,0.0000065891754,0.000009149966,0.000046695215,0.00006880132],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751335,0.000076177974,0.001274999,0.00024011785,0.0006297312,0.00026564245],"domain_scores_gemma":[0.9983352,0.00007354871,0.00076872576,0.00019839633,0.00036178838,0.00026233072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003914852,0.0001598491,0.0007232853,0.00012301323,0.000029382683,0.00002377767,0.00018473559,0.00022145605,0.00041526998],"category_scores_gemma":[0.00050812686,0.00014350013,0.00023674415,0.00026017785,0.0001401742,0.00014638712,0.00005416834,0.00095197477,0.0000038124654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029094221,0.005816125,0.15853128,0.00053471327,0.0008687735,0.059991673,0.0010419957,0.0111684445,0.43969238,0.00003001322,0.0151866395,0.27804375],"study_design_scores_gemma":[0.08450647,0.007689045,0.515192,0.09533067,0.0010868125,0.01325509,0.0003777361,0.00034915528,0.25469252,0.00032152742,0.026239464,0.0009595248],"about_ca_topic_score_codex":0.00091885414,"about_ca_topic_score_gemma":0.0011587278,"teacher_disagreement_score":0.35666072,"about_ca_system_score_codex":0.00030938626,"about_ca_system_score_gemma":0.0014841013,"threshold_uncertainty_score":0.5851766},"labels":[],"label_agreement":null},{"id":"W2084330540","doi":"10.1038/sj.bjc.6601676","title":"Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Hazard ratio; Fluorouracil; Regimen; Confidence interval; Gastroenterology; Population; Proportional hazards model; Colorectal cancer; Oncology; Surgery; Chemotherapy; Cancer","score_opus":0.10041048255055936,"score_gpt":0.4197499322979251,"score_spread":0.3193394497473658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084330540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89048755,0.10533347,0.0015534357,0.0007246131,0.00028998134,0.00041418735,0.0011019291,0.0000124157505,0.00008239916],"genre_scores_gemma":[0.96434,0.032940395,0.0014719815,0.00025552989,0.0007710001,0.00001190092,0.000097265554,0.000022134096,0.000089802874],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981767,0.00007976372,0.0008559845,0.00030117744,0.0003317113,0.00025464303],"domain_scores_gemma":[0.99856734,0.00024201022,0.00045847858,0.00017423986,0.0003204479,0.00023749484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075067306,0.00021659878,0.0014616867,0.0000924992,0.00015375727,0.0001218333,0.00012729637,0.00005823388,0.00024770884],"category_scores_gemma":[0.00069535594,0.00017018811,0.0001370593,0.00017049893,0.000119038814,0.00025171714,0.00009435774,0.00029683023,4.9817936e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062803864,0.001612749,0.0018502431,0.00004264151,0.005911595,0.002266887,0.00080560474,0.000047990583,0.007300331,0.000010719456,0.0016036277,0.91574377],"study_design_scores_gemma":[0.8974772,0.002725196,0.044778425,0.0021368987,0.0073090415,0.004070607,0.0011226528,0.0001999845,0.003018076,0.00018498457,0.03647838,0.0004985289],"about_ca_topic_score_codex":0.009698042,"about_ca_topic_score_gemma":0.007844936,"teacher_disagreement_score":0.91524523,"about_ca_system_score_codex":0.000185917,"about_ca_system_score_gemma":0.00039594463,"threshold_uncertainty_score":0.99689645},"labels":[],"label_agreement":null},{"id":"W2084375742","doi":"10.1038/sj.bjc.6600196","title":"A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Odds ratio; Incidence (geometry); Family planning; Gynecology; Demography; Population; Meta-analysis; Case-control study; Melanoma; Obstetrics; Internal medicine; Environmental health; Research methodology","score_opus":0.019551637615485708,"score_gpt":0.2633265008370647,"score_spread":0.243774863221579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084375742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7979642,0.20144044,0.00002430294,0.00006137706,0.000092968265,0.000048324935,0.00025379204,0.0000015435095,0.00011305203],"genre_scores_gemma":[0.98954684,0.008162611,0.00004735278,0.00004409518,0.000017567481,0.0000018487339,0.0000015046072,0.000005060445,0.002173139],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99915665,0.000120791265,0.00047064325,0.00008716484,0.00003920914,0.00012556091],"domain_scores_gemma":[0.99877226,0.00018161234,0.0005129318,0.000058736892,0.000453829,0.000020640426],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018832056,0.00007889305,0.00072226225,0.0001552784,0.000050508097,0.000008958826,0.000056858466,0.00007309217,0.0032814178],"category_scores_gemma":[0.00011030109,0.00007455739,0.0001692153,0.0001523829,0.00027798305,0.00009008959,0.0000153672,0.00012934685,0.000001199716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026828428,0.0011051537,0.08098762,0.00026871308,0.14900771,0.007009139,0.0055988124,0.0005059685,0.196249,0.00026276527,0.02483921,0.53148305],"study_design_scores_gemma":[0.050020263,0.00501306,0.6286595,0.0018486975,0.088229395,0.03831783,0.0078038266,0.0005330649,0.028279433,0.00011837371,0.14985807,0.0013185036],"about_ca_topic_score_codex":0.0010459084,"about_ca_topic_score_gemma":0.0049782177,"teacher_disagreement_score":0.54767185,"about_ca_system_score_codex":0.000021333954,"about_ca_system_score_gemma":0.000016833712,"threshold_uncertainty_score":0.9976297},"labels":[],"label_agreement":null},{"id":"W2084457650","doi":"10.1038/bjc.2011.213","title":"Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; Canada Research Chairs","funders":"","keywords":"Interquartile range; Medicine; Quality of life (healthcare); Visual analogue scale; Inpatient care; Ambulatory care; Pediatrics; Emergency medicine; Health care; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.05565188155210633,"score_gpt":0.3262071854759241,"score_spread":0.27055530392381777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084457650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878783,0.009229965,0.00060329493,0.00034881025,0.00033836233,0.00047906433,0.00004638528,0.000017593466,0.0010582283],"genre_scores_gemma":[0.9948672,0.0041217078,0.00038044294,0.00022731809,0.00016127758,0.000041896375,0.0000042161114,0.000024356323,0.00017157907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983748,0.0000741042,0.00087467884,0.00013829698,0.000295066,0.00024304756],"domain_scores_gemma":[0.99843174,0.0000276389,0.00080508017,0.00011544303,0.00040275295,0.00021736839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026403717,0.0001219032,0.00066641916,0.0001231365,0.00007872665,0.00002440902,0.00009093711,0.000045073037,0.00028956146],"category_scores_gemma":[0.000012679859,0.0001041025,0.00017945623,0.00022958011,0.00007395841,0.0001359177,0.000015952182,0.00020312797,6.35611e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02070465,0.0045427117,0.64522386,0.007639126,0.0073028137,0.0008118137,0.00260654,0.00075470126,0.0026597113,0.0060762595,0.026256697,0.27542108],"study_design_scores_gemma":[0.006563616,0.0016077326,0.98772055,0.00080867234,0.0004371492,0.0003703896,0.00053581555,0.0000056110516,0.000416387,0.00031499728,0.0010761615,0.00014292037],"about_ca_topic_score_codex":0.0027357487,"about_ca_topic_score_gemma":0.0017814719,"teacher_disagreement_score":0.34249666,"about_ca_system_score_codex":0.00010813571,"about_ca_system_score_gemma":0.00046196108,"threshold_uncertainty_score":0.4245177},"labels":[],"label_agreement":null},{"id":"W2085115464","doi":"10.1038/sj.bjc.6604054","title":"Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Medicine; Prostate; Erg; PCA3; Oncology; Hazard ratio; Internal medicine; Cancer; Cancer research; Disease; Gene; Biology; Genetics; Ophthalmology","score_opus":0.023943174988314376,"score_gpt":0.3299856356982167,"score_spread":0.3060424607099023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085115464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8696983,0.12615779,0.00018816063,0.0011560844,0.0014956156,0.0008263376,0.00041892438,0.000009163767,0.000049663577],"genre_scores_gemma":[0.92294353,0.07389889,0.00020779074,0.0002899705,0.0010166013,0.0002453637,0.000009203591,0.000041126954,0.0013474938],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753326,0.000064234344,0.0007694254,0.00024572134,0.0008741608,0.0005131849],"domain_scores_gemma":[0.99758047,0.00016682505,0.00059982046,0.0001927022,0.0011929383,0.0002672712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082934456,0.00018488655,0.00053439994,0.00014319732,0.00014557222,0.000032526394,0.00018421492,0.00012726567,0.00036586824],"category_scores_gemma":[0.00014137282,0.00012930867,0.00034922402,0.0003650846,0.00021716839,0.00020118956,0.000066695306,0.00037881683,4.2330183e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012940323,0.00037307054,0.33535892,0.0010551044,0.00031579423,0.0005582287,0.00066279754,0.00016108455,0.073923714,9.745793e-7,0.03724712,0.53740287],"study_design_scores_gemma":[0.0060195974,0.0003028077,0.45024875,0.01538631,0.00035697996,0.00037613636,0.00011210439,0.00006553347,0.49705678,0.000055437584,0.02975971,0.00025985972],"about_ca_topic_score_codex":0.0012948146,"about_ca_topic_score_gemma":0.0014331716,"teacher_disagreement_score":0.53714305,"about_ca_system_score_codex":0.00043020354,"about_ca_system_score_gemma":0.0016600288,"threshold_uncertainty_score":0.5273055},"labels":[],"label_agreement":null},{"id":"W2085251527","doi":"10.1038/bjc.2015.24","title":"Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2)","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; Medical Research Council; Regione Piemonte; Cancerfonden; Alberta Innovates; National Health and Medical Research Council; Karolinska Institutet; U.S. Department of Health and Human Services; National Institutes of Health; Canada Research Chairs; Alberta Cancer Foundation; Vetenskapsrådet","keywords":"Infertility; Medicine; Endometrial cancer; Gynecology; Obstetrics; Odds ratio; Unexplained infertility; Female infertility; Cancer; Internal medicine; Pregnancy; Biology","score_opus":0.06290100789887197,"score_gpt":0.3674113204230854,"score_spread":0.3045103125242134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085251527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8729116,0.12412043,0.00012339164,0.00075207534,0.0006814072,0.0002962031,0.00106075,0.000006249348,0.000047921712],"genre_scores_gemma":[0.9828352,0.015816882,0.00023958019,0.00041974382,0.0005399709,0.00007028219,0.000018146982,0.00001048719,0.00004971531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725974,0.0006414455,0.0011337778,0.0002529582,0.00042881354,0.0002832773],"domain_scores_gemma":[0.9948119,0.0024852536,0.0013117963,0.00018535445,0.0008476748,0.00035801146],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001581343,0.00016701617,0.0013387875,0.00027516732,0.0000998633,0.000021136475,0.00015409625,0.00015072605,0.0017981093],"category_scores_gemma":[0.009632052,0.00011595421,0.00044492545,0.00093157764,0.0003151781,0.00011453709,0.00007049108,0.00046091704,0.0000012406613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096972095,0.00019171929,0.96118474,0.0000074751865,0.0054719998,0.00011581591,0.00007633733,0.00021756307,0.00004822095,0.0000071255986,0.00067012216,0.031039169],"study_design_scores_gemma":[0.011825423,0.0004330381,0.976633,0.00013359048,0.0088428715,0.000042644642,0.00008613841,0.000049722574,0.00019738219,0.0007123389,0.00094609143,0.00009773125],"about_ca_topic_score_codex":0.082723185,"about_ca_topic_score_gemma":0.025137208,"teacher_disagreement_score":0.109923616,"about_ca_system_score_codex":0.00035028058,"about_ca_system_score_gemma":0.0006727878,"threshold_uncertainty_score":0.9991144},"labels":[],"label_agreement":null},{"id":"W2085491990","doi":"10.1038/sj.bjc.6602239","title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"Cancer Council Tasmania; Medical Research Council; National Cancer Institute; National Institutes of Health; Wellcome Trust; National Breast Cancer Foundation; University of Melbourne; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Ovarian cancer; Medicine; Odds ratio; Gynecology; Confidence interval; Cancer; BRCA mutation; Obstetrics; Population; Demography; Oncology; Internal medicine; Environmental health","score_opus":0.019340837229207666,"score_gpt":0.3000147470173663,"score_spread":0.28067390978815865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085491990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826692,0.01481912,0.00018931479,0.0011170299,0.00034114192,0.0003047262,0.0004607546,0.000007677035,0.0000910617],"genre_scores_gemma":[0.97405016,0.02368006,0.001518248,0.00023036082,0.00026252342,0.000038599464,0.0000036859078,0.000025460826,0.00019091435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987777,0.00004696312,0.00048015534,0.00017371448,0.00031182024,0.00020964537],"domain_scores_gemma":[0.99848664,0.00008128105,0.00052217604,0.00009711945,0.00054212473,0.00027063527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016041483,0.0001364772,0.0005103812,0.00009367574,0.00009725369,0.00006801266,0.000056581008,0.00008098567,0.00062832853],"category_scores_gemma":[0.00016437213,0.00012115607,0.00014378945,0.0001838901,0.00023058525,0.000338799,0.000013657838,0.00027022947,5.2486797e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010129214,0.00041505866,0.766815,0.00008898431,0.002294277,0.0021675818,0.0015568691,0.0015994424,0.00015928451,0.00009563356,0.0018061916,0.22198874],"study_design_scores_gemma":[0.011277237,0.0005141249,0.97868246,0.0019418424,0.0013108111,0.0007688097,0.00046662687,0.0000121533685,0.0013490188,0.00015395155,0.0033873417,0.00013562762],"about_ca_topic_score_codex":0.037132215,"about_ca_topic_score_gemma":0.035188057,"teacher_disagreement_score":0.2218531,"about_ca_system_score_codex":0.00034716056,"about_ca_system_score_gemma":0.0009246927,"threshold_uncertainty_score":0.9824172},"labels":[],"label_agreement":null},{"id":"W2085502397","doi":"10.1038/bjc.2013.295","title":"Tumour morphology predicts PALB2 germline mutation status","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Cancer Australia; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario; Peter MacCallum Cancer Centre; National Breast Cancer Foundation; University of Melbourne; Susan G. Komen; University of Utah","keywords":"PALB2; Germline mutation; Breast cancer; Mutation; Odds ratio; Population; Germline; Medicine; Oncology; Internal medicine; Genetics; Cancer; Biology; Gene","score_opus":0.007574670298178448,"score_gpt":0.2662748782126502,"score_spread":0.2587002079144718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085502397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760677,0.020625303,0.0014600346,0.00053975894,0.000737634,0.00013660133,0.000052035608,0.0000053981257,0.0003755334],"genre_scores_gemma":[0.9904305,0.0053334525,0.0018898016,0.00074507523,0.0010634167,0.000041437885,0.000032884553,0.000026811793,0.00043662687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989555,0.00005974572,0.00038007845,0.00016302735,0.00019344257,0.0002482146],"domain_scores_gemma":[0.9988599,0.000010671378,0.00030278764,0.000107443164,0.0005940252,0.00012519505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014026489,0.00009732898,0.0001563621,0.00005231082,0.000056862726,0.00005695395,0.0001573077,0.00010942818,0.00066120655],"category_scores_gemma":[0.000121891426,0.00011161986,0.00009069996,0.000087541586,0.0000826625,0.00001712145,0.00003727716,0.00016163145,0.000013456411],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009157221,0.00009930538,0.007459082,0.000030820374,0.00025986246,0.00020010669,0.00010978566,0.0033921783,0.5735914,0.0000076794995,0.13765463,0.27710354],"study_design_scores_gemma":[0.004915392,0.0009544624,0.4406158,0.00027473015,0.00017625936,0.008339317,0.0003553914,0.00026210575,0.30242983,0.0009668374,0.24007706,0.0006328322],"about_ca_topic_score_codex":0.00036401607,"about_ca_topic_score_gemma":0.00034167178,"teacher_disagreement_score":0.4331567,"about_ca_system_score_codex":0.00009392017,"about_ca_system_score_gemma":0.000425614,"threshold_uncertainty_score":0.7239748},"labels":[],"label_agreement":null},{"id":"W2086055140","doi":"10.1038/sj.bjc.6604088","title":"A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Trabectedin; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Phases of clinical research; Chemotherapy; Pathology; Sarcoma; Soft tissue sarcoma","score_opus":0.01891746772662693,"score_gpt":0.2959323091599805,"score_spread":0.27701484143335353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086055140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944233,0.003829237,0.000034121247,0.00017475875,0.00013020565,0.0012273944,0.000061665036,0.000010479307,0.00010886809],"genre_scores_gemma":[0.99891645,0.0002912937,0.00038640734,0.00009735814,0.0001321105,0.00007398122,0.000012379763,0.00004086276,0.00004918652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781543,0.00005836497,0.0007725406,0.00027365726,0.00072582957,0.00035418416],"domain_scores_gemma":[0.99821067,0.000043170094,0.0007377413,0.00016921839,0.00059497484,0.00024421597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002744167,0.00022458614,0.00070492586,0.00023120258,0.00006582835,0.000023391121,0.00008714299,0.000061237486,0.00022338255],"category_scores_gemma":[0.000021191197,0.00017723354,0.00008404155,0.00051800394,0.000057417852,0.00011017749,0.000011358401,0.00026807774,1.853751e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014110228,0.031175958,0.6202849,0.000088127184,0.00088321697,0.0017764873,0.0011659698,0.00026595176,0.000088168075,7.158045e-7,0.00047654816,0.32968372],"study_design_scores_gemma":[0.109631896,0.055166222,0.8246694,0.0065170843,0.0010496025,0.00009296277,0.00025026102,0.000010648349,0.0015141361,0.0000011899469,0.00087778614,0.0002188048],"about_ca_topic_score_codex":0.0036589655,"about_ca_topic_score_gemma":0.022712214,"teacher_disagreement_score":0.3294649,"about_ca_system_score_codex":0.00088969443,"about_ca_system_score_gemma":0.0005140111,"threshold_uncertainty_score":0.99512076},"labels":[],"label_agreement":null},{"id":"W2086097535","doi":"10.1038/sj.bjc.6604541","title":"A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Tolerability; Bolus (digestion); Tegafur; Internal medicine; Colorectal cancer; Phases of clinical research; Fluorouracil; Gastroenterology; Surgery; Cancer; Clinical trial; Adverse effect","score_opus":0.030373312189483113,"score_gpt":0.3328121462832735,"score_spread":0.30243883409379035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086097535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895327,0.009021658,0.0000012401678,0.00011072494,0.00006678144,0.0009994099,0.00009732269,0.0000029638252,0.0001671737],"genre_scores_gemma":[0.9967614,0.0026733908,0.000125611,0.000053079646,0.00005387509,0.00021370105,0.0000035545202,0.000018635026,0.00009674327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998384,0.00007971415,0.00051957153,0.00016909734,0.0006514118,0.00019620637],"domain_scores_gemma":[0.99875927,0.000059507078,0.0005154236,0.00011108111,0.00047415713,0.000080571466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088672816,0.00018394267,0.00077477616,0.00010194883,0.0001122762,0.0000093332665,0.00009535122,0.000021188926,0.00008966466],"category_scores_gemma":[0.000017958995,0.00010866865,0.0000948127,0.0003349184,0.00015597597,0.000101977916,0.000013491998,0.000121322126,1.508114e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048873365,0.055727027,0.76606375,0.00011349914,0.0042960886,0.0038459932,0.03268774,0.00007702222,0.00013384187,0.0000018231334,0.00014609983,0.08803376],"study_design_scores_gemma":[0.07153281,0.18268779,0.7355971,0.00075056014,0.0014434165,0.0007183661,0.005116078,0.0000047255867,0.0008860804,0.0000024164635,0.0011184886,0.0001421894],"about_ca_topic_score_codex":0.0060851746,"about_ca_topic_score_gemma":0.024123032,"teacher_disagreement_score":0.12696075,"about_ca_system_score_codex":0.00029168074,"about_ca_system_score_gemma":0.0006089923,"threshold_uncertainty_score":0.9936842},"labels":[],"label_agreement":null},{"id":"W2086422578","doi":"10.1038/bjc.2013.755","title":"Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer; Krebsliga Schweiz; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"CCL7; CCR2; Metastasis; Chemokine receptor; Brain metastasis; Pathology; Medicine; Chemokine; Cancer research; Cancer; Renal cell carcinoma; CXCR4; Biology; Receptor; Internal medicine","score_opus":0.010586164574241141,"score_gpt":0.27713526792189325,"score_spread":0.2665491033476521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086422578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807688,0.015971642,0.000048191836,0.0023990148,0.00019149875,0.00039434113,0.00018648534,0.00000920798,0.000030832583],"genre_scores_gemma":[0.9932517,0.0041116117,0.00078899827,0.0013024422,0.00014767231,0.00009825551,0.000027500631,0.000039376802,0.00023247767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99810165,0.00015531061,0.0006650234,0.00023290997,0.0005054298,0.0003396946],"domain_scores_gemma":[0.998639,0.00010389629,0.0004964236,0.000088246365,0.0004109716,0.00026144643],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033367425,0.00021076977,0.0006726313,0.00014401639,0.00006105498,0.0000885719,0.00009031432,0.000057896268,0.0028491807],"category_scores_gemma":[0.00023119643,0.00018164213,0.00015862193,0.0002103767,0.00007040563,0.00029178328,0.000044962446,0.00033856565,0.0000040224986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022497526,0.0014178442,0.1440801,0.00021353814,0.00097258354,0.001049912,0.00032423763,0.000038886927,0.016851392,9.719796e-7,0.03898907,0.7958365],"study_design_scores_gemma":[0.016958013,0.00074769906,0.9302214,0.0041385316,0.00075538486,0.0005548408,0.00023873356,0.00007632949,0.04190267,0.00008857528,0.003949265,0.00036856846],"about_ca_topic_score_codex":0.0035661494,"about_ca_topic_score_gemma":0.0006855227,"teacher_disagreement_score":0.7954679,"about_ca_system_score_codex":0.00028360597,"about_ca_system_score_gemma":0.0001346831,"threshold_uncertainty_score":0.9980624},"labels":[],"label_agreement":null},{"id":"W2087086368","doi":"10.1038/bjc.2012.496","title":"High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Choriocarcinoma; Gene knockdown; Biology; Trophoblast; Extracellular matrix; Integrin; Molecular biology; Cancer research; Andrology; Placenta; Cell culture; Cell biology; Cell; Biochemistry; Medicine; Fetus; Pregnancy","score_opus":0.016243868325963407,"score_gpt":0.2758320594697294,"score_spread":0.25958819114376597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087086368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769336,0.022070194,0.00017244073,0.00018440251,0.0003302425,0.00014155597,0.00006613015,0.000005477235,0.000095967895],"genre_scores_gemma":[0.9945553,0.0026482681,0.0022972797,0.000038709295,0.00038733645,0.0000063308016,0.0000038953544,0.000020485691,0.00004237215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99864584,0.00004140173,0.00053052575,0.000076653734,0.00053802144,0.00016754864],"domain_scores_gemma":[0.99863803,0.00008667485,0.00041782914,0.00007831314,0.00060209865,0.00017703032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001837956,0.000094209754,0.00041974869,0.00008738885,0.00003112139,0.000004949106,0.00006952911,0.000041451447,0.000228356],"category_scores_gemma":[0.0003448359,0.000086985085,0.00013910081,0.00011931741,0.00011001185,0.00017143802,0.000020716525,0.00014054398,0.0000011529244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018300718,0.0015767124,0.3204094,0.001596116,0.00041251467,0.0002332763,0.00096749916,0.00005591015,0.625679,0.00013633528,0.0041382946,0.04296489],"study_design_scores_gemma":[0.002097384,0.00035920844,0.7442847,0.002834823,0.00023083706,0.00033213515,0.00017801818,0.0000015162894,0.24924946,0.00007299976,0.00029004333,0.00006891211],"about_ca_topic_score_codex":0.00013860372,"about_ca_topic_score_gemma":0.000016439264,"teacher_disagreement_score":0.42387527,"about_ca_system_score_codex":0.000047332396,"about_ca_system_score_gemma":0.00019593388,"threshold_uncertainty_score":0.3547149},"labels":[],"label_agreement":null},{"id":"W2087672388","doi":"10.1038/sj.bjc.6603964","title":"Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McMaster University Medical Centre; McGill University","funders":"Cancer Research Society","keywords":"Tetraspanin; Mitotic catastrophe; Prostate cancer; Mitosis; Cancer research; Cancer cell; Biology; Immunoprecipitation; Cancer; Fusion protein; Cell; Cell biology; Immunology; Gene; Antibody; Genetics","score_opus":0.020026125853080255,"score_gpt":0.3479827625714604,"score_spread":0.3279566367183801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087672388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414676,0.0051501947,0.00001515308,0.000178291,0.00009211069,0.0003105722,0.000016259213,0.0000021691956,0.000088510315],"genre_scores_gemma":[0.99680567,0.0026304752,0.00017061102,0.00008367207,0.00011575873,0.000008517305,0.0000033739354,0.00001891972,0.00016298937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833643,0.00006255687,0.0006853499,0.00014302069,0.00050245173,0.00027018838],"domain_scores_gemma":[0.9991951,0.000042762833,0.00025279992,0.00007940452,0.0002735834,0.00015634616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007020175,0.000088153414,0.00035180832,0.00029439008,0.000023220742,0.00001905847,0.000078983794,0.000076023214,0.00016675025],"category_scores_gemma":[0.000056386598,0.00009609941,0.00004952711,0.0003066135,0.000084492196,0.000091404065,0.000027717893,0.00043989986,4.942242e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050627015,0.00019016486,0.12011544,0.0002142416,0.00003555613,0.0028345543,0.0003969805,0.00033499763,0.81106603,0.0000031835639,0.00038892106,0.063913666],"study_design_scores_gemma":[0.0046086004,0.00037464863,0.68676776,0.001938153,0.000041455452,0.000373284,0.00030541126,0.00013606047,0.30493686,0.000038694092,0.0003665086,0.00011253939],"about_ca_topic_score_codex":0.009854751,"about_ca_topic_score_gemma":0.025224537,"teacher_disagreement_score":0.56665236,"about_ca_system_score_codex":0.00032222318,"about_ca_system_score_gemma":0.00034713393,"threshold_uncertainty_score":0.99673873},"labels":[],"label_agreement":null},{"id":"W2087737791","doi":"10.1038/sj.bjc.6603363","title":"The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"National Cancer Institute; Fondation pour la Recherche Médicale","keywords":"Oncolytic virus; Raji cell; In vivo; In vitro; Cell culture; Virology; Biology; Lymphoma; Reoviridae; Virus; Cancer cell; Cell; Cancer research; Immunology; Cancer","score_opus":0.009758346366126757,"score_gpt":0.28035318042002155,"score_spread":0.2705948340538948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087737791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98480225,0.01392553,0.000008511443,0.000081906386,0.00019557927,0.00021945125,0.00003518635,0.0000015957801,0.00072997855],"genre_scores_gemma":[0.99181247,0.007191488,0.000027117369,0.000113067195,0.0002738896,0.00001501114,0.0000025705504,0.000031976695,0.00053240976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981209,0.00040289457,0.0004881218,0.00020440391,0.0004140623,0.00036958515],"domain_scores_gemma":[0.9991728,0.00013126852,0.00032046437,0.00018113997,0.00012834126,0.00006598375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013184999,0.00014747442,0.0003168258,0.00011051302,0.00006231458,0.000047957354,0.00035151668,0.00011980773,0.00003186325],"category_scores_gemma":[0.00004516295,0.00013424257,0.00016245803,0.0001372142,0.0000996488,0.000009607544,0.000042744803,0.00038417432,0.0000017739136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005173623,0.00010452856,0.0023030187,0.000025850548,0.000023371482,0.0001835808,0.00001485978,0.001902764,0.97465837,2.810034e-7,0.0008218441,0.014787924],"study_design_scores_gemma":[0.0022563965,0.0011984877,0.003003112,0.00020716128,0.000010414994,0.000028493641,0.000026828868,0.0000566343,0.9905009,0.000025806628,0.0025508767,0.0001348664],"about_ca_topic_score_codex":0.002576028,"about_ca_topic_score_gemma":0.012399055,"teacher_disagreement_score":0.015842568,"about_ca_system_score_codex":0.00014026253,"about_ca_system_score_gemma":0.00026550246,"threshold_uncertainty_score":0.6918964},"labels":[],"label_agreement":null},{"id":"W2087918707","doi":"10.1038/sj.bjc.6605934","title":"A systematic review and meta-analysis of the relationship between body size and testicular cancer","year":2010,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; National Institutes of Health; Università degli Studi di Torino; Universitetet i Bergen; Public Health Agency","keywords":"Meta-analysis; Overweight; Medicine; Odds ratio; Confidence interval; Testicular cancer; Body mass index; Internal medicine; Anthropometry; Cancer; Oncology; Demography","score_opus":0.08243679587950156,"score_gpt":0.3974073534401348,"score_spread":0.3149705575606332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087918707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001642163,0.9977509,0.0000022906943,0.00020342605,0.00003603124,0.0012175408,0.0006145106,0.0000029573214,0.0000081194985],"genre_scores_gemma":[0.0020181197,0.99728346,0.00007956387,0.00013759156,0.00006232105,0.00014396304,0.000008402613,0.000026662758,0.00023994572],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977546,0.00026714665,0.0012390503,0.00018353066,0.00043296756,0.00012270756],"domain_scores_gemma":[0.9960719,0.0010047326,0.0021177407,0.0002851049,0.00032757284,0.00019298989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004223939,0.00024176887,0.0061574345,0.00010265445,0.00006564123,0.000038511702,0.00012847001,0.00013588343,0.0001700631],"category_scores_gemma":[0.0026439505,0.00013748527,0.0022848307,0.0005330287,0.00009698363,0.00005119303,0.00004010331,0.00046780353,3.4587077e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016512255,0.00005142178,0.009655521,0.7124882,0.26323867,0.00013989411,0.000005955828,2.7476077e-7,4.910968e-8,0.000006733065,0.000075925556,0.014335725],"study_design_scores_gemma":[0.0001787031,0.000020212317,0.040081944,0.17731953,0.77685744,0.0007829501,0.0000010549635,2.0930786e-7,3.5157026e-8,0.000013702504,0.004657838,0.000086412605],"about_ca_topic_score_codex":0.00026218942,"about_ca_topic_score_gemma":0.00012337885,"teacher_disagreement_score":0.53516865,"about_ca_system_score_codex":0.000070254406,"about_ca_system_score_gemma":0.0004509476,"threshold_uncertainty_score":0.5606487},"labels":[],"label_agreement":null},{"id":"W2088386079","doi":"10.1038/sj.bjc.6605835","title":"Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chang Gung Medical Foundation; Hospital for Sick Children; National Science Council","keywords":"Urothelial carcinoma; Upper urinary tract; Carcinoma; Urinary system; Medicine; Oncology; Urothelium; Risk factor; Internal medicine; Urothelial Cell; Pathology; Urology; Cancer research; Cancer; Bladder cancer","score_opus":0.009652573629109361,"score_gpt":0.2665012435821361,"score_spread":0.25684866995302674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088386079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840844,0.0003914932,0.0000049473915,0.00008499683,0.00015181758,0.00055770954,0.00032946162,0.0000015224289,0.000069592475],"genre_scores_gemma":[0.99932724,0.000059490816,0.00026402067,0.000039045364,0.00010072593,0.000018035293,0.0000012475174,0.000019302046,0.00017090811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899495,0.00002533545,0.0002591595,0.00009294211,0.00046583873,0.00016180408],"domain_scores_gemma":[0.99893904,0.00006658312,0.00030056704,0.00011404591,0.00045776268,0.00012201349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004416423,0.000081853475,0.00023038685,0.000045732253,0.000039928673,0.00000907911,0.00011515879,0.00004121855,0.00023096197],"category_scores_gemma":[0.00007952917,0.00005139617,0.00014610682,0.00006250763,0.000076176526,0.00008383321,0.000021459897,0.0002430149,3.8953556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016521176,0.0019642722,0.938237,0.00020643022,0.000041912754,0.00009741818,0.00010950344,5.2980926e-7,0.045669757,2.3618502e-7,0.00049134955,0.011529435],"study_design_scores_gemma":[0.0049708756,0.002655087,0.80882245,0.0005316376,0.00007447491,0.00023831433,0.000009273897,0.0000017992263,0.18201205,0.000005984008,0.00063938106,0.000038664675],"about_ca_topic_score_codex":0.000060764472,"about_ca_topic_score_gemma":0.000016421769,"teacher_disagreement_score":0.13634229,"about_ca_system_score_codex":0.000020885689,"about_ca_system_score_gemma":0.00030192218,"threshold_uncertainty_score":0.25288716},"labels":[],"label_agreement":null},{"id":"W2088661059","doi":"10.1038/sj.bjc.6603684","title":"Brief smoking cessation advice from practice nurses during routine cervical smear tests appointments: a cluster randomised controlled trial assessing feasibility, acceptability and potential effectiveness","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Cancer Research UK","keywords":"Medicine; Smoking cessation; Randomized controlled trial; Physical therapy; Intervention (counseling); Cluster randomised controlled trial; Cervical screening; Cluster (spacecraft); Psychological intervention; Family medicine; Cervical cancer; Internal medicine; Nursing","score_opus":0.0163348335902607,"score_gpt":0.3572049236193045,"score_spread":0.3408700900290438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088661059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364907,0.000985766,0.0016294372,0.00023732545,0.0013833322,0.0018883918,0.000010133933,0.00003489623,0.00018164438],"genre_scores_gemma":[0.99799985,0.00014349165,0.00030258283,0.0001519028,0.0013060531,0.000041957246,0.000012000165,0.000029236811,0.0000129010505],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996802,0.00067562604,0.0010262348,0.00033141757,0.0008821467,0.00028263152],"domain_scores_gemma":[0.9966476,0.0011594422,0.0009529012,0.00014616846,0.0008935034,0.00020038775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003771299,0.00019294154,0.00081472594,0.00011597297,0.00021180676,0.00030345877,0.000090450485,0.00019299118,0.00025203326],"category_scores_gemma":[0.0025546085,0.00018950456,0.00025398392,0.00017730758,0.000096469885,0.0010577245,0.000039988212,0.00057772454,1.5120675e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5591955,0.00094074383,0.39175862,0.00014865454,0.00041839914,0.00038494242,0.00027835934,0.00004682887,0.0032356388,7.7815685e-7,0.000010595885,0.043580946],"study_design_scores_gemma":[0.4100124,0.00017592016,0.5860687,0.0005306416,0.0011293862,0.00064034923,0.00029421208,0.0000335713,0.0009625967,0.000027677967,0.00001978615,0.00010475458],"about_ca_topic_score_codex":0.0012249494,"about_ca_topic_score_gemma":0.00011932454,"teacher_disagreement_score":0.1943101,"about_ca_system_score_codex":0.00057995005,"about_ca_system_score_gemma":0.00024442322,"threshold_uncertainty_score":0.77277714},"labels":[],"label_agreement":null},{"id":"W2089000681","doi":"10.1038/bjc.2013.713","title":"Nuclear worker studies: promise and pitfalls","year":2013,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"International agency; Medicine; Environmental health; Agency (philosophy); Publicity; Nuclear power; Commission; Political science; Cancer; Law; Social science; Sociology","score_opus":0.022405284380990997,"score_gpt":0.30773102566861443,"score_spread":0.28532574128762345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089000681","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048015453,0.28040755,0.000006182736,0.6686509,0.0012832078,0.00038337646,0.000015312442,0.000019273004,0.0012187243],"genre_scores_gemma":[0.0029693688,0.12764439,0.00048277908,0.84028417,0.015348925,0.000015157745,0.0000052958144,0.0001032306,0.013146699],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987715,0.00003873215,0.00044698996,0.00014925652,0.00038404655,0.00020949768],"domain_scores_gemma":[0.9989399,0.000044390516,0.00044149428,0.00009458284,0.00037684225,0.00010284416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014757973,0.00014512187,0.0005877546,0.000114119226,0.000057949488,0.00013250465,0.00009054538,0.0001894078,0.00086685683],"category_scores_gemma":[0.00012643948,0.00013882863,0.0001333857,0.00006917719,0.00009454481,0.00022835912,0.000026417645,0.0013869958,0.00001860916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015896463,0.00000951417,0.000357691,0.00015867842,0.0004688217,0.0020724898,0.00013638164,4.8467894e-7,0.000024938392,1.7350673e-7,0.8364892,0.16026573],"study_design_scores_gemma":[0.0012241,0.0000742467,0.004699927,0.004649506,0.00034631175,0.004981522,0.0000848596,0.000006719485,0.000017524284,0.000028581191,0.9837427,0.0001439824],"about_ca_topic_score_codex":0.00008200707,"about_ca_topic_score_gemma":0.0000064899477,"teacher_disagreement_score":0.17163324,"about_ca_system_score_codex":0.00013507364,"about_ca_system_score_gemma":0.00017509049,"threshold_uncertainty_score":0.94914746},"labels":[],"label_agreement":null},{"id":"W2089164477","doi":"10.1038/sj.bjc.6600459","title":"Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Methionine; Methylenetetrahydrofolate reductase; Biology; Methionine synthase; Reductase; Cancer research; Molecular biology; Homocysteine; Cell culture; Biochemistry; Enzyme; Genetics; Amino acid","score_opus":0.03999828002745998,"score_gpt":0.33198152682292065,"score_spread":0.29198324679546067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089164477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96140045,0.036779284,0.000020938445,0.0007221481,0.00036224446,0.00012819623,0.00006279245,0.000006440034,0.00051752996],"genre_scores_gemma":[0.966386,0.03175535,0.0006275739,0.0000301671,0.00046179877,0.0000021832004,0.0000036368517,0.00002428065,0.0007090087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997684,0.00015788,0.0008679042,0.00015241708,0.0009003616,0.00023741019],"domain_scores_gemma":[0.9980259,0.000083666775,0.00054712524,0.00011768441,0.0010506009,0.0001750136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082678074,0.00012098258,0.0006170871,0.00028512423,0.000043066757,0.000020508081,0.00010442633,0.00010406089,0.00073781546],"category_scores_gemma":[0.00033740522,0.00011722749,0.00024184538,0.00035553385,0.0001492757,0.00019868357,0.000032370266,0.00044357224,0.0000032097196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029125158,0.00033762376,0.0008692026,0.00020025155,0.0002857018,0.0012373,0.0001581603,0.00005404891,0.9222522,0.0000056254353,0.0023251034,0.07198355],"study_design_scores_gemma":[0.0025837403,0.00073661713,0.011565955,0.0018697834,0.00025067653,0.002624014,0.0001927511,0.00013936851,0.97914666,0.000051690586,0.00071415276,0.00012460044],"about_ca_topic_score_codex":0.00063655723,"about_ca_topic_score_gemma":0.00012071465,"teacher_disagreement_score":0.07185896,"about_ca_system_score_codex":0.000061722545,"about_ca_system_score_gemma":0.00015918245,"threshold_uncertainty_score":0.80785614},"labels":[],"label_agreement":null},{"id":"W2090227074","doi":"10.1038/bjc.2014.445","title":"Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; London Health Sciences Centre; McMaster Children's Hospital; Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; Toronto General Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cognition; Pediatrics; Family medicine; Pediatric cancer; MEDLINE; Cancer; Psychiatry","score_opus":0.016328677220310343,"score_gpt":0.300228054269207,"score_spread":0.2838993770488967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090227074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845549,0.009036589,0.00044835973,0.0041630464,0.0007330984,0.00015998584,0.000013540543,0.000006460079,0.0008840371],"genre_scores_gemma":[0.99256116,0.0025040356,0.001101937,0.0018569594,0.0017175283,0.000004258265,8.5243255e-7,0.000021812792,0.00023142743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978061,0.000135582,0.0008795587,0.0001236956,0.00084892416,0.00020614905],"domain_scores_gemma":[0.9986212,0.0001572596,0.00063664495,0.00019166138,0.00029830833,0.0000949245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013181904,0.00010041833,0.00044239336,0.000101040474,0.00004144303,0.000021870032,0.00022249053,0.00006620975,0.00018136209],"category_scores_gemma":[0.0008046495,0.00009028693,0.00020214639,0.00030322841,0.000064583575,0.00009647545,0.000059918555,0.00044818068,9.1828497e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029957193,0.00025129892,0.69620323,0.00046999595,0.00013074058,0.000078688056,0.0008566683,0.00040264183,0.00031863808,0.000120360855,0.0161893,0.28467885],"study_design_scores_gemma":[0.0037446548,0.00019835035,0.94944245,0.0029181545,0.00016476648,0.0004771162,0.00019587636,0.00005077555,0.0006047818,0.00012593278,0.04193919,0.00013797787],"about_ca_topic_score_codex":0.0017070278,"about_ca_topic_score_gemma":0.0025783556,"teacher_disagreement_score":0.28454086,"about_ca_system_score_codex":0.00009441542,"about_ca_system_score_gemma":0.00031472245,"threshold_uncertainty_score":0.3681794},"labels":[],"label_agreement":null},{"id":"W2090283697","doi":"10.1038/sj.bjc.6601451","title":"Kallikrein gene downregulation in breast cancer","year":2004,"lang":"de","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Downregulation and upregulation; Cancer; Biology; Gene; Gene expression; Cancer research; In silico; Molecular biology; Genetics; Enzyme; Biochemistry","score_opus":0.01083030475192253,"score_gpt":0.27622129517292987,"score_spread":0.26539099042100733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090283697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56070805,0.43071666,0.00012620496,0.0055713197,0.0023721263,0.0002276771,0.00016575544,0.000013387201,0.000098813434],"genre_scores_gemma":[0.8619909,0.12973066,0.00024878368,0.000875998,0.0065433453,0.0000142815625,0.00001946087,0.0000614868,0.00051503873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969127,0.0000806624,0.0013048392,0.00031588,0.0008174642,0.0005684275],"domain_scores_gemma":[0.9979412,0.00004417229,0.00083451584,0.00017431674,0.00063534966,0.00037047509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051617087,0.00029054628,0.00077600434,0.00029021341,0.00012804812,0.0001379211,0.00021548916,0.00025331037,0.0018269458],"category_scores_gemma":[0.00005268697,0.00033902022,0.00033070703,0.0005433554,0.00015004545,0.00049543084,0.000035904603,0.00056039373,0.000029116562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012334142,0.00074471685,0.260304,0.00032736047,0.0010515926,0.003159515,0.0014071371,0.029781288,0.0037975213,0.00022163027,0.0050074765,0.6929643],"study_design_scores_gemma":[0.008896336,0.00013162757,0.9594787,0.008532414,0.0006845221,0.001866097,0.00008967031,0.00020535426,0.0020883472,0.0007251282,0.016913494,0.0003883326],"about_ca_topic_score_codex":0.0150707895,"about_ca_topic_score_gemma":0.0069355774,"teacher_disagreement_score":0.69917464,"about_ca_system_score_codex":0.0011167992,"about_ca_system_score_gemma":0.0016913355,"threshold_uncertainty_score":0.9999062},"labels":[],"label_agreement":null},{"id":"W2091194126","doi":"10.1038/sj.bjc.6603304","title":"Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; University of Birmingham; Cancer Research UK","keywords":"Ubiquitin ligase; Biology; Cell biology; Embryonic stem cell; Transformation (genetics); Malignant transformation; Ubiquitin; Genetics; Gene","score_opus":0.01430287038572891,"score_gpt":0.2866593822973404,"score_spread":0.2723565119116115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091194126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035554112,0.9947998,0.00018805037,0.0001441359,0.00011046538,0.0007750258,0.00019487324,0.0000014684197,0.00023078352],"genre_scores_gemma":[0.011729494,0.98732054,0.000030035111,0.000107773354,0.00048371142,0.00014668831,0.000024090512,0.000025450565,0.00013224031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883723,0.00016172638,0.00052954577,0.00015105573,0.00014647002,0.00017398286],"domain_scores_gemma":[0.99923056,0.00010138798,0.00044751388,0.00009137696,0.000078594996,0.00005055723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079994457,0.00017809671,0.00051932846,0.00004184592,0.00011350281,0.000117367264,0.00018814066,0.00018957895,0.0000071241084],"category_scores_gemma":[0.000038033457,0.00011691875,0.00022857441,0.0000502706,0.00011810978,0.000010223569,0.00003251731,0.00030829513,1.5991439e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009510775,0.000019841198,0.000005275056,0.0016993742,0.00007727358,0.000008814227,0.00005743002,0.00000756377,0.00010756838,0.00002261448,0.000508678,0.99739045],"study_design_scores_gemma":[0.001887548,0.00009412888,0.00002870464,0.0029651006,0.00034736682,0.0007836645,0.00008307449,0.0000076145257,0.00385045,0.000082668565,0.9896872,0.00018246632],"about_ca_topic_score_codex":0.00018147743,"about_ca_topic_score_gemma":0.00073510775,"teacher_disagreement_score":0.997208,"about_ca_system_score_codex":0.000026244355,"about_ca_system_score_gemma":0.00020817594,"threshold_uncertainty_score":0.47678083},"labels":[],"label_agreement":null},{"id":"W2091658544","doi":"10.1038/sj.bjc.6601424","title":"Germline truncating mutations in both MSH2 and BRCA2 in a single kindred","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; McGill University; University of Toronto; Jewish General Hospital; Sunnybrook Health Science Centre; North York General Hospital; McGill University Health Centre","funders":"Myriad Genetics; Cancer Research Society; Memorial Sloan-Kettering Cancer Center","keywords":"Germline mutation; Biology; MSH2; Mutation; Genetics; Exon; BRCA2 Protein; Microsatellite instability; Cancer research; Cancer; Microsatellite; Colorectal cancer; Gene; DNA mismatch repair; Allele","score_opus":0.017340784063021634,"score_gpt":0.295565854118558,"score_spread":0.27822507005553637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091658544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98529154,0.0131206,0.000054423785,0.0008204014,0.00021306044,0.00014333383,0.000006666055,0.0000046651257,0.00034528994],"genre_scores_gemma":[0.9955781,0.00090557855,0.0029563617,0.00030426565,0.00018601207,0.000010218859,0.0000012614609,0.00001701112,0.000041170326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898446,0.000024601288,0.0004552579,0.000119645716,0.0002346087,0.0001814406],"domain_scores_gemma":[0.99953145,0.000040289044,0.00016966445,0.000052455478,0.00011013361,0.00009599927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020757866,0.00007712919,0.00027309993,0.00016212303,0.000023626097,0.000029429368,0.000053238276,0.00006151919,0.0001039101],"category_scores_gemma":[0.00023333497,0.00008951066,0.000044735694,0.00025781998,0.00006453247,0.000091338414,0.000015319183,0.00031998384,5.2229984e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006184372,0.00078941905,0.39693013,0.00023563148,0.00011261335,0.0038170211,0.004063716,0.007861426,0.068242796,0.00002185639,0.00027538204,0.51703155],"study_design_scores_gemma":[0.0063483175,0.00035488332,0.98253185,0.0023068693,0.00004002687,0.003192662,0.00026940668,0.00004274846,0.0034407831,0.00062331924,0.0007288987,0.00012021074],"about_ca_topic_score_codex":0.00153488,"about_ca_topic_score_gemma":0.012767906,"teacher_disagreement_score":0.58560175,"about_ca_system_score_codex":0.00047216314,"about_ca_system_score_gemma":0.00040718916,"threshold_uncertainty_score":0.7124791},"labels":[],"label_agreement":null},{"id":"W2091756209","doi":"10.1038/sj.bjc.6601661","title":"Invasion and MMP expression profile in desmoid tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Vlaamse regering; Kom op tegen Kanker","keywords":"MMP3; TIMP1; MMP1; Matrix metalloproteinase; MMP2; Cancer research; Downregulation and upregulation; Transcription factor; Biology; Metalloproteinase; Gene expression; Pathology; Medicine; Gene; Genetics","score_opus":0.01589524333331587,"score_gpt":0.29519530589321036,"score_spread":0.2793000625598945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091756209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95205176,0.046438027,0.0000135655955,0.0007767564,0.00016249181,0.00012850002,0.000003804001,0.000007971089,0.000417106],"genre_scores_gemma":[0.991932,0.006226537,0.001239644,0.00020164844,0.00025463806,0.000008924248,6.8080277e-7,0.000014455327,0.00012150858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920976,0.000019555053,0.000277069,0.00010038814,0.00024628098,0.00014695415],"domain_scores_gemma":[0.9995604,0.000023098755,0.00013560452,0.000048600297,0.00012747858,0.000104775274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017537313,0.000073382536,0.00027137386,0.00008962805,0.00004354681,0.000017114506,0.00003867936,0.00003562792,0.00009394706],"category_scores_gemma":[0.00018427196,0.000071844974,0.000042329106,0.00011165204,0.000067151865,0.00013083317,0.00002977431,0.0002526126,0.0000021228168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012325319,0.0005055935,0.65236074,0.00047720838,0.0001025559,0.032723047,0.0024876087,0.00012043529,0.09948177,0.00003297893,0.010299252,0.20017625],"study_design_scores_gemma":[0.0060189553,0.00034019872,0.9183791,0.007568261,0.0000631098,0.016289828,0.0005326603,0.0000015061914,0.0480114,0.00036838566,0.002298596,0.0001279959],"about_ca_topic_score_codex":0.00037854843,"about_ca_topic_score_gemma":0.00047736242,"teacher_disagreement_score":0.26601833,"about_ca_system_score_codex":0.00014076185,"about_ca_system_score_gemma":0.00016502899,"threshold_uncertainty_score":0.2929753},"labels":[],"label_agreement":null},{"id":"W2091924611","doi":"10.1038/sj.bjc.6600959","title":"In vivo evolution of tumour cells after the generation of double-strand DNA breaks","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Institut Gustave-Roussy; Centre National de la Recherche Scientifique","keywords":"Programmed cell death; Apoptosis; In vivo; Mitosis; TUNEL assay; Bleomycin; Biology; Cell; DNA damage; In vitro; Mitotic catastrophe; Cell biology; Cancer research; Molecular biology; DNA; Genetics; Chemotherapy","score_opus":0.013536771673313302,"score_gpt":0.28112863663488213,"score_spread":0.26759186496156884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091924611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099773,0.0045711463,0.003841998,0.000051933435,0.00023836215,0.00007243376,0.000019825651,3.0997614e-7,0.00020622961],"genre_scores_gemma":[0.9976883,0.0008048435,0.0010598914,0.000059133374,0.00018825008,0.0000035589578,7.218034e-7,0.0000069097196,0.0001883976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930644,0.00012428491,0.000325172,0.00007026806,0.00009914032,0.00007471567],"domain_scores_gemma":[0.9994093,0.0000068262993,0.00027212573,0.00006463506,0.0002265958,0.00002047995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000417716,0.00004975897,0.000118868775,0.00003256172,0.00001489805,0.0000093746075,0.00007136503,0.000065689674,0.00013042371],"category_scores_gemma":[0.00003133521,0.000046999023,0.00006684533,0.00007581862,0.00004554618,0.000010161934,0.0000076994165,0.00007943618,9.662488e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001737805,0.000031600408,0.00037717825,0.000013224899,0.000018991663,0.0000036285767,0.00002603142,0.00054166385,0.99644166,0.000020620142,0.0015884053,0.0007632059],"study_design_scores_gemma":[0.0008737716,0.0000517055,0.0031129122,0.0000608834,0.00001503555,0.00012841854,0.000024760217,0.0000061078013,0.9865208,0.000036768535,0.009121348,0.00004746397],"about_ca_topic_score_codex":0.00024811501,"about_ca_topic_score_gemma":0.0007451521,"teacher_disagreement_score":0.009920845,"about_ca_system_score_codex":0.000032691692,"about_ca_system_score_gemma":0.0001453775,"threshold_uncertainty_score":0.19165646},"labels":[],"label_agreement":null},{"id":"W2092134714","doi":"10.1038/sj.bjc.6604547","title":"Poorer outcome in stromal HIF-2α- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Stromal cell; Cancer research; DNA methylation; Apoptosis; Adenocarcinoma; Colorectal cancer; Biology; Medicine; Oncology; Pathology; Internal medicine; Cancer; Gene; Genetics; Gene expression","score_opus":0.014332202287242054,"score_gpt":0.24776568666548646,"score_spread":0.2334334843782444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092134714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363565,0.005555735,0.00002602038,0.00016517095,0.00023572454,0.0002051268,0.00010950059,0.0000042043534,0.000062848],"genre_scores_gemma":[0.9957238,0.0025284032,0.00028997147,0.00035663173,0.0005262703,0.000012127825,0.000023007799,0.000034356686,0.00050547195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987364,0.00007655533,0.0003456612,0.0002635355,0.00029798585,0.00027989628],"domain_scores_gemma":[0.9990891,0.000016600952,0.00030244977,0.00008157123,0.00038330187,0.00012693352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015415656,0.00018056647,0.00038776547,0.00007405151,0.000101698926,0.000041357085,0.000102783684,0.00015804946,0.00011246837],"category_scores_gemma":[0.00006553572,0.00015339474,0.00006624418,0.00018076932,0.00015783015,0.00003084641,0.000031188774,0.00025270865,2.935978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009116568,0.00036216408,0.6320433,0.00004767998,0.0010606139,0.0007395465,0.0010914679,0.00013410475,0.32911217,0.0000027309502,0.001930071,0.024359582],"study_design_scores_gemma":[0.0038917547,0.0013916126,0.8962306,0.00019030705,0.00016167334,0.0029264828,0.00009243169,0.000009100577,0.09330688,0.0000025380077,0.0015119045,0.00028474405],"about_ca_topic_score_codex":0.00089780556,"about_ca_topic_score_gemma":0.002291421,"teacher_disagreement_score":0.26418728,"about_ca_system_score_codex":0.000080262136,"about_ca_system_score_gemma":0.00039385335,"threshold_uncertainty_score":0.6255256},"labels":[],"label_agreement":null},{"id":"W2092202241","doi":"10.1038/bjc.2014.357","title":"Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Research Council of Thailand; CHILDREN with CANCER UK; Scottish Government; Children's Cancer Research Fund; Newcastle University; National Institute for Health and Care Research","keywords":"Demography; Incidence (geometry); Medicine; Cancer incidence; Population; Cancer; Cohort; Cohort study; Environmental health; Pathology","score_opus":0.025357601663741867,"score_gpt":0.3417014061684248,"score_spread":0.31634380450468297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092202241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204683,0.0048358054,0.00002398143,0.002432077,0.00007106692,0.00019191547,0.000030432455,0.0000018385557,0.0003660482],"genre_scores_gemma":[0.9922898,0.006574793,0.00021537075,0.00065561855,0.00012883417,0.000013808604,0.0000023541738,0.000010098667,0.00010933058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998334,0.00019537183,0.00064062007,0.00010268949,0.0005533648,0.00017398878],"domain_scores_gemma":[0.9986472,0.00045544739,0.00034614798,0.0001135503,0.00034490463,0.00009273395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010719144,0.00007882437,0.00039596207,0.00019786507,0.00002635149,0.000022651142,0.00018197557,0.000081814964,0.00026536064],"category_scores_gemma":[0.0008729281,0.00005798866,0.000036212376,0.0004748778,0.00021783174,0.00011598799,0.000037430702,0.00036813575,2.4716908e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047359773,0.00018650398,0.9451188,0.00047508525,0.00018434758,0.0002764149,0.002889272,0.00029533758,0.0023507816,0.0000792908,0.020380085,0.027290508],"study_design_scores_gemma":[0.0047819256,0.0002788635,0.98027366,0.002893698,0.0001114166,0.0005461806,0.0006914665,0.00011145068,0.005387054,0.00045921956,0.0043843105,0.00008076101],"about_ca_topic_score_codex":0.020196829,"about_ca_topic_score_gemma":0.035709623,"teacher_disagreement_score":0.03515488,"about_ca_system_score_codex":0.00016827908,"about_ca_system_score_gemma":0.0013772402,"threshold_uncertainty_score":0.98632777},"labels":[],"label_agreement":null},{"id":"W2092228974","doi":"10.1038/bjc.2014.244","title":"Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"Genentech; Eisai; GlaxoSmithKline; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Axitinib; Sorafenib; Medicine; Sunitinib; Internal medicine; Oncology; Renal cell carcinoma; Urology; Hepatocellular carcinoma","score_opus":0.025548564476173617,"score_gpt":0.3147698027311995,"score_spread":0.2892212382550259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092228974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651513,0.04080908,0.0000942812,0.00021913314,0.0006595432,0.0008512248,0.00006377554,0.000012274905,0.00077554025],"genre_scores_gemma":[0.99454886,0.0033012882,0.00041688094,0.00018327318,0.0010614793,0.000078058096,0.000047284528,0.000047310245,0.0003155404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99731296,0.00025449807,0.0010613675,0.000326187,0.00066361745,0.00038135692],"domain_scores_gemma":[0.9981148,0.0003666053,0.00071027345,0.00022013279,0.0002644842,0.0003237047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000493714,0.00026616672,0.0011329302,0.00016096853,0.000070841816,0.000066194436,0.00018897817,0.00012402657,0.00066669035],"category_scores_gemma":[0.00015695863,0.00024853006,0.00048558018,0.00020849374,0.00007934106,0.00017723913,0.00001770816,0.0004607609,0.0000040630516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75942105,0.0011979146,0.0006453716,0.000018646595,0.00030033162,0.0012229953,0.00018413823,0.000037841008,0.043483607,5.4429677e-7,0.0027120274,0.19077553],"study_design_scores_gemma":[0.9012315,0.0039916383,0.0035698584,0.00027604194,0.0004757605,0.00013770242,0.00008460139,0.00005829041,0.08098451,0.000020392723,0.00893435,0.0002353434],"about_ca_topic_score_codex":0.0022264468,"about_ca_topic_score_gemma":0.0005957941,"teacher_disagreement_score":0.19054018,"about_ca_system_score_codex":0.00037009394,"about_ca_system_score_gemma":0.00045191302,"threshold_uncertainty_score":0.9999967},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2093012990","doi":"10.1038/sj.bjc.6603025","title":"The place of VEGF inhibition in the current management of renal cell carcinoma","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Autocrine signalling; Renal cell carcinoma; Vascular endothelial growth factor; Angiogenesis; Kidney cancer; Medicine; Cancer research; Carcinoma; Vascular endothelial growth factor A; Kidney; Oncology; VEGF receptors; Internal medicine; Pathology; Receptor","score_opus":0.033300005009721634,"score_gpt":0.32474219692272216,"score_spread":0.2914421919130005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093012990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010221248,0.9863745,0.000006461727,0.000057490357,0.00028438953,0.00083683623,0.000054523593,0.0000015715178,0.0021629632],"genre_scores_gemma":[0.023056066,0.97620964,0.000044638942,0.000010300649,0.00032033198,0.00006184163,0.00002144644,0.000030040283,0.0002457157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969232,0.00028748173,0.0014919263,0.00017295114,0.0008859115,0.00023853836],"domain_scores_gemma":[0.99759144,0.00014952266,0.0016931786,0.00026728204,0.00023726335,0.000061293766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008077665,0.00024646125,0.0012418489,0.0001585754,0.000048203972,0.000028533263,0.00023258489,0.00008865499,0.000022700826],"category_scores_gemma":[0.00001058608,0.00015115384,0.0007160619,0.000338639,0.000118084216,0.000046269608,0.000049305265,0.0007161462,0.000001413474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007825916,0.0002670788,0.0000663216,0.01554802,0.00015801826,0.0017282735,0.00003919319,0.000014623989,0.0000020692269,0.000012989062,0.0051165964,0.9769686],"study_design_scores_gemma":[0.0018737031,0.00038428075,0.0060866307,0.078486994,0.0030231737,0.0025852874,0.00006555562,0.000001212824,0.0001152713,0.00003160318,0.9071928,0.00015347004],"about_ca_topic_score_codex":0.00029332223,"about_ca_topic_score_gemma":0.0002151754,"teacher_disagreement_score":0.9768151,"about_ca_system_score_codex":0.00048622242,"about_ca_system_score_gemma":0.0004954991,"threshold_uncertainty_score":0.6163875},"labels":[],"label_agreement":null},{"id":"W2093082116","doi":"10.1038/sj.bjc.6600799","title":"Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Embarrassment; Health professionals; Health care; Perspective (graphical); Medicine; Reproductive health; Affect (linguistics); Quarter (Canadian coin); Gynecology; Family medicine; Nursing; Psychology; Social psychology; Population","score_opus":0.037093437747435024,"score_gpt":0.37851081253503394,"score_spread":0.3414173747875989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093082116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8912661,0.10434467,0.000013878827,0.0037431763,0.00012949966,0.00016442331,0.00007677148,0.0000056729286,0.00025582546],"genre_scores_gemma":[0.9850016,0.012901358,0.00024105723,0.0006916641,0.00024684833,0.000030723884,0.0000043079654,0.000021323476,0.00086108845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987444,0.00015198726,0.0004057021,0.00011394253,0.00038927284,0.00019468674],"domain_scores_gemma":[0.99860203,0.000046448982,0.0003877195,0.00014431689,0.00062090583,0.00019859859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045007616,0.00009785168,0.00046078567,0.000061642284,0.00007814601,0.000023193134,0.00008940289,0.00007953467,0.0003265551],"category_scores_gemma":[0.000035429734,0.00008872164,0.000029653373,0.0001648761,0.00010910132,0.00013033241,0.000017587594,0.00033642288,2.4856442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007041797,0.0001146088,0.70504266,0.0007753812,0.00044985884,0.000067787565,0.0066453125,0.000008473085,0.00021903297,0.00015054303,0.0029780485,0.2828441],"study_design_scores_gemma":[0.003204215,0.0006914938,0.90264237,0.005637119,0.00017621479,0.00049806153,0.0062869326,0.0000010974828,0.0011299518,0.0002444301,0.07929305,0.000195078],"about_ca_topic_score_codex":0.009355249,"about_ca_topic_score_gemma":0.0151001215,"teacher_disagreement_score":0.28264904,"about_ca_system_score_codex":0.00017076396,"about_ca_system_score_gemma":0.00066608377,"threshold_uncertainty_score":0.99724156},"labels":[],"label_agreement":null},{"id":"W2093178920","doi":"10.1038/sj.bjc.6600236","title":"Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo; McGill University","keywords":"Proteolysis; Myogenesis; Myocyte; Biology; Proteasome; Protein degradation; Ubiquitin; Biochemistry; Cell biology; Molecular biology; Enzyme","score_opus":0.017664290354230235,"score_gpt":0.24258552086069088,"score_spread":0.22492123050646065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093178920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997761,0.0012522589,0.000526899,0.000059697915,0.000047199523,0.00028130694,0.000033381606,0.0000017563322,0.0000365123],"genre_scores_gemma":[0.99746984,0.00005289631,0.002253577,0.000093708695,0.00004504912,0.000049342176,0.000004311782,0.000012605812,0.000018666296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990322,0.0000735346,0.0004332398,0.00014470858,0.00015900136,0.0001573439],"domain_scores_gemma":[0.9993329,0.0000030144336,0.00031389127,0.00013000864,0.00013614936,0.00008400528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019890393,0.000092902184,0.00021733792,0.000042307114,0.000051010225,0.000008876485,0.00023430197,0.000097179436,0.000009036352],"category_scores_gemma":[0.000040071045,0.00008518755,0.000054049367,0.0000856611,0.000034084347,0.00001164676,0.000046493602,0.00013571364,2.0458593e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000661419,0.000058489793,0.000006498917,0.00004799508,0.00003368518,0.0000018110546,0.0004649795,0.0004808818,0.9709778,0.0000122633155,0.000036765763,0.027812699],"study_design_scores_gemma":[0.0005611545,0.00008340541,0.0007524683,0.00019227366,0.0000098982455,0.000010620558,0.00024365268,0.00070089154,0.9971541,0.000035382796,0.00015013042,0.000105984764],"about_ca_topic_score_codex":0.00023947899,"about_ca_topic_score_gemma":0.00029498298,"teacher_disagreement_score":0.027706712,"about_ca_system_score_codex":0.000024427089,"about_ca_system_score_gemma":0.00016404325,"threshold_uncertainty_score":0.34738475},"labels":[],"label_agreement":null},{"id":"W2093182480","doi":"10.1038/bjc.2013.741","title":"Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; McGill University; Sunnybrook Health Science Centre; McGill University Health Centre; Université de Montréal; University of Toronto; Cancer Care Ontario; Women's College Hospital","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Colorectal cancer; Medicine; Incidence (geometry); Ovarian cancer; Cancer; Germline mutation; Breast cancer; Internal medicine; Oncology; Population; Gynecology; Mutation; Genetics; Biology; Gene","score_opus":0.008825550818224165,"score_gpt":0.2792668362178696,"score_spread":0.2704412853996454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093182480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834831,0.015325128,0.000038764876,0.00014057977,0.00046858215,0.00027767496,0.00021353518,0.0000019438085,0.000050723203],"genre_scores_gemma":[0.99661726,0.0025639434,0.00036457143,0.0000725734,0.00022195857,0.000065437875,0.000010000935,0.000016897602,0.000067345856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987122,0.0000929131,0.0005628354,0.00023609585,0.00024380609,0.00015214212],"domain_scores_gemma":[0.99888355,0.000034418485,0.00042214623,0.00010508944,0.00047940036,0.00007542175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582812,0.00010529208,0.00023807088,0.00006790076,0.000038747385,0.00004872144,0.00016839335,0.00009580813,0.0000921522],"category_scores_gemma":[0.00024569794,0.00012142517,0.000057308658,0.00014802374,0.00009548057,0.000030523322,0.000056129233,0.0001527259,5.208134e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001641798,0.0002833165,0.26846114,0.000041518215,0.00080104027,0.0001935633,0.0062370757,0.0043298164,0.36058462,0.0000015616607,0.006496523,0.350928],"study_design_scores_gemma":[0.007093202,0.00057176367,0.9178581,0.00038417973,0.00009475533,0.00016141181,0.0026832342,0.00015490064,0.069752045,0.00015308346,0.00084814936,0.0002451764],"about_ca_topic_score_codex":0.020669723,"about_ca_topic_score_gemma":0.053123735,"teacher_disagreement_score":0.64939696,"about_ca_system_score_codex":0.00013944112,"about_ca_system_score_gemma":0.0005042098,"threshold_uncertainty_score":0.9858517},"labels":[],"label_agreement":null},{"id":"W2093307943","doi":"10.1038/bjc.2014.264","title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"Medical Research Council; University of Dundee","keywords":"Medicine; Aspirin; Breast cancer; Internal medicine; Population; Cancer; Hazard ratio; Cancer registry; Gynecology; Cohort study; Surgery; Cohort; Oncology; Confidence interval","score_opus":0.009338513048600455,"score_gpt":0.27015924961911647,"score_spread":0.260820736570516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093307943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643993,0.0023372453,0.000010812886,0.0003496516,0.00044856276,0.00035858096,0.000040142007,0.0000045664924,0.000010497222],"genre_scores_gemma":[0.998237,0.00070933445,0.000017215634,0.000298944,0.00061018264,0.00008748117,0.0000011912249,0.000017993632,0.000020613705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987796,0.0001643704,0.00037293148,0.00010593268,0.00044020536,0.00013696558],"domain_scores_gemma":[0.9989484,0.00021471134,0.00027387906,0.00011342385,0.0003283966,0.00012118739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007288378,0.00009503796,0.000388133,0.000057153607,0.00005252362,0.000039082253,0.00006138492,0.00004278,0.00019152154],"category_scores_gemma":[0.00013703635,0.00007264638,0.00008908083,0.000094739946,0.000054167627,0.00011275631,0.00001387497,0.00019406232,3.9632044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004041232,0.00011418394,0.9673481,0.000073740324,0.00013902676,0.00010447979,0.00006141268,0.000055920234,0.000020139978,0.0000011220801,0.00024625563,0.031431507],"study_design_scores_gemma":[0.0020318835,0.00020601439,0.99529076,0.0008518941,0.00035452447,0.00019724612,0.000025000365,0.00007320436,0.000085881,0.000003813423,0.0008033859,0.00007639517],"about_ca_topic_score_codex":0.008548069,"about_ca_topic_score_gemma":0.007423529,"teacher_disagreement_score":0.031355113,"about_ca_system_score_codex":0.00006811928,"about_ca_system_score_gemma":0.0001298986,"threshold_uncertainty_score":0.9980541},"labels":[],"label_agreement":null},{"id":"W2093759824","doi":"10.1038/sj.bjc.6602393","title":"Comparison of 1- and 2-year screening intervals for women undergoing screening mammography","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mammography; Medicine; Mammography screening; Breast cancer; Cancer; Confidence interval; Gynecology; Breast cancer screening; Attendance; Demography; Oncology; Internal medicine; Obstetrics","score_opus":0.0764999125268508,"score_gpt":0.39516683079922793,"score_spread":0.31866691827237714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093759824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569358,0.024587499,0.017003056,0.00056260574,0.00009333335,0.00018346093,0.000023066397,0.000011599683,0.00059957703],"genre_scores_gemma":[0.9618942,0.0014407426,0.035629984,0.00037313678,0.00052255986,0.000009730236,0.0000014643937,0.000020393354,0.000107756474],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99844027,0.0000290416,0.000682716,0.00014342286,0.0004039025,0.00030063026],"domain_scores_gemma":[0.9986738,0.000115076116,0.00051626103,0.00007572101,0.0004098096,0.00020935632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006208686,0.000113351765,0.000582021,0.00015800151,0.00008597045,0.000054282278,0.000114150505,0.00006936463,0.000114697585],"category_scores_gemma":[0.00016528992,0.00012459014,0.00019291353,0.0001753015,0.00008818678,0.00030820764,0.000035782585,0.00025680504,2.277361e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008941748,0.000049846338,0.3291013,0.00024268351,0.0003199429,0.00003702107,0.0005877608,0.000656008,0.0009784376,0.000037122678,0.0022709158,0.6648248],"study_design_scores_gemma":[0.02664578,0.0059818644,0.74889773,0.03410997,0.0011797409,0.0058677974,0.018230695,0.0054489244,0.020165686,0.0009396218,0.13141508,0.001117137],"about_ca_topic_score_codex":0.00012198839,"about_ca_topic_score_gemma":0.00041797044,"teacher_disagreement_score":0.6637077,"about_ca_system_score_codex":0.000084098785,"about_ca_system_score_gemma":0.00011547866,"threshold_uncertainty_score":0.50806385},"labels":[],"label_agreement":null},{"id":"W2094188569","doi":"10.1038/bjc.2011.182","title":"Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Cetuximab; Pharmacodynamics; Pharmacokinetics; Internal medicine; Nausea; Response Evaluation Criteria in Solid Tumors; Adverse effect; Oncology; Gastroenterology; Cancer; Pharmacology; Colorectal cancer; Chemotherapy; Phases of clinical research","score_opus":0.015736151302106108,"score_gpt":0.2929622665639344,"score_spread":0.27722611526182833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094188569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974793,0.001027362,0.00006895479,0.0001057527,0.000035854537,0.0011965011,0.000028691366,0.0000039075844,0.000053673437],"genre_scores_gemma":[0.9982665,0.0010665277,0.00049979176,0.000067722816,0.000020813344,0.000035952682,0.0000034529808,0.000019489366,0.000019718886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881303,0.000059332106,0.00044870746,0.00015716755,0.000343522,0.00017820942],"domain_scores_gemma":[0.99900174,0.000036100602,0.00034155228,0.00006583237,0.00048487462,0.00006990553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017087294,0.00015563537,0.00041528686,0.000120687044,0.00005095666,0.000017045937,0.00007338519,0.000012656471,0.000022591865],"category_scores_gemma":[0.000022721466,0.00010736755,0.000028345585,0.00021176941,0.00007688422,0.00015140665,0.000026150934,0.00017402809,5.5082754e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029253293,0.003780385,0.695918,0.000026407399,0.00011926537,0.00024565723,0.0026405752,0.00009295354,0.00054628187,4.7574395e-7,0.000007006185,0.2673697],"study_design_scores_gemma":[0.064824626,0.018392332,0.91386324,0.0010578482,0.00012477217,0.00016482176,0.0006840035,0.00034787826,0.00041251918,0.000004123988,0.00002082912,0.00010297991],"about_ca_topic_score_codex":0.00038099266,"about_ca_topic_score_gemma":0.0041210717,"teacher_disagreement_score":0.26726672,"about_ca_system_score_codex":0.00016064636,"about_ca_system_score_gemma":0.000083662846,"threshold_uncertainty_score":0.43783218},"labels":[],"label_agreement":null},{"id":"W2094772566","doi":"10.1038/sj.bjc.6600951","title":"Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Lotta al Neuroblastoma","keywords":"CD40; CD80; CD86; Flow cytometry; Neuroblastoma; Biology; Molecular biology; Cell culture; Apoptosis; Transfection; Cancer research; Cell biology; T cell; In vitro; Immune system; Immunology; Cytotoxic T cell","score_opus":0.02973724825859501,"score_gpt":0.3260230338346965,"score_spread":0.29628578557610147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094772566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706024,0.0018133874,0.00022029736,0.00007411359,0.000252159,0.0002946958,0.000004760787,0.000012734446,0.00026763396],"genre_scores_gemma":[0.99816906,0.0010308522,0.0004408141,0.00013053865,0.0000465135,0.000014587859,8.306411e-7,0.000048366437,0.00011843937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977389,0.00025953876,0.00053241896,0.00027771498,0.00084056664,0.0003508556],"domain_scores_gemma":[0.9985983,0.00019742495,0.0005376659,0.00018247357,0.00022120464,0.00026293698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022828171,0.00020216359,0.0005007269,0.0003329284,0.000088242676,0.00005773387,0.00014323581,0.00006681119,0.00013867966],"category_scores_gemma":[0.00019555644,0.00018994506,0.00021307029,0.00031720518,0.00008353335,0.0005566249,0.00003449049,0.00056174677,0.000002236095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016423936,0.00068634487,0.025325365,0.00021882576,0.00017294902,0.0043179146,0.00010266937,0.0024381073,0.9572823,0.0000047410044,0.0005997441,0.007208633],"study_design_scores_gemma":[0.0046050227,0.0019766341,0.04788118,0.008433755,0.00014447446,0.001489084,0.00012504708,0.000033939436,0.93478155,0.000021943659,0.00034286038,0.00016453865],"about_ca_topic_score_codex":0.00019489473,"about_ca_topic_score_gemma":0.00033462403,"teacher_disagreement_score":0.022555815,"about_ca_system_score_codex":0.00021352824,"about_ca_system_score_gemma":0.00029041685,"threshold_uncertainty_score":0.77457345},"labels":[],"label_agreement":null},{"id":"W2095293611","doi":"10.1038/sj.bjc.6605972","title":"Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":85,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; Pfizer","keywords":"Medicine; Internal medicine; Biomarker; Oncology; Lung cancer; Proportional hazards model; Carboplatin; Progression-free survival; Clinical trial; non-small cell lung cancer (NSCLC); Chemotherapy; Biology; Cisplatin","score_opus":0.028793649387729322,"score_gpt":0.33747207351955105,"score_spread":0.3086784241318217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095293611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413586,0.0030888945,0.00005019032,0.00012459767,0.001413172,0.00025643516,0.0004831212,0.000011800557,0.00043593545],"genre_scores_gemma":[0.99667835,0.0011191838,0.0007799855,0.00020047274,0.0010401381,0.0000069657117,0.000019082116,0.000038350005,0.00011747568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973027,0.000046817157,0.001439488,0.00025874758,0.0006604911,0.00029176366],"domain_scores_gemma":[0.9973178,0.00017127176,0.0009970701,0.0003041734,0.0008770039,0.00033269188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023855268,0.00020113523,0.00083616056,0.000100311496,0.00008308362,0.000058103313,0.0002591117,0.00023389555,0.0006068092],"category_scores_gemma":[0.0006157637,0.00019442385,0.00047232746,0.00013446329,0.00012513371,0.0003279535,0.00006927024,0.00064812944,0.0000049306864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002491619,0.0004622477,0.7026397,0.000028359304,0.00051027077,0.00018836978,0.00027544174,0.00000453036,0.0034282217,0.0000056519875,0.001194002,0.29101405],"study_design_scores_gemma":[0.007230614,0.00075190974,0.9829767,0.0010181426,0.00040301203,0.0001508588,0.0000469253,0.00002097959,0.005433979,0.00042416624,0.0013738977,0.00016883721],"about_ca_topic_score_codex":0.002448364,"about_ca_topic_score_gemma":0.0013784801,"teacher_disagreement_score":0.29084522,"about_ca_system_score_codex":0.00014144665,"about_ca_system_score_gemma":0.0004432551,"threshold_uncertainty_score":0.79283744},"labels":[],"label_agreement":null},{"id":"W2097211264","doi":"10.1038/sj.bjc.6602956","title":"Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Immunohistochemistry; Biology; Cancer; Lung cancer; Pathology; Mammary gland; Medicine; Internal medicine","score_opus":0.008560901377213518,"score_gpt":0.26521641961723064,"score_spread":0.25665551824001714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097211264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97721684,0.02134334,0.0000048254824,0.00071734417,0.000099557,0.000119635864,0.00021908969,0.000008241796,0.0002711472],"genre_scores_gemma":[0.99694437,0.0014797018,0.000057464375,0.00022093231,0.0003344649,0.000005448962,0.000016059415,0.000027984208,0.0009135876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859875,0.000048444384,0.00048683467,0.00015934539,0.00043986022,0.00026673466],"domain_scores_gemma":[0.99889696,0.000038990107,0.00047884972,0.00005608006,0.00040375144,0.00012535093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014145087,0.00014025274,0.0004689228,0.00011926151,0.00007016168,0.000035919235,0.000053977106,0.000086809465,0.00039138334],"category_scores_gemma":[0.000010970316,0.00013000565,0.000080271035,0.0001891338,0.0001165587,0.0002077599,0.000016380533,0.00022280669,1.6999171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005363301,0.0003029259,0.94950867,0.000058365265,0.000136446,0.00053528015,0.00040290479,0.00005661905,0.034098312,0.000032828117,0.005705428,0.0086259],"study_design_scores_gemma":[0.0043363054,0.00017849999,0.97544456,0.004870738,0.0001361054,0.00041876364,0.00005745092,0.000011543511,0.014019119,0.00014530131,0.0002373284,0.00014430648],"about_ca_topic_score_codex":0.015650917,"about_ca_topic_score_gemma":0.0054856646,"teacher_disagreement_score":0.025935877,"about_ca_system_score_codex":0.00018853579,"about_ca_system_score_gemma":0.00020745612,"threshold_uncertainty_score":0.990904},"labels":[],"label_agreement":null},{"id":"W2097983921","doi":"10.1038/sj.bjc.6600215","title":"The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Vascular endothelial growth factor; Pathology; Biology; Angiogenesis; Immunostaining; Vascular endothelial growth factor A; Hypoxia (environmental); Hypoxia-inducible factors; Growth factor; Cancer research; Medicine; Immunohistochemistry; Chemistry; Gene; VEGF receptors; Receptor","score_opus":0.012731529573630006,"score_gpt":0.23742184501673014,"score_spread":0.22469031544310014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097983921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75326127,0.24462357,0.000006395852,0.0005580993,0.0013302742,0.00009835161,0.000040341096,0.0000024644842,0.00007924182],"genre_scores_gemma":[0.75526446,0.24049634,0.000021018046,0.00027854744,0.002824722,0.000020718848,0.0000028788484,0.000025019632,0.0010662867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872965,0.000085571664,0.0003914275,0.00024157693,0.00023121898,0.00032055972],"domain_scores_gemma":[0.99922764,0.000019949324,0.00025774704,0.0001485217,0.00022422416,0.00012189473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016703615,0.00015712128,0.0002920116,0.000052853415,0.00016116328,0.0001186894,0.00021842799,0.00015452359,0.00012789798],"category_scores_gemma":[0.00007566944,0.00014298841,0.000112642105,0.000119692246,0.00013861204,0.000016372396,0.00006625088,0.0002341878,7.6459935e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005385055,0.00017928504,0.018107232,0.000061048784,0.0005571268,0.0001236643,0.00039412276,0.0003225367,0.45737574,0.00001954479,0.04895445,0.47336674],"study_design_scores_gemma":[0.004900202,0.00027644867,0.30967894,0.0006307957,0.00024095378,0.0010361688,0.00039182705,0.00005617104,0.13851109,0.00015601538,0.5434743,0.00064704893],"about_ca_topic_score_codex":0.0009670641,"about_ca_topic_score_gemma":0.03070257,"teacher_disagreement_score":0.49451986,"about_ca_system_score_codex":0.000040052317,"about_ca_system_score_gemma":0.00019986277,"threshold_uncertainty_score":0.9869846},"labels":[],"label_agreement":null},{"id":"W2099091477","doi":"10.1038/bjc.2014.552","title":"Increased stomach cancer risk following radiotherapy for testicular cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; National Institute of Environmental Health Sciences; KWF Kankerbestrijding; National Institute of Allergy and Infectious Diseases; Lance Armstrong Foundation; Karolinska Institutet; Cancer Care Ontario; Armstrong Foundation; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Stomach; Radiation therapy; Stomach cancer; Cancer; Odds ratio; Internal medicine; Gastroenterology; Confidence interval","score_opus":0.008635559453689082,"score_gpt":0.3117807845559687,"score_spread":0.3031452251022796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099091477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81770337,0.17830226,0.0022795983,0.0003812887,0.0006551722,0.00039723094,0.00021773142,0.000024066401,0.00003928043],"genre_scores_gemma":[0.97915095,0.0148594575,0.0031956513,0.0009017125,0.0014552835,0.00017985403,0.000009129576,0.00006650789,0.0001814655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99858373,0.000068713874,0.00040127413,0.00020997172,0.00041848497,0.00031782093],"domain_scores_gemma":[0.9985702,0.00013729712,0.00042841208,0.00013901424,0.0003581146,0.0003669866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025201135,0.00017939883,0.0005469494,0.0000767175,0.00014836466,0.00006296513,0.000110126995,0.00007615398,0.0003291268],"category_scores_gemma":[0.00035392502,0.00016796934,0.0005168271,0.00013884484,0.000041660554,0.00011997687,0.000009839734,0.00019748474,9.381422e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043484633,0.00028112432,0.48407987,0.00010144536,0.0019884205,0.00042651952,0.000037274913,0.00049665617,0.0012360502,0.0000060072675,0.003290317,0.50762147],"study_design_scores_gemma":[0.018946376,0.00069487456,0.9019125,0.002929236,0.0047485083,0.00068527646,0.000023477874,0.0024740123,0.00093089935,0.00019249582,0.06611235,0.00035000878],"about_ca_topic_score_codex":0.008877909,"about_ca_topic_score_gemma":0.0009784192,"teacher_disagreement_score":0.50727147,"about_ca_system_score_codex":0.00036531052,"about_ca_system_score_gemma":0.00053826085,"threshold_uncertainty_score":0.997722},"labels":[],"label_agreement":null},{"id":"W2099552271","doi":"10.1038/sj.bjc.6600439","title":"Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Biology; Cancer; Cancer research; Breast cancer; Heat shock protein; Antigen; Immunology; Gene; Genetics","score_opus":0.01719396713597242,"score_gpt":0.2769171152518821,"score_spread":0.2597231481159097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099552271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891363,0.009189585,0.0008408571,0.00019412377,0.000016305168,0.0004103037,0.00008539995,0.000003617593,0.00012353042],"genre_scores_gemma":[0.9972456,0.00060841633,0.0015422533,0.00005625685,0.00016563226,0.000027568805,0.0000070516626,0.000026127786,0.00032108926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985611,0.00020834991,0.0004920055,0.00021252932,0.00032974835,0.00019627817],"domain_scores_gemma":[0.999306,0.0000057594443,0.00022290598,0.0001552254,0.0001633961,0.00014668713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029505324,0.00009950255,0.0002279684,0.00005936043,0.00006499119,0.000047214195,0.00022833058,0.00015805657,0.0002702465],"category_scores_gemma":[0.000085862426,0.00010279259,0.00006943318,0.00009135771,0.000117036936,0.00004232967,0.000087158456,0.00019439762,4.6334569e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020684364,0.00014723261,0.0065242443,0.00006431853,0.00003051117,0.000024923034,0.00003558148,0.000022080612,0.97991604,0.0000027372919,0.00036860685,0.012656867],"study_design_scores_gemma":[0.00071284326,0.00067382696,0.014965596,0.00029448458,0.000010122203,0.00021763006,0.000037027316,0.00015828342,0.9808527,0.000029753082,0.0019452784,0.0001024038],"about_ca_topic_score_codex":0.0002966938,"about_ca_topic_score_gemma":0.000031023643,"teacher_disagreement_score":0.012554463,"about_ca_system_score_codex":0.000008890345,"about_ca_system_score_gemma":0.00007451103,"threshold_uncertainty_score":0.419176},"labels":[],"label_agreement":null},{"id":"W2099836603","doi":"10.1038/bjc.2014.311","title":"Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Lymph node; Dissection (medical); Prostate cancer; Lymph; Radiology; Pathological staging; Lymphadenectomy; Cohort; Urology; Cancer; Surgery; Internal medicine; Pathology","score_opus":0.021615992552288934,"score_gpt":0.3907936973937461,"score_spread":0.3691777048414572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099836603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954881,0.020524096,0.01022412,0.006970967,0.0018817366,0.0039279526,0.0014074916,0.000028173597,0.00015443943],"genre_scores_gemma":[0.9317377,0.03527526,0.027412431,0.00090298685,0.0024300483,0.0017309928,0.000025874086,0.00006571398,0.00041898462],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980943,0.00010473433,0.0008204404,0.00029446796,0.00032807974,0.0003579809],"domain_scores_gemma":[0.9974816,0.00028290722,0.00070509233,0.000114544506,0.0011582905,0.00025757335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010293894,0.0001760253,0.0006836316,0.000057238467,0.0001858317,0.0001221021,0.00010079986,0.00006906297,0.00006078304],"category_scores_gemma":[0.0002682124,0.00015116637,0.0003663732,0.00007307722,0.00010600465,0.00020773005,0.000023649198,0.00032047863,4.334002e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009811827,0.0003344021,0.4561668,0.00021810789,0.0005836075,0.00003238473,0.00012870754,0.00012215915,0.00004192143,0.00009131076,0.008366742,0.53293264],"study_design_scores_gemma":[0.031456973,0.009921629,0.80475,0.006102317,0.0022615674,0.00025156114,0.0002010078,0.0028722384,0.003097619,0.002222813,0.13639267,0.00046956012],"about_ca_topic_score_codex":0.0005871786,"about_ca_topic_score_gemma":0.0012436636,"teacher_disagreement_score":0.53246313,"about_ca_system_score_codex":0.0004113846,"about_ca_system_score_gemma":0.0019358795,"threshold_uncertainty_score":0.61643857},"labels":[],"label_agreement":null},{"id":"W2100532998","doi":"10.1038/bjc.2015.268","title":"Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Lymphovascular invasion; Cohort; Endometrial cancer; Oncology; Internal medicine; Medicine; Concordance; Cancer; Adjuvant therapy; Stage (stratigraphy); Prognostic variable; Proportional hazards model; Biology; Metastasis","score_opus":0.15084996540408976,"score_gpt":0.3570143717754342,"score_spread":0.20616440637134445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100532998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421134,0.016489986,0.0036962237,0.0033267618,0.0010570892,0.0007505634,0.00034963264,0.000020071857,0.0000983616],"genre_scores_gemma":[0.98941547,0.0062622023,0.0027863537,0.0007833103,0.00044753044,0.00017974217,0.000012230518,0.000014075162,0.00009909054],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983457,0.000091214955,0.0005328894,0.0002552995,0.0005162563,0.00025864664],"domain_scores_gemma":[0.9987727,0.00038687608,0.00021984476,0.0000742861,0.00025972063,0.00028656475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004937513,0.0001435983,0.00054109626,0.00017896981,0.00004249795,0.000036231817,0.00008683965,0.00015511364,0.000052848995],"category_scores_gemma":[0.0013144236,0.00010160224,0.00015314417,0.00034079654,0.00014965507,0.000099742836,0.00001812905,0.0003976256,3.2422838e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12166389,0.0020267724,0.043013196,0.00012313452,0.00022910196,0.0015367015,0.0001386838,0.0070361947,0.0003037404,0.00009732375,0.003937676,0.8198936],"study_design_scores_gemma":[0.28663257,0.047134463,0.38300017,0.009775086,0.0016293458,0.004116429,0.00042976218,0.22391272,0.0010532234,0.008090622,0.032855533,0.0013700745],"about_ca_topic_score_codex":0.000127401,"about_ca_topic_score_gemma":0.0001845343,"teacher_disagreement_score":0.8185235,"about_ca_system_score_codex":0.00051855453,"about_ca_system_score_gemma":0.00055700255,"threshold_uncertainty_score":0.41432193},"labels":[],"label_agreement":null},{"id":"W2102509283","doi":"10.1038/sj.bjc.6601880","title":"Somatic mutations of KIT in familial testicular germ cell tumours","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Hungarian Scientific Research Fund; Cancer Research UK","keywords":"Somatic cell; Missense mutation; Germline mutation; Biology; Germline; Exon; Genetics; Germline mosaicism; Mutation; Cancer research; Germ cell; Proto-Oncogene Proteins c-kit; Gene","score_opus":0.005753231176069389,"score_gpt":0.22487229197666533,"score_spread":0.21911906080059596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102509283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722822,0.0263096,0.00011394293,0.00010020536,0.00040141985,0.00006133041,0.00003282555,0.000003171041,0.0006953385],"genre_scores_gemma":[0.9983274,0.00091407244,0.00024349197,0.00004181934,0.000041968113,0.000002865221,0.0000052272358,0.00000791572,0.0004152358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999277,0.00003995492,0.00042430556,0.0000677562,0.000045331646,0.0001456363],"domain_scores_gemma":[0.9994923,0.000036935657,0.00029106703,0.00005051685,0.00010966285,0.000019539997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013074931,0.00006357039,0.00024079368,0.00008764291,0.0000387258,0.000008348225,0.000108378495,0.00006911642,0.0005869295],"category_scores_gemma":[0.000045848818,0.00006939759,0.00008137808,0.000084729225,0.000110591056,0.0000616449,0.000012187387,0.00021694295,0.000013289609],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021378718,0.001492749,0.03934328,0.0003686701,0.00017165847,0.0015544523,0.0020001254,0.01050803,0.88692343,0.00029227577,0.0013855736,0.055745974],"study_design_scores_gemma":[0.01791339,0.0007950638,0.72613555,0.0023450588,0.00032788375,0.004880937,0.0010415716,0.000009930832,0.22480457,0.00283204,0.018413562,0.0005004414],"about_ca_topic_score_codex":0.00160012,"about_ca_topic_score_gemma":0.0014443295,"teacher_disagreement_score":0.68679225,"about_ca_system_score_codex":0.000062245264,"about_ca_system_score_gemma":0.00021995159,"threshold_uncertainty_score":0.6426466},"labels":[],"label_agreement":null},{"id":"W2104203198","doi":"10.1054/bjoc.2000.1376","title":"A pooled analysis of magnetic fields and childhood leukaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":735,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council","keywords":"Relative risk; Confounding; Childhood leukaemia; Medicine; Demography; Estimation; Risk factor; Environmental health; Pediatrics; Confidence interval; Internal medicine","score_opus":0.00251755663583781,"score_gpt":0.22133618756366347,"score_spread":0.21881863092782566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104203198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602266,0.038854614,0.000024116973,0.00012274244,0.000026215814,0.000039296836,0.000010676454,0.0000011684979,0.0006945539],"genre_scores_gemma":[0.98323375,0.015718633,0.00015655659,0.00036463563,0.000111354086,0.0000020100024,0.000004651419,0.000003964655,0.00040443105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994172,0.000041552914,0.00022561247,0.0001083216,0.000089213034,0.000118131036],"domain_scores_gemma":[0.9996978,0.0000139458025,0.00009371063,0.00006541753,0.000070219045,0.000058930276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011135378,0.00006520396,0.0002256062,0.000036851066,0.000022840613,0.00001542883,0.00009440518,0.000120178964,0.0007651813],"category_scores_gemma":[0.00003603023,0.00005868888,0.00014257808,0.00013848522,0.000053494616,0.0000024507829,0.000015152283,0.0001105063,2.2468585e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013887658,0.000092093,0.0058462373,0.0000144717615,0.0008032289,0.00004107383,0.000023294544,0.00015495227,0.13811009,0.0000063972366,0.0012080161,0.8535613],"study_design_scores_gemma":[0.0022389756,0.008943477,0.94036615,0.00019131337,0.0025129293,0.00073549256,0.000022506869,0.00014955604,0.03410556,0.00023173702,0.010147298,0.0003550321],"about_ca_topic_score_codex":0.00014329406,"about_ca_topic_score_gemma":0.00034134887,"teacher_disagreement_score":0.9345199,"about_ca_system_score_codex":0.000003621887,"about_ca_system_score_gemma":0.00003930262,"threshold_uncertainty_score":0.8378199},"labels":[],"label_agreement":null},{"id":"W2105145042","doi":"10.1038/sj.bjc.6602753","title":"Do septins have a role in cancer?","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Fungal and yeast genetics research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Pathological Society of Great Britain and Ireland","keywords":"Septin; Cytokinesis; Biology; Gene; Cell biology; Genetics; Microtubule; Alternative splicing; Cell division; Cell; Gene isoform","score_opus":0.03522322916562986,"score_gpt":0.3934724014999978,"score_spread":0.3582491723343679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105145042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001150189,0.9972636,0.0000032152288,0.00002988014,0.0002064309,0.00018473394,0.00018417221,0.0000013454119,0.0009764405],"genre_scores_gemma":[0.0003988213,0.9950148,0.00007381281,0.000051472016,0.002243551,0.000057533518,0.000018719964,0.000052664527,0.0020886443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827623,0.00013072969,0.00063335773,0.000272058,0.0003354825,0.0003521246],"domain_scores_gemma":[0.9990589,0.000011605592,0.00038484004,0.00015907819,0.00022452796,0.00016103899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028868055,0.00021953911,0.00078416785,0.00013040596,0.00003695831,0.00008512258,0.00046125118,0.0003276634,0.00032337004],"category_scores_gemma":[0.000045918012,0.00021905314,0.0004504442,0.0001387399,0.000058066747,0.0000042823303,0.00012531067,0.0006189171,0.0000063794023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001853878,0.000053844644,0.000071862,0.0006876784,0.00014385874,0.00011913697,0.000009905693,0.00005018669,0.00027285152,6.1578925e-7,0.0027684865,0.99580306],"study_design_scores_gemma":[0.0003619915,0.00010048943,0.00006204969,0.009130368,0.00010255371,0.00073335733,0.000012994483,0.000002090581,0.00018441197,0.000006404328,0.9890715,0.00023181939],"about_ca_topic_score_codex":0.00030572835,"about_ca_topic_score_gemma":0.004689195,"teacher_disagreement_score":0.9955712,"about_ca_system_score_codex":0.00013664253,"about_ca_system_score_gemma":0.0012168628,"threshold_uncertainty_score":0.89327276},"labels":[],"label_agreement":null},{"id":"W2105555634","doi":"10.1038/sj.bjc.6603220","title":"Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Biomarker; Pharmacodynamics; Cytokeratin; Surrogate endpoint; Medicine; Internal medicine; Apoptosis; Pharmacology; Oncology; Pharmacokinetics; Biology; Immunology; Programmed cell death; Caspase; Immunohistochemistry","score_opus":0.03403173599688246,"score_gpt":0.41665160155999836,"score_spread":0.3826198655631159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105555634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439585,0.0017565045,0.0024999387,0.000549799,0.00007283531,0.0006052518,0.00011023121,0.0000016670066,0.0000079325055],"genre_scores_gemma":[0.9958782,0.00044936093,0.0033048263,0.000042549807,0.00023847504,0.00001699597,0.000030236468,0.000015478407,0.000023845678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777365,0.0008011065,0.0007630806,0.00017667697,0.00035251415,0.00013295641],"domain_scores_gemma":[0.9986308,0.00011853976,0.00041855036,0.00017934408,0.0005720026,0.000080742735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019562973,0.00009053003,0.00025082545,0.000059099828,0.00006353746,0.000020801053,0.00022714837,0.00007399766,0.000014205011],"category_scores_gemma":[0.000262049,0.000069359994,0.00012670786,0.0001846171,0.0001349584,0.000012344845,0.00006525478,0.000115327064,2.5297174e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015729337,0.00019266136,0.0005089655,0.000036543523,0.00015158948,0.0000017599535,0.00004405182,0.00060936227,0.9269467,0.000001695674,0.0007714979,0.06916222],"study_design_scores_gemma":[0.0013236253,0.00091058615,0.034412723,0.00019716889,0.000110706584,0.000022859067,0.00009698231,0.00039227735,0.96175176,0.000016320519,0.0006802469,0.000084738494],"about_ca_topic_score_codex":0.0006037385,"about_ca_topic_score_gemma":0.00007787215,"teacher_disagreement_score":0.069077484,"about_ca_system_score_codex":0.000014686222,"about_ca_system_score_gemma":0.00016749001,"threshold_uncertainty_score":0.28284186},"labels":[],"label_agreement":null},{"id":"W2105649578","doi":"10.1038/bjc.2012.76","title":"Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Colorectal cancer; Body mass index; Internal medicine; Proportional hazards model; Relative risk; Magnesium; Confidence interval; Cancer; Incidence (geometry); Gastroenterology; Prospective cohort study; Endocrinology; Chemistry","score_opus":0.013278408012720186,"score_gpt":0.2927676394467558,"score_spread":0.27948923143403565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105649578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779138,0.017414032,8.959416e-7,0.00030942672,0.0034769948,0.00043677428,0.000042151085,0.000015452257,0.00039048944],"genre_scores_gemma":[0.9973183,0.00039421502,0.000072186085,0.0007279506,0.0010918656,0.00015091948,7.0498885e-7,0.000034140885,0.00020968207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759585,0.00021319475,0.0006986761,0.00021919217,0.00052285485,0.0007502404],"domain_scores_gemma":[0.998463,0.00010482394,0.00037512416,0.00010089284,0.00022836517,0.0007278332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008064532,0.00019036255,0.00044747733,0.00018853189,0.00014177486,0.000115566865,0.00020162525,0.00009550942,0.0008991341],"category_scores_gemma":[0.0003011894,0.00021597084,0.00006857365,0.00032760567,0.00009060937,0.00071481447,0.00005832463,0.00046903256,0.000006045907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032320423,0.00038658432,0.94325876,0.00025785668,0.000014240755,0.00026802943,0.0027365594,0.000024718902,0.00018486854,0.0000022829136,0.0018812602,0.04775281],"study_design_scores_gemma":[0.0057490785,0.0007345371,0.9873049,0.00020722752,0.00008923802,0.00047475696,0.0021417695,0.00003447197,0.00016597708,0.00004828577,0.0027792333,0.0002705271],"about_ca_topic_score_codex":0.0083278315,"about_ca_topic_score_gemma":0.022090118,"teacher_disagreement_score":0.047482282,"about_ca_system_score_codex":0.0005680126,"about_ca_system_score_gemma":0.0003284813,"threshold_uncertainty_score":0.9982758},"labels":[],"label_agreement":null},{"id":"W2109602297","doi":"10.1038/sj.bjc.6603556","title":"Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Downregulation and upregulation; Gene expression; Biology; Ovarian cancer; Regulation of gene expression; Cancer research; Gene; Cancer; Genetics","score_opus":0.030060278993326254,"score_gpt":0.3668676916118777,"score_spread":0.33680741261855146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109602297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97220284,0.024801413,0.0014470655,0.0005129466,0.00045957233,0.00016754761,0.000017698854,0.000006540949,0.00038437924],"genre_scores_gemma":[0.99571264,0.0025072426,0.00053446187,0.00014838744,0.00082295097,0.0000024655828,0.0000058633705,0.000016533391,0.00024944064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99836075,0.000043156873,0.0009240879,0.00014222371,0.0003536555,0.00017612992],"domain_scores_gemma":[0.99911135,0.000065970795,0.00033868226,0.00006171376,0.00026651568,0.00015576673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008482356,0.00009360904,0.00042295092,0.00013460187,0.000050780953,0.000018248196,0.00005890859,0.00011178225,0.00046203466],"category_scores_gemma":[0.00006805217,0.0001064667,0.000102492675,0.00015439406,0.00011154143,0.00013248304,0.0000081072885,0.0002206718,3.6477348e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010221521,0.00046706913,0.42769453,0.00028733737,0.00027254032,0.00083039835,0.0005708856,0.00011965419,0.06499106,0.011768899,0.0005551209,0.49142036],"study_design_scores_gemma":[0.0036174413,0.00029295898,0.98330045,0.0013019921,0.00014018704,0.0005467916,0.000046015582,0.00006772485,0.0052368925,0.003529023,0.0018185393,0.00010200769],"about_ca_topic_score_codex":0.0018833836,"about_ca_topic_score_gemma":0.008221283,"teacher_disagreement_score":0.5556059,"about_ca_system_score_codex":0.00007906599,"about_ca_system_score_gemma":0.00022814359,"threshold_uncertainty_score":0.50589556},"labels":[],"label_agreement":null},{"id":"W2112053462","doi":"10.1038/sj.bjc.6605966","title":"A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants","year":2010,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Instituto de Salud Carlos III; Medical Research Council; Association Anne de Bretagne Genetique; Conseil Régional des Pays de la Loire; National Cancer Institute; Cancer Research UK; Vetenskapsrådet; Cancerfonden","keywords":"MUTYH; Odds ratio; Allele; Colorectal cancer; Medicine; Oncology; Internal medicine; Genetics; Cancer; Biology; DNA repair; Gene; DNA glycosylase","score_opus":0.044855573910172496,"score_gpt":0.35821469340445616,"score_spread":0.3133591194942837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112053462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005190659,0.98871315,0.00016943787,0.00014136011,0.0008738971,0.0010753254,0.0035268653,0.000037998823,0.00027130812],"genre_scores_gemma":[0.0015012601,0.9928223,0.0029488155,0.00026329415,0.0006927417,0.0005402424,0.00008177721,0.0001998644,0.0009497128],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99470747,0.0003384381,0.0018247227,0.00076100073,0.0015380839,0.00083026197],"domain_scores_gemma":[0.9936966,0.00045608226,0.0029380245,0.0004337017,0.0017151185,0.0007605228],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013823712,0.0008106238,0.008473259,0.00072456803,0.00019086439,0.00017682514,0.00058012176,0.0007572236,0.007211263],"category_scores_gemma":[0.001106857,0.00062087603,0.0038077882,0.002407834,0.00014694029,0.000120869096,0.00012832081,0.0026576337,0.000012889184],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039202327,0.0004819457,0.00159667,0.0015352173,0.46034727,0.0014304217,0.00020570544,0.00031638867,0.000015426425,7.4235055e-7,0.005116607,0.5285616],"study_design_scores_gemma":[0.001014982,0.0005585061,0.003924884,0.0048401495,0.5818411,0.0012909867,0.000012287697,0.000021492518,0.000026564072,0.000007204257,0.4059183,0.00054354063],"about_ca_topic_score_codex":0.0016396139,"about_ca_topic_score_gemma":0.059408456,"teacher_disagreement_score":0.52801806,"about_ca_system_score_codex":0.0009961275,"about_ca_system_score_gemma":0.002703112,"threshold_uncertainty_score":0.99964327},"labels":[],"label_agreement":null},{"id":"W2112495854","doi":"10.1038/sj.bjc.6600323","title":"Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Tamoxifen; Breast cancer; Biology; Endocrinology; Internal medicine; Cancer research; Cancer; Medicine; Biochemistry; Enzyme","score_opus":0.019506552153429925,"score_gpt":0.29031418740335446,"score_spread":0.2708076352499245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112495854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88136005,0.11257965,0.000009222287,0.0020321035,0.0004676559,0.00020514727,0.00009568048,0.000018633122,0.0032318514],"genre_scores_gemma":[0.9699301,0.007131901,0.00014006179,0.00022867393,0.0009947419,0.0000137016905,0.0000040108266,0.00003411914,0.021522682],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99818575,0.000051557745,0.0007537853,0.00018710944,0.0005546195,0.0002671488],"domain_scores_gemma":[0.998773,0.000031852072,0.00051188393,0.00014737989,0.00035511234,0.0001807635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019087993,0.00014583018,0.0005130511,0.00013586963,0.000064956774,0.000026886699,0.00015252853,0.00012043174,0.00960668],"category_scores_gemma":[0.000024639005,0.00015172677,0.0001216572,0.00024576855,0.00010054555,0.00025281584,0.000024776307,0.00024829712,0.0000037947175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016430197,0.0011419798,0.29663846,0.000949131,0.0002763333,0.0021086996,0.0016385798,0.00026489125,0.121607475,0.0001251664,0.39487237,0.17873389],"study_design_scores_gemma":[0.0045981165,0.0001688799,0.89773214,0.009349917,0.00012422213,0.00041772568,0.000034533703,0.00002509304,0.019522376,0.00018203202,0.067620836,0.00022413165],"about_ca_topic_score_codex":0.0011334181,"about_ca_topic_score_gemma":0.0018389884,"teacher_disagreement_score":0.60109365,"about_ca_system_score_codex":0.00016601864,"about_ca_system_score_gemma":0.00010504493,"threshold_uncertainty_score":0.9912987},"labels":[],"label_agreement":null},{"id":"W2112508921","doi":"10.1038/sj.bjc.6601246","title":"A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the α-fetoprotein promoter","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Japan Society for the Promotion of Science; Uehara Memorial Foundation; F. Hoffmann-La Roche","keywords":"Midkine; Biology; Molecular biology; Transfection; Enhancer; Suicide gene; Gene; Gene expression; Promoter; Hepatocellular carcinoma; Thymidine kinase; Cancer research; Cell culture; Reporter gene; Genetic enhancement; Virus; Virology; Herpes simplex virus; Growth factor; Genetics","score_opus":0.02263377778941602,"score_gpt":0.2862450341669571,"score_spread":0.2636112563775411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112508921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891204,0.008855935,0.00003905865,0.0009066669,0.000079105484,0.00088485604,0.000028590468,0.0000023253888,0.0000830445],"genre_scores_gemma":[0.99774367,0.0008597507,0.000050032588,0.000613809,0.00016554998,0.00009733612,0.0000040145724,0.000050184313,0.00041564845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977404,0.00064441736,0.0004123093,0.0003106481,0.0005067113,0.00038552168],"domain_scores_gemma":[0.9987466,0.000017942868,0.00041881032,0.00042603508,0.00028994467,0.00010071475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068167574,0.00020773978,0.0003085548,0.000071639486,0.00013752829,0.000056257682,0.000544765,0.00015617923,0.0001013304],"category_scores_gemma":[0.00010506233,0.00015652837,0.00024784147,0.00017625147,0.00019350226,0.000014324426,0.00008254302,0.00041969973,8.2035973e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075744576,0.00011316901,0.017597651,0.000034334036,0.00016037429,0.00028198402,0.00022695008,0.000024690327,0.9751138,0.0000024263659,0.00016116047,0.005525994],"study_design_scores_gemma":[0.0019235583,0.0012131395,0.012299764,0.00026039712,0.000035426598,0.0010033743,0.00003071153,0.0000060577427,0.98082066,0.00038770647,0.0018442102,0.00017502187],"about_ca_topic_score_codex":0.0030824654,"about_ca_topic_score_gemma":0.001944748,"teacher_disagreement_score":0.008623256,"about_ca_system_score_codex":0.000121754296,"about_ca_system_score_gemma":0.0005139853,"threshold_uncertainty_score":0.63830423},"labels":[],"label_agreement":null},{"id":"W2112708133","doi":"10.1054/bjoc.1999.0985","title":"Reducing DCO registrations through electronic matching of cancer registry data and routine hospital data","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Medicine; Lung cancer; Cancer registry; Cancer; Colorectal cancer; Breast cancer; Propensity score matching; Surgery; Internal medicine","score_opus":0.06283408088926952,"score_gpt":0.37845735772372274,"score_spread":0.31562327683445324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112708133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8635007,0.13099368,0.0003082875,0.0030097747,0.0001903897,0.00013949623,0.00050892576,0.000011393361,0.0013373479],"genre_scores_gemma":[0.9279229,0.06811715,0.0019354625,0.00034759557,0.00093908666,0.000003175,0.00007985621,0.000021071393,0.00063366775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981554,0.00003391082,0.00064998056,0.00033743426,0.0004994464,0.000323832],"domain_scores_gemma":[0.9984259,0.00003124464,0.00050811295,0.0006910116,0.0002224382,0.000121320714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005018812,0.00012967187,0.0004219951,0.000031121817,0.000116937255,0.000082321196,0.0006253392,0.000075569485,0.0006168528],"category_scores_gemma":[0.00013398487,0.00013906613,0.00005404222,0.00019123,0.0001331252,0.0010756975,0.00013056507,0.00052857085,7.161574e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095270434,0.0002539208,0.05166315,0.00040398698,0.0010515825,0.0012277851,0.0011418915,0.0008665676,0.002226466,0.00020092267,0.09940086,0.84061015],"study_design_scores_gemma":[0.013622335,0.0021607704,0.35317057,0.037304908,0.004169509,0.02986762,0.004406894,0.0028247598,0.0026743487,0.0028494326,0.54529124,0.0016576126],"about_ca_topic_score_codex":0.020876324,"about_ca_topic_score_gemma":0.0063001346,"teacher_disagreement_score":0.83895254,"about_ca_system_score_codex":0.00014893674,"about_ca_system_score_gemma":0.0010746729,"threshold_uncertainty_score":0.98564374},"labels":[],"label_agreement":null},{"id":"W2114961850","doi":"10.1038/bjc.2013.278","title":"Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors","year":2013,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Temsirolimus; Everolimus; Medicine; Internal medicine; Renal cell carcinoma; Relative risk; Incidence (geometry); Oncology; Hazard ratio; Cancer; Genitourinary system; Discovery and development of mTOR inhibitors; Kidney cancer; Sirolimus; Confidence interval; PI3K/AKT/mTOR pathway; Biology","score_opus":0.007158168420119823,"score_gpt":0.2473748003285787,"score_spread":0.24021663190845888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114961850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4238489,0.57541895,0.000011257436,0.0000012716456,0.00012915181,0.00023885575,0.00027874747,9.159451e-7,0.00007198253],"genre_scores_gemma":[0.21464951,0.78464997,0.0002140445,0.0000063773446,0.00025126524,0.000036051875,0.000050689883,0.000048378664,0.000093727045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998034,0.00018528225,0.0009947675,0.0002819769,0.00026589868,0.0002380814],"domain_scores_gemma":[0.9973994,0.000027447764,0.0017665932,0.0001831553,0.000497402,0.0001260231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023116545,0.00029175528,0.0010949983,0.00020152492,0.000036721172,0.000023350321,0.00017764537,0.00033559714,0.000060880324],"category_scores_gemma":[0.00004862667,0.00026824334,0.00029405468,0.00024382738,0.00015170417,0.000014223611,0.00005768262,0.00042894421,3.6258027e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024033125,0.00059845956,0.27249086,0.0070051095,0.00089778524,0.00011314984,0.000079377074,0.00016839708,0.003051359,2.0862885e-7,0.0057210107,0.70963395],"study_design_scores_gemma":[0.010735957,0.0069216415,0.06065558,0.046233475,0.0031886846,0.0011691398,0.000048563004,0.000007033522,0.058692247,0.000013206726,0.81057477,0.001759725],"about_ca_topic_score_codex":0.001884635,"about_ca_topic_score_gemma":0.00073015236,"teacher_disagreement_score":0.80485374,"about_ca_system_score_codex":0.000099620614,"about_ca_system_score_gemma":0.00059218187,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W2115785123","doi":"10.1038/sj.bjc.6605642","title":"Guidelines for the welfare and use of animals in cancer research","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":1445,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Centre for the Replacement, Refinement and Reduction of Animals in Research; University of Leicester; Cancer Research UK; AstraZeneca","keywords":"Medicine; Cancer; Underpinning; Animal welfare; Animal testing; Welfare; Intensive care medicine; Medical physics; Biology; Internal medicine","score_opus":0.5279977563874871,"score_gpt":0.5586178454881463,"score_spread":0.030620089100659165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115785123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97751796,0.019146658,0.000017481228,0.0028630763,0.00021711049,0.00011343184,0.00007913686,0.0000029373093,0.000042208372],"genre_scores_gemma":[0.9926503,0.0047867517,0.0017085008,0.000060181916,0.00057356234,0.000020902078,1.1804265e-7,0.000013713592,0.00018601876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990947,0.000056787896,0.00036361263,0.000092891605,0.00023209602,0.00015986561],"domain_scores_gemma":[0.9979885,0.00045272603,0.00019686726,0.00006165081,0.0012580116,0.000042214466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009828763,0.00005491373,0.00016598671,0.000065250395,0.00010697497,0.00006939162,0.00016762041,0.000036498026,0.00013349607],"category_scores_gemma":[0.00152605,0.000043130993,0.000048738613,0.00010235125,0.00014866558,0.00014581098,0.00004601129,0.0003772805,1.478229e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015412772,0.00009746445,0.0959991,0.00016638967,0.0001473802,0.00035728273,0.0005259466,0.000109081004,0.104312934,0.0006134884,0.017004732,0.7791249],"study_design_scores_gemma":[0.0013251279,0.00086903933,0.7533348,0.0016071426,0.00003488895,0.0013150218,0.0006192131,0.0007269737,0.0017095107,0.000691413,0.23760894,0.00015789068],"about_ca_topic_score_codex":0.00880178,"about_ca_topic_score_gemma":0.006738605,"teacher_disagreement_score":0.778967,"about_ca_system_score_codex":0.000018514458,"about_ca_system_score_gemma":0.00008689566,"threshold_uncertainty_score":0.9977987},"labels":[],"label_agreement":null},{"id":"W2115899860","doi":"10.1038/bjc.2014.6","title":"Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Newfoundland and Labrador Centre for Applied Health Research; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Medicine; Microsatellite instability; Hazard ratio; Internal medicine; Colorectal cancer; Proportional hazards model; Confidence interval; Cohort; Cancer; Oncology; Gastroenterology; Microsatellite; Allele","score_opus":0.007947417274073987,"score_gpt":0.26597383263192337,"score_spread":0.25802641535784937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115899860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565936,0.0131365955,0.00018528147,0.00028544661,0.00030114333,0.00013962372,0.000025938738,0.000015670996,0.00025092863],"genre_scores_gemma":[0.99668366,0.0024241107,0.000037207006,0.00050371524,0.00027267332,0.000015895941,0.000001431662,0.00002710393,0.000034205346],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986598,0.000078094345,0.0003809867,0.00018189798,0.00050147966,0.00019776971],"domain_scores_gemma":[0.998818,0.00020625607,0.00037139698,0.00007248492,0.0003732422,0.00015861246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003226401,0.0001306254,0.00041046328,0.00007909476,0.000054748718,0.000032864555,0.00008424507,0.00008684884,0.00004635909],"category_scores_gemma":[0.0006146653,0.00014027671,0.00009136278,0.00014031219,0.00008233951,0.00011245282,0.000024735922,0.00039418528,2.1296263e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015335612,0.00033607995,0.19022469,0.00064770813,0.0011071971,0.00054294954,0.00057514996,0.029081624,0.21311222,0.00008627056,0.0056616366,0.5432889],"study_design_scores_gemma":[0.002889525,0.0029857117,0.90980464,0.0032020174,0.00031890222,0.0004629926,0.000014669351,0.00030471556,0.07738782,0.00012043557,0.0022939884,0.000214585],"about_ca_topic_score_codex":0.0033096338,"about_ca_topic_score_gemma":0.0006488904,"teacher_disagreement_score":0.71957994,"about_ca_system_score_codex":0.00014336202,"about_ca_system_score_gemma":0.00015236743,"threshold_uncertainty_score":0.57203186},"labels":[],"label_agreement":null},{"id":"W2116372322","doi":"10.1038/sj.bjc.6602121","title":"Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Multiplex ligation-dependent probe amplification; Familial adenomatous polyposis; Colorectal cancer; Proband; Gene duplication; Mutation; Adenomatous polyposis coli; Cancer; Germline mutation; Genetics; Mutation testing; Medicine; Point mutation; Multiplex; Biology; Gene; Exon","score_opus":0.012370022740910541,"score_gpt":0.3013767852610982,"score_spread":0.28900676252018764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116372322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580746,0.036231373,0.0040440457,0.0005555875,0.0003964521,0.0003417112,0.0002747725,0.000012301076,0.000069137],"genre_scores_gemma":[0.98715657,0.010712841,0.0014030765,0.00016412188,0.00028284112,0.00006773617,0.000043041433,0.000023893876,0.0001458713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981303,0.000037215217,0.0007240664,0.00020955889,0.0007087231,0.0001901321],"domain_scores_gemma":[0.99812293,0.000029301254,0.0007158266,0.00014958867,0.0008331689,0.0001491756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022151698,0.00013310376,0.00048420863,0.0002288795,0.00005950318,0.00003617881,0.00013778271,0.00011265899,0.0005216077],"category_scores_gemma":[0.00006468973,0.0001414936,0.00025364853,0.00059927866,0.00008698158,0.0001452679,0.000018364362,0.00021656968,0.0000010380165],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060941314,0.00046348764,0.15439375,0.00020510482,0.0031400903,0.000054722146,0.00058030663,0.02635394,0.6357671,0.000012370593,0.0009482272,0.1774715],"study_design_scores_gemma":[0.0030669612,0.00034469,0.6862066,0.0010179209,0.0036170674,0.0001499356,0.000117904405,0.00026434177,0.30335322,0.00012251693,0.0015266469,0.00021219531],"about_ca_topic_score_codex":0.004347995,"about_ca_topic_score_gemma":0.0048795613,"teacher_disagreement_score":0.53181285,"about_ca_system_score_codex":0.00060138304,"about_ca_system_score_gemma":0.00045460276,"threshold_uncertainty_score":0.6572897},"labels":[],"label_agreement":null},{"id":"W2117461801","doi":"10.1054/bjoc.2000.1649","title":"Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Biology; Ovarian cancer; Cancer; Internal medicine; Oncology; Molecular biology; Medicine; Genetics","score_opus":0.027338105157517993,"score_gpt":0.32242244239590157,"score_spread":0.29508433723838356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117461801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724273,0.025963131,0.000027603524,0.00090958213,0.00021686283,0.00021617193,0.000036590052,0.000010344438,0.00019243512],"genre_scores_gemma":[0.9916211,0.005880563,0.0005356698,0.00059981097,0.0008287677,0.000025320463,0.000007698026,0.000033348766,0.00046774547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981761,0.00005549256,0.0007732731,0.0002099602,0.00050813786,0.0002770247],"domain_scores_gemma":[0.9988043,0.000015362872,0.0005688012,0.000113316404,0.000248442,0.00024980647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030579304,0.00014280478,0.0004984451,0.00022229172,0.000078222976,0.000033965556,0.0001645868,0.00013175383,0.0018637269],"category_scores_gemma":[0.000029064613,0.00014863459,0.00015969807,0.00027561662,0.00007814267,0.00029563592,0.000025159601,0.00025451675,0.00000134788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031865353,0.00054508925,0.8007367,0.00009799345,0.00012989085,0.00064458925,0.0008990669,0.000045582732,0.08343129,0.000013385393,0.0053478666,0.10778987],"study_design_scores_gemma":[0.0034301204,0.00029229093,0.8759019,0.0024119432,0.00012958999,0.00069232873,0.000109976936,0.000037433176,0.110616915,0.00009811624,0.006108551,0.00017085583],"about_ca_topic_score_codex":0.0041979877,"about_ca_topic_score_gemma":0.002148132,"teacher_disagreement_score":0.10761901,"about_ca_system_score_codex":0.00014215395,"about_ca_system_score_gemma":0.00035291558,"threshold_uncertainty_score":0.9990487},"labels":[],"label_agreement":null},{"id":"W2119841327","doi":"10.1038/sj.bjc.6604426","title":"Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Cancer Research UK","keywords":"Immunohistochemistry; Pathology; Medicine; Angiogenesis; Combretastatin; Internal medicine; Biology","score_opus":0.09715634343784149,"score_gpt":0.3529410901311647,"score_spread":0.2557847466933232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119841327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902759,0.008567887,0.000014049677,0.0002727304,0.00015468546,0.0005155158,0.000035702673,0.000025753026,0.00013773632],"genre_scores_gemma":[0.9974522,0.001005145,0.0003557225,0.00015351624,0.0008436533,0.00006421625,0.000013166192,0.000049480557,0.000062926985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795485,0.00023928982,0.00064439425,0.00024792677,0.00066573906,0.00024782264],"domain_scores_gemma":[0.9985357,0.00011418539,0.00037096557,0.0002003828,0.00042483245,0.00035395357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065621384,0.00016194744,0.00054216385,0.00017289826,0.00029434636,0.000044900724,0.00014537376,0.000079304904,0.0002485454],"category_scores_gemma":[0.00009536048,0.00018262299,0.00014081746,0.0002555673,0.00009595436,0.000496641,0.000036121914,0.0005152418,0.000003864984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003933384,0.00032287423,0.98715365,0.000051250263,0.00023461225,0.0008470589,0.0016016944,0.0000047349763,0.00057972537,0.000004643205,0.004177768,0.0049826493],"study_design_scores_gemma":[0.0038991706,0.0012535008,0.9899646,0.0003809242,0.00052691024,0.0011911667,0.0009787449,0.0000020498603,0.0007575195,0.000046178782,0.00081339007,0.00018581189],"about_ca_topic_score_codex":0.0003628338,"about_ca_topic_score_gemma":0.0007805715,"teacher_disagreement_score":0.0075627426,"about_ca_system_score_codex":0.00018607252,"about_ca_system_score_gemma":0.00039693038,"threshold_uncertainty_score":0.7447149},"labels":[],"label_agreement":null},{"id":"W2120225922","doi":"10.1038/sj.bjc.6600869","title":"Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Prostate; Cytokine; PCA3; Cancer; Gene expression; Prostatectomy; Tissue microarray; Pathology; Medicine; Biomarker; Biology; Prostate-specific antigen; Cancer research; Immunohistochemistry; Gene; Internal medicine","score_opus":0.013539525066377534,"score_gpt":0.3192453480533851,"score_spread":0.3057058229870076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120225922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694957,0.029676175,0.000052771575,0.000043426146,0.00013723086,0.00012460294,0.000021791095,0.0000036644929,0.00044460435],"genre_scores_gemma":[0.99486864,0.0029933795,0.001663646,0.000047580426,0.00003869344,0.0000036635429,0.0000061189453,0.000014415395,0.000363846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865574,0.00009541478,0.0006288394,0.00012268328,0.00033762003,0.00015969781],"domain_scores_gemma":[0.99910164,0.000034649664,0.00042565394,0.000078551326,0.00025835593,0.00010117367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000367758,0.00009393169,0.0005148206,0.0004352125,0.000038655242,0.000013397874,0.000058780864,0.000094674644,0.0003056],"category_scores_gemma":[0.000105635416,0.00008628077,0.0001895188,0.0006443726,0.00009640191,0.00009336398,0.000009435178,0.00027187917,6.8629726e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031249056,0.00027396847,0.04640739,0.000121821555,0.001134164,0.0020308238,0.00075291033,0.00033418718,0.94300413,0.000012813338,0.0009319256,0.0046833497],"study_design_scores_gemma":[0.0045528323,0.0007398351,0.26108527,0.0040020715,0.0021006318,0.0007635491,0.0010898801,0.00011012929,0.72339827,0.0000908267,0.0018403687,0.00022634973],"about_ca_topic_score_codex":0.00025246028,"about_ca_topic_score_gemma":0.0002556837,"teacher_disagreement_score":0.2196059,"about_ca_system_score_codex":0.000101408055,"about_ca_system_score_gemma":0.00013341225,"threshold_uncertainty_score":0.35184276},"labels":[],"label_agreement":null},{"id":"W2120755219","doi":"10.1038/sj.bjc.6605937","title":"Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences; University of Guelph; University of Ottawa; National Research Council Canada","funders":"Canadian Institutes of Health Research","keywords":"Single-domain antibody; In vivo; Biodistribution; Ex vivo; Antibody; Molecular biology; Surface plasmon resonance; Chemistry; Molecular imaging; In vitro; Pathology; Biology; Biophysics; Materials science; Biochemistry; Medicine; Immunology; Nanotechnology; Nanoparticle","score_opus":0.012132804098043288,"score_gpt":0.26521721690828254,"score_spread":0.25308441281023925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120755219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934781,0.004074587,0.00056938827,0.00020878593,0.00097600045,0.0003867429,0.00006758887,0.000033812375,0.0002049933],"genre_scores_gemma":[0.9928374,0.00041113744,0.006047737,0.00014591665,0.0004373042,0.0000042219935,0.0000038887647,0.00008823851,0.00002411799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969654,0.00006888639,0.0011899997,0.00030601455,0.0008817772,0.0005878857],"domain_scores_gemma":[0.9972078,0.000047382135,0.0010396482,0.00022114205,0.0011279471,0.0003560398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039725858,0.0003327953,0.00091876666,0.00048725412,0.00016837836,0.0001068662,0.0002801888,0.00018291542,0.000113458416],"category_scores_gemma":[0.0003320915,0.00034658125,0.00043346686,0.0004522608,0.0002949163,0.00065003394,0.00008299443,0.0010290686,0.0000029785654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023892174,0.00023716425,0.06922634,0.00022294043,0.00021218929,0.0013353997,0.00022877539,0.0000070191436,0.91790015,0.000023265937,0.00009453326,0.010273303],"study_design_scores_gemma":[0.004259849,0.00045644274,0.06648051,0.0026612733,0.00026020783,0.005492187,0.0003528553,0.00015257242,0.91809136,0.00012810322,0.0011834021,0.0004812712],"about_ca_topic_score_codex":0.00043129778,"about_ca_topic_score_gemma":0.000081859114,"teacher_disagreement_score":0.009792032,"about_ca_system_score_codex":0.00016504286,"about_ca_system_score_gemma":0.00041405833,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W2121199363","doi":"10.1054/bjoc.1999.0927","title":"Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Prostate; Mammary gland; Internal medicine; Medicine; Prostate-specific antigen; Endocrinology; Receptor; Kallikrein; Progesterone receptor; Breast cancer; Biology; Pathology; Estrogen receptor; Cancer; Enzyme","score_opus":0.0065162042821127,"score_gpt":0.25067196213105103,"score_spread":0.24415575784893834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121199363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342185,0.0054641566,0.000001764578,0.00053169456,0.00003131405,0.0002885026,0.000086793494,0.000008104601,0.00016582475],"genre_scores_gemma":[0.99824476,0.0009910027,0.000046502242,0.00004476041,0.00011261528,0.000015618754,0.000022230872,0.000019994788,0.00050254056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985758,0.000072842005,0.00064270577,0.00014132464,0.0003270812,0.00024026529],"domain_scores_gemma":[0.9993067,0.000015514652,0.00028334654,0.000068480964,0.00018798983,0.00013798798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032228316,0.00011772701,0.00041158934,0.00016464097,0.000060161048,0.00002995474,0.00006792402,0.00009509328,0.00083633483],"category_scores_gemma":[0.000023025641,0.00012449466,0.00008437903,0.0002582079,0.00008496346,0.0002435759,0.000014578012,0.0002799855,5.3870053e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007164233,0.00041861544,0.9486982,0.000093129376,0.000033804718,0.00041240893,0.00067330955,0.0001187817,0.018415758,0.0000066454036,0.00030329672,0.03010963],"study_design_scores_gemma":[0.0048671165,0.00012964584,0.98356944,0.005945762,0.00003840294,0.0024291042,0.00009414489,0.000049020542,0.0024172908,0.00010826286,0.00022964655,0.00012214018],"about_ca_topic_score_codex":0.005406391,"about_ca_topic_score_gemma":0.005145952,"teacher_disagreement_score":0.03487127,"about_ca_system_score_codex":0.00010859241,"about_ca_system_score_gemma":0.00019040763,"threshold_uncertainty_score":0.915728},"labels":[],"label_agreement":null},{"id":"W2121322385","doi":"10.1038/bjc.2011.364","title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Dalhousie University; Juravinski Cancer Centre; Hôtel-Dieu de Québec","funders":"","keywords":"Nomogram; Medicine; Oncology; Concordance; Ovarian cancer; Cohort; Internal medicine; Chemotherapy; Progression-free survival; Confidence interval; Cancer; Surgery","score_opus":0.016965124006928674,"score_gpt":0.27703905316030875,"score_spread":0.26007392915338007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121322385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294823,0.002931804,0.00004337947,0.00073445984,0.0009640132,0.001263121,0.00023057657,0.000017671846,0.00086674455],"genre_scores_gemma":[0.995793,0.00074637355,0.002457276,0.0002594427,0.00041939606,0.00023066366,0.000010518007,0.000043645152,0.000039724757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792814,0.00006914994,0.00055865804,0.00029321882,0.0007685169,0.00038233917],"domain_scores_gemma":[0.9983014,0.000049954207,0.0003630229,0.00019456612,0.00071328634,0.00037779065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023351415,0.00021083704,0.00054665015,0.00016340864,0.000057583744,0.0000420679,0.00014997838,0.00007970125,0.00037867253],"category_scores_gemma":[0.00013469167,0.00017469602,0.00010425436,0.00035046728,0.000065020606,0.00016136994,0.000052776086,0.0003588196,0.0000027980648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001988385,0.001130189,0.7011298,0.000042136988,0.00028566548,0.0008460919,0.0004263762,0.000011335878,0.0000015359658,0.000007458039,0.0011977362,0.29293332],"study_design_scores_gemma":[0.009922588,0.0029130925,0.9770755,0.0076330644,0.00033131495,0.00012288433,0.000063572435,0.0000064154196,0.00015670455,0.00002711252,0.0015562354,0.00019152008],"about_ca_topic_score_codex":0.001743203,"about_ca_topic_score_gemma":0.005624971,"teacher_disagreement_score":0.29274178,"about_ca_system_score_codex":0.0004694906,"about_ca_system_score_gemma":0.0005627713,"threshold_uncertainty_score":0.7123897},"labels":[],"label_agreement":null},{"id":"W2122503009","doi":"10.1038/bjc.2011.552","title":"Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Health and Medical Research Council; Cancer Australia; Medical Research Council; Australian Government; U.S. Department of Veterans Affairs","keywords":"Medicine; Prostate cancer; Prostatectomy; Population; Androgen deprivation therapy; Radiation therapy; Urology; Internal medicine; Gynecology; Surgery; Cancer","score_opus":0.024364774139992027,"score_gpt":0.3181302098515638,"score_spread":0.29376543571157177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122503009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94683456,0.047936004,0.000008515225,0.0027756195,0.0011814603,0.00089960865,0.00012072264,0.000011430305,0.00023209915],"genre_scores_gemma":[0.9765017,0.020344032,0.00015351018,0.0014686591,0.00064954587,0.00035147247,0.000011360191,0.000037651746,0.0004820922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998281,0.000082706756,0.00048499426,0.00019138567,0.00042178066,0.00053812255],"domain_scores_gemma":[0.9987501,0.000060574166,0.00021460069,0.00013066543,0.00022538973,0.0006186499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023718098,0.0002182554,0.0006364497,0.00015933288,0.00005658514,0.000027143802,0.0000725661,0.0000663683,0.00021643865],"category_scores_gemma":[0.000044276403,0.00019390382,0.00031036974,0.0002651629,0.000041960087,0.00019965747,0.000023044027,0.00017743498,0.000009940879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019680473,0.0021574658,0.6061788,0.00024211976,0.0010875904,0.0019229356,0.003164383,0.0013548598,0.00087739597,0.000010991029,0.008659548,0.37237585],"study_design_scores_gemma":[0.023184357,0.003361207,0.8542886,0.0057514566,0.0011683556,0.000751074,0.001638246,0.00005863247,0.010351314,0.00000985522,0.098967336,0.00046956932],"about_ca_topic_score_codex":0.0076139453,"about_ca_topic_score_gemma":0.0036256504,"teacher_disagreement_score":0.37190628,"about_ca_system_score_codex":0.0022698282,"about_ca_system_score_gemma":0.0004480878,"threshold_uncertainty_score":0.9989944},"labels":[],"label_agreement":null},{"id":"W2122516297","doi":"10.1038/sj.bjc.6600590","title":"The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prostate-specific antigen; Kallikrein; Breast cancer; Prostate cancer; Hazard ratio; Androgen receptor; Oncology; Progesterone receptor; Biology; Cancer; Internal medicine; Prostate; Cancer research; Medicine; Estrogen receptor","score_opus":0.023587726819291242,"score_gpt":0.28315108858733234,"score_spread":0.2595633617680411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122516297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8891835,0.10740835,0.00003852033,0.0023933442,0.0002884308,0.000430527,0.00015186013,0.000017993685,0.000087431785],"genre_scores_gemma":[0.98253137,0.012405902,0.00012182856,0.00062807923,0.0008468169,0.00004337016,0.0000069407342,0.000046251895,0.0033694436],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839056,0.00004453658,0.0005397962,0.00022602796,0.00042811228,0.00037097395],"domain_scores_gemma":[0.998622,0.000060601786,0.00034469384,0.00014317269,0.00053905684,0.0002904513],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003487245,0.00017219358,0.0003751579,0.00006576796,0.0004276958,0.00018982834,0.00013773965,0.00010816301,0.0012372179],"category_scores_gemma":[0.000034510096,0.00014614448,0.00015423555,0.00013534252,0.00012268759,0.00026271548,0.000022872007,0.00020707298,0.000001321226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005462432,0.00031349284,0.2817343,0.00014123501,0.00083967106,0.00027694603,0.00060844683,0.00006393178,0.004421779,0.000054534354,0.022615593,0.6883838],"study_design_scores_gemma":[0.0050452864,0.00034559236,0.954524,0.0010091972,0.0005265093,0.006340807,0.00011967363,0.0021214825,0.0019985116,0.0003504154,0.027330324,0.00028820275],"about_ca_topic_score_codex":0.00082615344,"about_ca_topic_score_gemma":0.0018641154,"teacher_disagreement_score":0.6880956,"about_ca_system_score_codex":0.00011011161,"about_ca_system_score_gemma":0.00013135895,"threshold_uncertainty_score":0.9996758},"labels":[],"label_agreement":null},{"id":"W2123889466","doi":"10.1038/bjc.2012.160","title":"Association of PHB 1630 C&gt;T and MTHFR 677 C&gt;T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Cancer Care Ontario; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Sahlgrenska Universitetssjukhuset; Cancer Care Ontario; Akademiska Sjukhuset; Odense Universitetshospital; Mayo Clinic; Istituto Toscano Tumori; Lunds Universitet; ZonMw; Ministerio de Ciencia e Innovación; National Institute for Health and Care Research; Uppsala Universitet; Cancer Australia; National Health and Medical Research Council; Cancer Research UK; University of Pennsylvania; Susan G. Komen; Deutsches Krebsforschungszentrum; Royal Marsden NHS Foundation Trust; Medical Research Council; Breast Cancer Research Foundation; National Breast Cancer Foundation","keywords":"Methylenetetrahydrofolate reductase; Ovarian cancer; Breast cancer; Oncology; Genotype; Mutation; Medicine; Internal medicine; Genetics; Cancer research; Gynecology; Biology; Cancer; Gene","score_opus":0.006185870280546171,"score_gpt":0.2531326242416453,"score_spread":0.2469467539610991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123889466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98151034,0.016692773,0.00010162934,0.00026448944,0.0002849265,0.00022710628,0.00087468023,0.000002366123,0.000041705076],"genre_scores_gemma":[0.9950676,0.0035620898,0.0006208354,0.00007800399,0.00049853034,0.000027430759,0.000023171986,0.000024030209,0.0000983317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860543,0.00017249295,0.00048497206,0.00022343713,0.00029217254,0.00022147194],"domain_scores_gemma":[0.99862146,0.00004229452,0.0007686256,0.00011510264,0.00034024936,0.00011225164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055467477,0.00013352341,0.0002537132,0.00007628078,0.000062505096,0.00004883121,0.00008931981,0.00012146566,0.00003144589],"category_scores_gemma":[0.00013868758,0.00013942558,0.000040097777,0.00012660309,0.00006749947,0.000050399714,0.00003985929,0.00018678835,1.7241177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013375367,0.0002484318,0.902231,0.00001514152,0.00074229867,0.000026703625,0.0030795364,0.00046547985,0.0146173425,6.702161e-7,0.0009647744,0.07627109],"study_design_scores_gemma":[0.00798805,0.00021312475,0.98245233,0.00024572937,0.00028260722,0.00013591922,0.0009438078,0.000057152938,0.006038093,0.000012259415,0.0014470817,0.00018386239],"about_ca_topic_score_codex":0.009898346,"about_ca_topic_score_gemma":0.028709032,"teacher_disagreement_score":0.08022131,"about_ca_system_score_codex":0.00022672222,"about_ca_system_score_gemma":0.00022751777,"threshold_uncertainty_score":0.9966948},"labels":[],"label_agreement":null},{"id":"W2125348134","doi":"10.1038/sj.bjc.6605247","title":"Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"University College Dublin; Science Foundation Ireland; Higher Education Authority; Health Research Board","keywords":"Photodynamic therapy; In vivo; Biodistribution; Positron emission tomography; Magnetic resonance imaging; Medicine; Pathology; Nuclear medicine; Chemistry; Radiology; Biology","score_opus":0.01937040422838076,"score_gpt":0.348057357219539,"score_spread":0.32868695299115824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125348134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946153,0.034689393,0.014260084,0.002637355,0.00011457838,0.001549516,0.00003304679,0.00006065301,0.00050237495],"genre_scores_gemma":[0.98201174,0.0069747586,0.0069254464,0.0037220886,0.0001027483,0.00009187298,0.000012799318,0.000069297195,0.00008923773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965228,0.00028667634,0.0007155064,0.0004460258,0.0013468658,0.000682134],"domain_scores_gemma":[0.9979612,0.000042832122,0.00035749967,0.0003751751,0.00082441675,0.00043885846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011125174,0.0003601744,0.0009131766,0.00033790368,0.00017034999,0.0001278865,0.0003751038,0.00008939703,0.00013101392],"category_scores_gemma":[0.00006265663,0.00030628685,0.0003587332,0.00078861596,0.00013992649,0.00023607777,0.000034977038,0.000911545,0.0000014598388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001981887,0.0028228364,0.0031023899,0.00009250733,0.0045323423,0.0023620424,0.0007663996,0.0021214262,0.68463576,0.000014430282,0.0002858192,0.29728216],"study_design_scores_gemma":[0.02109872,0.0021380417,0.94012314,0.0017409362,0.0005224678,0.0037275075,0.00051950326,0.0074739316,0.01886171,0.00024364694,0.0027249998,0.0008253757],"about_ca_topic_score_codex":0.0004466551,"about_ca_topic_score_gemma":0.000057307258,"teacher_disagreement_score":0.9370208,"about_ca_system_score_codex":0.0007347658,"about_ca_system_score_gemma":0.0006014604,"threshold_uncertainty_score":0.9999389},"labels":[],"label_agreement":null},{"id":"W2127027577","doi":"10.1038/bjc.2011.82","title":"Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"DNA methylation; Colorectal cancer; Methylation; microRNA; Oncology; Cancer research; Gene silencing; Biology; Internal medicine; Medicine; Cancer; Gene expression; Gene; Genetics","score_opus":0.018687962807275492,"score_gpt":0.2813667076425773,"score_spread":0.26267874483530185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127027577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592132,0.011130555,0.028588846,0.00009332099,0.0002915106,0.0002717362,0.00018245084,0.0000054647594,0.00022292315],"genre_scores_gemma":[0.98637277,0.00049624615,0.011998873,0.00037322022,0.00049172336,0.00008115116,0.000020041942,0.000039034054,0.00012694509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988863,0.000035694862,0.00038109883,0.00022204182,0.00020731204,0.00026759208],"domain_scores_gemma":[0.9988692,0.00001787335,0.0003068627,0.00009798914,0.00053465454,0.00017341552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021182426,0.00013520755,0.00019847242,0.0000426853,0.000078386765,0.00003688901,0.00021086624,0.00014462174,0.00044151134],"category_scores_gemma":[0.00014329434,0.00015530393,0.00022684013,0.000070408605,0.00009936919,0.000009713299,0.00003222484,0.00010274419,9.529949e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015553188,0.00014144009,0.0071644625,0.000047786933,0.00026529058,0.000026047628,0.00002532341,0.00045854683,0.9372056,0.000009070184,0.0017023471,0.051398728],"study_design_scores_gemma":[0.0035332886,0.0005296185,0.2641214,0.00053597795,0.00022040297,0.00023654265,0.000029464813,0.0005371019,0.7102825,0.00009226585,0.019490477,0.000390942],"about_ca_topic_score_codex":0.0003247671,"about_ca_topic_score_gemma":0.0005109008,"teacher_disagreement_score":0.25695696,"about_ca_system_score_codex":0.00004592316,"about_ca_system_score_gemma":0.00048453477,"threshold_uncertainty_score":0.63331103},"labels":[],"label_agreement":null},{"id":"W2127958425","doi":"10.1038/bjc.2013.454","title":"Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Gene; Epigenetics; Cancer; Somatic cell; Cancer research; Lung cancer; Gene duplication; Biomarker; Genetics; Pathology; Medicine","score_opus":0.009375384420853316,"score_gpt":0.30702985745197425,"score_spread":0.2976544730311209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127958425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672083,0.02955104,0.0027925707,0.000103758,0.00017483658,0.00011103344,0.000020708798,0.0000015092545,0.000036218276],"genre_scores_gemma":[0.98884517,0.010028998,0.00064315234,0.000040752944,0.00021487944,0.000030833096,0.000042979176,0.000012141923,0.00014107108],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988199,0.00007285619,0.00056451216,0.00016076931,0.00024391421,0.00013808112],"domain_scores_gemma":[0.99877745,0.000016550672,0.00049954717,0.000096279444,0.0005503331,0.000059842576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018866826,0.00008701303,0.00022051572,0.00023063153,0.0000496814,0.00009055357,0.0001269868,0.00007480949,0.00016553595],"category_scores_gemma":[0.00006693391,0.000102540725,0.00013396102,0.00030784975,0.000043180313,0.000025232825,0.000021128559,0.000074198266,9.812828e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018885466,0.000052652154,0.21122846,0.00001528215,0.0002855586,0.000005281818,0.00009842162,0.041256532,0.6942949,0.0000059961394,0.000056086403,0.05268194],"study_design_scores_gemma":[0.0002832089,0.00005853819,0.7503927,0.00007312051,0.0001653349,0.000014761864,0.000059089198,0.00146196,0.24698375,0.0003010999,0.000110148954,0.00009634224],"about_ca_topic_score_codex":0.0030345663,"about_ca_topic_score_gemma":0.005115844,"teacher_disagreement_score":0.5391642,"about_ca_system_score_codex":0.000041393443,"about_ca_system_score_gemma":0.0001959361,"threshold_uncertainty_score":0.4587377},"labels":[],"label_agreement":null},{"id":"W2129685551","doi":"10.1038/sj.bjc.6604717","title":"Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Cancer research; Gene knockdown; Pancreatic cancer; Gene silencing; Immunohistochemistry; Tissue microarray; Cancer; Adenocarcinoma; Biology; Pathology; Medicine; Internal medicine; Gene; Genetics","score_opus":0.026604184542228557,"score_gpt":0.29858961185981714,"score_spread":0.27198542731758857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129685551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669789,0.03229675,0.000033117376,0.000100292906,0.00019617002,0.00025939252,0.000028228344,0.000005598495,0.00010156356],"genre_scores_gemma":[0.995725,0.0034581032,0.0002072038,0.00003907063,0.00028064454,0.0000077364175,0.0000087684475,0.000019938954,0.0002535657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888176,0.000032244476,0.00048326215,0.00012416726,0.0002979939,0.00018056024],"domain_scores_gemma":[0.99912685,0.00019321693,0.00028214,0.00006017217,0.00020150491,0.00013611246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015873204,0.00010498623,0.0004621612,0.000104905805,0.000062860985,0.000012424177,0.00005618478,0.000070527094,0.00010493976],"category_scores_gemma":[0.0003318541,0.00010135993,0.00011642,0.0000978333,0.00010924707,0.00014459858,0.000009198776,0.00013055977,3.261752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031307535,0.00009473406,0.9916313,0.00013140806,0.000045131146,0.00027080168,0.0005659432,0.0000062587997,0.0038358555,0.000010374068,0.0004541359,0.002640973],"study_design_scores_gemma":[0.0028798233,0.00040887133,0.9813825,0.0014210657,0.000109008615,0.0023014806,0.0002605179,0.00002236569,0.010632908,0.000097577205,0.00038639543,0.000097497636],"about_ca_topic_score_codex":0.00072156853,"about_ca_topic_score_gemma":0.0001673539,"teacher_disagreement_score":0.028838646,"about_ca_system_score_codex":0.000046494475,"about_ca_system_score_gemma":0.00026501948,"threshold_uncertainty_score":0.4133338},"labels":[],"label_agreement":null},{"id":"W2131784126","doi":"10.1038/bjc.2015.343","title":"A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Eribulin; Neutropenia; Internal medicine; Cohort; Oncology; Chemotherapy; Metastatic breast cancer; Cancer; Gastroenterology; Breast cancer","score_opus":0.017153020109714832,"score_gpt":0.34147396194387003,"score_spread":0.3243209418341552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131784126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975557,0.0009660086,0.0000024179094,0.000106191124,0.00017077899,0.0011498965,0.000015011899,0.0000025502393,0.00003144876],"genre_scores_gemma":[0.9997564,0.00010910389,0.000015567357,0.000024981848,0.00003192199,0.000026733045,0.000003226386,0.000010358195,0.00002171737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877465,0.000120983386,0.00049017795,0.0001089916,0.0004022816,0.000102914084],"domain_scores_gemma":[0.99865997,0.000025623624,0.00061023806,0.00007333507,0.0005565893,0.00007427306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023575584,0.00008901807,0.00040530672,0.00008937682,0.000023756418,0.000008408262,0.00006475142,0.000025344876,0.00002148829],"category_scores_gemma":[0.00003833564,0.00006789995,0.000024809406,0.00021313103,0.000057365785,0.00013949299,0.00002528479,0.00015545335,4.304719e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065806583,0.014017359,0.957963,0.000031076066,0.00021156733,0.000055216096,0.0022240202,0.00023719661,0.00013159754,7.7146814e-7,0.0000586259,0.018488903],"study_design_scores_gemma":[0.095214315,0.015240834,0.8871813,0.00033353802,0.00035374114,0.000033335524,0.0011938812,0.000043134183,0.00030493786,0.000010679853,0.000034267567,0.000056042514],"about_ca_topic_score_codex":0.0005902519,"about_ca_topic_score_gemma":0.0029099525,"teacher_disagreement_score":0.08863366,"about_ca_system_score_codex":0.00012356807,"about_ca_system_score_gemma":0.00018732723,"threshold_uncertainty_score":0.27688795},"labels":[],"label_agreement":null},{"id":"W2132378346","doi":"10.1038/sj.bjc.6601839","title":"Role of osteopontin in tumour progression","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Osteopontin; Metastasis; Cancer; Biology; Cancer research; Malignant transformation; Tumor progression; Pathology; Medicine; Bioinformatics; Immunology; Genetics","score_opus":0.020874727590489955,"score_gpt":0.3671525670849019,"score_spread":0.34627783949441193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132378346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058452203,0.9979628,6.338564e-7,0.0000266071,0.00016141169,0.00042789016,0.000016006497,0.000003454147,0.0008166867],"genre_scores_gemma":[0.0010106557,0.9981763,0.00021217972,0.000016242371,0.00034005573,0.000026781037,0.0000027360716,0.000027936396,0.00018716449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983109,0.000050865325,0.0009632725,0.00011723853,0.00039497335,0.0001627441],"domain_scores_gemma":[0.9986849,0.000020446312,0.000919477,0.000069674665,0.00022868419,0.000076811375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582113,0.00015574954,0.0017968294,0.00015902011,0.00002005072,0.000013659793,0.000100307225,0.00014526563,0.00007945313],"category_scores_gemma":[0.000085951426,0.00013197231,0.0003946684,0.00026373108,0.00006086477,0.00006507114,0.000048901347,0.0005839903,0.0000032042453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040902618,0.000110747504,0.00011757153,0.0114002675,0.00011583704,0.0010156232,0.000027849372,2.3002222e-7,0.000011138343,0.0000019944187,0.00030159895,0.9868562],"study_design_scores_gemma":[0.0010863066,0.00021193591,0.0010495709,0.37930098,0.0005546424,0.0058184597,0.000055387438,4.8766957e-8,0.000054438133,0.00005881788,0.6116977,0.00011175496],"about_ca_topic_score_codex":0.00041054699,"about_ca_topic_score_gemma":0.0003279389,"teacher_disagreement_score":0.98674446,"about_ca_system_score_codex":0.00019979478,"about_ca_system_score_gemma":0.00077768037,"threshold_uncertainty_score":0.5381674},"labels":[],"label_agreement":null},{"id":"W2132798572","doi":"10.1038/sj.bjc.6605279","title":"The TP53 Arg72Pro and MDM2 309G&gt;T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Cancer Care Ontario; Centre Hospitalier Universitaire Sainte-Justine; Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; Ministerio de Ciencia e Innovación; National Breast Cancer Foundation; National Cancer Institute; KWF Kankerbestrijding; National Institutes of Health; National Health and Medical Research Council; Cancer Research UK; Deutsche Krebshilfe; Cancer Care Ontario; Royal Marsden NHS Foundation Trust; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Breast cancer; Single-nucleotide polymorphism; Genotype; SNP; Oncology; Hazard ratio; Internal medicine; Carcinogenesis; Medicine; Allele; Cancer; Confidence interval; Genetics; Biology; Cancer research; Gene","score_opus":0.005273202937819501,"score_gpt":0.23216079520773003,"score_spread":0.22688759226991054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132798572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940576,0.054996952,0.000035102523,0.0036282442,0.00020298777,0.00027571985,0.00016470082,0.000013957067,0.000106334046],"genre_scores_gemma":[0.9798335,0.018953426,0.000043386215,0.0007810773,0.00022317897,0.000014026811,0.0000036664092,0.00003122519,0.00011652372],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983808,0.000103335995,0.00044130706,0.00023123724,0.0005096532,0.0003336623],"domain_scores_gemma":[0.99855316,0.00006363211,0.00064672367,0.0001116903,0.00038916265,0.0002356411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043356052,0.00017600482,0.00042284135,0.000113946466,0.00019088022,0.000112972215,0.0000836653,0.0001369517,0.00003598526],"category_scores_gemma":[0.00017551021,0.00014879923,0.00007294111,0.00031008935,0.00018065904,0.00017904452,0.0000136986755,0.0006812958,2.753638e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025598984,0.00016912755,0.15606529,0.000040758732,0.00087928434,0.0041522845,0.0011926229,0.00077606324,0.0055820714,0.0000171275,0.0026366753,0.8259288],"study_design_scores_gemma":[0.0062713074,0.00031145004,0.9822648,0.0024945952,0.00037532125,0.005833068,0.00022486411,0.00017058633,0.0008868615,0.000077281584,0.00089568633,0.00019417016],"about_ca_topic_score_codex":0.002508275,"about_ca_topic_score_gemma":0.01597699,"teacher_disagreement_score":0.82619953,"about_ca_system_score_codex":0.0005141653,"about_ca_system_score_gemma":0.00048444886,"threshold_uncertainty_score":0.8915535},"labels":[],"label_agreement":null},{"id":"W2132799739","doi":"10.1038/sj.bjc.6604838","title":"Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials","year":2009,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Associazione Italiana per la Ricerca sul Cancro; Cancer Research UK","keywords":"Folinic acid; Pancreatic cancer; Medicine; Hazard ratio; Adjuvant; Fluorouracil; Internal medicine; Gastroenterology; Randomized controlled trial; Adjuvant therapy; Cancer; Oncology; Surgery; Confidence interval","score_opus":0.28562900025022264,"score_gpt":0.48651150674616983,"score_spread":0.2008825064959472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132799739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00635213,0.9878371,0.00013032697,0.0015516285,0.0002890637,0.0017241456,0.0020799031,0.0000075882326,0.000028117289],"genre_scores_gemma":[0.000117512245,0.99421114,0.0019299537,0.000607816,0.0022832106,0.00013546704,0.00033494373,0.000042197735,0.0003377725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641955,0.0006543506,0.0017027565,0.00039238503,0.0004955526,0.00033538917],"domain_scores_gemma":[0.9946625,0.0025949026,0.0016868102,0.0004138136,0.00041325812,0.00022867102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033773435,0.00030980055,0.0047131195,0.00008341057,0.00017397918,0.00015500652,0.0004412688,0.0003183454,0.00014369132],"category_scores_gemma":[0.0019781059,0.00021086283,0.00033631403,0.0001523153,0.00017855554,0.00021543408,0.00012087324,0.0007688607,0.0000015078864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045706064,0.000051294308,0.0038943137,0.0025530723,0.0016333411,0.00011893987,0.000046773028,1.0744217e-7,0.000005708474,0.00000258444,0.017056484,0.97418034],"study_design_scores_gemma":[0.003945538,0.0005324808,0.023284758,0.053834226,0.017379444,0.0016212312,0.000026696922,0.00008954852,0.0000015155501,0.00014553493,0.89892524,0.00021377899],"about_ca_topic_score_codex":0.0017009635,"about_ca_topic_score_gemma":0.0013741791,"teacher_disagreement_score":0.97396654,"about_ca_system_score_codex":0.00021907223,"about_ca_system_score_gemma":0.0018005328,"threshold_uncertainty_score":0.85987365},"labels":[],"label_agreement":null},{"id":"W2133476042","doi":"10.1038/bjc.2015.231","title":"MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Brookhaven National Laboratory; BC Cancer Agency; Yale School of Public Health, Yale University; Cancer Council NSW; University of California, Irvine; National Institutes of Health; National Cancer Institute; Menzies Institute for Medical Research; Associazione Italiana per la Ricerca sul Cancro; Universidad de Murcia; Memorial Sloan-Kettering Cancer Center; Università degli Studi di Genova; Purdue University; Cancer Research UK; University of Sydney; University of Tasmania; Cancer Care Ontario; University of Edinburgh; INCLIVA Instituto de Investigación Sanitaria; University of Leeds; Menzies Research Institute Tasmania; Università degli Studi dell'Aquila; Universiteit Leiden; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; University of Ottawa; National and Kapodistrian University of Athens; Karolinska Institutet; University of Michigan; University of Pennsylvania; Leids Universitair Medisch Centrum; Missouri Department of Health and Senior Services; Yale University; Moffitt Cancer Center; University of North Carolina at Chapel Hill; Brigham and Women's Hospital; State of New Jersey Department of Health","keywords":"Melanocortin 1 receptor; Skin cancer; Basal cell carcinoma; Melanoma; Odds ratio; Phenotype; Cancer; Medicine; Basal cell; Genotype; Pooled analysis; Eye color; Dermatology; Biology; Internal medicine; Genetics; Gene; Confidence interval","score_opus":0.013750017902563057,"score_gpt":0.28668227018009645,"score_spread":0.27293225227753337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133476042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679797,0.030112185,0.00093899464,0.0002406257,0.00028629362,0.00009134259,0.0001463591,0.0000014438868,0.00020300748],"genre_scores_gemma":[0.9898761,0.007868769,0.0004997207,0.00045537195,0.0009766164,0.000015054423,0.000035097524,0.000011633973,0.00026162167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915993,0.000086195556,0.00025444274,0.00015726322,0.00021210966,0.00013007081],"domain_scores_gemma":[0.9993665,0.000013254881,0.00023015623,0.000111175614,0.00019147668,0.00008743948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002760875,0.00008742768,0.00019393003,0.000033815497,0.000058970516,0.00008605357,0.00016233616,0.00007354546,0.000056242156],"category_scores_gemma":[0.000045516426,0.00007344807,0.000105448846,0.00013281876,0.00003997925,0.000009513748,0.000042472482,0.00009612461,7.132698e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010269075,0.00021895967,0.34355235,0.00002803634,0.011442443,0.00042342354,0.0018434153,0.0012865438,0.21019939,0.000008548463,0.1410059,0.2889641],"study_design_scores_gemma":[0.006071718,0.00058774545,0.82863355,0.0002502482,0.004312064,0.00069293886,0.00094114436,0.0005701884,0.09295504,0.000239309,0.06414556,0.0006005226],"about_ca_topic_score_codex":0.006290224,"about_ca_topic_score_gemma":0.005246711,"teacher_disagreement_score":0.4850812,"about_ca_system_score_codex":0.00003087669,"about_ca_system_score_gemma":0.0002637216,"threshold_uncertainty_score":0.9508979},"labels":[],"label_agreement":null},{"id":"W2133961775","doi":"10.1038/sj.bjc.6601438","title":"The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Medicine; Transdermal; Hormone replacement therapy (female-to-male); Estrogen replacement therapy; Colorectal cancer; Postmenopausal women; Oncology; Internal medicine; Menopause; Estrogen therapy; Cancer; Gynecology; Pharmacology","score_opus":0.009949123474481038,"score_gpt":0.30821048047919486,"score_spread":0.29826135700471385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133961775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509327,0.04756293,0.0000013850241,0.000639552,0.0002654812,0.0005205899,0.000033394273,0.000003518073,0.000040489293],"genre_scores_gemma":[0.92498165,0.07433188,0.000044257344,0.00042342037,0.00010957018,0.000057760448,8.0045214e-7,0.000017436229,0.000033235003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986792,0.00008894009,0.0004257299,0.0001226181,0.00034556258,0.00033792562],"domain_scores_gemma":[0.9991804,0.0001044588,0.0003094826,0.000071828494,0.000096534575,0.00023734228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036616248,0.0001246344,0.0003767591,0.00006109669,0.00009837981,0.000023702207,0.00005956315,0.000053419193,0.000043037715],"category_scores_gemma":[0.00006053001,0.00008731657,0.000019179904,0.00010022269,0.00007892266,0.00007147107,0.000006817315,0.00028483494,3.4366934e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033785995,0.0016701365,0.18349317,0.00044369037,0.0017635667,0.0024511912,0.0037204844,0.00020196097,0.025817266,0.000034207944,0.00035326753,0.74626505],"study_design_scores_gemma":[0.044782676,0.029790547,0.9031929,0.0020316557,0.00016675868,0.00095000595,0.00008827421,0.0000027362667,0.01674349,0.00020984837,0.0019134092,0.00012772485],"about_ca_topic_score_codex":0.0041051246,"about_ca_topic_score_gemma":0.0015537539,"teacher_disagreement_score":0.7461373,"about_ca_system_score_codex":0.0004976086,"about_ca_system_score_gemma":0.0005315089,"threshold_uncertainty_score":0.6205748},"labels":[],"label_agreement":null},{"id":"W2134428662","doi":"10.1038/sj.bjc.6604059","title":"Photodynamic therapy-generated vaccines: relevance of tumour cell death expression","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Cancer research; Cytotoxic T cell; Cancer; CD8; Immunotherapy; Immunology; Ex vivo; Antigen; Biology; In vivo; Medicine; In vitro; Immune system; Chemistry; Internal medicine","score_opus":0.01633999605438702,"score_gpt":0.3204597724209386,"score_spread":0.3041197763665516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134428662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93312186,0.06534008,0.00023224902,0.00010058884,0.00026296408,0.00025815915,0.000023846967,0.000014329121,0.0006459155],"genre_scores_gemma":[0.9287303,0.06940238,0.00066981616,0.00017509378,0.0003236476,0.000006931404,0.000002679361,0.000036945745,0.000652174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801457,0.00006346029,0.0007132837,0.00017314688,0.00066133484,0.0003742289],"domain_scores_gemma":[0.99813974,0.00013026714,0.0005183003,0.00014889851,0.0008687753,0.00019402146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007569422,0.00016063191,0.00056160334,0.00017691888,0.000078561825,0.000018676255,0.00020510418,0.00008363068,0.0003340607],"category_scores_gemma":[0.00014119805,0.00014251849,0.00019387886,0.0002935591,0.00006707449,0.00014263234,0.00003415544,0.00047481916,0.0000012988081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018120194,0.00023944034,0.0025162555,0.00008513376,0.00013399053,0.0006611805,0.00014364328,0.000043983982,0.9453309,9.161461e-7,0.0010260969,0.048006408],"study_design_scores_gemma":[0.0053015887,0.0006003641,0.1504772,0.0015666453,0.000044019784,0.00094917347,0.00017009997,0.0000574874,0.8370821,0.000052728195,0.0035502345,0.00014835068],"about_ca_topic_score_codex":0.00045225472,"about_ca_topic_score_gemma":0.00034614437,"teacher_disagreement_score":0.14796095,"about_ca_system_score_codex":0.00020585877,"about_ca_system_score_gemma":0.0003172827,"threshold_uncertainty_score":0.58117354},"labels":[],"label_agreement":null},{"id":"W2135074415","doi":"10.1038/bjc.2011.427","title":"Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences; Université de Montréal; Angiochem (Canada); Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"LRP1; Glioma; Cancer research; Endocytosis; Abcg2; Tumor microenvironment; Gene silencing; Calcein; Transcytosis; Biology; Receptor; Chemistry; LDL receptor; Lipoprotein; ATP-binding cassette transporter; Biochemistry; Transporter","score_opus":0.013478454946882969,"score_gpt":0.2089404019426498,"score_spread":0.19546194699576683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135074415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820966,0.00085462997,0.000042787688,0.00016330817,0.0001785259,0.00026419552,0.000035130834,0.000006128964,0.00024565207],"genre_scores_gemma":[0.9991466,0.00043102892,0.0000698932,0.00017949274,0.00005324899,0.000011816586,1.3023181e-7,0.000013054809,0.000094769726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985054,0.00010532657,0.0005961785,0.00016943295,0.0004548033,0.00016886646],"domain_scores_gemma":[0.99894285,0.000031163378,0.000688146,0.00014008698,0.00013254044,0.000065184555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025812213,0.00012357545,0.00030770968,0.00006113815,0.00010930414,0.000007061655,0.00026844992,0.00006154534,0.00039212033],"category_scores_gemma":[0.000095816315,0.000098835546,0.00014238781,0.00021811458,0.000367794,0.00014274509,0.000026484113,0.00032187277,0.0000038261733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003233547,0.000089532434,0.001169449,0.0000333595,0.000046753776,0.00010084272,0.00058712385,0.00008853663,0.98708004,0.000057040794,0.00016609282,0.0102578625],"study_design_scores_gemma":[0.0003960183,0.00021810985,0.17331173,0.0004362539,0.000028171937,0.00024027146,0.00004449086,9.107234e-7,0.8244657,0.0002786033,0.0004954594,0.00008426734],"about_ca_topic_score_codex":0.0007414809,"about_ca_topic_score_gemma":0.00013125227,"teacher_disagreement_score":0.17214227,"about_ca_system_score_codex":0.000040209772,"about_ca_system_score_gemma":0.000055763165,"threshold_uncertainty_score":0.42934427},"labels":[],"label_agreement":null},{"id":"W2136365117","doi":"10.1038/bjc.2014.396","title":"Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Biopsy; Sampling (signal processing); Prostate biopsy; Prostate; Cancer; Biomarker; Oncology; Stage (stratigraphy); Pathology; Internal medicine; Biology","score_opus":0.02041064757438845,"score_gpt":0.3224703898355973,"score_spread":0.30205974226120885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136365117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683189,0.029373297,0.00030839402,0.0010058081,0.00036283565,0.00048363654,0.00012057033,0.000009969425,0.00001663574],"genre_scores_gemma":[0.98674273,0.012290849,0.00047842177,0.00006579132,0.00023114568,0.00012051067,0.0000048162324,0.00002371421,0.000042005984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984827,0.0000723421,0.00070006325,0.00021047851,0.0003319712,0.00020242923],"domain_scores_gemma":[0.99799883,0.00005253539,0.00109404,0.00011487282,0.00059016264,0.00014954436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068580935,0.00012712371,0.0004111914,0.00009431526,0.00009335588,0.000055262255,0.000072742456,0.000060699964,0.000029951196],"category_scores_gemma":[0.00018086744,0.00012237058,0.00010184869,0.00014876139,0.00013759363,0.0001958377,0.000026121605,0.00016163348,2.7042208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045097436,0.00012585419,0.58719146,0.0006160729,0.0004340831,0.0000641915,0.00032279795,0.00015706888,0.060312003,0.0000056052836,0.000078444486,0.35024148],"study_design_scores_gemma":[0.003276336,0.00025321936,0.9004911,0.00704031,0.00044103668,0.0006813921,0.00011969934,0.00027536208,0.08640538,0.00013018232,0.0007397185,0.00014623358],"about_ca_topic_score_codex":0.0011790767,"about_ca_topic_score_gemma":0.0001392367,"teacher_disagreement_score":0.35009524,"about_ca_system_score_codex":0.00020598744,"about_ca_system_score_gemma":0.0002524786,"threshold_uncertainty_score":0.4990127},"labels":[],"label_agreement":null},{"id":"W2138376272","doi":"10.1038/bjc.2013.515","title":"Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Centre hospitalier universitaire de Québec","funders":"Lady Davis Institute for Medical Research; McGill University Health Centre; Canadian Institutes of Health Research; Jewish General Hospital; Terry Fox Research Institute; McGill University","keywords":"Lung cancer; Medicine; Oncology; Internal medicine; Survival analysis; Cancer; Pathology","score_opus":0.01910628567510611,"score_gpt":0.31224568203143777,"score_spread":0.2931393963563317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138376272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955566,0.008293123,0.0002389269,0.00012104348,0.0008327048,0.0007387609,0.000048981932,0.000007073888,0.00016375222],"genre_scores_gemma":[0.9912105,0.0015367196,0.0065121455,0.00009847272,0.0005078455,0.000053533422,0.000006101124,0.000043139913,0.000031528783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804986,0.0000611652,0.00085831655,0.00022225852,0.00050595263,0.00030242527],"domain_scores_gemma":[0.9976013,0.00014262507,0.00088345644,0.00012811762,0.00097061245,0.0002739331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002364447,0.00017968848,0.0006714783,0.00007625403,0.0000643475,0.000052148243,0.00010903148,0.00008317158,0.00025094033],"category_scores_gemma":[0.00007099807,0.00014807192,0.00020082612,0.00017415357,0.00010731675,0.00018331484,0.000030511937,0.00025201257,8.840419e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002501791,0.0006363731,0.91986823,0.00034802363,0.00074855785,0.00013194031,0.00005889686,0.00045211025,0.000025238398,1.700413e-7,0.0013285849,0.07615168],"study_design_scores_gemma":[0.007630492,0.0006074639,0.98123014,0.006197366,0.0013472026,0.00005573769,0.000034803714,0.002526922,0.00017389849,0.000004361225,0.000038964623,0.0001526243],"about_ca_topic_score_codex":0.013301126,"about_ca_topic_score_gemma":0.0019759687,"teacher_disagreement_score":0.07599905,"about_ca_system_score_codex":0.00035332635,"about_ca_system_score_gemma":0.0007687811,"threshold_uncertainty_score":0.9932694},"labels":[],"label_agreement":null},{"id":"W2139475741","doi":"10.1038/sj.bjc.6601296","title":"Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Adenocarcinoma; Cervix; Cervical cancer; Gynecology; Cancer; Squamous carcinoma; Oncology; Population; Risk factor; Epidermoid carcinoma; Case-control study; Basal cell; Carcinoma; Internal medicine; Obstetrics; Environmental health","score_opus":0.021816315076982132,"score_gpt":0.30507381853606214,"score_spread":0.28325750345908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139475741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98002905,0.018312184,0.000006177707,0.00014432379,0.00016449261,0.0008216296,0.00033355647,0.0000020316932,0.00018653918],"genre_scores_gemma":[0.99904364,0.00037516298,0.000010634908,0.00016495865,0.00020117214,0.00008298602,3.6845336e-7,0.000026536118,0.00009452089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977723,0.0002980011,0.00063121656,0.0001788616,0.00080695417,0.00031270884],"domain_scores_gemma":[0.99825567,0.00050659804,0.0003789785,0.00014790011,0.0005544349,0.00015639707],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096420076,0.00012870767,0.0005047522,0.000113267444,0.00009053563,0.0000271652,0.00020256286,0.000082781575,0.0011702396],"category_scores_gemma":[0.00033512438,0.00009053937,0.0001604454,0.00030506778,0.00014498887,0.00006248778,0.000039670154,0.0005677966,1.1279592e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010377156,0.00044503238,0.97946024,0.00018706244,0.00014870323,0.00023042795,0.0039277333,0.00027228068,0.000128333,0.000007413065,0.00047499375,0.013680051],"study_design_scores_gemma":[0.010744579,0.00079055026,0.9827877,0.0000558721,0.00020029538,0.00046040936,0.003964581,0.000054725908,0.00039919713,0.00012878474,0.00032538833,0.000087912704],"about_ca_topic_score_codex":0.00973779,"about_ca_topic_score_gemma":0.020942738,"teacher_disagreement_score":0.019014595,"about_ca_system_score_codex":0.0003545588,"about_ca_system_score_gemma":0.0007103626,"threshold_uncertainty_score":0.9997428},"labels":[],"label_agreement":null},{"id":"W2140307236","doi":"10.1038/sj.bjc.6604630","title":"Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Oncology; Medicine; Internal medicine; Ovarian cancer; Hazard ratio; Receiver operating characteristic; Chemotherapy; Biomarker; Survival analysis; Cancer; Confidence interval; Biology","score_opus":0.0440023028744207,"score_gpt":0.2906049006289954,"score_spread":0.24660259775457471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140307236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97237223,0.024505883,0.00025887447,0.0020695245,0.00020494874,0.00031336004,0.00024624934,0.000015468335,0.0000134360225],"genre_scores_gemma":[0.99207455,0.005660076,0.000793065,0.000848017,0.00018891672,0.000028846727,0.0000041189733,0.000028702232,0.0003737277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986262,0.000067993264,0.0005122472,0.00017291584,0.00040821524,0.0002124488],"domain_scores_gemma":[0.9988451,0.00010592783,0.00031402003,0.000088665474,0.00041055345,0.00023574263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039981614,0.00012376091,0.0003879474,0.00020049205,0.000089851565,0.000020328785,0.00006592618,0.00009498471,0.00018974299],"category_scores_gemma":[0.00018795911,0.00012845719,0.00012546973,0.0005442137,0.00009698056,0.00012131727,0.0000096959775,0.00012448097,4.606097e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004602622,0.00026705093,0.5954321,0.00007737767,0.00024072488,0.00011081084,0.00062857574,0.0000552175,0.01570231,2.8069272e-7,0.011077874,0.37180504],"study_design_scores_gemma":[0.0055943853,0.0004079781,0.9662841,0.0009142604,0.00009738701,0.0006938498,0.00004867876,0.0005412287,0.013044803,0.000003106855,0.012262424,0.00010780778],"about_ca_topic_score_codex":0.001977583,"about_ca_topic_score_gemma":0.00014477939,"teacher_disagreement_score":0.37169725,"about_ca_system_score_codex":0.00013100426,"about_ca_system_score_gemma":0.00033569481,"threshold_uncertainty_score":0.5238332},"labels":[],"label_agreement":null},{"id":"W2140465264","doi":"10.1038/bjc.2011.33","title":"Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Academy of Medical Sciences; Queen's University; Cancer Research UK","keywords":"Osteopontin; Colorectal cancer; Medicine; Metastasis; Cancer; Oncology; Cancer research; Pathology; Internal medicine; Biology","score_opus":0.019318373880200867,"score_gpt":0.2603141133543458,"score_spread":0.24099573947414493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140465264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92211926,0.07704021,0.0000018785057,0.00002364834,0.00012115913,0.00013119463,0.000034818622,0.000003598714,0.0005242186],"genre_scores_gemma":[0.98883206,0.010610913,0.0002461001,0.000091718764,0.000058953105,0.000009860912,0.0000013512735,0.000010667868,0.0001383979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914026,0.00004028098,0.00036354875,0.000087041124,0.0002442973,0.00012458226],"domain_scores_gemma":[0.99932104,0.00002644299,0.00032216404,0.000031857937,0.00022996996,0.00006850907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021098673,0.00007732321,0.00042983974,0.00007376975,0.000028082177,0.0000064674023,0.000039109396,0.000055314686,0.00015613598],"category_scores_gemma":[0.00007681151,0.00007139685,0.00006581744,0.00013028743,0.00011247363,0.0001274706,0.000042892814,0.00016755173,2.3532573e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020704542,0.0005004861,0.7835456,0.00025029402,0.00035140038,0.00159702,0.0013230176,0.0000017392427,0.050760888,0.000004605238,0.005730664,0.15386382],"study_design_scores_gemma":[0.0022832684,0.00024379196,0.9162815,0.0021901925,0.00013584511,0.00034522967,0.00018793957,0.0000015617242,0.07802109,0.000024356557,0.00021537609,0.00006981467],"about_ca_topic_score_codex":0.0031648718,"about_ca_topic_score_gemma":0.002180025,"teacher_disagreement_score":0.15379399,"about_ca_system_score_codex":0.00008974718,"about_ca_system_score_gemma":0.00012190952,"threshold_uncertainty_score":0.47843608},"labels":[],"label_agreement":null},{"id":"W2142148410","doi":"10.1038/sj.bjc.6600533","title":"Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Hazard ratio; Debulking; Serous fluid; Immunohistochemistry; Pathology; Biology; Medicine; Survival analysis; Univariate analysis; Internal medicine; Ovarian cancer; Cancer; Multivariate analysis; Confidence interval; Enzyme","score_opus":0.031447423706217455,"score_gpt":0.2940202029017501,"score_spread":0.2625727791955327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142148410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8684525,0.12944189,0.000369639,0.001005928,0.00015494894,0.00045169453,0.000008212127,0.000007140945,0.0001080772],"genre_scores_gemma":[0.99372584,0.0042480784,0.0009317292,0.000078445904,0.00015595145,0.000024310588,0.0000052811633,0.000021236378,0.0008091603],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984414,0.000050079696,0.00069487427,0.00016314942,0.00045603007,0.00019446631],"domain_scores_gemma":[0.998973,0.000057668392,0.00044607793,0.00007801835,0.0002990867,0.00014613899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029006787,0.0001192743,0.0003816626,0.00035305973,0.000033273587,0.00003718022,0.00007269121,0.0001162388,0.0007968318],"category_scores_gemma":[0.00031168605,0.000129645,0.00007145523,0.000620588,0.000067037356,0.00026026557,0.000015121346,0.00020276017,0.0000014100837],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000690845,0.00041435883,0.12391217,0.00040147392,0.0002358025,0.0002630742,0.00089770026,0.000094462295,0.16551197,0.00010719105,0.0043753823,0.70309556],"study_design_scores_gemma":[0.007605609,0.00044439264,0.95975274,0.0040819915,0.00023986129,0.00082740764,0.00009405538,0.0010638835,0.020596182,0.00034578456,0.00470026,0.00024781123],"about_ca_topic_score_codex":0.007753956,"about_ca_topic_score_gemma":0.0011334528,"teacher_disagreement_score":0.8358406,"about_ca_system_score_codex":0.00025826125,"about_ca_system_score_gemma":0.00025536484,"threshold_uncertainty_score":0.9988535},"labels":[],"label_agreement":null},{"id":"W2143584015","doi":"10.1038/sj.bjc.6601887","title":"High levels of untreated distress and fatigue in cancer patients","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Cancer Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psychosocial; Distress; Anxiety; Depression (economics); Lung cancer; Social support; Prostate cancer; Breast cancer; Cancer; Internal medicine; Psychiatry; Clinical psychology; Psychology","score_opus":0.019432739183712577,"score_gpt":0.2948988533097637,"score_spread":0.2754661141260511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143584015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98358434,0.015130924,0.000016359463,0.00033379425,0.00041902665,0.000098643344,0.00029934684,0.000003225261,0.000114326635],"genre_scores_gemma":[0.9948609,0.0047151144,0.000037317666,0.00014427687,0.00014543084,0.0000069857433,0.0000047589215,0.000013558078,0.00007167616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990655,0.000020212794,0.00038253056,0.00010102626,0.00028740434,0.00014331641],"domain_scores_gemma":[0.99925935,0.000014614425,0.00022708038,0.000055287845,0.0003351373,0.00010854862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007299133,0.00008447475,0.0003521395,0.000080011196,0.00001878232,0.000014756081,0.000057200006,0.000058363934,0.0002556717],"category_scores_gemma":[0.00003170913,0.00008552642,0.000060668273,0.00017765572,0.00006662658,0.00010325265,0.000014776681,0.00018573467,1.4875333e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046109446,0.00030448902,0.60200053,0.00027548717,0.00014948793,0.00039739843,0.0009021267,0.00041241717,0.0005626013,0.00003770605,0.00023950155,0.39425716],"study_design_scores_gemma":[0.0059715607,0.00022208762,0.9844406,0.0035719816,0.00008885464,0.000102084305,0.000116501404,0.0000012699567,0.004522196,0.0001443752,0.00072114024,0.00009734814],"about_ca_topic_score_codex":0.043447632,"about_ca_topic_score_gemma":0.07367243,"teacher_disagreement_score":0.3941598,"about_ca_system_score_codex":0.00022328207,"about_ca_system_score_gemma":0.00021575544,"threshold_uncertainty_score":0.96292216},"labels":[],"label_agreement":null},{"id":"W2143602377","doi":"10.1038/sj.bjc.6605416","title":"Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Mount Sinai Hospital; Université Laval; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; National Health and Medical Research Council; National Institutes of Health; Fondazione Italiana per la Ricerca sul Cancro; Università degli Studi di Torino; Radboud Universitair Medisch Centrum; Deutsche Krebshilfe; Medical Research Council; lékařská fakulta Univerzity Karlovy; Leids Universitair Medisch Centrum; Associazione Italiana per la Ricerca sul Cancro; Odense Universitetshospital; Lunds Universitet; Vlaamse regering; Sahlgrenska Universitetssjukhuset; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Universiteit Leiden; Aarhus Universitetshospital; National Institute for Health and Care Research; Russian Foundation for Basic Research; KWF Kankerbestrijding; Cancer Research UK; Université Laval; Royal Marsden NHS Foundation Trust; Compagnia di San Paolo; Huntsman Cancer Institute; National Breast Cancer Foundation; Breast Cancer Research Foundation; Istituto Oncologico Veneto; Aarhus Universitet; Univerzita Karlova v Praze; Alleanza Contro il Cancro; Uppsala Universitet; Ministero dell’Istruzione, dell’Università e della Ricerca; Memorial Sloan-Kettering Cancer Center; Instituto de Salud Carlos III; Radboud Universiteit; Ohio State University; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Universiteit Gent; University of Pennsylvania; Ministero della Salute; Akademiska Sjukhuset; Cancer Care Ontario","keywords":"Breast cancer; Oncology; Medicine; BRCA mutation; SNP; Internal medicine; Allele; Population; Mutation; Cancer; BRCA2 Protein; Genotype; Genetics; Biology; Single-nucleotide polymorphism; Germline mutation; Gene","score_opus":0.01815313764229086,"score_gpt":0.30354838217498803,"score_spread":0.28539524453269716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143602377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198724,0.015046845,0.000019544468,0.0003457008,0.0001562953,0.00029530615,0.0020512238,0.0000013128873,0.0000965062],"genre_scores_gemma":[0.99431497,0.005315683,0.00011176708,0.00009849571,0.0000719116,0.000016333313,0.00004485376,0.000015950656,0.000010060882],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971644,0.0004947683,0.0011851344,0.00025764317,0.0007073334,0.00019069067],"domain_scores_gemma":[0.99646455,0.00008175171,0.0017902293,0.00020667544,0.0013787103,0.000078081226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019507066,0.00015070611,0.00046287803,0.00014502044,0.000032952725,0.000014131586,0.00022191522,0.00020549531,0.000028865239],"category_scores_gemma":[0.0012426297,0.0001540907,0.00011189269,0.0003898222,0.00033250646,0.00003141244,0.000030691222,0.00024966092,4.396394e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003555084,0.00052174827,0.2167157,0.00010795828,0.0019088201,0.000037423855,0.008786624,0.18916129,0.3198434,0.000028568713,0.0022461584,0.25708723],"study_design_scores_gemma":[0.008125018,0.00027642175,0.85500896,0.0010834768,0.00047921148,0.000059961676,0.0010468577,0.0024753772,0.12987697,0.001296056,0.00006500469,0.00020669763],"about_ca_topic_score_codex":0.03609555,"about_ca_topic_score_gemma":0.030909767,"teacher_disagreement_score":0.63829327,"about_ca_system_score_codex":0.00031981335,"about_ca_system_score_gemma":0.002094267,"threshold_uncertainty_score":0.9867736},"labels":[],"label_agreement":null},{"id":"W2143681410","doi":"10.1038/bjc.2011.516","title":"Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Terry Fox Foundation; Boehringer Ingelheim","keywords":"Trastuzumab; Lapatinib; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Bevacizumab; Adjuvant; Cancer; Cancer research; Chemotherapy","score_opus":0.0989027358661728,"score_gpt":0.4448493664120509,"score_spread":0.3459466305458781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143681410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008884898,0.995285,0.00012092205,0.0003441204,0.0008618696,0.0011187895,0.0010363943,0.000013893247,0.0011301687],"genre_scores_gemma":[0.0013617714,0.9951816,0.0003156793,0.0002681497,0.0018370266,0.0002949184,0.000024333176,0.0001957071,0.0005207693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950398,0.00038855692,0.0017212617,0.00043080715,0.0014412603,0.0009782962],"domain_scores_gemma":[0.997143,0.00021706075,0.0010863737,0.0002730313,0.00075755874,0.00052301853],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001209508,0.0005864907,0.0033611795,0.0005731843,0.00008242081,0.00024231404,0.00052503735,0.00032414676,0.002810367],"category_scores_gemma":[0.000028989863,0.00053200487,0.00085599214,0.00088136335,0.00028808237,0.00048786565,0.00007159828,0.0027001605,0.00001817615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010859484,0.00044767774,0.000107412605,0.011794674,0.0015161352,0.0012171974,0.00017704567,0.000011225087,0.000009171196,0.000041055497,0.000663385,0.98390645],"study_design_scores_gemma":[0.0020382027,0.00026290028,0.003966557,0.10711539,0.0042890417,0.027009265,0.00024976203,0.00000425999,0.0000044107314,0.000081230035,0.8544194,0.00055955583],"about_ca_topic_score_codex":0.005213878,"about_ca_topic_score_gemma":0.0036919706,"teacher_disagreement_score":0.9833469,"about_ca_system_score_codex":0.002660702,"about_ca_system_score_gemma":0.008942854,"threshold_uncertainty_score":0.9997131},"labels":[],"label_agreement":null},{"id":"W2145762305","doi":"10.1038/bjc.2015.312","title":"International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Fonds Wetenschappelijk Onderzoek; Fédération Wallonie-Bruxelles; Vlaamse regering; Institut National de la Santé et de la Recherche Médicale","keywords":"Place of death; Death certificate; Demography; Odds; Health care; Medicine; Cause of death; Population; End-of-life care; Logistic regression; Public health; Geography; Gerontology; Palliative care; Environmental health; Economic growth; Disease; Nursing; Sociology","score_opus":0.45399133644216305,"score_gpt":0.5092754873852535,"score_spread":0.05528415094309047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145762305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904223,0.0077645187,0.00019395271,0.00013202637,0.00028973457,0.00019386104,0.0009604125,0.0000014978322,0.000041678],"genre_scores_gemma":[0.99812233,0.0010814971,0.0006053784,0.000016768117,0.00009586981,0.0000023329085,0.000017025533,0.00001206153,0.000046747955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980254,0.000058820253,0.00084431085,0.00011404478,0.00084590906,0.00011151473],"domain_scores_gemma":[0.9960985,0.00007561609,0.0016486312,0.00020581733,0.0019134318,0.00005800021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033725414,0.00009327205,0.00068039284,0.000052488893,0.000027645485,0.000009759358,0.0003462397,0.000037693928,0.000026321242],"category_scores_gemma":[0.00024776073,0.0000733973,0.00005739498,0.00014365395,0.000095768155,0.00017580518,0.000092536786,0.0001329453,3.4865963e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001129322,0.00036574612,0.98833567,0.00014159599,0.00055874075,0.000006412203,0.0050845374,0.0019788705,0.0004770123,0.000004846655,0.000508663,0.0014085895],"study_design_scores_gemma":[0.0048492113,0.00032909669,0.975556,0.0051366603,0.00040556554,0.00005034529,0.005652344,0.0008759086,0.005754305,0.000007583373,0.0013073264,0.00007562496],"about_ca_topic_score_codex":0.042141635,"about_ca_topic_score_gemma":0.012280568,"teacher_disagreement_score":0.029861066,"about_ca_system_score_codex":0.00011256222,"about_ca_system_score_gemma":0.00038187983,"threshold_uncertainty_score":0.96423686},"labels":[],"label_agreement":null},{"id":"W2147711740","doi":"10.1038/sj.bjc.6604352","title":"Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Angiogenesis; In vivo; Vascular endothelial growth factor; Cancer research; Colorectal cancer; Irinotecan; Medicine; Apoptosis; Cancer; Cell growth; Pharmacology; Angiogenesis inhibitor; Biology; Internal medicine; VEGF receptors","score_opus":0.005146888277233859,"score_gpt":0.23552637050277056,"score_spread":0.2303794822255367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147711740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204304,0.07919075,0.0001063121,0.00007505559,0.000073521594,0.00010285745,0.0000085896945,0.0000010713954,0.00001140839],"genre_scores_gemma":[0.9343919,0.06515207,0.00021564633,0.00007898408,0.00010829008,0.000009244791,0.0000017434735,0.00001567188,0.00002641437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940646,0.000029227669,0.000205321,0.0001349288,0.00009937907,0.00012467238],"domain_scores_gemma":[0.99959505,0.000011628258,0.00019425988,0.000049945207,0.0000973232,0.000051794854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008784123,0.00008978644,0.00023894191,0.000060172693,0.000034406537,0.000009734198,0.000059022583,0.00006829262,0.000011596482],"category_scores_gemma":[0.000009596919,0.00008931898,0.0000544718,0.00008012325,0.00013492076,0.000010925781,0.00001771012,0.000060849135,3.6859586e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085690327,0.0002083863,0.45943967,0.00013864505,0.00040567762,0.000107807406,0.0001297919,0.00011558579,0.42506096,0.0000031786487,0.000421531,0.11311188],"study_design_scores_gemma":[0.003493919,0.0004990442,0.70741564,0.0002729502,0.000045551897,0.0006068354,0.000015885513,0.000020102152,0.28659964,0.000005982169,0.0008907353,0.00013372299],"about_ca_topic_score_codex":0.00052178354,"about_ca_topic_score_gemma":0.0011597236,"teacher_disagreement_score":0.24797599,"about_ca_system_score_codex":0.000026524924,"about_ca_system_score_gemma":0.00012929447,"threshold_uncertainty_score":0.3642322},"labels":[],"label_agreement":null},{"id":"W2149771219","doi":"10.1038/bjc.2012.269","title":"Independent and functional validation of a multi-tumour-type proliferation signature","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Breast cancer; Oncology; Hazard ratio; Gene signature; Cancer; Lung cancer; Internal medicine; Microarray; Adenocarcinoma; Medicine; Proportional hazards model; Microarray analysis techniques; Cancer research; Biology; Gene expression; Gene; Confidence interval; Genetics","score_opus":0.013275442058503553,"score_gpt":0.28275670382202817,"score_spread":0.2694812617635246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149771219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744168,0.012985164,0.0122689335,0.00007735176,0.000108262706,0.000093789524,0.000012689305,0.0000020650689,0.00003495925],"genre_scores_gemma":[0.99592316,0.0017922993,0.0018042065,0.0001006376,0.00026772023,0.000009705033,0.000028540295,0.0000064122582,0.00006733588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957687,0.000030841038,0.00016934608,0.00006568243,0.000082405604,0.00007485813],"domain_scores_gemma":[0.9995062,0.0000027107797,0.00017372536,0.000043509244,0.00022864252,0.000045208646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017174565,0.000046694102,0.00007630132,0.000021724232,0.000033619337,0.0000092694,0.000039787654,0.00010170122,0.00002521289],"category_scores_gemma":[0.000031951513,0.000048487294,0.000036678943,0.00003787435,0.00003218087,0.0000078552775,0.000020620328,0.000091064634,1.8693616e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004570959,0.000069432324,0.016572498,0.000008853803,0.00003944532,9.1342497e-7,0.000012024958,0.000048692393,0.9739959,0.000053135474,0.0011637752,0.007989592],"study_design_scores_gemma":[0.0004799763,0.00014284071,0.09659959,0.000042494503,0.000038010727,0.00045077145,0.000014814989,0.000017382954,0.8876144,0.000047727335,0.014465841,0.00008614183],"about_ca_topic_score_codex":0.000011960685,"about_ca_topic_score_gemma":0.00001817202,"teacher_disagreement_score":0.08638152,"about_ca_system_score_codex":0.000008089143,"about_ca_system_score_gemma":0.000052372106,"threshold_uncertainty_score":0.19772545},"labels":[],"label_agreement":null},{"id":"W2150577437","doi":"10.1038/sj.bjc.6605338","title":"COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"Instituto de Salud Carlos III; Universität Greifswald; Xunta de Galicia; Deutsche Krebshilfe; Siemens; Bundesministerium für Bildung und Forschung; Associazione Italiana per la Ricerca sul Cancro; Fonds NutsOhra; Grantová Agentura České Republiky; European Commission; Fondazione Italiana per la Ricerca sul Cancro; Vetenskapsrådet; Ontario Institute for Cancer Research; National Health and Medical Research Council; Cancer Research UK; Universidad del Tolima; Swedish Cancer Foundation; National Cancer Institute; KWF Kankerbestrijding; Ministry of Cultural Affairs; Genome Canada","keywords":"Penetrance; Colorectal cancer; Cancer genetics; Multifactorial Inheritance; Cancer; Genetics; Inheritance (genetic algorithm); Human genetics; Biology; Genetic variants; Medicine; Oncology; Bioinformatics; Single-nucleotide polymorphism; Genotype; Gene; Phenotype","score_opus":0.016332999656887805,"score_gpt":0.30299343038444293,"score_spread":0.28666043072755515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150577437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846424,0.0072425324,0.00002497341,0.0013616445,0.0013427811,0.0010142071,0.00027473952,0.000008569025,0.00026632973],"genre_scores_gemma":[0.99366266,0.004679301,0.00014856314,0.0006047414,0.0007230806,0.00011609532,0.0000020363007,0.000029952784,0.00003359172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997121,0.00029167312,0.0008738042,0.00027114962,0.0011617054,0.0002806895],"domain_scores_gemma":[0.9973414,0.00017406723,0.0009928619,0.00021982356,0.0010889281,0.00018290165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007695492,0.00021520807,0.00050668337,0.00013940618,0.00013282096,0.000044521843,0.000534939,0.000099317454,0.0013441674],"category_scores_gemma":[0.00026280375,0.00015507768,0.00021158492,0.0003438255,0.00015890016,0.0000861615,0.000054793043,0.00051144336,0.0000013468434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049659237,0.0015123977,0.5743599,0.000013476499,0.0018671253,0.000053527176,0.0037881238,0.008940606,0.13719869,0.000048367558,0.0005215067,0.2667304],"study_design_scores_gemma":[0.001669632,0.0031203432,0.8845437,0.00026031368,0.0005580196,0.0001360362,0.0005802307,0.0003994235,0.10778002,0.00015276337,0.00065558683,0.00014394487],"about_ca_topic_score_codex":0.005131032,"about_ca_topic_score_gemma":0.004770025,"teacher_disagreement_score":0.31018382,"about_ca_system_score_codex":0.00042391237,"about_ca_system_score_gemma":0.00072549767,"threshold_uncertainty_score":0.99956876},"labels":[],"label_agreement":null},{"id":"W2151382914","doi":"10.1038/sj.bjc.6604305","title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":535,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"National Health and Medical Research Council; Fondazione Italiana per la Ricerca sul Cancro; Medical Research Council; Hungarian Scientific Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Cancer Institute; Office of Defense Programs; Cancer Research UK; U.S. Department of Defense","keywords":"Breast cancer; Population; Ovarian cancer; Oncology; Medicine; Cancer; Demography; Internal medicine; Environmental health","score_opus":0.011943602200427483,"score_gpt":0.2618691185324316,"score_spread":0.24992551633200413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151382914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681782,0.02986775,0.0009764675,0.0006077828,0.000119749384,0.00009321248,0.00010397322,0.0000014172642,0.000051417595],"genre_scores_gemma":[0.9727082,0.023595665,0.0031192126,0.0002542175,0.0001827541,0.000008620626,0.000001432945,0.000012604875,0.000117281525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992343,0.000035455258,0.00028694962,0.00016065864,0.0001400726,0.00014256476],"domain_scores_gemma":[0.999212,0.00001559379,0.00015145566,0.00014366524,0.00036268076,0.00011455216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016911041,0.000078417455,0.0001431936,0.000024264658,0.00017401206,0.000024808458,0.00012500653,0.00005545441,0.000012286257],"category_scores_gemma":[0.000059306494,0.00007247926,0.000045378918,0.00006596385,0.00025940468,0.00000735458,0.0000683072,0.0000911715,1.3705888e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007548852,0.00010344551,0.08013111,0.00007175554,0.0005469903,0.00007574028,0.0008213951,0.029540138,0.42840612,0.000046369998,0.03360611,0.42589593],"study_design_scores_gemma":[0.0025901552,0.0005706527,0.917525,0.00038053456,0.00021346587,0.01254796,0.00053852715,0.002474865,0.03517846,0.00088900584,0.026533691,0.0005577172],"about_ca_topic_score_codex":0.0005215373,"about_ca_topic_score_gemma":0.0032756962,"teacher_disagreement_score":0.8373938,"about_ca_system_score_codex":0.00005425728,"about_ca_system_score_gemma":0.0005463994,"threshold_uncertainty_score":0.29556185},"labels":[],"label_agreement":null},{"id":"W2152734037","doi":"10.1038/sj.bjc.6605560","title":"Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"NONMEM; Dosing; Medicine; Pharmacokinetics; Population; Breast cancer; Covariate; Monoclonal antibody; Oncology; Cancer; Pharmacology; Antibody; Internal medicine; Immunology; Statistics; Mathematics","score_opus":0.03689079871606183,"score_gpt":0.4347484097484792,"score_spread":0.3978576110324174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152734037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411476,0.0017823845,0.000016658252,0.0012896834,0.0014387162,0.00062990806,0.0005800612,0.000010554457,0.0001372679],"genre_scores_gemma":[0.9963678,0.0011254698,0.00011897218,0.00036844332,0.0018238953,0.000028686274,0.000011028088,0.00004835749,0.00010733229],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997305,0.00014726119,0.0007112132,0.0002355319,0.0013017032,0.00029929559],"domain_scores_gemma":[0.99811584,0.00007491243,0.000548203,0.00027673843,0.0007588991,0.00022539226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004237113,0.0001750014,0.00051437743,0.00011730006,0.00013068429,0.00006069082,0.00037609672,0.000095290634,0.0031211043],"category_scores_gemma":[0.000095218165,0.00014818697,0.0002121429,0.00027168184,0.00014878387,0.00012119215,0.00006685949,0.0011703466,0.000002287118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017030719,0.0017428928,0.41995683,0.00005975992,0.0004744443,0.00034938473,0.0004373779,0.00010108462,0.42013848,0.000003741949,0.0023457916,0.15268713],"study_design_scores_gemma":[0.0105492985,0.00048181321,0.96311945,0.0009962996,0.00034126028,0.00043350345,0.00012975099,0.00015582808,0.021453718,0.000042354324,0.00215221,0.0001445215],"about_ca_topic_score_codex":0.010888608,"about_ca_topic_score_gemma":0.0037133892,"teacher_disagreement_score":0.5431626,"about_ca_system_score_codex":0.00021216333,"about_ca_system_score_gemma":0.0006206854,"threshold_uncertainty_score":0.99779016},"labels":[],"label_agreement":null},{"id":"W2154401489","doi":"10.1038/bjc.2011.448","title":"Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Breast cancer; Odds ratio; Oncology; Internal medicine; Medicine; Single-nucleotide polymorphism; Germline mutation; Cancer; Cancer research; Biology; Genotype; Mutation; Genetics; Gene","score_opus":0.02197608497636926,"score_gpt":0.28537586401692505,"score_spread":0.2633997790405558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154401489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95627767,0.04278817,0.00012465997,0.00006321152,0.00024120264,0.00014598061,0.0001698649,0.0000012121594,0.00018800692],"genre_scores_gemma":[0.98964626,0.00975056,0.000113302056,0.00012089784,0.0003060415,0.000028715081,0.00000589001,0.000014902892,0.000013408312],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859816,0.00025092755,0.00037254635,0.00015571807,0.00047664432,0.00014603026],"domain_scores_gemma":[0.9985431,0.000019576803,0.00048664582,0.00013708767,0.0007640823,0.000049497892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018424866,0.00009811498,0.00016628804,0.000049026497,0.000048365804,0.000022619164,0.0001943214,0.00008815539,0.00016393002],"category_scores_gemma":[0.000114450966,0.000093019014,0.000068109024,0.00012718924,0.00007840137,0.000018745315,0.00002684344,0.00016109763,3.3009292e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007399133,0.00034160525,0.0998492,0.00007424299,0.00064377073,0.000072678085,0.0018860453,0.0018095959,0.23890452,0.000015593982,0.002004503,0.65365833],"study_design_scores_gemma":[0.002724403,0.0002664704,0.8435769,0.00043426012,0.0007341515,0.00084316527,0.00015173624,0.00032173155,0.14937669,0.00039991728,0.00094427477,0.00022626879],"about_ca_topic_score_codex":0.008519529,"about_ca_topic_score_gemma":0.0055619846,"teacher_disagreement_score":0.74372774,"about_ca_system_score_codex":0.00010445557,"about_ca_system_score_gemma":0.00052462314,"threshold_uncertainty_score":0.9980828},"labels":[],"label_agreement":null},{"id":"W2154466617","doi":"10.1038/sj.bjc.6604652","title":"Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Eli Lilly and Company","keywords":"Ependymoma; Telomere; Telomerase; Telomerase reverse transcriptase; Biology; Oncology; Mitotic index; Anaplasia; Pathology; Cancer research; Medicine; Internal medicine; Mitosis; DNA; Genetics","score_opus":0.013600649574765403,"score_gpt":0.2492805203171823,"score_spread":0.23567987074241692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154466617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498688,0.048380196,0.000074569136,0.00046396191,0.0005992345,0.0001471047,0.000017053824,0.000013879258,0.00043522796],"genre_scores_gemma":[0.9323734,0.06593386,0.00035134447,0.0002801381,0.00058847707,0.000007454706,0.0000017073562,0.00001655108,0.0004470895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998514,0.000052432162,0.000527194,0.00020188924,0.00041590902,0.00028860013],"domain_scores_gemma":[0.9990845,0.000055267083,0.0002696193,0.000097704076,0.00027616555,0.00021678793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029293465,0.00012778863,0.0004014391,0.00021253015,0.000083466366,0.00002155731,0.00009483396,0.000090099966,0.00014935077],"category_scores_gemma":[0.00027425503,0.00012945374,0.00008397863,0.00041540022,0.00014600506,0.00028236263,0.000023406219,0.00051761745,0.0000035511123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000463565,0.00014704827,0.50727403,0.00013099345,0.000041757616,0.008816898,0.00027176636,0.000017325023,0.00036537906,0.000010091111,0.0103801405,0.47208104],"study_design_scores_gemma":[0.0028077965,0.00028189045,0.9448556,0.0012290057,0.000049537957,0.038567703,0.000114705785,0.000053749263,0.00027233045,0.000060189668,0.011559128,0.00014840039],"about_ca_topic_score_codex":0.0004208787,"about_ca_topic_score_gemma":0.00038526577,"teacher_disagreement_score":0.47193262,"about_ca_system_score_codex":0.0001353465,"about_ca_system_score_gemma":0.00034685415,"threshold_uncertainty_score":0.527897},"labels":[],"label_agreement":null},{"id":"W2155381516","doi":"10.1038/bjc.2011.323","title":"Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Single-nucleotide polymorphism; Medicine; Cancer cachexia; Cancer; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Genotype","score_opus":0.20834475573194852,"score_gpt":0.4694923327377807,"score_spread":0.26114757700583213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155381516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214214,0.0059037018,0.00004985149,0.00044635183,0.0006215947,0.0006936209,0.000029145449,0.000005478124,0.00010812003],"genre_scores_gemma":[0.9911195,0.0056891916,0.00089632906,0.001563611,0.0004992824,0.000085068,0.0000016417937,0.00002092826,0.00012445277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985462,0.000083689745,0.0007895978,0.00013888268,0.0002538342,0.00018778301],"domain_scores_gemma":[0.99889845,0.000036035784,0.0003414781,0.00007739669,0.00048591243,0.00016075987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045974646,0.000076030236,0.00034071712,0.00009144259,0.000046196954,0.000019963534,0.00007189254,0.00006702743,0.0006050058],"category_scores_gemma":[0.00008404748,0.000078378216,0.00010611644,0.00010859337,0.000026676245,0.00010344869,0.00001114763,0.00028202674,0.0000017956235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044109236,0.0009581514,0.8982813,0.000099445715,0.00007959794,0.00011947625,0.0007977971,0.0000011035228,0.0000044285835,8.388963e-7,0.0028843782,0.09633239],"study_design_scores_gemma":[0.009209883,0.0007974457,0.9827012,0.0011091104,0.00015465276,0.00006809411,0.0002622879,0.000018645673,0.000086708744,0.00009603713,0.005417742,0.00007819866],"about_ca_topic_score_codex":0.0019053016,"about_ca_topic_score_gemma":0.0033979516,"teacher_disagreement_score":0.09625419,"about_ca_system_score_codex":0.00015510792,"about_ca_system_score_gemma":0.00031073662,"threshold_uncertainty_score":0.66243887},"labels":[],"label_agreement":null},{"id":"W2155863110","doi":"10.1038/sj.bjc.6604485","title":"The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Glutathione; Pancreatic cancer; Cystine; Oxidative stress; Biology; Cell growth; Cancer research; Cancer cell; Biochemistry; Pharmacology; Endocrinology; Cell biology; Cancer; Cysteine; Enzyme","score_opus":0.0031854243321911236,"score_gpt":0.21140125475272947,"score_spread":0.20821583042053834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155863110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85210955,0.14711206,0.00003403024,0.00017187011,0.00016378933,0.000074220494,0.00003081416,0.000001638191,0.00030202614],"genre_scores_gemma":[0.8850741,0.11170622,0.00023310221,0.0000932467,0.00032294646,0.000018945664,0.000002019278,0.000018751805,0.0025306938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892116,0.000047146637,0.0004059582,0.00013644608,0.00026667863,0.00022261981],"domain_scores_gemma":[0.9990779,0.000018129424,0.0004085732,0.00012363013,0.00029538383,0.00007634768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024364641,0.000107467196,0.00027598807,0.000029226718,0.000067332105,0.000015851638,0.00021634827,0.000055341116,0.0000123334285],"category_scores_gemma":[0.000058467453,0.000082535444,0.00008170477,0.00011848792,0.00016928496,0.000011042883,0.000027883061,0.0001541827,1.9700238e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049714157,0.00044680247,0.3892855,0.000476477,0.0012921456,0.0020006069,0.0022760662,0.00048817744,0.48804438,0.0002133443,0.059701376,0.050803706],"study_design_scores_gemma":[0.0059458055,0.00022461357,0.44638044,0.0018814721,0.00024115914,0.0024526543,0.0005260097,0.00001881843,0.2720864,0.00019953721,0.26944837,0.0005947112],"about_ca_topic_score_codex":0.0011045911,"about_ca_topic_score_gemma":0.012353469,"teacher_disagreement_score":0.21595798,"about_ca_system_score_codex":0.000025762687,"about_ca_system_score_gemma":0.0004961648,"threshold_uncertainty_score":0.6893526},"labels":[],"label_agreement":null},{"id":"W2156216526","doi":"10.1038/sj.bjc.6603660","title":"Temozolomide as salvage treatment in primary brain lymphomas","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Chemotherapy; Methotrexate; Oncology; Internal medicine; Lymphoma; Primary central nervous system lymphoma; Dacarbazine; Confidence interval; Radiation therapy; Surgery","score_opus":0.009949082091629684,"score_gpt":0.3013391835404073,"score_spread":0.2913901014487776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156216526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95552933,0.03518632,0.000009101583,0.001750388,0.0002494213,0.00023993189,0.000011234072,0.000010435917,0.007013853],"genre_scores_gemma":[0.9864065,0.009071492,0.00041315792,0.0022541564,0.0004553694,0.00001798579,0.0000062727067,0.000028592453,0.0013464465],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859667,0.00003015923,0.000569579,0.00015700984,0.00034250916,0.00030404943],"domain_scores_gemma":[0.99918616,0.00014747951,0.00021924806,0.00011179205,0.000103661856,0.00023163426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003639135,0.00014327238,0.00048412412,0.00017260345,0.00003971444,0.00002996904,0.00006463885,0.00007974831,0.00035981042],"category_scores_gemma":[0.00006818125,0.00013301917,0.0002234701,0.00017907712,0.000058047033,0.000102201004,0.000014675725,0.00010295962,0.000014168404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005338862,0.0010086962,0.18458061,0.00002160186,0.00020960558,0.020422755,0.00015079643,0.0000067186284,0.0010090116,0.000019143614,0.0034638958,0.78857327],"study_design_scores_gemma":[0.009523505,0.0007697652,0.90187633,0.00077422836,0.00013432367,0.010860527,0.00010708592,0.0000012834828,0.005492308,0.000067365334,0.07028117,0.000112133996],"about_ca_topic_score_codex":0.003607417,"about_ca_topic_score_gemma":0.0039847,"teacher_disagreement_score":0.78846115,"about_ca_system_score_codex":0.0022330554,"about_ca_system_score_gemma":0.0006362731,"threshold_uncertainty_score":0.5839362},"labels":[],"label_agreement":null},{"id":"W2156285623","doi":"10.1038/sj.bjc.6605352","title":"Impaired TNFα-induced A20 expression in E1A/Ras-transformed cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; York University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Health Research Institutes; National Science Council","keywords":"FADD; Tumor necrosis factor alpha; Transactivation; Apoptosis; Biology; Programmed cell death; TRAF2; Cell biology; Molecular biology; Signal transduction; Cancer research; Caspase; Immunology; Transcription factor; Gene; Genetics; Tumor necrosis factor receptor","score_opus":0.010281128375806891,"score_gpt":0.26429977737806704,"score_spread":0.2540186490022601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156285623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192595,0.006803358,0.00029553857,0.00017446933,0.0003265515,0.00010183797,0.000016645992,0.0000050773046,0.00035056958],"genre_scores_gemma":[0.99633276,0.0021386289,0.000476713,0.00041614694,0.00048983254,0.0000040304926,0.0000057090033,0.000017549197,0.00011865302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886835,0.000060519822,0.00040869034,0.00017375885,0.00022646265,0.00026224946],"domain_scores_gemma":[0.9994319,0.0000074449995,0.00019064744,0.00011254301,0.00013514706,0.00012231719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002622248,0.00012010055,0.00021729076,0.000059134207,0.000042989766,0.000040266263,0.00021587031,0.00015611715,0.00006557041],"category_scores_gemma":[0.000037630554,0.000132499,0.0001394738,0.00009077306,0.000022612125,0.000012341125,0.000014992779,0.00022616528,0.0000016771723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014119387,0.00007533663,0.0003230671,0.000008909822,0.000014105083,0.00016393462,0.00004894424,0.00013127296,0.94272625,7.033374e-7,0.002537453,0.053828835],"study_design_scores_gemma":[0.0014884925,0.0003693539,0.010093634,0.00040236049,0.000012997173,0.0002737361,0.00003090521,0.0000066325515,0.9789784,0.00007446274,0.0081026675,0.00016637448],"about_ca_topic_score_codex":0.00007444243,"about_ca_topic_score_gemma":0.00031804445,"teacher_disagreement_score":0.05366246,"about_ca_system_score_codex":0.000046748963,"about_ca_system_score_gemma":0.00022131718,"threshold_uncertainty_score":0.5403152},"labels":[],"label_agreement":null},{"id":"W2156980365","doi":"10.1038/bjc.2013.219","title":"Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"European Commission; National Institute for Health and Care Research","keywords":"Menarche; Medicine; Breast cancer; Odds ratio; Gynecology; Obstetrics; Pregnancy; Radiation therapy; Cancer; Menopause; Confidence interval; Internal medicine","score_opus":0.009008912330090843,"score_gpt":0.2825341204406243,"score_spread":0.2735252081105335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156980365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98254025,0.015527125,0.000056307723,0.0008144833,0.00065204216,0.000305513,0.0000497327,0.000009632606,0.000044924058],"genre_scores_gemma":[0.9871885,0.011448225,0.00033125776,0.00017798912,0.00066487497,0.000022283166,0.0000011251998,0.000028341996,0.00013740743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987705,0.000050737148,0.00041304913,0.00023484498,0.00031068514,0.00022021859],"domain_scores_gemma":[0.99922454,0.000033475728,0.00026000594,0.0001006385,0.00017502184,0.00020631189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024134354,0.00012923109,0.00040936744,0.000163432,0.00006104889,0.000064507454,0.000057231424,0.00007602212,0.00036910098],"category_scores_gemma":[0.000055086588,0.00012383873,0.00011899323,0.00023614036,0.0000384632,0.00035678348,0.000013846838,0.00023280153,9.334419e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001423145,0.0000295909,0.59013414,0.0000076028455,0.00012386864,0.000046209316,0.0007828281,0.000076917735,0.0009804349,6.768814e-7,0.0009059401,0.40676945],"study_design_scores_gemma":[0.002620506,0.00012683368,0.9923234,0.0006586792,0.00008219882,0.000902432,0.00036450333,0.00002815468,0.00025381328,0.00003848418,0.002463075,0.0001379461],"about_ca_topic_score_codex":0.049402967,"about_ca_topic_score_gemma":0.0036486026,"teacher_disagreement_score":0.4066315,"about_ca_system_score_codex":0.0006205494,"about_ca_system_score_gemma":0.0002164824,"threshold_uncertainty_score":0.9569271},"labels":[],"label_agreement":null},{"id":"W2157768953","doi":"10.1038/bjc.2014.530","title":"Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Oncology; Medicine; Proportional hazards model; Internal medicine; Breast cancer; Exemestane; Tamoxifen; Adjuvant; Cancer","score_opus":0.0029053005113203125,"score_gpt":0.2337852177898039,"score_spread":0.2308799172784836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157768953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702276,0.012245875,0.00011682958,0.000053882326,0.00021815443,0.00011510392,0.00015791466,0.0000022394786,0.00006724812],"genre_scores_gemma":[0.99556035,0.003777256,0.00028594746,0.00002043715,0.00027638228,0.000025619634,0.000005836717,0.000019541978,0.00002861443],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99865294,0.000081636455,0.00056575285,0.00019782316,0.00030242765,0.00019939966],"domain_scores_gemma":[0.9986427,0.00005478739,0.00078145944,0.00012826748,0.0003267331,0.00006608844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028697017,0.00013705793,0.00036779695,0.000059955357,0.00003971511,0.000008363673,0.00019053949,0.00011686818,0.000034309654],"category_scores_gemma":[0.00016349182,0.0001446994,0.00015793122,0.00011482617,0.0002051917,0.000015045871,0.00007103922,0.00017548996,5.4773835e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009939317,0.0002320606,0.466236,0.00018421821,0.0008129118,0.0000434822,0.00017300104,0.00020176273,0.46677464,0.0000011934093,0.00047017832,0.06387661],"study_design_scores_gemma":[0.002364919,0.00019515798,0.8430008,0.0014596011,0.00015721354,0.00038932724,0.000023680192,0.000039207163,0.15210325,0.000029832981,0.00009495478,0.0001420096],"about_ca_topic_score_codex":0.0032856348,"about_ca_topic_score_gemma":0.0002567087,"teacher_disagreement_score":0.37676483,"about_ca_system_score_codex":0.00009147427,"about_ca_system_score_gemma":0.00020584965,"threshold_uncertainty_score":0.590067},"labels":[],"label_agreement":null},{"id":"W2159334966","doi":"10.1038/sj.bjc.6601856","title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Doxorubicin; Pharmacology; Toxicity; Medicine; Maximum tolerated dose; Poloxamer; Chemotherapy; Internal medicine; Chemistry","score_opus":0.008120481377496757,"score_gpt":0.304287108893021,"score_spread":0.29616662751552425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159334966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093485,0.008193352,0.000025369203,0.0001445046,0.00012045835,0.00052671175,0.000014392425,0.000004951202,0.00003543474],"genre_scores_gemma":[0.99764407,0.0019582915,0.000042162697,0.00016630298,0.00012851399,0.000016321255,0.0000032028017,0.000020934336,0.00002020606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881256,0.000034089484,0.00042122975,0.00014439042,0.00043275105,0.00015500622],"domain_scores_gemma":[0.9992579,0.000013976375,0.00032278345,0.00006898465,0.00023529484,0.00010104418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012450249,0.00011185551,0.0003710694,0.0001248919,0.000035159843,0.000018814304,0.000049893228,0.00004577866,0.00005143342],"category_scores_gemma":[0.000012932357,0.000110408524,0.00004673165,0.0002327574,0.000056017034,0.00022501555,0.000008903289,0.00024896642,1.1030225e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004699405,0.003957846,0.07952529,0.0001239386,0.00035798782,0.00014670927,0.0016700462,0.0019098716,0.15264632,0.0000025980635,0.000018618604,0.75494134],"study_design_scores_gemma":[0.11975961,0.004662715,0.70074314,0.0021381956,0.00034748996,0.0001399269,0.00037206552,0.000017340662,0.17149135,0.000026822323,0.000120929064,0.00018042934],"about_ca_topic_score_codex":0.0011054304,"about_ca_topic_score_gemma":0.0015496319,"teacher_disagreement_score":0.7547609,"about_ca_system_score_codex":0.00026600107,"about_ca_system_score_gemma":0.00024421996,"threshold_uncertainty_score":0.4502329},"labels":[],"label_agreement":null},{"id":"W2159482884","doi":"10.1038/bjc.2012.489","title":"Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Centre for Disease Control; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Cytology; Cervical intraepithelial neoplasia; Triage; Colposcopy; Cervical cancer; Gynecology; Randomized controlled trial; Cervical screening; Internal medicine; Obstetrics; Cancer; Pathology; Emergency medicine","score_opus":0.05744963594375095,"score_gpt":0.35182950360197934,"score_spread":0.2943798676582284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159482884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822581,0.010020733,0.0005277853,0.00084886013,0.00019103306,0.0034060031,0.000057277517,0.000012761271,0.002677453],"genre_scores_gemma":[0.9974851,0.00013396869,0.0006424799,0.00030689253,0.0010846474,0.0002451223,0.0000046747637,0.000038809074,0.000058277714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99592054,0.000504056,0.0013402301,0.00022224757,0.0014926997,0.0005202127],"domain_scores_gemma":[0.9948417,0.0015781517,0.0011025029,0.00024009866,0.00189812,0.00033941932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023751033,0.00022439232,0.0017760551,0.0001446359,0.00013807642,0.000038012688,0.0002846428,0.00009803116,0.0006877618],"category_scores_gemma":[0.00071777496,0.00013743038,0.00026121148,0.00051180844,0.00043670222,0.00016452746,0.000049619455,0.0008036491,2.2450111e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9287864,0.0013739304,0.025147129,0.00017747129,0.0012159613,0.00016967258,0.00035450692,0.0007027534,0.00023125098,0.0000012347941,0.0002737787,0.04156592],"study_design_scores_gemma":[0.7351794,0.008157368,0.25297797,0.0005565463,0.0012244021,0.00032544645,0.00044071992,0.00029907504,0.00044999894,0.0000015659872,0.000242182,0.0001452865],"about_ca_topic_score_codex":0.0043843933,"about_ca_topic_score_gemma":0.0038010832,"teacher_disagreement_score":0.22783084,"about_ca_system_score_codex":0.00020908291,"about_ca_system_score_gemma":0.001846831,"threshold_uncertainty_score":0.753051},"labels":[],"label_agreement":null},{"id":"W2161706255","doi":"10.1038/sj.bjc.6602449","title":"State-of-the-art management of nasopharyngeal carcinoma: current and future directions","year":2005,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Radiation therapy; Oncology; Head and neck; Disease; Immunotherapy; Chemotherapy; Carcinoma; Head and neck cancer; Internal medicine; Clinical trial; Cancer; Intensive care medicine; Surgery","score_opus":0.031172998257666323,"score_gpt":0.35102067379239343,"score_spread":0.3198476755347271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161706255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048117375,0.9962289,0.0000012296271,0.00021046914,0.0017398756,0.00036000166,0.00012825715,0.0000032062285,0.00084691565],"genre_scores_gemma":[0.00013448615,0.99772096,0.0000882917,0.000023074337,0.001310598,0.000025465457,0.0000025648676,0.00002467915,0.0006698931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984277,0.000056071774,0.0008165956,0.00014324104,0.00038944487,0.0001669725],"domain_scores_gemma":[0.998768,0.000024161747,0.0007378532,0.00012482305,0.00024085613,0.00010433799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016868132,0.00018279579,0.0015571724,0.00009789745,0.00006350987,0.00000992675,0.000120677316,0.0000589535,0.000075943804],"category_scores_gemma":[0.0000066303155,0.00013931506,0.00049019704,0.00023551028,0.00010269899,0.000050796258,0.00006934284,0.0004950602,6.15654e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020347861,0.000075997705,0.00010952883,0.015087282,0.0005692045,0.00008227561,0.000053861746,1.5232595e-7,9.927371e-8,0.000003770617,0.010458236,0.97353923],"study_design_scores_gemma":[0.0007089258,0.00009074923,0.0060309004,0.054087564,0.0021728496,0.0010629323,0.000018871424,1.5295518e-7,0.0000017855228,0.0000038921626,0.9357249,0.00009646605],"about_ca_topic_score_codex":0.000044998316,"about_ca_topic_score_gemma":0.00017813519,"teacher_disagreement_score":0.9734428,"about_ca_system_score_codex":0.00018189251,"about_ca_system_score_gemma":0.00038830272,"threshold_uncertainty_score":0.5681103},"labels":[],"label_agreement":null},{"id":"W2161722719","doi":"10.1038/bjc.2012.232","title":"Chromosome instability and benefit from adjuvant anthracyclines in breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Chromosome instability; Oncology; Medicine; Adjuvant; Genome instability; Chromosome; Cancer; Cancer research; Internal medicine; Bioinformatics; Biology; Genetics; DNA; DNA damage; Gene","score_opus":0.006655329400887406,"score_gpt":0.26089282592261054,"score_spread":0.2542374965217231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161722719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90845627,0.09053796,0.000022025204,0.0002046903,0.00034495533,0.0000525357,0.0003514399,0.0000014040338,0.000028711682],"genre_scores_gemma":[0.94321585,0.0553828,0.00012945545,0.0002293692,0.0009732137,0.000007303727,0.000011744452,0.000013443282,0.00003679896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992445,0.000020925056,0.00030062947,0.00013080281,0.00009613365,0.00020702643],"domain_scores_gemma":[0.9995234,0.0000076677225,0.00015821513,0.000086319196,0.00011133333,0.00011305931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013689724,0.00009449548,0.00020737093,0.00002547631,0.00003229377,0.000025145244,0.00010057661,0.00010001629,0.00011048398],"category_scores_gemma":[0.0000150092455,0.00010000821,0.00006171407,0.000047758036,0.000063888205,0.000022319033,0.000053816922,0.00013663778,3.7156175e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117813994,0.00016408738,0.60161036,0.000021107056,0.0000691396,0.000014764956,0.00006668479,0.000037450394,0.24436074,0.000004730432,0.00037799982,0.15315509],"study_design_scores_gemma":[0.0009974211,0.00003662178,0.9661397,0.0002559138,0.000037072114,0.00043923597,0.00005432651,0.0000131811275,0.019022658,0.00006344428,0.012773874,0.00016657673],"about_ca_topic_score_codex":0.0028318488,"about_ca_topic_score_gemma":0.007929262,"teacher_disagreement_score":0.36452928,"about_ca_system_score_codex":0.000038451904,"about_ca_system_score_gemma":0.00007133801,"threshold_uncertainty_score":0.4424714},"labels":[],"label_agreement":null},{"id":"W2165688222","doi":"10.1054/bjoc.2001.1883","title":"Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Prostate cancer; Androgen; Identification (biology); Prostate; Biology; Gene expression; Cancer; Cancer research; Differential (mechanical device); Differential display; Medicine; Endocrinology; Gene; Genetics; Hormone","score_opus":0.019773230577731435,"score_gpt":0.30706366908218485,"score_spread":0.2872904385044534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165688222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677405,0.031333815,0.0000517866,0.0002448284,0.00010043046,0.00045908804,0.000049726532,0.0000037847751,0.000016053586],"genre_scores_gemma":[0.95743626,0.041849677,0.00009438904,0.00000713484,0.00006183749,0.000029068824,0.000014002496,0.000014842878,0.0004927926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985509,0.000072908755,0.0006778588,0.00015916069,0.00038285853,0.00015630115],"domain_scores_gemma":[0.9990181,0.0000224121,0.0004534286,0.00007883253,0.00032701655,0.00010025451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023030356,0.00009830725,0.000366299,0.0001780863,0.00004147876,0.000022591918,0.000043174387,0.00007222239,0.00010526254],"category_scores_gemma":[0.000028339035,0.000085205655,0.000048491533,0.0001928401,0.0001406616,0.00025062117,0.00001603469,0.0001476448,4.9712735e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022247669,0.00015252712,0.10312243,0.0004435524,0.00005137456,0.00005710859,0.0007052911,0.000030484909,0.8204638,0.0000013951591,0.00017952202,0.072567776],"study_design_scores_gemma":[0.0057948725,0.00022473444,0.458657,0.005082383,0.000103173166,0.0002318576,0.000123831,0.000217901,0.52904373,0.00012318337,0.00032044644,0.00007689573],"about_ca_topic_score_codex":0.0002254548,"about_ca_topic_score_gemma":0.0001564562,"teacher_disagreement_score":0.35553455,"about_ca_system_score_codex":0.00006657497,"about_ca_system_score_gemma":0.0001573622,"threshold_uncertainty_score":0.34745857},"labels":[],"label_agreement":null},{"id":"W2165939716","doi":"10.1038/sj.bjc.6602020","title":"Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Cisplatin; Seminoma; Chemotherapy; Oncology; Internal medicine; Clinical endpoint; Radiation therapy; Clinical trial; Surgery","score_opus":0.030786319824425798,"score_gpt":0.32923925708860613,"score_spread":0.2984529372641803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165939716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240446,0.00539294,0.0012735967,0.00016867428,0.000030585696,0.00057860056,0.00008549062,0.0000103929515,0.000055259872],"genre_scores_gemma":[0.99756014,0.00013360563,0.0019108985,0.00017666082,0.000036204743,0.000027201984,0.000038743412,0.000026640702,0.000089924935],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983281,0.00013964878,0.0007797653,0.00013807342,0.00047030995,0.00014413848],"domain_scores_gemma":[0.99804157,0.00019362445,0.0010835176,0.00011369415,0.0004081762,0.00015939587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037360474,0.00015298954,0.0011951918,0.00025487345,0.00003512432,0.00003298103,0.00005124117,0.00003095194,0.0006170616],"category_scores_gemma":[0.0002466535,0.00010817804,0.00047997735,0.0006120192,0.00004850759,0.00005768944,0.0000029382281,0.000078528414,3.8889098e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12223668,0.013393108,0.17308694,0.0004638208,0.11988877,0.011787402,0.00067782996,0.056237698,0.035223477,0.000017995251,0.00017500899,0.46681127],"study_design_scores_gemma":[0.47667536,0.0035006036,0.3752769,0.002913651,0.10162192,0.00065007317,0.00010360121,0.0022108643,0.036609802,0.000068026995,0.0000513637,0.0003178257],"about_ca_topic_score_codex":0.0011611162,"about_ca_topic_score_gemma":0.0006847854,"teacher_disagreement_score":0.46649346,"about_ca_system_score_codex":0.00023682923,"about_ca_system_score_gemma":0.00047610473,"threshold_uncertainty_score":0.6756392},"labels":[],"label_agreement":null},{"id":"W2166119663","doi":"10.1038/sj.bjc.6603740","title":"Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Zoledronic acid; Medicine; Breast cancer; Bisphosphonate; Bone metastasis; Bone resorption; Internal medicine; Metastasis; Doxycycline; Oncology; Cancer; Osteoporosis; Antibiotics; Biology","score_opus":0.022502513674917776,"score_gpt":0.351250639085034,"score_spread":0.3287481254101162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166119663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883888,0.010085695,0.000004413201,0.0008309733,0.00007273108,0.00038991898,0.00006845013,0.000003096727,0.00015596852],"genre_scores_gemma":[0.99788594,0.0016499592,0.000039160266,0.00023136115,0.000105793806,0.0000265961,0.0000018360327,0.000023899951,0.000035424277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99800384,0.00013673496,0.0009095109,0.00014099597,0.00046819256,0.00034070766],"domain_scores_gemma":[0.998774,0.00012580812,0.00054062397,0.00013503146,0.00016928632,0.0002552835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014208977,0.00015195862,0.00074903277,0.000254765,0.00003457646,0.000006489583,0.00010762284,0.00008160788,0.00013032506],"category_scores_gemma":[0.0001218271,0.00011590265,0.00018012935,0.00029088024,0.000052456984,0.00007919666,0.000017629318,0.00048370293,6.4346966e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0143521605,0.0017071755,0.16817476,0.0009773921,0.0007036325,0.004089252,0.0006772163,0.0015238628,0.10341785,0.000047220816,0.00036039655,0.70396906],"study_design_scores_gemma":[0.030027583,0.0026631604,0.7989059,0.011968586,0.0008457892,0.0025305445,0.00013282889,0.0007093291,0.15174767,0.00015549031,0.0000411176,0.00027200827],"about_ca_topic_score_codex":0.0232314,"about_ca_topic_score_gemma":0.024119232,"teacher_disagreement_score":0.7036971,"about_ca_system_score_codex":0.0003989868,"about_ca_system_score_gemma":0.0006052445,"threshold_uncertainty_score":0.99368805},"labels":[],"label_agreement":null},{"id":"W2168362647","doi":"10.1038/sj.bjc.6605736","title":"BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":325,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Cancer Council Victoria; National Health and Medical Research Council; Cancer Research UK","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Univariate analysis; Proportional hazards model; Lymph node; Confidence interval; Stage (stratigraphy); Progesterone receptor; Multivariate analysis; Cancer; Prognostic variable; Estrogen receptor; Biology","score_opus":0.005290732897433089,"score_gpt":0.2664471361402568,"score_spread":0.2611564032428237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168362647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94958204,0.04921063,0.000008116863,0.0005783566,0.0002594219,0.00014002736,0.00017789574,0.0000022219442,0.000041287625],"genre_scores_gemma":[0.96193,0.037549056,0.00012075389,0.00014665672,0.00015507516,0.000037913975,0.0000041624903,0.000022374354,0.000034007982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989481,0.000048621823,0.0003353533,0.00020944506,0.0002067327,0.00025175468],"domain_scores_gemma":[0.9992012,0.000015115992,0.00027851053,0.000112483314,0.0003113902,0.00008130897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021884298,0.00014459554,0.00031834465,0.000036990863,0.000049669907,0.000032219163,0.00014825883,0.00011353478,0.00006381387],"category_scores_gemma":[0.000035823476,0.00014135226,0.000086571075,0.00009182572,0.00014639317,0.000017185272,0.000059780523,0.00023511259,1.9562923e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007832717,0.0001708643,0.6053178,0.000033496384,0.0003362775,0.00013251916,0.00014589148,0.00007212274,0.22925186,0.0000024058993,0.0002497338,0.1635038],"study_design_scores_gemma":[0.0028805183,0.000098881064,0.95508707,0.00029757922,0.000037723406,0.00106675,0.00011914806,0.0000049319733,0.037786394,0.000043882315,0.00241868,0.00015842686],"about_ca_topic_score_codex":0.0025887163,"about_ca_topic_score_gemma":0.0063632294,"teacher_disagreement_score":0.34976932,"about_ca_system_score_codex":0.000031953918,"about_ca_system_score_gemma":0.00020430563,"threshold_uncertainty_score":0.5764178},"labels":[],"label_agreement":null},{"id":"W2168380142","doi":"10.1038/bjc.2012.227","title":"Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Prevention, National Cancer Institute","keywords":"Medicine; Aspirin; Prostate cancer; Internal medicine; Prostate; Hazard ratio; Cancer; Confidence interval; Epidemiology; Ibuprofen; Confounding; Relative risk; Oncology; Gynecology; Pharmacology","score_opus":0.01776664014134578,"score_gpt":0.2907683792282006,"score_spread":0.2730017390868548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168380142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993177,0.005127694,0.0000019931063,0.000114362396,0.00063016475,0.00068598386,0.00020599939,0.000014507673,0.000042297324],"genre_scores_gemma":[0.9959277,0.0023015474,0.00005448893,0.00024910472,0.000705155,0.000050326827,0.000003174579,0.000047236783,0.0006612702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782896,0.0002093328,0.00062554533,0.00014593768,0.00077047676,0.00041975433],"domain_scores_gemma":[0.99757534,0.00010876774,0.0010628417,0.00015686317,0.0007669542,0.00032925582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001037827,0.00017803565,0.00071164244,0.00011283603,0.00008580388,0.00003310257,0.00010765137,0.000095356976,0.00018510978],"category_scores_gemma":[0.0003737444,0.00015251317,0.00013986739,0.00023542711,0.00008184542,0.0003805417,0.00002714053,0.000573209,0.0000023683622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016336751,0.0006261729,0.957839,0.00010351602,0.0012061577,0.0005780871,0.0024039513,0.000017627859,0.0033415002,4.9146536e-7,0.0031184074,0.029131409],"study_design_scores_gemma":[0.0072219134,0.0012548491,0.9607703,0.0026112553,0.0010942935,0.00042535854,0.00038459664,0.0000124926755,0.024575349,0.000001769025,0.0014562918,0.00019154517],"about_ca_topic_score_codex":0.0041794395,"about_ca_topic_score_gemma":0.0015202414,"teacher_disagreement_score":0.028939864,"about_ca_system_score_codex":0.00027005977,"about_ca_system_score_gemma":0.0005781585,"threshold_uncertainty_score":0.631809},"labels":[],"label_agreement":null},{"id":"W2168773053","doi":"10.1038/sj.bjc.6600283","title":"Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Gene expression; Real-time polymerase chain reaction; Cancer; Gene; Biology; Mammary gland; Polymerase chain reaction; Human breast; Medicine; Oncology; Pathology; Cancer research; Internal medicine; Genetics; Enzyme","score_opus":0.025809272270025847,"score_gpt":0.3069127058125378,"score_spread":0.281103433542512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168773053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94628525,0.05226756,0.00001978641,0.000671894,0.00018050054,0.00025350595,0.00017923133,0.0000129545115,0.00012933931],"genre_scores_gemma":[0.9906166,0.00802754,0.00031139643,0.00020693959,0.0002818019,0.000036295023,0.000012738105,0.000040216273,0.00046644273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977605,0.00010174154,0.0008601149,0.00025548466,0.00069840864,0.00032378267],"domain_scores_gemma":[0.99848086,0.000030319274,0.0007585675,0.00012179983,0.0003332446,0.00027523047],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033480913,0.00018204711,0.00060642924,0.00022027829,0.0001067195,0.00004858347,0.00019077316,0.0001458681,0.0023300608],"category_scores_gemma":[0.000027802103,0.00018711311,0.0001586999,0.0002645414,0.00011246325,0.00045411024,0.000029368204,0.00037406728,0.000002644271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003495277,0.0013983739,0.78895676,0.00018298456,0.0002501269,0.00038774338,0.0019076926,0.00020720379,0.11397466,0.000022947685,0.02039675,0.07196525],"study_design_scores_gemma":[0.004680143,0.00046295678,0.93425274,0.003318277,0.0001637879,0.0008294929,0.0004291326,0.00021165313,0.053756308,0.00006706849,0.0015460071,0.0002824358],"about_ca_topic_score_codex":0.0048126066,"about_ca_topic_score_gemma":0.0022738157,"teacher_disagreement_score":0.14529599,"about_ca_system_score_codex":0.00021235789,"about_ca_system_score_gemma":0.00017096005,"threshold_uncertainty_score":0.99858195},"labels":[],"label_agreement":null},{"id":"W2169344399","doi":"10.1038/bjc.2012.338","title":"PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; McGill University; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Cancer Research UK; Academy of Finland; National Institutes of Health; Kuopion Yliopistollinen Sairaala; Breast Cancer Campaign; Michael Smith Health Research BC; Susan G. Komen; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Cancer Institute; Itä-Suomen Yliopisto; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Cancer; Adjuvant; Confidence interval","score_opus":0.0205935707063703,"score_gpt":0.2789817684969163,"score_spread":0.258388197790546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169344399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699644,0.027214658,0.0021288134,0.0001274513,0.00016377456,0.00017264503,0.00020554732,0.0000024988444,0.000020231959],"genre_scores_gemma":[0.99446785,0.0033108462,0.0016229798,0.00004682455,0.00035558612,0.000104834115,0.000009796018,0.000017534778,0.000063753614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929136,0.000016761001,0.0002350585,0.00010668124,0.00016595157,0.00018417096],"domain_scores_gemma":[0.99935293,0.000012777398,0.00025252998,0.000049213228,0.00025445066,0.0000781016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014668111,0.00010107412,0.0001952841,0.000026540725,0.0000705716,0.000018409513,0.00007251331,0.000058028585,0.000007494397],"category_scores_gemma":[0.000020758924,0.000100107885,0.00005693812,0.00003209129,0.00005787808,0.000023708963,0.000050230265,0.000046938207,7.26119e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089527504,0.00025239034,0.84539646,0.000285277,0.0012489712,0.00000395092,0.0018334872,0.0011451548,0.0062831347,0.000007698491,0.0014404735,0.14120771],"study_design_scores_gemma":[0.003004503,0.00011198793,0.9125614,0.0008197889,0.00031383548,0.00034690587,0.00017774994,0.00013497865,0.07956273,0.000041595802,0.0026801373,0.00024434313],"about_ca_topic_score_codex":0.00019268972,"about_ca_topic_score_gemma":0.00032926345,"teacher_disagreement_score":0.14096338,"about_ca_system_score_codex":0.000076516924,"about_ca_system_score_gemma":0.00026541282,"threshold_uncertainty_score":0.40822813},"labels":[],"label_agreement":null},{"id":"W2169647448","doi":"10.1038/sj.bjc.6603289","title":"Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Radiation therapy; Chemotherapy; Internal medicine; Surgery; Cisplatin; Induction chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Cyclophosphamide","score_opus":0.01137640728690949,"score_gpt":0.29716569295313766,"score_spread":0.2857892856662282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169647448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002355,0.0075626015,0.0001572677,0.00019200485,0.00025177567,0.0011501147,0.0006383813,0.0000073872766,0.000016940048],"genre_scores_gemma":[0.9956105,0.0023639635,0.0006699174,0.00027739196,0.00023561902,0.00013411857,0.00013901948,0.00005209792,0.00051739113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805117,0.000058887075,0.0007653767,0.0002586893,0.00055103906,0.00031483063],"domain_scores_gemma":[0.9984374,0.00009244678,0.00070310954,0.00011588406,0.00040594803,0.00024519308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016339807,0.00024262081,0.00069667585,0.00018013512,0.00009158286,0.0000426624,0.00007067082,0.0000575221,0.00031189312],"category_scores_gemma":[0.000017359367,0.00018185536,0.00008379675,0.00026682112,0.00008279326,0.00021720085,0.000014490125,0.00015768896,7.988842e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1935814,0.006122854,0.77478355,0.0003942373,0.00081101165,0.0009477176,0.00029321958,0.00049481425,0.0009140759,3.1895544e-7,0.0039882925,0.017668493],"study_design_scores_gemma":[0.4048068,0.002737532,0.5852214,0.0038459438,0.0011373253,0.000015581301,0.00006748247,0.000264394,0.0011556062,7.013343e-7,0.00047072387,0.00027650507],"about_ca_topic_score_codex":0.0075837607,"about_ca_topic_score_gemma":0.0038792507,"teacher_disagreement_score":0.21122539,"about_ca_system_score_codex":0.0005143517,"about_ca_system_score_gemma":0.0015117772,"threshold_uncertainty_score":0.9990248},"labels":[],"label_agreement":null},{"id":"W2169912183","doi":"10.1038/sj.bjc.6600623","title":"Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Gene expression; Gene; Biology; Breast cancer; Association (psychology); Mammary gland; Genetic association; Pathology; Medicine; Internal medicine; Oncology; Bioinformatics; Genetics; Cancer research; Genotype; Cancer; Single-nucleotide polymorphism; Psychology","score_opus":0.018877763044691315,"score_gpt":0.28850639442133885,"score_spread":0.26962863137664755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169912183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874409,0.011377031,0.000042353957,0.00079420756,0.00004437637,0.00012379495,0.000045225115,0.000007509697,0.00012459584],"genre_scores_gemma":[0.99719965,0.0017140956,0.00059604255,0.00009089783,0.00010571982,0.0000095669075,0.000016597987,0.000016589436,0.0002508496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998441,0.00007058513,0.0005845141,0.00014138498,0.00057659094,0.00018594842],"domain_scores_gemma":[0.99834096,0.000069528534,0.00095707265,0.000053231834,0.0004767258,0.00010247726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033378942,0.00010555689,0.00055736024,0.0004328288,0.00005945201,0.00003116144,0.000080806996,0.00007989012,0.000581757],"category_scores_gemma":[0.0000703075,0.0000998846,0.00018430577,0.0008047335,0.00005005511,0.00020785481,0.000010912853,0.00018681715,9.673242e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001516744,0.00031094035,0.97499144,0.00003032407,0.00077132875,0.00010644277,0.00065636414,0.00026542286,0.013056489,0.00000752375,0.0011654526,0.008486589],"study_design_scores_gemma":[0.001833446,0.00029719624,0.9757563,0.0011985045,0.001203201,0.00013334873,0.00019820522,0.0005147932,0.018669836,0.000019613679,0.000064640764,0.00011091402],"about_ca_topic_score_codex":0.0008887101,"about_ca_topic_score_gemma":0.0015274307,"teacher_disagreement_score":0.009758734,"about_ca_system_score_codex":0.00020162098,"about_ca_system_score_gemma":0.000066895234,"threshold_uncertainty_score":0.63698316},"labels":[],"label_agreement":null},{"id":"W2170051100","doi":"10.1038/bjc.2012.231","title":"Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial College Healthcare Charity; Cancer Research UK; Brain Tumour Research; Canadian Institutes of Health Research; Imperial College Healthcare NHS Trust; Imperial College London","keywords":"DNA methylation; CpG site; Methylation; Cancer research; Breast cancer; Biology; Cancer; Epigenetics; Gene silencing; Gene expression; Gene; Genetics","score_opus":0.013194726982021851,"score_gpt":0.2330074876359368,"score_spread":0.21981276065391495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170051100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490745,0.012777834,0.00031594656,0.00016117064,0.0013023221,0.00015070531,0.000097051794,0.00000284229,0.00028466847],"genre_scores_gemma":[0.9970836,0.0008916541,0.00004780769,0.000094896146,0.0013951479,0.0000070568726,0.000053876178,0.000020377383,0.0004055791],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99880797,0.00016679945,0.00040985682,0.00012757354,0.00028777766,0.00020003394],"domain_scores_gemma":[0.9990103,0.000013086438,0.00039971614,0.00013564421,0.00034607854,0.00009514995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044109602,0.00010765915,0.00018236382,0.00007070225,0.00006377917,0.000014382517,0.00012288059,0.00016384113,0.00005859375],"category_scores_gemma":[0.00003128943,0.00010181839,0.00014776783,0.00015811561,0.00008859247,0.00003002602,0.00004839498,0.00019175508,0.0000012866576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013036112,0.00037003544,0.17172343,0.00008305855,0.00019284352,0.000010555626,0.00097543857,0.0029567715,0.77485454,0.000078823716,0.013889306,0.033561602],"study_design_scores_gemma":[0.0012996247,0.00010598696,0.8390382,0.0002503492,0.000038769074,0.00047430495,0.00014613036,0.000037296817,0.14467083,0.0000209627,0.013755791,0.00016176117],"about_ca_topic_score_codex":0.00008716378,"about_ca_topic_score_gemma":0.00007320297,"teacher_disagreement_score":0.66731477,"about_ca_system_score_codex":0.00012081037,"about_ca_system_score_gemma":0.00013513425,"threshold_uncertainty_score":0.41520333},"labels":[],"label_agreement":null},{"id":"W2170674868","doi":"10.1038/sj.bjc.6601150","title":"Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axillary Lymph Node Dissection; Breast cancer; Sentinel lymph node; Biopsy; Lymph node; Axillary Dissection; Axilla; Dissection (medical); Quality of life (healthcare); Surgery; Mammary gland; Radiology; Cancer; Pathology; Internal medicine","score_opus":0.012620976819395469,"score_gpt":0.2985745248092951,"score_spread":0.28595354798989964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170674868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98325294,0.015842525,0.000027109807,0.00013428307,0.00026139192,0.0000687819,0.0003322887,0.0000018010488,0.00007886094],"genre_scores_gemma":[0.9957602,0.0038128605,0.00011543946,0.00014992917,0.00010181023,0.000017804014,0.000013453748,0.000018483215,0.000009994581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849993,0.00012166516,0.00071216904,0.00020888909,0.00025865276,0.00019868568],"domain_scores_gemma":[0.99876493,0.000016923912,0.0006152707,0.00010625236,0.00040425372,0.000092374925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016953952,0.00015905697,0.00051326613,0.00006178664,0.000045072953,0.000014430601,0.00008546182,0.00009871178,0.0000506829],"category_scores_gemma":[0.0000520889,0.00016890657,0.00011328907,0.000117006515,0.00014836567,0.000015358588,0.000047737623,0.0000783278,1.80335e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010292636,0.0005724365,0.9893015,0.00014322855,0.00024976328,0.000007909533,0.00008790953,0.00010032865,0.0048531597,0.0000020521236,0.00009729084,0.0035551337],"study_design_scores_gemma":[0.0035261402,0.000023428112,0.9914212,0.0004213088,0.000056472436,0.00014619419,0.00012725545,0.0000068838817,0.0040113875,0.000009805826,0.00009466825,0.00015520521],"about_ca_topic_score_codex":0.0023171494,"about_ca_topic_score_gemma":0.00047841942,"teacher_disagreement_score":0.012507267,"about_ca_system_score_codex":0.00010370237,"about_ca_system_score_gemma":0.00015900769,"threshold_uncertainty_score":0.68878096},"labels":[],"label_agreement":null},{"id":"W2181053294","doi":"10.1038/bjc.2015.368","title":"Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Oncology; Internal medicine; Chemotherapy","score_opus":0.03413820746168045,"score_gpt":0.2742318485938646,"score_spread":0.24009364113218418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181053294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457617,0.013742823,7.8580246e-7,0.00022438903,0.00019030107,0.0002851802,0.000015009448,0.000005241676,0.0009601135],"genre_scores_gemma":[0.9985666,0.00065440004,0.00021673882,0.00025686118,0.000066918525,0.0000057266834,0.000014853405,0.000029664556,0.00018818394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833727,0.00016342672,0.0005292136,0.00017641278,0.00053084205,0.00026281804],"domain_scores_gemma":[0.99847704,0.00007956008,0.00033964758,0.00009189137,0.0006020924,0.00040977987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003468913,0.00015429735,0.0005079596,0.00018286292,0.00003767095,0.000044821678,0.00007470806,0.00005825109,0.00006744954],"category_scores_gemma":[0.00026134888,0.00014435984,0.00010375608,0.00022460599,0.00006375055,0.00014552451,0.000035581565,0.00026595508,0.0000067284527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005090727,0.0027749145,0.826835,0.00014295564,0.0007314865,0.029311292,0.00068689085,0.00006819391,0.008242051,0.0000030116198,0.011724657,0.11438887],"study_design_scores_gemma":[0.022440936,0.001626421,0.9675896,0.0006450898,0.0004503934,0.0022828034,0.00016928965,0.000027568374,0.003528383,0.000020920721,0.0010689292,0.00014963812],"about_ca_topic_score_codex":0.0025584432,"about_ca_topic_score_gemma":0.0004592761,"teacher_disagreement_score":0.14075467,"about_ca_system_score_codex":0.00040425922,"about_ca_system_score_gemma":0.00042207766,"threshold_uncertainty_score":0.58868235},"labels":[],"label_agreement":null},{"id":"W2184585808","doi":"10.1038/bjc.2015.352","title":"RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Vlaamse regering; Institut National Du Cancer; GlaxoSmithKline","keywords":"Medicine; Clear cell renal cell carcinoma; Internal medicine; Renal cell carcinoma; Metastasis; Proportional hazards model; Osteoprotegerin; DKK1; Carcinoma; Oncology; Cancer research; Cancer; Receptor; Wnt signaling pathway; Biology; Signal transduction; Activator (genetics)","score_opus":0.011860528270357489,"score_gpt":0.2347705929940472,"score_spread":0.2229100647236897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184585808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817555,0.017438034,0.0000044591197,0.000047866954,0.000014912426,0.0003439914,0.000056402747,0.0000034716188,0.0003353861],"genre_scores_gemma":[0.99854857,0.0009215289,0.00027125957,0.00006433818,0.000013374621,0.000015559148,0.000024792733,0.000023559058,0.00011704233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998598,0.00009126883,0.00045355078,0.00017819443,0.0004764624,0.0002025363],"domain_scores_gemma":[0.9989206,0.000020443487,0.0004697925,0.00006989323,0.00036100004,0.00015823745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784679,0.00015031036,0.00061162974,0.00016727184,0.000024825797,0.000021893502,0.000046499452,0.000072623065,0.000012322021],"category_scores_gemma":[0.000020193062,0.00011986749,0.000048538983,0.000309068,0.000059892147,0.00020806098,0.00001627159,0.00019474507,3.0119318e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002860121,0.001745011,0.9879298,0.000034430414,0.00009056511,0.0008852364,0.0004221393,0.000019706671,0.0017762176,2.4946962e-8,0.0017098201,0.0025268951],"study_design_scores_gemma":[0.037082165,0.0025091653,0.9354755,0.0008363748,0.00027128487,0.00010037699,0.00011629295,0.000024710767,0.02341236,0.0000018708552,0.00004610528,0.00012374646],"about_ca_topic_score_codex":0.0009623462,"about_ca_topic_score_gemma":0.00041050228,"teacher_disagreement_score":0.052454285,"about_ca_system_score_codex":0.00018676506,"about_ca_system_score_gemma":0.00028636353,"threshold_uncertainty_score":0.4888054},"labels":[],"label_agreement":null},{"id":"W2190726683","doi":"10.1054/bjoc.2000.1615","title":"Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministerstvo Zdravotnictví Ceské Republiky; Terry Fox Foundation; Grantová Agentura České Republiky","keywords":"Transformation (genetics); Human papillomavirus; Virology; Biology; Major histocompatibility complex; Immunology; MHC class I; Papillomaviridae; Medicine; Antigen; Cervical cancer; Genetics; Cancer; Gene; Internal medicine","score_opus":0.012411508695902086,"score_gpt":0.26128233641426446,"score_spread":0.2488708277183624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190726683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95082533,0.04758581,0.00047342456,0.00014065289,0.00030351878,0.00015383915,0.00005113361,0.00001565331,0.00045060387],"genre_scores_gemma":[0.976731,0.017766342,0.00005809988,0.0003402416,0.000026195386,0.000008952882,0.000020409105,0.00002567812,0.0050231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883527,0.0002791409,0.00044424916,0.00010425983,0.000074390184,0.00026267546],"domain_scores_gemma":[0.9992237,0.000073872914,0.00034838173,0.00008653136,0.00024327205,0.000024226525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022002192,0.00014663456,0.00034779846,0.000079625024,0.00023269642,0.000047900656,0.00017819338,0.000091741116,0.0016527127],"category_scores_gemma":[0.00001614919,0.00013213769,0.00009759813,0.0001353352,0.00018811779,0.0003619774,0.000007241299,0.0003659122,0.000029499684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023408486,0.00013253717,0.000069335234,0.000012086392,0.0006567592,0.000053665794,0.0005835254,0.000028143126,0.94368035,0.000011428667,0.004989834,0.047441516],"study_design_scores_gemma":[0.0045552915,0.0008322795,0.0009851278,0.00022650811,0.00012448126,0.0017302564,0.00056519767,6.075291e-7,0.8145154,0.000044967397,0.17621624,0.00020361134],"about_ca_topic_score_codex":0.00081453554,"about_ca_topic_score_gemma":0.00042975563,"teacher_disagreement_score":0.17122641,"about_ca_system_score_codex":0.00010451087,"about_ca_system_score_gemma":0.00012576081,"threshold_uncertainty_score":0.9992599},"labels":[],"label_agreement":null},{"id":"W2193923663","doi":"10.1038/bjc.2015.414","title":"1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of Alberta Hospital","funders":"Alberta Innovates; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; University of Alberta; Alberta Innovates - Health Solutions; Government of Canada","keywords":"Metabolomics; Receiver operating characteristic; Metabolite; Biomarker; Urine; Logistic regression; Medicine; Urinary system; Area under the curve; Internal medicine; Chromatography; Chemistry","score_opus":0.024920823519499744,"score_gpt":0.30396059332623454,"score_spread":0.2790397698067348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193923663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7874317,0.21105897,0.00042347357,0.00016395765,0.0005128633,0.0001439387,0.00015752665,0.0000018052717,0.000105758554],"genre_scores_gemma":[0.91467875,0.079385705,0.004393423,0.000119560485,0.0010079788,0.000110388864,0.000008244943,0.000024935147,0.00027104322],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989983,0.000036117253,0.00040754015,0.0001603928,0.00018079758,0.00021688336],"domain_scores_gemma":[0.99874693,0.000017796601,0.00042449156,0.00009571911,0.0006041922,0.0001108901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003741557,0.00011282477,0.0003664283,0.00007464329,0.000044573695,0.000018973868,0.00018710532,0.00007171378,0.00002714442],"category_scores_gemma":[0.00022810342,0.00011558092,0.00019708218,0.00012197344,0.000059018064,0.000009221881,0.00006520426,0.000098326534,2.1341641e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023827022,0.0008997696,0.35608682,0.00041095566,0.0035218915,0.00009833479,0.00015040449,0.0017371173,0.3184595,0.0003172161,0.09328303,0.22265224],"study_design_scores_gemma":[0.0056725536,0.0019890803,0.03273778,0.00033023526,0.0007290387,0.00067813706,0.000354012,0.000045126522,0.6033661,0.0006692465,0.3529066,0.0005221273],"about_ca_topic_score_codex":0.00020092363,"about_ca_topic_score_gemma":0.00017727708,"teacher_disagreement_score":0.32334903,"about_ca_system_score_codex":0.000035452267,"about_ca_system_score_gemma":0.00030628033,"threshold_uncertainty_score":0.47132534},"labels":[],"label_agreement":null},{"id":"W2196018385","doi":"10.1038/bjc.2015.402","title":"Aristolochic acid exposure in Romania and implications for renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Cancer Institute; Medical Research Council; National Institute of Environmental Health Sciences; lékařská fakulta Univerzity Karlovy; European Commission; Univerzita Karlova v Praze; World Health Organization","keywords":"Aristolochic acid; Renal cell carcinoma; Aristolochia; Biology; Medicine; Pathology; Genetics; Traditional medicine","score_opus":0.027832125731379182,"score_gpt":0.29504470512085595,"score_spread":0.2672125793894768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196018385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700356,0.027215438,0.00021990038,0.0015722094,0.0001291501,0.0002246748,0.000035736753,0.0000033128576,0.00056395505],"genre_scores_gemma":[0.99718654,0.00067456835,0.00095971255,0.00057673565,0.0003480553,0.000020044075,0.0000039580973,0.000009244955,0.00022115589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993363,0.0000185658,0.0002771372,0.00008889891,0.00013781602,0.00014125348],"domain_scores_gemma":[0.9993437,0.000025635432,0.0001409737,0.000054791675,0.0002047007,0.00023022137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002780148,0.00006089539,0.00024652673,0.00008041577,0.000029569652,0.000014506767,0.00005405759,0.00005928326,0.000010329678],"category_scores_gemma":[0.000098181285,0.00006201329,0.00004345299,0.000076703844,0.000036382942,0.00008337034,0.000009260377,0.00021787871,4.9472436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003402481,0.00068516034,0.4217428,0.0006179671,0.00014234861,0.002220604,0.0017018005,0.000017244874,0.17407988,0.00017871514,0.092388794,0.30282223],"study_design_scores_gemma":[0.008970246,0.0012334822,0.93795615,0.00074970926,0.00017451918,0.010524123,0.00038973277,0.000012136345,0.0064602294,0.00069408235,0.032712225,0.00012337502],"about_ca_topic_score_codex":0.00024181633,"about_ca_topic_score_gemma":0.0009039597,"teacher_disagreement_score":0.51621336,"about_ca_system_score_codex":0.00007682114,"about_ca_system_score_gemma":0.00034128822,"threshold_uncertainty_score":0.25288287},"labels":[],"label_agreement":null},{"id":"W2232773455","doi":"10.1054/bjoc.1999.1045","title":"The United Kingdom Childhood Cancer Study: objectives, materials and methods","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Moorfields Eye Hospital NHS Foundation Trust; Hospital for Sick Children; Great Ormond Street Hospital for Children; Trent University; University of Southampton; Middlesex University; Queen Mary University of London; National Research Program for Biopharmaceuticals; University of Oxford; Alder Hey Children's NHS Foundation Trust","keywords":"Residence; Medicine; Ionizing radiation; Childhood cancer; Cancer; Population; Pediatrics; Demography; Disease; Environmental health; Family medicine; Pathology; Internal medicine; Physics","score_opus":0.030012509791039536,"score_gpt":0.38884936910249324,"score_spread":0.3588368593114537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232773455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584113,0.036714185,0.000022050783,0.0033621166,0.00070861494,0.0004984751,0.000040969055,0.000024824536,0.00021748849],"genre_scores_gemma":[0.95906585,0.034051165,0.0010237606,0.003048003,0.002096951,0.000055567434,0.0000029983812,0.00006604011,0.0005896698],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99716765,0.0007522567,0.00087583746,0.00025043273,0.00060868217,0.00034512748],"domain_scores_gemma":[0.99841875,0.00029532454,0.0004522797,0.00022032076,0.0003623275,0.00025100415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022054436,0.00020215429,0.0006909651,0.00011030424,0.0003344928,0.00022748906,0.00022284109,0.0000832506,0.001496265],"category_scores_gemma":[0.00023568113,0.00016873406,0.00012393354,0.00036276566,0.0001820015,0.00018113764,0.00003983187,0.00048653455,0.0000022804581],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012272848,0.00063542713,0.017088879,0.00009826206,0.0017376615,0.00029393402,0.005320938,0.000043859258,0.0014286556,0.000025993952,0.006154079,0.965945],"study_design_scores_gemma":[0.005362853,0.00058127556,0.8001572,0.001631912,0.0005682815,0.0022136564,0.0014360327,0.000003708117,0.0020406782,0.00020475479,0.18553102,0.00026861427],"about_ca_topic_score_codex":0.023405869,"about_ca_topic_score_gemma":0.0051032314,"teacher_disagreement_score":0.9656764,"about_ca_system_score_codex":0.00016084986,"about_ca_system_score_gemma":0.00045504898,"threshold_uncertainty_score":0.99941653},"labels":[],"label_agreement":null},{"id":"W2278983443","doi":"10.1038/bjc.2016.22","title":"Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; Toronto General Hospital; Toronto East General Hospital; York Central Hospital; University Health Network","funders":"University of Toronto; University Health Network","keywords":"Hazard ratio; Medicine; Internal medicine; Odds ratio; Oncology; Epidermal growth factor receptor; Mutation; Cohort; Population; Proportional hazards model; Confidence interval; Cancer; Biology; Genetics; Gene","score_opus":0.015872836115168393,"score_gpt":0.385789185036649,"score_spread":0.3699163489214806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278983443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700856,0.00082831905,0.0007887645,0.00033293967,0.0003999743,0.00025098165,0.00020507502,0.000004816375,0.00018058844],"genre_scores_gemma":[0.9981801,0.001012716,0.00035438285,0.000075292635,0.0002603243,0.000009169477,0.000025205083,0.000015333895,0.00006749522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986295,0.00010356262,0.00071993563,0.000120530196,0.00029085574,0.00013558743],"domain_scores_gemma":[0.9981275,0.00016291936,0.00066123286,0.00004826383,0.00088197243,0.00011808834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016135632,0.000088865076,0.00033362227,0.00013672773,0.000028291248,0.000012463183,0.00003747674,0.00008084541,0.00037090408],"category_scores_gemma":[0.00038346785,0.00006685529,0.00022479634,0.00013619015,0.000049358732,0.0004648363,0.0000057924813,0.00014629713,0.0000042724414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005656714,0.00036340655,0.52338916,0.000012397753,0.0002890608,0.00008463775,0.0001376853,0.000008132346,0.0005444391,0.0000028751394,0.00054100994,0.47406152],"study_design_scores_gemma":[0.0072211092,0.0011202241,0.9883332,0.0013154683,0.00016814494,0.00014945448,0.000038687904,0.000006805096,0.0014145817,0.00010134395,0.000060886654,0.000070093716],"about_ca_topic_score_codex":0.0014607416,"about_ca_topic_score_gemma":0.00020343892,"teacher_disagreement_score":0.47399142,"about_ca_system_score_codex":0.0007276168,"about_ca_system_score_gemma":0.00046013907,"threshold_uncertainty_score":0.40611395},"labels":[],"label_agreement":null},{"id":"W2284575850","doi":"10.1038/bjc.2016.21","title":"Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Oncology; Biomarker; Urology; Confidence interval","score_opus":0.027802235006813142,"score_gpt":0.29442682614684274,"score_spread":0.26662459114002957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284575850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955811,0.0022339332,0.0002867319,0.00012322699,0.0001713601,0.0012023972,0.00033618265,0.0000043088335,0.000060797753],"genre_scores_gemma":[0.9976214,0.000117256444,0.0018535397,0.00005528624,0.00019035042,0.000047951842,0.000015273728,0.000032789598,0.000066120425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981691,0.00009373096,0.0008555976,0.00018592802,0.00046573614,0.00022989954],"domain_scores_gemma":[0.99789673,0.00040110832,0.00086749817,0.00011796312,0.00048821402,0.00022849644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003305302,0.0001691042,0.0008002458,0.00011578404,0.00007332098,0.000018712813,0.00006998037,0.000043692413,0.00011617235],"category_scores_gemma":[0.00021708866,0.00011537351,0.0002451609,0.00007974691,0.00009556541,0.00013564155,0.000019290555,0.000091768045,1.8231259e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7330748,0.0020139504,0.088757016,0.0002604354,0.0015324842,0.0010154742,0.00027124945,0.0000036796152,0.015481272,8.4124656e-7,0.00033638597,0.15725242],"study_design_scores_gemma":[0.8790612,0.011532823,0.09708143,0.0010293024,0.0019780484,0.00026839037,0.00004799679,0.000015026624,0.008584846,0.000031074098,0.00020420752,0.00016560759],"about_ca_topic_score_codex":0.0003922525,"about_ca_topic_score_gemma":0.00005682369,"teacher_disagreement_score":0.1570868,"about_ca_system_score_codex":0.00014854429,"about_ca_system_score_gemma":0.00024408668,"threshold_uncertainty_score":0.47047952},"labels":[],"label_agreement":null},{"id":"W2295297667","doi":"10.1038/bjc.2016.28","title":"Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis","year":2016,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Ottawa; Hospital for Sick Children","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Confidence interval; Logistic regression; Febrile neutropenia; Mucositis; Neutropenia; Internal medicine; Chemotherapy","score_opus":0.10499446424668663,"score_gpt":0.3575099082461568,"score_spread":0.2525154439994702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295297667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67165947,0.29350382,0.00025128663,0.0017945195,0.010694466,0.0022358198,0.016202688,0.000099181554,0.0035587586],"genre_scores_gemma":[0.9230258,0.063329786,0.00052431744,0.0010454963,0.0042693755,0.00025405144,0.0017265793,0.00010956344,0.005715061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593645,0.00043459903,0.0017433931,0.00070757436,0.000533873,0.0006441256],"domain_scores_gemma":[0.99745667,0.000099604105,0.0013185024,0.00054348825,0.00035696992,0.00022476731],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001394663,0.00040510384,0.002746169,0.00048792505,0.0001079876,0.0001763677,0.00058674184,0.00052472897,0.0017116872],"category_scores_gemma":[0.00043054108,0.00033000522,0.0010440986,0.0013307144,0.00012706815,0.0004678498,0.00033658795,0.0017034861,0.0000056475565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024808335,0.00044230756,0.8033189,0.000071340095,0.09100534,0.0003919173,0.000021397209,0.00055803696,0.0001059071,0.00000534157,0.09900442,0.0048270095],"study_design_scores_gemma":[0.0027091554,0.00024009755,0.7970462,0.0007679401,0.17100355,0.0020832673,0.00000827824,0.000024007559,0.000021966269,0.000037570127,0.025715243,0.00034274705],"about_ca_topic_score_codex":0.028644316,"about_ca_topic_score_gemma":0.08951293,"teacher_disagreement_score":0.25136632,"about_ca_system_score_codex":0.0005222388,"about_ca_system_score_gemma":0.0013676295,"threshold_uncertainty_score":0.9999152},"labels":[],"label_agreement":null},{"id":"W2297139589","doi":"10.1038/bjc.2016.18","title":"Arpin downregulation in breast cancer is associated with poor prognosis","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada; Institut National Du Cancer; Ligue Contre le Cancer; Fondation ARC pour la Recherche sur le Cancer; Russian Foundation for Basic Research; Agence Nationale de la Recherche","keywords":"Downregulation and upregulation; Breast cancer; Medicine; Cancer; Oncology; Internal medicine; Pathology; Biology; Genetics","score_opus":0.005909351375411245,"score_gpt":0.2330615791105795,"score_spread":0.22715222773516827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297139589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928215,0.0048802434,0.0001782159,0.001696723,0.00010876194,0.00010701063,0.00014747962,0.0000029542396,0.000057124016],"genre_scores_gemma":[0.9961639,0.0026408448,0.00006146656,0.00043596988,0.00036915168,0.000029756044,0.000003404715,0.000015682206,0.00027983251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992622,0.00003950801,0.00021909531,0.0001329799,0.00017911837,0.00016708886],"domain_scores_gemma":[0.99942786,0.0000041379626,0.00022559136,0.000048686226,0.00022961712,0.000064121785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015055164,0.00008070885,0.00013848835,0.00003627813,0.000028481923,0.000023663808,0.00009020278,0.00009285835,0.00018008071],"category_scores_gemma":[0.00002206592,0.000062562125,0.000058661026,0.000082461505,0.000031241616,0.000017407945,0.000017154463,0.00006899902,7.213108e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027305173,0.00009069026,0.02343086,0.000007724831,0.00013176317,0.000059340135,0.00001698521,0.000013434055,0.83857894,0.0000044627272,0.006684771,0.13070796],"study_design_scores_gemma":[0.002976288,0.00025321892,0.13858764,0.0021019944,0.000048241138,0.00046757306,0.000014843333,0.000008712622,0.850165,0.00012237231,0.005018577,0.00023555077],"about_ca_topic_score_codex":0.000249987,"about_ca_topic_score_gemma":0.0012151714,"teacher_disagreement_score":0.13047242,"about_ca_system_score_codex":0.000073983654,"about_ca_system_score_gemma":0.00019056957,"threshold_uncertainty_score":0.25512093},"labels":[],"label_agreement":null},{"id":"W2299393310","doi":"10.1038/bjc.2016.3","title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Occupational Cancer Research Centre; University of Alberta; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Cachexia; Medicine; Internal medicine; Cancer; Proteases; Wasting; Endocrinology; Cytokine; Gastroenterology; Biology; Enzyme","score_opus":0.021445345647760437,"score_gpt":0.3363336739466974,"score_spread":0.3148883282989369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299393310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612801,0.028818784,0.00004561796,0.009329469,0.00020712164,0.00022219204,0.0000563694,0.000005128172,0.000035227353],"genre_scores_gemma":[0.97896874,0.019961549,0.0003196642,0.00029000704,0.00022802081,0.000010017921,7.5157885e-7,0.000012426533,0.00020881632],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998893,0.0000380559,0.00059233425,0.00009963262,0.00025258158,0.00012435036],"domain_scores_gemma":[0.99849236,0.000026590267,0.0006289331,0.00007258798,0.0006455982,0.00013395825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002348141,0.00006549026,0.00030441504,0.00011814221,0.00005443985,0.000008008567,0.000047957143,0.00005199119,0.00018971751],"category_scores_gemma":[0.00010874691,0.000055894092,0.00007951781,0.00011135222,0.00014745537,0.00011255221,0.000014544277,0.00008716613,3.9443304e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060299196,0.00011308418,0.024838211,0.0003560712,0.00016188115,0.00005538931,0.000110391586,9.720064e-7,0.79234797,0.000019258343,0.0038977168,0.17749608],"study_design_scores_gemma":[0.005586019,0.0003785292,0.67625254,0.009185631,0.00024948196,0.0009530423,0.0001088545,0.000011314924,0.29831213,0.00033768496,0.008502894,0.00012186734],"about_ca_topic_score_codex":0.001254532,"about_ca_topic_score_gemma":0.00018511606,"teacher_disagreement_score":0.65141433,"about_ca_system_score_codex":0.000082892075,"about_ca_system_score_gemma":0.00028654755,"threshold_uncertainty_score":0.22792949},"labels":[],"label_agreement":null},{"id":"W2299537488","doi":"10.1038/bjc.2016.32","title":"Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Breast Cancer Foundation; National Institute for Health and Care Research; Cancer Research UK","keywords":"Mammography; Medicine; BRCA mutation; Breast cancer; Mutation; Oncology; Breast cancer screening; Cancer; Internal medicine; Genetics; Biology","score_opus":0.04558454609485871,"score_gpt":0.3541114611240218,"score_spread":0.3085269150291631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299537488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015424973,0.9862025,0.0025920442,0.000054409393,0.00013294618,0.00036526204,0.009100304,0.0000016659079,0.000008411637],"genre_scores_gemma":[0.009855834,0.98701566,0.001221945,0.00008521884,0.00011388102,0.00006084384,0.0015961356,0.000031877407,0.000018571573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738514,0.000307921,0.0011197639,0.00045420427,0.0004521673,0.00028080939],"domain_scores_gemma":[0.9976959,0.00005009198,0.0012722414,0.00035992207,0.0004529558,0.00016885251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006839186,0.00024839485,0.0016005188,0.00035662277,0.000049269143,0.000080048616,0.00041919097,0.00024592062,0.00006785339],"category_scores_gemma":[0.000213272,0.00023225587,0.0006946736,0.0006544144,0.00010663254,0.000025533145,0.00020511531,0.00023328263,2.0437591e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003331587,0.000026133093,0.00019336822,0.00023599999,0.051409855,0.00003997667,0.00004506751,0.00013319011,0.000039273764,0.000001047538,0.004737691,0.9431051],"study_design_scores_gemma":[0.0005659128,0.00014944532,0.0003857692,0.0009514052,0.06868534,0.00011931036,0.000044987595,0.000001435727,0.0001835091,0.000009641063,0.9286001,0.0003031582],"about_ca_topic_score_codex":0.00047151226,"about_ca_topic_score_gemma":0.002271173,"teacher_disagreement_score":0.94280195,"about_ca_system_score_codex":0.000094350464,"about_ca_system_score_gemma":0.00056401227,"threshold_uncertainty_score":0.94711196},"labels":[],"label_agreement":null},{"id":"W2301004704","doi":"10.1038/bjc.2016.58","title":"The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Incidence (geometry); Medicine; Prospective cohort study; Oncology; Cohort; Cohort study; Internal medicine; Gynecology","score_opus":0.005350874409664672,"score_gpt":0.2798680364894681,"score_spread":0.2745171620798034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301004704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972154,0.0020645405,0.00015003273,0.00014411594,0.00011850746,0.00019546742,0.000016737225,0.0000011008156,0.00009410119],"genre_scores_gemma":[0.99679935,0.002666832,0.00018987735,0.000039121067,0.00012738221,0.00008190067,6.294539e-7,0.000009371206,0.000085543084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923664,0.000054981323,0.00025621368,0.00014079102,0.00021035354,0.00010103675],"domain_scores_gemma":[0.9991964,0.000025354531,0.00022553367,0.00010020645,0.00041332448,0.00003916704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041223408,0.00005833142,0.00010557246,0.00003529587,0.000047651887,0.000035342237,0.00018801133,0.00003033562,0.000020277168],"category_scores_gemma":[0.00011903018,0.000041050174,0.000014142529,0.00007311524,0.00016037047,0.000029387007,0.000034953366,0.00007006653,1.2637713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004050826,0.00007790677,0.89649266,0.0000027126407,0.00019475707,0.000022980872,0.00043347917,0.00013118635,0.008902203,0.000009681764,0.00007980068,0.09324756],"study_design_scores_gemma":[0.0013785706,0.0004805699,0.990616,0.000109166765,0.000014544874,0.00024451324,0.00084464246,0.0000032496257,0.005029254,0.00019325099,0.0010179193,0.00006829687],"about_ca_topic_score_codex":0.00016103113,"about_ca_topic_score_gemma":0.0037760742,"teacher_disagreement_score":0.09412338,"about_ca_system_score_codex":0.00021297605,"about_ca_system_score_gemma":0.0003585675,"threshold_uncertainty_score":0.2107138},"labels":[],"label_agreement":null},{"id":"W2306896657","doi":"10.1038/bjc.2016.94","title":"Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"European Social Fund; National Cancer Institute; Instituto de Salud Carlos III; Medical Research Council; Prostate Cancer UK; Xunta de Galicia; Royal Marsden NHS Foundation Trust; Francis Crick Institute; Royal College of Radiologists; National Institute for Health and Care Research; Cancer Research UK; American Cancer Society; National Institutes of Health; NIHR Cambridge Biomedical Research Centre; European Regional Development Fund; U.S. Department of Defense","keywords":"Prostate cancer; Genetic predisposition; Radiation therapy; Medicine; Single-nucleotide polymorphism; Oncology; Toxicity; Genome-wide association study; Prostate; Internal medicine; Cancer; Biology; Genetics; Genotype; Gene; Disease","score_opus":0.007831549296548515,"score_gpt":0.2679854492678708,"score_spread":0.2601538999713223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306896657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150604,0.0049419054,0.00019982363,0.001300126,0.00015407115,0.0006541777,0.0012155272,0.0000139874755,0.000014365352],"genre_scores_gemma":[0.97600764,0.022388069,0.0006240264,0.00055485894,0.00020827066,0.00009306145,0.0000045305806,0.000031837175,0.00008770029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813604,0.00021746481,0.0006265366,0.000239526,0.00051676936,0.00026368877],"domain_scores_gemma":[0.9976637,0.00019342142,0.0008425091,0.0001902061,0.0007912086,0.00031900173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005298695,0.00017448833,0.000644016,0.000090016976,0.000068357505,0.000028723676,0.00010058012,0.00007261283,0.00040559],"category_scores_gemma":[0.00025952954,0.00010739874,0.00013898977,0.00020691873,0.00009862233,0.00014735784,0.000016979004,0.0001553696,5.522601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027549716,0.00055096566,0.82769686,0.000049005488,0.00086325133,0.00015816647,0.00022623842,0.00010396871,0.021360137,0.0000011774952,0.00035506874,0.14588019],"study_design_scores_gemma":[0.007920032,0.0014628363,0.95199406,0.0028208059,0.0005505371,0.00007018335,0.000015382677,0.000017202343,0.034534425,0.00005293672,0.00040912424,0.00015247152],"about_ca_topic_score_codex":0.02215305,"about_ca_topic_score_gemma":0.025023384,"teacher_disagreement_score":0.14572772,"about_ca_system_score_codex":0.0011007054,"about_ca_system_score_gemma":0.0006270642,"threshold_uncertainty_score":0.9927674},"labels":[],"label_agreement":null},{"id":"W2308659819","doi":"10.1038/bjc.2016.41","title":"Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"PARP inhibitor; Medicine; BRCA mutation; Ovarian cancer; Tolerability; Breast cancer; Olaparib; Dosing; Cancer; Pharmacodynamics; Internal medicine; Oncology; Pharmacology; Cancer research; Adverse effect; Pharmacokinetics; Biology; Poly ADP ribose polymerase; Polymerase; Genetics","score_opus":0.01034263473245879,"score_gpt":0.3000696872213802,"score_spread":0.28972705248892144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308659819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97890526,0.015390437,0.00012557687,0.004268816,0.00057643984,0.0005031211,0.00021306479,0.000008042928,0.0000092574755],"genre_scores_gemma":[0.9960165,0.0019939572,0.00072081183,0.0004442287,0.0007220061,0.000033318713,0.0000016988911,0.000031084088,0.00003641436],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830145,0.00012230876,0.00072763243,0.0002204843,0.00038239988,0.00024570033],"domain_scores_gemma":[0.99840426,0.00009379861,0.00083917024,0.00011071754,0.000331569,0.00022045891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002730495,0.00017529122,0.0005005713,0.00012268107,0.000087165696,0.000045117325,0.00007581405,0.000078801946,0.00006855121],"category_scores_gemma":[0.00014323786,0.00012228127,0.000075646814,0.0001980418,0.00043222852,0.00034429,0.000026846908,0.00028878584,6.854253e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02361539,0.0002839403,0.031969678,0.00014125288,0.00022589466,0.0002467998,0.0010529101,0.000020240992,0.14740203,0.000013413149,0.00008402502,0.7949444],"study_design_scores_gemma":[0.59639794,0.0021600062,0.14477693,0.049409095,0.00067904143,0.009587632,0.002314957,0.0002657317,0.19278966,0.00014260024,0.000816035,0.00066037185],"about_ca_topic_score_codex":0.001041992,"about_ca_topic_score_gemma":0.0012666392,"teacher_disagreement_score":0.79428405,"about_ca_system_score_codex":0.000270149,"about_ca_system_score_gemma":0.00055422576,"threshold_uncertainty_score":0.49864855},"labels":[],"label_agreement":null},{"id":"W2316917175","doi":"10.1038/bjc.2014.391","title":"BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Women's College Hospital; Ontario Institute for Cancer Research","funders":"Cancer Care Ontario","keywords":"Haploinsufficiency; Downregulation and upregulation; Medicine; Messenger RNA; Breast cancer; Cancer; Internal medicine; Biology; Oncology; Phenotype; Gene; Genetics","score_opus":0.0160760138488231,"score_gpt":0.2954893353750299,"score_spread":0.2794133215262068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316917175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734103,0.009457128,0.015653923,0.00018580756,0.0007127909,0.00008304621,0.00001636489,0.000005335333,0.0004753033],"genre_scores_gemma":[0.9944764,0.00030718843,0.003595782,0.00029546174,0.0006339156,0.000014345974,0.00000760195,0.000031104268,0.00063823344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989357,0.00009904971,0.00033599604,0.00017890935,0.00025464513,0.00019568884],"domain_scores_gemma":[0.9992192,0.000012295927,0.00029639978,0.00012958341,0.0002550295,0.00008752057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004904391,0.00011126989,0.0002056779,0.000053866355,0.0000646844,0.00007562082,0.00020561602,0.000083972074,0.00009481184],"category_scores_gemma":[0.00011266586,0.000116494004,0.00020837918,0.00010823542,0.000053915126,0.000017846201,0.00003801379,0.00016381526,0.0000022524703],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674151,0.00022902773,0.008822733,0.000060257527,0.0009359697,0.0001450747,0.000099066994,0.0018572912,0.090837575,0.00002038267,0.007866559,0.8885586],"study_design_scores_gemma":[0.01644602,0.005036761,0.112841375,0.0024642127,0.00065425533,0.0051505915,0.00038923052,0.00018131832,0.39019823,0.00068126916,0.46478236,0.0011743676],"about_ca_topic_score_codex":0.00017383923,"about_ca_topic_score_gemma":0.0017619819,"teacher_disagreement_score":0.8873843,"about_ca_system_score_codex":0.00008041343,"about_ca_system_score_gemma":0.00020160672,"threshold_uncertainty_score":0.47504878},"labels":[],"label_agreement":null},{"id":"W2339914653","doi":"10.1038/bjc.2016.71","title":"Adjuvant ovarian function suppression and cognitive function in women with breast cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council; ECOG-ACRIN Cancer Research Group; Canadian Cancer Society Research Institute; National Institutes of Health; National Cancer Institute; Breast Cancer Trials; National Breast Cancer Foundation; Ipsen; Swiss Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Pfizer; Oncosuisse; American College of Radiology Imaging Network","keywords":"Exemestane; Tamoxifen; Medicine; Breast cancer; Internal medicine; Oncology; Aromatase inhibitor; Gynecology; Cancer","score_opus":0.007049452502438039,"score_gpt":0.2521743627771369,"score_spread":0.24512491027469885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339914653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826836,0.013035649,0.0005515606,0.0024702912,0.00055225694,0.00030285335,0.00012657436,0.0000151486865,0.00026208334],"genre_scores_gemma":[0.98747206,0.010730202,0.000011995013,0.0006719882,0.00056919147,0.00009042923,0.0000011620768,0.000026942633,0.0004260324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987337,0.000055944805,0.00034102297,0.00020955865,0.00036526716,0.000294515],"domain_scores_gemma":[0.99879736,0.00006586998,0.00028245035,0.000046297646,0.0006358289,0.00017218954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021667288,0.00014771616,0.00038359957,0.00016378611,0.000080917554,0.00002661515,0.000027421782,0.00007581829,0.0009923239],"category_scores_gemma":[0.00005238326,0.0001044552,0.00003918207,0.00020683819,0.0001420841,0.0003950536,0.000024977713,0.0002738976,0.000002153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0202264,0.00012146071,0.14149772,0.000057200985,0.0005596202,0.0002516086,0.00022003773,0.0000034144953,0.0024934986,0.0000014755141,0.0014741041,0.83309346],"study_design_scores_gemma":[0.013020076,0.001235626,0.96754473,0.011807509,0.00052271265,0.0022945022,0.0006419711,0.0000030158071,0.00024447055,0.00007099697,0.002460861,0.0001535217],"about_ca_topic_score_codex":0.0005603372,"about_ca_topic_score_gemma":0.0012860426,"teacher_disagreement_score":0.8329399,"about_ca_system_score_codex":0.00043498268,"about_ca_system_score_gemma":0.00027603479,"threshold_uncertainty_score":0.9999209},"labels":[],"label_agreement":null},{"id":"W2340482034","doi":"10.1038/bjc.2015.347","title":"Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; National Cancer Institute; National Institutes of Health; Damon Runyon Cancer Research Foundation; State of Connecticut Department of Public Health; Gary Bennett Family Fund; Uehara Memorial Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; Entertainment Industry Foundation","keywords":"CDH1; Colorectal cancer; Medicine; Oncology; Microsatellite instability; Metastasis; Pathology; Cancer; Odds ratio; Internal medicine; Cancer research; Cadherin; Biology; Cell","score_opus":0.008716596819252777,"score_gpt":0.2376419024685291,"score_spread":0.22892530564927632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340482034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199766,0.006780378,0.00062529574,0.00017940335,0.000087744564,0.000046692167,0.00007752436,0.0000025629506,0.0002027331],"genre_scores_gemma":[0.9918822,0.00699638,0.00050440396,0.00015223655,0.00012358352,0.0000074085638,0.000003501481,0.00001819247,0.00031210395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909997,0.00005367423,0.00029410073,0.00015420147,0.00023936175,0.00015866986],"domain_scores_gemma":[0.9990589,0.000020223695,0.000406857,0.000054114793,0.00038252986,0.00007739325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017543203,0.000114497154,0.00023809136,0.000032443917,0.000045472883,0.000022217475,0.00013175342,0.000082979226,0.00013299607],"category_scores_gemma":[0.00008067768,0.00008438648,0.00006712708,0.000073407624,0.00013321562,0.000019721394,0.000039927534,0.00006288316,3.2279175e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003256345,0.000043456337,0.050685823,0.000026047226,0.00038586048,0.000050502887,0.000094421004,0.0000065416416,0.93501645,0.0000028647278,0.0026581173,0.010704301],"study_design_scores_gemma":[0.0018722967,0.00014567374,0.048151843,0.0011387762,0.0000649156,0.0002161964,0.000043268003,3.8290256e-7,0.9468796,0.000056783414,0.0012667266,0.00016353118],"about_ca_topic_score_codex":0.000051367744,"about_ca_topic_score_gemma":0.00003590793,"teacher_disagreement_score":0.011863177,"about_ca_system_score_codex":0.00002728723,"about_ca_system_score_gemma":0.0002050992,"threshold_uncertainty_score":0.3441181},"labels":[],"label_agreement":null},{"id":"W2342252157","doi":"10.1038/bjc.2016.79","title":"Hypoxia-activated prodrugs: paths forward in the era of personalised medicine","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prodrug; Hypoxia (environmental); Drug; Pharmacology; Tumor hypoxia; Cancer research; Tirapazamine; Effector; Biology; Medicine; Immunology; Internal medicine; In vitro; Cytotoxicity; Chemistry; Radiation therapy; Biochemistry; Oxygen","score_opus":0.01965660309295139,"score_gpt":0.3163151735600061,"score_spread":0.2966585704670547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342252157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011753923,0.99642646,0.000014807292,0.00020017748,0.0012928377,0.00038191775,0.00019219365,0.0000017083895,0.00031448447],"genre_scores_gemma":[0.00061240187,0.99335843,0.000034171415,0.0002096799,0.0053295237,0.000056841545,0.000028338505,0.000044479035,0.00032614905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977954,0.00028389643,0.0009588031,0.0002559542,0.0004335266,0.0002724311],"domain_scores_gemma":[0.9981031,0.000053125,0.0011707525,0.0002487304,0.00033501285,0.000089286594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007864175,0.00027023556,0.0013409953,0.000088987086,0.000038207883,0.00002072431,0.0005598174,0.00027238124,0.00014314105],"category_scores_gemma":[0.0002528996,0.00017404245,0.0005590676,0.00021141123,0.00018499061,0.000009647013,0.000045290843,0.0005116269,8.687908e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058194837,0.000042594183,0.0000029016423,0.0011755769,0.00025394704,0.000026192594,0.00008337806,4.0820345e-7,0.0019120014,0.0000039270944,0.014833212,0.9816077],"study_design_scores_gemma":[0.0011528038,0.00014831396,0.00008297004,0.021701088,0.00039142353,0.0010220396,0.00007041575,5.330192e-8,0.00023211456,0.000018859215,0.9749802,0.00019975308],"about_ca_topic_score_codex":0.00024822535,"about_ca_topic_score_gemma":0.0002919119,"teacher_disagreement_score":0.98140794,"about_ca_system_score_codex":0.00005532488,"about_ca_system_score_gemma":0.00094534055,"threshold_uncertainty_score":0.7097245},"labels":[],"label_agreement":null},{"id":"W2342916871","doi":"10.1038/bjc.2016.75","title":"Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Cancer Institute NSW; Cancer Australia","keywords":"Medicine; Cancer; Gerontology; End-of-life care; Health care; Cohort; Demography; Epidemiology; Health economics; Cohort study; Public health; Environmental health; Intensive care medicine; Emergency medicine; Palliative care; Internal medicine; Pathology; Nursing","score_opus":0.030503970559503768,"score_gpt":0.2649838652299107,"score_spread":0.23447989467040692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342916871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84053445,0.1551067,0.00012203594,0.0031701305,0.000118454125,0.0001827496,0.00063407427,0.0000014528721,0.00012993508],"genre_scores_gemma":[0.94905746,0.048682764,0.00012297984,0.002014064,0.00006742212,0.00001464471,0.0000012296591,0.000013467269,0.000025979774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822646,0.00007368552,0.0011101069,0.00024046397,0.00008836833,0.00026093033],"domain_scores_gemma":[0.9972725,0.00015574935,0.0019996995,0.00014971032,0.00028300207,0.00013936618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043280568,0.00013266764,0.001134365,0.00037055538,0.000026723676,0.000028839167,0.00021751778,0.000059671835,0.000082873165],"category_scores_gemma":[0.00008227609,0.000114741466,0.00011102012,0.00039490577,0.00011382634,0.00047939,0.000023835331,0.00019733445,5.999528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041020283,0.00013000968,0.9627385,0.000048922702,0.00048907945,0.000013596694,0.0046569686,0.0003112977,0.000005515673,0.0004915181,0.0012638087,0.029440576],"study_design_scores_gemma":[0.0028416726,0.00025575992,0.99045324,0.0008307495,0.00003289394,0.00000884513,0.00095603324,0.000054115488,0.0000018752672,0.00033532575,0.0040970575,0.00013240267],"about_ca_topic_score_codex":0.5026318,"about_ca_topic_score_gemma":0.65555656,"teacher_disagreement_score":0.1529248,"about_ca_system_score_codex":0.0021795768,"about_ca_system_score_gemma":0.0009831459,"threshold_uncertainty_score":0.5699517},"labels":[],"label_agreement":null},{"id":"W2344227124","doi":"10.1038/bjc.2015.415","title":"Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Cohort; Cancer; Cohort study; Internal medicine; Nuclear medicine; Oncology; Pathology; Radiology","score_opus":0.037087759392889344,"score_gpt":0.37425454398414176,"score_spread":0.33716678459125243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344227124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937273,0.004672131,0.00038672664,0.0007465156,0.00004022204,0.000107072075,0.00021099056,0.0000016505184,0.0001073828],"genre_scores_gemma":[0.99797964,0.0017563774,0.00010783682,0.000019675583,0.00009237847,0.0000015553466,0.0000014444729,0.000008028707,0.00003308101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905854,0.00010518562,0.00044806115,0.0000641945,0.00023393169,0.0000900559],"domain_scores_gemma":[0.99847084,0.00045545926,0.0007421711,0.00007293222,0.00017617154,0.00008239475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045633453,0.000058807735,0.00026727773,0.00011564014,0.000055446988,0.000011283517,0.00005106204,0.000023142624,0.000045105713],"category_scores_gemma":[0.00038897194,0.000039881812,0.00011164205,0.00017000527,0.00014116595,0.00018748475,0.000013554225,0.00016124966,4.1823483e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008634873,0.000017602382,0.98027927,0.000036290498,0.000112576796,0.0000054144975,0.00005782439,0.00007205854,0.0016178442,0.000024600415,0.00059812685,0.017169787],"study_design_scores_gemma":[0.0015797599,0.000121627636,0.9955231,0.00087747857,0.00029511456,0.0002865512,0.0000758471,0.00003086509,0.0007163636,0.00043656994,0.000015583244,0.000041138825],"about_ca_topic_score_codex":0.00084075186,"about_ca_topic_score_gemma":0.00007083839,"teacher_disagreement_score":0.017128648,"about_ca_system_score_codex":0.00013877165,"about_ca_system_score_gemma":0.0005498643,"threshold_uncertainty_score":0.16263331},"labels":[],"label_agreement":null},{"id":"W2345027487","doi":"10.1038/bjc.2016.72","title":"Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Refractory (planetary science); Prodrug; Medicine; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Cancer research; Pharmacology; Materials science","score_opus":0.024082570526278997,"score_gpt":0.33491649223630054,"score_spread":0.31083392171002155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345027487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978781,0.0004291541,0.00068701303,0.00012730488,0.00025637483,0.00049610366,0.00010614708,0.0000021271437,0.000017707014],"genre_scores_gemma":[0.9982367,0.0005284689,0.0009006068,0.000036015455,0.00012772232,0.000017499302,0.000024007582,0.000024236388,0.000104730956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982052,0.00009746673,0.0009448082,0.0002591136,0.00027986942,0.00021356637],"domain_scores_gemma":[0.99850684,0.00006292998,0.00086041354,0.00015100978,0.0003241941,0.000094589064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000513422,0.00013941435,0.0004103661,0.00009083386,0.000023839168,0.0000131867355,0.00013863033,0.000096178635,0.000023911027],"category_scores_gemma":[0.0003323239,0.00009651188,0.000115973475,0.00012479068,0.000076337776,0.000019085901,0.000017616047,0.00013958314,1.927373e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.533333,0.0071017933,0.007942939,0.00009236857,0.0002645721,0.0002030944,0.00005893512,0.0017957236,0.19350664,0.0000016587741,0.00042639213,0.2552729],"study_design_scores_gemma":[0.69823176,0.018819258,0.053867936,0.0034200684,0.00016397983,0.000051705465,0.000054770102,0.00016122508,0.20895103,0.000019784024,0.015681278,0.0005772325],"about_ca_topic_score_codex":0.000058530062,"about_ca_topic_score_gemma":0.0018351926,"teacher_disagreement_score":0.25469565,"about_ca_system_score_codex":0.000053356758,"about_ca_system_score_gemma":0.00034716097,"threshold_uncertainty_score":0.39356405},"labels":[],"label_agreement":null},{"id":"W2346159484","doi":"10.1038/bjc.2016.120","title":"First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Bayer","keywords":"Pharmacokinetics; Medicine; Radiation therapy; Adverse effect; Toxicity; Melanoma; Chemotherapy; Internal medicine; Surgery; Urology; Pathology; Oncology; Cancer research","score_opus":0.004820713414701175,"score_gpt":0.24263595231626423,"score_spread":0.23781523890156306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346159484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859726,0.000886397,0.000034817647,0.000041401432,0.000074015064,0.00031814876,0.00004061548,0.0000017170041,0.000005620897],"genre_scores_gemma":[0.9995889,0.00011035369,0.00016148415,0.000030613217,0.000050722836,0.000018125766,0.0000035446637,0.000016701759,0.000019564615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999006,0.00012714975,0.00033507522,0.00015722297,0.00025376867,0.000120804405],"domain_scores_gemma":[0.9994247,0.000012981225,0.00028160083,0.00013680363,0.000113105074,0.000030828236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018496212,0.00009459026,0.00021620093,0.00006576918,0.000020942885,0.000010925107,0.00015035494,0.000043690372,0.00002829735],"category_scores_gemma":[0.000020597125,0.000061879706,0.000046713438,0.00011098432,0.000041255713,0.00001755119,0.000022699898,0.00007797538,4.576525e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020546305,0.004651828,0.92333865,0.0000143290445,0.00024891208,0.00010450333,0.00035976397,0.0002018956,0.0492988,0.000003828346,0.00017987701,0.019542972],"study_design_scores_gemma":[0.038754325,0.005295726,0.8392241,0.0008540227,0.000036260688,0.000016981625,0.0001782447,0.000006997019,0.11494446,0.000036336365,0.0004880031,0.0001645485],"about_ca_topic_score_codex":0.0010229902,"about_ca_topic_score_gemma":0.025126262,"teacher_disagreement_score":0.08411457,"about_ca_system_score_codex":0.000083098304,"about_ca_system_score_gemma":0.000076394805,"threshold_uncertainty_score":0.99266267},"labels":[],"label_agreement":null},{"id":"W2396983630","doi":"10.1038/bjc.2015.443","title":"CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; Damon Runyon Cancer Research Foundation; Canadian Institutes of Health Research; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Canadian Cancer Society Research Institute; U.S. Department of Health and Human Services; National Institutes of Health; Sociedad Española de Oncología Médica; Ministerio de Economía y Competitividad; National Human Genome Research Institute; Ontario Institute for Cancer Research; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Division of Cancer Prevention, National Cancer Institute","keywords":"CYP24A1; Medicine; Colorectal cancer; Internal medicine; Progestogen; Logistic regression; Oncology; Cancer; Vitamin D and neurology; Hormone; Calcitriol receptor","score_opus":0.02386945472366439,"score_gpt":0.29910306347991517,"score_spread":0.2752336087562508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396983630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1156295,0.88317615,0.000011233757,0.000029497753,0.00021334713,0.00042465827,0.0004992023,0.0000027996962,0.0000136078015],"genre_scores_gemma":[0.0041430355,0.9945637,0.000041736497,0.000014891751,0.0009347798,0.00006245349,0.000022441367,0.000047121273,0.00016985653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981985,0.00042375032,0.0006205776,0.00021960255,0.00029029298,0.00024725928],"domain_scores_gemma":[0.99752176,0.00017809636,0.0017841281,0.00012584294,0.0002935944,0.00009658297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053044996,0.00024851016,0.00091205625,0.000049394323,0.000107976164,0.00007720689,0.00025121417,0.0005320253,0.000014152004],"category_scores_gemma":[0.00017627343,0.00015896934,0.00046032557,0.00009372832,0.00010960691,0.000014125971,0.00006853052,0.00045457706,8.9162927e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007026958,0.000019946136,0.0026886107,0.00028143247,0.0033069905,0.00002756267,0.000022280028,0.00000740652,0.0003305626,0.0000032333214,0.0008390441,0.9924027],"study_design_scores_gemma":[0.001102054,0.0003864819,0.0021736156,0.00655923,0.0018677616,0.0006121585,0.0000050593517,0.0000011585302,0.0019503969,0.000018855928,0.98500484,0.00031836118],"about_ca_topic_score_codex":0.0003915487,"about_ca_topic_score_gemma":0.000060941875,"teacher_disagreement_score":0.9920843,"about_ca_system_score_codex":0.00014863434,"about_ca_system_score_gemma":0.0008517072,"threshold_uncertainty_score":0.64825815},"labels":[],"label_agreement":null},{"id":"W2409151805","doi":"10.1038/bjc.2015.432","title":"Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Saskatchewan; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Biomarker; Internal medicine; Proportional hazards model; Neutrophil to lymphocyte ratio; Receiver operating characteristic; Complete blood count; Oncology; Cohort; Absolute neutrophil count; Gastroenterology; Urology; Cancer; Lymphocyte; Neutropenia; Chemotherapy","score_opus":0.020662572961699693,"score_gpt":0.28863703082779735,"score_spread":0.26797445786609764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409151805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364114,0.0039759465,0.00007546521,0.00052452495,0.00084958656,0.0006431746,0.00025912424,0.0000064959613,0.000024562323],"genre_scores_gemma":[0.99910617,0.00015885975,0.00016818703,0.00025653094,0.00015339143,0.00008210381,0.0000061608566,0.000025248572,0.000043351567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980173,0.00008571299,0.00082730426,0.00013637239,0.00073726516,0.00019601989],"domain_scores_gemma":[0.9979937,0.00010808785,0.00070763775,0.00014536516,0.0008923797,0.0001527958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048567867,0.00011333401,0.00037116153,0.0001104248,0.000053249554,0.000030749954,0.0002002722,0.00008131791,0.000035683264],"category_scores_gemma":[0.00058111065,0.00009724756,0.00020460061,0.00017494966,0.00016531973,0.00012425435,0.000024369512,0.00017489844,4.6807617e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005447804,0.00041057236,0.993323,0.00022930022,0.0003939825,0.00001874386,0.000064950735,0.00013427701,0.00033420388,0.0000030210456,0.0014156665,0.003127465],"study_design_scores_gemma":[0.015481962,0.00022218461,0.9768984,0.0020494629,0.0007901668,0.000028088372,0.00009727873,0.00020666637,0.0027229218,0.00003576264,0.0013509305,0.00011622495],"about_ca_topic_score_codex":0.00014918618,"about_ca_topic_score_gemma":0.00064624246,"teacher_disagreement_score":0.016424686,"about_ca_system_score_codex":0.00032083914,"about_ca_system_score_gemma":0.0011262483,"threshold_uncertainty_score":0.39656404},"labels":[],"label_agreement":null},{"id":"W2418450403","doi":"10.1038/bjc.2016.119","title":"Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Direction Générale de l’offre de Soins","keywords":"Medicine; Sorafenib; Toxicity; Quality of life (healthcare); Internal medicine; Adverse effect; Clinical endpoint; Melanoma; Phases of clinical research; Surgery; Progression-free survival; Oncology; Clinical trial; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05332202115739489,"score_gpt":0.400707147021521,"score_spread":0.3473851258641261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418450403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438203,0.013456099,0.0000053607905,0.0015509278,0.00009223305,0.0004633636,0.000026581649,0.000003140639,0.00002026797],"genre_scores_gemma":[0.9986639,0.0010008746,0.00011379778,0.00012905367,0.000023812307,0.0000067295177,0.0000010258324,0.000008287627,0.00005248856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981277,0.0003543175,0.0009818132,0.00013385282,0.00021829267,0.00018400424],"domain_scores_gemma":[0.999009,0.00012613928,0.00052436703,0.00007256364,0.0000954082,0.0001725009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010290926,0.0000907171,0.0007741917,0.0001163384,0.000035406363,0.0000040654527,0.000048651706,0.00005070796,0.000091889764],"category_scores_gemma":[0.0003081754,0.00007162965,0.00006758351,0.00013949731,0.00007178039,0.00009499443,0.00002424584,0.0002035006,6.6906176e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027444353,0.012434971,0.7884451,0.00007865844,0.000504885,0.0019704385,0.0013789833,0.000004428098,0.00033461393,0.000004266788,0.00007672298,0.19202249],"study_design_scores_gemma":[0.0890273,0.0031167485,0.90599406,0.00084286946,0.00011995695,0.0002645816,0.00037799292,0.00000535527,0.00011372085,0.00004071116,0.000034741344,0.00006195235],"about_ca_topic_score_codex":0.0039392957,"about_ca_topic_score_gemma":0.020921765,"teacher_disagreement_score":0.19196054,"about_ca_system_score_codex":0.00021259184,"about_ca_system_score_gemma":0.0004508355,"threshold_uncertainty_score":0.9969439},"labels":[],"label_agreement":null},{"id":"W2422966071","doi":"10.1038/bjc.2015.471","title":"Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Cancer Institute NSW","keywords":"Serous fluid; Ovarian cancer; Cancer research; Immunohistochemistry; Cancer; Biology; Cell growth; Cell culture; Medicine; Pathology; Immunology; Internal medicine; Biochemistry","score_opus":0.016944504501309826,"score_gpt":0.2887340898848981,"score_spread":0.27178958538358833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422966071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726362,0.022364767,0.00023294793,0.0040243524,0.00017151165,0.0003315452,0.00006877507,0.000013252747,0.0001566381],"genre_scores_gemma":[0.97702986,0.019550567,0.0012915389,0.00074374664,0.00024050854,0.000029752855,0.0000033951032,0.00005121026,0.0010594446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775815,0.00013203567,0.00065468665,0.0002764442,0.00071035314,0.00046831986],"domain_scores_gemma":[0.99856716,0.0000658797,0.00028984513,0.00015277226,0.00049959344,0.0004247301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002538656,0.0001742457,0.00051721267,0.00023819452,0.00005569321,0.000050061528,0.00014534495,0.00013929831,0.0007957306],"category_scores_gemma":[0.00010597797,0.00014570994,0.00009959438,0.0003016059,0.00010636092,0.0002296915,0.000076642704,0.0004938006,0.0000055491623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016769551,0.00042958432,0.00803169,0.0001576435,0.00015576954,0.0056158733,0.00033769957,0.00031620005,0.7431513,0.000008361061,0.007982825,0.23213612],"study_design_scores_gemma":[0.053282578,0.004203475,0.1747772,0.011927443,0.00037115262,0.0077509964,0.0004068686,0.0011572373,0.70345527,0.003680787,0.03770153,0.0012854877],"about_ca_topic_score_codex":0.00506336,"about_ca_topic_score_gemma":0.0010328734,"teacher_disagreement_score":0.23085062,"about_ca_system_score_codex":0.00032230577,"about_ca_system_score_gemma":0.00060940644,"threshold_uncertainty_score":0.8712692},"labels":[],"label_agreement":null},{"id":"W24231946","doi":"10.1038/bjc.2013.592","title":"Binary circular calculations method for the objects classification using their form","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Scientific Research Methods","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Binary number; Mathematics; Computer science; Artificial intelligence; Pattern recognition (psychology); Arithmetic","score_opus":0.14101413715624586,"score_gpt":0.4272705887020305,"score_spread":0.2862564515457846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W24231946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68426764,0.021463128,0.28455946,0.0073533948,0.0010473115,0.0008827287,0.00012997269,0.00002714525,0.00026921908],"genre_scores_gemma":[0.94896084,0.0011720564,0.048352472,0.0003541582,0.00094797317,0.000016495494,0.0000060012776,0.0000016411576,0.00018837741],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989713,0.00014736624,0.00026231544,0.00012927744,0.0002784518,0.00021132999],"domain_scores_gemma":[0.99872863,0.0005180802,0.00023100218,0.000044432647,0.00039756246,0.00008030254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015502465,0.00006364247,0.00014295033,0.00001530791,0.00047211396,0.00013737913,0.0002842198,0.000044784163,0.00007515813],"category_scores_gemma":[0.0002403669,0.000024304441,0.00016766172,0.00035151042,0.000049958977,0.00027184834,0.000014405306,0.00016127565,2.831877e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012027116,0.000017745548,0.00004582314,0.0000014548332,0.000011419108,0.0000032817425,0.000037368533,0.0008274263,0.33159095,0.000038104074,0.0002644774,0.6671499],"study_design_scores_gemma":[0.0008126538,0.0005469013,0.62973094,0.000365876,0.00012821105,0.0009886924,0.0023457585,0.1093701,0.021143816,0.031687293,0.202439,0.00044075],"about_ca_topic_score_codex":0.000119209486,"about_ca_topic_score_gemma":0.00028287532,"teacher_disagreement_score":0.6667092,"about_ca_system_score_codex":0.000082663246,"about_ca_system_score_gemma":0.000049066137,"threshold_uncertainty_score":0.36311665},"labels":[],"label_agreement":null},{"id":"W2461857735","doi":"10.1038/bjc.2016.212","title":"Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Nordic Pharma Group","keywords":"Nomogram; Pancreatic cancer; Medicine; Oncology; Internal medicine; Overall survival; Survival analysis; Cancer","score_opus":0.01888264858534303,"score_gpt":0.3256208548997112,"score_spread":0.30673820631436816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461857735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833381,0.012235163,0.00023614593,0.00271473,0.00019349907,0.00072289415,0.000048664955,0.000015313693,0.00049547973],"genre_scores_gemma":[0.97951263,0.0176131,0.0005960996,0.00044928023,0.00031950508,0.000131868,0.0000016315548,0.00003091059,0.0013449762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980789,0.00011429845,0.00058589847,0.00025042714,0.00050038216,0.00047012197],"domain_scores_gemma":[0.998362,0.00026586538,0.00018716641,0.00012169474,0.0006085772,0.0004547207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048061143,0.00016364639,0.0007977349,0.00018931688,0.000050889306,0.00003308439,0.00012661332,0.000116420575,0.0004675566],"category_scores_gemma":[0.00085822644,0.00012349828,0.00007550084,0.00025300228,0.00015780887,0.00016758237,0.00004688427,0.00030835744,0.0000049107766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015324028,0.00012607507,0.7588456,0.00009519826,0.0001714934,0.0010767793,0.0000714005,0.0000114974755,0.0016328642,0.000007400952,0.00057104963,0.23585822],"study_design_scores_gemma":[0.00892726,0.0012418634,0.9781008,0.007736743,0.00026304982,0.000983355,0.000043851083,0.00007396317,0.0001391978,0.00010613467,0.0022324482,0.0001513759],"about_ca_topic_score_codex":0.0017463433,"about_ca_topic_score_gemma":0.0051641837,"teacher_disagreement_score":0.23570685,"about_ca_system_score_codex":0.00036825633,"about_ca_system_score_gemma":0.0009662208,"threshold_uncertainty_score":0.5119417},"labels":[],"label_agreement":null},{"id":"W2462587944","doi":"10.1038/bjc.2016.195","title":"Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas MD Anderson Cancer Center; Curtin University of Technology; Melanoma Research Alliance","keywords":"Melanoma; Immune checkpoint; Immune system; Disease; Computational biology; Medicine; Precision medicine; Biology; Bioinformatics; Cancer research; Immunotherapy; Immunology; Genetics; Internal medicine","score_opus":0.013800042175460794,"score_gpt":0.29672233756004146,"score_spread":0.2829222953845807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462587944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012365038,0.98455495,0.0022186546,0.000012740978,0.0002708513,0.00027224942,0.00026352928,0.000002024224,0.000039955812],"genre_scores_gemma":[0.0048214262,0.992796,0.0015869145,0.000020243415,0.00058584474,0.000040195868,0.000043598684,0.000043158165,0.00006259383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884564,0.00008035526,0.0006298859,0.00017093193,0.0001182693,0.00015493085],"domain_scores_gemma":[0.9984277,0.000054314976,0.0011218047,0.00012188074,0.00021834027,0.000055989585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017741452,0.00018126568,0.00082687143,0.000050910927,0.000045023822,0.00003114437,0.00015661448,0.00030128672,0.000027888675],"category_scores_gemma":[0.00018351548,0.00015589184,0.00036810816,0.000037936486,0.000053935106,0.0000051962706,0.00003594268,0.00014058547,2.2819408e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044403576,0.000017016759,0.0000066467355,0.0018652758,0.00044033764,0.00004613837,0.000024081968,1.8414295e-7,0.01954036,0.00006697199,0.000038753773,0.9779098],"study_design_scores_gemma":[0.0005057181,0.00055299874,0.00005393122,0.025202274,0.00047644653,0.0029933292,0.000018354785,4.5172837e-7,0.010709616,0.00041942307,0.9587587,0.00030875823],"about_ca_topic_score_codex":0.000016355594,"about_ca_topic_score_gemma":0.000005811189,"teacher_disagreement_score":0.97760105,"about_ca_system_score_codex":0.000019548648,"about_ca_system_score_gemma":0.0002277143,"threshold_uncertainty_score":0.6357085},"labels":[],"label_agreement":null},{"id":"W2471425782","doi":"10.1038/bjc.2016.188","title":"Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"FP7 Health; National Center for Chronic Disease Prevention and Health Promotion; Kuopion Yliopistollinen Sairaala; National Cancer Institute; Academy of Finland; National Institute on Alcohol Abuse and Alcoholism; Medical Research Council; National Institutes of Health; Goddard Space Flight Center; Centers for Disease Control and Prevention; NordForsk; China Scholarship Council; Jane ja Aatos Erkon Säätiö; Opetus- ja Kulttuuriministeriö; Wellcome Trust; University of Southern California; Cancer Research UK; Netherlands eScience Center; European Commission; Cancer Research Wales; California Department of Public Health; McKnight Foundation; National Institute for Social Care and Health Research; Tenovus","keywords":"Medicine; Body mass index; Odds ratio; Confounding; Internal medicine; Obesity; Waist–hip ratio; Colorectal cancer; Overweight; Waist; Oncology; Cancer","score_opus":0.014888602128018262,"score_gpt":0.3190005981402095,"score_spread":0.30411199601219124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471425782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027158031,0.96817404,0.0037671805,0.000036289457,0.00011475423,0.00019955904,0.00051747117,0.0000017478096,0.00003094942],"genre_scores_gemma":[0.01197393,0.98636246,0.0010968221,0.000012919197,0.0003454021,0.000055308275,0.000061077626,0.000023443337,0.000068665446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981631,0.00033840231,0.0008713329,0.00024334107,0.00016134161,0.00022245865],"domain_scores_gemma":[0.99675936,0.00007756531,0.0024295729,0.00011834663,0.00053639483,0.00007875282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062741025,0.00020186986,0.0014311756,0.0001310007,0.00007671186,0.000017991872,0.0002337323,0.000275931,0.000058082835],"category_scores_gemma":[0.00015097181,0.00015289143,0.00062714436,0.00025358115,0.00008019197,0.0000052066475,0.000042519678,0.00018593275,4.7935544e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120741424,0.00001984291,0.0178524,0.0003478112,0.010555367,0.0000040733876,0.0000091453,0.0002533161,0.00010799443,0.000001981506,0.00055918196,0.9701682],"study_design_scores_gemma":[0.003666094,0.00043614677,0.062053688,0.008979646,0.023399105,0.0003440748,0.000026385804,0.000011851602,0.0005374514,0.000042605498,0.8997293,0.0007736559],"about_ca_topic_score_codex":0.0008227067,"about_ca_topic_score_gemma":0.0039297272,"teacher_disagreement_score":0.9693945,"about_ca_system_score_codex":0.00014604769,"about_ca_system_score_gemma":0.000973046,"threshold_uncertainty_score":0.62347317},"labels":[],"label_agreement":null},{"id":"W2472707660","doi":"10.1038/bjc.2016.185","title":"Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Capecitabine; Oncology; Pancreatic cancer; Regimen; Cancer; Gastroenterology; Performance status; Fluorouracil; Neutropenia; Chemotherapy; Colorectal cancer","score_opus":0.026351328569758692,"score_gpt":0.3404186780141752,"score_spread":0.3140673494444165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472707660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698718,0.02494104,0.0009904401,0.0018498565,0.0002853725,0.0012914557,0.00063691655,0.000016025077,0.00011710001],"genre_scores_gemma":[0.96530133,0.01468158,0.0037224006,0.0015604472,0.0008304741,0.0012620307,0.000010001102,0.00009643136,0.012535294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972469,0.00011737125,0.00086598925,0.0003346882,0.00076287484,0.0006721301],"domain_scores_gemma":[0.99687654,0.00044307357,0.00044982805,0.00024974602,0.001551826,0.0004289729],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005262905,0.0003056816,0.0012714387,0.00019492707,0.0000887783,0.000050169914,0.00018447476,0.00011516218,0.011978385],"category_scores_gemma":[0.00031750833,0.00017446784,0.00024328227,0.00023531457,0.00028243192,0.00035683924,0.00003409869,0.00030368904,0.000010347316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07838471,0.0010256064,0.69692403,0.00068480027,0.0032955708,0.0016581293,0.0003519392,0.0000031477286,0.00043696855,0.000006864705,0.00717967,0.21004856],"study_design_scores_gemma":[0.047109548,0.0060518784,0.9023641,0.004372689,0.0013126109,0.0007561927,0.00006365639,0.000034280358,0.00025762885,0.00016257775,0.037113145,0.0004016936],"about_ca_topic_score_codex":0.00020457331,"about_ca_topic_score_gemma":0.0018894374,"teacher_disagreement_score":0.20964687,"about_ca_system_score_codex":0.00054769067,"about_ca_system_score_gemma":0.001488642,"threshold_uncertainty_score":0.9889248},"labels":[],"label_agreement":null},{"id":"W2480793872","doi":"10.1038/bjc.2016.222","title":"FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"FOLFIRINOX; Medicine; Pancreatic cancer; Retrospective cohort study; Cancer; Gemcitabine; Adverse effect; Internal medicine; Surgery; Oncology; Irinotecan; Colorectal cancer","score_opus":0.026805956087333185,"score_gpt":0.3727332787228895,"score_spread":0.34592732263555637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480793872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378483,0.04577438,0.0007378425,0.0135754775,0.000666528,0.0007540274,0.00011399846,0.000015112189,0.00051427574],"genre_scores_gemma":[0.90143275,0.08679875,0.0007562979,0.0009849446,0.0011476295,0.00052955066,0.0000012089066,0.000039748567,0.008309097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980087,0.000085520034,0.0005671242,0.0002377171,0.00056677667,0.00053411484],"domain_scores_gemma":[0.99788475,0.00041640396,0.00041076905,0.00020606721,0.0008073956,0.00027458754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003962575,0.00016362828,0.0006652088,0.000059085138,0.00020149593,0.000038487928,0.00033906498,0.0000969873,0.0018188988],"category_scores_gemma":[0.00039479812,0.00009821995,0.00019867445,0.00016704752,0.0003216509,0.00021176583,0.000048381193,0.00024963802,0.0000034361287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012380686,0.0000974625,0.45224115,0.00014716055,0.00041250346,0.00019397924,0.00050089264,0.000009343206,0.0035912201,0.0000654693,0.010241146,0.5312616],"study_design_scores_gemma":[0.0142719345,0.0006678532,0.6134803,0.009723581,0.0010769226,0.0014047694,0.0010395143,0.00010744623,0.008103259,0.00053322583,0.3491621,0.0004290688],"about_ca_topic_score_codex":0.0013367542,"about_ca_topic_score_gemma":0.0031553188,"teacher_disagreement_score":0.5308325,"about_ca_system_score_codex":0.0004904551,"about_ca_system_score_gemma":0.0012560838,"threshold_uncertainty_score":0.9990936},"labels":[],"label_agreement":null},{"id":"W2501897050","doi":"10.1038/bjc.2016.225","title":"Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’’","year":2016,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Incidence (geometry); Prospective cohort study; Medicine; Cohort; Cohort study; Oncology; Internal medicine; Pediatrics","score_opus":0.008450640374822252,"score_gpt":0.2928092350950046,"score_spread":0.2843585947201824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501897050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514261,0.0004730145,0.00004135761,0.046995662,0.00024643852,0.0005851488,0.00014945504,0.0000016438566,0.00008121103],"genre_scores_gemma":[0.93841803,0.00061817263,0.00021148898,0.058837224,0.0010567096,0.0003909484,0.0000104432565,0.00004324115,0.0004137245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982824,0.00027313802,0.000430464,0.0003233754,0.0004987788,0.0001918658],"domain_scores_gemma":[0.9986243,0.00008412716,0.00044505793,0.00023480767,0.0005557831,0.000055915672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008549761,0.00015953173,0.0002650784,0.00015755359,0.000050222003,0.00006351377,0.00042935528,0.0001532421,0.00007202738],"category_scores_gemma":[0.00026009316,0.0001301237,0.000033323086,0.00012345577,0.00013304592,0.000021840406,0.00007823583,0.00045167597,7.593456e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015999012,0.0004917327,0.543845,0.00006481237,0.0028736617,0.0016350702,0.0038063629,0.0009828556,0.014195875,0.000004726762,0.34141898,0.07468191],"study_design_scores_gemma":[0.0023916957,0.002385792,0.822101,0.0011475803,0.000058211524,0.00052014296,0.00051136897,0.0000015724414,0.0031650502,0.000113586626,0.16728465,0.0003193578],"about_ca_topic_score_codex":0.00016053754,"about_ca_topic_score_gemma":0.0005823332,"teacher_disagreement_score":0.27825597,"about_ca_system_score_codex":0.00069657795,"about_ca_system_score_gemma":0.00065319025,"threshold_uncertainty_score":0.53062904},"labels":[],"label_agreement":null},{"id":"W2514715491","doi":"10.1038/bjc.2016.243","title":"A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"Alberta Cancer Foundation; University of Calgary","keywords":"Metabolomics; Colorectal cancer; Receiver operating characteristic; Medicine; Biomarker; Internal medicine; Stage (stratigraphy); Oncology; Cancer; Adenoma; Bioinformatics; Biology","score_opus":0.023198479378307997,"score_gpt":0.3248935800824965,"score_spread":0.30169510070418853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514715491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9451756,0.04967614,0.0025987595,0.0005981178,0.0011473442,0.00023602042,0.0005370532,0.0000015274246,0.000029437522],"genre_scores_gemma":[0.9345284,0.06342865,0.0011790928,0.000094577255,0.0005214877,0.000027747596,0.0000044209187,0.00001904611,0.00019657999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985806,0.00014039247,0.000748788,0.00017420706,0.0001914706,0.00016458366],"domain_scores_gemma":[0.998053,0.000066370994,0.0010169377,0.00013202247,0.000681872,0.000049783965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006913415,0.00011590287,0.0005035363,0.00004065244,0.000051684427,0.000010099221,0.0002813867,0.00014978118,0.00003099282],"category_scores_gemma":[0.0004998005,0.00007674422,0.0004361579,0.00012715466,0.00019421153,0.0000183102,0.00007897989,0.00011801168,9.2573174e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062053866,0.000081506514,0.0037579932,0.000024636689,0.00076570926,8.8177893e-7,0.000016926664,0.000081064165,0.9492181,0.0002844014,0.0039582127,0.041190065],"study_design_scores_gemma":[0.002195839,0.00031821453,0.017565913,0.00014010421,0.00037051193,0.000024028932,0.00003840638,0.000005617827,0.92835665,0.0006035543,0.050257128,0.0001240462],"about_ca_topic_score_codex":0.000068994275,"about_ca_topic_score_gemma":0.00036748435,"teacher_disagreement_score":0.046298917,"about_ca_system_score_codex":0.000019676212,"about_ca_system_score_gemma":0.0003413789,"threshold_uncertainty_score":0.31295383},"labels":[],"label_agreement":null},{"id":"W2515981989","doi":"10.1038/bjc.2016.272","title":"Increased pancreatic cancer risk following radiotherapy for testicular cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; KWF Kankerbestrijding; National Institute of Allergy and Infectious Diseases; Lance Armstrong Foundation; Karolinska Institutet; Cancer Care Ontario; Armstrong Foundation; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Radiation therapy; Pancreatic cancer; Pancreas; Odds ratio; Cancer; Chemotherapy; Testicular cancer; Internal medicine; Confidence interval; Incidence (geometry); Pancreatic disease; Gastroenterology; Oncology; Surgery; Urology","score_opus":0.02156252843213384,"score_gpt":0.3622311090299166,"score_spread":0.34066858059778277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515981989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88712335,0.10528954,0.003976478,0.002153171,0.0005221258,0.0005934075,0.00017785281,0.00001862973,0.00014544869],"genre_scores_gemma":[0.8446403,0.14335036,0.0054466124,0.000965893,0.0023460316,0.0004929004,0.0000023141918,0.00007975199,0.0026758013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793243,0.0001416385,0.00062669406,0.00023748445,0.0005554363,0.0005063035],"domain_scores_gemma":[0.9976904,0.00069040107,0.00045976948,0.0001678232,0.00060430454,0.0003873058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008652589,0.00018383462,0.0009785099,0.00013348258,0.00017118985,0.00003747651,0.00018180533,0.00014680329,0.0015387398],"category_scores_gemma":[0.0010157871,0.00013433649,0.00042693652,0.00018483018,0.00014698414,0.00017204597,0.000016678947,0.0002876524,0.0000027063595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009651286,0.00012479597,0.712728,0.00010226012,0.0019257843,0.00047182082,0.000070996735,0.000009838841,0.012663067,0.0000072715866,0.008708114,0.2622229],"study_design_scores_gemma":[0.027413657,0.001252632,0.8718692,0.009528264,0.004375769,0.0013657565,0.00007815267,0.00047604734,0.0030716248,0.0004942233,0.079621084,0.00045359],"about_ca_topic_score_codex":0.007385774,"about_ca_topic_score_gemma":0.0013658954,"teacher_disagreement_score":0.2617693,"about_ca_system_score_codex":0.00075432984,"about_ca_system_score_gemma":0.0017640999,"threshold_uncertainty_score":0.999374},"labels":[],"label_agreement":null},{"id":"W2517029840","doi":"10.1038/bjc.2016.249","title":"Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Univariate analysis; Cancer; Gynecology; Multivariate analysis; Confidence interval","score_opus":0.007243945685576175,"score_gpt":0.26830293288121104,"score_spread":0.26105898719563486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517029840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97352284,0.02417464,0.00005838716,0.0012965888,0.00030144298,0.00014581601,0.0004670174,0.0000030245176,0.000030232408],"genre_scores_gemma":[0.9669136,0.032011416,0.0002983116,0.000079735044,0.00037849552,0.00009183091,0.000009990932,0.000022627739,0.00019399695],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990903,0.00005679632,0.00029162745,0.00020105505,0.00013236924,0.00022781394],"domain_scores_gemma":[0.99939615,0.000011898556,0.00020880115,0.00006963399,0.00018957038,0.0001239698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110458575,0.00011353844,0.00016660009,0.000063511005,0.000045972465,0.000036375557,0.00007666228,0.00008902305,0.00016962108],"category_scores_gemma":[0.000022176144,0.00009689896,0.000064839456,0.00008868739,0.000088114444,0.000018625386,0.000018870158,0.00005888333,6.5749475e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025204866,0.000059867845,0.2745624,0.000015016993,0.00025094324,0.000041097333,0.00015175526,0.000103489896,0.07359158,0.000004642924,0.0018210532,0.64914614],"study_design_scores_gemma":[0.010214533,0.0009450396,0.6526522,0.0008397692,0.0002353606,0.0027591444,0.00046268114,0.000011128934,0.18681847,0.00011414088,0.14432913,0.00061838975],"about_ca_topic_score_codex":0.00080901297,"about_ca_topic_score_gemma":0.0048763584,"teacher_disagreement_score":0.64852774,"about_ca_system_score_codex":0.00047042346,"about_ca_system_score_gemma":0.00065552973,"threshold_uncertainty_score":0.3951425},"labels":[],"label_agreement":null},{"id":"W2519636597","doi":"10.1038/bjc.2016.273","title":"Ovarian carcinoma diagnosis: the clinical impact of 15 years of change","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Carcinoma; Ovarian carcinoma; Medicine; Pathology; Oncology; Gynecology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.0846219215148308,"score_gpt":0.3866383915693564,"score_spread":0.3020164700545256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519636597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639632,0.032227896,0.000007273662,0.002893561,0.00042967402,0.00021707712,0.00013145023,0.0000026138857,0.00012723099],"genre_scores_gemma":[0.9672782,0.031264447,0.000086884545,0.00022146793,0.0010463742,0.000037362955,5.5468433e-7,0.000017250308,0.00004747076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998618,0.0000840148,0.00068115944,0.00011400208,0.00033523823,0.00016757524],"domain_scores_gemma":[0.9984849,0.00024933156,0.0006067394,0.00018682206,0.00032110407,0.00015106615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004611436,0.000088480534,0.0005253022,0.000057714573,0.000018923065,0.0000097380225,0.00013591528,0.00007098373,0.0008917215],"category_scores_gemma":[0.00015696525,0.00005312957,0.00053538,0.000121997284,0.0001501981,0.0000996909,0.00002546949,0.00014365539,0.0000025422946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016678934,0.0002432628,0.5583408,0.00001642221,0.00041264377,0.00022865899,0.00006857524,4.5545434e-7,0.00003473626,0.00001045734,0.00581886,0.43465838],"study_design_scores_gemma":[0.0041905735,0.0011976247,0.9841457,0.0019673968,0.00041360286,0.00045222449,0.000021644271,6.820291e-7,0.00052973133,0.000055619403,0.0069682747,0.000056916702],"about_ca_topic_score_codex":0.002906614,"about_ca_topic_score_gemma":0.0003902202,"teacher_disagreement_score":0.43460146,"about_ca_system_score_codex":0.00015495394,"about_ca_system_score_gemma":0.00044183334,"threshold_uncertainty_score":0.97637254},"labels":[],"label_agreement":null},{"id":"W2519828822","doi":"10.1038/bjc.2016.293","title":"Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Ramucirumab; Medicine; Biomarker; Immunohistochemistry; Internal medicine; Cancer; Oncology; Vascular endothelial growth factor; Angiogenesis; Gastroenterology; VEGF receptors; Biology","score_opus":0.016792335087465637,"score_gpt":0.29909963420634667,"score_spread":0.282307299118881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519828822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145896,0.017766349,0.0002215234,0.000075251606,0.00012636145,0.00008643539,0.000077973156,0.0000031985178,0.00018392992],"genre_scores_gemma":[0.9951297,0.004065575,0.00013181372,0.00010533422,0.00019849013,0.000008880955,0.000024152134,0.00002956548,0.0003064611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877584,0.00007705668,0.00038449303,0.00023875634,0.0002443179,0.00027954453],"domain_scores_gemma":[0.99901235,0.000010796688,0.00030477144,0.0001427253,0.0004179454,0.000111412206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113111346,0.00015368822,0.00027572786,0.00010707865,0.00005095974,0.000031547916,0.00017761475,0.00010702024,0.00011811122],"category_scores_gemma":[0.000046534682,0.000111965266,0.00015307877,0.00021380714,0.000094720985,0.000015940119,0.0000327685,0.00006617351,0.0000013865182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005758817,0.00009743335,0.69370586,0.000008695193,0.00016558148,0.00012309139,0.0000051725538,0.000012170966,0.23541072,3.690942e-7,0.0023033991,0.06759159],"study_design_scores_gemma":[0.003679464,0.00048710126,0.92410207,0.00037820032,0.000069571455,0.00019975167,0.000017270146,0.0000030607978,0.0629501,0.0000030652493,0.007901618,0.00020874152],"about_ca_topic_score_codex":0.00051061617,"about_ca_topic_score_gemma":0.00062139484,"teacher_disagreement_score":0.23039617,"about_ca_system_score_codex":0.00008033673,"about_ca_system_score_gemma":0.00017901196,"threshold_uncertainty_score":0.45658112},"labels":[],"label_agreement":null},{"id":"W2529040040","doi":"10.1038/bjc.2016.308","title":"Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Pembrolizumab; Complete response; Radiological weapon; Response Evaluation Criteria in Solid Tumors; Oncology; Hazard ratio; Immunotherapy; Melanoma; Lung cancer; Proportional hazards model; Progressive disease; Cancer; Surgery; Chemotherapy; Confidence interval; Cancer research","score_opus":0.04788620324865843,"score_gpt":0.3419081425565475,"score_spread":0.29402193930788906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529040040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974613,0.0013393577,0.00006444152,0.0004346395,0.00010141794,0.00021013351,0.00038217867,0.000003026462,0.0000034881143],"genre_scores_gemma":[0.99876577,0.00082029443,0.00024223556,0.000081822516,0.00003294736,0.000010289865,0.0000032824796,0.000012960912,0.000030413472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982157,0.00065889524,0.0005748632,0.00012603159,0.00027653572,0.00014802588],"domain_scores_gemma":[0.9988026,0.00031981355,0.0004167598,0.00009536241,0.00025321147,0.00011225305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081555994,0.00010502001,0.0006055814,0.00015813926,0.000025185227,0.00001276166,0.0000643162,0.000045224624,0.00008969609],"category_scores_gemma":[0.00019966901,0.00007322234,0.000073669755,0.00010724056,0.00005678385,0.00015926258,0.000010625303,0.000067903384,1.3951951e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06839099,0.000546032,0.8479434,0.000019417246,0.0002876,0.00014949133,0.0012317472,0.0000036657514,0.051498342,7.2039103e-7,0.000084822736,0.029843748],"study_design_scores_gemma":[0.0120570995,0.0064852913,0.97584397,0.0009515081,0.000096853735,0.000088262546,0.00032868475,0.000002441544,0.0035569763,0.0000052620644,0.00049521227,0.00008844651],"about_ca_topic_score_codex":0.0003955175,"about_ca_topic_score_gemma":0.001232285,"teacher_disagreement_score":0.12790054,"about_ca_system_score_codex":0.00026782783,"about_ca_system_score_gemma":0.00024779543,"threshold_uncertainty_score":0.29859206},"labels":[],"label_agreement":null},{"id":"W2550709057","doi":"10.1038/bjc.2016.368","title":"Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; Canadian Centre for Applied Research in Cancer Control; McGill University; University of British Columbia; BC Centre for Disease Control; BC Cancer Agency","funders":"","keywords":"Colposcopy; Medicine; Referral; Cervical intraepithelial neoplasia; Gynecology; Cervical screening; Cervical cancer; Obstetrics; Internal medicine; Cancer; Family medicine","score_opus":0.026313958836227037,"score_gpt":0.31362751073428374,"score_spread":0.2873135518980567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550709057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96887344,0.017672976,0.0008213119,0.011680704,0.00016293663,0.00055687263,0.00009006882,0.0000034167722,0.00013824362],"genre_scores_gemma":[0.994059,0.004395909,0.000009634593,0.0007592991,0.00067479967,0.000017368779,1.677859e-7,0.000010484353,0.00007329316],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985524,0.00021640169,0.00037620898,0.00012483036,0.00054332457,0.0001868785],"domain_scores_gemma":[0.99902785,0.00035815788,0.00014711525,0.00010374651,0.00018356404,0.00017954306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006688759,0.00007638545,0.00027905387,0.000049425696,0.00007962953,0.000045348108,0.000108960434,0.000054152384,0.0003534429],"category_scores_gemma":[0.00042608913,0.000040068964,0.00010532365,0.0001402995,0.00023182794,0.00012256656,0.000037444595,0.00036275125,8.416902e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06336382,0.000055984903,0.06938182,0.000056907764,0.00006322235,0.00007446449,0.000097368466,0.00001059497,0.0003361102,0.000007874347,0.0001504262,0.86640143],"study_design_scores_gemma":[0.038707636,0.00025177927,0.94923776,0.00043508603,0.00013640113,0.00019366354,0.00007309191,0.00008755884,0.00011731862,0.000063174106,0.010640699,0.000055847915],"about_ca_topic_score_codex":0.0017440397,"about_ca_topic_score_gemma":0.0061015966,"teacher_disagreement_score":0.87985593,"about_ca_system_score_codex":0.00008869527,"about_ca_system_score_gemma":0.00018313539,"threshold_uncertainty_score":0.3869952},"labels":[],"label_agreement":null},{"id":"W2551017385","doi":"10.1038/bjc.2016.383","title":"Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Ontario Institute for Cancer Research","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Cervical cancer; Vismodegib; Cisplatin; Metastasis; Hedgehog signaling pathway; Toxicity; Oncology; Radiation therapy; Cancer; Internal medicine; Hedgehog; Urology; Pharmacology; Chemotherapy; Basal cell carcinoma; Signal transduction; Biology","score_opus":0.009739334376773006,"score_gpt":0.27777978992574925,"score_spread":0.26804045554897626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551017385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96913254,0.030056868,0.0002202,0.000244998,0.00019832775,0.00007477779,0.000025868701,0.0000016653929,0.000044754106],"genre_scores_gemma":[0.97991616,0.019431934,0.00007839393,0.00006449664,0.00043027665,0.000010194394,0.000001897916,0.0000093065255,0.000057331312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991852,0.000056742898,0.00035949147,0.0001320901,0.000136233,0.00013023015],"domain_scores_gemma":[0.99948776,0.00003020198,0.00024263898,0.00005242093,0.00013798563,0.00004899793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019391207,0.00007697054,0.0001936768,0.000053713997,0.000028375453,0.000011402783,0.000055886616,0.00007852655,0.00004416942],"category_scores_gemma":[0.00012749042,0.00006751018,0.00005596646,0.00007677226,0.00008724061,0.000011388425,0.00002865681,0.00006836902,2.6986032e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010778368,0.00004121033,0.051806103,0.000037527592,0.00005267954,0.000020128271,0.00008679356,0.000029029912,0.59030473,0.000004418984,0.00024950365,0.35726008],"study_design_scores_gemma":[0.0020224797,0.00017023867,0.38875943,0.00092522387,0.000024440818,0.00006152259,0.000027126154,0.0000023332907,0.60222584,0.000035438243,0.0056309993,0.00011493301],"about_ca_topic_score_codex":0.00022270258,"about_ca_topic_score_gemma":0.0019714453,"teacher_disagreement_score":0.35714513,"about_ca_system_score_codex":0.000028659635,"about_ca_system_score_gemma":0.00010385992,"threshold_uncertainty_score":0.2752985},"labels":[],"label_agreement":null},{"id":"W2551083370","doi":"10.1038/bjc.2016.380","title":"Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Children’s Oncology Group; National Institutes of Health; Jazz Pharmaceuticals","keywords":"Mucositis; Medicine; Placebo; Transplantation; Internal medicine; Population; Clinical endpoint; Clinical trial; Surgery; Toxicity","score_opus":0.023773989533237935,"score_gpt":0.34638597403771537,"score_spread":0.3226119845044774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551083370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513895,0.011038105,0.0019029516,0.0008087462,0.00031850228,0.00055695086,0.00011675413,0.000004232268,0.00011480177],"genre_scores_gemma":[0.9733111,0.02363354,0.0024785346,0.00005825547,0.00018874154,0.000050875813,0.0000032864086,0.000015779022,0.0002598478],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885607,0.00004418237,0.0005726167,0.00010424142,0.00023941846,0.00018346145],"domain_scores_gemma":[0.9990871,0.000073245814,0.00041805103,0.000049524715,0.00027469426,0.00009739759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002277238,0.00007703096,0.00033281543,0.00012809195,0.000020808311,0.000004696698,0.000044564396,0.000060475377,0.00012619628],"category_scores_gemma":[0.000021071832,0.00006575462,0.0001187942,0.0001344503,0.000027798365,0.00014587743,0.0000030752717,0.00008378615,0.0000010097901],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028761055,0.00069657405,0.21740152,0.0034302108,0.00010434102,0.0006110499,0.00086053513,0.000039857707,0.003468179,0.00002187502,0.001970175,0.7685196],"study_design_scores_gemma":[0.021887487,0.0029647732,0.8987847,0.006305341,0.000798286,0.00143417,0.00009673502,0.000013883335,0.06539437,0.0010070448,0.001122844,0.00019037465],"about_ca_topic_score_codex":0.00046655833,"about_ca_topic_score_gemma":0.001486676,"teacher_disagreement_score":0.7683292,"about_ca_system_score_codex":0.00034910807,"about_ca_system_score_gemma":0.00040785063,"threshold_uncertainty_score":0.26813954},"labels":[],"label_agreement":null},{"id":"W2554303407","doi":"10.1038/bjc.2016.360","title":"Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Trastuzumab; Breast cancer; Clinical trial; Systemic therapy; Oncology; Internal medicine; Population; Intensive care medicine; Adjuvant therapy; Randomized controlled trial; Cancer; Stage (stratigraphy); Adjuvant; Chemotherapy","score_opus":0.053753720127942994,"score_gpt":0.4222511520062968,"score_spread":0.3684974318783538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554303407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001450991,0.99265045,0.000012033679,0.0020807828,0.0004548792,0.0020986048,0.0010834326,0.00001736242,0.00015149268],"genre_scores_gemma":[0.00019020414,0.99500614,0.00009361945,0.00050288346,0.0018645532,0.00062594627,0.0000053577583,0.00014941925,0.0015618537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672973,0.00031965505,0.0010670258,0.0003966245,0.0008705017,0.0006164763],"domain_scores_gemma":[0.9977455,0.00037615228,0.0007425137,0.00030383878,0.0005903301,0.00024167229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013539937,0.0004023149,0.0021066207,0.000265024,0.00009565586,0.00017337991,0.0005243403,0.00033810604,0.001406769],"category_scores_gemma":[0.00007393535,0.00025408855,0.000588258,0.00042085166,0.00020262058,0.00014561812,0.000027004751,0.001158992,0.0000027177969],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037224387,0.00009569008,0.00039190755,0.0036671709,0.00045369106,0.00036926987,0.00012474578,1.3680352e-7,0.0000051979437,0.0000023023856,0.008445163,0.9860725],"study_design_scores_gemma":[0.0041525173,0.00055581355,0.0062846937,0.07227549,0.00020034381,0.0035548036,0.000024752857,0.0000013347064,0.000004206326,0.000022931983,0.9126552,0.0002679424],"about_ca_topic_score_codex":0.002047231,"about_ca_topic_score_gemma":0.001412588,"teacher_disagreement_score":0.98580456,"about_ca_system_score_codex":0.00061104127,"about_ca_system_score_gemma":0.0025274672,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W2554584411","doi":"10.1038/bjc.2016.378","title":"Impact of cause of death adjudication on the results of the European prostate cancer screening trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Adjudication; Prostate; Prostate cancer; Oncology; Cause of death; Clinical trial; Internal medicine; Gynecology; Disease; Political science","score_opus":0.041484834964517235,"score_gpt":0.3363100666499876,"score_spread":0.29482523168547037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554584411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894068,0.0064262515,0.0000092627515,0.002363855,0.00019883574,0.0004966556,0.0005518774,0.0000024375845,0.00054399477],"genre_scores_gemma":[0.9814075,0.01801957,0.000026790314,0.0000677999,0.0002892329,0.00001942458,0.0000013976679,0.000018444034,0.00014984331],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984422,0.00018461676,0.0006859906,0.00010981336,0.00043483786,0.00014256187],"domain_scores_gemma":[0.99773496,0.00015411187,0.0012996696,0.00021311734,0.0005257441,0.000072381474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064564927,0.00009867693,0.00034314574,0.00004796798,0.00004044936,0.000008237094,0.00014917491,0.000026103668,0.000075552976],"category_scores_gemma":[0.0002788767,0.000046276557,0.0002841085,0.00014091059,0.00012149892,0.00007452209,0.00002698083,0.00012988725,3.3996622e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037982456,0.00066222425,0.18665834,0.000075122836,0.0017363636,0.00008899584,0.00059503596,0.00022921954,0.008276843,0.000031965174,0.01085162,0.7528118],"study_design_scores_gemma":[0.034786858,0.0018098861,0.9273213,0.0073121786,0.00036491363,0.00006422498,0.000025527028,0.0000022867725,0.027182095,0.000036882,0.001032524,0.00006130481],"about_ca_topic_score_codex":0.0024830678,"about_ca_topic_score_gemma":0.0002907123,"teacher_disagreement_score":0.7527505,"about_ca_system_score_codex":0.00020848229,"about_ca_system_score_gemma":0.00046248152,"threshold_uncertainty_score":0.37536722},"labels":[],"label_agreement":null},{"id":"W2554614845","doi":"10.1038/bjc.2016.375","title":"The use of drugs acting on the renin–angiotensin system and the incidence of pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Renin–angiotensin system; Pancreatic cancer; Incidence (geometry); Medicine; Cancer; Internal medicine; Endocrinology; Pharmacology; Blood pressure","score_opus":0.02939141161726176,"score_gpt":0.280203789548143,"score_spread":0.25081237793088124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554614845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940193,0.04649627,0.00003900204,0.012277453,0.00042145705,0.00038218877,0.000019287394,0.000006352309,0.00016497597],"genre_scores_gemma":[0.98422056,0.014504232,0.00008154296,0.00020263344,0.0003916483,0.000015880314,4.6278494e-8,0.000020682855,0.00056274235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99790806,0.00032260694,0.00077077345,0.00012470232,0.0006651082,0.00020873488],"domain_scores_gemma":[0.9948115,0.0026715002,0.0012286464,0.00026773076,0.0009611113,0.00005956351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001345314,0.00013218747,0.0006646837,0.000043402077,0.0002150735,0.0000465945,0.00017876142,0.000051965948,0.000010438682],"category_scores_gemma":[0.0013863769,0.00005258502,0.00021051044,0.0001617283,0.0006199102,0.000109895314,0.00006374991,0.00020932313,6.047506e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070300344,0.00007647951,0.20954756,0.00034740902,0.0057142163,0.00046132237,0.007786006,0.00012262349,0.019388637,0.0013821307,0.06395356,0.68419003],"study_design_scores_gemma":[0.009119373,0.0004910551,0.84967315,0.08833589,0.002413851,0.0056587635,0.0028218906,0.00020165122,0.017292287,0.000102522245,0.023539942,0.0003496134],"about_ca_topic_score_codex":0.0037808337,"about_ca_topic_score_gemma":0.0007556948,"teacher_disagreement_score":0.6838404,"about_ca_system_score_codex":0.00015479024,"about_ca_system_score_gemma":0.00019990883,"threshold_uncertainty_score":0.5715515},"labels":[],"label_agreement":null},{"id":"W2555854562","doi":"10.1038/bjc.2016.367","title":"miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Science and Technology Development Plan of Shandong Province; National Natural Science Foundation of China","keywords":"Epithelial–mesenchymal transition; Basal cell; Cancer research; Mesenchymal stem cell; Transition (genetics); Pathology; Carcinoma; Medicine; Biology; Cancer; Internal medicine; Metastasis; Gene","score_opus":0.0043282026176133335,"score_gpt":0.22009015253309297,"score_spread":0.21576194991547964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555854562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97495127,0.02179678,0.002486218,0.00018628228,0.00028651248,0.00009004629,0.0001524378,0.0000031770478,0.000047261794],"genre_scores_gemma":[0.9977292,0.00073873304,0.0004469668,0.000059815364,0.00091313897,0.00000458282,0.000018706227,0.000024926929,0.00006397341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885476,0.000082880244,0.00046157214,0.00016319909,0.00023805586,0.00019952697],"domain_scores_gemma":[0.9990299,0.000021011501,0.00040177407,0.00009613588,0.0003365757,0.000114625305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022107088,0.000114137096,0.000199487,0.000046688783,0.000044774013,0.000014374739,0.00014955104,0.00011967941,0.00016473977],"category_scores_gemma":[0.000060436912,0.000105759056,0.0001853972,0.000054849592,0.000085822736,0.000017533574,0.000022413551,0.000076582015,0.0000020197401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016540762,0.00006198221,0.0019527123,0.000055954246,0.000025006835,0.00005693011,0.00004333468,0.000091565445,0.9791666,6.395212e-7,0.0013226299,0.017057223],"study_design_scores_gemma":[0.0016556487,0.0001846223,0.031814754,0.00010352812,0.00006511489,0.00019631967,0.000019430316,0.000021989503,0.9639605,0.00006259029,0.0017745546,0.00014089383],"about_ca_topic_score_codex":0.00011163372,"about_ca_topic_score_gemma":0.00006231652,"teacher_disagreement_score":0.02986204,"about_ca_system_score_codex":0.000040987892,"about_ca_system_score_gemma":0.00016117444,"threshold_uncertainty_score":0.43127292},"labels":[],"label_agreement":null},{"id":"W2565574808","doi":"10.1038/bjc.2016.400","title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; University of Calgary; University of Alberta; Canadian Centre for Applied Research in Cancer Control; The King's University; Alberta Health Services","funders":"National Cancer Institute; WorkSafe Victoria","keywords":"Medicine; Odds ratio; Gynecology; Case-control study; Obstetrics; Ovarian cancer; Pregnancy; Population; Tubal ligation; Confidence interval; Family planning; Cancer; Internal medicine; Environmental health","score_opus":0.012046660517742693,"score_gpt":0.2637765782554249,"score_spread":0.2517299177376822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565574808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95726955,0.011907314,0.00007471425,0.028748209,0.00075339316,0.000381823,0.00078693836,0.000012356267,0.000065702916],"genre_scores_gemma":[0.95992863,0.03699928,0.00014863261,0.0012294427,0.00088018284,0.000056925117,8.7060727e-7,0.000029204617,0.0007268458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988072,0.00006109849,0.00037489494,0.00018286226,0.0003156176,0.00025833986],"domain_scores_gemma":[0.9987953,0.00013115766,0.00039440562,0.00013628205,0.00034483473,0.00019806842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024799898,0.00015406366,0.00042351545,0.000047697995,0.00018837852,0.00010043762,0.00009407139,0.00007134318,0.0008103352],"category_scores_gemma":[0.00011146758,0.00008727996,0.00015537582,0.00009934569,0.00020319615,0.00024484037,0.000028160195,0.00023215057,0.0000036727429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006726408,0.00014085273,0.5209038,0.000017102719,0.00075603387,0.00042901927,0.00025809518,0.000004196904,0.000039953782,0.00008768462,0.007486257,0.46920434],"study_design_scores_gemma":[0.010213791,0.00060303113,0.84804565,0.0014040454,0.00055097125,0.00051310606,0.00004648098,0.0000068797845,0.00029167507,0.00021780924,0.13800934,0.00009718787],"about_ca_topic_score_codex":0.007837997,"about_ca_topic_score_gemma":0.025238955,"teacher_disagreement_score":0.46910715,"about_ca_system_score_codex":0.00027371914,"about_ca_system_score_gemma":0.000259357,"threshold_uncertainty_score":0.99876887},"labels":[],"label_agreement":null},{"id":"W2565711919","doi":"10.1038/bjc.2016.420","title":"EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Afatinib; Medicine; Lung cancer; Adenocarcinoma; Internal medicine; Epidermal growth factor receptor; Oncology; Liquid biopsy; Lung; Mutation; Pathology; Cancer; Biology; Gefitinib; Gene","score_opus":0.005319400910376899,"score_gpt":0.276573494396567,"score_spread":0.27125409348619006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565711919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223787,0.006574191,0.0006688259,0.00008767437,0.000097131015,0.00013987979,0.000051398038,0.0000024883934,0.00014055643],"genre_scores_gemma":[0.9989604,0.00073095947,0.00017270356,0.000021721444,0.0000486321,0.000006814727,0.0000043678,0.00000961584,0.000044806227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901366,0.000033745462,0.00050382584,0.000100059486,0.00025102132,0.00009765754],"domain_scores_gemma":[0.9989046,0.0000543454,0.00051138253,0.00007997927,0.00039166227,0.000058041158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121298486,0.00006498784,0.00032360852,0.00031895473,0.000026278776,0.0000081694425,0.00004050231,0.000042789703,0.00007223367],"category_scores_gemma":[0.00009789735,0.00005121472,0.00011027352,0.0003760792,0.00003725415,0.00018185384,0.000011946769,0.0000643172,6.150226e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009895827,0.000121920326,0.83874255,0.0001242702,0.00082962203,0.000055591066,0.00043524118,0.00013891958,0.0058081457,0.0000022698157,0.000044948123,0.15359758],"study_design_scores_gemma":[0.0046274518,0.00015795446,0.9853911,0.0008502986,0.002602706,0.00005991863,0.00012748914,0.00038830782,0.005691605,0.000029440678,0.000018852286,0.000054898792],"about_ca_topic_score_codex":0.0011592902,"about_ca_topic_score_gemma":0.0012845952,"teacher_disagreement_score":0.15354268,"about_ca_system_score_codex":0.00028955447,"about_ca_system_score_gemma":0.000108265325,"threshold_uncertainty_score":0.20884757},"labels":[],"label_agreement":null},{"id":"W2567825448","doi":"10.1038/bjc.2016.429","title":"Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute on Minority Health and Health Disparities; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Blockade; Breast cancer; Oncology; Chemotherapy; Cancer; CTLA-4; Internal medicine; Immunology; Receptor; T cell; Immune system","score_opus":0.01793608759319667,"score_gpt":0.35102083915400556,"score_spread":0.3330847515608089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567825448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331397,0.0041544596,0.000010166178,0.0016179474,0.00027711975,0.00017897668,0.00006514509,0.0000039940924,0.00037824595],"genre_scores_gemma":[0.9844888,0.014472968,0.000050038645,0.00024755218,0.00053869403,0.0000097802,9.4457937e-7,0.00002636127,0.00016485636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881786,0.00003552521,0.0005097682,0.00015454793,0.0002851794,0.00019709297],"domain_scores_gemma":[0.99858844,0.00003610513,0.00081372104,0.00018469593,0.0002717113,0.000105321444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034367782,0.00013472144,0.0005523454,0.00011991191,0.00006380907,0.000049478076,0.00017088102,0.000091776725,0.0006628444],"category_scores_gemma":[0.00003391497,0.000108246146,0.00027787164,0.00008624259,0.00019872317,0.00018864215,0.000009192498,0.00033786902,5.117371e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027276373,0.00034247592,0.66953593,0.00004441072,0.0009900527,0.00008568839,0.00006050879,0.00005582129,0.005414277,0.0000013821486,0.0014497784,0.29474333],"study_design_scores_gemma":[0.012911183,0.0013572099,0.9778302,0.0025656766,0.000109445435,0.0009240729,0.000014150536,0.000020058116,0.0036006824,0.00001128915,0.0005389362,0.0001171406],"about_ca_topic_score_codex":0.01391351,"about_ca_topic_score_gemma":0.0022674985,"teacher_disagreement_score":0.30829424,"about_ca_system_score_codex":0.0005234775,"about_ca_system_score_gemma":0.0007181555,"threshold_uncertainty_score":0.99265295},"labels":[],"label_agreement":null},{"id":"W2577051512","doi":"10.1038/bjc.2016.448","title":"Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Triple-negative breast cancer; Metastasis; Breast cancer; Cancer research; Lung cancer; Matrix metalloproteinase; Medicine; Pathology; Lung; Cancer; Oncology; Biology; Internal medicine","score_opus":0.016165578986429282,"score_gpt":0.29439491750346775,"score_spread":0.27822933851703846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577051512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919112,0.0059845485,0.0007837944,0.00039924163,0.00033136347,0.0002182494,0.00025324503,0.0000028475279,0.00011553372],"genre_scores_gemma":[0.99314386,0.004580611,0.0007215111,0.00039442914,0.00038825066,0.00006983491,0.0000045039083,0.00002450459,0.00067250576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987769,0.00004641555,0.00040947535,0.00022711355,0.00029302045,0.00024705616],"domain_scores_gemma":[0.9989027,0.0000037251575,0.0005100134,0.00018536231,0.0002690864,0.00012916047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030052144,0.00014465424,0.00025261941,0.0000619271,0.00019944267,0.00012494878,0.00032081344,0.00011726857,0.00010451122],"category_scores_gemma":[0.00006644913,0.00015911351,0.00011645297,0.000035001252,0.00002663619,0.000042597276,0.00008500654,0.0002014538,0.0000011270686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046660975,0.00018506471,0.0027268054,0.000043313627,0.0005666426,0.000105566876,0.00040739114,0.00079580955,0.7524974,0.000009132871,0.005180359,0.2370159],"study_design_scores_gemma":[0.0023681028,0.00004529888,0.005242456,0.00022435696,0.000048303787,0.00013402254,0.00003895563,0.0004416155,0.99042284,0.000074630196,0.0007253428,0.00023404116],"about_ca_topic_score_codex":0.0016318533,"about_ca_topic_score_gemma":0.003128992,"teacher_disagreement_score":0.23792548,"about_ca_system_score_codex":0.00017590071,"about_ca_system_score_gemma":0.0008038468,"threshold_uncertainty_score":0.6488461},"labels":[],"label_agreement":null},{"id":"W2577415758","doi":"10.1038/bjc.2016.426","title":"Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Queensland; Cancer Council NSW; Cancer Council Victoria; Cancer Council South Australia; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Helse Vest; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Lon V. Smith Foundation; Norges Forskningsråd; University of Cambridge; Cancer Research UK; American Cancer Society; Minnesota Ovarian Cancer Alliance; Imperial College London; Kreftforeningen; Helsingin ja Uudenmaan Sairaanhoitopiiri; WorkSafeBC; Rutgers Cancer Institute of New Jersey; Francis Crick Institute; Mayo Foundation for Medical Education and Research; European Commission; Oregon Health and Science University; Universität Ulm; Kræftens Bekæmpelse; National Center for Research Resources; Oak Foundation; Roswell Park Cancer Institute; Ovarian Cancer Research Fund","keywords":"PAX8; Genome-wide association study; Biology; Gene; Genetics; Carcinogenesis; Serous fluid; Transcriptome; Cancer research; Single-nucleotide polymorphism; Transcription factor; Gene expression; Genotype","score_opus":0.010092243727289996,"score_gpt":0.28862542018609755,"score_spread":0.27853317645880754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577415758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98516315,0.013356318,0.00024335264,0.00026695253,0.00050881726,0.00009597972,0.00019061418,0.0000014962269,0.0001733216],"genre_scores_gemma":[0.99180895,0.005982414,0.0007846221,0.0000896798,0.0004163861,0.0000090040485,0.000037923044,0.0000095465675,0.0008614978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991246,0.00006274441,0.0003299122,0.00017764246,0.0001443637,0.00016077972],"domain_scores_gemma":[0.99889356,0.000005679913,0.0005876618,0.00014536202,0.00029795495,0.0000697858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002718931,0.00010143216,0.00021282148,0.000018634984,0.00020232754,0.00002309716,0.00022014444,0.00012841902,0.00016085945],"category_scores_gemma":[0.000048523623,0.000102933154,0.00011288054,0.000020539668,0.00019123044,0.000012489577,0.0001097602,0.00007887063,0.0000012199513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043209142,0.00006569569,0.1743743,0.000029302224,0.0003047682,0.000026298503,0.00009569059,0.00030225355,0.66648036,0.0000038124872,0.0011525457,0.15673287],"study_design_scores_gemma":[0.0007958883,0.00012664535,0.4298,0.000042269297,0.000028438692,0.00011000738,0.000024911862,0.0000045904862,0.55125266,0.00012839863,0.017575024,0.000111126705],"about_ca_topic_score_codex":0.0005195885,"about_ca_topic_score_gemma":0.0020793073,"teacher_disagreement_score":0.25542572,"about_ca_system_score_codex":0.00007756837,"about_ca_system_score_gemma":0.0002213448,"threshold_uncertainty_score":0.41974923},"labels":[],"label_agreement":null},{"id":"W2579765256","doi":"10.1038/bjc.2016.443","title":"Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; SickKids Foundation; Hospital for Sick Children; McMaster Children's Hospital; London Health Sciences Centre","funders":"National Cancer Institute; Pediatric Oncology Group of Ontario","keywords":"Medicine; Cancer; Pediatrics; Population; Cancer registry; Cohort; Mortality rate; Internal medicine; Environmental health","score_opus":0.04512909757366945,"score_gpt":0.39329087251384354,"score_spread":0.3481617749401741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579765256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992455,0.0063762655,0.00013455084,0.00015343074,0.00019615452,0.00031064235,0.00007337093,0.0000061606643,0.0002944474],"genre_scores_gemma":[0.9972637,0.0021064114,0.00012128696,0.00002086456,0.0002845254,0.00003555637,0.000021832811,0.000017383167,0.00012842307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972326,0.00019899345,0.0006558656,0.00017480571,0.0015326005,0.00020509186],"domain_scores_gemma":[0.9963197,0.000064018146,0.0011880575,0.00030251913,0.0019474557,0.00017821135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015264541,0.00011725698,0.0005687142,0.0003250848,0.00014897254,0.000066961955,0.0001616665,0.00012056305,0.0010658907],"category_scores_gemma":[0.0007829324,0.00010968154,0.00038907182,0.0003792538,0.00009033446,0.00027936586,0.000018866034,0.00016680639,8.8894353e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010399655,0.0001030129,0.83956933,0.000028410195,0.0027230717,0.00008988952,0.00003792326,0.008296413,0.00012767228,8.0803125e-7,0.000112017326,0.14880745],"study_design_scores_gemma":[0.0066418597,0.00016122145,0.9123975,0.00031278864,0.014862256,0.00004350396,0.000014526379,0.06507365,0.00033180785,0.000049689344,0.00002986418,0.000081340404],"about_ca_topic_score_codex":0.06545773,"about_ca_topic_score_gemma":0.018293967,"teacher_disagreement_score":0.14872612,"about_ca_system_score_codex":0.003455452,"about_ca_system_score_gemma":0.0031126402,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W2585552374","doi":"10.1038/bjc.2017.1","title":"Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Trace Elements in Health","field":"Nursing","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; Cancerfonden; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; National Institute for Health and Care Research; Cancer Research UK; Centre International de Recherche sur le Cancer; Hellenic Health Foundation; Health Research Board; Deutsches Krebsforschungszentrum","keywords":"Zinc; Medicine; Internal medicine; Copper; Pathology; Gastroenterology; Oncology; Chemistry","score_opus":0.030718807222261953,"score_gpt":0.33641816355205545,"score_spread":0.3056993563297935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585552374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345524,0.015056494,0.000008503201,0.0002832604,0.0006633288,0.000106588566,0.00006949729,0.000003241072,0.00035387377],"genre_scores_gemma":[0.9931649,0.0059268475,0.00057983893,0.000093666444,0.00019561723,0.000001573197,1.4984978e-7,0.000020892527,0.00001653615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988273,0.00013311216,0.00048686864,0.00013494544,0.00021511348,0.00020265399],"domain_scores_gemma":[0.99876666,0.000078070836,0.00081911247,0.00012719771,0.00011248718,0.00009649962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077788025,0.00008190654,0.00027825753,0.00006030279,0.00021133316,0.000086096195,0.0001464241,0.00004105127,0.00003140744],"category_scores_gemma":[0.0003092403,0.00009610231,0.00003387861,0.000035345154,0.00016388767,0.00034326562,0.00004423173,0.0003488147,1.533209e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005385851,0.000011890642,0.7246076,0.00007502336,0.000028679187,0.000110361056,0.00036499283,0.00011608742,0.0004142194,0.0000022908437,0.00025069722,0.2739643],"study_design_scores_gemma":[0.0014281195,0.00008519934,0.9942134,0.0015724478,0.000047945294,0.00043205134,0.00013862272,0.00014204429,0.00036735402,0.00009606259,0.0013822133,0.000094534706],"about_ca_topic_score_codex":0.016054675,"about_ca_topic_score_gemma":0.02045285,"teacher_disagreement_score":0.27386975,"about_ca_system_score_codex":0.00019245452,"about_ca_system_score_gemma":0.000115952294,"threshold_uncertainty_score":0.9974213},"labels":[],"label_agreement":null},{"id":"W2585568219","doi":"10.1038/bjc.2017.15","title":"Asporin is a stromally expressed marker associated with prostate cancer progression","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"University of Oxford; AstraZeneca; University College London; Cancer Research UK; Prostate Cancer Canada; Movember Foundation","keywords":"Prostate cancer; Stromal cell; Stroma; Prostate; Pathology; Tissue microarray; Medicine; Oncology; Cancer; Immunohistochemistry; PCA3; Cancer research; Biology; Internal medicine","score_opus":0.012553120564562774,"score_gpt":0.3185869427778974,"score_spread":0.30603382221333464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585568219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876464,0.010320097,0.00004568443,0.000721481,0.00016076597,0.00025895558,0.00022743532,0.0000041667777,0.00061502453],"genre_scores_gemma":[0.9871111,0.007818121,0.00027554217,0.00014305135,0.00038821076,0.00008650967,0.00001218947,0.000036844198,0.004128423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985273,0.00006218876,0.00028464725,0.0002528004,0.0004981888,0.00037487957],"domain_scores_gemma":[0.9982743,0.0000062142512,0.000594869,0.0002811918,0.0006647736,0.00017863025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003522863,0.00014960105,0.0002433988,0.000038120717,0.00030408244,0.00028837234,0.00050105917,0.0001282641,0.00023381962],"category_scores_gemma":[0.00014532798,0.00013216183,0.000105024155,0.0000476624,0.00017748804,0.000031993623,0.00011885441,0.00028272966,6.594414e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036581391,0.0002813845,0.16333552,0.00007589026,0.0008335084,0.0010979006,0.000110133224,0.000054938515,0.27015206,0.000002130839,0.023412379,0.536986],"study_design_scores_gemma":[0.0056929775,0.0012657633,0.654251,0.0026646503,0.00009691895,0.00032938778,0.00005580965,0.000046541445,0.21199754,0.000043935746,0.12306645,0.0004890731],"about_ca_topic_score_codex":0.0007458518,"about_ca_topic_score_gemma":0.0024868103,"teacher_disagreement_score":0.53649694,"about_ca_system_score_codex":0.000057977475,"about_ca_system_score_gemma":0.0006394122,"threshold_uncertainty_score":0.5389403},"labels":[],"label_agreement":null},{"id":"W2586745916","doi":"10.1038/bjc.2017.19","title":"Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Oncology; BRCA mutation; Stage (stratigraphy); Medicine; Internal medicine; Mutation; Cancer; Cancer research; Biology; Genetics; Breast cancer; Gene","score_opus":0.04312976694103765,"score_gpt":0.40540402854847196,"score_spread":0.3622742616074343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586745916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489546,0.002836672,0.00006715221,0.00062957336,0.00027345377,0.00017594734,0.00009180412,0.0000031057489,0.0010268472],"genre_scores_gemma":[0.97699505,0.019860892,0.00046974877,0.00008924368,0.00046797097,0.0000073741962,0.0000030041415,0.000016484208,0.002090205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859124,0.00008458918,0.0005752729,0.00013011994,0.00042368995,0.00019510146],"domain_scores_gemma":[0.99802065,0.00013219776,0.00084624614,0.00016254728,0.0005998813,0.00023849912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007046107,0.000093653965,0.00080159405,0.000047811864,0.0001966334,0.000045492794,0.0001208524,0.000098886216,0.00028002163],"category_scores_gemma":[0.0005517116,0.00008105022,0.00008312353,0.000029275458,0.000484538,0.00015787556,0.000040651703,0.0003778489,4.9597963e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011427618,0.00009096826,0.93274724,0.00015372677,0.0005404853,0.0008520516,0.00012354853,0.0000011573635,0.0001602038,0.00001949471,0.0003080723,0.063860275],"study_design_scores_gemma":[0.004875255,0.0010556508,0.9888864,0.0013582312,0.0006839074,0.0005665004,0.000106452,0.00010544868,0.000060421626,0.000025041023,0.0021943718,0.000082281855],"about_ca_topic_score_codex":0.0029719106,"about_ca_topic_score_gemma":0.0019999368,"teacher_disagreement_score":0.063778,"about_ca_system_score_codex":0.000095319,"about_ca_system_score_gemma":0.0010314058,"threshold_uncertainty_score":0.449266},"labels":[],"label_agreement":null},{"id":"W2588578960","doi":"10.1038/bjc.2017.35","title":"Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Women's College Hospital","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Ovarian cancer; National Death Index; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Cancer registry; Confidence interval; Oncology; Gynecology","score_opus":0.06172330484195055,"score_gpt":0.3526062796316627,"score_spread":0.29088297478971215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588578960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96414596,0.029030591,0.00005576939,0.0021075252,0.0036985462,0.00032125087,0.00030744862,0.000012958809,0.0003199434],"genre_scores_gemma":[0.9538062,0.044478346,0.00016869903,0.00017651888,0.0010820258,0.000083992156,0.000006552396,0.00003931036,0.00015831598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00011735502,0.00076085306,0.000297101,0.00061730936,0.00040796684],"domain_scores_gemma":[0.99739385,0.00026630407,0.0013719178,0.0003813519,0.0002620571,0.00032453542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006414847,0.0002519118,0.0011976906,0.00009724446,0.00026707415,0.00010965554,0.000372837,0.0001656583,0.00095534953],"category_scores_gemma":[0.00050585734,0.00021527811,0.00077888026,0.000069491405,0.0001679787,0.0003494908,0.00007735515,0.0003705732,0.0000015794484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017923815,0.0002774627,0.8809871,0.0000965038,0.0014051155,0.0013273276,0.0000850151,0.000015945167,0.00008584416,0.0000104965575,0.0006707097,0.114859246],"study_design_scores_gemma":[0.0047919755,0.00038016486,0.9842288,0.004206348,0.0012359503,0.00014901362,0.000037028076,0.0000031699321,0.0031880029,0.00006549764,0.0015306612,0.00018342698],"about_ca_topic_score_codex":0.0113261035,"about_ca_topic_score_gemma":0.0046181194,"teacher_disagreement_score":0.11467582,"about_ca_system_score_codex":0.00036233463,"about_ca_system_score_gemma":0.00051122723,"threshold_uncertainty_score":0.9999579},"labels":[],"label_agreement":null},{"id":"W2588715080","doi":"10.1038/bjc.2017.38","title":"Oncogenic role of PDK4 in human colon cancer cells","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"PDK4; Cancer research; Downregulation and upregulation; Apoptosis; Biology; Colorectal cancer; DNA methylation; Cancer; Methylation; Gene; Gene expression; Biochemistry; Genetics","score_opus":0.010647611262014115,"score_gpt":0.3322914874620145,"score_spread":0.32164387620000034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588715080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543525,0.04455656,0.0000023903929,0.00017025183,0.00012208863,0.0000662218,0.00005653813,7.3683617e-7,0.00067272317],"genre_scores_gemma":[0.9790419,0.020104956,0.00006191436,0.000045716304,0.00036712893,0.000011815732,0.0000017306431,0.000010729413,0.00035415267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991503,0.000030555206,0.00028733606,0.00012796787,0.00020481873,0.00019904405],"domain_scores_gemma":[0.99916065,0.0000058509468,0.00034457011,0.00015201324,0.0002645366,0.00007235764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001993077,0.000076116616,0.0002200255,0.00002826723,0.000100599624,0.000034139794,0.00039491852,0.00009703597,0.000080551385],"category_scores_gemma":[0.00009389287,0.000079892256,0.000112014604,0.000028629864,0.00021926603,0.000007373241,0.00016087224,0.00019258514,6.0828546e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010890758,0.000058479225,0.007422822,0.000022906937,0.0001034428,0.000027852151,0.000014488928,0.000015727002,0.9681731,0.0000018329486,0.0036962014,0.020354224],"study_design_scores_gemma":[0.00082059536,0.00019034036,0.028601328,0.00021161111,0.000017689945,0.000026942478,0.000029991075,0.000002064168,0.95129275,0.00007907084,0.018638447,0.000089154026],"about_ca_topic_score_codex":0.0021967108,"about_ca_topic_score_gemma":0.003758696,"teacher_disagreement_score":0.024689369,"about_ca_system_score_codex":0.00004327271,"about_ca_system_score_gemma":0.00015315367,"threshold_uncertainty_score":0.33207843},"labels":[],"label_agreement":null},{"id":"W2590708113","doi":"10.1038/bjc.2017.28","title":"Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"Health Technology Assessment Programme; University College London; National Institute for Health and Care Research","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Human Epidermal Growth Factor Receptor 2; Cancer; Confidence interval; Clinical trial; Gynecology","score_opus":0.02109252661607599,"score_gpt":0.33229147070401877,"score_spread":0.3111989440879428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590708113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97278047,0.024958573,0.0000038404046,0.0011433495,0.000146201,0.0006044187,0.00024313484,7.3261975e-7,0.000119304255],"genre_scores_gemma":[0.9566758,0.04263216,0.0001609847,0.00018163148,0.00026618497,0.000062076666,0.0000039172533,0.000010243245,0.0000069705334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986645,0.00021691322,0.0005457483,0.00018238134,0.00020521811,0.00018523166],"domain_scores_gemma":[0.9985921,0.000114890114,0.0008064075,0.00013745642,0.00030309564,0.000046078992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004795321,0.00012334995,0.0004708307,0.000016695963,0.00009181505,0.000038641043,0.0002003331,0.00005183307,0.000010995584],"category_scores_gemma":[0.00048632917,0.000086975735,0.00009641925,0.000050055365,0.0002879197,0.000023962099,0.00006257545,0.00017373599,2.8996258e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06372975,0.00042076383,0.7814078,0.00015028659,0.0004116472,0.00006347474,0.00025785298,0.000039250408,0.000022058526,0.0000012219308,0.00044919323,0.15304671],"study_design_scores_gemma":[0.071718,0.00036207045,0.92303777,0.0042555267,0.00014441504,0.000044791417,0.00007341977,0.0000018892805,0.00009728774,0.000006918621,0.00016211391,0.00009577897],"about_ca_topic_score_codex":0.00528392,"about_ca_topic_score_gemma":0.013587918,"teacher_disagreement_score":0.15295093,"about_ca_system_score_codex":0.00004270553,"about_ca_system_score_gemma":0.0001787092,"threshold_uncertainty_score":0.7987742},"labels":[],"label_agreement":null},{"id":"W2591999938","doi":"10.1038/bjc.2017.53","title":"Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Odds ratio; Odds; Internal medicine; Blood test; Cancer; Population; Surgery; Oncology; Logistic regression; Environmental health","score_opus":0.02384627535080266,"score_gpt":0.35205221176684676,"score_spread":0.3282059364160441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591999938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97532964,0.022387782,0.0001902281,0.0011096622,0.00045191185,0.00019742062,0.00025860532,0.00000497876,0.000069751244],"genre_scores_gemma":[0.9936086,0.005653632,0.00038362594,0.0000805138,0.00020424141,0.000013012838,0.0000014288554,0.000012782499,0.00004214292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832255,0.00016430822,0.00066779007,0.0001327377,0.0005567643,0.00015583448],"domain_scores_gemma":[0.9971516,0.00013559283,0.0018530787,0.00015825352,0.00064133527,0.000060110684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016455797,0.000078120676,0.0004290611,0.00005368555,0.00015473021,0.000036287285,0.00016361364,0.00005230849,0.00014258387],"category_scores_gemma":[0.0009765844,0.00006974105,0.00006561268,0.0001517194,0.00013046298,0.0002015322,0.000029539116,0.00031880316,4.7259572e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034109573,0.000041065097,0.5116344,0.00015144462,0.00016085464,0.000014853367,0.0015004366,0.00082746724,0.012424219,8.4129175e-7,0.003134313,0.46669912],"study_design_scores_gemma":[0.0047270195,0.0028610206,0.9388917,0.010992733,0.00020982271,0.00006950818,0.0022731547,0.0057185288,0.032468215,0.00010121941,0.0015293187,0.00015772511],"about_ca_topic_score_codex":0.062386006,"about_ca_topic_score_gemma":0.0374668,"teacher_disagreement_score":0.46654138,"about_ca_system_score_codex":0.00042288192,"about_ca_system_score_gemma":0.0011806822,"threshold_uncertainty_score":0.98009694},"labels":[],"label_agreement":null},{"id":"W2596331703","doi":"10.1038/bjc.2017.51","title":"VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Canada Research Chairs; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Cancer research; Vascular endothelial growth factor A; Protein kinase B; Ovarian cancer; Angiogenesis; VEGF receptors; Interleukin 8; PI3K/AKT/mTOR pathway; Medicine; Biology; Cell biology; Signal transduction; Internal medicine; Cancer; Vascular endothelial growth factor; Inflammation","score_opus":0.01356968945570387,"score_gpt":0.29278360644267254,"score_spread":0.2792139169869687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596331703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378867,0.015267169,0.00059085805,0.00007433931,0.00011223341,0.0001147679,0.000019908433,0.000002213887,0.000029829107],"genre_scores_gemma":[0.9934273,0.005479325,0.00066241337,0.000050782248,0.00031977263,0.000017707087,0.00001594188,0.00001578204,0.000011018466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990843,0.00007032559,0.00032747,0.00018781223,0.00020888694,0.000121228084],"domain_scores_gemma":[0.99899846,0.000014856693,0.00056748505,0.00013737123,0.00020967844,0.00007215953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017510056,0.00010450883,0.00018442035,0.000049504673,0.0001531347,0.000088619876,0.000087912405,0.00012988366,0.00001837228],"category_scores_gemma":[0.0002593085,0.000112165806,0.00005111434,0.0000317277,0.00010969427,0.00009268675,0.00008236075,0.0001071679,5.382546e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023957642,0.00007345775,0.027044643,0.000077694815,0.00002589592,0.000010489302,0.00014557873,0.00011934113,0.9514208,0.0000021885908,0.00025289296,0.020587455],"study_design_scores_gemma":[0.0014146245,0.000063540756,0.18359482,0.0025526935,0.00002519737,0.00003300984,0.000052259154,0.000006140648,0.81108713,0.00011213275,0.00095349434,0.00010495317],"about_ca_topic_score_codex":0.0009823919,"about_ca_topic_score_gemma":0.0004954033,"teacher_disagreement_score":0.15655018,"about_ca_system_score_codex":0.000027362064,"about_ca_system_score_gemma":0.00013634613,"threshold_uncertainty_score":0.4573989},"labels":[],"label_agreement":null},{"id":"W2601140727","doi":"10.1038/bjc.2017.85","title":"Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sleep and related disorders","field":"Psychology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Hazard ratio; Internal medicine; Cancer; Proportional hazards model; Population; Oncology; Confidence interval; Gynecology","score_opus":0.010539461242535079,"score_gpt":0.30766813891818656,"score_spread":0.2971286776756515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601140727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775494,0.008155303,0.0000043377922,0.00057457254,0.0025097933,0.0002528604,0.000043735,0.000005937333,0.0006985119],"genre_scores_gemma":[0.9977634,0.001486409,0.0000059427393,0.00011658007,0.00020654201,0.00002535143,2.0858928e-7,0.000026901313,0.00036865668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998644,0.00016575975,0.00039779613,0.0001677623,0.00034428865,0.00028040085],"domain_scores_gemma":[0.998395,0.000036426463,0.0009963103,0.00024815806,0.00016913445,0.00015495646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063529745,0.00011178771,0.0003849829,0.000049749597,0.0002762149,0.00010077929,0.00036521463,0.000068451394,0.00047704118],"category_scores_gemma":[0.000019169456,0.000087667766,0.000051229064,0.00007552071,0.00035969337,0.0001548696,0.000032949396,0.00041825775,0.0000014598165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068250875,0.00027365342,0.62226397,0.000011461888,0.0017457546,0.0002035382,0.014818695,0.00006603789,0.0000026477169,0.000020892117,0.0014813301,0.3584295],"study_design_scores_gemma":[0.0062361406,0.00045398838,0.97396916,0.00026341603,0.00014276539,0.00036549292,0.017933046,0.0000036048061,9.191353e-7,0.00003749127,0.00048241267,0.00011157682],"about_ca_topic_score_codex":0.027445192,"about_ca_topic_score_gemma":0.022489578,"teacher_disagreement_score":0.3583179,"about_ca_system_score_codex":0.000078611854,"about_ca_system_score_gemma":0.00017868637,"threshold_uncertainty_score":0.99534744},"labels":[],"label_agreement":null},{"id":"W2601749821","doi":"10.1038/bjc.2017.87","title":"Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Logistic regression; Biopsy; Retrospective cohort study; Cancer; Breast biopsy; Anxiety; Breast cancer screening; Mammography; Gynecology; Obstetrics; Internal medicine","score_opus":0.0626489527466243,"score_gpt":0.4123612677679854,"score_spread":0.3497123150213611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601749821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989741,0.0062367567,0.0003060119,0.0018097105,0.00063030655,0.00027944698,0.00027245845,0.000024237683,0.0007000685],"genre_scores_gemma":[0.9898227,0.0020326762,0.0045028175,0.0012377171,0.0020002415,0.00014786734,0.0000070018014,0.000056597062,0.0001924004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700546,0.00008493017,0.0006731739,0.000371432,0.0012776267,0.0005873599],"domain_scores_gemma":[0.99700123,0.00012335736,0.0008565495,0.00032521778,0.0010986922,0.0005949543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059744046,0.00024329434,0.0007138621,0.00010583346,0.00070972036,0.00060404616,0.0004946053,0.000119143224,0.0037661362],"category_scores_gemma":[0.0003865061,0.0002624317,0.00019547157,0.00013690096,0.0001001602,0.00076684164,0.00018999186,0.00056558877,0.0000048098013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036413636,0.000027652284,0.6991164,0.00005320252,0.0003298119,0.0005573264,0.0009062521,0.0006353053,0.0004762657,0.000002288727,0.0028521211,0.29467922],"study_design_scores_gemma":[0.0034978257,0.0004334879,0.98044914,0.009012447,0.0003610401,0.00034111252,0.0033986678,0.00025498364,0.0007221407,0.000036385543,0.0011908073,0.00030195995],"about_ca_topic_score_codex":0.024072804,"about_ca_topic_score_gemma":0.011216962,"teacher_disagreement_score":0.29437727,"about_ca_system_score_codex":0.0014982008,"about_ca_system_score_gemma":0.0013889472,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2602010827","doi":"10.1038/bjc.2017.97","title":"Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Terry Fox Research Institute; Sheffield Hallam University","keywords":"Breast cancer; Medicine; Univariate; Oncology; Neoadjuvant therapy; Internal medicine; Multivariate statistics; Pattern recognition (psychology); Nuclear medicine; Artificial intelligence; Cancer; Mathematics; Computer science; Statistics","score_opus":0.0130348895969007,"score_gpt":0.3626205744561454,"score_spread":0.3495856848592447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602010827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98412895,0.0028854366,0.003237844,0.008957637,0.00021011467,0.00024486298,0.00005890154,0.00004110851,0.00023514403],"genre_scores_gemma":[0.9812151,0.0018273558,0.0148912165,0.0007003624,0.00077436684,0.0000146188595,8.837774e-7,0.000039755887,0.00053630077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982465,0.000054219836,0.0004819254,0.00027997087,0.00052918436,0.00040819892],"domain_scores_gemma":[0.9983892,0.0000441954,0.00037867003,0.0003794162,0.00037409936,0.00043442388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040773122,0.00020060333,0.0007361081,0.00021411618,0.0002975184,0.00034801866,0.00025380106,0.00010323073,0.00041051142],"category_scores_gemma":[0.00019872091,0.00018212908,0.0003350655,0.00021309647,0.00014085455,0.0002193839,0.00005246242,0.00047861645,0.000001274815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055318344,0.0007621156,0.7257192,0.00006150313,0.0029238388,0.0022784306,0.00030998825,0.00012599157,0.15023167,0.000012536732,0.000825358,0.111217506],"study_design_scores_gemma":[0.00311253,0.0005224658,0.9631133,0.0020823139,0.0022407148,0.0019086768,0.000043614204,0.0016878597,0.024453614,0.000034801098,0.0005708857,0.00022921815],"about_ca_topic_score_codex":0.002036897,"about_ca_topic_score_gemma":0.00038717617,"teacher_disagreement_score":0.2373941,"about_ca_system_score_codex":0.00068870466,"about_ca_system_score_gemma":0.0003523344,"threshold_uncertainty_score":0.7427008},"labels":[],"label_agreement":null},{"id":"W2605610797","doi":"10.1038/bjc.2017.105","title":"Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Cancer research; Biology; Metastasis; Gene knockdown; Cancer; microRNA; Oncology; Medicine; Cell culture; Gene","score_opus":0.009011913103816376,"score_gpt":0.29293424955503117,"score_spread":0.2839223364512148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605610797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700589,0.029080603,0.000047152396,0.00020738416,0.00012412712,0.00009044945,0.00031741688,0.0000013218005,0.00007265247],"genre_scores_gemma":[0.9969088,0.0024350784,0.00017596687,0.00003136207,0.00030243062,0.000009436112,0.000017351913,0.000019096395,0.0001004703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990768,0.000051680086,0.0003844244,0.00014632598,0.00017360788,0.00016715683],"domain_scores_gemma":[0.9988212,0.0000035948701,0.00068684045,0.00015334527,0.00026375215,0.00007129754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002677806,0.000093719034,0.00021381323,0.000034240846,0.00011191271,0.00006125096,0.0002780814,0.00007863009,0.00016051883],"category_scores_gemma":[0.00007019656,0.00010666398,0.00010768913,0.000030942454,0.00009631045,0.000020825742,0.00006202298,0.00010473935,2.0319861e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061024544,0.000076652745,0.02235802,0.000052698644,0.00012002561,0.000020303873,0.00001957171,0.00008967608,0.94179267,0.0000018197621,0.0061687017,0.029238826],"study_design_scores_gemma":[0.0019587574,0.000085521104,0.27746013,0.00086848217,0.000112448375,0.0002395864,0.00004497112,0.00002652464,0.7043852,0.00007134514,0.014457347,0.00028964036],"about_ca_topic_score_codex":0.0016117241,"about_ca_topic_score_gemma":0.0012163656,"teacher_disagreement_score":0.25510213,"about_ca_system_score_codex":0.000045196248,"about_ca_system_score_gemma":0.00013701411,"threshold_uncertainty_score":0.4349631},"labels":[],"label_agreement":null},{"id":"W2606399503","doi":"10.1038/bjc.2017.101","title":"Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’","year":2017,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Breast cancer; Cohort; Medicine; Cohort study; Demography; Population; Cohort effect; Gynecology; Oncology; Cancer; Internal medicine; Environmental health","score_opus":0.08496498256913693,"score_gpt":0.38388833214037577,"score_spread":0.29892334957123884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606399503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95516497,0.0012480008,0.0000073905435,0.040118057,0.0005685543,0.0010946181,0.0017432979,0.000008252987,0.00004683508],"genre_scores_gemma":[0.9344345,0.0007518076,0.000050259936,0.061025243,0.0033891255,0.00007995131,0.00012825063,0.000056861496,0.00008400963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960299,0.00035371783,0.0009357895,0.00048517273,0.0017266659,0.0004687519],"domain_scores_gemma":[0.99779665,0.00011032398,0.001067157,0.00039406487,0.00034732054,0.00028450164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019016684,0.00039358874,0.0014191977,0.00035000668,0.00014615337,0.00015970826,0.00035014635,0.0003464697,0.00014224608],"category_scores_gemma":[0.00009918681,0.00037561252,0.00016966532,0.00012338662,0.00007535559,0.00029907623,0.00007535863,0.0017754404,6.6379744e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013912863,0.00008356605,0.8047474,0.00016980672,0.000496752,0.0017742943,0.00024227927,0.0001711724,0.0000042826455,1.6066282e-7,0.06838988,0.1225291],"study_design_scores_gemma":[0.0047863424,0.0015031461,0.9669466,0.012593605,0.00067018415,0.0021851908,0.00006187871,0.000012861156,0.00001563154,0.000003840144,0.010907326,0.00031337928],"about_ca_topic_score_codex":0.071152166,"about_ca_topic_score_gemma":0.028170701,"teacher_disagreement_score":0.16219918,"about_ca_system_score_codex":0.0005767743,"about_ca_system_score_gemma":0.00020943672,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W2608603246","doi":"10.1038/bjc.2017.99","title":"A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; McGill University","keywords":"Medicine; Colorectal cancer; Odds ratio; Confidence interval; Pathological; Internal medicine; Meta-analysis; Vascular invasion; Cancer; Gastroenterology; Pathology; Oncology; Radiology; Surgery","score_opus":0.14446345131528043,"score_gpt":0.3714095057249086,"score_spread":0.22694605440962817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608603246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15737009,0.84050363,0.000004507828,0.000016809778,0.0001041416,0.0010531676,0.0009121687,0.000006143359,0.000029342891],"genre_scores_gemma":[0.16083457,0.83860815,0.00015733717,0.000013172516,0.00008712212,0.0001785258,0.00002982207,0.000049163056,0.000042165284],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957999,0.0008020228,0.0014345018,0.00048559924,0.001119441,0.00035855302],"domain_scores_gemma":[0.9944144,0.00086379587,0.0033347176,0.00042828222,0.000725919,0.00023287171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008110035,0.00054877246,0.0067921067,0.00046586647,0.00018301344,0.00011728018,0.0003372463,0.00017622637,0.00035199983],"category_scores_gemma":[0.0005150712,0.00032370444,0.0027322865,0.0008241901,0.00033810825,0.0002506558,0.00012278618,0.001019252,4.4422447e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013410635,0.0003126482,0.05921167,0.0014827084,0.2901779,0.001264274,0.00011345992,0.00008898027,9.54979e-8,2.4168037e-7,0.000043722786,0.6459632],"study_design_scores_gemma":[0.004938618,0.0009834978,0.18945248,0.01507123,0.76128274,0.000769282,0.000033659275,0.000016898513,0.000012893605,0.000005989722,0.026982361,0.00045033675],"about_ca_topic_score_codex":0.015099664,"about_ca_topic_score_gemma":0.045974754,"teacher_disagreement_score":0.6455129,"about_ca_system_score_codex":0.00055062794,"about_ca_system_score_gemma":0.00069706014,"threshold_uncertainty_score":0.9999215},"labels":[],"label_agreement":null},{"id":"W2611286974","doi":"10.1038/bjc.2017.168","title":"Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Cancer Research UK; Health and Social Care Research and Development Division; Public Health Agency; Friends of the Cancer Centre","keywords":"Microsatellite instability; DNA methylation; Immune checkpoint; Colorectal cancer; Cancer research; Biology; Signet ring cell; Immunohistochemistry; Methylation; CpG site; Immune system; Cancer; Adenocarcinoma; Immunotherapy; Immunology; Genetics; Gene; Microsatellite; Gene expression; Allele","score_opus":0.013194118503054814,"score_gpt":0.2747363519693475,"score_spread":0.2615422334662927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611286974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88401425,0.11453027,0.00018722165,0.00033377163,0.00023192272,0.00054221845,0.00007326729,0.0000036353917,0.000083421335],"genre_scores_gemma":[0.992087,0.0055736685,0.0017576274,0.00005024952,0.0003351281,0.000050411967,0.0000036652386,0.000025851088,0.000116418545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989942,0.000021605674,0.00048528836,0.00013013925,0.00019866294,0.00017014405],"domain_scores_gemma":[0.9987465,0.000028884802,0.00074685656,0.000087673994,0.00033053514,0.000059522838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031632467,0.000111235626,0.00035911883,0.00005548271,0.00014552119,0.00008676705,0.00011137006,0.000060681337,0.000077038974],"category_scores_gemma":[0.000049779854,0.0001101186,0.00017899225,0.000029600313,0.00015659444,0.00018271766,0.000025031324,0.00014245167,8.9896794e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024504424,0.000055459852,0.0052112076,0.0002884586,0.00035975233,0.00002689799,0.00029868406,0.000054916454,0.9544164,0.0000066369757,0.000045151985,0.036786005],"study_design_scores_gemma":[0.005922444,0.00046890994,0.0787079,0.0011616746,0.00014959964,0.00014326086,0.00030311232,0.00021663641,0.9118606,0.0000521625,0.0008806662,0.0001330333],"about_ca_topic_score_codex":0.00072423625,"about_ca_topic_score_gemma":0.00024199647,"teacher_disagreement_score":0.108956605,"about_ca_system_score_codex":0.00013116794,"about_ca_system_score_gemma":0.0004818743,"threshold_uncertainty_score":0.44905064},"labels":[],"label_agreement":null},{"id":"W2616059421","doi":"10.1038/bjc.2017.147","title":"Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University and Génome Québec Innovation Centre; Hospital for Sick Children; University of Toronto; Canada Research Chairs; McGill University","funders":"Hospital for Sick Children; State Government of Victoria; Childhood Cancer Canada; Jewish General Hospital; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Embryonal rhabdomyosarcoma; Sarcoma; Biology; Sanger sequencing; Germline; Rhabdomyosarcoma; Germline mutation; Somatic cell; Chondrosarcoma; Missense mutation; Genetics; Cancer research; Mutation; Pathology; Medicine; Gene","score_opus":0.03209571357458726,"score_gpt":0.34342314619863995,"score_spread":0.3113274326240527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616059421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178874,0.0060505467,0.000018111868,0.0009088904,0.00027603662,0.00025437688,0.000047762085,0.000007718348,0.00064783223],"genre_scores_gemma":[0.9977424,0.0012248802,0.0005476378,0.000119186116,0.00016961212,0.000025888039,0.000004179397,0.000024773914,0.00014144646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977715,0.000114170834,0.0010953548,0.00016764211,0.0005670483,0.00028428808],"domain_scores_gemma":[0.99816483,0.00016566568,0.0007467519,0.00026228375,0.0005131174,0.00014734233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005474184,0.00014978863,0.0006960502,0.00033821553,0.00014892929,0.00012097019,0.00031005536,0.00007602075,0.00018539935],"category_scores_gemma":[0.0014406636,0.0001633317,0.00015155833,0.0001575287,0.00027090168,0.0006054318,0.00007954533,0.0003894496,0.0000037863042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002289144,0.00035571476,0.8654539,0.0006638382,0.00028207758,0.0032591901,0.0039509833,0.00007826481,0.0084265405,0.000026415737,0.0002580344,0.11701613],"study_design_scores_gemma":[0.0032916248,0.00013077917,0.986778,0.00456833,0.00012990239,0.0012760984,0.0017919557,0.00033729163,0.00055357546,0.00094254577,0.000051842362,0.00014803163],"about_ca_topic_score_codex":0.005369971,"about_ca_topic_score_gemma":0.08995267,"teacher_disagreement_score":0.12132412,"about_ca_system_score_codex":0.00029288424,"about_ca_system_score_gemma":0.0006020989,"threshold_uncertainty_score":0.9266533},"labels":[],"label_agreement":null},{"id":"W2622052156","doi":"10.1038/bjc.2017.149","title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adipose tissue; Sarcopenia; Hazard ratio; Internal medicine; Proportional hazards model; Body mass index; Cachexia; Obesity; Obesity paradox; Cancer; Univariate analysis; Gastroenterology; Oncology; Multivariate analysis; Confidence interval; Overweight","score_opus":0.050808342916709034,"score_gpt":0.38600695047281697,"score_spread":0.3351986075561079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622052156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939188,0.004262139,0.0000034299978,0.0005132039,0.0006462521,0.00017726363,0.00015149084,0.0000039869706,0.00032343052],"genre_scores_gemma":[0.99341434,0.0053924527,0.00008022973,0.00065285916,0.00034841395,0.0000064796777,0.000002572516,0.00001173312,0.00009094332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859786,0.000037109516,0.00056222064,0.00012127261,0.00049744104,0.00018407858],"domain_scores_gemma":[0.99843657,0.000009078453,0.0006604149,0.00016711584,0.00049299485,0.00023384336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027795296,0.000074459334,0.00037242795,0.000073646166,0.000102413105,0.000036670077,0.0001700074,0.000078384204,0.00053199613],"category_scores_gemma":[0.00005961547,0.000081900966,0.00008004825,0.000038954353,0.00007603708,0.0002242593,0.000025863019,0.00035597585,5.450714e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032726515,0.00044244796,0.9647321,0.00022611379,0.000060671868,0.00045944023,0.00021163466,0.0000030691695,0.00019814125,0.0000029594978,0.0008936043,0.032442555],"study_design_scores_gemma":[0.0033563362,0.0003395973,0.9912779,0.0021293536,0.00008624599,0.00030969435,0.000022003313,0.000026410638,0.0007567278,0.00009610113,0.0015305273,0.00006913687],"about_ca_topic_score_codex":0.01024584,"about_ca_topic_score_gemma":0.010598676,"teacher_disagreement_score":0.032373417,"about_ca_system_score_codex":0.00023517474,"about_ca_system_score_gemma":0.0003409358,"threshold_uncertainty_score":0.99634504},"labels":[],"label_agreement":null},{"id":"W2624913702","doi":"10.1038/bjc.2017.161","title":"Prioritising action on occupational carcinogens in Europe: a socioeconomic and health impact assessment","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amec Foster Wheeler (Canada)","funders":"Cranfield University; European Commission; University of Warwick","keywords":"Environmental health; Directive; Health impact assessment; Socioeconomic status; Public health; Psychological intervention; European union; Business; Legislature; Medicine; Public economics; Political science; Population; Economics; Nursing","score_opus":0.056092271419687985,"score_gpt":0.44071620389850047,"score_spread":0.3846239324788125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624913702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995475,0.0026320384,0.000006875153,0.0013956993,0.00013678554,0.00008245583,0.000046840185,0.0000018661431,0.00022244113],"genre_scores_gemma":[0.9944527,0.004599747,0.00015729081,0.0004307052,0.0002866155,0.000002280397,0.000007271254,0.000008269695,0.00005511316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994109,0.000021055153,0.0002130205,0.00008554283,0.00016858245,0.000100886224],"domain_scores_gemma":[0.9994969,0.000011772969,0.0002715451,0.00005514884,0.000040643405,0.00012401899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016413972,0.000056669414,0.00017054916,0.000046770157,0.00014820474,0.00006565356,0.000037923226,0.000019978625,0.0001773482],"category_scores_gemma":[0.000019882056,0.00005830812,0.000050633145,0.00001285982,0.000046965222,0.0001874327,0.0000141061755,0.00014846212,0.0000019237757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016956148,0.00008123637,0.852685,0.000022738255,0.000031668995,0.000085951775,0.000015229697,0.00007717373,0.00012007217,0.0000065467984,0.0006513843,0.14605345],"study_design_scores_gemma":[0.0013689576,0.0002711069,0.99657416,0.0005048992,0.000020961352,0.00045087058,0.000018494025,0.000053087013,0.000020080659,0.000030282787,0.0006383396,0.00004876725],"about_ca_topic_score_codex":0.001417535,"about_ca_topic_score_gemma":0.00053842354,"teacher_disagreement_score":0.14600468,"about_ca_system_score_codex":0.000555057,"about_ca_system_score_gemma":0.00046274473,"threshold_uncertainty_score":0.23777361},"labels":[],"label_agreement":null},{"id":"W2635752945","doi":"10.1038/bjc.2017.231","title":"Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium","year":2017,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Francis Crick Institute; Ovarian Cancer Research Fund; National Cancer Institute; National Institutes of Health; Cancer Research UK; McGill University; European Commission; Breast Cancer Research Foundation","keywords":"Prostate cancer; Cancer; Prostate; Oncology; Medicine; Genetic marker; Bioinformatics; Internal medicine; Biology; Gynecology; Computational biology; Genetics; Gene","score_opus":0.01509033717269554,"score_gpt":0.29120461761633015,"score_spread":0.2761142804436346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2635752945","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47484434,0.47018138,0.000013006472,0.013171736,0.026175056,0.0013787805,0.0060990923,0.00004864348,0.0080879675],"genre_scores_gemma":[0.088572495,0.8392977,0.00056843023,0.0013549685,0.012684191,0.000060785973,0.00025418415,0.00018954721,0.0570177],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99641,0.00028163582,0.0012719792,0.0005096934,0.00097103504,0.0005556304],"domain_scores_gemma":[0.99453926,0.0003558665,0.002763207,0.00045826597,0.0014092993,0.0004741251],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005726094,0.00042731361,0.0011254654,0.00010365506,0.00043844944,0.00037358803,0.00034425466,0.0006027262,0.0003024207],"category_scores_gemma":[0.0027793457,0.00033407868,0.0002616774,0.00017021825,0.00047692863,0.00026719,0.00009713446,0.003902476,0.0000051337283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024582045,0.00006378977,0.024400275,0.00007554461,0.001097294,0.0020630439,0.00022317133,0.0000010678858,0.000038709033,2.7725008e-7,0.9041832,0.065395415],"study_design_scores_gemma":[0.0030237117,0.00023783316,0.49960384,0.0025554555,0.0014744994,0.0015052365,0.000048359325,0.00002318215,0.00003777406,0.000030688916,0.4912213,0.00023809717],"about_ca_topic_score_codex":0.016671043,"about_ca_topic_score_gemma":0.0054917773,"teacher_disagreement_score":0.47520357,"about_ca_system_score_codex":0.00024575615,"about_ca_system_score_gemma":0.0040139495,"threshold_uncertainty_score":0.9999111},"labels":[],"label_agreement":null},{"id":"W2667610","doi":"10.1038/bjc.1989.11","title":"Housing for People with Substance Use and Concurrent Disorders: Summary of Literature and Annotated Bibliography","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute","keywords":"Substance use; Annotated bibliography; Bibliography; Gerontology; Psychology; Computer science; Psychiatry; Library science; Medicine","score_opus":0.026124680648067077,"score_gpt":0.36816799572856,"score_spread":0.34204331508049296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2667610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9023978,0.0962552,0.00068688364,0.00006213571,0.00022252038,0.0002262122,0.00011766555,0.000005338456,0.00002623905],"genre_scores_gemma":[0.89290476,0.10657567,0.00028528098,0.00003816516,0.00015520079,0.000007267716,0.0000037197676,0.000014403604,0.000015522732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911326,0.000062132356,0.000362664,0.000091528425,0.00015163234,0.00021879186],"domain_scores_gemma":[0.99860734,0.0002611795,0.00037643584,0.000035301495,0.0006190717,0.00010066416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039595604,0.00007747601,0.0003733294,0.00044653236,0.00022657464,0.000050891867,0.00004447832,0.000085626845,0.000011312171],"category_scores_gemma":[0.000027604108,0.000070055554,0.000043968375,0.0011444275,0.00008363246,0.00035899528,0.000009871658,0.00026769526,1.6039278e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027599055,0.0000378687,0.929361,0.00048083035,0.00006657021,0.000022720393,0.010826569,0.0000019216945,0.00005607039,0.00005618649,0.00048061286,0.058333665],"study_design_scores_gemma":[0.0021997544,0.0001553063,0.97503984,0.0064074215,0.00005987642,0.00000681442,0.008671902,0.00000582167,0.000030793002,0.00025008104,0.007044731,0.00012767907],"about_ca_topic_score_codex":0.0014470409,"about_ca_topic_score_gemma":0.11704177,"teacher_disagreement_score":0.11559472,"about_ca_system_score_codex":0.000012942138,"about_ca_system_score_gemma":0.000064225416,"threshold_uncertainty_score":0.8990699},"labels":[],"label_agreement":null},{"id":"W2691308717","doi":"10.1038/bjc.2017.176","title":"Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?","year":2017,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Adjuvant chemotherapy; Adjuvant; Cancer; Intensity (physics); Internal medicine; Physics","score_opus":0.01725695604834053,"score_gpt":0.309248619271904,"score_spread":0.29199166322356346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2691308717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09315276,0.12996353,0.00027907244,0.7153452,0.038627442,0.0014019773,0.020944547,0.000029307244,0.00025617762],"genre_scores_gemma":[0.29646006,0.17594063,0.00050441734,0.36757606,0.15045764,0.0009454994,0.001552779,0.0006680608,0.0058948677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810284,0.000048005626,0.0005123354,0.0004856726,0.00035594837,0.00049517833],"domain_scores_gemma":[0.99744207,0.000023006593,0.0011539825,0.00033186053,0.0009476307,0.00010146158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012689363,0.00042689012,0.0008414364,0.00005476326,0.00024744394,0.00017460664,0.0005713624,0.0004893568,0.00028935712],"category_scores_gemma":[0.000023746556,0.0003844988,0.00060453004,0.000025882515,0.00028702186,0.000016626707,0.00012613322,0.0006666093,0.0000029099253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017161011,0.000049342667,0.0018939857,0.00016620045,0.002167534,0.00031540348,0.000026975496,0.000004063951,0.000630549,1.7398499e-7,0.8842604,0.108769275],"study_design_scores_gemma":[0.008231483,0.00018938984,0.019372426,0.0011592149,0.0007145938,0.0016447431,0.000019542063,0.0000011662676,0.0031136798,0.000019714824,0.964981,0.0005530211],"about_ca_topic_score_codex":0.0018983745,"about_ca_topic_score_gemma":0.0017731431,"teacher_disagreement_score":0.34776914,"about_ca_system_score_codex":0.00030099548,"about_ca_system_score_gemma":0.00057115144,"threshold_uncertainty_score":0.9998607},"labels":[],"label_agreement":null},{"id":"W2730119757","doi":"10.1038/bjc.2017.198","title":"Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"European Society for Medical Oncology","keywords":"Radiation therapy; Medicine; Chemotherapy; Multicenter study; Oncology; Pathology; Radiology; Internal medicine; Randomized controlled trial","score_opus":0.018004106672552853,"score_gpt":0.3234679987112252,"score_spread":0.30546389203867236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730119757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309796,0.0050543244,0.000016622063,0.0011200018,0.000076879274,0.0005132966,0.000003661036,0.0000050833764,0.00011216666],"genre_scores_gemma":[0.99584746,0.00076382275,0.0025189484,0.00049222243,0.00017414673,0.000039948012,5.1947444e-7,0.000022284094,0.00014062271],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988593,0.000027684358,0.00038682055,0.0001348934,0.00044104064,0.00015027597],"domain_scores_gemma":[0.99883306,0.000030662904,0.0005351464,0.00019480845,0.00026080693,0.00014553615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021192763,0.000119428085,0.00043959677,0.000087216,0.00014306723,0.000081415914,0.0001782875,0.00003106084,0.00044173322],"category_scores_gemma":[0.000033631633,0.00009575075,0.000068924914,0.000055342556,0.0000375215,0.000118308635,0.000012564424,0.000102538164,0.000004484817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004399966,0.0008835984,0.45032567,0.000010159197,0.00068941014,0.00019952666,0.0009178712,0.0000071814784,0.0017287307,9.8464085e-8,0.00025647585,0.5445413],"study_design_scores_gemma":[0.010470595,0.000960233,0.96479243,0.0008368342,0.000116460506,0.00013728674,0.00012824251,0.000007848971,0.013353816,8.645405e-7,0.009093706,0.00010170124],"about_ca_topic_score_codex":0.00032859886,"about_ca_topic_score_gemma":0.00045369743,"teacher_disagreement_score":0.5444396,"about_ca_system_score_codex":0.00015487552,"about_ca_system_score_gemma":0.00030367827,"threshold_uncertainty_score":0.4836669},"labels":[],"label_agreement":null},{"id":"W2735904407","doi":"10.1038/bjc.2017.220","title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Tumor microenvironment; Immune checkpoint; CD8; Cancer; Immunology; Immunotherapy; Cancer research; Cancer cell; Medicine; Biology; Internal medicine","score_opus":0.07567563179933269,"score_gpt":0.39825864361742486,"score_spread":0.3225830118180922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735904407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014658088,0.99557674,0.0000017417002,0.00021449085,0.0014190465,0.0008920622,0.00012216721,0.0000045041443,0.00030345024],"genre_scores_gemma":[0.00081806444,0.99686074,0.00007854019,0.00012527636,0.0009182915,0.00009488565,0.0000043071796,0.000062078354,0.0010378414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703187,0.00019655439,0.0017282988,0.00020111416,0.0005256651,0.00031652628],"domain_scores_gemma":[0.9961484,0.00026256594,0.0028590464,0.00033506955,0.00031096654,0.00008394772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010218109,0.0002968175,0.0022324757,0.00017310717,0.0001102698,0.00010889533,0.0005697033,0.00023971267,0.0005372389],"category_scores_gemma":[0.00027759245,0.0001932818,0.00080296054,0.00031950654,0.00024724336,0.0001475214,0.000051484814,0.0010311828,0.0000013540089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037171796,0.00008450526,0.000169921,0.0078018843,0.00080082146,0.00053104095,0.00009111709,0.0000044402964,0.00007090719,9.314536e-7,0.0013399717,0.98873276],"study_design_scores_gemma":[0.0015195346,0.0002456489,0.0019593092,0.17572783,0.001387701,0.0028756093,0.00004685636,0.0000018165174,0.00006385074,0.000003210413,0.81597507,0.00019354458],"about_ca_topic_score_codex":0.005237087,"about_ca_topic_score_gemma":0.0025409346,"teacher_disagreement_score":0.9885392,"about_ca_system_score_codex":0.00038733298,"about_ca_system_score_gemma":0.0039468696,"threshold_uncertainty_score":0.7916944},"labels":[],"label_agreement":null},{"id":"W2738694813","doi":"10.1038/bjc.2017.218","title":"Long-term outcomes of patients with 10 or more colorectal liver metastases","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Sanofi","keywords":"Medicine; Contraindication; Colorectal cancer; Multivariate analysis; Hepatectomy; Cohort; Internal medicine; Population; Surgery; Resection; Survival analysis; Gastroenterology; Cancer; Pathology","score_opus":0.05295032444628585,"score_gpt":0.30370739460487517,"score_spread":0.25075707015858933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738694813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951879,0.0040834676,0.0000056312683,0.0001363802,0.000115592105,0.00021677774,0.00011492447,0.000003963097,0.00013536647],"genre_scores_gemma":[0.99786055,0.0008810307,0.0003010703,0.00005519037,0.000096887685,0.000008647589,0.000012975147,0.000018001432,0.00076563575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990645,0.00002340379,0.0002829861,0.00009602172,0.00038809434,0.00014496832],"domain_scores_gemma":[0.9987355,0.000032060223,0.0005027749,0.0001332863,0.000464628,0.00013178239],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000090984024,0.000109652414,0.00046709174,0.0000535069,0.00009796289,0.0000525716,0.00012948133,0.000043471646,0.0014809709],"category_scores_gemma":[0.00009496486,0.00007544601,0.000167296,0.000034650166,0.00013217646,0.00020978566,0.000027149907,0.00011239769,0.0000025139425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001348287,0.00030015208,0.9158013,0.00006840242,0.0006946195,0.0027527974,0.00005026492,1.6581785e-7,0.00001574531,4.2930495e-7,0.00054000935,0.07842785],"study_design_scores_gemma":[0.004875919,0.0009786664,0.9897038,0.00059162633,0.0008610384,0.00030838102,0.000010104668,0.0000032857295,0.0020321568,8.334291e-7,0.0005485482,0.00008567888],"about_ca_topic_score_codex":0.00028545616,"about_ca_topic_score_gemma":0.00064450677,"teacher_disagreement_score":0.07834217,"about_ca_system_score_codex":0.000051461815,"about_ca_system_score_gemma":0.0001869081,"threshold_uncertainty_score":0.9994318},"labels":[],"label_agreement":null},{"id":"W2739680515","doi":"10.1038/bjc.2017.242","title":"Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Public Health Ontario; University of Toronto; Memorial University of Newfoundland","funders":"Newfoundland and Labrador Centre for Applied Health Research; Canadian Institutes of Health Research; Memorial University of Newfoundland; Faculty of Medicine, Memorial University of Newfoundland; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Calcitriol receptor; Colorectal cancer; Haplotype; Vitamin D and neurology; Internal medicine; Medicine; CYP24A1; Population; Single-nucleotide polymorphism; Oncology; Endocrinology; Calcium-sensing receptor; Gastroenterology; Cohort; Cancer; Calcium; Biology; Genetics; Allele; Genotype; Calcium metabolism; Gene","score_opus":0.03776331224151212,"score_gpt":0.35007601582115133,"score_spread":0.3123127035796392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739680515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783707,0.015154932,0.000008231615,0.005417952,0.0006155234,0.0002086099,0.000030350815,0.0000037585569,0.00018993046],"genre_scores_gemma":[0.98357123,0.01487344,0.00024201514,0.00012839466,0.0009211711,0.0000072468333,0.0000024075944,0.000016494427,0.00023757278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987575,0.00011625644,0.0003082141,0.00015496693,0.00041410344,0.00024896953],"domain_scores_gemma":[0.99915594,0.00012287433,0.0002826048,0.000103302336,0.00021648238,0.00011877789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007467697,0.00011253127,0.00037031647,0.000082249964,0.0003923344,0.00023109527,0.00011653499,0.00007257984,0.00006709783],"category_scores_gemma":[0.00057596056,0.00008892464,0.000050205785,0.00006764401,0.00028690905,0.00025263,0.00006724359,0.00040921714,5.81877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025804748,0.000033953464,0.75186205,0.000056271994,0.000106475716,0.00023747454,0.0005547126,0.0000020319278,0.007872497,0.000007922749,0.0022737943,0.23673476],"study_design_scores_gemma":[0.0023192987,0.00016378304,0.99243045,0.0011284332,0.00005821798,0.00080531935,0.00032288695,0.00003473634,0.00026679575,0.00003646941,0.0023332883,0.00010033863],"about_ca_topic_score_codex":0.023892852,"about_ca_topic_score_gemma":0.038913246,"teacher_disagreement_score":0.24056837,"about_ca_system_score_codex":0.00020286333,"about_ca_system_score_gemma":0.00012083766,"threshold_uncertainty_score":0.9826071},"labels":[],"label_agreement":null},{"id":"W2744987279","doi":"10.1038/bjc.2017.236","title":"Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; TrygFonden; Vrije Universiteit Amsterdam; Medical Research Council; Aarhus Universitet; Novo Nordisk; Sundhed og Sygdom, Det Frie Forskningsråd; Alberta Cancer Foundation","keywords":"Colorectal cancer; Medicine; Stage (stratigraphy); Primary care; Cancer; Oncology; Internal medicine; Family medicine; Biology","score_opus":0.02531502552746173,"score_gpt":0.335631026037238,"score_spread":0.31031600050977626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744987279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95573664,0.043302566,0.00004264463,0.000087655106,0.00017548694,0.0003378149,0.00023281931,0.0000040717996,0.00008027694],"genre_scores_gemma":[0.9888142,0.010569274,0.00030498946,0.00015922019,0.00006862452,0.0000226483,0.000010718121,0.000018428223,0.000031912805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976484,0.00007505765,0.0008502412,0.00023406734,0.00091985165,0.00027234724],"domain_scores_gemma":[0.9957254,0.00025941367,0.0017196873,0.00022102233,0.0019380413,0.00013644452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033071628,0.00017480845,0.0012167722,0.00024144999,0.00009810605,0.000062250976,0.00031383766,0.00007816482,0.0001340495],"category_scores_gemma":[0.00066262897,0.00016706905,0.00022392522,0.00033110759,0.00028585925,0.0006838243,0.00008330628,0.00028625,1.6929512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022613655,0.0000732208,0.96030176,0.00053067866,0.0010406224,0.0005867217,0.0017363804,0.0045015216,0.0002481035,7.1822495e-7,0.00008719966,0.028631726],"study_design_scores_gemma":[0.0026537557,0.0006693038,0.96172184,0.029294379,0.0023896254,0.000045765864,0.001125691,0.00006947227,0.0017875887,0.0000019671902,0.00008083622,0.00015975193],"about_ca_topic_score_codex":0.020528426,"about_ca_topic_score_gemma":0.071624056,"teacher_disagreement_score":0.051095627,"about_ca_system_score_codex":0.00066847284,"about_ca_system_score_gemma":0.00080295233,"threshold_uncertainty_score":0.985994},"labels":[],"label_agreement":null},{"id":"W2745775095","doi":"10.1038/bjc.2017.275","title":"Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Queen's University; Cancer Care Ontario","keywords":"Medicine; Radiation therapy; Internal medicine; Oncology; Chemoradiotherapy; Chemotherapy; Retrospective cohort study; Cancer; Population; Cohort; Gynecology","score_opus":0.017326038657880277,"score_gpt":0.33262057142297885,"score_spread":0.31529453276509856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745775095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123716,0.004395067,0.00021964141,0.0014855826,0.0009115148,0.0011544006,0.0005682212,0.00000428719,0.000024124693],"genre_scores_gemma":[0.9973808,0.0011996333,0.0001396811,0.00042690837,0.0006054899,0.00014989958,0.000012714408,0.00002408468,0.000060795304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880004,0.00003787948,0.00038391817,0.00016581384,0.0004473122,0.00016505196],"domain_scores_gemma":[0.9983606,0.000082043734,0.00057954655,0.00012776112,0.00074008835,0.000109993554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023448459,0.00012867023,0.00049726566,0.00004392163,0.0002753924,0.00005624462,0.00011665922,0.000032513,0.0002849307],"category_scores_gemma":[0.00006527917,0.00009574775,0.000102605736,0.000047657715,0.00008261696,0.00012067326,0.0000118592025,0.00012831512,8.154532e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031168815,0.0006393153,0.5233203,0.00011823874,0.000705107,0.000010379701,0.0004551152,0.000026251333,0.0001413069,0.000004577154,0.0025789794,0.46888354],"study_design_scores_gemma":[0.016843317,0.0028149707,0.9750338,0.0006678659,0.00017027867,0.0000063060315,0.000121057674,0.000046874597,0.0002382895,0.0000104765595,0.003930685,0.000116045325],"about_ca_topic_score_codex":0.0012938943,"about_ca_topic_score_gemma":0.0022870277,"teacher_disagreement_score":0.4687675,"about_ca_system_score_codex":0.0001732262,"about_ca_system_score_gemma":0.00028136745,"threshold_uncertainty_score":0.390448},"labels":[],"label_agreement":null},{"id":"W2746022200","doi":"10.1038/bjc.2017.282","title":"Circulating resistin levels and risk of multiple myeloma in three prospective cohorts","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"U.S. Public Health Service; Terry Fox Foundation; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American Cancer Society","keywords":"Resistin; Medicine; Prospective cohort study; Quartile; Odds ratio; Internal medicine; Confidence interval; Cohort; Cohort study; Endocrinology; Adipose tissue; Case-control study; Adiponectin; Obesity; Insulin resistance","score_opus":0.020704376483955317,"score_gpt":0.2945784047868466,"score_spread":0.2738740283028913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746022200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687464,0.011906046,0.00007901863,0.000063547435,0.00013513339,0.00018579891,0.00004780874,0.0000033937204,0.00070459984],"genre_scores_gemma":[0.9969356,0.002016977,0.00053188525,0.000014557268,0.00039628503,0.0000064801725,6.559595e-7,0.0000106662255,0.000086885324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911785,0.000025880121,0.00040676782,0.000098821925,0.0002362504,0.00011443272],"domain_scores_gemma":[0.9986403,0.000050227987,0.00073990086,0.000120623066,0.00035204712,0.00009688301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003441822,0.000068701105,0.0003564625,0.00006216853,0.000118229436,0.000037642625,0.00007144149,0.00003930967,0.00005096746],"category_scores_gemma":[0.0016864834,0.00006966963,0.00006703957,0.00003817472,0.00012096485,0.00020477346,0.00002093486,0.00014749194,1.9229356e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014101168,0.00003479446,0.8685673,0.00006938605,0.000102511956,0.00028150412,0.00013139188,0.00002608427,0.0005440366,0.000017893928,0.000048215603,0.13003585],"study_design_scores_gemma":[0.0027514151,0.000037330017,0.99310315,0.0015003068,0.00021815728,0.00048766637,0.00004924106,0.00008838252,0.00071248785,0.0005467112,0.00043868658,0.00006647452],"about_ca_topic_score_codex":0.0026454425,"about_ca_topic_score_gemma":0.008736873,"teacher_disagreement_score":0.12996937,"about_ca_system_score_codex":0.000040598417,"about_ca_system_score_gemma":0.00019717462,"threshold_uncertainty_score":0.487538},"labels":[],"label_agreement":null},{"id":"W2750806791","doi":"10.1038/bjc.2017.304","title":"Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Aldehyde dehydrogenase; ALDH2; Tissue microarray; Biology; Colorectal cancer; CD44; Cancer research; Biomarker; Pathology; Cancer; Isozyme; Microarray; Cell; Gene expression; Enzyme; Gene; Medicine; Genetics; Biochemistry","score_opus":0.032290023957398634,"score_gpt":0.34795283776726865,"score_spread":0.31566281380987005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750806791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9283024,0.065129526,0.00053360546,0.0020569519,0.0017618875,0.00040623525,0.0003423106,0.000012044206,0.0014550157],"genre_scores_gemma":[0.9755784,0.016963856,0.0028251987,0.00083261915,0.0015569553,0.00012255258,0.000004978065,0.000044758963,0.002070673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855185,0.000017876639,0.0005000103,0.00021384329,0.00035269046,0.00036373388],"domain_scores_gemma":[0.99828124,0.000048919163,0.0006772311,0.0001977823,0.0005224506,0.00027239515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003880816,0.00016080975,0.00061504147,0.00005969753,0.00033915273,0.00013248374,0.00027660793,0.00011639557,0.0014821882],"category_scores_gemma":[0.00027222192,0.00015305313,0.00046639045,0.00004795332,0.000207364,0.00018940822,0.00005257019,0.00032723203,0.0000021729954],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049914387,0.00055569055,0.017099349,0.00024344432,0.0011836361,0.0012402092,0.000102185,0.000033970628,0.11251873,0.00004789512,0.02879196,0.8331915],"study_design_scores_gemma":[0.012008798,0.0006105716,0.19530095,0.001484594,0.0010364263,0.006550735,0.000052450076,0.00009223866,0.023576265,0.00008343276,0.7588452,0.0003583275],"about_ca_topic_score_codex":0.0023403142,"about_ca_topic_score_gemma":0.0025935413,"teacher_disagreement_score":0.8328332,"about_ca_system_score_codex":0.00031761394,"about_ca_system_score_gemma":0.0006683753,"threshold_uncertainty_score":0.9994306},"labels":[],"label_agreement":null},{"id":"W2753773656","doi":"10.1038/bjc.2017.303","title":"Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Prostate cancer; Weight loss; Interquartile range; Overweight; Internal medicine; Prostate; Leptin; Obesity; Cancer; Prostatectomy; Endocrinology; Urology; Androgen suppression; Testosterone (patch); Gastroenterology","score_opus":0.011519466659057538,"score_gpt":0.2870053818559688,"score_spread":0.27548591519691124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753773656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95548636,0.04042769,0.0000022905817,0.0025413278,0.00009149998,0.00039187408,0.000041454186,0.0000059561803,0.0010115757],"genre_scores_gemma":[0.96917105,0.030149419,0.00013681017,0.00010178548,0.0002362413,0.00007987301,0.0000012035747,0.000025703519,0.00009789783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988499,0.000035753408,0.00029068912,0.00021498611,0.00032280548,0.00028581443],"domain_scores_gemma":[0.999073,0.000038266204,0.00042816025,0.00008283841,0.00014781492,0.00022991096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023529139,0.0001470949,0.00044629397,0.00006733815,0.00016491688,0.0001429111,0.00009086711,0.000052334042,0.00007188163],"category_scores_gemma":[0.000041109855,0.00012088257,0.000067272944,0.00006216689,0.00015053763,0.00029844916,0.000029079463,0.00022973225,2.7275442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011723568,0.00014339392,0.7117109,0.00018206998,0.00053117744,0.008292527,0.00028843016,0.000041655494,0.0007936241,0.000005929534,0.0010137917,0.2758242],"study_design_scores_gemma":[0.009419138,0.0003261803,0.97688353,0.0059185647,0.00020560733,0.0028890811,0.00004536318,0.00006566249,0.0018763345,0.00003335584,0.0021897347,0.00014744424],"about_ca_topic_score_codex":0.0017321511,"about_ca_topic_score_gemma":0.0021480608,"teacher_disagreement_score":0.27567673,"about_ca_system_score_codex":0.00025237107,"about_ca_system_score_gemma":0.00034045495,"threshold_uncertainty_score":0.4929448},"labels":[],"label_agreement":null},{"id":"W2754705845","doi":"10.1038/bjc.2017.326","title":"Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; HEC Montréal","funders":"Plan National Cancer","keywords":"Psychological intervention; Anxiety; Psychosocial; Distress; Breast cancer; Medicine; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Clinical psychology; Depression (economics); Cancer; Psychiatry; Internal medicine; Nursing","score_opus":0.02615321036503586,"score_gpt":0.3409716552106199,"score_spread":0.314818444845584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754705845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892751,0.0039221686,0.00006960127,0.0028475667,0.0027176982,0.00042348017,0.00050855527,0.0000053092012,0.00023050762],"genre_scores_gemma":[0.9971056,0.0013457686,0.000044506065,0.00019026811,0.0008261918,0.00008880771,0.00001471043,0.000019351533,0.00036478997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998599,0.000058685324,0.0005517518,0.00017672632,0.000412333,0.00020152295],"domain_scores_gemma":[0.99877393,0.000025304635,0.00044308926,0.00015085192,0.0003702583,0.00023656256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025689416,0.000118531134,0.00040045168,0.00010742785,0.00014877529,0.0001781992,0.00017295335,0.000062267376,0.00044434986],"category_scores_gemma":[0.00018798557,0.00012303083,0.00021349809,0.00008530826,0.0000737881,0.0003235539,0.000060367795,0.00027633877,6.9157255e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018240493,0.0009193884,0.26165763,0.00079118606,0.0002718261,0.00028848715,0.0010223897,0.000015271757,0.000094806695,0.000059027036,0.008466325,0.70817316],"study_design_scores_gemma":[0.04107923,0.00041023636,0.9432161,0.012625104,0.00016953323,0.00027209098,0.00019427636,0.000007083026,0.00001570593,0.00008652781,0.0017700178,0.00015413314],"about_ca_topic_score_codex":0.011791644,"about_ca_topic_score_gemma":0.11040096,"teacher_disagreement_score":0.708019,"about_ca_system_score_codex":0.00027568138,"about_ca_system_score_gemma":0.00016457941,"threshold_uncertainty_score":0.99478894},"labels":[],"label_agreement":null},{"id":"W2756366108","doi":"10.1038/bjc.2017.285","title":"Occupational solvent exposure and risk of glioma in the INTEROCC study","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal; University of Ottawa","funders":"Cancer Council NSW; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Cancer Council Victoria; Agence Française de Sécurité Sanitaire de l'Environnement et du Travail","keywords":"Solvent exposure; Glioma; Medicine; Occupational exposure; Occupational safety and health; Occupational medicine; Environmental health; Toxicology; Oncology; Pathology; Biology; Cancer research","score_opus":0.013539792632718813,"score_gpt":0.3153726950987497,"score_spread":0.3018329024660309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756366108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489796,0.0047403,0.000055765147,0.0000546199,0.00009123379,0.00008506932,0.000033787823,1.8589827e-7,0.00004107103],"genre_scores_gemma":[0.99780893,0.0019373596,0.000049592658,0.000028376633,0.00015412206,0.0000049644245,0.0000010149184,0.0000032204193,0.00001238769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948066,0.000055734596,0.0001905634,0.00006977909,0.00014187513,0.00006137094],"domain_scores_gemma":[0.9994736,0.0000064531278,0.000282577,0.00011482559,0.0001018788,0.000020679336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036593238,0.00004231273,0.00009840586,0.000018588491,0.00007764607,0.00005254944,0.00017562539,0.000027402455,0.000011014583],"category_scores_gemma":[0.000047422287,0.00003561391,0.000052698382,0.000013339583,0.000047262456,0.0000050202784,0.00005380455,0.00008245005,4.4724445e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016744275,0.00021343984,0.9318462,0.000008592622,0.00013617385,0.00008170772,0.00022558583,0.00003866177,0.03287168,0.000002493572,0.0004937434,0.033914264],"study_design_scores_gemma":[0.000948166,0.00043354728,0.9898874,0.000045049273,0.000034577508,0.00020886949,0.00045519264,0.0000032621265,0.0070108306,0.000021620863,0.00091092486,0.000040570536],"about_ca_topic_score_codex":0.00077429245,"about_ca_topic_score_gemma":0.008284245,"teacher_disagreement_score":0.058041174,"about_ca_system_score_codex":0.0000075821254,"about_ca_system_score_gemma":0.000060420938,"threshold_uncertainty_score":0.4622803},"labels":[],"label_agreement":null},{"id":"W2757923756","doi":"10.1038/bjc.2017.339","title":"Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Adipose tissue; Medicine; Colorectal cancer; Aerobic exercise; Internal medicine; Cancer; Gastroenterology; Endocrinology","score_opus":0.009010026074516455,"score_gpt":0.2946859092756634,"score_spread":0.28567588320114695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757923756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980377,0.012159926,0.000019282743,0.000395746,0.004054902,0.0026668152,0.000029460063,0.000014347639,0.0002824809],"genre_scores_gemma":[0.99142385,0.0062855654,0.000010457637,0.00017550112,0.0010560688,0.00041389235,0.0000034138518,0.000041081334,0.0005901704],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974638,0.00040310796,0.0008523107,0.00022524557,0.0007547692,0.00030072647],"domain_scores_gemma":[0.99655926,0.00058948726,0.0015624813,0.00032753168,0.0006930448,0.00026822113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011595902,0.00022931698,0.0015552978,0.000171201,0.00023560094,0.00013608234,0.00027840855,0.0001757256,0.00024448824],"category_scores_gemma":[0.00055331754,0.00021700806,0.00069126324,0.000093062634,0.00022297392,0.00024283161,0.000030765223,0.00045335127,0.0000016338429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9523615,0.00047125164,0.0021485295,0.00026840257,0.00051481545,0.0008662832,0.00031041645,0.000046285913,0.018930322,0.0000022868473,0.0009007895,0.023179067],"study_design_scores_gemma":[0.8694478,0.0024962858,0.08960507,0.010165158,0.0013764988,0.00012112187,0.00005557751,0.00004595396,0.02561072,0.000014581705,0.0008160885,0.00024514052],"about_ca_topic_score_codex":0.013204882,"about_ca_topic_score_gemma":0.012283257,"teacher_disagreement_score":0.08745654,"about_ca_system_score_codex":0.0002822029,"about_ca_system_score_gemma":0.00057368795,"threshold_uncertainty_score":0.9933663},"labels":[],"label_agreement":null},{"id":"W2758687153","doi":"10.1038/bjc.2017.322","title":"Response to Morrell et al's reply","year":2017,"lang":"fr","type":"letter","venue":"British Journal of Cancer","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Gynecology","score_opus":0.06875678559840283,"score_gpt":0.4262246829575901,"score_spread":0.35746789735918727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758687153","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016028928,0.21132828,0.00003980834,0.76036686,0.006284948,0.00058706384,0.0005281492,0.000013571566,0.0048223967],"genre_scores_gemma":[0.00063346693,0.07711198,0.0005882091,0.79280186,0.010331152,0.000060171922,0.0000059242966,0.00015270784,0.11831451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99288154,0.0011375181,0.0014541969,0.0005715533,0.0025683094,0.0013868709],"domain_scores_gemma":[0.9931879,0.0009631705,0.0014231353,0.00083558436,0.0028408584,0.0007493486],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0055634365,0.0005215244,0.0017098091,0.0005293989,0.0005096852,0.00054996455,0.0011275468,0.00035025357,0.0038822417],"category_scores_gemma":[0.012302935,0.0005733085,0.0007046791,0.00020485483,0.00060769834,0.00043635917,0.00042489913,0.0057512345,0.0004749215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057481513,0.00007800697,0.00089705054,0.00028408962,0.0011629758,0.051378753,0.00037638206,0.00007322456,0.0013048284,0.0000015059443,0.8467798,0.091915205],"study_design_scores_gemma":[0.003318729,0.0010277829,0.03374629,0.023487613,0.00036794643,0.010158375,0.00006251711,0.0000048530296,0.00030362364,0.000022799826,0.9270207,0.00047871098],"about_ca_topic_score_codex":0.0047066133,"about_ca_topic_score_gemma":0.0007457546,"teacher_disagreement_score":0.13421631,"about_ca_system_score_codex":0.0016036123,"about_ca_system_score_gemma":0.0035591656,"threshold_uncertainty_score":0.9996718},"labels":[],"label_agreement":null},{"id":"W2761998606","doi":"10.1038/bjc.2017.334","title":"International consensus guidelines for scoring the histopathological growth patterns of liver metastasis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Consensus conference; Pathology; Medicine; MEDLINE; Cancer; Internal medicine; Biology","score_opus":0.227342489823958,"score_gpt":0.37098292450673714,"score_spread":0.14364043468277915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761998606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98039454,0.010489273,0.00043886574,0.0075024283,0.00055664335,0.00018704457,0.00010422591,0.0000035518146,0.0003234297],"genre_scores_gemma":[0.9909725,0.005028825,0.002795695,0.00023660345,0.00067730166,0.000015140295,0.0000026437144,0.0000093160525,0.00026193252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991777,0.000026531163,0.00037412072,0.00008402986,0.00023713688,0.0001005116],"domain_scores_gemma":[0.9980999,0.00006574207,0.00046883148,0.000107660926,0.0012014692,0.000056393314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041897257,0.00006857686,0.00025299873,0.000035744568,0.00012064109,0.00004765701,0.0001934206,0.000036364505,0.0001747845],"category_scores_gemma":[0.0007283819,0.00004885588,0.0002540767,0.000013370935,0.00008015081,0.000058557558,0.000034325796,0.000103884464,5.113468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023137557,0.00007096928,0.7708801,0.000055856064,0.00029127926,0.0011060826,0.00004609864,0.0000010135903,0.0008108849,0.000049638555,0.004741321,0.22171535],"study_design_scores_gemma":[0.0042080004,0.0004458173,0.90799373,0.0013858527,0.0011198685,0.005275746,0.000089633904,0.00033079513,0.012876363,0.0001683535,0.06596155,0.00014429148],"about_ca_topic_score_codex":0.00066137785,"about_ca_topic_score_gemma":0.00013150775,"teacher_disagreement_score":0.22157106,"about_ca_system_score_codex":0.000050283365,"about_ca_system_score_gemma":0.000079423146,"threshold_uncertainty_score":0.1992285},"labels":[],"label_agreement":null},{"id":"W2766816570","doi":"10.1038/bjc.2017.357","title":"Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; University of Waterloo; Princess Margaret Cancer Centre","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Internal medicine; Oncology; Proportional hazards model; Progression-free survival; Meta-analysis; Survival analysis; Cochrane Library; Surgery; Overall survival; Radiation therapy","score_opus":0.15958450411061575,"score_gpt":0.443895993522228,"score_spread":0.2843114894116123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766816570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000038075216,0.9925842,0.000010327712,0.00016971247,0.0015015797,0.0053205397,0.00031988337,0.000012920243,0.00007699965],"genre_scores_gemma":[0.00003762079,0.995411,0.00014606115,0.00025844754,0.0010071116,0.0017194415,0.000014761214,0.00009651185,0.0013090699],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958385,0.00031381514,0.0025250514,0.00030831472,0.0006201323,0.0003941742],"domain_scores_gemma":[0.9943743,0.00037984876,0.00370478,0.0004170405,0.00088737934,0.00023668462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014285302,0.00048614846,0.0102693485,0.000160069,0.00021496131,0.000104780345,0.0004592899,0.0001238963,0.00009666709],"category_scores_gemma":[0.0011330436,0.00031817434,0.0019097227,0.00014329441,0.00008660947,0.00016017277,0.000046544385,0.0005943101,0.0000065884255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057813566,0.000036019883,6.130813e-7,0.60207623,0.0015816443,0.0006722175,0.000038373128,5.930169e-9,3.0509394e-8,0.0000017005301,0.0073612873,0.38817403],"study_design_scores_gemma":[0.0007730945,0.00046312733,0.0000017453252,0.55752975,0.020533765,0.019628102,0.00002452497,2.3083733e-7,6.563611e-8,0.0000018950246,0.4008748,0.00016891233],"about_ca_topic_score_codex":0.0000494642,"about_ca_topic_score_gemma":0.00015712818,"teacher_disagreement_score":0.39351353,"about_ca_system_score_codex":0.0005710126,"about_ca_system_score_gemma":0.0026546926,"threshold_uncertainty_score":0.99992704},"labels":[],"label_agreement":null},{"id":"W2767056572","doi":"10.1038/bjc.2017.360","title":"A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research","keywords":"Odds ratio; Medicine; Etiology; Meta-analysis; Odds; Childhood cancer; El Niño; Immunology; Pediatrics; Subgroup analysis; Internal medicine; Cancer; Logistic regression","score_opus":0.030811597510676227,"score_gpt":0.34930967165505034,"score_spread":0.3184980741443741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767056572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016692799,0.996066,0.000025724574,0.00026701108,0.0000631426,0.0022500057,0.0010646787,0.0000033660613,0.000093160284],"genre_scores_gemma":[0.0018563671,0.99731004,0.000022302396,0.00009498724,0.00013570355,0.00014282513,0.000010060257,0.000038334918,0.0003894028],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99433243,0.0015095125,0.0024387613,0.00025539708,0.0012113418,0.00025257538],"domain_scores_gemma":[0.9866903,0.0023690306,0.009238199,0.0006403821,0.00090820075,0.00015388722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003887939,0.0003466298,0.010960021,0.0003237517,0.00025205588,0.00009676112,0.00054683216,0.00027313613,0.00007332079],"category_scores_gemma":[0.006956973,0.00017599818,0.004148575,0.0008147356,0.0003454296,0.0001234268,0.00020500914,0.00095878285,8.7349315e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000078502,0.00007334098,0.0004558434,0.2305684,0.75136614,0.000017458717,0.00009297142,0.0000023961506,2.7950858e-8,0.000007060443,0.00045480859,0.016953686],"study_design_scores_gemma":[0.001406644,0.00006276573,0.006638299,0.12320094,0.8643438,0.0014925956,0.000006083433,0.0000035561236,2.5446448e-7,0.000018862365,0.0027096071,0.000116587486],"about_ca_topic_score_codex":0.0006494753,"about_ca_topic_score_gemma":0.00022141445,"teacher_disagreement_score":0.11297765,"about_ca_system_score_codex":0.00081852125,"about_ca_system_score_gemma":0.0022430674,"threshold_uncertainty_score":0.8328649},"labels":[],"label_agreement":null},{"id":"W2770226065","doi":"10.1038/bjc.2017.409","title":"Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Kansainvälisen Liikkuvuuden ja Yhteistyön Keskus; Karolinska Institutet","keywords":"Treponema denticola; Periodontitis; Carcinogenesis; Biology; Immunology; Pathology; Cancer research; Medicine; Porphyromonas gingivalis; Cancer; Internal medicine","score_opus":0.03138607066066604,"score_gpt":0.35624164077480464,"score_spread":0.32485557011413857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770226065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985164,0.009923678,0.00037662184,0.0006815931,0.0027534084,0.00040222882,0.0003357826,0.000011471558,0.000351243],"genre_scores_gemma":[0.9940296,0.0007766544,0.00034717156,0.00015341271,0.00062207674,0.00003506525,0.000010446156,0.000027382232,0.003998238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982975,0.0001742558,0.00053286756,0.00025534118,0.00032971954,0.00041028074],"domain_scores_gemma":[0.9979696,0.000048047707,0.00059807743,0.0003449248,0.0008803949,0.00015894267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046302448,0.00015797267,0.00044225296,0.000073585856,0.0007753565,0.00064928835,0.0006050952,0.00016952769,0.0009839563],"category_scores_gemma":[0.00054809544,0.00017409417,0.00020614215,0.000089102956,0.00018854436,0.000699857,0.00015312686,0.00038249418,0.00010726342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002186773,0.0003404958,0.6124069,0.00014944492,0.0008517278,0.013415018,0.00039738996,0.00016153387,0.18101498,0.00010945068,0.026558908,0.16240735],"study_design_scores_gemma":[0.001788892,0.00017518102,0.91113186,0.0005480155,0.00006764366,0.0037210595,0.00003591366,0.0000037661298,0.02260404,0.00008085699,0.059633102,0.00020966932],"about_ca_topic_score_codex":0.006114685,"about_ca_topic_score_gemma":0.0100545995,"teacher_disagreement_score":0.29872492,"about_ca_system_score_codex":0.00021285097,"about_ca_system_score_gemma":0.0002788785,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W2771164127","doi":"10.1038/bjc.2017.440","title":"Anthropometric measurements and survival after a prostate cancer diagnosis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Alberta Health Services","funders":"National Cancer Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research; Alberta Innovates; Fondation pour la Recherche Médicale; Canada Research Chairs","keywords":"Medicine; Prostate cancer; Anthropometry; Body mass index; Waist; Proportional hazards model; Cohort; Cancer; Prospective cohort study; Cohort study; Waist–hip ratio; Population; Relative survival; Oncology; Survival analysis; Internal medicine; Cancer registry","score_opus":0.04220580016837778,"score_gpt":0.3469454300764634,"score_spread":0.3047396299080856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771164127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8201628,0.17520177,0.0000031557756,0.0030776726,0.00088108645,0.0002623286,0.00013862636,0.000005979362,0.00026661356],"genre_scores_gemma":[0.7798318,0.21886489,0.000120952325,0.00022572928,0.000391292,0.00033078055,9.711471e-7,0.000023645034,0.00020992088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856687,0.000029835212,0.00037076088,0.000207511,0.000546609,0.00027840328],"domain_scores_gemma":[0.9985057,0.000027745542,0.00047891788,0.00018754078,0.00051965105,0.00028041046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026624498,0.00015238387,0.00047548316,0.00012166388,0.00023428157,0.0002511595,0.000116766176,0.000054519944,0.0006926411],"category_scores_gemma":[0.00015084127,0.00013962484,0.00013134639,0.00009970832,0.00018283458,0.00034101852,0.000056047847,0.00020000014,0.0000020767534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023630797,0.0001945701,0.6513756,0.000073500276,0.00033751174,0.00079814455,0.000058569447,9.347271e-7,0.00003854565,3.9527484e-7,0.0019212926,0.34496462],"study_design_scores_gemma":[0.004587913,0.00044704677,0.9610184,0.0024629454,0.00047253308,0.00033621438,0.000024286433,0.0000018976606,0.0026558726,0.00002579538,0.027820123,0.0001469746],"about_ca_topic_score_codex":0.0037930408,"about_ca_topic_score_gemma":0.0026844812,"teacher_disagreement_score":0.34481764,"about_ca_system_score_codex":0.0002951193,"about_ca_system_score_gemma":0.00027463405,"threshold_uncertainty_score":0.7583934},"labels":[],"label_agreement":null},{"id":"W2782277425","doi":"10.1038/bjc.2017.429","title":"Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"National Cancer Institute; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; Sidney Kimmel Center for Prostate and Urologic Cancers; Vetenskapsrådet; Javna Agencija za Raziskovalno Dejavnost RS; Royal Marsden NHS Foundation Trust; Prostate Cancer Foundation of Australia; Generalitat de Catalunya; National Institute for Health and Care Research; NorthShore University HealthSystem; Victorian Cancer Agency; Cancer Australia; Cancerfonden; Centro de Investigación Biomédica en Red de Cáncer; Prostate Cancer Foundation; Myriad Genetics; Cancer Research UK","keywords":"Prostate cancer; Prostate-specific antigen; Medicine; Genetic predisposition; Prostate; Prospective cohort study; Oncology; Antigen; Internal medicine; Cancer; Immunology; Disease","score_opus":0.013363397330363003,"score_gpt":0.28495939197612896,"score_spread":0.27159599464576595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782277425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802816,0.017258361,0.000038831855,0.00019807952,0.00010467341,0.0018318298,0.00008577604,0.000010081317,0.0001907512],"genre_scores_gemma":[0.98636633,0.012011465,0.0008314978,0.00004746004,0.00032454391,0.0003066492,0.000003702707,0.000036932015,0.00007143253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814475,0.00006518745,0.0006291797,0.00029603412,0.0005618116,0.00030302582],"domain_scores_gemma":[0.99817747,0.000018646144,0.00054087065,0.00013524042,0.0009856422,0.00014214494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022056459,0.00018069452,0.0005573063,0.00015412676,0.00008626786,0.000047427344,0.00009222096,0.000047197034,0.00010755031],"category_scores_gemma":[0.0000115439225,0.00015793837,0.000065920474,0.00042078077,0.00015552223,0.00022285686,0.000028932505,0.00025015383,6.291384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004311793,0.001266461,0.8592119,0.00007757504,0.00048478428,0.0009143128,0.004974138,0.00024069512,0.00079112203,0.0000010938203,0.00047764013,0.12724844],"study_design_scores_gemma":[0.011075837,0.007085554,0.96893847,0.0035082065,0.00019883079,0.00029333433,0.00132348,0.0000561667,0.006835808,0.000026023243,0.00050106883,0.0001572365],"about_ca_topic_score_codex":0.0038373806,"about_ca_topic_score_gemma":0.0055409074,"teacher_disagreement_score":0.1270912,"about_ca_system_score_codex":0.00048453946,"about_ca_system_score_gemma":0.00040740342,"threshold_uncertainty_score":0.644054},"labels":[],"label_agreement":null},{"id":"W2783352225","doi":"10.1038/s41416-018-0004-2","title":"Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Social Fund; European Commission; Novartis Pharma; Deutsche Krebshilfe; Eli Lilly and Company; Alfried Krupp von Bohlen und Halbach-Stiftung; Pancreatic Cancer UK; Deutsche Forschungsgemeinschaft; Cancer Research UK; Region Östergötland; Astellas Pharma; Pfizer; NuCana; Mylan; Bundesministerium für Bildung und Forschung; Taiho Pharmaceutical; European Regional Development Fund; Sanofi; Baxalta; Amgen; Celgene; AstraZeneca; National Institute for Health and Care Research; Falk Foundation","keywords":"Gemcitabine; Dihydropyrimidine dehydrogenase; Medicine; Hazard ratio; Internal medicine; Folinic acid; Oncology; Fluorouracil; Chemotherapy; Pancreatic cancer; Gastroenterology; Confidence interval; Cancer; Thymidylate synthase","score_opus":0.028852628722255896,"score_gpt":0.3535944034438522,"score_spread":0.32474177472159627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783352225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97157085,0.02674537,0.000047361184,0.0003242555,0.00020134718,0.00020167965,0.000026294503,0.0000046658242,0.0008781853],"genre_scores_gemma":[0.9749671,0.0235669,0.00038440715,0.00010172755,0.0005860879,0.000017360122,0.0000015293316,0.000017394039,0.00035745234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984127,0.00011645843,0.0005762984,0.00014971921,0.00047344182,0.00027135253],"domain_scores_gemma":[0.9988593,0.00011664795,0.00028088054,0.00010815847,0.00039529463,0.00023973842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005777291,0.00010604461,0.0006984834,0.00014816548,0.00005120477,0.0000125157685,0.0000986547,0.00010236735,0.0007327911],"category_scores_gemma":[0.00027508527,0.00009549366,0.00006920184,0.0001875891,0.00033580355,0.00011673516,0.000048331567,0.00029160304,0.000001282932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001172603,0.00022999018,0.93581086,0.00025377332,0.00015052262,0.000626917,0.00035997064,0.000005972882,0.04147985,0.000006824173,0.0014670073,0.018435722],"study_design_scores_gemma":[0.007870505,0.0012701926,0.9346568,0.0071427976,0.00041824617,0.0014053975,0.00022053753,0.00064012397,0.043845333,0.0001888845,0.0021836914,0.00015748237],"about_ca_topic_score_codex":0.0022482576,"about_ca_topic_score_gemma":0.0018997242,"teacher_disagreement_score":0.01827824,"about_ca_system_score_codex":0.00013097076,"about_ca_system_score_gemma":0.0005509908,"threshold_uncertainty_score":0.8023549},"labels":[],"label_agreement":null},{"id":"W2784065054","doi":"10.1054/bjoc.1999.1130","title":"Expression of αvβ6integrin in oral leukoplakia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Leukoplakia; Medicine; Oral leukoplakia; Pathology; Dermatology; Internal medicine; Cancer","score_opus":0.020866760188428188,"score_gpt":0.34733717667244585,"score_spread":0.32647041648401764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784065054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98769933,0.010175021,0.0000069965868,0.000058263893,0.0003610899,0.000052930554,0.000025653657,0.0000035845699,0.0016171067],"genre_scores_gemma":[0.9956768,0.0021106252,0.00035504394,0.000081214035,0.00010088825,0.0000040034665,0.0000010942261,0.000007624239,0.0016626809],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99906015,0.0000941862,0.0004424526,0.000080227765,0.00017209114,0.0001508676],"domain_scores_gemma":[0.9995921,0.000026316899,0.00018939275,0.00006242445,0.0000680601,0.00006170133],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021540096,0.00006074812,0.0002546943,0.00005033702,0.000028722576,0.000008609832,0.00009747937,0.00008712994,0.004643404],"category_scores_gemma":[0.000016042024,0.0000600819,0.000074168536,0.000082286664,0.000042456813,0.00012831534,0.000008853935,0.00027460663,0.000029515886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062124996,0.0003606416,0.2131208,0.00006762733,0.000026248397,0.007780477,0.00013881527,0.00020458194,0.0009468709,0.0000200493,0.005900299,0.77081233],"study_design_scores_gemma":[0.0029350424,0.00018490422,0.9664333,0.0014563677,0.000027029873,0.0038209856,0.00005095542,0.000005941275,0.009377464,0.00036122245,0.015253924,0.00009289458],"about_ca_topic_score_codex":0.0011489117,"about_ca_topic_score_gemma":0.00463381,"teacher_disagreement_score":0.77071947,"about_ca_system_score_codex":0.00008309763,"about_ca_system_score_gemma":0.00010405316,"threshold_uncertainty_score":0.9962665},"labels":[],"label_agreement":null},{"id":"W2786737956","doi":"10.1038/bjc.2017.447","title":"Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Council; Canadian Institutes of Health Research; Prostate Cancer UK; Cancer Research UK; Wellcome Trust","keywords":"Cancer research; Biology; Prostate cancer; Ex vivo; Prostate; Cancer; Gene silencing; Tissue microarray; Tumor suppressor gene; Cell growth; H3K4me3; Carcinogenesis; Gene expression; In vivo; Gene; Promoter; Genetics","score_opus":0.006896787882410925,"score_gpt":0.27716999775314566,"score_spread":0.2702732098707347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786737956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951813,0.0026448818,0.0005986407,0.000029436651,0.0002703057,0.000116335184,0.000043892807,0.0000058964984,0.0011093145],"genre_scores_gemma":[0.9953258,0.00037513472,0.00090647227,0.00009220239,0.00086564454,0.000007665179,0.00000851807,0.000030216299,0.0023883404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990902,0.000029769271,0.00035056975,0.00017076246,0.0001734501,0.00018524543],"domain_scores_gemma":[0.99905586,0.0000010178995,0.0003002386,0.00015637916,0.00037874116,0.00010773323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022825476,0.00010416904,0.00017049199,0.00003121956,0.00014057418,0.0001394475,0.0002449537,0.00009782142,0.000041988773],"category_scores_gemma":[0.000013463351,0.00011992399,0.00006415154,0.00003827847,0.00008749849,0.000013735217,0.00006155061,0.00010307489,0.0000041740573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005067282,0.00005000789,0.00014152468,0.00007695118,0.00008285321,0.000082514525,0.00015786133,0.0009358463,0.98268795,0.00012759355,0.002515433,0.013090775],"study_design_scores_gemma":[0.0021377723,0.0019335563,0.0018795741,0.0010633012,0.0001140218,0.003186747,0.00072460505,0.004735838,0.95710564,0.001396682,0.025041735,0.00068054505],"about_ca_topic_score_codex":0.00042026865,"about_ca_topic_score_gemma":0.0020240322,"teacher_disagreement_score":0.025582343,"about_ca_system_score_codex":0.000053755262,"about_ca_system_score_gemma":0.00017871655,"threshold_uncertainty_score":0.48903584},"labels":[],"label_agreement":null},{"id":"W2786964939","doi":"10.1038/bjc.2017.462","title":"Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital; Royal University Hospital; Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Izaak Walton Killam Health Centre; C17 Council; Pediatric Oncology Group; BC Children's Hospital","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Pediatrics; Clinical trial; Population; Event (particle physics); Acute lymphocytic leukemia; Oncology; Internal medicine; Lymphoblastic Leukemia; Leukemia","score_opus":0.030352725937987303,"score_gpt":0.3743429652699999,"score_spread":0.34399023933201256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786964939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963292,0.0002852947,0.0008773499,0.00030097476,0.0008451479,0.0011969118,0.000042520685,0.00003181986,0.00009078652],"genre_scores_gemma":[0.993617,0.00011231788,0.00074069866,0.00048590638,0.0047203954,0.000039677187,0.000008521326,0.00007692495,0.00019858198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586445,0.00030814548,0.0012409542,0.00041072667,0.0016955674,0.00048017688],"domain_scores_gemma":[0.9970633,0.0005128239,0.0007036665,0.00039206477,0.0008868808,0.00044129998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014327881,0.0002513482,0.0008831475,0.0002211793,0.00018348981,0.00013075785,0.0004649248,0.00016123822,0.00018762103],"category_scores_gemma":[0.0014151656,0.00020945928,0.00029027328,0.00038494935,0.00017349036,0.00016079703,0.00007318811,0.00067359215,0.000011586663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27792078,0.00375901,0.59326714,0.000046303547,0.004999786,0.0034324466,0.00014593248,0.00036535013,0.00024275902,0.0000079368,0.0044863275,0.111326225],"study_design_scores_gemma":[0.21824278,0.023946917,0.753379,0.00097606576,0.0010440933,0.0011560544,0.000056033216,0.0006935115,0.00009323356,0.000032813503,0.00013551813,0.00024396692],"about_ca_topic_score_codex":0.0014882081,"about_ca_topic_score_gemma":0.0017386394,"teacher_disagreement_score":0.16011186,"about_ca_system_score_codex":0.0010259766,"about_ca_system_score_gemma":0.0037333863,"threshold_uncertainty_score":0.8541501},"labels":[],"label_agreement":null},{"id":"W2787764040","doi":"10.1038/bjc.2017.474","title":"Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Prostate Cancer Canada","keywords":"Docetaxel; Prostate cancer; Metastasis; Medicine; Cancer research; Oncology; Cancer; Lung cancer; Internal medicine","score_opus":0.009538169039921787,"score_gpt":0.2506398880355324,"score_spread":0.24110171899561061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787764040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972021,0.0013196238,0.00085345475,0.00013864637,0.000030832005,0.0003343133,0.000107718,0.000001425944,0.000011877181],"genre_scores_gemma":[0.9970668,0.0011526933,0.0016395816,0.000032486845,0.000014383311,0.00004366323,0.000019319139,0.00001458792,0.000016508757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911284,0.000039894712,0.00036698114,0.00014160053,0.00020955194,0.00012911951],"domain_scores_gemma":[0.9990829,0.000002306415,0.0003154097,0.00007107411,0.00048051678,0.00004778675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006113807,0.00010068998,0.00022000512,0.0001251595,0.000015809508,0.000009103174,0.00004131659,0.000040626317,0.000007069344],"category_scores_gemma":[0.000005594875,0.00009098638,0.000041262978,0.00017888719,0.00007943008,0.000029593908,0.0000072786097,0.000048578604,5.7834136e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023246014,0.00026493391,0.009237902,0.000035990844,0.000055493678,0.000013722037,0.00058077415,0.052561246,0.8638268,0.0000022249078,0.000011319146,0.071085006],"study_design_scores_gemma":[0.006064422,0.005065202,0.03579935,0.0006469594,0.00005267012,0.000056887216,0.00020818145,0.0003863801,0.9513891,0.000018152008,0.00016994313,0.00014278371],"about_ca_topic_score_codex":0.0006251693,"about_ca_topic_score_gemma":0.01226793,"teacher_disagreement_score":0.087562285,"about_ca_system_score_codex":0.000120645294,"about_ca_system_score_gemma":0.00017702556,"threshold_uncertainty_score":0.6845793},"labels":[],"label_agreement":null},{"id":"W2791211520","doi":"10.1038/s41416-018-0005-1","title":"Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research; Region Östergötland; Cancer Research UK; Pancreatic Cancer UK","keywords":"Gemcitabine; Pancreatic cancer; Folinic acid; Internal medicine; Tissue microarray; Chemotherapy; Adenocarcinoma; Oncology; Biology; Medicine; Cancer research; Fluorouracil; Cancer","score_opus":0.018699508564711458,"score_gpt":0.32727253047265037,"score_spread":0.3085730219079389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791211520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971259,0.0010956582,0.000024950057,0.0005858949,0.00022131749,0.0006983145,0.00010514961,0.0000124496555,0.00013036664],"genre_scores_gemma":[0.99605113,0.001558876,0.0011091017,0.00017787608,0.00021518419,0.00004577603,0.000013940089,0.00005115919,0.0007769589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708354,0.00029634492,0.00093326165,0.00030111408,0.0008928524,0.00049290486],"domain_scores_gemma":[0.9970584,0.00016201497,0.0007041321,0.0002480075,0.0014125027,0.00041494306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060219504,0.00023032773,0.001112377,0.0003123076,0.00010594797,0.000025301917,0.00023277201,0.00017301513,0.0013459541],"category_scores_gemma":[0.00056081265,0.00017240216,0.00008780098,0.0006138047,0.0002819252,0.00021431505,0.00005937713,0.0006355702,0.000003093147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032820247,0.0007004526,0.89703757,0.00017678198,0.00019179753,0.001048162,0.0009386432,0.000021532298,0.054002203,8.7443834e-7,0.003321307,0.009740444],"study_design_scores_gemma":[0.012670611,0.0026013236,0.9008322,0.013456155,0.00016125395,0.00019529126,0.00033411654,0.000058756912,0.069232464,0.000019630548,0.00023792364,0.00020030954],"about_ca_topic_score_codex":0.0016877988,"about_ca_topic_score_gemma":0.0026085156,"teacher_disagreement_score":0.020149635,"about_ca_system_score_codex":0.0004167662,"about_ca_system_score_gemma":0.00095235254,"threshold_uncertainty_score":0.999567},"labels":[],"label_agreement":null},{"id":"W2792109841","doi":"10.1038/bjc.2017.427","title":"EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Equator; Latitude; Medicine; Clinical Oncology; Oncology; Cancer; MEDLINE; Internal medicine; Geography; Biology; Geodesy","score_opus":0.0426827504740321,"score_gpt":0.33835435494495586,"score_spread":0.2956716044709238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792109841","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52933687,0.33935866,0.0035961517,0.11469285,0.01037482,0.0016048526,0.00040928545,0.000008991914,0.00061751617],"genre_scores_gemma":[0.16342618,0.36294925,0.011737127,0.29178312,0.16665496,0.00033991205,0.00012125472,0.0004173893,0.0025708044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977352,0.00014704178,0.0013241828,0.00026336938,0.00027096277,0.00025925637],"domain_scores_gemma":[0.9950922,0.000133993,0.00397152,0.00021209911,0.00052960677,0.000060568622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011413918,0.0001821015,0.0005623678,0.0000456483,0.000105477855,0.00007605571,0.00029135795,0.0004920336,0.00006124833],"category_scores_gemma":[0.00088820595,0.00016436151,0.00021602969,0.000060122555,0.0002395343,0.000005249508,0.00011284402,0.0006901541,2.2053625e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017899117,0.000024472643,0.0001941953,0.00008215688,0.0005322581,0.00034792247,0.00006416284,0.00046753834,0.0069331913,9.1416183e-7,0.930124,0.0594393],"study_design_scores_gemma":[0.0050113536,0.0009183751,0.00021758414,0.00070141576,0.00037730605,0.0006788799,0.000019459096,0.000019985911,0.009250018,0.000083877385,0.98248047,0.00024130857],"about_ca_topic_score_codex":0.0014289344,"about_ca_topic_score_gemma":0.00069537235,"teacher_disagreement_score":0.36591068,"about_ca_system_score_codex":0.00011051639,"about_ca_system_score_gemma":0.0015338683,"threshold_uncertainty_score":0.6702468},"labels":[],"label_agreement":null},{"id":"W2792814802","doi":"10.1038/s41416-018-0012-2","title":"Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Monoclonal antibody; Colorectal cancer; Medicine; Cancer research; Oncology; Clinical significance; Antibody; Biomarker; Monoclonal; Cancer; Internal medicine; Immunology; Biology","score_opus":0.07379705001419633,"score_gpt":0.4074493872111625,"score_spread":0.33365233719696613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792814802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395989,0.0118599245,0.0000067950855,0.037602365,0.00064589654,0.007313004,0.0029326167,0.000008236679,0.000032241707],"genre_scores_gemma":[0.970203,0.015138463,0.00006777346,0.011883257,0.0006472573,0.0015775869,0.00023370983,0.00012898864,0.00011996974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942944,0.0010388824,0.0016147933,0.00072153995,0.0015713475,0.00075901195],"domain_scores_gemma":[0.9916191,0.003809592,0.0016681327,0.00041160505,0.002364739,0.0001268408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073425274,0.0007102082,0.0024001114,0.00035764856,0.00044421921,0.0000838179,0.0004916434,0.00024892806,0.00007457743],"category_scores_gemma":[0.00011622398,0.00042162233,0.00055102323,0.0006059797,0.0013670616,0.00009335848,0.00008669428,0.0013244282,8.9674734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018494446,0.010388837,0.657043,0.0011255096,0.029220596,0.000791636,0.0029638219,0.00029933092,0.0011062651,0.000002962041,0.2406315,0.03793213],"study_design_scores_gemma":[0.018910699,0.02721128,0.9181179,0.004247306,0.0032973094,0.000035372428,0.00067808485,0.00012246141,0.0033846537,0.000020650547,0.023502877,0.00047144564],"about_ca_topic_score_codex":0.010754369,"about_ca_topic_score_gemma":0.0026532526,"teacher_disagreement_score":0.2610749,"about_ca_system_score_codex":0.0016267864,"about_ca_system_score_gemma":0.0014502754,"threshold_uncertainty_score":0.9998236},"labels":[],"label_agreement":null},{"id":"W2794196479","doi":"10.1038/s41416-018-0011-3","title":"Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study","year":2018,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Toronto","funders":"Medical Research and Materiel Command; National Cancer Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Rutgers Cancer Institute of New Jersey; Radboud Universiteit; Helse Vest; Cancer Research UK; University College London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Public Health Service; U.S. Department of Defense; Lon V. Smith Foundation; Fred C. and Katherine B. Andersen Foundation; Helsingin ja Uudenmaan Sairaanhoitopiiri; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Mayo Foundation for Medical Education and Research; European Commission; University of Cambridge; Breast Cancer Research Foundation; Oregon Health and Science University; Kræftens Bekæmpelse; Ovarian Cancer Research Fund; National Center for Research Resources; Oak Foundation; Norges Forskningsråd; Kreftforeningen; Minnesota Ovarian Cancer Alliance","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Mendelian inheritance; Internal medicine; Gynecology; Biology; Genetics; Gene","score_opus":0.024505662964782574,"score_gpt":0.328953653169278,"score_spread":0.3044479902044954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794196479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007027808,0.9891979,0.000008378137,0.00012232053,0.00043446783,0.0018450982,0.0011464232,0.00001257137,0.00020502554],"genre_scores_gemma":[0.0074960804,0.9906105,0.00012382363,0.00013711622,0.001002236,0.00034342016,0.0000429039,0.00009552414,0.00014842516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961718,0.0005073917,0.0016248155,0.00040413474,0.0009766737,0.0003151906],"domain_scores_gemma":[0.99352646,0.00021025586,0.0039034917,0.00029861229,0.0017667837,0.0002944183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008551679,0.00044738286,0.0035784564,0.0002718441,0.000113712405,0.00006931648,0.00021104437,0.00025833258,0.0010866579],"category_scores_gemma":[0.000259015,0.0003399285,0.0008009187,0.0005535759,0.000101893645,0.00012477509,0.000026746537,0.00061662524,0.000003045839],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011176205,0.0017325962,0.012970992,0.002319737,0.019301504,0.0009893936,0.00031708652,0.0000014652226,1.5556303e-7,0.0000013914113,0.008874457,0.9523736],"study_design_scores_gemma":[0.06955528,0.0043196566,0.029348481,0.25397354,0.07482674,0.0015935781,0.00016036205,0.000006791156,0.000022351289,0.000022651644,0.56543106,0.0007395274],"about_ca_topic_score_codex":0.015122756,"about_ca_topic_score_gemma":0.009628198,"teacher_disagreement_score":0.95163405,"about_ca_system_score_codex":0.0011952885,"about_ca_system_score_gemma":0.0029134995,"threshold_uncertainty_score":0.9999053},"labels":[],"label_agreement":null},{"id":"W2794310103","doi":"10.1038/s41416-018-0045-6","title":"New opportunities for kinase drug repurposing and target discovery","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; Deutschen Konsortium für Translationale Krebsforschung; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Novartis Pharma; Wellcome Trust; Genome Canada; Ontario Genomics; Pfizer","keywords":"Kinome; Drug repositioning; Repurposing; Drug discovery; Drug; Kinase; Drug action; Computational biology; Mode of action; Drug development; Pharmacology; Biology; Bioinformatics; Toxicology; Cell biology","score_opus":0.022640698747415262,"score_gpt":0.28291910222041144,"score_spread":0.2602784034729962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794310103","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076149255,0.34539315,0.024243528,0.5351765,0.012217749,0.0015718528,0.0030807306,0.000026750886,0.0021404983],"genre_scores_gemma":[0.004723931,0.06659931,0.028281592,0.5162954,0.13167405,0.00019612242,0.00086505065,0.00042077183,0.25094378],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989642,0.00004970971,0.00037198866,0.000222502,0.00017118797,0.00022040746],"domain_scores_gemma":[0.99890435,0.000023570548,0.00050350965,0.00014452616,0.00034117632,0.000082892395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015157007,0.00016805163,0.00027226453,0.00006267622,0.00010118361,0.00026504262,0.00018963161,0.00027276156,0.000093995055],"category_scores_gemma":[0.00011041545,0.00019357962,0.00020447896,0.00002122107,0.000092960654,0.000027854174,0.00006400126,0.000479157,3.335811e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006495388,0.0000065125923,0.0000214721,0.00007797846,0.00018832902,0.00029621884,0.000013060937,0.0000018998629,0.0038193658,0.0000010026974,0.97294015,0.02256908],"study_design_scores_gemma":[0.00042393312,0.00015285847,0.000029027357,0.00083575107,0.00010146206,0.0017403474,0.00003837075,9.0858447e-7,0.016975135,0.00020409958,0.97927964,0.00021846098],"about_ca_topic_score_codex":0.00032228598,"about_ca_topic_score_gemma":0.00023583349,"teacher_disagreement_score":0.2787938,"about_ca_system_score_codex":0.000044425145,"about_ca_system_score_gemma":0.0005421488,"threshold_uncertainty_score":0.78939474},"labels":[],"label_agreement":null},{"id":"W2794881391","doi":"10.1038/s41416-018-0027-8","title":"Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Sociedad Española de Oncología Médica; Fundación Josep Carreras Contra la Leucemia; Canada Excellence Research Chairs, Government of Canada; European Society of Cardiology","keywords":"Medicine; Internal medicine; Cancer; Venous thromboembolism; Thrombosis; Framingham Risk Score; Risk assessment; Population; Intensive care medicine; Disease","score_opus":0.0208750334443442,"score_gpt":0.32653334533695577,"score_spread":0.30565831189261156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794881391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378115,0.0024660488,0.0018377427,0.00009353847,0.00069506135,0.0008861056,0.00009050823,0.000012105037,0.00013773833],"genre_scores_gemma":[0.9876808,0.006257589,0.004285972,0.0005360036,0.0009845244,0.00010087743,0.0000041086705,0.00005305395,0.00009706808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980093,0.00005981747,0.0008457736,0.00026250948,0.00042664257,0.00039591393],"domain_scores_gemma":[0.9981846,0.000051117648,0.0007007457,0.00015918045,0.0007190964,0.00018523821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005616184,0.00015544532,0.000784803,0.000105353,0.00013025981,0.000022481985,0.00015769327,0.00009667416,0.000117730255],"category_scores_gemma":[0.00018792608,0.00014463383,0.00014675432,0.00016491576,0.00008529009,0.00015212384,0.000041822124,0.0003193604,0.000001791446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047753824,0.0017783827,0.871451,0.00009562038,0.00042485705,0.000016054735,0.00030994276,0.0039281007,0.000006611394,0.0000028631832,0.0024972132,0.11901178],"study_design_scores_gemma":[0.00910993,0.001713937,0.9760591,0.0022227082,0.00067278085,0.0000140643415,0.000032725544,0.00843443,0.00002389673,0.00014836401,0.0014104217,0.0001576647],"about_ca_topic_score_codex":0.002654837,"about_ca_topic_score_gemma":0.00338055,"teacher_disagreement_score":0.11885412,"about_ca_system_score_codex":0.00021374108,"about_ca_system_score_gemma":0.0004033889,"threshold_uncertainty_score":0.58979964},"labels":[],"label_agreement":null},{"id":"W2795280927","doi":"10.1038/s41416-018-0071-4","title":"The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Regional Municipality of Durham; University of Toronto; University Health Network; Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Institute for Clinical Evaluative Sciences; Health Research Board; Johns Hopkins University","keywords":"Medicine; Prostate cancer; Radiation oncologist; Radiation therapy; Odds ratio; Referral; Prostatectomy; Comorbidity; Cohort; Cancer; Internal medicine; Confounding; Watchful waiting; Surgery; Family medicine","score_opus":0.025837425287112116,"score_gpt":0.32372004040739666,"score_spread":0.2978826151202845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795280927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344429,0.06378096,0.00002025158,0.00077114056,0.00021062202,0.0006930046,0.00007310862,0.000002724427,0.000005315339],"genre_scores_gemma":[0.8501716,0.14910305,0.000023410441,0.000035428333,0.0003224759,0.00023301863,0.0000026224886,0.00001210352,0.00009626812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992772,0.000046347646,0.00029091252,0.00008454255,0.00017424903,0.00012678221],"domain_scores_gemma":[0.99827534,0.0008600524,0.00039978875,0.000059473605,0.00035499776,0.000050367322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022322629,0.00008867887,0.00032633063,0.00003444405,0.00011786389,0.000022216744,0.0000253602,0.000024423429,0.000029481978],"category_scores_gemma":[0.00008341689,0.000040011742,0.000091300695,0.000120761986,0.00014440503,0.00006401674,0.0000025126333,0.000037140002,4.11136e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010602693,0.000103294835,0.15004314,0.00012407577,0.0007934683,0.000019543786,0.00020240697,0.000078417215,0.00019807344,9.82072e-7,0.0025242167,0.8353097],"study_design_scores_gemma":[0.01654947,0.03514331,0.59454834,0.004752516,0.0026468004,0.0007062504,0.00015278837,0.00037478053,0.28378662,0.0000135981045,0.061163373,0.00016216142],"about_ca_topic_score_codex":0.0017274509,"about_ca_topic_score_gemma":0.006341807,"teacher_disagreement_score":0.8351475,"about_ca_system_score_codex":0.00020012111,"about_ca_system_score_gemma":0.000378918,"threshold_uncertainty_score":0.3538877},"labels":[],"label_agreement":null},{"id":"W2800495434","doi":"10.1038/s41416-018-0044-7","title":"Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiorespiratory fitness; Medicine; High-intensity interval training; Interval training; Quality of life (healthcare); Physical therapy; Aerobic exercise; Anxiety; Depression (economics); Psychosocial; Physical fitness; Internal medicine; Psychiatry","score_opus":0.04457199078118381,"score_gpt":0.32971009472795,"score_spread":0.2851381039467662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800495434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738295,0.010872751,0.000115951625,0.00033386739,0.0010150314,0.00013861203,0.0000322413,0.0000047118283,0.00010388068],"genre_scores_gemma":[0.9968373,0.0020376218,0.000071830065,0.000527725,0.0004707399,0.000006484335,8.942245e-7,0.000016634185,0.000030752173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984436,0.00012454292,0.00067670917,0.00015337676,0.00041960677,0.00018218624],"domain_scores_gemma":[0.9983345,0.00020816032,0.0004931929,0.00009459529,0.00070391083,0.00016558854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005887579,0.000117940086,0.0009121809,0.000121141886,0.000023407943,0.000010872127,0.000086814325,0.00010859224,0.00008695368],"category_scores_gemma":[0.00071322615,0.00011843829,0.00012778428,0.00020422746,0.00023566824,0.000078331715,0.000026898168,0.00037506633,1.6760985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050553116,0.00042183758,0.6777421,0.0027359128,0.0006399591,0.0004048524,0.0071693473,0.00007602022,0.016768396,0.00011948992,0.0006674742,0.2881993],"study_design_scores_gemma":[0.0029732336,0.0006889879,0.97259295,0.006711652,0.000120355515,0.00009249361,0.00059418404,0.000019577154,0.01566474,0.0000588725,0.00035812194,0.00012480984],"about_ca_topic_score_codex":0.10543746,"about_ca_topic_score_gemma":0.16113637,"teacher_disagreement_score":0.2948509,"about_ca_system_score_codex":0.00010903154,"about_ca_system_score_gemma":0.00030305854,"threshold_uncertainty_score":0.9005195},"labels":[],"label_agreement":null},{"id":"W2803492840","doi":"10.1038/s41416-018-0108-8","title":"Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Groupement des Entreprises Françaises dans la lutte contre le Cancer; National Institutes of Health; Florida Department of Health; Centre Hospitalier Universitaire de Nantes; Cancer Council Victoria; Deutsche Krebshilfe; Ministerio de Economía y Competitividad; Deutsche Forschungsgemeinschaft; Broad Institute; University of South Florida; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; Bundesministerium für Bildung und Forschung; Association Anne de Bretagne Genetique; National Institute on Aging; Division of Cancer Prevention, National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Moffitt Cancer Center; National Health and Medical Research Council; American Cancer Society; Centers for Disease Control and Prevention; Génome Québec; Conseil Régional des Pays de la Loire; Ontario Institute for Cancer Research; U.S. Department of Health and Human Services","keywords":"Menarche; Odds ratio; Medicine; Menopause; Confidence interval; Confounding; Internal medicine; Body mass index; Oncology; Colorectal cancer; Gynecology; Demography; Cancer","score_opus":0.014230976188502482,"score_gpt":0.28543413347648394,"score_spread":0.27120315728798144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803492840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695942,0.02879456,0.0000064538885,0.00051099877,0.00015748796,0.0007001447,0.00003022614,0.0000033625427,0.00020258036],"genre_scores_gemma":[0.9853701,0.013726043,0.00008723671,0.000040629813,0.0003418667,0.000025188992,6.265095e-7,0.000016656828,0.00039163392],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984378,0.0002742051,0.0005353984,0.00017955978,0.0004318311,0.00014118047],"domain_scores_gemma":[0.9984443,0.00019094702,0.00070359214,0.00012463918,0.00044947572,0.000087049935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013101728,0.00011342951,0.0006906842,0.00007541223,0.00011125625,0.00001500358,0.0000789248,0.00004376739,0.00011881919],"category_scores_gemma":[0.00036879786,0.000081611965,0.000068353496,0.00009099334,0.0006205822,0.000089319496,0.00008210681,0.00018470593,2.5492878e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073156215,0.0006612627,0.32914993,0.00020866335,0.0051008044,0.0006972436,0.02747928,0.00004385357,0.38914013,0.00001201942,0.0024128638,0.17193772],"study_design_scores_gemma":[0.06960621,0.00198173,0.9071558,0.00039330716,0.0019106382,0.0011688472,0.0011581203,0.000059968253,0.014652563,0.0001330446,0.0016526848,0.00012704999],"about_ca_topic_score_codex":0.0037162467,"about_ca_topic_score_gemma":0.015438824,"teacher_disagreement_score":0.5780059,"about_ca_system_score_codex":0.00016209701,"about_ca_system_score_gemma":0.00008989746,"threshold_uncertainty_score":0.8615226},"labels":[],"label_agreement":null},{"id":"W2803557794","doi":"10.1038/s41416-018-0082-1","title":"Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Leukemia and Lymphoma Society; AstraZeneca","keywords":"Medicine; Rash; Tolerability; Pharmacology; Dosing; Adverse effect; Pharmacokinetics; Pharmacodynamics; Internal medicine","score_opus":0.037934648469208444,"score_gpt":0.39010684905211895,"score_spread":0.3521722005829105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803557794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95975024,0.039046388,0.00012193776,0.00039826552,0.00042360165,0.00018830386,0.000023006496,0.0000048762813,0.00004337412],"genre_scores_gemma":[0.9858659,0.01267138,0.00048201604,0.00035321817,0.00054607645,0.000017561812,8.1608437e-7,0.000011222146,0.00005179481],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989818,0.00003778282,0.00048105814,0.00012468318,0.0002231935,0.00015152224],"domain_scores_gemma":[0.9991124,0.000021631124,0.00029477954,0.000056756173,0.00042423228,0.00009019398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025916178,0.00009695244,0.0005196061,0.00011146727,0.00003864708,0.000016254275,0.000046699206,0.00006517701,0.00010367716],"category_scores_gemma":[0.00010053331,0.00008472703,0.00007051813,0.00014311893,0.0002339927,0.0001618425,0.000017886703,0.00021208219,3.378663e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051398147,0.00062607403,0.0011322506,0.0002074906,0.00031250238,0.0016211221,0.002195769,0.000007818827,0.20149347,0.00017061834,0.0030663712,0.7840267],"study_design_scores_gemma":[0.049564708,0.02176593,0.011364271,0.014096517,0.00048382202,0.00790055,0.0039681145,0.0006821937,0.8735375,0.0038351777,0.012211191,0.0005900197],"about_ca_topic_score_codex":0.0012823108,"about_ca_topic_score_gemma":0.008850762,"teacher_disagreement_score":0.78343666,"about_ca_system_score_codex":0.00021082236,"about_ca_system_score_gemma":0.0003411596,"threshold_uncertainty_score":0.49389327},"labels":[],"label_agreement":null},{"id":"W2808656778","doi":"10.1038/s41416-018-0036-7","title":"Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Etoposide; Chemotherapy; Debulking; Ovarian cancer; Cisplatin; Internal medicine; Clinical endpoint; Leukopenia; Gastroenterology; Surgery; Phases of clinical research; Chemotherapy regimen; Cancer; Oncology; Randomized controlled trial","score_opus":0.016098204122577453,"score_gpt":0.34985441520265376,"score_spread":0.3337562110800763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808656778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989357,0.008452632,0.0014469604,0.0066995188,0.0009496125,0.0019496621,0.0005032845,0.000009177153,0.00009560397],"genre_scores_gemma":[0.9744036,0.015320102,0.0050324914,0.0012059498,0.0034121098,0.00048285045,0.000014214271,0.00003741581,0.00009125668],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986787,0.000024861372,0.00063977204,0.00019740195,0.00025367358,0.00020557773],"domain_scores_gemma":[0.9986162,0.00011913991,0.0004204631,0.0000998541,0.00051864405,0.00022565594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025132814,0.00014294007,0.0006502811,0.00009339294,0.00008888501,0.00003261164,0.00006369603,0.000073902316,0.0008402949],"category_scores_gemma":[0.00010809249,0.00013857026,0.00018456424,0.00013882174,0.00008614987,0.00011766424,0.0000075347784,0.00011059312,4.3317064e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24873346,0.00057498814,0.00019648958,0.00009230383,0.00045940757,0.000052639687,0.00025184618,0.000020202659,0.0030656185,0.000012703006,0.0056873425,0.740853],"study_design_scores_gemma":[0.84397835,0.011470201,0.0040595937,0.0029489996,0.00071807206,0.00043998682,0.000048079473,0.000097400865,0.052497584,0.00015154114,0.08337251,0.00021769555],"about_ca_topic_score_codex":0.00048074833,"about_ca_topic_score_gemma":0.0012986296,"teacher_disagreement_score":0.7406353,"about_ca_system_score_codex":0.0001726196,"about_ca_system_score_gemma":0.00032039496,"threshold_uncertainty_score":0.9200639},"labels":[],"label_agreement":null},{"id":"W2883164443","doi":"10.1038/s41416-018-0176-9","title":"Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Genotyping; Anal cancer; Cytology; Men who have sex with men; Gynecology; Internal medicine; Cancer; Human immunodeficiency virus (HIV); Genotype; Virology; Pathology; Syphilis; Biology","score_opus":0.04340152142829211,"score_gpt":0.4138244997123991,"score_spread":0.370422978284107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883164443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9265332,0.03741364,0.004884697,0.00095090363,0.00004279872,0.00035835698,0.00016461089,0.000009627258,0.029642146],"genre_scores_gemma":[0.9950278,0.0033636475,0.00082537,0.00009797776,0.00051336916,0.000009660256,0.0000040043083,0.000023557464,0.00013465525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980228,0.0001022915,0.00058139855,0.00023496356,0.0006625098,0.00039606562],"domain_scores_gemma":[0.99838436,0.00007756379,0.00033179557,0.00008452945,0.0009016448,0.00022012326],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050229236,0.00015526678,0.000841268,0.0002459772,0.000147135,0.00009444106,0.00013198606,0.00009888267,0.0010041486],"category_scores_gemma":[0.000036958212,0.00014618099,0.000055343477,0.0002818053,0.00052181596,0.0002978284,0.00008485127,0.00063222996,1.9013437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074235434,0.00007152053,0.7091485,0.00023708318,0.00050592667,0.00036155886,0.0024798266,0.0004633105,0.001362093,0.000028316555,0.0037113596,0.27420694],"study_design_scores_gemma":[0.005230737,0.002112776,0.9675438,0.0017955113,0.00020268119,0.00044036726,0.008129583,0.0048343763,0.008674714,0.0000617604,0.0007738549,0.00019988598],"about_ca_topic_score_codex":0.009774016,"about_ca_topic_score_gemma":0.032368373,"teacher_disagreement_score":0.27400705,"about_ca_system_score_codex":0.00034143712,"about_ca_system_score_gemma":0.00088736246,"threshold_uncertainty_score":0.99990904},"labels":[],"label_agreement":null},{"id":"W2883606766","doi":"10.1038/s41416-018-0179-6","title":"25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"NIHR Oxford Biomedical Research Centre; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Cancer Research Institute","keywords":"Medicine; Vitamin D and neurology; Internal medicine; Confidence interval; Gastroenterology; Melanoma; Vitamin; Surgery","score_opus":0.01739024898045577,"score_gpt":0.30706469883670573,"score_spread":0.28967444985624996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883606766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724925,0.001310952,0.0000026435025,0.00017304005,0.0002507078,0.00067972625,0.00020952839,0.000012234143,0.000111900255],"genre_scores_gemma":[0.99832296,0.0005824003,0.00014491226,0.000049211798,0.0006109988,0.000028736978,0.00000864149,0.000038865386,0.0002132637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722373,0.00033573096,0.00072129455,0.0002779484,0.00092734594,0.00051394134],"domain_scores_gemma":[0.9981095,0.000077892095,0.00037110745,0.00019521186,0.0010071083,0.00023915064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380343,0.00018880835,0.00074092386,0.00042418193,0.0000969074,0.000051838084,0.00019765524,0.00012093281,0.0003681743],"category_scores_gemma":[0.0005944383,0.0001589611,0.000071847855,0.0006335859,0.00023507293,0.0003469503,0.000056636625,0.00072674145,0.00000410496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014968722,0.0007773692,0.86678225,0.00003311476,0.0002123292,0.001554955,0.00035575943,0.0000093212975,0.00010877309,6.796378e-7,0.0005431869,0.11465353],"study_design_scores_gemma":[0.12690768,0.008896874,0.8614724,0.0014304031,0.000084106745,0.00010161739,0.00010240245,0.000023413906,0.0006410243,0.000022309097,0.00016388207,0.00015385513],"about_ca_topic_score_codex":0.004290985,"about_ca_topic_score_gemma":0.047100615,"teacher_disagreement_score":0.11449967,"about_ca_system_score_codex":0.000567603,"about_ca_system_score_gemma":0.00035624622,"threshold_uncertainty_score":0.9702873},"labels":[],"label_agreement":null},{"id":"W2883924148","doi":"10.1038/s41416-018-0187-6","title":"L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"L1; Medicine; Internal medicine; Endometrial cancer; Immunohistochemistry; Oncology; Immunostaining; Cohort; Carcinoma; Pathology; Cancer","score_opus":0.01346104051835793,"score_gpt":0.23077901870984774,"score_spread":0.21731797819148982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883924148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966475,0.00038288385,0.00033656144,0.000018988536,0.0016486738,0.00023653595,0.00014387416,0.000014714004,0.0005702718],"genre_scores_gemma":[0.99800813,0.0004968289,0.00027239253,0.0002181858,0.0008463295,0.000007777517,4.876454e-7,0.000044027383,0.000105832776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980078,0.00021808839,0.00039557126,0.00030677047,0.0007657894,0.00030600914],"domain_scores_gemma":[0.99859905,0.00012452762,0.00050549547,0.00014624372,0.00047284216,0.00015186497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014140086,0.00016315254,0.00027408244,0.00012652189,0.00017349709,0.00018832952,0.00030106909,0.000045236276,0.0009354427],"category_scores_gemma":[0.00036252663,0.00014758065,0.00010978205,0.00032951412,0.00017064747,0.00024465538,0.00004106744,0.00027397423,0.00005004087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021264893,0.0005386858,0.018009324,0.00002665599,0.00005200632,0.0018963704,0.00012808501,0.00003834909,0.92844504,0.00012678029,0.0029296048,0.045682583],"study_design_scores_gemma":[0.0028710417,0.0017419133,0.028781079,0.000095356045,0.000045130077,0.00030195797,0.000009278283,0.000014859925,0.9592132,0.00003247826,0.006689973,0.00020370643],"about_ca_topic_score_codex":0.000038667255,"about_ca_topic_score_gemma":0.000037247304,"teacher_disagreement_score":0.045478877,"about_ca_system_score_codex":0.000034940935,"about_ca_system_score_gemma":0.00011034276,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W2884264032","doi":"10.1038/s41416-018-0188-5","title":"STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research; Imperial College London","keywords":"Carboplatin; Medicine; Chemotherapy; Agonist; Immune checkpoint; Cancer research; Internal medicine; Immunotherapy; Immunology; Oncology; Immune system; Receptor; Cisplatin","score_opus":0.010231777456984118,"score_gpt":0.2731240424598853,"score_spread":0.2628922650029012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884264032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788203,0.017495234,0.00005418538,0.00247904,0.0007741701,0.00028381555,0.00001744275,0.000014185038,0.00006162962],"genre_scores_gemma":[0.9944899,0.0038401445,0.0001651372,0.00040516607,0.00012357318,0.00004725866,0.0000031707843,0.000034760527,0.0008908588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979657,0.0005288539,0.00074321177,0.00023314383,0.00010573971,0.00042335113],"domain_scores_gemma":[0.998984,0.00013437547,0.00042291157,0.0001403901,0.00028330804,0.00003504515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095962716,0.00020319257,0.00050909794,0.00031490065,0.00013341739,0.000067777095,0.00029456732,0.00017057452,0.00066024164],"category_scores_gemma":[0.00010869634,0.000194515,0.00007662833,0.00039307898,0.00020713633,0.00017323007,0.000029234765,0.00055120233,0.000009699652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023495214,0.00025465369,0.0039287284,0.000008934486,0.00015506383,0.00010330672,0.0020805346,0.00004380716,0.8870456,0.000006889548,0.0001060995,0.082771145],"study_design_scores_gemma":[0.007973729,0.00143118,0.36748353,0.0010625434,0.000009917716,0.00044527507,0.00029557,0.000003849023,0.61405677,0.00002282493,0.0070110457,0.00020377933],"about_ca_topic_score_codex":0.017964765,"about_ca_topic_score_gemma":0.016716583,"teacher_disagreement_score":0.3635548,"about_ca_system_score_codex":0.00034797075,"about_ca_system_score_gemma":0.00044146838,"threshold_uncertainty_score":0.9885747},"labels":[],"label_agreement":null},{"id":"W2887114221","doi":"10.1038/s41416-018-0200-0","title":"Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Institute for Research in Immunology and Cancer; Université de Montréal","funders":"Integrated BioBank of Luxembourg","keywords":"Lung cancer; Biomarker; Medicine; Tissue microarray; Immunohistochemistry; Oncology; Cancer; Adenocarcinoma; Pathology; Internal medicine; Biology","score_opus":0.009776238330703763,"score_gpt":0.3011209812806427,"score_spread":0.29134474294993895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887114221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97082573,0.027359648,0.0009410426,0.000085348445,0.0006058988,0.000079393794,0.000022147526,0.0000011806167,0.00007960666],"genre_scores_gemma":[0.9931896,0.00601862,0.00011018027,0.000083088904,0.00040544386,0.00001306659,0.000003104253,0.000013374885,0.00016357042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907243,0.000049462997,0.00044854532,0.00012754078,0.00016964164,0.00013239545],"domain_scores_gemma":[0.9991425,0.00001983571,0.0003613308,0.00008105854,0.00034221617,0.000053025153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033964717,0.000069254216,0.00015976401,0.000052807794,0.000032720538,0.000027584485,0.00014533891,0.00007633866,0.00042139215],"category_scores_gemma":[0.00022135011,0.00007603984,0.00008491963,0.00010183199,0.000060978175,0.000009193987,0.000025084037,0.0000750503,0.0000010596825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006909032,0.00003763951,0.010604734,0.000027862854,0.000084412626,0.000022918355,0.00004818165,0.00009204654,0.9432522,0.000010469021,0.0018693159,0.04388113],"study_design_scores_gemma":[0.0008169637,0.00015231395,0.061419193,0.00060922874,0.00007647509,0.00014765147,0.000047248104,0.00013876862,0.9300146,0.00012618006,0.0062994757,0.00015190023],"about_ca_topic_score_codex":0.00067745324,"about_ca_topic_score_gemma":0.0010903243,"teacher_disagreement_score":0.05081446,"about_ca_system_score_codex":0.000028364448,"about_ca_system_score_gemma":0.0001742647,"threshold_uncertainty_score":0.46139485},"labels":[],"label_agreement":null},{"id":"W2888519303","doi":"10.1038/s41416-018-0117-7","title":"Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research Council; Vetenskapsrådet; Cancerfonden; Cancer Research UK; Wellcome Trust","keywords":"Colorectal cancer; Medicine; Oncology; Single-nucleotide polymorphism; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Survival analysis; Bioinformatics; Genetics; Biology; Confidence interval; Genotype; Gene","score_opus":0.019647258447109215,"score_gpt":0.32190954559920776,"score_spread":0.3022622871520985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888519303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900497,0.0050139106,0.0000054044217,0.00036878875,0.0029505834,0.0004250972,0.0000978847,0.0000072498624,0.0021261356],"genre_scores_gemma":[0.99790764,0.0006818963,0.00003900999,0.00023131253,0.0008362156,0.000019686657,0.0000010577576,0.00004291314,0.00024025433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748284,0.00022257329,0.0008647182,0.00018648764,0.000937269,0.0003060916],"domain_scores_gemma":[0.99783504,0.00030935212,0.00086494983,0.00023414352,0.0005968419,0.0001596672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006764776,0.0002032993,0.00093279063,0.00010501047,0.000081053564,0.000015989635,0.00039047576,0.00013097818,0.0009388504],"category_scores_gemma":[0.000402099,0.00015379292,0.0003971473,0.00033347405,0.00054063316,0.000051681396,0.00008384523,0.0005073627,0.0000024486012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002147728,0.00008503451,0.9449177,0.00020387574,0.00033699357,0.000038752725,0.00013533793,0.00014012403,0.022861676,0.0000019598629,0.0009939015,0.028136963],"study_design_scores_gemma":[0.0023791508,0.002981261,0.7850928,0.00109199,0.00027826568,0.0001909895,0.000022214996,0.000007783145,0.20532078,0.000014351947,0.0025056112,0.00011484613],"about_ca_topic_score_codex":0.002251864,"about_ca_topic_score_gemma":0.007116912,"teacher_disagreement_score":0.1824591,"about_ca_system_score_codex":0.0004657424,"about_ca_system_score_gemma":0.00042525036,"threshold_uncertainty_score":0.9999744},"labels":[],"label_agreement":null},{"id":"W2889696398","doi":"10.1038/s41416-018-0261-0","title":"Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Everolimus; Medicine; Oncology; Internal medicine; Clinical endpoint; PI3K/AKT/mTOR pathway; Progression-free survival; Targeted therapy; Cancer; Sunitinib; Chemotherapy; Clinical trial; Biology","score_opus":0.008266148816195511,"score_gpt":0.2463326452171442,"score_spread":0.2380664964009487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889696398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508065,0.0038535378,0.00005491044,0.00014492817,0.00018396937,0.00027219142,0.00009654513,0.0000102945905,0.00030299477],"genre_scores_gemma":[0.9970365,0.00046669535,0.0010754932,0.0005826083,0.00056771835,0.000010049571,0.0000052552277,0.000038607002,0.00021704903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988476,0.00002785664,0.00032785698,0.00017358475,0.0003758441,0.00024727263],"domain_scores_gemma":[0.9985149,0.000019793733,0.00020102585,0.00008856229,0.00093216373,0.00024356521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007435134,0.00014571013,0.00038380036,0.00007127085,0.00009123714,0.000050220915,0.00007492152,0.00004005779,0.00042007692],"category_scores_gemma":[0.000030025825,0.0001232578,0.000058373138,0.00015822265,0.00012739764,0.00013240796,0.000017336217,0.0001789618,0.0000045447614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004765192,0.00043378343,0.7998309,0.0000738975,0.0009535596,0.00052539574,0.0003243329,0.0000028122206,0.0010122291,0.000007815333,0.001110418,0.19095965],"study_design_scores_gemma":[0.011224834,0.0026426995,0.9791263,0.00030951097,0.0006767787,0.0014404685,0.000015584752,0.000007786942,0.0012755424,0.000054190885,0.0030876563,0.00013865512],"about_ca_topic_score_codex":0.000736877,"about_ca_topic_score_gemma":0.0007960821,"teacher_disagreement_score":0.19082099,"about_ca_system_score_codex":0.00013365322,"about_ca_system_score_gemma":0.0004075771,"threshold_uncertainty_score":0.5026307},"labels":[],"label_agreement":null},{"id":"W2890146531","doi":"10.1038/s41416-018-0207-6","title":"Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Pembrolizumab; Medicine; Melanoma; Mucosal melanoma; Internal medicine; Post-hoc analysis; Oncology; Post hoc; Gastroenterology; Surgery; Immunotherapy; Cancer; Cancer research","score_opus":0.008059760952273861,"score_gpt":0.2830765343105181,"score_spread":0.27501677335824426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890146531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953363,0.0023630864,0.00014484869,0.00026858418,0.0003448216,0.00016266311,0.00004945475,0.000008213594,0.0013220249],"genre_scores_gemma":[0.99744946,0.0013970064,0.00028277788,0.0001235056,0.00019451856,0.000003660778,0.0000032513456,0.000016096526,0.0005297366],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848807,0.00006417685,0.00061885116,0.00016520289,0.00045952707,0.00020417712],"domain_scores_gemma":[0.99837023,0.00003826991,0.0006478352,0.0001601145,0.0006716174,0.00011195968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027027001,0.00011735765,0.0007659769,0.0006412832,0.00003203912,0.000014147543,0.00012139606,0.000070192524,0.00082235446],"category_scores_gemma":[0.000107646694,0.00012534224,0.00029179448,0.0007777146,0.00011498969,0.00013559124,0.000039555667,0.000228009,0.0000021402068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019529281,0.0019322264,0.029882876,0.00046435697,0.0043050204,0.0030364627,0.00045812278,0.00052069477,0.14838482,0.000050757073,0.0021410447,0.7892943],"study_design_scores_gemma":[0.012766435,0.004362679,0.93399704,0.0010972252,0.0030177373,0.0028786957,0.00029676047,0.0009143891,0.026440209,0.00003154296,0.013899622,0.0002976523],"about_ca_topic_score_codex":0.0019978727,"about_ca_topic_score_gemma":0.0102380635,"teacher_disagreement_score":0.9041142,"about_ca_system_score_codex":0.00017174809,"about_ca_system_score_gemma":0.00018692546,"threshold_uncertainty_score":0.9004204},"labels":[],"label_agreement":null},{"id":"W2891078672","doi":"10.1038/s41416-018-0164-0","title":"Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Exelixis; Memorial Sloan-Kettering Cancer Center","keywords":"Cabozantinib; Pazopanib; Sunitinib; Medicine; Everolimus; Renal cell carcinoma; Internal medicine; Oncology; Urology; Progression-free survival; Tyrosine-kinase inhibitor; Surgery; Cancer; Chemotherapy","score_opus":0.03876065357668174,"score_gpt":0.34884107414325466,"score_spread":0.3100804205665729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891078672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327874,0.0033932198,0.000005159188,0.00049481756,0.00063898653,0.0007544935,0.000025865793,0.0000034214172,0.0014053143],"genre_scores_gemma":[0.9981695,0.0005889072,0.00030697635,0.00038578623,0.00041075388,0.00003748567,0.000003396161,0.00002433271,0.00007289983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978261,0.00022450999,0.0007616211,0.00019376102,0.0007153061,0.00027871717],"domain_scores_gemma":[0.9986214,0.00031520435,0.00047463056,0.000242459,0.0002496854,0.00009662874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067881733,0.00017818286,0.0006453918,0.00023959887,0.0000367764,0.000020039426,0.00020934286,0.000076507924,0.00022662952],"category_scores_gemma":[0.00014896234,0.0001295377,0.00026639516,0.00029813696,0.000105839674,0.00009130653,0.000010371926,0.0003624244,0.0000023331638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5613578,0.0047221007,0.045627847,0.000071669325,0.00015879168,0.0043535046,0.00077981554,0.00015761938,0.010411651,0.000003841135,0.00078385987,0.37157148],"study_design_scores_gemma":[0.5065209,0.023524215,0.41280046,0.0004973053,0.00014553533,0.00015873078,0.00019137084,0.000063885425,0.05259061,0.000009198165,0.0033337218,0.00016403882],"about_ca_topic_score_codex":0.00067993003,"about_ca_topic_score_gemma":0.0009188331,"teacher_disagreement_score":0.37140745,"about_ca_system_score_codex":0.00021813405,"about_ca_system_score_gemma":0.00049842766,"threshold_uncertainty_score":0.5282394},"labels":[],"label_agreement":null},{"id":"W2896626889","doi":"10.1038/s41416-018-0274-8","title":"Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NuCana; Myriad Genetics; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Medicine; BRCA mutation; Oncology; Cancer; Internal medicine; Cancer research; Population; Biology; Genetics; Gene; Poly ADP ribose polymerase; Polymerase","score_opus":0.015046316000926513,"score_gpt":0.31371684263174504,"score_spread":0.2986705266308185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896626889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96349436,0.02883145,0.00012913985,0.0047630654,0.0015223562,0.00026225575,0.00016039894,0.00000797019,0.00082897686],"genre_scores_gemma":[0.98421687,0.011460182,0.00024013742,0.001663094,0.0022190262,0.000021457648,0.0000023491139,0.000030534673,0.00014637833],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981502,0.00015577825,0.00068865693,0.00018402559,0.0005216114,0.00029970924],"domain_scores_gemma":[0.9983498,0.00008162407,0.0005594117,0.00018567071,0.00067841,0.00014509531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090045645,0.00014801291,0.0004815355,0.00015385692,0.00009367549,0.000033341064,0.00011868159,0.00010118267,0.00077102816],"category_scores_gemma":[0.00005839038,0.00012827438,0.000163391,0.0004282254,0.00046712797,0.00017655858,0.000029588831,0.00033419725,0.000002494525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037579874,0.0003305388,0.1920993,0.0001834514,0.001206312,0.0015407703,0.0015299061,0.000091578935,0.32146415,0.000049972725,0.053283114,0.4244629],"study_design_scores_gemma":[0.011939396,0.000583794,0.49775296,0.0052999337,0.0003465522,0.0048556207,0.0004628857,0.00013657588,0.39771014,0.00049078185,0.0799904,0.00043096012],"about_ca_topic_score_codex":0.007931285,"about_ca_topic_score_gemma":0.02932162,"teacher_disagreement_score":0.42403194,"about_ca_system_score_codex":0.00036392006,"about_ca_system_score_gemma":0.0008950224,"threshold_uncertainty_score":0.998675},"labels":[],"label_agreement":null},{"id":"W2897015353","doi":"10.1038/s41416-018-0236-1","title":"Phenotype-independent DNA methylation changes in prostate cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; BC Cancer Agency; Provincial Health Services Authority; Yorkshire Cancer Research","keywords":"Prostate cancer; DNA methylation; Biology; Prostate; CpG site; Cancer; Cancer research; Methylation; Cancer cell; Phenotype; Pathology; DNA; Gene; Medicine; Genetics; Gene expression","score_opus":0.011136492820038452,"score_gpt":0.29409484997648155,"score_spread":0.28295835715644313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897015353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548449,0.043685146,0.00024468548,0.0002778271,0.0005174712,0.0000920876,0.000018420345,0.0000018075159,0.00031769183],"genre_scores_gemma":[0.97540647,0.022673627,0.00022667044,0.00012771327,0.0011743631,0.000012704137,0.0000060572606,0.00001596902,0.00035641115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922013,0.000056216235,0.00024517433,0.00013710278,0.00018338584,0.00015800692],"domain_scores_gemma":[0.9993048,0.0000053469844,0.00022702206,0.00007230728,0.00033288175,0.000057687794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033501445,0.00007560375,0.00012748793,0.000057762943,0.000042361866,0.000035061865,0.00009873497,0.00007270291,0.000121090336],"category_scores_gemma":[0.00004797357,0.00008364438,0.000043989166,0.000093926996,0.000044457032,0.0000075940293,0.00002801981,0.00009881022,0.0000013349631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012666995,0.00003495828,0.01676382,0.000013677241,0.000045438795,0.000017924784,0.00011835393,0.000231159,0.6191318,0.00000480443,0.00035161528,0.3631598],"study_design_scores_gemma":[0.0010362417,0.00034451115,0.14169425,0.00017986221,0.000028033535,0.000023424052,0.00004594949,0.000037075388,0.78174245,0.00032359772,0.07437351,0.00017111703],"about_ca_topic_score_codex":0.0004741248,"about_ca_topic_score_gemma":0.02154074,"teacher_disagreement_score":0.36298868,"about_ca_system_score_codex":0.000044078115,"about_ca_system_score_gemma":0.0001361868,"threshold_uncertainty_score":0.9963136},"labels":[],"label_agreement":null},{"id":"W2897161745","doi":"10.1038/s41416-018-0225-4","title":"Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Denosumab; Breast cancer; Medicine; Hazard ratio; Oncology; Proportional hazards model; Internal medicine; Population; Cohort; Osteoporosis; Cohort study; Cancer; Gynecology; Confidence interval","score_opus":0.007708792042832116,"score_gpt":0.3088409880049742,"score_spread":0.30113219596214214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897161745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379873,0.0049796663,0.0000020681036,0.00037937137,0.00025024492,0.0004499331,0.00008274563,0.0000066356733,0.000050575094],"genre_scores_gemma":[0.9976383,0.001261913,0.00006883793,0.0005856525,0.00027604075,0.00006395993,0.0000023367134,0.000018362674,0.00008460848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878937,0.000071415445,0.00040804886,0.00015247522,0.00031928645,0.00025942287],"domain_scores_gemma":[0.9991162,0.000026459084,0.00025910893,0.00007780278,0.00025605745,0.00026436435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031290358,0.00010002127,0.00036785423,0.00011594318,0.00009433925,0.000027898077,0.000038273192,0.000048324768,0.00043127345],"category_scores_gemma":[0.000034384368,0.00009688251,0.000026038215,0.0001612379,0.00004181543,0.00009712046,0.0000090534695,0.00022740228,0.0000019942197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000870713,0.00045961072,0.9101995,0.00002225504,0.00014701085,0.00043877275,0.00016574659,0.0000049722876,0.0000054566945,2.7789977e-7,0.00016091835,0.087524734],"study_design_scores_gemma":[0.0075147646,0.0011228947,0.989298,0.00040426702,0.00016733675,0.0010549304,0.0000934936,0.000026131438,0.000005715357,0.000022498101,0.00021173146,0.00007825858],"about_ca_topic_score_codex":0.052238557,"about_ca_topic_score_gemma":0.033695057,"teacher_disagreement_score":0.08744648,"about_ca_system_score_codex":0.00057523354,"about_ca_system_score_gemma":0.0004840547,"threshold_uncertainty_score":0.9839375},"labels":[],"label_agreement":null},{"id":"W2897283341","doi":"10.1038/s41416-018-0220-9","title":"Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institute of Cancer Research; Institut Du Cancer de Montréal; Institut National Du Cancer","keywords":"Oncology; Lung cancer; Internal medicine; Medicine; Cohort; Immunotherapy; PD-L1; Immunohistochemistry; Cancer; Pathology","score_opus":0.006954791000340693,"score_gpt":0.27787800787922173,"score_spread":0.27092321687888105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897283341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750506,0.024380974,0.000035459216,0.00006277413,0.000106665626,0.00025144243,0.000035223737,0.000001711985,0.000075123025],"genre_scores_gemma":[0.99268115,0.0069887433,0.00010093036,0.00009595286,0.00009969825,0.0000049781934,0.0000019545628,0.000010334593,0.0000162547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992127,0.000034862805,0.00035572433,0.00008910776,0.00020982079,0.00009778681],"domain_scores_gemma":[0.999226,0.00003440477,0.00032082899,0.000043316322,0.00033155404,0.000043900473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016710383,0.000068359936,0.00025745842,0.00009985055,0.000022200882,0.000011027007,0.00003897666,0.000041289568,0.00006690892],"category_scores_gemma":[0.000036746827,0.00006512673,0.00003154734,0.000111886766,0.00018643893,0.00013050943,0.000010481039,0.000088604196,4.3094182e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002643387,0.00019166668,0.5981621,0.00010945183,0.00012336143,0.000022549277,0.00068998133,0.000001297094,0.026871715,0.0000011516552,0.00010094701,0.3710824],"study_design_scores_gemma":[0.004487278,0.0012791707,0.96950644,0.0013712941,0.000055557393,0.0001719362,0.00015928266,0.00009673368,0.022263983,0.000054976117,0.0004950665,0.000058278245],"about_ca_topic_score_codex":0.0003045756,"about_ca_topic_score_gemma":0.000209082,"teacher_disagreement_score":0.37134436,"about_ca_system_score_codex":0.00005438383,"about_ca_system_score_gemma":0.00010465711,"threshold_uncertainty_score":0.2655791},"labels":[],"label_agreement":null},{"id":"W2899462292","doi":"10.1038/s41416-018-0230-7","title":"Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Innovatiefonds Zorgverzekeraars; KWF Kankerbestrijding; ZonMw; Mach-Gaensslen Foundation of Canada; New York Stem Cell Foundation","keywords":"KRAS; Colorectal cancer; Tumor budding; Budding; Pathology; Cancer research; Biology; Epithelial–mesenchymal transition; Phenotype; Oncology; Tissue microarray; Immunohistochemistry; Medicine; Cancer; Internal medicine; Gene; Metastasis; Genetics","score_opus":0.02406353133911482,"score_gpt":0.3131442406647796,"score_spread":0.28908070932566476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899462292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98166555,0.01607593,0.000006471153,0.001007465,0.00014367637,0.00062530907,0.00024343353,0.000010054128,0.00022209712],"genre_scores_gemma":[0.99801767,0.0012992704,0.000066840206,0.00025536024,0.00017217254,0.000060078695,0.0000073029432,0.000031211264,0.00009010849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832195,0.00010233821,0.00038696596,0.00029252848,0.00062341033,0.00027278197],"domain_scores_gemma":[0.99786484,0.00014131345,0.0006125776,0.00016666845,0.001096058,0.00011852051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031356906,0.00019716368,0.00061850715,0.000077514815,0.00026667418,0.00005677687,0.00017548676,0.000050248498,0.000098575256],"category_scores_gemma":[0.0001268786,0.00013409214,0.000045494206,0.00042839762,0.0005116698,0.00010942107,0.00007561698,0.00026720332,1.9289772e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02327956,0.0017182509,0.8649809,0.0001874942,0.018466638,0.0074544647,0.01972723,0.00036492132,0.010401607,0.000015601134,0.016674493,0.036728874],"study_design_scores_gemma":[0.020313213,0.015080216,0.93353564,0.002650865,0.004926379,0.002696099,0.014335969,0.00043513998,0.004334854,0.0000144614605,0.0012321835,0.00044501093],"about_ca_topic_score_codex":0.016577173,"about_ca_topic_score_gemma":0.14549567,"teacher_disagreement_score":0.12891848,"about_ca_system_score_codex":0.00039802253,"about_ca_system_score_gemma":0.0010062829,"threshold_uncertainty_score":0.9899715},"labels":[],"label_agreement":null},{"id":"W2899843229","doi":"10.1038/s41416-018-0323-3","title":"North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Guideline; Prostate cancer; Lymph node; Cancer; Stage (stratigraphy); Population; Prostate-specific antigen; Prostate; Radiology; Internal medicine; Oncology; Surgery; Pathology","score_opus":0.022002389520070605,"score_gpt":0.3447491476882037,"score_spread":0.3227467581681331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899843229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711242,0.005584478,0.00012416995,0.021215273,0.0004891257,0.00072662864,0.0007148538,0.00000469987,0.000016575692],"genre_scores_gemma":[0.9843909,0.004781555,0.0034485308,0.006366561,0.00060455344,0.00023294582,0.00013973321,0.000022362148,0.000012817316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849796,0.00006700369,0.00067850895,0.00016814802,0.00040590708,0.00018245971],"domain_scores_gemma":[0.99548244,0.00017289938,0.001105721,0.00005855237,0.0031051983,0.00007516969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019249853,0.00011440822,0.00029562926,0.000079568905,0.00013209226,0.000028335731,0.0000572482,0.000016794214,0.000040834446],"category_scores_gemma":[0.0001530293,0.00010094516,0.00008013146,0.00032591648,0.00012571547,0.00021884828,0.000020043617,0.0001022452,1.0588448e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047479305,0.00019991126,0.8970751,0.000037370417,0.0000990368,0.0000029092005,0.00008301054,0.0055278586,0.000012309296,0.000004297483,0.0138467755,0.08263662],"study_design_scores_gemma":[0.0042106006,0.00012168818,0.9648639,0.0012617602,0.00019568572,0.00003484459,0.000042231022,0.0011096203,0.00020702044,0.000050981784,0.027800858,0.00010082592],"about_ca_topic_score_codex":0.0087791,"about_ca_topic_score_gemma":0.005943135,"teacher_disagreement_score":0.08253579,"about_ca_system_score_codex":0.0006565019,"about_ca_system_score_gemma":0.0006838716,"threshold_uncertainty_score":0.9978215},"labels":[],"label_agreement":null},{"id":"W2901896725","doi":"10.1038/s41416-018-0287-3","title":"Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Dasatinib; Paclitaxel; Cancer research; Breast cancer; Triple-negative breast cancer; Chemotherapy; Stem cell; Medicine; Cancer stem cell; Cancer; Oncology; Internal medicine; Biology; Imatinib","score_opus":0.01115178035035281,"score_gpt":0.2836793264439886,"score_spread":0.2725275460936358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901896725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398412,0.032092307,0.00043365516,0.012512242,0.0055278977,0.0010944108,0.007703125,0.00006556861,0.0007295621],"genre_scores_gemma":[0.9186565,0.052642386,0.0015978031,0.010735613,0.009279126,0.00009325675,0.000007931132,0.00021023257,0.006777132],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688816,0.00010935852,0.0009350821,0.000489739,0.00084793806,0.0007297119],"domain_scores_gemma":[0.9965922,0.00005950478,0.0007627668,0.00021776302,0.0016353267,0.00073241605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043647658,0.00038080476,0.0010157302,0.00015612565,0.00022998812,0.00015769963,0.00024559835,0.00014555773,0.0066096033],"category_scores_gemma":[0.0000114451495,0.00038445744,0.00034583342,0.00056945253,0.0002584802,0.00029928985,0.000055433586,0.0005170645,0.000022046039],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013344917,0.00015624787,0.0012159767,0.000112113405,0.00048490203,0.00018694533,0.00068677653,0.00006209724,0.20816897,6.3259665e-7,0.34333438,0.44425648],"study_design_scores_gemma":[0.008552822,0.00044083968,0.016023818,0.0039010912,0.0006526751,0.0028862345,0.0009332012,0.00005197319,0.6971646,0.000010597336,0.26861426,0.0007678897],"about_ca_topic_score_codex":0.015148536,"about_ca_topic_score_gemma":0.003931325,"teacher_disagreement_score":0.4889956,"about_ca_system_score_codex":0.00074695644,"about_ca_system_score_gemma":0.0010095703,"threshold_uncertainty_score":0.99986076},"labels":[],"label_agreement":null},{"id":"W2902071034","doi":"10.1038/s41416-018-0297-1","title":"Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Genentech; Cure Brain Cancer Foundation; University of Toronto","keywords":"Medicine; Breast cancer; Disease; Metastatic breast cancer; Cancer; Oncology; Kidney cancer; Internal medicine; Cancer research; Pathology","score_opus":0.02330542606875529,"score_gpt":0.3082916745140264,"score_spread":0.2849862484452711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902071034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94800097,0.050011482,0.000051811498,0.00052233035,0.00011666801,0.0004920054,0.0007634239,0.0000074991203,0.000033808952],"genre_scores_gemma":[0.9835429,0.01366823,0.00075420894,0.00036048616,0.0002828304,0.000034957797,0.000008411746,0.000048958693,0.0012989729],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980823,0.00012369026,0.00071029627,0.0002784128,0.00046208088,0.0003432133],"domain_scores_gemma":[0.9982695,0.000059557584,0.00040431388,0.00017185097,0.000768299,0.0003264614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002057258,0.00024831996,0.00080882077,0.00020719499,0.000074515025,0.00006256104,0.0001396396,0.000048713577,0.0006412799],"category_scores_gemma":[0.00003955262,0.00018249189,0.00018948462,0.00024569134,0.00032912756,0.00034131994,0.000041217067,0.00022192195,0.0000012938024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07279356,0.0024867211,0.1713341,0.0018651604,0.0069621373,0.027019773,0.013011494,0.0039791646,0.5648485,0.000026405904,0.0029868193,0.13268618],"study_design_scores_gemma":[0.014336024,0.0018558663,0.920307,0.0048820963,0.0012550183,0.013496878,0.00069705414,0.00082619046,0.041648842,0.000059046342,0.0001978084,0.00043820063],"about_ca_topic_score_codex":0.0035985617,"about_ca_topic_score_gemma":0.003808194,"teacher_disagreement_score":0.7489729,"about_ca_system_score_codex":0.00035171214,"about_ca_system_score_gemma":0.0015042343,"threshold_uncertainty_score":0.7441803},"labels":[],"label_agreement":null},{"id":"W29065105","doi":"10.1038/bjc.2017.360","title":"White-Nose SyndromeThe devastating disease of hibernating bats inNorth America","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bat Biology and Ecology Studies","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"White (mutation); Disease; Nose; Geography; Biology; Medicine; Pathology; Anatomy","score_opus":0.011397613098117279,"score_gpt":0.2361648433797352,"score_spread":0.22476723028161794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29065105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948094,0.0033527627,0.000012561589,0.0011624835,0.00024348013,0.000037568076,0.000033446562,0.0000066018565,0.00034170193],"genre_scores_gemma":[0.99781233,0.0010983581,0.000300713,0.00040584913,0.0002782946,0.0000039114416,0.000002776312,8.4178373e-7,0.00009691754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991015,0.0001265311,0.0003488203,0.00010744606,0.00012869293,0.00018698876],"domain_scores_gemma":[0.99897534,0.00025313205,0.000459184,0.000020334784,0.00020612469,0.00008591374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033653816,0.00007473703,0.00026072128,0.000012501555,0.0001718986,0.000017069357,0.00017761125,0.000043693475,0.00035207576],"category_scores_gemma":[0.00039405693,0.000035633468,0.00009632022,0.00017051618,0.00014823947,0.00009265175,0.000051512503,0.00017220029,0.0000021846365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039899714,0.00004889687,0.4141603,0.000011161692,0.000068609326,0.000040725612,0.00006364474,0.000047420388,0.0022207983,0.000011392973,0.0007440692,0.5825431],"study_design_scores_gemma":[0.00016709177,0.00019864776,0.9900189,0.00014854665,0.00003611503,0.00009851245,0.00021075427,0.00002628774,0.000116186064,0.00027533117,0.008611576,0.000092053844],"about_ca_topic_score_codex":0.0002874844,"about_ca_topic_score_gemma":0.0017148597,"teacher_disagreement_score":0.582451,"about_ca_system_score_codex":0.000015354499,"about_ca_system_score_gemma":0.000016861863,"threshold_uncertainty_score":0.38549826},"labels":[],"label_agreement":null},{"id":"W2913774914","doi":"10.1038/s41416-019-0382-0","title":"Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Université de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique; Korea University; Cancer Research UK","keywords":"Extracellular; Extracellular matrix; Cell biology; Biology; Intracellular; Elastin; Extracellular vesicle; Cell; Cancer cell; Biochemistry; Cancer; Microvesicles","score_opus":0.0028511838739615825,"score_gpt":0.20057441793620798,"score_spread":0.1977232340622464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913774914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9147654,0.08473292,0.00006237444,0.000034091725,0.00006484277,0.00013107348,0.000012103172,0.0000016325101,0.0001955662],"genre_scores_gemma":[0.99687606,0.0018613061,0.0007285447,0.000023741637,0.00023972499,0.000004211975,0.0000015311027,0.000014772946,0.0002501093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934095,0.000028366732,0.0002389159,0.00013248043,0.00012573076,0.00013354929],"domain_scores_gemma":[0.99953973,0.0000032421945,0.00021802899,0.000061801366,0.000102565755,0.00007464854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016711564,0.00008136463,0.00017279384,0.000026420146,0.000032506905,0.000035334324,0.00007797519,0.00007535403,0.00003217634],"category_scores_gemma":[0.000016039745,0.00008820901,0.000053742515,0.000030597104,0.000029776353,0.000015718502,0.000052437124,0.000096786294,5.143094e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007182139,0.000026387343,0.001574498,0.00006363334,0.00002078832,0.000019185318,0.000020859345,0.0000073276983,0.99221164,0.000032095093,0.000073084964,0.0058787004],"study_design_scores_gemma":[0.00079813914,0.00025085593,0.0010151814,0.00025575483,0.00002204718,0.00021707527,0.00009148965,0.0000352174,0.9905837,0.00022812253,0.0063968506,0.00010551851],"about_ca_topic_score_codex":0.00006113424,"about_ca_topic_score_gemma":0.00001314526,"teacher_disagreement_score":0.082871616,"about_ca_system_score_codex":0.00000762888,"about_ca_system_score_gemma":0.00006159007,"threshold_uncertainty_score":0.3597059},"labels":[],"label_agreement":null},{"id":"W2914739834","doi":"10.1038/s41416-019-0376-y","title":"Oestrogen receptor status and survival in women with BRCA2-associated breast cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; McGill University; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Gynecology; Survival analysis; Multivariate analysis; Progesterone receptor; Estrogen receptor","score_opus":0.004280236852257831,"score_gpt":0.24151342960373887,"score_spread":0.23723319275148103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914739834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869439,0.011957668,0.00000700589,0.00025023584,0.00036432667,0.000107917265,0.0002262515,0.0000027858746,0.00013990351],"genre_scores_gemma":[0.988419,0.010566428,0.00011924596,0.00021633325,0.00024354669,0.00002871556,0.0000074138648,0.000029769744,0.00036954897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989653,0.000062597486,0.00025448206,0.00019506889,0.00021008884,0.0003124668],"domain_scores_gemma":[0.9992857,0.000009717877,0.00022927903,0.000091121765,0.0002658474,0.00011832166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022211563,0.00010946956,0.00022200015,0.00004841323,0.000030588777,0.000049384635,0.0001167086,0.0000950356,0.00038263408],"category_scores_gemma":[0.000020285726,0.0001149262,0.00003168332,0.0001402245,0.00006348415,0.000015307603,0.00003678348,0.0001723261,0.0000014046432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001246281,0.00010858037,0.80960447,0.000037985777,0.00051961065,0.000034596247,0.00030439862,0.0013206304,0.052568175,0.0000037901655,0.0025839293,0.13166755],"study_design_scores_gemma":[0.004158069,0.00034854707,0.95676804,0.00040662708,0.00003158104,0.00030036247,0.0004988296,0.000008276493,0.0044897906,0.000024068726,0.03267063,0.00029521313],"about_ca_topic_score_codex":0.00095409417,"about_ca_topic_score_gemma":0.004637498,"teacher_disagreement_score":0.14716354,"about_ca_system_score_codex":0.0003865395,"about_ca_system_score_gemma":0.0007526848,"threshold_uncertainty_score":0.46865544},"labels":[],"label_agreement":null},{"id":"W2918113141","doi":"10.1038/s41416-019-0393-x","title":"Genome-wide association study of germline variants and breast cancer-specific mortality","year":2019,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; Sinai Health System; University of British Columbia; Centre hospitalier de l'Université Laval; Vancouver General Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University Health Network; University of Toronto","funders":"Servicio Gallego de Salud; Programme Grants for Applied Research; Biotieteiden ja Ympäristön Tutkimuksen Toimikunta; Instituto de Salud Carlos III; Medical Research Council; Imperial Experimental Cancer Medicine Centre; National Institutes of Health; Hellenic Health Foundation; Freistaat Sachsen; Deutschen Konsortium für Translationale Krebsforschung; Xunta de Galicia; Rheinische Friedrich-Wilhelms-Universität Bonn; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Centers for Disease Control and Prevention; Institut National Du Cancer; Canadian Institutes of Health Research; Sigrid Juséliuksen Säätiö; National Health and Medical Research Council; Oulun Yliopisto; Deutsche Krebshilfe; KWF Kankerbestrijding; Vetenskapsrådet; Stockholms Läns Landsting; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; Karolinska Institutet; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Air Force Materiel Command; European Regional Development Fund; King's College London; Academy of Finland; Russian Foundation for Basic Research; University of Crete; Institut National de la Santé et de la Recherche Médicale; Cancer Australia; Agence Nationale de la Recherche; National Institute on Aging; Robert Bosch Stiftung; University of Westminster; European Commission; Cancerfonden; National Cancer Institute; Breast Cancer Now; Cancer Institute NSW; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Campaign; Eberhard Karls Universität Tübingen; Fondation du cancer du sein du Québec; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Gentofte Hospital; Deutsche Gesetzliche Unfallversicherung; University of California, Irvine; Kreftforeningen; David F. and Margaret T. Grohne Family Foundation; Cancer Research UK; U.S. Department of Defense; National Heart, Lung, and Blood Institute; Itä-Suomen Yliopisto; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Centre International de Recherche sur le Cancer; Deutsches Krebsforschungszentrum; World Cancer Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; Susan G. Komen for the Cure; Stavros Niarchos Foundation; University of Southern California; Associazione Italiana per la Ricerca sul Cancro; Beckman Research Institute, City of Hope; Cancer Council Victoria; California Department of Public Health; Ministerio de Sanidad, Servicios Sociales e Igualdad; University of Cambridge; Government of Canada; U.S. Department of Health and Human Services; American Cancer Society; Breast Cancer Research Foundation; National Institute for Health and Care Research; Norges Forskningsråd; Division of Cancer Prevention, National Cancer Institute","keywords":"Breast cancer; Hazard ratio; Germline; Oncology; Genome-wide association study; Germline mutation; Cancer; Biology; Confidence interval; Internal medicine; Disease; Genetics; Medicine; Gene; Single-nucleotide polymorphism; Mutation; Genotype","score_opus":0.03285698338437489,"score_gpt":0.3435886946455268,"score_spread":0.31073171126115195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918113141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06211644,0.9355207,0.00002285717,0.000028565693,0.00087384525,0.00046577273,0.0009226168,0.0000020876187,0.00004713575],"genre_scores_gemma":[0.010193502,0.9880927,0.000043041542,0.00003986469,0.0011445121,0.000050462895,0.00004323384,0.000053707197,0.00033895418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977476,0.00022280552,0.0010403084,0.00034881904,0.00042271576,0.0002177506],"domain_scores_gemma":[0.99683934,0.000050366118,0.0020837174,0.0002594549,0.0006814776,0.00008563412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005910816,0.00024566025,0.0011748482,0.000093604795,0.00005492311,0.00006324141,0.00031235776,0.0003039102,0.00014080484],"category_scores_gemma":[0.000073264586,0.00026493368,0.00028188305,0.00018442061,0.000042126878,0.000012427406,0.00010263572,0.00035467822,0.0000011591584],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004102684,0.0002931585,0.018642714,0.00250855,0.0028902611,0.000045401957,0.00006558381,0.00010953236,0.00012522493,4.6147065e-7,0.003704464,0.9715736],"study_design_scores_gemma":[0.0011135343,0.00018685624,0.13032041,0.0033841173,0.0015960389,0.00032719184,0.00005277981,5.004715e-7,0.000013993772,0.000005410436,0.86266327,0.00033591402],"about_ca_topic_score_codex":0.0003681859,"about_ca_topic_score_gemma":0.001041962,"teacher_disagreement_score":0.9712377,"about_ca_system_score_codex":0.00051670126,"about_ca_system_score_gemma":0.0011535778,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W2920675014","doi":"10.1038/s41416-019-0390-0","title":"The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; Women's College Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Institute for Work & Health; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre","funders":"National Cancer Institute; Astellas Pharma; Ontario Ministry of Health and Long-Term Care; Canadian Urological Oncology Group; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Canadian Urological Association","keywords":"Cancer; Medicine; Solid organ; Oncology; Psychiatry; Internal medicine; Organ transplantation; Transplantation","score_opus":0.015110196320796672,"score_gpt":0.32595559364100496,"score_spread":0.31084539732020827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920675014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794133,0.017139938,0.000009894797,0.00086589245,0.001703605,0.00028287794,0.00020237046,0.00000465684,0.00037748393],"genre_scores_gemma":[0.9869063,0.012014556,0.00001634454,0.00015253187,0.0005159956,0.00002947737,0.0000013716758,0.000024833376,0.00033861178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984383,0.000063591746,0.0005576489,0.0001275185,0.0005942487,0.0002187061],"domain_scores_gemma":[0.9982411,0.0001316508,0.00052523735,0.00018116126,0.0007810305,0.00013978146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039110458,0.0001218683,0.00048415383,0.00012061618,0.000051700892,0.000021512531,0.00017530758,0.000064426036,0.0008065941],"category_scores_gemma":[0.000112753085,0.000092403636,0.00032864828,0.00040730636,0.000050822386,0.00008599974,0.000021169604,0.00021060323,0.000003027516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017034768,0.00018986719,0.722991,0.00020234856,0.00043439746,0.000025865062,0.0010612541,0.00058563496,0.0029821778,0.000028570686,0.011658425,0.25813702],"study_design_scores_gemma":[0.001669319,0.001270976,0.97743005,0.0017572952,0.00017334818,0.00009678909,0.0005904642,0.000009671857,0.009389549,0.000043800836,0.0074406336,0.00012810757],"about_ca_topic_score_codex":0.011337905,"about_ca_topic_score_gemma":0.014312366,"teacher_disagreement_score":0.2580089,"about_ca_system_score_codex":0.00026488033,"about_ca_system_score_gemma":0.0007502261,"threshold_uncertainty_score":0.9952457},"labels":[],"label_agreement":null},{"id":"W2938903157","doi":"10.1038/s41416-019-0446-1","title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; North York General Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"Peter Gilgan Foundation","keywords":"Medicine; BRCA mutation; Breast cancer; Prophylactic Mastectomy; Genetic testing; Ovarian cancer; Cohort; Mastectomy; Cancer; Gynecology; Breast MRI; Obstetrics; Internal medicine; Oncology; Mammography","score_opus":0.008740073433286425,"score_gpt":0.29334209267362016,"score_spread":0.28460201924033374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938903157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994998,0.0034404115,0.00005685523,0.00032655126,0.00040258124,0.00008882939,0.000051385392,0.0000012211411,0.00063420023],"genre_scores_gemma":[0.99395937,0.004976733,0.00032823085,0.00006801407,0.00029490766,0.000051227707,0.000008642394,0.000012684175,0.00030017804],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903136,0.000064210384,0.00037620857,0.00014398643,0.00024928237,0.00013496396],"domain_scores_gemma":[0.99927884,0.000008783488,0.00038207156,0.00009700664,0.00021177405,0.00002151554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035170713,0.000080330225,0.00014408852,0.00013250284,0.000019166362,0.000048316986,0.00021144659,0.00006591891,0.00037516162],"category_scores_gemma":[0.000020753716,0.000065253524,0.00003823108,0.00027181942,0.000056520603,0.000033117525,0.000014750805,0.00018130436,3.4357308e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024726386,0.00015570095,0.015341272,0.000033221462,0.00031021386,0.00006222374,0.0027347042,0.05825792,0.026495116,0.000015989075,0.0018521026,0.8922689],"study_design_scores_gemma":[0.0059341337,0.0009747127,0.9085958,0.00060585974,0.00006339407,0.0012751509,0.012648465,0.00016750587,0.011289018,0.00023797681,0.057904482,0.00030350924],"about_ca_topic_score_codex":0.00118575,"about_ca_topic_score_gemma":0.01027186,"teacher_disagreement_score":0.8932545,"about_ca_system_score_codex":0.00022208875,"about_ca_system_score_gemma":0.00054612634,"threshold_uncertainty_score":0.5731939},"labels":[],"label_agreement":null},{"id":"W2945221383","doi":"10.1038/s41416-019-0474-x","title":"A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"Pfizer Canada; Pfizer","keywords":"Paraganglioma; Sunitinib; SDHB; Medicine; Clinical endpoint; SDHA; Pheochromocytoma; Progressive disease; Internal medicine; Surgery; Metanephrines; Phases of clinical research; Oncology; Germline mutation; Randomized controlled trial; Chemotherapy; Cancer; Mutation","score_opus":0.014188885390452086,"score_gpt":0.31691925745473953,"score_spread":0.30273037206428743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945221383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961543,0.0014249838,0.0000024490214,0.00017505809,0.0005158159,0.0013976264,0.000040176637,0.000004735557,0.00028481695],"genre_scores_gemma":[0.99880993,0.000033843695,0.000040206713,0.000119027674,0.0006928548,0.000028995413,0.000006571984,0.00001960115,0.00024897902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824184,0.00011029138,0.00065923505,0.00012635432,0.0006373269,0.00022497987],"domain_scores_gemma":[0.9984805,0.0001138573,0.00074777653,0.00013065366,0.00042092547,0.00010630089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034224507,0.00012585161,0.00058107206,0.00011312171,0.000033980523,0.000023603887,0.0001513652,0.00006252036,0.00085937645],"category_scores_gemma":[0.0001482476,0.000074285985,0.00014073489,0.0003741919,0.00012196262,0.00013558174,0.000015480813,0.00034798132,0.0000031130098],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9427703,0.0027553912,0.001395886,0.000062849664,0.00019428732,0.01571195,0.00024522413,0.000008503473,0.000007508913,0.000008912061,0.00055003376,0.03628916],"study_design_scores_gemma":[0.94573814,0.023144882,0.017063936,0.00222211,0.00022082627,0.009771897,0.00020336194,0.000008411259,0.00072783604,0.00001848434,0.0007427457,0.00013734968],"about_ca_topic_score_codex":0.000091485774,"about_ca_topic_score_gemma":0.00012815032,"teacher_disagreement_score":0.03615181,"about_ca_system_score_codex":0.000060517355,"about_ca_system_score_gemma":0.00068091037,"threshold_uncertainty_score":0.94095695},"labels":[],"label_agreement":null},{"id":"W2948620437","doi":"10.1038/s41416-019-0494-6","title":"Reply to Comment on: “The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies’’","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health; Institute for Work & Health; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Solid organ; Cancer; Medicine; Psychiatry; Oncology; Intensive care medicine; Internal medicine; Organ transplantation; Transplantation","score_opus":0.20355364682130797,"score_gpt":0.4270784520811215,"score_spread":0.22352480525981352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948620437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1208543,0.005063697,0.000103490565,0.8627827,0.003530702,0.0013527718,0.005942303,0.0000069306093,0.0003630721],"genre_scores_gemma":[0.04645644,0.0032468971,0.0002677883,0.9438084,0.005059293,0.00033819038,0.000025887834,0.00011669652,0.0006804053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99242216,0.00049826363,0.0055924724,0.00051174214,0.00046630698,0.000509029],"domain_scores_gemma":[0.9891519,0.001515308,0.00790132,0.0006571617,0.0005867012,0.0001876412],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008132585,0.00035009015,0.0022270891,0.00073366164,0.00011826993,0.00008704064,0.0007990759,0.00032678735,0.0027860317],"category_scores_gemma":[0.0022836349,0.0003756611,0.0006284787,0.00040942666,0.00005565326,0.00018562427,0.00006326485,0.00092894095,0.00016593894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009165824,0.00010802006,0.018619956,0.00037873018,0.00037421403,0.000008843492,0.0005931013,0.0016821738,0.00000113186,0.00012311645,0.9765004,0.0015186353],"study_design_scores_gemma":[0.0010274699,0.0010382502,0.0674051,0.003228885,0.000057435725,0.000025980497,0.00013533629,0.00003674221,0.000047552894,0.00051238894,0.9260253,0.0004596165],"about_ca_topic_score_codex":0.0223094,"about_ca_topic_score_gemma":0.000753694,"teacher_disagreement_score":0.08102567,"about_ca_system_score_codex":0.0022851052,"about_ca_system_score_gemma":0.00109048,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W2948836473","doi":"10.1038/s41416-019-0484-8","title":"Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BRCA mutation; Medicine; Ovarian cancer; Cancer; Oncology; Breast cancer; Cancer prevention; Mutation; Internal medicine; Gynecology; Genetics; Biology; Gene","score_opus":0.025781895547536016,"score_gpt":0.30671751785145696,"score_spread":0.28093562230392094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948836473","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45553863,0.28645715,0.002938899,0.2474764,0.0045034396,0.0014003543,0.0008829952,0.000017881033,0.0007842312],"genre_scores_gemma":[0.18300615,0.123220176,0.00717861,0.6345737,0.028223095,0.00048931537,0.0015172892,0.00054917636,0.021242466],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835175,0.00015352822,0.00056348945,0.00032798445,0.0003356015,0.00026761618],"domain_scores_gemma":[0.9986535,0.000024357047,0.00070060877,0.00015756978,0.0003917046,0.000072302246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031462914,0.000206915,0.00036479346,0.00016951305,0.00005388302,0.00010279029,0.00021263391,0.0005683909,0.00017680695],"category_scores_gemma":[0.0001269497,0.00026484724,0.00015297627,0.00012645591,0.000078619334,0.00002365361,0.00005217731,0.0008997379,5.554929e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009510469,0.000015562478,0.0011447233,0.00022352056,0.00039295133,0.000616825,0.00010319059,0.00093070825,0.0032459523,2.6363017e-7,0.7601457,0.23308547],"study_design_scores_gemma":[0.0019896084,0.00018450055,0.003302397,0.00193825,0.00018676941,0.0012146302,0.00010935689,0.000044674183,0.0024191996,0.00008127574,0.9881261,0.00040326352],"about_ca_topic_score_codex":0.0008944671,"about_ca_topic_score_gemma":0.0020147066,"teacher_disagreement_score":0.38709733,"about_ca_system_score_codex":0.00022165624,"about_ca_system_score_gemma":0.001624895,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W2949918164","doi":"10.1038/s41416-019-0395-8","title":"MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; National Health and Medical Research Council; Medical Research Council; University of Queensland; National Breast Cancer Foundation; Tenovus; National Institutes of Health; U.S. Department of Health and Human Services; Cancer Research UK; Cardiff University","keywords":"Breast cancer; microRNA; Biomarker; Oncology; Cancer research; Medicine; Cancer; Pathology; Internal medicine; Biology; Gene; Genetics","score_opus":0.004789210654814933,"score_gpt":0.24470176672865,"score_spread":0.23991255607383505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949918164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419594,0.05650244,0.000011588542,0.0007711675,0.00016684385,0.00018827854,0.00034639332,0.0000025739896,0.000051359086],"genre_scores_gemma":[0.99238473,0.0059165927,0.000050270963,0.0007064788,0.00011970895,0.000011242082,0.000018459088,0.000029428877,0.000763081],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989606,0.000047272682,0.00034652473,0.0002478645,0.00017433219,0.00022337363],"domain_scores_gemma":[0.99927795,0.00000643966,0.00025419617,0.000122037505,0.00022637141,0.00011299693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013799194,0.00013251886,0.00020644348,0.00005760469,0.00002861066,0.00005990962,0.0001273518,0.0001501492,0.00063243223],"category_scores_gemma":[0.000014854851,0.0001480085,0.0000858278,0.00012201879,0.000064145905,0.000017275197,0.00004850327,0.000118141215,0.00000313582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017551717,0.00006014824,0.1139261,0.000061600746,0.00015617271,0.000028392351,0.00003887162,0.00001101856,0.7842722,2.8028026e-7,0.050403766,0.050865926],"study_design_scores_gemma":[0.0023353104,0.00006481073,0.872043,0.0008617817,0.000077159515,0.0012908159,0.000021434918,0.00007944031,0.06675345,0.000022639862,0.056157753,0.00029238258],"about_ca_topic_score_codex":0.0005101402,"about_ca_topic_score_gemma":0.00028264843,"teacher_disagreement_score":0.7581169,"about_ca_system_score_codex":0.00006474951,"about_ca_system_score_gemma":0.00019331447,"threshold_uncertainty_score":0.69246894},"labels":[],"label_agreement":null},{"id":"W2952644236","doi":"10.1038/s41416-019-0492-8","title":"Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; University of Toronto; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; Canadian Institutes of Health Research; lékařská fakulta Univerzity Karlovy; Manchester Biomedical Research Centre; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Medical Research Council; Uppsala Universitet; National Institute of General Medical Sciences; Institut National Du Cancer; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Associazione Italiana per la Ricerca sul Cancro; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Linköpings Universitet; Hungarian Scientific Research Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Russian Foundation for Basic Research; Cancer Association of South Africa; Ministerstvo Školství, Mládeže a Tělovýchovy; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; KWF Kankerbestrijding; Cancer Research UK; Government of Canada; National Cancer Institute; Liga Portuguesa Contra o Cancro; Hospital de Câncer de Barretos; NRG Oncology; Memorial Sloan-Kettering Cancer Center; Fondation du cancer du sein du Québec; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Genome Canada; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; Unicancer; Clalit Health Services; Deutsches Krebsforschungszentrum; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Beth Israel Deaconess Medical Center; Alpha Omega Alpha Honor Medical Society; Georgetown University; Susan G. Komen for the Cure; Instituto de Salud Carlos III; Ohio State University; Cancer Australia; National Health and Medical Research Council; Jewish General Hospital; Fundación Cellex; Fisher Center for Alzheimer's Research Foundation; Istituto Oncologico Veneto; Umeå Universitet; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Lietuvos Mokslo Taryba","keywords":"Ovarian cancer; Body mass index; Oncology; Medicine; Mendelian inheritance; Mutation; Internal medicine; Cancer; Genetics; Biology; Gynecology; Gene","score_opus":0.007762646086976757,"score_gpt":0.27740165255938026,"score_spread":0.2696390064724035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952644236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864959,0.011970795,0.000024079356,0.0002653511,0.0002531873,0.00071876415,0.00005257149,0.000002635416,0.00021668435],"genre_scores_gemma":[0.98594344,0.013723032,0.00007950977,0.00005511895,0.00008733411,0.000037367347,0.0000024624896,0.000018237937,0.000053526994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984981,0.00011122447,0.000633547,0.00020241016,0.00040542605,0.00014933004],"domain_scores_gemma":[0.99878216,0.00006726259,0.00064940355,0.000104212166,0.0002617738,0.00013518575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004235075,0.00012811674,0.00061722344,0.00020019387,0.000032978107,0.00002527735,0.00004881557,0.00008017864,0.00023423145],"category_scores_gemma":[0.00005141691,0.00012522146,0.00006786621,0.00018035666,0.000057668793,0.0001830612,0.000012692762,0.00021115967,2.1054527e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022840698,0.00032623176,0.91204643,0.00013946537,0.00086317386,0.00017962864,0.0019394362,0.0010864944,0.0006307148,0.000013318177,0.00010260804,0.0803884],"study_design_scores_gemma":[0.04574571,0.0010232561,0.94673127,0.0010666696,0.00059536163,0.0001775936,0.0025946377,0.00039790277,0.0011814848,0.00018446929,0.00018487709,0.000116787414],"about_ca_topic_score_codex":0.025373742,"about_ca_topic_score_gemma":0.0038157986,"teacher_disagreement_score":0.08027161,"about_ca_system_score_codex":0.00025373301,"about_ca_system_score_gemma":0.00033461224,"threshold_uncertainty_score":0.98111635},"labels":[],"label_agreement":null},{"id":"W2954453700","doi":"10.1038/s41416-019-0497-3","title":"Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"Terry Fox Research Institute; Terry Fox Foundation; Princess Margaret Cancer Foundation; University Health Network","keywords":"Plerixafor; Medicine; CXCR4; CXCR4 antagonist; Adjuvant; Cervical cancer; Oncology; Pharmacology; Cancer; Cancer research; Internal medicine; Chemokine; Inflammation","score_opus":0.007337979713770473,"score_gpt":0.2382224553489057,"score_spread":0.23088447563513523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954453700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98205876,0.015501784,0.00026681065,0.0014426954,0.00015485486,0.00050182577,0.000009728834,0.000007047639,0.000056460296],"genre_scores_gemma":[0.9920598,0.0054851966,0.00028661676,0.0016986073,0.00029308235,0.00002402527,0.0000014234308,0.000038586048,0.000112629365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987625,0.000049309787,0.00040612055,0.0001925307,0.00033130206,0.00025824958],"domain_scores_gemma":[0.9992781,0.00005374499,0.00021215451,0.00009162682,0.00022292926,0.00014141109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018865027,0.00015305077,0.0004289009,0.00006379202,0.000054541903,0.000081873215,0.00008742736,0.00006907204,0.00038065005],"category_scores_gemma":[0.0000069261555,0.00010729742,0.00007193402,0.0001890691,0.00003981655,0.00016921954,0.00001603322,0.00035271014,7.872207e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012928026,0.00009421152,0.0178727,0.00007710837,0.00024063775,0.00009944228,0.001642115,0.005310854,0.741728,0.0000030345248,0.00038390773,0.23125516],"study_design_scores_gemma":[0.028221397,0.003273954,0.04570986,0.00629204,0.0005560362,0.0018107624,0.0034248887,0.03155996,0.8653909,0.00016529472,0.012381269,0.0012136514],"about_ca_topic_score_codex":0.0015710786,"about_ca_topic_score_gemma":0.00034307825,"teacher_disagreement_score":0.23004152,"about_ca_system_score_codex":0.00018193912,"about_ca_system_score_gemma":0.00021015144,"threshold_uncertainty_score":0.43754616},"labels":[],"label_agreement":null},{"id":"W2957828588","doi":"10.1038/s41416-019-0517-3","title":"Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; University of California, Los Angeles; University of Toronto; Princess Margaret Cancer Foundation; California Institute of Regenerative Medicine; California Institute for Regenerative Medicine","keywords":"Tolerability; Medicine; Dosing; Neutropenia; Pharmacokinetics; Cmax; Adverse effect; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacology; Clinical trial; Oncology; Phases of clinical research; Toxicity","score_opus":0.004839703614920863,"score_gpt":0.27295384514515486,"score_spread":0.268114141530234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957828588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564,0.0034536615,0.000077962686,0.00007448916,0.00023441458,0.00037255196,0.000058596936,0.0000012160921,0.00008715623],"genre_scores_gemma":[0.9960418,0.0035010634,0.0001282667,0.000046932993,0.00020357722,0.000009356315,0.000012927933,0.000011766504,0.000044328146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988721,0.00006937579,0.0005721211,0.00019468309,0.00012593278,0.00016576408],"domain_scores_gemma":[0.9993324,0.000021353759,0.00032510114,0.000087431945,0.00018033823,0.0000533644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031551853,0.00009918085,0.0003439432,0.000057509038,0.000019919411,0.000016092888,0.00008363305,0.00012279201,0.000021019545],"category_scores_gemma":[0.000105947205,0.00011365968,0.00007974377,0.00011395918,0.000043847744,0.000020581921,0.000032340893,0.00019157236,2.2380317e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064516194,0.0013223406,0.05705097,0.00016840063,0.00013386882,0.000045134915,0.0003601498,0.0031158384,0.765258,0.000009353188,0.0005229418,0.10749682],"study_design_scores_gemma":[0.29028845,0.008251916,0.3202775,0.0026912733,0.00013319994,0.0005070551,0.00044631946,0.0015997812,0.35516703,0.00024380504,0.019407129,0.0009865151],"about_ca_topic_score_codex":0.00017419856,"about_ca_topic_score_gemma":0.00468033,"teacher_disagreement_score":0.41009095,"about_ca_system_score_codex":0.000086710184,"about_ca_system_score_gemma":0.00024878894,"threshold_uncertainty_score":0.4634907},"labels":[],"label_agreement":null},{"id":"W2965977634","doi":"10.1038/s41416-019-0543-1","title":"Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Texas MD Anderson Cancer Center; University of Oxford; Kaiser Permanente","keywords":"Medicine; Hazard ratio; Chemotherapy; Internal medicine; Ovarian cancer; Confidence interval; EPIC; Surgery; Oncology; Cancer","score_opus":0.01479247279584464,"score_gpt":0.30574270759039074,"score_spread":0.2909502347945461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965977634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567747,0.03511583,0.000018671915,0.0018536542,0.00082256924,0.0051982165,0.00012203903,0.000008355545,0.00008592264],"genre_scores_gemma":[0.9731511,0.024546776,0.0003587131,0.00052181544,0.00042656474,0.00070188264,0.000004450595,0.00005654781,0.00023213938],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976848,0.00014573254,0.0010603083,0.00030806087,0.00047872885,0.00032236503],"domain_scores_gemma":[0.9979561,0.00026426205,0.000658123,0.00017908393,0.0007907521,0.00015167863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006259537,0.00025937916,0.0018220969,0.00015144335,0.000046899975,0.0000469747,0.00014455126,0.0000992634,0.00065379794],"category_scores_gemma":[0.000060240243,0.00022198829,0.00040172812,0.00014407985,0.000047212303,0.0001826569,0.000008494477,0.00026684956,9.540523e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32629216,0.00399324,0.16104025,0.000066007604,0.003457226,0.00019996637,0.0032393883,0.0010257681,0.006263534,0.000017949193,0.00016894862,0.49423558],"study_design_scores_gemma":[0.5308363,0.0052799587,0.45791948,0.0009585768,0.0002456554,0.000055916986,0.00040085448,0.000052074847,0.003503302,0.000014713608,0.00055261835,0.00018058684],"about_ca_topic_score_codex":0.002788265,"about_ca_topic_score_gemma":0.003902817,"teacher_disagreement_score":0.494055,"about_ca_system_score_codex":0.00031017576,"about_ca_system_score_gemma":0.0006458396,"threshold_uncertainty_score":0.90524197},"labels":[],"label_agreement":null},{"id":"W2972107575","doi":"10.1038/s41416-019-0565-8","title":"Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary; Cumming School of Medicine, University of Calgary; National Cancer Institute; U.S. Department of Health and Human Services; Government of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Olaparib; Cancer research; Ataxia-telangiectasia; PARP inhibitor; Poly ADP ribose polymerase; Lung cancer; Adenocarcinoma; Cancer; Biology; Molecular biology; Medicine; DNA damage; Pathology; Polymerase; Genetics; DNA","score_opus":0.006268429481743964,"score_gpt":0.27431340489859357,"score_spread":0.26804497541684963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972107575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85167354,0.14212438,0.00011521623,0.0015647825,0.0022662964,0.0009121346,0.00064485054,0.00011022366,0.00058855116],"genre_scores_gemma":[0.9819114,0.013642241,0.00022421652,0.0015471552,0.00075110426,0.00007628068,0.00013642012,0.00015505949,0.0015561044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958079,0.00021008302,0.0014006576,0.0006369712,0.0010929508,0.000851451],"domain_scores_gemma":[0.9971247,0.000105938605,0.0011114305,0.00035509394,0.00066824903,0.00063461764],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050622434,0.00051606796,0.0011133049,0.00046755973,0.0002282642,0.00017777375,0.00021382097,0.00034945688,0.0039374777],"category_scores_gemma":[0.000047714027,0.00055685337,0.0003816332,0.0007153108,0.00025115669,0.0005612469,0.00007942962,0.0011241798,0.000057026406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503275,0.0018887204,0.061166927,0.0016497953,0.0039428407,0.012982912,0.0031896285,0.0018176526,0.6846778,0.00011226218,0.12671533,0.09335287],"study_design_scores_gemma":[0.07105635,0.003285466,0.095308505,0.018561028,0.0025755041,0.024693444,0.001122455,0.003574891,0.7376517,0.00038278976,0.038847424,0.0029404564],"about_ca_topic_score_codex":0.00234068,"about_ca_topic_score_gemma":0.00019111241,"teacher_disagreement_score":0.13023786,"about_ca_system_score_codex":0.0009286372,"about_ca_system_score_gemma":0.000778002,"threshold_uncertainty_score":0.99968827},"labels":[],"label_agreement":null},{"id":"W2972995783","doi":"10.1038/s41416-020-01106-x","title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research; National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Medicine; Internal medicine; Neutrophil to lymphocyte ratio; Proportional hazards model; Gastroenterology; Cancer; Radiation therapy; Oncology; Lymphocyte","score_opus":0.008582742535465118,"score_gpt":0.25138728573217484,"score_spread":0.24280454319670972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972995783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885024,0.009163999,0.00007912352,0.00054480456,0.000069227244,0.0014673871,0.00012365617,0.000015703805,0.000033722576],"genre_scores_gemma":[0.9959765,0.0018090935,0.0010732113,0.00057674746,0.00025073203,0.00021067592,0.000008683339,0.00006131477,0.000033043856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812645,0.00008714426,0.00060374395,0.0002893818,0.0005955634,0.00029769988],"domain_scores_gemma":[0.9983591,0.00003534133,0.0004787598,0.0001317536,0.0006033495,0.00039170243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007264684,0.00024327877,0.00072282134,0.00012276796,0.000040525665,0.00003267004,0.00014288885,0.00006193863,0.00020230649],"category_scores_gemma":[0.000031223903,0.00019510684,0.00010052111,0.0005045539,0.00011964334,0.00017432668,0.000012121484,0.00014977061,7.513693e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024954831,0.0005426357,0.9204377,0.00022256709,0.0007063636,0.0010257643,0.00037533508,0.0011685767,0.0020285146,5.4967603e-7,0.000264883,0.048272267],"study_design_scores_gemma":[0.016535062,0.0048561078,0.9662795,0.0019803375,0.00048866274,0.000066866545,0.000030817082,0.00011215679,0.008793484,5.7528e-7,0.00063996867,0.00021646344],"about_ca_topic_score_codex":0.00071519933,"about_ca_topic_score_gemma":0.00034643698,"teacher_disagreement_score":0.048055805,"about_ca_system_score_codex":0.00076852716,"about_ca_system_score_gemma":0.0011543588,"threshold_uncertainty_score":0.7956226},"labels":[],"label_agreement":null},{"id":"W2975219771","doi":"10.1038/s41416-019-0586-3","title":"Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Canadian Cancer Society Research Institute; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Photodynamic therapy; Medicine; Cancer research; Pharmacology; Dermatology; Chemistry","score_opus":0.01561563260470442,"score_gpt":0.32755857130427307,"score_spread":0.31194293869956863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975219771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280766,0.070097394,0.000019496389,0.00041476503,0.0004598564,0.0006041538,0.000026116864,0.0000110701485,0.00029053265],"genre_scores_gemma":[0.93402207,0.06498455,0.000023993529,0.00022231683,0.0002704223,0.000021241029,0.0000024471576,0.000024626239,0.00042832064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980083,0.00014556968,0.0006844281,0.00016124279,0.0007279925,0.00027247443],"domain_scores_gemma":[0.998312,0.00024165327,0.0006007156,0.00020762296,0.0005518215,0.000086186825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007468614,0.00014170787,0.0006022231,0.00011455974,0.00007161167,0.000031547122,0.00021734556,0.000071601666,0.00038154458],"category_scores_gemma":[0.0001336057,0.00010223436,0.0002847101,0.00024756376,0.0001965469,0.00014467991,0.000034407523,0.00048281928,0.000010015971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012470589,0.00016343755,0.001343862,0.00017694422,0.00062126905,0.000114537055,0.0004665571,0.000034451572,0.9131343,0.000007976224,0.00041188044,0.082277745],"study_design_scores_gemma":[0.020123148,0.003012056,0.29978678,0.012567732,0.00027770633,0.007735268,0.0017913204,0.00014733411,0.64937145,0.00024040908,0.004535283,0.00041151023],"about_ca_topic_score_codex":0.00025182666,"about_ca_topic_score_gemma":0.00016410736,"teacher_disagreement_score":0.2984429,"about_ca_system_score_codex":0.00018669819,"about_ca_system_score_gemma":0.0003769415,"threshold_uncertainty_score":0.41776457},"labels":[],"label_agreement":null},{"id":"W2975775173","doi":"10.1038/s41416-019-0580-9","title":"Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Health and Medical Research Council; Cedars-Sinai Medical Center; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Medical Research Council; California Department of Public Health; University of Southern California","keywords":"Lynch syndrome; Medicine; Colorectal cancer; Internal medicine; Diabetes mellitus; Triglyceride; Cholesterol; Metabolic syndrome; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology; Oncology; Cancer; Gastroenterology","score_opus":0.006566736898579511,"score_gpt":0.25219068415677515,"score_spread":0.24562394725819564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975775173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87529534,0.122753024,6.184168e-7,0.00016940162,0.0012313561,0.00033421547,0.000044779885,0.000010359801,0.00016089961],"genre_scores_gemma":[0.93690675,0.06212681,0.00017199341,0.00025906137,0.00024037485,0.000024288986,0.0000018233188,0.000042653945,0.00022621501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982087,0.00008540172,0.0005739982,0.00027555577,0.00046305274,0.00039328897],"domain_scores_gemma":[0.99889636,0.000096465345,0.0003702552,0.00012262222,0.0002867459,0.00022755035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036844568,0.00019231862,0.0006950985,0.00016847752,0.000036630277,0.000055850312,0.0001472691,0.00015831226,0.001171426],"category_scores_gemma":[0.00013047911,0.0001976178,0.00011021781,0.0003580809,0.0001081556,0.00016437266,0.00005034678,0.00068023166,0.000007851948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005080137,0.00012420617,0.8954522,0.0001690093,0.00031732794,0.0003740396,0.0001559818,0.00014735562,0.010072145,8.350244e-7,0.0003939977,0.09228488],"study_design_scores_gemma":[0.005281335,0.0013005631,0.97563785,0.0017753985,0.00033695594,0.002362227,0.000049116683,0.00005783524,0.009773431,0.00004936981,0.0031528336,0.00022310624],"about_ca_topic_score_codex":0.0013969275,"about_ca_topic_score_gemma":0.002710091,"teacher_disagreement_score":0.09206177,"about_ca_system_score_codex":0.00024006504,"about_ca_system_score_gemma":0.00044004977,"threshold_uncertainty_score":0.9997416},"labels":[],"label_agreement":null},{"id":"W2982313632","doi":"10.1038/s41416-019-0610-7","title":"Phospholipase D2 in prostate cancer: protein expression changes with Gleason score","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Prostate Cancer UK; Cancer and Polio Research Fund; Daphne Jackson Trust; Barts Charity; Vanderbilt University","keywords":"PLD2; Prostate cancer; Cancer research; Biology; Stromal cell; Carcinogenesis; Viability assay; Phospholipase D; Cell growth; LNCaP; Cell; Cancer; Cell biology; Phosphatidic acid; Signal transduction; Biochemistry; Phospholipid","score_opus":0.0065937933782848025,"score_gpt":0.24096294008594965,"score_spread":0.23436914670766484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982313632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95874405,0.040399056,0.000038489856,0.00026904664,0.00009069379,0.0003693317,0.000022877304,0.0000031892725,0.00006325543],"genre_scores_gemma":[0.99512273,0.003330867,0.0003703667,0.00015601881,0.00023653307,0.00006789554,0.000008046449,0.000022018578,0.0006855259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999209,0.000041996715,0.00017718355,0.00017132927,0.00021291149,0.00018760741],"domain_scores_gemma":[0.99940383,0.0000021451667,0.00025055106,0.00009455064,0.00016869402,0.00008023538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016089535,0.00010280858,0.00017212097,0.000045678426,0.000032097836,0.000038959875,0.00010570662,0.000064857144,0.00014993927],"category_scores_gemma":[0.000015370415,0.000096154225,0.000044490793,0.000097838194,0.000031479754,0.000012834541,0.000029083929,0.00014891362,0.0000010839067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006881621,0.000042674048,0.014699137,0.00008328678,0.0000241145,0.00013316782,0.00004116174,0.0009320586,0.9171904,0.0000030659135,0.00036947866,0.06579332],"study_design_scores_gemma":[0.0020875663,0.0002995278,0.007122036,0.0032558888,0.000010055201,0.0001906174,0.00004752905,0.00002459972,0.95511675,0.000015330212,0.031651434,0.00017868048],"about_ca_topic_score_codex":0.00032952533,"about_ca_topic_score_gemma":0.0014173384,"teacher_disagreement_score":0.06561464,"about_ca_system_score_codex":0.000041908606,"about_ca_system_score_gemma":0.00021502827,"threshold_uncertainty_score":0.39210555},"labels":[],"label_agreement":null},{"id":"W2988054158","doi":"10.1038/s41416-019-0665-5","title":"Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Oxford Cancer Imaging Centre; Medical Research Council; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Metformin; Transcriptome; Beta oxidation; Breast cancer; Gene expression profiling; Biology; Fatty acid; Medicine; AMPK; Cancer research; Cancer; Internal medicine; Bioinformatics; Pharmacology; Diabetes mellitus; Endocrinology; Gene expression; Gene; Biochemistry; Enzyme","score_opus":0.0066505518849471566,"score_gpt":0.2717331820543189,"score_spread":0.2650826301693717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988054158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96277815,0.032404672,0.0010628189,0.00007183754,0.0027671154,0.0001949245,0.000599379,0.0000027289545,0.000118385426],"genre_scores_gemma":[0.9824419,0.011880369,0.00038821323,0.00024188786,0.0038626164,0.00004204063,0.00014307573,0.00002775628,0.0009721611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884313,0.0000350984,0.00049757253,0.00019913205,0.00023267284,0.00019237495],"domain_scores_gemma":[0.9988596,0.000006561036,0.0004564545,0.00014027541,0.00046115753,0.00007594407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029012747,0.000121581084,0.00048344073,0.00014922382,0.000053436757,0.00004059498,0.00020340376,0.0001060277,0.0004005938],"category_scores_gemma":[0.000014171786,0.00013375988,0.0004966293,0.00018902525,0.000054939974,0.00003090903,0.000019485753,0.0000931843,5.4554823e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003173525,0.00005040807,0.0046245106,0.00009443314,0.0014625018,3.350379e-7,0.00007225979,0.00024296566,0.96317416,0.000014611608,0.005212681,0.024733795],"study_design_scores_gemma":[0.0035362814,0.00028623547,0.1755455,0.0002615907,0.0026121992,0.00018217687,0.00020383163,0.000029170844,0.6530074,0.00014396268,0.16379894,0.00039270413],"about_ca_topic_score_codex":0.0008740668,"about_ca_topic_score_gemma":0.0026555813,"teacher_disagreement_score":0.31016675,"about_ca_system_score_codex":0.000056698518,"about_ca_system_score_gemma":0.00029210927,"threshold_uncertainty_score":0.54545695},"labels":[],"label_agreement":null},{"id":"W2991054518","doi":"10.1038/s41416-019-0649-5","title":"FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Biotechnology and Biological Sciences Research Council; Almac Group; Almac Discovery; Medical Research Council; Department of Education and Learning, Northern Ireland","keywords":"Angiogenesis; Vasculogenic mimicry; Ovarian cancer; Cancer research; CD44; Cancer stem cell; Tissue microarray; Cancer; Immunohistochemistry; Medicine; Stem cell; Biology; Pathology; Cell; Internal medicine; Metastasis","score_opus":0.008069950884891174,"score_gpt":0.2466495777040419,"score_spread":0.2385796268191507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991054518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88976234,0.108804345,0.00006996119,0.00020328365,0.00069232436,0.00016276306,0.00023410689,0.0000034667385,0.000067395464],"genre_scores_gemma":[0.98959947,0.008316739,0.00019757675,0.0007544309,0.00047910918,0.000039972667,0.0000052754663,0.00004138014,0.00056602823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871504,0.000082127226,0.0003754712,0.00028764803,0.00024462288,0.00029510233],"domain_scores_gemma":[0.99914974,0.000016150507,0.00027874426,0.00015782662,0.00022052151,0.00017704217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024338135,0.0001630457,0.00028480327,0.00006615494,0.000039559996,0.000051808052,0.00021877847,0.00013761155,0.00038268275],"category_scores_gemma":[0.000014080826,0.00018674403,0.00014560559,0.000117239564,0.00006916498,0.000013060242,0.00004843806,0.00014507359,0.0000023183413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042282068,0.00010610115,0.19041325,0.0001481175,0.0002180969,0.0002138487,0.000050492723,0.008832584,0.74579054,0.0000022305624,0.0081887515,0.045613136],"study_design_scores_gemma":[0.004102746,0.00019262741,0.07052919,0.0012205091,0.00013835476,0.00010235949,0.0000690954,0.00015247728,0.8677983,0.000022379902,0.05514164,0.000530264],"about_ca_topic_score_codex":0.0017523065,"about_ca_topic_score_gemma":0.0020569325,"teacher_disagreement_score":0.12200779,"about_ca_system_score_codex":0.00008887361,"about_ca_system_score_gemma":0.0005834039,"threshold_uncertainty_score":0.7615201},"labels":[],"label_agreement":null},{"id":"W2991497553","doi":"10.1038/s41416-019-0645-9","title":"Genotype–phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer","year":2019,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Pancreatic cancer; Phenotype; Synthetic lethality; Genotype; Germline mutation; Biology; Mutation; Cancer research; Genetics; Germline; Homologous recombination; BRCA2 Protein; Population; PARP inhibitor; DNA repair; Cancer; Poly ADP ribose polymerase; Medicine; DNA; Gene; Polymerase","score_opus":0.017641569561614383,"score_gpt":0.30194003280151366,"score_spread":0.28429846323989927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991497553","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.303013,0.20607114,0.0005167084,0.46459168,0.015662368,0.0028155188,0.0011923476,0.00012772098,0.006009544],"genre_scores_gemma":[0.13253163,0.044273555,0.00038025566,0.79070985,0.014056785,0.00022605836,0.0006199702,0.00040338072,0.016798526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665636,0.00021620923,0.0012338267,0.0003444537,0.0010775847,0.00047158913],"domain_scores_gemma":[0.99676466,0.00025273356,0.0016147773,0.00021554565,0.0010601745,0.00009209014],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042650595,0.0003270042,0.0011617411,0.00041594682,0.00006197861,0.00008362962,0.00020393766,0.0008462576,0.0033038715],"category_scores_gemma":[0.00022414961,0.00038089635,0.00031590008,0.00049144746,0.00008862831,0.00024195347,0.000017905748,0.0029908107,0.000049493396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037141767,0.00009203628,0.014273532,0.0003885735,0.0008205999,0.0042601074,0.00025749463,0.0014703021,0.00023376549,0.0000018445922,0.94806415,0.029766183],"study_design_scores_gemma":[0.013816542,0.0004920683,0.17007276,0.022765081,0.0013679872,0.0027001414,0.000049500406,0.00043115567,0.00022974444,0.0004315644,0.78675073,0.00089272106],"about_ca_topic_score_codex":0.004507523,"about_ca_topic_score_gemma":0.0021597159,"teacher_disagreement_score":0.32611817,"about_ca_system_score_codex":0.0024063182,"about_ca_system_score_gemma":0.0020154554,"threshold_uncertainty_score":0.9998643},"labels":[],"label_agreement":null},{"id":"W2992176081","doi":"10.1038/s41416-019-0640-1","title":"Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Federal do Rio de Janeiro; Institut National Du Cancer; Ministério da Ciência, Tecnologia e Inovação; Johns Hopkins University; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Université Laval; American University of Beirut","keywords":"PKM2; Adenylyl cyclase; Biology; Glycolysis; Anaerobic glycolysis; Downregulation and upregulation; Pyruvate kinase; Cancer cell; Cell biology; Signal transduction; Endocrinology; Chemistry; Internal medicine; Biochemistry; Metabolism; Cancer; Medicine","score_opus":0.005777100606841385,"score_gpt":0.2506204117598505,"score_spread":0.2448433111530091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992176081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810504,0.017687798,0.000014325061,0.00024444892,0.00047953622,0.0002710861,0.00018573733,0.0000018312448,0.000064886335],"genre_scores_gemma":[0.97615665,0.02268159,0.000095936826,0.00013485602,0.0005555413,0.000022921618,0.0000027555582,0.0000241841,0.0003255731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998902,0.00008797489,0.00035199948,0.00025532965,0.00020694266,0.00019573423],"domain_scores_gemma":[0.9991443,0.000017161456,0.000423188,0.00014443668,0.00021101108,0.00005989231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013652394,0.00014720896,0.0003218961,0.00006125334,0.00007585627,0.000047257847,0.00015619809,0.00013235459,0.0000717263],"category_scores_gemma":[0.000018448956,0.00013497238,0.00010957228,0.00018074908,0.0001187718,0.000040855935,0.00007650378,0.00017572254,1.6257614e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031382852,0.000040850624,0.01738707,0.000045343597,0.00013929373,0.000001877288,0.00015689053,0.0001438083,0.9678264,0.000005943675,0.0007054375,0.013233209],"study_design_scores_gemma":[0.0015508793,0.00006328308,0.29001433,0.00036537883,0.000066943685,0.00011930643,0.00014683919,0.000004517464,0.6976515,0.00006417221,0.00980373,0.00014909996],"about_ca_topic_score_codex":0.0038266927,"about_ca_topic_score_gemma":0.0029626107,"teacher_disagreement_score":0.27262726,"about_ca_system_score_codex":0.000056331155,"about_ca_system_score_gemma":0.00018919572,"threshold_uncertainty_score":0.57848406},"labels":[],"label_agreement":null},{"id":"W2999038208","doi":"10.1038/s41416-019-0702-4","title":"Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Jonsson Comprehensive Cancer Center; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute on Drug Abuse; Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Odds ratio; Quartile; Confidence interval; Internal medicine; Cancer; Head and neck cancer; Epidemiology; Case-control study; Logistic regression; Meta-analysis; Oncology; Gastroenterology","score_opus":0.02376437409114696,"score_gpt":0.3403638599250474,"score_spread":0.31659948583390046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999038208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96586764,0.031356126,0.000013510085,0.0023569055,0.00009325413,0.00011650094,0.00008175905,0.000006668521,0.000107608044],"genre_scores_gemma":[0.9523657,0.046200953,0.00008765995,0.0008499023,0.0003703213,0.000007101973,0.0000065422987,0.000014475956,0.00009732481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984944,0.0000725556,0.00044638524,0.0002402386,0.00052124663,0.00022516682],"domain_scores_gemma":[0.9989864,0.000035068264,0.00020254585,0.00007516354,0.0003380916,0.0003626827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000253521,0.00011602142,0.00048221566,0.00022710639,0.00004856621,0.00008846644,0.00012684711,0.00008732001,0.00042336117],"category_scores_gemma":[0.00014395008,0.00011777566,0.00010245062,0.00046469172,0.000120913115,0.00034589652,0.000056889457,0.00063943665,9.047057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013472193,0.0000681822,0.8511741,0.000041663545,0.001018747,0.0010211974,0.000318605,0.00014053308,0.0024934572,4.4881912e-7,0.00036456712,0.14201124],"study_design_scores_gemma":[0.0043860804,0.0003950401,0.9866584,0.0003886342,0.00071760535,0.0005218175,0.00014578091,0.0046201255,0.00018042649,0.000014429406,0.0018481192,0.00012354448],"about_ca_topic_score_codex":0.009591322,"about_ca_topic_score_gemma":0.020445645,"teacher_disagreement_score":0.1418877,"about_ca_system_score_codex":0.0001902144,"about_ca_system_score_gemma":0.0003923742,"threshold_uncertainty_score":0.99742866},"labels":[],"label_agreement":null},{"id":"W2999383767","doi":"10.1038/s41416-019-0717-x","title":"Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Immune system; Cancer research; Phosphocholine; Biology; Tumor microenvironment; Pharmacology; Chemistry; Biochemistry; Immunology; Phospholipid","score_opus":0.0058796461725617085,"score_gpt":0.20129323455317685,"score_spread":0.19541358838061515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999383767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9283747,0.07064557,0.00016760259,0.00037597577,0.00016433679,0.0000885504,0.00005679407,0.0000048799143,0.00012158758],"genre_scores_gemma":[0.95582926,0.041117962,0.00030332268,0.0004905846,0.0021593508,0.000006374827,0.000009440911,0.000025292384,0.000058433692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991257,0.00003755947,0.00032043245,0.00018592995,0.00016265358,0.00016769985],"domain_scores_gemma":[0.9993661,0.0000067054843,0.00023773259,0.000066979796,0.00014313016,0.00017932616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097494274,0.00013371359,0.0002577055,0.000029771758,0.000054722543,0.000054649994,0.000100211095,0.00008442517,0.00004150181],"category_scores_gemma":[0.00002340702,0.00013379249,0.00009431448,0.000081646496,0.000064590335,0.000018994626,0.000016161744,0.00014604128,4.870876e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004502586,0.000045945777,0.0015280058,0.00004784081,0.000099103374,0.000025187439,0.00009550156,0.00008734249,0.9550756,6.5492117e-7,0.0007960717,0.041748453],"study_design_scores_gemma":[0.0018988968,0.00037314332,0.026370874,0.00019264493,0.00020466342,0.0005781409,0.00008645931,0.00001271076,0.87082446,0.0000045141605,0.09920249,0.00025102898],"about_ca_topic_score_codex":0.00029082852,"about_ca_topic_score_gemma":0.00042202923,"teacher_disagreement_score":0.09840642,"about_ca_system_score_codex":0.000008127714,"about_ca_system_score_gemma":0.00017736186,"threshold_uncertainty_score":0.54559},"labels":[],"label_agreement":null},{"id":"W3003195528","doi":"10.1038/s41416-019-0705-1","title":"The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Government of Canada; California HIV/AIDS Research Program","keywords":"Stroma; Cancer; Disease; Medicine; Oncology; Pathology; Cancer research; Internal medicine; Biology; Immunohistochemistry","score_opus":0.03368502467627746,"score_gpt":0.3460510608635846,"score_spread":0.3123660361873072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003195528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013756188,0.98332083,4.8967337e-7,0.0012197315,0.0004997987,0.00060657936,0.0005595934,0.0000056530903,0.00003113488],"genre_scores_gemma":[0.021301372,0.97755384,0.000012743325,0.00028686292,0.00053958764,0.00006167966,0.0000057474567,0.000056810655,0.00018136631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969646,0.00020048663,0.0016579556,0.00024866193,0.00062666944,0.00030162503],"domain_scores_gemma":[0.99661994,0.00020248628,0.0023091508,0.00016511712,0.00026962292,0.00043368546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000664618,0.00029054884,0.0019614724,0.00007013667,0.00010216674,0.000069376874,0.00032268843,0.00010699646,0.000083007646],"category_scores_gemma":[0.0007453498,0.00018738135,0.0005627141,0.00042870155,0.00011596497,0.00008887261,0.000078120785,0.0009877756,6.9520377e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002830295,0.00009418763,0.0049694125,0.008046836,0.0011771389,0.0012402697,0.000108709035,0.00003743985,0.000006327208,0.000015854803,0.0019523646,0.9820684],"study_design_scores_gemma":[0.0025435227,0.00020382616,0.03686378,0.07026998,0.005138219,0.0005434998,0.00010539349,0.000043203472,0.000006568958,0.00003856067,0.8838767,0.0003667701],"about_ca_topic_score_codex":0.001186167,"about_ca_topic_score_gemma":0.00983054,"teacher_disagreement_score":0.9817017,"about_ca_system_score_codex":0.00033220614,"about_ca_system_score_gemma":0.002738135,"threshold_uncertainty_score":0.76411897},"labels":[],"label_agreement":null},{"id":"W3006083633","doi":"10.1038/s41416-020-0749-2","title":"Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec-Société et Culture; Prostate Cancer Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Prostate cancer; Cancer research; Biochemical recurrence; Biology; Prostate; breakpoint cluster region; Androgen; Metastasis; Dihydrotestosterone; Internal medicine; Endocrinology; Cancer; Prostatectomy; Medicine; Gene; Hormone; Genetics","score_opus":0.01875105382115212,"score_gpt":0.34290333027836384,"score_spread":0.32415227645721173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006083633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92472345,0.06870821,0.0000027296774,0.005471065,0.0001164812,0.0007914389,0.00012781988,0.000008409504,0.00005040944],"genre_scores_gemma":[0.9598559,0.038561717,0.00002246366,0.0010020328,0.00028612875,0.00009946805,0.0000028486456,0.000022229933,0.00014718973],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984814,0.00006024927,0.00035863183,0.00023649656,0.00056611386,0.0002971124],"domain_scores_gemma":[0.999009,0.000026050215,0.00022936387,0.000051132858,0.00034406604,0.00034034517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000191853,0.00014080884,0.0003917983,0.000089449946,0.000054918408,0.00005780441,0.00010145738,0.000048063408,0.00006732461],"category_scores_gemma":[0.000083542465,0.000117018426,0.000053966505,0.00015473935,0.00007009538,0.000246029,0.000031798972,0.0004739643,0.000002347892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011819596,0.0004909043,0.28002807,0.0006645818,0.0006342151,0.015532491,0.003962431,0.0012237001,0.018395418,0.00002214494,0.0006958916,0.66653055],"study_design_scores_gemma":[0.11097486,0.0074493587,0.6614437,0.026419418,0.0006771096,0.0041333926,0.00069060153,0.0037480923,0.16772178,0.00024848385,0.015364963,0.0011282237],"about_ca_topic_score_codex":0.0005027798,"about_ca_topic_score_gemma":0.00016046924,"teacher_disagreement_score":0.6654023,"about_ca_system_score_codex":0.00022183599,"about_ca_system_score_gemma":0.00045048224,"threshold_uncertainty_score":0.4771873},"labels":[],"label_agreement":null},{"id":"W3006091015","doi":"10.1038/s41416-019-0722-0","title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Context (archaeology); Cancer; Drug; Drug resistance; Pharmacology; Pharmacogenomics; Medicine; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.09272287703452319,"score_gpt":0.4991450429838892,"score_spread":0.406422165949366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006091015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072545843,0.9949437,0.000025498211,0.0006774066,0.001875953,0.0008439034,0.00078072934,0.000012437766,0.00011493638],"genre_scores_gemma":[0.00027903073,0.99667776,0.00025630175,0.0004692147,0.0015989164,0.00034545086,0.000012467652,0.0000784117,0.00028243876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726295,0.00049693557,0.001169039,0.00037169294,0.00024132259,0.00045804615],"domain_scores_gemma":[0.9982661,0.0003375085,0.00078032096,0.00007221204,0.0001995772,0.0003442636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000771389,0.000383407,0.0017134438,0.00019035436,0.00016701715,0.00007186418,0.00038891713,0.00029557524,0.00027154406],"category_scores_gemma":[0.00008029027,0.00038661162,0.00041353793,0.0002747356,0.00012848311,0.00013738776,0.000056634643,0.0014182702,0.0000011461279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020295051,0.00008159099,0.00005766025,0.0059544644,0.00037457916,0.000333131,0.00019688177,0.000028039472,0.000056936125,0.000022913204,0.0065695792,0.9861213],"study_design_scores_gemma":[0.0017868945,0.000022141892,0.000020204707,0.014883778,0.0017208331,0.00015669622,0.00001949022,0.00002538141,0.0002838246,0.00008788341,0.98061204,0.00038080278],"about_ca_topic_score_codex":0.000046748853,"about_ca_topic_score_gemma":0.001004802,"teacher_disagreement_score":0.9857405,"about_ca_system_score_codex":0.00012740756,"about_ca_system_score_gemma":0.00079971825,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W3007081246","doi":"10.1038/s41416-020-0861-3","title":"Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Distress; Ovarian cancer; Breast cancer; Cancer; BRCA mutation; Internal medicine; Gynecology; Obstetrics; Oncology; Demography; Clinical psychology","score_opus":0.009895654135100853,"score_gpt":0.292723191179369,"score_spread":0.28282753704426816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007081246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757085,0.022014076,0.0005400379,0.00030417027,0.0005999579,0.00014624921,0.0006491528,0.00000870807,0.000029147306],"genre_scores_gemma":[0.9822257,0.016489536,0.00027412345,0.00014959808,0.00056879397,0.00012971701,0.0000986494,0.000030153775,0.0000336887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849296,0.00009526147,0.0005759423,0.00033415758,0.00032366745,0.00017799743],"domain_scores_gemma":[0.998402,0.000013023024,0.0006803091,0.00013038436,0.00054635014,0.00022790454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015090658,0.0001592274,0.00034364525,0.00010357714,0.000070482114,0.000078531826,0.0003026953,0.00013998341,0.00028684642],"category_scores_gemma":[0.00007969087,0.00018465942,0.00017957776,0.00033179924,0.00019149492,0.00005810394,0.000061228835,0.00018419678,1.196622e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001071594,0.000051765015,0.91976476,0.000047574973,0.0033850782,0.000043546373,0.0008294056,0.008803726,0.0033522286,6.6558243e-7,0.00025997503,0.063354135],"study_design_scores_gemma":[0.0014062652,0.00020235646,0.96681285,0.00023379107,0.0013832721,0.00005845594,0.0002302826,0.00071069464,0.027908867,0.00000334305,0.0008194464,0.00023037002],"about_ca_topic_score_codex":0.0014442471,"about_ca_topic_score_gemma":0.0076325852,"teacher_disagreement_score":0.06312376,"about_ca_system_score_codex":0.0001719913,"about_ca_system_score_gemma":0.0003794616,"threshold_uncertainty_score":0.7530193},"labels":[],"label_agreement":null},{"id":"W3010639071","doi":"10.1038/s41416-020-0764-3","title":"A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of General Medical Sciences; Wellcome Trust; National Cancer Institute; Ludwig Institute for Cancer Research","keywords":"Single-nucleotide polymorphism; Adrenocortical carcinoma; SNP; Allele; Minor allele frequency; Genotype; Genetics; Biology; Oncology; Retinoic acid; Genome-wide association study; Cancer research; Medicine; Bioinformatics; Internal medicine; Gene","score_opus":0.02752684396289872,"score_gpt":0.27927963588476507,"score_spread":0.25175279192186634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010639071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708568,0.021201706,0.00007569976,0.0069629154,0.00013852908,0.00016615592,0.000013669462,0.000009420691,0.00057509786],"genre_scores_gemma":[0.9944712,0.00042759514,0.000060614133,0.004216811,0.0007123542,0.000007794628,0.0000019698393,0.000015040672,0.00008665114],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99836385,0.00012385561,0.00053107867,0.00014259227,0.0005949086,0.00024368528],"domain_scores_gemma":[0.9993187,0.000059090944,0.00020540514,0.000104662744,0.00010168952,0.00021044115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030008698,0.00011602721,0.00038739797,0.000050363313,0.00006223667,0.00005250179,0.00026002657,0.00006393982,0.00022155727],"category_scores_gemma":[0.00015813773,0.00009040271,0.00014223931,0.00022721082,0.00011544186,0.000108291446,0.000044570097,0.0007494797,0.000008910473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030868363,0.00047620927,0.1319151,0.00025747917,0.00017805517,0.6085712,0.009617872,0.00023053687,0.0072397524,0.00036646248,0.009852113,0.22820838],"study_design_scores_gemma":[0.0043618334,0.0010087186,0.8662437,0.0013654486,0.00019251199,0.10878283,0.0011865685,0.00021452083,0.012146096,0.0005064857,0.0036987076,0.00029253302],"about_ca_topic_score_codex":0.0010469651,"about_ca_topic_score_gemma":0.00075998367,"teacher_disagreement_score":0.7343286,"about_ca_system_score_codex":0.00007421163,"about_ca_system_score_gemma":0.00028239735,"threshold_uncertainty_score":0.36865157},"labels":[],"label_agreement":null},{"id":"W3010696655","doi":"10.1038/s41416-020-0786-x","title":"Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society Research Institute; European Society for Medical Oncology; GlaxoSmithKline","keywords":"Medicine; Lapatinib; Trastuzumab; Internal medicine; Cardiotoxicity; Breast cancer; Ejection fraction; Hazard ratio; Gastroenterology; Concomitant; Asymptomatic; Cancer; Surgery; Chemotherapy; Heart failure; Confidence interval","score_opus":0.014444381743291932,"score_gpt":0.27775303814313135,"score_spread":0.2633086563998394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010696655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962045,0.0013909596,0.00006220724,0.0010919527,0.00008270523,0.0007961589,0.00033606857,0.0000046649934,0.000030811792],"genre_scores_gemma":[0.9955326,0.0036741353,0.00006756433,0.00037610377,0.0002412992,0.00004146265,0.000031740597,0.000017605244,0.000017488646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893653,0.00010162673,0.00036947388,0.00012921802,0.00034295968,0.00012017551],"domain_scores_gemma":[0.9992614,0.00005103344,0.0002961831,0.00005695078,0.00024664955,0.00008777662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089387155,0.00012778654,0.0005631989,0.000042604628,0.000036034457,0.000025351279,0.000048676822,0.00005995766,0.00008039074],"category_scores_gemma":[0.000019924531,0.0000817407,0.00013233164,0.00017229911,0.000055507513,0.00012348148,0.0000048238185,0.00013774632,7.602594e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03906302,0.0006697221,0.673325,0.00006528837,0.00096557586,0.00016434026,0.0025095667,0.00083637144,0.00032181706,6.38382e-7,0.0000631348,0.28201556],"study_design_scores_gemma":[0.04719129,0.0022611343,0.94619644,0.0006025314,0.00047761065,0.000091507325,0.0001795362,0.000033628236,0.002850248,4.1222552e-7,0.000023753777,0.00009189814],"about_ca_topic_score_codex":0.0008041566,"about_ca_topic_score_gemma":0.0005700266,"teacher_disagreement_score":0.28192365,"about_ca_system_score_codex":0.00021062318,"about_ca_system_score_gemma":0.00020521409,"threshold_uncertainty_score":0.3333289},"labels":[],"label_agreement":null},{"id":"W3012535443","doi":"10.1038/s41416-020-0774-1","title":"Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Chugai Pharmaceutical; Genentech; Ipsen; Astellas Pharma; Imperial Experimental Cancer Medicine Centre; Ono Pharmaceutical; Eisai; National Institute for Health and Care Research; Advanced Accelerator Applications; Daiichi Sankyo Europe; Bayer HealthCare; Sanofi; Exelixis; Astex Pharmaceuticals; Taiho Pharmaceutical; Boehringer Ingelheim; Yuhan; Gilead Sciences; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Internal medicine; Toxicity; Adverse effect; Dosing; Oncology; Insulin-like growth factor; Pharmacology; Growth factor; Gastroenterology; Receptor","score_opus":0.022605603460403474,"score_gpt":0.3198738740015921,"score_spread":0.29726827054118865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012535443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900575,0.008597305,0.000011035144,0.00040776152,0.00026855723,0.00047240482,0.00005019383,0.000017668839,0.000117546806],"genre_scores_gemma":[0.99521554,0.0036535896,0.0002446705,0.0005877294,0.00020410733,0.000009153327,0.000015068735,0.000060374117,0.000009769188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697864,0.00007987351,0.0013472146,0.0003394006,0.00076976273,0.00048511295],"domain_scores_gemma":[0.99779326,0.00007064197,0.00083747954,0.00013505996,0.00087007653,0.0002935105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001808706,0.000313686,0.0012698844,0.00032589553,0.000098545344,0.000037892176,0.00024369589,0.000089629604,0.00005566477],"category_scores_gemma":[0.00021574192,0.0003001316,0.0001964251,0.0005953366,0.00018830279,0.0005658765,0.00006514989,0.0007115959,0.0000011140423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002173773,0.00063527585,0.984222,0.00053257844,0.00033158,0.000884966,0.003107215,0.00021776118,0.0045223655,0.000017132863,0.00031460903,0.0030407608],"study_design_scores_gemma":[0.019485712,0.0023805315,0.9680312,0.0036490625,0.00014951748,0.000058059562,0.00067626237,0.000014342867,0.0049971435,0.000047361846,0.0001885074,0.0003222441],"about_ca_topic_score_codex":0.00056880014,"about_ca_topic_score_gemma":0.0009916084,"teacher_disagreement_score":0.01731194,"about_ca_system_score_codex":0.00035576566,"about_ca_system_score_gemma":0.00028208812,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W3015521901","doi":"10.1038/s41416-020-0835-5","title":"Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Centers for Disease Control and Prevention; National Cancer Institute; National Institutes of Health; Cancer Research UK; Purdue University; National Institute of Environmental Health Sciences; Women's Health Initiative; American Cancer Society","keywords":"Hazard ratio; Medicine; Biobank; Proportional hazards model; Cohort; Gynecology; Women's Health Initiative; Intrahepatic Cholangiocarcinoma; Cohort study; Internal medicine; Oncology; Cancer; Physiology; Confidence interval; Observational study; Bioinformatics; Biology","score_opus":0.07769936904308894,"score_gpt":0.3348850047663597,"score_spread":0.25718563572327074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015521901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43113655,0.56716365,3.4593938e-7,0.00007261972,0.00018285382,0.0009440675,0.0004865193,0.0000039864512,0.00000940788],"genre_scores_gemma":[0.19004063,0.80877227,0.000024537369,0.00006551239,0.00085158873,0.00017927036,0.000010646198,0.00003829148,0.000017231676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965482,0.00059912587,0.0013615385,0.0005659027,0.0005811755,0.00034410378],"domain_scores_gemma":[0.9962861,0.0011350475,0.0017351441,0.0003234051,0.00042095772,0.00009934586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012923697,0.00045757354,0.0031183488,0.00018886205,0.00017863268,0.00010445977,0.00025913448,0.00015347028,0.0000054048796],"category_scores_gemma":[0.0015180847,0.0002580373,0.00040373998,0.00051524356,0.0009150241,0.00017081939,0.00016128282,0.0012311701,1.3464599e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015476708,0.00007677284,0.40325865,0.0031919004,0.0147000095,0.001591393,0.053040788,0.0000014871191,9.949797e-7,0.0000012376082,0.002752241,0.51983684],"study_design_scores_gemma":[0.0044917427,0.00037928452,0.9183438,0.020906175,0.011396657,0.0011161023,0.0065100132,0.00000296289,0.000003317605,0.000020648984,0.036461547,0.00036777402],"about_ca_topic_score_codex":0.04930741,"about_ca_topic_score_gemma":0.0072161914,"teacher_disagreement_score":0.5194691,"about_ca_system_score_codex":0.0004286138,"about_ca_system_score_gemma":0.0005365406,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W3019565062","doi":"10.1038/s41416-020-0834-6","title":"Emerging role of PTEN loss in evasion of the immune response to tumours","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministério da Ciência, Tecnologia e Inovação; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"PTEN; PI3K/AKT/mTOR pathway; Immune system; Immunotherapy; Biology; Cancer research; Carcinogenesis; Tumor microenvironment; Immune checkpoint; Cancer; Immunology; Signal transduction; Genetics","score_opus":0.018383244696894705,"score_gpt":0.3345164446963467,"score_spread":0.316133199999452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019565062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012153409,0.9861499,0.000001615067,0.0007382868,0.00039651766,0.00042486758,0.000063300504,0.0000022973738,0.00006981148],"genre_scores_gemma":[0.008920431,0.9905429,0.000042176747,0.00010231602,0.00020733831,0.000011934575,0.0000014155975,0.000037011945,0.00013446948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751157,0.0002884481,0.0013667415,0.00014273642,0.00051620073,0.000174337],"domain_scores_gemma":[0.9981566,0.00009884115,0.0012480036,0.00019099894,0.00021890634,0.00008666823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096789317,0.00017505305,0.0016660208,0.00021395639,0.000025269792,0.000010745451,0.00035377595,0.00012541754,0.00017364102],"category_scores_gemma":[0.00024179176,0.0001355365,0.0008762681,0.0007094664,0.00008183001,0.00004916427,0.0000680603,0.00054457237,7.769998e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003449698,0.00005129073,0.000164546,0.002288188,0.00027371838,0.00021390646,0.00017886405,0.0000032101202,0.0016795113,5.34896e-7,0.0003538722,0.99134266],"study_design_scores_gemma":[0.0013493851,0.0002239223,0.009711542,0.12275064,0.00051172083,0.0017447848,0.00009788341,6.7160425e-7,0.0006253951,0.0000046248915,0.8628627,0.000116707124],"about_ca_topic_score_codex":0.0007631928,"about_ca_topic_score_gemma":0.00016554438,"teacher_disagreement_score":0.99122596,"about_ca_system_score_codex":0.00033780068,"about_ca_system_score_gemma":0.001454548,"threshold_uncertainty_score":0.5527018},"labels":[],"label_agreement":null},{"id":"W3019614276","doi":"10.1038/bjc.2013.782","title":"Erratum: DICER1 hotspot mutations in non-epithelial gonadal tumours","year":2013,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"Medical Research Council","keywords":"Hotspot (geology); Biology; Pathology; Computational biology; Bioinformatics; Medicine; Cancer research","score_opus":0.011330797069957578,"score_gpt":0.2840847547807891,"score_spread":0.2727539577108315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019614276","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41899735,0.27541012,0.00005538668,0.009570241,0.09079919,0.0026663106,0.0018149765,0.000082031984,0.2006044],"genre_scores_gemma":[0.31301928,0.071242005,0.0009442384,0.0022714494,0.020983223,0.00035159473,0.0002683973,0.00042563083,0.59049416],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99679434,0.000079294434,0.0012648292,0.00029505367,0.0010440041,0.00052248064],"domain_scores_gemma":[0.99755764,0.00010151099,0.0008317666,0.00019647893,0.000975853,0.0003367433],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003469176,0.00037341643,0.0014065283,0.0004565627,0.00010219859,0.00013469504,0.00029955088,0.00040665944,0.0015644314],"category_scores_gemma":[0.0005305936,0.00039927714,0.0004306538,0.00037992792,0.00021205796,0.0002345915,0.00008127533,0.0024893153,0.00006438567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080312464,0.00015738339,0.0019107785,0.00036443598,0.00044700532,0.0037904803,0.0004290354,0.000009326827,0.00009889293,0.0000016481849,0.9018771,0.09083362],"study_design_scores_gemma":[0.0040738382,0.000324195,0.55838454,0.011917301,0.001034069,0.0051464573,0.00063658244,0.00007153519,0.000014369373,0.00030460124,0.4174989,0.0005935913],"about_ca_topic_score_codex":0.0052442057,"about_ca_topic_score_gemma":0.019410256,"teacher_disagreement_score":0.5564738,"about_ca_system_score_codex":0.0006141113,"about_ca_system_score_gemma":0.0021446713,"threshold_uncertainty_score":0.9998459},"labels":[],"label_agreement":null},{"id":"W3021122327","doi":"10.1038/s41416-020-0860-4","title":"Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; China Scholarship Council; University of Aberdeen; Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Medicine; Odds ratio; Hazard ratio; Internal medicine; Cancer; Biobank; Confidence interval; Cohort study; Cohort; Population; Proportional hazards model; Bioinformatics; Environmental health","score_opus":0.030104596785992536,"score_gpt":0.33056230266264053,"score_spread":0.300457705876648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021122327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983416,0.015812326,0.00000423215,0.00023858878,0.000074596974,0.00031561506,0.0001342709,0.0000025565782,0.0000018158009],"genre_scores_gemma":[0.98496485,0.014219236,0.00060496543,0.000055292097,0.00010569516,0.000016958207,0.0000032895582,0.000011923981,0.000017770437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990158,0.000049810653,0.00046792283,0.00011633793,0.00023868063,0.00011144602],"domain_scores_gemma":[0.9990723,0.0000534498,0.0004782336,0.000039104343,0.00023666809,0.00012025182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009949001,0.00009459579,0.00045193612,0.00009021796,0.000024204726,0.000011174438,0.000024353032,0.000025438274,0.000027325994],"category_scores_gemma":[0.00021855618,0.000086249966,0.0000525482,0.00016229617,0.000072184856,0.000116115356,0.000014533066,0.00014849442,6.1627034e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033340938,0.00007691154,0.9554026,0.00032624058,0.0002092826,0.00020332784,0.00013834989,0.00011463756,0.0008896724,3.0211504e-7,0.000095800075,0.042209465],"study_design_scores_gemma":[0.0042059193,0.00050884933,0.9864434,0.001345973,0.00026098132,0.00006346232,0.000041009385,0.00006487382,0.0068776067,0.000005517809,0.00014101336,0.00004138201],"about_ca_topic_score_codex":0.002890402,"about_ca_topic_score_gemma":0.0006884663,"teacher_disagreement_score":0.04216808,"about_ca_system_score_codex":0.000113413415,"about_ca_system_score_gemma":0.00013061904,"threshold_uncertainty_score":0.43694425},"labels":[],"label_agreement":null},{"id":"W3022795538","doi":"10.1038/s41416-020-0874-y","title":"Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; World Health Organization","keywords":"Downregulation and upregulation; Indoleamine 2,3-dioxygenase; Cancer research; Nicotinamide phosphoribosyltransferase; Biology; Kynurenine; Immune system; Immunology; NAD+ kinase; Enzyme; Biochemistry; Gene","score_opus":0.02757297852138995,"score_gpt":0.2764715563612481,"score_spread":0.24889857783985814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022795538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97386825,0.0066089216,0.00034128237,0.017641507,0.00029981727,0.00039311583,0.000791358,0.000009078202,0.000046643945],"genre_scores_gemma":[0.99745023,0.001082758,0.00016590084,0.0009071651,0.0001993493,0.000020338151,0.0000021555409,0.000018241251,0.00015384285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988934,0.00006249162,0.00042750884,0.00016912377,0.00029113883,0.00015633277],"domain_scores_gemma":[0.9986666,0.00011184449,0.0007626511,0.00011572892,0.00026971434,0.00007345769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010098329,0.00009592848,0.00025486338,0.000035171597,0.00013572395,0.000019771081,0.00034344796,0.000062528765,0.00008338269],"category_scores_gemma":[0.00043676552,0.00008265563,0.00024382092,0.00030040985,0.000104655664,0.00013247614,0.00006341116,0.00016408949,3.45343e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002683843,0.000047977734,0.001459609,0.000058535083,0.000017239168,0.0000019556273,0.00027757164,0.00048089988,0.9532628,0.000032439275,0.008261678,0.03583089],"study_design_scores_gemma":[0.0017562319,0.00011248831,0.17593104,0.00037631433,0.000028335502,0.0000941948,0.00002825755,0.000343884,0.8134501,0.00024532978,0.0075459024,0.00008789346],"about_ca_topic_score_codex":0.000107381384,"about_ca_topic_score_gemma":0.0005136624,"teacher_disagreement_score":0.17447144,"about_ca_system_score_codex":0.00007029562,"about_ca_system_score_gemma":0.0001970643,"threshold_uncertainty_score":0.3370599},"labels":[],"label_agreement":null},{"id":"W3025515234","doi":"10.1038/s41416-020-0887-6","title":"UGT2B17 modifies drug response in chronic lymphocytic leukaemia","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; March of Dimes Canada; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Chronic lymphocytic leukemia; Drug; Medicine; Drug response; Immunology; Leukemia; Cancer research; Pharmacology","score_opus":0.02609349524528102,"score_gpt":0.3257147506949732,"score_spread":0.29962125544969215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025515234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94568497,0.05079399,0.000038741604,0.002547452,0.00018049934,0.0002247404,0.000011393902,0.000019098043,0.00049912825],"genre_scores_gemma":[0.9884666,0.00819371,0.00013668365,0.0012422554,0.0009831198,0.000014432759,0.0000014329848,0.000043698707,0.00091804384],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975375,0.00018844692,0.00070307794,0.00023942473,0.0008587481,0.00047283628],"domain_scores_gemma":[0.99864405,0.00021984591,0.00022419979,0.00016513013,0.0002970601,0.00044970895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007938955,0.00015501092,0.0005787367,0.00016521502,0.000051617968,0.00007388847,0.00029090772,0.000101605176,0.0006073569],"category_scores_gemma":[0.0008683194,0.00016553579,0.00019680362,0.00047115234,0.00016217919,0.00022548184,0.00008450368,0.0006366253,0.000036628364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09930284,0.00038114167,0.0058774147,0.0040478916,0.0014435607,0.16636592,0.0089823445,0.06324679,0.07757559,0.00010654802,0.18797478,0.38469517],"study_design_scores_gemma":[0.31768852,0.005436089,0.07349578,0.021388723,0.00077018014,0.073649086,0.0023567693,0.157898,0.0512186,0.0004602988,0.29374322,0.0018947413],"about_ca_topic_score_codex":0.0031691915,"about_ca_topic_score_gemma":0.00077236426,"teacher_disagreement_score":0.38280043,"about_ca_system_score_codex":0.0649833,"about_ca_system_score_gemma":0.057086796,"threshold_uncertainty_score":0.94825864},"labels":[],"label_agreement":null},{"id":"W3027041709","doi":"10.1038/s41416-020-0868-9","title":"Rising to the challenge: designing, implementing and reporting exercise oncology trials in understudied populations","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Rigour; Credibility; Medicine; Transparency (behavior); Oncology; Multiple myeloma; Quality of life (healthcare); Open data; Clinical trial; Internal medicine; Physical therapy; Computer science; World Wide Web; Nursing","score_opus":0.2392579811663438,"score_gpt":0.4402579144362099,"score_spread":0.20099993326986607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027041709","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007475046,0.069826625,0.00045265618,0.9190038,0.0017478676,0.00082472304,0.00003070131,0.000014017993,0.0006246059],"genre_scores_gemma":[0.32322553,0.0356489,0.002124464,0.6103726,0.027633255,0.0002054823,0.000050953222,0.00019389145,0.00054489274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957471,0.0004277234,0.002706769,0.00027500454,0.00047709793,0.00036633358],"domain_scores_gemma":[0.9953749,0.00033835115,0.0037585783,0.00012483864,0.00028583244,0.000117511074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041951183,0.00018615801,0.0016923619,0.00018702028,0.00018015043,0.00012426908,0.00012462643,0.00022306756,0.00012310065],"category_scores_gemma":[0.0025214115,0.00016425124,0.00030576118,0.00025051436,0.000038189508,0.00006947071,0.00008741826,0.0018884648,5.956913e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016255549,0.000017486387,0.0029466774,0.00032322822,0.00024530446,0.009468766,0.0030595572,0.000018637902,0.00003367778,0.0000019807328,0.6297178,0.35400432],"study_design_scores_gemma":[0.0015130986,0.0002228062,0.0036433456,0.0064084013,0.0009694584,0.0018609388,0.0024591596,0.0000069160587,0.00002359036,0.0002635268,0.9824128,0.00021594702],"about_ca_topic_score_codex":0.004212231,"about_ca_topic_score_gemma":0.02906028,"teacher_disagreement_score":0.35378838,"about_ca_system_score_codex":0.0004613457,"about_ca_system_score_gemma":0.00059757853,"threshold_uncertainty_score":0.9886568},"labels":[],"label_agreement":null},{"id":"W3027443262","doi":"10.1038/s41416-020-0903-x","title":"Translating current basic research into future therapies for neurofibromatosis type 1","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Neurofibromatosis; Plexiform neurofibroma; Medicine; Neurofibroma; Cancer research; Janus kinase; Pathology; Biology; Bioinformatics; Immunology; Cytokine","score_opus":0.13250873565255855,"score_gpt":0.4413424741178399,"score_spread":0.30883373846528134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027443262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006007932,0.99543613,0.000008964929,0.0011378281,0.0017377968,0.00086826255,0.00013001719,0.000020546806,0.00005968769],"genre_scores_gemma":[0.00013748034,0.99384564,0.0005792434,0.0000803975,0.0050795986,0.000073046154,0.000022242119,0.00013420651,0.000048173162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690765,0.00035182352,0.0011688435,0.00036191772,0.0008151898,0.00039455856],"domain_scores_gemma":[0.99769086,0.00033048048,0.00063558144,0.00018633895,0.00083324005,0.00032350016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005944588,0.0003225936,0.002183975,0.00026710654,0.00021016982,0.00018822557,0.00031801753,0.00019858671,0.00012929637],"category_scores_gemma":[0.0002482552,0.00028106215,0.0011083405,0.00067708327,0.00009226076,0.00013824066,0.000042643613,0.0015487437,0.000006922747],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011675339,0.000058948226,0.000014759105,0.023515532,0.00030333432,0.00070655823,0.0001248227,8.119095e-8,0.000024882022,0.000018439978,0.015644968,0.9594709],"study_design_scores_gemma":[0.00065402413,0.0007119798,0.000036847086,0.057207018,0.0009645579,0.0056469273,0.00006209552,0.0000012704625,0.000012329399,0.000051983377,0.9344457,0.00020530824],"about_ca_topic_score_codex":0.00002540561,"about_ca_topic_score_gemma":0.000024096214,"teacher_disagreement_score":0.9592656,"about_ca_system_score_codex":0.00014544277,"about_ca_system_score_gemma":0.0016879576,"threshold_uncertainty_score":0.9999642},"labels":[],"label_agreement":null},{"id":"W3036702906","doi":"10.1038/s41416-020-0900-0","title":"Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Health Services; Royal Alexandra Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Vancouver General Hospital; University of Calgary; Vancouver Coastal Health","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; National Center for Research Resources; Oak Foundation; BC Cancer Foundation; Canada Research Chairs; Conselho Nacional de Desenvolvimento Científico e Tecnológico; National Institutes of Health; Cancer Institute NSW; National Health and Medical Research Council; American Cancer Society; Academy of Medical Sciences; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Michael Smith Health Research BC; Deutsches Krebsforschungszentrum; Cancer Council Victoria; Cancer Australia; Kræftens Bekæmpelse; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Ovarian Cancer Australia","keywords":"Ovarian cancer; PTEN; Pathological; Oncology; Medicine; Pathology; Ovarian tissue; Ovary; Cancer; Internal medicine; Biology; Genetics; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.04998682333486856,"score_gpt":0.3713108150198223,"score_spread":0.32132399168495374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036702906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97701985,0.013121101,0.00008564585,0.008774634,0.00016396327,0.00043558754,0.00035426632,0.000005306024,0.000039640523],"genre_scores_gemma":[0.99190784,0.0060553337,0.00061525917,0.0008653258,0.0004945573,0.000031332725,0.000008351758,0.000011348138,0.000010653835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788916,0.00035520695,0.0009484265,0.000261706,0.00038099795,0.0001645106],"domain_scores_gemma":[0.99847674,0.00034012046,0.00061848725,0.00011733974,0.00023335282,0.00021395674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048166356,0.000121319725,0.00085120945,0.000053391355,0.00006895885,0.000043844324,0.00012381005,0.00009520246,0.00051289046],"category_scores_gemma":[0.00040267076,0.00009067269,0.00020195181,0.000395326,0.00008362809,0.000078438374,0.000054865755,0.000411589,6.816486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027307458,0.00082914106,0.95689785,0.000008003811,0.0012547188,0.0010221845,0.0011918708,0.0000890019,0.00033782315,0.0000025223574,0.0006962692,0.03739753],"study_design_scores_gemma":[0.0068757306,0.00034580205,0.9875217,0.0003380812,0.0028481884,0.00002287441,0.0009439719,0.00011201874,0.00023620247,0.000016741835,0.0006561219,0.00008255189],"about_ca_topic_score_codex":0.006971242,"about_ca_topic_score_gemma":0.0094182985,"teacher_disagreement_score":0.037314977,"about_ca_system_score_codex":0.00009643672,"about_ca_system_score_gemma":0.00024847087,"threshold_uncertainty_score":0.9996414},"labels":[],"label_agreement":null},{"id":"W3043725192","doi":"10.1038/s41416-020-0990-8","title":"Increasing operational and scientific efficiency in clinical trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Clinical trial; Drug development; Key (lock); Medicine; MEDLINE; Intensive care medicine; Medical physics; Computer science; Drug; Pathology; Pharmacology; Political science","score_opus":0.23072288466261529,"score_gpt":0.42167349427240414,"score_spread":0.19095060960978885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043725192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96020955,0.03201961,0.00019284856,0.0057476326,0.0005911426,0.000072891824,0.00010855746,0.000002194436,0.0010555773],"genre_scores_gemma":[0.9918173,0.0045792027,0.00025858838,0.0026532072,0.0006524223,0.0000017443846,0.0000010000279,0.000007227792,0.000029341049],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800766,0.00010618692,0.0015451106,0.00017208097,0.000031924086,0.00013701638],"domain_scores_gemma":[0.9989715,0.00022711515,0.00052464183,0.00003610314,0.00004187019,0.00019873037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006476092,0.000054744683,0.00050369557,0.00008844203,0.00006199133,0.0002879545,0.00013009417,0.00004998397,0.00047488508],"category_scores_gemma":[0.002348506,0.000068398294,0.00011806719,0.0001398903,0.000102219456,0.00023338896,0.000033547436,0.00026000713,0.000017067227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041628422,0.00031346316,0.6444348,0.00007544739,0.00018174523,0.00016010458,0.0007293669,0.001216445,0.00030157284,0.054655828,0.012344518,0.2851704],"study_design_scores_gemma":[0.0062251673,0.00017573684,0.34221354,0.0002062639,0.000025611529,0.00035648362,0.000048140428,0.024872366,0.000076947465,0.013722329,0.6116691,0.00040827674],"about_ca_topic_score_codex":0.00018863821,"about_ca_topic_score_gemma":0.000073168136,"teacher_disagreement_score":0.59932464,"about_ca_system_score_codex":0.000041085386,"about_ca_system_score_gemma":0.00011599856,"threshold_uncertainty_score":0.5199659},"labels":[],"label_agreement":null},{"id":"W3045062385","doi":"10.1038/s41416-020-1006-4","title":"Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; March of Dimes Canada","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Drug; Medicine; Chronic lymphocytic leukemia; Leukemia; Immunology; Pharmacology","score_opus":0.028905233874551697,"score_gpt":0.3272973650289938,"score_spread":0.29839213115444213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045062385","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047859285,0.018830014,0.000015037883,0.93071204,0.00088757963,0.00097613345,0.00011325343,0.00003451247,0.0005721267],"genre_scores_gemma":[0.020280201,0.0055126618,0.00015074637,0.96002334,0.008046838,0.000109735185,0.000027489074,0.00018384363,0.005665154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940269,0.0005767009,0.001441869,0.00065330067,0.002324272,0.0009769482],"domain_scores_gemma":[0.99694496,0.00084485405,0.0005869043,0.0006146161,0.00048709838,0.0005215377],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011518244,0.00047661425,0.0015466368,0.0006818887,0.00009351015,0.00018342087,0.0007559134,0.00041352236,0.00065361086],"category_scores_gemma":[0.0012214058,0.0005112672,0.00047476884,0.00049142767,0.00018803688,0.00012823947,0.00021975649,0.004147419,0.00011904513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007175389,0.00003437884,0.000008328027,0.00072413,0.00025165276,0.09478046,0.00037310767,0.0012803859,0.00010525253,9.605918e-7,0.8862493,0.00901667],"study_design_scores_gemma":[0.02043024,0.0014906474,0.00012984083,0.013372635,0.0001679691,0.007829445,0.000056827655,0.00069597876,0.00071278424,0.00005973144,0.95462626,0.00042764764],"about_ca_topic_score_codex":0.01420895,"about_ca_topic_score_gemma":0.0004690825,"teacher_disagreement_score":0.15987176,"about_ca_system_score_codex":0.23740163,"about_ca_system_score_gemma":0.07752988,"threshold_uncertainty_score":0.99973387},"labels":[],"label_agreement":null},{"id":"W3048232459","doi":"10.1038/s41416-020-1025-1","title":"Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Egyptian Cultural and Educational Bureau","keywords":"Cancer research; Viability assay; Sulforaphane; SOX2; Cancer stem cell; Head and neck squamous-cell carcinoma; CD44; Cisplatin; In vivo; Stem cell; Cancer cell; Cytotoxicity; Cancer; Cell; Biology; Medicine; Head and neck cancer; Internal medicine; In vitro; Embryonic stem cell; Chemotherapy; Cell biology; Biochemistry","score_opus":0.012612729225990894,"score_gpt":0.24696906013518025,"score_spread":0.23435633090918936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048232459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95282096,0.04604417,0.000042711923,0.00014608464,0.00011712931,0.00013845813,0.0005598345,0.0000033887832,0.00012726847],"genre_scores_gemma":[0.99190086,0.0067034117,0.00015883226,0.0004917755,0.0006148787,0.000009099658,0.0000113747665,0.000026492633,0.00008329678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987834,0.0000684169,0.0004660767,0.00025161836,0.00019726797,0.00023319341],"domain_scores_gemma":[0.9988396,0.000020639916,0.00044769424,0.00009824228,0.00031759922,0.00027620554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000904927,0.00016856278,0.0003856748,0.000026459706,0.0000462689,0.0000325487,0.00022263227,0.00011349112,0.000068003144],"category_scores_gemma":[0.00004100614,0.00018899587,0.00014577221,0.000075444026,0.00015351363,0.000012831356,0.00009057665,0.00020338525,6.221953e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038822752,0.00011778284,0.024242114,0.0001883325,0.000053249176,0.000053715386,0.00011958463,0.00009402648,0.9633848,2.7459586e-7,0.0044280486,0.006929837],"study_design_scores_gemma":[0.0018190113,0.00026035646,0.049034435,0.00009646963,0.00006107157,0.00005617722,0.00013828286,0.000021377378,0.9431235,0.0000054232,0.00517891,0.00020498413],"about_ca_topic_score_codex":0.001779702,"about_ca_topic_score_gemma":0.0006903817,"teacher_disagreement_score":0.039340757,"about_ca_system_score_codex":0.000036004207,"about_ca_system_score_gemma":0.00034305776,"threshold_uncertainty_score":0.7707028},"labels":[],"label_agreement":null},{"id":"W3084155739","doi":"10.1038/s41416-020-01041-x","title":"Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"National Cancer Institute; Takeda Oncology; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Tolerability; Endometrial cancer; Medicine; Pharmacodynamics; Renal cell carcinoma; Pharmacokinetics; Rash; Internal medicine; Bladder cancer; Urology; Dosing; Cancer; Carcinoma; Oncology; Gastroenterology; Adverse effect","score_opus":0.02676153683504138,"score_gpt":0.3543512937309712,"score_spread":0.3275897568959298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084155739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885006,0.009872014,0.00014461264,0.00010260782,0.00036198512,0.0005151292,0.00013435232,0.000006693719,0.000012549574],"genre_scores_gemma":[0.99538016,0.0025014344,0.00029263686,0.00029071615,0.0013567068,0.00007564529,0.000015230253,0.000063287844,0.000024177303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973763,0.00020708167,0.0009915906,0.0004747942,0.00055993604,0.00039030152],"domain_scores_gemma":[0.99839294,0.000032655644,0.0007030608,0.00020514656,0.00039092623,0.00027529657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035442162,0.0002665584,0.00069280574,0.00018352168,0.000048108817,0.000049141494,0.00037901787,0.00014325259,0.00021227167],"category_scores_gemma":[0.00025117322,0.00025486248,0.000102021724,0.0006178782,0.00009300569,0.00006153283,0.00006616402,0.00041830368,3.2585615e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028413322,0.0036714792,0.0045936177,0.000050069044,0.00022329566,0.0010451304,0.0007698954,0.0069595617,0.87880045,3.058716e-7,0.000945673,0.07452722],"study_design_scores_gemma":[0.12107837,0.040372368,0.0018909336,0.0015246411,0.00022865678,0.000295427,0.0020457874,0.00023142772,0.82678896,0.0000056944964,0.004768398,0.00076932687],"about_ca_topic_score_codex":0.0007882387,"about_ca_topic_score_gemma":0.008851558,"teacher_disagreement_score":0.09266505,"about_ca_system_score_codex":0.00014408365,"about_ca_system_score_gemma":0.0009647135,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W3087415923","doi":"10.1038/s41416-020-01056-4","title":"Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Oestrogen receptor; Breast cancer; Oncology; Cancer; Internal medicine; Cancer research; Medicine; Mutation; BRCA2 Protein; Biology; Genetics; Germline mutation; Gene","score_opus":0.010174748481304088,"score_gpt":0.2650833726159853,"score_spread":0.25490862413468124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087415923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882879,0.0077410424,0.0003758457,0.0021545081,0.0005900601,0.00012898675,0.00061420246,0.0000051009415,0.00010232774],"genre_scores_gemma":[0.9945203,0.0030174477,0.00050401554,0.00044710236,0.0012252383,0.000036938854,0.000073429466,0.00003169289,0.00014384504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986111,0.00010177559,0.00037724306,0.00022000019,0.00043413625,0.00025576595],"domain_scores_gemma":[0.9987261,0.000014204632,0.00045278284,0.00006242502,0.0005901264,0.00015436023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022826437,0.000118231044,0.00020544564,0.000044530567,0.000057172594,0.00005921198,0.00013412385,0.00011630639,0.0003916714],"category_scores_gemma":[0.00007226707,0.00013593746,0.00009510081,0.00022980824,0.00004318681,0.000027619255,0.000024960607,0.00022925509,0.0000024460103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010818427,0.00009145149,0.832504,0.000060683342,0.00080254825,0.000099476456,0.0003986346,0.015013142,0.03301519,0.000009447073,0.015891084,0.101032495],"study_design_scores_gemma":[0.010410448,0.00068926986,0.8321524,0.0005671775,0.00028985288,0.0009209694,0.001185007,0.00022041399,0.036264345,0.00006456696,0.11640573,0.0008297692],"about_ca_topic_score_codex":0.00093477406,"about_ca_topic_score_gemma":0.0052641607,"teacher_disagreement_score":0.10051465,"about_ca_system_score_codex":0.0006438171,"about_ca_system_score_gemma":0.0014124975,"threshold_uncertainty_score":0.55433685},"labels":[],"label_agreement":null},{"id":"W3090245160","doi":"10.1038/s41416-020-01102-1","title":"Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Izaak Walton Killam Health Centre; Hospital for Sick Children; McMaster University; University of Toronto","funders":"National Cancer Institute; Sick Kids Foundation; Children’s Oncology Group","keywords":"DNA methylation; Epigenomics; Exome; Epigenetics; Biology; Methylation; Subgroup analysis; Oncology; Wilms' tumor; Genome instability; Bioinformatics; Internal medicine; Exome sequencing; Genetics; Medicine; DNA; Mutation; Gene; Confidence interval; Gene expression; DNA damage","score_opus":0.01815998166339994,"score_gpt":0.2883479635874976,"score_spread":0.27018798192409765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090245160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8973846,0.1017101,0.00014857532,0.00053805293,0.00006116555,0.00004646258,0.000049139842,0.0000018036535,0.00006011262],"genre_scores_gemma":[0.87421095,0.124597564,0.00041505482,0.0005557329,0.00017178507,0.0000012802087,0.0000063232137,0.000010092252,0.000031193686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903435,0.00005599566,0.0005051045,0.0001848125,0.00008653777,0.00013319097],"domain_scores_gemma":[0.99929327,0.000020834665,0.00037252306,0.000046007706,0.00010477868,0.00016258053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016264501,0.00009762812,0.00030120794,0.000016605458,0.000036326448,0.000022297358,0.0001227786,0.00012633418,0.000018677389],"category_scores_gemma":[0.00010617807,0.00008384182,0.00010750806,0.00005085283,0.00016586378,0.000004950055,0.00005752706,0.00016972014,3.3817958e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035558938,0.000020893833,0.008049543,0.000027048718,0.00021221004,0.000034519824,0.000019241506,0.00008639399,0.96660125,0.0000021176072,0.0018105194,0.022780662],"study_design_scores_gemma":[0.011431863,0.01025492,0.39197183,0.0010173847,0.0011015191,0.0034005078,0.0004146872,0.0002492103,0.48209265,0.00057769543,0.096039236,0.0014485038],"about_ca_topic_score_codex":0.00010118759,"about_ca_topic_score_gemma":0.000030898864,"teacher_disagreement_score":0.48450863,"about_ca_system_score_codex":0.000010098907,"about_ca_system_score_gemma":0.00010713333,"threshold_uncertainty_score":0.34189704},"labels":[],"label_agreement":null},{"id":"W3090805719","doi":"10.1038/s41416-020-01077-z","title":"First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pharmacokinetics; Medicine; Nausea; Vomiting; Toxicity; Anorexia; Discontinuation; Pharmacology; Cmax; Internal medicine; Gastroenterology","score_opus":0.014423949262874767,"score_gpt":0.29599145480369526,"score_spread":0.2815675055408205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090805719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866927,0.0005101191,0.000004349158,0.00025246516,0.00007174728,0.00043100587,0.000026425934,0.0000010629451,0.000033570574],"genre_scores_gemma":[0.99953353,0.0000591778,0.00003644145,0.00020954754,0.00009628279,0.000013368563,0.000007635916,0.000012945393,0.000031058407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990763,0.00007673898,0.00036426212,0.00013598465,0.00022639082,0.00012028967],"domain_scores_gemma":[0.99929786,0.0000030037675,0.00029340485,0.00008272687,0.00026059756,0.000062432424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011860418,0.00008001946,0.00019188705,0.000027873113,0.000045976354,0.000037956404,0.0003241847,0.00004646067,0.000020670124],"category_scores_gemma":[0.000076827564,0.00006782337,0.0000240943,0.000237782,0.00003279285,0.000016926773,0.00010173934,0.0001837223,1.3526996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027665268,0.007836106,0.88089645,0.00006264329,0.00022282344,0.00008972006,0.00096346694,0.0004282277,0.08153498,0.0000020555044,0.011785142,0.013411865],"study_design_scores_gemma":[0.051021975,0.006635362,0.8053249,0.00067551754,0.00005043322,0.000019000623,0.0003519111,0.000029317629,0.13073243,0.000008227178,0.0048455284,0.00030539365],"about_ca_topic_score_codex":0.00028293818,"about_ca_topic_score_gemma":0.004899078,"teacher_disagreement_score":0.075571544,"about_ca_system_score_codex":0.000028947723,"about_ca_system_score_gemma":0.00015260781,"threshold_uncertainty_score":0.27657565},"labels":[],"label_agreement":null},{"id":"W3106721187","doi":"10.1038/s41416-020-01194-9","title":"Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity","year":2020,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Phosphatase; Gain of function; Mutant; Identification (biology); Phosphorylation; Function (biology); Enzyme; Biochemistry; Biology; Cancer; Computational biology; Cancer research; Chemistry; Cell biology; Genetics; Gene","score_opus":0.033658489468397584,"score_gpt":0.28386616807224735,"score_spread":0.25020767860384974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106721187","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003855783,0.8201033,0.0036331164,0.15715097,0.0030978296,0.0009269943,0.014408929,0.000044826433,0.00024847747],"genre_scores_gemma":[0.012320585,0.09677752,0.0034832526,0.8527877,0.027101003,0.000120831966,0.0046445914,0.00047432573,0.0022901988],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649405,0.00016909337,0.001068976,0.00068678433,0.0008653233,0.00071576284],"domain_scores_gemma":[0.9975005,0.000062332314,0.0013857711,0.00043679032,0.00031187752,0.00030274654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000283153,0.0005608648,0.0009036948,0.000088896944,0.00021580175,0.00029585487,0.0010697055,0.0007631357,0.0007634649],"category_scores_gemma":[0.00046149944,0.00059549266,0.00053464586,0.00026901127,0.0002604576,0.000035124012,0.00030405412,0.0018960722,0.0000136387835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058043073,0.000041716623,0.00005567341,0.00025860168,0.0006318989,0.011608801,0.000008184661,0.000018462282,0.00055442745,0.00003738345,0.9782271,0.007977334],"study_design_scores_gemma":[0.001611163,0.00054297515,0.000033327633,0.0010364334,0.0003520768,0.003664076,0.000023150214,0.0000042856104,0.0850734,0.00025475718,0.90671456,0.0006897779],"about_ca_topic_score_codex":0.0004832662,"about_ca_topic_score_gemma":0.00051769917,"teacher_disagreement_score":0.7233258,"about_ca_system_score_codex":0.00042540688,"about_ca_system_score_gemma":0.0017006152,"threshold_uncertainty_score":0.99964964},"labels":[],"label_agreement":null},{"id":"W3111987827","doi":"10.1038/s41416-020-01196-7","title":"Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Nova Scotia Health Authority; Canadian Partnership Against Cancer; Cancer Care Ontario; CancerCare Manitoba","funders":"Cancer Research UK; World Health Organization","keywords":"Cancer survival; Cancer registry; Cancer; Demography; Medicine; Population; Survival analysis; Statistics; Environmental health; Mathematics; Internal medicine","score_opus":0.40449665826576664,"score_gpt":0.4494096764824256,"score_spread":0.04491301821665894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111987827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932886,0.0037307336,0.00012792824,0.0014862601,0.00080820464,0.00023753323,0.0001120216,0.0000097479915,0.00019902048],"genre_scores_gemma":[0.9946662,0.003216783,0.00001681267,0.00039209437,0.0016185421,0.000039459454,0.0000020763414,0.000018272243,0.000029765919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980059,0.000083350016,0.00057856465,0.00018679204,0.00094538525,0.00019997892],"domain_scores_gemma":[0.99826205,0.00011553521,0.00059671636,0.000116890646,0.0007404185,0.00016837523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025916842,0.00015046957,0.00049332227,0.00005446263,0.000088141605,0.00006800413,0.00032747415,0.000033471217,0.00047273762],"category_scores_gemma":[0.00020506328,0.000112009,0.00024898193,0.00026496433,0.0000718345,0.0002846403,0.00004545252,0.00042137384,7.8672826e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001874782,0.00015573348,0.80957633,0.000039529947,0.00079794653,0.00022606972,0.0011578101,0.09033647,0.00044993628,0.0000048449374,0.00060642645,0.09477411],"study_design_scores_gemma":[0.0021340775,0.0007383816,0.9898694,0.0015791637,0.0001887318,0.00004845897,0.0014014008,0.0031876597,0.00012437122,0.000011210576,0.0005970601,0.00012008931],"about_ca_topic_score_codex":0.02526632,"about_ca_topic_score_gemma":0.0031705832,"teacher_disagreement_score":0.18029305,"about_ca_system_score_codex":0.00037574655,"about_ca_system_score_gemma":0.0005047622,"threshold_uncertainty_score":0.98122454},"labels":[],"label_agreement":null},{"id":"W3111996930","doi":"10.1038/s41416-020-01234-4","title":"Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"North Bristol NHS Trust; Newcastle upon Tyne Hospitals NHS Foundation Trust; University of Sussex; University of Oxford; Cancer Research UK; Queen's University Belfast; University College London; Imperial College London; Imperial College Healthcare NHS Trust; National Institute for Health and Care Research; Queen's University; Royal Marsden NHS Foundation Trust; Middlesex University","keywords":"Medicine; Pandemic; Breast cancer; Coronavirus disease 2019 (COVID-19); Cohort; Radiation therapy; Cancer; Internal medicine; Oncology; Disease; Infectious disease (medical specialty)","score_opus":0.1600086476791071,"score_gpt":0.4267537584642302,"score_spread":0.2667451107851231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111996930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935852,0.01744798,0.000046268742,0.044230096,0.00091200677,0.0006031083,0.00084057765,0.000010631785,0.000057362362],"genre_scores_gemma":[0.9765196,0.0068096034,0.000017715895,0.01522689,0.00071453553,0.000035207806,0.000002207413,0.000023960616,0.0006502958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761647,0.0002583141,0.00069914496,0.00020841311,0.00090070337,0.0003169622],"domain_scores_gemma":[0.9980404,0.0003462798,0.00051439326,0.00042096892,0.00040674352,0.0002712478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071464275,0.00016953338,0.0005039976,0.000039931037,0.0003690716,0.00007073069,0.00040914505,0.00005840595,0.0011334599],"category_scores_gemma":[0.00024233686,0.0000937191,0.00029827355,0.00026390556,0.00011956082,0.00008180228,0.00016805512,0.00060786196,0.0000012333976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047665666,0.0004203728,0.88690096,0.0002231799,0.0009549673,0.001167729,0.0021959934,0.0000878805,0.00040736576,0.0000065270156,0.008028472,0.09912988],"study_design_scores_gemma":[0.0078003146,0.00006890229,0.97016513,0.00093587587,0.0005212128,0.0017458341,0.0032216494,0.0000036292847,0.00011176058,0.00007222732,0.015247895,0.00010553717],"about_ca_topic_score_codex":0.021739127,"about_ca_topic_score_gemma":0.040720057,"teacher_disagreement_score":0.09902434,"about_ca_system_score_codex":0.0007025704,"about_ca_system_score_gemma":0.0017026266,"threshold_uncertainty_score":0.99977964},"labels":[],"label_agreement":null},{"id":"W3121425442","doi":"10.1038/s41416-020-01185-w","title":"CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; McGill University; University of Toronto; Royal Victoria Hospital; Queen's University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; Servicio Gallego de Salud; Robert Bosch Stiftung; Programme Grants for Applied Research; Instituto de Salud Carlos III; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Cancer Council Tasmania; World Cancer Research Fund; Medical Research Council; European Commission; Canadian Institutes of Health Research; Ministry of Science and Higher Education of the Russian Federation; U.S. Army; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Hellenic Health Foundation; Deutschen Konsortium für Translationale Krebsforschung; Universitätsklinikum Hamburg-Eppendorf; Xunta de Galicia; Rheinische Friedrich-Wilhelms-Universität Bonn; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Deutsche Krebshilfe; National Health and Medical Research Council; Oulun Yliopisto; Cancer Institute NSW; Medizinischen Hochschule Hannover; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Centre International de Recherche sur le Cancer; Kreftforeningen; Cancer Council South Australia; Institut National Du Cancer; Leids Universitair Medisch Centrum; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; KWF Kankerbestrijding; Vetenskapsrådet; Norges Forskningsråd; Stockholms Läns Landsting; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; Fonds Wetenschappelijk Onderzoek; Cancer Australia; Russian Foundation for Basic Research; Freistaat Sachsen; University of Technology Sydney; University of Crete; Institut National de la Santé et de la Recherche Médicale; Wellcome Trust; Agence Nationale de la Recherche; University of Southern California; Cancerfonden; Ministerio de Sanidad, Servicios Sociales e Igualdad; European Regional Development Fund; National Cancer Institute; Cancer Council Western Australia; Academy of Finland; Gentofte Hospital; King's College London; Génome Québec; Fondation du cancer du sein du Québec; University of Cambridge; Government of Canada; Stavros Niarchos Foundation; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Ministerio de Economía y Competitividad; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; University of California; McGill University Health Centre; David F. and Margaret T. Grohne Family Foundation; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Deutsches Krebsforschungszentrum; Université Laval; Cancer Council Victoria; California Department of Public Health; Brigham and Women's Hospital; University of Sydney; Cancer Research UK; Deutsche Gesetzliche Unfallversicherung; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation; McGill University; University of California, San Francisco; U.S. Department of Health and Human Services; Cancer Council NSW; Susan G. Komen for the Cure","keywords":"Oestrogen receptor; Internal medicine; Medicine; Breast cancer; Endocrinology; Allele; Progesterone receptor; Hormone; Hormone receptor; Mammary gland; Gynecology; Biology; Cancer; Estrogen receptor; Genetics; Gene","score_opus":0.004149702866736928,"score_gpt":0.22521270384589423,"score_spread":0.2210630009791573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121425442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995941,0.09960762,0.00025630396,0.0000844406,0.00008367683,0.00011200841,0.00016776937,0.0000029303967,0.00009112956],"genre_scores_gemma":[0.9695581,0.02838488,0.0015042584,0.000040029576,0.00030808564,0.0000074544528,0.000030479809,0.00002956472,0.0001371041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886173,0.00012225349,0.00032384507,0.00022080925,0.00024268033,0.00022867018],"domain_scores_gemma":[0.99884236,0.000013639235,0.0004360834,0.00010461621,0.00046615614,0.00013716717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020642913,0.00014822924,0.00029322394,0.00002883499,0.000080396,0.000042893917,0.00010005262,0.00014973612,0.000015570988],"category_scores_gemma":[0.000024086483,0.0001431309,0.00006371267,0.000102051,0.00014413155,0.000017612854,0.00005650425,0.0003225765,2.8222993e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009722731,0.000114846494,0.01258277,0.00005547677,0.0015187252,0.00031639828,0.0001462011,0.0005094523,0.91243786,0.000005521036,0.00095885305,0.07038164],"study_design_scores_gemma":[0.0070256507,0.0039044225,0.15493213,0.0017730916,0.0007660245,0.01513097,0.00035675513,0.000029937175,0.81138617,0.000025568503,0.004060851,0.0006084592],"about_ca_topic_score_codex":0.00022280098,"about_ca_topic_score_gemma":0.00027247178,"teacher_disagreement_score":0.14234935,"about_ca_system_score_codex":0.00005466386,"about_ca_system_score_gemma":0.00050827337,"threshold_uncertainty_score":0.58367085},"labels":[],"label_agreement":null},{"id":"W3127009987","doi":"10.1038/s41416-020-01233-5","title":"Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment","year":2021,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research; UCL Hospitals Charitable Foundation","keywords":"Lumpectomy; Medicine; Radiation therapy; Breast cancer; Mastectomy; Intraoperative radiotherapy; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.015612509006318885,"score_gpt":0.26802084697008755,"score_spread":0.25240833796376866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127009987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6504352,0.25320476,0.000047878726,0.08250041,0.0025460168,0.0011893006,0.009999076,0.000022847978,0.000054505883],"genre_scores_gemma":[0.40220115,0.2497177,0.0049659954,0.24430712,0.087536454,0.0030158027,0.0041445526,0.001149666,0.0029615485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976884,0.00015814272,0.0006630007,0.0006154254,0.0003335461,0.000541479],"domain_scores_gemma":[0.99718416,0.000025710726,0.00079948525,0.00025083323,0.0016289452,0.00011085777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00003386442,0.0005328483,0.00087169814,0.00010550144,0.00022126327,0.0001674477,0.00024598715,0.0004243756,0.0002023458],"category_scores_gemma":[0.00002061396,0.0005377615,0.00036113954,0.00020347514,0.00015376041,0.000029089164,0.000049424732,0.000445662,2.4937137e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030716076,0.0012977904,0.00278735,0.00030001986,0.0139847165,0.0036926642,0.003285398,0.00017042903,0.07508041,9.829564e-7,0.22691554,0.6694131],"study_design_scores_gemma":[0.013725681,0.0021376116,0.00969552,0.0018950272,0.0007238794,0.0065230713,0.00082319515,0.0000043644955,0.08245113,0.00000850928,0.8807285,0.0012835497],"about_ca_topic_score_codex":0.0007864389,"about_ca_topic_score_gemma":0.0016858191,"teacher_disagreement_score":0.66812956,"about_ca_system_score_codex":0.0011047448,"about_ca_system_score_gemma":0.00096987776,"threshold_uncertainty_score":0.9997074},"labels":[],"label_agreement":null},{"id":"W3130785111","doi":"10.1038/s41416-020-01247-z","title":"Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Cochrane; Impact; Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Guideline; Grading (engineering); Observational study; Cancer; Family medicine; Gynecology; Bioinformatics; Pathology; Biology","score_opus":0.047959592241852415,"score_gpt":0.32081713207558876,"score_spread":0.27285753983373634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130785111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011934357,0.95463693,0.00007254992,0.0016880278,0.00032057756,0.001370563,0.029934453,0.0000043597197,0.000038189515],"genre_scores_gemma":[0.0038820896,0.99260604,0.0012632541,0.0006969916,0.00078759575,0.00030527718,0.00029473944,0.00010808377,0.000055927027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99765843,0.00059382914,0.0007829888,0.00039749817,0.00029151127,0.0002757218],"domain_scores_gemma":[0.99657166,0.00042893222,0.0012496008,0.00025217104,0.0013986608,0.00009898568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002336296,0.00038841524,0.00096079503,0.000054108135,0.00022102239,0.00008028294,0.00037098528,0.0001017917,0.000036073292],"category_scores_gemma":[0.00014970315,0.00025185253,0.00026380064,0.00033475505,0.00012273864,0.000022577595,0.00011737267,0.00035000462,3.881406e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005897304,0.00023600123,0.0045376755,0.000074148564,0.0013864038,0.000006404824,0.0003214915,0.000075942924,0.00003772227,2.3710862e-7,0.009496045,0.9832382],"study_design_scores_gemma":[0.0038571695,0.00044951946,0.59266704,0.04400711,0.0007323278,0.000054751537,0.00016085032,0.000001198349,0.00010919063,0.000001298525,0.35751167,0.0004478517],"about_ca_topic_score_codex":0.010434854,"about_ca_topic_score_gemma":0.005055286,"teacher_disagreement_score":0.98279035,"about_ca_system_score_codex":0.00040389472,"about_ca_system_score_gemma":0.0006672119,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W3131950767","doi":"10.1038/s41416-020-01164-1","title":"Survival from breast cancer in women with a BRCA2 mutation by treatment","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Women's College Hospital","funders":"National Health and Medical Research Council; National Cancer Institute; Cancer Australia; Manchester Biomedical Research Centre; National Breast Cancer Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Breast cancer; Medicine; Hazard ratio; Oophorectomy; Internal medicine; Oncology; Cancer; Ovarian cancer; Proportional hazards model; Gynecology; Retrospective cohort study; Prospective cohort study; Surgery; Hysterectomy; Confidence interval","score_opus":0.005801225448483067,"score_gpt":0.2584716869826394,"score_spread":0.25267046153415634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131950767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96179336,0.03597936,0.00017332063,0.000603621,0.0003133255,0.00005960363,0.0009543028,0.0000022160398,0.00012091471],"genre_scores_gemma":[0.9829935,0.015264412,0.00030406791,0.0002836649,0.00052633084,0.00007175931,0.000048946396,0.000026520525,0.00048078556],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99908984,0.00006851851,0.00025399015,0.00020677624,0.00019045219,0.00019043608],"domain_scores_gemma":[0.99933565,0.0000106372,0.00017168223,0.00010218615,0.00029806796,0.000081780454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007985061,0.000106569954,0.00019479536,0.000026510943,0.000035809928,0.000054229902,0.0000910767,0.0000732362,0.0006062931],"category_scores_gemma":[0.0000115725115,0.00011147906,0.000045230678,0.00013501731,0.000043498905,0.000012029142,0.00001752409,0.00009274655,9.3645383e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012813264,0.00036563742,0.03813438,0.000017804825,0.0009984245,0.00091934623,0.00058663555,0.0056256307,0.2261229,0.0000014213903,0.008865958,0.71708053],"study_design_scores_gemma":[0.014358562,0.000884241,0.519756,0.0009092154,0.00022307925,0.0037303078,0.0023913665,0.00005269913,0.2346893,0.00017883274,0.22196089,0.0008655142],"about_ca_topic_score_codex":0.0023289325,"about_ca_topic_score_gemma":0.01886802,"teacher_disagreement_score":0.716215,"about_ca_system_score_codex":0.0005916703,"about_ca_system_score_gemma":0.0010988083,"threshold_uncertainty_score":0.99903506},"labels":[],"label_agreement":null},{"id":"W3133504058","doi":"10.1038/s41416-021-01311-2","title":"Correction: Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Phosphatase; Alkaline phosphatase; Pathology; Medicine; Biology; Bioinformatics; Computational biology; Biochemistry; Enzyme","score_opus":0.024376626158605905,"score_gpt":0.28852579073058204,"score_spread":0.2641491645719761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133504058","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040172193,0.93609047,0.013858698,0.00066827843,0.0064196456,0.0003300546,0.0016008797,0.000028296588,0.0008314637],"genre_scores_gemma":[0.9302843,0.057813674,0.0031127408,0.0020200496,0.0023599048,0.00003505823,0.0003979485,0.00009188516,0.0038843907],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836063,0.00008908984,0.00052408763,0.0003209302,0.00036654153,0.00033871905],"domain_scores_gemma":[0.99871707,0.000038215705,0.00041626752,0.00024417785,0.0003713652,0.00021289712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028760012,0.00018863362,0.0003172709,0.00003512911,0.00019010965,0.0001563372,0.0002725331,0.00014558861,0.0008738695],"category_scores_gemma":[0.0005017035,0.00020690398,0.00020513448,0.00026363434,0.000110264504,0.000033953682,0.00013036255,0.0002837736,0.0000044931608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016064063,0.00036676443,0.0026106583,0.0001075482,0.00072049245,0.0054274783,0.000031085077,0.0004565443,0.01956982,0.00084754697,0.8662155,0.102040134],"study_design_scores_gemma":[0.0016459504,0.00027897273,0.001226645,0.00047626602,0.000111176116,0.008151938,0.0001510948,0.000020854348,0.74204135,0.00017472291,0.24542046,0.00030056367],"about_ca_topic_score_codex":0.00027515148,"about_ca_topic_score_gemma":0.002275194,"teacher_disagreement_score":0.89011216,"about_ca_system_score_codex":0.00022596018,"about_ca_system_score_gemma":0.0011852217,"threshold_uncertainty_score":0.95682585},"labels":[],"label_agreement":null},{"id":"W3135466700","doi":"10.1038/s41416-020-01253-1","title":"Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; American Society of Clinical Oncology","keywords":"Microbiome; Fusobacterium nucleatum; Internal medicine; Metagenomics; Saliva; Head and neck squamous-cell carcinoma; Stage (stratigraphy); Medicine; Gut flora; Cohort; Chemoradiotherapy; Oncology; Gastroenterology; Biology; Cancer; Head and neck cancer; Immunology; Bioinformatics; Genetics","score_opus":0.008450015526898672,"score_gpt":0.27179689571798876,"score_spread":0.2633468801910901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135466700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96919376,0.030131571,0.000028849889,0.00011760016,0.00012582455,0.00010418174,0.000089428,0.0000012545408,0.00020751002],"genre_scores_gemma":[0.9974128,0.0016387905,0.00055324985,0.00019481347,0.000079353114,0.000003881829,0.000014167165,0.000019413743,0.0000835447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990644,0.00012771349,0.00036076686,0.00017689064,0.00008736781,0.00018288802],"domain_scores_gemma":[0.99955255,0.000011591275,0.00013904697,0.000077280296,0.00014320199,0.00007632184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018669442,0.000104034196,0.00033514085,0.000057993784,0.00004937883,0.000029179313,0.000084834974,0.00009478883,0.00006299361],"category_scores_gemma":[0.000012892419,0.0001252797,0.00012768195,0.00012456553,0.000054546264,0.000009550093,0.000021681126,0.00016525656,1.7294427e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012508355,0.00042029386,0.020514403,0.000069521746,0.00005569329,0.0010491027,0.0005455301,0.000007342956,0.9682104,0.0000016250325,0.0003173524,0.008683637],"study_design_scores_gemma":[0.012168779,0.0012860944,0.72321415,0.00016296301,0.0001584228,0.0032666486,0.0017422,0.0000035597416,0.25370866,0.000024846946,0.0039044162,0.00035926697],"about_ca_topic_score_codex":0.00045602073,"about_ca_topic_score_gemma":0.0025288353,"teacher_disagreement_score":0.71450174,"about_ca_system_score_codex":0.00003577109,"about_ca_system_score_gemma":0.00040202338,"threshold_uncertainty_score":0.51087576},"labels":[],"label_agreement":null},{"id":"W3136463040","doi":"10.1038/s41416-021-01317-w","title":"Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Strong; Government of Canada; CancerCare Manitoba Foundation; Canadian Institutes of Health Research; Cancer Research Society; University of Pennsylvania","keywords":"Cyclin E1; Cyclin D; Cancer research; Ubiquitin ligase; Cyclin B; Cyclin E; Cyclin A; Biology; Cell cycle; Skp1; Cyclin; Cyclin A2; Cell biology; Medicine; Cancer; Ubiquitin; Genetics; Gene","score_opus":0.01569016937950446,"score_gpt":0.28367592865697416,"score_spread":0.2679857592774697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136463040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8983374,0.0999637,0.0000032098396,0.0012382177,0.00014505917,0.00020348867,0.00006960442,0.000003904041,0.000035378685],"genre_scores_gemma":[0.946312,0.052873187,0.00047399913,0.000104105995,0.00014653173,0.000037730297,0.000006025614,0.000018436065,0.000027997989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998463,0.00014742912,0.0006187681,0.00027670807,0.00028782783,0.00020629163],"domain_scores_gemma":[0.9991601,0.000098733064,0.00028246205,0.00013132866,0.0001629332,0.00016445215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002472136,0.00014814398,0.0006620437,0.000118034935,0.000035230176,0.000036165027,0.00005272732,0.00010730956,0.00020103919],"category_scores_gemma":[0.00011101559,0.0001485169,0.00006773012,0.00025963684,0.00011912669,0.0001875336,0.00004908684,0.0002792706,9.210705e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006692677,0.0017665451,0.8390049,0.00073512376,0.00025934778,0.0034828964,0.0009155735,0.00015751213,0.042599145,0.00004605639,0.00024589678,0.110117756],"study_design_scores_gemma":[0.0068714707,0.00019319938,0.89518726,0.0059440495,0.00014915386,0.0005535312,0.00037162966,0.000011746977,0.08980879,0.00042846793,0.00034570688,0.00013498525],"about_ca_topic_score_codex":0.018585518,"about_ca_topic_score_gemma":0.015104417,"teacher_disagreement_score":0.109982766,"about_ca_system_score_codex":0.0003386109,"about_ca_system_score_gemma":0.0005835756,"threshold_uncertainty_score":0.9879498},"labels":[],"label_agreement":null},{"id":"W3137052566","doi":"10.1038/s41416-021-01277-1","title":"Post-diagnostic coffee and tea consumption and breast cancer survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coffee research and impacts","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Prospective cohort study; Confidence interval; Cancer; Cohort study; Lower risk; Internal medicine; Proportional hazards model; Gynecology","score_opus":0.027862600210642057,"score_gpt":0.34653366667669677,"score_spread":0.3186710664660547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137052566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8731883,0.12111447,0.000007916658,0.005096308,0.00022309806,0.00008141766,0.00015244952,0.0000044113567,0.00013160562],"genre_scores_gemma":[0.84610134,0.15245815,0.000038362195,0.0004911257,0.00045983546,0.0000035667958,0.0000031516831,0.000012009596,0.00043249186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990515,0.000062274565,0.00020936303,0.00011438414,0.00034303422,0.00021941788],"domain_scores_gemma":[0.99857634,0.00020072043,0.000089927176,0.000054301083,0.00066382653,0.00041486404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021017688,0.00007644376,0.00027501793,0.000057340494,0.00006361234,0.00009808359,0.000030236677,0.00004579131,0.0013030439],"category_scores_gemma":[0.00063728064,0.00007673852,0.00004757937,0.000078723795,0.00010686784,0.00016709472,0.000032907734,0.0002932166,0.000001968588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036342663,0.000083581624,0.41206536,0.00025689817,0.000203854,0.003161401,0.000069004265,0.0000014908492,0.010910066,0.000006896004,0.005328462,0.5675496],"study_design_scores_gemma":[0.0025826409,0.00013667272,0.9639716,0.0017646324,0.00012705267,0.025025416,0.0000745599,0.0000102889,0.00073254347,0.000022841647,0.0054720617,0.000079649806],"about_ca_topic_score_codex":0.0011530488,"about_ca_topic_score_gemma":0.0027552743,"teacher_disagreement_score":0.5674699,"about_ca_system_score_codex":0.00008682834,"about_ca_system_score_gemma":0.00065797527,"threshold_uncertainty_score":0.9996099},"labels":[],"label_agreement":null},{"id":"W3138474425","doi":"10.1038/s41416-021-01321-0","title":"Achieving clinical success with BET inhibitors as anti-cancer agents","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":354,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.040768426589829036,"score_gpt":0.40492071774622207,"score_spread":0.364152291156393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138474425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017023094,0.98096204,0.000027551003,0.000060555707,0.0013728351,0.00024633302,0.000096838055,0.0000047026797,0.00020607295],"genre_scores_gemma":[0.0006717519,0.993932,0.00011616859,0.00028089932,0.003796455,0.000037776856,0.00009042015,0.000075120166,0.0009994267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973251,0.00033033415,0.0012127263,0.00041765577,0.00043298828,0.0002811926],"domain_scores_gemma":[0.9976456,0.000020488145,0.0014185157,0.00023192946,0.00045481263,0.00022860905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005157742,0.00031402404,0.0013592839,0.0000803507,0.00009809661,0.00017950758,0.0004236014,0.00044858857,0.00033514175],"category_scores_gemma":[0.00018714472,0.00028465397,0.00078657956,0.00021308093,0.0001269983,0.000018898287,0.00013733108,0.000730964,0.0000040705204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017594013,0.00007243109,0.0011332141,0.00089065614,0.0006854127,0.00024024777,0.000002749938,0.0000059916524,0.0000257841,0.0000013175912,0.019378064,0.9775465],"study_design_scores_gemma":[0.0005726383,0.0001749362,0.00018405126,0.024256282,0.0004774469,0.0010094459,0.000008386013,1.552542e-7,0.000561782,4.372411e-7,0.97240746,0.00034699077],"about_ca_topic_score_codex":0.00010107496,"about_ca_topic_score_gemma":0.00014376034,"teacher_disagreement_score":0.97719955,"about_ca_system_score_codex":0.00006762819,"about_ca_system_score_gemma":0.0016581134,"threshold_uncertainty_score":0.99996054},"labels":[],"label_agreement":null},{"id":"W3139510287","doi":"10.1038/s41416-021-01297-x","title":"Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; Dan L. Duncan Cancer Center, Baylor College of Medicine; Cancer Prevention and Research Institute of Texas; U.S. Department of Health and Human Services","keywords":"Lactate dehydrogenase A; Glycolysis; Head and neck squamous-cell carcinoma; Cancer research; Warburg effect; Clonogenic assay; Lactate dehydrogenase; Small hairpin RNA; Cancer cell; Biology; Cancer; Head and neck cancer; Cell; Internal medicine; Medicine; Biochemistry; Metabolism; Enzyme; Gene knockdown; Apoptosis","score_opus":0.028225011515535015,"score_gpt":0.33133292809371484,"score_spread":0.3031079165781798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139510287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9017343,0.08217449,0.015230554,0.00008599225,0.00043430724,0.00017794438,0.00015409106,8.8164614e-7,0.000007416836],"genre_scores_gemma":[0.95661646,0.0172606,0.024739537,0.00013533884,0.00085092237,0.000108409484,0.00008613809,0.000020704334,0.0001819098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992339,0.000022238526,0.00038419946,0.00012769795,0.00012457979,0.00010737182],"domain_scores_gemma":[0.9989277,0.000013337658,0.0002858039,0.000050318264,0.00066864723,0.00005418273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014962329,0.00007971618,0.00021235266,0.000027090256,0.000052041087,0.000018501467,0.000058363596,0.000067949346,0.000019517807],"category_scores_gemma":[0.000034739154,0.00008093547,0.00009932652,0.00004467103,0.000038003993,0.000012759495,0.000016287882,0.000049236656,1.4048665e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002716779,0.000044162436,0.00005708774,0.00006891995,0.00011194514,6.5637954e-7,0.00014585686,0.000112759044,0.6209887,0.000013449979,0.00037183898,0.37781295],"study_design_scores_gemma":[0.002284678,0.00015466647,0.0027742933,0.00032582032,0.000075624215,0.00006934653,0.00014419193,0.00019197352,0.9053773,0.00024477224,0.088254794,0.00010252417],"about_ca_topic_score_codex":0.00009809882,"about_ca_topic_score_gemma":0.0032614,"teacher_disagreement_score":0.37771043,"about_ca_system_score_codex":0.000023935709,"about_ca_system_score_gemma":0.0010229432,"threshold_uncertainty_score":0.33004528},"labels":[],"label_agreement":null},{"id":"W3141177924","doi":"10.1038/bjc.2012.530","title":"Comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study’","year":2012,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Digit ratio; Medicine; Reliability (semiconductor); Cohort; Cancer; Numerical digit; Prospective cohort study; Cohort study; Oncology; Statistics; Internal medicine; Mathematics; Arithmetic","score_opus":0.008053885097827184,"score_gpt":0.2600191696000782,"score_spread":0.25196528450225103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141177924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93694615,0.00983938,0.00014104291,0.03668891,0.001762411,0.0013918836,0.013066499,0.000013117748,0.000150603],"genre_scores_gemma":[0.8671508,0.010427659,0.000024460158,0.11435735,0.006384897,0.00028452327,0.00031645206,0.00013475108,0.0009191293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974732,0.00023407376,0.0006077097,0.0005715701,0.00060652406,0.00050691946],"domain_scores_gemma":[0.99790823,0.000034599285,0.0009423652,0.00027149488,0.0005455046,0.0002978172],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020291602,0.0004883675,0.00070451334,0.00012128169,0.00026796098,0.0003343139,0.00030823573,0.00039962417,0.0016107945],"category_scores_gemma":[0.000039937142,0.00046301144,0.00022040181,0.000114958035,0.000107534506,0.000029551346,0.00011577538,0.0011579389,0.0000028120762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020141638,0.00018604209,0.5737745,0.000030285635,0.0011933603,0.000024921283,0.00017043372,0.000041684973,0.00003312354,3.4129923e-7,0.41395146,0.010392397],"study_design_scores_gemma":[0.001604072,0.00026150348,0.7470877,0.00019799743,0.0004707294,0.00016462627,0.00015484357,0.0000023112686,0.00019227919,0.000008257953,0.2493817,0.00047398757],"about_ca_topic_score_codex":0.0077441535,"about_ca_topic_score_gemma":0.01384296,"teacher_disagreement_score":0.17331316,"about_ca_system_score_codex":0.00026944207,"about_ca_system_score_gemma":0.000387949,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W3142622887","doi":"10.1038/s41416-021-01330-z","title":"Vascular normalisation as the stepping stone into tumour microenvironment transformation","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norges Forskningsråd; Universitetet i Bergen; Queen's University; Rosetrees Trust; Prostate Cancer UK; University of Oxford","keywords":"Tumor microenvironment; Cancer; Cancer research; Vascular network; Metastasis; Medicine; Cancer cell; Biology; Pathology; Anatomy; Internal medicine","score_opus":0.016092786897582787,"score_gpt":0.2987482935599764,"score_spread":0.2826555066623936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142622887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014698162,0.9968718,0.0008638392,0.0000822327,0.00039381278,0.00021831882,0.000027983371,0.0000015028069,0.00007064309],"genre_scores_gemma":[0.00051867793,0.9977269,0.00009830628,0.00023369664,0.0011135188,0.000044735556,0.00009645738,0.00003742422,0.00013028253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850386,0.00019081026,0.00065674825,0.00018041683,0.00029923065,0.00016895271],"domain_scores_gemma":[0.99903494,0.00001050866,0.0005964093,0.0001554801,0.00013798806,0.000064682325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004358697,0.00019563545,0.0005775257,0.00003797773,0.00013903764,0.000088871224,0.00026788894,0.00019226245,0.00014120665],"category_scores_gemma":[0.00002180758,0.00016405544,0.0008132073,0.000088574896,0.000058824226,0.000012528158,0.000044791126,0.00022963573,0.00000392731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005675724,0.000022172799,0.0000031881639,0.0009955558,0.00049770257,0.000023810602,0.000060368406,0.00007545161,0.0005773556,0.000004120058,0.001212522,0.99652207],"study_design_scores_gemma":[0.00022432211,0.000057774672,0.000037251586,0.0060360627,0.00068111124,0.00096171256,0.000077375575,8.848488e-7,0.0007137532,0.0000034287377,0.99101734,0.00018898501],"about_ca_topic_score_codex":0.00016793408,"about_ca_topic_score_gemma":0.0001385768,"teacher_disagreement_score":0.99633306,"about_ca_system_score_codex":0.0001402079,"about_ca_system_score_gemma":0.00045860355,"threshold_uncertainty_score":0.6689987},"labels":[],"label_agreement":null},{"id":"W3143375719","doi":"10.1038/s41416-021-01376-z","title":"Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier de l’Université de Montréal; McGill University; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Urinary system; Prostate cancer; Medicine; Urine; Prospective cohort study; Internal medicine; Metastasis; Gynecology; Cancer; Cohort study; Oncology; Physiology; Endocrinology","score_opus":0.013711611370692328,"score_gpt":0.3457214588175842,"score_spread":0.3320098474468919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143375719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150042,0.08336553,0.000002040244,0.0007529331,0.0002271751,0.0003328858,0.0001973619,0.0000042938063,0.00011360389],"genre_scores_gemma":[0.96024805,0.03851473,0.00016255275,0.00008944488,0.00022436015,0.00003374739,0.00000714671,0.000024772296,0.00069519767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998114,0.00018961946,0.0005141197,0.00016720855,0.0007778374,0.00023725041],"domain_scores_gemma":[0.9981555,0.000029860068,0.00068173744,0.00020446179,0.0007189971,0.00020944006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031210535,0.00011221523,0.00042324237,0.00007284826,0.000079483594,0.000022581336,0.00017977876,0.000076193355,0.00046603318],"category_scores_gemma":[0.00007485701,0.00007762445,0.00021214607,0.0002924147,0.00025118087,0.00015361208,0.00007522786,0.00040174837,7.5274653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002700082,0.0010276499,0.7328019,0.0004726332,0.0008745845,0.0017891955,0.00074898166,0.00004066877,0.022447659,0.0000045481765,0.0010363664,0.23605572],"study_design_scores_gemma":[0.008843781,0.001741333,0.6307154,0.0056008887,0.0006610824,0.0024972016,0.0005558251,0.000022018792,0.3426635,0.00018958755,0.006361437,0.00014792653],"about_ca_topic_score_codex":0.0006091385,"about_ca_topic_score_gemma":0.00016795035,"teacher_disagreement_score":0.32021585,"about_ca_system_score_codex":0.00016751431,"about_ca_system_score_gemma":0.0021166613,"threshold_uncertainty_score":0.51027364},"labels":[],"label_agreement":null},{"id":"W3144193261","doi":"10.1038/s41416-018-0213-8","title":"Reply to ‘Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis”","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Anthropometry; Prostate cancer; Medicine; Prostate; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.045299850297419,"score_gpt":0.3361512723776937,"score_spread":0.2908514220802747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144193261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014848981,0.026260586,0.00006747859,0.954005,0.002627921,0.0013340047,0.0003184824,0.00006352909,0.0004739943],"genre_scores_gemma":[0.009066233,0.017666614,0.0015037495,0.9603294,0.0094211195,0.0009890855,0.000018447658,0.0001546695,0.00085064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954255,0.00020818278,0.0009635944,0.0005152663,0.0023685894,0.00051885593],"domain_scores_gemma":[0.996787,0.00006933955,0.0007176906,0.00033125078,0.0017762593,0.0003184302],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091386505,0.00041733892,0.0009950593,0.0007985191,0.00011566641,0.00020344925,0.00025442283,0.00031725218,0.0017795885],"category_scores_gemma":[0.00019514814,0.00042467043,0.00024936537,0.00041209676,0.00015834052,0.00015493092,0.00008802026,0.0016727033,0.000012247977],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053368526,0.00017917936,0.02130108,0.00030373252,0.0005294521,0.0019260723,0.000060889877,4.3138934e-7,0.00009655043,8.9310646e-8,0.9310855,0.04398333],"study_design_scores_gemma":[0.0017158817,0.0016913768,0.019794162,0.013211263,0.0005813278,0.0004947432,0.000004981811,3.0752037e-7,0.0036662084,0.000024227156,0.9584124,0.00040312295],"about_ca_topic_score_codex":0.0017486385,"about_ca_topic_score_gemma":0.00021142185,"teacher_disagreement_score":0.043580204,"about_ca_system_score_codex":0.0011663771,"about_ca_system_score_gemma":0.0003787549,"threshold_uncertainty_score":0.99982053},"labels":[],"label_agreement":null},{"id":"W3160120934","doi":"10.1038/s41416-021-01420-y","title":"Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; Cancer Institute NSW; Cooperative Research Centres, Australian Government Department of Industry; NSW Health; Department of Education and Training; Australian Research Council","keywords":"Vinorelbine; Mitosis; Ovarian cancer; Cancer research; Biology; Paclitaxel; Microtubule; Cell biology; Cancer; Chemotherapy; Genetics","score_opus":0.006620576433483745,"score_gpt":0.24413412924272496,"score_spread":0.23751355280924122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160120934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98549014,0.00937715,0.004252507,0.0002746506,0.0003063285,0.00012955556,0.000121631856,0.0000020257248,0.000046000463],"genre_scores_gemma":[0.9853062,0.012062098,0.0015246734,0.00039962426,0.00034996402,0.000015873577,0.00002009848,0.000033182467,0.0002882995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987073,0.00011434488,0.00047704863,0.00021730812,0.00021320742,0.0002707942],"domain_scores_gemma":[0.99893355,0.000019568724,0.00045440134,0.0001584862,0.00036880534,0.000065180146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030570905,0.0001407522,0.00031170712,0.00003783288,0.000078381614,0.000040068302,0.00024558915,0.00012193847,0.00009745496],"category_scores_gemma":[0.00010141231,0.00012329794,0.00012684503,0.00015443668,0.00006288053,0.000012637838,0.00008004217,0.00023749362,3.206432e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012938076,0.00008772434,0.005409902,0.0000409947,0.00016592309,0.00014568784,0.00004708012,0.0014515858,0.98251396,0.000019388206,0.0010311622,0.008957214],"study_design_scores_gemma":[0.0020075003,0.00013578046,0.009152692,0.0006957849,0.00007157352,0.00054093846,0.0002334945,0.00008511085,0.97062004,0.000075789874,0.016164225,0.00021704556],"about_ca_topic_score_codex":0.001559111,"about_ca_topic_score_gemma":0.004767965,"teacher_disagreement_score":0.015133061,"about_ca_system_score_codex":0.00005384558,"about_ca_system_score_gemma":0.0004044205,"threshold_uncertainty_score":0.50279444},"labels":[],"label_agreement":null},{"id":"W3160472279","doi":"10.1038/s41416-021-01373-2","title":"Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Prospective cohort study; Meta-analysis; Confidence interval; Lower risk; Cancer; Incidence (geometry); Gynecology; Internal medicine","score_opus":0.10831066124080356,"score_gpt":0.42856289284079085,"score_spread":0.3202522315999873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160472279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032038218,0.9976264,0.0000019060374,0.000102247424,0.00006528881,0.0012638278,0.0006122623,0.0000032298292,0.0000044336043],"genre_scores_gemma":[0.0004209158,0.99889976,0.000023535982,0.00013465928,0.00006343104,0.00024089306,0.000005233113,0.000023722683,0.00018787172],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975395,0.00019626052,0.0014174437,0.0002900499,0.0004095613,0.00014714013],"domain_scores_gemma":[0.99666977,0.00014455516,0.0020388386,0.00015162332,0.0008441835,0.00015101816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068084244,0.00028815222,0.011441488,0.00023464356,0.000054647913,0.000058499198,0.000061004685,0.00009876011,0.00023293836],"category_scores_gemma":[0.00013643906,0.00020890376,0.0010906738,0.00041592057,0.00016096627,0.00011826483,0.00007036628,0.00035503626,1.204208e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070719075,0.000023762641,0.0016468248,0.7080563,0.2553929,0.00011976026,0.000082341125,3.219134e-7,1.2939998e-7,0.0000029528358,0.00014648445,0.034521166],"study_design_scores_gemma":[0.00024644413,0.000034484663,0.0028543822,0.27300778,0.71359634,0.0048487345,0.000040945335,3.2117813e-7,1.9003677e-7,0.0000024681726,0.0052372636,0.0001306164],"about_ca_topic_score_codex":0.0011945001,"about_ca_topic_score_gemma":0.002497597,"teacher_disagreement_score":0.45820346,"about_ca_system_score_codex":0.00030686168,"about_ca_system_score_gemma":0.0003973855,"threshold_uncertainty_score":0.8518848},"labels":[],"label_agreement":null},{"id":"W3162357932","doi":"10.1038/s41416-021-01410-0","title":"PALB2 mutations and prostate cancer risk and survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Narodowe Centrum Nauki","keywords":"Prostate cancer; Hazard ratio; Medicine; Odds ratio; PALB2; Confidence interval; Internal medicine; Cancer; Oncology; Prostate; Gynecology; Mutation; Genetics; Biology; Germline mutation","score_opus":0.017558245570224507,"score_gpt":0.33631361155831363,"score_spread":0.3187553659880891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162357932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8056025,0.19162737,0.000011507599,0.0019877162,0.00020673934,0.00010102165,0.0001102668,0.0000045910133,0.00034831566],"genre_scores_gemma":[0.69899154,0.29729453,0.00024040314,0.00011497167,0.00027749926,0.000017154442,0.0000061449177,0.000014527209,0.003043247],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991532,0.000056889494,0.00021447868,0.00013072106,0.00026792363,0.00017676846],"domain_scores_gemma":[0.99908996,0.00005176765,0.00011841953,0.000049943934,0.00048770677,0.00020220896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017587497,0.000074118114,0.00024374972,0.000049021182,0.000116950476,0.00008064109,0.000025027664,0.000037916856,0.00030878143],"category_scores_gemma":[0.00008352332,0.00006817659,0.000049544087,0.00013933584,0.000121967954,0.00012166101,0.000025933185,0.00027673852,6.5886553e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002629002,0.000070389455,0.45818654,0.00012224005,0.00034489884,0.0026498253,0.00042878103,0.000011408059,0.0014296205,0.000009040785,0.0014751331,0.5350092],"study_design_scores_gemma":[0.0065966574,0.00021583863,0.9467345,0.0012323554,0.00042968793,0.0032030002,0.00065748265,0.00003598581,0.0041544186,0.00038737588,0.03621394,0.00013875935],"about_ca_topic_score_codex":0.0010312394,"about_ca_topic_score_gemma":0.0018571336,"teacher_disagreement_score":0.53487045,"about_ca_system_score_codex":0.00008017961,"about_ca_system_score_gemma":0.00059844484,"threshold_uncertainty_score":0.33809403},"labels":[],"label_agreement":null},{"id":"W3164536770","doi":"10.1038/s41416-021-01417-7","title":"The risk of contralateral breast cancer: a SEER-based analysis","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Cancer; Mastectomy; Ductal carcinoma; Gynecology; Internal medicine; Oncology; Obstetrics","score_opus":0.00375210834689115,"score_gpt":0.24932975891662035,"score_spread":0.2455776505697292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164536770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9199876,0.0774271,0.00019399491,0.0012319296,0.0002561158,0.000040589985,0.00080548093,0.0000019459128,0.000055224376],"genre_scores_gemma":[0.96975994,0.029469207,0.000111441106,0.00016107068,0.00032738212,0.0000133408475,0.000011360513,0.000011152962,0.00013508332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903893,0.000103778104,0.0003289668,0.0001417856,0.000205094,0.00018147046],"domain_scores_gemma":[0.99867076,0.000030826326,0.00040935888,0.00014394589,0.0006822809,0.00006282982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015330173,0.00010113607,0.00029490472,0.000028087585,0.00012708301,0.00004048798,0.00014182155,0.00005246331,0.00009577043],"category_scores_gemma":[0.00003936734,0.00008354513,0.00039129527,0.00022558447,0.0001153063,0.0000048426086,0.00003335049,0.0001085144,1.9401737e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005958379,0.00014191776,0.84611845,0.00002098098,0.010632745,0.0001303197,0.000044881235,0.004892654,0.008801015,0.0000045232205,0.0031566755,0.12546],"study_design_scores_gemma":[0.0016951892,0.000046839963,0.96138,0.00011153539,0.0019063359,0.00030633685,0.00006756671,0.00004349119,0.024411459,0.000021688247,0.009889885,0.00011965024],"about_ca_topic_score_codex":0.002159604,"about_ca_topic_score_gemma":0.014798929,"teacher_disagreement_score":0.12534034,"about_ca_system_score_codex":0.000049891583,"about_ca_system_score_gemma":0.00039217446,"threshold_uncertainty_score":0.82581496},"labels":[],"label_agreement":null},{"id":"W3164978296","doi":"10.1038/s41416-021-01440-8","title":"New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Bundesministerium für Gesundheit; Bundeszentrale für gesundheitliche Aufklärung; University of Oxford; Health Technology Assessment Programme; University College London; Menzies Centre for Australian Studies, King's College London, University of London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Queen Mary University of London","keywords":"Medicine; Lumpectomy; Intraoperative radiotherapy; Breast cancer; External beam radiotherapy; Cancer; Radiation therapy; Radiology; Oncology; Surgery; Mastectomy; Internal medicine; Brachytherapy","score_opus":0.015317250788076003,"score_gpt":0.30903321430414055,"score_spread":0.29371596351606455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164978296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354082,0.0607288,0.0003557444,0.0018714605,0.0009389233,0.00022860883,0.0004534408,0.0000019716724,0.00001286874],"genre_scores_gemma":[0.93329453,0.06116501,0.0010566615,0.00037279652,0.003970129,0.000045523433,0.000024872501,0.000013794568,0.00005666066],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998957,0.0001161032,0.00046974394,0.00020939545,0.00013835459,0.000109430846],"domain_scores_gemma":[0.99907076,0.00011143804,0.00028587334,0.00007774255,0.0003849749,0.00006919261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011776212,0.000113183916,0.00036556553,0.000013000883,0.000076675664,0.00004105037,0.0001544718,0.000094599316,0.00017810513],"category_scores_gemma":[0.00013701979,0.00008356675,0.00021631732,0.00004466404,0.0001414426,0.000010604279,0.00004950053,0.000119476,5.3367867e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32999077,0.0005927385,0.07622536,0.000022438233,0.010411489,0.00013251719,0.00066159054,0.000117557676,0.28014103,0.000034069868,0.013292954,0.28837746],"study_design_scores_gemma":[0.33258,0.0003523172,0.5912188,0.00027547465,0.00022140819,0.00036080225,0.00021353172,0.000013344626,0.05819025,0.00016090058,0.016171498,0.00024162851],"about_ca_topic_score_codex":0.00045640994,"about_ca_topic_score_gemma":0.0011204173,"teacher_disagreement_score":0.5149935,"about_ca_system_score_codex":0.00003561074,"about_ca_system_score_gemma":0.00039863936,"threshold_uncertainty_score":0.34077534},"labels":[],"label_agreement":null},{"id":"W3169994688","doi":"10.1038/sj.bjc.6601930","title":"Oral Presentations 4","year":2004,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.03377068451095193,"score_gpt":0.41469568713158056,"score_spread":0.3809250026206286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169994688","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07691005,0.875582,0.0006577031,0.034382652,0.0063173347,0.00029552475,0.00011638623,0.00001131378,0.005727062],"genre_scores_gemma":[0.5845487,0.37227547,0.0019839474,0.0011144142,0.009653257,0.000032400676,0.0000030994438,0.00006083852,0.030327847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978821,0.000082340266,0.00053123577,0.0001390686,0.0008413445,0.0005238801],"domain_scores_gemma":[0.9982712,0.00006894319,0.00025683042,0.000103875645,0.0009222547,0.00037688896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004253145,0.00012678612,0.00043171243,0.000111448346,0.00015120815,0.000105691,0.00018511976,0.00008079924,0.002064825],"category_scores_gemma":[0.00047597164,0.0001440733,0.00022494818,0.0003217705,0.00039395597,0.0004140149,0.00006083759,0.0007178743,0.00005353012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003167886,0.0005539987,0.019376671,0.00067862717,0.0019342194,0.010307318,0.0010875566,0.0028285661,0.00044914038,0.0008296819,0.23047815,0.73115927],"study_design_scores_gemma":[0.01021754,0.0007776332,0.18813197,0.011150836,0.0008963454,0.009722003,0.00095841376,0.000013820244,0.0015253538,0.0024866008,0.7738647,0.00025477004],"about_ca_topic_score_codex":0.008863702,"about_ca_topic_score_gemma":0.0057681203,"teacher_disagreement_score":0.7309045,"about_ca_system_score_codex":0.0009698124,"about_ca_system_score_gemma":0.0020850615,"threshold_uncertainty_score":0.9988474},"labels":[],"label_agreement":null},{"id":"W3170783756","doi":"10.1038/s41416-021-01455-1","title":"Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"King's College London; Medical Research Council; National Institute for Health and Care Research; King's Health Partners; Cancer Research UK","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; Machine learning; Cancer; Stage (stratigraphy); Artificial intelligence; Bioinformatics; Computer science; Biology","score_opus":0.019309270440219187,"score_gpt":0.29338630509970814,"score_spread":0.27407703465948896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170783756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87125427,0.11348042,0.009371673,0.002895978,0.00041276656,0.0003659883,0.0021991038,0.000013531073,0.000006257308],"genre_scores_gemma":[0.9710646,0.024743933,0.0027711466,0.00023730728,0.00043943967,0.0005174271,0.00006411767,0.00005044532,0.000111577996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986381,0.00008821909,0.00041688085,0.00035108687,0.00019852215,0.00030718098],"domain_scores_gemma":[0.9986503,0.000019610014,0.0004905149,0.0001031124,0.00064366974,0.00009278168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018742082,0.00018677732,0.00031177222,0.00005879107,0.00014805819,0.000053075484,0.00013845334,0.00012050814,0.000030068637],"category_scores_gemma":[0.00008003604,0.00020449389,0.00020051832,0.00015757844,0.000060252096,0.000016885184,0.00004219679,0.00025259278,1.6154354e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006888749,0.0005421998,0.58330804,0.00014852935,0.00051779277,0.000060294547,0.00010611002,0.09259458,0.10286424,0.0000013814137,0.00054238585,0.21862559],"study_design_scores_gemma":[0.012485218,0.00017550074,0.72252053,0.0008451363,0.0007174415,0.00047063784,0.00016310399,0.10114599,0.15675762,0.000028126304,0.0039763586,0.00071436266],"about_ca_topic_score_codex":0.0046883128,"about_ca_topic_score_gemma":0.03016176,"teacher_disagreement_score":0.21791123,"about_ca_system_score_codex":0.00026178162,"about_ca_system_score_gemma":0.0008316675,"threshold_uncertainty_score":0.98753524},"labels":[],"label_agreement":null},{"id":"W3174841530","doi":"10.1038/s41416-021-01415-9","title":"Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Breast cancer; Medicine; Oncology; Hormone receptor; Cancer; Internal medicine; Oestrogen receptor; Clinical trial; Hormone","score_opus":0.016977192218138756,"score_gpt":0.3431304860266393,"score_spread":0.32615329380850056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174841530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453079,0.050459813,0.000015127818,0.0029757726,0.00012696936,0.0005888196,0.00041093284,0.0000037745244,0.00011086307],"genre_scores_gemma":[0.93452775,0.064472936,0.00037812252,0.00019007573,0.00029029476,0.00004283754,0.0000052818514,0.000023988829,0.0000687297],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975713,0.0006134402,0.0009903403,0.00022936653,0.00036187295,0.00023366504],"domain_scores_gemma":[0.9976595,0.0010093407,0.00066084316,0.00012302399,0.00042310773,0.00012418318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188418,0.00018705065,0.0011589397,0.00015853015,0.000063185806,0.000031123967,0.00008051106,0.000076834505,0.00020275656],"category_scores_gemma":[0.00074254733,0.00014635357,0.00023169455,0.00047263814,0.00022911177,0.00023575817,0.000019996656,0.0005308268,1.5576875e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10442823,0.0007422061,0.0069034086,0.00006705061,0.0008556269,0.00045404208,0.0025214525,0.002828301,0.04404943,0.000016441492,0.00022676837,0.836907],"study_design_scores_gemma":[0.06949982,0.0003717647,0.91987824,0.0030936159,0.0001590407,0.0030048762,0.0010111041,0.00000943898,0.0022806155,0.00011920135,0.0004269653,0.00014528651],"about_ca_topic_score_codex":0.0017555741,"about_ca_topic_score_gemma":0.0010940653,"teacher_disagreement_score":0.91297483,"about_ca_system_score_codex":0.00044396342,"about_ca_system_score_gemma":0.0006084856,"threshold_uncertainty_score":0.59681255},"labels":[],"label_agreement":null},{"id":"W3187840688","doi":"10.1038/s41416-021-01432-8","title":"Mendelian randomisation study of smoking exposure in relation to breast cancer risk","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; McGill University; University of Toronto; Royal Victoria Hospital; Queen's University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research and Materiel Command; Servicio Gallego de Salud; Instituto de Salud Carlos III; Medical Research Council; European Commission; Canadian Institutes of Health Research; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Hellenic Health Foundation; Freistaat Sachsen; Deutschen Konsortium für Translationale Krebsforschung; Universitätsklinikum Hamburg-Eppendorf; Xunta de Galicia; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Cancer Council South Australia; Memorial Sloan-Kettering Cancer Center; Centre International de Recherche sur le Cancer; Kreftforeningen; Institut National Du Cancer; Deutsche Krebshilfe; National Health and Medical Research Council; University of California, Irvine; Oulun Yliopisto; Cancer Institute NSW; Medizinischen Hochschule Hannover; Scottish Government; KWF Kankerbestrijding; Vetenskapsrådet; Norges Forskningsråd; Stockholms Läns Landsting; University of Westminster; Ligue Contre le Cancer; Kuopion Yliopistollinen Sairaala; University of Southern California; Cancerfonden; Cancer Council Tasmania; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; American Cancer Society; Cancer Australia; Russian Foundation for Basic Research; University of Crete; Institut National de la Santé et de la Recherche Médicale; Programme Grants for Applied Research; Robert Bosch Stiftung; Academy of Finland; Gentofte Hospital; King's College London; World Cancer Research Fund; Scottish Funding Council; University College London; Stavros Niarchos Foundation; Fondation de France; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Campaign; National Cancer Institute; European Regional Development Fund; Ministerio de Sanidad, Servicios Sociales e Igualdad; University of Cambridge; Government of Canada; Fondation du cancer du sein du Québec; Génome Québec; National Breast Cancer Foundation; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; Agency for Science, Technology and Research; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; McGill University Health Centre; David F. and Margaret T. Grohne Family Foundation; Centre Hospitalier Universitaire de Québec; Genome Canada; Sundhed og Sygdom, Det Frie Forskningsråd; Deutsches Krebsforschungszentrum; Deutsche Gesetzliche Unfallversicherung; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation; McGill University; Associazione Italiana per la Ricerca sul Cancro; Karolinska Institutet; Harvard T.H. Chan School of Public Health; Ministry of Science and Higher Education of the Russian Federation; U.S. Army; Université Laval; Agence Nationale de la Recherche; Wellcome Trust; Cancer Council Victoria; California Department of Public Health; Brigham and Women's Hospital; Rheinische Friedrich-Wilhelms-Universität Bonn; Oak Foundation; Cancer Research UK; Beckman Research Institute, City of Hope; Cancer Council NSW; Susan G. Komen for the Cure; U.S. Department of Health and Human Services; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Ministerio de Economía y Competitividad; Bundesministerium für Bildung und Forschung; Ovarian Cancer Research Fund; Fonds Wetenschappelijk Onderzoek","keywords":"Breast cancer; Medicine; Oncology; Mendelian randomization; Cancer; Internal medicine; Genetics; Biology; Genotype; Gene; Genetic variants","score_opus":0.010123799043327197,"score_gpt":0.28303937869203893,"score_spread":0.2729155796487117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187840688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933479,0.0055769086,0.00038132857,0.00027700915,0.0002288827,0.00010045133,0.000041267984,7.703662e-7,0.000045523666],"genre_scores_gemma":[0.9949731,0.004349441,0.0002602083,0.00009415199,0.00022531398,0.000014705564,0.000005485753,0.000008037613,0.000069548085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893826,0.00024099425,0.0004620218,0.0001242789,0.00012538067,0.000109042936],"domain_scores_gemma":[0.9991082,0.000019323796,0.00038086151,0.00007419302,0.00037344045,0.000044006752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000556235,0.00005674909,0.00021237276,0.000046332807,0.000036799614,0.000010335734,0.000065003354,0.00008061024,0.000060975515],"category_scores_gemma":[0.00022317382,0.000064612344,0.00006144672,0.00013223353,0.000009273631,0.000005169358,0.000025533189,0.000114308874,1.495606e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016471023,0.000117554635,0.91069585,0.0000050653675,0.00012957436,0.000012626976,0.00026539588,0.018454187,0.012939331,6.6042475e-7,0.00058657915,0.05662845],"study_design_scores_gemma":[0.0032572157,0.00013644817,0.9938177,0.000088721594,0.00005511835,0.00007885331,0.00063873164,0.000027937038,0.0010958281,0.000033826374,0.00070242863,0.00006721194],"about_ca_topic_score_codex":0.0018257236,"about_ca_topic_score_gemma":0.013431196,"teacher_disagreement_score":0.083121814,"about_ca_system_score_codex":0.00005277274,"about_ca_system_score_gemma":0.00016246489,"threshold_uncertainty_score":0.7494923},"labels":[],"label_agreement":null},{"id":"W3196604109","doi":"10.1038/s41416-021-01542-3","title":"The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Breast cancer; Medicine; Anxiety; Mental health; Depression (economics); Meta-analysis; Distress; Cancer; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.0655620932208791,"score_gpt":0.4042981221627581,"score_spread":0.33873602894187904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196604109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003835016,0.9927692,0.0000046179607,0.0030762195,0.0009303176,0.00042456345,0.0027058865,0.0000062426043,0.000044593005],"genre_scores_gemma":[0.0004702379,0.99736816,0.00002050896,0.00053415535,0.0008019069,0.00033785438,0.000035590558,0.0000652131,0.0003663996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956518,0.00057262497,0.0019003502,0.00031858575,0.0011041391,0.00045253237],"domain_scores_gemma":[0.9951161,0.0002676201,0.0029564684,0.0003644922,0.00088244013,0.00041284878],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013871432,0.00037973642,0.0065881656,0.00027640985,0.0001873181,0.00014556109,0.00035506205,0.00017170655,0.0026538488],"category_scores_gemma":[0.00009940221,0.00026330972,0.007454997,0.0014813681,0.00010775228,0.00011586219,0.00007756324,0.0009154034,7.1929327e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025918713,0.000065412896,0.0002601172,0.004116061,0.16164595,0.00014811072,0.00017967058,0.0000017018374,5.48523e-8,0.0000014804923,0.013478575,0.82007694],"study_design_scores_gemma":[0.00027524083,0.000058424295,0.0004980151,0.02322542,0.25113836,0.002858979,0.0001652669,2.978048e-7,9.729758e-7,0.0000012013353,0.7216154,0.00016242251],"about_ca_topic_score_codex":0.031879887,"about_ca_topic_score_gemma":0.16957508,"teacher_disagreement_score":0.8199145,"about_ca_system_score_codex":0.0009869962,"about_ca_system_score_gemma":0.0046820706,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W3198184344","doi":"10.1038/s41416-021-01533-4","title":"Timeliness of diagnosis and treatment: the challenge of childhood cancers","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; McGill University","funders":"","keywords":"Pejorative; Medicine; Childhood cancer; Disease; Cancer; Intensive care medicine; Stage (stratigraphy); Cancer treatment; Pediatrics; Pathology; Internal medicine","score_opus":0.060591707003170056,"score_gpt":0.3747154553498467,"score_spread":0.3141237483466766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198184344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086891354,0.9962071,0.0000024615301,0.0010090182,0.0005594658,0.00064853963,0.00044912955,0.0000054548314,0.00024987894],"genre_scores_gemma":[0.00079897995,0.9972148,0.00008590766,0.00013415675,0.0014752706,0.000092737624,0.000018710889,0.00007203308,0.00010738026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965433,0.0003254514,0.0018605277,0.00030107045,0.00071866286,0.00025098288],"domain_scores_gemma":[0.9959329,0.0004822418,0.0024234871,0.00036856532,0.00059239945,0.00020043839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006239432,0.0003694338,0.003947996,0.0001550271,0.000060461352,0.000028247188,0.00027657815,0.0002334358,0.00043064044],"category_scores_gemma":[0.00029281777,0.0002799967,0.0011291044,0.00036077647,0.00024967422,0.00008560992,0.00006800065,0.00056974386,5.841527e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002303446,0.00029345538,0.00015850083,0.008609772,0.0024224094,0.00017668794,0.00061290176,0.0000023139103,9.2350916e-8,0.000009328108,0.0012784173,0.98641306],"study_design_scores_gemma":[0.0016377171,0.00050655595,0.0008414571,0.1473718,0.0052350317,0.0018468141,0.00018876298,3.8122656e-7,0.000014487826,0.000014822455,0.8421247,0.00021745941],"about_ca_topic_score_codex":0.003980283,"about_ca_topic_score_gemma":0.003480802,"teacher_disagreement_score":0.9861956,"about_ca_system_score_codex":0.00039921884,"about_ca_system_score_gemma":0.0031980108,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W3201227094","doi":"10.1038/s41416-021-01548-x","title":"Correction to: Timeliness of diagnosis and treatment: the challenge of childhood cancers","year":2021,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; McGill University","funders":"","keywords":"Medicine; Childhood cancer; MEDLINE; Cancer; Internal medicine; Biology","score_opus":0.022725443292512897,"score_gpt":0.31330757920217567,"score_spread":0.29058213590966275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201227094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062369745,0.8511879,0.000029375873,0.015414677,0.061978415,0.0012773668,0.00089651323,0.000021201678,0.0068248506],"genre_scores_gemma":[0.12927629,0.8350266,0.0001619955,0.001362326,0.012797038,0.00014955041,0.00008383258,0.00015726527,0.020985054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970388,0.00018725863,0.0012707968,0.0003297308,0.00091022305,0.00026322654],"domain_scores_gemma":[0.9965087,0.00028148215,0.0015621522,0.0003328436,0.0010686157,0.00024616515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049209414,0.00031588372,0.0016480464,0.00018915135,0.00008124659,0.00003662071,0.00022330582,0.0002562524,0.00049871346],"category_scores_gemma":[0.00060706097,0.00027803468,0.00048977137,0.00036376176,0.00017003278,0.00009221302,0.00006381459,0.0009016708,6.358364e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021598731,0.0004095226,0.0018310132,0.0006133718,0.0015554379,0.00015618108,0.0025948375,0.00005171264,0.000008828448,0.0000018923464,0.60402226,0.38853896],"study_design_scores_gemma":[0.0049518943,0.002902535,0.12796342,0.05525988,0.0029942032,0.0021338298,0.0017494876,0.000022536511,0.0010721768,0.000041620267,0.80036914,0.0005392446],"about_ca_topic_score_codex":0.019812934,"about_ca_topic_score_gemma":0.043601613,"teacher_disagreement_score":0.3879997,"about_ca_system_score_codex":0.0005600057,"about_ca_system_score_gemma":0.0029255354,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W3202324966","doi":"10.1038/s41416-021-01525-4","title":"Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Hazard ratio; Internal medicine; Population; Cancer; Lymphoma; Regimen; Proportional hazards model; Cancer registry; Pediatrics; Oncology; Confidence interval","score_opus":0.014400843372268678,"score_gpt":0.3071092908532081,"score_spread":0.29270844748093944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202324966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968452,0.0022808055,0.0000011808612,0.00013113527,0.000063408224,0.00008031074,0.0004923892,0.0000011076169,0.000104455255],"genre_scores_gemma":[0.99072367,0.008853718,0.00014517832,0.000108739856,0.00003184593,0.0000026697946,0.000059656544,0.000009868183,0.00006468006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987799,0.0000857634,0.00049747265,0.00015880507,0.0003413327,0.0001367064],"domain_scores_gemma":[0.99897873,0.000148618,0.00040314844,0.00020735827,0.00018612102,0.00007600232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024362029,0.00007867431,0.0005935141,0.00025350245,0.000007713211,0.00001871962,0.000085133375,0.000032821517,0.00006321994],"category_scores_gemma":[0.0001325015,0.00007644417,0.00008743793,0.00040658793,0.00002182749,0.0001750001,0.00008009739,0.000072776515,2.2467998e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014978711,0.0063741095,0.959329,0.000045376,0.00070941495,0.0010478124,0.00042783975,0.0000019191714,0.0000052268156,0.0000014793223,0.00008514104,0.031822875],"study_design_scores_gemma":[0.026660627,0.00009369148,0.9701327,0.00053059513,0.0010509097,0.000022907807,0.00022120659,0.000013034237,0.00015919226,0.0000012936003,0.0010538594,0.0000599879],"about_ca_topic_score_codex":0.009176668,"about_ca_topic_score_gemma":0.06774043,"teacher_disagreement_score":0.058563765,"about_ca_system_score_codex":0.0001159046,"about_ca_system_score_gemma":0.00014704299,"threshold_uncertainty_score":0.9974213},"labels":[],"label_agreement":null},{"id":"W3207301911","doi":"10.1038/s41416-021-01560-1","title":"Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Cancer Research UK; Ottawa Hospital Research Institute; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Oncology; Medicine; Internal medicine; Biomarker; Ovarian cancer; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.017735269981261938,"score_gpt":0.34137995415041744,"score_spread":0.3236446841691555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207301911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698403,0.0065853815,0.00044680425,0.021976825,0.00042528094,0.0002891172,0.00011583168,0.000013080056,0.00030738744],"genre_scores_gemma":[0.99215937,0.0010651115,0.00038802018,0.0052133226,0.00037623255,0.000030101033,0.0000014231042,0.000026881362,0.0007395228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976665,0.00046100112,0.00060450437,0.00020598716,0.0008204068,0.00024165082],"domain_scores_gemma":[0.99743384,0.00052422367,0.00040914936,0.00037889724,0.0010977604,0.00015613678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017948684,0.00014280318,0.0006768804,0.00024879773,0.00018826114,0.00008947816,0.00026294836,0.00005577452,0.000759929],"category_scores_gemma":[0.0012083023,0.000097282,0.0004894127,0.0017690627,0.00011999079,0.00010963349,0.000059858172,0.00043452467,0.0000024930162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007948967,0.0003918374,0.7211997,0.00005923672,0.02078225,0.0012928075,0.01599873,0.003477882,0.14373164,0.00013246485,0.026594346,0.058390137],"study_design_scores_gemma":[0.0012801298,0.00030850427,0.96764094,0.0005953748,0.0011271334,0.0003222286,0.0019764064,0.000016692682,0.015488112,0.0000686346,0.011071188,0.000104653955],"about_ca_topic_score_codex":0.0002374476,"about_ca_topic_score_gemma":0.0013359737,"teacher_disagreement_score":0.24644125,"about_ca_system_score_codex":0.00037124509,"about_ca_system_score_gemma":0.00046892854,"threshold_uncertainty_score":0.832069},"labels":[],"label_agreement":null},{"id":"W3210328397","doi":"10.1038/s41416-021-01580-x","title":"A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Lustgarten Foundation; U.S. Department of Health and Human Services","keywords":"Ovarian cancer; Family history; Breast cancer; Pancreatic cancer; Medicine; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.010733809409504353,"score_gpt":0.25556795125196285,"score_spread":0.2448341418424585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210328397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90085506,0.08945278,0.005988815,0.00018221316,0.00093046343,0.00030432706,0.0021108026,0.00000622016,0.00016933074],"genre_scores_gemma":[0.9172727,0.049125995,0.023201743,0.0008389723,0.0025639106,0.00050625164,0.000102969905,0.00011454159,0.006272948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871194,0.000081217586,0.00049577485,0.00023832124,0.0002782421,0.00019453013],"domain_scores_gemma":[0.99807143,0.000031378746,0.0006449888,0.00017666409,0.0010064099,0.00006910896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028394302,0.00012890804,0.00031049343,0.000050376613,0.00005222105,0.000024981684,0.00015446293,0.0001199508,0.00015793924],"category_scores_gemma":[0.00012919703,0.0001277622,0.00014157208,0.00012950259,0.00010644516,0.000018079601,0.00003033713,0.00015000782,1.879906e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033825145,0.00042819048,0.12282395,0.00053218537,0.003968989,0.0001560188,0.00063094136,0.005151357,0.18962535,0.000019613823,0.19765973,0.47562113],"study_design_scores_gemma":[0.0086026285,0.0011327374,0.24368589,0.0016359022,0.0014612058,0.0049570724,0.0003764262,0.00010650171,0.043071195,0.000121049015,0.694339,0.00051042775],"about_ca_topic_score_codex":0.00043700472,"about_ca_topic_score_gemma":0.0012157856,"teacher_disagreement_score":0.49667925,"about_ca_system_score_codex":0.0004355111,"about_ca_system_score_gemma":0.004365999,"threshold_uncertainty_score":0.77450943},"labels":[],"label_agreement":null},{"id":"W3211988828","doi":"10.1038/s41416-021-01616-2","title":"CSNK2 in cancer: pathophysiology and translational applications","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; American Society of Clinical Oncology","keywords":"Cancer; Cancer research; Metastasis; Protein kinase B; Kinase; PTEN; Biology; Medicine; Cancer cell; Translational research; Cell cycle; PI3K/AKT/mTOR pathway; Bioinformatics; Signal transduction; Pathology; Internal medicine; Cell biology","score_opus":0.028644542494351825,"score_gpt":0.3613751296212475,"score_spread":0.3327305871268957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211988828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000665663,0.9983621,0.000156259,0.0001955045,0.00030136833,0.00052853633,0.00024869124,0.000005945586,0.00013501744],"genre_scores_gemma":[0.000030777755,0.99815106,0.0003395875,0.0001730439,0.00081374025,0.0002735315,0.000059124883,0.00005168239,0.00010742042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982612,0.000113910864,0.0008685968,0.0002746155,0.00027217306,0.00020949935],"domain_scores_gemma":[0.99885803,0.00006742614,0.00052569434,0.00012840492,0.00026699493,0.00015346927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016856616,0.00020646944,0.0016546125,0.0002126849,0.00003935431,0.000027149015,0.000106215084,0.00031272156,0.0003478169],"category_scores_gemma":[0.00003148605,0.00022596229,0.00042727325,0.0004084767,0.00008550898,0.000053744345,0.0000230356,0.0009982852,0.0000016221784],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012643844,0.00006370186,0.000021703376,0.0031630795,0.00026110033,0.0006977364,0.0000177724,0.000016231987,0.00001932387,0.000023978317,0.0007309133,0.9949718],"study_design_scores_gemma":[0.0009400878,0.000045462344,0.00025717623,0.04309927,0.0010780534,0.005100023,0.0000062712984,0.000002838421,0.0000029269456,0.00006576247,0.9492282,0.00017390087],"about_ca_topic_score_codex":0.00028095182,"about_ca_topic_score_gemma":0.0008539004,"teacher_disagreement_score":0.9947979,"about_ca_system_score_codex":0.00023764445,"about_ca_system_score_gemma":0.0026571152,"threshold_uncertainty_score":0.92144746},"labels":[],"label_agreement":null},{"id":"W3215143226","doi":"10.1038/s41416-021-01608-2","title":"Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University; University of Toronto; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba","funders":"Karyopharm Therapeutics; American Society of Clinical Oncology","keywords":"Carfilzomib; Medicine; Refractory (planetary science); Dexamethasone; Adverse effect; Internal medicine; Nausea; Multiple myeloma; Oncology; Gastroenterology; Lenalidomide","score_opus":0.016647814103603182,"score_gpt":0.30554761793782803,"score_spread":0.28889980383422487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215143226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757092,0.022956323,0.00002694238,0.00035313232,0.00027156327,0.0002465914,0.00011002813,0.0000074773957,0.00031874957],"genre_scores_gemma":[0.9860635,0.010569012,0.002015567,0.00027196165,0.00031060493,0.000020172674,0.000028309662,0.00003506498,0.00068580953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793714,0.00012000595,0.00058572623,0.00028609473,0.00064701226,0.000424013],"domain_scores_gemma":[0.99813133,0.00018141004,0.0002442844,0.00015492168,0.0008485847,0.0004394434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027093707,0.00017753975,0.0005921116,0.00015666561,0.00007630673,0.00006831884,0.00009920318,0.00011527138,0.00024639774],"category_scores_gemma":[0.00087915827,0.0001822383,0.00013588207,0.00029357706,0.00008703311,0.00025524388,0.000072791925,0.0005822914,0.0000054135803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058401056,0.0005143417,0.64103436,0.0000961518,0.00019871692,0.005169254,0.00014633813,0.000013027212,0.0038507392,4.289733e-7,0.0010124764,0.34738013],"study_design_scores_gemma":[0.017153706,0.00035712266,0.96762806,0.0013849292,0.00008522591,0.0011173937,0.00018367854,0.00021316315,0.0041159466,0.000011295459,0.007586127,0.0001633646],"about_ca_topic_score_codex":0.0023389412,"about_ca_topic_score_gemma":0.004822416,"teacher_disagreement_score":0.34721678,"about_ca_system_score_codex":0.00035685487,"about_ca_system_score_gemma":0.0006757067,"threshold_uncertainty_score":0.74314624},"labels":[],"label_agreement":null},{"id":"W3216876515","doi":"10.1038/s41416-021-01634-0","title":"Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Terumo BCT; Innovative Medicines Initiative; KWF Kankerbestrijding","keywords":"Circulating tumor cell; Medicine; Interquartile range; Lung cancer; Hazard ratio; Leukapheresis; Internal medicine; Oncology; Cancer; Confidence interval; Metastasis; Biology; Stem cell","score_opus":0.014093433957203234,"score_gpt":0.27833031426310023,"score_spread":0.264236880305897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216876515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93272185,0.063564226,0.000018255829,0.00038355522,0.00044815766,0.0001369729,0.000050875464,0.0000067148003,0.002669407],"genre_scores_gemma":[0.9832032,0.012588714,0.0003504315,0.0004470457,0.00024144059,0.000010373989,0.0000019795993,0.000035499517,0.0031213223],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858725,0.00011316712,0.00049544824,0.00021749514,0.00031735734,0.0002692945],"domain_scores_gemma":[0.9989586,0.00015637465,0.00020925143,0.00009468459,0.00031281108,0.00026829308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005558666,0.0001340334,0.00046326983,0.00011865068,0.000054631244,0.00006090141,0.00007509241,0.00007792608,0.0013809641],"category_scores_gemma":[0.00021495312,0.00015581476,0.00011504487,0.0003477556,0.000023720233,0.00007528168,0.00004503156,0.00038100182,0.0000039549814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003213539,0.00059686217,0.2643206,0.0013869286,0.00034198773,0.0239186,0.0009907257,0.0013633046,0.5509182,0.0000037034945,0.039439525,0.11350599],"study_design_scores_gemma":[0.008233154,0.00028123675,0.8739216,0.009604362,0.0007821297,0.003457668,0.0013562341,0.0002089265,0.0781225,0.00002112775,0.023369595,0.0006415197],"about_ca_topic_score_codex":0.0070071593,"about_ca_topic_score_gemma":0.0049930196,"teacher_disagreement_score":0.60960096,"about_ca_system_score_codex":0.00027560565,"about_ca_system_score_gemma":0.0010459721,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W322014996","doi":"10.1054/bjoc.2001.1870","title":"Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Kræftens Bekæmpelse","keywords":"Biology; Seminoma; Tumor suppressor gene; Germ cell; Cancer research; Gene expression; Pathology; Immunohistochemistry; Gene; Immunology; Carcinogenesis; Medicine; Genetics","score_opus":0.009509666767870082,"score_gpt":0.24579812205035867,"score_spread":0.2362884552824886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W322014996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96203446,0.03670162,0.000066363726,0.00041001258,0.0004004848,0.00018545636,0.00005219266,0.00000529597,0.00014411319],"genre_scores_gemma":[0.99002004,0.0084115965,0.00031651702,0.000117954885,0.0006253329,0.000005941227,0.0000040672885,0.000023705044,0.00047484023],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998423,0.000066452514,0.00062617275,0.00016216848,0.0004402856,0.00028193],"domain_scores_gemma":[0.99906504,0.000046166733,0.0003843333,0.00013435559,0.00021225915,0.00015787107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002771571,0.00014180472,0.0003994917,0.00009376269,0.00009343692,0.000037522816,0.0001468038,0.00008325503,0.0003820991],"category_scores_gemma":[0.00004576461,0.000115141615,0.000111206806,0.00018529147,0.00011239259,0.00019453558,0.000057218258,0.0002378733,0.0000012320979],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000689135,0.00023733595,0.24208845,0.00011803324,0.00003392446,0.0017483436,0.0006105328,0.0004104703,0.7287929,0.000005392356,0.0024284392,0.022837056],"study_design_scores_gemma":[0.0027978497,0.00013387411,0.5449021,0.001252049,0.000069892696,0.003799094,0.000066908804,0.000055851317,0.43744773,0.000023003082,0.009331502,0.0001201617],"about_ca_topic_score_codex":0.001103817,"about_ca_topic_score_gemma":0.00037082014,"teacher_disagreement_score":0.30281365,"about_ca_system_score_codex":0.000056805413,"about_ca_system_score_gemma":0.00018613623,"threshold_uncertainty_score":0.4695339},"labels":[],"label_agreement":null},{"id":"W41764704","doi":"10.1054/bjoc.2001.1885","title":"Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Gene; RNA splicing; Cloning (programming); Cancer; Biology; Messenger RNA; Alternative splicing; Ovarian cancer; Genetics; Cancer research; Molecular biology; RNA","score_opus":0.02413331272117781,"score_gpt":0.3283993022758709,"score_spread":0.3042659895546931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W41764704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851662,0.013979428,0.00032311433,0.000039976057,0.00008729276,0.00022220354,0.000047985053,0.0000010294825,0.00013278739],"genre_scores_gemma":[0.99398583,0.004960378,0.0003432531,0.000035156594,0.00029732808,0.0000097898255,0.0000037348857,0.000021463004,0.00034305293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985404,0.00007079411,0.0006098768,0.00016880092,0.00033406485,0.00027604194],"domain_scores_gemma":[0.998382,0.000033790417,0.0009867208,0.00015662116,0.00034902044,0.00009187852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002925927,0.000121286095,0.00035329172,0.00007851107,0.00007249697,0.00001873502,0.0003198266,0.00011714404,0.000037141774],"category_scores_gemma":[0.0001869641,0.00010311077,0.00019269138,0.0001684267,0.00006372479,0.000021167725,0.00008714809,0.00020004831,1.7838651e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002667425,0.00004442161,0.049177162,0.00009796924,0.00010069022,0.000011154757,0.00023382272,0.001604439,0.9416918,0.000004260997,0.00042890638,0.006338608],"study_design_scores_gemma":[0.0017525034,0.00018192719,0.096163966,0.004079619,0.000029859902,0.000062037805,0.00018371626,0.00006604722,0.89684165,0.00004641852,0.00048144232,0.00011083688],"about_ca_topic_score_codex":0.00678136,"about_ca_topic_score_gemma":0.0021818955,"teacher_disagreement_score":0.046986803,"about_ca_system_score_codex":0.00006179776,"about_ca_system_score_gemma":0.00040517768,"threshold_uncertainty_score":0.9998326},"labels":[],"label_agreement":null},{"id":"W4200219593","doi":"10.1038/s41416-021-01655-9","title":"Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Medical Research Council; Darwin Trust of Edinburgh; Cancer Research UK","keywords":"Biobank; Phenome; Colorectal cancer; Medicine; SNP; Epidemiology; Bioinformatics; Oncology; Internal medicine; Single-nucleotide polymorphism; Cancer; Biology; Genetics; Genotype; Genome","score_opus":0.009343082196304735,"score_gpt":0.3075991321943103,"score_spread":0.29825604999800553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200219593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851973,0.012621557,0.000041521234,0.0012299697,0.0005877357,0.00017316616,0.00008607206,0.0000016035657,0.00006105733],"genre_scores_gemma":[0.98582125,0.012745583,0.00021896319,0.00078726193,0.00019538835,0.000025248231,0.000010143309,0.00001332005,0.00018285748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820673,0.0005248956,0.0006056667,0.00019082497,0.00021981692,0.00025208312],"domain_scores_gemma":[0.9983697,0.00021614876,0.0009896571,0.00009046186,0.0002602628,0.00007378527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000903433,0.00010832878,0.0005096664,0.000052785097,0.00006082759,0.000014878993,0.00011298892,0.00012455709,0.0000396458],"category_scores_gemma":[0.0015937522,0.00011671453,0.00014871822,0.00014077031,0.000017134214,0.0000038017376,0.00003864989,0.00022027345,6.7807e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053767904,0.00024666995,0.9707764,0.000014085642,0.00031721347,0.00002059158,0.00009489359,0.00075837807,0.0014926465,6.553112e-7,0.0041077677,0.02211696],"study_design_scores_gemma":[0.0018290408,0.00065204676,0.9924492,0.00010710425,0.00004933979,0.0000069699963,0.00018913197,0.000006243497,0.0031891135,0.00006323466,0.001356779,0.00010176117],"about_ca_topic_score_codex":0.0029607217,"about_ca_topic_score_gemma":0.029850235,"teacher_disagreement_score":0.026889514,"about_ca_system_score_codex":0.00027798925,"about_ca_system_score_gemma":0.0005005568,"threshold_uncertainty_score":0.98785245},"labels":[],"label_agreement":null},{"id":"W4200493934","doi":"10.1038/s41416-021-01650-0","title":"Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Manchester Biomedical Research Centre; Breast Cancer Research Trust; National Institute for Health and Care Research","keywords":"Breast cancer; Chemotherapy; Medicine; Oncology; Internal medicine; Randomized controlled trial; Cancer; Surgery","score_opus":0.008070169246526761,"score_gpt":0.2764005687684838,"score_spread":0.26833039952195703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200493934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666406,0.009809953,0.00027560728,0.00077581144,0.0016140521,0.00067109556,0.00009026074,0.0000085603,0.00009062437],"genre_scores_gemma":[0.9616432,0.034740277,0.000045297522,0.0002385363,0.002030848,0.00015781696,0.0000027917886,0.00003064114,0.0011105498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984598,0.000052265892,0.00080960896,0.00014981393,0.0003313986,0.00019706899],"domain_scores_gemma":[0.99806255,0.00007961944,0.00072389824,0.000093344046,0.0009094317,0.00013113282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019905846,0.00012303556,0.0010062505,0.00008771788,0.000049878705,0.000041060233,0.00006865064,0.00008691312,0.0003711818],"category_scores_gemma":[0.00008527212,0.0001164437,0.00062397344,0.00012523732,0.000043364253,0.000099879864,0.00000959523,0.00017301657,7.953036e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80858046,0.0002902498,0.005759895,0.000076132426,0.00097462937,0.00018172622,0.00008782197,0.000025047682,0.011802637,0.000004140469,0.0014266974,0.17079057],"study_design_scores_gemma":[0.87211025,0.0005747034,0.11273137,0.0011344303,0.0004854502,0.0010309833,0.00005527792,0.000020086058,0.0071517224,0.00001993854,0.004563813,0.00012196382],"about_ca_topic_score_codex":0.0028151628,"about_ca_topic_score_gemma":0.00082533964,"teacher_disagreement_score":0.17066862,"about_ca_system_score_codex":0.00023219893,"about_ca_system_score_gemma":0.0005837121,"threshold_uncertainty_score":0.47484362},"labels":[],"label_agreement":null},{"id":"W4200511560","doi":"10.1038/s41416-021-01676-4","title":"No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Trastuzumab; Oncology; Hazard ratio; Breast cancer; Taxane; Proportional hazards model; Radiation therapy; Lapatinib; Chemotherapy; Cancer; Surgery; Confidence interval","score_opus":0.07852426429881962,"score_gpt":0.4304724511525911,"score_spread":0.3519481868537715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200511560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84291893,0.1403709,0.00011903366,0.013924957,0.00078386796,0.000904068,0.00095420313,0.000009907075,0.000014142333],"genre_scores_gemma":[0.92639345,0.06992348,0.000498351,0.0009692775,0.00093536807,0.00026018717,0.000019335237,0.00007647344,0.00092405855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967825,0.00022616699,0.00085077644,0.00039010175,0.0012176029,0.0005328519],"domain_scores_gemma":[0.99585867,0.0005060392,0.00029894142,0.00033307404,0.0020088784,0.0009943879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007870119,0.00021029708,0.00067101495,0.0002537688,0.00007271397,0.00007150206,0.00030620513,0.000052684878,0.0021070156],"category_scores_gemma":[0.0017527678,0.00022099855,0.0002868401,0.0006774913,0.00013865819,0.0002756567,0.00006643341,0.00042168325,0.0000039111724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3175881,0.0018305946,0.35351646,0.00524325,0.0013621104,0.014298903,0.000523171,0.005256193,0.0047465474,0.000009911412,0.026352918,0.26927185],"study_design_scores_gemma":[0.013354981,0.001201932,0.959907,0.018554626,0.00036331758,0.00015726581,0.00006075826,0.00008713984,0.0018140385,0.000045187753,0.0041540987,0.000299673],"about_ca_topic_score_codex":0.0015834798,"about_ca_topic_score_gemma":0.008467875,"teacher_disagreement_score":0.60639054,"about_ca_system_score_codex":0.00076531543,"about_ca_system_score_gemma":0.005413647,"threshold_uncertainty_score":0.99880517},"labels":[],"label_agreement":null},{"id":"W4205412845","doi":"10.1038/s41416-021-01691-5","title":"Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ionizing radiation; Radiation therapy; Radiation sensitivity; Cell culture; Hypoxia (environmental); Cell survival; Cell; Cell growth","score_opus":0.005800646764930241,"score_gpt":0.2345790990590582,"score_spread":0.22877845229412794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205412845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94492644,0.053562474,0.00005399761,0.00010497974,0.000991685,0.00009781215,0.000074218595,0.0000025116467,0.00018590738],"genre_scores_gemma":[0.9916665,0.0061812643,0.000040110146,0.0002780087,0.0015267029,0.000010940709,0.000014362335,0.000020154737,0.00026198316],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989387,0.00013111124,0.0002974185,0.00018797966,0.00023636551,0.00020844322],"domain_scores_gemma":[0.999548,0.0000067875453,0.00020549646,0.00006742424,0.000077033204,0.00009522051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043607032,0.00010459693,0.0002161548,0.00008131638,0.00013144937,0.000039605537,0.000086141954,0.000051239356,0.000063194326],"category_scores_gemma":[0.000014696428,0.00013517347,0.00010701671,0.00011253705,0.000042173724,0.000014238083,0.000046878908,0.00027388474,1.8476564e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120466924,0.00011187378,0.002843781,0.000021353202,0.00002928399,0.00010720668,0.00014119019,0.00092896796,0.9549348,0.0000036541737,0.0066736564,0.034083813],"study_design_scores_gemma":[0.005486903,0.00040998834,0.38781458,0.00007926531,0.0001009427,0.0028192585,0.0003011139,0.00003454038,0.18492502,0.000072361756,0.41751465,0.0004413695],"about_ca_topic_score_codex":0.0005541598,"about_ca_topic_score_gemma":0.0026036883,"teacher_disagreement_score":0.77000976,"about_ca_system_score_codex":0.000053831725,"about_ca_system_score_gemma":0.0001595864,"threshold_uncertainty_score":0.55122143},"labels":[],"label_agreement":null},{"id":"W4206312263","doi":"10.1038/s41416-021-01692-4","title":"Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Natural Science Foundation of Zhejiang Province","keywords":"Evasion (ethics); Ovarian cancer; Immune system; Serous ovarian cancer; Serous fluid; Immunotherapy; Selection (genetic algorithm); Cancer","score_opus":0.01715629107594695,"score_gpt":0.26333862470955716,"score_spread":0.2461823336336102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206312263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93038595,0.06787757,0.00004868856,0.00078241865,0.00029807838,0.00053019065,0.000059517643,0.000014410995,0.0000031611046],"genre_scores_gemma":[0.97326124,0.025867442,0.0003303552,0.00021048042,0.000080206286,0.000088592715,0.00001466051,0.00003454946,0.00011244943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983793,0.00017858806,0.0006181088,0.00024149808,0.0003455566,0.0002369752],"domain_scores_gemma":[0.99875367,0.00004080109,0.0007584585,0.00014920895,0.00022082608,0.00007702738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586663,0.00017481025,0.0005847715,0.00012964482,0.0002687141,0.000087679764,0.000143683,0.00007964293,0.00035074298],"category_scores_gemma":[0.000013960209,0.00015485425,0.000096396245,0.00021653714,0.00014843758,0.00025958507,0.000059220183,0.00038665964,9.450567e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073446278,0.0002504744,0.0030820614,0.00008206423,0.0006416931,0.000055362772,0.00050825876,0.000009366529,0.8003099,0.00001185184,0.0000092335495,0.18769509],"study_design_scores_gemma":[0.009280504,0.0032885992,0.9424097,0.0008017,0.00048619293,0.0031178,0.00078399904,0.0000413325,0.038932238,0.00020680239,0.00041080816,0.00024031303],"about_ca_topic_score_codex":0.0054754955,"about_ca_topic_score_gemma":0.00027816425,"teacher_disagreement_score":0.93932766,"about_ca_system_score_codex":0.00022731523,"about_ca_system_score_gemma":0.00027107802,"threshold_uncertainty_score":0.8277348},"labels":[],"label_agreement":null},{"id":"W4206398506","doi":"10.1038/s41416-021-01667-5","title":"Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal; Institute of Cancer Research; International Hepato-Pancreato-Biliary Association","keywords":"Colorectal cancer; Immune system; Medicine; Tissue microarray; Internal medicine; Oncology; Acquired immune system; Phenotype; CD3; Pathology; Gastroenterology; Immunohistochemistry; CD8; Cancer; Immunology; Biology","score_opus":0.02002393869796565,"score_gpt":0.27344139741426166,"score_spread":0.253417458716296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206398506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384275,0.05884108,0.00017888748,0.0006873327,0.00025120736,0.0003734723,0.0009976486,0.0000068248414,0.00023606562],"genre_scores_gemma":[0.99479246,0.004273622,0.00029702776,0.00023261853,0.00007496196,0.00012561756,0.000028349748,0.00001665443,0.0001586993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99845845,0.00016079414,0.0005514283,0.00018624576,0.0004235915,0.00021947394],"domain_scores_gemma":[0.99898845,0.00008402994,0.000451145,0.0000893449,0.00027978575,0.00010722292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039658707,0.00011380162,0.00049377227,0.00013869643,0.00008951091,0.000014009593,0.00015665767,0.00003925633,0.00079954136],"category_scores_gemma":[0.00010282828,0.00011317523,0.00021628321,0.000295133,0.00010514018,0.00006209978,0.00007936811,0.0005226051,3.6283086e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065160496,0.005763128,0.35088265,0.00051692943,0.0008611572,0.00652827,0.0018287859,0.00046371415,0.18439049,0.00070324616,0.057918105,0.38362747],"study_design_scores_gemma":[0.0025623927,0.001419441,0.97490865,0.0003132371,0.000411614,0.0045036958,0.0007331975,0.0000104671535,0.009294576,0.000054108055,0.0056289146,0.00015968042],"about_ca_topic_score_codex":0.001813055,"about_ca_topic_score_gemma":0.0005418645,"teacher_disagreement_score":0.62402606,"about_ca_system_score_codex":0.00041567726,"about_ca_system_score_gemma":0.00031930493,"threshold_uncertainty_score":0.8754417},"labels":[],"label_agreement":null},{"id":"W4213427343","doi":"10.1038/s41416-022-01750-5","title":"Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Garlic and Onion Studies","field":"Agricultural and Biological Sciences","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences","keywords":"Odds ratio; Medicine; Confidence interval; Allium; Stomach cancer; Confounding; Allium sativum; Epidemiology; Cancer; Internal medicine; Biology; Botany","score_opus":0.01782355509378698,"score_gpt":0.2579065310850546,"score_spread":0.24008297599126766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213427343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8587932,0.13803902,7.858428e-7,0.0025402575,0.0002123091,0.00015329084,0.00014257974,0.0000025432566,0.00011604352],"genre_scores_gemma":[0.92854756,0.07056232,0.000008503688,0.00037680165,0.0003137779,0.00008768461,6.2175405e-7,0.0000010215896,0.0001017277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986805,0.00032736818,0.00031852428,0.000110137,0.00037955522,0.00018392487],"domain_scores_gemma":[0.9992261,0.00022518866,0.00038834492,0.000025726917,0.00011141608,0.000023258139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000987917,0.00008216643,0.0002559002,0.000017353013,0.00038168416,0.000049814804,0.00029703235,0.000021207496,0.00024834494],"category_scores_gemma":[0.000045379344,0.000028132634,0.00011967441,0.00038670044,0.00014652994,0.00007307478,0.00009541737,0.00037904037,7.678192e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003862929,0.00010124539,0.27009118,0.00002010515,0.00024880958,0.000044871937,0.0026807382,0.0012591633,0.0010506726,0.00007410465,0.0058438405,0.718199],"study_design_scores_gemma":[0.00086934917,0.00011499477,0.94086796,0.00012448437,0.00011613666,0.00019565398,0.005891998,0.000048660226,0.000035664667,0.00017221355,0.051467553,0.000095319476],"about_ca_topic_score_codex":0.051746007,"about_ca_topic_score_gemma":0.04409672,"teacher_disagreement_score":0.71810365,"about_ca_system_score_codex":0.000055715813,"about_ca_system_score_gemma":0.00006266059,"threshold_uncertainty_score":0.973346},"labels":[],"label_agreement":null},{"id":"W4214892600","doi":"10.1038/s41416-022-01752-3","title":"Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; University of Calgary; Cancer Care Ontario","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Public Health Agency; Cancer Society of New Zealand; Cancer Institute NSW; Cancer Research UK; Public Health Wales; World Health Organization","keywords":"Pancreatic cancer; Stage (stratigraphy); Medicine; Cancer; Population; Cancer registry; Survival rate; Internal medicine; Environmental health; Biology","score_opus":0.023853098063496968,"score_gpt":0.3506016265377209,"score_spread":0.326748528474224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214892600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862925,0.011673104,0.000012014676,0.0008462714,0.00025480342,0.0005459185,0.00028152415,0.0000086237105,0.00008524974],"genre_scores_gemma":[0.9955324,0.0017892172,0.0000734503,0.00028222374,0.00014797678,0.00015437584,0.000018570463,0.000026404516,0.001975381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750096,0.0004898809,0.00061349315,0.00019984199,0.0008822102,0.00031361272],"domain_scores_gemma":[0.998896,0.0003420048,0.00028842417,0.00011717337,0.00017986207,0.00017650449],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014640847,0.00013326218,0.00086134323,0.00018277127,0.00019833066,0.000049205977,0.00013596586,0.000051528146,0.0020106093],"category_scores_gemma":[0.00015215336,0.00014080001,0.000060631843,0.00028002146,0.00007113703,0.00010171829,0.000061483275,0.0006405455,5.8642e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009194032,0.00031605552,0.992457,0.00011654252,0.00022930249,0.0023474004,0.00030157276,0.00018727734,0.00003665569,0.0000064904257,0.0007430028,0.0023392986],"study_design_scores_gemma":[0.0069902414,0.0007475316,0.98796755,0.00033357023,0.00022926848,0.00014216019,0.0007987717,0.00014339725,0.0000059373233,0.000030841835,0.00247754,0.00013316963],"about_ca_topic_score_codex":0.048882283,"about_ca_topic_score_gemma":0.041859202,"teacher_disagreement_score":0.009883887,"about_ca_system_score_codex":0.0007537722,"about_ca_system_score_gemma":0.0009726965,"threshold_uncertainty_score":0.99890167},"labels":[],"label_agreement":null},{"id":"W4220831994","doi":"10.1038/s41416-022-01770-1","title":"The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"CHEK2; Medicine; Oophorectomy; Breast cancer; Internal medicine; Tamoxifen; Cancer; Gynecology; Oncology; Survival analysis; Surgery; Hysterectomy; Mutation; Germline mutation; Biology","score_opus":0.005139853108606226,"score_gpt":0.2682768304072974,"score_spread":0.2631369772986912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220831994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332404,0.004105081,0.000009413832,0.00014781754,0.0003554669,0.00010727101,0.0018463585,0.0000010806392,0.00010347281],"genre_scores_gemma":[0.9987684,0.00080969586,0.000033276327,0.000042408694,0.00019282787,0.000046861278,0.0000365804,0.000019739613,0.00005021414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904084,0.00009950764,0.00027255152,0.00012815258,0.00031434145,0.00014460167],"domain_scores_gemma":[0.9992029,0.000028453022,0.00030735263,0.000119261815,0.00029905172,0.000042961045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015795391,0.00008512469,0.00014602157,0.000042529777,0.00012560726,0.00002423017,0.00022181227,0.00003066918,0.00033190474],"category_scores_gemma":[0.00002132194,0.00007068139,0.00009870563,0.00018360048,0.00007621653,0.000006587997,0.000044892357,0.00020829034,1.8863197e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002387573,0.00035281415,0.7508971,0.0000052206733,0.00072060927,0.000020655407,0.00019229793,0.10828977,0.005608076,0.0000036728459,0.0047912095,0.12673101],"study_design_scores_gemma":[0.0019860065,0.0003693395,0.99369097,0.000058421974,0.000027387505,0.000028030527,0.000117683805,0.000018149418,0.0013653552,0.000037277317,0.002200756,0.00010061889],"about_ca_topic_score_codex":0.003551882,"about_ca_topic_score_gemma":0.0035410826,"teacher_disagreement_score":0.24279389,"about_ca_system_score_codex":0.0003412942,"about_ca_system_score_gemma":0.0007845426,"threshold_uncertainty_score":0.5369407},"labels":[],"label_agreement":null},{"id":"W4220935466","doi":"10.1038/s41416-022-01776-9","title":"Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Liquid biopsy; Minimal residual disease; Cell-free fetal DNA; Circulating tumor DNA; Medicine; Precision medicine; Clinical Practice; Biomarker; Disease; Lung cancer; Molecular diagnostics; Pathology; Oncology; Computational biology; Bioinformatics; Internal medicine; Cancer; Biology; Genetics","score_opus":0.1290395294019193,"score_gpt":0.40521467459769245,"score_spread":0.27617514519577313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220935466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023355128,0.9976959,0.00006201956,0.0003203131,0.0006327313,0.00013856916,0.00017277805,0.000003171627,0.00074092374],"genre_scores_gemma":[0.00006584197,0.99665195,0.0011724163,0.0002428775,0.0016170113,0.000034346194,0.00008765821,0.000051974035,0.00007590227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974718,0.0003743035,0.0012517652,0.00037403582,0.0003196418,0.00020845381],"domain_scores_gemma":[0.996984,0.00040820162,0.0017887751,0.00033518652,0.00029275098,0.00019105682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013966683,0.0002619282,0.0013726448,0.00016223147,0.00015041354,0.00015060298,0.0004688511,0.00027423416,0.00011968191],"category_scores_gemma":[0.0026449827,0.00028556393,0.0008957938,0.00016261732,0.00012549761,0.0000128237425,0.0004165559,0.0006368422,2.155809e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016358199,0.000049486225,0.000016665464,0.0010922657,0.00271072,0.00034906465,0.000036289613,0.000009041626,0.0000012086218,0.00005306371,0.0019389171,0.9937269],"study_design_scores_gemma":[0.00030667955,0.0002450605,0.000035034966,0.001644161,0.005122877,0.0015979303,0.00049678126,0.0000034782422,8.5427695e-7,0.000046719942,0.99020326,0.00029716355],"about_ca_topic_score_codex":0.00024990228,"about_ca_topic_score_gemma":0.0015739718,"teacher_disagreement_score":0.9934298,"about_ca_system_score_codex":0.000100647805,"about_ca_system_score_gemma":0.0011388472,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W4221040837","doi":"10.1038/s41416-022-01778-7","title":"VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Ottawa Hospital Foundation","keywords":"Invasive lobular carcinoma; Cancer research; Metastasis; In vitro; In vivo; Cell culture; Pathology; Cancer; Cancer cell; Cell growth; Breast cancer; Biology; Medicine; Internal medicine; Invasive ductal carcinoma","score_opus":0.014830665083671007,"score_gpt":0.24681060766266577,"score_spread":0.23197994257899476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221040837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974274,0.023768226,0.00031324016,0.00035377906,0.00025041928,0.00052645046,0.00036975197,0.000006910962,0.00013726791],"genre_scores_gemma":[0.99264604,0.004690062,0.0016175641,0.0006202116,0.00016700242,0.0000651927,0.000021071306,0.00005898083,0.000113851165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970369,0.00020484292,0.0008938522,0.00029606785,0.0011559657,0.00041241923],"domain_scores_gemma":[0.9980216,0.00008760309,0.0008054454,0.00022680365,0.0005520596,0.00030649145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004977464,0.00023791316,0.0010412893,0.00040507974,0.00010087708,0.00003422907,0.0002564831,0.000045437602,0.0006136224],"category_scores_gemma":[0.000048045877,0.00024575953,0.00031929053,0.00067084766,0.00016943584,0.00024965443,0.00011130647,0.0006676386,6.7573694e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034024943,0.01563764,0.07187299,0.0062774946,0.008355581,0.19512928,0.012879913,0.2221639,0.3191905,0.00011259418,0.021988012,0.09236716],"study_design_scores_gemma":[0.22803132,0.016063262,0.13542213,0.012364563,0.014573624,0.0709987,0.031453572,0.002816235,0.4708401,0.0017067058,0.012259252,0.003470551],"about_ca_topic_score_codex":0.01680357,"about_ca_topic_score_gemma":0.0042430973,"teacher_disagreement_score":0.21934766,"about_ca_system_score_codex":0.00044335998,"about_ca_system_score_gemma":0.0021987557,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W4225262145","doi":"10.1038/s41416-022-01823-5","title":"BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Texas MD Anderson Cancer Center; Genentech; Conquer Cancer Foundation; Science Foundation Ireland; Irish Research eLibrary; Michael Smith Health Research BC; American Society of Clinical Oncology","keywords":"XIAP; Inhibitor of apoptosis; PARP inhibitor; Cancer research; Ovarian cancer; Apoptosis; Cell culture; Olaparib; Biology; In vivo; Poly ADP ribose polymerase; Cancer; Programmed cell death; Caspase; Enzyme; Genetics; Biochemistry","score_opus":0.0077800579727623715,"score_gpt":0.2541820066008831,"score_spread":0.2464019486281207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225262145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350977,0.0044261394,0.00066595327,0.000426521,0.0005800116,0.00016745758,0.00016098193,0.0000025767463,0.00006057459],"genre_scores_gemma":[0.9965299,0.0010053149,0.0010093984,0.00045102957,0.0005444624,0.000028461343,0.000014034033,0.000020014138,0.00039742893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990474,0.000055338387,0.00031530453,0.00017519962,0.0002664355,0.0001403238],"domain_scores_gemma":[0.9993785,0.000006798948,0.00019287187,0.00008259403,0.00020720587,0.0001320289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015749302,0.00008920946,0.00017092023,0.00008456527,0.00014744843,0.000028516908,0.00007907772,0.00005697861,0.00006994545],"category_scores_gemma":[0.000025888812,0.00010297454,0.000079891055,0.0001397202,0.000022701219,0.000009583105,0.00012537409,0.00010954579,2.7002264e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012198228,0.000035345005,0.00016668154,0.000015477402,0.000036160363,0.0000072165576,0.00013707514,0.004028011,0.90518814,0.000006098181,0.0070962883,0.0831615],"study_design_scores_gemma":[0.0009798395,0.00047949492,0.0076195584,0.00037973543,0.00005234946,0.00018614923,0.0004093951,0.000050962844,0.92872137,0.00004569883,0.06086615,0.00020927525],"about_ca_topic_score_codex":0.0007210258,"about_ca_topic_score_gemma":0.00017578287,"teacher_disagreement_score":0.08295222,"about_ca_system_score_codex":0.00005604216,"about_ca_system_score_gemma":0.00014259717,"threshold_uncertainty_score":0.419918},"labels":[],"label_agreement":null},{"id":"W4226025919","doi":"10.1038/s41416-022-01797-4","title":"The STING pathway: Therapeutic vulnerabilities in ovarian cancer","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Government of Canada","keywords":"Immune system; Ovarian cancer; Cancer research; Tumor microenvironment; Biology; Immunology; Immunotherapy; Interferon; Cancer; Medicine; Genetics","score_opus":0.04738821610387843,"score_gpt":0.3369371907084461,"score_spread":0.28954897460456763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226025919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014526391,0.9950613,0.0000023660484,0.00010583717,0.003906991,0.00025523387,0.00011954316,0.00000771287,0.00039577452],"genre_scores_gemma":[0.00033572575,0.9927773,0.0000023414625,0.00011552167,0.00019305195,0.00018425962,0.0000087610515,0.000047720587,0.006335335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646217,0.0016773461,0.0011362025,0.00019381708,0.000093852366,0.0004366223],"domain_scores_gemma":[0.99775815,0.0010295465,0.0009102686,0.0001809745,0.00010203859,0.000019001889],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012583956,0.0002621837,0.0012276825,0.00016126854,0.00043752007,0.000099713856,0.0006715888,0.0002391863,0.00481253],"category_scores_gemma":[0.00023132809,0.0001992109,0.0005486774,0.00020970896,0.00021322629,0.00009075476,0.00012025654,0.0021211565,0.000011124474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011051242,0.000034841174,0.000009439531,0.0005263031,0.0005672994,0.00009484164,0.00014635878,0.000002801564,0.000031052525,0.00006663118,0.0010778185,0.9973321],"study_design_scores_gemma":[0.0005068837,0.00011861407,0.000060782266,0.009432925,0.00021322099,0.0026995556,0.0003322375,1.02604055e-7,0.000040788982,0.000042106094,0.98633826,0.00021451227],"about_ca_topic_score_codex":0.0017327948,"about_ca_topic_score_gemma":0.0019853571,"teacher_disagreement_score":0.9971176,"about_ca_system_score_codex":0.0005266358,"about_ca_system_score_gemma":0.0016586585,"threshold_uncertainty_score":0.9960972},"labels":[],"label_agreement":null},{"id":"W4230911957","doi":"10.1038/bjc.2015.81","title":"A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Kingston General Hospital; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"Fonds de Recherche du Québec - Santé; Queen's University; Ontario Institute for Cancer Research; Government of Ontario; Cancer Research Society","keywords":"Tumor microenvironment; Ovarian cancer; Immune system; Biology; Gene signature; Gene expression profiling; Cancer research; Tissue microarray; Chemotherapy; Serous fluid; Microarray analysis techniques; Cancer; Immunology; Gene expression; Medicine; Immunohistochemistry; Pathology; Internal medicine; Gene","score_opus":0.0198028542356665,"score_gpt":0.27721992786304395,"score_spread":0.2574170736273774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230911957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917706,0.005228914,0.000095583026,0.0020075843,0.00029888583,0.00020365634,0.00012647371,0.00001555043,0.00025271892],"genre_scores_gemma":[0.99604553,0.0008763957,0.0005888443,0.00067625864,0.000691595,0.000028367764,0.000006056595,0.000048077483,0.0010388702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838096,0.00006734126,0.00057883374,0.00019733036,0.00048967917,0.00028587598],"domain_scores_gemma":[0.9987996,0.000043493535,0.00058409973,0.000104325816,0.00025378636,0.00021464839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036383228,0.0001651941,0.0004516814,0.00009254767,0.000071717106,0.000057211746,0.00011116254,0.00007317715,0.00026357992],"category_scores_gemma":[0.00012918348,0.00016003325,0.000096956486,0.00017321622,0.0000763642,0.00015792555,0.000016060925,0.000520115,0.0000015330587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012240077,0.002726776,0.65583146,0.00042216157,0.0025788122,0.013298224,0.010473039,0.001811723,0.19290751,0.00005681125,0.04903758,0.05861581],"study_design_scores_gemma":[0.01223549,0.00042963054,0.9164652,0.008339393,0.00021547779,0.0011445695,0.00018948712,0.00006848241,0.018086165,0.00011101561,0.042383783,0.0003312834],"about_ca_topic_score_codex":0.0029558113,"about_ca_topic_score_gemma":0.0141434735,"teacher_disagreement_score":0.26063374,"about_ca_system_score_codex":0.0010669952,"about_ca_system_score_gemma":0.0005938838,"threshold_uncertainty_score":0.789239},"labels":[],"label_agreement":null},{"id":"W4231536325","doi":"10.1038/sj/bjc/6699167","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Medical Research Council; Medical Research Council","keywords":"Mifepristone; Progesterone receptor; Cell growth; Focal adhesion; MAPK/ERK pathway; Agonist; Transfection; Kinase; Chemistry; Cell biology; Endocrinology; Internal medicine; Receptor; Cell culture; Signal transduction; Biology; Medicine; Estrogen receptor; Cancer; Biochemistry; Breast cancer","score_opus":0.005171132987545773,"score_gpt":0.25775109446938793,"score_spread":0.25257996148184214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231536325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5113878,0.48339525,0.000096288626,0.001011382,0.0017684816,0.000039182953,0.000012755148,0.0000013555072,0.0022874842],"genre_scores_gemma":[0.60517097,0.37574118,0.0002032206,0.00038346168,0.0027612953,0.0000021903732,0.0000045662255,0.000026839052,0.015706247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897623,0.00009776858,0.00033968638,0.00013329688,0.00016835479,0.00028469056],"domain_scores_gemma":[0.9992289,0.00000966983,0.0002502437,0.0000923906,0.00022599469,0.00019282615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002176186,0.000120501005,0.00021336599,0.000030973995,0.00006938176,0.000060658116,0.0001723697,0.00030773136,0.0004282507],"category_scores_gemma":[0.000054244105,0.00014156279,0.00025126268,0.00010298346,0.000119441494,0.000010754651,0.000033848235,0.0003798624,0.000014969795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024456257,0.0001777693,0.00320494,0.00004488799,0.0005388563,0.0030788654,0.000030487206,0.00030427333,0.060478687,0.00003723139,0.0649409,0.86691856],"study_design_scores_gemma":[0.0013714678,0.00052094687,0.0028372,0.00068787514,0.00016782097,0.016965775,0.00003107499,0.000018809866,0.030481407,0.00007830692,0.9466426,0.00019674168],"about_ca_topic_score_codex":0.00022237517,"about_ca_topic_score_gemma":0.00016165929,"teacher_disagreement_score":0.88170165,"about_ca_system_score_codex":0.000045217712,"about_ca_system_score_gemma":0.00027270094,"threshold_uncertainty_score":0.5772763},"labels":[],"label_agreement":null},{"id":"W4232472258","doi":"10.1038/sj/bjc/6692125","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Ottawa; Statistics Canada","funders":"National Cancer Institute","keywords":"Tamoxifen; Medicine; Breast cancer; Gynecology; Endometrial cancer; Population; Cancer; Internal medicine; Demography; Obstetrics; Oncology; Environmental health","score_opus":0.01801247497500425,"score_gpt":0.3237475982634707,"score_spread":0.30573512328846647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232472258","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42435756,0.5589999,0.00012282546,0.0028639447,0.00906645,0.00007253764,0.000047736245,0.000006174242,0.004462863],"genre_scores_gemma":[0.5006932,0.45893312,0.000105676154,0.00096032064,0.010491443,0.0000024729266,0.0000010663323,0.00003294675,0.028779779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837726,0.000048507558,0.00058966706,0.00012615992,0.00044034462,0.00041805164],"domain_scores_gemma":[0.9987389,0.000042446707,0.00036135348,0.00010112273,0.00035563955,0.0004005745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031699316,0.00013285404,0.0004733233,0.00008388528,0.000066198554,0.00008111313,0.00013499436,0.00013945624,0.013744711],"category_scores_gemma":[0.00008896041,0.000154492,0.0003023992,0.00023442981,0.00014389779,0.00025438875,0.000018685101,0.0006366114,0.00004420017],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021266159,0.00013049698,0.08092356,0.00007369703,0.00022856101,0.006114226,0.00013022173,0.00006785389,0.00019087267,0.000028682256,0.065573014,0.8463262],"study_design_scores_gemma":[0.0021041462,0.00024902404,0.19983532,0.0037224083,0.00032738794,0.017541943,0.00014072371,0.000020911406,0.0001127587,0.00010935848,0.7757054,0.00013063547],"about_ca_topic_score_codex":0.008422395,"about_ca_topic_score_gemma":0.005225762,"teacher_disagreement_score":0.8461955,"about_ca_system_score_codex":0.0005095442,"about_ca_system_score_gemma":0.0006999142,"threshold_uncertainty_score":0.9981806},"labels":[],"label_agreement":null},{"id":"W4232940111","doi":"10.1038/sj/bjc/6692165","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"National Institutes of Health","keywords":"P-glycoprotein; Chemosensitizer; Umbilical vein; Cytotoxicity; Pharmacology; Cancer cell; Cytotoxic T cell; Cell culture; Poloxamer; Chemistry; Multiple drug resistance; Biochemistry; Biology; Medicine; In vitro; Cancer; Internal medicine","score_opus":0.014471694898980102,"score_gpt":0.26917431887659626,"score_spread":0.25470262397761617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232940111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78582627,0.2012305,0.00017174185,0.0041961432,0.0074767834,0.00007434189,0.00006544554,0.00001119685,0.0009476109],"genre_scores_gemma":[0.9288821,0.052123748,0.0012302327,0.0012079293,0.0036504806,0.0000053828917,5.042448e-7,0.00004174725,0.012857861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976485,0.00022164178,0.00077932404,0.00019288412,0.00061328005,0.0005443901],"domain_scores_gemma":[0.9983198,0.0000977728,0.00054549036,0.00015279962,0.0005535126,0.00033060394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009203643,0.00014953109,0.00039045216,0.00007914419,0.00012941044,0.0003388742,0.00040306582,0.00011568681,0.01346797],"category_scores_gemma":[0.00018606073,0.0001888287,0.00019364253,0.000317628,0.00025886163,0.0008954011,0.00005332756,0.00033225658,0.00030157607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038959328,0.0004962079,0.0047454,0.00010521199,0.00009846911,0.0138078,0.00023562076,0.0027634006,0.21666668,0.00020255244,0.08081629,0.6796728],"study_design_scores_gemma":[0.003154279,0.00037498033,0.01134207,0.0033543715,0.00029398178,0.018779801,0.00019155399,0.00023793803,0.14883858,0.0010479917,0.81189793,0.00048650696],"about_ca_topic_score_codex":0.0027428067,"about_ca_topic_score_gemma":0.0023380306,"teacher_disagreement_score":0.73108166,"about_ca_system_score_codex":0.00032989727,"about_ca_system_score_gemma":0.0006087761,"threshold_uncertainty_score":0.98743385},"labels":[],"label_agreement":null},{"id":"W4233215484","doi":"10.1038/sj/bjc/6692090","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnancy; Medicine; Gestation; Malignancy; In utero; Fetus; Cancer; Obstetrics; Pediatrics; Pathology; Internal medicine","score_opus":0.01801247497500425,"score_gpt":0.3237475982634707,"score_spread":0.30573512328846647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233215484","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42435756,0.5589999,0.00012282546,0.0028639447,0.00906645,0.00007253764,0.000047736245,0.000006174242,0.004462863],"genre_scores_gemma":[0.5006932,0.45893312,0.000105676154,0.00096032064,0.010491443,0.0000024729266,0.0000010663323,0.00003294675,0.028779779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837726,0.000048507558,0.00058966706,0.00012615992,0.00044034462,0.00041805164],"domain_scores_gemma":[0.9987389,0.000042446707,0.00036135348,0.00010112273,0.00035563955,0.0004005745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031699316,0.00013285404,0.0004733233,0.00008388528,0.000066198554,0.00008111313,0.00013499436,0.00013945624,0.013744711],"category_scores_gemma":[0.00008896041,0.000154492,0.0003023992,0.00023442981,0.00014389779,0.00025438875,0.000018685101,0.0006366114,0.00004420017],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021266159,0.00013049698,0.08092356,0.00007369703,0.00022856101,0.006114226,0.00013022173,0.00006785389,0.00019087267,0.000028682256,0.065573014,0.8463262],"study_design_scores_gemma":[0.0021041462,0.00024902404,0.19983532,0.0037224083,0.00032738794,0.017541943,0.00014072371,0.000020911406,0.0001127587,0.00010935848,0.7757054,0.00013063547],"about_ca_topic_score_codex":0.008422395,"about_ca_topic_score_gemma":0.005225762,"teacher_disagreement_score":0.8461955,"about_ca_system_score_codex":0.0005095442,"about_ca_system_score_gemma":0.0006999142,"threshold_uncertainty_score":0.9981806},"labels":[],"label_agreement":null},{"id":"W4235465754","doi":"10.1038/bjc.2013.828","title":"Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; York University; St. Michael's Hospital","funders":"Kidney Foundation of Canada; Prostate Cancer Canada; Canadian Institutes of Health Research; Government of Ontario; Cancer Research Society","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Clear cell renal cell carcinoma; Protein kinase B; Biology; Renal cell carcinoma; Metastasis; Galectin-1; Galectin-3; Targeted therapy; Signal transduction; Cancer; Medicine; Pathology; Internal medicine; Immunology; Cell biology","score_opus":0.011038901967490721,"score_gpt":0.24253939947210065,"score_spread":0.23150049750460994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235465754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396489,0.058024377,0.00028845042,0.0009054525,0.00055881543,0.00026488688,0.000021245956,0.000011474213,0.00027635758],"genre_scores_gemma":[0.99751145,0.0013501971,0.00017078605,0.00035146033,0.00024555202,0.000029740377,0.0000046349874,0.000023403043,0.0003127737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983232,0.0003510857,0.00051834685,0.00030259654,0.00007851537,0.00042627042],"domain_scores_gemma":[0.9990369,0.00011035534,0.0004739709,0.00014336684,0.00019608739,0.0000393174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039186678,0.00017443263,0.00036076305,0.000056268316,0.00032975955,0.000077364486,0.000323469,0.00022253909,0.0004373631],"category_scores_gemma":[0.000056082958,0.00014207463,0.000108538494,0.00018488822,0.00033597456,0.0001059612,0.000081822494,0.0007166328,0.000008166462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073826517,0.00018796047,0.018967938,0.00007039209,0.000071391965,0.0000770748,0.000866259,0.000048294245,0.90095454,0.0000043768223,0.009760487,0.06825304],"study_design_scores_gemma":[0.006550236,0.002480794,0.18546322,0.00060568564,0.00026328376,0.003277809,0.0004998348,0.00003857151,0.6948247,0.0006171291,0.104798846,0.00057991646],"about_ca_topic_score_codex":0.0014887346,"about_ca_topic_score_gemma":0.00040570306,"teacher_disagreement_score":0.20612985,"about_ca_system_score_codex":0.00006639646,"about_ca_system_score_gemma":0.00019711102,"threshold_uncertainty_score":0.57936347},"labels":[],"label_agreement":null},{"id":"W4235802262","doi":"10.1038/sj/bjc/6692170","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Conjugate; Carcinoembryonic antigen; Molecular biology; Monoclonal antibody; Cell culture; Incubation; Antigen; Chemistry; Cytotoxicity; Antibody; Biology; Biochemistry; In vitro; Immunology; Cancer","score_opus":0.019332793656473023,"score_gpt":0.3553876841786613,"score_spread":0.3360548905221883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235802262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43832034,0.54807407,0.000046129066,0.0065229926,0.0031128011,0.00010590785,0.00003715254,0.000005177412,0.0037754185],"genre_scores_gemma":[0.33681267,0.61438566,0.00010962549,0.00069519575,0.005063509,0.0000062002728,6.7935747e-7,0.000030376077,0.042896077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979427,0.00012705692,0.00054326694,0.00012997366,0.0006734451,0.00058358995],"domain_scores_gemma":[0.9985277,0.0001162462,0.00026849314,0.000111842506,0.0006091968,0.0003665357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068408623,0.00013686229,0.0005288574,0.00010900623,0.00010555829,0.000067051966,0.00020725852,0.00010144878,0.0067193345],"category_scores_gemma":[0.0003551595,0.00015302519,0.00025147962,0.00028521882,0.00030902476,0.00024085009,0.00004253792,0.0008016951,0.000037797116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051678426,0.00023498366,0.005125723,0.0001327631,0.00090823974,0.015762005,0.00023268115,0.000039006565,0.004552668,0.00002945566,0.051335327,0.92113036],"study_design_scores_gemma":[0.0037205643,0.0005652765,0.09261419,0.0065379986,0.0002412077,0.02251785,0.00033487417,0.00006717492,0.0007938566,0.000391586,0.87205386,0.00016154366],"about_ca_topic_score_codex":0.0019940634,"about_ca_topic_score_gemma":0.002175215,"teacher_disagreement_score":0.92096883,"about_ca_system_score_codex":0.00059282937,"about_ca_system_score_gemma":0.0006773951,"threshold_uncertainty_score":0.99418867},"labels":[],"label_agreement":null},{"id":"W4237285223","doi":"10.1038/s41416-018-0079-9","title":"Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study","year":2018,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Radiation therapy; Chemotherapy; Medicine; Multicenter study; Oncology; Medical physics; Radiology; Nuclear medicine; Surgery; Randomized controlled trial","score_opus":0.012780960527582512,"score_gpt":0.3004080317907772,"score_spread":0.2876270712631947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237285223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90406775,0.07419297,0.00005485472,0.0014215973,0.015249586,0.002858597,0.00003963541,0.00003995715,0.0020750451],"genre_scores_gemma":[0.63954526,0.063681155,0.016553551,0.01164057,0.03434934,0.001466923,0.00017935807,0.0010882578,0.2314956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975847,0.000078771016,0.0008371732,0.0003025179,0.00094029657,0.00025653082],"domain_scores_gemma":[0.9976593,0.000063629705,0.00101721,0.0002111502,0.000820699,0.00022798398],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028782486,0.00031807958,0.0010862029,0.00029445492,0.000103087914,0.000073153366,0.0002033253,0.00017398164,0.0019226164],"category_scores_gemma":[0.00004348486,0.00026765128,0.00016673878,0.0002982318,0.00005940572,0.00008723121,0.00001619506,0.00047809148,0.00001334414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009028977,0.0016969065,0.044490445,0.000053819767,0.0027043766,0.0003411334,0.0014690291,0.000005852223,0.00010572485,1.3411416e-8,0.41641283,0.53181696],"study_design_scores_gemma":[0.008771268,0.0031321263,0.46002662,0.0057173986,0.0005002412,0.0005683793,0.0002163329,0.000016591652,0.0016812296,3.5520063e-7,0.51908606,0.0002833615],"about_ca_topic_score_codex":0.0003705531,"about_ca_topic_score_gemma":0.0010909544,"teacher_disagreement_score":0.5315336,"about_ca_system_score_codex":0.0006067323,"about_ca_system_score_gemma":0.0015454995,"threshold_uncertainty_score":0.9999776},"labels":[],"label_agreement":null},{"id":"W4238063550","doi":"10.1038/sj/bjc/6692068","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CDKN2A; Loss of heterozygosity; Biology; Cancer; Head and neck cancer; Genetic predisposition; Cancer research; Tumor suppressor gene; Epidermoid carcinoma; Genetics; Oncology; Gene; Pathology; Medicine; Allele; Carcinogenesis","score_opus":0.012580388318726245,"score_gpt":0.28550654181072066,"score_spread":0.2729261534919944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238063550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19472039,0.7745077,0.00086816243,0.005543398,0.013810243,0.00016760497,0.00005553088,0.000013624677,0.01031333],"genre_scores_gemma":[0.41241124,0.5381114,0.00069716416,0.002227885,0.013783506,0.0000094275865,0.000004004439,0.00011749048,0.032637857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976194,0.00011249577,0.0008083537,0.00019736472,0.0006698787,0.0005924871],"domain_scores_gemma":[0.9981335,0.00004758757,0.00050817593,0.00018016598,0.00061136886,0.00051920675],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004733621,0.00019311512,0.00058093737,0.0001408472,0.00008378798,0.00008752238,0.0002058543,0.00026963593,0.008734884],"category_scores_gemma":[0.00025012207,0.00025175067,0.00041397518,0.00041512857,0.0001934117,0.0002485251,0.000033876604,0.0011123485,0.00010942054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031243666,0.0002220752,0.0017613664,0.00012689157,0.0005281444,0.028121056,0.00013293486,0.00052309,0.0039488864,0.00007598988,0.08563344,0.8786137],"study_design_scores_gemma":[0.0044227703,0.0004428862,0.012966895,0.0095799295,0.00075262197,0.06536445,0.00010833852,0.00010184707,0.0022545815,0.00018196291,0.90358657,0.00023712045],"about_ca_topic_score_codex":0.0018771482,"about_ca_topic_score_gemma":0.0016649887,"teacher_disagreement_score":0.87837654,"about_ca_system_score_codex":0.0008514767,"about_ca_system_score_gemma":0.0012890124,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W4239805948","doi":"10.1038/s41416-020-0841-7","title":"Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ataxia-telangiectasia; Poly ADP ribose polymerase; Polymerase; Cancer research; Medicine; License; Genetics; Biology; DNA; DNA damage; Computer science","score_opus":0.004985807314524316,"score_gpt":0.2337666823136347,"score_spread":0.2287808749991104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239805948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8990076,0.096128196,0.0007667766,0.00078372494,0.0023411151,0.00036647273,0.00037048713,0.000055821554,0.00017980217],"genre_scores_gemma":[0.9913909,0.0058684265,0.00020380758,0.0009371087,0.00076030736,0.000033099004,0.00015659574,0.000086081054,0.0005636804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976721,0.0001601089,0.0007267826,0.00052087737,0.0004312202,0.0004889426],"domain_scores_gemma":[0.9984426,0.000020074976,0.0005918833,0.00017693045,0.00032870134,0.0004398493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021245173,0.00033379078,0.00046332448,0.000099000004,0.00019982134,0.00013798013,0.00020984032,0.00028505322,0.00039103915],"category_scores_gemma":[0.00008603767,0.00038545957,0.00024026274,0.00032251462,0.0001199397,0.000043925203,0.0001326409,0.0004875677,0.0000075422367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008410693,0.00018597233,0.001108511,0.00011099622,0.0005755364,0.0014730295,0.00035569278,0.0008665754,0.90885425,0.0000061466144,0.06207486,0.023547338],"study_design_scores_gemma":[0.0040963795,0.00087805995,0.0017880428,0.0005546565,0.00032829487,0.0026981095,0.00023429026,0.0023317665,0.9751594,0.000020861617,0.011291677,0.0006184612],"about_ca_topic_score_codex":0.00078291347,"about_ca_topic_score_gemma":0.00025946047,"teacher_disagreement_score":0.092383295,"about_ca_system_score_codex":0.00013425479,"about_ca_system_score_gemma":0.00033204997,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W4240087065","doi":"10.1038/s41416-019-0545-z","title":"Correction: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Cervical cancer; Medicine; Chemotherapy; Oncology; Cancer; Myeloid; CXCR4; Cancer research; Internal medicine; Medical physics; Computer science; Bioinformatics; Biology; Receptor","score_opus":0.009744363842875914,"score_gpt":0.2517582186876948,"score_spread":0.2420138548448189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240087065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977654,0.01885026,0.0001245799,0.0016479132,0.00073252956,0.0007231986,0.000016460483,0.000010880044,0.00024022574],"genre_scores_gemma":[0.9896969,0.0068864827,0.00014319322,0.0024359573,0.00035934712,0.00006920618,0.0000020658626,0.000035274865,0.00037153318],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985608,0.00007629993,0.00043459976,0.00023754728,0.00041204115,0.00027870535],"domain_scores_gemma":[0.99910223,0.000104116756,0.0002326213,0.00010874817,0.00026561794,0.00018663182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015474338,0.00017912073,0.0004893029,0.0000985531,0.00007320262,0.00008365714,0.00009340367,0.00007632985,0.0005284594],"category_scores_gemma":[0.000013660055,0.00012062382,0.00009084274,0.00043074274,0.0000482805,0.00021488796,0.000017707702,0.0003567491,0.0000021902586],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007462458,0.0003310549,0.043525644,0.00009371679,0.0007193775,0.0002677324,0.0013932392,0.0033249706,0.08078604,0.0000047275553,0.0010593212,0.8610317],"study_design_scores_gemma":[0.09677473,0.015899306,0.4473158,0.00789597,0.0017026677,0.0035741567,0.0046136715,0.011584243,0.38029405,0.00038677434,0.027992344,0.0019662706],"about_ca_topic_score_codex":0.0039429795,"about_ca_topic_score_gemma":0.0011878734,"teacher_disagreement_score":0.8590654,"about_ca_system_score_codex":0.0003404527,"about_ca_system_score_gemma":0.0002332464,"threshold_uncertainty_score":0.5960632},"labels":[],"label_agreement":null},{"id":"W4243200943","doi":"10.1038/sj/bjc/6692061","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Thyroid cancer; Medicine; Incidence (geometry); Cohort; Cohort effect; Demography; Cohort study; Thyroid; Internal medicine","score_opus":0.05867303821499509,"score_gpt":0.3668876207907418,"score_spread":0.3082145825757467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243200943","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3139082,0.6607032,0.0003131797,0.0058708307,0.0063575855,0.000075941054,0.000023496237,0.0000066586335,0.01274094],"genre_scores_gemma":[0.65651983,0.3034741,0.000661946,0.0032550644,0.012335795,0.0000034203892,0.0000011749463,0.00003133444,0.02371735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979131,0.00007408455,0.00067046337,0.00014433064,0.0006757286,0.00052225916],"domain_scores_gemma":[0.9983769,0.00004856039,0.00039939742,0.00010964159,0.00062840653,0.00043710804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058629515,0.00014122107,0.00048161895,0.00007720924,0.00009229645,0.00010319183,0.0002083581,0.00015186629,0.008348431],"category_scores_gemma":[0.00022982984,0.00017016224,0.00028634325,0.00032222134,0.00015128845,0.00045998424,0.000027318685,0.00067831,0.00006673156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030306986,0.00007409712,0.037292648,0.00007217349,0.0002054462,0.018058252,0.0001013624,0.00021974168,0.00022745336,0.00009403093,0.09198804,0.85136366],"study_design_scores_gemma":[0.0020555344,0.0004086914,0.09044522,0.010438319,0.00041690655,0.044644877,0.00038381558,0.00006263823,0.00026324598,0.00031477815,0.8503942,0.00017177737],"about_ca_topic_score_codex":0.005183428,"about_ca_topic_score_gemma":0.002460898,"teacher_disagreement_score":0.8511919,"about_ca_system_score_codex":0.00050084695,"about_ca_system_score_gemma":0.0007959291,"threshold_uncertainty_score":0.99255806},"labels":[],"label_agreement":null},{"id":"W4249260600","doi":"10.1038/sj/bjc/6692196","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Epithelial ovarian cancer; Gynecology; Cytoreductive surgery; Multivariate analysis; Surgery; General surgery; Internal medicine","score_opus":0.016977546098720382,"score_gpt":0.3110622925530365,"score_spread":0.29408474645431615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249260600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1638099,0.7986739,0.00007041575,0.01934573,0.009308364,0.00013609447,0.00006000126,0.000005976127,0.0085895695],"genre_scores_gemma":[0.43346965,0.53571117,0.00036177947,0.001454057,0.009076863,0.00001145599,0.0000015963607,0.000034957517,0.019878484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983487,0.00006590991,0.0005872819,0.00015574339,0.0004263665,0.00041599126],"domain_scores_gemma":[0.99868965,0.00006539004,0.0003590261,0.00012189815,0.00036740044,0.00039660462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028847466,0.00015091516,0.00050671643,0.000075076525,0.00007228449,0.00009220135,0.000116002426,0.0001238347,0.013994917],"category_scores_gemma":[0.00006764312,0.00016898365,0.00030856737,0.0002214298,0.00010750039,0.0002264115,0.000017579832,0.0004022996,0.000080300546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001518521,0.0005522832,0.05289582,0.00008453623,0.0007000967,0.019290188,0.00008474144,0.000072896335,0.00003067568,0.00014442891,0.084143296,0.8418492],"study_design_scores_gemma":[0.0042261076,0.00047597417,0.18978012,0.0067928075,0.00086157053,0.016702812,0.000080741665,0.000014977428,0.00028251062,0.00019979294,0.7804522,0.00013038128],"about_ca_topic_score_codex":0.0026511438,"about_ca_topic_score_gemma":0.0014348637,"teacher_disagreement_score":0.8417188,"about_ca_system_score_codex":0.0007090435,"about_ca_system_score_gemma":0.00072410936,"threshold_uncertainty_score":0.9869064},"labels":[],"label_agreement":null},{"id":"W4249395892","doi":"10.1038/sj/bjc/6692123","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Radiosensitivity; Perfusion; Hypoxia (environmental); Oxygenation; Biology; Cancer research; In vivo; Pathology; Cell; Medicine; Radiation therapy; Internal medicine; Chemistry; Oxygen; Biochemistry","score_opus":0.008798194602253308,"score_gpt":0.26561899820854096,"score_spread":0.2568208036062877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249395892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31367743,0.66853505,0.00031827722,0.0015304113,0.013004937,0.00006255393,0.000072540955,0.0000021264143,0.0027966816],"genre_scores_gemma":[0.18926856,0.7433156,0.00039906995,0.0012208287,0.028878607,0.000006115267,0.0000074392296,0.00004250512,0.03686128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856323,0.000088990906,0.000493051,0.00020231186,0.00025736814,0.00039505673],"domain_scores_gemma":[0.9987918,0.000009008197,0.0003618515,0.00015359109,0.00042476028,0.00025895674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029126427,0.0001632984,0.000344176,0.000046160323,0.00008455248,0.00009476172,0.00025880893,0.00024793614,0.0011987544],"category_scores_gemma":[0.00008644561,0.00020956121,0.00034065923,0.00013349832,0.00015927413,0.000019078063,0.00004940793,0.0003253905,0.000010565929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017113863,0.00011026987,0.00078587735,0.000038025468,0.00023816756,0.00020664422,0.000037308666,0.00013062346,0.02663002,0.00003476805,0.16057298,0.8110442],"study_design_scores_gemma":[0.0016038121,0.0001789773,0.0060965098,0.00042155644,0.00018207415,0.0072977617,0.000054417535,0.0000057956554,0.007478019,0.00011452129,0.97633153,0.00023503577],"about_ca_topic_score_codex":0.0008738772,"about_ca_topic_score_gemma":0.00278132,"teacher_disagreement_score":0.8157585,"about_ca_system_score_codex":0.0000603579,"about_ca_system_score_gemma":0.00058451685,"threshold_uncertainty_score":0.99971426},"labels":[],"label_agreement":null},{"id":"W4250051927","doi":"10.1038/bjc.2011.413","title":"Reply: ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.07103125588195205,"score_gpt":0.35296899868407755,"score_spread":0.28193774280212547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250051927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894819,0.007143858,0.000093941264,0.000060929993,0.0015156872,0.00031515406,0.00033188512,0.000012100777,0.001044539],"genre_scores_gemma":[0.9944549,0.0015497816,0.0027643205,0.00037976998,0.0006306605,0.0000142490035,0.00000627067,0.00004604143,0.00015401468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971238,0.00008062557,0.0014648081,0.0003228414,0.0007108446,0.00029708244],"domain_scores_gemma":[0.99706876,0.00017101233,0.0011423007,0.00037918313,0.0009585731,0.00028015117],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026707753,0.0002079802,0.00086491514,0.00008567716,0.00006221962,0.000031491672,0.00029815608,0.00016510201,0.001886829],"category_scores_gemma":[0.00064453424,0.00020917786,0.00045209745,0.00013283484,0.0001548397,0.00016361279,0.000101300124,0.00035925602,0.0000036866816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005908337,0.00038340205,0.68979216,0.000035309782,0.00064769207,0.0002421832,0.00072196824,0.000016458607,0.00054675475,0.0000016924602,0.0013931376,0.3056284],"study_design_scores_gemma":[0.005756459,0.0013483824,0.97954184,0.0021078617,0.00045464764,0.0001712447,0.00008053531,0.000012633033,0.008816435,0.00073302916,0.0007978939,0.00017903009],"about_ca_topic_score_codex":0.0060738097,"about_ca_topic_score_gemma":0.0014644108,"teacher_disagreement_score":0.30544937,"about_ca_system_score_codex":0.0004412963,"about_ca_system_score_gemma":0.0005432596,"threshold_uncertainty_score":0.9990256},"labels":[],"label_agreement":null},{"id":"W4251412578","doi":"10.1038/s41416-019-0512-8","title":"Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy","year":2019,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; PD-L1; Internal medicine; Oncology; Immunotherapy; Pathology; Cancer","score_opus":0.006148988101065753,"score_gpt":0.26583518499217446,"score_spread":0.2596861968911087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251412578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.839063,0.1526418,0.000022585346,0.00006363252,0.0067034066,0.00071674003,0.00016700776,0.0000036722026,0.00061814307],"genre_scores_gemma":[0.92282987,0.073758796,0.00003165622,0.00010816658,0.00049548765,0.000015500034,0.00004219566,0.00003842182,0.0026799215],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853045,0.00006747464,0.0006543986,0.00018216282,0.0004187956,0.00014674845],"domain_scores_gemma":[0.99830544,0.000059438782,0.0009692989,0.000083566185,0.00052343524,0.00005883231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021201196,0.00016729686,0.00068217446,0.00023451715,0.00002671147,0.000023334811,0.000072343915,0.00019681282,0.00010129304],"category_scores_gemma":[0.00006400341,0.00016744494,0.00008739989,0.00016785611,0.00014676571,0.00015510668,0.00001862711,0.00047746577,7.6280365e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063002594,0.0005147525,0.27147138,0.001289399,0.0007332329,0.00010410327,0.0008466146,0.0000135315495,0.0025901918,4.24237e-7,0.053711116,0.662425],"study_design_scores_gemma":[0.0052017136,0.0014972318,0.96725184,0.009066446,0.00020653066,0.0005126404,0.0002017588,0.00019367244,0.0012982195,0.000015233474,0.014401723,0.00015297695],"about_ca_topic_score_codex":0.00067428505,"about_ca_topic_score_gemma":0.00031191084,"teacher_disagreement_score":0.69578046,"about_ca_system_score_codex":0.00017411106,"about_ca_system_score_gemma":0.00047494087,"threshold_uncertainty_score":0.6828207},"labels":[],"label_agreement":null},{"id":"W4281391945","doi":"10.1038/s41416-022-01856-w","title":"Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Universidade do Porto; Fundação de Amparo à Pesquisa do Estado de São Paulo; Fundação para a Ciência e a Tecnologia; Associazione Italiana per la Ricerca sul Cancro; Kræftens Bekæmpelse","keywords":"Stomach cancer; Stomach; Pooling; Cancer; Medicine; Oncology; Internal medicine; Computer science","score_opus":0.01947061261795343,"score_gpt":0.3111726811699044,"score_spread":0.29170206855195097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281391945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8374543,0.15998286,0.000056019206,0.0013648755,0.00042472422,0.00028532278,0.0003870757,0.000015037376,0.000029765826],"genre_scores_gemma":[0.97766423,0.019909585,0.000084848,0.0012688168,0.00068672665,0.00013475814,0.000011747026,0.000024227767,0.00021505202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998278,0.0001977474,0.00044941416,0.00022519562,0.00056203606,0.00028756273],"domain_scores_gemma":[0.99894357,0.00014033892,0.00048233898,0.00013112338,0.00016630854,0.00013629731],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042940077,0.00014435804,0.0005436276,0.00018052306,0.00032807383,0.0000855629,0.00014450515,0.000039391995,0.0014595378],"category_scores_gemma":[0.00006313239,0.00012463861,0.0002216043,0.0006134379,0.0000939295,0.00010084951,0.00007159126,0.0006405517,5.918253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007993103,0.000115164854,0.65641177,0.0000674275,0.0043019815,0.00069877267,0.00076630095,0.0017325919,0.0041271984,0.0000038374615,0.011142249,0.31983343],"study_design_scores_gemma":[0.0038981487,0.0002465558,0.9643029,0.0005469085,0.008965918,0.0018297501,0.0006610666,0.0014397489,0.00033269823,0.000016337073,0.017536584,0.00022341515],"about_ca_topic_score_codex":0.049163386,"about_ca_topic_score_gemma":0.007302506,"teacher_disagreement_score":0.31961,"about_ca_system_score_codex":0.00038557392,"about_ca_system_score_gemma":0.00064977625,"threshold_uncertainty_score":0.99945325},"labels":[],"label_agreement":null},{"id":"W4281561154","doi":"10.1038/s41416-022-01844-0","title":"Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ontario Institute for Cancer Research; Cancer Care Ontario","funders":"Medical Research Council; Cancer Research UK","keywords":"Medicine; Referral; Benchmarking; Cancer; General partnership; Family medicine; Ovarian cancer; Internal medicine","score_opus":0.0191230772184172,"score_gpt":0.3031562460684541,"score_spread":0.2840331688500369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281561154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8734452,0.054541435,0.00008618161,0.064108856,0.004238364,0.0007302844,0.0022439472,0.000017065378,0.00058864185],"genre_scores_gemma":[0.97518724,0.017823862,0.000306532,0.0024335627,0.002398264,0.00096421543,0.00006646635,0.000033341308,0.00078650727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838763,0.00006335346,0.0005475557,0.0002649038,0.00051625556,0.00022030363],"domain_scores_gemma":[0.99856985,0.00068032695,0.00032170783,0.000092331284,0.00023132982,0.00010442841],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048586517,0.00014881084,0.00034401505,0.00013073235,0.00018597877,0.00014515931,0.00027156825,0.000044844837,0.008527371],"category_scores_gemma":[0.00021197108,0.00013711404,0.00016291748,0.0001552856,0.000059957318,0.00019649639,0.00012122825,0.00042043693,9.4681474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006476544,0.00032407683,0.7337521,0.000020835021,0.0013913028,0.00031813115,0.0010809334,0.00165133,0.00020893842,0.000106027204,0.058472972,0.20202571],"study_design_scores_gemma":[0.006420145,0.00023720946,0.7970349,0.0018576366,0.0004750719,0.00037671532,0.00019380094,0.0014758913,0.00021237327,0.0003536093,0.19117136,0.00019124537],"about_ca_topic_score_codex":0.007116893,"about_ca_topic_score_gemma":0.0046099266,"teacher_disagreement_score":0.20183447,"about_ca_system_score_codex":0.0010323412,"about_ca_system_score_gemma":0.00042692974,"threshold_uncertainty_score":0.9994948},"labels":[],"label_agreement":null},{"id":"W4281703599","doi":"10.1038/s41416-022-01859-7","title":"Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"National Cancer Institute; European Regional Development Fund; Engineering and Physical Sciences Research Council; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; Fondation contre le Cancer; Stichting Tegen Kanker; Generalitat de Catalunya; Umeå Universitet; Koning Boudewijnstichting; Knut och Alice Wallenbergs Stiftelse; Cancerfonden; Vetenskapsrådet; Government of Canada; Cancer Research Foundation in Northern Sweden; Research Councils UK; McGill University","keywords":"Histopathology; Metastasis; Liver cancer; Biology; Cancer; Colorectal cancer; Pathology; Medicine; Bioinformatics; Internal medicine","score_opus":0.10417403090189503,"score_gpt":0.39629367409761557,"score_spread":0.29211964319572054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281703599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074728683,0.995565,0.0020447206,0.00042539398,0.0005338106,0.00046332975,0.00018398916,0.000011064583,0.000025383963],"genre_scores_gemma":[0.00048435695,0.9965496,0.0018418165,0.00032151403,0.00057293935,0.00004497828,0.000037864836,0.000055744706,0.0000911727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975583,0.00024794065,0.0011953312,0.00032342318,0.00045819054,0.00021680284],"domain_scores_gemma":[0.9972566,0.00021721197,0.0012663465,0.00011812901,0.0009453553,0.00019638405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078022596,0.0002614808,0.0019352465,0.00022560368,0.00009946601,0.000035584588,0.00018280848,0.000116077965,0.00061604247],"category_scores_gemma":[0.0019641668,0.00021909285,0.00045722033,0.00012793284,0.00011404003,0.0000328519,0.000087739936,0.0009182836,2.2464968e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044103806,0.00009428162,0.000045195262,0.005298313,0.00046255958,0.0019503922,0.00009493206,0.0000014356689,0.000004333735,0.000046629826,0.002736104,0.9892217],"study_design_scores_gemma":[0.0011493146,0.00039884556,0.00013530445,0.017361354,0.0034285968,0.013344104,0.00018811265,0.000074973526,0.0000026239954,0.00006854329,0.963631,0.00021723098],"about_ca_topic_score_codex":0.00032930326,"about_ca_topic_score_gemma":0.00003278151,"teacher_disagreement_score":0.9890045,"about_ca_system_score_codex":0.0002682353,"about_ca_system_score_gemma":0.0004698083,"threshold_uncertainty_score":0.8934347},"labels":[],"label_agreement":null},{"id":"W4283018691","doi":"10.1038/s41416-022-01840-4","title":"Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Ovarian cancer; Medicine; Germline mutation; Oncology; Serous fluid; Internal medicine; Cancer; Germline; BRCA mutation; Survival rate; Serous carcinoma; Stage (stratigraphy); Mutation; Gynecology; Biology; Genetics; Gene","score_opus":0.01579432277681403,"score_gpt":0.31718922269611755,"score_spread":0.3013948999193035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283018691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989206,0.008335873,0.000006476384,0.00047577848,0.0005763145,0.0003930954,0.00095731736,0.0000042531465,0.000044847184],"genre_scores_gemma":[0.99602586,0.0032589808,0.00005767408,0.00009139031,0.00031942583,0.00014370464,0.000030058956,0.000036624897,0.000036274847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998135,0.00010113894,0.00061689864,0.00021581972,0.00064787647,0.00028326598],"domain_scores_gemma":[0.9989397,0.000054801134,0.00048123318,0.000121657715,0.00027021562,0.00013239893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002031372,0.00016780333,0.00057543034,0.00028833933,0.00007630914,0.000024456845,0.00011594231,0.00004190154,0.001261847],"category_scores_gemma":[0.000017826862,0.00015463067,0.00016745085,0.00045193982,0.00005376601,0.00013227265,0.000030411686,0.00039016886,2.4251784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019169523,0.001335752,0.83916944,0.000042978445,0.0003772881,0.00059054623,0.00021461214,0.017249638,0.00007692687,0.0000027872738,0.000051668696,0.13897139],"study_design_scores_gemma":[0.013221856,0.001579844,0.9826438,0.0017796543,0.00022587043,0.00007010268,0.000031225394,0.000027845203,0.00019776258,0.000008190987,0.000072692266,0.00014116736],"about_ca_topic_score_codex":0.023094371,"about_ca_topic_score_gemma":0.021736596,"teacher_disagreement_score":0.14347433,"about_ca_system_score_codex":0.0019168544,"about_ca_system_score_gemma":0.001246024,"threshold_uncertainty_score":0.99965113},"labels":[],"label_agreement":null},{"id":"W4285095591","doi":"10.1038/s41416-022-01904-5","title":"Multistate models for the natural history of cancer progression","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Inference; Markov model; Computer science; Markov chain; Markov process; Homogeneous; Process (computing); Statistics; Cancer; Econometrics; Statistical inference; Mathematics; Medicine; Artificial intelligence; Internal medicine","score_opus":0.06620877547627355,"score_gpt":0.3699848139367611,"score_spread":0.3037760384604875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285095591","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20569956,0.78762627,0.0006678458,0.0019212178,0.003078359,0.0005051366,0.00012916853,0.000010183808,0.00036225488],"genre_scores_gemma":[0.9887478,0.006779618,0.00082115683,0.0009945369,0.00045697673,0.00012824626,0.000002604601,0.000018011804,0.0020510603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867874,0.00003507431,0.0003819875,0.00010366261,0.0006167669,0.00018377231],"domain_scores_gemma":[0.9988651,0.000057392383,0.00046135308,0.00008426576,0.00046148998,0.00007035981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040053777,0.00007566564,0.000267625,0.00004472428,0.00012234588,0.000009941962,0.00018718831,0.000022981376,0.00034307595],"category_scores_gemma":[0.000045422057,0.000062062325,0.00019782069,0.00008957411,0.0000829219,0.00015029991,0.00004651666,0.0003874694,8.390606e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002313891,0.000074081916,0.00273582,0.0001269713,0.0002722961,0.00025635934,0.0007085822,0.0140966615,0.0023192198,0.000048056016,0.12200709,0.85504097],"study_design_scores_gemma":[0.0070419763,0.0010035435,0.021117786,0.002626031,0.0007757109,0.0028252732,0.0012414497,0.026616203,0.0012270208,0.0003993549,0.93483317,0.00029246107],"about_ca_topic_score_codex":0.0032512334,"about_ca_topic_score_gemma":0.0009974833,"teacher_disagreement_score":0.8547485,"about_ca_system_score_codex":0.0010062744,"about_ca_system_score_gemma":0.000991457,"threshold_uncertainty_score":0.4914914},"labels":[],"label_agreement":null},{"id":"W4286111339","doi":"10.1038/s41416-022-01855-x","title":"Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma—a pilot study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Neuroblastoma; Epitope; Medicine; Flow cytometry; Biopsy; CD14; Liquid biopsy; Malignancy; Pathology; Immunology; Antibody; Internal medicine; Biology; Cell culture; Cancer","score_opus":0.03526806573449105,"score_gpt":0.3383743668063413,"score_spread":0.30310630107185027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286111339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971472,0.0015630443,0.000035040328,0.00016227893,0.0002727399,0.00077066815,0.000033238404,0.0000058538594,0.00000991437],"genre_scores_gemma":[0.9990928,0.00050106953,0.00003255022,0.000031281117,0.00010416166,0.00017739488,0.000002162075,0.000022402668,0.00003618652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998378,0.0001460301,0.0006563658,0.0001706689,0.00044732125,0.00020161388],"domain_scores_gemma":[0.9992385,0.00007536232,0.0003500757,0.00009013916,0.00016790467,0.000078015604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056264276,0.0000840991,0.00030136065,0.00045468757,0.00009264128,0.000021140737,0.00011871788,0.000014314262,0.0000375946],"category_scores_gemma":[0.00022040121,0.0000981503,0.00006352747,0.00051042164,0.000023843466,0.00015968805,0.000068088346,0.00034931535,4.0223006e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01785375,0.013573253,0.07256492,0.00021716766,0.0003643173,0.003019363,0.001094004,0.002003182,0.6323085,0.0000031151953,0.00015480391,0.25684363],"study_design_scores_gemma":[0.010866277,0.017952988,0.8982371,0.00030540922,0.00007301636,0.0016549607,0.00052647194,0.00015201182,0.069945425,0.000051222305,0.00013703242,0.000098063596],"about_ca_topic_score_codex":0.00081325055,"about_ca_topic_score_gemma":0.0020429452,"teacher_disagreement_score":0.8256722,"about_ca_system_score_codex":0.00031398903,"about_ca_system_score_gemma":0.0001999189,"threshold_uncertainty_score":0.40024534},"labels":[],"label_agreement":null},{"id":"W4286561096","doi":"10.1038/s41416-022-01903-6","title":"Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"AstraZeneca","keywords":"Selumetinib; Gemcitabine; Medicine; Chemotherapy; MEK inhibitor; Cisplatin; Internal medicine; Toxicity; Oncology; Urology; Gastroenterology; Surgery; Cancer; MAPK/ERK pathway; Biology; Kinase; Colorectal cancer","score_opus":0.01100035852035191,"score_gpt":0.2962305676332977,"score_spread":0.2852302091129458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286561096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929435,0.005212801,0.000013480522,0.00016946117,0.000109600674,0.0014080111,0.00012966678,0.0000036708582,0.0000097869515],"genre_scores_gemma":[0.99866277,0.0005821191,0.0003304817,0.00008276037,0.000058842284,0.00021757754,0.000011874174,0.00002743065,0.000026140202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861085,0.000068743575,0.00053073786,0.00017500565,0.0004697968,0.00014484792],"domain_scores_gemma":[0.9987301,0.000057670568,0.0005612245,0.000081460224,0.0004995988,0.000069902046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031970965,0.00012919948,0.0006662752,0.00014820664,0.00009571487,0.000007815244,0.000066679546,0.000021888949,0.000057076326],"category_scores_gemma":[0.000027883578,0.00011106939,0.000056493704,0.00025020764,0.000063553845,0.00019358679,0.00002101313,0.00019617697,3.086257e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08164002,0.009250029,0.6391133,0.00017531186,0.00044577135,0.000054374545,0.0043432494,0.00019914616,0.0008209906,6.06087e-7,0.00024252181,0.26371464],"study_design_scores_gemma":[0.31520557,0.033546418,0.6469772,0.00048298703,0.0003339007,0.00006521514,0.0022137274,0.000057072353,0.00063317164,0.000006243028,0.00034112824,0.00013739022],"about_ca_topic_score_codex":0.0006685581,"about_ca_topic_score_gemma":0.001805213,"teacher_disagreement_score":0.26357725,"about_ca_system_score_codex":0.00011852195,"about_ca_system_score_gemma":0.00019349146,"threshold_uncertainty_score":0.45292783},"labels":[],"label_agreement":null},{"id":"W4293222009","doi":"10.1038/s41416-022-01926-z","title":"Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Clinical trial; MEDLINE; Dermatology; Surgery; Internal medicine","score_opus":0.7884720102891636,"score_gpt":0.6858444371946468,"score_spread":0.10262757309451676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293222009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930824,0.00050012424,0.0025788618,0.00005305638,0.0025604775,0.0009628327,0.00019126486,0.0000035517066,0.000067442845],"genre_scores_gemma":[0.95585984,0.00010531895,0.043598957,0.0000983881,0.00024156833,0.000065980144,1.8762465e-7,0.00002077324,0.000008989542],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9790474,0.013538307,0.004254724,0.00017424492,0.0028261933,0.00015911687],"domain_scores_gemma":[0.97481704,0.018350916,0.0054591415,0.0002768975,0.0010031662,0.000092845716],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04448237,0.00011039778,0.0011120668,0.000060546972,0.00010780533,0.0000065504155,0.00039535764,0.000066198045,0.0014099507],"category_scores_gemma":[0.21701151,0.00008896015,0.00057843054,0.00025576953,0.00016428252,0.0000720868,0.0001297482,0.0004528674,2.6265724e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014934011,0.003706861,0.0019127642,0.00019316324,0.000672002,0.00002859101,0.0010696169,0.0032160343,0.0015708247,0.0006667555,0.0008955915,0.9845744],"study_design_scores_gemma":[0.048331235,0.0067700096,0.013129037,0.0110028675,0.008086581,0.00055619545,0.0032543354,0.026592245,0.02230436,0.8585125,0.0006995564,0.0007610601],"about_ca_topic_score_codex":0.00003330054,"about_ca_topic_score_gemma":0.0000060881434,"teacher_disagreement_score":0.98381335,"about_ca_system_score_codex":0.00026372282,"about_ca_system_score_gemma":0.00070771744,"threshold_uncertainty_score":0.9995029},"labels":[],"label_agreement":null},{"id":"W4294308288","doi":"10.1038/s41416-022-01963-8","title":"Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Adjuvant chemotherapy; Adjuvant; Cancer; Adjuvant therapy; Trastuzumab","score_opus":0.005413167065929589,"score_gpt":0.22794554883141163,"score_spread":0.22253238176548204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294308288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336034,0.004985151,0.0000056421795,0.00019693759,0.000028086222,0.00033213067,0.0010802015,0.0000015350446,0.00000997648],"genre_scores_gemma":[0.9973208,0.002367914,0.000037987003,0.00014987406,0.00002126252,0.000048569633,0.0000070244396,0.00002335235,0.000023246046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988872,0.00013261693,0.00028515785,0.0002306484,0.00031892912,0.00014545297],"domain_scores_gemma":[0.99876225,0.000023957693,0.00056711806,0.00013327909,0.00046627366,0.00004711156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009523641,0.00017878444,0.0005710448,0.00006526163,0.00013772455,0.000017184162,0.00013395042,0.000028642587,0.000029369516],"category_scores_gemma":[0.0000042579413,0.00011826611,0.000109524735,0.0003077515,0.00020925282,0.000010755266,0.000070551934,0.00011270747,6.9563235e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017520178,0.0005595072,0.96887666,0.000006676412,0.010585563,0.000009778637,0.0008683205,0.00022324872,0.0006483437,1.7135986e-7,0.00001667161,0.01645306],"study_design_scores_gemma":[0.00574298,0.00088733755,0.9868343,0.00006269847,0.0013520288,0.000032491753,0.00062355644,0.0000015749009,0.0042964052,0.000001131298,0.000029575438,0.0001359444],"about_ca_topic_score_codex":0.008223623,"about_ca_topic_score_gemma":0.0068524093,"teacher_disagreement_score":0.017957633,"about_ca_system_score_codex":0.000055356755,"about_ca_system_score_gemma":0.000107681146,"threshold_uncertainty_score":0.9983807},"labels":[],"label_agreement":null},{"id":"W4307977544","doi":"10.1038/s41416-022-02026-8","title":"Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; Simon Fraser University","funders":"National Health and Medical Research Council","keywords":"Medicine; Lung cancer screening; Lung cancer; National Lung Screening Trial; Cost effectiveness; Quality-adjusted life year; Cohort; Incremental cost-effectiveness ratio; Cost–benefit analysis; Internal medicine","score_opus":0.058508620106800656,"score_gpt":0.41979913207592556,"score_spread":0.36129051196912493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307977544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853905,0.012710717,0.000031919197,0.0005293715,0.00011178867,0.00055077986,0.00066971633,0.0000015064782,0.0000037261727],"genre_scores_gemma":[0.99697006,0.0026666883,0.00003482831,0.000072786715,0.000042768348,0.00017640887,0.00001485204,0.000008995956,0.000012622712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888486,0.00013417922,0.00047582784,0.00012942366,0.00020292605,0.00017276574],"domain_scores_gemma":[0.99901205,0.00018798471,0.0005754108,0.000077392215,0.000079708305,0.00006745205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005824558,0.00010035055,0.00081751624,0.00021150944,0.00007445671,0.000019696885,0.00009339872,0.000021061676,0.00021878754],"category_scores_gemma":[0.000012234562,0.00007585356,0.00031754337,0.00022523486,0.00003920336,0.00007359843,0.000021416989,0.00015696755,8.359941e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040333296,0.000100298756,0.96360123,0.00012539557,0.0034788132,0.000018896546,0.00042023748,0.014139491,0.00001597911,0.000004786086,0.0002456591,0.017445853],"study_design_scores_gemma":[0.002950429,0.00049110333,0.99297404,0.00052394444,0.0015045364,0.000046550416,0.00026641611,0.00103664,0.00007565107,0.0000060546085,0.00006234718,0.00006227175],"about_ca_topic_score_codex":0.09085899,"about_ca_topic_score_gemma":0.014740902,"teacher_disagreement_score":0.07611808,"about_ca_system_score_codex":0.0012077977,"about_ca_system_score_gemma":0.0003931903,"threshold_uncertainty_score":0.91519505},"labels":[],"label_agreement":null},{"id":"W4308057531","doi":"10.1038/s41416-022-02014-y","title":"Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Canada's Michael Smith Genome Sciences Centre; Vancouver General Hospital; University of British Columbia; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; National Health and Medical Research Council; Horizon 2020 Framework Programme; National Institutes of Health; Translational Cancer Research Network; University College London; Cancer Institute NSW; National Cancer Institute; Peter MacCallum Foundation; NSW Ministry of Health; American Cancer Society; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Cancer Council Victoria; University of Pittsburgh; University of New South Wales; Cancer Council NSW; Universität Heidelberg; Canadian Institutes of Health Research; Medical Research Council; Department of Health and Social Care; National Institute for Health and Care Research; Michael Smith Health Research BC; Canada Research Chairs; NIHR Cambridge Biomedical Research Centre; University of Cambridge; Fred C. and Katherine B. Andersen Foundation; Cancer Australia; Ovarian Cancer Action; Calgary Laboratory Services; Mayo Foundation for Medical Education and Research; Deutsche Forschungsgemeinschaft; VGH and UBC Hospital Foundation; U.S. Department of Defense; Cancer Research UK; Minnesota Ovarian Cancer Alliance; National Center for Research Resources; BC Cancer Foundation; Oak Foundation; Ovarian Cancer Australia; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Cancer Research Society; European Commission","keywords":"Immunohistochemistry; Serous carcinoma; Serous fluid; Tissue microarray; Ovarian carcinoma; Ovarian cancer; Oncology; Univariate analysis; Survival analysis; Medicine; Pathology; Biology; Multivariate analysis; Internal medicine; Cancer","score_opus":0.009728865835018344,"score_gpt":0.2471646536283157,"score_spread":0.23743578779329735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308057531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824464,0.00050792727,0.000257436,0.00008208088,0.00013055211,0.00051108084,0.00024815672,0.000008426353,0.000009704617],"genre_scores_gemma":[0.9991949,0.000009353022,0.00018212986,0.000102330014,0.00011178704,0.00008178242,0.0001634423,0.000033219923,0.000121029916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997778,0.0006196169,0.00051645504,0.00034653922,0.0004883074,0.00025107613],"domain_scores_gemma":[0.99890405,0.000008510524,0.0005023049,0.00021121062,0.0002379886,0.00013594258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055395695,0.00017135184,0.00040730872,0.00017139653,0.00015885745,0.00008004605,0.0002420954,0.00007326053,0.00026110347],"category_scores_gemma":[0.000038703092,0.00019123351,0.000107518856,0.0003995343,0.00003873575,0.000033238477,0.000049636226,0.00030757952,1.1804521e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011592098,0.0010036709,0.23564199,0.000009175548,0.0006492508,0.00045227422,0.0002423986,0.0018523631,0.75825375,0.0000022463284,0.00008813542,0.0006455378],"study_design_scores_gemma":[0.007059832,0.0015210984,0.9404998,0.000041158604,0.00034546212,0.00011023276,0.00034985793,0.00021386928,0.049153637,0.000014424056,0.00040077168,0.00028988728],"about_ca_topic_score_codex":0.011444862,"about_ca_topic_score_gemma":0.01859961,"teacher_disagreement_score":0.7091001,"about_ca_system_score_codex":0.00018557465,"about_ca_system_score_gemma":0.0002870031,"threshold_uncertainty_score":0.9993084},"labels":[],"label_agreement":null},{"id":"W4308260067","doi":"10.1038/s41416-022-02025-9","title":"A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Tolerability; Medicine; Mucositis; Docetaxel; Internal medicine; Response Evaluation Criteria in Solid Tumors; Breast cancer; Triple-negative breast cancer; Oncology; Cancer; Phases of clinical research; Adverse effect; Gastroenterology; Chemotherapy; Surgery","score_opus":0.015299509663367824,"score_gpt":0.32773498653910155,"score_spread":0.3124354768757337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308260067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564785,0.0017572889,0.00009641024,0.000066145745,0.00019856261,0.0011960617,0.0010187629,0.0000023586713,0.000016571925],"genre_scores_gemma":[0.99869114,0.00032874505,0.00028380752,0.00016731724,0.00007117905,0.0003230009,0.00002226081,0.000050869727,0.00006165258],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984255,0.00013633462,0.00045569253,0.0003204044,0.00041566772,0.0002464002],"domain_scores_gemma":[0.9983967,0.000021450489,0.0007761118,0.00012225592,0.0005955143,0.00008795586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003029935,0.00017898851,0.0004254466,0.00009627566,0.00013936435,0.000054242373,0.00034067302,0.000041872172,0.000046891717],"category_scores_gemma":[0.00003354978,0.00017711462,0.000033047025,0.00021891478,0.0000785287,0.000050720064,0.00012073448,0.00020650163,3.2355405e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053900607,0.05897875,0.6457976,0.0003007388,0.002451276,0.0002498141,0.0027013018,0.009208588,0.050703518,0.000014265684,0.0045320312,0.17116152],"study_design_scores_gemma":[0.5020479,0.047339924,0.4041786,0.0019552475,0.00064062444,0.0006030829,0.0034864217,0.00040954258,0.033592466,0.0000907939,0.004279405,0.0013759974],"about_ca_topic_score_codex":0.0011437077,"about_ca_topic_score_gemma":0.0028384011,"teacher_disagreement_score":0.4481473,"about_ca_system_score_codex":0.00014685979,"about_ca_system_score_gemma":0.00038117619,"threshold_uncertainty_score":0.7222525},"labels":[],"label_agreement":null},{"id":"W4308524642","doi":"10.1038/s41416-022-02040-w","title":"Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; McGill University Health Centre; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Canada Research Chairs; Government of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Prostate cancer; Biology; Gene; Metabolomics; Glycosyltransferase; Gene expression profiling; Metabolic pathway; Germline; Cancer research; Kynurenine; Cancer; Gene expression; Genetics; Bioinformatics","score_opus":0.014416089131540591,"score_gpt":0.31288699359598343,"score_spread":0.29847090446444285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308524642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94162977,0.057317536,0.000025180188,0.0002763761,0.00014403333,0.00019885704,0.00025541382,0.0000015598023,0.00015128656],"genre_scores_gemma":[0.9814224,0.017450813,0.00007775106,0.00020214419,0.00012374924,0.00007867341,0.000012249165,0.000015489959,0.00061671337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863577,0.00016671434,0.00042906194,0.00016492498,0.00038974188,0.00021378625],"domain_scores_gemma":[0.9991984,0.0000075572284,0.0002107617,0.00009668065,0.00040233237,0.00008427416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003485521,0.00008958072,0.00024881112,0.00011643796,0.00010937318,0.00002120867,0.00021693112,0.000035242607,0.0008900777],"category_scores_gemma":[0.00004862419,0.000102600476,0.000110768284,0.00020470541,0.00013041869,0.000009581581,0.000061286286,0.0002558762,3.2157843e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032949972,0.00008971367,0.006480146,0.000023320757,0.00008903292,0.0003014927,0.00011473894,0.0025853042,0.96771085,0.000021611162,0.0010120894,0.021242205],"study_design_scores_gemma":[0.0024535537,0.00047229134,0.0149646355,0.00010570345,0.000029767692,0.00076289417,0.0002473838,0.000009760773,0.9043189,0.00017092408,0.07627465,0.00018952244],"about_ca_topic_score_codex":0.0027702316,"about_ca_topic_score_gemma":0.0029447635,"teacher_disagreement_score":0.07526256,"about_ca_system_score_codex":0.0000430795,"about_ca_system_score_gemma":0.0005367315,"threshold_uncertainty_score":0.97457266},"labels":[],"label_agreement":null},{"id":"W4310962312","doi":"10.1038/s41416-022-02022-y","title":"Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"EMD Serono; Genentech; Foundation Medicine; Sierra Oncology; PharmaMar; Newcastle University; MacroGenics; Relay Therapeutics; NGM Biopharmaceuticals; Loxo Oncology; Ribon Therapeutics; Mersana Therapeutics; Eisai; Adaptive Biotechnologies; Pharmacyclics; Agios Pharmaceuticals; Syndax Pharmaceuticals; BeiGene; Mirati Therapeutics; Clovis Oncology; Daiichi Sankyo Europe; Gilead Sciences; Calithera Biosciences; TG Therapeutics; Moderna; NuCana; Pfizer; HCA Healthcare; Incyte; Taiho Pharmaceutical; Merck KGaA; Array BioPharma; Revolution Medicines; Exelixis; GlaxoSmithKline; Verastem Oncology; Jounce Therapeutics; Celgene; AstraZeneca; Ignyta; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Ovarian cancer; BRCA mutation; Adverse effect; Oncology; Cancer; Progressive disease; Disease","score_opus":0.018940959345750533,"score_gpt":0.2929071395730326,"score_spread":0.2739661802272821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310962312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923923,0.0047712727,0.0000044448348,0.0005166216,0.000265313,0.0007439067,0.0011304668,0.00000741442,0.00016823472],"genre_scores_gemma":[0.9974038,0.0017080194,0.00015973498,0.00014126766,0.00015874024,0.000078233075,0.00004789436,0.000028056544,0.00027427205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784803,0.00018268419,0.000837963,0.00025852112,0.00067138823,0.0002013876],"domain_scores_gemma":[0.99868214,0.00010286879,0.0006573106,0.00016055802,0.00026261137,0.00013453496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000295263,0.00015466509,0.00058908423,0.00014453326,0.00011075537,0.000019227966,0.00010090302,0.00003867559,0.0011095944],"category_scores_gemma":[0.000037040118,0.00014993596,0.00006450923,0.00030264514,0.0000765785,0.00010332839,0.000030418823,0.0003566218,4.0196016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14572382,0.00539763,0.6170193,0.000028094955,0.0013871954,0.0013873938,0.004523486,0.0036314486,0.0002480602,0.000002484956,0.0026793012,0.21797179],"study_design_scores_gemma":[0.12065355,0.005275365,0.8645774,0.0007679638,0.00024789476,0.0001223832,0.00041189784,0.00001239124,0.00022270752,0.000015631413,0.0075517967,0.0001409968],"about_ca_topic_score_codex":0.0116785895,"about_ca_topic_score_gemma":0.0032076638,"teacher_disagreement_score":0.24755812,"about_ca_system_score_codex":0.00100934,"about_ca_system_score_gemma":0.00067651493,"threshold_uncertainty_score":0.99980354},"labels":[],"label_agreement":null},{"id":"W4312091642","doi":"10.1038/s41416-022-02123-8","title":"Synthetic miR-34a against solid tumours: a predictable failure","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Fondation ARC pour la Recherche sur le Cancer","keywords":"microRNA; Suppressor; Bioinformatics; Clinical trial; Medicine; Computational biology; Biology; Cancer research; Cancer; Internal medicine; Genetics; Gene","score_opus":0.015193418699762835,"score_gpt":0.29842661459529934,"score_spread":0.2832331958955365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312091642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064385065,0.99774885,0.00003013045,0.000023287514,0.00054201356,0.00030644832,0.00043680338,0.000006432371,0.00026219524],"genre_scores_gemma":[0.00027554802,0.997411,0.00011947515,0.000069386326,0.0013040284,0.0000823277,0.00023553449,0.00009164325,0.00041102446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979774,0.0002246932,0.0007801605,0.00033019003,0.00038422915,0.00030334323],"domain_scores_gemma":[0.9983052,0.000019284505,0.0010647088,0.00027061053,0.00016411969,0.00017606944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003343078,0.00027903184,0.00089374767,0.00010288078,0.00011701098,0.00009834291,0.0005064558,0.0002543611,0.0007596288],"category_scores_gemma":[0.00014332958,0.00031128668,0.00077331916,0.00015355046,0.00006795279,0.000009312762,0.00015579589,0.00046951007,0.00000412489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022922486,0.00008693998,0.0000040301893,0.0028388496,0.00060036796,0.000310679,0.0000067471046,0.000076074015,0.0007355282,0.0000012756697,0.042764027,0.95255256],"study_design_scores_gemma":[0.00028508413,0.0000794565,0.000010698068,0.00907368,0.00073093316,0.0027401377,0.000012030619,0.0000017742422,0.00015269534,0.000007081818,0.9866112,0.00029525216],"about_ca_topic_score_codex":0.000019698939,"about_ca_topic_score_gemma":0.00007276622,"teacher_disagreement_score":0.95225734,"about_ca_system_score_codex":0.00020035538,"about_ca_system_score_gemma":0.0012949834,"threshold_uncertainty_score":0.9999339},"labels":[],"label_agreement":null},{"id":"W4312110018","doi":"10.1038/s41416-022-02109-6","title":"Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours","year":2022,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Cancer cell; Necrosis; Doxorubicin; Chemotherapy; Programmed cell death; Cell; Cell growth; Biology; Autophagy; Pathology; Cancer; Medicine; Apoptosis; Internal medicine; Biochemistry","score_opus":0.00855830196501309,"score_gpt":0.26733162080179573,"score_spread":0.2587733188367826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312110018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047723665,0.9931179,0.0003197467,0.000020168103,0.0010136154,0.00059324276,0.0001468455,0.0000016533173,0.000014459468],"genre_scores_gemma":[0.013193783,0.9854005,0.000015538399,0.000036854857,0.0010690587,0.000115407856,0.000068848996,0.00002373428,0.000076296135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985446,0.00034806147,0.00054362713,0.00017784369,0.00024567044,0.00014022978],"domain_scores_gemma":[0.999109,0.00002675012,0.00055061607,0.00013664107,0.00011909624,0.00005787408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066618045,0.00014654205,0.00061210664,0.00005728215,0.000073721305,0.000028502793,0.00017615156,0.000104588566,0.0000070041933],"category_scores_gemma":[0.000050782135,0.00012697208,0.00024611168,0.00017059242,0.000026473157,0.000005379096,0.0000507367,0.00027354236,2.611045e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034509216,0.00004230194,0.00004920687,0.0047699506,0.00017406646,0.000008784019,0.00009660308,0.0002768903,0.00014119892,0.00001588716,0.003483137,0.9909075],"study_design_scores_gemma":[0.00042054005,0.00007083356,0.0007257042,0.0033691674,0.00048764326,0.00027797025,0.00004081524,0.0000042795527,0.00014115492,0.0000044693456,0.99432534,0.00013211086],"about_ca_topic_score_codex":0.000101923055,"about_ca_topic_score_gemma":0.00019453412,"teacher_disagreement_score":0.99084216,"about_ca_system_score_codex":0.00010693106,"about_ca_system_score_gemma":0.00040955615,"threshold_uncertainty_score":0.51777714},"labels":[],"label_agreement":null},{"id":"W4315798461","doi":"10.1038/s41416-022-02130-9","title":"Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Women's College Hospital","funders":"","keywords":"Breast cancer; Oncology; Medicine; BRCA2 Protein; Mutation; Cancer; Internal medicine; Bioinformatics; Gynecology; Biology; Genetics; Germline mutation; Gene","score_opus":0.005261641868805272,"score_gpt":0.2533590535479434,"score_spread":0.24809741167913815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315798461","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82113624,0.11115913,0.00015588052,0.0007865937,0.049172588,0.00060130813,0.016253985,0.000021587515,0.0007126816],"genre_scores_gemma":[0.29167047,0.4866488,0.00013857706,0.0014661946,0.029751007,0.0010139132,0.004581514,0.000469096,0.18426044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986547,0.00007649696,0.00036151352,0.00032896997,0.00030022737,0.0002780698],"domain_scores_gemma":[0.998999,0.000011488418,0.0003019506,0.00012278506,0.0003331618,0.00023162612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008900359,0.00021660363,0.00035925664,0.000093156865,0.00005104608,0.00008433933,0.0001389977,0.00020692534,0.00020392549],"category_scores_gemma":[0.000027189695,0.00023487337,0.00009362513,0.00014982987,0.000038750084,0.000007689495,0.000021935208,0.00021980003,0.0000030251335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015226679,0.00018508946,0.0020901442,0.000031751173,0.00033375202,0.00020464622,0.00009470321,0.00044371403,0.0025987893,2.5985365e-8,0.91103995,0.08145479],"study_design_scores_gemma":[0.0064886007,0.0016336865,0.19468294,0.0034585926,0.00030640545,0.0004199502,0.0006434764,0.000024677542,0.0019398559,0.000049419545,0.7895032,0.00084919715],"about_ca_topic_score_codex":0.0106696505,"about_ca_topic_score_gemma":0.055799317,"teacher_disagreement_score":0.5294658,"about_ca_system_score_codex":0.00049576693,"about_ca_system_score_gemma":0.0009992347,"threshold_uncertainty_score":0.9959184},"labels":[],"label_agreement":null},{"id":"W4316881885","doi":"10.1038/s41416-022-02116-7","title":"Thinking inside the box: intracellular roles for complement system proteins come into focus","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Academy of Medical Sciences; Cancer Research UK; Medical Research Council; Irish Cancer Society; Health Research Board","keywords":"Complement system; Anaphylatoxin; C3-convertase; Cell biology; Complement membrane attack complex; Intracellular; Extracellular; Biology; Mediator; Chemistry; Immunology; Alternative complement pathway; Antibody","score_opus":0.0184290485034194,"score_gpt":0.2804550445930981,"score_spread":0.2620259960896787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316881885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8293359,0.15170369,0.005689643,0.0052703754,0.0040554726,0.002955804,0.00052860304,0.00020286193,0.0002575949],"genre_scores_gemma":[0.99855626,0.00035020718,0.00017475137,0.000111057976,0.00031696606,0.00023691526,0.000027190263,0.000025932599,0.0002007486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837947,0.00025106076,0.000714156,0.00015709554,0.00015150839,0.000346702],"domain_scores_gemma":[0.9987597,0.0002220085,0.0005289625,0.00016884695,0.000286732,0.00003377285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010887167,0.0001349394,0.00036828936,0.00010371393,0.0005290055,0.00010811627,0.00055125693,0.00006620875,0.00023347772],"category_scores_gemma":[0.00008863791,0.00011418982,0.00020883708,0.00015549747,0.00009667435,0.00010344434,0.00014062482,0.00023242501,0.000034887886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001357977,0.00047277007,0.027310263,0.002371263,0.0055959774,0.0009788732,0.006055449,0.0014178714,0.19891873,0.017206127,0.3675883,0.3707264],"study_design_scores_gemma":[0.008344988,0.00069996447,0.03150236,0.0071118437,0.00064734364,0.0027807937,0.011103184,0.00011748592,0.05607305,0.0056467378,0.8752857,0.00068657263],"about_ca_topic_score_codex":0.0008253393,"about_ca_topic_score_gemma":0.002506093,"teacher_disagreement_score":0.50769734,"about_ca_system_score_codex":0.00020098331,"about_ca_system_score_gemma":0.00015705102,"threshold_uncertainty_score":0.46565256},"labels":[],"label_agreement":null},{"id":"W4317718278","doi":"10.1038/s41416-023-02141-0","title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Manchester Biomedical Research Centre; Leids Universitair Medisch Centrum; Universiteit Leiden; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Immunohistochemistry; Oestrogen receptor; Endometrial cancer; Medicine; Oncology; Internal medicine; Pathology; Biology; Breast cancer; Cancer","score_opus":0.023853030225662156,"score_gpt":0.31905856328287124,"score_spread":0.2952055330572091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317718278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765093,0.021297643,0.000029020486,0.00013155215,0.0013075361,0.00028577098,0.00025509275,0.000021591026,0.00016249168],"genre_scores_gemma":[0.9821945,0.0148386285,0.0010967297,0.000055438613,0.0013879258,0.00002994662,0.00002587245,0.00003716751,0.00033378231],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997818,0.00006145522,0.00083416665,0.00019409077,0.0007692869,0.00032299265],"domain_scores_gemma":[0.9981652,0.00016138084,0.00081705226,0.00014522042,0.00048834045,0.00022281296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043351616,0.00016180915,0.000683393,0.00026656504,0.00008395417,0.00002353465,0.00015690285,0.0000980567,0.0011263443],"category_scores_gemma":[0.00079849287,0.00015701615,0.00033022233,0.0011875347,0.000096048025,0.00008352041,0.00004593501,0.00033557657,0.0000064286232],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008648569,0.00066375843,0.18373889,0.0010294616,0.004530661,0.001472312,0.00018269876,0.001169141,0.20464215,0.000012880641,0.007922119,0.5859874],"study_design_scores_gemma":[0.13450706,0.009463061,0.374327,0.018526614,0.010957077,0.0037374285,0.0010383195,0.00023224729,0.4026734,0.0006038379,0.042192955,0.0017410112],"about_ca_topic_score_codex":0.0073076286,"about_ca_topic_score_gemma":0.0000615896,"teacher_disagreement_score":0.58424634,"about_ca_system_score_codex":0.00095394405,"about_ca_system_score_gemma":0.0008841456,"threshold_uncertainty_score":0.99978673},"labels":[],"label_agreement":null},{"id":"W4318041801","doi":"10.1038/s41416-023-02161-w","title":"Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.03128342957775556,"score_gpt":0.39316411581247945,"score_spread":0.3618806862347239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318041801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126047,0.0007773989,0.000071881805,0.0004022883,0.0022613045,0.0036196979,0.0013869482,0.00001313073,0.00020686754],"genre_scores_gemma":[0.989103,0.0016690382,0.00017312772,0.00022472366,0.00047856252,0.0007940845,0.00010863498,0.00011813455,0.007330692],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99804246,0.000055019376,0.00068611547,0.00038192733,0.0005587062,0.00027575993],"domain_scores_gemma":[0.9974611,0.000087165805,0.0009251456,0.00013007059,0.0011483708,0.00024819176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002221647,0.00027010893,0.0009324135,0.00017670965,0.000107653024,0.00007443709,0.00022252386,0.00011394774,0.000042894993],"category_scores_gemma":[0.00012656288,0.00024786856,0.000044916353,0.0005780245,0.00008289998,0.0002612698,0.000043071377,0.00074728887,3.2774415e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044750538,0.06356725,0.074412294,0.002293236,0.003068746,0.0005255709,0.0022289797,0.00065654994,0.0014676165,0.00000498245,0.5713543,0.23566991],"study_design_scores_gemma":[0.35160267,0.01393564,0.5714122,0.034800448,0.003018304,0.00095044245,0.002131993,0.0012463604,0.002785481,0.00004099415,0.016834797,0.0012406453],"about_ca_topic_score_codex":0.0013266096,"about_ca_topic_score_gemma":0.0026823834,"teacher_disagreement_score":0.55451953,"about_ca_system_score_codex":0.00032428262,"about_ca_system_score_gemma":0.0005906011,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W4318253712","doi":"10.1038/s41416-023-02154-9","title":"Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Medical Research Council; Newcastle University; Cancer Research UK; Pathological Society of Great Britain and Ireland; JGW Patterson Foundation; National Health and Medical Research Council; Johns Hopkins University; George Washington University","keywords":"Biology; Cancer research; Gene knockdown; Hedgehog signaling pathway; Immunohistochemistry; Downregulation and upregulation; Hepatocellular carcinoma; In vivo; Signal transduction; Gene; Genetics; Immunology","score_opus":0.016043906315493135,"score_gpt":0.231639922575584,"score_spread":0.21559601626009087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318253712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979656,0.0014947986,9.1025225e-7,0.00011903573,0.000046486155,0.00019910448,0.0001065945,0.0000048431098,0.0000626603],"genre_scores_gemma":[0.9995321,0.0002710978,0.0000129068885,0.0000054051284,0.00013533617,0.000011649534,0.000009448735,0.0000013105725,0.000020765354],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990331,0.00008970115,0.00036799227,0.00009592805,0.00027828797,0.00013499674],"domain_scores_gemma":[0.99945927,0.000053993648,0.00029017337,0.000037435246,0.000117205906,0.000041906347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002194985,0.00007125802,0.00018182876,0.00002313174,0.00006149357,0.000014447021,0.0001660027,0.000062487925,0.00016034428],"category_scores_gemma":[0.00002806925,0.000030349824,0.00017883135,0.0003911936,0.00003042397,0.0000663744,0.00001675607,0.00012921938,0.0000012547171],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008507457,0.0000612096,0.12590143,0.0000063632497,0.000010800976,0.000009292812,0.000115503644,0.0006627117,0.8317267,0.000012316984,0.000026799366,0.041381825],"study_design_scores_gemma":[0.0002772232,0.00040134197,0.8337475,0.00035892226,0.000009889967,0.000022896598,0.00007278814,0.00043638688,0.16356178,0.00088737597,0.00016899242,0.000054893717],"about_ca_topic_score_codex":0.0015593295,"about_ca_topic_score_gemma":0.001001057,"teacher_disagreement_score":0.7078461,"about_ca_system_score_codex":0.000054268734,"about_ca_system_score_gemma":0.000054583164,"threshold_uncertainty_score":0.235725},"labels":[],"label_agreement":null},{"id":"W4319915926","doi":"10.1038/s41416-023-02174-5","title":"Tumour-educated platelets for breast cancer detection: biological and technical insights","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Translational Molecular Medicine; KWF Kankerbestrijding; Centre for Transportation Engineering and Planning","keywords":"Breast cancer; Platelet; Medicine; Cancer; Oncology; Pathology; Biology; Cancer research; Internal medicine","score_opus":0.021379074131127104,"score_gpt":0.30838560488878836,"score_spread":0.28700653075766125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985864,0.011554896,0.000031274292,0.0014332071,0.0005950945,0.00030747123,0.00010170371,0.000048802205,0.00006356259],"genre_scores_gemma":[0.9916348,0.0068498994,0.00018029529,0.00025298542,0.0008919827,0.00010818583,0.000004127537,0.000023105882,0.00005461238],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892116,0.000035169003,0.00039654577,0.0001804158,0.00022411032,0.00024260808],"domain_scores_gemma":[0.9990261,0.0000722016,0.00019138395,0.00006246999,0.00040622096,0.00024158534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002323092,0.00011572146,0.00032123824,0.00014589715,0.00012556172,0.000043570188,0.00008505633,0.00014411565,0.00028455586],"category_scores_gemma":[0.00012506412,0.00010549872,0.0001460983,0.00029999772,0.00015159874,0.00010096836,0.000035230365,0.00023707499,0.0000033762763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036101025,0.00022281754,0.0665866,0.000328685,0.00067295384,0.0027595141,0.00007937761,0.000010523904,0.12398287,0.000013281723,0.022350343,0.77938294],"study_design_scores_gemma":[0.0023534812,0.00018697219,0.96177787,0.0010090582,0.00020120155,0.0127134705,0.0000586451,0.000053645414,0.009306717,0.00023576946,0.011936141,0.00016702247],"about_ca_topic_score_codex":0.000033904682,"about_ca_topic_score_gemma":0.00012397306,"teacher_disagreement_score":0.89519125,"about_ca_system_score_codex":0.00014836942,"about_ca_system_score_gemma":0.00026392515,"threshold_uncertainty_score":0.4302113},"labels":[],"label_agreement":null},{"id":"W4319930498","doi":"10.1038/s41416-023-02167-4","title":"Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges","year":2023,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer; National Health and Medical Research Council; Servier; National Institutes of Health; Cancer Australia; Garnett Passe and Rodney Williams Memorial Foundation; Royal Brisbane and Women's Hospital Foundation; Medical Research Council; Cancer Research Institute","keywords":"Head and neck cancer; Cancer; Head and neck; Medicine; Disease; Precision medicine; In vivo; Tumour heterogeneity; Oncology; Bioinformatics; Pathology; Internal medicine; Biology; Surgery; Genetics","score_opus":0.17303086899871398,"score_gpt":0.38569863340021987,"score_spread":0.2126677644015059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319930498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001541848,0.9957752,4.2770077e-7,0.0008746819,0.00072802097,0.0004076994,0.00039150153,0.000019114976,0.00026148136],"genre_scores_gemma":[0.000024223385,0.997626,0.000074203985,0.00024177817,0.0011410993,0.00008179527,0.000013392948,0.00009590547,0.00070162467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979929,0.00009384202,0.00085584813,0.00030450628,0.00043197133,0.0003209535],"domain_scores_gemma":[0.99824566,0.00006692988,0.0008364006,0.00012579084,0.00030585445,0.0004193871],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020862253,0.00034964824,0.0021568618,0.0001918811,0.00009704735,0.00010455322,0.000102763195,0.000192593,0.00018494249],"category_scores_gemma":[0.00005856034,0.00030459088,0.0003775637,0.00012615975,0.00015265546,0.00012943566,0.00008107106,0.0006078134,0.0000013478219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038050075,0.00003094206,0.0000048071606,0.02191609,0.0007134275,0.0015107861,0.00022292686,2.2337197e-7,0.0000039716383,0.0000063497346,0.005160721,0.9703917],"study_design_scores_gemma":[0.0008780864,0.00024490076,0.00013796048,0.09333934,0.0022820213,0.0062048202,0.00045010884,1.433071e-7,0.0000055629666,0.000010912003,0.8961882,0.00025794032],"about_ca_topic_score_codex":0.0010184632,"about_ca_topic_score_gemma":0.002434838,"teacher_disagreement_score":0.9701338,"about_ca_system_score_codex":0.00016926687,"about_ca_system_score_gemma":0.0009901709,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W4321766116","doi":"10.1038/s41416-023-02201-5","title":"Alternative methods to measure breast density in younger women","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Australia; National Breast Cancer Foundation; Australian Government","keywords":"Measure (data warehouse); Medicine; Breast cancer; Internal medicine; Computer science; Cancer; Data mining","score_opus":0.02053188281437466,"score_gpt":0.3424959251825704,"score_spread":0.3219640423681957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321766116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938677,0.0015173219,0.0007729814,0.0013621326,0.00044316257,0.000115698655,0.000028143215,0.000020358011,0.0018725302],"genre_scores_gemma":[0.99646544,0.00034486467,0.0015381383,0.00089050195,0.00040627416,0.000011167162,9.78756e-7,0.000017872784,0.00032474156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886817,0.00006694316,0.0002923482,0.00012438482,0.00036092632,0.00028721197],"domain_scores_gemma":[0.9992149,0.000041503343,0.000103978426,0.000066911874,0.00031495228,0.00025774943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009012845,0.00008470051,0.00032523423,0.00035568955,0.000027381173,0.000062820436,0.00010211853,0.00003153282,0.00008498687],"category_scores_gemma":[0.00012259294,0.000087844186,0.00012540456,0.00084982236,0.000037513386,0.00031078144,0.000029832285,0.00027055584,0.000007912675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003701623,0.00006922561,0.032625545,0.000027929227,0.00016851825,0.002575845,0.000477706,0.00006228482,0.0015892119,0.000016819422,0.0016978158,0.9603189],"study_design_scores_gemma":[0.0016994862,0.00012683094,0.97276354,0.0017051514,0.00004577992,0.01513424,0.00043564063,0.000038909584,0.0009737591,0.001134988,0.0057968865,0.00014480452],"about_ca_topic_score_codex":0.00044107315,"about_ca_topic_score_gemma":0.00011006325,"teacher_disagreement_score":0.96017414,"about_ca_system_score_codex":0.00020347035,"about_ca_system_score_gemma":0.00013903507,"threshold_uncertainty_score":0.3582182},"labels":[],"label_agreement":null},{"id":"W4322733329","doi":"10.1038/s41416-023-02166-5","title":"The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Thrombus; Nephrectomy; Systemic therapy; Urology; Internal medicine; Progression-free survival; Oncology; Surgery; Gastroenterology; Cancer; Overall survival; Kidney","score_opus":0.010381064924269066,"score_gpt":0.24133690922868262,"score_spread":0.23095584430441354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322733329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737536,0.025304038,9.205575e-7,0.000073810515,0.00004162672,0.0005554019,0.000011580163,0.0000016141314,0.00025741433],"genre_scores_gemma":[0.9954896,0.0043213633,0.00008309385,0.000012960609,0.000024613466,0.000026623005,0.0000019934332,0.000013856914,0.000025909374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865925,0.00013470859,0.00043780025,0.0001058538,0.00049636746,0.00016599776],"domain_scores_gemma":[0.99925226,0.000073283314,0.00035333625,0.00011064278,0.00017229666,0.000038177986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004181881,0.000100571444,0.00034428368,0.00011321811,0.000032792672,0.000015779557,0.0001228806,0.000017444265,0.000006151082],"category_scores_gemma":[0.000004859784,0.000058154186,0.00006183747,0.0003531199,0.000087737215,0.00006254222,0.000019272593,0.00016432909,2.5723932e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030704571,0.00054976495,0.8959768,0.000466455,0.0006697754,0.0016126076,0.0030521723,0.00029175586,0.0035202508,0.000035268138,0.00015738774,0.0905973],"study_design_scores_gemma":[0.0056109293,0.0009185984,0.98265266,0.0011581909,0.0001563895,0.00026851,0.004219852,0.0000106328835,0.004799528,0.00008837397,0.00006388327,0.00005246666],"about_ca_topic_score_codex":0.00069423235,"about_ca_topic_score_gemma":0.00016887671,"teacher_disagreement_score":0.090544835,"about_ca_system_score_codex":0.00012395551,"about_ca_system_score_gemma":0.00010027754,"threshold_uncertainty_score":0.23714589},"labels":[],"label_agreement":null},{"id":"W4327549845","doi":"10.1038/s41416-023-02214-0","title":"Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Ontario Institute for Cancer Research; Public Health Ontario; Western University; McGill University Health Centre; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Dalhousie University; University Health Network","funders":"Canadian Cancer Society Research Institute; Hebrew University of Jerusalem; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Medicine; Internal medicine; Adenocarcinoma; Oncology; Neutrophil to lymphocyte ratio; Pancreatic cancer; CD8; Gastroenterology; Immune system; Lymphocyte; Cancer; Immunology","score_opus":0.011382360203243397,"score_gpt":0.27653842993922073,"score_spread":0.26515606973597733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327549845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518676,0.04668288,0.000004639029,0.00016817728,0.0005012581,0.0005350157,0.000014503881,0.00006443322,0.00016149084],"genre_scores_gemma":[0.99421847,0.0047815857,0.00017578225,0.000121002915,0.00035795727,0.00013320538,0.0000049331716,0.000048436697,0.00015864657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784917,0.00010866834,0.00085868104,0.0002040651,0.00058133045,0.00039810993],"domain_scores_gemma":[0.99873364,0.00012560637,0.0003924366,0.00016377031,0.0003452808,0.00023926316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057632796,0.00016272023,0.0005230361,0.00042913557,0.000057441473,0.00004839207,0.0001869479,0.000103292936,0.0001292344],"category_scores_gemma":[0.0005893425,0.0001782969,0.00018978532,0.00061037845,0.0001031144,0.00023331778,0.000048959475,0.00034954844,0.000033315857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005434168,0.000050286664,0.9364791,0.0009600161,0.00017237169,0.010992822,0.00012905097,0.00009827482,0.0016645179,0.000007389263,0.0015679606,0.047334787],"study_design_scores_gemma":[0.0030309246,0.00011996895,0.9786196,0.011921868,0.00023262545,0.004403583,0.00027649832,0.00012300455,0.00057654234,0.00007661699,0.00044700276,0.00017176109],"about_ca_topic_score_codex":0.000040812574,"about_ca_topic_score_gemma":0.0001014852,"teacher_disagreement_score":0.04716303,"about_ca_system_score_codex":0.0003147024,"about_ca_system_score_gemma":0.0006203969,"threshold_uncertainty_score":0.72707367},"labels":[],"label_agreement":null},{"id":"W4328049371","doi":"10.1038/s41416-023-02226-w","title":"Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Pfizer Canada; Université de Montréal; Pfizer","keywords":"Carboplatin; Triple-negative breast cancer; Cancer research; Micrometastasis; Medicine; Metastasis; PARP inhibitor; Breast cancer; Oncology; Cancer; Internal medicine; Chemotherapy; Biology; Poly ADP ribose polymerase; Cisplatin","score_opus":0.015518409706924417,"score_gpt":0.29165390653839224,"score_spread":0.2761354968314678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328049371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986985,0.01030132,0.000058063713,0.0013200503,0.00026163642,0.0003043366,0.00051215774,0.00001822437,0.0002392054],"genre_scores_gemma":[0.98699784,0.011700372,0.0005312746,0.00023303795,0.00038240204,0.000046269215,0.000010864924,0.00004240261,0.000055519537],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793017,0.000119769495,0.00077373785,0.00022944521,0.0006356167,0.000311278],"domain_scores_gemma":[0.99856365,0.00009310336,0.00065418746,0.00006601209,0.00045104878,0.00017197417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005164491,0.00017654715,0.00069976563,0.000266966,0.000058701702,0.00003288193,0.00008149498,0.00006522684,0.00018073813],"category_scores_gemma":[0.000070926864,0.00016696297,0.00010570394,0.00075965904,0.00019587883,0.0002724604,0.000032358297,0.00043224165,4.26135e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015512012,0.0005999222,0.26386085,0.0027457497,0.002465453,0.0074513927,0.0049026837,0.0013579037,0.53592604,0.0001099522,0.010687057,0.15438096],"study_design_scores_gemma":[0.025872653,0.0006330879,0.7284697,0.013605578,0.000582774,0.005733204,0.0013294416,0.00014862679,0.22205304,0.00051016844,0.00047435876,0.000587316],"about_ca_topic_score_codex":0.0034324615,"about_ca_topic_score_gemma":0.0014437954,"teacher_disagreement_score":0.4646089,"about_ca_system_score_codex":0.00032979512,"about_ca_system_score_gemma":0.0007539914,"threshold_uncertainty_score":0.6808553},"labels":[],"label_agreement":null},{"id":"W4360608486","doi":"10.1038/s41416-023-02222-0","title":"Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Daiichi Sankyo Europe; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Collier Charitable Fund","keywords":"Biology; Transcriptome; Cell cycle; Drug discovery; Cancer research; Computational biology; Genomics; Exome; DNA repair; Genetics; Exome sequencing; Cell; Gene; Bioinformatics; Mutation; Genome; Gene expression","score_opus":0.023454103193158313,"score_gpt":0.27874714000716455,"score_spread":0.2552930368140062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360608486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714433,0.027238945,0.000017617602,0.00046698214,0.00022835903,0.00023741725,0.0001589969,0.000013387522,0.00019496973],"genre_scores_gemma":[0.9909156,0.0076870476,0.00044249362,0.00020582316,0.0005001173,0.00002018222,0.000043880573,0.000041284395,0.0001435998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99885803,0.000028963983,0.0005059243,0.00019738215,0.00014664012,0.00026306784],"domain_scores_gemma":[0.9992661,0.000092471426,0.00023625467,0.00009300203,0.0001543791,0.00015779625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020051652,0.00013613177,0.0004968437,0.0001300667,0.00007840136,0.000021454889,0.00008995972,0.000117754826,0.00024136937],"category_scores_gemma":[0.000011348421,0.00013926507,0.00025790773,0.00009150548,0.00009734876,0.00004694994,0.000026624446,0.00019681074,0.000005859161],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025900465,0.0012604877,0.13122581,0.00048882666,0.00060192536,0.0004063098,0.00035043128,0.00004159228,0.75335306,0.00010257377,0.03342946,0.07614946],"study_design_scores_gemma":[0.034449324,0.0032144329,0.71806175,0.00052491104,0.0012982085,0.002299745,0.0005254001,0.00024154571,0.1678541,0.0009894088,0.07002205,0.0005191361],"about_ca_topic_score_codex":0.00011353412,"about_ca_topic_score_gemma":0.000056201538,"teacher_disagreement_score":0.5868359,"about_ca_system_score_codex":0.00010719644,"about_ca_system_score_gemma":0.00013896557,"threshold_uncertainty_score":0.5679065},"labels":[],"label_agreement":null},{"id":"W4362735313","doi":"10.1038/s41416-023-02236-8","title":"A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Queen's University; McGill University Health Centre; Dartmouth General Hospital","funders":"Fonds de Recherche du Québec - Santé; Prostate Cancer Canada; McGill University Health Centre; Movember Foundation; McGill University","keywords":"Prostatectomy; Biochemical recurrence; Prostate cancer; Oncology; Medicine; Hazard ratio; Internal medicine; Multiplex ligation-dependent probe amplification; Proportional hazards model; Pathology; Cancer; Biology; Gene","score_opus":0.01697119278800655,"score_gpt":0.3237219752878316,"score_spread":0.306750782499825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920508,0.0031849043,0.000021129907,0.0019529479,0.00093630975,0.0013228846,0.00034454867,0.000029180415,0.00015728305],"genre_scores_gemma":[0.98009825,0.014851793,0.00016287273,0.0009962661,0.0006527542,0.0012356234,0.000082419836,0.000048657388,0.0018713403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852306,0.000026812078,0.0004992953,0.00020537857,0.00041735393,0.0003280901],"domain_scores_gemma":[0.9984982,0.00007569461,0.0003256166,0.0000800421,0.0008567105,0.00016370564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017097767,0.00014496136,0.00036069352,0.000071107046,0.000106857915,0.00010356636,0.000061711165,0.00006285598,0.00040021545],"category_scores_gemma":[0.00015755935,0.00013674593,0.00018028593,0.00023913429,0.00003978088,0.00022616597,0.000017809023,0.00015373531,0.000027703942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072230946,0.00035289666,0.67940986,0.00021980407,0.00038583786,0.00030999206,0.0002847416,0.000046721303,0.00017075124,0.000016661494,0.07296714,0.24511327],"study_design_scores_gemma":[0.012705091,0.0015111053,0.84116375,0.0042560506,0.00066631753,0.00032251963,0.000063607506,0.0001330553,0.005646646,0.0004639492,0.1327744,0.0002935223],"about_ca_topic_score_codex":0.00027740898,"about_ca_topic_score_gemma":0.00022628944,"teacher_disagreement_score":0.24481975,"about_ca_system_score_codex":0.00032823105,"about_ca_system_score_gemma":0.00060171407,"threshold_uncertainty_score":0.55763376},"labels":[],"label_agreement":null},{"id":"W4366448631","doi":"10.1038/s41416-023-02263-5","title":"Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Centre hospitalier universitaire de Québec; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Juravinski Hospital; McMaster University; University of Toronto","funders":"Medical Research and Materiel Command; European Social Fund; National Center for Advancing Translational Sciences; European Regional Development Fund; Instituto de Salud Carlos III; Cancer Council Tasmania; Cancer Council NSW; Cancer Council Victoria; Medical Research Council; Canadian Institutes of Health Research; Cancer Center, University of Kansas; National Institutes of Health; Government of Canada; Centre Léon Bérard; NIH Office of the Director; Maastricht Universitair Medisch Centrum; Universiteit Leiden; Institut Claudius Regaud; Deutsches Krebsforschungszentrum; Unicancer; Freistaat Sachsen; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Hospices Civils de Lyon; Cancer Council South Australia; Institut Bergonié; Deutsche Krebshilfe; National Institute of General Medical Sciences; Leids Universitair Medisch Centrum; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Institut Gustave-Roussy; Erasmus Medisch Centrum; Radboud Universitair Medisch Centrum; Generalitat de Catalunya; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Universiteit Maastricht; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Radboud Universiteit; National Cancer Institute; Peter MacCallum Foundation; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; Fondation du cancer du sein du Québec; Gray Foundation; Royal Marsden NHS Foundation Trust; Centres de Recerca de Catalunya; Ovarian Cancer Australia; Associazione Italiana per la Ricerca sul Cancro; Genome Canada; Breast Cancer Research Foundation; Univerzita Karlova v Praze; National Institute for Health and Care Research; Kansas Bioscience Authority; Amsterdam University Medical Centers; Rijksuniversiteit Groningen; Cancer Australia; Ministerstvo Zdravotnictví Ceské Republiky; European Commission; Lietuvos Mokslo Taryba; National Health and Medical Research Council; Fundación Cellex; Universitair Medisch Centrum Groningen","keywords":"Cancer; Ovarian cancer; Pathogenicity; Pathology; Medicine; Biology; Oncology; Internal medicine","score_opus":0.008675891185583793,"score_gpt":0.2730566383193235,"score_spread":0.26438074713373966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366448631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886036,0.009610886,0.0001012149,0.00030781672,0.0008686092,0.00010393841,0.00031240532,0.000004615579,0.00008693669],"genre_scores_gemma":[0.9709829,0.02780208,0.00020275549,0.00021265836,0.0005716675,0.000026592652,0.000019681478,0.000025229781,0.00015644748],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987642,0.00009331248,0.0005191192,0.00021600488,0.0001843966,0.00022292684],"domain_scores_gemma":[0.9991433,0.000020197911,0.00036323367,0.00013152273,0.00025723042,0.00008453936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004263942,0.00011126062,0.0002841925,0.000111601934,0.000040542676,0.000023020672,0.00017622668,0.00016328512,0.00009020016],"category_scores_gemma":[0.00019100179,0.00013114717,0.00007729754,0.00023272364,0.00012917322,0.000010275336,0.00008755454,0.0001900154,0.0000010152136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050070666,0.00016903864,0.23023182,0.00018244877,0.0005564566,0.0021875477,0.00091977423,0.00096933864,0.49856192,0.00006838371,0.006968858,0.25868368],"study_design_scores_gemma":[0.0018532224,0.0002650902,0.94615203,0.00034898767,0.00009478903,0.0021104303,0.00014862111,0.000068541885,0.026650585,0.00024693954,0.02181617,0.00024457992],"about_ca_topic_score_codex":0.00045813387,"about_ca_topic_score_gemma":0.0013726605,"teacher_disagreement_score":0.7159202,"about_ca_system_score_codex":0.00008248883,"about_ca_system_score_gemma":0.00062042795,"threshold_uncertainty_score":0.5348027},"labels":[],"label_agreement":null},{"id":"W4366815856","doi":"10.1038/s41416-023-02272-4","title":"Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Breast cancer; Drug; Oncology; Cancer; Internal medicine; Pharmacology","score_opus":0.022176495954511766,"score_gpt":0.37173380882424717,"score_spread":0.3495573128697354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366815856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94053996,0.044199403,0.0000075972753,0.011763351,0.0015189858,0.00033862566,0.00018029548,0.000062293686,0.0013894778],"genre_scores_gemma":[0.8839374,0.104163,0.00007591167,0.0014548934,0.0028512238,0.00005019036,0.000005614906,0.00008393039,0.007377822],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747,0.00010239635,0.00058901997,0.00024383703,0.0010217004,0.0005730379],"domain_scores_gemma":[0.998261,0.000120751334,0.00023878513,0.00020718074,0.0007679095,0.00040442162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060849864,0.00018062023,0.0005862105,0.00023405894,0.00013231783,0.00013753827,0.00030795185,0.00010776929,0.0039736126],"category_scores_gemma":[0.00014732625,0.00017908592,0.00021801876,0.0007523657,0.00018233086,0.000179802,0.00005691943,0.00075806386,0.00013046442],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005340739,0.00015897719,0.16023351,0.0004279331,0.00068139174,0.006780368,0.0004516259,0.00028944516,0.00860276,0.000039341925,0.28858256,0.533218],"study_design_scores_gemma":[0.0045547243,0.0003026893,0.59055704,0.005044753,0.00027078186,0.011505464,0.00034075527,0.0001568707,0.009501795,0.00034948133,0.37701428,0.00040138903],"about_ca_topic_score_codex":0.004606738,"about_ca_topic_score_gemma":0.0008274241,"teacher_disagreement_score":0.53281665,"about_ca_system_score_codex":0.00036200418,"about_ca_system_score_gemma":0.0015967473,"threshold_uncertainty_score":0.9969369},"labels":[],"label_agreement":null},{"id":"W4367367470","doi":"10.1038/s41416-023-02289-9","title":"Precision medicine for prostate cancer—improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier","year":2023,"lang":"en","type":"editorial","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostate cancer; Classifier (UML); Medicine; Oncology; Cohort; Internal medicine; Pathology; Artificial intelligence; Computer science; Cancer","score_opus":0.03510274844559041,"score_gpt":0.39934056784165556,"score_spread":0.36423781939606514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367367470","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03604871,0.020965375,0.0034769175,0.000929416,0.9077478,0.005465696,0.025271151,0.00008389094,0.000011050524],"genre_scores_gemma":[0.008775945,0.11509285,0.000723701,0.00009669401,0.86283153,0.0020330485,0.0028187525,0.00036369756,0.007263774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526685,0.00012765067,0.0017021799,0.0006486741,0.0015226648,0.0007319477],"domain_scores_gemma":[0.9929742,0.0009426735,0.001642806,0.00026216672,0.0035141974,0.00066395145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013501392,0.00047856887,0.0013523492,0.00031244036,0.0003464023,0.00017661812,0.00024708323,0.0005326223,0.00016964546],"category_scores_gemma":[0.0032160026,0.00041339092,0.0005944838,0.00029639393,0.00020643482,0.00036749232,0.00006048829,0.0011297433,0.0000026020373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019120043,0.00018144441,0.009617141,0.002445467,0.0011942333,0.00034678075,0.00018401322,0.000257304,0.0010904442,2.7042248e-7,0.9103509,0.05521192],"study_design_scores_gemma":[0.06333162,0.004160891,0.010777278,0.036947995,0.009274068,0.00014701576,0.00016289276,0.01726048,0.0018015062,0.00045040585,0.8545939,0.0010919513],"about_ca_topic_score_codex":0.0012127635,"about_ca_topic_score_gemma":0.000781044,"teacher_disagreement_score":0.094127476,"about_ca_system_score_codex":0.0019210184,"about_ca_system_score_gemma":0.0033759668,"threshold_uncertainty_score":0.9998318},"labels":[],"label_agreement":null},{"id":"W4367395065","doi":"10.1038/s41416-023-02279-x","title":"A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Cancer Research UK; Incyte; NuCana; Astex Pharmaceuticals; Carrick Therapeutics; Sierra Oncology; National Institute for Health and Care Research; Verastem Oncology","keywords":"Medicine; Cancer; Oncology; Internal medicine","score_opus":0.009254080624268702,"score_gpt":0.2939590683124058,"score_spread":0.2847049876881371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367395065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975099,0.0013999427,0.00001732462,0.000050541566,0.0005634193,0.000280404,0.000116025025,0.0000054202737,0.000057040917],"genre_scores_gemma":[0.99779785,0.0012816975,0.00024572245,0.00008086134,0.0002970221,0.000039732255,0.000023012013,0.00002902111,0.00020510446],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987645,0.000050618,0.00046539557,0.00017990946,0.00032278424,0.00021677041],"domain_scores_gemma":[0.99906,0.000007196408,0.00041155584,0.0001247232,0.00030770572,0.00008886526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001903493,0.00011314079,0.000285684,0.000083126906,0.00002223358,0.000018473755,0.00017002688,0.00008807057,0.000046203022],"category_scores_gemma":[0.00007289471,0.00011599447,0.00009860713,0.00021597528,0.00004458248,0.000014797758,0.000047188478,0.00012474137,6.80008e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11608057,0.0021773947,0.010647119,0.00013968661,0.00041322742,0.0003713958,0.00016854309,0.00059783354,0.28229472,0.0000054520724,0.0041449303,0.5829591],"study_design_scores_gemma":[0.4460668,0.027438382,0.029998764,0.0023295982,0.00015732856,0.00008860322,0.00017771093,0.000033451703,0.4640372,0.00007989021,0.028833803,0.0007584652],"about_ca_topic_score_codex":0.00008557502,"about_ca_topic_score_gemma":0.00073026365,"teacher_disagreement_score":0.58220065,"about_ca_system_score_codex":0.000043983895,"about_ca_system_score_gemma":0.0003707267,"threshold_uncertainty_score":0.47301173},"labels":[],"label_agreement":null},{"id":"W4376106635","doi":"10.1038/s41416-023-02281-3","title":"Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster Children's Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre; Pediatric Oncology Group; Hamilton Health Sciences; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Pregnancy; Epidemiology; Medical history; Pediatrics; Logistic regression; Family history; Early childhood; Past medical history; Epilepsy; Case-control study; Psychiatry; Internal medicine; Psychology","score_opus":0.00597192283805433,"score_gpt":0.24261298985610405,"score_spread":0.2366410670180497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376106635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747516,0.009781275,0.0000037158588,0.001998408,0.00020133903,0.00040509203,0.00004392536,0.0000043632435,0.000086753505],"genre_scores_gemma":[0.9974512,0.0014660174,0.000012839712,0.00059622346,0.00020934815,0.000015658226,4.6008668e-7,0.000019402496,0.00022889019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976233,0.00028870793,0.00057621,0.00015942474,0.0010745554,0.00027780677],"domain_scores_gemma":[0.99863786,0.00054503145,0.00027520332,0.00010484003,0.00014404712,0.00029301445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018412141,0.00011577897,0.0005618495,0.00013704994,0.00005903906,0.000019744632,0.0001443673,0.0000622657,0.0004478386],"category_scores_gemma":[0.0010497802,0.000088616594,0.000060064183,0.00013195665,0.0002403466,0.00006808196,0.000071415765,0.0008769977,2.8782873e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007716155,0.00020207159,0.8712909,0.00003713793,0.00064906664,0.06525212,0.003029742,0.000020427715,0.0000043033383,0.0000036773247,0.015576496,0.04316241],"study_design_scores_gemma":[0.029350972,0.0002436615,0.9130422,0.0005819696,0.00022884837,0.054912567,0.00067759666,0.00018464225,0.0000032829416,0.000023156357,0.0006825463,0.00006858604],"about_ca_topic_score_codex":0.98036504,"about_ca_topic_score_gemma":0.995855,"teacher_disagreement_score":0.043093823,"about_ca_system_score_codex":0.0016695529,"about_ca_system_score_gemma":0.009218677,"threshold_uncertainty_score":0.99639815},"labels":[],"label_agreement":null},{"id":"W4376598097","doi":"10.1038/s41416-023-02290-2","title":"Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Cancer; Confidence interval; FOLFOX; Proportional hazards model; Prospective cohort study; Oncology; Oxaliplatin","score_opus":0.013881931258799033,"score_gpt":0.2797538136270308,"score_spread":0.2658718823682317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376598097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96630156,0.030906253,0.000005624137,0.0006147814,0.0010844573,0.00031485615,0.0006737727,0.000022645554,0.00007604284],"genre_scores_gemma":[0.953631,0.045167148,0.00002711566,0.00024080287,0.00032745337,0.000059012684,0.000027961876,0.00004000454,0.00047949783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797076,0.000079830264,0.0004796704,0.00036254615,0.0006912552,0.00041596667],"domain_scores_gemma":[0.99872357,0.000102431426,0.00027494822,0.00012439906,0.0004877322,0.00028692128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029063394,0.00020731524,0.0006449237,0.00014687012,0.00010228083,0.00008896052,0.00012975489,0.00012870866,0.00039186515],"category_scores_gemma":[0.0000710153,0.00020625388,0.000054989654,0.0006735124,0.00015702014,0.00026451173,0.000062652616,0.00060932443,8.9585336e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019523691,0.00004840202,0.86476403,0.00013414245,0.00014221517,0.00038429612,0.0009647301,0.00003555621,0.00016893148,0.0000026320897,0.0016512381,0.12975147],"study_design_scores_gemma":[0.0074375654,0.00034268567,0.9776732,0.0033990175,0.00013033711,0.000023664514,0.00039214033,0.000074572716,0.00023922493,0.000018708375,0.010014509,0.00025440886],"about_ca_topic_score_codex":0.076993756,"about_ca_topic_score_gemma":0.30449957,"teacher_disagreement_score":0.22750582,"about_ca_system_score_codex":0.0003705123,"about_ca_system_score_gemma":0.0003773927,"threshold_uncertainty_score":0.9291526},"labels":[],"label_agreement":null},{"id":"W4376601978","doi":"10.1038/s41416-023-02299-7","title":"Neighbourhood social deprivation and risk of prostate cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Social deprivation; Demography; Medicine; Neighbourhood (mathematics); Odds ratio; Gerontology; Confounding; Logistic regression; Confidence interval; Incidence (geometry); Epidemiology; Androgen deprivation therapy; Psychological intervention; Cancer; Internal medicine; Psychiatry","score_opus":0.014302874808182564,"score_gpt":0.2988885482956417,"score_spread":0.28458567348745917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376601978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97264826,0.025139734,0.000005860924,0.0015063977,0.00021685948,0.00017333374,0.00018288147,0.0000105813115,0.000116067116],"genre_scores_gemma":[0.81955355,0.1798161,0.000058912294,0.00009421451,0.00031237566,0.00003214198,0.000004680571,0.0000145806835,0.00011345881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911803,0.000027620918,0.00033357128,0.000103455364,0.00026284138,0.00015447027],"domain_scores_gemma":[0.99914,0.000031901036,0.00039820807,0.000042569976,0.00030019705,0.00008707742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019056982,0.000076480675,0.00029945205,0.000081196944,0.00007282191,0.000023181536,0.00003609106,0.000042349995,0.00014237594],"category_scores_gemma":[0.000050182258,0.000073585885,0.00009246006,0.0002185433,0.00005794479,0.00010846136,0.00001968671,0.00015360973,0.0000010500569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014335236,0.00005370706,0.5217264,0.00008112194,0.0003230713,0.00013408906,0.00034631908,0.000028957878,0.00027938897,0.00001135762,0.00320131,0.4736709],"study_design_scores_gemma":[0.0029464588,0.00021528556,0.98692274,0.00077879475,0.00039611454,0.0001323558,0.00011225086,0.000026353364,0.0032975029,0.00026491366,0.0048386026,0.000068655965],"about_ca_topic_score_codex":0.0016715539,"about_ca_topic_score_gemma":0.00065936474,"teacher_disagreement_score":0.47360224,"about_ca_system_score_codex":0.00012209678,"about_ca_system_score_gemma":0.00023736659,"threshold_uncertainty_score":0.30007452},"labels":[],"label_agreement":null},{"id":"W4378471674","doi":"10.1038/s41416-023-02276-0","title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dosing; Medicine; Pharmacokinetics; Pharmacodynamics; Incidence (geometry); Limiting; Internal medicine; Pulmonary embolism; Maximum tolerated dose; Pharmacology","score_opus":0.005854355098554552,"score_gpt":0.2836575779162561,"score_spread":0.2778032228177016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378471674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768335,0.0017669307,0.000007728514,0.000016172755,0.0002518386,0.00023057064,0.000016091402,0.000003481573,0.00002384994],"genre_scores_gemma":[0.99912155,0.00055354537,0.000033595024,0.0000134381535,0.00015422865,0.000008613892,0.00001890404,0.000020741012,0.000075405434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905443,0.000038709535,0.00037049377,0.00013903894,0.0002520601,0.00014527306],"domain_scores_gemma":[0.9991724,0.0000043718687,0.0003131568,0.0000972999,0.00036295468,0.00004984347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012311875,0.00008226164,0.0002011906,0.00009404338,0.000023331673,0.000011031035,0.000093409886,0.000054674427,0.000015243336],"category_scores_gemma":[0.00004145111,0.00008766987,0.000038352606,0.00034351388,0.00002901489,0.000011527972,0.000029816894,0.00010815803,5.807719e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009758664,0.004851037,0.24106546,0.00012982517,0.0006316549,0.0002284093,0.0007669747,0.05369328,0.16609988,0.0000012219792,0.0063705104,0.5164031],"study_design_scores_gemma":[0.042385764,0.017137388,0.85856277,0.0013918359,0.00011525903,0.00008213444,0.00055720645,0.00010335838,0.07393915,0.000017979644,0.0052531203,0.00045401635],"about_ca_topic_score_codex":0.00007790182,"about_ca_topic_score_gemma":0.0009870464,"teacher_disagreement_score":0.6174973,"about_ca_system_score_codex":0.000045799596,"about_ca_system_score_gemma":0.00020031819,"threshold_uncertainty_score":0.35750735},"labels":[],"label_agreement":null},{"id":"W4382046876","doi":"10.1038/s41416-023-02312-z","title":"Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ontario Ministry of Research and Innovation; School of Public Health, Imperial College London; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; Centers for Disease Control and Prevention; Instituto de Salud Carlos III; Xarxa de Bancs de Tumors de Catalunya; National Institutes of Health; Centre Hospitalier Universitaire de Nantes; Conseil Régional des Pays de la Loire; National Institute of Diabetes and Digestive and Kidney Diseases; Herzfelder'sche Familienstiftung; NIHR Imperial Biomedical Research Centre; Centre International de Recherche sur le Cancer; Grantová Agentura České Republiky; Medizinische Universität Graz; Imperial College London; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; National Institute on Aging; Harvard T.H. Chan School of Public Health; National Institute for Health and Care Research; Johns Hopkins University; Brigham and Women's Hospital; Emory University; Fred Hutchinson Cancer Research Center; Centres de Recerca de Catalunya; Ministerstvo Zdravotnictví Ceské Republiky; World Health Organization; Cancer Research UK; American Cancer Society; Office of Research Infrastructure Programs, National Institutes of Health; Junta de Castilla y León; Karl-Franzens-Universität Graz; U.S. Department of Health and Human Services","keywords":"Colorectal cancer; Diabetes mellitus; Medicine; Cancer; Internal medicine; Oncology; Bioinformatics; Cancer research; Computational biology; Biology; Endocrinology","score_opus":0.04011756778376931,"score_gpt":0.3241981905296975,"score_spread":0.2840806227459282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382046876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7334516,0.26608744,0.000040043848,0.000043055352,0.00028757655,0.000056520934,0.00001835506,0.000002443039,0.000012979304],"genre_scores_gemma":[0.8527556,0.14628032,0.0000771573,0.00011942569,0.00067103986,0.000021188347,0.0000067008295,0.000013908727,0.000054674587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926597,0.00007516837,0.00022388608,0.00012764924,0.00014610688,0.00016120469],"domain_scores_gemma":[0.9995894,0.000022677381,0.00021297856,0.000059436003,0.00006411399,0.000051426458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025530244,0.00007901988,0.00013457812,0.000042265743,0.00014333862,0.00006085143,0.00008460067,0.000055264838,0.00005770115],"category_scores_gemma":[0.000047685196,0.0000696124,0.00007615627,0.00009932213,0.00006881469,0.000015969474,0.000042560085,0.000131594,8.4157745e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055350272,0.000023831193,0.055494364,0.00003262254,0.0003669952,0.000011378517,0.0001789944,0.013282872,0.572061,0.0000032628984,0.0020460638,0.35644323],"study_design_scores_gemma":[0.0013628688,0.00016454086,0.2784713,0.0004561137,0.0005416157,0.00018445894,0.0005226515,0.0017438252,0.5505105,0.00020029796,0.16540055,0.0004412508],"about_ca_topic_score_codex":0.00011086526,"about_ca_topic_score_gemma":0.00016697805,"teacher_disagreement_score":0.35600197,"about_ca_system_score_codex":0.00004374787,"about_ca_system_score_gemma":0.00008275189,"threshold_uncertainty_score":0.2838711},"labels":[],"label_agreement":null},{"id":"W4382929676","doi":"10.1038/s41416-023-02346-3","title":"ACE inhibitors and the risk of lung cancer—is there causality?","year":2023,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"","keywords":"Causality (physics); Lung cancer; Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.01541183887034652,"score_gpt":0.31455842654885324,"score_spread":0.2991465876785067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382929676","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028866293,0.18184258,0.02104907,0.7595857,0.007145254,0.00054292247,0.00071114243,0.000050131464,0.00020695305],"genre_scores_gemma":[0.02812824,0.36053976,0.022047078,0.54097605,0.039318454,0.0002648804,0.000021197022,0.00045512192,0.008249192],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965457,0.0009140637,0.0008268561,0.00032878225,0.0010948499,0.00028979997],"domain_scores_gemma":[0.9960226,0.0014152514,0.0016406373,0.00029642603,0.0005576501,0.00006746545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017894104,0.00022907888,0.0007070221,0.00015035975,0.00013940311,0.00034235884,0.0011844301,0.0002278977,0.000045945184],"category_scores_gemma":[0.0002432353,0.000189832,0.00035126184,0.0004773737,0.00029041525,0.0004101504,0.00036951897,0.0018038027,9.953854e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023735234,0.0000080763475,0.0014673301,0.00020837379,0.0005603632,0.00045735895,0.00055526185,0.0032930828,0.0000016879688,0.00008588105,0.9127957,0.08054312],"study_design_scores_gemma":[0.0038521148,0.000091465394,0.04422582,0.0075158784,0.00095025817,0.0016095946,0.00006604841,0.025610704,0.00025852304,0.022816166,0.8920607,0.00094274955],"about_ca_topic_score_codex":0.006567633,"about_ca_topic_score_gemma":0.0006881277,"teacher_disagreement_score":0.21860959,"about_ca_system_score_codex":0.00016492602,"about_ca_system_score_gemma":0.00078294985,"threshold_uncertainty_score":0.99283403},"labels":[],"label_agreement":null},{"id":"W4383551038","doi":"10.1038/s41416-023-02307-w","title":"A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Tolerability; Clinical trial; Medicine; Adverse effect; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.42334773358831657,"score_gpt":0.5319927219761352,"score_spread":0.10864498838781866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383551038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082124,0.0004060088,0.005508949,0.00018102417,0.0019328609,0.0007463873,0.00032309088,0.000028910137,0.000051526575],"genre_scores_gemma":[0.9666187,0.00027096426,0.032472916,0.00024705444,0.00014843294,0.000095405776,0.000002190865,0.000048009828,0.00009633795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99428236,0.0010795138,0.0028184087,0.00025686008,0.0012014405,0.0003614277],"domain_scores_gemma":[0.98799294,0.008649303,0.0018648009,0.00039183887,0.0008422942,0.00025884123],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031477653,0.00019514794,0.0009055568,0.00014542814,0.00009735894,0.000027048847,0.0004639925,0.00010874071,0.00052196975],"category_scores_gemma":[0.04593473,0.00015349229,0.00029070728,0.0009557604,0.0001413551,0.00010877867,0.00013209385,0.0003888439,0.000011210867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038275113,0.0032460927,0.08340465,0.00071753544,0.0016953645,0.0034378867,0.019128544,0.0007019907,0.0026216076,0.00091316784,0.06710666,0.813199],"study_design_scores_gemma":[0.030814132,0.005570455,0.6897764,0.012783119,0.0014357123,0.0021541794,0.013903935,0.0008923741,0.00956765,0.21507859,0.015205565,0.0028178466],"about_ca_topic_score_codex":0.00022894933,"about_ca_topic_score_gemma":0.00013449338,"teacher_disagreement_score":0.8103811,"about_ca_system_score_codex":0.000117505144,"about_ca_system_score_gemma":0.00013230596,"threshold_uncertainty_score":0.96210176},"labels":[],"label_agreement":null},{"id":"W4383618206","doi":"10.1038/s41416-023-02353-4","title":"Fracture risk among patients with cancer compared to individuals without cancer: a population-based study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; Women's College Hospital; University of Toronto","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Cancer; Internal medicine; Breast cancer; Lung cancer; Prostate cancer; Population; Proportional hazards model; Relative risk; Osteoporosis; Oncology; Surgery; Confidence interval","score_opus":0.01498883161055673,"score_gpt":0.3314391492485287,"score_spread":0.31645031763797193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383618206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954362,0.0017346367,0.000012235492,0.00069838593,0.0003905607,0.0012345464,0.00043977695,0.000037529968,0.000016126818],"genre_scores_gemma":[0.99745256,0.00040191764,0.00015160024,0.0012729063,0.00021785729,0.00023950599,0.000046784688,0.00004804709,0.0001688202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978778,0.00008955088,0.00053462124,0.00023607616,0.0008883458,0.000373622],"domain_scores_gemma":[0.9981607,0.000047052494,0.00059074373,0.0001430041,0.0005534698,0.0005049919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020604861,0.00018653864,0.00061022944,0.00021462953,0.0001969029,0.000054992335,0.00010130633,0.00007048986,0.00035841935],"category_scores_gemma":[0.00006136408,0.00015841378,0.00008290104,0.0005579859,0.00002140591,0.00013777518,0.000015828304,0.00040273403,0.000005744572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065967895,0.00044171323,0.9570234,0.000044543332,0.00046377184,0.00016726277,0.00033075115,0.004369767,4.0418433e-7,3.087969e-8,0.0039755437,0.03252317],"study_design_scores_gemma":[0.010888194,0.0006056861,0.98397744,0.0015922383,0.0006117369,0.0000100153065,0.00009213916,0.00004347518,0.000010226924,0.0000038833355,0.0020088044,0.00015616001],"about_ca_topic_score_codex":0.09387926,"about_ca_topic_score_gemma":0.08030482,"teacher_disagreement_score":0.03236701,"about_ca_system_score_codex":0.0004275874,"about_ca_system_score_gemma":0.00066425133,"threshold_uncertainty_score":0.93647724},"labels":[],"label_agreement":null},{"id":"W4384155464","doi":"10.1038/s41416-023-02344-5","title":"Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; Oncolytics Biotech; Merck","keywords":"Pembrolizumab; Medicine; Internal medicine; Chemotherapy; Oncology; CD8; Immunotherapy; Immune system; Gastroenterology; Regimen; Chemotherapy regimen; Immunology; Cancer","score_opus":0.012853819566891618,"score_gpt":0.2831648186824827,"score_spread":0.2703109991155911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384155464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637641,0.03517466,0.0000052146265,0.00051916885,0.00015780053,0.0002193464,0.000015952994,0.000011157065,0.0001326073],"genre_scores_gemma":[0.9820843,0.017564457,0.00008207777,0.00006593918,0.00005321338,0.000009294123,0.000007682056,0.000017126269,0.000115946685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988422,0.00007235142,0.0005200733,0.00010674647,0.00028368388,0.0001749866],"domain_scores_gemma":[0.99922,0.000058419802,0.00033341677,0.00008820909,0.00023812131,0.000061802646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045019464,0.00009364266,0.00042286067,0.00022361423,0.000045218476,0.000020919508,0.00008267849,0.000059788545,0.00008118097],"category_scores_gemma":[0.000119722274,0.00009805724,0.00009750151,0.00044085592,0.00010265995,0.00017196263,0.000023378669,0.00024622565,5.2517674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040053143,0.00035990772,0.50399894,0.0007858569,0.0003511497,0.0010110387,0.0010165416,0.000028227158,0.12448922,0.00002382656,0.0006380611,0.3632919],"study_design_scores_gemma":[0.007711505,0.00055800984,0.9786598,0.0022557795,0.00008073483,0.0014726694,0.00041934507,0.000087882414,0.008156576,0.00016947082,0.00033463156,0.00009361256],"about_ca_topic_score_codex":0.00083012943,"about_ca_topic_score_gemma":0.00028071972,"teacher_disagreement_score":0.4746608,"about_ca_system_score_codex":0.00011449336,"about_ca_system_score_gemma":0.00021432994,"threshold_uncertainty_score":0.3998658},"labels":[],"label_agreement":null},{"id":"W4386047586","doi":"10.1038/s41416-023-02397-6","title":"Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Natural Science Foundation of Zhejiang Province; Medical Research Council; Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Wellcome Trust; British Heart Foundation; Academy of Medical Sciences; Diabetes UK; Cancer Research UK","keywords":"DNA methylation; Colorectal cancer; Epigenetics; Methylation; Mendelian randomization; Oncology; Medicine; CpG site; MLH1; Cancer; Internal medicine; Genetics; Bioinformatics; Biology; Gene; Genotype; DNA mismatch repair; Gene expression; Genetic variants","score_opus":0.006909366524287928,"score_gpt":0.26966526445769423,"score_spread":0.2627558979334063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386047586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945143,0.054335076,0.000018736611,0.000034693185,0.00030502043,0.00010831388,0.000015925829,0.0000017820082,0.000037454483],"genre_scores_gemma":[0.949997,0.04967249,0.00001257198,0.000013069714,0.00024978165,0.000013369435,0.0000035670757,0.00001258895,0.00002556651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992261,0.00011602848,0.00025688694,0.000118198084,0.00015812895,0.00012464728],"domain_scores_gemma":[0.99936795,0.00009985361,0.0003051456,0.000046354744,0.00014693427,0.00003376732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055504084,0.00007047013,0.00013465487,0.000055363285,0.00006493035,0.000020746582,0.000075814205,0.000082652165,0.0000044800668],"category_scores_gemma":[0.00041660224,0.00006423292,0.00006342143,0.00015322078,0.000022028877,0.000005706454,0.00003131825,0.0001623584,8.056488e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006349443,0.00002403982,0.06478166,0.000042694053,0.00010616485,0.000021918455,0.00011864589,0.0022199517,0.8507664,0.0000046819664,0.000012425291,0.08183793],"study_design_scores_gemma":[0.00055485347,0.00015863415,0.4533095,0.00021958855,0.00006018685,0.000009684883,0.000028464943,0.000120911885,0.54527557,0.0000930134,0.000111959445,0.000057632107],"about_ca_topic_score_codex":0.00024305537,"about_ca_topic_score_gemma":0.0015832493,"teacher_disagreement_score":0.38852784,"about_ca_system_score_codex":0.000015056437,"about_ca_system_score_gemma":0.0000527315,"threshold_uncertainty_score":0.26193425},"labels":[],"label_agreement":null},{"id":"W4386695399","doi":"10.1038/s41416-023-02415-7","title":"Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada","year":2023,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster Children's Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre; Pediatric Oncology Group; Hamilton Health Sciences; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Public Health Ontario","funders":"","keywords":"Childhood cancer; Medicine; Case-control study; Pediatrics; Pathology; Cancer; Internal medicine","score_opus":0.008532451240408051,"score_gpt":0.25192345993760373,"score_spread":0.24339100869719568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386695399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8096751,0.14131498,0.0000043698415,0.005971846,0.040381506,0.0014135218,0.00036331557,0.000022588853,0.0008527487],"genre_scores_gemma":[0.95361507,0.017717496,0.000014573824,0.0036755088,0.0057228217,0.00007161827,0.00001231579,0.00016066318,0.019009907],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99409264,0.00096587226,0.0018525912,0.00046772047,0.0021891287,0.00043206892],"domain_scores_gemma":[0.9960975,0.0009025647,0.0018449744,0.00029551145,0.00035282847,0.0005066064],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037320454,0.0004264314,0.0021475041,0.00028390565,0.00013682591,0.000058260877,0.00032268226,0.00035609413,0.0008191324],"category_scores_gemma":[0.0022424604,0.00038011998,0.00026726982,0.00019393228,0.00041396465,0.000117342046,0.00011879385,0.0048590032,3.66625e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006617264,0.00036171896,0.18861163,0.00017419025,0.0017669114,0.021344343,0.005603152,0.0000077362465,5.826613e-8,9.783959e-7,0.76043713,0.021030445],"study_design_scores_gemma":[0.019350382,0.00047601538,0.8716001,0.0069900155,0.0013353057,0.06442397,0.0016660866,0.00002434464,3.2471698e-7,0.000022142534,0.033830505,0.00028079134],"about_ca_topic_score_codex":0.99398977,"about_ca_topic_score_gemma":0.99970853,"teacher_disagreement_score":0.7266066,"about_ca_system_score_codex":0.002046685,"about_ca_system_score_gemma":0.01818329,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W4386861913","doi":"10.1038/s41416-023-02429-1","title":"Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Nursing Research; National Human Genome Research Institute; Cancer Institute NSW; National Health and Medical Research Council; McGill University; Foundation for the National Institutes of Health","keywords":"Regret; Medicine; Clinical trial; Family medicine; Receipt; Precision medicine; Qualitative property; Qualitative research; Randomized controlled trial; Childhood cancer; Clinical psychology; Psychology; Cancer; Internal medicine; Pathology","score_opus":0.22070539878110393,"score_gpt":0.5879041545990111,"score_spread":0.3671987558179072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386861913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95534784,0.04030077,0.00003558241,0.002535434,0.0004844143,0.0012393423,0.00003345387,0.0000057781945,0.000017392527],"genre_scores_gemma":[0.90335035,0.09543854,0.00054640556,0.00006426006,0.0004422016,0.00010443688,9.533815e-7,0.000016838056,0.000036023208],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975329,0.00034082227,0.0008792599,0.00025857252,0.0008051073,0.00018332884],"domain_scores_gemma":[0.9952441,0.0032969788,0.00043391588,0.000105900195,0.0007594198,0.00015970776],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038883013,0.00009836768,0.0006390435,0.00021179175,0.00006014399,0.000020340975,0.000064457054,0.00012991414,0.00005276656],"category_scores_gemma":[0.010149709,0.000085189306,0.0000615963,0.00029009284,0.00020768121,0.00008333538,0.00007247448,0.0008253937,5.584988e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012157699,0.00036177287,0.043948736,0.00016947719,0.00018422084,0.000074745745,0.008495069,0.000019458477,0.0001579839,0.000023155018,0.0016101936,0.9327975],"study_design_scores_gemma":[0.07284223,0.011667655,0.8838556,0.0053506433,0.00016869114,0.0001084216,0.022831053,0.0000715691,0.00009918336,0.002024789,0.00088274427,0.000097457785],"about_ca_topic_score_codex":0.006484675,"about_ca_topic_score_gemma":0.016455155,"teacher_disagreement_score":0.93270004,"about_ca_system_score_codex":0.00017848985,"about_ca_system_score_gemma":0.0004429138,"threshold_uncertainty_score":0.9981882},"labels":[],"label_agreement":null},{"id":"W4387220566","doi":"10.1038/s41416-023-02443-3","title":"Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto","funders":"Movember Foundation","keywords":"Internal medicine; Seminoma; Stage (stratigraphy); Germ cell tumors; Oncology; Progression-free survival; Medicine; Cancer; Overall survival; Chemotherapy; Biology","score_opus":0.04783151474138426,"score_gpt":0.4064626711563925,"score_spread":0.35863115641500826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387220566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939799,0.0033094024,0.000040974723,0.0001714586,0.00037831758,0.00016885772,0.0019336778,0.00000844946,0.000008980615],"genre_scores_gemma":[0.9962962,0.0027981934,0.00050076976,0.00017682619,0.000047263038,0.000010170051,0.00008414198,0.000019860063,0.00006655263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981078,0.00015223512,0.00079341826,0.00015639645,0.0005943399,0.00019583006],"domain_scores_gemma":[0.99800223,0.00021165298,0.00077145756,0.00027912806,0.00050777383,0.00022774038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003612761,0.00011506367,0.00069832156,0.00015228664,0.000044190958,0.000014374424,0.00017332418,0.00003594125,0.00032603907],"category_scores_gemma":[0.0010125772,0.00008533049,0.0005534821,0.0007600381,0.00012005605,0.00012524918,0.00005041675,0.00017676741,0.0000011531336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044704266,0.00096205267,0.97651124,0.00006935902,0.0066523324,0.0005645804,0.00003408056,0.0013451857,0.000050562114,0.000008191108,0.00024636256,0.013108994],"study_design_scores_gemma":[0.0070809214,0.0003620221,0.97529703,0.00036298114,0.015599493,0.000014806978,0.00008874269,0.000667389,0.00011060394,0.000008777994,0.00033222002,0.000075013886],"about_ca_topic_score_codex":0.0019562752,"about_ca_topic_score_gemma":0.0015196524,"teacher_disagreement_score":0.01303398,"about_ca_system_score_codex":0.000113809074,"about_ca_system_score_gemma":0.00050823984,"threshold_uncertainty_score":0.3569899},"labels":[],"label_agreement":null},{"id":"W4387389324","doi":"10.1038/s41416-023-02405-9","title":"Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute; Government of Canada","keywords":"Medicine; Basal cell; Oncology; Internal medicine; Carcinoma; microRNA; Pathology; Biology; Gene","score_opus":0.016418653455615294,"score_gpt":0.29690532326803254,"score_spread":0.28048666981241727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387389324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865811,0.011873606,0.00020239083,0.00046559857,0.00043295597,0.000183233,0.0002444706,0.0000058124424,0.000010829082],"genre_scores_gemma":[0.9983606,0.00069460855,0.00010330291,0.00032074592,0.00027413692,0.000009401983,0.000038563074,0.000027298302,0.00017139317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984414,0.00009827331,0.0006865764,0.0002328445,0.000342197,0.00019870832],"domain_scores_gemma":[0.9983183,0.000019003373,0.0008407531,0.00020110462,0.00050436246,0.00011644127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045945603,0.0001263825,0.00022264889,0.00008226729,0.000051950436,0.000046922225,0.00026647598,0.00018510249,0.0000808214],"category_scores_gemma":[0.000120941026,0.00014308511,0.00028406677,0.00017719067,0.0000622887,0.000012557638,0.0000505887,0.00018063484,0.000003888658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036285332,0.00013543924,0.023571651,0.00029238037,0.00006203695,0.00007933143,0.00009179161,0.00060874224,0.888764,2.863801e-7,0.029585345,0.056446142],"study_design_scores_gemma":[0.0015290966,0.00038353322,0.25332975,0.00028107286,0.00012674907,0.000066488166,0.000051546536,0.00026710174,0.73828,0.00003673611,0.005472199,0.00017573849],"about_ca_topic_score_codex":0.000031640757,"about_ca_topic_score_gemma":0.0002802281,"teacher_disagreement_score":0.22975811,"about_ca_system_score_codex":0.00006131696,"about_ca_system_score_gemma":0.00034610977,"threshold_uncertainty_score":0.5834842},"labels":[],"label_agreement":null},{"id":"W4388600728","doi":"10.1038/s41416-023-02492-8","title":"Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development; European Society for Medical Oncology","keywords":"Medicine; Hazard ratio; Prostate cancer; Internal medicine; Enzalutamide; Proportional hazards model; Post-hoc analysis; Androgen deprivation therapy; Placebo; Antiandrogen; Oncology; Confidence interval; Cancer; Pathology; Androgen receptor","score_opus":0.027072574063498757,"score_gpt":0.39766135972430433,"score_spread":0.37058878566080555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388600728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94598114,0.05195445,0.0000024969875,0.0008877049,0.00022126385,0.0007783991,0.00013408605,0.000012827518,0.000027611557],"genre_scores_gemma":[0.7975895,0.20161568,0.00011190448,0.00011691654,0.00017775754,0.000039589777,0.000020370899,0.00002631335,0.0003019874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983362,0.00009663386,0.00062088197,0.0002595254,0.00038253135,0.00030421946],"domain_scores_gemma":[0.99884516,0.00030063005,0.00024166096,0.00007790039,0.00030815694,0.00022649804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004620698,0.00014878926,0.00070503994,0.00012012418,0.00009261804,0.000040047697,0.0000512463,0.000054593816,0.000049404778],"category_scores_gemma":[0.00018504518,0.00011438797,0.00006340898,0.00025012222,0.00023487014,0.00017789275,0.000043604192,0.00036163494,7.5997934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03201673,0.00027084703,0.51827985,0.000100400015,0.0005954354,0.0010565153,0.0007084044,0.00003888074,0.00011344607,3.5487466e-7,0.00057413505,0.446245],"study_design_scores_gemma":[0.17300345,0.0006474081,0.81938386,0.0035468687,0.00021084643,0.000028397866,0.00036194624,0.00004649384,0.00017122761,0.000023995959,0.0024440766,0.00013141513],"about_ca_topic_score_codex":0.00026090344,"about_ca_topic_score_gemma":0.0011377151,"teacher_disagreement_score":0.4461136,"about_ca_system_score_codex":0.00016348594,"about_ca_system_score_gemma":0.00024346869,"threshold_uncertainty_score":0.4664606},"labels":[],"label_agreement":null},{"id":"W4388794355","doi":"10.1038/s41416-023-02487-5","title":"Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bristol-Myers Squibb Canada; Gateway for Cancer Research; National Cancer Institute; Celgene; Prostate Cancer Foundation","keywords":"Enzalutamide; Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Rash; Adverse effect; PI3K/AKT/mTOR pathway; Oncology; Cancer; Urology; Pharmacology; Gastroenterology; Clinical trial; Androgen receptor","score_opus":0.034558653523682564,"score_gpt":0.36477653629771967,"score_spread":0.3302178827740371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388794355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844245,0.013661755,0.0000021606506,0.00046493436,0.00009418967,0.0010321403,0.00017255513,0.0000131482575,0.00013463515],"genre_scores_gemma":[0.9910336,0.0073784813,0.0000749473,0.000035024477,0.00016703861,0.00016970436,0.000011460481,0.000037176855,0.001092578],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99771255,0.00011702376,0.0006829538,0.00025099932,0.00085314224,0.00038331235],"domain_scores_gemma":[0.998784,0.00007633237,0.00034801546,0.00011459019,0.00044343865,0.00023360201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051906507,0.00018442393,0.00064628164,0.00033217136,0.00008575242,0.00006810975,0.00007594135,0.000040148305,0.000056828685],"category_scores_gemma":[0.00004235306,0.00015134034,0.00005963376,0.00067946315,0.00014822544,0.00026173957,0.000037653415,0.00035009955,8.739267e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076685034,0.045770086,0.109190956,0.0038008923,0.008062128,0.12397301,0.049375515,0.0018988369,0.12104493,0.000031847536,0.019142382,0.4410244],"study_design_scores_gemma":[0.6554853,0.029087963,0.21850595,0.012824346,0.0025072396,0.003983199,0.037995912,0.00069274683,0.031997684,0.0001405801,0.005754557,0.001024579],"about_ca_topic_score_codex":0.0057443692,"about_ca_topic_score_gemma":0.016945155,"teacher_disagreement_score":0.5788002,"about_ca_system_score_codex":0.0004287323,"about_ca_system_score_gemma":0.0015647921,"threshold_uncertainty_score":0.9455794},"labels":[],"label_agreement":null},{"id":"W4389134878","doi":"10.1038/s41416-023-02503-8","title":"Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan; University of Toronto; Royal University Hospital; University Health Network; Health Sciences Centre; McGill University; North York General Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital","funders":"Canadian Institutes of Health Research; Women's College Hospital; Canada Research Chairs","keywords":"Breast cancer; Medicine; Hazard ratio; Mastectomy; Oncology; Cancer; Internal medicine; Prophylactic Mastectomy; Confidence interval; Gynecology","score_opus":0.010400639128705539,"score_gpt":0.29486935890653143,"score_spread":0.2844687197778259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389134878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668205,0.0019529127,0.00024395455,0.00019245816,0.00022474861,0.000084729836,0.0005730031,0.0000068687523,0.00003927527],"genre_scores_gemma":[0.9866571,0.0121660875,0.00032971404,0.00012533822,0.00046823206,0.00006706173,0.000019238483,0.000024436065,0.00014281634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987056,0.0000983731,0.0003607292,0.000309706,0.0002731676,0.00025242218],"domain_scores_gemma":[0.9990995,0.0000126609575,0.0003219814,0.0001624854,0.00027712225,0.00012627052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005115591,0.00012377443,0.00025134944,0.00022013004,0.00007101335,0.0001004595,0.00022578104,0.00008388047,0.00034634536],"category_scores_gemma":[0.000041348078,0.000118966214,0.00006466265,0.0007097015,0.00007634757,0.000038091417,0.000062185965,0.00018830098,4.7677884e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015111887,0.00013281881,0.59772944,0.000038468228,0.0044087833,0.00084606773,0.000910119,0.046776462,0.013430366,0.0000021697485,0.0004723636,0.33374175],"study_design_scores_gemma":[0.001454884,0.0001160594,0.99342316,0.000116974436,0.00027987812,0.0009949232,0.00036647296,0.00067440956,0.00049,0.000021452242,0.0018724578,0.00018929651],"about_ca_topic_score_codex":0.0022697032,"about_ca_topic_score_gemma":0.021915695,"teacher_disagreement_score":0.39569375,"about_ca_system_score_codex":0.0002404344,"about_ca_system_score_gemma":0.00056984177,"threshold_uncertainty_score":0.9959318},"labels":[],"label_agreement":null},{"id":"W4389297538","doi":"10.1038/s41416-023-02511-8","title":"Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Mutation; Medicine; Cancer research; Myeloid; Sorafenib; Transcriptome; Point mutation; Myeloid leukaemia; Oncology; Bioinformatics; Internal medicine; Biology; Genetics; Gene","score_opus":0.014348140268831489,"score_gpt":0.31258867330632395,"score_spread":0.2982405330374925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389297538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971749,0.00090692315,0.000070435344,0.0011327825,0.00021266787,0.00016552131,0.000046867204,0.000012092878,0.00027778195],"genre_scores_gemma":[0.9927935,0.0058012973,0.00017872968,0.00016746754,0.00042250502,0.000014963785,0.000022552667,0.000021600497,0.0005773543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986584,0.000048285365,0.00054008706,0.00010457476,0.0004326829,0.0002159415],"domain_scores_gemma":[0.99917287,0.0000660479,0.0002346481,0.000093019546,0.00032112873,0.00011231111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035927742,0.000074620104,0.00032298974,0.00034849072,0.00003688466,0.000028315184,0.00011073563,0.00006798588,0.00025891536],"category_scores_gemma":[0.00022370671,0.000080931146,0.00009956995,0.0005896095,0.00005042516,0.00021195428,0.000030450712,0.0003266222,0.000016670732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014785408,0.0006328499,0.12848341,0.00043026073,0.0012104652,0.008232655,0.0034918995,0.001292958,0.17859301,0.00008233512,0.034601025,0.6414706],"study_design_scores_gemma":[0.0033826854,0.0001884509,0.9855107,0.001283508,0.00009176296,0.00231502,0.00010711178,0.00060994376,0.005057133,0.000072461444,0.001302077,0.00007914569],"about_ca_topic_score_codex":0.00033957427,"about_ca_topic_score_gemma":0.00023913298,"teacher_disagreement_score":0.8570273,"about_ca_system_score_codex":0.00045382217,"about_ca_system_score_gemma":0.001047527,"threshold_uncertainty_score":0.33002764},"labels":[],"label_agreement":null},{"id":"W4389382645","doi":"10.1038/s41416-023-02489-3","title":"Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Cambridge University Hospitals; Research Councils UK; National Institute for Health and Care Research; Department of Health and Social Care; National Institutes of Health; University of Cambridge; Cancer Research UK; Economic and Social Research Council; World Health Organization","keywords":"Biobank; Cardiorespiratory fitness; Observational study; Medicine; Cancer; Gerontology; Environmental health; Demography; Internal medicine; Bioinformatics; Biology","score_opus":0.047476351132995614,"score_gpt":0.3413944226316898,"score_spread":0.2939180714986942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389382645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98441947,0.014177681,0.000055259057,0.0006782933,0.00023300816,0.00009951901,0.0003146599,0.000003451742,0.000018689243],"genre_scores_gemma":[0.98495483,0.013946382,0.00018861625,0.00018938824,0.00052091957,0.00002046563,0.000028280412,0.000009896948,0.00014119342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991233,0.0000972412,0.00034439645,0.00017090877,0.00012784536,0.00013632872],"domain_scores_gemma":[0.9992971,0.000056241108,0.00025827895,0.00005014148,0.0002585848,0.00007967968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003829307,0.00007934239,0.0002203268,0.00005563241,0.000117797936,0.000046314133,0.000078555386,0.000088068984,0.000015901178],"category_scores_gemma":[0.00023483139,0.00009059158,0.000038932052,0.00008242326,0.000079310266,0.0000070260194,0.00008275639,0.000095720214,2.6957068e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069388584,0.000010983764,0.9592894,0.000003541652,0.00029632094,0.000011490654,0.00004792784,0.000110494475,0.0008047981,0.0000023159796,0.0026058753,0.03680997],"study_design_scores_gemma":[0.00074753416,0.00009220027,0.99245757,0.000022377275,0.000087937864,0.00005350236,0.00011699325,0.00003047063,0.000034296285,0.000114504764,0.006149347,0.000093289214],"about_ca_topic_score_codex":0.0003793551,"about_ca_topic_score_gemma":0.0008725182,"teacher_disagreement_score":0.03671668,"about_ca_system_score_codex":0.00002727269,"about_ca_system_score_gemma":0.00013658716,"threshold_uncertainty_score":0.36942175},"labels":[],"label_agreement":null},{"id":"W4389786703","doi":"10.1038/s41416-023-02518-1","title":"Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Cancer Care South East; Health Sciences Centre; Cancer Care Ontario; Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Government of Canada","keywords":"Medicine; Interquartile range; Conventional PCI; Comorbidity; Confidence interval; Melanoma; Population; Cancer; Internal medicine; Environmental health","score_opus":0.023713238149567623,"score_gpt":0.25587841752159074,"score_spread":0.2321651793720231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389786703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983895,0.00012462828,0.0000042087395,0.0007609445,0.00033296394,0.00029263,0.0000063684924,0.000011676925,0.00007711922],"genre_scores_gemma":[0.9986428,0.000006978259,0.0000010325127,0.0002890566,0.000046623045,0.000014683675,0.000007657383,0.000012254318,0.0009788944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905133,0.00005871563,0.00025320068,0.000082721155,0.00041114335,0.00014286213],"domain_scores_gemma":[0.9993811,0.0002210916,0.00016723496,0.00006087653,0.00010345581,0.00006619409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020410867,0.00007558662,0.000226379,0.000094867675,0.000058543592,0.00003181368,0.0000690387,0.000020425838,0.0003478127],"category_scores_gemma":[0.000243443,0.000054949378,0.000046181085,0.00026298437,0.0000091460715,0.000029500767,0.000011862918,0.00027629678,4.1461774e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073896816,0.00010275532,0.9883804,0.000005276588,0.000175184,0.002844319,0.00023007306,0.0009899258,0.0000022974082,3.437993e-7,0.0035962765,0.0035992826],"study_design_scores_gemma":[0.0016171082,0.00033948806,0.99417055,0.00036669598,0.00012373863,0.000065372195,0.0010121176,0.00004946405,0.0000063382818,0.0000017360907,0.0021853808,0.00006203137],"about_ca_topic_score_codex":0.9574781,"about_ca_topic_score_gemma":0.99981546,"teacher_disagreement_score":0.042337373,"about_ca_system_score_codex":0.0011951977,"about_ca_system_score_gemma":0.00076930784,"threshold_uncertainty_score":0.38083053},"labels":[],"label_agreement":null},{"id":"W4390706040","doi":"10.1038/s41416-023-02560-z","title":"Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Minnesota Ovarian Cancer Alliance; Division of Cancer Prevention, National Cancer Institute; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Autoantibody; Ovarian cancer; Medicine; Biomarker; Antigen; Stage (stratigraphy); Osteopontin; Oncology; Cancer; Immunology; Internal medicine; Antibody; Biology","score_opus":0.02331385625616697,"score_gpt":0.3370818268723073,"score_spread":0.31376797061614037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84920186,0.1450898,0.0015216675,0.0015282079,0.0012983832,0.0005748796,0.0006554181,0.00002543945,0.00010435866],"genre_scores_gemma":[0.95389426,0.044073705,0.0009868123,0.00013277469,0.0006782468,0.000044032604,0.000010337372,0.000038458013,0.00014139022],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984529,0.00003065634,0.0006414304,0.00025079356,0.00034601963,0.00027821917],"domain_scores_gemma":[0.99898857,0.0000796712,0.00027340656,0.00010548129,0.00039679365,0.00015608984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002742641,0.0001727869,0.0006000088,0.00017609191,0.0001192473,0.000118643606,0.00007218321,0.00006896983,0.00026469782],"category_scores_gemma":[0.000020470012,0.00016675392,0.00023594414,0.0001903317,0.00010593119,0.00016492838,0.000024726542,0.0001876869,7.821053e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061380485,0.00041073546,0.19389646,0.0017005025,0.0034416975,0.00078121235,0.0007524701,0.000047964248,0.041911785,0.0005573324,0.0057494356,0.7501366],"study_design_scores_gemma":[0.003428544,0.0009012341,0.8512043,0.004840892,0.0008484273,0.0009938477,0.00008712703,0.0003324523,0.023266995,0.00017491363,0.11372668,0.000194622],"about_ca_topic_score_codex":0.0062538492,"about_ca_topic_score_gemma":0.0028441083,"teacher_disagreement_score":0.749942,"about_ca_system_score_codex":0.00021168042,"about_ca_system_score_gemma":0.00043282812,"threshold_uncertainty_score":0.9453991},"labels":[],"label_agreement":null},{"id":"W4391843582","doi":"10.1038/s41416-023-02550-1","title":"AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stiftung Charité; Deutsche Forschungsgemeinschaft; Deutschen Konsortium für Translationale Krebsforschung; European Commission; Berlin Institute of Health; Bundesministerium für Bildung und Forschung; Ministère de l'Économie, de la Science et de l'Innovation - Québec","keywords":"Serous fluid; In silico; Wnt signaling pathway; Biology; Oncology; Immunohistochemistry; Ovarian carcinoma; Cancer research; Pathology; Medicine; Cancer; Ovarian cancer; Gene; Immunology; Genetics","score_opus":0.018112362515437807,"score_gpt":0.2784674219992432,"score_spread":0.2603550594838054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391843582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84425485,0.152962,0.000025507137,0.0019579665,0.00047090976,0.00019961307,0.000023324284,0.00001097875,0.00009485589],"genre_scores_gemma":[0.9749457,0.024318242,0.0001515017,0.0001458568,0.00035345007,0.00003920906,0.0000040588293,0.000020277605,0.000021685277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99913216,0.00003421963,0.00031318484,0.0001872628,0.0001666274,0.00016656402],"domain_scores_gemma":[0.9995674,0.00006229157,0.0000869974,0.000063900174,0.00009206375,0.00012735468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019787591,0.00010618982,0.00027901898,0.00010232107,0.00003528504,0.000102466816,0.00004848735,0.00006209354,0.00003469365],"category_scores_gemma":[0.000025679132,0.00009623748,0.000052864245,0.00017127307,0.000053959135,0.00014831653,0.00002123203,0.00031225564,4.768663e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044949373,0.00009235811,0.060380884,0.00045373134,0.00012051522,0.00028328062,0.0003406087,0.0000018712436,0.0014354958,0.000058643065,0.0011481697,0.93523496],"study_design_scores_gemma":[0.002644945,0.0005979889,0.983931,0.002318081,0.00016685035,0.0019109613,0.00010604949,0.00009600798,0.0007133757,0.000111100875,0.0072830566,0.00012057809],"about_ca_topic_score_codex":0.00067425444,"about_ca_topic_score_gemma":0.0004364142,"teacher_disagreement_score":0.9351144,"about_ca_system_score_codex":0.00020311355,"about_ca_system_score_gemma":0.00024489037,"threshold_uncertainty_score":0.39244506},"labels":[],"label_agreement":null},{"id":"W4392139117","doi":"10.1038/s41416-024-02604-y","title":"Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"KRAS; Medicine; Oncology; Internal medicine; Cetuximab; Hazard ratio; Colorectal cancer; Panitumumab; Capecitabine; Confidence interval; Progression-free survival; Chemotherapy; Cancer","score_opus":0.03489373490124312,"score_gpt":0.3311728517719328,"score_spread":0.29627911687068964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392139117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96000993,0.031139523,0.000004117532,0.000040067673,0.00011271467,0.00085658394,0.007822309,0.000004797044,0.000009937455],"genre_scores_gemma":[0.9934104,0.005495761,0.00026695334,0.00003963023,0.000033205288,0.000051183757,0.00067370705,0.000023375973,0.000005755623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974153,0.00018794123,0.0011032986,0.00031699956,0.00075435045,0.00022212151],"domain_scores_gemma":[0.99772376,0.00055844383,0.0008800144,0.00016204974,0.00056623487,0.00010951285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003911089,0.00022662888,0.0014620002,0.00032261314,0.000060388993,0.00005710704,0.00012152487,0.000034288547,0.00012650213],"category_scores_gemma":[0.00030128047,0.00013597187,0.00011683253,0.0007879177,0.00016462711,0.00025085142,0.000081935745,0.00017923575,9.216349e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05199469,0.0006443749,0.683425,0.00016121294,0.019160641,0.0014118904,0.0033882756,0.0006230769,0.0003384079,9.286413e-7,0.00013513285,0.23871633],"study_design_scores_gemma":[0.023477396,0.0029119884,0.94485843,0.0027852955,0.021196289,0.000048735543,0.0010490441,0.00057671795,0.002870401,0.000008326616,0.000046471865,0.00017089509],"about_ca_topic_score_codex":0.020354668,"about_ca_topic_score_gemma":0.034335766,"teacher_disagreement_score":0.2614334,"about_ca_system_score_codex":0.00017220553,"about_ca_system_score_gemma":0.0005048138,"threshold_uncertainty_score":0.98616886},"labels":[],"label_agreement":null},{"id":"W4392763594","doi":"10.1038/s41416-024-02643-5","title":"Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"China Scholarship Council; Darwin Trust of Edinburgh; Cancer Research UK","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Proportional hazards model; Cancer; Population; Confidence interval; Prospective cohort study; Vitamin D and neurology; Oncology; Gastroenterology","score_opus":0.02017495063852357,"score_gpt":0.33765037535441805,"score_spread":0.31747542471589446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392763594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330218,0.065346986,0.000088235545,0.00079028576,0.00030584744,0.0003388691,0.000070938724,0.000011505446,0.000025549043],"genre_scores_gemma":[0.99195385,0.0074439817,0.00029151482,0.000025085408,0.000193009,0.000032357093,0.0000036756967,0.000017269465,0.00003922809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854493,0.00008772216,0.00045174302,0.0001946595,0.00056854496,0.00015239527],"domain_scores_gemma":[0.99863684,0.0006435844,0.0002029866,0.000048087128,0.00036020693,0.00010826719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057181285,0.000112263544,0.0005819441,0.00012447359,0.00008488488,0.00007088589,0.000042121075,0.00005248377,0.00006427433],"category_scores_gemma":[0.00088787574,0.0001009078,0.000086395434,0.00016150827,0.00011982968,0.00023223988,0.000028117356,0.00024627906,1.2302714e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001398675,0.000021673923,0.96299,0.00026140842,0.0005064797,0.0002679217,0.00042803463,0.0001279343,0.0050222077,0.000003323691,0.00007691424,0.030154252],"study_design_scores_gemma":[0.0032700507,0.00013167415,0.98698026,0.0051069744,0.00030272276,0.00013317184,0.00017749662,0.0024238818,0.0012530619,0.00011435124,0.00001538678,0.00009094991],"about_ca_topic_score_codex":0.009645702,"about_ca_topic_score_gemma":0.0038080902,"teacher_disagreement_score":0.0589321,"about_ca_system_score_codex":0.00025847068,"about_ca_system_score_gemma":0.00029853574,"threshold_uncertainty_score":0.99694914},"labels":[],"label_agreement":null},{"id":"W4392989411","doi":"10.1038/s41416-024-02660-4","title":"Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","year":2024,"lang":"en","type":"retraction","venue":"British Journal of Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Docetaxel; Autophagy; Medicine; Pantoprazole; Cancer research; Pharmacology; Oncology; Internal medicine; Chemotherapy; Biology; Apoptosis; Biochemistry","score_opus":0.007665110844710987,"score_gpt":0.35716640631994345,"score_spread":0.34950129547523245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392989411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8949833,0.09870786,0.00009880436,0.00014034047,0.0034807401,0.00050237076,0.0004298222,0.00003129684,0.0016254915],"genre_scores_gemma":[0.95618474,0.03805001,0.000046364898,0.00010495007,0.00315219,0.000024386034,0.00005398002,0.00009785083,0.0022855473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969264,0.0001717802,0.0010893214,0.00034789953,0.0011364951,0.0003280566],"domain_scores_gemma":[0.99704325,0.00014585565,0.0018198304,0.00017804148,0.0005531028,0.00025990157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000901832,0.0003493525,0.0014506811,0.00038592776,0.00008755546,0.000054776676,0.00017427148,0.0006224931,0.00025051605],"category_scores_gemma":[0.00021348716,0.00036258242,0.0006751028,0.00041591105,0.000088390385,0.00029267368,0.000038217615,0.0021167628,0.0000066001803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071893824,0.00023566461,0.000051343803,0.0027969384,0.0006387383,0.00063156337,0.00006877839,0.000015677713,0.5309737,5.821797e-7,0.04204912,0.42181894],"study_design_scores_gemma":[0.0013398237,0.0013213597,0.0036719597,0.022085799,0.0010443055,0.000713051,0.000011866909,0.000017421655,0.9279255,0.000013690019,0.041566625,0.00028855886],"about_ca_topic_score_codex":0.000758384,"about_ca_topic_score_gemma":0.00010513849,"teacher_disagreement_score":0.4215304,"about_ca_system_score_codex":0.00050810527,"about_ca_system_score_gemma":0.0005685762,"threshold_uncertainty_score":0.99988264},"labels":[],"label_agreement":null},{"id":"W4393392723","doi":"10.1038/s41416-024-02638-2","title":"Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Faculty of Medicine and Health, University of Sydney; Wallenberg Centre for Molecular and Translational Medicine; School of Public Health, Imperial College London; National Health and Medical Research Council; Canadian Cancer Society Research Institute; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health; Deutschen Konsortium für Translationale Krebsforschung; Canadian Institutes of Health Research; Technion-Israel Institute of Technology; Universitat de Barcelona; Tokyo Medical and Dental University; Deutsches Krebsforschungszentrum; Clalit Health Services; Binus University; Massey University; Umeå Universitet; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Memorial University of Newfoundland; Imperial College London; University of Toronto; Ministerio de Economía y Competitividad; Vetenskapsrådet; National Natural Science Foundation of China; Monash University; Génome Québec; Medical Center, University of Pittsburgh; City of Hope; World Health Organization; Cedars-Sinai Medical Center; School of Public Health, University of Michigan; Swedish Cancer Foundation; American Cancer Society; University of Ioannina; Kaiser Permanente Washington Health Research Institute; Johns Hopkins University; Centre International de Recherche sur le Cancer; Capital Medical University; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Huntsman Cancer Institute; University of Leeds; McGill University; Division of Cancer Prevention, National Cancer Institute; University of Pittsburgh; University of Washington; Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill; University of Texas MD Anderson Cancer Center; Centers for Disease Control and Prevention; Cancer Council Victoria; University of Melbourne; University of North Carolina at Chapel Hill; Harvard University; Brigham and Women's Hospital; National Center for Advancing Translational Sciences; Kaiser Permanente; Broad Institute; Wageningen University and Research; Cancer Research UK; University of Southern California; Massachusetts General Hospital; U.S. Department of Health and Human Services","keywords":"Quartile; Medicine; Odds ratio; Internal medicine; Logistic regression; Colorectal cancer; Absolute risk reduction; Relative risk; Menopause; Oncology; Cancer; Gynecology; Demography; Confidence interval","score_opus":0.011795836408629563,"score_gpt":0.3085199928284912,"score_spread":0.2967241564198616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393392723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7818914,0.2164006,0.000016705548,0.00070142595,0.00032749661,0.00030169814,0.00020639386,0.000009949416,0.00014433607],"genre_scores_gemma":[0.7763524,0.22261105,0.0001179374,0.00015464277,0.00053031737,0.000019984253,0.0000014613939,0.000028124128,0.00018409056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982908,0.00013917316,0.0004797692,0.00012995662,0.0006537459,0.0003065736],"domain_scores_gemma":[0.9984239,0.00015084125,0.0007470851,0.00008588118,0.00036750594,0.0002248027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059493486,0.00013838818,0.00039373603,0.00007556214,0.000121673445,0.00007556005,0.00007993997,0.000078345874,0.00022445503],"category_scores_gemma":[0.000101511076,0.00008458183,0.00003224096,0.00025428127,0.000050783972,0.00012534791,0.000008714216,0.000499162,0.0000025829993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046134475,0.00040774333,0.39893633,0.00022264337,0.006158392,0.0012523913,0.0013588483,0.00029835317,0.018321235,0.000004694592,0.019338373,0.5490875],"study_design_scores_gemma":[0.005672787,0.0070662927,0.97326213,0.0011509203,0.0012209036,0.0009527636,0.000033649892,0.000053673295,0.0014807156,0.00006270975,0.008944158,0.000099321085],"about_ca_topic_score_codex":0.010455055,"about_ca_topic_score_gemma":0.00321985,"teacher_disagreement_score":0.5743258,"about_ca_system_score_codex":0.00060915615,"about_ca_system_score_gemma":0.0010741785,"threshold_uncertainty_score":0.9961344},"labels":[],"label_agreement":null},{"id":"W4394691025","doi":"10.1038/s41416-024-02679-7","title":"Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; BC Cancer Agency; Cancer Research UK; National Cancer Institute; Breast Cancer Now","keywords":"Breast cancer; Medicine; Oncology; Invasive lobular carcinoma; Metastasis; Cancer; Internal medicine; Disease; Bioinformatics; Biology","score_opus":0.006398528452897989,"score_gpt":0.2459426886190653,"score_spread":0.2395441601661673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394691025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83654404,0.16138309,0.00003351903,0.0010699447,0.00036274237,0.00012386838,0.00043544208,0.000007365178,0.000040015555],"genre_scores_gemma":[0.9857179,0.013215344,0.000100008554,0.00050492666,0.0003294127,0.000054093045,0.0000074187537,0.000034447432,0.000036459212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988001,0.00003782388,0.00036630157,0.0002845867,0.00026828144,0.00024291746],"domain_scores_gemma":[0.9994779,0.00003512006,0.00013886746,0.00009700262,0.00016394208,0.000087173335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011759159,0.00019213287,0.00028827944,0.00008530317,0.000057723566,0.00008186439,0.000106851636,0.00012360536,0.000084491105],"category_scores_gemma":[0.000027860966,0.00018331897,0.00013053416,0.00010797781,0.0001139539,0.000016095404,0.000045279845,0.00022025363,4.4435106e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011093008,0.0003427297,0.29004106,0.0005009883,0.0013645432,0.0027924355,0.0006144092,0.0045394176,0.039902724,0.000028409475,0.0025501128,0.6562139],"study_design_scores_gemma":[0.0048274933,0.00060344406,0.8704451,0.0049908273,0.00030520564,0.0045850603,0.00045467148,0.00012317556,0.09569007,0.00024330086,0.016879871,0.000851834],"about_ca_topic_score_codex":0.0010397371,"about_ca_topic_score_gemma":0.0052603236,"teacher_disagreement_score":0.65536207,"about_ca_system_score_codex":0.00013548789,"about_ca_system_score_gemma":0.00038808203,"threshold_uncertainty_score":0.7475531},"labels":[],"label_agreement":null},{"id":"W4394813416","doi":"10.1038/s41416-024-02677-9","title":"Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono; Government of Canada; Merck KGaA","keywords":"Ovarian cancer; Immunotherapy; Cancer research; Cytotoxic T cell; Immune system; Medicine; CD8; Perforin; Immunology; Cancer; Transforming growth factor; Tumor microenvironment; Biology; Internal medicine","score_opus":0.02035811710824899,"score_gpt":0.32039403510583647,"score_spread":0.3000359179975875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394813416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7447517,0.25292113,0.000028896207,0.0014274701,0.00029963086,0.0002901969,0.00021995492,0.000010188294,0.000050813906],"genre_scores_gemma":[0.9471509,0.051840488,0.00014058681,0.000114935865,0.0002629039,0.00002412246,0.0000040316304,0.000036658355,0.00042538202],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981329,0.0002247269,0.00075695524,0.00027598892,0.00034795955,0.00026146026],"domain_scores_gemma":[0.9990364,0.0003616605,0.00024227482,0.0000838363,0.00011419928,0.00016167627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013746409,0.00016171783,0.0005636558,0.00011765211,0.000041983734,0.00009270621,0.00008654377,0.00014720121,0.00012132451],"category_scores_gemma":[0.00012383984,0.00015609931,0.00011577931,0.00021666469,0.00018681776,0.00020200139,0.000029664745,0.00048342967,1.5953201e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065523144,0.00031638236,0.014996547,0.0018096728,0.000526451,0.0004232595,0.00093879347,0.000009006885,0.46898842,0.0000022447687,0.005902601,0.4995343],"study_design_scores_gemma":[0.05043527,0.007892807,0.1931245,0.074775055,0.0022000556,0.0075560478,0.00068809034,0.011979943,0.5701961,0.0006442703,0.07845,0.002057878],"about_ca_topic_score_codex":0.002955832,"about_ca_topic_score_gemma":0.0007425505,"teacher_disagreement_score":0.49747643,"about_ca_system_score_codex":0.00011835584,"about_ca_system_score_gemma":0.00044358513,"threshold_uncertainty_score":0.6365545},"labels":[],"label_agreement":null},{"id":"W4396688575","doi":"10.1038/s41416-024-02701-y","title":"Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Department of Medicine, University of Toronto; Instituto de Salud Carlos III; Conquer Cancer Foundation; Sociedad Española de Oncología Médica; American Society of Clinical Oncology; University of Toronto; Princess Margaret Cancer Foundation","keywords":"Microbiome; Medicine; Oncology; Carcinoma; Cancer; Basal cell; Cancer research; Internal medicine; Bioinformatics; Biology","score_opus":0.005781766799883451,"score_gpt":0.23897171963758207,"score_spread":0.2331899528376986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396688575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671809,0.03130992,0.000038443803,0.0001507677,0.00044624216,0.00063484977,0.00006940551,0.000005024273,0.00016442714],"genre_scores_gemma":[0.9985783,0.00073551224,0.0000658188,0.0000935083,0.00020834342,0.000026868966,0.000015178019,0.000043317665,0.00023311553],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985571,0.00016105083,0.000561961,0.00029983307,0.00018920086,0.00023085714],"domain_scores_gemma":[0.9991623,0.00002687736,0.00039651402,0.00014117,0.00022078541,0.000052337804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002520298,0.00018052004,0.00033552398,0.0000965831,0.000082991166,0.00006030313,0.00021709794,0.00012813933,0.00004130959],"category_scores_gemma":[0.000006023366,0.00015447111,0.00012611711,0.0003167213,0.00006306812,0.000027454336,0.000048229234,0.00030605006,6.005315e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005285786,0.00033149542,0.06666063,0.0005656975,0.00017704851,0.00015889379,0.00062095205,0.0019668764,0.92203796,0.000008401502,0.00028240916,0.0066610444],"study_design_scores_gemma":[0.0056127664,0.00077944115,0.9455613,0.00078553555,0.00018855659,0.0012185697,0.0003483352,0.000051304323,0.04433542,0.000021904118,0.0008032944,0.0002936003],"about_ca_topic_score_codex":0.00041334977,"about_ca_topic_score_gemma":0.007300244,"teacher_disagreement_score":0.87890065,"about_ca_system_score_codex":0.00039133383,"about_ca_system_score_gemma":0.0012694504,"threshold_uncertainty_score":0.6299149},"labels":[],"label_agreement":null},{"id":"W4396920139","doi":"10.1038/s41416-024-02709-4","title":"Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"EMD Serono; Merck KGaA","keywords":"DNA sequencing; Workflow; Best practice; Computational biology; Medicine; Lung cancer; Bioinformatics; Computer science; Biology; Oncology; DNA; Genetics","score_opus":0.08287403178115656,"score_gpt":0.3611814531473736,"score_spread":0.27830742136621706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396920139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011615242,0.9857015,0.00030480753,0.00011566623,0.001139641,0.00053005933,0.00051936787,0.0000029640942,0.00007073877],"genre_scores_gemma":[0.004556166,0.99075145,0.0013321826,0.00008123957,0.0025942244,0.0001513769,0.0002446392,0.00007267398,0.00021603174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972662,0.0000506568,0.0019162615,0.0004041168,0.00010635219,0.00025644733],"domain_scores_gemma":[0.9971745,0.000054263433,0.002318123,0.00012394505,0.00023247149,0.00009672222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000811375,0.00023892043,0.00074245763,0.00012215493,0.000100932826,0.0002553651,0.00013736993,0.00015787924,0.000006681873],"category_scores_gemma":[0.0004631826,0.00026933686,0.00024389653,0.00012184096,0.000019917123,0.000013251925,0.00007941019,0.00035140582,1.9995382e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008504051,0.000013154682,0.00002005704,0.0045518912,0.00012822753,0.00018213702,0.000060652623,0.00034603072,0.006847496,0.0000017515524,0.009032579,0.9788075],"study_design_scores_gemma":[0.000702435,0.00008780573,0.000014481843,0.026510451,0.0010594777,0.001571585,0.00005825809,0.0005677596,0.002211578,0.000018459568,0.966728,0.00046975227],"about_ca_topic_score_codex":0.0012137849,"about_ca_topic_score_gemma":0.005471236,"teacher_disagreement_score":0.97833776,"about_ca_system_score_codex":0.00036837248,"about_ca_system_score_gemma":0.0014353421,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W4399071000","doi":"10.1038/s41416-024-02692-w","title":"The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cohort; Oncology; Adjuvant chemotherapy; Cohort study; Pancreatic cancer; Adjuvant; Periampullary cancer; General surgery; Gastroenterology; Cancer","score_opus":0.03661280621149079,"score_gpt":0.4207692226584384,"score_spread":0.38415641644694765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399071000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256767,0.0077843205,0.0029046405,0.0031969033,0.0012669036,0.0017545951,0.000037638358,0.000018164616,0.00046918454],"genre_scores_gemma":[0.97301763,0.010727727,0.008602617,0.0011058709,0.002491446,0.00050632673,0.000009550054,0.000061226994,0.0034776058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998126,0.00012484792,0.00054693053,0.00025338458,0.0006233117,0.0003255734],"domain_scores_gemma":[0.99852264,0.0002813055,0.0001305835,0.00018204411,0.000599057,0.00028434795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018692706,0.00014028752,0.0005744879,0.00011791526,0.00014139155,0.00019553631,0.00031370285,0.00007212995,0.00035511798],"category_scores_gemma":[0.00034035422,0.00010755355,0.00017093567,0.0001464558,0.00007525062,0.00018322727,0.000032331725,0.00035185774,0.000005282124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003071398,0.00036552214,0.33799133,0.000091360605,0.0040182727,0.0012712876,0.0024921212,0.00006762903,0.001544368,0.000006851793,0.016606295,0.6324736],"study_design_scores_gemma":[0.00502046,0.002520167,0.90527123,0.0009376451,0.0008065479,0.0017229331,0.0013445856,0.013466413,0.00010034009,0.00008712238,0.06854677,0.00017576838],"about_ca_topic_score_codex":0.0021269685,"about_ca_topic_score_gemma":0.0014478525,"teacher_disagreement_score":0.6322978,"about_ca_system_score_codex":0.00062155805,"about_ca_system_score_gemma":0.001144954,"threshold_uncertainty_score":0.43859065},"labels":[],"label_agreement":null},{"id":"W4399322010","doi":"10.1038/s41416-024-02730-7","title":"Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Ono Pharmaceutical; Hirosaki University","keywords":"Nivolumab; Microsatellite instability; Medicine; Colorectal cancer; Internal medicine; Chemoradiotherapy; Gastroenterology; Oncology; Cancer; Surgery; Immunotherapy; Microsatellite","score_opus":0.009738101648636052,"score_gpt":0.2845658555059519,"score_spread":0.2748277538573159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399322010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7366583,0.26169854,0.00008141099,0.0005169846,0.00047790958,0.00035694678,0.00013869614,0.000012768982,0.000058476155],"genre_scores_gemma":[0.88394517,0.11365025,0.0012268247,0.00036827353,0.00018152804,0.000029261062,0.000006778655,0.000055004348,0.00053688826],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981037,0.000051946186,0.0008492131,0.00032086772,0.00035084388,0.00032343643],"domain_scores_gemma":[0.9991073,0.00007489429,0.00023824634,0.00014937739,0.00031316228,0.00011700348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045600973,0.00022869153,0.000892637,0.00018139037,0.000049980186,0.00011093076,0.00013301743,0.00013007215,0.00052404415],"category_scores_gemma":[0.000027569415,0.0002134071,0.00020914784,0.00043567055,0.0002993168,0.00036382693,0.000025229434,0.00047007634,6.761922e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008091464,0.00020994007,0.1640629,0.00091278,0.0011094621,0.00048388774,0.0019715214,0.000108111635,0.14302647,0.000016418486,0.00031645483,0.6796906],"study_design_scores_gemma":[0.019339211,0.0011900526,0.8296674,0.014197969,0.00026003696,0.0011141605,0.0005515646,0.00016274804,0.10230368,0.00019999298,0.03040824,0.00060497684],"about_ca_topic_score_codex":0.0066130315,"about_ca_topic_score_gemma":0.011904359,"teacher_disagreement_score":0.6790856,"about_ca_system_score_codex":0.0006837033,"about_ca_system_score_gemma":0.0010888774,"threshold_uncertainty_score":0.99969697},"labels":[],"label_agreement":null},{"id":"W4399764893","doi":"10.1038/s41416-024-02755-y","title":"Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Government of Canada; Terry Fox Research Institute; Lung Cancer Research Foundation","keywords":"Biology; Adenocarcinoma; Lung cancer; Cancer research; DNA repair; Transcriptome; Gene; Genomics; Copy-number variation; Genetics; Cancer; Gene expression; Oncology; Medicine; Genome","score_opus":0.01157266906522251,"score_gpt":0.3248591430253017,"score_spread":0.3132864739600792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399764893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8941036,0.10285655,0.000027379483,0.0016162513,0.0006455681,0.00026918133,0.000115440715,0.00001844967,0.0003475744],"genre_scores_gemma":[0.9918265,0.0026405146,0.0002950946,0.0002841107,0.00032210402,0.00004104447,0.000011815354,0.00004049117,0.0045383526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987303,0.000100416684,0.00042187146,0.00021253825,0.00030048654,0.00023441229],"domain_scores_gemma":[0.9992556,0.00013450143,0.00014770169,0.0001213625,0.00019711367,0.00014374033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003355318,0.00015150971,0.00037088667,0.00026674083,0.000066467954,0.00022622912,0.00011631956,0.0000564202,0.00046482263],"category_scores_gemma":[0.00012747996,0.00013626892,0.00017617803,0.00023258549,0.000089886424,0.0003663995,0.000031592765,0.00034735564,0.000007795639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018727748,0.0011643237,0.077106945,0.0017950885,0.0084619885,0.19433638,0.044399243,0.00067111617,0.47346294,0.0003675349,0.115617834,0.06388887],"study_design_scores_gemma":[0.005031757,0.0005963075,0.7711518,0.008739851,0.0015454263,0.015873373,0.0036469924,0.0004557944,0.17317143,0.0010078002,0.018398741,0.00038072374],"about_ca_topic_score_codex":0.000955488,"about_ca_topic_score_gemma":0.0010649909,"teacher_disagreement_score":0.6940448,"about_ca_system_score_codex":0.00083158654,"about_ca_system_score_gemma":0.0010775988,"threshold_uncertainty_score":0.5556885},"labels":[],"label_agreement":null},{"id":"W4400099932","doi":"10.1038/s41416-024-02748-x","title":"The Physical Activity and Cancer Control (PACC) framework: update on the evidence, guidelines, and future research priorities","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Cancer; Internal medicine","score_opus":0.15273906993052414,"score_gpt":0.48168691488541976,"score_spread":0.3289478449548956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400099932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010274439,0.9715647,0.0000034777518,0.02437235,0.0020343026,0.0006830997,0.00020750685,0.000011074758,0.00009601959],"genre_scores_gemma":[0.0013489901,0.9824434,0.0000054197817,0.0006688336,0.014465605,0.00018901417,8.057553e-7,0.00006509055,0.000812824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969188,0.00057704374,0.0005315894,0.0003582962,0.0011856791,0.0004285906],"domain_scores_gemma":[0.9963567,0.0017350633,0.00037599873,0.00030627378,0.001014619,0.00021133006],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021367155,0.00033116227,0.0014085822,0.00012212589,0.00041128177,0.0006045054,0.00032640388,0.00028273958,0.00006857922],"category_scores_gemma":[0.0005845647,0.00017576222,0.00045890835,0.0004370948,0.00046216883,0.0001424859,0.000119324126,0.0038321575,0.0000032132734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015872167,0.000015674872,0.000013014165,0.0038335444,0.0005489679,0.00022754932,0.00011798976,1.180743e-7,3.8202475e-7,0.00040612853,0.03464584,0.96003205],"study_design_scores_gemma":[0.00021595332,0.00012861175,0.00016026942,0.105191365,0.0017173314,0.0009456634,0.00019967041,0.000005653003,7.7886335e-7,0.0003669615,0.8909093,0.00015840644],"about_ca_topic_score_codex":0.0016095531,"about_ca_topic_score_gemma":0.0034935956,"teacher_disagreement_score":0.9598737,"about_ca_system_score_codex":0.00034525507,"about_ca_system_score_gemma":0.0018623552,"threshold_uncertainty_score":0.998466},"labels":[],"label_agreement":null},{"id":"W4400367857","doi":"10.1038/s41416-024-02782-9","title":"Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Health Sciences Centre; University of Toronto; University of Windsor; Sunnybrook Health Science Centre","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Movember Foundation","keywords":"Invadopodia; Extravasation; Cancer; Matrix metalloproteinase; Medicine; Cancer research; Pathology; Cancer cell; Internal medicine","score_opus":0.00952251555105756,"score_gpt":0.2626276060215666,"score_spread":0.25310509047050905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400367857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86615187,0.13143997,0.00027335086,0.000110753885,0.0012008232,0.000059911767,0.000101403144,0.000004345663,0.0006575637],"genre_scores_gemma":[0.9355615,0.062148392,0.000068908426,0.00010156095,0.00054572715,0.000008176538,0.000030180137,0.000021872896,0.0015137277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991694,0.00003613062,0.0003445576,0.00014708897,0.00016845953,0.00013434271],"domain_scores_gemma":[0.9993629,0.000018902363,0.00019575721,0.0000809057,0.00027426335,0.00006729683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001430934,0.000085974476,0.00014138057,0.00004523602,0.00005043396,0.000045014604,0.00011027457,0.000093121154,0.0008921693],"category_scores_gemma":[0.000034957324,0.00009548262,0.00015753129,0.00008807517,0.00002739428,0.00001896112,0.000042291496,0.00013628928,0.000003189224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006543613,0.0000349075,0.00024624422,0.0000544037,0.00012273769,0.000043269527,0.000046133948,0.00008065206,0.9607247,0.000009052023,0.0150848655,0.023487596],"study_design_scores_gemma":[0.00040440768,0.0002047711,0.001163654,0.00042919745,0.00009071009,0.00032272178,0.000066328896,0.00028437955,0.80702233,0.0000513074,0.18981303,0.00014717247],"about_ca_topic_score_codex":0.0015398473,"about_ca_topic_score_gemma":0.006286167,"teacher_disagreement_score":0.17472816,"about_ca_system_score_codex":0.000108830245,"about_ca_system_score_gemma":0.00028880997,"threshold_uncertainty_score":0.97686285},"labels":[],"label_agreement":null},{"id":"W4400781872","doi":"10.1038/s41416-024-02792-7","title":"Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Coffee research and impacts","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research and Materiel Command; Congressionally Directed Medical Research Programs; National Health and Medical Research Council; Medical Research Council; Peter MacCallum Foundation; National Cancer Institute; Ovarian Cancer Australia; Rutgers Cancer Institute of New Jersey; California Breast Cancer Research Program; Kræftens Bekæmpelse; U.S. Department of Health and Human Services; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Council Victoria; Cancer Australia; U.S. Department of Defense","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Gynecology; Internal medicine; Traditional medicine","score_opus":0.024101199573402246,"score_gpt":0.32874444264456454,"score_spread":0.3046432430711623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400781872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7980158,0.18630356,0.000010689357,0.012558542,0.00061737385,0.0003201847,0.0021006328,0.00001109476,0.000062136816],"genre_scores_gemma":[0.73277444,0.26576683,0.000031896816,0.0002898565,0.00077614747,0.00012693355,0.000007814794,0.000019393303,0.00020670444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795943,0.00020574685,0.0005858041,0.00024231379,0.0006920193,0.0003146512],"domain_scores_gemma":[0.9976265,0.0011871131,0.00033810522,0.000118916265,0.00043762094,0.00029173485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093606237,0.00014679253,0.0004633184,0.0001009552,0.00008759916,0.00023015802,0.0000858775,0.00012831169,0.0008869021],"category_scores_gemma":[0.0011290999,0.00012113376,0.00011309745,0.0002008351,0.00014591466,0.0002878074,0.00005049662,0.00052981894,0.0000012044214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013663868,0.00006310162,0.75060076,0.00018645212,0.0008482687,0.00023819636,0.00066125713,0.0000051634934,0.00030958024,0.000005773073,0.021801459,0.22391362],"study_design_scores_gemma":[0.0034636518,0.00018036044,0.95988023,0.0062370864,0.000652538,0.00012321385,0.00006589472,0.00007557631,0.0009864675,0.00008233933,0.028129224,0.00012339195],"about_ca_topic_score_codex":0.041459844,"about_ca_topic_score_gemma":0.031514905,"teacher_disagreement_score":0.22379023,"about_ca_system_score_codex":0.00041783164,"about_ca_system_score_gemma":0.0007580878,"threshold_uncertainty_score":0.9861574},"labels":[],"label_agreement":null},{"id":"W4400933413","doi":"10.1038/s41416-024-02796-3","title":"COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Bevacizumab; Medicine; Durvalumab; FOLFOX; Oxaliplatin; Colorectal cancer; Internal medicine; Confidence interval; Adverse effect; Oncology; Cancer; Surgery; Chemotherapy; Nivolumab; Immunotherapy","score_opus":0.0119592495075272,"score_gpt":0.2942578742307003,"score_spread":0.28229862472317313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400933413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273343,0.071078844,0.0000044621443,0.00021779805,0.0001431891,0.0010851953,0.00002899595,0.000006765854,0.000100416815],"genre_scores_gemma":[0.9844406,0.014975331,0.00007770843,0.0000441432,0.000037865702,0.00018362422,0.0000020314014,0.00002606951,0.00021257668],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856126,0.00008345397,0.00058314606,0.00021005845,0.0003590027,0.0002030593],"domain_scores_gemma":[0.9993694,0.00010082336,0.0001935653,0.000051755564,0.00022056821,0.00006387516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033836855,0.0001379151,0.00080706604,0.00019029944,0.000043720353,0.00008534334,0.000052818843,0.00003559254,0.00012248219],"category_scores_gemma":[0.000028376846,0.00013442937,0.00006785529,0.00046640114,0.00008596888,0.00015228504,0.000016499713,0.0002486475,1.2738366e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06664812,0.0041034,0.4060288,0.0012972861,0.0036196273,0.0063683297,0.021578588,0.00054508785,0.0024023978,0.000005529997,0.00054653996,0.48685628],"study_design_scores_gemma":[0.1978602,0.005677514,0.7833339,0.004773877,0.00073832343,0.0010386159,0.0037621178,0.0006285771,0.0011336246,0.00007513151,0.00072019757,0.00025796026],"about_ca_topic_score_codex":0.026765853,"about_ca_topic_score_gemma":0.19933343,"teacher_disagreement_score":0.48659834,"about_ca_system_score_codex":0.0007093759,"about_ca_system_score_gemma":0.0006132658,"threshold_uncertainty_score":0.979715},"labels":[],"label_agreement":null},{"id":"W4401118527","doi":"10.1038/s41416-024-02799-0","title":"Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG)","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent","keywords":"Wilms tumour; Medicine; Wilms' tumor; Urology; Internal medicine; Oncology","score_opus":0.010615376200675927,"score_gpt":0.2814045815394234,"score_spread":0.27078920533874745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401118527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791878,0.019294184,0.000017222792,0.0003167212,0.0007157277,0.00033268658,0.00007334092,0.000004036254,0.000058293317],"genre_scores_gemma":[0.99376935,0.0049604606,0.000017977036,0.0001786798,0.00086177327,0.000018925562,0.000014105998,0.000025425636,0.00015331602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799484,0.00019910453,0.0008659114,0.00029274958,0.00040221435,0.0002451736],"domain_scores_gemma":[0.999171,0.000047590307,0.00037919934,0.00019567326,0.00012881879,0.00007772268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000891949,0.00018160054,0.00037680665,0.00004664238,0.00009424506,0.00014942301,0.00034964766,0.00010198045,0.00004299775],"category_scores_gemma":[0.0000829379,0.0001137626,0.00014580098,0.00015831675,0.00011052146,0.00001752843,0.00010032296,0.0005272497,6.96107e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007816535,0.0011941731,0.75293076,0.000111769295,0.0015120726,0.023275448,0.0025240337,0.00022923916,0.15992521,0.0000023369446,0.010516145,0.04699716],"study_design_scores_gemma":[0.0013749301,0.0010680393,0.98393875,0.00061992,0.00031659383,0.0038258405,0.001676949,0.00003907447,0.0013538294,0.000034353365,0.00552709,0.00022463896],"about_ca_topic_score_codex":0.002192513,"about_ca_topic_score_gemma":0.0013410455,"teacher_disagreement_score":0.23100798,"about_ca_system_score_codex":0.000047972284,"about_ca_system_score_gemma":0.00017719669,"threshold_uncertainty_score":0.46391043},"labels":[],"label_agreement":null},{"id":"W4401562362","doi":"10.1038/s41416-024-02819-z","title":"Cost-effectiveness of point of care smoking cessation interventions in oncology clinics","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Horizon Health Network; Government of New Brunswick; Ottawa Public Health; University of Ottawa","funders":"","keywords":"Medicine; Smoking cessation; Varenicline; Psychological intervention; Nicotine replacement therapy; Cost effectiveness; Bupropion; Psychiatry","score_opus":0.0796864497507714,"score_gpt":0.44783552567187856,"score_spread":0.3681490759211072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401562362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836999,0.014165068,0.00070807175,0.00006399445,0.0009130852,0.00017543028,0.000025584917,0.000004734426,0.00024410467],"genre_scores_gemma":[0.99791014,0.0018849196,0.000048902948,0.000011754451,0.00009866455,0.0000140182665,0.000009446386,0.000010000488,0.000012166083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989387,0.00012359611,0.00057762273,0.00007440346,0.00021497608,0.0000707426],"domain_scores_gemma":[0.99909174,0.00013682396,0.0002688889,0.00004692987,0.00042492547,0.000030659317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008057879,0.000046375695,0.00030520337,0.00019533133,0.0000116767205,0.000011143892,0.000047031197,0.00008565945,0.00011948307],"category_scores_gemma":[0.000117188065,0.00005047899,0.00020159378,0.00020787973,0.000041966447,0.00011908859,0.000011450189,0.00028519175,7.64734e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002644392,0.00018212733,0.37216327,0.002178291,0.0001063503,0.00026954044,0.00096621533,0.00023588003,0.0011780094,0.00006200872,0.0000634191,0.6223304],"study_design_scores_gemma":[0.0018545344,0.0005659097,0.9655827,0.022807846,0.00036088526,0.00043760496,0.0010027959,0.00002290477,0.0062739137,0.00015171521,0.00089070207,0.000048447862],"about_ca_topic_score_codex":0.000408939,"about_ca_topic_score_gemma":0.00047163537,"teacher_disagreement_score":0.62228197,"about_ca_system_score_codex":0.00040075247,"about_ca_system_score_gemma":0.0003323322,"threshold_uncertainty_score":0.20584735},"labels":[],"label_agreement":null},{"id":"W4402635099","doi":"10.1038/s41416-024-02739-y","title":"Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Medical Research Council; Maastricht Universitair Medisch Centrum","keywords":"Breast cancer; Multivariate statistics; Multivariate analysis; Medicine; Pathology; Computational biology; Cancer; Ex vivo; Oncology; Bioinformatics; Computer science; Biology; In vivo; Internal medicine; Machine learning; Genetics","score_opus":0.042403991679281154,"score_gpt":0.34582916297869204,"score_spread":0.3034251712994109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402635099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93769884,0.034911055,0.02584409,0.00024320716,0.00004998179,0.0003394073,0.0001323673,0.00003307402,0.0007479636],"genre_scores_gemma":[0.96307534,0.0013307179,0.035366565,0.000011421368,0.00006788737,0.00008956041,0.0000037179323,0.000015239671,0.00003953138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908626,0.000020583586,0.0004374628,0.00017512511,0.00015771374,0.0001228629],"domain_scores_gemma":[0.9991971,0.00025947668,0.00023851595,0.00007954658,0.00017686909,0.000048459682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024861656,0.00008643521,0.0002465861,0.000121514466,0.000030930147,0.00005297491,0.000108147404,0.00006720109,0.00020518624],"category_scores_gemma":[0.0003735483,0.00009338318,0.000047176338,0.00033208262,0.00005016567,0.0000682947,0.000019491552,0.00025543573,1.9100295e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038424907,0.000530442,0.045417283,0.00034055766,0.000108085835,0.00041627517,0.00019078495,0.00001651019,0.83107686,0.001001017,0.00043101315,0.12043275],"study_design_scores_gemma":[0.007467732,0.003312261,0.36162615,0.0058592265,0.0010255558,0.0024031561,0.002872246,0.015931875,0.54533345,0.022498857,0.03014432,0.0015251815],"about_ca_topic_score_codex":0.00009527657,"about_ca_topic_score_gemma":0.00006905777,"teacher_disagreement_score":0.31620887,"about_ca_system_score_codex":0.00014810594,"about_ca_system_score_gemma":0.000072872186,"threshold_uncertainty_score":0.38080558},"labels":[],"label_agreement":null},{"id":"W4403074281","doi":"10.1038/s41416-024-02855-9","title":"Loss of EMI1 compromises chromosome stability and is associated with cellular transformation in colonic epithelial cell contexts","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada; CancerCare Manitoba Foundation; Cancer Research Society; Strong; Research Manitoba","keywords":"Biology; Gene silencing; Chromosome instability; Genome instability; CRISPR; Phenotype; Cell biology; Genetics; Cancer research; Gene; Chromosome; DNA damage; DNA","score_opus":0.006419839051853307,"score_gpt":0.2304855794365222,"score_spread":0.2240657403846689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403074281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98184496,0.017460108,0.0001702984,0.000059386726,0.00009825682,0.0001281457,0.00016591743,0.000003123098,0.000069798254],"genre_scores_gemma":[0.99762285,0.002184095,0.00004575057,0.000033376367,0.000047959868,0.000005092774,0.000009349676,0.000011774534,0.00003973907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992599,0.00005716543,0.00030095433,0.00011652861,0.00015162227,0.00011386202],"domain_scores_gemma":[0.99962026,0.0000135340315,0.00012978404,0.000052292493,0.00013939502,0.00004471078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002822086,0.00007426943,0.00019387853,0.000030295781,0.000017852117,0.000028827231,0.00007041797,0.00008703388,0.00005854732],"category_scores_gemma":[0.000017231983,0.0000751888,0.000059621354,0.00007136148,0.00007239332,0.000015428457,0.000012018121,0.0001230183,2.1949461e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019275368,0.00010150439,0.0012471573,0.00017115824,0.00008956359,0.00011784991,0.00035744667,0.000023176788,0.9930355,0.0000061110713,0.00006453394,0.0045932694],"study_design_scores_gemma":[0.0014974828,0.00054026605,0.002816515,0.000573111,0.000045175453,0.0001445606,0.00006431302,0.00009370393,0.99301267,0.00008058754,0.0010332143,0.00009837689],"about_ca_topic_score_codex":0.00009110673,"about_ca_topic_score_gemma":0.0006985529,"teacher_disagreement_score":0.015777897,"about_ca_system_score_codex":0.000046028712,"about_ca_system_score_gemma":0.00019926956,"threshold_uncertainty_score":0.30661103},"labels":[],"label_agreement":null},{"id":"W4404575005","doi":"10.1038/s41416-024-02899-x","title":"Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research","year":2024,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre; Takeda (Canada); University Health Network","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Observational study; Translational research; Stakeholder; Data science; Clinical study design; Management science; Precision medicine; Computer science; Clinical trial; Medicine; Medical physics; Pathology; Engineering; Political science; Public relations","score_opus":0.7331778549258957,"score_gpt":0.592358564171885,"score_spread":0.14081929075401067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404575005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009091774,0.9934836,0.001247996,0.00031085842,0.0009926157,0.0018298439,0.0010384958,0.0000071443233,0.00018025229],"genre_scores_gemma":[0.00005736301,0.9438887,0.04976099,0.00022744294,0.0035145723,0.00077957276,0.00028011194,0.000070374466,0.0014208548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995899,0.0006722224,0.00181092,0.0008303443,0.00032992146,0.00045755424],"domain_scores_gemma":[0.99127066,0.004479561,0.0010401623,0.00022209012,0.0027529749,0.00023457406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006151051,0.00035943187,0.0020227053,0.00028522342,0.00033659552,0.000101446065,0.00044862297,0.00034005832,0.0000022020454],"category_scores_gemma":[0.005036367,0.00032531712,0.0005431148,0.00034686356,0.00038265937,0.00002561271,0.00043625326,0.00058539386,4.5399878e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000975814,0.00024078021,0.00040922355,0.0045106397,0.0032431025,0.000032512075,0.00013807398,0.0006255438,0.000024426869,0.0051480606,0.14969528,0.8349565],"study_design_scores_gemma":[0.00068526156,0.0017869484,0.0008850901,0.0065309717,0.0010020382,0.000050811967,0.00035906903,0.00006907499,0.000007869579,0.0019906939,0.98627657,0.00035558295],"about_ca_topic_score_codex":0.00015471556,"about_ca_topic_score_gemma":0.0047925515,"teacher_disagreement_score":0.8365813,"about_ca_system_score_codex":0.00072353415,"about_ca_system_score_gemma":0.0028301799,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W4404642217","doi":"10.1038/s41416-024-02900-7","title":"Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Medical Research Council; World Cancer Research Fund; Wereld Kanker Onderzoek Fonds; National Cancer Institute; Cancer Research UK; World Cancer Research Fund International; World Health Organization","keywords":"Medicine; Blood lipids; Internal medicine; Diabetes mellitus; Colorectal cancer; Mendelian randomization; Cholesterol; Endocrinology; Cancer; Oncology; Bioinformatics; Biology; Genetics; Genotype; Genetic variants; Gene","score_opus":0.0057676751744467295,"score_gpt":0.25840113006603205,"score_spread":0.25263345489158534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404642217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93083656,0.06596024,0.000110404406,0.00006271671,0.0025490182,0.00021863502,0.00020303366,0.000005258076,0.000054137006],"genre_scores_gemma":[0.97246724,0.022173861,0.00006770166,0.000031552754,0.005045152,0.00003789384,0.000006481024,0.000023930854,0.00014617188],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99899197,0.00007197078,0.00036315358,0.00018790047,0.0002296429,0.00015534337],"domain_scores_gemma":[0.99930865,0.000018757752,0.00028397734,0.000063768595,0.00024177243,0.00008308121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003937673,0.00011516298,0.00029654216,0.000065737826,0.000074686686,0.0000795884,0.000085438085,0.00006054006,0.000025646852],"category_scores_gemma":[0.000040099407,0.000111941365,0.000095166615,0.00010817686,0.000053538257,0.000021632151,0.000027416274,0.00017481188,1.3067695e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023243378,0.00086789887,0.33744618,0.00027544104,0.0075459788,0.00002056404,0.004995692,0.0018531458,0.39272085,0.0000069903003,0.014971406,0.23697151],"study_design_scores_gemma":[0.027357025,0.0015569825,0.78404725,0.0014751867,0.0039647515,0.0006172568,0.0011954099,0.00009688058,0.09425385,0.000041383653,0.08466909,0.0007249551],"about_ca_topic_score_codex":0.0020708772,"about_ca_topic_score_gemma":0.015261084,"teacher_disagreement_score":0.44660103,"about_ca_system_score_codex":0.00003296663,"about_ca_system_score_gemma":0.00030105168,"threshold_uncertainty_score":0.85160434},"labels":[],"label_agreement":null},{"id":"W4404974723","doi":"10.1038/s41416-024-02918-x","title":"Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Clusterin; Sorafenib; Renal cell carcinoma; Cancer research; Carcinoma; Medicine; Oncology; Internal medicine; Apoptosis; Biology; Hepatocellular carcinoma","score_opus":0.03053364576089337,"score_gpt":0.33815987954380083,"score_spread":0.3076262337829075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404974723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781073,0.0029599003,0.0029555282,0.000037539612,0.0057627102,0.00015380656,0.000103389015,0.000007895762,0.00020849853],"genre_scores_gemma":[0.9903473,0.0002606284,0.0008707603,0.000013976585,0.008434843,0.0000060528364,0.0000033066751,0.000025594923,0.000037525584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824476,0.00010769616,0.00072468823,0.00020624546,0.0005171582,0.00019943273],"domain_scores_gemma":[0.99896073,0.00006130992,0.00041244322,0.000108085056,0.00034090976,0.00011650835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035052554,0.00013117715,0.0005509251,0.00019864547,0.00003303481,0.000024871697,0.00009314926,0.00015058964,0.00010069653],"category_scores_gemma":[0.00009345325,0.0001420416,0.00016752906,0.00015356977,0.00019553497,0.00022594727,0.00008375536,0.00042305785,2.8170112e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010726008,0.00021926951,0.0005172969,0.00091224,0.00001743807,0.0010107531,0.00018835004,0.0030952569,0.98942083,0.000007561574,0.0021229668,0.0014154537],"study_design_scores_gemma":[0.0038503075,0.00053944514,0.0073603177,0.010284328,0.00026863918,0.00093816174,0.000073070696,0.009216768,0.9667392,0.000338913,0.00018157969,0.00020930922],"about_ca_topic_score_codex":0.00053738477,"about_ca_topic_score_gemma":0.0001826583,"teacher_disagreement_score":0.022681652,"about_ca_system_score_codex":0.00021257137,"about_ca_system_score_gemma":0.0006685605,"threshold_uncertainty_score":0.5792288},"labels":[],"label_agreement":null},{"id":"W4406823484","doi":"10.1038/s41416-024-02915-0","title":"Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Technische Universität Dresden; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung","keywords":"Pancreatic cancer; Cancer research; Tumor microenvironment; Cell migration; Metastasis; Downregulation and upregulation; Biology; Phenotype; Extracellular vesicles; Cancer cell; Extracellular vesicle; Cancer; Cell; Microvesicles; Medicine; Cell biology; Internal medicine; microRNA; Gene","score_opus":0.004792139690771729,"score_gpt":0.2305673150484834,"score_spread":0.2257751753577117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406823484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.664162,0.33506265,0.0001841714,0.00020344616,0.000115443836,0.00013298131,0.0001013503,0.0000031640038,0.000034809476],"genre_scores_gemma":[0.96810204,0.029864792,0.00064496393,0.00016991766,0.00031219173,0.000025763642,0.00002950259,0.000024487472,0.00082631584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882525,0.00009307115,0.00041059373,0.00027306782,0.0001928922,0.00020511981],"domain_scores_gemma":[0.9993017,0.000013725078,0.0002897004,0.00013651216,0.00011200405,0.0001464148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018172474,0.00015948799,0.00022636335,0.00004607752,0.000097239696,0.00008221182,0.00019358865,0.00011092922,0.000088659974],"category_scores_gemma":[0.00005548745,0.00018593458,0.00010768272,0.00006696663,0.000071420356,0.000018624509,0.00007296592,0.00016758061,0.0000018144054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015232075,0.00012313527,0.008069745,0.00006977793,0.00013349474,0.00011997704,0.000026688702,0.00008001477,0.9701752,0.0000041650037,0.0013931878,0.019652272],"study_design_scores_gemma":[0.0014655048,0.000081586266,0.048684932,0.00061900634,0.00029327025,0.000046479367,0.000054858276,0.00015651225,0.925647,0.00017516846,0.022559214,0.00021643352],"about_ca_topic_score_codex":0.0006168977,"about_ca_topic_score_gemma":0.00054201914,"teacher_disagreement_score":0.30519786,"about_ca_system_score_codex":0.00006445869,"about_ca_system_score_gemma":0.00023834665,"threshold_uncertainty_score":0.7582192},"labels":[],"label_agreement":null},{"id":"W4408253655","doi":"10.1038/s41416-025-02969-8","title":"The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics","year":2025,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Epigenetics; microRNA; Hepatocellular carcinoma; DNA methylation; Biology; Cancer research; Chromatin; Epigenetic therapy; Histone; Cancer; Bioinformatics; Genetics; Gene; Gene expression","score_opus":0.01711381264686379,"score_gpt":0.29949748922974884,"score_spread":0.28238367658288505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408253655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002034904,0.992387,0.0047004363,0.000028865665,0.00037516773,0.0003167868,0.00013801928,8.579464e-7,0.000017992117],"genre_scores_gemma":[0.003856524,0.9950604,0.0006971886,0.000011017362,0.00015333349,0.000032065338,0.000014685159,0.000020700807,0.00015408079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903506,0.00010697137,0.00046459335,0.0001600866,0.00010740501,0.00012590468],"domain_scores_gemma":[0.99907506,0.000070095826,0.00046037315,0.000108057015,0.00023722573,0.000049166625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034494133,0.00013847166,0.00043409894,0.00005710854,0.00014510436,0.000053687472,0.00012293764,0.0001862307,0.0000020228676],"category_scores_gemma":[0.000051981337,0.00011819724,0.00026406362,0.00007325344,0.00008905365,0.0000022073268,0.000048091737,0.0000926582,1.5691626e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018216298,0.000010883287,0.000054420045,0.0012027057,0.00042729772,0.0000027731055,0.0000031439588,0.0000015228154,0.001615669,0.000011700642,0.000041275613,0.9966104],"study_design_scores_gemma":[0.00040504508,0.00023637443,0.00022966316,0.0023970907,0.0016585345,0.00011223466,0.00001738768,0.000026571053,0.006242194,0.00046445485,0.98802924,0.00018118261],"about_ca_topic_score_codex":0.00004581822,"about_ca_topic_score_gemma":0.00008480127,"teacher_disagreement_score":0.9964292,"about_ca_system_score_codex":0.000014203777,"about_ca_system_score_gemma":0.0002918924,"threshold_uncertainty_score":0.48199436},"labels":[],"label_agreement":null},{"id":"W4408519118","doi":"10.1038/s41416-025-02966-x","title":"Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck; AstraZeneca","keywords":"Olaparib; Medicine; BRCA mutation; Oncology; Ovarian cancer; Internal medicine; Germline mutation; Cohort; Cancer; Mutation; Biology; Genetics","score_opus":0.009865581849015198,"score_gpt":0.2956261631054802,"score_spread":0.285760581256465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408519118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98586845,0.007841884,0.0013506865,0.002826536,0.00064623007,0.0005158211,0.00013807151,0.00003911548,0.00077319087],"genre_scores_gemma":[0.9831585,0.011060056,0.0017562216,0.0014050006,0.00015375778,0.00007612424,0.000026445237,0.000034946574,0.0023288936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981003,0.00016694299,0.0007421019,0.0002736076,0.0003897627,0.0003272963],"domain_scores_gemma":[0.9983789,0.0001910687,0.0005530785,0.00011530966,0.0006360859,0.0001256053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048636156,0.00017929816,0.0005722376,0.00021408209,0.0000865387,0.000053428204,0.00005721418,0.00012653605,0.00019441219],"category_scores_gemma":[0.0002150655,0.00016806033,0.00007396397,0.00039673163,0.00013673838,0.00030388864,0.000014923782,0.0005101208,5.198934e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045880567,0.0019615449,0.20314267,0.0020452251,0.0034135876,0.016458876,0.005258516,0.0030663735,0.020420045,0.0010146104,0.08397623,0.6133618],"study_design_scores_gemma":[0.06693385,0.0019515451,0.87745047,0.021821521,0.0005337012,0.006897282,0.0010650442,0.0024442521,0.0071994094,0.0023913342,0.010596783,0.000714783],"about_ca_topic_score_codex":0.0034474465,"about_ca_topic_score_gemma":0.0071548196,"teacher_disagreement_score":0.6743078,"about_ca_system_score_codex":0.0010039127,"about_ca_system_score_gemma":0.0009989502,"threshold_uncertainty_score":0.68533015},"labels":[],"label_agreement":null},{"id":"W4410027641","doi":"10.1038/s41416-025-03029-x","title":"Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; McGill University; Sunnybrook Health Science Centre; University of Manitoba; Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Public Health Ontario; University of British Columbia; McMaster University; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Canada Research Chairs; Kreftforeningen; Cleveland Clinic","keywords":"Breastfeeding; Breast cancer; Parity (physics); Medicine; Breast feeding; Oncology; Obstetrics; Gynecology; Cancer; Internal medicine; Pediatrics","score_opus":0.003493009805482302,"score_gpt":0.24228740530966075,"score_spread":0.23879439550417844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410027641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695016,0.02852271,0.0001942421,0.0009957056,0.00017309116,0.00013187708,0.00034577618,0.0000015352414,0.00013343028],"genre_scores_gemma":[0.9775292,0.02173847,0.00014195032,0.00024461144,0.00015192389,0.00006144331,9.783525e-7,0.0000132789755,0.000118089345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989713,0.00012945686,0.00035671686,0.00017248966,0.00017147264,0.00019857127],"domain_scores_gemma":[0.9991608,0.000029182995,0.0003364341,0.000134344,0.0002851967,0.00005402543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005947474,0.00010648336,0.00026053542,0.00006673397,0.000065012166,0.000048055106,0.0002091953,0.00008286578,0.000058700192],"category_scores_gemma":[0.000045937817,0.000085963955,0.000060394388,0.00021774296,0.00027888163,0.000010523562,0.00007945445,0.00023150313,8.973627e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006418402,0.00014934303,0.46734986,0.00011235308,0.0015507047,0.000103934115,0.00086306734,0.0018118819,0.006365036,0.000051613886,0.0029908477,0.51223296],"study_design_scores_gemma":[0.004659174,0.00011276673,0.9892274,0.0005466838,0.00014644962,0.001462615,0.00017706357,0.000030813404,0.0010747638,0.00041960803,0.00201544,0.00012718946],"about_ca_topic_score_codex":0.0029117763,"about_ca_topic_score_gemma":0.0058961646,"teacher_disagreement_score":0.5218776,"about_ca_system_score_codex":0.00012266557,"about_ca_system_score_gemma":0.00079129974,"threshold_uncertainty_score":0.4401754},"labels":[],"label_agreement":null},{"id":"W4410111629","doi":"10.1038/s41416-025-03025-1","title":"Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"FOLFIRINOX; Gemcitabine; Paclitaxel; Medicine; Adenocarcinoma; Oncology; Neoadjuvant therapy; Internal medicine; Nab-paclitaxel; Induction chemotherapy; Chemotherapy; Oxaliplatin; Cancer","score_opus":0.01697114853347862,"score_gpt":0.33562212314476114,"score_spread":0.3186509746112825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410111629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961533,0.0021606747,0.000028555327,0.00024792415,0.0005035372,0.0006146684,0.00001828051,0.0000073071574,0.00026577187],"genre_scores_gemma":[0.99883825,0.0004347799,0.00023144686,0.00005973356,0.00017089267,0.000041266576,0.000010067196,0.000014681588,0.00019891167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982488,0.00021441738,0.00048294401,0.00023216047,0.00057165074,0.00024998977],"domain_scores_gemma":[0.9986947,0.0001225112,0.00015986274,0.0001365307,0.000720176,0.00016618913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041094047,0.00012968389,0.0005131252,0.00028417207,0.00005405307,0.000054054242,0.00011877782,0.00008790471,0.00013822086],"category_scores_gemma":[0.00033869443,0.00011615009,0.00003927888,0.00026806854,0.00011695888,0.00030364725,0.00004853127,0.00045809514,8.1689655e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017547939,0.0011224513,0.9635131,0.000042425672,0.00050183345,0.0006828532,0.0004093597,0.0000069291796,0.0000134556085,0.0000033830288,0.00004838052,0.016107924],"study_design_scores_gemma":[0.03475083,0.0020241889,0.96022415,0.0007248117,0.00040596444,0.000051964646,0.0015000923,0.00012578614,0.0000057797283,0.000013862644,0.00007731427,0.00009527161],"about_ca_topic_score_codex":0.0018804228,"about_ca_topic_score_gemma":0.005802894,"teacher_disagreement_score":0.01720289,"about_ca_system_score_codex":0.00037371548,"about_ca_system_score_gemma":0.00041169734,"threshold_uncertainty_score":0.4736463},"labels":[],"label_agreement":null},{"id":"W4411231153","doi":"10.1038/s41416-025-03064-8","title":"Association between methylation quantitative trait loci and colorectal cancer risk, survival and cancer recurrence","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Cancer Research UK","keywords":"Colorectal cancer; Oncology; Cancer; Methylation; DNA methylation; Quantitative trait locus; Biology; Internal medicine; Medicine; Genetics; Gene","score_opus":0.01592854420507332,"score_gpt":0.325806770660358,"score_spread":0.3098782264552847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411231153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394206,0.057467397,0.0013136868,0.00090526306,0.00036950738,0.000092088936,0.0003106149,0.000002172001,0.00011869416],"genre_scores_gemma":[0.91750807,0.081150815,0.000598921,0.00008438388,0.00028443924,0.000022259494,0.000015628013,0.000007823419,0.0003276403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888897,0.0002801695,0.00035089068,0.00018309477,0.00012259888,0.0001742561],"domain_scores_gemma":[0.9987956,0.00014878018,0.0005664142,0.000036220477,0.00039332928,0.0000596338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083232345,0.00009505461,0.0002832125,0.000045743804,0.00013230821,0.000036733178,0.00007193788,0.0001758096,0.00002619643],"category_scores_gemma":[0.0006775309,0.00010595559,0.00006058307,0.00010992358,0.00006247346,0.000011474665,0.00003609279,0.00021016912,1.1976883e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004570607,0.000010951708,0.83192587,0.000014928054,0.0005120693,9.342425e-7,0.00006690978,0.00021415038,0.003410051,0.000016856047,0.0036377383,0.16014382],"study_design_scores_gemma":[0.00070779986,0.00011052155,0.9868035,0.000102515245,0.00024795055,0.0000051615752,0.000117292126,0.00008980239,0.0017146457,0.0004384579,0.0095484285,0.00011392758],"about_ca_topic_score_codex":0.0038501674,"about_ca_topic_score_gemma":0.009975113,"teacher_disagreement_score":0.1600299,"about_ca_system_score_codex":0.00010929521,"about_ca_system_score_gemma":0.0002296577,"threshold_uncertainty_score":0.58203274},"labels":[],"label_agreement":null},{"id":"W4411687141","doi":"10.1038/s41416-025-03023-3","title":"Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition network","year":2025,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of British Columbia; McMaster University Medical Centre","funders":"Faculty of Medical and Health Sciences, University of Auckland","keywords":"Medicine; Dosing; Systematic review; MEDLINE; Cochrane Library; Pediatric cancer; Overweight; Meta-analysis; Malnutrition; Cancer; Obesity; Pediatrics; Internal medicine","score_opus":0.00975793712829588,"score_gpt":0.3129931161485618,"score_spread":0.3032351790202659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411687141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090213463,0.993113,0.000027461147,0.0014459753,0.00016599555,0.0038470856,0.00047089843,0.00001185407,0.000015605985],"genre_scores_gemma":[0.00023733394,0.99656564,0.00012984498,0.0016037623,0.0007079011,0.00048254916,0.00018805535,0.000050034898,0.00003488498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99655443,0.00056794536,0.001507838,0.00033877694,0.00068692706,0.00034410393],"domain_scores_gemma":[0.99765944,0.00028396846,0.0014245012,0.00018451831,0.0002732552,0.0001742868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010239577,0.00037311026,0.0033706843,0.00013128063,0.00016268194,0.00015378842,0.00015865479,0.0001652014,0.000041655883],"category_scores_gemma":[0.00006283525,0.0002923612,0.0002674357,0.00057694956,0.00011199257,0.0001753339,0.00003471412,0.0008559772,1.8407376e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011723021,0.00022224154,0.00227437,0.90418637,0.0010923105,0.000030998614,0.000101782935,8.545024e-7,4.1680966e-7,0.0000059453355,0.015672246,0.07629526],"study_design_scores_gemma":[0.002704523,0.0001211072,0.00447789,0.95974517,0.0045104264,0.009082758,0.0000306032,0.0000017076289,3.6003806e-7,0.000016675664,0.019033222,0.00027555923],"about_ca_topic_score_codex":0.002433419,"about_ca_topic_score_gemma":0.0022167314,"teacher_disagreement_score":0.0760197,"about_ca_system_score_codex":0.00046368004,"about_ca_system_score_gemma":0.0008233075,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W4412020425","doi":"10.1038/s41416-025-03093-3","title":"AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research UK; National Cancer Institute; Medical Research Council; University of Edinburgh; Institute of Genetics; Chief Scientist Office","keywords":"Gefitinib; PI3K/AKT/mTOR pathway; Protein kinase B; Epidermal growth factor receptor; EGFR inhibitors; Cancer research; Medicine; Oncology; Cancer; Internal medicine; Biology; Signal transduction","score_opus":0.004327264510138713,"score_gpt":0.2609226785418296,"score_spread":0.2565954140316909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412020425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947597,0.04850762,0.00028361558,0.0005252946,0.0012717652,0.00028777122,0.00008500339,0.0000072480507,0.0014346548],"genre_scores_gemma":[0.99018383,0.00024107669,0.0015447304,0.0015996108,0.0007945809,0.000054378736,0.000006050817,0.00004177332,0.0055339504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794686,0.00008684223,0.0006516787,0.00043554002,0.0003742901,0.00050477544],"domain_scores_gemma":[0.9988778,0.000027976532,0.00020800607,0.0002560944,0.00035504432,0.00027504083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037187713,0.00022830498,0.0003943331,0.0001637465,0.000090102214,0.0000955619,0.000478646,0.00019767732,0.00012599217],"category_scores_gemma":[0.00016217232,0.00028438648,0.00018092517,0.0004168908,0.00004775493,0.000020337802,0.00014912692,0.00034093647,0.000009840864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021640677,0.0003858731,0.051407132,0.00030206767,0.000117085794,0.0014677697,0.00034489363,0.007750587,0.8012999,0.000023530614,0.119893,0.014844073],"study_design_scores_gemma":[0.0035223549,0.0005670209,0.04858475,0.00085495587,0.000057827583,0.000108114844,0.00012127682,0.000013228576,0.77044016,0.00009569122,0.17511064,0.0005239594],"about_ca_topic_score_codex":0.0016475029,"about_ca_topic_score_gemma":0.0033234,"teacher_disagreement_score":0.055217635,"about_ca_system_score_codex":0.00037666113,"about_ca_system_score_gemma":0.00077307795,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4412493537","doi":"10.1038/s41416-025-03117-y","title":"Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"NIHR Cambridge Biomedical Research Centre; European Commission; National Research Foundation Singapore; Fondation du cancer du sein du Québec; National Cancer Institute; National Medical Research Council; National Research Foundation; Canadian Institutes of Health Research; Gray Foundation; Cancer Research UK; Government of Canada; Wellcome Trust; National Institute for Health and Care Research; Genome Canada","keywords":"Ethnic group; Breast cancer; Demography; Population; Ovarian cancer; Risk assessment; Medicine; Gerontology; Cancer; Gynecology; Environmental health; Computer science; Internal medicine; Political science; Sociology","score_opus":0.01439992445351368,"score_gpt":0.2992882903027251,"score_spread":0.2848883658492114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412493537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7278871,0.18927574,0.06950284,0.009505394,0.0019636394,0.00073257985,0.00067307916,0.000008217434,0.0004514255],"genre_scores_gemma":[0.97863597,0.01852891,0.00090550364,0.00084403047,0.0006626494,0.000059757374,0.0000050691724,0.000012181986,0.00034590645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992701,0.00006133944,0.00025901562,0.00014257169,0.00012814262,0.00013887572],"domain_scores_gemma":[0.9992104,0.0000655666,0.00025842251,0.00012497148,0.00030640507,0.000034198685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004742702,0.000079599304,0.000113213064,0.000021504859,0.0003323663,0.00008059834,0.00020691082,0.000079283775,0.00002458288],"category_scores_gemma":[0.00009257859,0.00006062368,0.00009745676,0.00008673939,0.0000854222,0.000011292454,0.000064827174,0.00017744202,6.4265336e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030600317,0.000018409972,0.012150309,0.00002367943,0.0005930099,0.0000032855617,0.00013299016,0.060671262,0.002369152,0.00022865499,0.0155812865,0.90792197],"study_design_scores_gemma":[0.005793407,0.00020324008,0.804882,0.0010553224,0.0017684448,0.000921053,0.0012654731,0.023865724,0.0026225832,0.007999135,0.1490223,0.00060135545],"about_ca_topic_score_codex":0.003377767,"about_ca_topic_score_gemma":0.008472055,"teacher_disagreement_score":0.9073206,"about_ca_system_score_codex":0.00007625987,"about_ca_system_score_gemma":0.00029771804,"threshold_uncertainty_score":0.5106196},"labels":[],"label_agreement":null},{"id":"W4412591591","doi":"10.1038/s41416-025-03123-0","title":"Postdiagnosis physical activity is associated with improved survival in prostate cancer patients treated with surgery but not with radiation therapy","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Radiation therapy; Surgery; Prostate; Oncology; Urology; Cancer; Internal medicine","score_opus":0.010123719431410964,"score_gpt":0.26672569454115513,"score_spread":0.2566019751097442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412591591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996299,0.0017291595,0.0000041682774,0.0009429373,0.00021307213,0.00048351922,0.00023095564,0.000018905577,0.000078257784],"genre_scores_gemma":[0.9938859,0.0048229895,0.0000030432004,0.0006391062,0.00013696766,0.00012408411,0.000020283962,0.000040278497,0.00032739024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842083,0.00012181179,0.00028420947,0.00026759325,0.00057705917,0.00032849988],"domain_scores_gemma":[0.99823284,0.00018350103,0.00045712187,0.00011121185,0.0008883248,0.00012699675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019841878,0.00022329022,0.0007456076,0.00018383564,0.00006943337,0.000072077266,0.000073689494,0.00007535555,0.00004553326],"category_scores_gemma":[0.0000470298,0.00017212909,0.000116424686,0.00076691137,0.00008501494,0.00028813403,0.000009384733,0.00043148155,1.7535449e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008779604,0.0007139238,0.7800447,0.000044496035,0.00062149926,0.0002091476,0.00036101104,0.000019742934,0.00041653085,2.540469e-7,0.0003481382,0.20844099],"study_design_scores_gemma":[0.008583593,0.00093666516,0.96925765,0.002723523,0.00023856718,0.000027187794,0.000091383175,0.000040249495,0.017401917,0.0000014345914,0.00047765917,0.0002201507],"about_ca_topic_score_codex":0.0282234,"about_ca_topic_score_gemma":0.059254438,"teacher_disagreement_score":0.20822084,"about_ca_system_score_codex":0.00067500124,"about_ca_system_score_gemma":0.0011974411,"threshold_uncertainty_score":0.97824776},"labels":[],"label_agreement":null},{"id":"W4412655860","doi":"10.1038/s41416-025-03111-4","title":"Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Sarcoma; Incidence (geometry); Liposarcoma; Retrospective cohort study; Proportional hazards model; Cohort; Oncology; Soft tissue sarcoma; Internal medicine; Single Center; Surgery; Pathology","score_opus":0.01659102603506322,"score_gpt":0.3358464172746656,"score_spread":0.31925539123960234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412655860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775051,0.020553662,0.00009811202,0.0012508915,0.000082704544,0.00011305079,0.00013264989,0.0000026688688,0.0002611506],"genre_scores_gemma":[0.9980003,0.001253402,0.00028070208,0.0003346487,0.000021221724,0.000006539582,0.0000037285386,0.0000058137744,0.000093609386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988802,0.00009954516,0.00045458914,0.00013817048,0.00027974413,0.00014773963],"domain_scores_gemma":[0.99910915,0.0002304074,0.00025161635,0.000080539525,0.00026750087,0.000060814367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003682842,0.00009480978,0.00077914126,0.00033429547,0.000027693197,0.000021530248,0.000052041672,0.000035075536,0.00010230256],"category_scores_gemma":[0.00034258014,0.00008563965,0.0002222497,0.0005750276,0.000058483136,0.00010916309,0.000037820442,0.00014351777,1.4055682e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010244988,0.00087832205,0.9845657,0.00002228787,0.0021080112,0.0005868644,0.00013287523,0.000012216007,0.00006802564,0.00010492905,0.00024497608,0.01117339],"study_design_scores_gemma":[0.0041136127,0.00012879194,0.9926936,0.0005818564,0.0010429325,0.000085775566,0.00020280601,0.000024495048,0.0004884377,0.00019635462,0.00038422307,0.000057096997],"about_ca_topic_score_codex":0.0015998597,"about_ca_topic_score_gemma":0.012798192,"teacher_disagreement_score":0.020495223,"about_ca_system_score_codex":0.00021906538,"about_ca_system_score_gemma":0.00009169336,"threshold_uncertainty_score":0.71416914},"labels":[],"label_agreement":null},{"id":"W4414030845","doi":"10.1038/s41416-025-03158-3","title":"Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dalhousie University; Sunnybrook Health Science Centre; Kingston Health Sciences Centre; Public Health Ontario; Queen's University","funders":"","keywords":"Medicine; Cancer; Interval (graph theory); Oncology; Association (psychology); Internal medicine; Surgery; Psychology; Mathematics","score_opus":0.13350112965896796,"score_gpt":0.47431983917714954,"score_spread":0.3408187095181816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414030845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7998794,0.0022228714,0.0020739946,0.18975122,0.0012568813,0.0024327827,0.00024909864,0.00002378925,0.002109988],"genre_scores_gemma":[0.99337596,0.003382575,0.00021032117,0.00037818783,0.0001831938,0.0013744568,4.1010816e-7,0.000009325925,0.0010855807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856657,0.0002574785,0.00031613946,0.00010517363,0.0005493118,0.0002053465],"domain_scores_gemma":[0.9978045,0.0006031006,0.00036414797,0.00008825037,0.0010949132,0.000045048706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015796274,0.00006348379,0.00018754596,0.00006248825,0.00041879193,0.0001374323,0.0004907676,0.00004599929,0.000050580988],"category_scores_gemma":[0.00062882813,0.000042908858,0.0001083303,0.00044726668,0.00006425643,0.00014154412,0.0000395691,0.00015107097,8.130266e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003682376,0.00046140532,0.22433658,0.00007116917,0.00096189155,0.0000047046515,0.017211093,0.0020857786,0.00005155039,0.0015394527,0.060796537,0.6921116],"study_design_scores_gemma":[0.0057846867,0.0009015335,0.2679818,0.0076147416,0.0008523104,0.000008492386,0.026082901,0.00022332181,0.0050596236,0.008809861,0.6761745,0.0005062028],"about_ca_topic_score_codex":0.017211165,"about_ca_topic_score_gemma":0.1605863,"teacher_disagreement_score":0.6916054,"about_ca_system_score_codex":0.001212265,"about_ca_system_score_gemma":0.0009466027,"threshold_uncertainty_score":0.98933333},"labels":[],"label_agreement":null},{"id":"W4414042072","doi":"10.1038/s41416-025-03140-z","title":"Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Wellcome Trust; Wellcome; U.S. Department of Health and Human Services","keywords":"Albuminuria; Kidney disease; Cancer; Kidney cancer; Disease; Incidence (geometry); Risk factor; MEDLINE","score_opus":0.08808982380877839,"score_gpt":0.38158669503425685,"score_spread":0.29349687122547846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414042072","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39673036,0.5959277,0.000051510175,0.0033607776,0.00017923088,0.00018780824,0.0035057566,0.000013219416,0.000043631146],"genre_scores_gemma":[0.9661084,0.0296555,0.000087825654,0.0029308288,0.00062914076,0.00004534188,0.00016905901,0.000017052695,0.00035688016],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997987,0.00014607237,0.00062236685,0.00036178142,0.0005523716,0.00033042298],"domain_scores_gemma":[0.99750394,0.00006428815,0.0003955744,0.0005050844,0.00025584985,0.0012752754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006768465,0.00017089417,0.0010114562,0.00022572828,0.00013033682,0.00016170497,0.00033880307,0.00005479539,0.002651409],"category_scores_gemma":[0.0005944257,0.00015302928,0.00050745124,0.00045211063,0.00012955596,0.00043325164,0.00019905278,0.000323173,0.0000012009971],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040402744,0.0004963111,0.3894336,0.00047763638,0.45276332,0.000966161,0.00016277612,0.00058662274,0.00009870638,0.000027702703,0.06618892,0.08839424],"study_design_scores_gemma":[0.0016654544,0.00006320188,0.41383627,0.00020880478,0.5635212,0.000019108815,0.000040909046,0.0006135471,0.00006228266,0.000105868516,0.01973697,0.00012636479],"about_ca_topic_score_codex":0.0033770234,"about_ca_topic_score_gemma":0.0052211485,"teacher_disagreement_score":0.569378,"about_ca_system_score_codex":0.00013577218,"about_ca_system_score_gemma":0.0043453653,"threshold_uncertainty_score":0.9982603},"labels":[],"label_agreement":null},{"id":"W4414195648","doi":"10.1038/s41416-025-03181-4","title":"Single-cell multiomic modelling of early metastatic events promoted by the extracellular matrix","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Ministry of Science and ICT, South Korea; Korea Advanced Institute of Science and Technology; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Extracellular matrix; Metastasis; Carcinogenesis; In vitro; Matrix (chemical analysis); Extracellular","score_opus":0.029136422061138565,"score_gpt":0.29651867957370276,"score_spread":0.26738225751256417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8046952,0.17693704,0.017085582,0.00039925548,0.0003388989,0.00029095335,0.000056981433,0.000005515757,0.00019056977],"genre_scores_gemma":[0.9846795,0.005449775,0.0029780648,0.00008157581,0.00009158029,0.000008707457,0.0000031815869,0.000022486927,0.0066851075],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985335,0.00007365229,0.00066531106,0.00013096012,0.00039389695,0.00020267555],"domain_scores_gemma":[0.99889386,0.000055547272,0.0004671567,0.0001385806,0.0003549146,0.000089968664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042781993,0.00011608222,0.0004421275,0.00010014012,0.00005944184,0.000029215305,0.000156001,0.000043313932,0.00017164768],"category_scores_gemma":[0.000029270526,0.00009856264,0.0002483993,0.00026351525,0.00006076305,0.00009703613,0.000021766313,0.00030944755,0.0000013529504],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001524833,0.0018369127,0.0024996833,0.0014630903,0.0017376735,0.00047027695,0.00068155024,0.010251082,0.45087966,0.000030138064,0.01441108,0.51421404],"study_design_scores_gemma":[0.033350047,0.002018747,0.0033576516,0.014663511,0.009234251,0.0028667096,0.0009852655,0.0113780955,0.6887656,0.0011370905,0.23132664,0.0009164079],"about_ca_topic_score_codex":0.0013975366,"about_ca_topic_score_gemma":0.000069995236,"teacher_disagreement_score":0.5132976,"about_ca_system_score_codex":0.00012930208,"about_ca_system_score_gemma":0.0003272933,"threshold_uncertainty_score":0.4019268},"labels":[],"label_agreement":null},{"id":"W4414788238","doi":"10.1038/s41416-025-03150-x","title":"Machine learning-based prediction of luminal breast cancer subtypes using polarised light microscopy","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Optical Polarization and Ellipsometry","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Universiteit Gent; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Princess Margaret Hospital Foundation","keywords":"Breast cancer; Microscopy; Cancer; Human breast; Mammary gland","score_opus":0.005449196015842769,"score_gpt":0.24483597486627168,"score_spread":0.23938677885042892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414788238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8958441,0.06881604,0.030170063,0.00056244683,0.0031788044,0.00014305014,0.0004932086,0.00008761445,0.00070467463],"genre_scores_gemma":[0.9971561,0.0017958756,0.00050687115,0.0000810386,0.0002654485,0.0000013798243,0.000003821993,0.000021298534,0.00016820725],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99916965,0.000029061674,0.00038820456,0.00007521322,0.00018344301,0.00015443024],"domain_scores_gemma":[0.9994984,0.000018885368,0.00012322686,0.00004978799,0.00023740217,0.00007224262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012698736,0.00009256556,0.00022904767,0.00019127743,0.000063949774,0.00004740868,0.000097656586,0.00008764904,0.0002369267],"category_scores_gemma":[0.00002770756,0.000107742475,0.000091140246,0.00037853135,0.00003972048,0.0001464462,0.000009411471,0.00035663013,7.7662094e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026591055,0.00015976204,0.32432878,0.00060555007,0.00045943473,0.0000453869,0.000074916104,0.4139404,0.2144158,0.000024024741,0.0027516792,0.04292835],"study_design_scores_gemma":[0.0050269235,0.00015378384,0.47440228,0.0058886004,0.000663175,0.00040590944,0.00007527557,0.33065477,0.13590059,0.00006495707,0.04623998,0.000523761],"about_ca_topic_score_codex":0.0005777187,"about_ca_topic_score_gemma":0.0001470682,"teacher_disagreement_score":0.15007348,"about_ca_system_score_codex":0.0001562782,"about_ca_system_score_gemma":0.00016378856,"threshold_uncertainty_score":0.43936107},"labels":[],"label_agreement":null},{"id":"W4414861549","doi":"10.1038/s41416-025-03207-x","title":"Lung cancer burden attributable to ambient particulate matter: a nationally representative population-based case-control study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Office of the First Minister and Deputy First Minister; Queen's University; Health and Social Care Research and Development Division; Public Health Agency; Centre for Ageing Research and Development in Ireland; Queen's University Belfast; Wellcome Trust; United Kingdom Clinical Research Collaboration; Economic and Social Research Council; World Health Organization","keywords":"Lung cancer; Particulates; Cancer; Respiratory disease; Lung disease; Air pollution; Air pollutants; Air quality index","score_opus":0.019185132473935253,"score_gpt":0.3581152801409979,"score_spread":0.33893014766706264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414861549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98257726,0.0010189703,0.0022260689,0.012788227,0.00034687488,0.00069835444,0.00015013009,0.000009365523,0.00018472546],"genre_scores_gemma":[0.99122375,0.000037054404,0.00030007891,0.0075281123,0.00012758352,0.00008814711,0.0000014666192,0.000009913649,0.00068388804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981073,0.00023245302,0.00060363056,0.00021655308,0.00052673934,0.00031331513],"domain_scores_gemma":[0.99909824,0.00013715804,0.00030162957,0.00011208109,0.00011729698,0.00023357349],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007879994,0.00010857032,0.00029091237,0.00006959923,0.00027862616,0.00010312147,0.00015623633,0.000042070053,0.0054520825],"category_scores_gemma":[0.00014516484,0.00011761376,0.0000743029,0.0003658225,0.000032188465,0.00028037198,0.000046728685,0.00020006507,0.000018331817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014006264,0.00011927145,0.7578615,0.00002376928,0.00009078084,0.0005677983,0.00049786345,0.2039387,0.000036950973,0.0000032081932,0.026184129,0.010535947],"study_design_scores_gemma":[0.001737107,0.000081218546,0.99157655,0.00029288867,0.00011896459,0.00012296032,0.00023069215,0.0034527453,0.000056228382,0.00006752536,0.002136479,0.00012665735],"about_ca_topic_score_codex":0.05960269,"about_ca_topic_score_gemma":0.024076244,"teacher_disagreement_score":0.23371501,"about_ca_system_score_codex":0.00096554286,"about_ca_system_score_gemma":0.00019722748,"threshold_uncertainty_score":0.99545705},"labels":[],"label_agreement":null},{"id":"W4415067350","doi":"10.1038/s41416-025-03216-w","title":"Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Genome British Columbia; Genome Canada; Scheme for Promotion of Academic and Research Collaboration; AstraZeneca","keywords":"Acquired resistance; Drug resistance; Primary (astronomy); Cancer; Resistance (ecology)","score_opus":0.005566039474640553,"score_gpt":0.23504852688843866,"score_spread":0.22948248741379812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415067350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963947,0.025874961,0.0077111293,0.0009714896,0.0008324362,0.00028826605,0.000016126283,0.0000054817906,0.0003531136],"genre_scores_gemma":[0.99332684,0.0019861818,0.0017119731,0.0021580453,0.00029637304,0.00004828283,0.0000060524867,0.000021907032,0.0004443535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982807,0.00028648687,0.0006094791,0.00027818294,0.00027636957,0.0002687669],"domain_scores_gemma":[0.9991137,0.000031220097,0.0001823848,0.00024813396,0.00030926717,0.00011531735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056204986,0.00016355175,0.00029216902,0.00013416598,0.00014313223,0.0000726508,0.00034672243,0.00014758426,0.000008946974],"category_scores_gemma":[0.00026565342,0.0001503436,0.00013270882,0.0002577702,0.000035674682,0.00001656668,0.00014811865,0.00024972853,0.0000016302181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019490777,0.000055235545,0.00005797699,0.000041505245,0.00005743142,0.00013289702,0.00036254464,0.0009500395,0.9692653,0.000048842023,0.004968382,0.022110762],"study_design_scores_gemma":[0.004362353,0.0010140283,0.006394949,0.0046228236,0.000105433726,0.00019752716,0.0008231978,0.00018228787,0.77320516,0.0041085505,0.2041586,0.0008250886],"about_ca_topic_score_codex":0.00013496478,"about_ca_topic_score_gemma":0.0024302779,"teacher_disagreement_score":0.19919021,"about_ca_system_score_codex":0.00011988327,"about_ca_system_score_gemma":0.00045984966,"threshold_uncertainty_score":0.6130834},"labels":[],"label_agreement":null},{"id":"W4415242909","doi":"10.1038/s41416-025-03176-1","title":"Correction: Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis","year":2025,"lang":"en","type":"erratum","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Single Center; Retrospective cohort study; Incidence (geometry); Cumulative incidence; Survival analysis; Center (category theory)","score_opus":0.008666260954167565,"score_gpt":0.2912496759025512,"score_spread":0.2825834149483836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415242909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65936106,0.24689662,0.0065507777,0.002424111,0.05830301,0.0012836097,0.0064540687,0.00002347042,0.018703284],"genre_scores_gemma":[0.9212874,0.012066541,0.00024480277,0.00048254317,0.00097470894,0.000016949341,0.00039904364,0.000033064127,0.06449491],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985064,0.00020557416,0.00057672994,0.00024755098,0.00030212078,0.0001615793],"domain_scores_gemma":[0.99861336,0.000037739064,0.00069365517,0.00012214416,0.00047809686,0.000055019827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043323997,0.000165424,0.0007094795,0.00028418176,0.000042354197,0.000042409505,0.00015237284,0.00021699414,0.00007399903],"category_scores_gemma":[0.0007631687,0.00017784478,0.0002949957,0.00040440483,0.000082816696,0.000016450977,0.000101121776,0.00042274213,8.176769e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018100804,0.0003770197,0.36505562,0.00008682018,0.0029678044,0.00010280703,0.00007929566,0.00005014764,0.001244262,0.000014312932,0.6217602,0.008080734],"study_design_scores_gemma":[0.0032368717,0.0005574902,0.6923003,0.0018039511,0.0009561563,0.00016525379,0.00026862096,0.000092471855,0.007727338,0.000092229144,0.2922542,0.00054506736],"about_ca_topic_score_codex":0.00070476445,"about_ca_topic_score_gemma":0.019664796,"teacher_disagreement_score":0.32950595,"about_ca_system_score_codex":0.000103662336,"about_ca_system_score_gemma":0.00029400096,"threshold_uncertainty_score":0.9982238},"labels":[],"label_agreement":null},{"id":"W4416745819","doi":"10.1038/s41416-025-03291-z","title":"Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Cardiff University; Cancer Research UK","keywords":"Pathological; Cancer; Correlation; Clinical trial; Radiation therapy; Randomized controlled trial","score_opus":0.017806048284632902,"score_gpt":0.3358578400001948,"score_spread":0.3180517917155619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416745819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95926106,0.038494155,0.00007207224,0.0008154105,0.0003792492,0.0006007832,0.00002254371,0.000008642715,0.00034610133],"genre_scores_gemma":[0.9912488,0.007833938,0.00004187958,0.00031262322,0.00038758857,0.000057456502,0.0000035730445,0.000011858334,0.00010226964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837923,0.00017823599,0.0007334145,0.00022621185,0.0002445079,0.00023840221],"domain_scores_gemma":[0.9992931,0.0001484658,0.0002027303,0.000056537432,0.00021017285,0.00008900891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050831214,0.00013955605,0.00085699104,0.00023571895,0.00008711947,0.000028741086,0.00004705978,0.000101394595,0.00007287751],"category_scores_gemma":[0.00018531198,0.00013267831,0.00010605041,0.000281766,0.00012198392,0.00013537862,0.00003024329,0.0005578458,1.9964007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120194025,0.00029715517,0.43648884,0.000114335446,0.00016819607,0.004616892,0.00067515415,0.000032209355,0.016859801,0.000009307381,0.0008612745,0.41968283],"study_design_scores_gemma":[0.21018054,0.00033204514,0.7853904,0.002845007,0.00014487338,0.00014549852,0.00007137023,0.000060161477,0.00047784287,0.000099844525,0.00015156077,0.00010085821],"about_ca_topic_score_codex":0.0016192361,"about_ca_topic_score_gemma":0.002112388,"teacher_disagreement_score":0.41958195,"about_ca_system_score_codex":0.0002855934,"about_ca_system_score_gemma":0.0002631821,"threshold_uncertainty_score":0.54104644},"labels":[],"label_agreement":null},{"id":"W4417156739","doi":"10.1038/s41416-025-03287-9","title":"Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Natural Science Foundation of Heilongjiang Province; National Natural Science Foundation of China; Harbin Medical University","keywords":"Breast cancer; Endocrine system; Mammary gland; Oestrogen receptor; Key (lock); Cancer","score_opus":0.013944085488671354,"score_gpt":0.3942441363294163,"score_spread":0.3803000508407449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417156739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703236,0.015889565,0.00020441892,0.0116632385,0.00026746927,0.00054774794,0.0003041128,0.000017283517,0.00078252825],"genre_scores_gemma":[0.99330604,0.0014433204,0.00038050732,0.0023200708,0.00020122882,0.00008741014,0.000006249071,0.000046650144,0.00220853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99706584,0.00045534072,0.0005792117,0.0003421466,0.0010238414,0.0005336419],"domain_scores_gemma":[0.9976596,0.00020177063,0.0002583828,0.00019232639,0.0013606397,0.00032722807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008769354,0.00021660393,0.00074321165,0.00051438867,0.00008103661,0.00009434454,0.00025798185,0.00014683582,0.00031078636],"category_scores_gemma":[0.0007782689,0.00021191598,0.00016159499,0.0013281208,0.00012159884,0.00014432293,0.000065607695,0.00095742836,0.0000017389366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06494402,0.00081064977,0.17361134,0.00026015815,0.002385751,0.022361498,0.00087167724,0.0067021046,0.1366696,0.000010479821,0.029710174,0.56166255],"study_design_scores_gemma":[0.0050134147,0.00064095395,0.96014297,0.013575813,0.00023041418,0.00086882024,0.0001574962,0.00001770398,0.016382307,0.000024356234,0.0027222682,0.00022347555],"about_ca_topic_score_codex":0.0132601345,"about_ca_topic_score_gemma":0.028258117,"teacher_disagreement_score":0.7865316,"about_ca_system_score_codex":0.0018759056,"about_ca_system_score_gemma":0.0027589214,"threshold_uncertainty_score":0.99331063},"labels":[],"label_agreement":null},{"id":"W4417180871","doi":"10.1038/s41416-025-03283-z","title":"RNLS hypomethylation as a potential epigenetic marker of lung cancer metastasis: an epigenome-wide association study","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Lung cancer; DNA methylation; Biomarker; Methylation; Cancer; Epigenesis","score_opus":0.006221083234359233,"score_gpt":0.30815077420217146,"score_spread":0.30192969096781225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417180871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91190267,0.08358525,0.0032275,0.00015853098,0.0006080022,0.0002868817,0.00004801866,0.0000031989473,0.0001799473],"genre_scores_gemma":[0.983611,0.014912568,0.00032130774,0.00012399635,0.00031608058,0.000030286397,0.000016828866,0.000021729544,0.0006461861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980648,0.0003363875,0.00071714167,0.0002419838,0.0004173958,0.0002222515],"domain_scores_gemma":[0.99802065,0.00004471065,0.0007756952,0.00017033149,0.00089792215,0.00009067714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010762588,0.0001424886,0.00033170555,0.00015297347,0.00009727586,0.0000664037,0.00021090591,0.000150499,0.00013035627],"category_scores_gemma":[0.00040515157,0.00016643455,0.00017662511,0.00024791394,0.000028401604,0.000022369979,0.000053012744,0.00016102339,4.091363e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028866596,0.00042336484,0.71746236,0.000056477606,0.0011832946,0.00002042246,0.00012927307,0.0051924116,0.16884838,0.0000039969677,0.00055194873,0.105839424],"study_design_scores_gemma":[0.001817988,0.00056029984,0.9094228,0.00016317231,0.00065575214,0.000003102425,0.00017410846,0.000083429826,0.08036657,0.0004027317,0.0061229086,0.0002271376],"about_ca_topic_score_codex":0.0011493837,"about_ca_topic_score_gemma":0.0017968399,"teacher_disagreement_score":0.19196045,"about_ca_system_score_codex":0.00014162369,"about_ca_system_score_gemma":0.00044917496,"threshold_uncertainty_score":0.6787004},"labels":[],"label_agreement":null},{"id":"W4417457436","doi":"10.1038/s41416-025-03296-8","title":"Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Hazard ratio; Hepatocellular carcinoma; Circulating tumor DNA; Meta-analysis; Confidence interval; Prospective cohort study; Minimal residual disease; Cochrane Library; Retrospective cohort study","score_opus":0.02065616346553874,"score_gpt":0.311864347715507,"score_spread":0.29120818424996825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417457436","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4731377,0.52536017,0.00063401257,0.00024249658,0.000024710816,0.00036943698,0.00022352762,5.5507155e-7,0.0000074001787],"genre_scores_gemma":[0.9533219,0.04559028,0.0005238286,0.00034754685,0.000040241073,0.000121102625,0.000010361139,0.000007232992,0.000037510497],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99890685,0.0001112113,0.0005391659,0.00020924234,0.00010490439,0.00012865085],"domain_scores_gemma":[0.99915296,0.00007228469,0.00038468774,0.00011277658,0.00018742443,0.00008987667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064591254,0.00010577808,0.00076691544,0.000072721574,0.000057220182,0.00006539954,0.000090872025,0.000036755893,0.000006143457],"category_scores_gemma":[0.00041987305,0.00010546227,0.00028536443,0.00013749785,0.00003360634,0.0000060278285,0.000054029624,0.000093693845,1.7028274e-8],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056717714,0.0005638291,0.5904852,0.27727503,0.11161608,0.0012877965,0.0001897778,0.0011583463,0.0070836586,0.00032786586,0.005612693,0.0038325624],"study_design_scores_gemma":[0.002835123,0.00031893497,0.2202502,0.008247289,0.76317614,0.00028419777,0.00014891768,0.0020580543,0.00082013244,0.0006054937,0.0005744039,0.00068109],"about_ca_topic_score_codex":0.00021199467,"about_ca_topic_score_gemma":0.00059548736,"teacher_disagreement_score":0.65156007,"about_ca_system_score_codex":0.00003886098,"about_ca_system_score_gemma":0.00029241515,"threshold_uncertainty_score":0.43006265},"labels":[],"label_agreement":null},{"id":"W61689417","doi":"10.1054/bjoc.2001.2090","title":"Neurodevelopment of children exposed in utero to treatment of maternal malignancy","year":2001,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"In utero; Pregnancy; Medicine; Gestation; Malignancy; Fetus; Cancer; Obstetrics; Pediatrics; Pathology; Internal medicine","score_opus":0.04197365772468709,"score_gpt":0.3453487714311606,"score_spread":0.3033751137064735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W61689417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094246656,0.9045205,0.0000060992393,0.000018668798,0.0003783307,0.00056402426,0.00016909881,0.0000028905638,0.00009373755],"genre_scores_gemma":[0.002472141,0.996479,0.0002927638,0.000028612047,0.00031325273,0.00003124345,0.0000096116,0.000045418237,0.00032798044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759245,0.000043102144,0.00151574,0.00019606724,0.00042103478,0.00023160406],"domain_scores_gemma":[0.99844587,0.000019490826,0.0010445153,0.00015124567,0.00015987926,0.0001790022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011416547,0.00025738621,0.002347361,0.00034972263,0.000011292206,0.00001442966,0.00016306933,0.00012005067,0.0004163249],"category_scores_gemma":[0.000013031813,0.00022363622,0.0005394175,0.0003041332,0.000030215804,0.00004601486,0.000024919089,0.0001938313,0.000001472552],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008087185,0.0002681617,0.011613193,0.0016511936,0.0003545268,0.0011195632,0.000084309446,0.0000033891167,0.000008260734,3.3932437e-7,0.00021826559,0.9845979],"study_design_scores_gemma":[0.0026700825,0.0010785218,0.14521725,0.0902434,0.0009132272,0.009456881,0.00000880627,1.06758336e-7,0.0001514154,0.000002345696,0.7500226,0.00023539238],"about_ca_topic_score_codex":0.0029351288,"about_ca_topic_score_gemma":0.00093807233,"teacher_disagreement_score":0.98436254,"about_ca_system_score_codex":0.0005915785,"about_ca_system_score_gemma":0.0009038969,"threshold_uncertainty_score":0.91196203},"labels":[],"label_agreement":null},{"id":"W7640235","doi":"10.1038/bjc.1995.358","title":"귀납적 방식과 연역적 방식의 기술자료가 중학생들의 생물 지식 구성에 미치는 영향","year":2008,"lang":"en","type":"dissertation","venue":"British Journal of Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.014185161097180269,"score_gpt":0.32846176431068486,"score_spread":0.3142766032135046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7640235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82496196,0.1582758,0.000012289066,0.0002989128,0.0055444487,0.00032282996,0.00018542113,0.000033387078,0.010364963],"genre_scores_gemma":[0.6077937,0.32618868,0.00019188225,0.00096906885,0.0073064133,0.000036218822,0.00033264165,0.00021345993,0.05696798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972856,0.00003676249,0.0009664596,0.000299689,0.0010034846,0.0004080195],"domain_scores_gemma":[0.99753773,0.000036126512,0.001025689,0.00019826938,0.00081834017,0.00038386037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017426019,0.0003294895,0.0010707978,0.0002535708,0.00014053812,0.00008931188,0.00023236651,0.00041969842,0.0024990223],"category_scores_gemma":[0.000097862074,0.0003554117,0.00063426694,0.00023514636,0.00006978787,0.00019428684,0.000013341457,0.0013750383,0.000022183403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014544945,0.00024537995,0.014722154,0.0006037876,0.00093929545,0.005377461,0.0009830794,0.000020960699,0.0010793853,0.000007880265,0.2538213,0.7207448],"study_design_scores_gemma":[0.003428303,0.00039681743,0.33167154,0.0068558636,0.00081477844,0.008027332,0.00058480253,0.000004195157,0.0009807659,0.000053022686,0.6466756,0.0005069842],"about_ca_topic_score_codex":0.004169042,"about_ca_topic_score_gemma":0.011067879,"teacher_disagreement_score":0.72023785,"about_ca_system_score_codex":0.000532667,"about_ca_system_score_gemma":0.0016206584,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null}]}